PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kuwabara, MF; Wasano, K; Takahashi, S; Bodner, J; Komori, T; Uemura, S; Zheng, J; Shima, T; Homma, K				Kuwabara, Makoto F.; Wasano, Koichiro; Takahashi, Satoe; Bodner, Justin; Komori, Tomotaka; Uemura, Sotaro; Zheng, Jing; Shima, Tomohiro; Homma, Kazuaki			The extracellular loop of pendrin and prestin modulates their voltage-sensing property	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; molecular motor; electrophysiology; anion transport; cell motility; electromotility; SLC26	OUTER HAIR CELL; ENLARGED VESTIBULAR AQUEDUCT; NONSYNDROMIC HEARING-LOSS; MOTOR PROTEIN; GUINEA-PIG; MOTILITY; MUTATIONS; TRANSPORTER; DEPENDENCE; ZEBRAFISH	Pendrin and prestin belong to the solute carrier 26 (SLC26) family of anion transporters. Prestin is unique among the SLC26 family members in that it displays voltage-driven motor activity (electromotility) and concurrent gating currents that manifest as nonlinear cell membrane electrical capacitance (nonlinear capacitance (NLC)). Although the anion transport mechanism of the SLC26 proteins has begun to be elucidated, the molecular mechanism of electromotility, which is thought to have evolved from an ancestral ion transport mechanism, still remains largely elusive. Here, we demonstrate that pendrin also exhibits large NLC and that charged residues present in one of the extracellular loops of pendrin and prestin play significant roles in setting the voltage-operating points of NLC. Our results suggest that the molecular mechanism responsible for sensing voltage is not unique to prestin among the members of the SLC26 family and that this voltage-sensing mechanism works independently of the anion transport mechanism.	[Kuwabara, Makoto F.; Komori, Tomotaka; Uemura, Sotaro; Shima, Tomohiro] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Wasano, Koichiro; Takahashi, Satoe; Zheng, Jing; Homma, Kazuaki] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, 303 E Chicago Ave, Chicago, IL 60611 USA; [Bodner, Justin] Depaul Univ, Chicago, IL 60614 USA; [Zheng, Jing; Homma, Kazuaki] Northwestern Univ, Hugh Knowles Ctr Clin & Basic Sci Hearing & Its D, Chicago, IL 60608 USA	University of Tokyo; Northwestern University; Feinberg School of Medicine; DePaul University; Northwestern University	Shima, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.; Homma, K (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol Head & Neck Surg, 303 E Chicago Ave, Chicago, IL 60611 USA.	tomohiro.shima@bs.s.u-tokyo.ac.jp; k-homma@northwestern.edu	Wasano, Koichiro/AAY-1414-2020	Homma, Kazuaki/0000-0002-4440-2277; Wasano, Koichiro/0000-0001-7335-3622; Bodner, Justin/0000-0001-7369-7724	National Institutes of Health [DC014553]; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology Grant [JPMJCR14W1]; Ministry of Education, Culture, Sports, Science and Technology, Japan [15K18514, 17K15100]; Hugh Knowles Center; University of Tokyo; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC014553, R56DC011813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Science and Technology Agency, Core Research for Evolutional Science and Technology Grant; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hugh Knowles Center; University of Tokyo; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health Grant DC014553 (to K. H.); Japan Science and Technology Agency, Core Research for Evolutional Science and Technology Grant JPMJCR14W1 (to S. U.); Ministry of Education, Culture, Sports, Science and Technology, Japan Grants 15K18514 (to T. S.) and 17K15100 (to T. K.); and the Hugh Knowles Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Ashmore J. F, 1990, NEUROSCI RES       S, V12, pS39, DOI DOI 10.1016/0921-8696(90)90007-P; Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Beurg M, 2013, NEURON, V79, P69, DOI 10.1016/j.neuron.2013.05.018; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chai YC, 2013, AM J MED GENET A, V161, P2226, DOI 10.1002/ajmg.a.36068; Chang YN, 2017, BIOL CHEM, V398, P165, DOI 10.1515/hsz-2016-0254; Dai P, 2009, PHYSIOL GENOMICS, V38, P281, DOI 10.1152/physiolgenomics.00047.2009; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Deak L, 2005, J PHYSIOL-LONDON, V563, P483, DOI 10.1113/jphysiol.2004.078857; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Geertsma ER, 2015, NAT STRUCT MOL BIOL, V22, P803, DOI 10.1038/nsmb.3091; Gorbunov D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4622; Grandori R, 1997, PROTEIN ENG, V10, P1099, DOI 10.1093/protein/10.9.1099; Homma K, 2013, J BIOL CHEM, V288, P2452, DOI 10.1074/jbc.M112.411579; Homma K, 2011, J BIOL CHEM, V286, P2297, DOI 10.1074/jbc.M110.185694; Homma K, 2010, BBA-BIOMEMBRANES, V1798, P1029, DOI 10.1016/j.bbamem.2010.02.001; KAKEHATA S, 1995, BIOPHYS J, V68, P2190, DOI 10.1016/S0006-3495(95)80401-7; Keller JP, 2014, J NEUROSCI, V34, P1325, DOI 10.1523/JNEUROSCI.4020-13.2014; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim M, 2011, INT J PEDIATR OTORHI, V75, P1538, DOI 10.1016/j.ijporl.2011.09.002; Kowarz E, 2015, BIOTECHNOL J, V10, P647, DOI 10.1002/biot.201400821; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Mistrik P, 2012, J PHYSIOL-LONDON, V590, P5597, DOI 10.1113/jphysiol.2012.241448; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D., 2006, NOVART FDN SYMP, V273, P261; Oliver D., 2006, NOVART FDN SYMP, V273, P253; Oliver Dominik, 2006, Novartis Found Symp, V273, P244; Park HJ, 2005, CLIN GENET, V67, P160, DOI 10.1111/j.1399-0004.2004.00386.x; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rybalchenko V, 2003, J PHYSIOL-LONDON, V547, P873, DOI 10.1113/jphysiol.2002.036434; Rybalchenko V, 2008, BIOPHYS J, V95, P4439, DOI 10.1529/biophysj.108.134197; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Schaechinger TJ, 2011, EMBO J, V30, P2793, DOI 10.1038/emboj.2011.202; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sloan-Heggen CM, 2016, HUM GENET, V135, P441, DOI 10.1007/s00439-016-1648-8; Sloan-Heggen CM, 2015, J MED GENET, V52, P823, DOI 10.1136/jmedgenet-2015-103389; Tan XD, 2012, J CELL SCI, V125, P1039, DOI 10.1242/jcs.097337; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054388; Tang J, 2011, J BIOL CHEM, V286, P31014, DOI 10.1074/jbc.M111.259564; Taylor JP, 2002, J CLIN ENDOCR METAB, V87, P1778, DOI 10.1210/jc.87.4.1778; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Yao GD, 2013, ACTA OTO-LARYNGOL, V133, P833, DOI 10.3109/00016489.2013.777160; Yuan YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049984	52	11	11	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9970	9980		10.1074/jbc.RA118.001831	http://dx.doi.org/10.1074/jbc.RA118.001831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29777056	hybrid, Green Published			2022-12-26	WOS:000437096700004
J	Arshad, N; Cresswell, P				Arshad, Najla; Cresswell, Peter			Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						major histocompatibility complex (MHC); antigen presentation; antigen processing; protein export; tumor immunology; immunotherapy; calreticulin; myeloproliferative neoplasms; peptide-loading complex; protein secretion	MAJOR HISTOCOMPATIBILITY COMPLEX; MUTANT MYELOPROLIFERATIVE NEOPLASMS; THROMBOPOIETIN RECEPTOR; CANCER-IMMUNOTHERAPY; SOMATIC MUTATIONS; HLA-B; MOLECULES; TAPASIN; CELLS; MECHANISM	Major histocompatibility complex-I-(2)m dimers (MHC-I) bind peptides derived from intracellular proteins, enabling the immune system to distinguish between normal cells and those expressing pathogen-derived or mutant proteins. The peptides bind to MHC-I in the endoplasmic reticulum (ER), and this binding is facilitated by the peptide loading complex (PLC), which contains calreticulin (CRT). CRT associates with MHC-I via a conserved glycan present on MHC-I and recruits it to the PLC for peptide binding. Somatic frameshift mutations in CRT (CRT-FS) drive the proliferation of a subset of myeloproliferative neoplasms, which are chronic blood tumors. All CRT-FS proteins have a C-terminal sequence lacking the normal ER-retention signal and possessing a net negative charge rather than the normal positive charge. We characterized the effect of CRT-FS on antigen presentation by MHC-I in human cells. Our results indicate that CRT-FS cannot mediate CRT's peptide loading function in the PLC. Cells lacking CRT exhibited reduced surface MHC-I levels, consistent with reduced binding of high-affinity peptides, and this was not reversed by CRT-FS expression. CRT-FS was secreted and not detectably associated with the PLC, leading to poor MHC-I recruitment, although CRT-FS could still associate with MHC-I in a glycan-dependent manner. The addition of an ER-retention sequence to CRT-FS restored its association with the PLC but did not rescue MHC-I recruitment or its surface expression, indicating that the CRT-FS mutants functionally compromise the PLC. MHC-I down-regulation permits tumor cells to evade immune surveillance, and these findings may therefore be relevant for designing effective immunotherapies for managing myeloproliferative neoplasms.	[Arshad, Najla; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Cresswell, Peter] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University	Arshad, N; Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA.	najla.arshad@yale.edu; peter.cresswell@yale.edu	Arshad, Najla/H-9453-2019	Arshad, Najla/0000-0001-5553-311X	National Institutes of Health Grant [RO1-AI097206]; CRI Irvington Postdoctoral Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097206] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRI Irvington Postdoctoral Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant RO1-AI097206 (to P.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the CRI Irvington Postdoctoral Fellowship Program.	Al-Akhrass H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01172-5; Araki M, 2017, CANCER SCI, V108, P1907, DOI 10.1111/cas.13327; Araki M, 2016, BLOOD, V127, P1307, DOI 10.1182/blood-2015-09-671172; Barkal AA, 2018, NAT IMMUNOL, V19, P76, DOI 10.1038/s41590-017-0004-z; BARNSTABLE CJ, 1978, BRIT MED BULL, V34, P241, DOI 10.1093/oxfordjournals.bmb.a071504; Beatty GL, 2015, CLIN CANCER RES, V21, P687, DOI 10.1158/1078-0432.CCR-14-1860; Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Byrne JC, 2013, J IMMUNOL, V190, P5207, DOI 10.4049/jimmunol.1300057; Cathro HP, 2010, CANCER IMMUNOL IMMUN, V59, P465, DOI 10.1007/s00262-009-0765-9; Chachoua I, 2016, BLOOD, V127, P1325, DOI 10.1182/blood-2015-11-681932; Cooper A, 2006, J BIOL CHEM, V281, P16563, DOI 10.1074/jbc.M601418200; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Dierssen JWF, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-33; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Elf S, 2016, CANCER DISCOV, V6, P368, DOI 10.1158/2159-8290.CD-15-1434; Everett MW, 2007, J IMMUNOL, V179, P7646, DOI 10.4049/jimmunol.179.11.7646; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Gao B, 2002, IMMUNITY, V16, P99, DOI 10.1016/S1074-7613(01)00260-6; Garbati MR, 2016, AM J HEMATOL, V91, P211, DOI 10.1002/ajh.24245; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Guo D., 2015, J INTEGRATIVE BIOINF, V12, P35; Han LJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0275-0; Hermouet S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/145293; Hofmann S, 2011, CURR CANCER DRUG TAR, V11, P72, DOI 10.2174/156800911793743682; Holmstrom MO, 2018, LEUKEMIA, V32, P429, DOI 10.1038/leu.2017.214; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Jiang JS, 2017, SCIENCE, V358, P1064, DOI 10.1126/science.aao5154; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; Leonhardt RM, 2007, INFECT IMMUN, V75, P5105, DOI 10.1128/IAI.00668-07; Leonhardt RM, 2010, J IMMUNOL, V184, P2985, DOI 10.4049/jimmunol.0900308; Li J, 2018, BLOOD, V131, P649, DOI 10.1182/blood-2017-09-806356; Liu CZ, 2010, BBA-MOL CELL RES, V1803, P544, DOI 10.1016/j.bbamcr.2010.03.001; Liu HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002690; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Nagler E, 2017, TRANSL CANCER RES, V6, P86, DOI 10.21037/tcr.2017.02.14; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Panter MS, 2012, J BIOL CHEM, V287, P31172, DOI 10.1074/jbc.M112.387704; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; Patel U, 2017, CL LYMPH MYELOM LEUK, V17, pS62, DOI 10.1016/j.clml.2017.02.015; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pietra D, 2016, LEUKEMIA, V30, P431, DOI 10.1038/leu.2015.277; Pocanschi CL, 2011, J BIOL CHEM, V286, P27266, DOI 10.1074/jbc.M111.258467; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Shide K, 2017, LEUKEMIA, V31, P1136, DOI 10.1038/leu.2016.308; Sim ACN, 2013, SCI REP-UK, V3, DOI 10.1038/srep03232; Stahlschmidt W, 2014, J BIOL CHEM, V289, P4906, DOI 10.1074/jbc.M113.535211; STAM NJ, 1986, J IMMUNOL, V137, P2299; Theocharides APA, 2016, BLOOD, V127, P3253, DOI 10.1182/blood-2016-02-696310; Thomas C, 2017, SCIENCE, V358, P1060, DOI 10.1126/science.aao6001; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108	60	41	41	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9555	9569		10.1074/jbc.RA118.002836	http://dx.doi.org/10.1074/jbc.RA118.002836			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29769311	Green Published, hybrid			2022-12-26	WOS:000436102300001
J	Hamlin, AN; Chinnarasu, S; Ding, YY; Xian, XD; Herz, J; Jaeschke, A; Hui, DY				Hamlin, Allyson N.; Chinnarasu, Sivaprakasam; Ding, Yinyuan; Xian, Xunde; Herz, Joachim; Jaeschke, Anja; Hui, David Y.			Low-density lipoprotein receptor-related protein-1 dysfunction synergizes with dietary cholesterol to accelerate steatohepatitis progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoprotein receptor; liver metabolism; lipoprotein receptor-related protein (LPR); fibrosis; cholesterol metabolism; inflammation	FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; MICE; INFLAMMATION; EXPRESSION; GENE; LRP	Reduced low-density lipoprotein receptor-related protein-1 (LRP1) expression in the liver is associated with poor prognosis of liver cirrhosis and hepatocellular carcinoma. Previous studies have shown that hepatic LRP1 deficiency exacerbates palmitate-induced steatosis and toxicity in vitro and also promotes high-fat diet-induced hepatic insulin resistance and hepatic steatosis in vivo. The current study examined the impact of liver-specific LRP1 deficiency on disease progression to steatohepatitis. hLrp1(+/+) mice with normal LRP1 expression and hLrp1(-/-) mice with hepatocyte-specific LRP1 inactivation were fed a high-fat, high-cholesterol (HFHC) diet for 16 weeks. Plasma lipid levels and body weights were similar between both groups. However, the hLrp1(-/-) mice displayed significant increases in liver steatosis, inflammation, and fibrosis compared with the hLrp1(+/+) mice. Hepatocyte cell size, liver weight, and cell death, as measured by serum alanine aminotransferase levels, were also significantly increased in hLrp1(-/-) mice. The accelerated liver pathology observed in HFHC-fed hLrp1(-/-) mice was associated with reduced expression of cholesterol excretion and bile acid synthesis genes, leading to elevated immune cell infiltration and inflammation. Additional in vitro studies revealed that cholesterol loading induced significantly higher expression of genes responsible for hepatic stellate cell activation and fibrosis in hLrp1(-/-) hepatocytes than in hLrp1(+/+) hepatocytes. These results indicate that hepatic LRP1 deficiency accelerates liver disease progression by increasing hepatocyte death, thereby causing inflammation and increasing sensitivity to cholesterol-induced pro-fibrotic gene expression to promote steatohepatitis. Thus, LRP1 may be a genetic variable that dictates individual susceptibility to the effects of dietary cholesterol on liver diseases.	[Hamlin, Allyson N.] Univ Cincinnati, Coll Med, Dept Pharmacol & Cell Biophys, Metab Dis Res Ctr, Cincinnati, OH 45237 USA; [Chinnarasu, Sivaprakasam; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Metab Dis Res Ctr, Cincinnati, OH 45237 USA; [Ding, Yinyuan; Xian, Xunde; Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas Southwestern Med Ctr Dallas, Dept Neurotherapeut, Dallas, TX 75390 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Metab Dis Res Ctr, Dept Pathol, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	huidy@ucmail.uc.edu	Xian, Xunde/B-9490-2012; Chinnarasu, Sivaprakasam/AAU-4373-2020	Xian, Xunde/0000-0003-3059-1254; COJANDARAJ, Dr LOUIS/0000-0002-5264-6546; Ding, Yinyuan/0000-0003-4918-8457	National Institutes of Health Grants [RO1 DK074932, R37 HL63762, RO1 NS093382, 1RF1 AG053391]; Consortium for Frontotemporal Dementia Research; Bright Focus Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK074932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS093382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG053391] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consortium for Frontotemporal Dementia Research; Bright Focus Foundation(BrightFocus Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants RO1 DK074932 (to D.Y.H.) and R37 HL63762, RO1 NS093382, and 1RF1 AG053391 (to J.H.) and by the Consortium for Frontotemporal Dementia Research and the Bright Focus Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basford JE, 2011, J BIOL CHEM, V286, P13079, DOI 10.1074/jbc.M111.229369; Day CP, 2011, CLIN MED, V11, P176, DOI 10.7861/clinmedicine.11-2-176; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Ding YY, 2016, EBIOMEDICINE, V7, P135, DOI 10.1016/j.ebiom.2016.04.002; Ferrell JM, 2016, J LIPID RES, V57, P1144, DOI 10.1194/jlr.M064709; Hamlin AN, 2016, J BIOL CHEM, V291, P16610, DOI 10.1074/jbc.M116.717744; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Huang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032775; Ioannou GN, 2009, HEPATOLOGY, V50, P175, DOI 10.1002/hep.22941; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kneeman JM, 2012, THER ADV GASTROENTER, V5, P199, DOI 10.1177/1756283X11430859; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Machado MV, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060857; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; NISHINA PM, 1993, J LIPID RES, V34, P1413; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Savard C, 2013, HEPATOLOGY, V57, P81, DOI 10.1002/hep.25789; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Strnad R, 2008, BBA-MOL BASIS DIS, V1782, P764, DOI 10.1016/j.bbadis.2008.08.008; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xian XD, 2017, ELIFE, V6, DOI 10.75549/eLife.29292; Zhang J, 2017, EBIOMEDICINE, V15, P173, DOI 10.1016/j.ebiom.2016.12.016; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006853	29	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9674	9684		10.1074/jbc.RA118.001952	http://dx.doi.org/10.1074/jbc.RA118.001952			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29752404	hybrid, Green Published			2022-12-26	WOS:000436102300012
J	Park, S; Cui, J; Yu, WS; Wu, L; Carmon, KS; Liu, QYJ				Park, Soohyun; Cui, Jie; Yu, Wangsheng; Wu, Ling; Carmon, Kendra S.; Liu, Qingyun J.			Differential activities and mechanisms of the four R-spondins in potentiating Wnt/-catenin signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; stem cells; 7-helix receptor; Wnt signaling; beta-catenin (-catenin); LGR4; LGR5; organoids; R-spondin	HIGH-AFFINITY LIGAND; STEM-CELLS; VASCULAR DEVELOPMENT; R-SPONDIN-4 RSPO4; CRYSTAL-STRUCTURE; CANCER CELLS; COLON-CANCER; LGR5; RECEPTORS; COMPLEX	The four R-spondins (RSPO1-4) strongly potentiate Wnt signaling and play critical roles in normal development, adult stem cell survival, and cancer development and aggressiveness. All four RSPOs have been suggested to potentiate Wnt signaling by binding to three related receptors, i.e. leucine-rich repeat-containing, G protein-coupled receptors 4, 5, and 6 (LGR4/5/6), and then inducing the clearance of two E3 ubiquitin ligases (RNF43 and ZNRF3) that otherwise would ubiquitinate Wnt receptors for degradation. Here, we show that RSPO1-4 have differential dependence on LGRs in potentiating Wnt/-catenin signaling and that RSPO2 can enhance this pathway without any LGR. LGR4 knockout (LGR4KO) in HEK293 cells completely abrogated the Wnt/-catenin signaling response to RSPO1 and RSPO4 and strongly impaired the response to RSPO3. RSPO2, however, retained robust activity albeit with decreased potency. Complete rescue of RSPO1-4 activity in LGR4KO cells required the seven-transmembrane domain of LGR4. Furthermore, an RSPO2 mutant with normal binding affinity to ZNRF3 but no or little binding to LGR4 or LGR5 still potentiated Wnt/-catenin signaling in vitro, supported the growth of intestinal organoids ex vivo, and stimulated intestinal crypt growth in vivo. Mechanistically, RSPO2 could increase Wnt receptor levels in the absence of any LGR without affecting ZNRF3 endocytosis and stability. These findings suggest that RSPO1-4 use distinct mechanisms in regulating Wnt and other signaling pathways, which have important implications for understanding the pleiotropic functions of RSPOs and LGRs in both normal and cancer development.	[Park, Soohyun; Yu, Wangsheng; Wu, Ling; Carmon, Kendra S.; Liu, Qingyun J.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, 1825 Pressler St, Houston, TX 77030 USA; [Park, Soohyun; Yu, Wangsheng; Wu, Ling; Carmon, Kendra S.; Liu, Qingyun J.] Univ Texas Hlth Sci Ctr Houston, Texas Therapeut Inst, Houston, TX 77030 USA; [Cui, Jie] Wntrix Inc, Houston, TX 77021 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Liu, QYJ (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med, 1825 Pressler St, Houston, TX 77030 USA.	Qingyun.liu@uth.tmc.edu		park, soohyun/0000-0001-9847-9985	Cancer Prevention and Research Institute of Texas [RP160235, RP170245]; Janice D. Gordon endowment for bowel cancer research	Cancer Prevention and Research Institute of Texas; Janice D. Gordon endowment for bowel cancer research	This work was supported in part by Cancer Prevention and Research Institute of Texas Grants RP160235 and RP170245 and the Janice D. Gordon endowment for bowel cancer research (to Q.J.L). Q.J.L. is a cofounder of Wntrix, and J.C. is a full-time employee of Wntrix.	Aoki M, 2008, DEV GROWTH DIFFER, V50, P85, DOI 10.1111/j.1440-169x.2007.00978.x; Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Bell SM, 2008, DEVELOPMENT, V135, P1049, DOI 10.1242/dev.013359; Bergmann C, 2006, AM J HUM GENET, V79, P1105, DOI 10.1086/509789; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Carmon KS, 2017, J BIOL CHEM, V292, P14989, DOI 10.1074/jbc.M117.786798; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chartier C, 2016, CANCER RES, V76, P713, DOI 10.1158/0008-5472.CAN-15-0561; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130348; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lebensohn AM, 2018, ELIFE, V7, DOI 10.7554/eLife.33126; Moad HE, 2013, BIOCHEMISTRY-US, V52, P7295, DOI 10.1021/bi401090h; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Peng WC, 2013, CELL REP, V3, P1885, DOI 10.1016/j.celrep.2013.06.009; Ren ZM, 2018, BLOOD, V131, P982, DOI 10.1182/blood-2017-07-797050; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; Warner ML, 2015, MOL PHARMACOL, V87, P410, DOI 10.1124/mol.114.095133; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Xie Y, 2013, EMBO REP, V14, P1120, DOI 10.1038/embor.2013.167; Xu JG, 2015, J BIOL CHEM, V290, P2455, DOI 10.1074/jbc.M114.599134; Xu K, 2013, STRUCTURE, V21, P1683, DOI 10.1016/j.str.2013.07.001; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Yi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078144; Zebisch M, 2015, J STRUCT BIOL, V191, P149, DOI 10.1016/j.jsb.2015.05.008; Zebisch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3787	43	43	45	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9759	9769		10.1074/jbc.RA118.002743	http://dx.doi.org/10.1074/jbc.RA118.002743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29752411	Green Published, hybrid			2022-12-26	WOS:000436102300020
J	Kerbel, B; Badal, K; Sundarrajan, L; Blanco, A; Unniappan, S				Kerbel, Brent; Badal, Kimberly; Sundarrajan, Lakshminarasimhan; Blanco, Ayelen; Unniappan, Suraj			Xenin is a novel anorexigen in goldfish (Carassius auratus)	PLOS ONE			English	Article							EXOCRINE PANCREATIC-SECRETION; PEPTIDE XENIN; FOOD-INTAKE; INSULIN-SECRETION; GENE-EXPRESSION; GUT; HUMANS; BRAIN; RATS; CHOLECYSTOKININ	Xenin, a highly conserved 25 amino acid peptide cleaved from the N-terminus of the coatomer protein alpha (COPA), is emerging as a food intake regulator in mammals and birds. To date, no research has been conducted on xenin biology in fish. This study aims to identify the copa mRNA encoding xenin in goldfish (Carassius auratus) as a model, to elucidate its regulation by feeding, and to describe the role of xenin on appetite. First, a partial sequence of copa cDNA, a region encoding xenin, was identified from goldfish brain. This sequence is highly conserved among both vertebrates and invertebrates. RT-qPCR revealed that copa mRNAs are widely distributed in goldfish tissues, with the highest levels detected in the brain, gill, pituitary and J-loop. Immunohistochemistry confirmed also the presence of COPA peptide in the hypothalamus and enteroendocrine cells on the J-loop mucosa. In line with its anorexigenic effects, we found important periprandial fluctuations in copa mRNA expression in the hypothalamus, which were mainly characterized by a gradually decrease in copa mRNA levels as the feeding time was approached, and a gradual increase after feeding. Additionally, fasting differently modulated the expression of copa mRNA in a tissue dependent manner. Peripheral and central injections of xenin reduce food intake in goldfish. This research provides the first report of xenin in fish, and shows that this peptide is a novel anorexigen in goldfish.	[Kerbel, Brent; Badal, Kimberly] York Univ, Dept Biol, Toronto, ON, Canada; [Sundarrajan, Lakshminarasimhan; Blanco, Ayelen; Unniappan, Suraj] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Lab Integrat Neuroendocrinol, Saskatoon, SK, Canada	York University - Canada; University of Saskatchewan	Unniappan, S (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Lab Integrat Neuroendocrinol, Saskatoon, SK, Canada.	suraj.unniappan@usask.ca		Blanco, Ayelen Melisa/0000-0002-7683-4154	Natural Sciences and Engineering Research Council of Canada [492436-2012]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by grant number 492436-2012 to Suraj Unniappan; Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou C, 1998, BRAIN RES, V800, P294, DOI 10.1016/S0006-8993(98)00535-6; Anlauf M, 2000, J HISTOCHEM CYTOCHEM, V48, P1617, DOI 10.1177/002215540004801205; Arcamone N, 2009, MICROSC RES TECHNIQ, V72, P525, DOI 10.1002/jemt.20709; Bhavya S, 2017, NEUROPEPTIDES, V63, P67, DOI 10.1016/j.npep.2017.01.007; BURNSTOCK G, 1958, J PHYSIOL-LONDON, V141, P35, DOI 10.1113/jphysiol.1958.sp005953; Cerda-Reverter JM, 2003, REGUL PEPTIDES, V115, P101, DOI 10.1016/S0167-0115(03)00144-7; CHANGEUX JP, 1992, Q REV BIOPHYS, V25, P395, DOI 10.1017/S0033583500004352; Chlabicz M, 2011, FOLIA HISTOCHEM CYTO, V49, P547, DOI 10.5603/FHC.2011.0078; Chow VTK, 1997, ANN HUM GENET, V61, P369, DOI 10.1017/S0003480097006295; Chowdhury S, 2014, AM J PHYSIOL-GASTR L, V306, pG301, DOI 10.1152/ajpgi.00383.2013; Clemens A, 1997, AM J PHYSIOL-GASTR L, V272, pG190, DOI 10.1152/ajpgi.1997.272.1.G190; Cline MA, 2007, BEHAV BRAIN RES, V179, P28, DOI 10.1016/j.bbr.2007.01.008; Cooke JH, 2009, OBESITY, V17, P1135, DOI 10.1038/oby.2008.652; DEBAS HT, 1975, GASTROENTEROLOGY, V68, P1211; FEURLE GE, 1992, J BIOL CHEM, V267, P22305; Feurle GE, 2003, REGUL PEPTIDES, V111, P153, DOI 10.1016/S0167-0115(02)00281-1; Feurle GE, 2002, PEPTIDES, V23, P1517, DOI 10.1016/S0196-9781(02)00064-5; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; Gonzalez R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015201; Hamscher G, 1996, PEPTIDES, V17, P889; HAMSCHER G, 1995, PEPTIDES, V16, P791, DOI 10.1016/0196-9781(95)00053-M; HIMICK BA, 1994, AM J PHYSIOL, V267, pR841, DOI 10.1152/ajpregu.1994.267.3.R841; Hwang JI, 2009, ANN NY ACAD SCI, V1163, P169, DOI 10.1111/j.1749-6632.2008.03636.x; Ivy A.C., 1929, AM J SURG, V7, P455, DOI DOI 10.1016/S0002-9610(29)90551-1; Kaji I, 2017, J PHARMACOL EXP THER, V361, P151, DOI 10.1124/jpet.116.238485; Kamiyama Y, 2007, NEUROGASTROENT MOTIL, V19, P233, DOI 10.1111/j.1365-2982.2006.00881.x; Kim ER, 2010, NEUROSCI LETT, V481, P59, DOI 10.1016/j.neulet.2010.06.055; Kim ER, 2010, NEUROSCI LETT, V468, P64, DOI 10.1016/j.neulet.2009.10.064; Leckstrom A, 2009, DIABETES, V58, P87, DOI 10.2337/db08-0260; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nandar W, 2008, GEN COMP ENDOCR, V157, P58, DOI 10.1016/j.ygcen.2008.03.012; PENG C, 1994, ENDOCRINOLOGY, V134, P1095, DOI 10.1210/en.134.3.1095; REIDELBERGER RD, 1986, AM J PHYSIOL, V251, pR97, DOI 10.1152/ajpregu.1986.251.1.R97; Riggio M, 2000, GENE, V260, P67, DOI 10.1016/S0378-1119(00)00469-8; Taylor AI, 2010, J ENDOCRINOL, V207, P87, DOI 10.1677/JOE-10-0085; Wice BM, 2012, DIABETES, V61, P1793, DOI 10.2337/db11-1451; Wice BM, 2010, J BIOL CHEM, V285, P19842, DOI 10.1074/jbc.M110.129304	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197817	10.1371/journal.pone.0197817	http://dx.doi.org/10.1371/journal.pone.0197817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791497	gold, Green Published, Green Submitted			2022-12-26	WOS:000433077000062
J	Catchlove, SJ; Macpherson, H; Hughes, ME; Chen, YF; Parrish, TB; Pipingas, A				Catchlove, Sarah J.; Macpherson, Helen; Hughes, Matthew E.; Chen, Yufen; Parrish, Todd B.; Pipingas, Andrew			An investigation of cerebral oxygen utilization, blood flow and cognition in healthy aging	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; AGE-RELATED DIFFERENCES; METABOLIC-RATE; CARDIOVASCULAR-DISEASE; WORKING-MEMORY; CARBON-DIOXIDE; BRAIN ACTIVITY; GRAY-MATTER; PERFUSION; GLUCOSE	Background Understanding how vascular and metabolic factors impact on cognitive function is essential to develop efficient therapies to prevent and treat cognitive losses in older age. Cerebral metabolic rate of oxygen (CMRO2), cerebral blood flow (CBF) and venous oxygenation (Y-v) comprise key physiologic processes that maintain optimum functioning of neural activity. Changes to these parameters across the lifespan may precede neurodegeneration and contribute to age -related cognitive decline. This study examined differences in blood flow and metabolism between 31 healthy younger (<50 years) and 29 healthy older (>50 years) adults; and investigated whether these parameters contribute to cognitive performance. Method Participants underwent a cognitive assessment and MRI scan. Grey matter CMRO2 was calculated from measures of CBF (phase contrast MRI), arterial and venous oxygenation (TRUST MRI) to assess group differences in physiological function and the contribution of these parameters to cognition. Results Performance on memory (p<0.001) and attention tasks (p<0.001) and total CBF were reduced (p<0.05), and Y-v trended toward a decrease (p =.06) in the older group, while grey matter CBF and CMRO2 did not differ between the age groups. Attention was negatively associated with CBF when adjusted (p<0.05) in the older adults, but not in the younger group. There was no such relationship with memory. Neither cognitive measure was associated with oxygen metabolism or venous oxygenation in either age group. Conclusion Findings indicated an age-related imbalance between oxygen delivery, consumption and demand, evidenced by a decreased supply of oxygen with unchanged metabolism resulting in increased oxygen extraction. CBF predicted attention when the age-effect was controlled, suggesting a task-specific CBF-cognition relationship.	[Catchlove, Sarah J.; Pipingas, Andrew] Swinburne Univ, Ctr Human Psychopharmacol, Hawthorn, Vic, Australia; [Macpherson, Helen] Deakin Univ, Inst Phys Act & Nutr, Geelong, Vic, Australia; [Hughes, Matthew E.] Swinburne Univ, Ctr Mental Hlth, Hawthorn, Vic, Australia; [Hughes, Matthew E.] Univ Queensland, Australian Natl Imaging Facil, St Lucia, Qld, Australia; [Chen, Yufen; Parrish, Todd B.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Swinburne University of Technology; Deakin University; Swinburne University of Technology; University of Queensland; Northwestern University; Feinberg School of Medicine	Catchlove, SJ (corresponding author), Swinburne Univ, Ctr Human Psychopharmacol, Hawthorn, Vic, Australia.	scatchlove@swin.edu.au		Parrish, Todd/0000-0002-1184-1572; Macpherson, Helen/0000-0002-3603-9359; Catchlove, Sarah/0000-0003-2314-1706; Hughes, Matthew/0000-0001-5057-5556	Barbara Dicker Brain Sciences Foundation; Australian National Imaging Facility; Barbara Dicker Brain Sciences Association	Barbara Dicker Brain Sciences Foundation; Australian National Imaging Facility; Barbara Dicker Brain Sciences Association	Research was supported by a grant from the Barbara Dicker Brain Sciences Foundation awarded to MEH. ME Hughes is supported by the Australian National Imaging Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Denny Meyer and Sarah Mourn for statistical support. Research was supported by a grant from the Barbara Dicker Brain Sciences Association, awarded to ME Hughes. ME Hughes is supported by the Australian National Imaging Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanerud J, 2012, J CEREBR BLOOD F MET, V32, P1177, DOI 10.1038/jcbfm.2012.18; Ances BM, 2009, HUM BRAIN MAPP, V30, P1120, DOI 10.1002/hbm.20574; Asllani I, 2009, HUM BRAIN MAPP, V30, P2927, DOI 10.1002/hbm.20719; Bentourkia M, 2000, J NEUROL SCI, V181, P19, DOI 10.1016/S0022-510X(00)00396-8; BERENT S, 1986, NEUROLOGY, V36, P337; Bertsch K, 2009, BRAIN RES, V1267, P77, DOI 10.1016/j.brainres.2009.02.053; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; Brundel M, 2012, J DIABETES COMPLICAT, V26, P205, DOI 10.1016/j.jdiacomp.2012.03.021; Buijs PC, 1998, RADIOLOGY, V209, P667, DOI 10.1148/radiology.209.3.9844657; BURNS A, 1992, AGE AGEING, V21, P316, DOI 10.1093/ageing/21.5.316; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Cohen RA, 2009, J CLIN EXP NEUROPSYC, V31, P96, DOI 10.1080/13803390802014594; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; CROUGHWELL ND, 1994, ANN THORAC SURG, V58, P1702, DOI 10.1016/0003-4975(94)91666-7; DASTUR DK, 1985, J CEREBR BLOOD F MET, V5, P1, DOI 10.1038/jcbfm.1985.1; Dastur OK, 1963, HUMAN AGING BIOL BEH, P59; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; DeCarli C, 2001, ARCH NEUROL-CHICAGO, V58, P643, DOI 10.1001/archneur.58.4.643; Dubeau S, 2011, NEUROIMAGE, V57, P1480, DOI 10.1016/j.neuroimage.2011.04.030; Dubeau S, 2011, NEUROIMAGE, V56, P1892, DOI 10.1016/j.neuroimage.2011.03.076; Elias MF, 2009, HYPERTENSION, V53, P668, DOI 10.1161/HYPERTENSIONAHA.108.126342; EUSTACHE F, 1995, NEUROPSYCHOLOGIA, V33, P867, DOI 10.1016/0028-3932(95)00021-T; Forman DE, 2008, ARTERY RES, V2, P35, DOI 10.1016/j.artres.2008.01.001; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Ge YL, 2012, J CEREBR BLOOD F MET, V32, P403, DOI 10.1038/jcbfm.2011.191; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; Glodzik L, 2013, J ALZHEIMERS DIS, V35, P427, DOI 10.3233/JAD-122011; GOLDSTEIN S, 1991, CLIN NEUROPHARMACOL, V14, pS34, DOI 10.1097/00002826-199114001-00006; GUR RE, 1990, SCHIZOPHRENIA BULL, V16, P247, DOI 10.1093/schbul/16.2.247; HAIER RJ, 1988, INTELLIGENCE, V12, P199, DOI 10.1016/0160-2896(88)90016-5; Hall JE., 2011, TXB MED PHYSL; HAXBY JV, 1986, ARCH NEUROL-CHICAGO, V43, P882, DOI 10.1001/archneur.1986.00520090022010; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Heo S, 2010, BRAIN RES, V1315, P119, DOI 10.1016/j.brainres.2009.12.020; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hutchison JL, 2013, CEREB CORTEX, V23, P2337, DOI 10.1093/cercor/bhs233; Iadecola C, 2010, ACTA NEUROPATHOL, V120, P287, DOI 10.1007/s00401-010-0718-6; Ibaraki M, 2010, J CEREBR BLOOD F MET, V30, P1296, DOI 10.1038/jcbfm.2010.13; ITOH M, 1990, GERONTOLOGY, V36, P43; KETY S S, 1956, J Chronic Dis, V3, P478, DOI 10.1016/0021-9681(56)90146-1; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Liu PY, 2016, MAGN RESON MED, V75, P680, DOI 10.1002/mrm.25627; Liu PY, 2014, NMR BIOMED, V27, P332, DOI 10.1002/nbm.3067; Liu PY, 2013, MAGN RESON MED, V69, P675, DOI 10.1002/mrm.24295; Lu HZ, 2008, MAGN RESON MED, V60, P357, DOI 10.1002/mrm.21627; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Macpherson H, 2012, PSYCHOPHARMACOLOGY, V220, P351, DOI 10.1007/s00213-011-2481-3; MARCHAL G, 1992, ARCH NEUROL-CHICAGO, V49, P1013, DOI 10.1001/archneur.1992.00530340029014; MARTIN AJ, 1991, J CEREBR BLOOD F MET, V11, P684, DOI 10.1038/jcbfm.1991.121; Milham MP, 2002, BRAIN COGNITION, V49, P277, DOI 10.1006/brcg.2001.1501; Mohtasib RS, 2012, NEUROIMAGE, V59, P1143, DOI 10.1016/j.neuroimage.2011.07.092; Moss MC, 1998, PSYCHOPHARMACOLOGY, V138, P27, DOI 10.1007/s002130050641; Nash DT, 2006, AM J CARDIOL, V97, P1262, DOI 10.1016/j.amjcard.2005.12.031; PANTANO P, 1984, STROKE, V15, P635, DOI 10.1161/01.STR.15.4.635; Park DC, 2003, J COGNITIVE NEUROSCI, V15, P1122, DOI 10.1162/089892903322598094; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Peng SL, 2014, NEUROIMAGE, V98, P176, DOI 10.1016/j.neuroimage.2014.04.078; Picano E, 2014, INT J CARDIOL, V175, P21, DOI 10.1016/j.ijcard.2014.05.004; Pipingas A, 2010, CURR TOP NUTRACEUT R, V8, P79; Poels MMF, 2008, J CEREBR BLOOD F MET, V28, P1652, DOI 10.1038/jcbfm.2008.62; Rabbitt P, 2006, NEUROPSYCHOLOGY, V20, P549, DOI 10.1037/0894-4105.20.5.549; Rodgers ZB, 2016, J CEREBR BLOOD F MET, V36, P1165, DOI 10.1177/0271678X16643090; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; SALTHOUSE TA, 1991, DEV PSYCHOL, V27, P763, DOI 10.1037/0012-1649.27.5.763; Scholey AB, 1998, PSYCHOPHARMACOLOGY, V140, P123, DOI 10.1007/s002130050748; Souchay C, 2004, BRAIN COGNITION, V56, P89, DOI 10.1016/j.bandc.2004.06.002; Steffener J, 2013, HUM BRAIN MAPP, V34, P3267, DOI 10.1002/hbm.22142; Strehler B., 1983, FUNDAMENTAL MECH NEU, P75; TAKADA H, 1992, NEUROL RES, V14, P128, DOI 10.1080/01616412.1992.11740031; Thomas BP, 2017, J CEREBR BLOOD F MET, V37, P1508, DOI 10.1177/0271678X16658662; Tiehuis AM, 2008, DIABETOLOGIA, V51, P1321, DOI 10.1007/s00125-008-1041-9; Tumeh PC, 2007, SEMIN NUCL MED; WALDEMAR G, 1991, J CEREBR BLOOD F MET, V11, P508, DOI 10.1038/jcbfm.1991.95; Xu F, 2015, HUM BRAIN MAPP, V36, P707, DOI 10.1002/hbm.22658; Xu F, 2011, J CEREBR BLOOD F MET, V31, P58, DOI 10.1038/jcbfm.2010.153; Xu F, 2009, MAGN RESON MED, V62, P141, DOI 10.1002/mrm.21994; Yablonskiy DA, 2013, NMR BIOMED, V26, P963, DOI 10.1002/nbm.2839; YAMAGUCHI T, 1986, STROKE, V17, P1220, DOI 10.1161/01.STR.17.6.1220; Zhang Yu, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1237; Zhao JM, 2007, MAGN RESON MED, V58, P592, DOI 10.1002/mrm.21342	85	29	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197055	10.1371/journal.pone.0197055	http://dx.doi.org/10.1371/journal.pone.0197055			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG6DG	29787609	Green Published, Green Submitted, gold			2022-12-26	WOS:000432785700012
J	Makarevich, PI; Dergilev, KV; Tsokolaeva, ZI; Boldyreva, MA; Shevchenko, EK; Gluhanyuk, EV; Gallinger, JO; Menshikov, MY; Parfyonova, YV				Makarevich, Pavel I.; Dergilev, Konstantin V.; Tsokolaeva, Zoya I.; Boldyreva, Maria A.; Shevchenko, Evgeniy K.; Gluhanyuk, Evgeny V.; Gallinger, Julia O.; Menshikov, Mikhail Yu.; Parfyonova, Yelena V.			Angiogenic and pleiotropic effects of VEGF165 and HGF combined gene therapy in a rat model of myocardial infarction	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; CONTROLLED CLINICAL-TRIALS; HIND-LIMB ISCHEMIA; ENDOTHELIAL-CELLS; RECEPTOR FLT-1; IN-VITRO; ARTERIOGENESIS; EXPRESSION; MONOCYTES; DNA	Since development of plasmid gene therapy for therapeutic angiogenesis by J. Isner this approach was an attractive option for ischemic diseases affecting large cohorts of patients. However, first placebo-controlled clinical trials showed its limited efficacy questioning further advance to practice. Thus, combined methods using delivery of several angiogenic factors got into spotlight as a way to improve outcomes. This study provides experimental proof of concept for a combined approach using simultaneous delivery of VEGF165 and HGF genes to alleviate consequences of myocardial infarction (MI). However, recent studies suggested that angiogenic growth factors have pleiotropic effects that may contribute to outcome so we expanded focus of our work to investigate potential mechanisms underlying action of VEGF165, HGF and their combination in MI. Briefly, Wistar rats underwent coronary artery ligation followed by injection of plasmid bearing VEGF165 or HGF or mixture of these. Histological assessment showed decreased size of post-MI fibrosis in both-VEGF165- or HGF-treated animals yet most prominent reduction of collagen deposition was observed in VEGF165+HGF group. Combined delivery group rats were the only to show significant increase of left ventricle (LV) wall thickness. We also found dilatation index improved in HGF or VEGF165+HGF treated animals. These effects were partially supported by our findings of c-kit+ cardiac stem cell number increase in all treated animals compared to negative control. Sporadic Ki-67+ mature cardiomyocytes were found in peri-infarct area throughout study groups with comparable effects of VEGF165, HGF and their combination. Assessment of vascular density in peri-infarct area showed efficacy of both VEGF165 and HGF while combination of growth factors showed maximum increase of CD31+ capillary density. To our surprise arteriogenic response was limited in HGF-treated animals while VEGF165 showed potent positive influence on a-SMA+ blood vessel density. The latter hinted to evaluate infiltration of monocytes as they are known to modulate arteriogenic response in myocardium. We found that monocyte infiltration was driven by VEGF165 and reduced by HGF resulting in alleviation of VEGF-stimulated monocyte taxis after combined delivery of these 2 factors. Changes of monocyte infiltration were concordant with a-SMA+ arteriole density so we tested influence of VEGF165 or HGF on endothelial cells (EC) that mediate angiogenesis and inflammatory response. In a series of in vitro experiments we found that VEGF165 and HGF regulate production of inflammatory chemokines by human EC. In particular MCP 1 levels changed after treatment by recombinant VEGF, HGF or their combination and were concordant with NF-KB activation and monocyte infiltration in corresponding groups in vivo. We also found that both VEGF165 and HGF upregulated IL-8 production by EC while their combination showed additive type of response reaching peak values. These changes were HIF-2 dependent and siRNA-mediated knockdown of HIF-2 alpha abolished effects of VEGF165 and HGF on IL-8 production. To conclude, our study supports combined gene therapy by VEGF165 and HGF to treat MI and highlights neglected role of pleiotropic effects of angiogenic growth factors that may define efficacy via regulation of inflammatory response and endothelial function.	[Makarevich, Pavel I.; Dergilev, Konstantin V.; Tsokolaeva, Zoya I.; Boldyreva, Maria A.; Shevchenko, Evgeniy K.; Gluhanyuk, Evgeny V.; Gallinger, Julia O.; Menshikov, Mikhail Yu.; Parfyonova, Yelena V.] Natl Med Res Ctr Cardiol, Lab Angiogenesis, Moscow, Russia; [Makarevich, Pavel I.] Lomonosov Moscow State Univ, Inst Regenerat Med, Lab Gene & Cell Therapy, Moscow, Russia; [Tsokolaeva, Zoya I.; Boldyreva, Maria A.; Shevchenko, Evgeniy K.; Menshikov, Mikhail Yu.; Parfyonova, Yelena V.] Lomonosov Moscow State Univ, Lab Gene & Cell Technol, Fac Med, Moscow, Russia	National Medical Research Center of Cardiology; Lomonosov Moscow State University; Lomonosov Moscow State University	Makarevich, PI (corresponding author), Natl Med Res Ctr Cardiol, Lab Angiogenesis, Moscow, Russia.; Makarevich, PI (corresponding author), Lomonosov Moscow State Univ, Inst Regenerat Med, Lab Gene & Cell Therapy, Moscow, Russia.	pmakarevich@mc.msu.ru	Parfyonova, Yelena V/B-9307-2014; Shevchenko, Evgeny/B-1306-2014; Makarevich, Pavel/A-8157-2014; Дергилев, Константин/J-9423-2015; Boldyreva, Maria/J-9417-2015	Parfyonova, Yelena V/0000-0002-0969-5780; Makarevich, Pavel/0000-0001-8869-5190; Дергилев, Константин/0000-0003-2712-4997; Boldyreva, Maria/0000-0002-8309-0018; Men'sikov, Mihail/0000-0002-9949-0534	Russian Science Foundation [16-15-00181]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by Russian Science Foundation grant 16-15-00181. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2000, GENE THER, V7, P417, DOI 10.1038/sj.gt.3301104; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Beilmann M, 2000, BLOOD, V95, P3964; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Besse S, 2010, J PHYSIOL PHARMACOL, V61, P651; Chambers SEJ, 2013, IMMUNOBIOLOGY, V218, P1370, DOI 10.1016/j.imbio.2013.06.010; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; De Haro J, 2009, HEART VESSELS, V24, P321, DOI 10.1007/s00380-008-1140-z; Florczyk U, 2011, FREE RADICAL BIO MED, V51, P1882, DOI 10.1016/j.freeradbiomed.2011.08.023; Fong GH, 2009, J MOL MED-JMM, V87, P549, DOI 10.1007/s00109-009-0458-z; Gerritsen ME, 2005, CIRC RES, V96, P272, DOI 10.1161/01.RES.0000157575.66295.e0; Gerritsen ME, 2003, BRIT J PHARMACOL, V140, P595, DOI 10.1038/sj.bjp.0705494; Gude N, 2006, CIRC RES, V99, P381, DOI 10.1161/01.RES.0000236754.21499.1c; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; HOCHMAN JS, 1987, CIRCULATION, V75, P299, DOI 10.1161/01.CIR.75.1.299; Hoefer IE, 2005, ATHEROSCLEROSIS, V181, P285, DOI 10.1016/j.atherosclerosis.2005.01.047; Iwasaki M, 2005, STEM CELLS, V23, P1589, DOI 10.1634/stemcells.2005-0049; Jang HS, 2004, MOL THER, V9, P464, DOI 10.1016/j.ymthe.2003.12.002; Jetten N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068811; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034; Kojima I, 2009, KIDNEY INT, V75, P268, DOI 10.1038/ki.2008.488; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kostner KM, 2006, CLIN CHIM ACTA, V365, P129, DOI 10.1016/j.cca.2005.08.028; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Lee JS, 2007, BIOCHEM BIOPH RES CO, V360, P752, DOI 10.1016/j.bbrc.2007.06.120; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Liu X, 2007, SCAND CARDIOVASC J, V41, P95, DOI 10.1080/14017430701197593; Loboda A, 2012, VASC PHARMACOL, V56, P245, DOI 10.1016/j.vph.2012.02.006; Makarevich PI, 2013, EUR J HEART FAIL, V12, pS44; Makarevich P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038776; Miao YL, 2014, VASC ENDOVASC SURG, V48, P372, DOI 10.1177/1538574414539397; Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Mizuno S, 2005, AM J PATHOL, V166, P1895, DOI 10.1016/S0002-9440(10)62498-4; Moldovan NI, 2000, CIRC RES, V87, P378; Morishita R, 1999, HYPERTENSION, V33, P1379, DOI 10.1161/01.HYP.33.6.1379; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; ROBERTS R, 1976, CIRCULATION, V53, P204; RUBANYI GM, 1993, J CARDIOVASC PHARM, V22, pS1, DOI 10.1097/00005344-199304000-00002; Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shirakawa Y, 2005, J THORAC CARDIOV SUR, V130, P624, DOI 10.1016/j.jtcvs.2004.02.045; Shireman PK, 2007, J VASC SURG, V45, p48A, DOI 10.1016/j.jvs.2007.02.030; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sulpice E, 2009, BIOL CELL, V101, P525, DOI 10.1042/BC20080221; Tao ZX, 2010, J BIOMED RES, V24, P198, DOI 10.1016/S1674-8301(10)60029-2; Traktuev DO, 2007, MOL THER, V15, P1939, DOI 10.1038/sj.mt.6300262; Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; van Royen N, 2001, CARDIOVASC RES, V49, P543, DOI 10.1016/S0008-6363(00)00206-6; WOLF HK, 1991, HEPATOLOGY, V14, P488, DOI 10.1016/0270-9139(91)90188-2; Wolff JA, 2005, ADV GENET, V54, P3, DOI 10.1016/S0065-2660(05)54001-X; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8; Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049	59	22	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197566	10.1371/journal.pone.0197566	http://dx.doi.org/10.1371/journal.pone.0197566			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787588	Green Published, gold, Green Submitted			2022-12-26	WOS:000432785700030
J	van den Boer, M; de Bree, EH; de Jong, PF				van den Boer, Madelon; de Bree, Elise H.; de Jong, Peter F.			Simulation of dyslexia. How literacy and cognitive skills can help distinguish college students with dyslexia from malingerers	PLOS ONE			English	Article							VISUAL-ATTENTION SPAN; DEVELOPMENTAL DYSLEXIA; STROOP INTERFERENCE; PHONOLOGICAL DEFICIT; PERFORMANCE VALIDITY; READING DISABILITIES; NAMING SPEED; ADULTS; CHILDREN; METAANALYSIS	Academic accommodations associated with a diagnosis of dyslexia might be incentives for college students without reading or spelling difficulties to feign dyslexia and obtain the diagnosis unfairly. In the current study we examined malingering practices by comparing the performance of college students instructed to malinger dyslexia (n = 28) to that of students actually diagnosed with dyslexia (n = 16). We also included a control group of students without reading and spelling difficulties (n = 28). The test battery included tasks tapping literacy skills as well as underlying cognitive skills associated with literacy outcomes. These tasks are commonly used in diagnosing dyslexia. We examined patterns in the performance of malingerers across tasks and tested whether malingerers could be identified based on their performance on a limited number of tasks. Results indicated that malingerers scored significantly lower than students with dyslexia on reading and spelling skills; i.e., the core characteristics of dyslexia. Especially reading performance was extremely low and not in line with students' age and level of education. Findings for underlying cognitive skills were mixed. Overall, malingerers scored lower than students with dyslexia on tasks tapping mainly speed, whereas the two groups did not differ on tasks reflecting mainly accuracy. Based on word and pseudoword reading and letter and digit naming, the three groups could be distinguished with reasonable sensitivity and specificity. In all, results indicate that college students seem to understand on which tasks they should feign dyslexia, but tend to exaggerate difficulties on these tasks to the point where diagnosticians should mistrust performance.	[van den Boer, Madelon; de Bree, Elise H.; de Jong, Peter F.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands	University of Amsterdam	van den Boer, M (corresponding author), Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands.	m.vandenboer@uva.nl						American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Bosse ML, 2009, J RES READ, V32, P230, DOI 10.1111/j.1467-9817.2008.01387.x; Brus B, 1995, VERANTWOORDING HANDL; Callens M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038081; de Jong PF, 2003, J EDUC PSYCHOL, V95, P22, DOI 10.1037/0022-0663.95.1.22; De Pessemier P, 2009, TEST GEVORDERD LEZEN; Faccioli C, 2008, CHILD NEUROPSYCHOL, V14, P277, DOI 10.1080/09297040701290040; Gagliano A, 2015, J CLIN EXP NEUROPSYC, V37, P972, DOI 10.1080/13803395.2015.1072498; Germano GD, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01169; Hammes JGW., 1971, STROOP KLEUR WOORD T; Harrison AG, 2008, DYSLEXIA, V14, P228, DOI 10.1002/dys.366; Harrison AG, 2010, ARCH CLIN NEUROPSYCH, V25, P89, DOI 10.1093/arclin/acp104; Hatcher J, 2002, BRIT J EDUC PSYCHOL, V72, P119, DOI 10.1348/000709902158801; Hurtubise JL, 2017, PSYCHOL INJ LAW, V10, P121, DOI 10.1007/s12207-017-9287-5; Kirby JR, 2010, READ RES QUART, V45, P341, DOI 10.1598/RRQ.45.3.4; Kuijpers C., 2003, PEDAGOG STUD, V80, P272; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lindstrom W, 2011, CLIN NEUROPSYCHOL, V25, P302, DOI 10.1080/13854046.2010.537280; Lobier M, 2012, NEUROPSYCHOLOGIA, V50, P2195, DOI 10.1016/j.neuropsychologia.2012.05.023; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Melby-Lervag M, 2012, SCI STUD READ, V16, P1, DOI 10.1080/10888438.2010.537715; NRD, 2013, PROT DYSL DIAGN BEH; Osmon DC, 2006, CLIN NEUROPSYCHOL, V20, P315, DOI 10.1080/13854040590947434; Parrila R, 2004, SCI STUD READ, V8, P3, DOI 10.1207/s1532799xssr0801_2; Patel TK, 2004, J EDUC PSYCHOL, V96, P785, DOI 10.1037/0022-0663.96.4.785; Pennington BF, 2012, J ABNORM PSYCHOL, V121, P212, DOI 10.1037/a0025823; Peterson RL, 2015, ANNU REV CLIN PSYCHO, V11, P283, DOI 10.1146/annurev-clinpsy-032814-112842; Peyrin C, 2012, BRAIN LANG, V120, P381, DOI 10.1016/j.bandl.2011.12.015; Protopapas A, 2007, COGNITIVE PSYCHOL, V54, P251, DOI 10.1016/j.cogpsych.2006.07.003; Protopapas A, 2014, ACTA PSYCHOL, V148, P204, DOI 10.1016/j.actpsy.2014.02.006; Proulx MJ, 2015, NEUROCASE, V21, P413, DOI 10.1080/13554794.2014.914544; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Saksida A, 2016, DEV PSYCHOL, V52, P1503, DOI 10.1037/dev0000184; Schneider W., 2007, E PRIME 2 0; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Snowling MJ, 2016, PSYCHOL BULL, V142, P498, DOI 10.1037/bul0000037; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Swanson HL, 2009, REV EDUC RES, V79, P1362, DOI 10.3102/0034654309350931; Valdois S, 2004, DYSLEXIA, V10, P339, DOI 10.1002/dys.284; Valdois S., 2003, READ WRIT, V16, P541, DOI DOI 10.1023/A:1025501406971; van Bergen E, 2015, SCI STUD READ, V19, P325, DOI 10.1080/10888438.2015.1050103; van den Boer M, 2015, LEARN INDIVID DIFFER, V39, P141, DOI 10.1016/j.lindif.2015.03.017; van den Boer M, 2013, SCI STUD READ, V17, P243, DOI 10.1080/10888438.2012.683222; Van Den Bos K. P., 1994, KLEPEL TEST LEESVAAR; van den Bos KP, 2007, TEST DIAGNOSTI CEREN; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wechsler D, 1997, WAIS 3 NEDERLANDSTAL; Ziegler JC, 2010, DEVELOPMENTAL SCI, V13, pF8, DOI 10.1111/j.1467-7687.2010.00983.x	56	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0196903	10.1371/journal.pone.0196903	http://dx.doi.org/10.1371/journal.pone.0196903			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG2QJ	29782515	gold, Green Published			2022-12-26	WOS:000432537100010
J	Estrin, MA; Hussein, ITM; Puryear, WB; Kuan, AC; Artim, SC; Runstadler, JA				Estrin, Michael A.; Hussein, Islam T. M.; Puryear, Wendy B.; Kuan, Anne C.; Artim, Stephen C.; Runstadler, Jonathan A.			Host-directed combinatorial RNAi improves inhibition of diverse strains of influenza A virus in human respiratory epithelial cells	PLOS ONE			English	Article							WEST-NILE-VIRUS; MESSENGER-RNA; SEASONAL INFLUENZA; NEURAMINIDASE INHIBITORS; SCREEN REVEALS; NUCLEAR EXPORT; UNITED-STATES; IN-VIVO; REPLICATION; INFECTION	Influenza A virus infections are important causes of morbidity and mortality worldwide, and currently available prevention and treatment methods are suboptimal. In recent years, genome-wide investigations have revealed numerous host factors that are required for influenza to successfully complete its life cycle. However, only a select, small number of influenza strains were evaluated using this platform, and there was considerable variation in the genes identified across different investigations. In an effort to develop a universally efficacious therapeutic strategy with limited potential for the emergence of resistance, this study was performed to investigate the effect of combinatorial RNA interference (RNAi) on inhibiting the replication of diverse influenza A virus subtypes and strains. Candidate genes were selected for targeting based on the results of multiple previous independent genome-wide studies. The effect of single and combinatorial RNAi on the replication of 12 diverse influenza A viruses, including three strains isolated from birds and one strain isolated from seals, was then evaluated in primary normal human bronchial epithelial cells. After excluding overly toxic siRNA, two siRNA combinations were identified that reduced mean viral replication by greater than 79 percent in all mammalian strains, and greater than 68 percent in all avian strains. Host-directed combinatorial RNAi effectively prevents growth of a broad range of influenza virus strains in vitro, and is a potential therapeutic candidate for further development and future in vivo studies.	[Estrin, Michael A.; Hussein, Islam T. M.; Puryear, Wendy B.; Kuan, Anne C.; Artim, Stephen C.; Runstadler, Jonathan A.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Runstadler, Jonathan A.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hussein, Islam T. M.] Microbiotix, One Innovat Dr, Worcester, MA USA; [Puryear, Wendy B.; Runstadler, Jonathan A.] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, Grafton, MA 01536 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tufts University	Runstadler, JA (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.; Runstadler, JA (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Runstadler, JA (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, Grafton, MA 01536 USA.	jonathan.runstadler@tufts.edu		/0000-0003-4503-9024; Runstadler, Jonathan/0000-0002-6747-7765	National Institute of Allergy and Infectious Diseases [CEIRS - HHSN272201400008C, HHSN266200700010C]; National Institutes of Health [T32-OD010978]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010978] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institute of Allergy and Infectious Diseases: CEIRS - HHSN272201400008C (current); and HHSN266200700010C (2007-2014). M. E. was supported in part by National Institutes of Health grant #T32-OD010978, which supported his postdoctoral training. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chen HW, 2013, ANTIVIR RES, V99, P371, DOI 10.1016/j.antiviral.2013.06.014; Clarke DTW, 2014, CURRENT DRUG DELIVER; Cruz DJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002471; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; de Francisco N, 2015, VACCINE, V33, P6537, DOI 10.1016/j.vaccine.2015.10.066; Ebina H, 2004, MICROBES INFECT, V6, P715, DOI 10.1016/j.micinf.2004.04.002; Flannery B, 2014, MMWR-MORBID MORTAL W, V63, P137; Fujita Y, 2015, INT J MOL SCI, V16, P5254, DOI 10.3390/ijms16035254; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Govorkova EA, 2013, ANTIVIR RES, V98, P297, DOI 10.1016/j.antiviral.2013.02.013; GUINEA R, 1995, J VIROL, V69, P2306, DOI 10.1128/JVI.69.4.2306-2312.1995; GUINEA R, 1994, FEBS LETT, V349, P327, DOI 10.1016/0014-5793(94)00695-4; Hai R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3854; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Keightley MC, 2013, FEBS LETT, V587, P2150, DOI 10.1016/j.febslet.2013.05.030; Kobayashi H, 2015, BIOCHEM BIOPH RES CO, V467, P121, DOI 10.1016/j.bbrc.2015.09.106; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kurtovic-Kozaric A, 2015, LEUKEMIA, V29, P126, DOI 10.1038/leu.2014.144; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Li TJ, 2014, NUCLEIC ACID THER, V24, P302, DOI 10.1089/nat.2014.0480; Liu Y, 2015, NUCLEIC ACIDS RES, V43, pD946, DOI 10.1093/nar/gku1086; Margine I, 2014, PATHOGENS, V3, P845, DOI 10.3390/pathogens3040845; Meliopoulos VA, 2012, FASEB J, V26, P1372, DOI 10.1096/fj.11-193466; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Merkel OM, 2014, ADV DRUG DELIVER REV, V75, P112, DOI 10.1016/j.addr.2014.05.018; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Murray James L., 2012, Antiviral Chemistry & Chemotherapy, V22, P205, DOI 10.3851/IMP2080; Nguyen HT, 2012, ANTIVIR THER, V17, P159, DOI 10.3851/IMP2067; Okomo-Adhiambo M, 2013, INFLUENZA OTHER RESP, V7, P44, DOI [10.1111/irv.12113, 10.1111/irv.12051]; Ooi YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003835; Palese P., 2007, FIELDS VIROLOGY, P1647; Panda D, 2011, P NATL ACAD SCI USA, V108, P19036, DOI 10.1073/pnas.1113643108; Perwitasari O, 2014, J VIROL, V88, P10228, DOI 10.1128/JVI.01774-14; Perwitasari O, 2013, J VIROL, V87, P13775, DOI 10.1128/JVI.01509-13; Perwitasari O, 2013, ANTIMICROB AGENTS CH, V57, P475, DOI 10.1128/AAC.01532-12; Petrie JG, 2016, CLIN INFECT DIS, V62, P448, DOI 10.1093/cid/civ952; Prussia A, 2011, INT J MOL SCI, V12, P4027, DOI 10.3390/ijms12064027; Qi W, 2014, EUROPEAN COMMUNICABL, V19; Rajani KR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002929; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; Reed R, 2005, CURR OPIN CELL BIOL, V17, P269, DOI 10.1016/j.ceb.2005.04.011; Runstadler J, 2013, INFECT GENET EVOL, V17, P162, DOI 10.1016/j.meegid.2013.02.020; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Scott LM, 2013, JNCI-J NATL CANCER I, V105, P1540, DOI 10.1093/jnci/djt257; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Silva-Ayala D, 2013, P NATL ACAD SCI USA, V110, P10270, DOI 10.1073/pnas.1304932110; Sivan G, 2013, P NATL ACAD SCI USA, V110, P3519, DOI 10.1073/pnas.1300708110; Stertz S, 2011, MICROBES INFECT, V13, P516, DOI 10.1016/j.micinf.2011.01.012; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Su WC, 2013, P NATL ACAD SCI USA, V110, P17516, DOI 10.1073/pnas.1312374110; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Torner N, 2014, HUMAN VACCINES IMMUN, V11; Tran AT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.296; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Ward SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039284; Watanabe T, 2014, CELL HOST MICROBE, V16, P795, DOI 10.1016/j.chom.2014.11.002; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; WHITNEY JA, 1995, CELL, V83, P703; Yang C, 2014, IEEE COMPUT SOC CONF, P9, DOI 10.1109/CVPRW.2014.7; Yang J, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0077-6; Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914; Zhou X, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.445122	75	5	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197246	10.1371/journal.pone.0197246	http://dx.doi.org/10.1371/journal.pone.0197246			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775471	gold, Green Submitted, Green Published			2022-12-26	WOS:000432521100014
J	Wang, YX; Xu, L; Wei, WB; Jonas, JB				Wang, Ya Xing; Xu, Liang; Wei, Wen Bin; Jonas, Jost B.			Intraocular pressure and its normal range adjusted for ocular and systemic parameters. The Beijing Eye Study 2011	PLOS ONE			English	Article							CENTRAL CORNEAL THICKNESS; OPEN-ANGLE GLAUCOMA; DEFINED POPULATION; BLOOD-PRESSURE; JAPANESE; CHINESE; ASSOCIATION; PREVALENCE; PROGRESSION; CURVATURE	Purpose To examine the distribution of intraocular pressure (IOP) in a normal population and the associations of IOP with other ocular and systemic parameters. Methods Out of 3468 participants of the population-based cross-sectional Beijing Eye Study 2011 we selected those individuals without glaucomatous optic neuropathy. The study particpants underwent a detailed ophthalmologic and systemic examination. IOP was measured by air puff non-contact tonometry. Results The study included 3135 eyes of 3135 participants with a mean age of 64.1 +/- 9.6 years (mean +/- standard deviation). The mean IOP was 14.7 +/- 2.8 mmHg. The 95% percentile and 97.5% percentile of the IOP distribution decreased from 20 mmHg / 21 mmHg in individuals aged 40 to 54 years to 18 mmHg /19 mmHg in individuals aged >= 80 years. In multivariable analysis, higher IOP was associated with the systemic parameters of younger age (P < 0.001), higher blood concentration of glucose (P = 0.03) and triglycerides (P < 0.001), higher diastolic blood pressure (P < 0.001), higher pulse rate (P = 0.003) and higher quantity of alcohol consumption (P = 0.004), and with the ocular parameters of larger central corneal thickness (P < 0.001), more myopic refractive error (P = 0.01) and steeper anterior corneal curvature radius (P = 0.006). IOP decreased significantly by 0.50 mmHg and 0.76 mmHg for each increase in age by 10 years and each increase in corneal curvature radius by 1.0 mm, respectively. The range of the mean +/- 2 standard deviations of the IOP adjusted for the parameters of the multivariable model was 9.0 to 18.1 mmHg versus 9.2-20.2 mmHg for the unadjusted IOP. In the age group of 50 to 55 years, the age-adjusted IOP range (mean +/- 2 Conclusions IOP physiologically depends on a multitude of systemic and ocular factors including age and blood pressure. These physiological associations of the IOP may be taken into account in the definition of the normal range of the IOP.	[Wang, Ya Xing; Xu, Liang; Jonas, Jost B.] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab,Beijing I, Beijing, Peoples R China; [Wei, Wen Bin] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab,Dept Opht, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Capital Medical University; Ruprecht Karls University Heidelberg	Wang, YX; Jonas, JB (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab,Beijing I, Beijing, Peoples R China.; Jonas, JB (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany.	yaxingw@gmail.com; jost.jonas@medma.uni-heidelberg.de	wei, wei/HHR-8613-2022; wang, YA XING/K-9671-2016	wang, YA XING/0000-0003-2749-7793; Jonas, Jost/0000-0003-2972-5227	National Natural Science Foundation of China [81570835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (grant # 81570835) to author Ya Xing Wang. The funder has no role in the study design, data collection and analysis, decision to publish or preparation of the manuscripts. No additional external funding received for this study.	Ahrlich KG, 2010, INVEST OPHTH VIS SCI, V51, P1458, DOI 10.1167/iovs.09-3806; [Anonymous], 1991, Ophthalmology, V98, P786; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; Chan MPY, 2016, OPHTHALMOLOGY, V123, P771, DOI 10.1016/j.ophtha.2015.11.031; Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x; Foster PJ, 2003, INVEST OPHTH VIS SCI, V44, P3885, DOI 10.1167/iovs.03-0012; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Fukuoka S, 2008, ACTA OPHTHALMOL, V86, P434, DOI 10.1111/j.1600-0420.2007.01068.x; HOLLOWS FC, 1966, BRIT J OPHTHALMOL, V50, P570, DOI 10.1136/bjo.50.10.570; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jonas JB, 2017, LANCET, V390, P2183, DOI 10.1016/S0140-6736(17)31469-1; Jonas JB, 2015, ACTA OPHTHALMOL, V93, pE7, DOI 10.1111/aos.12480; Jonas JB, 2011, J GLAUCOMA, V20, P405, DOI 10.1097/IJG.0b013e3181f7af9b; Kassoff A, 2001, AM J OPHTHALMOL, V131, P167; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Kohlhaas M, 2006, ARCH OPHTHALMOL-CHIC, V124, P471, DOI 10.1001/archopht.124.4.471; Krupin T, 2011, AM J OPHTHALMOL, V151, P671, DOI 10.1016/j.ajo.2010.09.026; Leske MC, 1997, ARCH OPHTHALMOL-CHIC, V115, P1051, DOI 10.1001/archopht.1997.01100160221012; LEYDHECKER W, 1958, Klin Monbl Augenheilkd Augenarztl Fortbild, V133, P662; MCLEOD SD, 1990, INVEST OPHTH VIS SCI, V31, P2361; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Mitchell P, 2005, AM J OPHTHALMOL, V140, P131, DOI 10.1016/j.ajo.2004.12.088; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Pekmezci M, 2009, ARCH OPHTHALMOL-CHIC, V127, P167, DOI 10.1001/archophthalmol.2008.593; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; Tomoyose E, 2010, AM J OPHTHALMOL, V150, P279, DOI 10.1016/j.ajo.2010.03.009; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Wang DD, 2011, AM J OPHTHALMOL, V152, P454, DOI 10.1016/j.ajo.2011.03.005; Wang YX, 2012, BRIT J OPHTHALMOL, V96, P811, DOI 10.1136/bjophthalmol-2011-301224; Wolfs RC, 1997, AM J OPHTHALMOL, V123, P767, DOI 10.1016/S0002-9394(14)71125-0; Wong TT, 2009, INVEST OPHTH VIS SCI, V50, P4097, DOI 10.1167/iovs.08-2822; Xu L, 2007, AM J OPHTHALMOL, V144, P541, DOI 10.1016/j.ajo.2007.05.038; Zhang HT, 2008, GRAEF ARCH CLIN EXP, V246, P587, DOI 10.1007/s00417-007-0760-9; Zhang JS, 2011, OPHTHALMOLOGY, V118, P711, DOI 10.1016/j.ophtha.2010.08.021; Zhou JQ, 2013, OPHTHALMOLOGY, V120, P803, DOI 10.1016/j.ophtha.2012.09.033; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	38	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196926	10.1371/journal.pone.0196926	http://dx.doi.org/10.1371/journal.pone.0196926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771944	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900024
J	Zamli, KZ; Din, F; Ahmed, BS; Bures, M				Zamli, Kamal Z.; Din, Fakhrud; Ahmed, Bestoun S.; Bures, Miroslav			A hybrid Q-learning sine-cosine-based strategy for addressing the combinatorial test suite minimization problem	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; COVERING ARRAYS; STRENGTH; SYSTEM	The sine-cosine algorithm (SCA) is a new population-based meta-heuristic algorithm. In addition to exploiting sine and cosine functions to perform local and global searches (hence the name sine-cosine), the SCA introduces several random and adaptive parameters to facilitate the search process. Although it shows promising results, the search process of the SCA is vulnerable to local minima/maxima due to the adoption of a fixed switch probability and the bounded magnitude of the sine and cosine functions (from -1 to 1). In this paper, we propose a new hybrid Q-learning sine-cosine- based strategy, called the Q-learning sinecosine algorithm (QLSCA). Within the QLSCA, we eliminate the switching probability. Instead, we rely on the Q-learning algorithm (based on the penalty and reward mechanism) to dynamically identify the best operation during runtime. Additionally, we integrate two new operations (Levy flight motion and crossover) into the QLSCA to facilitate jumping out of local minima/maxima and enhance the solution diversity. To assess its performance, we adopt the QLSCA for the combinatorial test suite minimization problem. Experimental results reveal that the QLSCA is statistically superior with regard to test suite size reduction compared to recent state-of-the-art strategies, including the original SCA, the particle swarm test generator (PSTG), adaptive particle swarm optimization (APSO) and the cuckoo search strategy (CS) at the 95% confidence level. However, concerning the comparison with discrete particle swarm optimization (DPSO), there is no significant difference in performance at the 95% confidence level. On a positive note, the QLSCA statistically outperforms the DPSO in certain configurations at the 90% confidence level.	[Zamli, Kamal Z.; Din, Fakhrud] Univ Malaysia Pahang Lebuhraya Tun Razak, Fac Comp Syst & Software Engn, IBM Ctr Excellence, Kuantan 26300, Pahang Darul Ma, Malaysia; [Ahmed, Bestoun S.; Bures, Miroslav] Czech Tech Univ, Software Testing Intelligent Lab STILL, Dept Comp Sci, Fac Elect Engn, Karlovo Nam 13, Prague 12135 2, Czech Republic	Universiti Malaysia Pahang; Czech Technical University Prague	Zamli, KZ (corresponding author), Univ Malaysia Pahang Lebuhraya Tun Razak, Fac Comp Syst & Software Engn, IBM Ctr Excellence, Kuantan 26300, Pahang Darul Ma, Malaysia.	kamalz@ump.edu.my	Bures, Miroslav/AAQ-3424-2020; Ahmed, Bestoun S./B-4429-2010; Zamli, Kamal Z./F-6437-2010	Bures, Miroslav/0000-0002-2994-7826; Ahmed, Bestoun S./0000-0001-9051-7609; Zamli, Kamal Z./0000-0003-4626-0513	Ministry of Science, Technology, and Innovation, Malaysia; Ministry of Higher Education Malaysia; MOHE [RDU170103]	Ministry of Science, Technology, and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); MOHE(Ministry of Higher Education & Scientific Research (MHESR))	This study is funded by the Science Fund Grant for the project entitled, Constraints T-Way Testing Strategy with Modified Condition/Decision Coverage from the Ministry of Science, Technology, and Innovation, Malaysia. The work reported in this paper is funded by Fundamental Research Grant from Ministry of Higher Education Malaysia titled: A Reinforcement Learning Sine Cosine based Strategy for Combinatorial Test Suite Generation. We thank MOHE for the contribution and support, Grant number: RDU170103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work reported in this paper is funded by Fundamental Research Grant from Ministry of Higher Education Malaysia titled: A Reinforcement Learning Sine Cosine based Strategy for Combinatorial Test Suite Generation. We thank MOHE for the contribution and support, Grant number: RDU170103.	Ahmed BS, 2015, INFORM SOFTWARE TECH, V66, P13, DOI 10.1016/j.infsof.2015.05.005; Ahmed BS, 2012, APPL SOFT COMPUT, V12, P1330, DOI 10.1016/j.asoc.2011.11.029; Ahmed BS, 2011, J SYST SOFTWARE, V84, P2171, DOI 10.1016/j.jss.2011.06.004; Alsewari ARA, 2012, INFORM SOFTWARE TECH, V54, P553, DOI 10.1016/j.infsof.2012.01.002; Alsewari ARA., 2012, INT J PHYS SCI, V7, P1062, DOI DOI 10.5897/IJPS11.1633; Camastra F, 2015, EXPERT SYST APPL, V42, P1710, DOI 10.1016/j.eswa.2014.09.041; Chen X, 2009, ASIA PAC SOFWR ENG, P160, DOI 10.1109/APSEC.2009.18; Cohen M., 2005, THESIS; Cohen MB, 2003, 27TH ANNUAL INTERNATIONAL COMPUTER SOFTWARE AND APPLICATIONS CONFERENCE, PROCEEDINGS, P413; Cohen MB, 2008, DISCRETE MATH, V308, P2709, DOI 10.1016/j.disc.2006.06.036; Colbourn CJ, 2010, DISCRETE APPL MATH, V158, P1158, DOI 10.1016/j.dam.2010.03.008; Cordon O, 2011, INT J APPROX REASON, V52, P894, DOI 10.1016/j.ijar.2011.03.004; Din F, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON SOFTWARE QUALITY, RELIABILITY AND SECURITY COMPANION (QRS-C), P85, DOI 10.1109/QRS-C.2017.22; Eberhart R., 1995, P 6 INT S MICR HUM S, P39, DOI DOI 10.1109/MHS.1995.494215; Fisher K., 2008, GLOB TELECOMM CONF, P1, DOI DOI 10.1109/GLOCOM.2008.ECP.9; Gambardella L. M., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P252; Ghedira K., 2011, 2011 IEEE S SWARM IN, P1; Guo MZ, 2004, IEEE T SYST MAN CY B, V34, P2140, DOI 10.1109/TSMCB.2004.832154; Harman M, 2001, INFORM SOFTWARE TECH, V43, P833, DOI 10.1016/S0950-5849(01)00189-6; Holland J.H., 1975, ADAPTATION NATURAL A; HOLM S, 1979, SCAND J STAT, V6, P65; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Machado L, 2002, ANN NUCL ENERGY, V29, P1455, DOI 10.1016/S0306-4549(01)00118-9; Mahmoud T, 2015, EXPERT SYST APPL, V42, P8753, DOI 10.1016/j.eswa.2015.07.029; Mirjalili S, 2016, KNOWL-BASED SYST, V96, P120, DOI 10.1016/j.knosys.2015.12.022; Othman R. R., 2011, SCI RES ESSAYS, V6, P3638, DOI DOI 10.5897/SRE10.1196; Press W. H., 1992, ART SCI COMPUTING; Robinson J, 2004, IEEE T ANTENN PROPAG, V52, P397, DOI 10.1109/TAP.2004.823969; Samma H, 2016, APPL SOFT COMPUT, V43, P276, DOI 10.1016/j.asoc.2016.01.006; Shiba T., 2004, Proceedings of the 28th Annual International Computer Software and Applications Conference. COMPSAC 2004, P72, DOI 10.1109/CMPSAC.2004.1342808; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Wolpert D. H., 1997, IEEE Transactions on Evolutionary Computation, V1, P67, DOI 10.1109/4235.585893; Wu HY, 2015, IEEE T EVOLUT COMPUT, V19, P575, DOI 10.1109/TEVC.2014.2362532; Yang X., 2008, NATURE INSPIRED META, V2nd; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Yang XS, 2010, STUD COMPUT INTELL, V284, P65, DOI 10.1007/978-3-642-12538-6_6; Zamli KZ, 2017, INFORM SCIENCES, V399, P121, DOI 10.1016/j.ins.2017.03.007; Zamli KZ, 2017, ENG APPL ARTIF INTEL, V59, P35, DOI 10.1016/j.engappai.2016.12.014; Zamli KZ, 2016, APPL SOFT COMPUT, V44, P57, DOI 10.1016/j.asoc.2016.03.021	40	37	37	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0195675	10.1371/journal.pone.0195675	http://dx.doi.org/10.1371/journal.pone.0195675			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771918	Green Published, gold, Green Submitted			2022-12-26	WOS:000432348900004
J	Jain, P; Bhatla, SC				Jain, Prachi; Bhatla, Satish C.			Tyrosine nitration of cytosolic peroxidase is probably triggered as a long distance signaling response in sunflower seedling cotyledons subjected to salt stress	PLOS ONE			English	Article							EXOGENOUS NITRIC-OXIDE; INDUCED OXIDATIVE STRESS; SODIUM-NITROPRUSSIDE; ASCORBATE PEROXIDASE; HORSERADISH-PEROXIDASE; S-NITROSYLATION; GROWTH; METABOLISM; ACCUMULATION; TOLERANCE	Present work focuses on tissue and concentration-dependent effect of nitric oxide (NO) on the modulation of cytosolic peroxidase (POD; EC 1.11.1.7) activity in 2-day old etiolated sunflower (Helianthus annuus L.) seedlings. Exogenously supplied NO (in the form of sodium nitroprusside [SNP] or diethylenetriamine NONOate [DETA]; 125 to 500 mu M) results in noteworthy enhancement in seedling growth in a concentration dependent manner irrespective of salt-stress and differentially affects POD activity in 2-day old seedling cotyledons. Elevated NO availability leads to an increase in the specific activity of POD in a concentration-dependent manner within 48 hrs as a rapid signaling response. Purification of POD protein using immunoprecipitation technique has shown that cotyledons derived from salt stressed seedlings exhibit a higher extent of tyrosine nitration of POD as compared to the control seedlings. Out of the four tyrosine residues found in the amino acid sequence of POD, the one at position 100 has been predicted to undergo nitration. Thus, a probable NO-POD crosstalk is evident in sunflower seedling cotyledons accompanying salt stress.	[Jain, Prachi; Bhatla, Satish C.] Univ Delhi, Dept Bot, Lab Plant Physiol & Biochem, Delhi, India	University of Delhi	Bhatla, SC (corresponding author), Univ Delhi, Dept Bot, Lab Plant Physiol & Biochem, Delhi, India.	bhatlasc@gmail.com			University of Delhi; University Grants Commission; UGC Non-NET scholarship	University of Delhi(University of Delhi); University Grants Commission(University Grants Commission, India); UGC Non-NET scholarship	The authors are grateful to University of Delhi and University Grants Commission for providing financial assistance and UGC Non-NET scholarship to PJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba CM, 1998, J PLANT GROWTH REGUL, V17, P7, DOI 10.1007/PL00007013; Arora D, 2017, FREE RADICAL BIO MED, V106, P315, DOI 10.1016/j.freeradbiomed.2017.02.042; Arora D, 2016, FREE RADICAL RES, V50, P291, DOI 10.3109/10715762.2015.1118473; Arora D, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1071753; ASCENZI P, 1989, BIOCHEM J, V258, P473, DOI 10.1042/bj2580473; Asgher M, 2017, ENVIRON SCI POLLUT R, V24, P2273, DOI 10.1007/s11356-016-7947-8; Begara-Morales JC, 2014, J EXP BOT, V65, P527, DOI 10.1093/jxb/ert396; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIBBAR RN, 1984, PLANT PHYSIOL, V75, P956, DOI 10.1104/pp.75.4.956; Clark D, 2000, MOL PLANT MICROBE IN, V13, P1380, DOI 10.1094/MPMI.2000.13.12.1380; Monzon GC, 2014, NITRIC OXIDE-BIOL CH, V39, P20, DOI 10.1016/j.niox.2014.04.004; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Creus CM, 2005, PLANTA, V221, P297, DOI 10.1007/s00425-005-1523-7; David A, 2010, PHYSIOL PLANTARUM, V140, P342, DOI 10.1111/j.1399-3054.2010.01408.x; de Montellano PRO, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P79, DOI 10.1007/978-3-642-12627-7_5; de Pinto MC, 2013, PLANT PHYSIOL, V163, P1766, DOI 10.1104/pp.113.222703; Dong YJ, 2014, J SOIL SCI PLANT NUT, V14, P1, DOI 10.4067/S0718-95162014005000001; Ebrahimi R, 2011, COMMUN SOIL SCI PLAN, V42, P815, DOI 10.1080/00103624.2011.552657; Esim N., 2013, Australian Journal of Crop Science, V7, P1085; Fan Huaifu, 2007, Frontiers of Agriculture in China, V1, P308, DOI 10.1007/s11703-007-0052-5; Fatma M, 2016, CROP J, V4, P153, DOI 10.1016/j.cj.2016.01.009; Fatma M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00521; Feelisch M, 1998, N-S ARCH PHARMACOL, V358, P113, DOI 10.1007/PL00005231; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; Huang JM, 2002, J AM CHEM SOC, V124, P3473, DOI 10.1021/ja012271v; Jain P, 2018, FUNCT PLANT BIOL, V45, P70, DOI [10.1071/FP16279, 10.1071/fp16279]; Jain P, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.977746; Jamali Babak, 2014, Journal of Horticultural Research, V22, P139, DOI 10.2478/johr-2014-0031; KATERJI N, 1994, AGR WATER MANAGE, V26, P81, DOI 10.1016/0378-3774(94)90026-4; Kaur H, 2016, NITRIC OXIDE-BIOL CH, V59, P42, DOI 10.1016/j.niox.2016.07.001; Keyster M, 2011, PLANT SIGNAL BEHAV, V6, P956, DOI 10.4161/psb.6.7.14879; Kim YH, 2014, J PLANT BIOCHEM BIOT, V23, P440, DOI 10.1007/s13562-014-0272-8; Kumari Anita, 2010, Braz. J. Plant Physiol., V22, P271, DOI 10.1590/S1677-04202010000400007; Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007; Liu S, 2014, PLANT GROWTH REGUL, V73, P67, DOI 10.1007/s10725-013-9868-6; Liu XW, 2011, AFR J BIOTECHNOL, V10, P4380; Lozano-Juste J, 2011, J EXP BOT, V62, P3501, DOI 10.1093/jxb/err042; Manai J, 2014, J SOIL SCI PLANT NUT, V14, P433; Mata CG, 2001, PLANT PHYSIOL, V126, P1196, DOI 10.1104/pp.126.3.1196; Nasrin F., 2012, Journal of Stress Physiology & Biochemistry, V8, P214; Parvaiz Ahmad, 2012, African Journal of Biotechnology, V11, P2694, DOI 10.5897/AJB11.3203; Per TS, 2017, NITRIC OXIDE-BIOL CH, V68, P111, DOI 10.1016/j.niox.2016.12.012; Planchet E, 2006, J EXP BOT, V57, P3043, DOI 10.1093/jxb/erl070; Ruan HH, 2002, CHINESE SCI BULL, V47, P677, DOI 10.1360/02tb9154; Sheokand Sunita, 2010, Braz. J. Plant Physiol., V22, P81, DOI 10.1590/S1677-04202010000200002; Shi QH, 2007, PLANT PHYSIOL BIOCH, V45, P542, DOI 10.1016/j.plaphy.2007.05.005; Shi SY, 2005, NITRIC OXIDE-BIOL CH, V13, P1, DOI 10.1016/j.niox.2005.04.006; Singh HP, 2008, ENVIRON EXP BOT, V63, P158, DOI 10.1016/j.envexpbot.2007.12.005; Singh N, 2016, NITRIC OXIDE-BIOL CH, V53, P54, DOI 10.1016/j.niox.2016.01.003; Sreenivasulu N, 1999, PLANT SCI, V141, P1, DOI 10.1016/S0168-9452(98)00204-0; Tan JinFang, 2008, World Journal of Agricultural Sciences, V4, P307; Tanou G, 2012, PLANT J, V72, P585, DOI 10.1111/j.1365-313X.2012.05100.x; Uchida A, 2002, PLANT SCI, V163, P515, DOI 10.1016/S0168-9452(02)00159-0; Wang SH, 2010, RUSS J PLANT PHYSL+, V57, P833, DOI 10.1134/S1021443710060129; Wang YS, 2013, J AGR FOOD CHEM, V61, P8880, DOI 10.1021/jf401447y; Wang YS, 2005, PLANT CELL PHYSIOL, V46, P1915, DOI 10.1093/pcp/pci202; Welinder KG, 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [DOI 10.1016/0959-440X(92)90230-5, 10.1016/0959-440x(92)90230-5]; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xiong J, 2010, ARCH BIOCHEM BIOPHYS, V497, P13, DOI 10.1016/j.abb.2010.02.014; Yadav S, 2010, PLANT SIGNAL BEHAV, V5, P1163, DOI 10.4161/psb.5.10.12159; Yang HJ, 2015, PLANT PHYSIOL, V167, P1604, DOI 10.1104/pp.114.255216; Yang JD, 2006, BOT STUD, V47, P129; Zhang LS, 2016, TURK J BOT, V40, P17, DOI 10.3906/bot-1407-31; Zhou BY, 2005, J EXP BOT, V56, P3223, DOI 10.1093/jxb/eri319	67	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197132	10.1371/journal.pone.0197132	http://dx.doi.org/10.1371/journal.pone.0197132			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768452	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200059
J	Lehtovirta, L; Reito, A; Parkkinen, J; Peraniemi, S; Vepsalainen, J; Eskelinen, A				Lehtovirta, Lari; Reito, Aleksi; Parkkinen, Jyrki; Peraniemi, Sirpa; Vepsalainen, Jouko; Eskelinen, Antti			Association between periprosthetic tissue metal content, whole blood and synovial fluid metal ion levels and histopathological findings in patients with failed metal-on-metal hip replacement	PLOS ONE			English	Article							WEAR PARTICLES; ADVERSE-REACTIONS; DEBRIS; CORROSION; FAILURE; COBALT; PSEUDOTUMORS; PROSTHESES; FEATURES	Adverse Reaction to Metal Debris (ARMD) is a major cause of implant failure leading to revision surgery in patients with metal-on-metal (MoM) hip arthroplasties. However, the pathogenesis and its association to implant wear are poorly understood and previous studies have yielded discrepant results. We sought to investigate the associations between histological findings, whole blood and synovial fluid metal ion concentrations and periprosthetic tissue metal concentrations in patients with MoM total hip replacements and hip resurfacings revised for ARMD. 107 hips in total were included in our study. Of these, 87 were total hip replacements and 20 were hip resurfacings, respectively. We found that whole blood, synovial fluid and periprosthetic tissue metal concentrations correlated poorly with histological findings. We suggest that the lack of a clear association between histological findings and wear measures in the present study as well as in previous studies is mostly influenced by variability in patient susceptibility. However, patients presenting with perivascular lymphocytic infiltration had lower chromium concentration in their periprosthetic tissues than patients with no perivascular lymphocytic infiltration. This may reflect the role of metal hypersensitivity in implant failure in these patients. Patients with total hip replacements evinced more necrosis and lymphocytic infiltration in their tissues than patients with hip resurfacings. This suggests that trunnion wear debris is more cytotoxic and/or immunogenic than bearing wear debris leading to higher failure rates seen in patients with total hip replacements.	[Lehtovirta, Lari] Univ Tampere, Tampere, Finland; [Lehtovirta, Lari; Reito, Aleksi; Eskelinen, Antti] Coxa Hosp Joint Replacement, Tampere, Finland; [Parkkinen, Jyrki] Fimlab Labs, Tampere, Finland; [Peraniemi, Sirpa; Vepsalainen, Jouko] Univ Eastern Finland, Kuopio, Finland	Coxa Hospital for Joint Replacement; University of Eastern Finland	Lehtovirta, L (corresponding author), Univ Tampere, Tampere, Finland.; Lehtovirta, L (corresponding author), Coxa Hosp Joint Replacement, Tampere, Finland.	lehtovirta.lari.a@student.uta.fi	Eskelinen, Antti/AAW-9209-2021; Reito, Aleksi/AAC-3832-2020; Lehtovirta, Lari/AAH-3342-2021; Eskelinen, Antti/AAW-9223-2021	Eskelinen, Antti/0000-0003-0302-0253; Reito, Aleksi/0000-0002-6903-6461; Lehtovirta, Lari/0000-0002-9391-8915; Peraniemi, Sirpa/0000-0002-8670-6885	Competitive Research Funds of Pirkanmaa Hospital Didstrict [9N044]	Competitive Research Funds of Pirkanmaa Hospital Didstrict	The study was funded by the Competitive Research Funds of Pirkanmaa Hospital Didstrict (Grant 9N044, representing governmental funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasou NA, 2016, BONE JOINT RES, V5, P162, DOI 10.1302/2046-3758.55.BJR-2016-0086; Barrett WP, 2012, J ARTHROPLASTY, V27, P976, DOI 10.1016/j.arth.2012.01.019; Bosker BH, 2012, J BONE JOINT SURG BR, V94B, P755, DOI 10.1302/0301-620X.94B6.28373; BROWN SA, 1993, J BIOMED MATER RES, V27, P1007, DOI 10.1002/jbm.820270806; Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y; Catelas I, 2006, P I MECH ENG H, V220, P195, DOI 10.1243/09544119JEIM112; Catelas I, 2004, J BIOMED MATER RES B, V70B, P167, DOI 10.1002/jbm.b.20036; Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949; Ebramzadeh E, 2015, CLIN ORTHOP RELAT R, V473, P487, DOI 10.1007/s11999-014-3874-5; Ebramzadeh E, 2011, ORTHOP CLIN N AM, V42, P241, DOI 10.1016/j.ocl.2011.01.001; Grammatopoulos George, 2013, J Bone Joint Surg Am, V95, pe81, DOI 10.2106/JBJS.L.00775; Hart AJ, 2014, J BONE JOINT SURG AM, V96A, P1091, DOI 10.2106/JBJS.M.00957; Hart AJ, 2012, J BONE JOINT SURG AM, V94A, P317, DOI [10.2106/JBJS.J.01508, 10.2106/JBJS.K.01266]; Hart AJ, 2010, ACTA BIOMATER, V6, P4439, DOI 10.1016/j.actbio.2010.06.006; Hothi HS, 2016, J ARTHROPLASTY, V31, P1123, DOI 10.1016/j.arth.2015.11.014; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Lainiala OS, 2016, J ARTHROPLASTY, V31, P1261, DOI 10.1016/j.arth.2015.11.045; Langton D, 2013, BONE JOINT J, V95, P1; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P164, DOI 10.1302/0301-620X.93B2.25099; Liow MHL, 2016, J ARTHROPLASTY, V31, P1797, DOI 10.1016/j.arth.2016.01.041; Lohmann CH, 2013, J BONE JOINT SURG AM, V95A, P1561, DOI 10.2106/JBJS.L.01273; Mahendra G, 2009, ACTA ORTHOP, V80, P653, DOI 10.3109/17453670903473016; Matthies AK, 2013, J ORTHOP RES, V31, P1677, DOI 10.1002/jor.22431; Matthies AK, 2012, CLIN ORTHOP RELAT R, V470, P1895, DOI 10.1007/s11999-011-2201-7; MERRITT K, 1989, J BIOMED MATER RES, V23, P845, DOI 10.1002/jbm.820230804; Natu S, 2012, J CLIN PATHOL, V65, P409, DOI 10.1136/jclinpath-2011-200398; Nawabi DH, 2014, CLIN ORTHOP RELAT R, V472, P543, DOI 10.1007/s11999-013-3199-9; Paukkeri EL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155121; Reito A, 2015, BMC MUSCULOSKEL DIS, V16, P1, DOI DOI 10.1186/s12891-015-0454-0; Reito A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147872; Reito A, 2014, INT ORTHOP, V38, P2251, DOI 10.1007/s00264-014-2429-4; Reito A, 2014, INT ORTHOP, V38, P1353, DOI 10.1007/s00264-014-2300-7; Reito A, 2013, CLIN ORTHOP RELAT R, V471, P2954, DOI 10.1007/s11999-013-3023-6; Renner L, 2016, ARCH ORTHOP TRAUM SU, V136, P715, DOI 10.1007/s00402-016-2439-3; Scharf B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05729; Scheuer P, 1980, LIVER BIOPSY INTERPR, P189; Searle J, 1994, PATHOLOGY LIVER, P219; Vendittoli PA, 2010, J BONE JOINT SURG BR, V92B, P12, DOI 10.1302/0301-620X.92B1.22226; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; Xia ZD, 2017, NANOMED-NANOTECHNOL, V13, P1205, DOI 10.1016/j.nano.2016.11.003	41	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197614	10.1371/journal.pone.0197614	http://dx.doi.org/10.1371/journal.pone.0197614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768492	Green Published, gold			2022-12-26	WOS:000432329200096
J	Ogneva, IV; Loktev, SS; Sychev, VN				Ogneva, Irina, V; Loktev, Sergey S.; Sychev, Vladimir N.			Cytoskeleton structure and total methylation of mouse cardiac and lung tissue during space flight	PLOS ONE			English	Article							DNA METHYLATION; GENE-EXPRESSION; CARDIOVASCULAR ADAPTATION; CORTICAL CYTOSKELETON; MODELED MICROGRAVITY; HISTONE DEACETYLASE; SKELETAL-MUSCLES; ALPHA-ACTININ; CELLS; FIBERS	The purpose of this work was to evaluate the protein and mRNA expression levels of multiple cytoskeletal proteins in the cardiac and lung tissue of mice that were euthanized onboard the United States Orbital Segment of the International Space Station 37 days after the start of the SpaceX-4 mission (September 2014, USA). The results showed no changes in the cytoskeletal protein content in the cardiac and lung tissue of the mice, but there were significant changes in the mRNA expression levels of the associated genes, which may be due to an increase in total genome methylation. The mRNA expression levels of DNA methylases, the cytosine demethylases Tet1 and Tet3, histone acetylase and histone deacetylase did not change, and the mRNA expression level of cytosine demethylase Tet2 was significantly decreased.	[Ogneva, Irina, V; Loktev, Sergey S.; Sychev, Vladimir N.] Russian Acad Sci, Russian Federat Inst Biomed Problems, Cell Biophys Lab, State Sci Ctr, Moscow, Russia; [Ogneva, Irina, V] IM Sechenov First Moscow State Med Univ, Moscow, Russia	Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Sechenov First Moscow State Medical University	Ogneva, IV (corresponding author), Russian Acad Sci, Russian Federat Inst Biomed Problems, Cell Biophys Lab, State Sci Ctr, Moscow, Russia.; Ogneva, IV (corresponding author), IM Sechenov First Moscow State Med Univ, Moscow, Russia.	iogneva@yandex.ru	Ogneva, Irina V/Q-8783-2018	Ogneva, Irina V/0000-0003-0125-5876	program of fundamental research SSC RF-IBMP RAS; RAS Presidium	program of fundamental research SSC RF-IBMP RAS; RAS Presidium(Russian Academy of Sciences)	The tissue sharing was conducted in accordance with the NASA-Roscosmos protocol "Utilization Sharing Plan on-board ISS" (signed July 18, 2013). The study was financially supported by the program of fundamental research SSC RF-IBMP RAS, program "Cell and Molecular Biology" of the RAS Presidium.	BARON MD, 1987, BIOCHEM SOC T, V15, P796, DOI 10.1042/bst0150796; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Broderick MJF, 2002, J STRUCT BIOL, V137, P184, DOI 10.1006/jsbi.2002.4465; BUNGO MW, 1987, J APPL PHYSIOL, V62, P278, DOI 10.1152/jappl.1987.62.1.278; CHARLES JB, 1991, J CLIN PHARMACOL, V31, P1010, DOI 10.1002/j.1552-4604.1991.tb03665.x; Chowdhury B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147514; Corydon TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20043; Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gaboyard S, 2002, NEUROREPORT, V13, P2139, DOI 10.1097/00001756-200211150-00030; Gazenko O G, 1980, Physiologist, V23, pS11; Gershovich P.M., 2008, J GRAV PHYSL, V15, P203; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goffart S, 2006, CURR GENET, V49, P125, DOI 10.1007/s00294-005-0043-0; Gonzalez AM, 2001, J CELL SCI, V114, P4197; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Jangiam W, 2015, INT J RADIAT BIOL, V91, P389, DOI 10.3109/09553002.2015.1001882; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Kinney SM, 2011, J BIOL CHEM, V286, P24685, DOI 10.1074/jbc.M110.217083; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Krais AM, 2011, EPIGENETICS-US, V6, P560, DOI 10.4161/epi.6.5.15678; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McArthur M, 1996, EMBO J, V15, P1705, DOI 10.1002/j.1460-2075.1996.tb00516.x; MCKEON C, 1982, CELL, V29, P203, DOI 10.1016/0092-8674(82)90104-0; Menon MP, 2015, AM J SURG PATHOL, V39, P1719, DOI 10.1097/PAS.0000000000000503; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; NIXON JV, 1979, J APPL PHYSIOL, V46, P541, DOI 10.1152/jappl.1979.46.3.541; Ogneva IV, 2014, J APPL PHYSIOL, V116, P1315, DOI 10.1152/japplphysiol.00134.2014; Ogneva IV, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/598461; Ogneva IV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153650; Ogneva IV, 2015, J APPL PHYSIOL, V118, P613, DOI 10.1152/japplphysiol.00812.2014; Ogneva IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096395; Ou XF, 2009, MUTAT RES-FUND MOL M, V662, P44, DOI 10.1016/j.mrfmmm.2008.12.004; Park JB, 2000, J BIOL CHEM, V275, P21295, DOI 10.1074/jbc.M002463200; PENN NW, 1972, BIOCHEM J, V126, P781, DOI 10.1042/bj1260781; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Povysheva T V, 2016, Dokl Biol Sci, V469, P163, DOI 10.1134/S0012496616040153; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Riley D A, 1995, Basic Appl Myol, V5, P139; RILEY DA, 1990, FASEB J, V4, P84, DOI 10.1096/fasebj.4.1.2153085; Riley DA, 1996, J APPL PHYSIOL, V81, P133, DOI 10.1152/jappl.1996.81.1.133; RILEY DA, 1992, J APPL PHYSIOL, V73, pS33, DOI 10.1152/jappl.1992.73.2.S33; Riley DA, 2000, J APPL PHYSIOL, V88, P567, DOI 10.1152/jappl.2000.88.2.567; Rithidech KN, 2015, MUTAT RES-FUND MOL M, V781, P22, DOI 10.1016/j.mrfmmm.2015.09.001; SAVIK ZF, 1981, KOSM BIOL AVIAK MED+, V15, P78; Schatten H, 2001, ACTA ASTRONAUT, V49, P399, DOI 10.1016/S0094-5765(01)00116-3; Shimada N, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-10; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Tauber S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175599; THORNTON WE, 1987, AVIAT SPACE ENVIR MD, V58, pA86; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Uva BM, 2002, BRAIN RES, V934, P132, DOI 10.1016/S0006-8993(02)02415-0; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; VELEZ C, 1995, P SOC EXP BIOL MED, V210, P57; Vitorino R, 2007, ANAL BIOCHEM, V366, P156, DOI 10.1016/j.ab.2007.04.009; Watenpaugh D.E., 2011, COMPR PHYSIOL, DOI [10.1002/cphy.cp040129, DOI 10.1002/CPHY.CP040129]; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2002, APPL ENVIRON MICROB, V68, P5408, DOI 10.1128/AEM.68.11.5408-5416.2002	67	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0192643	10.1371/journal.pone.0192643	http://dx.doi.org/10.1371/journal.pone.0192643			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768411	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200002
J	Shimo, T; Tachibana, K; Obika, S				Shimo, Takenori; Tachibana, Keisuke; Obika, Satoshi			Construction of a tri-chromatic reporter cell line for the rapid and simple screening of splice-switching oligonucleotides targeting DMD exon 51 using high content screening	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ANTISENSE OLIGONUCLEOTIDES; IN-VIVO; MAMMALIAN-CELLS; MESSENGER-RNA; ASSAY; DESIGN; EXPRESSION; LNA; DIFFERENTIATION	Splice-switching oligonucleotides (SSOs) that can modulate RNA splicing are used for the treatment of many genetic disorders. To enhance the efficacy of modulating splicing, it is important to optimize SSOs with regard to target sites, GC content, melting temperature (T-m value), chemistries, and lengths. Thus, in vitro assay systems that allow for the rapid and simple screening of SSOs are essential for optimizing SSO design. In this study, we established a novel tri-chromatic reporter cell line for SSO screening. This reporter cell line is designed to express three different fluorescent proteins (blue, green, and red) and was employed for high content screening (HCS, also known as high content analysis; HCA) for the evaluation of SSO-induced exon skipping by analyzing the expression levels of fluorescent proteins. The blue fluorescent protein is stably expressed throughout the cell and is useful for data normalization using cell numbers. Furthermore, both the green and red fluorescent proteins were used for monitoring the splicing patterns of target genes. Indeed, we demonstrated that this novel reporter cell line involving HCS leads to a more rapid and simple approach for the evaluation of exon skipping than widely used methods, such as RTPCR, western blotting, and quantitative RT-PCR. Additionally, a brief screening of Locked nucleic acids (LNA)-based SSOs targeting exon 51 in DMD was performed using the reporter cell line. The LNA-based SSO cocktail shows high exon 51 skipping in a dose-dependent manner. Furthermore, the LNA-based SSO cocktails display high exon 51 skipping activities on endogenous DMD mRNA in human rhabdomyosarcoma cells.	[Shimo, Takenori; Tachibana, Keisuke; Obika, Satoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan	Osaka University	Obika, S (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan.	obika@phs.osaka-u.ac.jp	Obika, Satoshi/F-2742-2018	Obika, Satoshi/0000-0002-6842-6812	Project MEET, Osaka University; JSPS KAKENHI [23651236]; Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical Research and development (AMED);  [15J05689]	Project MEET, Osaka University; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); 	T.S. was supported by Grant-in-Aid for JSPS Research Fellow Grant Number 15J05689. K. T. was supported by Project MEET, Osaka University. S.O. was supported by JSPS KAKENHI Grant Number 23651236 and the Basic Science and Platform Technology Program for Innovative Biological Medicine from Japan Agency for Medical Research and development (AMED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2009, MOL THER, V17, P548, DOI 10.1038/mt.2008.205; Adams AM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-57; AGUANNO S, 1990, CANCER RES, V50, P3377; Aoki Y, 2010, MOL THER, V18, P1995, DOI 10.1038/mt.2010.186; Bellomo F, 2017, J INHERIT METAB DIS, V40, P601, DOI 10.1007/s10545-017-0055-1; BOUCHE M, 1993, EXP CELL RES, V208, P209, DOI 10.1006/excr.1993.1239; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Disterer P, 2014, HUM GENE THER, V25, P587, DOI 10.1089/hum.2013.234; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Echigoya Y, 2017, MOL THER, V25, P2561, DOI 10.1016/j.ymthe.2017.07.014; Graziewicz MA, 2008, MOL THER, V16, P1316, DOI 10.1038/mt.2008.85; Gurskaya NG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1314; Guterstam P, 2008, BIOCHEM J, V412, P307, DOI 10.1042/BJ20080013; Hoffman AF, 2007, METH MOL B, V356, P19; Ittig D, 2004, NUCLEIC ACIDS RES, V32, P346, DOI 10.1093/nar/gkh187; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h; Kishore S, 2008, GENE, V427, P104, DOI 10.1016/j.gene.2008.09.021; Kuroyanagi H, 2006, NAT METHODS, V3, P909, DOI 10.1038/NMETH944; Kuroyanagi H, 2010, NAT PROTOC, V5, P1495, DOI 10.1038/nprot.2010.107; Le BT, 2017, MOL THER-NUCL ACIDS, V9, P155, DOI 10.1016/j.omtn.2017.09.002; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Maruyama R, 2017, METHODS MOL BIOL, V1565, P201, DOI 10.1007/978-1-4939-6817-6_17; Naito Y, 2012, NUCLEIC ACIDS RES, V40, pW592, DOI 10.1093/nar/gks448; Nasim MT, 2006, NAT PROTOC, V1, P1022, DOI 10.1038/nprot.2006.148; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Nierode G, 2016, J MICROBIOL BIOTECHN, V26, P213, DOI 10.4014/jmb.1508.08007; Obika S, 1997, TETRAHEDRON LETT, V38, P8735, DOI 10.1016/S0040-4039(97)10322-7; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Palacino J, 2015, NAT CHEM BIOL, V11, P511, DOI [10.1038/NCHEMBIO.1837, 10.1038/nchembio.1837]; Roberts J, 2006, MOL THER, V14, P471, DOI 10.1016/j.ymthe.2006.05.017; Shi YH, 2017, BIOORG MED CHEM LETT, V27, P406, DOI 10.1016/j.bmcl.2016.12.056; Shimo T, 2014, NUCLEIC ACIDS RES, V42, P8174, DOI 10.1093/nar/gku512; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Somarelli JA, 2013, RNA, V19, P116, DOI 10.1261/rna.035097.112; Stein CA, 2017, MOL THER, V25, P1069, DOI 10.1016/j.ymthe.2017.03.023; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Takeuchi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010946; Touznik A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03850-2; Touznik A, 2014, EXPERT OPIN BIOL TH, V14, P809, DOI 10.1517/14712598.2014.896335; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yilmaz-Elis AS, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.58; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005	46	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197373	10.1371/journal.pone.0197373	http://dx.doi.org/10.1371/journal.pone.0197373			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768479	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200077
J	Zhang, D; Liu, YF; Tang, Y; Wang, XF; Li, ZC; Li, R; Ti, ZY; Gao, WD; Bai, JG; Lv, Y				Zhang, Da; Liu, Yanfang; Tang, Yao; Wang, Xiaofeng; Li, Zhichao; Li, Rui; Ti, Zhenyu; Gao, Weidong; Bai, Jigang; Lv, Yi			Increased mitochondrial fission is critical for hypoxia-induced pancreatic beta cell death	PLOS ONE			English	Article							CYTOCHROME-C; APOPTOSIS; CRISTAE; FUSION; PATHWAYS; DIVISION; BAX/BAK; ISLETS; DAMAGE	Hypoxia-mediated pancreatic beta cell death is one of the main causes of pancreatic beta celldeath, which leads to the loss of functional pancreatic beta cell mass and type 1 diabetes andtype 2 diabetes. However, the molecular mechanisms that control life and death of pancreatic beta cells remain poorly understood. Here we showed that mitochondrial fission was strongly induced in pancreatic beta cellsmainly due to an elevation of DRP1(S616) phosphorylation through HIF-1 alpha activation and subsequent DRP1 mitochondrial translocation. Hypoxia-induced pancreatic beta cell death can be reversed by the inhibition of mitochondrial fission viaDRP1 knockdown. We further demonstrated that hypoxia-induced mitochondrial fission untightened the cristae formation, which subsequently triggers mitochondrial cytochrome c release and consequent caspase activation. Moreover, treatment with mitochondrial division inhibitor-1 (Mdivi-1), a specific inhibitor of DRP1-mediated mitochondrial fission, significantly suppressedbeta cell death in vitro, indicating a promising therapeutic strategy for treatment of diabetes. Taken together, our results reveal a crucial role for the DRP1-mediated mitochondrial fission in hypoxia-induced beta cell death, which provides a strong evidence for thisprocessas drug target indiabetestreatment.	[Zhang, Da; Bai, Jigang; Lv, Yi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Inst Adv Surg Technol & Engn, Shaanxi Ctr Regenerat Med & Surg Engn,Dept Hepato, Xian, Shaanxi, Peoples R China; [Zhang, Da; Tang, Yao; Wang, Xiaofeng; Li, Zhichao; Li, Rui; Ti, Zhenyu; Gao, Weidong] Xian 3 Hosp, Dept Gen Surg, Xian, Shaanxi, Peoples R China; [Liu, Yanfang] Xian Childrens Hosp, Dept Ophthalmol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University	Lv, Y (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Inst Adv Surg Technol & Engn, Shaanxi Ctr Regenerat Med & Surg Engn,Dept Hepato, Xian, Shaanxi, Peoples R China.	luyi169@126.com	liu, yan/HGV-1365-2022; liu, yan/HCI-5542-2022; Gao, Wei/GXH-0380-2022		Natural science foundation research project of Shaanxi province [2017JC2-07]; scientific and technological projects of Xi'an of China [2017115SF/YX009]	Natural science foundation research project of Shaanxi province(Natural Science Foundation of Shaanxi Province); scientific and technological projects of Xi'an of China	This study was funded by the Natural science foundation research project of Shaanxi province (grant number 2017JC2-07, website: http://www.sninfo.gov.cn:8083/initSnFirstPageList.do?method=initSoFirstPageList&a=1/) and scientific and technological projects of Xi'an (grant number 2017115SF/YX009, webset: http://shb.xainfo.gov.cn/system/sbsystem/login.jsp) of China. The authors declare that they do not have any conflict of interest.	An HJ, 2013, P NATL ACAD SCI USA, V110, P13014, DOI 10.1073/pnas.1307170110; Arnoult D, 2007, TRENDS CELL BIOL, V17, P6, DOI 10.1016/j.tcb.2006.11.001; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen JL, 2017, BRAIN RES, V1666, P17, DOI 10.1016/j.brainres.2017.04.006; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Gogvadze V, 2006, BBA-BIOENERGETICS, V1757, P639, DOI 10.1016/j.bbabio.2006.03.016; Hoppins S, 2012, SCIENCE, V337, P1052, DOI 10.1126/science.1224709; Huang QC, 2016, AUTOPHAGY, V12, P999, DOI 10.1080/15548627.2016.1166318; Jain K, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/742059; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Lazard D, 2012, DIABETES-METAB RES, V28, P475, DOI 10.1002/dmrr.2294; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Pyakurel A, 2015, MOL CELL, V58, P244, DOI 10.1016/j.molcel.2015.02.021; Sanderson TH, 2015, NEUROSCIENCE, V301, P71, DOI 10.1016/j.neuroscience.2015.05.078; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Scott I, 2010, ESSAYS BIOCHEM, V47, P85, DOI [10.1042/BSE0470085, 10.1042/bse0470085]; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yamaguchi R, 2008, MOL CELL, V31, P557, DOI 10.1016/j.molcel.2008.07.010; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	26	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197266	10.1371/journal.pone.0197266	http://dx.doi.org/10.1371/journal.pone.0197266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768513	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200072
J	Ramirez, K; Cazarez-Montoya, C; Lopez-Moreno, HS; Castro-Del Campo, N				Ramirez, Karina; Cazarez-Montoya, Carmina; Samuel Lopez-Moreno, Hector; Castro-Del Campo, Nohelia			Bacteriophage cocktail for biocontrol of Escherichia coli O157:H7: Stability and potential allergenicity study	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; FOODBORNE PATHOGENS; GENOME SEQUENCE; PHAGE COCKTAIL; IN-VITRO; SALMONELLA; WATER; FOOD; ENVIRONMENTS; PREDICTION	Escherichia coli O157:H7 has become a global public health and a food safety problem. Despite the implementation of control strategies that guarantee the safety in various products, outbreaks persist and new alternatives are necessary to reduce this pathogen along the food chain. Recently, our group isolated and characterised lytic bacteriophages against E. coli O157:H7 with potential to be used as biocontrol agents in food. To this end, phages need certain requirements to allow their manufacture and application. The aim of this study was to determine the physical stability and allergenic potential of free and microencapsulated (ME) bacteriophage cocktails against E. coli O157:H7. In vitro and in vivo studies were performed to determine phage survival under different pH, gastrointestinal conditions, temperature and UV light intensities. Results showed that the stability of ME phages was significantly (P<0.05) higher than free phages after ultraviolet irradiation, pH conditions between 3 to 7, and exposure to temperatures between at -80 degrees C and 70 degrees C. Both formulations were highly sensitive to very low pH in simulated gastric fluid, but stable in bile salts. In vivo studies in mice confirmed these phages passed through the gastrointestinal tract and were excreted in faeces. In silico, full-length alignment analysis showed that all phage proteins were negative for allergenic potential, but different predicting criteria classified seven phage proteins with a very low probability to be an allergen. In conclusion, these data demonstrated that microencapsulation provided a greater stability to phage formulation under stress conditions and assure a more suitable commercial formulation for the biological control of E. coli O157:H7.	[Ramirez, Karina] Teconl Nacl Mexico Inst Tecnol Culiacan, Div Estudios Posgrad & Invest, Culiacan, Sinaloa, Mexico; [Cazarez-Montoya, Carmina; Castro-Del Campo, Nohelia] Ctr Invest Alimentac & Desarrollo AC, Culiacan, Sinaloa, Mexico; [Samuel Lopez-Moreno, Hector] Univ Autonoma Sinaloa, Fac Ciencias Quim Biol, CAEC BB UAS 264, Culiacan, Sinaloa, Mexico	CIAD - Centro de Investigacion en Alimentacion y Desarrollo; Universidad Autonoma de Sinaloa	Castro-Del Campo, N (corresponding author), Ctr Invest Alimentac & Desarrollo AC, Culiacan, Sinaloa, Mexico.		Ramirez, Karina/H-7792-2018; Ramirez, Karina/AAT-4522-2020	Ramirez, Karina/0000-0003-0138-992X; Ramirez, Karina/0000-0003-0138-992X; Castro-del Campo, Nohelia/0000-0002-0738-492X; Lopez-Moreno, Hector Samuel/0000-0001-7391-205X	Fundacion Produce Sinaloa [164601]; SEP-PRODEP [ITCUL-PTC-010]	Fundacion Produce Sinaloa; SEP-PRODEP	This study was supported by Fundacion Produce Sinaloa (http://www.fps.org.mx/portal/index.php) [grant number 164601 to NCC] and SEP-PRODEP (http://www.dgesus.ses.sep.gob.mx/PRODEP.htm)[grant number ITCUL-PTC-010 to KR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Ackermann H.-W., 2004, WFCC NEWSLETTER, V38, P35; Adams MH., 1959, METHODS STUDY BACTER; Allue-Guardia A, 2012, APPL ENVIRON MICROB, V78, P5818, DOI 10.1128/AEM.00997-12; Amarillas L, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0211-5; Amarillas L, 2016, PEERJ, V4, DOI 10.7717/peerj.2423; Amezquita-Lopez BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051565; Basdew I. H., 2014, African Journal of Microbiology Research, V8, P200; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Born Yannick, 2015, Bacteriophage, V5, pe1074330, DOI 10.1080/21597081.2015.1074330; Carey-Smith GV, 2006, FEMS MICROBIOL LETT, V258, P182, DOI 10.1111/j.1574-6968.2006.00217.x; Carlton RM, 2005, REGUL TOXICOL PHARM, V43, P301, DOI 10.1016/j.yrtph.2005.08.005; Centers for Disease Control and Prevention (CDC), 2018, ESTIMATES FOODBORNE; Chaidez C, 2007, INT J ENVIRON HEAL R, V17, P311, DOI 10.1080/09603120701417063; Chandra M, 2011, AFR J MICROBIOL RES, V5, P2044; Chibani-Chennoufi S, 2004, ANTIMICROB AGENTS CH, V48, P2558, DOI 10.1128/AAC.48.7.2558-2569.2004; Chibeu A., 2013, MICROBIAL PATHOGENS, P1041; Coffey B, 2011, INT J FOOD MICROBIOL, V147, P188, DOI 10.1016/j.ijfoodmicro.2011.04.001; Colom J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41441; Denou E, 2009, VIROLOGY, V388, P21, DOI 10.1016/j.virol.2009.03.009; Dimitrov I, 2014, BIOINFORMATICS, V30, P846, DOI 10.1093/bioinformatics/btt619; Dimitrov I, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S4; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Endersen L, 2014, ANNU REV FOOD SCI T, V5, P327, DOI 10.1146/annurev-food-030713-092415; FDA Food and Drug Administration, 2014, FOOD SAF MOMS TO BE; Fister S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01152; Frenzen PD, 2005, J FOOD PROTECT, V68, P2623, DOI 10.4315/0362-028X-68.12.2623; Garcia P, 2008, LETT APPL MICROBIOL, V47, P479, DOI 10.1111/j.1472-765X.2008.02458.x; Goodman RE, 2008, NAT BIOTECHNOL, V26, P73, DOI 10.1038/nbt1343; Goodman RE, 2006, MOL NUTR FOOD RES, V50, P655, DOI 10.1002/mnfr.200500277; Gouma M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/436030; Gupta S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0928-3; Hagens S, 2007, APPL MICROBIOL BIOT, V76, P513, DOI 10.1007/s00253-007-1031-8; Hagens S, 2010, CURR PHARM BIOTECHNO, V11, P58, DOI 10.2174/138920110790725429; Hileman RE, 2002, INT ARCH ALLERGY IMM, V128, P280, DOI 10.1159/000063861; Ibrahim O. O., 2015, ECON MICROBIOL, V2, P214; Ivanciuc O, 2003, NUCLEIC ACIDS RES, V31, P359, DOI 10.1093/nar/gkg010; Jamalludeen N, 2007, VET MICROBIOL, V124, P47, DOI 10.1016/j.vetmic.2007.03.028; Jarke C, 2013, FOOD ENVIRON VIROL, V5, P135, DOI 10.1007/s12560-013-9112-6; Jonczyk E, 2011, FOLIA MICROBIOL, V56, P191, DOI 10.1007/s12223-011-0039-8; Lang MM, 2004, J FOOD PROTECT, V67, P732, DOI 10.4315/0362-028X-67.4.732; Li J., 2015, ALLERGEN PREDICTION; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041124; Lopez-Cuevas O, 2017, J MICROB BIOTEC FOOD, V7, P149, DOI 10.15414/jmbfs.2017.7.2.149-152; Ly-Chatain MH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00051; Ma YS, 2008, APPL ENVIRON MICROB, V74, P4799, DOI 10.1128/AEM.00246-08; McCallin S, 2013, VIROLOGY, V443, P187, DOI 10.1016/j.virol.2013.05.022; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; National Research Council Committee for the Update of the Guide for the C. U. o. L., 2011, DRUG DISCOVERY EVALU; Olson MR, 2004, J VIROL METHODS, V122, P147, DOI 10.1016/j.jviromet.2004.08.010; Perez-Gallardo A, 2012, STARCH-STARKE, V64, P27, DOI 10.1002/star.201100042; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Roda A, 2010, NEUROGASTROENT MOTIL, V22, P1117, DOI 10.1111/j.1365-2982.2010.01535.x; Rode TM, 2011, APPL ENVIRON MICROB, V77, P5336, DOI 10.1128/AEM.00180-11; Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343; Sillankorva Sanna M, 2012, Int J Microbiol, V2012, P863945, DOI 10.1155/2012/863945; Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280; U.S. Phamacopeial Convention, 2004, US PHARM; University of Nebraska-Lincoln, 2010, FOOD ALL RES RES PRO; Ventola C Lee, 2015, P T, V40, P277	60	34	35	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0195023	10.1371/journal.pone.0195023	http://dx.doi.org/10.1371/journal.pone.0195023			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763937	Green Published, Green Submitted, gold			2022-12-26	WOS:000432118800002
J	Giboin, LS; Amiri, E; Bertschinger, R; Gruber, M				Giboin, Louis-Solal; Amiri, Ehsan; Bertschinger, Raphael; Gruber, Markus			Active recovery affects the recovery of the corticospinal system but not of muscle contractile properties	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN KNEE EXTENSORS; VOLUNTARY ACTIVATION; FATIGUE; MECHANISMS; EXERCISE; TIME; DETERMINANTS; PERFORMANCE; METABOLISM	Purpose Active recovery is often used by athletes after strenuous exercise or competition but its underlying mechanisms are not well understood. We hypothesized that active recovery speeds-up recovery processes within the muscle and the central nervous system (CNS). Methods We assessed muscular and CNS recovery by measuring the voluntary activation (VA) in the vastus lateralis muscle with transcranial magnetic stimulation (VA(TMS)) and peripheral nerve stimulation (VA(PNS)) during maximal voluntary contractions (MVC) of the knee extensors in 11 subjects. Measurements were performed before and after a fatiguing cycling time-trial, after an active and a passive recovery treatment and after another fatiguing task (1 min MVC). The measurements were performed a second time 24 h after the time-trial. Results We observed a time x group interaction effect for VA(TMS) (p = 0.013). Post-hoc corrected T-tests demonstrated an increased VA(TMS) after active recovery when measured after the 1 min MVC performed 24 h after the time-trial (mean +/- SD; 95.2 +/- 4.1% vs. 89.2 +/- 6.6%, p = 0.026). No significant effects were observed for all other variables. Conclusions Active recovery increased aspects of central, rather than muscle recovery. However, no effect on MVC was seen, implying that even if active recovery speeds up CNS recovery, without affecting the recovery of muscle contractile properties, this doesn't translate into increases in overall performance.	[Giboin, Louis-Solal; Bertschinger, Raphael; Gruber, Markus] Univ Konstanz, Sensorimotor Performance Lab, Constance, Germany; [Amiri, Ehsan] Razi Univ, Fac Sport Sci, Kermanshah, Iran	University of Konstanz; Razi University	Giboin, LS (corresponding author), Univ Konstanz, Sensorimotor Performance Lab, Constance, Germany.	louis-solal.giboin@uni-konstanz.de	Amiri, Ehsan/AAA-1956-2021	Amiri, Ehsan/0000-0001-6120-9252; Gruber, Markus/0000-0002-0233-3912	Iranian Ministry of Science, Research and Technology	Iranian Ministry of Science, Research and Technology	EA was supported by the Iranian Ministry of Science, Research and Technology.	Ahmaidi S, 1996, MED SCI SPORT EXER, V28, P450, DOI 10.1097/00005768-199604000-00009; Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; BANGSBO J, 1994, J APPL PHYSIOL, V77, P1890, DOI 10.1152/jappl.1994.77.4.1890; Barnett A, 2006, SPORTS MED, V36, P781, DOI 10.2165/00007256-200636090-00005; Carroll TJ, 2017, J APPL PHYSIOL, V122, P1068, DOI 10.1152/japplphysiol.00775.2016; Connolly Declan Aj, 2003, J Sports Sci Med, V2, P47; Dahmen T, 2011, SPORTS ENG, V14, P95, DOI 10.1007/s12283-011-0076-1; Finsterer J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-218; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Giboin LS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00150; Goodall S, 2009, EXP PHYSIOL, V94, P995, DOI 10.1113/expphysiol.2009.047902; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Herbert RD, 1999, J NEUROPHYSIOL, V82, P2271, DOI 10.1152/jn.1999.82.5.2271; Husmann F, 2017, MED SCI SPORT EXER, V49, P440, DOI 10.1249/MSS.0000000000001133; Koizumi K, 2011, J SPORT SCI, V29, P919, DOI 10.1080/02640414.2011.572990; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Mika A, 2007, AM J PHYS MED REHAB, V86, P474, DOI 10.1097/PHM.0b013e31805b7c79; Mika A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164216; Minett GM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00024; Nedelec M, 2012, SPORTS MED, V42, P997, DOI 10.2165/11635270-000000000-00000; Rattray B, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00079; Roelands B, 2013, SPORTS MED, V43, P301, DOI 10.1007/s40279-013-0030-4; Sargeant AJ, 2007, EXP PHYSIOL, V92, P323, DOI 10.1113/expphysiol.2006.034322; Sidhu SK, 2009, MUSCLE NERVE, V39, P186, DOI 10.1002/mus.21064; Simjanovic M, 2009, J SCI MED SPORT; SKINNER JS, 1980, RES Q EXERCISE SPORT, V51, P234, DOI 10.1080/02701367.1980.10609285; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Thomas K, 2017, MED SCI SPORT EXER, V49, P955, DOI 10.1249/MSS.0000000000001196; Thomas K, 2015, MED SCI SPORT EXER, V47, P537, DOI 10.1249/MSS.0000000000000448; Todd G, 2003, J PHYSIOL-LONDON, V551, P661, DOI 10.1113/jphysiol.2003.044099; Todd G, 2016, J APPL PHYSIOL, V121, P678, DOI 10.1152/japplphysiol.00293.2016; Yang JZ, 2014, AM J SPORT MED, V42, P1456, DOI 10.1177/0363546514524699	33	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197339	10.1371/journal.pone.0197339	http://dx.doi.org/10.1371/journal.pone.0197339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758055	Green Published, Green Submitted, gold			2022-12-26	WOS:000432082900041
J	Al Habyan, S; Kalos, C; Szymborski, J; McCaffrey, L				Al Habyan, Sara; Kalos, Christina; Szymborski, Joseph; McCaffrey, Luke			Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer	ONCOGENE			English	Article							EXPRESSION; ASCITES; CADHERIN; HETEROGENEITY; BEHAVIOR; MODEL	Ovarian cancer is the most lethal gynecological cancer, where survival rates have had modest improvement over the last 30 years. Metastasis of cancer cells is a major clinical problem, and patient mortality occurs when ovarian cancer cells spread beyond the confinement of ovaries. Disseminated ovarian cancer cells typically spread within the abdomen, where ascites accumulation aids in their transit. Metastatic ascites contain multicellular spheroids, which promote chemo-resistance and recurrence. However, little is known about the origin and mechanisms through which spheroids arise. Using live-imaging of 3D culture models and animal models, we report that epithelial ovarian cancer (EOC) cells, the most common type of ovarian cancer, can spontaneously detach as either single cells or clusters. We report that clusters are more resistant to anoikis and have a potent survival advantage over single cells. Using in vivo lineage tracing, we found that multicellular spheroids arise preferentially from collective detachment, rather than aggregation in the abdomen. Finally, we report that multicellular spheroids from collective detachment are capable of seeding intra-abdominal metastases that retain intra-tumoral heterogeneity from the primary tumor.	[Al Habyan, Sara; Kalos, Christina; Szymborski, Joseph; McCaffrey, Luke] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Al Habyan, Sara; Kalos, Christina; Szymborski, Joseph; McCaffrey, Luke] McGill Univ, Div Expt Med, Montreal, PQ H4A 3J1, Canada; [McCaffrey, Luke] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ H4A 3T2, Canada	McGill University; McGill University; McGill University	McCaffrey, L (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; McCaffrey, L (corresponding author), McGill Univ, Div Expt Med, Montreal, PQ H4A 3J1, Canada.; McCaffrey, L (corresponding author), McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ H4A 3T2, Canada.	luke.mccaffrey@mcgill.ca		Szymborski, Joseph/0000-0003-1559-6225	CIHR [MOP-119482]	CIHR(Canadian Institutes of Health Research (CIHR))	We thank Dr. Didier Trono (Ecole Polytechnique Federale de Lausanne, Switzerland) for lentiviral plasmids acquired through Addgene, and Dr. Patricia Tonin (McGill University) for OV90 cells. This project was supported by funds from CIHR (MOP-119482) to LM. LM is a FRQS Research Scholar - Junior 2.	Ahmed N, 2007, J CELL PHYSIOL, V213, P581, DOI 10.1002/jcp.21240; Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; ALLEN HJ, 1987, EXP CELL BIOL, V55, P194; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Cai Q, 2015, ONCOGENE, V34, P3315, DOI 10.1038/onc.2014.264; Cody NAL, 2007, ONCOGENE, V26, P618, DOI 10.1038/sj.onc.1209821; Davidowitz RA, 2014, J CLIN INVEST, V124, P2611, DOI 10.1172/JCI69815; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hudson LG, 2008, CLIN EXP METASTAS, V25, P643, DOI 10.1007/s10585-008-9171-5; Katz E, 2009, CLIN CANCER RES, V15, P70, DOI 10.1158/1078-0432.CCR-08-1233; Kim S, 2016, CANCER SCI, V107, P1173, DOI 10.1111/cas.12987; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Klymenko Y, 2017, NEOPLASIA, V19, P549, DOI 10.1016/j.neo.2017.04.002; Kobel M, 2011, INT J GYNECOL PATHOL, V30, P366, DOI 10.1097/PGP.0b013e31820d20ba; Koensgen D, 2010, ANTICANCER RES, V30, P2525; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Latifi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046858; Manning AP, 1999, MOL CARCINOGEN, V24, P218, DOI 10.1002/(SICI)1098-2744(199903)24:3<218::AID-MC8>3.0.CO;2-A; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Narod S, 2016, NAT REV CLIN ONCOL, V13, P255, DOI 10.1038/nrclinonc.2015.224; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Timmins Nicholas E., 2007, V140, P141; Vankelecom H, 2009, COLD SPRING HARB PRO, V4, P1; Wintzell M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-359; Xu S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05646; Yin MZ, 2016, J CLIN INVEST, V126, P4157, DOI 10.1172/JCI87252; Zhang M, 2015, CANCER DISCOV, V5, P520, DOI 10.1158/2159-8290.CD-14-1101	32	74	74	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 13	2018	37	37					5127	5135		10.1038/s41388-018-0317-x	http://dx.doi.org/10.1038/s41388-018-0317-x			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT3LT	29789717	Green Published, hybrid			2022-12-26	WOS:000444405300008
J	Grudnik, P; Kaminski, MM; Rembacz, KP; Kuska, K; Madej, M; Potempa, J; Dawidowski, M; Dubin, G				Grudnik, Przemyslaw; Kaminski, Marcin M.; Rembacz, Krzysztof P.; Kuska, Katarzyna; Madej, Mariusz; Potempa, Jan; Dawidowski, Maciej; Dubin, Grzegorz			Structural basis for ADP-dependent glucokinase inhibition by 8-bromo-substituted adenosine nucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; enzyme inhibitor; glucose metabolism; crystal structure; X-ray crystallography; 8-bromo-adenosine monophosphate; 8-bromo-AMP; ADP-dependent glucokinase; reactive oxygen species; T cell activation	ACTIVATED PROTEIN-KINASE; T-CELL-ACTIVATION; CRYSTAL-STRUCTURES; AMP; EXPRESSION; MITOCHONDRIA; SPECIFICITY; GLYCOLYSIS; FAMILY; SITES	In higher eukaryotes, several ATP-utilizing enzymes known as hexokinases activate glucose in the glycolysis pathway by phosphorylation to glucose 6-phosphate. In contrast to canonical hexokinases, which use ATP, ADP-dependent glucokinase (ADPGK) catalyzes noncanonical phosphorylation of glucose to glucose 6-phosphate using ADP as a phosphate donor. Initially discovered in Archaea, the human homolog of ADPGK was described only recently. ADPGK's involvement in modified bioenergetics of activated T cells has been postulated, and elevated ADPGK expression has been reported in various cancer tissues. However, the physiological role of ADPGK is still poorly understood, and effective ADPGK inhibitors still await discovery. Here, we show that 8-bromo-substituted adenosine nucleotide inhibits human ADPGK. By solving the crystal structure of archaeal ADPGK in complex with 8-bromoadenosine phosphate (8-Br-AMP) at 1.81 angstrom resolution, we identified the mechanism of inhibition. We observed that 8-Br-AMP is a competitive inhibitor of ADPGK and that the bromine substitution induces marked structural changes within the protein's active site by engaging crucial catalytic residues. The results obtained using the Jurkat model of activated human T cells suggest its moderate activity in a cellular setting. We propose that our structural insights provide a critical basis for rational development of novel ADPGK inhibitors.	[Grudnik, Przemyslaw; Rembacz, Krzysztof P.; Kuska, Katarzyna; Madej, Mariusz; Potempa, Jan; Dubin, Grzegorz] Jagiellonian Univ Krakow, Fac Biochem Biophys & Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland; [Grudnik, Przemyslaw; Madej, Mariusz; Potempa, Jan; Dubin, Grzegorz] Jagiellonian Univ Krakow, Malopolska Ctr Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland; [Kaminski, Marcin M.] St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Dawidowski, Maciej] Warsaw Med Univ, Fac Pharm, Banacha 1 St, PL-02097 Warsaw, Poland	Jagiellonian University; Jagiellonian University; St Jude Children's Research Hospital; Medical University of Warsaw	Grudnik, P (corresponding author), Jagiellonian Univ Krakow, Fac Biochem Biophys & Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland.; Dubin, G (corresponding author), Jagiellonian Univ Krakow, Malopolska Ctr Biotechnol, Gronostajowa 7 St, PL-30387 Krakow, Poland.; Kaminski, MM (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	przemyslaw.grudnik@uj.edu.pl; marcin.kaminski@stjude.org; grzegorz.dubin@uj.edu.pl	Kaminski, Marcin/L-6974-2015; Potempa, Jan/AAA-6850-2021; Grudnik, Przemyslaw/AAV-7097-2020; Dubin, Grzegorz/J-8168-2014; Dawidowski, Maciej/U-9307-2017	Kaminski, Marcin/0000-0002-9026-0185; Grudnik, Przemyslaw/0000-0002-7157-0014; Dubin, Grzegorz/0000-0002-5535-5760; Dawidowski, Maciej/0000-0002-7262-5718; Potempa, Jan/0000-0002-3600-7461	Ministry of Science and Higher Education	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	We thank Urszula Nowak for help during the initial phase of the project, Klaudia Wo from the MCB Structural Biology Core Facility for help in crystallization, and Helmholtz-Zentrum Berlin for the allocation of beamtime. The Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alba G, 2004, FEBS LETT, V573, P219, DOI 10.1016/j.febslet.2004.07.077; Rivas-Pardo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066687; Brenner C, 1997, NAT STRUCT BIOL, V4, P231, DOI 10.1038/nsb0397-231; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hughes TS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4571; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaminski MM, 2013, ARCH IMMUNOL THER EX, V61, P367, DOI 10.1007/s00005-013-0235-0; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Lee KE, 2016, CANCER DISCOV, V6, P256, DOI 10.1158/2159-8290.CD-15-0822; Ludlow RF, 2015, P NATL ACAD SCI USA, V112, P15910, DOI 10.1073/pnas.1518946112; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merino F, 2008, FEBS J, V275, P4033, DOI 10.1111/j.1742-4658.2008.06544.x; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Musi N, 2001, AM J PHYSIOL-ENDOC M, V280, pE677, DOI 10.1152/ajpendo.2001.280.5.E677; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Richter JP, 2016, J BIOL CHEM, V291, P3694, DOI 10.1074/jbc.M115.679902; Richter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065267; Richter S, 2012, MOL CELL BIOCHEM, V364, P131, DOI 10.1007/s11010-011-1212-8; Robak T, 2011, EXPERT OPIN INV DRUG, V20, P343, DOI 10.1517/13543784.2011.554822; Ronimus RS, 2004, BIOCHEM BIOPH RES CO, V315, P652, DOI 10.1016/j.bbrc.2004.01.103; Seidel SAI, 2012, ANGEW CHEM INT EDIT, V51, P10656, DOI 10.1002/anie.201204268; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; SHOHAM M, 1980, J MOL BIOL, V140, P1, DOI 10.1016/0022-2836(80)90353-8; Sparta KM, 2016, J APPL CRYSTALLOGR, V49, P1085, DOI 10.1107/S1600576716004416; Tokarz P, 2018, PROTEIN SCI, V27, P790, DOI 10.1002/pro.3377; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wu DY, 2014, NUCLEIC ACIDS RES, V42, P3607, DOI 10.1093/nar/gkt1382; Xu RX, 2004, J MOL BIOL, V337, P355, DOI 10.1016/j.jmb.2004.01.040; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Yang J, 2009, J CELL BIOCHEM, V106, P414, DOI 10.1002/jcb.22024	43	4	4	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11088	11099		10.1074/jbc.RA117.001562	http://dx.doi.org/10.1074/jbc.RA117.001562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784881	hybrid, Green Published			2022-12-26	WOS:000438882800021
J	Zeng, XJ; Gao, H; Wei, XB				Zeng, Xuejiao; Gao, Hao; Wei, Xunbin			Rapid direct aperture optimization via dose influence matrix based piecewise aperture dose model	PLOS ONE			English	Article							CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; COLUMN GENERATION; IMRT; ALGORITHM; DISTRIBUTIONS	In the traditional two-step procedure used in intensity-modulated radiation therapy, fluence map optimization (FMO) is performed first, followed by use of a leaf sequencing algorithm (LSA). By contrast, direct aperture optimization (DAO) directly optimizes aperture leaf positions and weights. However, dose calculation using the Monte Carlo (MC) method for DAO is often time-consuming. Therefore, a rapid DAO (RDAO) algorithm is proposed that uses a dose influence matrix based piecewise aperture dose model (DIM-PADM). In the proposed RDAO algorithm, dose calculation is based on the dose influence matrix instead of MC. The dose dependence of aperture leafs is modeled as a piecewise function using the DIM. The corresponding DIM-PADM-based DAO problem is solved using a simulated annealing algorithm. The proposed algorithm was validated through application to TG119, prostate, liver, and head and neck (H&N) cases from the common optimization for radiation therapy data set. Compared with the two-step FMO-LSA procedure, the proposed algorithm resulted in more precise dose conformality in all four cases. Specifically, for the H&N dataset, the cost value for the planned target volume (PTV) was decreased by 32%, whereas the cost value for the two organs at risk (OARs) was decreased by 60% and 92%. Our study of the proposed novel DIM-PADM-based RDAO algorithm makes two main contributions: First, we validate the use of the proposed algorithm, in contrast to the FMO-LSA framework, for direct optimization of aperture leaf positions and show that this method results in more precise dose conformality. Second, we demonstrate that compared to MC, the DIM-PADM-based method significantly reduces the computational time required for DAO.	[Zeng, Xuejiao; Wei, Xunbin] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China; [Zeng, Xuejiao; Gao, Hao; Wei, Xunbin] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Gao, Hao] Shanghai Jiao Tong Univ, Dept Math, Shanghai, Peoples R China; [Wei, Xunbin] Foshan Univ, Sch Phys & Optoelect Engn, Foshan, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Foshan University	Wei, XB (corresponding author), Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China.; Gao, H; Wei, XB (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China.; Gao, H (corresponding author), Shanghai Jiao Tong Univ, Dept Math, Shanghai, Peoples R China.; Wei, XB (corresponding author), Foshan Univ, Sch Phys & Optoelect Engn, Foshan, Peoples R China.	hao.gao2012@gmail.com; xwei01@sjtu.edu.cn			National Science Fund for Distinguished Young Scholars [61425006]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work is supported by the National Science Fund for Distinguished Young Scholars (Grant No. 61425006)(http://npd.nsfc.gov.cn/undingProjectSearchActionIsearch.action). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORTFELD T, 1990, PHYS MED BIOL, V35, P1423, DOI 10.1088/0031-9155/35/10/007; Bortfeld T, 2006, PHYS MED BIOL, V51, pR363, DOI 10.1088/0031-9155/51/13/R21; BRAHME A, 1982, PHYS MED BIOL, V27, P1221, DOI 10.1088/0031-9155/27/10/002; Cassioli A, 2013, PHYS MED BIOL, V58, P301, DOI 10.1088/0031-9155/58/2/301; Cerny V., 1982, JOURANL OPTIMIZATION, P41; CONVERY DJ, 1992, PHYS MED BIOL, V37, P1359, DOI 10.1088/0031-9155/37/6/012; Cotrutz C, 2003, PHYS MED BIOL, V48, P2987, DOI 10.1088/0031-9155/48/18/303; Craft D, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-37; De Gersem W, 2001, INT J RADIAT ONCOL, V51, P1371, DOI 10.1016/S0360-3016(01)02607-4; Ehrgott M, 2008, 4OR-Q J OPER RES, V6, P199, DOI 10.1007/s10288-008-0083-7; Engel K, 2005, DISCRETE APPL MATH, V152, P35, DOI 10.1016/j.dam.2004.10.007; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Hardemark B, 2003, DIRECT MACHINE PARAM; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Li YJ, 2003, PHYS MED BIOL, V48, P3353, DOI 10.1088/0031-9155/48/20/007; MAGERAS GS, 1993, MED PHYS, V20, P639, DOI 10.1118/1.597012; PINCUS M, 1970, OPER RES, V18, P1225, DOI 10.1287/opre.18.6.1225; Preciado-Walters F, 2006, ANN OPER RES, V148, P65, DOI 10.1007/s10479-006-0080-1; Que W, 1999, MED PHYS, V26, P2390, DOI 10.1118/1.598755; Romeijn HE, 2005, SIAM J OPTIMIZ, V15, P838, DOI 10.1137/040606612; Shepard DM, 2002, MED PHYS, V29, P1007, DOI 10.1118/1.1477415; Shepard DM, 1999, SIAM REV, V41, P721, DOI 10.1137/S0036144598342032; Siebers JV, 2002, MED PHYS, V29, P952, DOI 10.1118/1.1477230; SPIROU SV, 1994, MED PHYS, V21, P1031, DOI 10.1118/1.597345; Stauffer D., 1987, SIMPLE INTRO MONTE C, P1; WEBB S, 1989, PHYS MED BIOL, V34, P1349, DOI 10.1088/0031-9155/34/10/002; Xia P, 1998, MED PHYS, V25, P1424, DOI 10.1118/1.598315; Yang Y, 2003, INT J RADIAT ONCOL, V55, P1121, DOI 10.1016/S0360-3016(02)04417-6	28	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197926	10.1371/journal.pone.0197926	http://dx.doi.org/10.1371/journal.pone.0197926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791505	gold, Green Submitted, Green Published			2022-12-26	WOS:000433077000070
J	Coops, NC; Hermosilla, T; Wulder, MA; White, JC; Bolton, DK				Coops, Nicholas C.; Hermosilla, Txomin; Wulder, Michael A.; White, Joanne C.; Bolton, Douglas K.			A thirty year, fine-scale, characterization of area burned in Canadian forests shows evidence of regionally increasing trends in the last decade	PLOS ONE			English	Article							LANDSAT TIME-SERIES; FIRE REGIME; CLIMATE-CHANGE; BOREAL FORESTS; DISTURBANCE; RECOVERY; PATTERNS; EMISSIONS; WEATHER	Fire as a dominant disturbance has profound implications on the terrestrial carbon cycle. We present the first ever multi-decadal, spatially-explicit, 30 meter assessment of fire regimes across the forested ecoregions of Canada at an annual time-step. From 1985 to 2015, 51 Mha burned, impacting over 6.5% of forested ecosystems. Mean annual area burned was 1,651,818 ha and varied markedly (sigma = 1,116,119), with 25% of the total area burned occurring in three years: 1989, 1995, and 2015. Boreal forest types contained 98% of the total area burned, with the conifer-dominated Boreal Shield containing one-third of all burned area. While results confirm no significant national trend in burned area for the period of 1985 to 2015, a significant national increasing trend (alpha = 0.05) of 11% per year was evident for the past decade (2006 to 2015). Regionally, a significant increasing trend in total burned area from 1985 to 2015 was observed in the Montane Cordillera (2.4% increase per year), while the Taiga Plains and Taiga Shield West displayed significant increasing trends from 2006 to 2015 (26.1% and 12.7% increases per year, respectively). The Atlantic Maritime, which had the lowest burned area of all ecozones (0.01% burned per year), was the only ecozone to display a significant negative trend (2.4% decrease per year) from 1985 to 2015. Given the century-long fire return intervals in many of these ecozones, and large annual variability in burned area, short-term trends need to be interpreted with caution. Additional interpretive cautions are related to year used for trend initiation and the nature and extents of spatial regionalizations used for summarizing findings. The results of our analysis provide a baseline for monitoring future national and regional trends in burned area and offer spatially and temporally detailed insights to inform science, policy, and management.	[Coops, Nicholas C.; Hermosilla, Txomin; Bolton, Douglas K.] Univ British Columbia, Dept Forest Resources Management, Integrated Remote Sensing Studio, Vancouver, BC, Canada; [Wulder, Michael A.; White, Joanne C.] Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC, Canada	University of British Columbia; Natural Resources Canada; Canadian Forest Service	Coops, NC (corresponding author), Univ British Columbia, Dept Forest Resources Management, Integrated Remote Sensing Studio, Vancouver, BC, Canada.	nicholas.coops@ubc.ca	Coops, Nicholas/L-3652-2019; Wulder, Michael A/J-5597-2016; White, Joanne C./Z-1981-2019; Coops, Nicholas C/J-1543-2012; Hermosilla, Txomin/K-6206-2014	Coops, Nicholas/0000-0002-0151-9037; Wulder, Michael A/0000-0002-6942-1896; White, Joanne C./0000-0003-4674-0373; Coops, Nicholas C/0000-0002-0151-9037; Hermosilla, Txomin/0000-0002-5445-0360	Canadian Space Agency (CSA); Government Related Initiatives Program (GRIP); Canadian Forest Service (CFS) of Natural Resources Canada; NSERC; WestGrid; Compute Canada; NSERC Discovery grant	Canadian Space Agency (CSA)(Canadian Space Agency); Government Related Initiatives Program (GRIP)(Canadian Space Agency); Canadian Forest Service (CFS) of Natural Resources Canada(Natural Resources CanadaCanadian Forest Service); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); WestGrid; Compute Canada; NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Space Agency (CSA), Government Related Initiatives Program (GRIP), Canadian Forest Service (CFS) of Natural Resources Canada and; This research was undertaken as part of the "National Terrestrial Ecosystem Monitoring System (NTEMS): Timely and detailed national cross-sector monitoring for Canada" and "Earth Observation to Inform Canada's Climate Change Agenda (EO3C)" projects jointly funded by the Canadian Space Agency (CSA), Government Related Initiatives Program (GRIP), and the Canadian Forest Service (CFS) of Natural Resources Canada. We thank Dr. Sylvie Gauthier of the Canadian Forest Service for valuable comments on earlier versions of this manuscript. This research was enabled in part by support provided by WestGrid (www.westgrictea) and Compute Canada (www.computecanada.ca) and a NSERC Discovery grant to Coops.NSERC.	Amiro BD, 2004, INT J WILDLAND FIRE, V13, P391, DOI 10.1071/WF03066; Bolton DK, 2015, REMOTE SENS ENVIRON, V163, P48, DOI 10.1016/j.rse.2015.03.004; Boschetti L, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000686; Boulanger Y, 2014, CAN J FOREST RES, V44, P365, DOI 10.1139/cjfr-2013-0372; Boulanger Y, 2012, INT J WILDLAND FIRE, V21, P1052, DOI 10.1071/WF11073; Brassard BW, 2006, CRIT REV PLANT SCI, V25, P115, DOI 10.1080/07352680500348857; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Canadian Forest Service. Canadian Forest Service, 2016, STA CAN FOR ANN REP; Cohen WB, 2002, ECOSYSTEMS, V5, P122, DOI 10.1007/s10021-001-0060-X; CRIST EP, 1985, REMOTE SENS ENVIRON, V17, P301, DOI 10.1016/0034-4257(85)90102-6; Daniels LD, 2006, BC J ECOSYST MANAG, V7, P4444; de Groot WJ, 2007, INT J WILDLAND FIRE, V16, P593, DOI 10.1071/WF06150; de Groot WJ, 2013, FOREST ECOL MANAG, V294, P23, DOI 10.1016/j.foreco.2012.07.033; Drusch M, 2012, REMOTE SENS ENVIRON, V120, P25, DOI 10.1016/j.rse.2011.11.026; Ecological Stratification Working Group, 1995, NAT EC FRAM CAN; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Frazier RJ, 2015, REMOTE SENS ENVIRON, V170, P317, DOI 10.1016/j.rse.2015.09.015; Frejaville T, 2015, CLIMATIC CHANGE, V129, P239, DOI 10.1007/s10584-015-1332-3; Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042; Girardin MP, 2009, ECOSYSTEM MANAGEMENT, P80; Griffiths P, 2013, IEEE J-STARS, V6, P2088, DOI 10.1109/JSTARS.2012.2228167; Hansen MC, 2012, REMOTE SENS ENVIRON, V122, P66, DOI 10.1016/j.rse.2011.08.024; Hermosilla T, 2017, INT J APPL EARTH OBS, V63, P104, DOI 10.1016/j.jag.2017.07.013; Hermosilla T, 2016, INT J DIGIT EARTH, V9, P1035, DOI 10.1080/17538947.2016.1187673; Hermosilla T, 2015, REMOTE SENS ENVIRON, V170, P121, DOI 10.1016/j.rse.2015.09.004; Hermosilla T, 2015, REMOTE SENS ENVIRON, V158, P220, DOI 10.1016/j.rse.2014.11.005; Heyerdahl EK, 2001, ECOLOGY, V82, P660, DOI 10.1890/0012-9658(2001)082[0660:SCOHFR]2.0.CO;2; Huang CQ, 2010, REMOTE SENS ENVIRON, V114, P183, DOI 10.1016/j.rse.2009.08.017; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Kasischke ES, 2010, CAN J FOREST RES, V40, P1313, DOI 10.1139/X10-098; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Kennedy RE, 2007, REMOTE SENS ENVIRON, V110, P370, DOI 10.1016/j.rse.2007.03.010; Key C.H., 2006, LANDSCAPE ASSESSMENT; Kneeshaw Daniel, 2003, Environmental Reviews, V11, pS99, DOI 10.1139/a03-010; Krebs P, 2010, THEOR BIOSCI, V129, P53, DOI 10.1007/s12064-010-0082-z; KRUMMEL JR, 1987, OIKOS, V48, P321, DOI 10.2307/3565520; Kurz WA, 1992, NORX326 ENFOR; Lefort P, 2003, FOREST SCI, V49, P509; Lempriere TC, 2013, ENVIRON REV, V21, P293, DOI 10.1139/er-2013-0039; Magnussen S, 2012, REMOTE SENS-BASEL, V4, P1600, DOI 10.3390/rs4061600; Masek JG, 2006, IEEE GEOSCI REMOTE S, V3, P68, DOI 10.1109/LGRS.2005.857030; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; Parisien MA, 2006, INT J WILDLAND FIRE, V15, P361, DOI 10.1071/WF06009; Price DT, 2013, ENVIRON REV, V21, P322, DOI 10.1139/er-2013-0042; R Core Team, 2021, R LANGUAGE ENV STAT; Roy DP, 2010, REMOTE SENS ENVIRON, V114, P35, DOI 10.1016/j.rse.2009.08.011; Stocks B. J., 2003, Journal of Geophysical Research, V108, pFFR5, DOI 10.1029/2001JD000484; VANWAGNER CE, 1978, CAN J FOREST RES, V8, P220, DOI 10.1139/x78-034; Weber M. G., 1997, Environmental Reviews, V5, P145, DOI 10.1139/a97-008; White JC, 2014, CAN J REMOTE SENS, V40, P192, DOI 10.1080/07038992.2014.945827; White JC, 2017, REMOTE SENS ENVIRON, V194, P303, DOI 10.1016/j.rse.2017.03.035; White P.S., 1985, ECOLOGY NATURAL DIST, P3, DOI 10.1016/B978-0-12-554520-4.50006-X; Whitman E, 2015, J BIOGEOGR, V42, P1736, DOI 10.1111/jbi.12533; Wotton BM, 2010, INT J WILDLAND FIRE, V19, P253, DOI 10.1071/WF09002; Wulder M, 2001, CAN J REMOTE SENS, V27, P225, DOI 10.1080/07038992.2001.10854939; Wulder MA, 2016, REMOTE SENS ENVIRON, V185, P271, DOI 10.1016/j.rse.2015.11.032; Wulder MA, 2012, REMOTE SENS ENVIRON, V122, P2, DOI 10.1016/j.rse.2012.01.010; Wulder MA, 2008, CAN J REMOTE SENS, V34, P549, DOI 10.5589/m08-066; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028	60	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197218	10.1371/journal.pone.0197218	http://dx.doi.org/10.1371/journal.pone.0197218			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787562	Green Submitted, gold, Green Published			2022-12-26	WOS:000432785700016
J	Cui, ZK; Zeng, QL; Guo, YL; Liu, SW; Wang, PY; Xie, MY; Chen, JS				Cui, Zekai; Zeng, Qiaolang; Guo, Yonglong; Liu, Shiwei; Wang, Peiyuan; Xie, Mengyuan; Chen, Jiansu			Pathological molecular mechanism of symptomatic late-onset Fuchs endothelial corneal dystrophy by bioinformatic analysis	PLOS ONE			English	Article							DENDRITIC CELLS; EXTRACELLULAR-MATRIX; OXIDATIVE STRESS; MUTATIONS; DIFFERENTIATION; INTERLEUKIN-6; PATHOGENESIS; MACROPHAGES; SENESCENCE; EXPRESSION	Fuchs endothelial corneal dystrophy (FECD) is a degenerative disease characterized by corneal endothelial decompensation. FECD causes corneal stromal and epithelial edema and progressively develops into bullous keratopathy, which can eventually lead to blindness. However, the exact pathogenesis is unknown. In this study, we performed an in-depth bioinformatic analysis of the dataset GSE74123 to determine the differentially expressed genes (DEGs) of symptomatic late-onset FECD compared with a normal control. Gene ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analysis were used to analyze the pathological molecular mechanism of FECD. We found that cell senescence, reactive oxygen species (ROS), the extracellular matrix (ECM), epithelial-mesenchymal transition (EMT) and immune response-related genes play an important role in the pathological development of symptomatic late-onset FECD. In addition, we revealed that down-regulated IL-6, enhanced NF-kB activity and a suite of orchestrated chemokine responses induce fibrocyte differentiation from monocyte to dendritic cell maturation. PI3K plays a key role in the molecular mechanism of symptomatic late-onset FECD. This study enhances our understanding of the molecular mechanism of FECD pathogenesis and will improve the diagnostics and therapy of FECD patients in the future.	[Cui, Zekai; Guo, Yonglong; Chen, Jiansu] Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou, Guangdong, Peoples R China; [Zeng, Qiaolang; Liu, Shiwei; Wang, Peiyuan; Chen, Jiansu] Jinan Univ, Dept Ophthalmol, Clin Med Coll 1, Guangzhou, Guangdong, Peoples R China; [Xie, Mengyuan] Jinan Univ, Guangdong Higher Educ Inst, Key Lab Optoelect Informat & Sensing Technol, Guangzhou, Guangdong, Peoples R China; [Chen, Jiansu] Jinan Univ, Inst Ophthalmol, Coll Med, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University; Jinan University	Chen, JS (corresponding author), Jinan Univ, Key Lab Regenerat Med, Minist Educ, Guangzhou, Guangdong, Peoples R China.; Chen, JS (corresponding author), Jinan Univ, Dept Ophthalmol, Clin Med Coll 1, Guangzhou, Guangdong, Peoples R China.; Chen, JS (corresponding author), Jinan Univ, Inst Ophthalmol, Coll Med, Guangzhou, Guangdong, Peoples R China.	chenjiansu2000@163.com		Cui, Zekai/0000-0003-3670-6219; Chen, Jiansu/0000-0001-6703-9573	National Natural Science Foundation of China [81371689]; Special Funds for Major Science and Technology Projects of Guangdong Province [2015B010125007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds for Major Science and Technology Projects of Guangdong Province	This study was supported by the National Natural Science Foundation of China (no. 81371689) and Special Funds for Major Science and Technology Projects of Guangdong Province (2015B010125007).	ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; Arabzadeh A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-196; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; De Roo AK, 2017, CORNEA, V36, P866, DOI 10.1097/ICO.0000000000001212; De Roo AK, 2017, INVEST OPHTH VIS SCI, V58, P670, DOI 10.1167/iovs.16-20880; Elhalis H, 2010, OCUL SURF, V8, P173, DOI 10.1016/S1542-0124(12)70232-X; Fuchs E, 1910, GRAEFES ARCH CLIN EX, V76, P478, DOI DOI 10.1007/BF01986362; Hegde S, 2004, FASEB J, V18, P1439, DOI 10.1096/fj.03-0969fje; Inagaki E, 2013, INVEST OPHTH VIS SCI, V54, P7258, DOI 10.1167/iovs.13-12022; IWAMOTO T, 1971, INVEST OPHTH VISUAL, V10, P9; Johnson A. A, 2017, PROG RETIN EYE RES; Jurkunas UV, 2010, AM J PATHOL, V177, P2278, DOI 10.2353/ajpath.2010.100279; Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654; Katikireddy KR, 2017, FREE RADICAL BIOL ME; KAUFMAN SC, 1993, AM J OPHTHALMOL, V116, P652, DOI 10.1016/S0002-9394(14)73217-9; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Li QJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1597; LINSLEY PS, 1994, IMMUNITY, V1, P793, DOI 10.1016/S1074-7613(94)80021-9; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Matthaei M, 2014, EXP EYE RES, V129, P13, DOI 10.1016/j.exer.2014.10.011; Megaw RD, 2015, EXP EYE RES, V138, P32, DOI 10.1016/j.exer.2015.06.007; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; Mitani H, 2000, BRIT J HAEMATOL, V109, P288, DOI 10.1046/j.1365-2141.2000.02020.x; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Novick D, 2013, SEMINARS IMMUNOLOGY; Okumura N, 2015, LAB INVEST, V95, P1291, DOI 10.1038/labinvest.2015.111; Pendyala S, 2010, RESP PHYSIOL NEUROBI, V174, P265, DOI 10.1016/j.resp.2010.09.016; Pousen ET, 2014, J PROTEOME RES, V13, P4659, DOI 10.1021/pr500252r; Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552; Riazuddin SA, 2013, AM J HUM GENET, V93, P758, DOI 10.1016/j.ajhg.2013.08.010; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Richardson MR, 2010, MOL VIS, V16, P2376; Roy F., 1995, CURRENT OCULAR THERA; Schmedt T, 2012, EXP EYE RES, V95, P24, DOI 10.1016/j.exer.2011.08.002; Snow BE, 1998, GENE, V206, P247, DOI 10.1016/S0378-1119(97)00593-3; Sultana A, 2011, INVEST OPHTH VIS SCI, V52, P2584, DOI 10.1167/iovs.10-6356; Thompson RW, 2003, OPHTHALMOLOGY, V110, P1396, DOI 10.1016/S0161-6420(03)00463-9; Troy TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007814; Turksen K., 2010, AM PHYSL SOC; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; WILSON SE, 1988, CORNEA, V7, P2; WILSON SE, 1988, AM J OPHTHALMOL, V106, P270, DOI 10.1016/0002-9394(88)90360-1; Yanoff M., 1996, BS FINE OCULAR PATHO, P276; 김진주, 2010, Clinical and Experimental Reproductive Medicine, V37, P89; Zhang J, 2015, EXP EYE RES, V130, P97, DOI 10.1016/j.exer.2014.10.023	53	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197750	10.1371/journal.pone.0197750	http://dx.doi.org/10.1371/journal.pone.0197750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787599	Green Published, Green Submitted, gold			2022-12-26	WOS:000432785700042
J	Klement, AH; Hadi, E; Asali, A; Shavit, T; Wiser, A; Haikin, E; Barkan, Y; Biron-Shental, T; Zer, A; Gadot, Y				Klement, Anat Hershko; Hadi, Efrat; Asali, Aula; Shavit, Tal; Wiser, Amir; Haikin, Einat; Barkan, Yael; Biron-Shental, Tal; Zer, Alona; Gadot, Yifat			Neutrophils to lymphocytes ratio and platelets to lymphocytes ratio in pregnancy: A population study	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; EARLY PREDICTOR; MARKER	Background Neutrophils to lymphocytes ratio (NLR) and platelets to lymphocytes ratio (PLR) are both inflammatory ratios that can be easily calculated from a simple blood count. They are frequently reported and tested as prognostic factors in several medical disciplines. Pregnancy involves special reference values for laboratory assays. Objective The aim of this study was to define pregnancy-related reference values for NLR and PLR according to trimester, background morbidity and according to the patient's age. Study design A retrospective analysis of a large cohort undergoing community-based pregnancy surveillance between the years 2011-2016. Data were analyzed according to high-risk patient versus normal-risk patient. Results A total of 11,415 patients were included. Mean PLR and NLR values were 136.3 +/- 44.3, 2.6 +/- 1, respectively during the first trimester, 144.6 +/- 47.1, 4.0 +/- 1.4 respectively during the second trimester and 118.1 +/- 42.0, 3.5 +/- 1.2 respectively during the third trimester. No difference was detected between the high-risk and the normal population (P-values 0.3, 0.5 and 0.4 for PLR in each trimester respectively and 0.3, 0.4, 0.6 for NLR in each trimester, respectively). No differences were detected among parity categories. The correlation between patient's age and either PLR and NLR was a weak positive correlation (though statistically significant). Both PLR and NLR reached a maximum value during the second trimester. The differences between mean NLR and PLR between trimesters were significant (P<0.01 for all differences tested). PLR rises in the presence of anemia, reaching statistical significance (P-value for PLR in each trimester was <0.01). NLR showed an opposite trend (P-values for NLR were 0.4, 0.005 and 0.06 in each trimester, respectively). Conclusions In our cohort, there were generally no differences between the high-risk and the normal population, excluding patients with a fibroid uterus or inflammatory bowel disease who presented a significantly elevated PLR through all trimesters. Both PLR and NLR reached a maximum value during the second trimester and were positively correlated with age. We anticipate that the population-based data will assist in providing accurate reference values for future research testing NLR and PLR measures during pregnancy.	[Klement, Anat Hershko; Hadi, Efrat; Asali, Aula; Shavit, Tal; Wiser, Amir; Haikin, Einat; Barkan, Yael; Biron-Shental, Tal] Meir Med Ctr, Div Obstet & Gynecol, Kefar Sava, Israel; [Klement, Anat Hershko; Hadi, Efrat; Asali, Aula; Shavit, Tal; Wiser, Amir; Haikin, Einat; Barkan, Yael; Biron-Shental, Tal] Tel Aviv Univ, Tel Aviv, Israel; [Barkan, Yael] Clalit Hlth Serv, Netanya, Israel; [Zer, Alona] Tel Aviv Univ, Inst Oncol, Rabin Med Ctr, Tel Aviv, Israel; [Gadot, Yifat] Hebrew Univ Jerusalem, Div Obstet & Gynecol, Kaplan Med Ctr, Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Clalit Health Services; Rabin Medical Center; Tel Aviv University; Hebrew University of Jerusalem; Kaplan Medical Center	Klement, AH (corresponding author), Meir Med Ctr, Div Obstet & Gynecol, Kefar Sava, Israel.; Klement, AH (corresponding author), Tel Aviv Univ, Tel Aviv, Israel.	Anat.klement@gmail.com	Biron-Shental, Tal/L-6035-2019; Zer, Alona/AAW-8442-2020	Haikin Herzberger, Einat/0000-0001-9930-0051; Shavit, Tal/0000-0001-9482-6484; Zer, Alona/0000-0001-6597-5261				Aktulay A, 2015, ACTA CLIN CROAT, V54, P475; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Caglayan EK, 2016, J PERINAT MED, V44, P315, DOI 10.1515/jpm-2015-0178; Cho S, 2008, FERTIL STERIL, V90, P2073, DOI 10.1016/j.fertnstert.2008.03.061; Diem S, 2017, LUNG CANCER, V111, P176, DOI 10.1016/j.lungcan.2017.07.024; Duchesne JC, 2017, J TRAUMA ACUTE CARE, V83, P888, DOI 10.1097/TA.0000000000001683; Ethier JL, 2017, GYNECOL ONCOL, V145, P584, DOI 10.1016/j.ygyno.2017.02.026; Feng JR, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/3526460; Hong TT, 2018, AM J SURG, V216, P450, DOI 10.1016/j.amjsurg.2017.07.021; Ilhan Gulsah, 2016, J Family Reprod Health, V10, P211; Ilhan M, 2016, J MATERN-FETAL NEO M, V29, P1476, DOI 10.3109/14767058.2015.1051026; Kim MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107880; Kirbas A, 2014, EUR J OBSTET GYN R B, V180, P12, DOI 10.1016/j.ejogrb.2014.05.042; Lieto E, 2017, J GASTROINTEST SURG, V21, P1764, DOI 10.1007/s11605-017-3515-x; Sargin MA, 2016, THER CLIN RISK MANAG, V12, P657, DOI 10.2147/TCRM.S104247; Serin S, 2016, PREGNANCY HYPERTENS, V6, P22, DOI 10.1016/j.preghy.2016.01.005; Seropian IM, 2018, ESC HEART FAIL, V5, P149, DOI 10.1002/ehf2.12199; Verit FF, 2014, J OBSTET GYNAECOL, V34, P639, DOI 10.3109/01443615.2014.920792; Weiser C, 2017, RESUSCITATION, V116, P49, DOI 10.1016/j.resuscitation.2017.05.006; Yucel B, 2017, PREGNANCY HYPERTENS, V7, P29, DOI 10.1016/j.preghy.2016.12.002	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0196706	10.1371/journal.pone.0196706	http://dx.doi.org/10.1371/journal.pone.0196706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787560	Green Published, Green Submitted, gold			2022-12-26	WOS:000432785700005
J	Kolovetsiou-Kreiner, V; Moertl, MG; Papousek, I; Schmid-Zalaudek, K; Lang, U; Schlembach, D; Cervar-Zivkovic, M; Lackner, HK				Kolovetsiou-Kreiner, Vassiliki; Moertl, Manfred Georg; Papousek, Ilona; Schmid-Zalaudek, Karin; Lang, Uwe; Schlembach, Dietmar; Cervar-Zivkovic, Mila; Lackner, Helmut Karl			Maternal cardiovascular and endothelial function from first trimester to postpartum	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; HEART-RATE-VARIABILITY; NORMAL-PREGNANCY; ASYMMETRIC DIMETHYLARGININE; ENDOGENOUS INHIBITORS; PREECLAMPSIA; SENSITIVITY; INTERVAL; TONE	Objective To explore noninvasively the complex interactions of the maternal hemodynamic system throughout pregnancy and the resulting after-effect six weeks postpartum. Methods Eighteen women were tested beginning at the 12th week of gestation at six time-points throughout pregnancy and six weeks postpartum. Heart rate, heart rate variability, blood pressure, pulse transit time (PTT), respiration, and baroreceptor sensitivity were analyzed in resting conditions. Additionally, hemoglobin, asymmetric and symmetric dimethylarginine and Endothelin (ET-1) were obtained. Results Heart rate and sympathovagal balance favoring sympathetic drive increased, the vagal tone and the baroreflex sensitivity decreased during pregnancy. Relative sympathetic drive (sympathovagal balance) reached a maximum at 6 weeks postpartum whereas the other variables did not differ compared to first trimester levels. Postpartum diastolic blood pressure was higher compared to first and second trimester. Pulse transit time and endothelial markers showed no difference throughout gestation. However, opposing variables PTT and asymmetric dimethylarginine (ADMA) were both higher six weeks postpartum. Conclusions The sympathetic up regulation throughout pregnancy goes hand in hand with a decreased baroreflex sensitivity. In the postpartum period, the autonomic nervous system, biochemical endothelial reactions and PTT show significant and opposing changes compared to pregnancy findings, indicating the complex aftermath of the increase of blood volume, the changes in perfusion strategies and blood pressure regulation that occur in pregnancy.	[Kolovetsiou-Kreiner, Vassiliki; Lang, Uwe; Cervar-Zivkovic, Mila] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria; [Moertl, Manfred Georg] Clin Ctr, Dept Obstet & Gynecol, Klagenfurt, Austria; [Papousek, Ilona] Karl Franzens Univ Graz, Biol Psychol Unit, Dept Psychol, Graz, Austria; [Schmid-Zalaudek, Karin; Lackner, Helmut Karl] Med Univ Graz, Otto Loewi Res Ctr, Physiol, Graz, Austria; [Schlembach, Dietmar] Clinicum Neukoelln, Clin Obstet Med, Vivantes Network Hlth, Berlin, Germany; [Lackner, Helmut Karl] Graz Univ Technol, Dept Med Engn, Graz, Austria	Medical University of Graz; University of Graz; Medical University of Graz; Graz University of Technology	Lackner, HK (corresponding author), Med Univ Graz, Otto Loewi Res Ctr, Physiol, Graz, Austria.; Lackner, HK (corresponding author), Graz Univ Technol, Dept Med Engn, Graz, Austria.	helmut.lackner@medunigraz.at	Schlembach, Dietmar/AAJ-4433-2020; Schmid-Zalaudek, Karin/AAJ-2417-2021; Papousek, Ilona/H-3043-2019	Schlembach, Dietmar/0000-0003-3641-5278; Schmid-Zalaudek, Karin/0000-0002-3422-0031; Papousek, Ilona/0000-0002-6620-0318; Lackner, Helmut/0000-0002-0159-3720	OeNB Anniversary Fund [16426]	OeNB Anniversary Fund	This work was supported by OeNB Anniversary Fund (Projectnr. 16426); https://www.oenb.at/en/About-Us/Research-Promotion/The-DeNB-Anniversary-Fund.html.	Abbas AE, 2005, INT J CARDIOL, V98, P179, DOI 10.1016/j.ijcard.2003.10.028; Ajne G, 2005, AM J OBSTET GYNECOL, V193, P234, DOI 10.1016/j.ajog.2004.11.023; Baumert M, 2012, COMPUT BIOL MED, V42, P347, DOI 10.1016/j.compbiomed.2011.03.019; Blake MJ, 2000, CLIN SCI, V98, P259, DOI 10.1042/CS19990270; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; Braekke K, 2009, PEDIATR RES, V66, P411, DOI 10.1203/PDR.0b013e3181b33392; CAMERON IT, 1995, J STEROID BIOCHEM, V53, P209, DOI 10.1016/0960-0760(95)00048-5; Camm AJ, 1996, EUR HEART J, V17, P354; CAPELESS EL, 1991, AM J OBSTET GYNECOL, V165, P883, DOI 10.1016/0002-9378(91)90432-Q; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Duvekot JJ, 1994, OBSTET GYNECOL SURV, V49, P1; EKHOLM EMK, 1992, CLIN PHYSIOL, V12, P527, DOI 10.1111/j.1475-097X.1992.tb00356.x; EKHOLM EMK, 1993, BRIT J OBSTET GYNAEC, V100, P177, DOI 10.1111/j.1471-0528.1993.tb15217.x; Ekholm EMK, 1996, EUR J OBSTET GYN R B, V64, P29, DOI 10.1016/0301-2115(95)02255-4; Eneroth E, 1999, HYPERTENS PREGNANCY, V18, P1, DOI 10.3109/10641959909009606; Foo Jong Yong Abdiel, 2006, Technol Health Care, V14, P97; Fortin J, 2006, COMPUT BIOL MED, V36, P941, DOI 10.1016/j.compbiomed.2005.04.003; Fu Q, 2009, SEMIN REPROD MED, V27, P330, DOI 10.1055/s-0029-1225261; Goldoozian LS, 2017, COMPUT BIOL MED, V89, P355, DOI 10.1016/j.compbiomed.2017.07.022; Holden DP, 1998, AM J OBSTET GYNECOL, V178, P551, DOI 10.1016/S0002-9378(98)70437-5; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Khalil A, 2015, AMINO ACIDS, V47, P1715, DOI 10.1007/s00726-015-2014-1; Khalil A, 2012, FETAL DIAGN THER, V32, P179, DOI 10.1159/000337550; Lackner HK, 2014, PHYSIOL RES, V63, P439, DOI 10.33549/physiolres.932603; LEDUC L, 1991, AM J OBSTET GYNECOL, V165, P886, DOI 10.1016/0002-9378(91)90433-R; Lucini D, 1999, J HYPERTENS, V17, P1899, DOI 10.1097/00004872-199917121-00019; Lucovnik M, 2017, HYPERTENS PREGNANCY, V36, P276, DOI 10.1080/10641955.2017.1364381; MABIE WC, 1994, AM J OBSTET GYNECOL, V170, P849, DOI 10.1016/S0002-9378(94)70297-7; Macedo ML, 2008, HYPERTENSION, V51, P1047, DOI 10.1161/HYPERTENSIONAHA.107.106062; Maeda T, 2003, J SOC GYNECOL INVEST, V10, P2, DOI 10.1016/S1071-5576(02)00192-2; Mahendru AA, 2012, J HYPERTENS, V30, P2168, DOI 10.1097/HJH.0b013e3283588189; Miyake Y, 2002, CLIN EXP HYPERTENS, V24, P23, DOI 10.1081/CEH-100108712; Moertl MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060675; Murphy MSQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138664; Ouzounian JG, 2012, CARDIOL CLIN, V30, P317, DOI 10.1016/j.ccl.2012.05.004; Rizos D, 2012, J MATERN-FETAL NEO M, V25, P1311, DOI 10.3109/14767058.2011.632037; Sakurai M, 2007, J HYPERTENS, V25, P391, DOI 10.1097/HJH.0b013e3280115b7c; SELIGMAN SA, 1971, J OBSTET GYN BR COMM, V78, P413; Slaghekke F, 2006, J MATERN-FETAL NEO M, V19, P447, DOI 10.1080/14767050600852171; Su FM, 2014, BIO-MED MATER ENG, V24, P209, DOI 10.3233/BME-130801; Tomsin K, 2013, FACTS VIEWS VIS OBGY, V5, P116; VALDES G, 1986, HYPERTENSION, V8, P161; VALLANCE P, 1992, LANCET, V339, P572; VALLANCE P, 1989, LANCET, V2, P997; Valtonen P, 2009, CYTOKINE, V46, P216, DOI 10.1016/j.cyto.2009.01.011; Voss A, 2000, AM J HYPERTENS, V13, P1218, DOI 10.1016/S0895-7061(00)01199-7; Walther T, 2014, HYPERTENS PREGNANCY, V33, P1, DOI 10.3109/10641955.2013.821481; [No title captured], DOI DOI 10.1097/HJH.0B013E3283588189	48	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197748	10.1371/journal.pone.0197748	http://dx.doi.org/10.1371/journal.pone.0197748			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782509	Green Submitted, Green Published, gold			2022-12-26	WOS:000432537100041
J	Krauson, AJ; Rooney, JG; Carattino, MD				Krauson, Aram J.; Rooney, James G.; Carattino, Marcelo D.			Molecular basis of inhibition of acid sensing ion channel 1A by diminazene	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; TARANTULA TOXIN PSALMOTOXIN-1; CATION CHANNEL; SODIUM-CHANNEL; PHARMACOLOGICAL PROFILE; PROTON RECEPTOR; AMILORIDE BLOCK; ALPHA-SUBUNIT; ASIC1A; EXPRESSION	Acid-sensing ion channels (ASICs) are trimeric proton-gated cation permeable ion channels expressed primarily in neurons. Here we employed site-directed mutagenesis and electrophysiology to investigate the mechanism of inhibition of ASIC1a by diminazene. This compound inhibits mouse ASIC1a with a half-maximal inhibitory concentration (IC50) of 2.4 mu M. At first, we examined whether neutralizing mutations of Glu79 and Glu416 alter diminazene block. These residues form a hexagonal array in the lower palm domain that was previously shown to contribute to pore opening in response to extracellular acidification. Significantly, single Gln substitutions at positions 79 and 416 in ASIC1a reduced diminazene apparent affinity by 6-7 fold. This result suggests that diminazene inhibits ASIC1a in part by limiting conformational rearrangement in the lower palm domain. Because diminazene is charged at physiological pHs, we assessed whether it inhibits ASIC1a by blocking the ion channel pore. Consistent with the notion that diminazene binds to a site within the membrane electric field, diminazene block showed a strong dependence with the membrane potential. Moreover, a Gly to Ala mutation at position 438, in the ion conduction pathway of ASIC1a, increased diminazene IC50 by one order of magnitude and eliminated the voltage dependence of block. Taken together, our results indicate that the inhibition of ASIC1a by diminazene involves both allosteric modulation and blocking of ion flow through the conduction pathway. Our findings provide a foundation for the development of more selective and potent ASIC pore blockers.	[Krauson, Aram J.; Rooney, James G.; Carattino, Marcelo D.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA; [Carattino, Marcelo D.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15260 USA.; Carattino, MD (corresponding author), Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15260 USA.	mdc4@pitt.edu	Krauson, Aram/ABH-1593-2021; Krauson, Aram J/M-4866-2013	Krauson, Aram/0000-0001-7948-5730; Krauson, Aram J/0000-0001-7948-5730; Rooney, James/0000-0001-6101-3735	NIH [R01DK084060]; Cellular Physiology Core of the Pittsburgh Center for Kidney Research [P30-DK079307]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007357] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular Physiology Core of the Pittsburgh Center for Kidney Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant R01DK084060 to MDC and by the Cellular Physiology Core of the Pittsburgh Center for Kidney Research (P30-DK079307).	Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Arias RL, 2008, NEUROBIOL DIS, V31, P334, DOI 10.1016/j.nbd.2008.05.008; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Bubien JK, 2004, AM J PHYSIOL-CELL PH, V287, pC1282, DOI 10.1152/ajpcell.00077.2004; Carattino MD, 2012, J BIOL CHEM, V287, P12927, DOI 10.1074/jbc.M111.329284; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2010, NEUROPHARMACOLOGY, V58, P1045, DOI 10.1016/j.neuropharm.2010.01.011; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Dorofeeva NA, 2008, J NEUROCHEM, V106, P429, DOI 10.1111/j.1471-4159.2008.05412.x; Dube GR, 2005, PAIN, V117, P88, DOI 10.1016/j.pain.2005.05.021; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Grunder S, 2000, NEUROREPORT, V11, P1607; Holland PR, 2012, ANN NEUROL, V72, P559, DOI 10.1002/ana.23653; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Kashlan OB, 2005, J BIOL CHEM, V280, P26206, DOI 10.1074/jbc.M503500200; Kellenberger S, 2003, MOL PHARMACOL, V64, P848, DOI 10.1124/mol.64.4.848; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Kuduk SD, 2010, ACS CHEM NEUROSCI, V1, P19, DOI 10.1021/cn9000186; Leng TD, 2016, CNS NEUROSCI THER, V22, P468, DOI 10.1111/cns.12524; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; PALMER LG, 1984, J MEMBRANE BIOL, V80, P153, DOI 10.1007/BF01868771; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Schmidt A, 2017, MOL PHARMACOL, V92, P665, DOI 10.1124/mol.117.110064; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Tolino LA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.202366; Ugawa S, 2007, BIOCHEM BIOPH RES CO, V363, P203, DOI 10.1016/j.bbrc.2007.08.133; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wiemuth D, 2011, MOL PHARMACOL, V80, P911, DOI 10.1124/mol.111.073726; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103	51	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0196894	10.1371/journal.pone.0196894	http://dx.doi.org/10.1371/journal.pone.0196894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782492	Green Published, gold			2022-12-26	WOS:000432537100009
J	Bonaventura, P; Lamboux, A; Albarede, F; Miossec, P				Bonaventura, Paola; Lamboux, Aline; Albarede, Francis; Miossec, Pierre			Differential effects of TNF-alpha and IL-1 beta on the control of metal metabolism and cadmium-induced cell death in chronic inflammation	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; IL-17; BETA; ACTIVATION; EXPRESSION; RECEPTORS; ZINC	Objective Interleukin-1-beta (IL-1 beta) and tumour necrosis factor-alpha (TNF-alpha) are both monocyte-derived cytokines. Both cytokines have been previously described to exert a role in rheumatoid arthritis (RA) pathogenesis synergizing with other pro-inflammatory mediators, such as interleukin-17 (IL-17) on target cells, for the perpetuation of the inflammatory response (e.g. IL-6 production). In the context of experimental RA, Cd addition has an anti-proliferative and anti-inflammatory effect when associated to IL-17/TNF-alpha stimulation, due to its accumulation in synoviocytes. The aim of this work was to evaluate if IL-1 beta interaction with IL-17 also contributes to metal-import mechanisms and its effects on cell viability and inflammation. Methods IL-17 and IL-1 beta were added to synoviocyte cultures with or without exogenous Cd addition (0.1 ppm, 0.89 mu M). IL-6 production, Cd import kinetics, gene expression of ZIP-8 importer and metallothioneins (MTs) and cell viability were evaluated by ELISA, inductively-coupled mass spectrometry (ICP-MS), q-RT-PCR and viability assays (neutral red and annexin V) respectively. Results IL-17 and IL-1 beta acted in synergy on synoviocytes to induce IL-6 production similarly to the IL-17/TNF-alpha combination. Metal import was lower with IL17/IL-1 beta in comparison to IL-17/ TNF-alpha exposed-synoviocytes, as the expression of ZIP-8 and MT-1F was less induced. Monocyte and PBMCs exposure to Cd resulted in a reduced production of IL-1 beta and an increased production of TNF-alpha and this result was confirmed in co-cultures of synoviocytes and PBMCs. The IL-17/IL-1 beta combination with Cd slightly reduced cell viability in comparison to the IL-17/TNF-alpha combination and resulted in a strong induction of IL-6 production. Conclusion IL-17/TNF-alpha combination but not IL-17/IL-1 beta combination mainly drives the accumulation of Cd in synoviocytes and its effects on cell viability and inflammation.	[Bonaventura, Paola; Miossec, Pierre] Univ Lyon, Edouard Herriot Hosp, EA 4130, Dept Immunol & Rheumatol,Immunogen & Inflammat Re, Lyon, France; [Lamboux, Aline; Albarede, Francis] Ecole Normale Super Lyon, Geol Lab, Dept Earth Sci, Lyon, France; [Lamboux, Aline; Albarede, Francis] CNRS, Lyon, France	CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS)	Miossec, P (corresponding author), Univ Lyon, Edouard Herriot Hosp, EA 4130, Dept Immunol & Rheumatol,Immunogen & Inflammat Re, Lyon, France.	pierre.miossec@univ-lyon1.fr	; Albarede, Francis/A-8871-2011	Miossec, Pierre/0000-0002-3280-6346; Albarede, Francis/0000-0003-1994-1428	7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-ITN, under the Marie Sklodowska-Curie grant [289903]; IHU prometteur OPERA; Cluster 1 region Rhone-Alpes; Institut Universitaire de France	7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-ITN, under the Marie Sklodowska-Curie grant; IHU prometteur OPERA; Cluster 1 region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Institut Universitaire de France	This project and PB have received funding from the 7th Framework program of the EU, SP3-People, support for training and career development for researchers (Marie Curie), Network for Initial Training (ITN), FP7-PEOPLE-2011-ITN, under the Marie Sklodowska-Curie grant agreement No 289903. This work has been supported in part by grants from the IHU prometteur OPERA and the "Cluster 1 region Rhone-Alpes." PM is a senior member of and supported by the "Institut Universitaire de France".	[Anonymous], 2016, FRONT IMMUNOL, V7, P254, DOI [10.3389/fimmu.2016.00254, DOI 10.3389/FIMMU.2016.00254]; Benedetti G, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00254; Bonaventura P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02611-5; Bonaventura P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147146; Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Chabaud M, 1998, J IMMUNOL, V161, P409; Chabaud M, 2001, J IMMUNOL, V167, P6015, DOI 10.4049/jimmunol.167.10.6015; Chu WA, 1999, J BIOL CHEM, V274, P5279, DOI 10.1074/jbc.274.9.5279; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; El Muayed M, 2012, ISLETS, V4, P405, DOI 10.4161/isl.23101; Fox DA, 2010, RHEUM DIS CLIN N AM, V36, P311, DOI 10.1016/j.rdc.2010.02.004; Freisinger E, 2013, METAL IONS LIFE SCI, V11, P339, DOI 10.1007/978-94-007-5179-8_11; Hot A, 2012, ANN RHEUM DIS, V71, P768, DOI 10.1136/annrheumdis-2011-200468; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kim JH, 2014, CELL, V156, P730, DOI 10.1016/j.cell.2014.01.007; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; KOVACS EJ, 1988, J IMMUNOL, V141, P3101; Lichten LA, 2009, AM J PHYSIOL-GASTR L, V296, pG860, DOI 10.1152/ajpgi.90676.2008; Liu ZH, 1996, AM J PHYSIOL-CELL PH, V270, pC1595, DOI 10.1152/ajpcell.1996.270.6.C1595; Min YG, 1998, AM J RHINOL, V12, P279, DOI 10.2500/105065898781390064; Miossec P, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2413; Noack M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1046-6; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Takahashi S, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-41; Utaisincharoen P, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P167; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036	28	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196285	10.1371/journal.pone.0196285	http://dx.doi.org/10.1371/journal.pone.0196285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768427	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200019
J	Morgan, RF				Morgan, Ryan FitzGerald			Niche partitioning as a mechanism for locally high species diversity within a geographically limited genus of blastoid	PLOS ONE			English	Article							DIFFERENTIATION	Deltoblastus batheri and Deltoblastus delta occur concurrently in many Permian deposits from Timor. Closely related sister species living in direct proximity without alteration in feeding habit would be in direct violation of Lotka-Volterra dynamics. These two species were measured and compared to see if any evidence of differentiation along feeding lines has occurred in order to reduce direct competition. P-values obtained via Student's t test display significant differentiation across all measured parameters. Thin-plate splines were used to visualize these differences, and clearly show the differences which are focused on the ambulacral region of the blastoids, which are the primary food gathering point for these species.	[Morgan, Ryan FitzGerald] Tarleton State Univ, Dept Chem Geosci & Phys, Stephenville, TX 76401 USA	Texas A&M University System; Tarleton State University	Morgan, RF (corresponding author), Tarleton State Univ, Dept Chem Geosci & Phys, Stephenville, TX 76401 USA.	rmorgan@tarleton.edu						AUSICH WI, 1980, J PALEONTOL, V54, P273; Beaver H.H, 1967, TREATISE INVERTEBRAT, V1; Cavender-Bares J, 2003, ECOLOGY, V84, P592, DOI 10.1890/0012-9658(2003)084[0592:IMAMPI]2.0.CO;2; Charlton TR, 2002, J ASIAN EARTH SCI, V20, P719, DOI 10.1016/S1367-9120(02)00018-4; Fay R. O., 1961, Oklahoma Geology Notes, V21, P36; Grossowicz M, 2012, MAR BIODIVERS, V42, P65, DOI 10.1007/s12526-011-0093-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HARPER, 2005, PALEONTOLOGICAL DATA; HARTMAN WD, 1957, EVOLUTION, V11, P294, DOI 10.1111/j.1558-5646.1957.tb02897.x; Hopkins MJ, 2014, ECOL LETT, V17, P314, DOI 10.1111/ele.12232; JANSEN H., 1934, K AKAD WETENSCH AMSTERDAM PROC SECT SCI, V37, P819; KATZ SG, 1976, SCIENCE, V192, P1137, DOI 10.1126/science.192.4244.1137; Meyer DL, 2002, J PALEONTOL, V76, P725, DOI 10.1666/0022-3360(2002)076<0725:CDAFMT>2.0.CO;2; Morgan RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127727; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Speden I. G., 1966, New Zealand Journal of Geology and Geophysics, V9, P408; TEICHERT CURT, 1951, PALAONT ZEITSCHR [STUTTGART], V24, P76; Thompson D. W., 1917, GROWTH FORM; Wanner J., 1924, Jaarb Mijnw Ned Ost Ind Weltefreden, V1922, P163; Wanner J, 1924, PERMISCHEN ECHINOD 2, P1; Webster GD, 2007, PALAEONTOL Z, V81, P399, DOI 10.1007/BF02990251	22	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197512	10.1371/journal.pone.0197512	http://dx.doi.org/10.1371/journal.pone.0197512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768486	gold, Green Submitted, Green Published			2022-12-26	WOS:000432329200088
J	Yuan, ZH; Zhou, T; Bao, LS; Liu, SK; Shi, HT; Yang, YJ; Gao, DY; Dunham, R; Waldbieser, G; Liu, ZJ				Yuan, Zihao; Zhou, Tao; Bao, Lisui; Liu, Shikai; Shi, Huitong; Yang, Yujia; Gao, Dongya; Dunham, Rex; Waldbieser, Geoff; Liu, Zhanjiang			The annotation of repetitive elements in the genome of channel catfish (Ictalurus punctatus)	PLOS ONE			English	Article							SELFISH GENETIC ELEMENTS; DE-NOVO IDENTIFICATION; MISMATCH REPAIR GENES; TRANSPOSABLE ELEMENTS; DROSOPHILA-MELANOGASTER; CENTROMERE IDENTITY; TANDEM REPEATS; EUKARYOTIC GENOMES; SIMPLE SEQUENCES; DNA ELEMENTS	Channel catfish (Ictalurus punctatus) is a highly adaptive species and has been used as a research model for comparative immunology, physiology, and toxicology among ectothermic vertebrates. It is also economically important for aquaculture. As such, its reference genome was generated and annotated with protein coding genes. However, the repetitive elements in the catfish genome are less well understood. In this study, over 417.8 Megabase (MB) of repetitive elements were identified and characterized in the channel catfish genome. Among them, the DNA/TcMar-Tc1 transposons are the most abundant type, making up similar to 20% of the total repetitive elements, followed by the microsatellites (14%). The prevalence of repetitive elements, especially the mobile elements, may have provided a driving force for the evolution of the catfish genome. A number of catfish-specific repetitive elements were identified including the previously reported Xba elements whose divergence rate was relatively low, slower than that in untranslated regions of genes but faster than the protein coding sequences, suggesting its evolutionary restrictions.	[Yuan, Zihao; Zhou, Tao; Bao, Lisui; Liu, Shikai; Shi, Huitong; Yang, Yujia; Gao, Dongya; Dunham, Rex] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA; [Waldbieser, Geoff] USDA ARS, Warmwater Aquaculture Res Unit, Stoneville, MS 38776 USA; [Liu, Zhanjiang] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Auburn University System; Auburn University; United States Department of Agriculture (USDA); Syracuse University	Liu, ZJ (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	johnliu@syr.edu	Liu, Shikai/AAO-2247-2021; Liu, Zhanjiang/R-9633-2019	Liu, Shikai/0000-0001-5777-489X; Liu, Zhanjiang/0000-0003-3495-135X; Zhou, Tao/0000-0002-2353-7404	USDA grant from the Agriculture and Food Research Initiative (AFRI) under the Animal Breeding, Genetics and Genomics Program [2017-67015-26295]; China Scholarship Council [201406330063]	USDA grant from the Agriculture and Food Research Initiative (AFRI) under the Animal Breeding, Genetics and Genomics Program; China Scholarship Council(China Scholarship Council)	This project was supported by a USDA grant (grant no. 2017-67015-26295) from the Agriculture and Food Research Initiative (AFRI) under the Animal Breeding, Genetics and Genomics Program. Zihao Yuan was supported by China Scholarship Council (201406330063).	Areshchenkova T, 1999, GENOME, V42, P536, DOI 10.1139/gen-42-3-536; Aziz RK, 2010, NUCLEIC ACIDS RES; Bachtrog D, 1999, MOL BIOL EVOL, V16, P602, DOI 10.1093/oxfordjournals.molbev.a026142; Balaresque P, 2014, HUM MUTAT, V35, P609, DOI 10.1002/humu.22542; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Bengten E, 2006, DEV COMP IMMUNOL, V30, P77, DOI 10.1016/j.dci.2005.06.016; Benton M.J., 1993, THE FOSSIL RECORD 2; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blanton RE, 2013, MOL PHYLOGENET EVOL, V66, P679, DOI 10.1016/j.ympev.2012.10.022; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Castillo-Lizardo M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00403; Castoe TA, 2011, GENOME BIOL EVOL, V3, P641, DOI 10.1093/gbe/evr043; Chang DK, 2001, GENOME RES, V11, P1145, DOI 10.1101/gr.186301; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chen CY, 2003, AQUACULTURE, V218, P89, DOI 10.1016/S0044-8486(02)00499-4; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Chen XH, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0142-5; Conte MA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3723-5; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; FINNEGAN DJ, 1985, INT REV CYTOL, V93, P281, DOI 10.1016/S0074-7696(08)61376-5; Glenn TC, 1996, MOL BIOL EVOL, V13, P1151, DOI 10.1093/oxfordjournals.molbev.a025678; Gonzalez J, 2009, MOL BIOL EVOL, V26, P1949, DOI 10.1093/molbev/msp107; Gonzalez J, 2008, PLOS BIOL, V6, P2109, DOI 10.1371/journal.pbio.0060251; GRADY DL, 1992, P NATL ACAD SCI USA, V89, P1695, DOI 10.1073/pnas.89.5.1695; Hardman M, 2008, SYST BIOL, V57, P116, DOI 10.1080/10635150801902193; HATCH FT, 1974, NUCLEIC ACIDS RES, V1, P559, DOI 10.1093/nar/1.4.559; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Hurst GDD, 1998, HEREDITY, V80, P2, DOI 10.1046/j.1365-2540.1998.00337.x; Ibarra-Laclette E, 2013, NATURE, V498, P94, DOI 10.1038/nature12132; INGLE J, 1975, PLANT PHYSIOL, V55, P496, DOI 10.1104/pp.55.3.496; Janes DE, 2010, ANNU REV GENOM HUM G, V11, P239, DOI 10.1146/annurev-genom-082509-141646; Kamnert I, 1997, HEREDITAS, V127, P175, DOI 10.1111/j.1601-5223.1997.00175.x; Kapitonov VV, 2007, TRENDS GENET, V23, P521, DOI 10.1016/j.tig.2007.08.004; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kim S, 2000, GENE, V252, P173, DOI 10.1016/S0378-1119(00)00198-0; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 2011, CELL MOL LIFE SCI, V68, P1395, DOI 10.1007/s00018-010-0613-2; Kubis S, 1998, ANN BOT-LONDON, V82, P45, DOI 10.1006/anbo.1998.0779; LAWRENCE JG, 1992, GENETICS, V131, P753; Lee Sung-Il, 2014, Genomics & Informatics, V12, P87, DOI 10.5808/GI.2014.12.3.87; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; Li W, 1992, FUNDAMENTAL MOL EVOL, P67; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LINDAHL T, 1994, CURR BIOL, V4, P249, DOI 10.1016/S0960-9822(00)00056-7; Liu Z, 1999, FISH PHYSIOL BIOCHEM, V21, P65, DOI 10.1023/A:1007710212254; Liu ZJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11757; Liu ZJ, 2011, COMP BIOCHEM PHYS D, V6, P11, DOI 10.1016/j.cbd.2010.03.001; Liu ZJ, 1998, MOL MAR BIOL BIOTECH, V7, P232; LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; MARUYAMA K, 1991, J MOL EVOL, V33, P514, DOI 10.1007/BF02102804; Maumus F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094101; McCullers Tabitha J, 2017, Mob Genet Elements, V7, P1, DOI 10.1080/2159256X.2017.1318201; Meagher TR, 2005, NEW PHYTOL, V168, P71, DOI 10.1111/j.1469-8137.2005.01527.x; Mehta GD, 2010, MOL GENET GENOMICS, V284, P75, DOI 10.1007/s00438-010-0553-4; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; Melters DP, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r10; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Nagarajan N, 2008, TROPICAL PLANT BIOL, V1, P191; Nandi S, 2007, GENETICA, V131, P81, DOI 10.1007/s10709-006-9115-4; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; PARDUE ML, 1987, EMBO J, V6, P1781, DOI 10.1002/j.1460-2075.1987.tb02431.x; Petitpierre E., 1995, Proceedings of the Kew chromosome conference IV, held at the Jodrell Laboratory, Royal Botanic Gardens, Kew, UK, 30 August-2 September 1994., P351; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Plohl M, 2014, CHROMOSOMA, V123, P313, DOI 10.1007/s00412-014-0462-0; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; Quiniou SMA, 2005, ANIM GENET, V36, P353, DOI 10.1111/j.1365-2052.2005.01304.x; Richard GF, 2000, EMBO REP, V1, P122, DOI 10.1093/embo-reports/kvd031; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P1886, DOI 10.1093/nar/30.9.1886; Rosenberg M, 1997, GENOME RES, V7, P917, DOI 10.1101/gr.7.9.917; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Schmidt AL, 2006, BIOL REV, V81, P531, DOI 10.1017/S146479310600710X; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Serapion J, 2004, MAR BIOTECHNOL, V6, P364, DOI 10.1007/s10126-003-0039-z; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; Sun YB, 2015, P NATL ACAD SCI USA, V112, pE1257, DOI 10.1073/pnas.1501764112; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; THOMAS CA, 1971, ANNU REV GENET, V5, P237, DOI 10.1146/annurev.ge.05.120171.001321; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Ugarkovic D, 2002, EMBO J, V21, P5955, DOI 10.1093/emboj/cdf612; United States Department of Agriculture, 2014, CENS AQ 51, V1; USDA-NASS (United States Department of Agriculture National Agriculture Statistic Service), 2005, SPEC STUD 2, V3; Ventura-Holman T, 2002, MOL IMMUNOL, V38, P557, DOI 10.1016/S0161-5890(01)00075-X; Vicient CM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-601; Vidaurreta M, 2007, WORLD J GASTROENTERO, V13, P3868; Wang GX, 2009, J GENET GENOMICS, V36, P529, DOI 10.1016/S1673-8527(08)60144-7; Wang QR, 2015, GENET MOL RES, V14, P18198, DOI 10.4238/2015.December.23.7; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; Wedemeyer G., 1996, PHYSL FISH INTENSIVE, P54; Wellborn T.L, 1988, SRAC PUBLICATION, V180; Werner Christa, 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P221; Westhorpe FG, 2013, CURR OPIN CELL BIOL, V25, P334, DOI 10.1016/j.ceb.2013.02.001; Wheeler TJ, 2013, NUCLEIC ACIDS RES, V41, pD70, DOI 10.1093/nar/gks1265; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicky C, 1996, P NATL ACAD SCI USA, V93, P8983, DOI 10.1073/pnas.93.17.8983; Xu P, 2006, ANIM GENET, V37, P321, DOI 10.1111/j.1365-2052.2006.01453.x; Xu P, 2007, GENOMICS, V90, P380, DOI 10.1016/j.ygeno.2007.05.008; Yang JQ, 2012, INT J MOL SCI, V13, P1405, DOI 10.3390/ijms13021405; Yi S, 2005, TRENDS GENET, V21, P643, DOI 10.1016/j.tig.2005.09.003; Yu L, 2016, NAT GENET	120	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197371	10.1371/journal.pone.0197371	http://dx.doi.org/10.1371/journal.pone.0197371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763462	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800044
J	Martemyanov, KA; Garcia-Marcos, M				Martemyanov, Kirill A.; Garcia-Marcos, Mikel			Making useful gadgets with miniaturized G proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ACTIVATION	G protein-coupled receptors (GPCRs) relay information from extracellular stimuli to intracellular responses in a wide range of physiological and pathological processes, but understanding their complex effects in live cells is a daunting task. In this issue of JBC, Wan et al. repurpose mini G proteinspreviously used as affinity tools for structural studiesto develop a suite of probes to visualize GPCR activation in live cells. The approach is expected to revolutionize our understanding of the spatiotemporal control and mechanisms of GPCR signaling.	[Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33453 USA; [Garcia-Marcos, Mikel] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Scripps Research Institute; Boston University	Garcia-Marcos, M (corresponding author), Boston Univ, 72 E Concord St,Rm K206, Boston, MA 02118 USA.	mgm1@bu.edu			NIDA, National Institutes of Health [DA026405]; NIGMS, National Institutes of Health [R01GM112631, R01GM108733]; American Cancer Society [RSG-13-362-01-TBE]; Karin Grunebaum Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108733, R01GM112631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026405] Funding Source: NIH RePORTER	NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Cancer Society(American Cancer Society); Karin Grunebaum Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by NIDA, National Institutes of Health Grant DA026405.r Supported by NIGMS, National Institutes of Health Grants R01GM112631 and R01GM108733, American Cancer Society Grant RSG-13-362-01-TBE, and the Karin Grunebaum Cancer Research Foundation.	Carpenter B, 2016, NATURE, V536, P104, DOI 10.1038/nature18966; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Nehme R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175642; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975	10	1	1	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 11	2018	293	19					7474	7475		10.1074/jbc.H118.002879	http://dx.doi.org/10.1074/jbc.H118.002879			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF7UT	29752421	Green Published, hybrid			2022-12-26	WOS:000432174500038
J	Zhu, B; Tang, LM; Chen, SY; Yin, CQ; Peng, SG; Li, X; Liu, TZ; Liu, W; Han, CP; Stawski, L; Xu, ZX; Zhou, GB; Chen, X; Gao, XM; Goding, CR; Xu, N; Cui, RT; Cao, P				Zhu, Bo; Tang, Liming; Chen, Shuyang; Yin, Chengqian; Peng, Shiguang; Li, Xin; Liu, Tongzheng; Liu, Wei; Han, Changpeng; Stawski, Lukasz; Xu, Zhi-Xiang; Zhou, Guangbiao; Chen, Xiang; Gao, Xiumei; Goding, Colin R.; Xu, Nan; Cui, Rutao; Cao, Peng			Targeting the upstream transcriptional activator of PD-L1 as an alternative strategy in melanoma therapy	ONCOGENE			English	Article							OXIDATIVE STRESS; MESSENGER-RNA; EXPRESSION; PTEN; STABILIZATION; PEMBROLIZUMAB; MODULATION; MECHANISMS; IPILIMUMAB; NIVOLUMAB	Programmed cell death ligand 1 (PD-L1) interacts with programmed cell death protein-1 (PD-1) as an immune checkpoint. Reactivating the immune response by inhibiting PD-L1 using therapeutic antibodies provides substantial clinical benefits in many, though not all, melanoma patients. However, transcriptional suppression of PD-L1 expression as an alternative therapeutic anti-melanoma strategy has not been exploited. Here we provide biochemical evidence demonstrating that ultraviolet radiation (UVR) induction of PD-L1 in skin is directly controlled by nuclear factor E2-related transcription factor 2 (NRF2). Depletion of NRF2 significantly induces tumor infiltration by both CD8(+) and CD4(+) T cells to suppress melanoma progression, and combining NRF2 inhibition with anti-PD-1 treatment enhanced its anti-tumor function. Our studies identify a critical and targetable PD-L1 upstream regulator and provide an alternative strategy to inhibit the PD-1/PD-L1 signaling in melanoma treatment.	[Zhu, Bo; Chen, Shuyang; Yin, Chengqian; Peng, Shiguang; Li, Xin; Liu, Tongzheng; Liu, Wei; Han, Changpeng; Cui, Rutao] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Tang, Liming; Cao, Peng] Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing 210028, Jiangsu, Peoples R China; [Tang, Liming] Nanjing Med Univ, Affiliated Changzhou Peoples Hosp 2, Changzhou, Jiangsu, Peoples R China; [Peng, Shiguang] Capital Med Univ, Beijing Chaoyang Hosp, Dept Dermatol, Beijing 100020, Peoples R China; [Liu, Wei; Gao, Xiumei] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin 300193, Peoples R China; [Stawski, Lukasz] Boston Univ, Sch Med, Arthrit Ctr, Sect Rheumatol, Boston, MA 02118 USA; [Xu, Zhi-Xiang] Univ Alabama Birmingham, Sch Med, Dept Med, Div Hematol & Oncol, Birmingham, AL 35233 USA; [Zhou, Guangbiao] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, 1 Beichen West Rd, Beijing 100101, Peoples R China; [Chen, Xiang] Cent Suth Univ, Xiangya Hosp, Hunan Key Lab Skin Canc & Psoriasis, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Chen, Xiang] Cent Suth Univ, Xiangya Hosp, Dept Dermatol, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Goding, Colin R.] Univ Oxford, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Xu, Nan] Tongji Univ, Shanghai East Hosp, Dermatol Dept, Shanghai 200120, Peoples R China; [Cao, Peng] Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Nanjing 211166, Jiangsu, Peoples R China	Boston University; Nanjing University of Chinese Medicine; Nanjing Medical University; Capital Medical University; Tianjin University of Traditional Chinese Medicine; Boston University; University of Alabama System; University of Alabama Birmingham; Chinese Academy of Sciences; Institute of Zoology, CAS; Central South University; Central South University; Ludwig Institute for Cancer Research; University of Oxford; Tongji University; Nanjing Medical University	Cui, RT (corresponding author), Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA.; Cao, P (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing 210028, Jiangsu, Peoples R China.; Xu, N (corresponding author), Tongji Univ, Shanghai East Hosp, Dermatol Dept, Shanghai 200120, Peoples R China.; Cao, P (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Nanjing 211166, Jiangsu, Peoples R China.	xnhrb@aliyun.com; rutaocui@bu.edu; pcao79@yahoo.com	Yin, Chengqian/AAK-2991-2020; Zhou, Guangbiao/J-6575-2017; Zhou, Guang-Biao/ABG-5795-2021; Liu, Wei/E-8826-2018	Zhou, Guangbiao/0000-0002-6327-2316; , Peng/0000-0002-2044-3074; Li, Xin/0000-0003-2525-9679; Zhou, Guang-Biao/0000-0001-6778-7133; Yin, Chengqian/0000-0003-4247-6245; Liu, Wei/0000-0003-1792-6048	National Institutes of Health [R01CA137098, R01CA193913, R01CA196896]; Melanoma Research Foundation Establish Investigator Award, Hong Kong; National Natural Science Foundation of China [81428025, 81630106, 31771619, 81673977]; Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Chinese and Western Medicine) grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Foundation Establish Investigator Award, Hong Kong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Chinese and Western Medicine) grant	We thank Drs. Wenshu Wu and Rui He for carefully reading and suggestions. This work was supported by the National Institutes of Health (RC: R01CA137098, R01CA193913 and R01CA196896), Melanoma Research Foundation Establish Investigator Award (RC), Hong Kong, Macao Young Scientists of the National Natural Science Foundation of China (Grant No. 81428025 for RC) and National Natural Science Foundation of China (81630106), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Integration of Chinese and Western Medicine) grant (PC). National Natural Science Foundation of China (31771619) for HH. The National Natural Science Foundation of China (Grant No. 81673977 for 2016 for XM). RC is an American Cancer Society Research Scholar.	Beyer TA, 2007, CELL DEATH DIFFER, V14, P1250, DOI 10.1038/sj.cdd.4402133; Blattner C, 2000, MOL CELL BIOL, V20, P3616, DOI 10.1128/MCB.20.10.3616-3625.2000; Cao JX, 2013, MOL CELL, V51, P409, DOI 10.1016/j.molcel.2013.08.010; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Gogas H, 2015, AM J THER, V22, P54, DOI 10.1097/MJT.0b013e31829e883d; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; Heckman CJ, 2013, JOVE-J VIS EXP, V75, P50175, DOI DOI 10.3791/5017523748556; Hintsala HR, 2016, ANTICANCER RES, V36, P1497; Hybertson BM, 2014, CLIN GENET, V86, P447, DOI 10.1111/cge.12474; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim JH, 2016, J ALLERGY CLIN IMMUN, V137, P1466, DOI 10.1016/j.jaci.2015.11.021; Kondo A, 2010, BLOOD, V116, P1124, DOI 10.1182/blood-2009-12-255125; Lastwika KJ, 2016, CANCER RES, V76, P227, DOI 10.1158/0008-5472.CAN-14-3362; Li J, 2004, PHYSIOL GENOMICS, V18, P261, DOI 10.1152/physiolgenomics.00209.2003; Menter A, 2010, J AM ACAD DERMATOL, V62, P114, DOI 10.1016/j.jaad.2009.08.026; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Romero Diana, 2016, Nat Rev Clin Oncol, V13, P266, DOI 10.1038/nrclinonc.2016.52; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schadendorf D, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.3; Sidaway Peter, 2016, Nat Rev Clin Oncol, V13, P652, DOI [10.1038/nrclinonc.2016.158, 10.1038/nrclinonc.2016.156]; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Umansky V, 2014, J DTSCH DERMATOL GES, V12, P1021, DOI 10.1111/ddg.12411; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Westmark CJ, 2005, ONCOGENE, V24, P502, DOI 10.1038/sj.onc.1208224; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x; Zhu B, 2016, ONCOGENE, V35, P4212, DOI 10.1038/onc.2015.486	48	45	47	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 6	2018	37	36					4941	4954		10.1038/s41388-018-0314-0	http://dx.doi.org/10.1038/s41388-018-0314-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS6QR	29786078	Green Submitted			2022-12-26	WOS:000443823600003
J	Yang, Y; Liu, FG; Liu, AM				Yang, Yu; Liu, Fange; Liu, Aimin			Adapting to oxygen: 3-Hydroxyanthrinilate 3,4-dioxygenase employs loop dynamics to accommodate two substrates with disparate polarities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dioxygenase; iron; enzyme structure; oxygen binding; crystal structure; conformational change; Extradiol dioxygenase; hydrophobicity; Nonheme iron enzyme; Oxygen activation; Tryptophan-kynurenine pathway	CRYSTAL-STRUCTURE; X-RAY; TRYPTOPHAN; MECHANISM; PATHWAY; 3-HYDROXYANTHRANILATE-3,4-DIOXYGENASE; IDENTIFICATION; KETOGLUTARATE; KYNURENINES; DEGRADATION	3-Hydroxyanthranilate 3,4-dioxygenase (HAO) is an iron-dependent protein that activates O-2 and inserts both oxygen atoms into 3-hydroxyanthranilate (3-HAA). An intriguing question is how HAO can rapidly bind O-2, even though local O-2 concentrations and diffusion rates are relatively low. Here, a close inspection of the HAO structures revealed that substrate- and inhibitor-bound structures exhibit a closed conformation with three hydrophobic loop regions moving toward the catalytic iron center, whereas the ligand-free structure is open. We hypothesized that these loop movements enhance O-2 binding to the binary complex of HAO and 3-HAA. We found that the carboxyl end of 3-HAA triggers changes in two loop regions and that the third loop movement appears to be driven by an H-bond interaction between Asn(27) and Ile(142). Mutational analyses revealed that N27A, I142A, and I142P variants cannot form a closed conformation, and steady-state kinetic assays indicated that these variants have a substantially higher K-m for O-2 than WT HAO. This observation suggested enhanced hydrophobicity at the iron center resulting from the concerted loop movements after the binding of the primary substrate, which is hydrophilic. Given that O-2 is nonpolar, the increased hydrophobicity at the iron center of the binary complex appears to be essential for rapid O-2 binding and activation, explaining the reason for the 3-HAA-induced loop movements. Because substrate binding-induced open-to-closed conformational changes are common, the results reported here may help further our understanding of how oxygen is enriched in nonheme iron-dependent dioxygenases.	[Yang, Yu; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Liu, Fange] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Pennsylvania; Pennsylvania Medicine	Liu, AM (corresponding author), Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA.; Liu, FG (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	liufg@pennmedicine.upenn.edu; Feradical@utsa.edu	Liu, Aimin/C-1572-2017	Liu, Aimin/0000-0002-4182-8176; Yang, Yu/0000-0001-5305-2435	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357, DE-AC02-76SF00515]; National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107529, P41GM103393, R01GM108988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107985] Funding Source: NIH RePORTER	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Drs. Tadhg P. Begley and Steven E. Ealick for providing the HAO expression plasmid. We are indebted to Ian Davis for constructive discussions and manuscript editing. We thank the staff scientists at the sections 19 and 22 beamlines of the Advanced Photon Source (APS), Argonne National Laboratory and the beamline 9-2 of the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory. Use of the APS and SSRL is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contracts DE-AC02-06CH11357 and DE-AC02-76SF00515, respectively. The SSRL facility is additionally supported by National Institutes of Health Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boechi L, 2013, J BIOL CHEM, V288, P6754, DOI 10.1074/jbc.M112.426056; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho JH, 2009, J BIOL CHEM, V284, P34321, DOI 10.1074/jbc.M109.031054; Cohen J, 2007, BIOPHYS J, V93, P3591, DOI 10.1529/biophysj.107.108712; Colabroy KL, 2005, J BACTERIOL, V187, P7866, DOI 10.1128/JB.187.22.7866-7869.2005; Colabroy KL, 2005, BIOCHEMISTRY-US, V44, P7623, DOI 10.1021/bi0473455; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; DEVILLOTA ED, 1981, BRIT J ANAESTH, V53, P1325, DOI 10.1093/bja/53.12.1325; Dilovic I, 2009, BIOPOLYMERS, V91, P1189, DOI 10.1002/bip.21167; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Erlandsen H, 2000, BIOCHEMISTRY-US, V39, P2208, DOI 10.1021/bi992531+; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khare D, 2010, P NATL ACAD SCI USA, V107, P14099, DOI 10.1073/pnas.1006738107; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; Li XW, 2006, PROTEIN SCI, V15, P761, DOI 10.1110/ps.051967906; Liu FG, 2015, J BIOL CHEM, V290, P15621, DOI 10.1074/jbc.M115.650259; Muraki T, 2003, APPL ENVIRON MICROB, V69, P1564, DOI 10.1128/AEM.69.3.1564-1572.2003; O'Brien JR, 2003, BIOCHEMISTRY-US, V42, P5547, DOI 10.1021/bi0341096; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERUTZ MF, 1966, J MOL BIOL, V21, P199, DOI 10.1016/0022-2836(66)90088-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Volner A, 2003, J BIOL INORG CHEM, V8, P121, DOI 10.1007/s00775-002-0395-6; Zhang Y, 2005, BIOCHEMISTRY-US, V44, P7632, DOI 10.1021/bi047353l	31	8	8	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10415	10424		10.1074/jbc.RA118.002698	http://dx.doi.org/10.1074/jbc.RA118.002698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29784877	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000437828400001
J	Yuan, L; Wang, HY; Liu, Q; Wang, Z; Zhang, MS; Zhao, Y; Liang, K; Chen, LY; Xu, T; Xu, PY				Yuan, Lin; Wang, Huiyu; Liu, Qi; Wang, Zhe; Zhang, Mingshu; Zhao, Yan; Liang, Kuo; Chen, Liangyi; Xu, Tao; Xu, Pingyong			Etoposide-induced protein 2.4 functions as a regulator of the calcium ATPase and protects pancreatic -cell survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; pancreatic islet; cell metabolism; calcium ATPase; apoptosis; ATPase sarcoplasmic; endoplasmic reticulum Ca2+-transporting 2; etoposide-induced protein 2; 4; glucose tolerance	AUTOPHAGY; KINASE; EXPRESSION; APOPTOSIS; EI24; ACTIVATION; P53	Calcium homeostasis is essential for maintaining the viability and function of pancreatic cells and plays a key role in preventing the development of diabetes. Decreased levels of ATPase sarcoplasmic/endoplasmic reticulum Ca2+-transporting 2 (ATP2a2), the main calcium pump in cells, are often found in individuals with diabetes and in diabetic animal models. However, the regulators of ATP2a2 and the molecular mechanisms responsible for controlling ATP2a2 activity remain unclear. Etoposide-induced protein 2.4 (Ei24) is also down-regulated in cells of diabetic individuals, whereas the effect of decreased Ei24 level on -cell function is not clarified. Here, using Cre-LoxP and CRISPR/Cas9-based genomic knockout (KO) approaches to generate pancreatic cell-specific Ei24 KO mice and pancreatic -cell lines, we found that Ei24 regulates ATP2a2 activity. Specifically, we observed that Ei24 binds to ATP2a2 through Ei24 residues 293-299, which we named here the ATP2a2-interacting region (AIR). Loss of Ei24 inactivated ATP2a2, disrupted calcium homeostasis, and deactivated the calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2)-AMP-activated protein kinase (AMPK) pathway. Elevation of calcium concentration in the endoplasmic reticulum or agonist-induced AMPK activation rescued pancreatic -cell survival and improved glucose tolerance of Ei24 KO mice. Our findings indicate that targeting the Ei24-ATP2a2 interaction to increase ATP2a2 activity can protect pancreatic cells and improve glucose homeostasis in diabetic models, suggesting that Ei24 could potentially serve as a target to prevent or manage diabetes.	[Yuan, Lin; Wang, Huiyu; Liu, Qi; Wang, Zhe; Zhang, Mingshu; Xu, Pingyong] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China; [Zhao, Yan; Xu, Tao] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Liu, Qi; Wang, Zhe; Zhang, Mingshu; Xu, Tao; Xu, Pingyong] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100101, Peoples R China; [Liang, Kuo] Capital Med Univ, XuanWu Hosp, Dept Gen Surg, Beijing 100053, Peoples R China; [Xu, Pingyong] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing Key Lab Cardiometab Mol Med, Inst Mol Med, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital Medical University; Peking University	Xu, PY (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing 100101, Peoples R China.; Xu, T (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Xu, T; Xu, PY (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100101, Peoples R China.	xutao@ibp.ac.cn; pyxu@ibp.ac.cn	王, 慧玉/GPX-6583-2022	王, 慧玉/0000-0001-7855-9769	National Key R&D Program of China [2016YFA0501500]; National Basic Research Program [2013CB910103]; National Natural Science Foundation of China [31421002, 31401174, 21778069]; Chinese Academy of Sciences [XDA12030201, XDB08030203]; CAST; Beijing Natural Science Foundation [7182063]; Beijing Health System High Level Health Technical Personnel Grant [2014-3-058]	National Key R&D Program of China; National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); CAST; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Health System High Level Health Technical Personnel Grant	This work was supported by National Key R&D Program of China Grant 2016YFA0501500; National Basic Research Program Grant 2013CB910103; National Natural Science Foundation of China Grants 31421002, 31401174, and 21778069; Project of the Chinese Academy of Sciences Grants XDA12030201 and XDB08030203; Young Elite Scientist Sponsorship Program by CAST; Beijing Natural Science Foundation Grant 7182063; and Beijing Health System High Level Health Technical Personnel Grant 2014-3-058. The authors declare that they have no conflicts of interest with the contents of this article.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; de Juan-Sanz J, 2017, NEURON, V93, P867, DOI 10.1016/j.neuron.2017.01.010; Devkota S, 2016, AUTOPHAGY, V12, P2038, DOI 10.1080/15548627.2016.1217371; Devkota S, 2012, INT J BIOCHEM CELL B, V44, P1887, DOI 10.1016/j.biocel.2012.06.034; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Johnson JD, 2010, ADV EXP MED BIOL, V654, P447, DOI 10.1007/978-90-481-3271-3_19; Kang S, 2016, J BIOL CHEM, V291, P5185, DOI 10.1074/jbc.M115.705012; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Lehar SM, 1996, ONCOGENE, V12, P1181; Liang K, 2014, PROTEIN CELL, V5, P783, DOI 10.1007/s13238-014-0075-7; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; Mork CN, 2007, FEBS LETT, V581, P5440, DOI 10.1016/j.febslet.2007.10.046; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Sundararaman A, 2016, J BIOL CHEM, V291, P14410, DOI 10.1074/jbc.M116.731257; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yuan K, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0166-2; Yuan L, 2013, STEM CELLS DEV, V22, P2384, DOI 10.1089/scd.2012.0717; Zarain-Herzberg A, 2014, CELL CALCIUM, V56, P302, DOI 10.1016/j.ceca.2014.09.005; Zhao X, 2001, CELL DEATH DIFFER, V8, P878, DOI 10.1038/sj.cdd.4400894; Zhao XS, 2005, CANCER RES, V65, P2125, DOI 10.1158/0008-5472.CAN-04-3377; Zhao YG, 2012, J BIOL CHEM, V287, P42053, DOI 10.1074/jbc.M112.415968	28	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10128	10140		10.1074/jbc.RA118.002399	http://dx.doi.org/10.1074/jbc.RA118.002399			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769309	Green Published, hybrid			2022-12-26	WOS:000437096700016
J	David, B; Duchene, MC; Haustenne, GL; Perez-Nunez, D; Chapot-Chartier, MP; De Bolle, X; Guedon, E; Hols, P; Hallet, B				David, Blandine; Duchene, Marie-Clemence; Haustenne, Gabrielle Laurie; Perez-Nunez, Daniel; Chapot-Chartier, Marie-Pierre; De Bolle, Xavier; Guedon, Eric; Hols, Pascal; Hallet, Bernard			PBP2b plays a key role in both peripheral growth and septum positioning in Lactococcus lactis	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; STREPTOCOCCUS-PNEUMONIAE D39; CELL-DIVISION; PEPTIDOGLYCAN SYNTHESIS; HIGH-THROUGHPUT; BACTERIA; FTSZ; LOCALIZATION; MORPHOGENESIS; ELONGATION	Lactococcus lactis is an ovoid bacterium that forms filaments during planktonic and biofilm lifestyles by uncoupling cell division from cell elongation. In this work, we investigate the role of the leading peptidoglycan synthase PBP2b that is dedicated to cell elongation in ovococci. We show that the localization of a fluorescent derivative of PBP2b remains associated to the septal region and superimposed with structural changes of FtsZ during both vegetative growth and filamentation indicating that PBP2b remains intimately associated to the division machinery during the whole cell cycle. In addition, we show that PBP2b-negative cells of L. lactis are not only defective in peripheral growth; they are also affected in septum positioning. This septation defect does not simply result from the absence of the protein in the cell growth machinery since it is also observed when PBP2b-deficient cells are complemented by a catalytically inactive variant of PBP2b. Finally, we show that round cells resulting from p-lactam treatment are not altered in septation, suggesting that shape elongation as such is not a major determinant for selection of the division site. Altogether, we propose that the specific PBP2b transpeptidase activity at the septum plays an important role for tagging future division sites during L. lactis cell cycle.	[David, Blandine; Duchene, Marie-Clemence; Haustenne, Gabrielle Laurie; Hols, Pascal; Hallet, Bernard] UCL, ISV, Louvain La Neuve, Belgium; [Perez-Nunez, Daniel; Chapot-Chartier, Marie-Pierre; Guedon, Eric] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, Jouy En Josas, France; [De Bolle, Xavier] Univ Namur UNamur, Microorganisms Biol Res Unit URBM, Namur, Belgium; [Guedon, Eric] INRA, STLO, Agrocampus Ouest, Rennes, France; [Perez-Nunez, Daniel] CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Universite Catholique Louvain; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut Agro; Agrocampus Ouest; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Hols, P; Hallet, B (corresponding author), UCL, ISV, Louvain La Neuve, Belgium.	pascal.hols@uclouvain.be; bernard.hallet@uclouvain.be	Guedon, Eric/S-5635-2016; Guédon, Eric/AAP-4143-2021; GUEDON, Eric/N-8624-2019; Pérez-Núñez, Daniel/S-4195-2018	Guedon, Eric/0000-0002-0901-4447; GUEDON, Eric/0000-0002-0901-4447; Perez-Nunez, Daniel/0000-0002-0901-8309; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519; De Bolle, Xavier/0000-0002-3845-3043	Fonds Speciaux de la Recherche (FSR), Universite catholique de Louvain (UCL); Fonds National de Recherche Scientifique (FNRS-FRS) [2.4.620.07]; Actions de Recherche Concertees (ARC), Universite catholique de Louvain (UCL); Communaute Frangaise de Belgique [07/12-004, 012/17-046]	Fonds Speciaux de la Recherche (FSR), Universite catholique de Louvain (UCL); Fonds National de Recherche Scientifique (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees (ARC), Universite catholique de Louvain (UCL); Communaute Frangaise de Belgique	This work was supported by Fonds Speciaux de la Recherche (FSR), Universite catholique de Louvain (UCL, https://uclouvain.be/fr/index.html) to PH; Fonds National de Recherche Scientifique (FNRS-FRS, www.fnrs.be), Grant number 2.4.620.07 to PH; Actions de Recherche Concertees (ARC), Universite catholique de Louvain (UCL, https://uclouvain.be/fr/index.html) and Communaute Frangaise de Belgique, Grant numbers 07/12-004 and 012/17-046 to PH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron M, 2007, MOL MICROBIOL, V64, P938, DOI 10.1111/j.1365-2958.2007.05720.x; Andre G, 2011, ACS CHEM BIOL, V6, P366, DOI 10.1021/cb1003509; Barendt SM, 2011, J BACTERIOL, V193, P2290, DOI 10.1128/JB.01555-10; Berg KH, 2014, MICROBIOL-SGM, V160, P1585, DOI 10.1099/mic.0.078535-0; Berg KH, 2013, J BACTERIOL, V195, P4342, DOI 10.1128/JB.00184-13; Bernard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047893; Bramkamp M, 2015, TRENDS MICROBIOL, V23, P121, DOI 10.1016/j.tim.2015.02.001; Dahesh S, 2008, ANTIMICROB AGENTS CH, V52, P2915, DOI 10.1128/AAC.00461-08; Deghorain M, 2010, J BIOL CHEM, V285, P24003, DOI 10.1074/jbc.M110.143636; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; Desguin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4615; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Ducret A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.77, 10.1038/nmicrobiol.2016.77]; Fadda D, 2007, J BACTERIOL, V189, P1288, DOI 10.1128/JB.01168-06; Fleurie A, 2014, NATURE, V516, P259, DOI 10.1038/nature13966; Fleurie A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004275; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Grebe T, 1996, ANTIMICROB AGENTS CH, V40, P829, DOI 10.1128/AAC.40.4.829; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; HIGGINS ML, 1970, J BACTERIOL, V101, P643, DOI 10.1128/JB.101.2.643-648.1970; HIGGINS ML, 1976, J BACTERIOL, V127, P1346, DOI 10.1128/JB.127.3.1346-1358.1976; Holeckova N, 2015, MBIO, V6, DOI 10.1128/mBio.01700-14; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Jacq M, 2015, MBIO, V6, DOI 10.1128/mBio.01108-15; Jennings PC, 2011, MICRON, V42, P336, DOI 10.1016/j.micron.2010.09.003; KELL CM, 1993, FEMS MICROBIOL LETT, V106, P171; Kuipers OP, 1997, TRENDS BIOTECHNOL, V15, P135, DOI 10.1016/S0167-7799(97)01029-9; Land AD, 2013, MOL MICROBIOL, V90, P939, DOI 10.1111/mmi.12408; Manuse S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12071; Massidda O, 2013, ENVIRON MICROBIOL, V15, P3133, DOI 10.1111/1462-2920.12189; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; Morlot C, 2003, MOL MICROBIOL, V50, P845, DOI 10.1046/j.1365-2958.2003.03767.x; Morlot C, 2004, MOL MICROBIOL, V51, P1641, DOI 10.1046/j.1365-2958.2003.03953.x; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Perez-Nunez D, 2011, MOL MICROBIOL, V79, P759, DOI 10.1111/j.1365-2958.2010.07483.x; Peters K, 2014, MOL MICROBIOL, V92, P733, DOI 10.1111/mmi.12588; Philippe J, 2015, ANTIMICROB AGENTS CH, V59, P609, DOI 10.1128/AAC.04283-14; Philippe J, 2014, MICROB DRUG RESIST, V20, P215, DOI 10.1089/mdr.2014.0032; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; SCHUSTER C, 1990, J BACTERIOL, V172, P6499, DOI 10.1128/jb.172.11.6499-6505.1990; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Stamsas GA, 2017, MOL MICROBIOL, V105, P954, DOI 10.1111/mmi.13748; Straume D, 2017, MOL MICROBIOL, V103, P99, DOI 10.1111/mmi.13543; Thibessard A, 2002, J BACTERIOL, V184, P2821, DOI 10.1128/JB.184.10.2821-2826.2002; Tsui HCT, 2014, MOL MICROBIOL, V94, P21, DOI 10.1111/mmi.12745; Tsui HCT, 2016, MOL MICROBIOL, V100, P1039, DOI 10.1111/mmi.13366; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Wheeler R, 2011, MOL MICROBIOL, V82, P1096, DOI 10.1111/j.1365-2958.2011.07871.x; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	55	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0198014	10.1371/journal.pone.0198014	http://dx.doi.org/10.1371/journal.pone.0198014			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791496	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000074
J	Raccagni, I; Belloli, S; Valtorta, S; Stefano, A; Presotto, L; Pascali, C; Bogni, A; Tortoreto, M; Zaffaroni, N; Daidone, MG; Russo, G; Bombardieri, E; Moresco, RM				Raccagni, Isabella; Belloli, Sara; Valtorta, Silvia; Stefano, Alessandro; Presotto, Luca; Pascali, Claudio; Bogni, Anna; Tortoreto, Monica; Zaffaroni, Nadia; Daidone, Maria Grazia; Russo, Giorgio; Bombardieri, Emilio; Moresco, Rosa Maria			[F-18]FDG and [F-18]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EARLY PREDICTION; PATHOLOGICAL RESPONSE; F-18-FDG PET; THERAPY; TUMOR; PROLIFERATION; ASSOCIATION	Rationale Pathological response to neo-adjuvant chemotherapy (NAC) represents a commonly used predictor of survival in triple negative breast cancer (TNBC) and the need to identify markers that predict response to NAC is constantly increasing. Aim of this study was to evaluate the potential usefulness of PET imaging with [F-18]FDG and [F-18]FLT for the discrimination of TNBC responders to Paclitaxel (PTX) therapy compared to the response assessed by an adapted Response Evaluation Criteria In Solid Tumors (RECIST) criteria based on tumor volume (Tumor Volume Response). Methods Nu/nu mice bearing TNBC lesions of different size were evaluated with [F-18]FDG and [F-18] FLT PET before and after PTX treatment. SUVmax, Metabolic Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) and Proliferation (TLP) were assessed using a graph-based random walk algorithm. Results We found that in our TNBC model the variation of [F-18]FDG and [F-18]FLT SUVmax similarly defined tumor response to therapy and that SUVmax variation represented the most accurate parameter. Response evaluation using Tumor Volume Response (TVR) showed that the effectiveness of NAC with PTX was completely independent from lesions size at baseline. Conclusions Our study provided interesting results in terms of sensitivity and specificity of PET in TNBC, revealing the similar performances of [F-18]FDG and [F-18]FLT in the identification of responders to Paclitaxel.	[Raccagni, Isabella; Belloli, Sara; Valtorta, Silvia; Stefano, Alessandro; Russo, Giorgio; Moresco, Rosa Maria] CNR, Inst Mol Bioimaging & Physiol IBFM, Segrate, Italy; [Raccagni, Isabella; Moresco, Rosa Maria] Tecnomed, Monza, Italy; [Raccagni, Isabella; Belloli, Sara; Valtorta, Silvia; Moresco, Rosa Maria] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy; [Valtorta, Silvia; Moresco, Rosa Maria] Univ Milano Bicocca, Med & Surg Dept, Monza, Italy; [Presotto, Luca] IRCCS San Raffaele Sci Inst, Nucl Med Unit, Milan, Italy; [Pascali, Claudio; Bogni, Anna] Fdn IRCCS Ist Nazl Tumori, Nucl Med Unit, Milan, Italy; [Tortoreto, Monica; Zaffaroni, Nadia] Fdn IRCCS Ist Nazl Tumori, Expt Oncol & Mol Med Dept, Mol Pharmacol Unit, Milan, Italy; [Daidone, Maria Grazia] Fdn IRCCS Ist Nazl Tumori, Expt Oncol & Mol Med Dept, Biomarkers Unit, Milan, Italy; [Bombardieri, Emilio] Humanitas Gavazzeni, Nucl Med Dept, Bergamo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Istituto Clinico Humanitas Gavazzeni	Moresco, RM (corresponding author), CNR, Inst Mol Bioimaging & Physiol IBFM, Segrate, Italy.; Moresco, RM (corresponding author), Tecnomed, Monza, Italy.; Moresco, RM (corresponding author), IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy.; Moresco, RM (corresponding author), Univ Milano Bicocca, Med & Surg Dept, Monza, Italy.	moresco.rosamaria@hsr.it	Stefano, Alessandro/E-4432-2013; Russo, Giorgio/AAY-4770-2020; Zaffaroni, Nadia/J-8178-2016; Presotto, Luca/U-7660-2019; Valtorta, Silvia/AAI-1459-2020; moresco, rosa maria/AAN-1987-2020	Stefano, Alessandro/0000-0002-7189-1731; Russo, Giorgio/0000-0003-1493-1087; Zaffaroni, Nadia/0000-0002-4669-0890; Presotto, Luca/0000-0002-8809-0877; Belloli, Sara/0000-0002-3079-3932	AIRC (Associazione Italiana per la Ricerca sul Cancro) Project Molecular and Cellular Imaging of Cancer; grant PIO (Programma Integrato Oncologia) under the Italian Ministry of Health [R04/07]; project grant "SysBioNet", a MIUR initiative for the Italian Roadmap of European Strategy Forum on Research Infrastructures (ESFRI); AIRC (Associazione Italiana per la Ricerca sul Cancro) Project Molecular and Cellular Imaging of Cancer [RFPS-2006-2-342023.8]	AIRC (Associazione Italiana per la Ricerca sul Cancro) Project Molecular and Cellular Imaging of Cancer(Fondazione AIRC per la ricerca sul cancro); grant PIO (Programma Integrato Oncologia) under the Italian Ministry of Health; project grant "SysBioNet", a MIUR initiative for the Italian Roadmap of European Strategy Forum on Research Infrastructures (ESFRI); AIRC (Associazione Italiana per la Ricerca sul Cancro) Project Molecular and Cellular Imaging of Cancer(Fondazione AIRC per la ricerca sul cancro)	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro) Project Molecular and Cellular Imaging of Cancer and by grant 2006 PIO (Programma Integrato Oncologia) under grant agreement No: R04/07 from the Italian Ministry of Health. This work was partially supported by the project grant "SysBioNet", a MIUR initiative for the Italian Roadmap of European Strategy Forum on Research Infrastructures (ESFRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro) Project Molecular and Cellular Imaging of Cancer (RFPS-2006-2-342023.8) and by grant 2006 PIO (Programma Integrato Oncologia) under grant agreement No : R04/07 from the Italian Ministry of Health.	Amendt C, 2014, CLIN CANCER RES, V20, P4478, DOI 10.1158/1078-0432.CCR-13-3385; Been LB, 2004, EUR J NUCL MED MOL I, V31, P1659, DOI 10.1007/s00259-004-1687-6; Bensch F, 2013, EUR J PHARMACOL, V717, P2, DOI 10.1016/j.ejphar.2013.01.079; Cao QZ, 2008, EUR J NUCL MED MOL I, V35, P1489, DOI 10.1007/s00259-008-0744-y; Chacon RD, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2574; Chavez Kathryn J, 2010, Breast Dis, V32, P35, DOI 10.3233/BD-2010-0307; Cheng JY, 2015, ONCOTARGET, V6, P29388, DOI 10.18632/oncotarget.5001; Contractor KB, 2011, CLIN CANCER RES, V17, P7664, DOI 10.1158/1078-0432.CCR-11-0783; Crippa F, 2015, EUR J NUCL MED MOL I, V42, P818, DOI 10.1007/s00259-015-2995-8; Curtarello M, 2015, CANCER RES, V75, P120, DOI 10.1158/0008-5472.CAN-13-2037; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gayed I, 2004, J NUCL MED, V45, P17; Giordano S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39284; Groheux D, 2015, EUR J NUCL MED MOL I, V42, P377, DOI 10.1007/s00259-014-2941-1; Groheux D, 2014, EUR J RADIOL, V83, P1925, DOI 10.1016/j.ejrad.2014.05.037; Groheux D, 2011, EUR J NUCL MED MOL I, V38, P419, DOI 10.1007/s00259-010-1660-5; Hatt M, 2013, J NUCL MED, V54, P341, DOI 10.2967/jnumed.112.108837; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Honndorf VS, 2016, MOL IMAGING BIOL, V18, P249, DOI 10.1007/s11307-015-0881-1; Humbert O, 2015, CLIN CANCER RES, V21, P5460, DOI 10.1158/1078-0432.CCR-15-0384; Jensen MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085126; Jensen MM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-168; Jensen MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053410; Jensen MA, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011024, 10.1371/journal.pone.0012965]; Johnbeck CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091387; Kenny L, 2007, EUR J NUCL MED MOL I, V34, P1339, DOI 10.1007/s00259-007-0379-4; Kenny LM, 2005, CANCER RES, V65, P10104, DOI 10.1158/0008-5472.CAN-04-4297; Kim KI, 2014, J BREAST CANCER, V17, P40, DOI 10.4048/jbc.2014.17.1.40; Koolen BB, 2012, EUR J NUCL MED MOL I, V39, P1830, DOI 10.1007/s00259-012-2211-z; Kostakoglu L, 2015, J NUCL MED, V56, P1681, DOI 10.2967/jnumed.115.160663; Le Du F, 2015, ONCOTARGET, V6, P12890, DOI 10.18632/oncotarget.3849; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lopergolo A, 2016, ONCOTARGET, V7, P49649, DOI 10.18632/oncotarget.10105; Malhotra GK, 2010, CANCER BIOL THER, V10, P955, DOI 10.4161/cbt.10.10.13879; Mankoff David A, 2008, Breast Cancer Res, V10 Suppl 1, pS3, DOI 10.1186/bcr2126; Mollard S, 2011, CANCER BIOL THER, V12, P855, DOI 10.4161/cbt.12.10.18139; Pascali C, 2012, NUCL MED BIOL, V39, P540, DOI 10.1016/j.nucmedbio.2011.10.005; Pio BS, 2006, MOL IMAGING BIOL, V8, P36, DOI 10.1007/s11307-005-0029-9; Stefano A, 2017, MED BIOL ENG COMPUT, V55, P897, DOI 10.1007/s11517-016-1571-0; Tomao F, 2015, ONCOTARGETS THER, V8, P177, DOI 10.2147/OTT.S67673; von Minckwitz G, 2012, BREAST CANCER RES TR, V132, P779, DOI 10.1007/s10549-012-2029-1; Woolf DK, 2014, BRIT J CANCER, V110, P2847, DOI 10.1038/bjc.2014.207	43	10	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197754	10.1371/journal.pone.0197754	http://dx.doi.org/10.1371/journal.pone.0197754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791503	gold, Green Submitted, Green Published			2022-12-26	WOS:000433077000059
J	Daboul, A; Ivanovska, T; Bulow, R; Biffar, R; Cardini, A				Daboul, Amro; Ivanovska, Tatyana; Buelow, Robin; Biffar, Reiner; Cardini, Andrea			Procrustes-based geometric morphometrics on MRI images: An example of inter-operator bias in 3D landmarks and its impact on big datasets	PLOS ONE			English	Article							MEASUREMENT ERROR; BRAIN; SHAPE; RELIABILITY	Using 3D anatomical landmarks from adult human head MRIs, we assessed the magnitude of inter-operator differences in Procrustes-based geometric morphometric analyses. An in depth analysis of both absolute and relative error was performed in a subsample of individuals with replicated digitization by three different operators. The effect of inter-operator differences was also explored in a large sample of more than 900 individuals. Although absolute error was not unusual for MRI measurements, including bone landmarks, shape was particularly affected by differences among operators, with up to more than 30% of sample variation accounted for by this type of error. The magnitude of the bias was such that it dominated the main pattern of bone and total (all landmarks included) shape variation, largely surpassing the effect of sex differences between hundreds of men and women. In contrast, however, we found higher reproducibility in soft-tissue nasal landmarks, despite relatively larger errors in estimates of nasal size. Our study exemplifies the assessment of measurement error using geometric morphometrics on landmarks from MRIs and stresses the importance of relating it to total sample variance within the specific methodological framework being used. In summary, precise landmarks may not necessarily imply negligible errors, especially in shape data; indeed, size and shape may be differentially impacted by measurement error and different types of landmarks may have relatively larger or smaller errors. Importantly, and consistently with other recent studies using geometric morphometrics on digital images (which, however, were not specific to MRI data), this study showed that inter-operator biases can be a major source of error in the analysis of large samples, as those that are becoming increasingly common in the 'era of big data'.	[Daboul, Amro; Biffar, Reiner] Univ Med Greifswald, Dept Prosthodont Gerodontol & Biomat, Greifswald, Germany; [Ivanovska, Tatyana] Georg August Univ, Inst Biophys, Gottingen, Germany; [Buelow, Robin] Univ Med Greifswald, Inst Radiol & Neuroradiol, Greifswald, Germany; [Cardini, Andrea] Univ Modena & Reggio Emilia, Dipartimento Sci Chim & Geol, Modena, Italy; [Cardini, Andrea] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia	Greifswald Medical School; University of Gottingen; Greifswald Medical School; Universita di Modena e Reggio Emilia; University of Western Australia	Daboul, A (corresponding author), Univ Med Greifswald, Dept Prosthodont Gerodontol & Biomat, Greifswald, Germany.	daboula@uni-greifswald.de	cardini, andrea/G-9951-2011	cardini, andrea/0000-0003-2910-632X				Adams D.C., 2017, GEOMORPH SOFTWARE GE; Adams DC, 2013, HYSTRIX, V24, P8; Arnqvist G, 1998, MEASUREMENT ERROR GE, P73; Barbeito-Andres J, 2016, MAGN RESON IMAGING, V34, P980, DOI 10.1016/j.mri.2016.04.006; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bookstein FL, 2001, TERATOLOGY, V64, P4, DOI 10.1002/tera.1044.abs; Bookstein FL, PSYCHIAT RES NEUROIM, V67, P81; Bookstein FL, 2017, EVOL BIOL, V44, P522, DOI 10.1007/s11692-017-9424-9; Bookstein Fred L., 2002, Anatomical Record, V269, P162, DOI 10.1002/ar.10110; Bruner E, 2014, J ANAT, V224, P367, DOI 10.1111/joa.12155; Cardini A., 2013, EOLSS ENCY LIFE SUPP; Chollet MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086005; Daboul A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048281; DeQuardo JR, 1996, PSYCHIAT RES-NEUROIM, V67, P81; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fruciano C, 2017, ECOL EVOL, V7, P7034, DOI 10.1002/ece3.3256; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; Gharaibeh WS, 2000, BIOL PSYCHIAT, V48, P398, DOI 10.1016/S0006-3223(00)00916-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hegenscheid K, 2009, ROFO-FORTSCHR RONTG, V181, P748, DOI 10.1055/s-0028-1109510; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2002, SHAPE ANAL SYMMETRIC, P1909; Kuzminsky SC, 2012, J ARCHAEOL SCI, V39, P2744, DOI 10.1016/j.jas.2012.04.020; Liu F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002932; Marcus L, 2000, HYSTRIX ITALIAN J MA, V11; Mareckova K, 2011, HORM BEHAV, V60, P681, DOI 10.1016/j.yhbeh.2011.09.004; Maudgil DD, 1998, J ANAT, V193, P559, DOI 10.1046/j.1469-7580.1998.19340559.x; Moro-Oka T, 2007, J ORTHOP RES, V25, P867, DOI 10.1002/jor.20355; Oksanen J., 2007, THE VEGAN PACKAGE; Polly PD, 1998, BIOL J LINN SOC, V64, P83; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1998, APPL GEOMETRIC MORPH, P147; Salti L, 2017, J CLIN PERIODONTOL, V44, P363, DOI 10.1111/jcpe.12661; Schlager S., 2017, STAT SHAPE DEFORMATI, P217; Shearer BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187452; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; von Cramon-Taubadel N, 2007, AM J PHYS ANTHROPOL, V134, P24, DOI 10.1002/ajpa.20616; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Weinberg SM, 2009, J ANAT, V214, P926, DOI 10.1111/j.1469-7580.2009.01084.x; Wilcox JJ, 2012, CLIN ORTHOP RELAT R, V470, P2253, DOI 10.1007/s11999-012-2269-8	42	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197675	10.1371/journal.pone.0197675	http://dx.doi.org/10.1371/journal.pone.0197675			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787586	Green Published, gold, Green Submitted			2022-12-26	WOS:000432785700034
J	Roszko, ML; Kaminska, M; Szymczyk, K; Piasecka-Jozwiak, K; Chablowska, B				Roszko, Marek Lukasz; Kaminska, Marta; Szymczyk, Krystyna; Piasecka-Jozwiak, Katarzyna; Chablowska, Beata			Endocrine disrupting potency of organic pollutant mixtures isolated from commercial fish oil evaluated in yeast-based bioassays	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; POLYCHLORINATED-BIPHENYLS PCBS; COD GADUS-MORHUA; ESTROGENIC ACTIVITY; ORGANOCHLORINE PESTICIDES; HYDROXYLATED METABOLITES; COMBINED EXPOSURE; ANTI-ANDROGENS; DOSE-RESPONSE; IN-VIVO	The aim of this work was to evaluate the activity of xenobiotic mixtures containing persistent organic pollutants isolated from commercial fish oil samples against sex hormone receptors, including estrogen and androgen. The applied bioassay was based on transgenic yeast strains. The mixtures were extracted from the samples using the semi-permeable membrane dialysis technique and analyzed with gas chromatography/ion trap mass spectrometry. It turned out that mixtures of chemicals isolated from fish oil may interact with human steroid sex hormone receptors in various ways: the tested samples showed both estrogenic and anti-androgenic activity. Calculated 17 beta-estradiol equivalents for the tested samples ranged between 0.003 and 0.073 pg g(-1) (fat). Anti-androgenic activity expressed as the flutamide equivalent concentration was in the 18.58-216.21 ng g(-1) (fat) range. Polychlorinated biphenyls and various DDT metabolites were the main fish oil pollutants influencing the receptors. Additivity and/or synergy between chemicals was observed in the ER/AR mediated response.	[Roszko, Marek Lukasz; Kaminska, Marta; Szymczyk, Krystyna] Inst Agr & Food Biotechnol, Dept Food Anal, Warsaw, Poland; [Piasecka-Jozwiak, Katarzyna; Chablowska, Beata] Inst Agr & Food Biotechnol, Dept Fermentat Technol, Warsaw, Poland	Warsaw University of Life Sciences	Roszko, ML (corresponding author), Inst Agr & Food Biotechnol, Dept Food Anal, Warsaw, Poland.	roszko@ibprs.pl		Szymczyk, Krystyna/0000-0001-6486-2660; Roszko, Marek/0000-0003-1848-2100				Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2156; Alexander J, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3132; Behr M, 2011, FOOD CHEM TOXICOL, V49, P2681, DOI 10.1016/j.fct.2011.07.039; Bergman A, 2013, ENVIRON HEALTH PERSP, V121, pA104, DOI 10.1289/ehp.1205448; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Brinkmann M, 2018, TOXICOL IN VITRO, V46, P294, DOI 10.1016/j.tiv.2017.10.022; Caldwell DJ, 2010, ENVIRON HEALTH PERSP, V118, P338, DOI 10.1289/ehp.0900654; Campbell CG, 2006, CHEMOSPHERE, V65, P1265, DOI 10.1016/j.chemosphere.2006.08.003; Charles GD, 2000, TOXICOL SCI, V55, P320, DOI 10.1093/toxsci/55.2.320; Conley JM, 2016, TOXICOL SCI, V153, P382, DOI 10.1093/toxsci/kfw134; Connor K, 1997, TOXICOL APPL PHARM, V145, P111, DOI 10.1006/taap.1997.8169; Cooper RL, 1997, J ENDOCRINOL, V152, P159, DOI 10.1677/joe.0.1520159; De Falca M, 2017, FRONT ENV SCI, V3, P1; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dybing E, 2002, FOOD CHEM TOXICOL, V40, P237, DOI 10.1016/S0278-6915(01)00115-6; Elsby R, 2000, BIOCHEM PHARMACOL, V60, P1519, DOI 10.1016/S0006-2952(00)00466-4; Elsby R, 2001, J PHARMACOL EXP THER, V296, P329; Elsby R, 2001, J PHARMACOL EXP THER, V297, P103; Fertuck KC, 2001, TOXICOL SCI, V59, P231, DOI 10.1093/toxsci/59.2.231; Filby AL, 2007, ENVIRON HEALTH PERSP, V115, P1704, DOI 10.1289/ehp.10443; Frische T, 2009, ENVIRON SCI POLLUT R, V16, P593, DOI 10.1007/s11356-009-0184-7; Fucic A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-S1-S8; Garg N, 2016, BIODEGRADATION, V27, P179, DOI 10.1007/s10532-016-9765-6; Garner CE, 1999, TOXICOL APPL PHARM, V154, P188, DOI 10.1006/taap.1998.8560; Hadrup N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070490; Hartmann S, 1998, FOOD CHEM, V62, P7, DOI 10.1016/S0308-8146(97)00150-7; Hass U., 2013, INPUT REACH REV 2013; Hass U, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9360; Jeng HA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00055; Julshamn K, 2013, MAR POLLUT BULL, V75, P250, DOI 10.1016/j.marpolbul.2013.07.017; KemI (Swedish Chemical Agency), 2013, MEM 2013, DOI [10.1007/s12254-012-0061-9, DOI 10.1007/S12254-012-0061-9]; Kim TS, 2011, TOX RESEARCH, V27, P181, DOI 10.5487/TR.2011.27.3.181; Kitamura S, 2008, J HEALTH SCI, V54, P343, DOI 10.1248/jhs.54.343; Klotz DM, 1996, ENVIRON HEALTH PERSP, V104, P1084, DOI 10.2307/3433121; Kortenkamp A, 1998, SCI TOTAL ENVIRON, V221, P59, DOI 10.1016/S0048-9697(98)00261-7; Layton AC, 2002, TOXICOL APPL PHARM, V180, P157, DOI 10.1006/taap.2002.9395; Legler J, 2002, ENVIRON SCI TECHNOL, V36, P4410, DOI 10.1021/es010323a; Liem A.K.D., 1997, DIOXINS CHEM ANAL EX; Longnecker MP, 2007, AM J EPIDEMIOL, V165, P1015, DOI 10.1093/aje/kwk109; Malekinejad H, 2015, IRAN J PUBLIC HEALTH, V44, P742; Marino M, 2012, STEROIDS, V77, P910, DOI 10.1016/j.steroids.2012.02.019; Montagnani DB, 1996, J CHART INST WATER E, V10, P399; Nakagawa Y, 2002, CHEM-BIOL INTERACT, V139, P115, DOI 10.1016/S0009-2797(01)00293-9; Okoumassoun LE, 2002, TOXICOLOGY, V178, P193, DOI 10.1016/S0300-483X(02)00228-7; Payne J, 2000, ENVIRON HEALTH PERSP, V108, P983, DOI 10.1289/ehp.00108983; Pinto B, 2008, ENVIRON MONIT ASSESS, V144, P445, DOI 10.1007/s10661-007-0007-6; Pliskova M, 2005, ENVIRON HEALTH PERSP, V113, P1277, DOI 10.1289/ehp.7745; Preuss TG, 2006, ENVIRON SCI TECHNOL, V40, P5147, DOI 10.1021/es060709r; Qin LQ, 2004, MED HYPOTHESES, V62, P133, DOI 10.1016/S0306-9877(03)00295-0; Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917, DOI 10.1289/ehp.02110917; Rajapakse N, 2001, TOXICOL SCI, V60, P296, DOI 10.1093/toxsci/60.2.296; Rawn DFK, 2009, J FOOD SCI, V74, pT14, DOI 10.1111/j.1750-3841.2008.01020.x; Roszko M, 2015, TALANTA, V144, P171, DOI 10.1016/j.talanta.2015.04.070; Roszko M, 2015, MAR POLLUT BULL, V96, P165, DOI 10.1016/j.marpolbul.2015.05.032; Roszko M, 2014, SCI TOTAL ENVIRON, V466, P136, DOI [10.1015/j.scitotenv.2013.07.016, 10.1016/j.scitotenv.2013.07.016]; Roszko M, 2013, ANAL CHIM ACTA, V799, P88, DOI 10.1016/j.aca.2013.08.053; Roszko M, 2012, ANAL CHIM ACTA, V748, P9, DOI 10.1016/j.aca.2012.08.037; SAFE SH, 1995, ENVIRON HEALTH PERSP, V103, P346, DOI 10.2307/3432287; Schneider S, 2017, ARCH TOXICOL, V91, P3961, DOI 10.1007/s00204-017-2053-3; Schultis T, 2004, CHEMOSPHERE, V57, P1649, DOI 10.1016/j.chemosphere.2004.06.027; Seeger B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147490; Siddiqi Muhammad Akmal, 2003, Clin Med Res, V1, P281; Silva E, 2002, ENVIRON SCI TECHNOL, V36, P1751, DOI 10.1021/es0101227; Sonnenschein C, 1998, J STEROID BIOCHEM, V65, P143, DOI 10.1016/S0960-0760(98)00027-2; Strucinski P, 2013, ENVIRON INT, V56, P32, DOI 10.1016/j.envint.2013.03.002; Sugihara K, 2000, TOXICOL APPL PHARM, V167, P46, DOI 10.1006/taap.2000.8979; Suominen K, 2011, CHEMOSPHERE, V85, P300, DOI 10.1016/j.chemosphere.2011.06.010; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; Wang XX, 2013, ENVIRON SCI TECHNOL, V47, P11802, DOI 10.1021/es4029364; WHO. World Health Organization, WHO FOOD ADD SER, V43; Yang WH, 2009, CHEMOSPHERE, V75, P1159, DOI 10.1016/j.chemosphere.2009.02.047	72	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197907	10.1371/journal.pone.0197907	http://dx.doi.org/10.1371/journal.pone.0197907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787602	Green Published, Green Submitted, gold			2022-12-26	WOS:000432785700056
J	Cassimeris, L; Leung, JC; Odde, DJ				Cassimeris, Lynne; Leung, Jessica C.; Odde, David J.			Monte Carlo simulations of microtubule arrays: The critical roles of rescue transitions, the cell boundary, and tubulin concentration in shaping microtubule distributions	PLOS ONE			English	Article							DYNAMIC INSTABILITY; IN-VIVO; INDIVIDUAL MICROTUBULES; PROMOTES MICROTUBULE; PROTEINS CONTROL; CATASTROPHE; NUCLEATION; FREQUENCIES; INTERPHASE; KINETICS	Microtubules are dynamic polymers required for a number of processes, including chromosome movement in mitosis. While regulators of microtubule dynamics have been well characterized, we lack a convenient way to predict how the measured dynamic parameters shape the entire microtubule system within a cell, or how the system responds when specific parameters change in response to internal or external signals. Here we describe a Monte Carlo model to simulate an array of dynamic microtubules from parameters including the cell radius, total tubulin concentration, microtubule nucleation rate from the centrosome, and plus end dynamic instability. The algorithm also allows dynamic instability or position of the cell edge to vary during the simulation. Outputs from simulations include free tubulin concentration, average microtubule lengths, length distributions, and individual length changes over time. Using this platform and reported parameters measured in interphase LLCPK1 epithelial cells, we predict that sequestering similar to 15-20% of total tubulin results in fewer micro tubules, but promotes dynamic instability of those remaining. Simulations also predict that lowering nucleation rate will increase the stability and average length of the remaining micro tubules. Allowing the position of the cell's edge to vary over time changed the average length but not the number of microtubules and generated length distributions consistent with experimental measurements. Simulating the switch from interphase to prophase demonstrated that decreased rescue frequency at prophase is the critical factor needed to rapidly clear the cell of interphase microtubules prior to mitotic spindle assembly. Finally, consistent with several previous simulations, our results demonstrate that microtubule nucleation and dynamic instability in a confined space determines the partitioning of tubulin between monomer and polymer pools. The model and simulations will be useful for predicting changes to the entire microtubule array after modification to one or more parameters, including predicting the effects of tubulin-targeted chemotherapies.	[Cassimeris, Lynne; Leung, Jessica C.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA	Lehigh University; University of Minnesota System; University of Minnesota Twin Cities	Cassimeris, L (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	lc07@lehigh.edu	Odde, David/AAY-1720-2020	Odde, David/0000-0001-7731-2799; Leung, Jessica/0000-0001-9682-9160; Cassimeris, Lynne/0000-0003-1058-0734	NIH [GM117560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM117560] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM117560, nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Al-Bassam J, 2010, DEV CELL, V19, P245, DOI 10.1016/j.devcel.2010.07.016; Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; Barsegov V, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa8670; Brisch E, 1996, J CELL SCI, V109, P2885; Brittle AL, 2005, EMBO J, V24, P1387, DOI 10.1038/sj.emboj.7600629; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; CASSIMERIS LU, 1986, J CELL BIOL, V102, P2023, DOI 10.1083/jcb.102.6.2023; Castle BT, 2017, MOL BIOL CELL, V28, P1238, DOI 10.1091/mbc.E16-08-0567; Coombes CE, 2013, CURR BIOL, V23, P1342, DOI 10.1016/j.cub.2013.05.059; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Gardner MK, 2013, CURR OPIN CELL BIOL, V25, P14, DOI 10.1016/j.ceb.2012.09.006; Gardner MK, 2011, CELL, V147, P1092, DOI 10.1016/j.cell.2011.10.037; GLIKSMAN NR, 1993, MOL BIOL CELL, V4, P1035, DOI 10.1091/mbc.4.10.1035; Govindan BS, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.032901; Gregoretti IV, 2006, J CELL SCI, V119, P4781, DOI 10.1242/jcs.03240; Hamill DR, 1998, J BIOL CHEM, V273, P9285, DOI 10.1074/jbc.273.15.9285; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Komarova YA, 2002, J CELL SCI, V115, P3527; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; MITCHISON TJ, 1987, CELL BIOPHYS, V11, P35, DOI 10.1007/BF02797111; Oakley BR, 2015, MOL BIOL CELL, V26, P2957, DOI 10.1091/mbc.E14-11-1514; Odde DJ, 1996, AICHE J, V42, P1434, DOI 10.1002/aic.690420524; ODDE DJ, 1995, BIOPHYS J, V69, P796, DOI 10.1016/S0006-3495(95)79953-2; OOSAWA F, 1970, J THEOR BIOL, V27, P69, DOI 10.1016/0022-5193(70)90129-3; PFEFFER TA, 1976, J CELL BIOL, V69, P599, DOI 10.1083/jcb.69.3.599; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Prahl LS, 2014, METHOD ENZYMOL, V540, P35, DOI 10.1016/B978-0-12-397924-7.00003-0; Ringhoff DN, 2009, MOL BIOL CELL, V20, P3451, DOI 10.1091/mbc.E09-02-0140; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Rusan NM, 2002, J CELL BIOL, V158, P997, DOI 10.1083/jcb.200204109; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; SCHULZE E, 1987, J CELL BIOL, V104, P277, DOI 10.1083/jcb.104.2.277; Seeptapun D, 2010, CURR BIOL, V20, P979, DOI [10.1016/j.cub.2010.04.040, DOI 10.1016/J.CUB.2010.04.040]; Seetapun D, 2012, CURR BIOL, V22, P1681, DOI 10.1016/j.cub.2012.06.068; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang G, 2014, J CELL SCI, V127, P4111, DOI 10.1242/jcs.151753; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Wieczorek M, 2015, NAT CELL BIOL, V17, P907, DOI 10.1038/ncb3188; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201; ZHAI Y, 1994, J CELL SCI, V107, P881	50	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197538	10.1371/journal.pone.0197538	http://dx.doi.org/10.1371/journal.pone.0197538			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782540	Green Submitted, Green Published, gold			2022-12-26	WOS:000432537100030
J	Huang, ZY; Sun, XD; Wagner, AL; Ren, J; Boulton, ML; Prosser, LA; Zikmund-Fisher, BJ				Huang, Zhuoying; Sun, Xiaodong; Wagner, Abram L.; Ren, Jia; Boulton, Matthew L.; Prosser, Lisa A.; Zikmund-Fisher, Brian J.			Parent and caregiver perceptions about the safety and effectiveness of foreign and domestic vaccines in Shanghai, China	PLOS ONE			English	Article							HEALTH; VACCINATION; ATTITUDES; MEDICINE; CAM	Background Chinese parents have access to domestic and foreign vaccines for their children. Their vaccine preferences are unclear, especially given recent pharmaceutical quality scandals and widely held beliefs deriving from Traditional Chinese Medicine (TCM). This study characterized parental beliefs about the safety and effectiveness of Chinese and foreign vaccines. Methods In May 2014, caregivers of young children at public immunization clinics in Shanghai, China, responded to a survey on vaccine perceptions. The two outcomes (differential belief in the effectiveness and safety of foreign vs domestic vaccines) were separately regressed onto demographic predictors in multinomial logistic regression models. Results Among 618 caregivers, 56% thought the effectiveness of domestic and foreign vaccines were comparable; 33% thought domestic were more effective and 11% foreign. Two-thirds thought foreign and domestic vaccines had similar safety; 11% thought domestic were safer and 21% thought foreign were safer. Compared to college graduates, those with a high school education or less had greater odds of believing domestic vaccines were more effective, and also had greater odds of believing imported vaccines were safer. Greater trust in TCM was not associated with differential beliefs in the effectiveness or safety of domestic vs foreign vaccines. Conclusions Although there is no evidence that foreign and domestic vaccines differ in either effectiveness or safety, less educated caregivers in China (but not those with greater trust in TCM) appear to believe such differences exist. Further exploration of the causes of these beliefs may be necessary in order to optimize vaccine communications in China.	[Huang, Zhuoying; Sun, Xiaodong; Ren, Jia] Shanghai Municipal Ctr Dis Control & Prevent, Dept Immunizat Program, Shanghai, Peoples R China; [Wagner, Abram L.; Boulton, Matthew L.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Boulton, Matthew L.] Univ Michigan, Med Sch, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48109 USA; [Prosser, Lisa A.] Univ Michigan, Med Sch, Dept Pediat & Communicable Dis, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; [Zikmund-Fisher, Brian J.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA; [Zikmund-Fisher, Brian J.] Univ Michigan, Med Sch, Div Gen Med, Dept Internal Med, Ann Arbor, MI 48109 USA	Shanghai Center for Disease Control & Prevention; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sun, XD (corresponding author), Shanghai Municipal Ctr Dis Control & Prevent, Dept Immunizat Program, Shanghai, Peoples R China.	sunxiaodong@scdc.sh.cn	Wagner, Abram/X-6379-2019; Zikmund-Fisher, Brian J./A-7677-2009	Wagner, Abram/0000-0003-4691-7802; Zikmund-Fisher, Brian/0000-0002-1637-4176; Boulton, Matthew/0000-0002-0565-9010	University of Michigan Office of Global Public Health; University of Michigan Rackham International Research Award; Fourth Round of the Three-Year Public Health Action Plan of Shanghai, China [15GWZK0101]; Health Outcomes Post Doctoral Fellowship from the PhRMA Foundation	University of Michigan Office of Global Public Health; University of Michigan Rackham International Research Award; Fourth Round of the Three-Year Public Health Action Plan of Shanghai, China; Health Outcomes Post Doctoral Fellowship from the PhRMA Foundation	This research was funded by the University of Michigan Office of Global Public Health (https://sph.umich.edu/global/), by a University of Michigan Rackham International Research Award (http://www.rackham.umich.edu/), and by the Fourth Round of the Three-Year Public Health Action Plan of Shanghai, China (No. 15GWZK0101). ALWs salary was funded through a Health Outcomes Post Doctoral Fellowship from the PhRMA Foundation (http://www.phrmafoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell K, 2018, SOC SCI MED, V196, P106, DOI 10.1016/j.socscimed.2017.11.022; Bryden GM, 2018, VACCINE, V36, P1227, DOI 10.1016/j.vaccine.2017.12.068; Casiday R, 2006, VACCINE, V24, P177, DOI 10.1016/j.vaccine.2005.07.063; Cheng TM, 2012, HEALTH AFFAIR, V31, P2536, DOI 10.1377/hlthaff.2012.1017; China Food and Drug Administration, 2004, SUPPL APPL APPR PROC; Fu J, 2013, CHIN J VAC IMMUN, V19, P222; Liao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023786; Poland CM, 2011, VACCINE, V29, P6145, DOI 10.1016/j.vaccine.2011.07.131; Qiu J, 2016, LANCET, V387, P2382, DOI 10.1016/S0140-6736(16)30737-1; Standing Committee of the People's Republic of China, 2004, LAW PEOPL REP CHIN P; Sun XD, 2011, NEW ENGL J MED, V365, P378, DOI 10.1056/NEJMc1106415; Todorova I, 2014, INT J BEHAV MED, V21, P1, DOI 10.1007/s12529-013-9383-1; Tomlinson R, 1999, BRIT MED J, V318, P624, DOI 10.1136/bmj.318.7184.624b; Wagner AL, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0900-2; Wagner AL, 2016, PEDIATR INFECT DIS J, V35, pE311, DOI 10.1097/INF.0000000000001267; Wagner AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097800; Wong WD, 2014, COMPLEMENT THER MED, V22, P670, DOI 10.1016/j.ctim.2014.05.009; Xu J, 2009, HEALTH POLICY, V90, P133, DOI 10.1016/j.healthpol.2008.09.003; Xu XiaoLin, 2011, Modern Preventive Medicine, V38, P3643; Yu HJ, 2012, HEALTH AFFAIR, V31, P2545, DOI 10.1377/hlthaff.2011.1272; Zheng H.Y., 2012, S CHINA J PREV MED, V38, P34; Zheng JS, 2010, VACCINE, V28, pA84, DOI 10.1016/j.vaccine.2010.02.039	22	6	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197437	10.1371/journal.pone.0197437	http://dx.doi.org/10.1371/journal.pone.0197437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG2QJ	29782508	gold, Green Published, Green Submitted			2022-12-26	WOS:000432537100023
J	Tsuru, M; Ono, A; Umeyama, H; Takeuchi, M; Nagata, K				Tsuru, Michiyo; Ono, Atsushi; Umeyama, Hideaki; Takeuchi, Masahiro; Nagata, Kensei			Ubiquitin-dependent proteolysis of CXCL7 leads to posterior longitudinal ligament ossification	PLOS ONE			English	Article							PROTEIN-KINASE-C; IN-VITRO; OSTEOCLAST DIFFERENTIATION; DIABETIC-NEPHROPATHY; CERVICAL-SPINE; STEM-CELLS; E3 LIGASE; BONE; EXPRESSION; AUTOPHAGY	Ossification of the posterior longitudinal ligament (OPLL), a spinal ligament, reduces the range of motion in limbs. No treatment is currently available for OPLL, which is why therapies are urgently needed. OPLL occurs in obesity, is more common in men, and has an onset after 40 years of age. The mechanisms underlying OPLL remain unclear. In this study, we performed a serum proteomic analysis in both OPLL patients and healthy subjects to identify factors potentially involved in the development of OPLL, and found reduced levels of a protein that might underlie the pathology of OPLL. We isolated the protein, determined its amino acid sequence, and identified it as chemokine (C-X-C motif) ligand 7 (CXCL7). Based on these proteomics findings, we generated a CXCL7 knockout mouse model to study the molecular mechanisms underlying OPLL. CXCL7-null mice presented with a phenotype of OPLL, showing motor impairment, heterotopic ossification in the posterior ligament tissue, and osteoporosis in vertebrate tissue. To identify the mechanisms of CXCL7 deficiency in OPLL, we searched for single nucleotide polymorphisms and altered DNA exons, but no abnormalities were found. Although miR-340 levels were found to be high in an miRNA array, they were insufficient to reduce CXCL7 levels. Ubiquitin C-terminal hydrolasel (UCHL1) was found to be overexpressed in CXCL7-null mice and in the sera of patients with OPLL, and was correlated with OPLL severity. Post-translational modifications of proteins with ubiquitin and ubiquitin-like modifiers, orchestrated by a cascade of specialized ubiquitin activating enzyme (El), ubiquitin conjugating enzyme (E2), and ubiquitin ligase (E3) enzymes, are thought to control a wide range of cellular processes, and alterations in the ubiquitin proteasome system have been associated with several degenerative disorders. In addition, the OPLL tissue of CXCL7-null mouse and its primary cells expressed the antibody to ubiquitin (linkage-specific K48). Our data clearly show decreased CXCL7 levels in patients with OPLL, and that OPLL developed in mice lacking CXCL7. Tumor necrosis factor receptor-associated factor (TRAF)6 expression was decreased in CXCL7null mouse primary cells. Furthermore, K48 polyubiquitination was found in posterior longitudinal ligament ossified tissue and primary cells from CXCL7-null mice. We performed a phosphoproteomics analysis in CXCL 7-deficient mice and identified increased phosphorylation of mitogen-activated protein kinase kinase (ME3K)15, ubiquitin protein ligase E3C (UBE3C) and protein kinase C (PKC) alpha, suggesting that ubiquitin-dependent degradation is involved in CXCL7 deficiency. Future studies in the CXCL 7-null mouse model are, therefore, warranted to investigate the role of ubiquitination in the onset of OPLL. In conclusion, CXCL7 levels may be useful as a serum marker for the progression of OPLL. This study also suggests that increasing CXCL7 levels in patients can serve as an effective therapeutic strategy for the treatment of OPLL.	[Tsuru, Michiyo] Kurume Univ, Clin Prote & Gene Therapy Lab, Fukuoka, Fukuoka, Japan; [Ono, Atsushi] Hirosaki Mem Hosp, Dept Orthopaed Surg, Hirosaki, Aomori, Japan; [Umeyama, Hideaki] Chuo Univ, Dept Biol Sci, Tokyo, Japan; [Takeuchi, Masahiro] Kitasato Univ, Sch Pharm, Dept Clin Med Biostat, Tokyo, Japan; [Nagata, Kensei] Kurume Univ, Sch Med, Dept Orthopaed Surg, Fukuoka, Fukuoka, Japan	Kurume University; Chuo University; Kitasato University; Kurume University	Tsuru, M (corresponding author), Kurume Univ, Clin Prote & Gene Therapy Lab, Fukuoka, Fukuoka, Japan.	michiyo@med.kurume-u.ac.jp		Tsuru, Michiyo/0000-0002-1557-7131	Ministry of Health, Labour, Cabinet Office Special Coordination Funds for Promoting Science and Technology and Welfare Sciences; Japan Society for the Promotion of Science Kakenhi [24592215, 22591648]	Ministry of Health, Labour, Cabinet Office Special Coordination Funds for Promoting Science and Technology and Welfare Sciences; Japan Society for the Promotion of Science Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a research grant for Disease Treatment and Ossification of Spinal Ligaments (2009-2013) from the Ministry of Health, Labour, Cabinet Office Special Coordination Funds for Promoting Science and Technology (2004-2009) and Welfare Sciences and the Japan Society for the Promotion of Science Kakenhi (Grant nos. 24592215 and 22591648).	Akune T, 2002, J CELL BIOL, V159, P147, DOI 10.1083/jcb.200204046; Akune T, 2001, J BONE JOINT SURG AM, V83A, P1537, DOI 10.2106/00004623-200110000-00013; [Anonymous], 1987, LAB ANIM SCI, V37, P11; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Bai T, 2016, AM J PHYSIOL-ENDOC M, V310, pE473, DOI 10.1152/ajpendo.00467.2015; BOISKIN I, 1989, CLIN NEPHROL, V31, P316; Bourzac C, 2010, EQUINE VET J, V42, P519, DOI 10.1111/j.2042-3306.2010.00098.x; Caramori ML, 2002, DIABETES, V51, P506, DOI 10.2337/diabetes.51.2.506; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Ehara S, 1998, EUR J RADIOL, V27, P196, DOI 10.1016/S0720-048X(97)00164-2; El-Gedaily A, 2004, J LEUKOCYTE BIOL, V75, P495, DOI 10.1189/jlb.0603288; Elliott AD, 2015, AM J PHYSIOL-ENDOC M, V308, pE130, DOI 10.1152/ajpendo.00344.2014; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fioretto P, 2007, SEMIN NEPHROL, V27, P195, DOI 10.1016/j.semnephrol.2007.01.012; Gallot YS, 2017, ONCOTARGET, V8, P112565, DOI 10.18632/oncotarget.22575; Genc B, 2016, ANN CLIN TRANSL NEUR, V3, P331, DOI 10.1002/acn3.298; Gonzalez-Cortes C, 2012, IMMUNOBIOLOGY, V217, P394, DOI 10.1016/j.imbio.2011.10.015; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; HAYASHI K, 1977, J ANAT, V124, P633; Herring CA, 2015, PROTEINS, V83, P1987, DOI 10.1002/prot.24913; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda Y, 2011, EUR SPINE J, V20, P1450, DOI 10.1007/s00586-011-1688-7; ISHIDA Y, 1993, J BONE MINER RES, V8, P1291; ISHIDA Y, 1993, BONE, V14, P85, DOI 10.1016/8756-3282(93)90232-Y; Jain J, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0147-4; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Kalb S, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2010.12.FOCUS10265; Kaya HEK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006438; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; KODAMA H, 1984, J CELL PHYSIOL, V118, P233, DOI 10.1002/jcp.1041180303; LANIR Y, 1979, J BIOMECH, V12, P423, DOI 10.1016/0021-9290(79)90027-7; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Medina-Medina I, 2016, MOL CELL BIOL, V36, P2195, DOI 10.1128/MCB.00113-16; MORIO Y, 1993, SPINE, V18, P2513, DOI 10.1097/00007632-199312000-00022; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Nakao K, 2009, BIOCHEM BIOPH RES CO, V378, P462, DOI 10.1016/j.bbrc.2008.11.083; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Ohishi H, 2003, J PHARMACOL EXP THER, V305, P818, DOI 10.1124/jpet.102.047142; Ohtsuka K, 1986, Nihon Seikeigeka Gakkai Zasshi, V60, P1087; OKAZAKI T, 1984, METABOLISM, V33, P710, DOI 10.1016/0026-0495(84)90209-9; Park JH, 2017, MOL CELLS, V40, P706, DOI 10.14348/molcells.2017.0225; Paul PK, 2011, AUTOPHAGY, V7, P555, DOI 10.4161/auto.7.5.15102; Pritchett-Corning KR, 2014, J AM ASSOC LAB ANIM, V53, P633; Reddy SS, 2014, BBA-GEN SUBJECTS, V1840, P2924, DOI 10.1016/j.bbagen.2014.06.005; Remoli AL, 2016, MBIO, V7, DOI 10.1128/mBio.01528-16; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Sato N, 2016, J PROTEOME RES, V15, P4709, DOI 10.1021/acs.jproteome.6b00806; Seales EC, 2006, J CELL BIOCHEM, V97, P45, DOI 10.1002/jcb.20659; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shingyouchi Y, 1996, SPINE, V21, P2474, DOI 10.1097/00007632-199611010-00013; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Tsuru M, 2013, STEM CELLS DEV, V22, P2057, DOI 10.1089/scd.2012.0695; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; VILLANUEVA AR, 1977, AM J MED TECHNOL, V43, P536; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; WITTERS LA, 1985, NATURE, V315, P777, DOI 10.1038/315777a0; Xu CF, 2014, AUTOPHAGY, V10, P2239, DOI 10.4161/15548627.2014.981792; Yoshimura N, 2014, OSTEOPOROSIS INT, V25, P1089, DOI 10.1007/s00198-013-2489-0; Yu FB, 2015, J SPINAL DISORD TECH, V28, P389, DOI 10.1097/BSD.0000000000000031; Zheng SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045437	68	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0196204	10.1371/journal.pone.0196204	http://dx.doi.org/10.1371/journal.pone.0196204			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782494	Green Published, gold, Green Submitted			2022-12-26	WOS:000432537100004
J	Ejigu, BA; Wencheko, E; Berhane, K				Ejigu, Bedilu Alamirie; Wencheko, Eshetu; Berhane, Kiros			Spatial pattern and determinants of anaemia in Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; PREGNANT-WOMEN; YOUNG-CHILDREN; PREVALENCE; MALARIA; BURDEN; INFECTION; INFANTS; MODELS; HEALTH	Anaemia is a condition in which the haemoglobin concentration falls below an established cut-off value due to a decrease in the number and size of red blood cells. The current study aimed (i) to assess the spatial pattern and (ii) to identify determinants related to anaemia using the third Ethiopian demographic health survey. To achieve these objectives, this study took into account the sampling weight and the clustered nature of the data. As a result, multilevel modeling has been used in the statistical analysis. The analysis included complete cases from 15,909 females, and 13,903 males. Among all subjects who agreed for hemeoglobin test, 5.22% males, and 16.60% females were anemic. In both binary and ordinal outcome modeling approaches, educational level, age, wealth index, BMI and HIV status were found to be significant predictors of anaemia prevalence. Furthermore, this study applied spatial methods to generate maps at regional level which could be useful for policy makers where great efforts should be concentrated to reduce the prevalence of anaemia. As revealed by Moran's/test, significant spatial autocorrelation were noted across clusters. The risk of anaemia was found to vary across different regions, and higher prevalences were observed in Somali and Affar regions.	[Ejigu, Bedilu Alamirie; Wencheko, Eshetu] Addis Ababa Univ, Dept Stat, Coll Nat & Computat Sci, Addis Ababa, Ethiopia; [Berhane, Kiros] Univ Southern Calif, Dept Prevent Med, Div Biostat, Los Angeles, CA USA	Addis Ababa University; University of Southern California	Ejigu, BA (corresponding author), Addis Ababa Univ, Dept Stat, Coll Nat & Computat Sci, Addis Ababa, Ethiopia.	bedilu.alamirie@aau.edu.et		Ejigu, Bedilu Alamirie/0000-0003-1159-6308	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES007048] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Banerjee S, HIERARCHICAL MODELIN, P2; Bencaiova G, 2012, EUR J INTERN MED, V23, P529, DOI 10.1016/j.ejim.2012.04.008; Bodnar LM, 2001, AM J OBSTET GYNECOL, V185, P438, DOI 10.1067/mob.2001.115996; Bondevik GT, 2001, ACTA OBSTET GYN SCAN, V80, P402, DOI 10.1034/j.1600-0412.2001.080005402.x; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Carneiro IA, 2006, AM J TROP MED HYG, V75, P82, DOI 10.4269/ajtmh.2006.75.82; Central Statistical Agency (CSA), 2011, FOOD KNOWL SURV 2011; Chaix B, 2005, J EPIDEMIOL COMMUN H, V59, P517, DOI 10.1136/jech.2004.025478; Cheng Y, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-222; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Cressie N., 2011, STAT SPATIO TEMPORAL; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; EPHI Ethiopian Public Health Institute, 2016, ETH NAT MAL IND SURV; ESRI, 2011, ARCGIS DESKT REL 10; FMOH, 2014, NAT STRAT PLAN MAL P; Fowles Eileen R, 2002, MCN Am J Matern Child Nurs, V27, P171; Gayawan E, 2014, INT HEALTH, V6, P35, DOI 10.1093/inthealth/iht034; Gebre A, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/165430; Goldstein H., MULTILEVEL STAT METH, P3; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Guyatt HL, 2001, AM J TROP MED HYG, V64, P36, DOI 10.4269/ajtmh.2001.64.36; Habte Dereje, 2013, Afr J Reprod Health, V17, P110; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Lakew Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006001; Leeuw Jde., 2008, HDB MULTILEVEL ANAL; Lover AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091252; Magalhaes RJS, 2013, GEOSPATIAL HEALTH, V7, P341; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; Malaria Atlas Project, MAL ATL PROJ PLASM F; Messina JP, 2013, HEALTH PLACE, V24, P54, DOI 10.1016/j.healthplace.2013.07.009; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Ngnie-Teta I, 2007, FOOD NUTR BULL, V28, P76, DOI 10.1177/156482650702800109; Ngwira A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1494-y; Quintero JP, 2011, MEM I OSWALDO CRUZ, V106, P91, DOI 10.1590/S0074-02762011000900012; Park YM, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-6; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Rabe-Hesketh S, 2005, J ECONOMETRICS, V128, P301, DOI 10.1016/j.jeconom.2004.08.017; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Rozi S., 2017, OPEN J EPIDEMIOL, V7, P27, DOI [10.4236/ojepi.2017.71004, DOI 10.4236/OJEPI.2017.71004]; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; SCHOLL TO, 1994, AM J CLIN NUTR, V59, p492S, DOI 10.1093/ajcn/59.2.492S; Smith JL, 2010, TROP MED INT HEALTH, V15, P776, DOI 10.1111/j.1365-3156.2010.02542.x; Snijders TA, 2013, MULTILEVEL ANAL; StataCorp, 2015, STAT STAT SOFTW REL; Taner CE, 2015, J TURK-GER GYNECOL A, V16, P231, DOI 10.5152/jtgga.2015.15071; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; van Eijk AM, 2002, AM J TROP MED HYG, V67, P44, DOI 10.4269/ajtmh.2002.67.44; WHO, 2014, WHONMHNHD144; WHO, 2011, GLOB PREV AN 2011; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2014, IRON DEFICIENCY ANAE; Xu HW, 2014, SOCIOL METHODOL, V44, P229, DOI 10.1177/0081175013490188	57	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197171	10.1371/journal.pone.0197171	http://dx.doi.org/10.1371/journal.pone.0197171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG2KJ	29775472	Green Published, gold, Green Submitted			2022-12-26	WOS:000432521100011
J	Glozah, FN; Asante, KO; Kugbey, N				Glozah, Franklin N.; Asante, Kwaku Oppong; Kugbey, Nuworza			Parental involvement could mitigate the effects of physical activity and dietary habits on mental distress in Ghanaian youth	PLOS ONE			English	Article							SUICIDAL IDEATION; VEGETABLE CONSUMPTION; HEALTH PROBLEMS; SOCIAL SUPPORT; HIGH-SCHOOL; ADOLESCENTS; DEPRESSION; CHILDREN; RISK; DISORDERS	Introduction Parental involvement in physical activity and dietary habits have been found to play a substantial role in the mental health of young people. However, there is little evidence about the associations between parental involvement, health behaviours and mental health among Ghanaian youth. This study sought to examine the role of parental involvement in the association between physical activity, dietary habits and mental health among Ghanaian youth. Methods Data were obtained from the 2012 Ghana Global School-based Student Health Survey (GSHS). The study population consisted of 1,984 school going youth in high schools with a median age of 15 years old, (53.7%) males. Bivariate and multivariate logistic regression statistical models using complex samples method were performed. Results The prevalence of mental distress was 18.1%, 16.6% and 23% for loneliness, feeling worried and suicidal ideation respectively. Younger students were more likely to feel lonely, worried and have suicidal ideation than older students. Students from low socio-economic backgrounds were significantly more likely to report loneliness, worry and suicidal ideation. After adjusting for socio-demographic characteristics, some physical activity and eating habits were associated with experiencing loneliness, worry and suicidal ideation but after introducing parental involvement, there was a decrease in the likelihood of some health behaviour factors in both physical activity and dietary habits to be associated with loneliness, worry and suicidal ideation. Conclusion Physical inactivity and poor dietary habits could have a negative effect on mental distress, however, parental involvement could mitigate the impact of these lifestyle habits on mental distress and should therefore be taken into consideration in efforts aimed at encouraging positive lifestyle habits for good mental health among Ghanaian youth.	[Glozah, Franklin N.] Univ Ghana, Sch Publ Hlth, Dept Social & Behav Sci, Accra, Ghana; [Glozah, Franklin N.; Asante, Kwaku Oppong] Inst Psychosocial Res Child & Adolescent Wellbein, Accra, Ghana; [Asante, Kwaku Oppong] Univ Ghana, Dept Psychol, Accra, Ghana; [Kugbey, Nuworza] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Family & Community Hlth, Ho, Ghana	University of Ghana; University of Ghana	Glozah, FN (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Social & Behav Sci, Accra, Ghana.; Glozah, FN (corresponding author), Inst Psychosocial Res Child & Adolescent Wellbein, Accra, Ghana.	fglozah@ug.edu.gh	Asante, Kwaku Oppong/B-1310-2014; Kugbey, Nuworza/H-9264-2019	Asante, Kwaku Oppong/0000-0002-0206-3326; Kugbey, Nuworza/0000-0002-0413-0350; Glozah, Franklin N./0000-0002-4178-963X				[Anonymous], 2011, PROFESSIONAL SCH COU, DOI DOI 10.5330/PSC.N.2011-15.77; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Blanchette L, 2005, J HUM NUTR DIET, V18, P431, DOI 10.1111/j.1365-277X.2005.00648.x; Blum R, 2012, J ADOLESCENT HEALTH, V50, pS37, DOI 10.1016/j.jadohealth.2011.12.006; Bois JE, 2005, PSYCHOL SPORT EXERC, V6, P381, DOI 10.1016/j.psychsport.2004.03.003; Brausch AM, 2009, SUICIDE LIFE-THREAT, V39, P58, DOI 10.1521/suli.2009.39.1.58; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Bronfenbrenner U., 2007, HDB CHILD DEV, V6th ed., P793, DOI DOI 10.1002/9780470147658.CHPSY0114; Brosnahan J, 2004, ARCH PEDIAT ADOL MED, V158, P818, DOI 10.1001/archpedi.158.8.818; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Cortina MA, 2012, ARCH PEDIAT ADOL MED, V166, P276, DOI 10.1001/archpediatrics.2011.592; Costello EJ, 2005, CHILD ADOL PSYCH CL, V14, P631, DOI 10.1016/j.chc.2005.06.003; Edwardson CL, 2010, PSYCHOL SPORT EXERC, V11, P522, DOI 10.1016/j.psychsport.2010.05.001; Epstein J., 2002, SCH FAMILY COMMUNITY; Glozah FN, 2017, J HEALTH PSYCHOL, V22, P1376, DOI 10.1177/1359105316628736; Glozah FN, 2014, J ADOLESCENCE, V37, P451, DOI 10.1016/j.adolescence.2014.03.010; Granero R, 2008, P R HEALTH SCI J, V27, P337; Insel TR, 2005, ARCH GEN PSYCHIAT, V62, P590, DOI 10.1001/archpsyc.62.6.590; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kulkarni AA, 2015, EUR J CLIN NUTR, V69, P79, DOI 10.1038/ejcn.2014.130; Langille DB, 2012, SOC PSYCH PSYCH EPID, V47, P1549, DOI 10.1007/s00127-011-0461-x; Lewinsohn PM, 1999, J AM ACAD CHILD PSY, V38, P56, DOI 10.1097/00004583-199901000-00020; McMartin SE, 2013, PREV MED, V56, P225, DOI 10.1016/j.ypmed.2012.12.016; Morgan C, 2007, BRIT J PSYCHIAT, V191, P477, DOI 10.1192/bjp.bp.106.034942; Mutumba M, 2014, J CHILD ADOLESC MENT, V26, P139, DOI 10.2989/17280583.2014.907169; Nieto S., 1987, NABE J, V11, P189, DOI [10.1080/08855072.1997.10668528, DOI 10.1080/08855072.1997.10668528]; O'Neil A, 2014, AM J PUBLIC HEALTH, V104, pE31, DOI 10.2105/AJPH.2014.302110; O'Sullivan TA, 2009, PUBLIC HEALTH NUTR, V12, P249, DOI 10.1017/S1368980008003935; Owusu A., 2008, GLOBAL SCH BASED STU; Peltzer K, 2010, INT J PUBLIC HEALTH, V55, P669, DOI 10.1007/s00038-010-0194-8; Randall JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088233; RANSFORD CP, 1982, MED SCI SPORT EXER, V14, P1, DOI 10.1249/00005768-198201000-00001; Reiss F, 2013, SOC SCI MED, V90, P24, DOI 10.1016/j.socscimed.2013.04.026; Rice P, 2002, ADOLESCENTS THEORETI; Sagatun A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-155; Sanchez-Villegas A, 2012, PUBLIC HEALTH NUTR, V15, P424, DOI 10.1017/S1368980011001856; Scribner J.D., 1999, LESSONS HIGH PERFORM; Starfield B, 2002, J EPIDEMIOL COMMUN H, V56, P354, DOI 10.1136/jech.56.5.354; Taliaferro LA, 2008, J SCHOOL HEALTH, V78, P545, DOI 10.1111/j.1746-1561.2008.00342.x; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; Videon TM, 2003, J ADOLESCENT HEALTH, V32, P365, DOI 10.1016/S1054-139X(02)00711-5; Von Essen E, 2014, J QUAL STUD HLTH WEL, V9, DOI [10.3402/qhvv.v9.23000, DOI 10.3402/QHVV.V9.23000]; Wang MT, 2014, CHILD DEV, V85, P610, DOI 10.1111/cdev.12153; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; WHO, 2012, PUBL HLTH ACT PREV S; Wiles NJ, 2012, SOC PSYCH PSYCH EPID, V47, P1023, DOI 10.1007/s00127-011-0422-4; World Health Organization, GLOB SCH BAS STUD HL; World Health Organization, 2003, CAR CHILDR AD MENT D; WORLD HEALTH ORGANIZATION (WHO), GLOB STRAT DIET PHYS	52	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197551	10.1371/journal.pone.0197551	http://dx.doi.org/10.1371/journal.pone.0197551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG0DP	29771990	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900072
J	Kresse, SH; Namlos, HM; Lorenz, S; Berner, JM; Myklebost, O; Bjerkehagen, B; Meza-Zepeda, LA				Kresse, Stine H.; Namlos, Heidi M.; Lorenz, Susanne; Berner, Jeanne-Marie; Myklebost, Ola; Bjerkehagen, Bodil; Meza-Zepeda, Leonardo A.			Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; AVAILABLE KITS; NUCLEIC-ACIDS; FORMALIN; FIXATION	Nucleic acid material of adequate quality is crucial for successful high-throughput sequencing (HTS) analysis. DNA and RNA isolated from archival FFPE material are frequently degraded and not readily amplifiable due to chemical damage introduced during fixation. To identify optimal nucleic acid extraction kits, DNA and RNA quantity, quality and performance in HTS applications were evaluated. DNA and RNA were isolated from five sarcoma archival FFPE blocks, using eight extraction protocols from seven kits from three different commercial vendors. For DNA extraction, the truXTRAC FFPE DNA kit from Covaris gave higher yields and better amplifiable DNA, but all protocols gave comparable HTS library yields using Agilent SureSelect XT and performed well in downstream variant calling. For RNA extraction, all protocols gave comparable yields and amplifiable RNA. However, for fusion gene detection using the Archer FusionPlex Sarcoma Assay, the truXTRAC FFPE RNA kit from Covaris and Agencourt FormaPure kit from Beckman Coulter showed the highest percentage of unique read-pairs, providing higher complexity of HTS data and more frequent detection of recurrent fusion genes. truXTRAC simultaneous DNA and RNA extraction gave similar outputs as individual protocols. These findings show that although successful HTS libraries could be generated in most cases, the different protocols gave variable quantity and quality for FFPE nucleic acid extraction. Selecting the optimal procedure is highly valuable and may generate results in borderline quality specimens.	[Kresse, Stine H.; Namlos, Heidi M.; Lorenz, Susanne; Myklebost, Ola; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumor Biol, Oslo, Norway; [Lorenz, Susanne; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Core Facil, Genom Core Facil, Oslo, Norway; [Berner, Jeanne-Marie; Bjerkehagen, Bodil; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Myklebost, Ola] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Myklebost, Ola; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Norwegian Canc Genom Consortium Cancergenomics No, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Bergen; University of Oslo	Meza-Zepeda, LA (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumor Biol, Oslo, Norway.; Meza-Zepeda, LA (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Core Facil, Genom Core Facil, Oslo, Norway.; Meza-Zepeda, LA (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway.; Meza-Zepeda, LA (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Norwegian Canc Genom Consortium Cancergenomics No, Oslo, Norway.	Leonardo.Meza-Zepeda@rr-research.no	Namløs, Heidi Maria/AAB-2843-2021; Meza-Zepeda, Leonardo Andres/CAG-5229-2022	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X	Norwegian Cancer Society [PR-2007-0163]; Norges Forskningsrad [221580]; Gene Therapy program at Oslo University Hospital	Norwegian Cancer Society(Norwegian Cancer Society); Norges Forskningsrad; Gene Therapy program at Oslo University Hospital	This project was supported by grants from the Norwegian Cancer Society (PR-2007-0163) to Leonardo A. Meza-Zepeda, Norges Forskningsrad (221580) to Ola Myklebost and the Gene Therapy program at Oslo University Hospital to Leonardo A. Meza-Zepeda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Evers DL, 2011, J MOL DIAGN, V13, P687, DOI 10.1016/j.jmoldx.2011.06.007; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Heydt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104566; Howat WJ, 2014, METHODS, V70, P12, DOI 10.1016/j.ymeth.2014.01.022; Huijsmans Cornelis Jj, 2010, BMC Res Notes, V3, P239, DOI 10.1186/1756-0500-3-239; Janecka A, 2015, ANAL BIOCHEM, V476, P8, DOI 10.1016/j.ab.2015.01.019; Kocjan BJ, 2015, ACTA DERMATOVEN ALP, V24, P47, DOI 10.15570/actaapa.2015.12; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Patel PG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179732; Rabelo-Goncalves E, 2014, PATHOL RES PRACT, V210, P142, DOI 10.1016/j.prp.2013.11.003; Sam SS, 2012, PATHOL RES PRACT, V208, P705, DOI 10.1016/j.prp.2012.08.008; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Watanabe M, 2017, EXP THER MED, V14, P2683, DOI 10.3892/etm.2017.4797; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2	17	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197456	10.1371/journal.pone.0197456	http://dx.doi.org/10.1371/journal.pone.0197456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771965	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900062
J	Maczka, W; Grabarczyk, M; Winska, K; Gebarowska, E; Strzala, T; Durajczyk, M				Maczka, Wanda; Grabarczyk, Malgorzata; Winska, Katarzyna; Gebarowska, Elzbieta; Strzala, Tomasz; Durajczyk, Marek			Salt mine microorganisms used for the biotransformation of chlorolactones	PLOS ONE			English	Article							MARINE-DERIVED FUNGI; MICROCOCCUS-LUTEUS; WHOLE CELLS; ASPERGILLUS-SYDOWII; DEHALOGENATION; HALOGENATION; HALOLACTONES; CULTURES; STRAINS; NIGER	The aim of the project was to find new catalysts capable of chlorolactone biotransformation. Three bicyclic chlorolactones with structures possessing one or two methyl groups in their cyclohexane ring were subjected to screening biotransformation using seven bacterial strains and one fungal strain from a salt mine. Three strains of bacteria (Micrococcus luteus Pb10, Micrococcus luteus WSP45, Gordonia alkanivorans Pd25) and one fungal strain (Aspergillus sydowii KGJ10) were able to catalyse hydrolytic dehalogenation of one substrate. The classification of the strains that were effective biocatalysts was confirmed by 16S rDNA analysis. The best result (76%) was obtained using Aspergillus sydowii KGJ10. All strains catalysed hydrolytic dehalogenation without changing the conformation. The equatorial position of the chlorine atom in the substrate turned out to be warrant of the positive result of the biotransformation process.	[Maczka, Wanda; Grabarczyk, Malgorzata; Winska, Katarzyna] Wroclaw Univ Environm & Life Sci, Fac Biotechnol & Food Sci, Dept Chem, Wroclaw, Poland; [Gebarowska, Elzbieta] Wroclaw Univ Environm & Life Sci, Fac Life Sci & Technol, Dept Plant Protect, Agr Microbiol Lab, Wroclaw, Poland; [Strzala, Tomasz; Durajczyk, Marek] Wroclaw Univ Environm & Life Sci, Fac Biol & Anim Sci, Dept Genet, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences	Maczka, W (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Biotechnol & Food Sci, Dept Chem, Wroclaw, Poland.	wanda.maczka@upwr.edu.pl	Wińska, Katarzyna/A-4397-2017; Grabarczyk, Małgorzata/A-1342-2017; Durajczyk, Marek/A-3024-2014; Strzała, Tomasz/P-3357-2019	Wińska, Katarzyna/0000-0003-2320-6610; Grabarczyk, Małgorzata/0000-0002-1097-7216; Strzała, Tomasz/0000-0002-7761-1630; Gebarowska, Elzbieta/0000-0002-7856-9331	Wroclaw Centre of Biotechnology; programme The Leading National Research Centre (KNOW)	Wroclaw Centre of Biotechnology; programme The Leading National Research Centre (KNOW)	Publication supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018, https://www.binoz.upwr.edu.pl/wnozeng/. The funder will support fees of publication.; Publication supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018.	Agarwal V, 2017, CHEM REV, V117, P5619, DOI 10.1021/acs.chemrev.6b00571; Allpress JD, 1998, BIOCHEM EDUC, V26, P267, DOI 10.1016/S0307-4412(98)00090-9; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarenga N, 2014, CHEMOSPHERE, V117, P47, DOI 10.1016/j.chemosphere.2014.05.069; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Birolli WG, 2015, BIOTECHNOL ADV, V33, P481, DOI 10.1016/j.biotechadv.2015.02.001; Borges KB, 2009, TETRAHEDRON-ASYMMETR, V20, P385, DOI 10.1016/j.tetasy.2009.02.009; Bultel-Ponce V, 1998, J MAR BIOTECHNOL, V6, P233; Cantillo D, 2017, REACT CHEM ENG, V2, P7, DOI 10.1039/c6re00186f; Cong BL, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1028-0; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Das S, 2014, ELSEV INSIGHT, P1; de Oliveira JR, 2014, MAR BIOTECHNOL, V16, P156, DOI 10.1007/s10126-013-9534-z; Dib J, 2008, CURR MICROBIOL, V56, P510, DOI 10.1007/s00284-008-9103-2; Dogra N, 2001, FOLIA MICROBIOL, V46, P17, DOI 10.1007/BF02825877; Du LN, 2012, ENVIRON SCI POLLUT R, V19, P2898, DOI 10.1007/s11356-012-0796-1; ESAKI N, 1994, BIOSCI BIOTECH BIOCH, V58, P319, DOI 10.1271/bbb.58.319; Fischer-Colbrie G, 2007, J BIOTECHNOL, V129, P62, DOI 10.1016/j.jbiotec.2006.11.018; Fisher F.W., 1998, FUNDAMENTALS DIAGNOS; Fraczek K, 2013, AEROBIOLOGIA, V29, P481, DOI 10.1007/s10453-013-9298-y; Gfadkowski W, 2011, ENZYME MICROB TECHNO, V48, P326, DOI [10.1016/j.enzmictec.2010.12.007, DOI 10.1016/J.ENZMICTEC.2010.12.007]; Grabarczyk M, 2015, ARAB J CHEM, DOI [10.1016/j.arabic.2015.02.018, DOI 10.1016/J.ARABIC.2015.02.018]; Grabarczyk M, 2015, MOLECULES, V20, P3335, DOI 10.3390/molecules20023335; Grabarczyk M, 2014, J MOL CATAL B-ENZYM, V102, P195, DOI 10.1016/j.molcatb.2014.02.012; Grabarczyk M, 2013, J BRAZIL CHEM SOC, V24, P1913, DOI 10.5935/0103-5053.20130238; Grabarczyk M, 2012, MOLECULES, V17, P9741, DOI 10.3390/molecules17089741; Grabarczyk M, 2010, BIOCATAL BIOTRANSFOR, V28, P408, DOI 10.3109/10242422.2010.538688; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; H?ggblom MM., 2004, DEHALOGENATION MICRO; Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI citeulike-article-id:691774; Hori MON, 2000, Z NATURFORSCH C, V55, P890; Jeschke P, 2017, PEST MANAG SCI, V73, P1053, DOI 10.1002/ps.4540; Lin MLM, 2016, DRUG SAFETY, V39, P675, DOI 10.1007/s40264-016-0418-9; LUDWIG W, 1993, INT J SYST BACTERIOL, V43, P363, DOI 10.1099/00207713-43-2-363; Martins MP, 2015, MAR BIOTECHNOL, V17, P211, DOI 10.1007/s10126-015-9610-7; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Orbegozo T, 2009, TETRAHEDRON, V65, P6805, DOI 10.1016/j.tet.2009.06.088; Ortega SN, 2011, BIODEGRADATION, V22, P43, DOI 10.1007/s10532-010-9374-8; Parshikov IA, 2015, APPL MICROBIOL BIOT, V99, P6971, DOI 10.1007/s00253-015-6765-0; Parshikov IA, 2015, APPL BIOCHEM BIOTECH, V176, P903, DOI 10.1007/s12010-015-1619-x; Perelo LW, 2010, J HAZARD MATER, V177, P81, DOI 10.1016/j.jhazmat.2009.12.090; Dib JR, 2013, APPL MICROBIOL BIOT, V97, P63, DOI 10.1007/s00253-012-4539-5; Rocha LC, 2012, MAR BIOTECHNOL, V14, P358, DOI 10.1007/s10126-011-9419-y; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Samson R., 2004, INTRO FOOD AIRBORNE; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Winska K, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7010012; Zadlo A, 2016, EUR J ORG CHEM, V2016, P1007, DOI 10.1002/ejoc.201501460	49	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197384	10.1371/journal.pone.0197384	http://dx.doi.org/10.1371/journal.pone.0197384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771957	gold, Green Submitted, Green Published			2022-12-26	WOS:000432348900055
J	Gigante, CM; Dettinger, L; Powell, JW; Seiders, M; Condori, REC; Griesser, R; Okogi, K; Carlos, M; Pesko, K; Breckenridge, M; Simon, EMM; Chu, MYJV; Davis, AD; Brunt, SJ; Orciari, L; Yager, P; Carson, WC; Hartloge, C; Saliki, JT; Sanchez, S; Deldari, M; Hsieh, K; Wadhwa, A; Wilkins, K; Peredo, VY; Rabideau, P; Gruhn, N; Cadet, R; Isloor, S; Nath, SS; Joseph, T; Gao, JX; Wallace, R; Reynolds, M; Olson, VA; Li, Y				Gigante, Crystal M.; Dettinger, Lisa; Powell, James W.; Seiders, Melanie; Condori, Rene Edgar Condori; Griesser, Richard; Okogi, Kenneth; Carlos, Maria; Pesko, Kendra; Breckenridge, Mike; Simon, Edson Michael M.; Chu, Maria Yna Joyce, V; Davis, April D.; Brunt, Scott J.; Orciari, Lillian; Yager, Pamela; Carson, William C.; Hartloge, Claire; Saliki, Jeremiah T.; Sanchez, Susan; Deldari, Mojgan; Hsieh, Kristina; Wadhwa, Ashutosh; Wilkins, Kimberly; Peredo, Veronica Yung; Rabideau, Patricia; Gruhn, Nina; Cadet, Rolain; Isloor, Shrikrishna; Nath, Sujith S.; Joseph, Tomy; Gao, Jinxin; Wallace, Ryan; Reynolds, Mary; Olson, Victoria A.; Li, Yu			Multi-site evaluation of the LN34 pan-lyssavirus real-time RT-PCR assay for post-mortem rabies diagnostics	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; POLYMERASE-CHAIN-REACTION; MOLECULAR DIAGNOSIS; VIRUS DETECTION; SAMPLES; RNA; SPECIMENS; STORAGE; BRAIN; ANTE	Rabies is a fatal zoonotic disease that requires fast, accurate diagnosis to prevent disease in an exposed individual. The current gold standard for post-mortem diagnosis of human and animal rabies is the direct fluorescent antibody (DFA) test. While the DFA test has proven sensitive and reliable, it requires high quality antibody conjugates, a skilled technician, a fluorescence microscope and diagnostic specimen of sufficient quality. The LN34 pan-lyssavirus real-time RT-PCR assay represents a strong candidate for rabies post-mortem diagnostics due to its ability to detect RNA across the diverse Lyssavirus genus, its high sensitivity, its potential for use with deteriorated tissues, and its simple, easy to implement design. Here, we present data from a multi-site evaluation of the LN34 assay in 14 laboratories. A total of 2,978 samples (1,049 DFA positive) from Africa, the Americas, Asia, Europe, and the Middle East were tested. The LN34 assay exhibited low variability in repeatability and reproducibility studies and was capable of detecting viral RNA in fresh, frozen, archived, deteriorated and formalin-fixed brain tissue. The LN34 assay displayed high diagnostic specificity (99.68%) and sensitivity (99.90%) when compared to the DFA test, and no DFA positive samples were negative by the LN34 assay. The LN34 assay produced definitive findings for 80 samples that were inconclusive or untestable by DFA; 29 were positive. Five samples were inconclusive by the LN34 assay, and only one sample was inconclusive by both tests. Furthermore, use of the LN34 assay led to the identification of one false negative and 11 false positive DFA results. Together, these results demonstrate the reliability and robustness of the LN34 assay and support a role for the LN34 assay in improving rabies diagnostics and surveillance.	[Gigante, Crystal M.; Condori, Rene Edgar Condori; Orciari, Lillian; Yager, Pamela; Carson, William C.; Hartloge, Claire; Wadhwa, Ashutosh; Wilkins, Kimberly; Gao, Jinxin; Wallace, Ryan; Reynolds, Mary; Olson, Victoria A.; Li, Yu] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Dettinger, Lisa; Seiders, Melanie] Penn Dept Hlth, Bur Labs, Exton, PA USA; [Powell, James W.; Griesser, Richard] Wisconsin State Lab Hyg, Rabies Unit, Madison, WI USA; [Okogi, Kenneth; Carlos, Maria] Maryland Dept Hlth, Ctr Zoonot & Vectorborne Dis, Rabies Lab, Baltimore, MD USA; [Pesko, Kendra; Breckenridge, Mike] New Mexico Dept Hlth, Sci Lab Div, Santa Fe, NM USA; [Simon, Edson Michael M.; Chu, Maria Yna Joyce, V] Res Inst Trop Med, Dept Hlth, Special Pathogens Lab, Manila, Philippines; [Davis, April D.; Brunt, Scott J.] New York State Dept Hlth, Wadsworth Ctr, Rabies Lab, Albany, NY USA; [Saliki, Jeremiah T.; Sanchez, Susan] Univ Georgia, Athens Vet Diagnost Lab, Athens, GA 30602 USA; [Deldari, Mojgan; Hsieh, Kristina] Calif Dept Publ Hlth, Sacramento, CA USA; [Peredo, Veronica Yung] Publ Hlth Inst Chile, Viral Dis, Rabies Sect, Santiago, Chile; [Rabideau, Patricia; Gruhn, Nina] Kirchberg Kaserne, Biol Anal Div, Lab Sci, Publ Hlth Command Europe, Landstuhl, Germany; [Cadet, Rolain] Minist Agr, Port Au Prince, Haiti; [Isloor, Shrikrishna; Nath, Sujith S.] KVAFSU, Vet Coll, Dept Vet Microbiol, OIE Twinned KVAFSU CVA Crucell Rabies Diagnost La, Bangalore, Karnataka, India; [Joseph, Tomy] Minist Agr, Anim Hlth Ctr, Abbotsford, BC, Canada	Centers for Disease Control & Prevention - USA; New Mexico Department of Health; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; State University of New York (SUNY) System; Wadsworth Center; University System of Georgia; University of Georgia; California Department of Public Health	Li, Y (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	yuli@cdc.gov	Gigante, Crystal/AAE-2060-2021	Saliki, Jeremiah/0000-0003-0050-4324; Joseph, Tomy/0000-0001-6693-578X; Reynolds, Mary/0000-0001-7882-4614	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was funded by the regular operations of the Centers for Disease Control and Prevention. CMG, RECC, CH and AW were supported in part by appointments to the Research Participation Program at the Centers for Disease Control and Prevention, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and CDC. JG was supported in part by an appointment administered by Corporate Temps Professional Temporary Service and CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albas A, 1999, Rev Soc Bras Med Trop, V32, P19, DOI 10.1590/S0037-86821999000100004; Bujang MA, 2016, J CLIN DIAGN RES, V10, pYE1, DOI 10.7860/JCDR/2016/18129.8744; Centers for Disease Control and Prevention, 2015, COST RAB PREV; Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Coertse J, 2010, J CLIN MICROBIOL, V48, P3949, DOI 10.1128/JCM.01256-10; Coetzer A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003189; Dacheux L, 2008, CLIN INFECT DIS, V47, P1410, DOI 10.1086/592969; Dacheux L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004812; David D, 2002, VET MICROBIOL, V87, P111, DOI 10.1016/S0378-1135(02)00041-X; Dean D.J., 1996, LAB TECHNIQUES RABIE, P88; Faye M, 2017, J VIROL METHODS, V243, P120, DOI 10.1016/j.jviromet.2016.12.019; Fooks AR, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.91; Fooks AR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000530; Gardner IA, 2006, VET CLIN PATH, V35, P8, DOI 10.1111/j.1939-165X.2006.tb00082.x; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hayman DTS, 2011, J VIROL METHODS, V177, P87, DOI 10.1016/j.jviromet.2011.07.002; Heaton PR, 1997, J CLIN MICROBIOL, V35, P2762, DOI 10.1128/JCM.35.11.2762-2766.1997; Hoffmann B, 2010, J CLIN MICROBIOL, V48, P3970, DOI 10.1128/JCM.00612-10; Hofmann MA, 2000, J VIROL METHODS, V87, P29, DOI 10.1016/S0166-0934(00)00154-3; Huang GL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06739-2; KAMOLVARIN N, 1993, J INFECT DIS, V167, P207, DOI 10.1093/infdis/167.1.207; Lembo T, 2006, EMERG INFECT DIS, V12, P310; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lou JJ, 2014, CLIN BIOCHEM, V47, P267, DOI 10.1016/j.clinbiochem.2013.12.011; Meslin FX, 1996, LAB TECHNIQUES RABIE; Nadin-Davis SA, 2009, J MED VIROL, V81, P1484, DOI 10.1002/jmv.21547; Nagaraj T, 2006, J CLIN VIROL, V36, P17, DOI 10.1016/j.jcv.2006.01.009; OIE] World Organisation for Animal Health, 2017, MANUAL DIAGNOSTIC TE; Panning M, 2010, J CLIN MICROBIOL, V48, P2960, DOI 10.1128/JCM.00728-10; Petersen B. W., NONFLAVIVIRUS ENCEPH, DOI [10.5772/21708, DOI 10.5772/21708]; Picard-Meyer E, 2007, J VIROL METHODS, V140, P174, DOI 10.1016/j.jviromet.2006.11.011; Picard-Meyer E, 2004, VACCINE, V22, P1921, DOI 10.1016/j.vaccine.2003.11.015; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; R Development Core Team, 2016, R LANG ENV STAT COMP, DOI [10.1371/journal.pone.0146021, DOI 10.1371/JOURNAL.PONE.0146021]; R Studio Team, 2016, RSTUDIO INT DEV ENV; Rahmadane I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006079; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ronald G.P., 2003, PROTOCOL POSTMORTEM; Rupprecht C., 2017, F1000 RES, V6, P184, DOI [DOI 10.12688/F1000RESEARCH.10416.1, 10.12688/f1000research.10416.1]; Smith IL, 2002, J CLIN VIROL, V25, P285, DOI 10.1016/S1386-6532(02)00083-5; Wacharapluesadee S, 2006, J VIROL METHODS, V134, P267, DOI 10.1016/j.jviromet.2006.02.002; Wacharapluesadee S, 2012, J VIROL METHODS, V184, P109, DOI 10.1016/j.jviromet.2012.05.013; Wacharapluesadee S, 2011, J VIROL METHODS, V175, P278, DOI 10.1016/j.jviromet.2011.05.007; Wadhwa A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005258; Wakeley PR, 2005, J CLIN MICROBIOL, V43, P2786, DOI 10.1128/JCM.43.6.2786-2792.2005; Whitby JE, 1997, J WILDLIFE DIS, V33, P912, DOI 10.7589/0090-3558-33.4.912; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2013, WHO EXP CONS RAB 2 R	52	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197074	10.1371/journal.pone.0197074	http://dx.doi.org/10.1371/journal.pone.0197074			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768505	gold, Green Published, Green Submitted			2022-12-26	WOS:000432329200057
J	Heyer, M; Scholz, SS; Voigt, D; Reichelt, M; Aldon, D; Oelmuller, R; Boland, W; Mithofer, A				Heyer, Monika; Scholz, Sandra S.; Voigt, Dagmar; Reichelt, Michael; Aldon, Didier; Oelmueller, Ralf; Boland, Wilhelm; Mithoefer, Axel			Herbivory-responsive calmodulin-like protein CML9 does not guide jasmonate-mediated defenses in Arabidopsis thaliana	PLOS ONE			English	Article							INDUCED RESISTANCE; ABSCISIC-ACID; SPODOPTERA-LITTORALIS; ABIOTIC STRESS; CALCIUM; EXPRESSION; TRANSITION; MUTATIONS; INFECTION; PATHWAYS	Calcium is an important second messenger in plants that is released into the cytosol early after recognition of various environmental stimuli. Decoding of such calcium signals by calcium sensors is the key for the plant to react appropriately to each stimulus. Several members of Calmodulin-like proteins (CMLs) act as calcium sensors and some are known to mediate both abiotic and biotic stress responses. Here, we study the role of the Arabidopsis thaliana CML9 in different stress responses. CML9 was reported earlier as defense regulator against Pseudomonas syringae. In contrast to salicylic acid-mediated defense against biotrophic pathogens such as P. syringae, defenses against herbivores and necrotrophic fungi are mediated by jasmonates. We demonstrate that CML9 is induced upon wounding and feeding of the insect herbivore Spodoptera littoralis. However, neither different CML9 loss-of-function mutant lines nor overexpression lines were impaired upon insect feeding. No difference in herbivore-induced phytohormone elevation was detected in cml9 lines. The defense against the spider mite Tetranychus urticae was also unaffected. In addition, cml9 mutant lines showed a wild type-like reaction to the necrotrophic fungus Alternaria brassicicola. Thus, our data suggest that CML9 might be a regulator involved only in the defense against biotrophic pathogens, independent of jasmonates. In addition, our data challenge the involvement of CML9 in plant drought stress response. Taken together, we suggest that CML9 is a specialized rather than a general regulator of stress responses in Arabidopsis.	[Heyer, Monika; Boland, Wilhelm; Mithoefer, Axel] Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany; [Scholz, Sandra S.; Oelmueller, Ralf] Friedrich Schiller Univ, Matthias Schleiden Inst, Dept Plant Physiol, Jena, Germany; [Voigt, Dagmar] Tech Univ Dresden, Inst Bot, Dresden, Germany; [Reichelt, Michael] Max Planck Inst Chem Ecol, Dept Biochem, Jena, Germany; [Aldon, Didier] Univ Toulouse III, UMR CNRS 5546, Pole Biotechnol Vegetale, Castanet Tolosan, France	Max Planck Society; Friedrich Schiller University of Jena; Technische Universitat Dresden; Max Planck Society; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Mithofer, A (corresponding author), Max Planck Inst Chem Ecol, Dept Bioorgan Chem, Jena, Germany.	amithoefer@ice.mpg.de	Boland, Wilhelm/K-7762-2012; Voigt, Dagmar/H-2220-2011	Boland, Wilhelm/0000-0001-6784-2534; Voigt, Dagmar/0000-0003-2772-8504; Mithofer, Axel/0000-0001-5229-6913; Scholz, Sandra/0000-0002-5389-5296	Federal Ministry of Education and Science, BMBF, Germany (SPIRED) [KMU-i 031A216B]; Max Planck society	Federal Ministry of Education and Science, BMBF, Germany (SPIRED)(Federal Ministry of Education & Research (BMBF)); Max Planck society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Federal Ministry of Education and Science, BMBF, Germany (SPIRED, KMU-i 031A216B) to DV and the Max Planck society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGOMAZ R, 1986, Journal of the Lepidopterists' Society, V40, P131; Bodenhausen N, 2007, MOL PLANT MICROBE IN, V20, P1406, DOI 10.1094/MPMI-20-11-1406; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Chehab EW, 2011, PLANT PHYSIOL, V156, P770, DOI 10.1104/pp.111.174169; Cipollini D, 2004, MOL ECOL, V13, P1643, DOI 10.1111/j.1365-294X.2004.02161.x; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; Delk NA, 2005, PLANT PHYSIOL, V139, P240, DOI 10.1104/pp.105.062612; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Jimenez-Aleman GH, 2015, BBA-MOL CELL BIOL L, V1851, P1545, DOI 10.1016/j.bbalip.2015.09.002; Johnson JM., 2013, PIRIFORMOSPORA INDIC, V33, P325, DOI DOI 10.1007/978-3-642-33802-1_20; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Leba LJ, 2012, PLANT J, V71, P976, DOI 10.1111/j.1365-313X.2012.05045.x; Lee D, 2005, NEW PHYTOL, V165, P429, DOI 10.1111/j.1469-8137.2004.01238.x; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; Merz D, 2017, J EXP BOT, V68, P4583, DOI 10.1093/jxb/erx263; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Redondo-Gomez S., 2013, MOL STRESS PHYSL PLA, P1; Rodriguez MC, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.975659; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Scholz SS, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1011951; Scholz SS, 2014, MOL PLANT, V7, P1712, DOI 10.1093/mp/ssu102; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Tsai YC, 2007, PLANT SIGNAL BEHAV, V2, P446, DOI 10.4161/psb.2.6.4695; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Vadassery J, 2012, PLANT SIGNAL BEHAV, V7, P1277, DOI 10.4161/psb.21664; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; Vanderbeld B, 2007, PLANT MOL BIOL, V64, P683, DOI 10.1007/s11103-007-9189-0; Wang YH, 2008, J BIOTECHNOL TECHNOL, V1, P11; Wattier C, 2019, INSECT SCI, V26, P753, DOI 10.1111/1744-7917.12563	41	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197633	10.1371/journal.pone.0197633	http://dx.doi.org/10.1371/journal.pone.0197633			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768484	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200101
J	Segovia, C; Arias-Carrasco, R; Yanez, AJ; Maracaja-Coutinho, V; Santander, J				Segovia, Cristopher; Arias-Carrasco, Raul; Yanez, Alejandro J.; Maracaja-Coutinho, Vinicius; Santander, Javier			Core non-coding RNAs of Piscirickettsia salmonis	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; PSEUDOMONAS-AERUGINOSA; PATHOGEN; SYSTEM; METABOLISM; SEQUENCE; PROTEIN; GROWTH; RESISTANCE	Piscirickettsia salmonis, a fastidious Gram-negative intracellular facultative bacterium, is the causative agent o Piscirickettsiosis. P. salmonis has broad host range with a nearly worldwide distribution, causing significant mortality. The molecular regulatory mechanisms of P. salmonis pathogenesis are relatively unknown, mainly due to its difficult in vitro culture and genomic differences between genogroups. Bacterial non-coding RNAs (ncRNAs) are important post-transcriptional regulators of bacterial physiology and virulence that are predominantly transcribed from intergenic regions (trans-acting) or antisense strand of open reading frames (cis-acting). The repertoire of ncRNAs present in the genome of P. salmonis and its possible role in bacterial physiology and pathogenesis are unknown. Here, we predicted and analyzed the core ncRNAs of P. salmonis base on structure and correlate this prediction to RNA sequencing data. We identified a total of 69 ncRNA classes related to tRNAs, rRNA, thermoregulators, antitoxins, ribozymes, riboswitches, miRNAs and antisense-RNAs. Among these ncRNAs, 29 classes of ncRNAs are shared between all P. salmonis genomes, constituting the core ncRNAs of P. salmonis. The ncRNA core of P. salmonis could serve to develop diagnostic tools and explore the role of ncRNA in fish pathogenesis.	[Segovia, Cristopher; Santander, Javier] Mem Univ Newfoundland, Dept Ocean Sci, Marine Microbial Pathogenesis & Vaccinol Lab, Logy Bay, NF, Canada; [Segovia, Cristopher; Arias-Carrasco, Raul] Univ Mayor, PhD Program Integrat Genom, Huechuraba, Chile; [Arias-Carrasco, Raul; Maracaja-Coutinho, Vinicius] Univ Mayor, Ctr Genom & Bioinformat, Lab Integrat Bioinformat, Fac Sci, Huechuraba, Chile; [Yanez, Alejandro J.] Univ Austral Chile, Inst Bioquim & Microbiol, Fac Ciencias, Valdivia, Chile; [Maracaja-Coutinho, Vinicius] Beagle Bioinformat, Santiago, Chile	Memorial University Newfoundland; Universidad Mayor; Universidad Mayor; Universidad Austral de Chile	Santander, J (corresponding author), Mem Univ Newfoundland, Dept Ocean Sci, Marine Microbial Pathogenesis & Vaccinol Lab, Logy Bay, NF, Canada.	jsantander@mun.ca	Arias-Carrasco, Raul/GPP-3739-2022; Maracaja-Coutinho, Vinicius/R-5256-2019; Santander, Javier/AAU-9423-2020	Arias-Carrasco, Raul/0000-0003-1698-9282; Maracaja-Coutinho, Vinicius/0000-0002-8873-9381; Santander, Javier/0000-0002-7701-3147	University Mayor [COPEC-UC 2014.J0.71]; Research & Development Corporation (RDC) of Newfoundland and Labrador (R&DIgnite Project), Memorial University of Newfoundland, Canada [5404.2113.10]; CONICYT, FONDECYT-Regular competition [1140330]; Universidad Mayor, Chile; CONICYT, FONDECYT-Initiation, Universidad Mayor [11161020]; Beagle Bioinformatics	University Mayor; Research & Development Corporation (RDC) of Newfoundland and Labrador (R&DIgnite Project), Memorial University of Newfoundland, Canada; CONICYT, FONDECYT-Regular competition; Universidad Mayor, Chile; CONICYT, FONDECYT-Initiation, Universidad Mayor; Beagle Bioinformatics	This work was supported by: COPEC-UC 2014.J0.71, Iron acquisition proteins as vaccines against Piscirikettsia salmonis, University Mayor, PI: Javier Santander; Research & Development Corporation (RDC) of Newfoundland and Labrador (R&DIgnite Project #5404.2113.10), Memorial University of Newfoundland, Canada, PI: Javier Santander; CONICYT, FONDECYT-Regular competition 1140330; Universidad Mayor, Chile (PhD Fellowship for Cristopher Segovia), Universidad Mayor, PI: Javier Santander; and CONICYT, FONDECYT-Initiation, 11161020, Universidad Mayor, PI: Vinicius Maracaja-Coutinho. Beagle Bioinformatics provided support in the form of salaries for author VMC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abu-Qatouseh LF, 2010, J MOL MED, V88, P565, DOI 10.1007/s00109-010-0597-2; Almarza O, 2016, INT MICROBIOL, V19, P49, DOI 10.2436/20.1501.01.263; Almendras FE, 1997, DIS AQUAT ORGAN, V29, P137, DOI 10.3354/dao029137; [Anonymous], 2015, INF SAN SALM CENTR M; Arias-Carrasco R, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2052-2; Babski J, 2014, RNA BIOL, V11, P484, DOI 10.4161/rna.28452; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Bina JE, 2001, INFECT IMMUN, V69, P4681, DOI 10.1128/IAI.69.7.4681-4685.2001; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Bravo S., 1989, FHS AFS NEWSL, V17, P3; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Busch A, 2008, BIOINFORMATICS, V24, P2849, DOI 10.1093/bioinformatics/btn544; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; CASTRIC PA, 1977, J BACTERIOL, V130, P826, DOI 10.1128/JB.130.2.826-831.1977; Chabelskaya S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000927; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P277, DOI 10.1093/femsre/fuv025; CUI Y, 1995, J BACTERIOL, V177, P5108, DOI 10.1128/jb.177.17.5108-5115.1995; Davis BM, 2007, MOL MICROBIOL, V65, P373, DOI 10.1111/j.1365-2958.2007.05796.x; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Dogini DB, 2014, GENET MOL BIOL, V37, P285, DOI 10.1590/S1415-47572014000200014; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fortune DR, 2006, INFECT IMMUN, V74, P331, DOI 10.1128/IAI.74.1.331-339.2006; FRYER JL, 1992, INT J SYST BACTERIOL, V42, P120, DOI 10.1099/00207713-42-1-120; Fryer JL, 2003, J FISH DIS, V26, P251, DOI 10.1046/j.1365-2761.2003.00460.x; Fryer JL, 1997, EMERG INFECT DIS, V3, P137, DOI 10.3201/eid0302.970206; Furuse Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106434; Ghaz-Jahanian MA, 2013, MOL BIOTECHNOL, V55, P288, DOI 10.1007/s12033-013-9700-6; Giovannoni SJ, 2014, ISME J, V8, P1553, DOI 10.1038/ismej.2014.60; Gomez FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054934; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hershko-Shalev T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005975; Heueis N, 2014, RNA BIOL, V11, P464, DOI 10.4161/rna.28262; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Hyytiainen H, 2001, MOL PLANT MICROBE IN, V14, P931, DOI 10.1094/MPMI.2001.14.8.931; Joloba ML, 2003, FEMS MICROBIOL LETT, V228, P151, DOI 10.1016/S0378-1097(03)00754-7; Kidwell MG, 2002, GENETICA, V115, P49, DOI 10.1023/A:1016072014259; Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x; Kusters I, 2011, CELL MOL LIFE SCI, V68, P2053, DOI 10.1007/s00018-011-0681-y; Lagos F, 2017, J FISH DIS, V40, P1321, DOI 10.1111/jfd.12604; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Makrinos DL, 2017, J FISH DIS, V40, P1115, DOI 10.1111/jfd.12578; Marcos-Lopez M, 2017, J FISH DIS, V40, P1625, DOI 10.1111/jfd.12630; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Marshall S, 1998, APPL ENVIRON MICROB, V64, P3066; Marshall SH, 2012, RES MICROBIOL, V163, P557, DOI 10.1016/j.resmic.2012.08.002; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; Mentz A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-714; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nord S, 2009, J MOL BIOL, V386, P742, DOI 10.1016/j.jmb.2008.12.076; Nourdin-Galindo G, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00459; NYGAARD P, 1993, J BACTERIOL, V175, P3591, DOI 10.1128/jb.175.11.3591-3597.1993; Oliver C, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00420; Oliver C, 2016, VET MICROBIOL, V184, P94, DOI 10.1016/j.vetmic.2015.09.012; Ortega AD, 2012, RNA BIOL, V9, P469, DOI 10.4161/rna.19317; Otterlei A, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0681-0; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Palmer LD, 2013, J BIOL CHEM, V288, P30693, DOI 10.1074/jbc.M113.500280; Panwar B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-127; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Paschoal AR, 2012, RNA BIOL, V9, P274, DOI 10.4161/rna.19352; Pena-Castillo L, 2016, BIOCOMPUT-PAC SYM, P456; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Price IR, 2015, MOL CELL, V57, P1110, DOI 10.1016/j.molcel.2015.02.016; Pulgar R, 2015, J BIOTECHNOL, V212, P30, DOI 10.1016/j.jbiotec.2015.07.017; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajas V, 2009, J CELL BIOCHEM, V108, P631, DOI 10.1002/jcb.22295; Ramirez R, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu012; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Romilly C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003979; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Shao Y, 2013, EMBO J, V32, P2158, DOI 10.1038/emboj.2013.155; Sharma CM, 2011, MOL MICROBIOL, V81, P1144, DOI 10.1111/j.1365-2958.2011.07751.x; Shmaryahu A, 2014, J MICROBIOL, V52, P482, DOI 10.1007/s12275-014-3658-3; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; SMITH JM, 1986, J BIOL CHEM, V261, P632; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; STOCK A, 1988, P NATL ACAD SCI USA, V85, P1403, DOI 10.1073/pnas.85.5.1403; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Taft R, 2003, GENOME BIOL, V5, P1, DOI [10.1186/gb-2003-5-1-p1, DOI 10.1186/GB-2003-5-1-P1]; THISTED T, 1992, J MOL BIOL, V223, P41, DOI 10.1016/0022-2836(92)90714-U; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Waldminghaus T, 2009, RNA BIOL, V6, P455, DOI 10.4161/rna.6.4.9014; Wan XH, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01252-16; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wei BD, 2000, J BACTERIOL, V182, P1632, DOI 10.1128/JB.182.6.1632-1640.2000; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Yanez AJ, 2012, DIS AQUAT ORGAN, V97, P197, DOI 10.3354/dao02403; Yang HH, 1996, J BACTERIOL, V178, P1012, DOI 10.1128/jb.178.4.1012-1017.1996; Yoo W, 2016, SCI REP-UK, V6, DOI 10.1038/srep33055	106	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197206	10.1371/journal.pone.0197206	http://dx.doi.org/10.1371/journal.pone.0197206			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768466	gold, Green Published, Green Submitted			2022-12-26	WOS:000432329200067
J	Wanford, JJ; Green, LR; Aidley, J; Bayliss, CD				Wanford, Joseph J.; Green, Luke R.; Aidley, Jack; Bayliss, Christopher D.			Phasome analysis of pathogenic and commensal Neisseria species expands the known repertoire of phase variable genes, and highlights common adaptive strategies	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; OUTER-MEMBRANE PROTEIN; DNA METHYLTRANSFERASES; OPA PROTEINS; MENINGITIDIS; GONORRHOEAE; EXPRESSION; PILIN; MICROSATELLITES; GLYCOSYLATION	Pathogenic Neisseria are responsible for significantly higher levels of morbidity and mortality than their commensal relatives despite having similar genetic contents. Neisseria possess a disparate arsenal of surface determinants that facilitate host colonisation and evasion of the immune response during persistent carriage. Adaptation to rapid changes in these hostile host environments is enabled by phase variation (PV) involving high frequency, stochastic switches in expression of surface determinants. In this study, we analysed 89 complete and 79 partial genomes, from the NCBI and Neisseria PubMLST databases, representative of multiple pathogenic and commensal species of Neisseria using Phasome/t, a new program that identifies putatively phase-variable genes and homology groups by the presence of simple sequence repeats (SSR). We detected a repertoire of 884 putative PV loci with maxima of 54 and 47 per genome in gonococcal and meningococcal isolates, respectively. Most commensal species encoded a lower number of PV genes (between 5 and 30) except N. lactamica wherein the potential for PV (36-82 loci) was higher, implying that PV is an adaptive mechanism for persistence in this species. We also characterised the repeat types and numbers in both pathogenic and commensal species. Conservation of SSR-mediated PV was frequently observed in outer membrane proteins or modifiers of outer membrane determinants. Intermittent and weak selection for evolution of SSR-mediated PV was suggested by poor conservation of tracts with novel PV genes often occurring in only one isolate. Finally, we describe core phasomes-the conserved repertoires of phase-variable genes-for each species that identify overlapping but distinctive adaptive strategies for the pathogenic and commensal members of the Neisseria genus.	[Wanford, Joseph J.; Green, Luke R.; Aidley, Jack; Bayliss, Christopher D.] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England	University of Leicester	Wanford, JJ (corresponding author), Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England.	jjw40@le.ac.uk		Wanford, Joe/0000-0002-8099-8696; Bayliss, Christopher/0000-0002-5564-2145	Medical Research Council [MR/M020193/1]; Biotechnology and Biological Sciences Research Council [BB1193044]; MRC IMPACT PhD studentship scheme; MRC [1853003, MR/M020193/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC IMPACT PhD studentship scheme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are thankful for funding from the Medical Research Council (grant MR/M020193/1) awarded to Christopher Bayliss, the Biotechnology and Biological Sciences Research Council (grant BB1193044) for funding Jack Aidley. The authors would like to acknowledge the MRC IMPACT PhD studentship scheme for funding JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk-Poplawska M, 2011, J BACTERIOL, V193, P6750, DOI 10.1128/JB.05672-11; Alamro M, 2014, INFECT IMMUN, V82, P2472, DOI 10.1128/IAI.01521-14; Banerjee A, 2003, MOL CELL BIOCHEM, V253, P179, DOI 10.1023/A:1026058311857; Bayliss CD, 2008, INFECT IMMUN, V76, P5038, DOI 10.1128/IAI.00395-08; Bayliss CD, 2009, FEMS MICROBIOL REV, V33, P504, DOI 10.1111/j.1574-6976.2009.00162.x; Bennett JS, 2005, INFECT IMMUN, V73, P2424, DOI 10.1128/IAI.73.4.2424-2432.2005; Bidmos FA, 2014, PATHOGENS, V3, P164, DOI 10.3390/pathogens3010164; Bidmos FA, 2011, J CLIN MICROBIOL, V49, P506, DOI 10.1128/JCM.01322-10; Carson SDB, 2000, MOL MICROBIOL, V36, P585, DOI 10.1046/j.1365-2958.2000.01873.x; Chung GT, 2008, J BACTERIOL, V190, P6035, DOI 10.1128/JB.00566-08; Cohn MT, 2007, APPL ENVIRON MICROB, V73, P7803, DOI 10.1128/AEM.00698-07; De Bolle X, 2000, MOL MICROBIOL, V35, P211, DOI 10.1046/j.1365-2958.2000.01701.x; DENNING DW, 1991, REV INFECT DIS, V13, P216; Eckert KA, 2000, NUCLEIC ACIDS RES, V28, P2831, DOI 10.1093/nar/28.14.2831; Giufre M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-83; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; Hallet B, 2001, CURR OPIN MICROBIOL, V4, P570, DOI 10.1016/S1369-5274(00)00253-8; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; Jordan P, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-23; Jordan PW, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-21; Klughammer J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169892; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Le Bars H, 2013, FEMS MICROBIOL LETT, V338, P101, DOI 10.1111/1574-6968.12039; Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x; Lewis LA, 1999, MOL MICROBIOL, V32, P977, DOI 10.1046/j.1365-2958.1999.01409.x; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lucidarme J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076932; MAKINO S, 1991, EMBO J, V10, P1307, DOI 10.1002/j.1460-2075.1991.tb07649.x; Marceau M, 1998, MOL MICROBIOL, V27, P705, DOI 10.1046/j.1365-2958.1998.00706.x; Marri PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011835; Martin P, 2004, MICROBIOL-SGM, V150, P3001, DOI 10.1099/mic.0.27182-0; Metruccio MME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000710; Minogue TD, 2014, GENOME ANNOUNC, V2; Oldfield NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069746; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Richardson AR, 2002, P NATL ACAD SCI USA, V99, P6103, DOI 10.1073/pnas.092568699; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; Richardson AR, 1999, J BACTERIOL, V181, P2067, DOI 10.1128/JB.181.7.2067-2074.1999; Sadarangani M, 2011, FEMS MICROBIOL REV, V35, P498, DOI 10.1111/j.1574-6976.2010.00260.x; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; Seib KL, 2015, NUCLEIC ACIDS RES, V43, P4150, DOI 10.1093/nar/gkv219; Siena E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3185-1; Sintsova A, 2015, INFECT IMMUN, V83, P1372, DOI 10.1128/IAI.03123-14; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; Sprong T, 2001, J LEUKOCYTE BIOL, V70, P283; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; STEPHENS DS, 1981, J INFECT DIS, V143, P525, DOI 10.1093/infdis/143.4.525; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Tan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21015; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Toleman M, 2001, CELL MICROBIOL, V3, P33, DOI 10.1046/j.1462-5822.2001.00089.x; Tzeng YL, 2002, J BACTERIOL, V184, P2379, DOI 10.1128/JB.184.9.2379-2388.2002; VANPUTTEN JPM, 1993, EMBO J, V12, P4043, DOI 10.1002/j.1460-2075.1993.tb06088.x; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Watkins ER, 2014, SCI REP-UK, V4, DOI 10.1038/srep06554; WONG JD, 1992, J CLIN MICROBIOL, V30, P719, DOI 10.1128/JCM.30.3.719-720.1992; Zelewska MA, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000078; Zhou K, 2012, PLOS ONE, V7	67	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196675	10.1371/journal.pone.0196675	http://dx.doi.org/10.1371/journal.pone.0196675			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763438	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800015
J	O'Neill, TA; White, J; Delaloye, N; Gilfoyle, E				O'Neill, Thomas A.; White, Jesse; Delaloye, Nicole; Gilfoyle, Elaine			A taxonomy and rating system to measure situation awareness in resuscitation teams	PLOS ONE			English	Article							EMERGENCY CARDIOVASCULAR CARE; ASSOCIATION GUIDELINES UPDATE; CRISIS-RESOURCE-MANAGEMENT; OF-THE-LITERATURE; CARDIOPULMONARY-RESUSCITATION; NONTECHNICAL SKILLS; ASSESSMENT-TOOL; HEALTH-CARE; TEAMWORK; PERFORMANCE	Team SA involves a common perspective between two or more individuals regarding current environmental events, their meaning, and projected future status. Team SA has been theorized to be important for resuscitation team effectiveness. Accordingly, multidimensional frameworks of observable behaviors relevant to resuscitation teams are needed to understand more deeply the nature of team SA, its implications for team effectiveness, and whether it can be trained. A seven-dimension team resuscitation SA framework was developed following a literature review and consensus process using a modified Delphi approach with a group of content experts. We applied a pre-post design within a day-long team training program involving four video-recorded simulated resuscitation events and 42 teams across Canada. The first and fourth events represented "pre" and "post" training events, respectively. Teams were scored on SA five times within each 15-minute event. Distractions were introduced to investigate whether SA scores would be affected. The current study provides initial construct validity evidence for a new measure of SA and explicates SA's role in resuscitation teams.	[O'Neill, Thomas A.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [White, Jesse] Univ Toronto, Fac Law, Toronto, ON, Canada; [Delaloye, Nicole; Gilfoyle, Elaine] Univ Calgary, Dept Pediat, Calgary, AB, Canada	University of Calgary; University of Toronto; University of Calgary	O'Neill, TA (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.	toneill@ucalgary.ca		O'Neill, Thomas/0000-0002-8336-5763	 [PG-10-0482];  [OMF-110353]	; 	Two external research grants awarded to the last author supported this research: Grant # PG-10-0482 (http://www.heartandstroke.ca/) and Grant # OMF-110353 (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the funders had no role in contracting individuals in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt M.G., 2007, IND ORG PSYCHOL APPL; [Anonymous], 1998, HEALTH TECHNOL ASSES, DOI DOI 10.1186/s12888-014-0241-8; Baker D., 2003, MED TEAMWORK PATIENT; Bell HH, 2000, SITUATION AWARENESS ANALYSIS AND MEASUREMENT, P129; Bhanji F, 2015, CIRCULATION, V132, pS561, DOI 10.1161/CIR.0000000000000268; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Cooper S, 2014, OPEN ACCESS EMERG M, V6, P1, DOI 10.2147/OAEM.S53679; Cooper S, 2010, RESUSCITATION, V81, P446, DOI 10.1016/j.resuscitation.2009.11.027; Crozier MS, 2015, J SURG EDUC, V72, P156, DOI 10.1016/j.jsurg.2014.07.009; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; Durso F.T., 1995, EXPT ANAL MEASUREMEN, P295; Durso FT, 2008, HUM FACTORS, V50, P442, DOI 10.1518/001872008X288448; Endsley M.R., 2000, SITUATION AWARENESS; Endsley M.R., 2012, DESIGNING SITUATION, V2; ENDSLEY MR, 1995, HUM FACTORS, V37, P65, DOI 10.1518/001872095779049499; Endsley MR, 2001, NEW TRENDS COOPERATI, P47; Endsley MR., 2012, P NAT AER EL C 1988; Eppich WJ, 2008, CURR OPIN PEDIATR, V20, P255, DOI 10.1097/MOP.0b013e3282ffb3f3; Fernandez R, 2008, ACAD EMERG MED, V15, P1025, DOI 10.1111/j.1553-2712.2008.00232.x; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Fletcher G, 2003, BRIT J ANAESTH, V90, P580, DOI 10.1093/bja/aeg112; Flin R, 2004, QUAL SAF HEALTH CARE, V13, pI80, DOI 10.1136/qshc.2004.009993; Gaba DM, 1994, CRISIS MANAGEMENT AN; Gartenberg D, 2014, HUM FACTORS, V56, P710, DOI 10.1177/0018720813506223; Gilfoyle E, 2010, THESIS; Gilfoyle E, 2017, PEDIATR CRIT CARE ME, V18, pE62, DOI 10.1097/PCC.0000000000001025; Goldstein IL, 1993, PERSONNEL SELECTION, P3; Guise JM, 2008, SIMUL HEALTHC, V3, P217, DOI 10.1097/SIH.0b013e31816fdd0a; Hackman J.R., 1987, HDB ORG BEHAV, P315; Hansel M, 2012, MINERVA ANESTESIOL, V78, P901; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; JACKSON DN, 1971, PSYCHOL REV, V78, P229, DOI 10.1037/h0030852; Jones DG, 1996, AVIAT SPACE ENVIR MD, V67, P507; Kaber DB, 2005, P 11 INT C HCI 2005; Kim J, 2006, CRIT CARE MED, V34, P2167, DOI 10.1097/01.CCM.0000229877.45125.CC; King HB., 2008, ADV PATIENT SAFETY N, V3, P5; Lampton D. R., 2006, USE IMMERSIVE VIRTUA; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Manser T, 2009, ACTA ANAESTH SCAND, V53, P143, DOI 10.1111/j.1399-6576.2008.01717.x; Matthews M. D., 2000, P HUM PERF SIT AW AU; Messick S., 1995, ED MEASUREMENT ISSUE, V14, P5, DOI [10.1111/j.17453992.1995.tb00881.x, DOI 10.1111/J.1745-3992.1995.TB00881.X]; Muniz E, 1998, P S COLL CREW PERF C; Murray WB, 2000, J CLIN ANESTH, V12, P633, DOI 10.1016/S0952-8180(00)00223-3; Nemeth C. P., 2008, IMPROVING HEALTHCARE; Nunnally J, 1978, PSYCHOMETRIC METHODS; Rall M, 2009, MILLERS ANESTHESIA, P106; Reid J, 2012, RESUSCITATION, V83, P879, DOI 10.1016/j.resuscitation.2011.12.012; Rosen MA, 2008, ACAD EMERG MED, V15, P1190, DOI 10.1111/j.1553-2712.2008.00180.x; SALAS E, 1995, HUM FACTORS, V37, P123, DOI 10.1518/001872095779049525; Salas E, 2008, ACAD EMERG MED, V15, P1002, DOI 10.1111/j.1553-2712.2008.00254.x; Sarter NB, 1991, INT J AVIAT PSYCHOL, V1, P45, DOI DOI 10.1207/S15327108IJAP0101_4; Schulz CM, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0172-7; Schulz CM, 2013, ANESTHESIOLOGY, V118, P729, DOI 10.1097/ALN.0b013e318280a40f; Singh H, 2012, BMJ QUAL SAF, V21, P30, DOI 10.1136/bmjqs-2011-000310; Wallin CJ, 2007, MED EDUC, V41, P173, DOI 10.1111/j.1365-2929.2006.02670.x; Weinstock P, 2008, PEDIATR CLIN N AM, V55, P1011, DOI 10.1016/j.pcl.2008.04.001; Wright M.C., IMPROVING HEALTHCARE, P97; Wright MC, 2004, QUAL SAF HEALTH CARE, V13, pI65, DOI 10.1136/qshc.2004.009951; Yule S, 2006, SURGERY, V139, P140, DOI 10.1016/j.surg.2005.06.017	59	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196825	10.1371/journal.pone.0196825	http://dx.doi.org/10.1371/journal.pone.0196825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF6MZ	29758042	Green Submitted, Green Published, gold			2022-12-26	WOS:000432082900015
J	Gabbasov, R; Xiao, F; Howe, CG; Bickel, LE; O'Brien, SW; Benrubi, D; Do, TV; Zhou, Y; Nicolas, E; Cai, KQ; Litwin, S; Seo, S; Golemis, EA; Connolly, DC				Gabbasov, Rashid; Xiao, Fang; Howe, Caitlin G.; Bickel, Laura E.; O'Brien, Shane W.; Benrubi, Daniel; Do, Thuy-Vy; Zhou, Yan; Nicolas, Emmanuelle; Cai, Kathy Q.; Litwin, Samuel; Seo, Sachiko; Golemis, Erica A.; Connolly, Denise C.			NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice	ONCOGENE			English	Article							SUBSTRATE LYMPHOCYTE TYPE; EPITHELIAL-CELL; FALLOPIAN-TUBE; T-CELLS; EXPRESSION; CARCINOMA; KINASE; DIFFERENTIATION; MIGRATION; SURVIVAL	Neural precursor cell expressed, developmentally downregulated 9 (NEDD9) supports oncogenic signaling in a number of solid and hematologic tumors. Little is known about the role of NEDD9 in ovarian carcinoma (OC), but available data suggest elevated mRNA and protein expression in advanced stage high-grade cancers. We used a transgenic MISIIR-TAg mouse OC model combined with genetic ablation of Nedd9 to investigate its action in the development and progression of OC. A Nedd9(-/-)genotype delayed tumor growth rate, reduced incidence of ascites, and reduced expression and activation of signaling proteins including SRC, STAT3, E-cadherin, and AURKA. Cell lines established from MISIIR-TAg; Nedd9(-/-) and MISIIR-TAg; Nedd9(+/+) mice exhibited altered migration and invasion. Growth of these cells in a syngeneic allograft model indicated that systemic Nedd9 loss in the microenvironment had little impact on tumor allograft growth, but in a Nedd9 wildtype background Nedd9(-/-) allografts exhibited significantly reduced growth, dissemination, and oncogenic signaling compared to Nedd9(+/+) allografts. Gene expression analysis revealed that Nedd9(+/+) tumors exhibited more mesenchymal "stem-like" transcriptional program, including increased expression of Aldh1a1 and Aldh1a2. Conversely, loss of Nedd9 resulted in increased expression of differentiation genes, including fallopian tube markers Foxj1, Ovgp1, and Pax8. Collectively, these data suggest that tumor cell-intrinsic Nedd9 expression promotes OC development and progression by broad induction of oncogenic protein signaling and stem/mesenchymal gene expression.	[Gabbasov, Rashid; Xiao, Fang; Howe, Caitlin G.; Bickel, Laura E.; O'Brien, Shane W.; Do, Thuy-Vy; Golemis, Erica A.; Connolly, Denise C.] Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Gabbasov, Rashid] Kazan Fed Univ, Dept Biochem & Biotechnol, Kazan, Russia; [Benrubi, Daniel] Fox Chase Canc Ctr, Div Gynecol Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Zhou, Yan; Litwin, Samuel] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Nicolas, Emmanuelle] Fox Chase Canc Ctr, Genom Facil, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Cai, Kathy Q.] Fox Chase Canc Ctr, Histopathol Facil, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Seo, Sachiko] Natl Canc Res Ctr East, Dept Hematol & Oncol, Kashiwa, Chiba, Japan	Fox Chase Cancer Center; Kazan Federal University; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center	Connolly, DC (corresponding author), Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Denise.Connolly@fccc.edu	Gabbasov, Rashid/D-2482-2019; Howe, Caitlin/ABF-3709-2020	Gabbasov, Rashid/0000-0001-7621-7407; Howe, Caitlin/0000-0002-4935-9298; Golemis, Erica/0000-0003-3618-3673	Ovarian SPORE [P50 CA083638]; FCCC Core Grant [NCI P30 CA006927];  [R01 CA136596];  [R01 CA63366]; NATIONAL CANCER INSTITUTE [R01CA063366, R01CA136596, P50CA083638, P30CA006927] Funding Source: NIH RePORTER	Ovarian SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FCCC Core Grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01 CA136596 (to DCC); R01 CA63366 (to EAG); Ovarian SPORE P50 CA083638, the FCCC Core Grant NCI P30 CA006927, and charitable donations from the Roberta Dubrow Fund, the Teal Tea Foundation, and the Bucks County Board of Associates (to DCC).	Beck TN, 2014, PHYSIOL GENOMICS, V46, P699, DOI 10.1152/physiolgenomics.00062.2014; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bowen NJ, 2007, GYNECOL ONCOL, V104, P331, DOI 10.1016/j.ygyno.2006.08.052; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Colvin EK, 2014, SEMIN CELL DEV BIOL, V27, P61, DOI 10.1016/j.semcdb.2014.02.004; Connolly DC, 2003, CANCER RES, V63, P1389; Connolly DC, 2009, CURR PROTOC PHARM; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Do TV, 2014, ONCOGENE, V33, P539, DOI 10.1038/onc.2012.632; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Fuller ES, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00057; Gritsina G, 2015, MOL CANCER THER, V14, P1035, DOI 10.1158/1535-7163.MCT-14-0800; Hensley H, 2007, CANCER BIOL THER, V6, P1717, DOI 10.4161/cbt.6.11.4830; Ice RJ, 2013, CANCER RES, V73, P3168, DOI 10.1158/0008-5472.CAN-12-4008; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Little JL, 2014, ONCOGENE, V33, P411, DOI 10.1038/onc.2012.607; Liu HQ, 2013, CLIN CANCER RES, V19, P5053, DOI 10.1158/1078-0432.CCR-13-1115; Ma Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-85; McPherson A, 2016, NAT GENET, V48, P758, DOI 10.1038/ng.3573; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Natraj U, 2002, BIOL REPROD, V67, P1897, DOI 10.1095/biolreprod67.6.1897; Nikonova AS, 2014, IUBMB LIFE, V66, P387, DOI 10.1002/iub.1282; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Paik DY, 2012, STEM CELLS, V30, P2487, DOI 10.1002/stem.1207; Perets R, 2016, CANCER RES, V76, P10, DOI 10.1158/0008-5472.CAN-15-1382; Quinn BA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-24; Ratushny V, 2012, ONCOGENE, V31, P1217, DOI 10.1038/onc.2011.314; Schwede M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057799; Seo S, 2005, J IMMUNOL, V175, P3492, DOI 10.4049/jimmunol.175.6.3492; Seo S, 2011, CANCER SCI, V102, P2109, DOI 10.1111/j.1349-7006.2011.02066.x; Shagisultanova E, 2015, GENE, V567, P1, DOI 10.1016/j.gene.2015.04.086; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Singh MK, 2010, CANCER RES, V70, P8907, DOI 10.1158/0008-5472.CAN-10-0353; Siu MKY, 2013, ONCOGENE, V32, P3500, DOI 10.1038/onc.2012.363; Sivertsen S, 2006, ACTA CYTOL, V50, P603, DOI 10.1159/000326027; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Wang HX, 2014, HUM PATHOL, V45, P401, DOI 10.1016/j.humpath.2013.10.005; Wang Z, 2016, ONCOTARGET, V8, P1714; Ward KK, 2013, CLIN EXP METASTAS, V30, P579, DOI 10.1007/s10585-012-9562-5; Wiener JR, 2003, GYNECOL ONCOL, V88, P73, DOI 10.1006/gyno.2002.6851; Wu R, 2016, J PATHOL, V240, P341, DOI 10.1002/path.4783; Xu S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05646; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035058	56	15	16	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 30	2018	37	35					4854	4870		10.1038/s41388-018-0296-y	http://dx.doi.org/10.1038/s41388-018-0296-y			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS0BA	29773902	Green Accepted			2022-12-26	WOS:000443146000007
J	Sharma, S; Arunachalam, PS; Menon, M; Ragupathy, V; Satya, RV; Jebaraj, J; Aralaguppe, SG; Rao, C; Pal, S; Saravanan, S; Murugavel, KG; Balakrishnan, P; Solomon, S; Hewlett, I; Ranga, U				Sharma, Shilpee; Arunachalam, Prabhu S.; Menon, Malini; Ragupathy, Viswanath; Satya, Ravi Vijaya; Jebaraj, Joshua; Aralaguppe, Shambhu Ganeshappa; Rao, Chaitra; Pal, Sreshtha; Saravanan, Shanmugam; Murugavel, Kailapuri G.; Balakrishnan, Pachamuthu; Solomon, Suniti; Hewlett, Indira; Ranga, Udaykumar			PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); infectious disease; viral DNA; viral protein; viral replication; Gag; HIV-1C; NGS; PTAP duplication; Replication advantage	IMMUNODEFICIENCY-VIRUS TYPE-1; LONG TERMINAL REPEAT; PRIMER-BINDING SITE; LATE DOMAIN; DRUG-NAIVE; IN-VIVO; ANTIRETROVIRAL THERAPY; VIRAL PARTICLES; SOUTH-AFRICA; SEQUENCE	HIV-1 subtype C (HIV-1C) may duplicate longer amino acid stretches in the p6 Gag protein, leading to the creation of an additional Pro-Thr/Ser-Ala-Pro (PTAP) motif necessary for viral packaging. However, the biological significance of a duplication of the PTAP motif for HIV-1 replication and pathogenesis has not been experimentally validated. In a longitudinal study of two different clinical cohorts of select HIV-1 seropositive, drug-naive individuals from India, we found that 8 of 50 of these individuals harbored a mixed infection of viral strains discordant for the PTAP duplication. Conventional and next-generation sequencing of six primary viral quasispecies at multiple time points disclosed that in a mixed infection, the viral strains containing the PTAP duplication dominated the infection. The dominance of the double-PTAP viral strains over a genetically similar single-PTAP viral clone was confirmed in viral proliferation and pairwise competition assays. Of note, in the proximity ligation assay, double-PTAP Gag proteins exhibited a significantly enhanced interaction with the host protein tumor susceptibility gene 101 (Tsg101). Moreover, Tsg101 overexpression resulted in a biphasic effect on HIV-1C proliferation, an enhanced effect at low concentration and an inhibitory effect only at higher concentrations, unlike a uniformly inhibitory effect on subtype B strains. In summary, our results indicate that the duplication of the PTAP motif in the p6 Gag protein enhances the replication fitness of HIV-1C by engaging the Tsg101 host protein with a higher affinity. Our results have implications for HIV-1 pathogenesis, especially of HIV-1C.	[Sharma, Shilpee; Arunachalam, Prabhu S.; Menon, Malini; Jebaraj, Joshua; Aralaguppe, Shambhu Ganeshappa; Rao, Chaitra; Pal, Sreshtha; Ranga, Udaykumar] Jawaharlal Nehru Ctr Adv Sci Res, HIV AIDS Lab, Bengaluru 56006, India; [Ragupathy, Viswanath; Hewlett, Indira] US FDA, Off Blood Review & Res, Ctr Biol Evaluat & Res, Div Emerging & Transmission Transmitted Dis,Lab M, Silver Spring, MD 20993 USA; [Satya, Ravi Vijaya] GRAIL Inc, Menlo Pk, CA 94025 USA; [Saravanan, Shanmugam; Murugavel, Kailapuri G.; Balakrishnan, Pachamuthu; Solomon, Suniti] Y R Gaitonde Ctr AIDS Res & Educ, Chennai 600113, Tamil Nadu, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); US Food & Drug Administration (FDA)	Ranga, U (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, HIV AIDS Lab, Bengaluru 56006, India.	udaykumar@jncasr.ac.in	Saravanan, Shanmugam/GOG-9024-2022; Sharma, Shilpee/AAA-8379-2022; Aralaguppe, Shambhu/AAU-4474-2020; Ragupathy, Viswanath/ABA-3444-2021; Balakrishnan, Pachamuthu/ABV-6282-2022	Saravanan, Shanmugam/0000-0002-5991-8022; Balakrishnan, Pachamuthu/0000-0002-1710-9155; Sharma, Shilpee/0000-0003-4645-9442; Rao, Chaitra/0000-0002-2834-7458	Department of Science and Technology, Government of India [DST/INT/SAFR/MEGA-P(5)/2011]; Jawaharlal Nehru Centre for Advanced Scientific Research	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India))	This work was supported in part by Grant DST/INT/SAFR/MEGA-P(5)/2011 from Department of Science and Technology, Government of India (to U.R.), and intramural funds from Jawaharlal Nehru Centre for Advanced Scientific Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and the Food and Drug Administration (FDA).	Abraha Awet, 2005, Methods Mol Biol, V304, P355; Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Bachu M, 2012, J BIOL CHEM, V287, P44714, DOI 10.1074/jbc.M112.397158; Bachu M, 2012, AIDS RES HUM RETROV, V28, P1362, DOI 10.1089/aid.2011.0388; Bano AS, 2009, J GEN VIROL, V90, P2768, DOI 10.1099/vir.0.011080-0; Bell NM, 2013, TRENDS MICROBIOL, V21, P136, DOI 10.1016/j.tim.2012.11.006; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bilodeau PS, 1999, J VIROL, V73, P9764, DOI 10.1128/JVI.73.12.9764-9772.1999; Boullosa J, 2014, VIRUSES-BASEL, V6, P2495, DOI 10.3390/v6062495; Brumme ZL, 2003, ANTIVIR THER, V8, P91; Cao J, 2008, J VIROL, V82, P495, DOI 10.1128/JVI.01096-07; Chang SY, 1999, AIDS RES HUM RETROV, V15, P1591, DOI 10.1089/088922299309892; Chang SY, 1999, AIDS RES HUM RETROV, V15, P1703, DOI 10.1089/088922299309748; CHECROUNE F, 1995, J ACQ IMMUN DEF SYND, V10, P1; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chopera DR, 2012, J VIROL, V86, P13423, DOI 10.1128/JVI.02171-12; Colgrove RC, 2005, AIDS RES HUM RETROV, V21, P191, DOI 10.1089/aid.2005.21.191; de Arellano ER, 2006, AIDS REV, V8, P9; De Baar MP, 2000, AIDS RES HUM RETROV, V16, P499; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Dettenhofer M, 1999, J VIROL, V73, P4696, DOI 10.1128/JVI.73.6.4696-4704.1999; Flys T, 2005, AIDS RES HUM RETROV, V21, P739, DOI 10.1089/aid.2005.21.739; Fun A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-63; Gallego O, 2003, HIV CLIN TRIALS, V4, P372, DOI 10.1310/X618-KWKJ-WCTQ-LQ2L; Gallego O, 2003, J CLIN MICROBIOL, V41, P1245, DOI 10.1128/JCM.41.3.1245-1247.2003; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Ghanam RH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00055; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Guimaraes AP, 2008, AIDS RES HUM RETROV, V24, P967, DOI 10.1089/aid.2008.0020; Hahn S, 2011, J IMMUNOL, V186, P5706, DOI 10.4049/jimmunol.1003764; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Holguin A, 2005, AIDS RES HUM RETROV, V21, P886, DOI 10.1089/aid.2005.21.886; Ibe S, 2003, MICROBIOL IMMUNOL, V47, P71, DOI 10.1111/j.1348-0421.2003.tb02788.x; Josephs TM, 2017, BIOL CHEM, V398, P1027, DOI 10.1515/hsz-2016-0305; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Lastere S, 2004, ANTIVIR THER, V9, P221; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Marlowe N, 2004, AIDS RES HUM RETROV, V20, P1119, DOI 10.1089/aid.2004.20.1119; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martins AN, 2016, J VIROL, V90, P768, DOI 10.1128/JVI.01640-15; Martins AN, 2011, AIDS RES HUM RETROV, V27, P687, DOI [10.1089/AID.2010.0282, 10.1089/aid.2010.0282]; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Mishra M, 2008, ANN NEUROL, V63, P366, DOI 10.1002/ana.21292; Neogi U, 2016, AIDS RES HUM RETROV, V32, P80, DOI [10.1089/aid.2015.0266, 10.1089/AID.2015.0266]; Neogi U, 2011, AIDS RES HUM RETROV, V27, P1249, DOI [10.1089/aid.2011.0078, 10.1089/AID.2011.0078]; Neogi U, 2009, INDIAN J EXP BIOL, V47, P424; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Ntale RS, 2012, J VIROL, V86, P12013, DOI 10.1128/JVI.00539-12; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Peters S, 2001, J VIROL, V75, P9644, DOI 10.1128/JVI.75.20.9644-9653.2001; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Prescher J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004677; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; Resh MD, 2005, AIDS REV, V7, P84; Rossi AH, 2013, AIDS RES HUM RETROV, V29, P1056, DOI [10.1089/aid.2012.0311, 10.1089/AID.2012.0311]; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sharma S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2184-4; Siddappa NB, 2005, AIDS, V19, P1426, DOI 10.1097/01.aids.0000180795.49016.89; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Simon V, 2003, NAT REV MICROBIOL, V1, P181, DOI 10.1038/nrmicro772; Song YH, 2007, ARCH VIROL, V152, P1553, DOI 10.1007/s00705-007-0973-6; Sood V, 2008, AIDS, V22, P1683, DOI 10.1097/QAD.0b013e3282f56114; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Swanstrom R., 1997, P263; Tamiya S, 2004, J VIROL, V78, P12030, DOI 10.1128/JVI.78.21.12030-12040.2004; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	81	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11687	11708		10.1074/jbc.M117.815829	http://dx.doi.org/10.1074/jbc.M117.815829			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29773649	Green Published, hybrid			2022-12-26	WOS:000440134500004
J	Klychnikov, OI; Shamorkina, TM; Weeks, SD; van Leeuwen, HC; Corver, J; Drijfhout, JW; van Veelen, PA; Sluchanko, NN; Strelkov, SV; Hensbergen, PJ				Klychnikov, Oleg I.; Shamorkina, Tatiana M.; Weeks, Stephen D.; van Leeuwen, Hans C.; Corver, Jeroen; Drijfhout, Jan W.; van Veelen, Peter A.; Sluchanko, Nikolai N.; Strelkov, Sergei V.; Hensbergen, Paul J.			Discovery of a new Pro-Pro endopeptidase, PPEP-2, provides mechanistic insights into the differences in substrate specificity within the PPEP family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOSTRIDIUM-DIFFICILE; STRUCTURAL BASIS; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; PROTEASES; SORTASE; IDENTIFICATION; ENDOPROTEASE; DEGRADATION; PEPTIDES	Pro-Pro endopeptidases (PPEPs) belong to a recently discovered family of proteases capable of hydrolyzing a Pro-Pro bond. The first member from the bacterial pathogen Clostridium difficile (PPEP-1) cleaves two C. difficile cell-surface proteins involved in adhesion, one of which is encoded by the gene adjacent to the ppep-1 gene. However, related PPEPs may exist in other bacteria and may shed light on substrate specificity in this enzyme family. Here, we report on the homolog of PPEP-1 in Paenibacillus alvei, which we denoted PPEP-2. We found that PPEP-2 is a secreted metalloprotease, which likewise cleaved a cell-surface protein encoded by an adjacent gene. However, the cleavage motif of PPEP-2, PLPPVP, is distinct from that of PPEP-1 (VNPPVP). As a result, an optimal substrate peptide for PPEP-2 was not cleaved by PPEP-1 and vice versa. To gain insight into the specificity mechanism of PPEP-2, we determined its crystal structure at 1.75 resolution and further confirmed the structure in solution using small-angle X-ray scattering (SAXS). We show that a four-amino-acid loop, which is distinct in PPEP-1 and -2 (GGST in PPEP-1 and SERV in PPEP-2), plays a crucial role in substrate specificity. A PPEP-2 variant, in which the four loop residues had been swapped for those from PPEP-1, displayed a shift in substrate specificity toward PPEP-1 substrates. Our results provide detailed insights into the PPEP-2 structure and the structural determinants of substrate specificity in this new family of PPEP proteases.	[Klychnikov, Oleg I.; Weeks, Stephen D.; Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, B-3000 Leuven, Belgium; [Shamorkina, Tatiana M.; van Veelen, Peter A.; Hensbergen, Paul J.] Leiden Univ, Med Ctr, Ctr Prote & Metabol, POB 9600, NL-2300 RC Leiden, Netherlands; [van Leeuwen, Hans C.; Corver, Jeroen] Leiden Univ, Med Ctr, Dept Med Microbiol, NL-2300 Leiden, Netherlands; [Drijfhout, Jan W.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 Leiden, Netherlands; [Sluchanko, Nikolai N.] Russian Acad Sci, Fed Res Ctr Biotechnol, AN Bach Inst Biochem, Moscow 119071, Russia; [Sluchanko, Nikolai N.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Biophys, Moscow 119991, Russia	KU Leuven; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Hensbergen, PJ (corresponding author), Leiden Univ, Med Ctr, Ctr Prote & Metabol, POB 9600, NL-2300 RC Leiden, Netherlands.	P.Hensbergen@lumc.nl	Klychnikov, Oleg I./AAN-6167-2020; Weeks, Stephen/N-4813-2019; Sluchanko, Nikolai/R-4110-2016; Weeks, Stephen D/G-6150-2017; Drijfhout, Jan Wouter/ABA-6318-2021	Klychnikov, Oleg I./0000-0002-0383-9237; Weeks, Stephen/0000-0002-1360-0852; Sluchanko, Nikolai/0000-0002-8608-1416; Weeks, Stephen D/0000-0002-1360-0852; Drijfhout, Jan Wouter/0000-0003-4808-5296; Shamorkina, Tatiana/0000-0002-4191-6061; Corver, Jeroen/0000-0002-9262-5475; Hensbergen, Paul/0000-0002-3193-5445; van Veelen, Peter/0000-0002-7898-9408	Department of Pharmaceutical and Pharmacological Sciences of KU Leuven	Department of Pharmaceutical and Pharmacological Sciences of KU Leuven	This work was supported in part by funds from the Department of Pharmaceutical and Pharmacological Sciences of KU Leuven. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balog CIA, 2010, MOL CELL PROTEOMICS, V9, P667, DOI 10.1074/mcp.M900537-MCP200; Banerjee G, 2017, BIOTECHNOL GENET ENG, V33, P119, DOI 10.1080/02648725.2017.1408256; Bondt A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27955; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Chen AGY, 2011, RNA, V17, P1967, DOI 10.1261/rna.2757311; Corver J, 2017, MOL MICROBIOL, V105, P663, DOI 10.1111/mmi.13736; Cunningham DF, 1997, BBA-PROTEIN STRUCT M, V1343, P160, DOI 10.1016/S0167-4838(97)00134-9; Donahue EH, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0219-1; Aguilar JGD, 2018, FOOD RES INT, V103, P253, DOI 10.1016/j.foodres.2017.10.044; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fagan RP, 2014, NAT REV MICROBIOL, V12, P211, DOI 10.1038/nrmicro3213; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Friebe S, 2016, TOXINS, V8, DOI 10.3390/toxins8030069; Grady EN, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0603-7; Grams F, 1996, NAT STRUCT BIOL, V3, P671, DOI 10.1038/nsb0896-671; Heirbaut M, 2016, ARCH BIOCHEM BIOPHYS, V610, P41, DOI 10.1016/j.abb.2016.10.002; Hensbergen PJ, 2015, FEBS LETT, V589, P3952, DOI 10.1016/j.febslet.2015.10.027; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Hiemstra HS, 1997, P NATL ACAD SCI USA, V94, P10313, DOI 10.1073/pnas.94.19.10313; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Janesch B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076566; Kasana RC, 2011, CRIT REV MICROBIOL, V37, P262, DOI 10.3109/1040841X.2011.577029; Kern J, 2011, J BIOL CHEM, V286, P26042, DOI 10.1074/jbc.M111.248070; Kirk JA, 2017, MICROB BIOTECHNOL, V10, P76, DOI 10.1111/1751-7915.12372; Klein T, 2018, CHEM REV, V118, P261, DOI 10.1021/acs.chemrev.7b00120; Krishnan V, 2013, ACTA CRYSTALLOGR D, V69, P1073, DOI 10.1107/S0907444913004642; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Marshall NC, 2017, MOL CELL PROTEOMICS, V16, pS161, DOI 10.1074/mcp.O116.066456; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Peltier J, 2015, J BIOL CHEM, V290, P24453, DOI 10.1074/jbc.M115.665091; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rey M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30980; Rubino JT, 2016, J BIOL INORG CHEM, V21, P185, DOI 10.1007/s00775-015-1319-6; Schacherl M, 2015, STRUCTURE, V23, P1632, DOI 10.1016/j.str.2015.06.018; Schradert CU, 2017, MOL CELL PROTEOMICS, V16, P1162, DOI 10.1074/mcp.M116.066803; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Springer TA, 2006, STRUCTURE, V14, P1611, DOI 10.1016/j.str.2006.10.001; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tack GJ, 2013, WORLD J GASTROENTERO, V19, P5837, DOI 10.3748/wjg.v19.i35.5837; Talamantes D, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0538-6; Tonry JH, 2012, CELL MICROBIOL, V14, P1219, DOI 10.1111/j.1462-5822.2012.01791.x; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; van Leeuwen HC, 2014, FEBS LETT, V588, P4325, DOI 10.1016/j.febslet.2014.09.041; VANHOOF G, 1995, FASEB J, V9, P736, DOI 10.1096/fasebj.9.9.7601338; Vergnolle N, 2016, GUT, V65, P1215, DOI 10.1136/gutjnl-2015-309147; Walden M, 2015, ELIFE, V4, DOI 10.7554/eLife.06638; Wang YC, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0802-8; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Yang YH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004169; Yiallouros I, 2000, FEBS LETT, V484, P224, DOI 10.1016/S0014-5793(00)02163-3; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	61	5	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11154	11165		10.1074/jbc.RA118.003244	http://dx.doi.org/10.1074/jbc.RA118.003244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794027	Green Published, hybrid			2022-12-26	WOS:000438882800027
J	van Eijk, M; Rynkiewicz, MJ; Khatri, K; Leymarie, N; Zaia, J; White, MR; Hartshorn, KL; Cafarella, TR; van Die, I; Hessing, M; Seaton, BA; Haagsman, HP				van Eijk, Martin; Rynkiewicz, Michael J.; Khatri, Kshitij; Leymarie, Nancy; Zaia, Joseph; White, Mitchell R.; Hartshorn, Kevan L.; Cafarella, Tanya R.; van Die, Irma; Hessing, Martin; Seaton, Barbara A.; Haagsman, Henk P.			Lectin-mediated binding and sialoglycans of porcine surfactant protein D synergistically neutralize influenza A virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						host-pathogen interaction; innate immunity; influenza virus; collectin; N-linked glycosylation; sialic acid; antiviral agent; structural biology; drug design; viral immunology; porcine immunology; pulmonary defense; recombinant protein; surfactant protein D	CARBOHYDRATE-RECOGNITION DOMAIN; COLLISION-INDUCED DISSOCIATION; STRUCTURAL-CHARACTERIZATION; ANTIINFLUENZA ACTIVITY; ANTIVIRAL ACTIVITY; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; IMMUNE-RESPONSE; N-GLYCOSYLATION; LUNG	Innate immunity is critical in the early containment of influenza A virus (IAV) infection, and surfactant protein D (SP-D) plays a crucial role in the pulmonary defense against IAV. In pigs, which are important intermediate hosts during the generation of pandemic IAVs, SP-D uses its unique carbohydrate recognition domain (CRD) to interact with IAV. An N-linked CRD glycosylation provides interactions with the sialic acid-binding site of IAV, and a tripeptide loop at the lectin-binding site facilitates enhanced interactions with IAV glycans. Here, to investigate both mechanisms of IAV neutralization in greater detail, we produced an N-glycosylated neck-CRD fragment of porcine SP-D (RpNCRD) in HEK293 cells. X-ray crystallography disclosed that the N-glycan did not alter the CRD backbone structure, including the lectin site conformation, but revealed a potential second nonlectin-binding site for glycans. IAV hemagglutination inhibition, IAV aggregation, and neutralization of IAV infection studies showed that RpNCRD, unlike the human analogue RhNCRD, exhibits potent neutralizing activity against pandemic A/Aichi/68 (H3N2), enabled by both porcine-specific structural features of its CRD. MS analysis revealed an N-glycan site-occupancy of >98% at Asn-303 of RpNCRD with complex-type, heterogeneously branched and predominantly (2,3)-sialylated oligosaccharides. Glycan-binding array data characterized both RpNCRD and RhNCRD as mannose-type lectins. RpNCRD also bound Lewis(Y) structures, whereas RhNCRD bound polylactosamine-containing glycans. The presence of the N-glycan in the CRD increases the glycan-binding specificity of RpNCRD. These insights increase our understanding of porcine-specific innate defense against pandemic IAV and may inform the design of recombinant SP-D-based antiviral drugs.	[van Eijk, Martin; Haagsman, Henk P.] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands; [Rynkiewicz, Michael J.; Cafarella, Tanya R.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [White, Mitchell R.; Hartshorn, Kevan L.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Khatri, Kshitij; Leymarie, Nancy; Zaia, Joseph] Boston Univ, Sch Med, Ctr Biomed Mass Spectrometry, Boston, MA 02118 USA; [van Die, Irma] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 HZ Amsterdam, Netherlands; [Hessing, Martin] U Prot Express BV, Life Sci Incubator, Utrecht Sci Pk,Yalelaan 62, NL-3584 CM Utrecht, Netherlands	Utrecht University; Boston University; Boston University; Boston University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Eijk, M (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, NL-3584 CL Utrecht, Netherlands.	m.vaneijk@uu.nl	Khatri, Kshitij/I-7013-2019; Haagsman, Henk P/F-8919-2010; Zaia, Joseph/U-7850-2019	Khatri, Kshitij/0000-0002-6592-869X; Zaia, Joseph/0000-0001-9497-8701; Rynkiewicz, Michael/0000-0002-4717-5700	National Institutes of Health from NIGMS [GM62116]; NATIONAL CANCER INSTITUTE [U01CA221234] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM104603] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010724] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the Protein-Glycan Interaction Core (Emory University School of Medicine, Atlanta, GA) of the Consortium for Functional Glycomics (supported by National Institutes of Health Grant GM62116 from NIGMS) for performing the glycan array analysis.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Appelmelk BJ, 1997, TRENDS MICROBIOL, V5, P70, DOI 10.1016/S0966-842X(96)10084-6; Berg T, 2000, BBA-PROTEIN STRUCT M, V1543, P159, DOI 10.1016/S0167-4838(00)00184-9; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Clark HW, 2016, INFECT IMMUN, V84, P1585, DOI 10.1128/IAI.01239-15; CONBOY JJ, 1992, J AM SOC MASS SPECTR, V3, P804, DOI 10.1016/1044-0305(92)80003-4; CROUCH E, 1994, J BIOL CHEM, V269, P17311; Crouch E, 2011, J BIOL CHEM, V286, P40681, DOI 10.1074/jbc.M111.300673; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Crouch EC, 2006, AM J RESP CELL MOL, V35, P84, DOI 10.1165/rcmb.2005-0462OC; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Goh BC, 2013, BIOCHEMISTRY-US, V52, P8527, DOI 10.1021/bi4010683; GONZALEZ J, 1992, ANAL BIOCHEM, V205, P151, DOI 10.1016/0003-2697(92)90592-U; HAAGSMAN HP, 1991, BIOCHEM J, V275, P273, DOI 10.1042/bj2750273; Hartshorn K, 1996, AM J PHYSIOL-LUNG C, V271, pL753, DOI 10.1152/ajplung.1996.271.5.L753; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; HARTSHORN KL, 1993, J IMMUNOL, V151, P6265; Hartshorn KL, 2003, AM J PHYSIOL-LUNG C, V285, pL1066, DOI 10.1152/ajplung.00057.2003; Hartshorn KL, 2002, BIOCHEM J, V366, P87, DOI 10.1042/BJ20011868; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Hillaire MLB, 2014, VIRUS RES, V181, P22, DOI 10.1016/j.virusres.2013.12.032; Hillaire MLB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025005; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; JOHNSON RS, 1987, ANAL CHEM, V59, P2621, DOI 10.1021/ac00148a019; Khatri K, 2016, MOL CELL PROTEOMICS, V15, P1895, DOI 10.1074/mcp.M116.058016; Khatri K, 2014, J PROTEOME RES, V13, P4347, DOI 10.1021/pr500506z; Leth-Larsen R, 1999, BIOCHEM J, V343, P645, DOI 10.1042/0264-6021:3430645; Morlot C, 2007, ACTA CRYSTALLOGR D, V63, P961, DOI 10.1107/S0907444907035470; MUNAKATA H, 1982, BIOCHEM BIOPH RES CO, V108, P1401, DOI 10.1016/S0006-291X(82)80062-4; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng WC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732191; Nikolaidis NM, 2014, AM J PHYSIOL-LUNG C, V306, pL1036, DOI 10.1152/ajplung.00035.2014; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qi L, 2011, VIROLOGY, V412, P426, DOI 10.1016/j.virol.2011.01.029; Reiding KR, 2014, ANAL CHEM, V86, P5784, DOI 10.1021/ac500335t; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Seaton BA, 2010, INNATE IMMUN-LONDON, V16, P143, DOI 10.1177/1753425910368716; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294; Tripathi S, 2015, INNATE IMMUN-LONDON, V21, P73, DOI 10.1177/1753425913508992; van Eijk M, 2004, AM J RESP CELL MOL, V30, P871, DOI 10.1165/rcmb.2003-0355OC; van Eijk M, 2003, J IMMUNOL, V171, P1431, DOI 10.4049/jimmunol.171.3.1431; van Eijk M, 2002, AM J RESP CELL MOL, V26, P739, DOI 10.1165/ajrcmb.26.6.4520; van Eijk M, 2000, J IMMUNOL, V164, P1442, DOI 10.4049/jimmunol.164.3.1442; van Eijk M, 2012, J BIOL CHEM, V287, P26666, DOI 10.1074/jbc.M112.368571; van Eijk M, 2011, J BIOL CHEM, V286, P20137, DOI 10.1074/jbc.M111.224469; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; World Health Organization, 2016, INFL SEAS	55	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10646	10662		10.1074/jbc.RA117.001430	http://dx.doi.org/10.1074/jbc.RA117.001430			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29769321	Green Published, hybrid			2022-12-26	WOS:000437828400022
J	Senanayake, S; Harrison, K; Lewis, M; McNarry, M; Hudson, J				Senanayake, Sameera; Harrison, Kim; Lewis, Michael; McNarry, Melitta; Hudson, Joanne			Patients' experiences of coping with Idiopathic Pulmonary Fibrosis and their recommendations for its clinical management	PLOS ONE			English	Article							QUALITY-OF-LIFE; DISEASE; BURDEN; NEEDS	Background Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive and life-limiting condition. From a healthcare perspective it is vital to establish effective methods of improving the quality of remaining life in these patients. This requires a detailed understanding of the multiple impacts of an IPF diagnosis on the individual. Methods We sought to understand how patients coped with their initial diagnosis, how they live with the disease day-to-day, and their experiences and opinions of the professional support they receive. A patient-centred approach was used to explore the social, psychological and physical impacts of IPF. Semi-structured interviews were conducted by an experienced academic. Interview questions were written by the researchers but guided by informal conversations with patients and clinicians. An inductive thematic approach was used to analyse the data, allowing us to identify common themes in the patients' experiences. Results Of fifty invited participants, ten took part in the study (aged 53-81 years; 9 male). Inductive analysis of interviews identified seven second-order themes and eleven first-order themes, represented by two General Dimensions: 'Patient experience with the condition' and 'Patient-led recommendations for practice'. The key message on 'coping' in these patients was that acceptance of their condition led to a sense of optimism. Participants reported using appraisal-focused coping strategies to change their perspectives (thinking positively) and emotion-focused strategies to overcome depression (the main opportunity for emotional expression being an IPF support group). The support group also facilitated problem-focused coping: individuals exchanged knowledge and experience and gave one another tips on how to live with their condition. Conclusions Health professionals should provide patients with information that focuses on living with IPF, encouraging them to make lifestyle changes and adaptations to improve quality of life. Family members should receive education about IPF so that they can support such changes. Patients should be encouraged to join a support group and to participate in physical activity (again preferably group-based). This study offers novel findings that will help inform much needed changes in the practice of supporting IPF patients to cope with their diagnosis and disease progression.	[Senanayake, Sameera; Lewis, Michael; McNarry, Melitta; Hudson, Joanne] Swansea Univ, Sch Sport & Exercise Sci, Coll Engn, Swansea, W Glam, Wales; [Senanayake, Sameera] Gen Sir John Kotelawala Def Univ, Fac Allied Hlth Sci, Rathmalana, Sri Lanka; [Harrison, Kim] Morriston Hosp, Dept Resp Med, Swansea, W Glam, Wales	Swansea University; General Sir John Kotelawala Defence University; Morriston Hospital	Lewis, M (corresponding author), Swansea Univ, Sch Sport & Exercise Sci, Coll Engn, Swansea, W Glam, Wales.	m.j.lewis@Swansea.ac.uk	McNarry, Melitta/AAC-6899-2020; senanayake, Sameera/ABC-7104-2021	McNarry, Melitta/0000-0003-0813-7477; senanayake, Sameera/0000-0002-5533-8661; Lewis, Michael/0000-0002-6709-9215	Kotelawala Defence University KDU), Sri Lanka	Kotelawala Defence University KDU), Sri Lanka	Sameera Senanayake received a PhD studentship from Kotelawala Defence University KDU), Sri Lanka. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonella F, 2016, EUR RESPIR J, V47, P597, DOI 10.1183/13993003.01204-2015; Cicutto L, 2004, PATIENT EDUC COUNS, V55, P168, DOI 10.1016/j.pec.2003.08.012; Fernandez Stephanie, 2015, Can Oncol Nurs J, V25, P37; Folkman S., 1990, PSYCHOL BIOL APPROAC, P313; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Lindell KO, 2010, HEART LUNG, V39, P304, DOI 10.1016/j.hrtlng.2009.08.005; Navaratnam V, 2013, CHEST, V143, P1078, DOI 10.1378/chest.12-0803; Overgaard D, 2016, EUR RESPIR J, V47, P1472, DOI 10.1183/13993003.01566-2015; Raghu G, 2015, AM J RESP CRIT CARE, V192, P644; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Russell AM, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0171-y; Sampson C, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0145-5; Schoenheit G, 2011, CHRON RESP DIS, V8, P225, DOI 10.1177/1479972311416382; Swigris Jeffrey J, 2005, Health Qual Life Outcomes, V3, P61, DOI 10.1186/1477-7525-3-61; Thomas DR, 2016, GEN INDUCTIVE APPROA; van Manen MJG, 2017, THER ADV RESPIR DIS, V11, P157, DOI 10.1177/1753465816686743; WHO, 2014, WHOQOL MEAS QUAL LIF; Yount SE, 2016, LUNG, V194, P227, DOI 10.1007/s00408-016-9850-y	18	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197660	10.1371/journal.pone.0197660	http://dx.doi.org/10.1371/journal.pone.0197660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791487	gold, Green Published, Green Submitted			2022-12-26	WOS:000433077000049
J	Myung, Y; Son, Y; Nam, TH; Kang, E; Kim, EK; Kim, IA; Eom, KY; Heo, CY; Jeong, JH				Myung, Yujin; Son, Yousung; Nam, Tae-Hyun; Kang, Eunyoung; Kim, Eun-Kyu; Kim, In Ah; Eom, Keun-Yong; Heo, Chan Yeong; Jeong, Jae Hoon			Objective assessment of flap volume changes and aesthetic results after adjuvant radiation therapy in patients undergoing immediate autologous breast reconstruction	PLOS ONE			English	Article							CLINICAL-OUTCOMES; RADIOTHERAPY; MASTECTOMY; CANCER; COMPLICATIONS; SATISFACTION; BCCT.CORE; COSMESIS; SURGERY	Background The use of immediate breast reconstruction and adjuvant radiation therapy is increasing in breast cancer patients. This study aimed to analyze the aesthetic outcome and changes in flap volume in patients with breast cancer undergoing radiation therapy of the surgical site after immediate autologous tissue reconstruction. Methods Immediate abdominal free flap breast reconstruction following unilateral mastectomy was performed in 42 patients; 21 patients received adjuvant radiation (study group) and 21 patients did not (control group). To compare flap volume, three-dimensional computed tomography (CT) was performed before and after radiation. Also, aesthetic analysis was performed in both groups to evaluate shape changes. Results There was a 12.3% flap volume reduction after the completion of radiation in the experimental group that was significantly greater than the 2.6% volume reduction observed in the non radiation group (P<0.01). There was no significant difference in the short- and long-term aesthetic results between the groups. Conclusions When performing immediate autologous breast reconstruction, 14% volume overcorrection is recommended for patients in whom adjuvant radiation therapy is anticipated to improve aesthetic outcomes.	[Myung, Yujin; Son, Yousung; Heo, Chan Yeong; Jeong, Jae Hoon] Seoul Natl Univ, Bundang Hosp, Dept Plast & Reconstruct Surg, Seongnam, South Korea; [Nam, Tae-Hyun] Seoul Natl Univ, Bundang Hosp, Dept Diagnost Radiol, Seongnam, South Korea; [Kang, Eunyoung; Kim, Eun-Kyu] Seoul Natl Univ, Bundang Hosp, Dept Surg, Seongnam, South Korea; [Kim, In Ah; Eom, Keun-Yong] Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Jeong, JH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Plast & Reconstruct Surg, Seongnam, South Korea.	psdrj2h@gmail.com						Anderson PR, 2004, INT J RADIAT ONCOL, V59, P1080, DOI 10.1016/j.ijrobp.2003.12.036; Baschnagel AM, 2012, CLIN BREAST CANCER, V12, P428, DOI 10.1016/j.clbc.2012.09.001; Behranwala KA, 2006, J PLAST RECONSTR AES, V59, P1043, DOI 10.1016/j.bjps.2006.01.051; Cardoso MJ, 2007, BREAST, V16, P456, DOI 10.1016/j.breast.2007.05.002; Carnevale A, 2013, RADIOL MED, V118, P1240, DOI 10.1007/s11547-013-0947-6; Choppin SB, 2016, BREAST, V28, P121, DOI 10.1016/j.breast.2016.05.010; Cordeiro PG, 2006, PLAST RECONSTR SURG, V118, P832, DOI 10.1097/01.prs.0000232397.14818.0e; Eric M, 2014, INT J SURG, V12, P912, DOI 10.1016/j.ijsu.2014.07.018; Guyomard V, 2007, BREAST, V16, P547, DOI 10.1016/j.breast.2007.04.004; Halyard MY, 2004, AM J CLIN ONCOL-CANC, V27, P389, DOI 10.1097/01.COC.0000071946.11078.7E; Jhaveri JD, 2008, INT J RADIAT ONCOL, V72, P859, DOI 10.1016/j.ijrobp.2008.01.055; Munhoz AM, 2009, BREAST, V18, P47, DOI 10.1016/j.breast.2008.10.005; Muresan H, 2017, PLAST RECONSTR SURG, V139, p1232E, DOI 10.1097/PRS.0000000000003341; O'Connell RL, 2015, BREAST, V24, P331, DOI 10.1016/j.breast.2015.03.011; Petit JY, 2012, WORLD J SURG, V36, P1486, DOI 10.1007/s00268-012-1486-3; Roth RS, 2005, PLAST RECONSTR SURG, V116, P993, DOI 10.1097/01.prs.0000178395.19992.ca; Rozen WM, 2012, GLAND SURG, V1, P119, DOI 10.3978/j.issn.2227-684X.2012.05.02; Soong IS, 2004, CLIN ONCOL-UK, V16, P283, DOI 10.1016/j.clon.2004.01.007; Steele KH, 2018, J PLAST RECONSTR AES, V71, P185, DOI 10.1016/j.bjps.2017.10.030; Yu T, 2016, CANCER RES TREAT, V48, P491, DOI 10.4143/crt.2015.088; Zimmerman RP, 1998, AM J CLIN ONCOL-CANC, V21, P381, DOI 10.1097/00000421-199808000-00013	21	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197615	10.1371/journal.pone.0197615	http://dx.doi.org/10.1371/journal.pone.0197615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782518	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100036
J	Drummond, CA; Fan, XM; Haller, ST; Kennedy, DJ; Liu, J; Tian, J				Drummond, Christopher A.; Fan, Xiaoming; Haller, Steven T.; Kennedy, David J.; Liu, Jiang; Tian, Jiang			Na/K-ATPase signaling mediates miR-29b-3p regulation and cardiac fibrosis formation in mice with chronic kidney disease	PLOS ONE			English	Article							NF-KAPPA-B; EXPERIMENTAL UREMIC CARDIOMYOPATHY; IDIOPATHIC DILATED CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; RENAL FIBROSIS; MICRORNAS; COLLAGEN; MARINOBUFAGENIN; EXPRESSION; NA,K-ATPASE	The Na/K-ATPase is an important membrane ion transporter and a signaling receptor that is essential for maintaining normal cell function. The current study examined the role of Na/K-ATPase signaling in regulating miR-29b-3p, an anti-fibrotic microRNA, in a mouse chronic kidney disease (CKD) model (5/6th partial nephrectomy or PNx). The results showed that CKD induced significant reduction of miR-29b-3p expression in the heart tissue by activation of Src and NF kappa B signaling in these animals. To demonstrate the role of Na/K-ATPase signaling, we also performed the PNx surgery on Na/K-ATPase alpha 1 heterozygous (alpha 1+/-) mice, which expresses similar to 40% less Na/K-ATPase alpha 1 compared to their wild type littermates (WT) and exhibits deficiency in Na/K-ATPase signaling. We found that CKD did not significantly change the miR-29b-3p expression in heart tissue from the a1+/- animals. We also found that CKD failed to activate Src and NF kappa B signaling in these animals. Using isolated cardiac fibroblasts from alpha 1+/- mice and their WT littermates, we showed that ouabain, a specific Na/K-ATPase ligand, induces decreased miR-29b-3p expression in fibroblasts isolated from WT mice, but had no effect in cells from alpha 1+/- mice. Inhibition of NF kappa B by Bay 11-7082 prevented ouabain-induced miR-29b-3p reduction in WT fibroblasts. To further confirm the in vivo effect of Na/K-ATPase signaling in regulation of miR-29b-3p and cardiac fibrosis in CKD animals, we used pNaKtide, a Src inhibiting peptide derived from the sequence of Na/K-ATPase, to block the activation of Na/K-ATPase signaling. The result showed that pNaKtide injection significantly increased miR-29b-3p expression and mitigated the CKD-induced cardiac fibrosis in these animals. These results clearly demonstrated that Na/K-ATPase signaling is an important mediator in CKD that regulates miR-29b-3p expression and cardiac fibrosis, which provides a novel target for regulation of miR-29b-3p in CKD. We also demonstrate that antagonizing Na/K-ATPase signaling by pNaKtide can reduce organ fibrosis through the stimulation of tissue miR-29b-3p expression.	[Drummond, Christopher A.; Fan, Xiaoming; Haller, Steven T.; Kennedy, David J.; Tian, Jiang] Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA; [Liu, Jiang] Marshall Univ, Joan C Edwards Sch Med, Huntington, WV USA; [Drummond, Christopher A.] MPI Res, Mattawan, MI USA	University System of Ohio; University of Toledo; Marshall University	Tian, J (corresponding author), Univ Toledo, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA.	Jiang.Tian@utoledo.edu	Liu, Jiang/AAF-2742-2021; Fan, Xiaoming/AAU-7713-2021; Drummond, Christopher A/A-4482-2017	Drummond, Christopher A/0000-0002-0378-9882	National Institutes of Health [HL-105649, HL-137004, DK-106666, F32DK104615]; National Affiliate of the American Heart Association [12SDG12050473]; David and Helen Boone Foundation Research Fund; Early Career Development Award from the Central Society for Clinical and Translational Research; University of Toledo Women and Philanthropy Genetic Analysis Instrumentation Center; University of Toledo Medical Research Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137004, R01HL105649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK106666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Affiliate of the American Heart Association; David and Helen Boone Foundation Research Fund; Early Career Development Award from the Central Society for Clinical and Translational Research; University of Toledo Women and Philanthropy Genetic Analysis Instrumentation Center; University of Toledo Medical Research Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (HL-105649 to JT, HL-137004 to DJK, DK-106666 to JL, and F32DK104615 to CAD). Additional support was from the National Affiliate of the American Heart Association (12SDG12050473 to DJK), the David and Helen Boone Foundation Research Fund (DJK), an Early Career Development Award from the Central Society for Clinical and Translational Research (DJK), the University of Toledo Women and Philanthropy Genetic Analysis Instrumentation Center (DJK and STH), and the University of Toledo Medical Research Society (STH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bai HT, 2011, FEBS LETT, V585, P402, DOI 10.1016/j.febslet.2010.12.027; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brecher AS, 1996, J INVEST MED, V44, P36; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Drummond CA, 2016, PHYSIOL GENOMICS, V48, P220, DOI 10.1152/physiolgenomics.00116.2015; Drummond CA, 2014, AM J PHYSIOL-HEART C, V306, pH1631, DOI 10.1152/ajpheart.00102.2014; Elkareh J, 2007, HYPERTENSION, V49, P215, DOI 10.1161/01.HYP.0000252409.36927.05; Elkareh J, 2009, AM J PHYSIOL-RENAL, V296, pF1219, DOI 10.1152/ajprenal.90710.2008; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Haller ST, 2012, AM J HYPERTENS, V25, P690, DOI 10.1038/ajh.2012.17; Ishino K, 1999, AM J CARDIOL, V83, P396, DOI 10.1016/S0002-9149(98)00876-5; JALIL JE, 1989, CIRC RES, V64, P1041, DOI 10.1161/01.RES.64.6.1041; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Jones JA, 2011, CIRC-CARDIOVASC GENE, V4, P605, DOI 10.1161/CIRCGENETICS.111.960419; Kennedy DJ, 2008, AM J PHYSIOL-RENAL, V294, pF450, DOI 10.1152/ajprenal.00472.2007; Kennedy DJ, 2006, HYPERTENSION, V47, P488, DOI 10.1161/01.HYP.0000202594.82271.92; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; LAST JA, 1985, FUND APPL TOXICOL, V5, P210, DOI 10.1016/0272-0590(85)90069-7; Latronico Michael V G, 2011, Curr Heart Fail Rep, V8, P193, DOI 10.1007/s11897-011-0068-2; Li JYZ, 2010, NEPHROLOGY, V15, P599, DOI 10.1111/j.1440-1797.2010.01363.x; Li JA, 2006, J AM SOC NEPHROL, V17, P1848, DOI 10.1681/ASN.2005080894; Li ZC, 2011, J BIOL CHEM, V286, P32394, DOI 10.1074/jbc.M110.207597; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Lima LD, 2013, NEUROPHARMACOLOGY, V73, P327, DOI 10.1016/j.neuropharm.2013.06.006; Liu CX, 2012, J BIOL CHEM, V287, P16390, DOI 10.1074/jbc.M111.304451; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Montgomery RL, 2010, CURR DRUG TARGETS, V11, P936; Moseley AE, 2004, J MOL CELL CARDIOL, V37, P913, DOI 10.1016/j.yjmcc.2004.06.005; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; NORGAARD A, 1988, AM J CARDIOL, V61, P1312, DOI 10.1016/0002-9149(88)91175-7; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Ramdas V, 2013, AM J PATHOL, V183, P1885, DOI 10.1016/j.ajpath.2013.08.027; Rathore MG, 2012, INT J BIOCHEM CELL B, V44, P1448, DOI 10.1016/j.biocel.2012.05.011; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Villa C, 2013, J ALZHEIMERS DIS, V35, P487, DOI 10.3233/JAD-122263; Wang G, 2012, AM J NEPHROL, V36, P412, DOI 10.1159/000343452; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhang Y, 2012, J CELL MOL MED, V16, P249, DOI 10.1111/j.1582-4934.2011.01291.x; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	47	22	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197688	10.1371/journal.pone.0197688	http://dx.doi.org/10.1371/journal.pone.0197688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775473	Green Published, Green Submitted, gold			2022-12-26	WOS:000432521100022
J	Astudillo, JC; Bonebrake, TC; Leung, KMY				Astudillo, Juan C.; Bonebrake, Timothy C.; Leung, Kenneth M. Y.			Deterred but not preferred: Predation by native whelk Reishia clavigera on invasive bivalves	PLOS ONE			English	Article							MYTILOPSIS-SALLEI BIVALVIA; HONG-KONG; BIOTIC RESISTANCE; XENOSTROBUS-SECURIS; MUSSEL; COMPETITION; MYTILIDAE; EXPOSURE; HISTORY; CRAB	This study tested the potential bio-control role of the common native predatory whelk Reishia clavigera on the invasive bivalves Xenostrobus securis and Mytilopsis sallei and the native Brachidontes variabilis in Hong Kong. Predation experiments were conducted in the laboratory under salinity levels of 22 parts per thousand and 32 parts per thousand, as well as under field conditions. The results indicate that the invasive bivalves are more vulnerable to predation than the native bivalve in environments with high salinity, whereas environments with moderately low salinity (22 parts per thousand) may reduce predation. Because R. clavigera did not show clear prey preference, the low survival of the invasive species might be due to a lack of effective anti-predatory defenses under experimental conditions. These findings could explain the high abundance of the invasive bivalves in disturbed environments in Hong Kong where predation appears to be lower.	[Astudillo, Juan C.; Leung, Kenneth M. Y.] Univ Hong Kong, Fac Sci, Swire Inst Marine Sci, Shek O, Hong Kong, Peoples R China; [Astudillo, Juan C.; Bonebrake, Timothy C.; Leung, Kenneth M. Y.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Leung, Kenneth M. Y.] City Univ Hong Kong, State Key Lab Marine Pollut, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; City University of Hong Kong	Astudillo, JC; Leung, KMY (corresponding author), Univ Hong Kong, Fac Sci, Swire Inst Marine Sci, Shek O, Hong Kong, Peoples R China.; Astudillo, JC; Leung, KMY (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.; Leung, KMY (corresponding author), City Univ Hong Kong, State Key Lab Marine Pollut, Hong Kong, Hong Kong, Peoples R China.	jcarlos@connect.hku.hk; kmyleung@hku.hk	Bonebrake, Timothy Carlton/M-3559-2019; Leung, Kenneth Mei Yee/C-1055-2009	Bonebrake, Timothy Carlton/0000-0001-9999-2254; Leung, Kenneth Mei Yee/0000-0002-2164-4281; Astudillo Placencia, Juan Carlos/0000-0002-3350-8279	Environment and Conservation Fund (ECF Project) of the Hong Kong Special Administration Region Government [2010-28]	Environment and Conservation Fund (ECF Project) of the Hong Kong Special Administration Region Government	This study was partially supported by the Environment and Conservation Fund (ECF Project: 2010-28) of the Hong Kong Special Administration Region Government. There was no additional external funding received for this study.	Astudillo JC, 2017, MAR POLLUT BULL, V118, P229, DOI 10.1016/j.marpolbul.2017.02.046; Astudillo JC, 2014, BIOINVASIONS REC, V3, P123, DOI 10.3391/bir.2014.3.3.01; Atalah J, 2014, BIOFOULING, V30, P999, DOI 10.1080/08927014.2014.956734; Atalah J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080365; Byers James E., 2009, V204, P245; Byers JE, 2002, OECOLOGIA, V130, P146, DOI 10.1007/s004420100777; Byers JE, 2000, ECOLOGY, V81, P1225, DOI 10.2307/177203; Caro AU, 2008, MAR ECOL PROG SER, V372, P127, DOI 10.3354/meps07701; CASTILLA JC, 1985, OIKOS, V45, P391, DOI 10.2307/3565575; Cheng BS, 2010, OECOLOGIA, V164, P1049, DOI 10.1007/s00442-010-1700-7; Cheung SG, 2004, MAR BIOL, V144, P675, DOI 10.1007/s00227-003-1233-2; Claremont M, 2013, MOL PHYLOGENET EVOL, V66, P91, DOI 10.1016/j.ympev.2012.09.014; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Dethier MN, 2005, ECOL APPL, V15, P1273, DOI 10.1890/04-0505; Dumont CP, 2011, BIOL INVASIONS, V13, P2023, DOI 10.1007/s10530-011-0018-7; Dumont CP, 2009, AQUACULTURE, V292, P74, DOI 10.1016/j.aquaculture.2009.03.044; EPD (Environmental Protection Department), 2013, MAR WAT QUAL HONG KO; Epelbaum A, 2009, MAR BIOL, V156, P1311, DOI 10.1007/s00227-009-1172-7; Fitzer SC, 2015, ECOL EVOL, V5, P4875, DOI 10.1002/ece3.1756; Guo X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129715; Harper E, 1997, P 8 INT MAR BIOL WOR, P263; Huang ZG, 2003, ACTA OCEANOL SIN, V22, P467; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Lai RWS, 2016, REG STUD MAR SCI, V8, P259, DOI 10.1016/j.rsma.2016.09.001; Lopez MS, 2010, MAR ECOL PROG SER, V403, P101, DOI 10.3354/meps08409; MORTON B, 1989, J ZOOL, V219, P469, DOI 10.1111/j.1469-7998.1989.tb02594.x; Morton B., 1983, SEA SHORE ECOLOGY HO; Morton B, 2015, MAR POLLUT BULL, V92, P134, DOI 10.1016/j.marpolbul.2014.12.046; Munari C, 2011, J EXP MAR BIOL ECOL, V407, P166, DOI 10.1016/j.jembe.2011.06.003; Ng TPT, 2017, BIODIVERS CONSERV, V26, P23, DOI 10.1007/s10531-016-1224-5; Piola RF, 2008, DIVERS DISTRIB, V14, P329, DOI 10.1111/j.1472-4642.2007.00430.x; Preisler Rikke K., 2009, V204, P587, DOI 10.1007/978-3-540-79236-9_33; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reimer O, 1997, MAR FRESHW BEHAV PHY, V30, P251, DOI 10.1080/10236249709379029; Reimer O, 1996, OIKOS, V75, P383, DOI 10.2307/3545878; SEED R, 1990, P993; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Shin PKS, 2009, MAR FRESHW BEHAV PHY, V42, P343, DOI 10.1080/10236240903454202; Taylor John D., 1996, Asian Marine Biology, V13, P141; Tong L.K.Y., 1986, Asian Marine Biology, V3, P163; Underwood AJ, 2005, J EXP MAR BIOL ECOL, V318, P227, DOI [10.1016/j.jembe.2004.12.014, 10.1016/j.jembre.2004.12.014]; Veiga P, 2011, J EXP MAR BIOL ECOL, V406, P14, DOI 10.1016/j.jembe.2011.05.035; WILSON BR, 1968, J NAT HIST, V2, P307, DOI 10.1080/00222936800770341	43	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196578	10.1371/journal.pone.0196578	http://dx.doi.org/10.1371/journal.pone.0196578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768424	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200036
J	Sniderman, JMK; Matley, KA; Haberle, SG; Cantrill, DJ				Sniderman, J. M. Kale; Matley, Kia A.; Haberle, Simon G.; Cantrill, David J.			Pollen analysis of Australian honey	PLOS ONE			English	Article							SOUTH-WESTERN AUSTRALIA; UNIFLORAL HONEYS; ATLANTIC FOREST; APIS-MELLIFERA; PHYSICOCHEMICAL CHARACTERISTICS; ARGENTINEAN PATAGONIA; MULTIVARIATE-ANALYSIS; BOTANICAL ORIGIN; ALGERIAN HONEYS; MYRTACEAE	Pollen analysis is widely used to verify the geographic origin of honeys, but has never been employed in Australia. In this study, we analysed the pollen content of 173 unblended honey samples sourced from most of the commercial honey producing regions in southern Australia. Southern Australian vegetation is dominated by Eucalyptus (Myrtaceae) forests and, as expected, most Australian honeys are palynologically dominated by Eucalyptus, while other important components include Myrtaceae taxa such as Corymbia/Angophora and the tribe Leptospermeae; plus Brassicaceae, Echium, Macadamia, and Acacia. An important feature of the honeys is the number of Myrtaceae pollen morphotypes per sample, which is generally high (mean = 4.6) compared to honeys produced outside of Australia, including Eucalyptus honeys produced in the Mediterranean region, and honeys produced in South America, which has its own rich indigenous Myrtaceae flora. In the latter regions, the number of Myrtaceae morphotypes is apparently generally <= 2. A high number of Myrtaceae morphotypes may be a feasible criterion for authenticating the origin of Australian honeys, since most Australian honey is produced by honey bees mainly working indigenous floral resources. Myrtaceae morphotype diversity is a convenient melissopalynological measure that could be applied even where detailed knowledge of the pollen morphology of the many component genera and species is absent. Palynological criteria developed in Europe for authenticating Eucalyptus honeys should not be relied upon for Australian honeys, since those criteria are not based on samples of Australian honey.	[Sniderman, J. M. Kale; Matley, Kia A.] Univ Melbourne, Sch Earth Sci, Parkville, Vic, Australia; [Haberle, Simon G.] Australian Natl Univ, Coll Asia & Pacific, Dept Archaeol & Nat Hist, Canberra, ACT, Australia; [Cantrill, David J.] Royal Bot Gardens Victoria, South Yarra, Vic, Australia	University of Melbourne; Australian National University	Sniderman, JMK (corresponding author), Univ Melbourne, Sch Earth Sci, Parkville, Vic, Australia.	kale.sniderman@unimelb.edu.au	Haberle, Simon/U-4118-2019; Cantrill, David/R-1415-2019	Cantrill, David/0000-0002-1185-4015; Sniderman, Kale/0000-0002-3963-4049; Haberle, Simon/0000-0001-5802-6535	AgriFutures Australia [PRJ-009770]	AgriFutures Australia	This study was funded by the Australian Government Rural Industries Research and Development Corporation (now AgriFutures Australia, www.agrifutures.com.au), Grant PRJ-009770 to JMKS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the funders and two industry partners commented on the manuscript.	Alves RD, 2014, PALYNOLOGY, V38, P90, DOI 10.1080/01916122.2013.846280; Aries E, 2016, JRC TECHNICAL REPORT, P1; Aronne G, 2010, PLANT BIOSYST, V144, P833, DOI 10.1080/11263504.2010.514125; BARTH OM, 1990, J APICULT RES, V29, P89, DOI 10.1080/00218839.1990.11101202; Barth OM, 1998, GRANA, V37, P97, DOI 10.1080/00173139809362650; Benitez-Bosco L, 2017, GRANA, V57, P144; Braga JA, 2012, REV BIOL TROP, V60, P1491; Caccavari M, 2010, SPAN J AGRIC RES, V8, P42, DOI 10.5424/sjar/2010081-1142; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V305, P129, DOI 10.1016/j.foreco.2013.05.037; Cardillo M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-155; Sanchez AC, 2017, GRANA, V56, P462, DOI 10.1080/00173134.2017.1284260; Carroll T., 2006, BEGINNERS GUIDE BEEK, DOI 10.1017/CBO9781107415324.004; Cerasoli S, 2016, EUROPEAN ATLAS FORES, pe01b5bb+; Chalson Jane M., 1995, Proceedings of the Linnean Society of New South Wales, V115, P163; Chamorro FJ, 2017, GRANA, V56, P386, DOI 10.1080/00173134.2017.1283440; Chauhan Mohan Singh, 2017, Acta Palaeobotanica, V57, P119, DOI 10.1515/acpa-2017-0003; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Commonwealth of Australia, 2012, INT BIOG REG AUSTR V; CORTOPASSILAURINO M, 1988, APIDOLOGIE, V19, P1, DOI 10.1051/apido:19880101; Corvucci F, 2015, FOOD CHEM, V169, P297, DOI 10.1016/j.foodchem.2014.07.122; Costa MC, 2013, GRANA, V52, P229, DOI 10.1080/00173134.2013.819525; Da Luz Cynthia F. P., 2007, Revista Brasileira de Botanica, V30, P29, DOI 10.1590/S0100-84042007000100004; da Silveira TA, 2012, SOCIOBIOLOGY, V59, P1229; Daners G, 1998, J APICULT RES, V37, P221, DOI 10.1080/00218839.1998.11100976; Dawes J, 2014, RIRDC PUBLICATION; de Freitas AD, 2018, PALYNOLOGY, V42, P392, DOI 10.1080/01916122.2017.1363827; de Novais JS, 2015, APIDOLOGIE, V46, P417, DOI 10.1007/s13592-014-0332-z; Dimou M, 2007, GRANA, V46, P292, DOI 10.1080/00173130701760718; Dimou M, 2014, J APIC SCI, V58, P11, DOI 10.2478/JAS-2014-0018; European Commission, 2015, COM2015583 EUR COMM, P13; Fagundez GA, 2006, GRANA, V45, P305, DOI 10.1080/00173130601086636; Feas X, 2010, FOOD CHEM TOXICOL, V48, P3462, DOI 10.1016/j.fct.2010.09.024; Feas X, 2010, INT J FOOD SCI TECH, V45, P1255, DOI 10.1111/j.1365-2621.2010.02268.x; Forcone A, 2005, GRANA, V44, P202, DOI 10.1080/00173130500205816; Forcone A, 2008, GRANA, V47, P147, DOI 10.1080/10652460802106340; Forcone A, 2009, GRANA, V48, P67, DOI 10.1080/00173130802602033; Fox Marilyn D., 1994, V108, P137; Genersch E, 2010, APPL MICROBIOL BIOT, V87, P87, DOI 10.1007/s00253-010-2573-8; Gorley C.K., 2006, GETTING STARTED PRIM; Hilgert-Moreira SB, 2014, APIDOLOGIE, V45, P129, DOI 10.1007/s13592-013-0234-5; Hilgert-Moreira SB, 2014, FOREST ECOL MANAG, V313, P153, DOI 10.1016/j.foreco.2013.10.049; Hope G, 2000, QUAT STUD M REG AN A; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; HOPPER SD, 1992, BIODIVERSITY OF MEDITERRANEAN ECOSYSTEMS IN AUSTRALIA, P27; House Susan M., 1997, P30; IMPERATRIZFONSECA VL, 1989, J TROP ECOL, V5, P239, DOI 10.1017/S0266467400003539; Itzstein-Davey F, 2004, AUST GEOGR, V35, P317, DOI 10.1080/0004918042000311340; Itzstein-Davey F, 2003, AUST J BOT, V51, P135, DOI 10.1071/BT02048; Karabournioti SE, 2009, J APICULT RES, V48, P104, DOI 10.3896/IBRA.1.48.2.04; Korth W, 2002, RIRDC PUBLICATION; Ladiges PY, 2003, J BIOGEOGR, V30, P989, DOI 10.1046/j.1365-2699.2003.00881.x; LIEUX M H, 1980, Grana, V19, P57, DOI 10.1080/00173138009424988; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Lucas EJ, 2005, PLANT SYST EVOL, V251, P35, DOI 10.1007/s00606-004-0164-9; Lucas EJ, 2015, BIODIVERS CONSERV, V24, P2165, DOI 10.1007/s10531-015-0992-7; Mack CL, 2016, AUST SYST BOT, V29, P303, DOI 10.1071/SB15049; Makhloufi C, 2010, APIDOLOGIE, V41, P509, DOI 10.1051/apido/2010002; Arroyo TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185405; Martin HA, 1997, AUST J BOT, V45, P475, DOI 10.1071/BT96037; Moar N.T., 1993, POLLEN GRAINS NZ DIC; MOAR NT, 1985, NEW ZEAL J AGR RES, V28, P39, DOI 10.1080/00288233.1985.10426997; Moore P.D., 1991, BLACKWELL SCI PUBLI; Mucina LEL, 2014, PLANT LIFE SANDPLAIN, P35; Naab OA, 2008, SPAN J AGRIC RES, V6, P566, DOI 10.5424/sjar/2008064-351; Navarrete C, 2016, GAYANA BOT, V73, P268; Novais J.S., 2013, PALYNOLOGY, V37, P218, DOI DOI 10.1080/01916122.2013.787127; Oddo L., 2004, APIDOLOGIE, V35, pS38, DOI [10.1051/apido:2004049, DOI 10.1051/APIDO:2004049]; Oddo LP, 1995, APIDOLOGIE, V26, P453, DOI 10.1051/apido:19950602; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Ortega-Bonilla Rubén Andrés, 2016, Cienc. Tecnol. Agropecuaria, V17, P73; Ortiz Pedro L., 1992, Acta Botanica Malacitana, V17, P183; Ouchemoukh S, 2007, FOOD CONTROL, V18, P52, DOI 10.1016/j.foodcont.2005.08.007; Parra-O C, 2009, AUST SYST BOT, V22, P384, DOI 10.1071/SB09028; PATON DC, 1993, BIOSCIENCE, V43, P95, DOI 10.2307/1311970; Pendleton M, 2006, GRANA, V45, P71, DOI 10.1080/00173130500520479; da Luz CFP, 2012, BRAZ J BOT, V35, P79, DOI 10.1590/S1806-99592012000100009; Ramos ILS, 2002, GRANA, V41, P48, DOI 10.1080/00173130260045503; Rasoloarijao T. M., 2014, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V67, P128; Reille M., 1995, POLLEN SPORES EUROPE; Reille M., 1992, POLLEN SPORES EUROPE; Reille M., 1998, POLLEN SPORES EUR S2; Flores MSR, 2014, INT J FOOD PROP, V17, P2177, DOI 10.1080/10942912.2013.790050; Rodriguez I, 2015, INT J FOOD SCI TECH, V50, P1545, DOI 10.1111/ijfs.12802; Rural Industries Research and Development Corporation, RUR IND RES DEV CORP; Sa-Otero MP, 2006, GRANA, V45, P137; Salgado-Laurenti CR, 2017, GRANA, V56, P450, DOI 10.1080/00173134.2016.1276619; Sauquet H, 2009, P NATL ACAD SCI USA, V106, P221, DOI 10.1073/pnas.0805607106; Seijo M. C., 2001, AEROBIOLOGIA, V17, P255; Seijo MC, 2003, GRANA, V42, P183, DOI 10.1080/00173130310011784; Sivic F., 2013, Bee World, V90, P6; Sniderman JMK, 2016, P NATL ACAD SCI USA, V113, P1999, DOI 10.1073/pnas.1520188113; Sniderman JMK, 2013, P NATL ACAD SCI USA, V110, P3423, DOI 10.1073/pnas.1216747110; Soares S, 2017, COMPR REV FOOD SCI F, V16, P1072, DOI 10.1111/1541-4337.12278; Somerville D., 2005, FAT BEES SKINNY BEES; South African National Biodiversity Institute, GUMS BEES ROADM LAND; STOCKMARR J, 1971, Pollen et Spores, V13, P615; Tang L.Y., 2016, ILLUSTRATED HDB QUAT; Terrab A, 2003, INT J FOOD SCI TECH, V38, P379, DOI 10.1046/j.1365-2621.2003.00715.x; Thornhill AH, 2005, ALTERED ECOLOGIES FI, P405, DOI 322010; Thornhill AH, 2012, AUST SYST BOT, V25, P171, DOI 10.1071/SB11019; Thornhill AH, 2012, AUST J BOT, V60, P225, DOI 10.1071/BT11176; Thornhill AH, 2012, AUST J BOT, V60, P260, DOI 10.1071/BT11177; Thornhill AH, 2012, AUST J BOT, V60, P165, DOI 10.1071/BT11174; Thornhill AH, 2012, MOL PHYLOGENET EVOL, V63, P15, DOI 10.1016/j.ympev.2011.12.003; van Dijk J, 2016, ABARES RES REPORT, V16.18; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; VANDERMOEZEL PG, 1987, J APICULT RES, V26, P224, DOI 10.1080/00218839.1987.11100764; Von Der Ohe W., 2004, APIDOLOGIE, V35, P18, DOI [10.1051/apido:2004050, DOI 10.1051/APIDO]; Wave Metrics, 2017, IGOR PRO VERS 7; Williams J. E., 1997, EUCALYPT ECOLOGY IND; Wilson Peter G., 2011, V10, P212	111	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197545	10.1371/journal.pone.0197545	http://dx.doi.org/10.1371/journal.pone.0197545			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768495	Green Published, gold			2022-12-26	WOS:000432329200093
J	Pauly, M; Black, AP; Khampanisong, P; Nouanthong, P; Hubschen, JM; Nanthavong, N; Sayasinh, K; Jutavijittum, P; Samountry, B; Xeuatvongsa, A; Diedrich, S; Muller, CP				Pauly, Maude; Black, Antony P.; Khampanisong, Phonepaseuth; Nouanthong, Phonethipsavanh; Huebschen, Judith M.; Nanthavong, Naphavanh; Sayasinh, Kong; Jutavijittum, Prapan; Samountry, Bounthome; Xeuatvongsa, Anonh; Diedrich, Sabine; Muller, Claude P.			Immunity levels to poliovirus in Lao children and adults before the vaccine-derived poliovirus outbreak: A retrospective study	PLOS ONE			English	Article							WESTERN PACIFIC; POLIOMYELITIS; IMMUNOGENICITY; ERADICATION	In 2015, several provinces in Lao People's Democratic Republic (Lao PDR) experienced a vaccine-derived poliovirus outbreak. This survey was conducted (i) to evaluate the vaccination coverage in different settings and cohorts using the seroprevalence of anti-poliovirus (PV) antibodies as a surrogate measure, and (ii) to explore the usefulness of an ELISA in a country with limited resources and a specific epidemiological setting. IgG antibodies were assessed by ELISA in Lao children (n = 1216) and adults (n = 1228), including blood donors and health care workers. Protective antibody titers against the 3 vaccine serotypes were determined by microneutralization (VNT) in a subset of participants. More than 92% of the children had anti-poliovirus antibodies, regardless of nutritional status or access to health care, highlighting the success of the vaccination outreach activities in the country. In contrast, anti-poliovirus seroprevalence reached only 81.7% in blood donors and 71.9% in health care workers. Participants born before the introduction of poliovirus vaccination in Lao PDR were considerably less likely to be seropositive. These findings align with the epidemiology of the outbreak. Neutralizing antibodies against at least one of the 3 poliovirus serotypes were detected in all children (99/99) and 93/99 had antibodies against all serotypes. Similarly, all health care workers had neutralizing antibodies against at least one and 92/99 against all serotypes. The comparison of both assays shows an acceptable underestimation of vaccine coverage in children by ELISA, but a low sensitivity of the ELISA in the adults. We show that the ELISA is a reasonable alternative to the VNT in particular in vaccinated children, that an improved version should be serotype specific, and that negativity thresholds should be revisited for optimal sensitivity and specificity. Thus, polio-free countries with an uncertain vaccination coverage and limited laboratory capacity, that are at risk of vaccine-derived poliovirus outbreaks or of re-importation of wild poliovirus may benefit from an improved ELISA for cohort studies to evaluate their immunization program in children.	[Pauly, Maude; Huebschen, Judith M.; Muller, Claude P.] Luxembourg Inst Hlth, Infect Dis Res Unit, Dept Infect & Immun, Esch Sur Alzette, Luxembourg; [Black, Antony P.; Khampanisong, Phonepaseuth; Nouanthong, Phonethipsavanh; Muller, Claude P.] Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos; [Nanthavong, Naphavanh; Sayasinh, Kong] Inst Francophonie Med Trop, Lao Peoples Democrat Republ, Viangchan, Laos; [Jutavijittum, Prapan] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand; [Samountry, Bounthome] Univ Hlth Sci, Fac Basic Sci, Viangchan, Laos; [Xeuatvongsa, Anonh] Lao Minist Hlth, Natl Immunizat Programme, Viangchan, Laos; [Diedrich, Sabine] Robert Koch Inst, Dept Infect Dis, Berlin, Germany; [Muller, Claude P.] Lab Natl Sante, Dudelange, Luxembourg	Luxembourg Institute of Health; Chiang Mai University; Robert Koch Institute	Pauly, M (corresponding author), Luxembourg Inst Hlth, Infect Dis Res Unit, Dept Infect & Immun, Esch Sur Alzette, Luxembourg.	maude.pauly@lih.lu	Hübschen, Judith/ABA-7931-2021; Hübschen, Judith/AAF-5113-2020	Hübschen, Judith/0000-0002-5001-2128; 	Ministry of Foreign and European Affairs, Luxembourg; project "Lao Luxembourg Partnership for Research and Capacity Building in Infectious Disease Surveillance II"	Ministry of Foreign and European Affairs, Luxembourg; project "Lao Luxembourg Partnership for Research and Capacity Building in Infectious Disease Surveillance II"	CPM received the funding for this study from the Ministry of Foreign and European Affairs, Luxembourg, project "Lao Luxembourg Partnership for Research and Capacity Building in Infectious Disease Surveillance II" (http://www.gouvernement.lu/maee).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink F, 2005, J INFECT DIS, V191, P990, DOI 10.1086/427810; Adams A, 2014, J INFECT DIS, V210, pS259, DOI 10.1093/infdis/jiu164; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P337; [Anonymous], 2000, Wkly Epidemiol Rec, V75, P399; Burns CC, 2014, J INFECT DIS, V210, pS283, DOI 10.1093/infdis/jiu295; Chand T, 2008, CURR SCI INDIA, V94, P172; Eddelbuettel D, 2011, J STAT SOFTW, V40, P1; Evdokimov K, 2017, CLIN MICROBIOL INFEC, V23, P197, DOI 10.1016/j.cmi.2016.10.007; Fox J., 2019, R COMPANION APPL REG, V.; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; Kalkowska DA, 2012, AM J EPIDEMIOL, V175, P936, DOI 10.1093/aje/kwr399; Kuroiwa C, 2000, LANCET, V356, P1487, DOI 10.1016/S0140-6736(00)02874-9; Morales M, 2016, MMWR-MORBID MORTAL W, V65, P470, DOI 10.15585/mmwr.mm6518a4; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Platt LR, 2014, J INFECT DIS, V210, pS380, DOI 10.1093/infdis/jiu184; Prime Minister of Lao PDR Thongsing Thammavong, 2016, DECL PUBL HLTH EM LA; Saleem AF, 2015, VACCINE, V33, P2757, DOI 10.1016/j.vaccine.2015.04.055; Tangermann RH, 1997, J INFECT DIS, V175, pS97, DOI 10.1093/infdis/175.Supplement_1.S97; UNICEF WHO, WHO UNICEF EST POL3; Venables WN., 2002, MODERN APPL STAT S 4; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organization, 2013, 50 YEARS WORK HLTH L; World Health Organization, 2013, POL ER ENDG 2013 201; world Health Organization, 2011, GUID STAB EV VACC; World Health Organization, 2004, POL LAB MAN, V4th; World Health Organization, 2008, POL REG STRAT PLAN 2; World Health Organization Regional Office for the Western Pacific, 2017, WHO POL B, V2017; World Hlth Org, 2017, VACCINE, V35, P1197, DOI 10.1016/j.vaccine.2016.11.017	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197370	10.1371/journal.pone.0197370	http://dx.doi.org/10.1371/journal.pone.0197370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763458	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800043
J	Omata, S; Someya, Y; Adachi, S; Masuda, T; Hayakawa, T; Harada, K; Mitsuishi, M; Totsuka, K; Araki, F; Takao, M; Aihara, M; Arai, F				Omata, Seiji; Someya, Yusei; Adachi, Shynya; Masuda, Taisuke; Hayakawa, Takeshi; Harada, Kanako; Mitsuishi, Mamoru; Totsuka, Kiyohito; Araki, Fumiyuki; Takao, Muneyuki; Aihara, Makoto; Arai, Fumihito			A surgical simulator for peeling the inner limiting membrane during wet conditions	PLOS ONE			English	Article							ELASTIC PROPERTIES; SURGERY	The present study was performed to establish a novel ocular surgery simulator for training in peeling of the inner limited membrane (ILM). This simulator included a next-generation artificial ILM with mechanical properties similar to the natural ILM that could be peeled underwater in the same manner as in actual surgery. An artificial eye consisting of a fundus and eyeball parts was fabricated. The artificial eye was installed in the eye surgery simulator. The fundus part was mounted in the eyeball, which consisted of an artificial sclera, retina, and ILM. To measure the thickness of the fabricated ILM on the artificial retina, we calculated the distance of the step height as the thickness of the artificial ILM. Two experienced ophthalmologists then assessed the fabricated ILM by sensory evaluation. The minimum thickness of the artificial ILM was 1.9 +/- 0.3 mu m (n = 3). We were able to perform the peeling task with the ILM in water. Based on the sensory evaluation, an ILM with a minimum thickness and 1000 degrees of polymerization was suitable for training. We installed the eye model on an ocular surgery simulator, which allowed for the performance of a sequence of operations similar to ILM peeling. In conclusion, we developed a novel ocular surgery simulator for ILM peeling. The artificial ILM was peeled underwater in the same manner as in an actual operation.	[Omata, Seiji; Someya, Yusei; Adachi, Shynya; Masuda, Taisuke; Arai, Fumihito] Nagoya Univ, Grad Sch Engn, Dept Micronano Mech Sci & Engn, Nagoya, Aichi, Japan; [Hayakawa, Takeshi] Chuo Univ, Fac Sci & Engn, Dept Precis Mech, Bunkyo Ku, Tokyo, Japan; [Harada, Kanako; Mitsuishi, Mamoru] Univ Tokyo, Sch Engn, Dept Mech Engn, Bunkyo Ku, Tokyo, Japan; [Harada, Kanako] Japan Sci & Technol Agcy JST, Chiyoda Ku, Tokyo, Japan; [Totsuka, Kiyohito; Araki, Fumiyuki; Takao, Muneyuki; Aihara, Makoto] Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo, Japan	Nagoya University; Chuo University; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Omata, S (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Micronano Mech Sci & Engn, Nagoya, Aichi, Japan.	s-omata@mech.nagoya-u.ac.jp	Hayakawa, Takeshi/M-1818-2019	Hayakawa, Takeshi/0000-0002-8420-3758; omata, seiji/0000-0003-0985-8567	Japan Society for the Promotion of Science [20360078]; ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	This study was financially supported by the Grant-in-Aid for Scientific Research of Japan Society for the Promotion of Science (20360078) (http://www.jst.go.jp/impact/bionichumanoids/en/index.html). Financial support for this study was provided by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan).	Akura J, 2011, WO Patent App., Patent No. [PCT/JP2010/002,630, 002630]; Basinger BC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055006; Bernal A, 2016, US Patent App, Patent No. [14/468,769, 14468769]; Bernal R, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437672; Brooks HL, 2000, OPHTHALMOLOGY, V107, P1939, DOI 10.1016/S0161-6420(00)00331-6; Carda DD, 2012, US Patent App., Patent No. [13/189,434, 13189434]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Deuchler S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150690; FRIBERG TR, 1988, EXP EYE RES, V47, P429, DOI 10.1016/0014-4835(88)90053-X; Halfter W, 2014, VITREOUS HLTH DIS, P165, DOI [10.1007/978-1-4939-1086-1_11, DOI 10.1007/978-1-4939-1086-1_11]; Haritoglou C, 2013, EYE, V27, P1308, DOI 10.1038/eye.2013.178; Hirata A, 2013, GRAEF ARCH CLIN EXP, V251, P1621, DOI 10.1007/s00417-012-2247-6; Hogan MJ, 1971, HISTOLOGY HUMAN EYE, P492; Jonas JB, 2003, ACTA OPHTHALMOL SCAN, V81, P600, DOI 10.1046/j.1395-3907.2003.0078.x; JONES IL, 1992, EYE, V6, P556, DOI 10.1038/eye.1992.121; Lai CC, 2015, RETINAL TODAY, P35; Li JY, 2014, J MATER CHEM B, V2, P6708, DOI 10.1039/c4tb01194e; Messmer EM, 1998, GRAEF ARCH CLIN EXP, V236, P248, DOI 10.1007/s004170050072; Otsuka E, 2011, J POLYM SCI POL PHYS, V49, P96, DOI 10.1002/polb.22161; Semeraro F, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/671905; Someya Y, 2016, INT SYM MICRO-NANOM; Strobl GR, 2007, PHYS POLYM, P357; Vaziri K, 2016, OPHTHALMOLOGY, V123, P26, DOI 10.1016/j.ophtha.2015.09.015; Vergmann AS, 2017, ACTA OPHTHALMOL, V95, P60, DOI 10.1111/aos.13209; Yoon HS, 1996, AM J OPHTHALMOL, V122, P67, DOI 10.1016/S0002-9394(14)71965-8	25	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196131	10.1371/journal.pone.0196131	http://dx.doi.org/10.1371/journal.pone.0196131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758028	Green Published, gold, Green Submitted			2022-12-26	WOS:000432082900007
J	Cui, W; Yoneda, R; Ueda, N; Kurokawa, R				Cui, Wei; Yoneda, Ryoma; Ueda, Naomi; Kurokawa, Riki			Arginine methylation of translocated in liposarcoma (TLS) inhibits its binding to long noncoding RNA, abrogating TLS-mediated repression of CBP/p300 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fused in sarcoma (FUS); long noncoding RNA (long ncRNA; lncRNA); post-translational modification (PTM); RNA-protein interaction; cyclin D1; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); histone acetylase; histone; RNA; gene expression; CBP; HAT activity; lncRNA; p300; TLS	SARCOMA PROTEIN; PRMT1; TRANSCRIPTION; METHYLTRANSFERASES; RECOGNITION; PEPTIDE	Translocated in liposarcoma (TLS) is an RNA-binding protein and a transcription-regulatory sensor of DNA damage. TLS binds promoter-associated noncoding RNA (pncRNA) and inhibits histone acetyltransferase (HAT) activity of CREB-binding protein (CBP)/E1A-binding protein P300 (p300) on the cyclin D1 (CCND1) gene. Although post-translational modifications of TLS, such as arginine methylation, are known to regulate TLS's nucleocytoplasmic shuttling and assembly in stress granules, its interactions with RNAs remain poorly characterized. Herein, using various biochemical assays, we confirmed the earlier observations that TLS is methylated by protein arginine methyltransferase 1 (PRMT1) in vitro. The arginine methylation of TLS disrupted binding to pncRNA and also prevented binding of TLS to and inhibition of CBP/p300. This result indicated that arginine methylation of TLS abrogates both binding to pncRNA and TLS-mediated inhibition of CBP/p300 HAT activities. We also report that an arginine residue within the Arg-Gly-Gly domain of TLS, Arg-476, serves as the major determinant for binding to pncRNA. Either methylation or mutation of Arg-476 of TLS significantly decreased pncRNA binding and thereby prevented a pncRNA-induced allosteric alteration in TLS that is required for its interaction with CBP/p300. Moreover, unlike WT TLS, an R476A TLS mutant did not inhibit CCND1 promoter activity in luciferase reporter assays. Taken together, we propose the hypothesis that arginine methylation of TLS regulates both TLS-nucleic acid and TLS-protein interactions and thereby participates in transcriptional regulation.	[Cui, Wei; Yoneda, Ryoma; Ueda, Naomi; Kurokawa, Riki] Saitama Med Univ, Res Ctr Genom Med, Div Gene Struct & Funct, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan	Saitama Medical University	Kurokawa, R (corresponding author), Saitama Med Univ, Res Ctr Genom Med, Div Gene Struct & Funct, 1397-1 Yamane, Hidaka, Saitama 3501241, Japan.	rkurokaw@saitama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT); KAKENHI from JSPS to MEXT of Japan [22390057, 25293073, 18K06939]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); KAKENHI from JSPS to MEXT of Japan	This work was supported in part by a grant-in-aid for "Support Project of Strategic Research Center in Private Universities" from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) to Saitama Medical University Research Center for Genomic Medicine and by KAKENHI from JSPS to MEXT of Japan (KibanB Grants 22390057 and 25293073, KibanC Grant 18K06939). The authors declare that they have no conflicts of interest with the contents of this article.	Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Araya N, 2005, BIOCHEM BIOPH RES CO, V329, P653, DOI 10.1016/j.bbrc.2005.02.018; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Belyanskaya LL, 2001, J BIOL CHEM, V276, P18681, DOI 10.1074/jbc.M011446200; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Brooke GN, 2011, CANCER RES, V71, P914, DOI 10.1158/0008-5472.CAN-10-0874; Burdach J, 2012, TRENDS BIOCHEM SCI, V37, P199, DOI 10.1016/j.tibs.2012.02.001; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Du K, 2011, BIOCHEM BIOPH RES CO, V404, P991, DOI 10.1016/j.bbrc.2010.12.097; Fujimoto K., 2013, CELL BIOL, V1, P18, DOI [10.11648/j.cb.20130102.11, DOI 10.11648/J.CB.20130102.11]; Fujimoto K, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-77; Hung CJ, 2009, PROTEIN J, V28, P139, DOI 10.1007/s10930-009-9174-3; Jobert L, 2009, EXP CELL RES, V315, P1273, DOI 10.1016/j.yexcr.2008.12.008; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Morettin A, 2015, MUTAGENESIS, V30, P177, DOI 10.1093/mutage/geu039; Ozdilek BA, 2017, NUCLEIC ACIDS RES, V45, P7984, DOI 10.1093/nar/gkx460; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Ramos A, 2003, RNA, V9, P1198, DOI 10.1261/rna.5960503; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Scaramuzzino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061576; Takahama K, 2013, CHEM BIOL, V20, P341, DOI 10.1016/j.chembiol.2013.02.013; Takahama K, 2011, FEBS J, V278, P988, DOI 10.1111/j.1742-4658.2011.08020.x; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049267; Yang L., 2015, THESIS; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yoneda R, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0068-8; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou Yueqin, 2014, Rare Dis, V2, pe29515, DOI 10.4161/rdis.29515	33	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10937	10948		10.1074/jbc.RA117.000598	http://dx.doi.org/10.1074/jbc.RA117.000598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784880	hybrid, Green Published			2022-12-26	WOS:000438882800008
J	DeColli, AA; Nemeria, NS; Majumdar, A; Gerfen, GJ; Jordan, F; Meyers, CLF				DeColli, Alicia A.; Nemeria, Natalia S.; Majumdar, Ananya; Gerfen, Gary J.; Jordan, Frank; Meyers, Caren L. Freel			Oxidative decarboxylation of pyruvate by 1-deoxy-d-xyulose 5-phosphate synthase, a central metabolic enzyme in bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						decarboxylase; oxygen binding; oxidation-reduction (redox); thiamine; enzyme mechanism; pyridoxal phosphate; DXP synthase; oxidative decarboxylation; oxygenase	COLI 1-DEOXY-D-XYLULOSE-5-PHOSPHATE SYNTHASE; ACETOLACTATE SYNTHASE; THIAMIN DIPHOSPHATE; DEPENDENT ENZYMES; SUBSTRATE-BINDING; DXP SYNTHASE; BIOSYNTHESIS; INTERMEDIATE; MECHANISM; OXIDOREDUCTASE	The underexploited antibacterial target 1-deoxy-d-xyluose 5-phosphate (DXP) synthase catalyzes the thiamin diphosphate (ThDP)-dependent formation of DXP from pyruvate and d-glyceraldehyde 3-phosphate (d-GAP). DXP is an essential intermediate in the biosynthesis of ThDP, pyridoxal phosphate, and isoprenoids in many pathogenic bacteria. DXP synthase catalyzes a distinct mechanism in ThDP decarboxylative enzymology in which the first enzyme-bound pre-decarboxylation intermediate, C2-lactyl-ThDP (LThDP), is stabilized by DXP synthase in the absence of d-GAP, and d-GAP then induces efficient LThDP decarboxylation. Despite the observed LThDP accumulation and lack of evidence for C2-carbanion formation in the absence of d-GAP, CO2 is released at appreciable levels under these conditions. Here, seeking to resolve these conflicting observations, we show that DXP synthase catalyzes the oxidative decarboxylation of pyruvate under conditions in which LThDP accumulates. O-2-dependent LThDP decarboxylation led to one-electron transfer from the C2-carbanion/enamine to O-2, with intermediate ThDP-enamine radical formation, followed by peracetic acid formation en route to acetate. Thus, LThDP formation and decarboxylation and DXP formation were studied under anaerobic conditions. Our results support a model in which O-2-dependent LThDP decarboxylation and peracetic acid formation occur in the absence of d-GAP, decreasing the levels of pyruvate and O-2 in solution. The relative pyruvate and O-2 concentrations then dictate the extent of LThDP accumulation, and its buildup can be observed when [pyruvate] > [O-2]. The finding that O-2 acts as a structurally distinct trigger of LThDP decarboxylation supports the hypothesis that a mechanism involving small molecule-dependent LThDP decarboxylation equips DXP synthase for diverse, yet uncharacterized cellular functions.	[DeColli, Alicia A.; Meyers, Caren L. Freel] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Majumdar, Ananya] Johns Hopkins Univ, Sch Med, Dept Chem, Baltimore, MD 21205 USA; [Nemeria, Natalia S.; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Gerfen, Gary J.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Johns Hopkins University; Johns Hopkins University; Rutgers State University Newark; Rutgers State University New Brunswick; Yeshiva University; Albert Einstein College of Medicine	Meyers, CLF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	cmeyers@jhmi.edu		Freel Meyers, Caren/0000-0003-1458-0897	National Institutes of Health [R01 GM084998]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084998, T32GM008763, R15GM116077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM084998 (to C.L.F.M). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABELL LM, 1991, BIOCHEMISTRY-US, V30, P7883, DOI 10.1021/bi00246a002; Applied Photophysics, 2012, US MAN SX20 STOPP FL; Bartee D, 2015, CHEMBIOCHEM, V16, P1771, DOI 10.1002/cbic.201500119; Basta LAB, 2014, FEBS J, V281, P2820, DOI 10.1111/febs.12823; Battistini MR, 2016, PROTEIN EXPRES PURIF, V120, P16, DOI 10.1016/j.pep.2015.12.003; Brammer LA, 2011, J BIOL CHEM, V286, P36522, DOI 10.1074/jbc.M111.259747; Brammer LA, 2009, ORG LETT, V11, P4748, DOI 10.1021/ol901961q; Bunik Victoria I, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P307; BURGHAUS O, 1992, MEAS SCI TECHNOL, V3, P765, DOI 10.1088/0957-0233/3/8/013; Du QL, 2011, INT J BIOL SCI, V7, P41, DOI 10.7150/ijbs.7.41; Eubanks LM, 2003, BIOCHEMISTRY-US, V42, P1140, DOI 10.1021/bi0205303; Gonzalez-James OM, 2010, J AM CHEM SOC, V132, P6896, DOI 10.1021/ja101775s; Kluger R, 2015, ACCOUNTS CHEM RES, V48, P2843, DOI 10.1021/acs.accounts.5b00306; Laber B, 1999, FEBS LETT, V449, P45, DOI 10.1016/S0014-5793(99)00393-2; Mansoorabadi SO, 2006, BIOCHEMISTRY-US, V45, P7122, DOI 10.1021/bi0602516; Morris F, 2013, CHEMBIOCHEM, V14, P1309, DOI 10.1002/cbic.201300187; Mundle SOC, 2009, J AM CHEM SOC, V131, P11638, DOI 10.1021/ja902686h; Nemeria NS, 2018, FREE RADICAL BIO MED, V115, P136, DOI 10.1016/j.freeradbiomed.2017.11.018; Nemeria NS, 2017, FREE RADICAL BIO MED, V108, P644, DOI 10.1016/j.freeradbiomed.2017.04.017; Nemeria NS, 2016, BIOCHEMISTRY-US, V55, P1135, DOI 10.1021/acs.biochem.5b01300; Nemeria NS, 2014, J BIOL CHEM, V289, P29859, DOI 10.1074/jbc.M114.591073; Patel H, 2012, J AM CHEM SOC, V134, P18374, DOI 10.1021/ja307315u; Pierce E, 2017, BIOCHEMISTRY-US, V56, P2824, DOI 10.1021/acs.biochem.7b00222; Putt KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079218; Rodriguez-Concepion M, 2004, CURR PHARM DESIGN, V10, P2391, DOI 10.2174/1381612043384006; Sanders S, 2017, ACS INFECT DIS, V3, P467, DOI 10.1021/acsinfecdis.6b00168; Schloss J. V., 1996, BIOCH PHYSL THIAMIN, P580; Schorken U, 1998, BBA-PROTEIN STRUCT M, V1385, P229, DOI 10.1016/S0167-4838(98)00071-5; Smith JM, 2014, J ANTIBIOT, V67, P77, DOI 10.1038/ja.2013.105; Smith JM, 2012, MEDCHEMCOMM, V3, P65, DOI 10.1039/c1md00233c; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Sung MG, 2015, BIOPROC BIOSYST ENG, V38, P517, DOI 10.1007/s00449-014-1291-5; Tittmann K, 2005, BIOCHEMISTRY-US, V44, P13291, DOI 10.1021/bi051058z; TSE JMT, 1993, BIOCHEMISTRY-US, V32, P10398, DOI 10.1021/bi00090a015; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Zhou JY, 2017, P NATL ACAD SCI USA, V114, P9355, DOI 10.1073/pnas.1619981114	36	7	7	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10857	10869		10.1074/jbc.RA118.001980	http://dx.doi.org/10.1074/jbc.RA118.001980			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784878	Green Published, hybrid			2022-12-26	WOS:000438882800002
J	Molparia, B; Oliveira, G; Wagner, JL; Spencer, EG; Torkamani, A				Molparia, Bhuvan; Oliveira, Glenn; Wagner, Jennifer L.; Spencer, Emily G.; Torkamani, Ali			A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection	PLOS ONE			English	Article							CELL-FREE DNA; PATTERNS	Circulating tumor DNA (ctDNA) has shown great promise as a biomarker for early detection of cancer. However, due to the low abundance of ctDNA, especially at early stages, it is hard to detect at high accuracies while keeping sequencing costs low. Here we present a pilot stage study to detect large scale somatic copy numbers variations (CNVs), which contribute more molecules to ctDNA signal compared to point mutations, via cell free DNA sequencing. We show that it is possible to detect somatic CNVs in early stage colorectal cancer (CRC) patients and subsequently discriminate them from normal patients. With 25 normal and 24 CRC samples, we achieve 100% specificity (lower bound confidence interval: 86%) and similar to 9% sensitivity (95% confidence interval: 63% - 95%,), though the performance should be considered with caution given the limited sample size. We report a lack of concordance between the CNVs detected via cfDNA sequencing and CNVs identified in parent tissue samples. However, recent findings suggest that a lack of concordance is expected for CNVs in CRC because of their sub-clonal nature. Finally, the CNVs we detect very likely contribute to cancer progression as they lie in functionally important regions, and have been shown to be associated with CRC specifically. This study paves the path for a larger scale exploration of the potential of CNV detection for both diagnoses and prognoses of cancer.	[Molparia, Bhuvan; Oliveira, Glenn; Spencer, Emily G.; Torkamani, Ali] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Molparia, Bhuvan; Oliveira, Glenn; Torkamani, Ali] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Oliveira, Glenn; Torkamani, Ali] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Wagner, Jennifer L.] Scripps Hlth, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Torkamani, A (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Torkamani, A (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	atorkama@scripps.edu		Spencer, Emily/0000-0003-2650-4357	Scripps Translational Science, an NIH-NCATS Clinical and Translational Science Award (CTSA) [5 UL1 TR001114]; Sequenom Inc.	Scripps Translational Science, an NIH-NCATS Clinical and Translational Science Award (CTSA); Sequenom Inc.	This work is supported by The Scripps Translational Science, an NIH-NCATS Clinical and Translational Science Award (CTSA; 5 UL1 TR001114), with additional funding from Sequenom Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bianchi DW, 2015, JAMA-J AM MED ASSOC, V314, P162, DOI 10.1001/jama.2015.7120; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cao Y, 2018, GUT, V67, P672, DOI 10.1136/gutjnl-2016-313413; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Inamura K, 2018, CANCERS, V10, DOI 10.3390/cancers10010026; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2017, MOL ONCOL, V11, P1099, DOI 10.1002/1878-0261.12077; Lin HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009895; Mamlouk S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14093; Molparia B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180647; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Phallen J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2415; Rousseeuw PJ, 2011, WIRES DATA MIN KNOWL, V1, P73, DOI 10.1002/widm.2; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Thompson Amy E, 2015, JAMA, V314, P198, DOI 10.1001/jama.2015.7655; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; Weerakoon KG, 2016, TRENDS PARASITOL, V32, P378, DOI 10.1016/j.pt.2016.01.006; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	24	19	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196826	10.1371/journal.pone.0196826	http://dx.doi.org/10.1371/journal.pone.0196826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791457	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000024
J	Robbins, R; Seixas, A; Jean-Louis, G; Parthasarathy, S; Rapoport, DM; Ogedegbe, G; Ladapo, JA				Robbins, Rebecca; Seixas, Azizi; Jean-Louis, Girardin; Parthasarathy, Sairam; Rapoport, David M.; Ogedegbe, Gbenga; Ladapo, Joseph A.			National patterns of physician management of sleep apnea and treatment among patients with hypertension	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; BLOOD-PRESSURE; DURATION; RISK; INSOMNIA; PREVENTION; HEALTH; EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION	Study objectives Sleep apnea is associated with hypertension, and treatment may improve outcomes. We examine national burden of sleep apnea, rates of sleep apnea treatment, and whether racial/ethnic disparities exist among patients with hypertension. Methods Data from the National Ambulatory Medical Care Survey/National Hospital Ambulatory Medical Care Survey (NAMCS/NHAMCS), 2005-2012, were analyzed (N = 417,950). We identified hypertension patient visits where sleep apnea diagnosis or complaint was recorded. Primary outcome measures were sleep study, medication, or behavioral therapy (diet, weight loss, or exercise counseling). We used multivariate logistic regression to examine treatment by demographic/clinical factors. Results Among patients with hypertension, sleep apnea was identified in 11.2-per-1,000 visits. Overall, patients with hypertension and a sleep disorder were referred for sleep study in 14.4% of visits, prescribed sleep medication in 11.2% of visits, and offered behavioral therapy in 34.8% of visits. Adjusted analyses show behavioral therapy more likely to be provided to obese patients than normal/overweight (OR = 4.96, 95%CI[2.93-8.38]), but less likely to be provided to smokers than nonsmokers (OR = 0.54, 95%)/CI[0.32-0.93]). Non-Hispanic blacks were less likely to receive medications than non-Hispanic whites (OR = 0.19, 95% CI[0.06-0.65]). Conclusions In the U.S., sleep apnea were observed in a small proportion of hypertension visits, a population at high-risk for the disorder. One explanation for the low prevalence of sleep apnea observed in this patient population at high risk for the disorder is under-diagnosis of sleep related breathing disorders. Behavioral therapy was underutilized, and non-Hispanic Blacks were less likely to receive medications than non-Hispanic Whites.	[Robbins, Rebecca; Seixas, Azizi; Jean-Louis, Girardin; Ogedegbe, Gbenga] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Parthasarathy, Sairam] Univ Arizona, Dept Med, Tucson, AZ USA; [Rapoport, David M.] Icahn Sch Med Mt Sinai, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA; [Ladapo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA	New York University; University of Arizona; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ladapo, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA.	JLadapo@mednet.ucla.edu		Jean-Louis, Girardin/0000-0001-6777-2724; Rapoport, David/0000-0002-4855-2600; Seixas, Azizi/0000-0003-0843-2679; Ladapo, Joseph/0000-0002-8518-4800	National Heart, Lung, and Blood Institute [R25HL116378, K23 HL116787]; National Institutes of Health [R01 MD011544]; Robert Wood Johnson Foundation [72426]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL135452] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by National Heart, Lung, and Blood Institute R25HL116378 Girardin Jean-Louis National Heart, Lung, and Blood Institute K23 HL116787 Joseph A Ladapo, National Institutes of Health R01 MD011544 Joseph A Ladapo, Robert Wood Johnson Foundation 72426 Joseph A Ladapo.	Araghi MH, 2013, SLEEP, V36, P1553, DOI 10.5665/sleep.3056; Bathgate CJ, 2016, SLEEP, V39, P1037, DOI 10.5665/sleep.5748; Berger JS, 2017, J AM COLL CARDIOL, V69, P2293, DOI 10.1016/j.jacc.2017.02.064; Billings ME, 2011, SLEEP, V34, P1653, DOI 10.5665/sleep.1428; Bonnet MH, 1998, PSYCHOSOM MED, V60, P610, DOI 10.1097/00006842-199809000-00017; Bonnet MH, 2014, SLEEP MED REV, V18, P111, DOI 10.1016/j.smrv.2013.02.003; Bratton DJ, 2015, JAMA-J AM MED ASSOC, V314, P2280, DOI 10.1001/jama.2015.16303; Buratti L, 2017, SLEEP MED, V34, P251, DOI 10.1016/j.sleep.2017.01.015; Buratti L, 2017, J ALZHEIMERS DIS, V60, P1195, DOI 10.3233/JAD-170445; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; Chyun Deborah A, 2003, J Cardiovasc Nurs, V18, P302; Dudley KA, 2016, SLEEP MED, V18, P96, DOI 10.1016/j.sleep.2015.01.015; Eckert Danny J, 2008, Proc Am Thorac Soc, V5, P144, DOI 10.1513/pats.200707-114MG; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Fang J, 2012, AM J HYPERTENS, V25, P335, DOI 10.1038/ajh.2011.201; FLETCHER EC, 1995, AM J MED, V98, P118, DOI 10.1016/S0002-9343(99)80395-7; Flygare J, 2015, AM J MED, V128, P10, DOI 10.1016/j.amjmed.2014.05.037; Ford ES, 2014, SLEEP, V37, P1283, DOI 10.5665/sleep.3914; Galani C, 2007, INT J PUBLIC HEALTH, V52, P348, DOI 10.1007/s00038-007-7015-8; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Heck T, 2015, NEUROPSYCH DIS TREAT, V11, P2691, DOI 10.2147/NDT.S90521; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1007/s11325-002-0049-5; Krakow Barry, 2004, Sleep Breath, V8, P15, DOI 10.1007/s11325-004-0015-5; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Kripke DF, 2000, SLEEP MED REV, V4, P5, DOI 10.1053/smrv.1999.0076; Ladapo JA, 2014, ANN INTERN MED, V161, P482, DOI 10.7326/M14-0296; Lettieri CJ, 2009, ANN INTERN MED, V151, P696, DOI 10.7326/0003-4819-151-10-200911170-00006; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; LOUBE DI, 1994, J AM DIET ASSOC, V94, P1291, DOI 10.1016/0002-8223(94)92462-7; Mason M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011090.pub2; Meng L, 2013, HYPERTENS RES, V36, P985, DOI 10.1038/hr.2013.70; Montesi SB, 2012, J CLIN SLEEP MED, V8, P587, DOI 10.5664/jcsm.2170; Nunes J, 2008, J NATL MED ASSOC, V100, P317, DOI 10.1016/S0027-9684(15)31244-X; Pandey A, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/436502; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Takaesu Y, 2012, SLEEP MED, V13, P156, DOI 10.1016/j.sleep.2011.10.016; Trakada G, 2015, SLEEP BREATH, V19, P467, DOI 10.1007/s11325-014-1050-5; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; Wassertheil-Smoller S, 2004, ARCH INTERN MED, V164, P289, DOI 10.1001/archinte.164.3.289; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zheng JM, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.976057	45	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196981	10.1371/journal.pone.0196981	http://dx.doi.org/10.1371/journal.pone.0196981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791455	Green Submitted, Green Published, gold			2022-12-26	WOS:000433077000026
J	Andersen, M; Boesen, M; Ellegaard, K; Soderstrom, K; Soe, NH; Spee, P; Morch, UGW; Torp-Pedersen, S; Bartels, EM; Danneskiold-Samsoe, B; Karlsson, L; Bliddal, H				Andersen, Martin; Boesen, Mikael; Ellegaard, Karen; Soderstrom, Kalle; Soe, Niels H.; Spee, Pieter; Morch, Ulrik G. W.; Torp-Pedersen, Soren; Bartels, Else M.; Danneskiold-Samsoe, Bente; Karlsson, Lars; Bliddal, Henning			Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study	PLOS ONE			English	Article							DISEASE-ACTIVITY SCORE; IN-VITRO MODEL; ULTRASONOGRAPHIC ASSESSMENT; PROINFLAMMATORY CYTOKINES; BONE-RESORPTION; JOINT DAMAGE; VALIDATION; BIOMARKER; INTERLEUKIN-17; INFLAMMATION	Introduction The need for biomarkers which can predict disease course and treatment response in rheumatoid arthritis (RA) is evident. We explored whether clinical and imaging responses to biologic disease modifying anti-rheumatic drug treatment (bDMARD) were associated with the individual's mediator production in explants obtained at baseline. Methods RA Patients were evaluated by disease activity score 28 joint C-reactive protein (DAS 28-)), colour Doppler ultrasound (CDUS) and 3 Tesla RA magnetic resonance imaging scores (RAMRIS). Explants were established from synovectomies from a needle arthroscopic procedure prior to initiation of bDMARD. Explants were incubated with the bDMARD in question, and the productions of interleukin-6 (IL-6), monocyte chemo-attractive protein-1 (MCP-1) and macrophage inflammatory protein-1-beta (MIP-1b) were measured by multiplex immunoassays. The changes in clinical and imaging variables following a minimum of 3 months bDMARD treatment were compared to the baseline explant results. Mixed models and Spearman's rank correlations were performed. P-values below 0.05 were considered statistically significant. Results 16 patients were included. IL-6 production in bDMARD-treated explants was significantly higher among clinical non-responders compared to responders (P = 0.04), and a lack of suppression of IL-6 by the bDMARDS correlated to a high DAS-28 (p = 0.57, P = 0.03), CDUS (p = 0.53, P = 0.04) and bone marrow oedema (p = 0.56, P = 0.03) at follow-up. No clinical association was found with explant MCP-1 production. MIP-1b could not be assessed due to a large number of samples below the detection limit. Conclusions Synovial explants appear to deliver a disease-relevant output testing which when carried out in advance of bDMARD treatment can potentially pave the road for a more patient tailored treatment approach with better treatment effects.	[Andersen, Martin; Ellegaard, Karen; Torp-Pedersen, Soren; Bartels, Else M.; Danneskiold-Samsoe, Bente; Bliddal, Henning] Copenhagen Univ Hosp, Parker Inst, Dept Rheumatol, Copenhagen, Denmark; [Andersen, Martin; Soderstrom, Kalle; Spee, Pieter; Karlsson, Lars] Novo Nordisk, Biopharmaceut Res Unit, Translat Immunol, Malov, Denmark; [Boesen, Mikael] Copenhagen Univ Hosp, Dept Radiol, Copenhagen, Denmark; [Soe, Niels H.] Gentofte Univ Hosp, Sect Hand Surg, Dept Orthopaed, Hellerup, Denmark; [Morch, Ulrik G. W.] Novo Nordisk, Biomarkers, Soborg, Denmark	University of Copenhagen; Novo Nordisk; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Novo Nordisk	Andersen, M; Bliddal, H (corresponding author), Copenhagen Univ Hosp, Parker Inst, Dept Rheumatol, Copenhagen, Denmark.; Andersen, M (corresponding author), Novo Nordisk, Biopharmaceut Res Unit, Translat Immunol, Malov, Denmark.	martin.andersen@regionh.dk; henning.bliddal@region.dk	Bliddal, Henning/AAB-3168-2019	Bliddal, Henning/0000-0002-7951-1668	Danish Agency for Science, Technology and Innovation; Novo Nordisk; Parker Institute; Oak Foundation	Danish Agency for Science, Technology and Innovation; Novo Nordisk(Novo Nordisk); Parker Institute; Oak Foundation	This study was supported by unrestricted grants from the Danish Agency for Science, Technology and Innovation, Novo Nordisk, and the Parker Institute. The Parker Institute is supported by grants from the Oak Foundation, a nonprofit funding source that had no role in the design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, and approval of the manuscript. During the course of this study Martin Andersen, Kalle Soderstom, Pieter Spee, Ulrik GW Morch, and Lars Karlsson were employed at Novo Nordisk. Novo Nordisk provided support in the form of salaries for authors MA, KS, PS, UGWM and LK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4557; Bakker MF, 2012, ANN RHEUM DIS, V71, P1692, DOI 10.1136/annrheumdis-2011-200963; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chabaud M, 2001, ARTHRITIS RHEUM, V44, P1293, DOI 10.1002/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T; Chevrel G, 2002, ANN RHEUM DIS, V61, P730, DOI 10.1136/ard.61.8.730; Conaghan PG, 2011, ANN RHEUM DIS, V70, P1968, DOI 10.1136/ard.2010.146068; Curtis JR, 2012, ARTHRIT CARE RES, V64, P1794, DOI 10.1002/acr.21767; Ejbjerg BJ, 2005, ARTHRITIS RHEUM-US, V52, P2300, DOI 10.1002/art.21207; Ellegaard K, 2008, ULTRASCHALL MED, V29, P393, DOI 10.1055/s-2008-1027196; Ford AL, 1996, J IMMUNOL METHODS, V194, P71, DOI 10.1016/0022-1759(96)00067-1; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Grassi F, 2003, HISTOCHEM CELL BIOL, V120, P391, DOI 10.1007/s00418-003-0587-3; Guyot P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3537; Hamdi H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1994; Hammer HB, 2010, ANN RHEUM DIS, V69, P1349, DOI 10.1136/ard.2009.126995; Hirata S, 2013, RHEUMATOLOGY, V52, P1202, DOI 10.1093/rheumatology/kes362; Hosaka K, 2005, CYTOKINE, V32, P263, DOI 10.1016/j.cyto.2005.11.005; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Laurell L, 2012, PEDIATR RHEUMATOL, V10, DOI 10.1186/1546-0096-10-23; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; MIOSSEC P, 1994, ARTHRITIS RHEUM, V37, P1715, DOI 10.1002/art.1780371202; MIOSSEC P, 1992, ARTHRITIS RHEUM, V35, P874, DOI 10.1002/art.1780350805; Moran EM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2772; Naredo E, 2007, ARTHRIT RHEUM-ARTHR, V57, P116, DOI 10.1002/art.22461; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Nozaki T, 2007, ARTHRITIS RHEUM-US, V56, P2875, DOI 10.1002/art.22849; Salliot C, 2011, ANN RHEUM DIS, V70, P266, DOI 10.1136/ard.2010.132134; Schultz O, 1997, ARTHRITIS RHEUM-US, V40, P1420, DOI 10.1002/art.1780400809; Shimamoto K, 2013, J RHEUMATOL, V40, P1074, DOI 10.3899/jrheum.121389; Tak PP, 2012, RHEUMATOLOGY, V51, P600, DOI 10.1093/rheumatology/ker300; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Takeuchi T, 2012, ANN RHEUM DIS, V71, P1583, DOI 10.1136/annrheumdis-2011-201069; Tektonidou MG, 2011, NAT REV RHEUMATOL, V7, P708, DOI 10.1038/nrrheum.2011.157; Ultaigh SNA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3261; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Yazici Y, 2009, J RHEUMATOL, V36, P907, DOI 10.3899/jrheum.080592	38	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197001	10.1371/journal.pone.0197001	http://dx.doi.org/10.1371/journal.pone.0197001			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787569	Green Submitted, Green Published, gold			2022-12-26	WOS:000432785700009
J	Bin Gwag, H; Chun, KJ; Hwang, JK; Park, SJ; Kim, JS; Park, KM; On, YK				Bin Gwag, Hye; Chun, Kwang Jin; Hwang, Jin Kyung; Park, Seung-Jung; Kim, June Soo; Park, Kyoung-Min; On, Young Keun			Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients	PLOS ONE			English	Article							SINUS RHYTHM; RANDOMIZED-TRIAL; MAINTENANCE; MANAGEMENT; EFFICACY; PROPAFENONE; THERAPIES; SOTALOL	The relative efficacy of antiarrhythmic drugs (AADs) after electrical cardioversion are not well established. This study aimed to investigate the efficacies of different AADs for maintaining sinus rhythm (SR) after electrical cardioversion for atrial fibrillation (AF). We selected patients from a retrospective registry including patients admitted for cardioversion between January 2012 and June 2016. The primary outcome was time to AF recurrence during the first year after cardioversion. The secondary outcomes included AF recurrence within 1 month, and first readmission due to heart failure, stroke, or additional non-pharmacological rhythm control. A total of 265 patients were divided into the 4 groups according to AAD type: flecainide (n = 33), propafenone (n = 64), amiodarone (n = 128), and dronedarone (n = 40). During the first year after cardioversion, the AF recurrence-free survival was similar between all AAD groups (69.7% vs. 67.2% vs. 71.9% vs. 80.0%, p = 0.439). About half of all recurrences occurred during the first month. There was no difference in any of the secondary outcomes, although the amiodarone group showed a trend toward more non-pharmacological rhythm control. AAD type was not associated with recurrence in multivariate analysis. In this study, half of all patients received amiodarone after electrical cardioversion. Flecainide, propafenone, amiodarone, and dronedarone showed similar efficacies for maintaining SR after electrical cardioversion. Thus, it might be reasonable to reconsider amiodarone use after cardioversion, since it did not show superior efficacy to the other drugs considered and is associated with potential side effects.	[Bin Gwag, Hye; Hwang, Jin Kyung; Park, Seung-Jung; Kim, June Soo; Park, Kyoung-Min; On, Young Keun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med,Heart Vasc Stroke I, Seoul, South Korea; [Chun, Kwang Jin] Hallym Univ, Med Ctr, Kangnam Sacred Heart Hosp, Div Cardiol,Dept Med, Seoul, South Korea; [Chun, Kwang Jin] Kangwon Natl Univ, Div Cardiol, Dept Med, Coll Med, Chunchon, South Korea; [Hwang, Jin Kyung] VHS Med Ctr, Div Cardiol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hallym University; Kangwon National University; Veterans Health Service Medical Center	On, YK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med,Heart Vasc Stroke I, Seoul, South Korea.	yk.on@samsung.com						Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Bellandi F, 2001, AM J CARDIOL, V88, P640, DOI 10.1016/S0002-9149(01)01806-9; Chun KJ, 2014, CLIN THER, V36, P1169, DOI 10.1016/j.clinthera.2014.07.013; Fetsch T, 2004, EUR HEART J, V25, P1385, DOI 10.1016/j.ehj.2004.04.015; Hagens VE, 2004, EUR HEART J, V25, P1542, DOI 10.1016/j.ehj.2004.06.020; Hohnloser SH, 2001, EUR HEART J, V22, P801, DOI 10.1053/euhj.2001.2596; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kim SK, 2009, EUROPACE, V11, P1632, DOI 10.1093/europace/eup321; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Kuhn EW, 2014, EUR J CARDIO-THORAC, V45, P17, DOI 10.1093/ejcts/ezt181; Lafuente-Lafuente C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub2; Lindholm CJA, 2004, HEART, V90, P534, DOI 10.1136/hrt.2003.017707; Macchia A, 2013, J AM COLL CARDIOL, V61, P463, DOI 10.1016/j.jacc.2012.11.021; Alegret JM, 2008, REV ESP CARDIOL, V61, P1274, DOI 10.1016/S1885-5857(09)60055-4; Nergardh AK, 2007, EUR HEART J, V28, P1351, DOI 10.1093/eurheartj/ehl544; Overvad TF, 2013, HEART, V99, P1093, DOI 10.1136/heartjnl-2013-304036; Plewan A, 2001, EUR HEART J, V22, P1504, DOI 10.1053/euhj.2000.2546; Qin DX, 2016, J CARDIOL, V67, P471, DOI 10.1016/j.jjcc.2015.07.001; Saksena S, 2011, J AM COLL CARDIOL, V58, P1975, DOI 10.1016/j.jacc.2011.07.036; Savelieva I, 2011, EUROPACE, V13, P610, DOI 10.1093/europace/eur023; Schilling RJ, 2010, HEART, V96, P333, DOI 10.1136/hrt.2008.155812; Shin DG, 2015, YONSEI MED J, V56, P1552, DOI 10.3349/ymj.2015.56.6.1552	22	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197352	10.1371/journal.pone.0197352	http://dx.doi.org/10.1371/journal.pone.0197352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787592	Green Submitted, gold, Green Published			2022-12-26	WOS:000432785700023
J	Estrada, A; Real, R				Estrada, Alba; Real, Raimundo			Assessment of the National Park network of mainland Spain by the Insecurity Index of vertebrate species	PLOS ONE			English	Article							PROTECTED AREAS; CLIMATE-CHANGE; DARK DIVERSITY; FUZZY-LOGIC; TERRESTRIAL VERTEBRATES; CONSERVATION PRIORITIES; GAP ANALYSIS; LAND-USE; BIODIVERSITY; PATTERNS	The evaluation of protected area networks on their capacity to preserve species distributions is a key topic in conservation biology. There are different types of protected areas, with National Parks those with highest level of protection. National Parks can be declared attending to many ecological features that include the presence of certain animal species. Here, we selected 37 vertebrate species that were highlighted as having relevant natural value for at least one of the 10 National Parks of mainland Spain. We modelled species distributions with the favourability function, and applied the Insecurity Index to detect the degree of protection of favourable areas for each species. Two metrics of Insecurity Index were defined for each species: the Insecurity Index in each of the cells, and the Overall Insecurity Index of a species. The former allows the identification of insecure areas for each species that can be used to establish spatial conservation priorities. The latter gives a value of Insecurity for each species, which we used to calculate the Representativeness of favourable areas for the species in the network. As expected, due to the limited extension of the National Park network, all species have high values of Insecurity; i.e., just a narrow proportion of their favourable areas are covered by a National Park. However, the majority of species favourable areas are well represented in the network, i.e., the percentage of favourable areas covered by the National Park network is higher than the percentage of mainland Spain covered by the network (result also supported by a randomization approach). Even if a reserve network only covers a low percentage of a country, the Overall Insecurity Index allows an objective assessment of its capacity to represent species. Beyond the results presented here, the Insecurity Index has the potential to be extrapolated to other areas and to cover a wide range of species.	[Estrada, Alba; Real, Raimundo] Univ Malaga, Dept Anim Biol, Biogeog Div & Conservat Res Team, Malaga, Spain; [Estrada, Alba] Oviedo Univ, CSIC, UMIB, Res Unit Biodivers UO,PA, Campus Mieres, Mieres, Spain; [Estrada, Alba] CSIC, JCCM, UCLM, Inst Invest Recursos Cinegeticos IREC, Ciudad Real, Spain	Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	Estrada, A (corresponding author), Univ Malaga, Dept Anim Biol, Biogeog Div & Conservat Res Team, Malaga, Spain.; Estrada, A (corresponding author), Oviedo Univ, CSIC, UMIB, Res Unit Biodivers UO,PA, Campus Mieres, Mieres, Spain.; Estrada, A (corresponding author), CSIC, JCCM, UCLM, Inst Invest Recursos Cinegeticos IREC, Ciudad Real, Spain.	albaestradaa@gmail.com	ESTRADA, ALBA/A-9632-2018; Real, Raimundo/E-6559-2010	ESTRADA, ALBA/0000-0003-2727-1970; Real, Raimundo/0000-0002-6642-1284	Organismo Autonomo Parques Nacionales of Spain [1098/2014]	Organismo Autonomo Parques Nacionales of Spain	This study was funded by Organismo Autonomo Parques Nacionales of Spain (http://www.mapama.gob.es/es/parques-nacionales-oapn/) through the project 1098/2014 (AE and RR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan MD, 2011, ENVIRON MANAGE, V47, P983, DOI 10.1007/s00267-011-9640-5; Acevedo P, 2012, NATURWISSENSCHAFTEN, V99, P515, DOI 10.1007/s00114-012-0926-0; Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; Allen CR, 2001, BIOL CONSERV, V99, P135, DOI 10.1016/S0006-3207(00)00084-7; Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], 2016, FUZZYSIM FUZZY SIMIL; Araujo MB, 2004, BIOL CONSERV, V118, P533, DOI 10.1016/j.biocon.2003.10.006; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Bagchi R, 2013, GLOBAL CHANGE BIOL, V19, P1236, DOI 10.1111/gcb.12123; Barbosa A, 2015, MODEVA MODEL EVALUAT; Barbosa A.M., 2005, Wildlife Biology in Practice, V1, P3; Benayas JMR, 2003, BIOL CONSERV, V114, P357, DOI 10.1016/S0006-3207(03)00064-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bivand R., 2016, MAPTOOLS TOOLS READI; Bonet-Garcia FJ, 2015, BIOL CONSERV, V187, P221, DOI 10.1016/j.biocon.2015.04.027; Brooks TM, 2004, CONSERV BIOL, V18, P616, DOI 10.1111/j.1523-1739.2004.01836.x; Castro AJ, 2015, APPL GEOGR, V60, P1, DOI 10.1016/j.apgeog.2015.02.012; Cramer JS, 1999, J ROY STAT SOC D-STA, V48, P85, DOI 10.1111/1467-9884.00173; Diaz-Gomez DL, 2013, ECOL INDIC, V26, P174, DOI 10.1016/j.ecolind.2012.10.019; Estrada A., 2008, Ecosistemas, V17, P149; Estrada A, 2008, BIODIVERS CONSERV, V17, P857, DOI 10.1007/s10531-008-9328-1; Estrada A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149810; Estrada A, 2012, BIOL CONSERV, V152, P37, DOI 10.1016/j.biocon.2012.03.031; Estrada A, 2011, BIOL CONSERV, V144, P1120, DOI 10.1016/j.biocon.2010.12.031; Faith D. P., 1996, Biodiversity Letters, V3, P18, DOI 10.2307/2999706; Faleiro FV, 2013, BIOL CONSERV, V158, P248, DOI 10.1016/j.biocon.2012.09.020; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jackson SF, 2008, GLOBAL CHANGE BIOL, V14, P2132, DOI 10.1111/j.1365-2486.2008.01628.x; Johnston A, 2013, NAT CLIM CHANGE, V3, P1055, DOI 10.1038/NCLIMATE2035; Legendre P., 2012, NUMERICAL ECOLOGY; Lewis RJ, 2017, CONSERV BIOL, V31, P40, DOI 10.1111/cobi.12723; Lison F, 2015, BIODIVERS CONSERV, V24, P2459, DOI 10.1007/s10531-015-0937-1; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Marquez AL, 2011, CLIMATIC CHANGE, V108, P135, DOI 10.1007/s10584-010-0010-8; Madrono A., 2004, LIBRO ROJO AVES ESPA; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Barbosa AM, 2015, METHODS ECOL EVOL, V6, P853, DOI 10.1111/2041-210X.12372; Martinez I, 2006, BIOL CONSERV, V133, P500, DOI 10.1016/j.biocon.2006.08.003; Martui R., 2003, ATLAS AVES REPRODUCT; Partel M, 2014, J VEG SCI, V25, P1154, DOI 10.1111/jvs.12169; Partel M, 2013, FOLIA GEOBOT, V48, P307, DOI 10.1007/s12224-013-9169-x; Partel M, 2011, TRENDS ECOL EVOL, V26, P124, DOI 10.1016/j.tree.2010.12.004; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Parga IC, 1996, BOT J LINN SOC, V121, P189; Pascual LL, 2011, ACTA OECOL, V37, P399, DOI 10.1016/j.actao.2011.05.004; Pleguezuelos J. M., 2004, ATLAS LIBRO ROJO ANF; Pulido-Pastor A, 2018, INSECT CONSERV DIVER, V11, P479, DOI 10.1111/icad.12297; QGIS Development Team, 2018, GEOGRAPHIC INFORM SY; R Core Team, 2013, R LANG ENV STAT COMP; Real R, 2017, SYST BIOL, V66, P453, DOI 10.1093/sysbio/syw072; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Real R, 2009, DIVERS DISTRIB, V15, P390, DOI 10.1111/j.1472-4642.2008.00546.x; Regos A, 2016, DIVERS DISTRIB, V22, P83, DOI 10.1111/ddi.12375; Reino L, 2017, J BIOGEOGR, V44, P88, DOI 10.1111/jbi.12850; Romo H., 2007, Animal Biodiversity and Conservation, V30, P7; Ronk A, 2015, ECOGRAPHY, V38, P1015, DOI 10.1111/ecog.01236; Rouget M, 2003, BIOL CONSERV, V112, P129, DOI 10.1016/S0006-3207(02)00396-8; Sanchez-Fernandez D, 2015, BIOL CONSERV, V184, P290, DOI 10.1016/j.biocon.2015.02.006; Sanchez-Fernandez D, 2013, DIVERS DISTRIB, V19, P1407, DOI 10.1111/ddi.12104; Sara M, 2014, BIOL CONSERV, V178, P173, DOI 10.1016/j.biocon.2014.08.004; SCOTT JM, 1993, WILDLIFE MONOGR, P1; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Traba J, 2007, BIODIVERS CONSERV, V16, P3255, DOI 10.1007/s10531-006-9138-2; Yosemite Greene L., 1987, YOSEMITE PARK ITS RE	66	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197496	10.1371/journal.pone.0197496	http://dx.doi.org/10.1371/journal.pone.0197496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782506	Green Submitted, Green Published, gold			2022-12-26	WOS:000432537100027
J	Jasso-Martinez, JM; Machkour-M'Rabet, S; Vila, R; Rodriguez-Arnaiz, R; Castaneda-Sortibran, AN				Jasso-Martinez, Jovana M.; Machkour-M'Rabet, Salima; Vila, Roger; Rodriguez-Arnaiz, Rosario; Nitxin Castaneda-Sortibran, America			Molecular evidence of hybridization in sympatric populations of the Enantia jethys complex (Lepidoptera: Pieridae)	PLOS ONE			English	Article							DANAUS-CHRYSIPPUS L.; ISSR MARKERS; INTROGRESSIVE HYBRIDIZATION; BUTTERFLIES NYMPHALIDAE; PHYLOGENETIC INFERENCE; HELICONIUS BUTTERFLIES; HYBRID SPECIATION; GENETIC DIVERSITY; SEQUENCE DATA; MITOCHONDRIAL	Hybridization events are frequently demonstrated in natural butterfly populations. One interesting butterfly complex species is the Enantia jethys complex that has been studied for over a century; many debates exist regarding the species composition of this complex. Currently, three species that live sympatrically in the Gulf slope of Mexico (Enantia jethys, E. mazai, and E. albania) are recognized in this complex (based on morphological and molecular studies). Where these species live in sympatry, some cases of interspecific mating have been observed, suggesting hybridization events. Considering this, we employed a multilocus approach (analyses of mitochondrial and nuclear sequences: COI, RpS5, and Wg; and nuclear dominant markers: inter-simple sequence repeat (ISSRs) to study hybridization in sympatric populations from Vera-cruz, Mexico. Genetic diversity parameters were determined for all molecular markers, and species identification was assessed by different methods such as analyses of molecular variance (AMOVA), clustering, principal coordinate analysis (PC(O)A), gene flow, and PhiPT parameters. ISSR molecular markers were used for a more profound study of hybridization process. Although species of the Enantia jethys complex have a low dispersal capacity, we observed high genetic diversity, probably reflecting a high density of individuals locally. ISSR markers provided evidence of a contemporary hybridization process, detecting a high number of hybrids (from 17% to 53%) with significant differences in genetic diversity. Furthermore, a directional pattern of hybridization was observed from E. albania to other species. Phylogenetic study through DNA sequencing confirmed the existence of three clades corresponding to the three species previously recognized by morphological and molecular studies. This study underlines the importance of assessing hybridization in evolutionary studies, by tracing the lineage separation process that leads to the origin of new species. Our research demonstrates that hybridization processes have a high occurrence in natural populations.	[Jasso-Martinez, Jovana M.; Rodriguez-Arnaiz, Rosario; Nitxin Castaneda-Sortibran, America] Univ Nacl Autonoma Mexico, Lab Genet & Evoluc, Dept Biol Celular, Ciudad De Mexico, Mexico; [Machkour-M'Rabet, Salima] El Colegio Frontera Sur, Lab Ecol Mol & Conservac, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Vila, Roger] Inst Biol Evolut CSIC UPF, Barcelona, Spain; [Jasso-Martinez, Jovana M.] Univ Nacl Autonoma Mexico, Colecc Nacl Insectos, Inst Biol, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; El Colegio de la Frontera Sur (ECOSUR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Universidad Nacional Autonoma de Mexico	Castaneda-Sortibran, AN (corresponding author), Univ Nacl Autonoma Mexico, Lab Genet & Evoluc, Dept Biol Celular, Ciudad De Mexico, Mexico.; Machkour-M'Rabet, S (corresponding author), El Colegio Frontera Sur, Lab Ecol Mol & Conservac, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico.	smachkou@ecosur.mx; nixin@ciencias.unam.mx	Castañeda-Sortibrán, América Nitxin/AAY-6661-2020; Vila, Roger/A-1817-2012	Castañeda-Sortibrán, América Nitxin/0000-0002-1206-4971; Vila, Roger/0000-0002-2447-4388; Machkour-M'Rabet, Salima/0000-0002-9505-3900; Jasso-Martinez, Jovana M./0000-0001-6497-7150	Spanish government grants [CGL2013-48277-P, CGL2016-76322-P]; Catalan Government project [SGR 2014-274]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [385777]	Spanish government grants; Catalan Government project; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by the Spanish government grants CGL2013-48277-P (MINECO) and CGL2016-76322-P (AEI/FEDER, UE), and by the Catalan Government project SGR 2014-274 to RV. This work represents a contribution of the "Red Tematica Codigo de Barras de la villa (Redes Tematicas Continuidad, 280896)" (Consejo Nacional de Ciencia y Tecnologia, Mexico). The scholarship No 385777 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT) was attributed to JMJM to realize this Research.	Abbasi R, 2015, EVOL DEV, V17, P63, DOI 10.1111/ede.12109; Archibald JK, 2004, AM J BOT, V91, P1333, DOI 10.3732/ajb.91.9.1333; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barilani M, 2007, CONSERV GENET, V8, P343, DOI 10.1007/s10592-006-9174-1; Brower AVZ, 1998, INSECT MOL BIOL, V7, P73, DOI 10.1046/j.1365-2583.1998.71052.x; Bull V, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-11; Casu M, 2011, GENETICA, V139, P1293, DOI 10.1007/s10709-012-9631-3; Chen F, 2014, J ASIA-PAC ENTOMOL, V17, P793, DOI 10.1016/j.aspen.2014.07.011; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dinca V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12395; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards S, 2009, MOL ECOL, V18, P2930, DOI 10.1111/j.1365-294X.2009.04270.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FEDERLEY H, 1949, HEREDITAS, V35, P49; Friberg M, 2008, BEHAV ECOL SOCIOBIOL, V62, P873, DOI 10.1007/s00265-007-0511-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; Harrison RG, 1993, HYBRID ZONES EVOLUTI; HEDRICK PW, 1976, ANNU REV ECOL SYST, V7, P1, DOI 10.1146/annurev.es.07.110176.000245; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Hundsdoerfer AK, 2005, Z NATURFORSCH C, V60, P618; Hundsdoerfer AK, 2005, ORG DIVERS EVOL, V5, P173, DOI 10.1016/j.ode.2004.11.012; Jasso-Martinez JM, 2016, SOUTHWEST ENTOMOL, V41, P1005, DOI 10.3958/059.041.0401; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khurad AM, 2006, J INVERTEBR PATHOL, V92, P59, DOI 10.1016/j.jip.2006.03.005; Kleckova I, 2015, MOL PHYLOGENET EVOL, V92, P255, DOI 10.1016/j.ympev.2015.06.012; Kodandaramaiah U, 2011, J EVOLUTION BIOL, V24, P2173, DOI 10.1111/j.1420-9101.2011.02352.x; Kronforst MR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-98; Kronforst MR, 2006, EVOLUTION, V60, P1254, DOI 10.1554/06-005.1; Lamas G., 2003, ATLAS NEOTROPICAL 4A; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096680; Llorente J., 1984, FOLIA ENTOMOL MEX, V58, P3; Lukhtanov VA, 2005, NATURE, V436, P385, DOI 10.1038/nature03704; Luque C, 2002, HEREDITAS, V136, P251, DOI 10.1034/j.1601-5223.2002.1360312.x; Luque C, 2009, BIOCHEM SYST ECOL, V37, P6, DOI 10.1016/j.bse.2009.01.008; Lushai G, 2005, BIOL J LINN SOC, V86, P117, DOI 10.1111/j.1095-8312.2005.00526.x; Lushai G, 2003, HEREDITY, V90, P236, DOI 10.1038/sj.hdy.6800219; Machkour-M'Rabet S, 2017, BIOCHEM SYST ECOL, V70, P260, DOI 10.1016/j.bse.2016.12.013; Machkour-M'Rabet S, 2014, J INSECT CONSERV, V18, P385, DOI 10.1007/s10841-014-9647-3; Machkour-M'Rabet S, 2012, J INSECT CONSERV, V16, P479, DOI 10.1007/s10841-011-9434-3; Machkour-M'Rabet S, 2009, MAR BIOL, V156, P1321, DOI 10.1007/s00227-009-1174-5; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Mayr E, 1942, SYSTEMATICS ORIGIN S; Mende MB, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-83; Mendelson TC, 2007, EVOLUTION, V61, P2596, DOI 10.1111/j.1558-5646.2007.00220.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Monteiro A., 2015, ANNU REV ENTOMOL, P60; Mort ME, 2003, TAXON, V52, P511, DOI 10.2307/3647449; Moyal P, 2011, SYST ENTOMOL, V36, P421, DOI 10.1111/j.1365-3113.2011.00570.x; Mullen SP, 2008, EVOLUTION, V62, P1400, DOI 10.1111/j.1558-5646.2008.00366.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pena C, 2010, ZOOL SCR, V39, P243, DOI 10.1111/j.1463-6409.2010.00421.x; Prado BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027776; Pritchard JK, 2000, GENETICS, V155, P945; Radjabi R., 2012, World Journal of Zoology, V7, P17; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rougerie R, 2012, INVERTEBR SYST, V26, P445, DOI 10.1071/IS12029; Roux O, 2007, MOL PHYLOGENET EVOL, V43, P240, DOI 10.1016/j.ympev.2006.09.017; Schulte K, 2010, MOL PHYLOGENET EVOL, V57, P1105, DOI 10.1016/j.ympev.2010.09.001; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Sortibra A., THESIS; SPERLING FAH, 1994, EVOLUTION, V48, P408, DOI [10.2307/2410101, 10.1111/j.1558-5646.1994.tb01320.x]; Sutkowska A, 2015, ACTA BIOL CRACOV BOT, V57, P82, DOI 10.1515/abcsb-2015-0015; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Talavera G, 2013, MOL PHYLOGENET EVOL, V69, P469, DOI 10.1016/j.ympev.2013.08.004; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vandewoestijne S, 2004, MOL PHYLOGENET EVOL, V31, P630, DOI 10.1016/j.ympev.2003.09.007; Voda R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117802; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wang CZ, 2001, CHINESE SCI BULL, V46, P489, DOI 10.1007/BF03187264; Wink M, 2006, J ORNITHOL, V147, P234, DOI 10.1007/s10336-006-0065-5; Wolfe A, 1998, PLANT MOL SYSTEMATIC, DOI [10.1007/978-1-4615-5419-6, DOI 10.1007/978-1-4615-5419-6]; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157	86	6	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197116	10.1371/journal.pone.0197116	http://dx.doi.org/10.1371/journal.pone.0197116			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771959	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900029
J	Ralambondrainy, M; Belarbi, E; Viranaicken, W; Baranauskiene, R; Venskutonis, PR; Despres, P; Roques, P; El Kalamouni, C; Selambarom, J				Ralambondrainy, Miora; Belarbi, Essia; Viranaicken, Wildriss; Baranauskiene, Renata; Venskutonis, Petras Rimantas; Despres, Philippe; Roques, Pierre; El Kalamouni, Chaker; Selambarom, Jimmy			In vitro comparison of three common essential oils mosquito repellents as inhibitors of the Ross River virus	PLOS ONE			English	Article							ANTIVIRAL ACTIVITY; DISEASE; PLANTS	Background The essential oils of Cymbopogon citratus (CC), Pelargonium graveolens (PG) and Vetiveria zizanioides (VZ) are commonly used topically to prevent mosquito bites and thus the risk of infection by their vectored pathogens such as arboviruses. However, since mosquito bites are not fully prevented, the effect of these products on the level of viral infection remains unknown. Objectives To evaluate in vitro the essentials oils from Reunion Island against one archetypal arbovirus, the Ross River virus (RRV), and investigate the viral cycle step that was impaired by these oils. Methods The essential oils were extracted by hydrodistillation and analyzed by a combination of GCFID and GCxC-TOF MS techniques. In vitro studies were performed on HEK293T cells to determine their cytotoxicity, their cytoprotective and virucidal capacities on RRV-T48 strain, and the level of their inhibitory effect on the viral replication and residual infectivity prior, during or following viral adsorption using the reporter virus RRV-renLuc. Results Each essential oil was characterized by an accurate quantification of their terpenoid content. PG yielded the least-toxic extract (CC50 > 1000 mu g.mL(-1)). For the RRV-T48 strain, the monoterpene-rich CC and PG essential oils reduced the cytopathic effect but did not display virucidal activity. The time-of-addition assay using the gene reporter RRV-renLuc showed that the CC and PG essential oils significantly reduced viral replication and infectivity when applied prior, during and early after viral adsorption. Overall, no significant effect was observed for the low monoterpene-containing VZ essential oil. Conclusion The inhibitory profiles of the three essential oils suggest the high value of the monoterpenerich essential oils from CC and PG against RRV infection. Combined with their repellent activity, the antiviral activity of the essential oils of CC and PG may provide a new option to control arboviral infection.	[Ralambondrainy, Miora; Viranaicken, Wildriss; Despres, Philippe; El Kalamouni, Chaker; Selambarom, Jimmy] Univ Reunion, INSERM U1187, CNRS UMR9192, Plateforme Technol CYROI,PIMIT,IRD UMR249,UM 134, St Clotilde, Reunion, France; [Belarbi, Essia; Roques, Pierre] Univ Paris Sud, INSERM U1184, CEA, Inst Biol Francois Jacob,Immunol Viral Infect & A, Fontenay Aux Roses, France; [Baranauskiene, Renata; Venskutonis, Petras Rimantas] Kaunas Univ Technol, Dept Food Sci & Technol, Kaunas, Lithuania	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Kaunas University of Technology	El Kalamouni, C; Selambarom, J (corresponding author), Univ Reunion, INSERM U1187, CNRS UMR9192, Plateforme Technol CYROI,PIMIT,IRD UMR249,UM 134, St Clotilde, Reunion, France.	pierre.roques@cea.fr; chaker.el-kalamouni@univ-reunion.fr; jimmy.selambarom@univ-reunion.fr	Venskutonis, Petras Rimantas/A-1498-2008; Roques, Pierre/M-2212-2013	Venskutonis, Petras Rimantas/0000-0002-6063-8132; Roques, Pierre/0000-0003-1825-1054; El Kalamouni, Chaker/0000-0003-4673-6614; SELAMBAROM, JIMMY/0000-0001-9950-2542	Conseil Regional de La Reunion (Regional Council of Reunion Island); Region Ile-de-France (grant DIM-MALINF) [130053]; MALINF (Region Ile de France); Regional Council of Reunion Island	Conseil Regional de La Reunion (Regional Council of Reunion Island); Region Ile-de-France (grant DIM-MALINF); MALINF (Region Ile de France); Regional Council of Reunion Island	This work was supported by the Conseil Regional de La Reunion (Regional Council of Reunion Island) to MR and Region Ile-de-France (grant DIM-MALINF N#130053) to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r To Professor Richard J. Kuhn, Purdue University for the generous gift of the plasmid containing the Ross River virus strain T48 (RRV-T48) sequence, GenBank GQ433359. To Dr George Snounou for English wording review. To DIM-MALINF (Region Ile de France) for support of E.B and Regional Council of Reunion Island for support to M.R.	Assi M, 2015, CYTOKINE, V76, P572, DOI 10.1016/j.cyto.2015.07.003; Astani A, 2014, IRAN J MICROBIOL, V6, P149; Astani A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep187; Astani A, 2010, PHYTOTHER RES, V24, P673, DOI 10.1002/ptr.2955; Atkins GJ, 2013, ISRN VIROLOGY, V2013, P22, DOI [10.5402/2013/861912, DOI 10.5402/2013/861912]; Aubry M, 2017, EMERG INFECT DIS, V23, P1751, DOI 10.3201/eid2310.170583; Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005; Avoseh O, 2015, MOLECULES, V20, P7438, DOI 10.3390/molecules20057438; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Baranauskiene R, 2016, FOOD FUNCT, V7, P3555, DOI [10.1039/C6FO00775A, 10.1039/c6fo00775a]; Chahal KK, 2015, INDIAN J NAT PROD RE, V6, P251; Claflin SB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005070; Dye C, 2013, LANCET, V381, P413, DOI 10.1016/S0140-6736(12)61812-1; Faddy HM, 2018, TRANSFUSION, V58, P485, DOI 10.1111/trf.14472; Flies EJ, 2018, J INFECT DIS, V217, P807, DOI 10.1093/infdis/jix615; FRASER JRE, 1980, MED J AUSTRALIA, V1, P550; Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006; Gad HH, 2012, VIROLOGY, V434, P27, DOI 10.1016/j.virol.2012.07.019; Garcia CC, 2003, PHYTOTHER RES, V17, P1073, DOI 10.1002/ptr.1305; Governement of Western Australia, ROSS RIV BARM FOR VI; Gunn BM, 2018, VIROLOGY, V515, P250, DOI 10.1016/j.virol.2017.12.022; Gunn BM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002586; Haist KC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006748; Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001; Herrero LJ, 2015, J VIROL, V89, P8063, DOI 10.1128/JVI.00224-15; Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x; Klapsing P, 2005, EMERG INFECT DIS, V11, P613, DOI 10.3201/eid1104.041070; Krejbich-Trotot P, 2016, VIRUS RES, V225, P64, DOI 10.1016/j.virusres.2016.09.007; KUHN RJ, 1991, VIROLOGY, V182, P430, DOI 10.1016/0042-6822(91)90584-X; Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18; Liu X, 2017, MICROBES INFECT, V19, P496, DOI 10.1016/j.micinf.2017.07.001; Mackenzie JS, 2017, T ROY SOC TROP MED H, V111, P248, DOI 10.1093/trstmh/trx045; Mazzon M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006835; Meneses R, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-8; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakatsu T, 2000, STUD NAT PROD CHEM, V21, P571; Pohlit AM, 2011, PLANTA MED, V77, P598, DOI 10.1055/s-0030-1270723; Properzi A., 2013, MED AROMAT PLANTS, V2, P136, DOI DOI 10.4172/2167-0412.1000136; Raut JS, 2014, IND CROP PROD, V62, P250, DOI 10.1016/j.indcrop.2014.05.055; Roy S, 2015, PHARMACOGN RES, V7, P263, DOI 10.4103/0974-8490.157977; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; Semple SJ, 1998, J ETHNOPHARMACOL, V60, P163, DOI 10.1016/S0378-8741(97)00152-9; Sharopov F.S., 2014, AM J ESSENT OILS NAT, V2, P13; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64	45	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196757	10.1371/journal.pone.0196757	http://dx.doi.org/10.1371/journal.pone.0196757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771946	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900018
J	Fontoura, VM; Graepp-Fontoura, I; Santos, FS; Neto, MS; Tavares, HSD; Bezerra, MOL; Feitosa, MD; Neves, AF; de Morais, JCM; Nascimento, LFC				Fontoura, Volmar Morais; Graepp-Fontoura, Iolanda; Santos, Floriacy Stabnow; Neto, Marcelino Santos; de Almeida Tavares, Hanari Santos; Lopes Bezerra, Maria Onice; Feitosa, Marcela de Oliveira; Neves, Adriano Figueredo; Melo de Morais, Jesuane Cavalcante; Costa Nascimento, Luiz Fernando			Socio-environmental factors and diarrheal diseases in under five-year old children in the state of Tocantins, Brazil	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; SPATIAL-ANALYSIS; ESCHERICHIA-COLI; SAO-PAULO; MORTALITY; WATER; IDENTIFICATION; COMMUNITIES; SANITATION; ROTAVIRUS	Background Diarrhea is a waterborne disease that affects children, especially those under 5 years of age. The objective of this study was to identify the spatial patterns of distribution of diarrheal disease in under 5-year-old children in the State of Tocantins, Brazil, from 2008 to 2013. Methods Geoprocessing tools were used to carry out an epidemiological study, to prepare thematic maps in the TerraView 4.2.2 software based on secondary data. General indicators of the disease, presence of spatial dependence through the Global Moran's Index (I) and the Spatial Association Index (LISA) were described. Results There were 3,015 cases of under 5-year-old children hospitalized for diarrhea, with an average annual rate (AAR) of 4.10/1,000 inhabitants (inhab.). Among the main characteristics were: increasing rates in under 1-year-old children (6.16 to 9.66/1,000 inhabitants); children aged 1 to 4 full years (63%); males (55%); 8 deaths of under one-year-old children (75%); county of Araguaina (67%); incidence in the county of Nazare (63.97/1,000 inhab.); prevalence and incidence in the Araguaina microregion (45%, AAR 9.38/1,000 inhab.). The presence of a cluster with spatial autocorrelation was found in the Araguaina microregion, which was statistically significant (I = 0.11, p-value < 0.03), with priority of intervention (Moran Map). Conclusions There was an increase in the number of hospitalizations for diarrhea in under 5-year-old children in the state of Tocantins. The spatial analysis identified clusters of priority areas for measures of maintenance and control of diarrheal diseases.	[Fontoura, Volmar Morais; de Almeida Tavares, Hanari Santos; Lopes Bezerra, Maria Onice; Neves, Adriano Figueredo; Melo de Morais, Jesuane Cavalcante] State Univ Tocantins, Dept Nursing, Augustinopolis, Tocantins, Brazil; [Fontoura, Volmar Morais; Costa Nascimento, Luiz Fernando] Univ Taubate, Posgrad Program Environm Sci, Taubate, SP, Brazil; [Graepp-Fontoura, Iolanda; Santos, Floriacy Stabnow; Neto, Marcelino Santos; Feitosa, Marcela de Oliveira] Univ Fed Maranhao, Dept Nursing, Imperatriz, Maranhao, Brazil	Universidade de Taubate; Universidade Federal do Maranhao	Fontoura, VM (corresponding author), State Univ Tocantins, Dept Nursing, Augustinopolis, Tocantins, Brazil.; Fontoura, VM (corresponding author), Univ Taubate, Posgrad Program Environm Sci, Taubate, SP, Brazil.	volmar_morais@hotmail.com	Fontoura, Iolanda Graepp/AAD-8505-2022; Santos, Floriacy S. F. S. Stabnow/A-8896-2019; NASCIMENTO, LUIZ FERNANDO C/B-5007-2015; Nascimento, Luiz Fernando/O-2400-2018; Neto, Marcelino Santos/A-8910-2019	Fontoura, Iolanda Graepp/0000-0002-9201-480X; Nascimento, Luiz Fernando/0000-0001-9793-750X; Neto, Marcelino Santos/0000-0002-6105-1886				Barbosa DS, 2014, ACTA TROP, V131, P56, DOI 10.1016/j.actatropica.2013.12.002; Barbosa DS, 2011, SPATIAL DISTRIBUTION, P30; Bener Abdulbari, 2011, Rev. Bras. Saude Mater. Infant., V11, P83, DOI 10.1590/S1519-38292011000100009; Brandt KG, 2015, J PEDIAT-BRAZIL, V91, pS36, DOI 10.1016/j.jped.2015.06.002; [Brasil. Ministe A rio da Sau A de Ministerio da Sau de.], 2017, MAN QUADR PROC AIDP; Buhler HF, 2014, CAD SAUDE PUBLICA, V30, P1921, DOI 10.1590/0102-311X00078013; Cauás Renata Cavalcanti, 2006, Rev. Bras. Saude Mater. Infant., V6, ps77, DOI 10.1590/S1519-38292006000500011; Curtis A, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-21; David EB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0714-8; De Carvalho RM, 2014, REV ASSOC MED BRAS, V60, P565, DOI 10.1590/1806-9282.60.06.016; de Oliveira AF, 2015, CIENC SAUDE COLETIVA, V20, P1027, DOI 10.1590/1413-81232015204.00372014; Duarte-Cunha M, 2012, CAD SAUDE PUBLICA, V28, P1143, DOI 10.1590/S0102-311X2012000600013; Fontoura I. G., 2016, Ambiente & Agua, V11, P1088; Furtado AS, 2015, CIENC SAUDE COLETIVA, V20, P3935, DOI 10.1590/1413-812320152012.01672015; Goncalves AC, 2011, CAD SAUDE PUBLICA, V27, P1581, DOI 10.1590/S0102-311X2011000800013; Rocha Monica Couto Guedes Sejanes da, 2012, Arq. Gastroenterol., V49, P259, DOI 10.1590/S0004-28032012000400006; Iijimal Y, 2017, JPN J INFECT DIS, V70, P80, DOI 10.7883/yoken.JJID.2016.064; INPE (Instituto de Pesquisas espaciais), 2015, AULA 8 OP AN ESP, P1; Joventino ES, 2010, TEXTO CONTEXTO ENFER, V19, P691, DOI 10.1590/S0104-07072010000400012; Koster C, 2016, VACCINE, V34, P90, DOI 10.1016/j.vaccine.2015.11.002; Leyk S, 2012, SPAT SPATIO-TEMPORAL, V3, P95, DOI 10.1016/j.sste.2012.04.003; Lima AAM, 2014, CLIN INFECT DIS, V59, pS287, DOI 10.1093/cid/ciu438; Martins-Melo FR, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093770, DOI 10.1371/J0URNAL.P0NE.0093770]; Mbuya MNN, 2016, MATERN CHILD NUTR, V12, P106, DOI 10.1111/mcn.12220; Mirhoseini A, 2018, MICROB PATHOGENESIS, V117, P162, DOI 10.1016/j.micpath.2018.02.032; Morais MB de, 2017, DEP CIENTIFICO GASTR, P1; Fonseca PAM, 2016, CIENC SAUDE COLETIVA, V21, P731, DOI 10.1590/1413-81232015213.20162015; Cardim MFM, 2015, REV SOC BRAS MED TRO, V48, P716, DOI 10.1590/0037-8682-0213-2015; Nayak MK, 2018, ARCH VIROL, V163, P745, DOI 10.1007/s00705-017-3670-0; Oliveira FJP de, 2009, REV AMBIENT AGUA, V4, P115, DOI [10.4136/1980-993X, DOI 10.4136/1980-993X]; Parise EV, 2011, REV SOC BRAS MED TRO, V44, P63, DOI [10.1590/S0037-86822011000100015, DOI 10.1590/S0037-86822011000100015]; Paulo RLP, 2016, REV ASSOC MED BRAS, V62, P506, DOI 10.1590/1806-9282.62.06.506; Perez-Heydrich C, 2013, HEALTH PLACE, V19, P45, DOI 10.1016/j.healthplace.2012.10.002; Sevilimedu V, 2016, T ROY SOC TROP MED H, V110, P637, DOI 10.1093/trstmh/trw080; Masukawa MDT, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00080515; Tickell KD, 2017, LANCET GLOB HEALTH, V5, pE1235, DOI 10.1016/S2214-109X(17)30392-3; Tubatsi G, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0031-z; Venancio TS, 2015, CIENC SAUDE COLETIVA, V20, P1540, DOI 10.1590/1413-81232015205.14672014	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196702	10.1371/journal.pone.0196702	http://dx.doi.org/10.1371/journal.pone.0196702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768428	gold, Green Published, Green Submitted			2022-12-26	WOS:000432329200041
J	Groch, KR; Diaz-Delgado, J; Marcondes, MCC; Colosio, AC; Santos-Neto, EB; Carvalho, VL; Boos, GS; de Meirelles, ACO; Ramose, HGD; Guimaraes, JP; Borges, JCG; Vergara-Parente, JE; St Leger, JA; Fernandez, A; Catao-Dias, JL				Groch, Katia Regina; Diaz-Delgado, Josue; Marcondes, Milton C. C.; Colosio, Adriana Castaldo; Santos-Neto, Elitieri B.; Carvalho, Vitor Luz; Boos, Gisela Silva; Oliveira de Meirelles, Ana Carolina; da Cunha Ramose, Hernani Gomes; Guimaraes, Juliana Placido; Gomes Borges, Joao Carlos; Vergara-Parente, Jociery Einhardt; St Leger, Judy A.; Fernandez, Antonio; Catao-Dias, Jose Luiz			Pathology and causes of death in stranded humpback whales (Megaptera novaeangliae) from Brazil	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; BOTTLE-NOSED-DOLPHIN; ACUTE LUNG INJURY; TURSIOPS-TRUNCATUS; SOUTHEASTERN BRAZIL; MECONIUM ASPIRATION; MARINE MAMMALS; CANARY-ISLANDS; CETACEANS; MORBILLIVIRUS	This study describes the pathologic findings of 24 humpback whales (Megaptera novaeangliae) found stranded along the Brazilian coast from 2004 to 2016. Eighteen (75%) animals evaluated were found stranded alive. From these, 13 died naturally on shore and five were euthanized. Six died at sea and were washed ashore. Of the 24, 19 (79.2%) were calves, four (16.7%) were juveniles, and one (4.2%) was an adult. The most probable cause of stranding and/or death (CSD) was determined in 23/24 (95.8%) individuals. In calves, CSD included neonatal respiratory distress (13/19; 68.4%), infectious disease (septicemia, omphaloarteritis and urachocystitis; 3/19; 15.8%), trauma of unknown origin (2/19; 10.5%), and vehicular trauma (vessel strike; 1/19; 5.3%). In juveniles and adult individuals, CSD was: emaciation (2/5; 40%), sunlight-thermal burn shock (1/5; 20%); and discospondylitis (1/5; 20%). In one juvenile, the CSD was undetermined (1/5; 20%). This study integrates novel findings and published case reports to delineate the pathology of a South-western Atlantic population of humpback whales. This foundation will aid in the assessment of the population health and establish a baseline for development of conservation policies.	[Groch, Katia Regina; Diaz-Delgado, Josue; Catao-Dias, Jose Luiz] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Lab Wildlife Comparat Pathol, Sao Paulo, Brazil; [Groch, Katia Regina; Marcondes, Milton C. C.; Colosio, Adriana Castaldo; Santos-Neto, Elitieri B.; da Cunha Ramose, Hernani Gomes] Inst Baleia Jubarte, Caravelas, Ba, Brazil; [Diaz-Delgado, Josue; Fernandez, Antonio] Univ Las Palmas Gran Canaria, Vet Sch, Inst Anim Hlth, Div Histol & Anim Pathol, Arucas, Canary Islands, Spain; [Carvalho, Vitor Luz; Oliveira de Meirelles, Ana Carolina] Assoc Pesquisa & Preservacao Ecossistemas Aquat, Caucaia, Ceara, Brazil; [Boos, Gisela Silva] Univ Fed Rio Grande do Sul, Fac Vet, Setor Patol Vet, Porto Alegre, RS, Brazil; [Guimaraes, Juliana Placido; Gomes Borges, Joao Carlos; Vergara-Parente, Jociery Einhardt] Fundacao Mamiferos Aquat, Recife, Pe, Brazil; [Guimaraes, Juliana Placido] Univ Santa Cecilia, Posgrad Sustentabilidade Ecossistemas Costeiros &, Sao Paulo, Brazil; [Vergara-Parente, Jociery Einhardt] Inst Tecnol & Pesquisa, Aracaju, Sergipe, Brazil; [St Leger, Judy A.] SeaWorld, San Diego, CA USA	Universidade de Sao Paulo; Universidad de Las Palmas de Gran Canaria; Universidade Federal do Rio Grande do Sul; Universidade Santa Cecilia	Groch, KR (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Lab Wildlife Comparat Pathol, Sao Paulo, Brazil.; Groch, KR (corresponding author), Inst Baleia Jubarte, Caravelas, Ba, Brazil.	katia.groch@gmail.com	Fernandez, Antonio/G-3448-2015; Oliveira Meirelles A Campos, Ana Carolina/AFR-3399-2022; Boos, Gisele Silva/ABA-1246-2020; St. Leger, Judy/AAD-3565-2019; CATÃO-DIAS, JOSE LUIZ/C-4897-2012	Fernandez, Antonio/0000-0001-5281-0521; Oliveira Meirelles A Campos, Ana Carolina/0000-0001-5879-3064; Boos, Gisele Silva/0000-0002-7843-2749; St. Leger, Judy/0000-0002-6213-3429; CATÃO-DIAS, JOSE LUIZ/0000-0003-2999-3395	Coordination for the Improvement of Higher Education Personnel (CAPES); Sao Paulo Research Foundation (FAPESP) [2011/08357-0, 2012/00021-5, 2014/24932-2, 2015/00735-6, 2015/05043-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq [301517/2006-1]; Petroleo Brasileiro S.A. (Petrobras)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Petroleo Brasileiro S.A. (Petrobras)(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras)	We very much appreciate the support of Coordination for the Improvement of Higher Education Personnel (CAPES) and Sao Paulo Research Foundation (FAPESP), grants #2011/08357-0; #2012/00021-5; 2014/24932-2; #2015/00735-6 and #2015/05043-5. J.L.C.D. is a recipient of a professorship by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (301517/2006-1). Projeto Baleia Jubarte is sponsored by Petroleo Brasileiro S.A. (Petrobras). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SeaWorld provided support in the form of salaries for authors [JASL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Alava Juan Jose, 2005, Journal of Cetacean Research and Management, V7, P163; Andriolo A., 2006, Journal of Cetacean Research and Management, V8, P307; Andriolo Artur, 2010, Endangered Species Research, V11, P233, DOI 10.3354/esr00282; Arbelo M, 2013, DIS AQUAT ORGAN, V103, P87, DOI 10.3354/dao02558; BAKER CS, 1984, CAN J ZOOL, V62, P1922, DOI 10.1139/z84-282; BARROS NB, 1991, MAR MAMMAL SCI, V7, P296, DOI 10.1111/j.1748-7692.1991.tb00104.x; Bogomolni AL, 2010, DIS AQUAT ORGAN, V88, P143, DOI 10.3354/dao02146; Bornatowski H, 2012, J MAR BIOL ASSOC UK, V92, P1767, DOI 10.1017/S0025315412001154; Bortolotto GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164596; Bortolotto Guilherme Augusto, 2016, Marine Biodiversity Records, V9, P29, DOI 10.1186/s41200-016-0043-4; Braithwaite JE, 2015, POLAR BIOL, V38, P1195, DOI 10.1007/s00300-015-1685-0; Braye F., 1997, Journal of Burn Care and Rehabilitation, V18, P321, DOI 10.1097/00004630-199707000-00008; BUCK JD, 1991, DIS AQUAT ORGAN, V10, P147, DOI 10.3354/dao010147; Camphuysen Kees C. J., 2007, Lutra, V50, P31; Capella J., 2001, MEM QUEENSL MUS, V47, P547; Caswell J., 2016, JUBB KENNEDY PALMERS, V6th, P564, DOI DOI 10.1016/B978-0-7020-5318-4.00011-5; CHITTLEBOROUGH R. G., 1959, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V10, P125; Clapham PJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P582; CLAPHAM PJ, 1994, J ZOOL, V234, P265, DOI 10.1111/j.1469-7998.1994.tb06074.x; CLAPHAM PJ, 1992, CAN J ZOOL, V70, P1470, DOI 10.1139/z92-202; Cowan DF, 2008, J COMP PATHOL, V139, P24, DOI 10.1016/j.jcpa.2007.11.009; Cowan DF, 1999, J ANAT, V194, P505, DOI 10.1046/j.1469-7580.1999.19440505.x; Deaville R., 2011, UK CETACEAN STRANDIN; Diaz- Delgado J, 2015, THESIS; Engel MH, 2009, MAR MAMMAL SCI, V25, P964, DOI 10.1111/j.1748-7692.2009.00301.x; Engel M.H., 1996, COMPORTAMENTO REPROD, V14, P275; Felix F, 1997, REPORT INT WHALING C; GERACI JR, 1989, CAN J FISH AQUAT SCI, V46, P1895, DOI 10.1139/f89-238; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; GILCHREST BA, 1981, J AM ACAD DERMATOL, V5, P411, DOI 10.1016/S0190-9622(81)70103-8; Gonzales-Viera O, 2013, VET PARASITOL, V191, P358, DOI 10.1016/j.vetpar.2012.09.012; GOODING CA, 1971, RADIOLOGY, V100, P137, DOI 10.1148/100.1.137; Groch KR, 2014, EMERG INFECT DIS, V20, P511, DOI 10.3201/eid2003.131557; Groch KR, 2012, DIS AQUAT ORGAN, V101, P145, DOI 10.3354/dao02518; Herr H, 2007, BURNS, V33, P372, DOI 10.1016/j.burns.2006.07.005; Herraez P, 2013, VET J, V196, P181, DOI 10.1016/j.tvjl.2012.09.021; Hill AN, 2017, MAR MAMMAL SCI, V33, P558, DOI 10.1111/mms.12386; Holyoake C, 2011, COLLECTION BASELINE; Jaber JR, 2004, VET PATHOL, V41, P147, DOI 10.1354/vp.41-2-147; Jacob JM, 2016, DIS AQUAT ORGAN, V117, P215, DOI 10.3354/dao02941; Jauniaux T, 2000, J COMP PATHOL, V123, P198, DOI 10.1053/jcpa.2000.0395; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; JONES EC, 1971, FISH BULL NATL OC AT, V69, P791; Joseph B. E., 2000, BOTTL DOLPH BREED WO, P43; KOGURE K, 1988, TOXICON, V26, P191, DOI 10.1016/0041-0101(88)90171-7; Kumar V, 2015, ROBBINS COTRAN PATHO, P403; Lair S, 2016, VET PATHOL, V53, P22, DOI 10.1177/0300985815604726; Lowry D, 2009, MAR BIOL, V156, P2483, DOI 10.1007/s00227-009-1273-3; LUND T, 1992, WORLD J SURG, V16, P2, DOI 10.1007/BF02067107; Maitra A, 2015, ROBBINS COTRAN PATHO, P451; Martins CCA., 2001, MEMOIRS QUEENSLAND M, V47, P563; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Mazzariol S, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-20; Mazzuca L., 1998, Pacific Science, V52, P1; Meirelles Ana Carolina O., 2016, Latin American Journal of Aquatic Mammals, V11, P178; Moore MJ, 2013, DIS AQUAT ORGAN, V103, P229, DOI 10.3354/dao02566; Moura JF, 2013, BIOLOGIA, V68, P992, DOI 10.2478/s11756-013-0237-8; Nishiwaki M., 1959, Scientific Reports of the Whales Research Institute Tokyo, VNo. 14, P49; PATERSON R A, 1991, Memoirs of the Queensland Museum, V30, P343; Paterson R. A., 1993, Memoirs of the Queensland Museum, V33, P291; Resendes AR, 2002, J PARASITOL, V88, P1029, DOI 10.1645/0022-3395(2002)088[1029:DTIAMP]2.0.CO;2; Rice D. W., 1963, Norsk Hvalfangsttidende Sandefjord, V52, P181; Rowles TK, 2011, MAR MAMMAL SCI, V27, P1, DOI 10.1111/j.1748-7692.2010.00393.x; Rowntree VJ, 1996, CAN J ZOOL, V74, P103, DOI 10.1139/z96-014; Saliki JT, 2002, ANN NY ACAD SCI, V969, P51, DOI 10.1111/j.1749-6632.2002.tb04350.x; Santos-Neto E, 2008, J MAR BIOL ASS UK 2, V2, pe97; Scheidat Meike, 2000, Journal of Cetacean Research and Management, V2, P165; SHIRAI S, 1992, ZOOL SCI, V9, P811; SMITH RW, 1984, BURNS, V10, P420, DOI 10.1016/0305-4179(84)90082-2; Stone J.R., 2016, CARDIOVASC PATHOL, P125, DOI DOI 10.1016/B978-0-12-420219-1.00004-5; Tanaka M, 2014, J VET MED SCI, V76, P81, DOI 10.1292/jvms.13-0227; Tomilin AG., 1967, MAMMALS USSR ADJACEN, VIX; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; WILEY DN, 1995, FISH B-NOAA, V93, P196; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295	75	15	15	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0194872	10.1371/journal.pone.0194872	http://dx.doi.org/10.1371/journal.pone.0194872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768405	Green Submitted, gold, Green Published			2022-12-26	WOS:000432329200005
J	King, N; Vriezen, R; Edge, VL; Ford, J; Wood, M; Harper, S				King, Nia; Vriezen, Rachael; Edge, Victoria L.; Ford, James; Wood, Michele; Harper, Sherilee		IHACC Res Team; Rigolet Inuit Community Govt	The hidden costs: Identification of indirect costs associated with acute gastrointestinal illness in an Inuit community	PLOS ONE			English	Article							CLIMATE-CHANGE; MENTAL-HEALTH; CHANGING CLIMATE; NUNATSIAVUT; CANADA; DETERMINANTS; BURDEN; FOCUS; GASTROENTERITIS; FOODBORNE	Background Acute gastrointestinal illness (AGI) incidence and per-capita healthcare expenditures are higher in some Inuit communities as compared to elsewhere in Canada. Consequently, there is a demand for strategies that will reduce the individual-level costs of AGI; this will require a comprehensive understanding of the economic costs of AGI. However, given Inuit communities' unique cultural, economic, and geographic contexts, there is a knowledge gap regarding the context-specific indirect costs of AGI borne by Inuit community members. This study aimed to identify the major indirect costs of AGI, and explore factors associated with these indirect costs, in the Inuit community of Rigolet, Canada, in order to develop a casebased context-specific study framework that can be used to evaluate these costs. Methods A mixed methods study design and community-based methods were used. Qualitative indepth, group, and case interviews were analyzed using thematic analysis to identify and describe indirect costs of AGI specific to Rigolet. Data from two quantitative cross-sectional retrospective surveys were analyzed using univariable regression models to examine potential associations between predictor variables and the indirect costs. Results/Significance The most notable indirect costs of AGI that should be incorporated into cost-of-illness evaluations were the tangible costs related to missing paid employment and subsistence activities, as well as the intangible costs associated with missing community and cultural events. Seasonal cost variations should also be considered. This study was intended to inform cost-of-illness studies conducted in Rigolet and other similar research settings. These results contribute to a better understanding of the economic impacts of AGI on Rigolet residents, which could be used to help identify priority areas and resource allocation for public health policies and programs.	[King, Nia; Edge, Victoria L.; Harper, Sherilee] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Vriezen, Rachael] Univ Guelph, Dept Food Agr & Resource Econ, Guelph, ON, Canada; [Edge, Victoria L.; Ford, James; Harper, Sherilee; IHACC Res Team] Indigenous Hlth Adaptat Climate Change Res Team, Guelph, ON, Canada; [Ford, James] Univ Leeds, Priestley Int Ctr Climate, Leeds, W Yorkshire, England; [Wood, Michele] Nunatsiavut Govt, Dept Hlth & Social Dev, Goose Bay, NF, Canada; [Rigolet Inuit Community Govt] Rigolet Inuit Community Govt, Rigolet, NF, Canada	University of Guelph; University of Guelph; University of Leeds	King, N (corresponding author), Univ Guelph, Dept Populat Med, Guelph, ON, Canada.	nking@mail.uoguelph.ca	Ford, James/A-4284-2013	Ford, James/0000-0002-2066-3456; Vriezen, Rachael/0000-0003-3648-9218; King, Nia/0000-0003-1829-8098	International Development Research Centre Tri-Council Initiative on Adaptation to Climate Change, IHACC, IDRC [106372-003, 106372-004, 106372-005]; University of Guelph Arthur D. Latornell Undergraduate Travel Grant	International Development Research Centre Tri-Council Initiative on Adaptation to Climate Change, IHACC, IDRC; University of Guelph Arthur D. Latornell Undergraduate Travel Grant	Funding was provided by the International Development Research Centre Tri-Council Initiative on Adaptation to Climate Change, IHACC, IDRC File nos. 106372-003, 004, 005 (https://www.idrc.ca/en/article/idrc-climate-change-adaptation) (IHACC Research Team). Additional financial support was provided by the University of Guelph Arthur D. Latornell Undergraduate Travel Grant (NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson N, 2005, CAN J PUBLIC HEALTH, V96, pS45, DOI 10.1007/BF03403702; Adler M, 2005, QALYS POLICY EVALUAT; [Anonymous], 2001, MACR HLTH INV HLTH E; [Anonymous], 2015, REG ENVIRON CHANGE, DOI DOI 10.1007/s10113-014-0630-z; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burt RS, 2005, BROKERAGE CLOSURE IN; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2014, TRIC POL STAT ETH CO, P210; Castleden H, 2012, CAN GEOGR-GEOGR CAN, V56, P160, DOI 10.1111/j.1541-0064.2012.00432.x; Chan HM, 2006, INT J CIRCUMPOL HEAL, V65, P416, DOI 10.3402/ijch.v65i5.18132; Chen Y, 2015, CHEM ENG SCI, V132, P1, DOI 10.1016/j.ces.2015.04.006; Creery David, 2005, Int J Circumpolar Health, V64, P38; Creswell J.W., 2007, DESIGNING CONDUCTING; Cunsolo W. A., 2013, EMOT SPACE SOC, V6, P14, DOI DOI 10.1016/J.EM0SPA.2011.08.005; DeCuir-Gunby JT, 2011, FIELD METHOD, V23, P136, DOI 10.1177/1525822X10388468; Duggleby W, 2005, QUAL HEALTH RES, V15, P832, DOI 10.1177/1049732304273916; Duhaime G, 2002, ECOL FOOD NUTR, V41, P91, DOI 10.1080/03670240214491; Elias PD., 1997, INT J SOC ECON, V24, P1241; Elliott-Schmidt R, 1997, Aust J Rural Health, V5, P59, DOI 10.1111/j.1440-1584.1997.tb00239.x; EWING VL, 2011, MAIER J, V10, DOI DOI 10.1186/1475-2875-10; FDA, 2004, REQ PERT SAMPL SERV; Finner KL, 2015, FOOD HERE THERE US T; Ford JD, 2011, GEOGR J, V177, P44, DOI 10.1111/j.1475-4959.2010.00374.x; Gauci C, 2007, EPIDEMIOL INFECT, V135, P1290, DOI 10.1017/S0950268807008084; Giaquinto C, 2007, J INFECT DIS, V195, pS36, DOI 10.1086/516716; Gold MR, 2002, ANNU REV PUBL HEALTH, V23, P115, DOI 10.1146/annurev.publhealth.23.100901.140513; Goldstein Joshua H., 2014, Human Dimensions of Wildlife, V19, P347, DOI 10.1080/10871209.2014.917345; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Harper S., 2013, GASTROINTESTINAL ILL; Harper SL, 2015, EPIDEMIOL INFECT, V143, P3048, DOI 10.1017/S0950268814003744; Harper SL, 2012, ECOHEALTH, V9, P89, DOI 10.1007/s10393-012-0762-x; Harper SL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1874-3; Harper SL, 2015, INT J CIRCUMPOL HEAL, V74, DOI 10.3402/ijch.v74.26290; Harper SL, 2015, SOC SCI MED, V126, P86, DOI 10.1016/j.socscimed.2014.12.011; Harper SL, 2011, ECOHEALTH, V8, P93, DOI 10.1007/s10393-011-0690-1; Havelaar AH, 2000, EPIDEMIOL INFECT, V125, P505, DOI 10.1017/S0950268800004933; Hellard ME, 2003, J GASTROEN HEPATOL, V18, P322, DOI 10.1046/j.1440-1746.2003.02959.x; Henson SJ, 2008, INT J FOOD MICROBIOL, V127, P43, DOI 10.1016/j.ijfoodmicro.2008.06.007; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Huet C, 2017, BMC PUBLIC HEALTH, V17, P1, DOI [10.1186/s12889-016-3954-4, DOI 10.1186/S12889-016-3954-4]; Inuit Tapiriit Kanatami, 2015, SOCIAL DETERMINANTS; Johnson-Down LM, 2013, APPL PHYSIOL NUTR ME, V38, P300, DOI 10.1139/apnm-2012-0167; Kessler RC, 2003, J OCCUP ENVIRON MED, V45, P1257, DOI 10.1097/01.jom.0000100000.70011.bb; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Krueger R., 2008, FOCUS GROUPS PRACTIC; Kuhnlein HV, 1996, J AM DIET ASSOC, V96, P155, DOI 10.1016/S0002-8223(96)00045-4; Kvale S., 2009, INTERVIEWS LEARNING; Ledrou Ingird, 2005, Health Rep, V16, P47; Lehti V, 2009, SOC SCI MED, V69, P1194, DOI 10.1016/j.socscimed.2009.07.045; MacDonald JP, 2015, SOC SCI MED, V141, P133, DOI 10.1016/j.socscimed.2015.07.017; MacDougall C, 1997, QUAL HEALTH RES, V7, P532, DOI 10.1177/104973239700700407; Majowicz SE, 2006, J FOOD PROTECT, V69, P651, DOI 10.4315/0362-028X-69.3.651; Majowicz SE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-162; Mangen MJJ, 2010, RISK ANAL, V30, P782, DOI 10.1111/j.1539-6924.2009.01291.x; McGrath-Hanna Nancy K, 2003, Int J Circumpolar Health, V62, P228; McLinden T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-509; Olar M., 2011, EVIDENCE SOCIO EC IM; Oostenbrink J, 2000, GUIDELINES COST RES; Patton M. Q., 2005, ENCY STAT BEHAV SCI, DOI 10.1002/0470013192.bsa514; Pauktuutit Inuit Women of Canda, 2006, IN WAY GUID IN CULT; Pufall EL, 2011, ARCTIC, V64, P242; Ratcliffe J, 1995, PROJ APPR, V10, P13; Richmond CAM, 2009, INT J CIRCUMPOL HEAL, V68, P471; Romm NRA, 2015, FORUM QUAL SOC RES, V16; Sargeant JM, 2008, EPIDEMIOL INFECT, V136, P451, DOI 10.1017/S0950268807008837; Sauerborn R, 1996, SOC SCI MED, V43, P281, DOI 10.1016/0277-9536(95)00374-6; Scharff RL, 2015, J FOOD PROTECT, V78, P1064, DOI 10.4315/0362-028X.JFP-14-505; Segel J, 2006, COST OF ILLNESS STUD; Seidman I., 2006, INTERVIEWING QUALITA; Sim J, 1998, J ADV NURS, V28, P345, DOI 10.1046/j.1365-2648.1998.00692.x; Statistics Canada, 2016, RIG NEWF LABR; Stein AJ, 2014, GLOB FOOD SECUR-AGR, V3, P193, DOI 10.1016/j.gfs.2014.09.003; Stephens C, 2005, LANCET, V366, P10, DOI 10.1016/S0140-6736(05)66801-8; Thomas MK, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-307; Usher PJ, 2003, SOC INDIC RES, V61, P175, DOI 10.1023/A:1021344707027; USHER PJ, 1976, ARCTIC, V29, P105; van den Brandhof WE, 2004, EPIDEMIOL INFECT, V132, P211, DOI 10.1017/S0950268803001559; Willows ND, 2005, CAN J PUBLIC HEALTH, V96, pS32, DOI 10.1007/BF03405199; Willox AC, 2013, INT J CIRCUMPOL HEAL, V72, P519; Willox AC, 2013, CLIMATIC CHANGE, V121, P255, DOI 10.1007/s10584-013-0875-4; Willox AC, 2012, SOC SCI MED, V75, P538, DOI 10.1016/j.socscimed.2012.03.043; World Health Organization, 2009, WHO GUID ID EC CONS; Young TK, 2011, CAN MED ASSOC J, V183, P209, DOI 10.1503/cmaj.100948; Zhang W, 2011, SOC SCI MED, V72, P185, DOI 10.1016/j.socscimed.2010.10.026	83	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196990	10.1371/journal.pone.0196990	http://dx.doi.org/10.1371/journal.pone.0196990			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF9WG	29768456	Green Published, gold			2022-12-26	WOS:000432329200052
J	Liu, ZQ; Liu, YF; Kuermanali, N; Wang, DF; Chen, SJ; Guo, HL; Zhao, L; Wang, JW; Han, T; Wang, YZ; Wang, J; Shen, CF; Zhang, ZZ; Chen, CF				Liu, Zhi-Qiang; Liu, Yan-Feng; Kuermanali, Nuer; Wang, Deng-Feng; Chen, Shi-Jun; Guo, Hui-Ling; Zhao, Li; Wang, Jun-Wei; Han, Tao; Wang, Yuan-Zhi; Wang, Jie; Shen, Chen-Feng; Zhang, Zhuang-Zhi; Chen, Chuang-Fu			Sequencing of complete mitochondrial genomes confirms synonymization of Hyalomma asiaticum asiaticum and kozlovi, and advances phylogenetic hypotheses for the Ixodidae	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; GENUS AMBLYOMMA; ACARI IXODIDAE; SOFT TICKS; HARD TICKS; TOOL; DNA; GENERATION; ALIGNMENTS; EVOLUTION	Phylogeny of hard ticks (Ixodidae) remains unresolved. Mitochondrial genomes (mitogenomes) are increasingly used to resolve phylogenetic controversies, but remain unavailable for the entire large Hyalomma genus. Hyalomma asiaticum is a parasitic tick distributed throughout the Asia. As a result of great morphological variability, two subspecies have been recognised historically; until a morphological data-based synonymization was proposed. However, this hypothesis was never tested using molecular data. Therefore, objectives of this study were to: 1. sequence the first Hyalomma mitogenome; 2. scrutinise the proposed synonymization using molecular data, i.e. complete mitogenomes of both subspecies: H. a. asiaticum and kozlovi; 3. conduct phylogenomic and comparative analyses of all available Ixodidae mitogenomes. Results corroborate the proposed synonymization: the two mitogenomes are almost identical (99.6%). Genomic features of both mitogenomes are standard for Metastriata; which includes the presence of two control regions and all three "Tick-Box" motifs. Gene order and strand distribution are perfectly conserved for the entire Metastriata group. Suspecting compositional biases, we conducted phylogenetic analyses (29 almost complete mitogenomes) using homogeneous and heterogeneous (CAT) models of substitution. The results were congruent, apart from the deep-level topology of prostriate ticks (Ixodes): the homogeneous model produced a monophyletic Ixodes, but the CAT model produced a paraphyletic Ixodes (and thereby Prostriata), divided into Australasian and non-Australasian clades. This topology implies that all metastriate ticks have evolved from the ancestor of the non-Australian branch of prostriate ticks. Metastriata was divided into three clades: 1. Amblyomminae and Rhipicephalinae (Rhipicephalus, Hyalomma, Dermacentor); 2. Haemaphysalinae and Bothriocrotoninae, plus Amblyomma sphenodonti; 3. Amblyomma elaphense, basal to all Metastriata. We conclude that mitogenomes have the potential to resolve the long-standing debate about the evolutionary history of ticks, but heterogeneous evolutionary models should be used to alleviate the effects of compositional heterogeneity on deep-level relationships.	[Liu, Zhi-Qiang; Liu, Yan-Feng; Chen, Chuang-Fu] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang Uygur, Peoples R China; [Liu, Zhi-Qiang; Kuermanali, Nuer; Wang, Deng-Feng; Chen, Shi-Jun; Guo, Hui-Ling; Zhao, Li; Wang, Jun-Wei; Han, Tao; Wang, Jie; Shen, Chen-Feng; Zhang, Zhuang-Zhi] Xinjiang Acad Anim Sci, Inst Vet Med, Urumqi, Xinjiang Uygur, Peoples R China; [Wang, Yuan-Zhi] Shihezi Univ, Sch Med, Shihezi, Xinjiang Uygur, Peoples R China	Shihezi University; Shihezi University	Chen, CF (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang Uygur, Peoples R China.	ccf-xb@163.com		Liu, ZhiQiang/0000-0002-6382-1135	China Agriculture Research System [CARS-39-15]; Special Fund for Agro-scientific Research in the Public Interest [201303037]	China Agriculture Research System; Special Fund for Agro-scientific Research in the Public Interest	This study was supported by the China Agriculture Research System (CARS-39-15) and Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201303037) (ZQL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apanaskevich DA, 2010, EXP APPL ACAROL, V52, P207, DOI 10.1007/s10493-010-9361-0; Barker SC, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P1, DOI 10.1017/CBO9780511551802.002; Barker SC, 2014, ZOOTAXA, V3816, P1, DOI 10.11646/zootaxa.3816.1.1; Black WC, 1997, MOL PHYLOGENET EVOL, V7, P129, DOI 10.1006/mpev.1996.0382; BLACK WC, 1994, P NATL ACAD SCI USA, V91, P10034, DOI 10.1073/pnas.91.21.10034; Black WC, 1998, MOL BIOL EVOL, V15, P1772, DOI 10.1093/oxfordjournals.molbev.a025903; Burger TD, 2014, TICKS TICK-BORNE DIS, V5, P195, DOI 10.1016/j.ttbdis.2013.10.009; Burger TD, 2013, TICKS TICK-BORNE DIS, V4, P265, DOI 10.1016/j.ttbdis.2013.02.002; Burger TD, 2012, MOL PHYLOGENET EVOL, V64, P45, DOI 10.1016/j.ympev.2012.03.004; Burland T G, 2000, Methods Mol Biol, V132, P71; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen Z, 2015, KOREAN J PARASITOL, V53, P361, DOI 10.3347/kjp.2015.53.3.361; de Lima PHC, 2017, VET PARASITOL, V247, P121, DOI 10.1016/j.vetpar.2017.10.007; Dobson SJ, 1999, MOL PHYLOGENET EVOL, V11, P288, DOI 10.1006/mpev.1998.0565; Doublet V, 2015, RNA BIOL, V12, P1159, DOI 10.1080/15476286.2015.1090078; Edwards SV, 2016, P NATL ACAD SCI USA, V113, P8025, DOI 10.1073/pnas.1601066113; Gibson AK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-135; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Goddard J., 1993, PHYS S GUIDE ARTHROP, DOI [10.3201/eid1309.070706, DOI 10.3201/EID1309.070706]; Guglielmone AA, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2528.1.1; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Jakovlic I, 2013, ARCH BIOL SCI, V65, P1463, DOI 10.2298/ABS1304463J; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Klompen JSH, 2000, CLADISTICS, V16, P79, DOI 10.1111/j.1096-0031.2000.tb00349.x; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2000, MOL BIOL EVOL, V17, P813, DOI 10.1093/oxfordjournals.molbev.a026360; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liu FF, 2017, EUR J ENTOMOL, V114, P407, DOI 10.14411/eje.2017.052; Liu GH, 2013, INT J BIOL SCI, V9, P361, DOI 10.7150/ijbs.6081; Maddock ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156757; Mallet J, 2016, BIOESSAYS, V38, P140, DOI 10.1002/bies.201500149; Mans BJ, 2016, TICKS TICK-BORNE DIS, V7, P509, DOI 10.1016/j.ttbdis.2016.02.002; Mans BJ, 2015, TICKS TICK-BORNE DIS, V6, P450, DOI 10.1016/j.ttbdis.2015.03.013; Mans BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049461; Mans BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023675; Mathison BA, 2014, CLIN MICROBIOL REV, V27, P48, DOI 10.1128/CMR.00008-13; Miller M.A., 2010, P GAT COMP ENV WORKS; Montagna M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047538; Morgan CC, 2013, MOL BIOL EVOL, V30, P2145, DOI 10.1093/molbev/mst117; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Rubinoff D, 2005, SYST BIOL, V54, P952, DOI 10.1080/10635150500234674; Sands AF, 2017, MOL PHYLOGENET EVOL, V114, P153, DOI 10.1016/j.ympev.2017.06.002; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shao R, 2004, INSECT MOL BIOL, V13, P219, DOI 10.1111/j.0962-1075.2004.00447.x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; TALAVERA G, 2011, BIOMED CENTRAL, V11, DOI DOI 10.1186/1471-2148-11-315; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Wang JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181699; Wen HB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169749; Williams-Newkirk AJ, 2015, TICKS TICK-BORNE DIS, V6, P793, DOI 10.1016/j.ttbdis.2015.07.006; Yu X, 1997, TICKS FAUNA XINJIANG; Zhang D, 2017, J HELMINTHOL, P1, DOI DOI 10.1017/S0022149X17000578; Zhang D., MITOTOOL INTERNET; Zhang D., BIOSUITE; Zhang D, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2404-1; Zou H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4237-x	67	12	12	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197524	10.1371/journal.pone.0197524	http://dx.doi.org/10.1371/journal.pone.0197524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768482	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200091
J	Raboisson, D; Trillat, P; Derville, M; Cahuzac, C; Maigne, E				Raboisson, Didier; Trillat, Pauline; Derville, Marie; Cahuzac, Celia; Maigne, Elise			Defining health standards through economic optimisation: The example of colostrum management in beef and dairy production	PLOS ONE			English	Article							SERUM IGG CONCENTRATIONS; BULL CALVES; IMMUNITY; COWS; BOTTLE	There is extensive literature addressing acceptable practices of colostrum distribution to new-born calves; however, no economic analyses are available concerning the profitability of this practice. Moreover, the health standards associated with colostrum management have been defined through the observation of reference farms without explicit reference to economic assessments. The objective of the current study was to evaluate the profitability of farm colostrum management and to define the optimal economic situations for given livestock systems and farm situations. The herd-level net value was calculated using the value of calf products, the cost of passive transfer failure and the cost of prevention. This value was determined for various beef and dairy scenarios and the various time periods spent managing colostrum. The maximal net values defined the optimal economic situations and enabled the determination of the optimal times for colostrum management and respective health standards (i.e., the prevalence of disorders at optimum). The results showed that the optimal time farmers should spend on colostrum management is approximately 15 min per calf. Furthermore, farmers should err on the side of spending too much time (> 15 min) on colostrum management rather than not enough, unless the cost of labour is high. This is all the more true that potential long term consequences of passive transfer failure on milk yields were not accounted for here due to scarcity of data, leading to consider this time threshold (15 min) as a minimal recommendation. This potential underestimation may arise from the greater nutrient content and bioactive compounds identified in colostrum although the passive immune transfer is here defined through immunoglobulins only. The present results show that for small farms that cannot hire colostrum managers, this work can be performed by the farmer after subcontracting other tasks. Moreover, the method proposed here-the definition of health standards through economic optimisation-is a promising approach to analysing health conventions in the cattle industry.	[Raboisson, Didier; Trillat, Pauline; Cahuzac, Celia] Univ Toulouse, IHAP, INRA, ENVT, Toulouse, France; [Derville, Marie] Univ Toulouse, IEP Toulouse, ENSFEA, LEREPS, Toulouse, France; [Maigne, Elise] INRA, ODR, Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut d'Etudes Politiques Toulouse (SciencePo Toulouse); INRAE	Raboisson, D (corresponding author), Univ Toulouse, IHAP, INRA, ENVT, Toulouse, France.	d.raboisson@envt.fr	Raboisson, Didier/AAL-4025-2020	Raboisson, Didier/0000-0003-1630-6218				Allaire G, 2006, EC CONVENTIONS METHO, P279; Beam AL, 2009, J DAIRY SCI, V92, P3973, DOI 10.3168/jds.2009-2225; Berge ACB, 2005, J DAIRY SCI, V88, P2166, DOI 10.3168/jds.S0022-0302(05)72892-7; BESSER TE, 1991, J AM VET MED ASSOC, V198, P419; Blum JW, 2002, DOMEST ANIM ENDOCRIN, V23, P101, DOI 10.1016/S0739-7240(02)00149-2; Chigerwe M, 2008, AM J VET RES, V69, P1158, DOI 10.2460/ajvr.69.9.1158; Chigerwe M, 2008, JAVMA-J AM VET MED A, V233, P761, DOI 10.2460/javma.233.5.761; Chigerwe M, 2012, JAVMA-J AM VET MED A, V241, P104, DOI 10.2460/javma.241.1.104; Chigerwe M, 2009, JAVMA-J AM VET MED A, V234, P785, DOI 10.2460/javma.234.6.785; Faber S. N., 2005, Professional Animal Scientist, V21, P420; Favereau Olivier, 2002, CONVENTIONS STRUCTUR; French Livestock Institut [Insitut de l'Elevage], 2013, RES 2011 EXP BOV VIA; French Livestock Institut [Insitut de l'Elevage], 2013, RES NAT COLL RES ANN, P52; Gay C., 1994, Hoard's Dairyman, V139, P256; Godden S, 2008, VET CLIN N AM-FOOD A, V24, P19, DOI 10.1016/j.cvfa.2007.10.005; Hedegaard CJ, 2016, VET IMMUNOL IMMUNOP, V174, P50, DOI 10.1016/j.vetimm.2016.04.007; Hortet P, 1998, VET RES, V29, P497; Lhermie G., 2015, EC RURALE, V348, P3, DOI [10.4000/economierurale.4671, DOI 10.4000/ECONOMIERURALE.4671, DOI 10.4000/EC0N0MIERURALE.4671]; McAloon CG, 2016, VET REC, V179, DOI 10.1136/vr.103547; National Animal Health Monotoring Sytem (NAHMS), 1993, NAT DAIR HEIF EV PRO; PRITCHETT LC, 1991, J DAIRY SCI, V74, P2336, DOI 10.3168/jds.S0022-0302(91)78406-3; Quigley JD, 1998, J DAIRY SCI, V81, P2779, DOI 10.3168/jds.S0022-0302(98)75836-9; Raboisson D, 2011, APPROCHE I SANTE ANI; Raboisson D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150452; Smith L, 1998, NAT MAST COUNC 1998; Trotz-Williams LA, 2008, J DAIRY SCI, V91, P3840, DOI 10.3168/jds.2007-0898	26	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196377	10.1371/journal.pone.0196377	http://dx.doi.org/10.1371/journal.pone.0196377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768425	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200023
J	Lee, SS; Lee, YI; Kim, DU; Lee, DH; Moon, YW				Lee, Sung-Sahn; Lee, Yong-In; Kim, Dong-Uk; Lee, Dae-Hee; Moon, Young-Wan			Factors affecting femoral rotational angle based on the posterior condylar axis in gap-based navigation-assisted total knee arthroplasty for valgus knee	PLOS ONE			English	Article							DISTAL FEMUR; COMPONENT ROTATION; LIMB ALIGNMENT; GEOMETRY; FLEXION; TKA	Background Achieving proper rotational alignment of the femoral component in total knee arthroplasty (TKA) for valgus knee is challenging because of lateral condylar hypoplasia and lateral cartilage erosion. Gap-based navigation-assisted TKA enables surgeons to determine the angle of femoral component rotation (FCR) based on the posterior condylar axis. This study evaluated the possible factors that affect the rotational alignment of the femoral component based on the posterior condylar axis. Materials and methods Between 2008 and 2016, 28 knees were enrolled. The dependent variable for this study was FCR based on the posterior condylar axis, which was obtained from the navigation system archives. Multiple regression analysis was conducted to identify factors that might predict FCR, including body mass index (BMI), Kellgren-Lawrence grade (K-L grade), lateral distal femoral angles obtained from the navigation system and radiographs (NaviLDFA, XrayLDFA), hip-knee-ankle (HKA) axis, lateral gap under varus stress (LGVS), medial gap under valgus stress (MGVS), and side-to-side difference (STSD, MGVS - LGVS). Results The mean FCR was 6.1 degrees +/- 2.0 degrees. Of all the potentially predictive factors evaluated in this study, only NaviLDFA (beta = -0.668) and XrayLDFA (beta = -0.714) predicted significantly FCR. Conclusions The LDFAs, as determined using radiographs and the navigation system, were both predictive of the rotational alignment of the femoral component based on the posterior condylar axis in gap-based TKA for valgus knee. A 1 degrees increment with NaviLDFA led to a 0.668 degrees decrement in FCR, and a 1 degrees increment with XrayLDFA led to a 0.714 degrees decrement. This suggests that symmetrical lateral condylar hypoplasia of the posterior and distal side occurs in lateral compartment end-stage osteoarthritis with valgus deformity.	[Lee, Sung-Sahn; Lee, Yong-In; Kim, Dong-Uk; Lee, Dae-Hee; Moon, Young-Wan] Sungkyunkwan Univ, Samsung Med Ctr, Dept Orthoped Surg, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Moon, YW (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Orthoped Surg, Sch Med, Seoul, South Korea.	yw1moon@gmail.com						Akagi M, 1999, CLIN ORTHOP RELAT R, P155; ANOUCHI YS, 1993, CLIN ORTHOP RELAT R, P170; Asano T, 2005, J ARTHROPLASTY, V20, P1060, DOI 10.1016/j.arth.2004.08.005; Bae DK, 2017, KNEE SURG SPORT TR A, V25, P3747, DOI 10.1007/s00167-016-4264-1; Berger RA, 1998, CLIN ORTHOP RELAT R, P144, DOI 10.1097/00003086-199811000-00021; Brouwer R W, 2007, J Knee Surg, V20, P210; Fehring TK, 2000, CLIN ORTHOP RELAT R, P72, DOI 10.1097/00003086-200011000-00010; Griffin FM, 2000, J ARTHROPLASTY, V15, P354, DOI 10.1016/S0883-5403(00)90739-3; Heesterbeek PJC, 2009, CLIN ORTHOP RELAT R, V467, P1015, DOI 10.1007/s11999-008-0539-2; Hunt MA, 2006, CAN J SURG, V49, P401; Jenny Jean-Yves, 2004, Comput Aided Surg, V9, P161, DOI 10.1080/10929080500095517; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lange J, 2017, BONE JOINT J, V99B, P60, DOI 10.1302/0301-620X.99B1.BJJ-2016-0340.R1; Lee DH, 2011, KNEE SURG SPORT TR A, V19, P1141, DOI 10.1007/s00167-011-1422-3; Lee SY, 2017, CLIN ORTHOP RELAT R, V475, P1999, DOI 10.1007/s11999-017-5319-4; Lonner JH, 1996, CLIN ORTHOP RELAT R, P102; Luyckx T, 2013, KNEE SURG SPORT TR A, V21, P2331, DOI 10.1007/s00167-012-2306-x; Matsuda S, 1998, CLIN ORTHOP RELAT R, P183; Matsuda S, 2004, J ORTHOP RES, V22, P104, DOI 10.1016/S0736-0266(03)00134-7; Nagamine R, 1998, J Orthop Sci, V3, P194; Olcott CW, 1999, CLIN ORTHOP RELAT R, P39; Rossi R, 2014, INT ORTHOP, V38, P273, DOI 10.1007/s00264-013-2227-4; Tashiro Y, 2012, KNEE SURG SPORT TR A, V20, P1463, DOI 10.1007/s00167-011-1691-x; Thienpont E, 2014, KNEE SURG SPORT TR A, V22, P2995, DOI 10.1007/s00167-014-3086-2; Victor J, 2009, ORTHOP TRAUMATOL-SUR, V95, P365, DOI 10.1016/j.otsr.2009.04.011; Yaffe MA, 2008, CLIN ORTHOP RELAT R, V466, P2736, DOI 10.1007/s11999-008-0427-9; Yau WP, 2005, J ARTHROPLASTY, V20, P591, DOI 10.1016/j.arth.2005.02.011	27	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197335	10.1371/journal.pone.0197335	http://dx.doi.org/10.1371/journal.pone.0197335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763429	Green Published, Green Submitted, gold			2022-12-26	WOS:000432118800038
J	Azumaya, CM; Sierra-Valdez, F; Cordero-Morales, JF; Nakagawa, T				Azumaya, Caleigh M.; Sierra-Valdez, Francisco; Cordero-Morales, Julio F.; Nakagawa, Terunaga			Cryo-EM structure of the cytoplasmic domain of murine transient receptor potential cation channel subfamily C member 6 (TRPC6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; transient receptor potential channels (TRP channels); cryo-electron microscopy; membrane protein; calcium channel; kidney; electrophysiology; glomerulosclerosis; vasoconstriction; TRPC6; purification	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ION-CHANNEL; ELECTRON CRYOMICROSCOPY; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; ACTIVATION; PAIN	The kidney maintains the internal milieu by regulating the retention and excretion of proteins, ions, and small molecules. The glomerular podocyte forms the slit diaphragm of the ultrafiltration filter, whose damage leads to progressive kidney failure and focal segmental glomerulosclerosis (FSGS). The canonical transient receptor potential 6 (TRPC6) ion channel is expressed in the podocyte, and mutations in its cytoplasmic domain cause FSGS in humans. In vitro evaluation of disease-causing mutations in TRPC6 has revealed that these genetic alterations result in abnormal ion channel gating. However, the mechanism whereby the cytoplasmic domain modulates TRPC6 function is largely unknown. Here, we report a cryo-EM structure of the cytoplasmic domain of murine TRPC6 at 3.8 resolution. The cytoplasmic fold of TRPC6 is characterized by an inverted dome-like chamber pierced by four radial horizontal helices that converge into a vertical coiled-coil at the central axis. Unlike other TRP channels, TRPC6 displays a unique domain swap that occurs at the junction of the horizontal helices and coiled-coil. Multiple FSGS mutations converge at the buried interface between the vertical coiled-coil and the ankyrin repeats, which form the dome, suggesting these regions are critical for allosteric gating modulation. This functionally critical interface is a potential target for drug design. Importantly, dysfunction in other family members leads to learning deficits (TRPC1/4/5) and ataxia (TRPC3). Our data provide a structural framework for the mechanistic investigation of the TRPC family.	[Azumaya, Caleigh M.; Nakagawa, Terunaga] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Sch Med, Ctr Struct Biol, Nashville, TN 37232 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37232 USA; [Sierra-Valdez, Francisco; Cordero-Morales, Julio F.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Cordero-Morales, JF (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA.; Nakagawa, T (corresponding author), 702 Light Hall, Nashville, TN 37232 USA.	jcordero@uthsc.edu; terunaga.nakagawa@vanderbilt.edu		Cordero Morales, Julio/0000-0002-6505-5403; Sierra-Valdez, Francisco J/0000-0002-7803-9701	National Institutes of Health [S10RR031634]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125629, T32GM008320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	EM data collections using FEI Polara and FEI TF20 were conducted at the Center for Structural Biology's Molecular CryoEM facility at Vanderbilt University. We thank Dr. Scott Collier and Dr. Elad Binshtein for their support at the facility. We thank Dr. James Fitzpatrick and Michael Rau for providing access and facilitating data collection using the Titan Krios at the Washington University Center for Cellular Imaging, Washington University at St. Louis Medical School. This work was conducted in part using the Central Processing Unit and Graphical Processing Unit resources of the Advanced Computing Center for Research and Education (ACCRE) at Vanderbilt University. We used Distributed Online Research Storage (DORS) system supported by the National Institutes of Health Grant S10RR031634 (to Jarrod Smith). We acknowledge the use of SBGrid-supported software (22). We thank Dr. Vasquez for experimental advice and critically reading the manuscript, and Dr. Efren Garcia Maldonado and Dr. Erkan Karakas for advice during model construction.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Broker-Lai J, 2017, EMBO J, V36, P2770, DOI 10.15252/embj.201696369; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Dietrich A, 2014, HANDB EXP PHARMACOL, V222, P157, DOI 10.1007/978-3-642-54215-2_7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duan J., 2018, BIORXIV282715, DOI [10.1101/282715, DOI 10.1101/282715]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; Fan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36852; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Greger IH, 2017, NEURON, V94, P713, DOI 10.1016/j.neuron.2017.04.009; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jin P, 2017, NATURE, V547, P118, DOI 10.1038/nature22981; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/NMETH.2727, 10.1038/nmeth.2727]; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Madej MG, 2018, PFLUG ARCH EUR J PHY, V470, P213, DOI 10.1007/s00424-018-2107-2; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Mottl AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-104; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Santin S, 2009, NEPHROL DIAL TRANSPL, V24, P3089, DOI 10.1093/ndt/gfp229; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Tang QL, 2018, CELL RES, V28, P746, DOI 10.1038/s41422-018-0038-2; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Urban N, 2017, BRIT J PHARMACOL, V174, P4099, DOI 10.1111/bph.13977; Vinayagam D, 2018, ELIFE, V7, DOI 10.7554/eLife.36615; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	48	28	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10381	10391		10.1074/jbc.RA118.003183	http://dx.doi.org/10.1074/jbc.RA118.003183			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29752403	Green Published, hybrid			2022-12-26	WOS:000437096700035
J	Steiger, D; Yokota, T; Li, J; Ren, SX; Minamisawa, S; Wang, YB				Steiger, DeAnna; Yokota, Tomohiro; Li, Jin; Ren, Shuxun; Minamisawa, Susumu; Wang, Yibin			The serine/threonine-protein kinase/endoribonuclease IRE1 protects the heart against pressure overload-induced heart failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); cardiomyocyte; cardiomyopathy; heart failure; signal transduction	ENDOPLASMIC-RETICULUM STRESS; P38 MAP KINASES; ER STRESS; CELL-DEATH; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; RESPONSE PATHWAY; GENE-EXPRESSION; TRANSGENIC MICE; QUALITY-CONTROL	Heart failure is associated with induction of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). The serine/threonine protein kinase/endoribonuclease IRE1 is a key protein in ER stress signal transduction. IRE1 activity can induce both protective UPR and apoptotic downstream signaling events, but the specific role for IRE1 activity in the heart is unknown. A major aim of this study was to characterize the specific contribution of IRE1 in cardiac physiology and pathogenesis. We used both cultured myocytes and a transgenic mouse line with inducible and cardiomyocyte-specific IRE1 overexpression as experimental models to achieve targeted IRE1 activation. IRE1 expression induced a potent but transient ER stress response in cardiomyocytes and did not cause significant effects in the intact heart under normal physiological conditions. Furthermore, the IRE1-activated transgenic heart responding to pressure overload exhibited preserved function and reduced fibrotic area, associated with increased adaptive UPR signaling and with blunted inflammatory and pathological gene expression. Therefore, we conclude that IRE1 induces transient ER stress signaling and confers a protective effect against pressure overload-induced pathological remodeling in the heart. To our knowledge, this report provides first direct evidence of a specific and protective role for IRE1 in the heart and reveals an interaction between ER stress signaling and inflammatory regulation in the pathologically stressed heart.	[Steiger, DeAnna; Yokota, Tomohiro; Li, Jin; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Steiger, DeAnna; Yokota, Tomohiro; Li, Jin; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Steiger, DeAnna; Yokota, Tomohiro; Li, Jin; Ren, Shuxun; Wang, Yibin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Minamisawa, Susumu] Jikei Univ, Sch Med, Dept Cell Physiol, Tokyo 1058461, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Jikei University	Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.; Wang, YB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	yibinwang@mednet.ucla.edu		Minamisawa, Susumu/0000-0003-4728-2116; Yokota, Tomohiro/0000-0003-2540-3810; Wang, Yibin/0000-0003-0852-0767	National Institutes of Health [HL103205, HL070079]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Vehicle Racing Commemorative Foundation; Jikei University Graduate Research Fund; MEXT Supported Program for the Strategic Research Foundation at Private Universities; National Institutes of Health Ruth L. Kirschstein National Research Service Award [F31 AG038156]; UCLA-Waseda Brain Circulation fellowship award from the Japanese Ministry of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103205, R01HL070079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG038156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Jikei University Graduate Research Fund; MEXT Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA-Waseda Brain Circulation fellowship award from the Japanese Ministry of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants HL103205 and HL070079 (to Y.W.) and additional funding from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S.M.), the Vehicle Racing Commemorative Foundation (to S.M.), The Jikei University Graduate Research Fund (to S.M.), and the MEXT Supported Program for the Strategic Research Foundation at Private Universities (to S.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Ruth L. Kirschstein National Research Service Award F31 AG038156.; Supported by a UCLA-Waseda Brain Circulation fellowship award from the Japanese Ministry of Science and Technology.	Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Briot A, 2014, DEV CELL, V31, P707, DOI 10.1016/j.devcel.2014.11.023; Bulleid NJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013219; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cool AR, 2009, J MOL CELL CARDIOL, V46, P225, DOI 10.1016/j.yjmcc.2008.10.013; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Ishikawa T, 2006, GENESIS, V44, P143, DOI 10.1002/gene.20192; Isodono K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009746; IWAKI K, 1990, J BIOL CHEM, V265, P13809; JANERO DR, 1991, J CELL PHYSIOL, V149, P347, DOI 10.1002/jcp.1041490302; Kadowaki H, 2004, J CHEM NEUROANAT, V28, P93, DOI 10.1016/j.jchemneu.2004.05.004; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Li MX, 2005, CIRCULATION, V111, P2494, DOI 10.1161/01.CIR.0000165117.71483.0C; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; Lu G, 2013, MOL METAB, V2, P405, DOI 10.1016/j.molmet.2013.07.005; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Mitchell S, 2006, PHYSIOL GENOMICS, V25, P50, DOI 10.1152/physiolgenomics.00224.2005; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Ota A, 2012, J BIOL CHEM, V287, P6266, DOI 10.1074/jbc.M111.331264; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Petrich BG, 2003, FASEB J, V17, P749, DOI 10.1096/fj.02-0438fje; Prins D, 2009, CAN J PHYSIOL PHARM, V87, P419, DOI [10.1139/Y09-032, 10.1139/y09-032]; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Stadtman ER, 2004, CURR MED CHEM, V11, P1105, DOI 10.2174/0929867043365341; Streicher JM, 2010, CIRC RES, V106, P1434, DOI 10.1161/CIRCRESAHA.109.213199; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Yokota T, 2016, GENE, V575, P369, DOI 10.1016/j.gene.2015.09.030; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zhang C, 2001, BIOCHEM BIOPH RES CO, V289, P718, DOI 10.1006/bbrc.2001.6044; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	63	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9652	9661		10.1074/jbc.RA118.003448	http://dx.doi.org/10.1074/jbc.RA118.003448			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29769316	Green Published, hybrid			2022-12-26	WOS:000436102300010
J	Marck, CH; De Livera, AM; Brown, CR; Neate, SL; Taylor, KL; Weiland, TJ; Hadgkiss, EJ; Jelinek, GA				Marck, Claudia H.; De Livera, Alysha M.; Brown, Chelsea R.; Neate, Sandra L.; Taylor, Keryn L.; Weiland, Tracey J.; Hadgkiss, Emily J.; Jelinek, George A.			Health outcomes and adherence to a healthy lifestyle after a multimodal intervention in people with multiple sclerosis: Three year follow-up	PLOS ONE			English	Article							QUALITY-OF-LIFE; IMPACT; ASSOCIATION; DISABILITY; PROMOTION; DISEASE	Background Modifiable risk factors such as smoking and sedentary lifestyle adversely affect multiple sclerosis (MS) progression. Few multimodal behavioural interventions have been conducted for people with MS, and follow-up beyond 1 year is rare for lifestyle interventions. This study assessed adoption and adherence to healthy lifestyle behaviours and health outcomes 3 years after a lifestyle modification intervention, using generalized estimating equation models to account for within-participant correlation over time. Methods 95 people with MS completed baseline surveys before participating in 5-day MS lifestyle risk-factor modification workshops. 76 and 78 participants completed the 1-year and 3-year follow-up surveys respectively. Mean age at 3-year follow-up was 47 years, 72% were female, most (62.8%) had MS for 5 years or less, and 73% had relapsing remitting MS (RRMS). Results Compared to baseline, participants reported clinically meaningful increases in physical (mean difference (MD): 8.0, 95% Confidence Interval (CI): 5.2-10.8) and mental health (MD: 9.2, CI: 5.8-12.6) quality of life (QOL) at 1-year, and physical (MD: 8.7, CI: 5.3-12.2) and mental health (MD: 8.0, CI: 4.2-11.8) QOL at 3-year follow-up. There was a small decrease in disability from baseline to 1-year follow-up (MD: 0.9, CI: 0.9,1.0) and to 3-year follow-up (MD: 1.0, CI: 0.9,1.0), which was not clinically meaningful. Of those with RRMS, compared to baseline, fewer had a relapse during the year before 1-year follow-up (OR: 0.1, CI 0.0-0.2) and 3-year follow-up (OR: 0.15, CI 0.06-0.33). Participants' healthy diet score, the proportion meditating >= 1 hours a week, supplementing with >= 5000IU vitamin D daily, and supplementing with omega-3 flaxseed oil increased at 1-year follow-up and was sustained, although slightly lower at 3-year follow-up. However, there was no evidence for a change in physical activity and not enough smokers to make meaningful comparisons. Medication use increased at 1-year follow-up and at 3-year follow-up. Conclusion The results provide evidence that lifestyle risk factor modification is feasible and sustainable over time, in a small self-selected and motivated sample of people with MS. Furthermore, participation in a lifestyle intervention is not associated with a decrease in MS medication use.	[Marck, Claudia H.; De Livera, Alysha M.; Brown, Chelsea R.; Neate, Sandra L.; Taylor, Keryn L.; Weiland, Tracey J.; Jelinek, George A.] Univ Melbourne, Neuroepidemiol Unit, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Marck, Claudia H.] Univ Melbourne, Disabil & Hlth, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Hadgkiss, Emily J.] City Whittlesea, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Marck, CH (corresponding author), Univ Melbourne, Neuroepidemiol Unit, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.; Marck, CH (corresponding author), Univ Melbourne, Disabil & Hlth, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.	claudia.marck@unimelb.edu.au	Weiland, Tracey/Y-2029-2018; De Livera, Alysha/AAU-6661-2021	Weiland, Tracey/0000-0002-4053-5507; De Livera, Alysha/0000-0003-4981-4155; Marck, Claudia/0000-0002-3173-1522	Bloom Foundation; Horne Family Trust; University of Melbourne; National Health and Medical Research Council [1120014]	Bloom Foundation; Horne Family Trust; University of Melbourne(University of Melbourne); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Bloom Foundation, the Horne Family Trust and a University of Melbourne Early Career Researcher Grant. CM is funded by an Early Career Fellowship from the National Health and Medical Research Council (ID: 1120014).	Bisht B, 2014, J ALTERN COMPLEM MED, V20, P347, DOI 10.1089/acm.2013.0188; Brenton JN, 2016, MULT SCLER RELAT DIS, V8, P54, DOI 10.1016/j.msard.2016.04.009; Calandri E, 2017, DISABIL REHABIL, V39, P1474, DOI 10.1080/09638288.2016.1198430; Costelloe L, 2007, J NEUROL NEUROSUR PS, V78, P841, DOI 10.1136/jnnp.2006.105759; Coyle Patricia K, 2016, Continuum (Minneap Minn), V22, P815, DOI 10.1212/CON.0000000000000325; D'hooghe MB, 2013, J NEUROL SCI, V325, P120, DOI 10.1016/j.jns.2012.12.018; Fuentes B, 2012, NEUROLOGIA, V27, P560, DOI 10.1016/j.nrl.2011.06.002; Grant WB, 2016, NEUROLOGY, V86, P1275, DOI 10.1212/WNL.0000000000002487; Hadgkiss EJ, 2015, NUTR NEUROSCI, V18, P125, DOI 10.1179/1476830514Y.0000000117; Hadgkiss EJ, 2013, NEUROL SCI, V34, P187, DOI 10.1007/s10072-012-0982-4; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Heesen Christoph, 2015, Mult Scler J Exp Transl Clin, V1, p2055217315585333, DOI 10.1177/2055217315585333; Hempel S, 2017, MULT SCLER J, V23, P525, DOI 10.1177/1352458517690270; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Holman H, 2004, PUBLIC HEALTH REP, V119, P239, DOI 10.1016/j.phr.2004.04.002; Jelinek G., 2003, OVERCOMING MULTIPLE; Kalincik T, 2013, BRAIN, V136, P3609, DOI 10.1093/brain/awt281; Kappos L, 2014, MULT SCLER J, V20, P243, DOI 10.1177/1352458513507817; Kelly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145074; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Lee JE, 2017, J AM COLL NUTR, V36, P150, DOI 10.1080/07315724.2016.1255160; Li Michelle Pui-Ming, 2010, Qual Prim Care, V18, P379; Lysandropoulos AP, 2015, EUR J NEUROL, V22, P28, DOI 10.1111/ene.12801; Marck CH, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-143; Marrie RA, 2009, MULT SCLER J, V15, P105, DOI 10.1177/1352458508096680; Motl Robert W, 2015, Int J MS Care, V17, P65, DOI 10.7224/1537-2073.2014-016; Olsson T, 2017, NAT REV NEUROL, V13, P25, DOI 10.1038/nrneurol.2016.187; Palmer AJ, 2013, MULT SCLER J, V19, P1640, DOI 10.1177/1352458513488230; Pan Gb, 2016, J NEUROL NEUROSUR PS, V87, P1204, DOI 10.1136/jnnp-2016-313722; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Penwell-Waines L, 2017, PSYCHOL HEALTH MED, V22, P205, DOI 10.1080/13548506.2016.1226506; Phillips GA, 2014, MULT SCLER J, V20, P1753, DOI 10.1177/1352458514530489; Rice Claire M, 2014, Pract Neurol, V14, P6, DOI 10.1136/practneurol-2013-000601; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Tramacere I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011381.pub2; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Younge JO, 2015, INT J EPIDEMIOL, V44, P2006, DOI 10.1093/ije/dyv183	39	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197759	10.1371/journal.pone.0197759	http://dx.doi.org/10.1371/journal.pone.0197759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791509	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000060
J	Chachaj, A; Wisniewski, J; Rybka, J; Butrym, A; Biedron, M; Krzystek-Korpacka, M; Fleszar, MG; Karczewski, M; Wrobel, T; Mazur, G; Gamian, A; Szuba, A				Chachaj, Angelika; Wisniewski, Jerzy; Rybka, Justyna; Butrym, Aleksandra; Biedron, Monika; Krzystek-Korpacka, Malgorzata; Fleszar, Mariusz Grzegorz; Karczewski, Maciej; Wrobel, Tomasz; Mazur, Grzegorz; Gamian, Andrzej; Szuba, Andrzej			Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CARDIOVASCULAR RISK-FACTOR; STAGE RENAL-DISEASE; L-ARGININE PARADOX; ENDOTHELIAL DYSFUNCTION; DIMETHYLAMINOHYDROLASE DDAH; ACCURATE QUANTIFICATION; RAT-KIDNEY; ADMA; PLASMA	The study was designed to determine the associations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginines plasma concentrations with all-cause mortality in patients with hematological malignancies. 33 patients with acute myeloid leukemia (AML), 31 patients with non-Hodgkin's lymphoma (nHL), 32 patients with chronic lymphocytic leukemia (CLL) and 48 patients without malignancy were enrolled into the study. Each patient was followed until death or for at least 14.5 months (range: 14.5-53). Median ADMA and SDMA were significantly elevated in AML, nHL and CLL compared to controls (ADMA: 1.36, 1.24, 1.03, 0.55 mu mol/l respectively, p<0.0001; SDMA: 0.86, 0.76, 0.71, 0.52 mu mol/l respectively, p<0.0001). High ADMA and SDMA were associated with increased risk for all-cause mortality in CLL group (Hazard ratio (HR) for ADMA: 3.05, 95% CI:1.58-5.88, p = 0.001; HR for SDMA: 4.71, 95% CI:1.91-11.58, p = 0.001). Our study suggests that ADMA and SDMA could be novel prognostic factors for all-cause mortality in CLL patients.	[Chachaj, Angelika; Szuba, Andrzej] Wroclaw Med Univ, Dept Angiol, Wroclaw, Poland; [Wisniewski, Jerzy; Krzystek-Korpacka, Malgorzata; Fleszar, Mariusz Grzegorz; Gamian, Andrzej] Wroclaw Med Univ, Dept Biochem, Wroclaw, Poland; [Rybka, Justyna; Biedron, Monika; Wrobel, Tomasz] Wroclaw Med Univ, Dept Haematol Blood Neoplasms & Bone Marrow Trans, Wroclaw, Poland; [Butrym, Aleksandra] Wroclaw Med Univ, Dept Physiol, Wroclaw, Poland; [Butrym, Aleksandra; Mazur, Grzegorz] Wroclaw Med Univ, Dept Internal Med, Wroclaw, Poland; [Karczewski, Maciej] Wroclaw Univ Environm & Life Sci, Fac Environm Engn & Geodesy, Dept Math, Wroclaw, Poland; [Gamian, Andrzej] Polish Acad Sci, Inst Immunol & Expt Therapy, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University; Wroclaw Medical University; Wroclaw University of Environmental & Life Sciences; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Chachaj, A (corresponding author), Wroclaw Med Univ, Dept Angiol, Wroclaw, Poland.	angelika_chachaj@wp.pl	Szuba, Andrzej/AAY-1162-2020; Krzystek-Korpacka, Małgorzata/ABA-4556-2021; Wiśniewski, Jerzy/AAV-7279-2020; Fleszar, Mariusz/AAY-9914-2021; Butrym, Aleksandra/T-6582-2018	, Justyna/0000-0001-7965-3589; Szuba, Andrzej/0000-0002-7555-6201; Fleszar, Mariusz/0000-0001-7857-327X; Karczewski, Maciej/0000-0001-8811-8916; Mazur, Grzegorz/0000-0001-6610-2008; Butrym, Aleksandra/0000-0002-8199-2018; Gamian, Andrzej/0000-0002-2206-6591; Chachaj, Angelika/0000-0001-8087-8005; Wrobel, Tomasz/0000-0002-6612-3535	Wroclaw Medical University [18/Pbmn]	Wroclaw Medical University	The study was supported by Wroclaw Medical University, Grant number 18/Pbmn. The funding body accepted the study protocol and had no later influence on study performance, collection, analysis and interpretation of data, the writing of the manuscript or in the decision to submit the manuscript for publication.	Abbasi F, 2001, AM J CARDIOL, V88, P1201, DOI 10.1016/S0002-9149(01)02063-X; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Aucella F, 2009, ATHEROSCLEROSIS, V207, P541, DOI 10.1016/j.atherosclerosis.2009.05.011; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Boger RH, 2011, J INTERN MED, V269, P349, DOI 10.1111/j.1365-2796.2010.02322.x; Boger RH, 2009, PHARMACOL RES, V60, P447, DOI 10.1016/j.phrs.2009.10.001; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 2005, VASC MED, V10, pS1, DOI 10.1191/1358863xvm594ed; Boger RH, 2004, J NUTR, V134, p2842S, DOI 10.1093/jn/134.10.2842S; Boger RH, 2003, ATHEROSCLEROSIS SUPP, V4, P23, DOI 10.1016/S1567-5688(03)00030-8; Boger RH, 2003, ATHEROSCLEROSIS SUPP, V4, P1, DOI 10.1016/S1567-5688(03)00027-8; Cavalca V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048499; Chobanyan K, 2007, J CHROMATOGR B, V851, P240, DOI 10.1016/j.jchromb.2007.03.006; Choudhari SK, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-118; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Dayal S, 2005, VASC MED, V10, pS27, DOI 10.1191/1358863x05vm599oa; Doroszko A, 2016, POSTEP HIG MED DOSW, V70, P562, DOI 10.5604/17322693.1203720; Ferrigno A, 2016, BASIC CLIN PHARMACOL, V119, P101, DOI 10.1111/bcpt.12540; Ferrigno A, 2015, WORLD J GASTROENTERO, V21, P5131, DOI 10.3748/wjg.v21.i17.5131; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Ghebremariam YT, 2012, J BIOMOL SCREEN, V17, P651, DOI 10.1177/1087057112441521; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; KIMOTO M, 1995, J BIOCHEM-TOKYO, V117, P237, DOI 10.1093/jb/117.2.237; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Napora M, 2012, POL ARCH MED WEWN, V122, P226, DOI 10.20452/pamw.1222; Nemeth B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177493; Nijveldt RJ, 2003, CLIN NUTR, V22, P17, DOI 10.1054/clnu.2002.0612; Nijveldt RJ, 2003, NEPHROL DIAL TRANSPL, V18, P2542, DOI 10.1093/ndt/gfg452; Nijveldt RJ, 2003, CLIN NUTR, V22, P23, DOI 10.1054/clnu.2002.0613; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Perticone F, 2010, INT J CARDIOL, V142, P236, DOI 10.1016/j.ijcard.2008.12.131; Rodionov RN, 2016, NEPHROL DIAL TRANSPL, V31, P57, DOI 10.1093/ndt/gfv390; Schlesinger S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165811; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Scicinski J, 2015, REDOX BIOL, V6, P1, DOI 10.1016/j.redox.2015.07.002; Sen N, 2011, ATHEROSCLEROSIS, V219, P304, DOI 10.1016/j.atherosclerosis.2011.06.021; Siegerink B, 2013, CLIN RES CARDIOL, V102, P193, DOI 10.1007/s00392-012-0515-4; Sorrenti V, 2006, CURR NEUROVASC RES, V3, P49, DOI 10.2174/156720206775541778; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Szuba A, 2008, LEUKEMIA LYMPHOMA, V49, P2316, DOI 10.1080/10428190802510323; Tojo A, 1997, KIDNEY INT, V52, P1593, DOI 10.1038/ki.1997.490; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Tsikas D, 2007, J CHROMATOGR B, V851, P229, DOI 10.1016/j.jchromb.2006.09.015	48	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197148	10.1371/journal.pone.0197148	http://dx.doi.org/10.1371/journal.pone.0197148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787597	Green Submitted, gold, Green Published			2022-12-26	WOS:000432785700014
J	Dann, LM; McKerra, JC; Smith, RJ; Tobe, SS; Paterson, JS; Seymour, JR; Oliver, RL; Mitchell, JG				Dann, Lisa M.; McKerra, Jody C.; Smith, Renee J.; Tobe, Shanan S.; Paterson, James S.; Seymour, Justin R.; Oliver, Rod L.; Mitchell, James G.			Microbial micropatches within microbial hotspots	PLOS ONE			English	Article							MICROSCALE NUTRIENT PATCHES; PARTICLE ABUNDANCES; BACTERIAL; VIRUSES; PATCHINESS; HETEROGENEITY; DISTRIBUTIONS; ENUMERATION; VARIABILITY; MECHANISMS	The spatial distributions of organism abundance and diversity are often heterogeneous. This includes the sub-centimetre distributions of microbes, which have 'hotspots' of high abundance, and 'coldspots' of low abundance. Previously we showed that 300 mu l abundance hot spots, coldspots and background regions were distinct at all taxonomic levels. Here we build on these results by showing taxonomic micropatches within these 300 mu l microscale hot spots, coldspots and background regions at the 1 mu l scale. This heterogeneity among 1 mu l subsamples was driven by heightened abundance of specific genera. The micropatches were most pronounced within hotspots. Micropatches were dominated by Pseudomonas, Bacteroides, Parasporobacterium and Lachnospiraceae incertae sedis, with Pseudomonas and Bacteroides being responsible for a shift in the most dominant genera in individual hot spot subsamples, representing up to 80.6% and 47.3% average abundance, respectively. The presence of these micropatches implies the ability these groups have to create, establish themselves in, or exploit heterogeneous microenvironments. These genera are often particle -associated, from which we infer that these micropatches are evidence for sub-millimetre aggregates and the aquatic polymer matrix. These findings support the emerging paradigm that the microscale distributions of planktonic microbes are numerically and taxonomically heterogeneous at scales of millimetres and less. We show that microscale microbial hotspots have internal structure within which specific local nutrient exchanges and cellular interactions might occur.	[Dann, Lisa M.; Smith, Renee J.; Tobe, Shanan S.; Paterson, James S.; Mitchell, James G.] Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia; [McKerra, Jody C.] Flinders Univ S Australia, Sch Comp Sci Engn & Math, Adelaide, SA, Australia; [Seymour, Justin R.] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster C3, Sydney, NSW, Australia; [Oliver, Rod L.] CSIRO Land & Water Waite Res Inst, Adelaide, SA, Australia	Flinders University South Australia; Flinders University South Australia; University of Technology Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Dann, LM (corresponding author), Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia.	Lisa.dann@flinders.edu.au	Tobe, Shanan/U-1859-2019; Tobe, Shanan/AAL-9771-2021	Tobe, Shanan/0000-0002-4854-6278; Seymour, Justin/0000-0002-3745-6541; Dann, Lisa/0000-0002-2525-5523; Mitchell, Jim/0000-0002-8445-0935; Fisher, Jody/0000-0002-1830-6695; Paterson, James/0000-0002-1193-5739	CSIRO Land and Water Top-Up PhD Scholarship; CSIRO consumables grant; Australian Research Council grants [LP-130100508, DP-150103018]	CSIRO Land and Water Top-Up PhD Scholarship; CSIRO consumables grant(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Research Council grants(Australian Research Council)	This research was supported by a CSIRO Land and Water Top-Up PhD Scholarship (LD), a CSIRO consumables grant (LD), an APA to LD and Australian Research Council grants, www.aragov.au, LP-130100508 and DP-150103018 to JGM.	Abraham ER, 1998, NATURE, V391, P577, DOI 10.1038/35361; ADLER J, 1966, SCIENCE, V153, P708, DOI 10.1126/science.153.3737.708; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Baldridge E, 2016, PEERJ, V4, DOI 10.7717/peerj.2823; Barbara GM, 2003, FEMS MICROBIOL ECOL, V43, P99, DOI 10.1111/j.1574-6941.2003.tb01049.x; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Blackburn N, 1999, MAR ECOL PROG SER, V189, P1, DOI 10.3354/meps189001; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Burns A, 2000, HYDROBIOLOGIA, V437, P83, DOI 10.1023/A:1026555501638; Carrias JF, 2009, ENCY INLAND WATERS, P182; Chow CET, 2014, ISME J, V8, P816, DOI 10.1038/ismej.2013.199; Clarke K.R., 2006, USER MANUAL TUTORIAL, P93; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Dann LM, 2017, MAR FRESHWATER RES, V68, P851, DOI 10.1071/MF16010; Dann LM, 2016, AQUAT MICROB ECOL, V77, P65, DOI 10.3354/ame01788; Dann LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146984; Dann LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102805; Department of Environment Water and Natural Resources (DEWNR), 2014, RIV MURR; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Durham WM, 2012, ANNU REV MAR SCI, V4, P177, DOI 10.1146/annurev-marine-120710-100957; Durham WM, 2009, SCIENCE, V323, P1067, DOI 10.1126/science.1167334; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fenchel T, 2001, AQUAT MICROB ECOL, V24, P197, DOI 10.3354/ame024197; Hillmer I, 2008, ECOL MODEL, V218, P49, DOI 10.1016/j.ecolmodel.2008.06.017; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Hondzo M, 1999, FRESHWATER BIOL, V41, P51, DOI 10.1046/j.1365-2427.1999.00389.x; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; KOLMOGOROV AN, 1991, P R SOC-MATH PHYS SC, V434, P15, DOI 10.1098/rspa.1991.0076; Legendre P., 2012, NUMERICAL ECOLOGY, V24; Liu AC, 2015, J BIOTECHNOL, V194, P124, DOI 10.1016/j.jbiotec.2014.11.026; Liu H, 2002, DEEP SEA RES 2, V49, P24, DOI DOI 10.1016/S0967-0645(02)00199-6; Lomans BP, 2001, APPL ENVIRON MICROB, V67, P4017, DOI 10.1128/AEM.67.9.4017-4023.2001; Long RA, 2001, AQUAT MICROB ECOL, V26, P103, DOI 10.3354/ame026103; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Matz C, 2005, APPL ENVIRON MICROB, V71, P921, DOI 10.1128/AEM.71.2.921-929.2005; Meckenstock RU, 2014, SCIENCE, V345, P673, DOI 10.1126/science.1252215; Mitchell JG, 2008, J MARINE SYST, V69, P247, DOI 10.1016/j.jmarsys.2006.01.019; MITCHELL JG, 1989, MAR ECOL PROG SER, V54, P141, DOI 10.3354/meps054141; MITCHELL JG, 1985, NATURE, V316, P58, DOI 10.1038/316058a0; Mitchell JG, 2002, AM NAT, V160, P727, DOI 10.1086/343874; Mitchell JG, 2004, HDB SCALING METHODS, P257; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Palleroni NJ, 1981, PROKARYOTES, P655, DOI DOI 10.1007/978-3-662-13187-9_58; Pollard PC, 2011, LIMNOL OCEANOGR, V56, P1115, DOI 10.4319/lo.2011.56.3.1115; Pylro VS, 2014, J MICROBIOL METH, V107, P30, DOI 10.1016/j.mimet.2014.08.018; Roudnew B, 2014, GROUNDWATER, V52, P118, DOI 10.1111/gwat.12044; Roudnew B, 2012, GROUND WATER MONIT R, V32, P72, DOI 10.1111/j.1745-6592.2011.01393.x; Seuront L, 2010, FRACTALS MULTIFRACTA, P155; Seymour JR, 2007, ESTUAR COAST SHELF S, V73, P651, DOI 10.1016/j.ecss.2007.03.004; Seymour JR, 2008, ESTUAR COAST SHELF S, V80, P589, DOI 10.1016/j.ecss.2008.09.011; Seymour JR, 2000, AQUAT MICROB ECOL, V22, P143, DOI 10.3354/ame022143; Seymour JR, 2006, J MAR BIOL ASSOC UK, V86, P551, DOI 10.1017/S0025315406013464; Seymour JR, 2005, MAR ECOL PROG SER, V300, P21, DOI 10.3354/meps300021; Seymour JR, 2004, AQUAT MICROB ECOL, V35, P1, DOI 10.3354/ame035001; Siegel DA, 1998, LIMNOL OCEANOGR, V43, P1133, DOI 10.4319/lo.1998.43.6.1133; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Smith RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129004; Smriga S, 2016, P NATL ACAD SCI USA, V113, P1576, DOI 10.1073/pnas.1512307113; Son K, 2016, P NATL ACAD SCI USA, V113, P8624, DOI 10.1073/pnas.1602307113; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Stocker R, 2012, MICROBIOL MOL BIOL R, V76, P792, DOI 10.1128/MMBR.00029-12; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Tang KW, 2005, AQUAT MICROB ECOL, V38, P31, DOI 10.3354/ame038031; Taylor JR, 2012, SCIENCE, V338, P675, DOI 10.1126/science.1219417; Telgmann U, 2004, WATER RES, V38, P3671, DOI 10.1016/j.watres.2004.05.020; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Waters RL, 2003, MAR ECOL PROG SER, V251, P49, DOI 10.3354/meps251049; Weinbauer MG, 2006, ENVIRON MICROBIOL, V9, P777, DOI [10.1111/j.1462-2929.2006.01200.x, DOI 10.1111/J.1462-2929.2006.01200.X]; WIEBE PH, 1970, LIMNOL OCEANOGR, V15, P205, DOI 10.4319/lo.1970.15.2.0205; Young WR, 2001, NATURE, V412, P328, DOI 10.1038/35085561; Zheng G, 2009, J APPL MICROBIOL, V106, P634, DOI 10.1111/j.1365-2672.2008.04037.x	78	4	4	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197224	10.1371/journal.pone.0197224	http://dx.doi.org/10.1371/journal.pone.0197224			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787564	Green Published, gold			2022-12-26	WOS:000432785700017
J	Ryan-Stewart, H; Faulkner, J; Jobson, S				Ryan-Stewart, Helen; Faulkner, James; Jobson, Simon			The influence of somatotype on anaerobic performance	PLOS ONE			English	Article							MUSCLE TORQUE; STRENGTH; VARIABLES; HERITABILITY; COMPONENTS; POWER; FAT	The link between athlete physique and performance in sports is well established. However, a direct link between somatotype three-numeral rating and anaerobic performance has not yet been reported. The purpose of this study was to assess the relations between somatotype and anaerobic performance using both singular and multivariate analyses. Thirty-six physically active males (mean standard deviation age 26.0 +/- 9.8 years; body mass 79.5 +/- 12.9 kg; height 1.82 +/- 0.07 m) were somatotype-rated using the Heath-Carter method. Subjects were assessed for 3 repetition maximum (3 RM) bench press and back squat, and completed a 30-second maximal sprint cycle test. Positive correlations were observed between mesomorphy and 3 RM bench press (r = 0.560, p < 0.001), mesomorphy and 3 RM back squat (r = 0.550, p = 0.001) and between mesomorphy and minimum power output (r = 0.357, p = 0.033). Negative correlations were observed between ectomorphy and 3 RM bench press (r =-0.381, p = 0.022), and ectomorphy and 3 RM back squat (r =-0.336, p = 0.045). Individual regression analysis indicated that mesomorphy was the best predictor of 3 RM bench press performance, with 31.4% of variance in 3 RM bench press performance accounted for by the mesomorphy rating (p < 0.001). A combination of mesomorphy and ectomorphy best predicted 3 RM back squat performance (R-2 = 0.388, p < 0.04). Around one third of strength performance is predicted by somatotype-assessed physique in physically active males. This could have important implications for the identification of those predisposed to perform well in sports containing strength-based movements and prescription of training programmes.	[Ryan-Stewart, Helen; Faulkner, James; Jobson, Simon] Univ Winchester, Dept Sport Exercise & Hlth, Winchester, Hants, England	University of Winchester	Ryan-Stewart, H (corresponding author), Univ Winchester, Dept Sport Exercise & Hlth, Winchester, Hants, England.	helen.ryan@winchester.ac.uk		Ryan-Stewart, Helen/0000-0002-9059-912X				ACSM, 2010, GUID EX TEST PRESCR, V8th; Barbieri D, 2012, HIGH ALT MED BIOL, V13, P46, DOI 10.1089/ham.2011.1062; BOUCHARD C, 1984, SPORTS MED, V1, P38, DOI 10.2165/00007256-198401010-00004; Busko K, 2013, ACTA BIOENG BIOMECH, V15, P119, DOI 10.5277/abb130214; Carter J. E. L., 1990, SOMATOTYPING DEV APP; Carter JE, 2012, BODY COMPOSITION SPO, P64; CARTER JEL, 1970, HUM BIOL, V42, P535; CARTER JEL, 1969, J APPL PHYSIOL, V27, P787, DOI 10.1152/jappl.1969.27.6.787; Cohen J.E., 1988, STAT POWER ANAL BEHA; Draper N, 2013, EXERCISE PHYSL HLTH; Field A., 2009, DISCOVERING STAT USI, V3, DOI DOI 10.1080/1057610X.2016.1157408; Goldstein E, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-18; Gottlieb G, 2007, DEVELOPMENTAL SCI, V10, P1, DOI 10.1111/j.1467-7687.2007.00556.x; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; Handziska E, 2015, J SPORTS MED PHYS FI; HEATH BH, 1967, AM J PHYS ANTHROPOL, V27, P57, DOI 10.1002/ajpa.1330270108; Ignjatovic A., 2009, Facta Universitatis: Series Physical Education and Sport, V7, P189; Kandel M, 2014, EUR J SPORT SCI, V14, P301, DOI 10.1080/17461391.2013.813971; Kokkonen J, 1998, RES Q EXERCISE SPORT, V69, P411, DOI 10.1080/02701367.1998.10607716; Laubach L.L., 1969, MED SCI SPORT EXER, V1, P189, DOI [10.1249/00005768-196912000-00004, DOI 10.1249/00005768-196912000-00004]; Leveritt M, 1999, J STRENGTH COND RES, V13, P52; Lewandowska J, 2011, J HUM KINET, V30, P21, DOI 10.2478/v10078-011-0069-y; Logan P, 2000, PHYSL TESTS ELITE AT, P220; Malina RM, 1991, GROWTH MALNUTRITION; Marta C, 2011, J HUM KINET, P83, DOI 10.2478/v10078-011-0063-4; Marta CC, 2013, J STRENGTH COND RES, V27, P3233, DOI 10.1519/JSC.0000000000000252; McCurdy K, 2004, J SPORT SCI MED, V3, P190; Medved R, 1966, J Sports Med Phys Fitness, V6, P89; Miles J., 2001, APPL REGRESSION CORR; MURPHY SM, 1988, J SPORT EXERCISE PSY, V10, P334, DOI 10.1123/jsep.10.3.334; Nelson AG, RES Q EX SPORT, V72, P415; NORTON K, 1996, ANTHROPOMETRICA, P287; Peeters MW, 2007, INT J OBESITY, V31, P1295, DOI 10.1038/sj.ijo.0803575; Peeters MW, 2003, ANN HUM BIOL, V30, P402, DOI 10.1080/0301446031000102744; Rubini EC, 2007, SPORTS MED, V37, P213, DOI 10.2165/00007256-200737030-00003; Saha S., 2014, J SPORTS MED DOPING, V4, P2, DOI [10.4172/2161-0673.1000137, DOI 10.4172/2161-0673.1000137]; Song JK, 1994, HUMANBIOLOGIA BUDAPE, V25, P419; Stepnicka J., 1986, KINANTHROPOMETRY; Stewart A., 2011, INT STANDARDS ANTHRO; Tanner J.M., 1964, PHYS OLYMPIC ATHLETE; WILKES RL, 1984, J SPORT PSYCHOL, V6, P351, DOI 10.1123/jsp.6.3.351; Willgoose CE, 1949, J EDUC RES, V42, P704, DOI 10.1080/00220671.1949.10881739; Wright CJ, 2011, INT J SPORT EX PSYCH, V7, P18	43	18	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197761	10.1371/journal.pone.0197761	http://dx.doi.org/10.1371/journal.pone.0197761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG6DG	29787610	gold, Green Published			2022-12-26	WOS:000432785700043
J	Minashima, T; Kirsch, T				Minashima, Takeshi; Kirsch, Thorsten			Annexin A6 regulates catabolic events in articular chondrocytes via the modulation of NF-kappa B and Wnt/beta-catenin signaling	PLOS ONE			English	Article							GENE-EXPRESSION; GROWTH-PLATE; DEP DOMAIN; WNT; OSTEOARTHRITIS; CARTILAGE; INTERLEUKIN-1; MEMBRANE; INHIBITION; INDUCTION	Annexin A6 (AnxA6) is expressed in articular chondrocytes at levels higher than in other mesenchymal cell types. However, the role of AnxA6 in articular chondrocytes is not known. Here we show that complete lack of AnxA6 functions resulted in increased beta-catenin activation in Wnt3a-treated murine articular chondrocytes, whereas AnxA6 expressing articular chondrocytes showed decreased beta-catenin activation. High expression of AnxA6 in human articular chondrocytes showed the highest inhibition of Wnt/beta-catenin signaling. Inhibition of Wnt/beta-catenin signaling activity by AnxA6 together with cytosolic Ca2+ was achieved by interfering with the plasma membrane association of the Wnt signaling complex. AnxA6 also affected the cross-talk between Wnt/beta-catenin signaling and NF-kappa B signaling by decreasing beta-catenin activity and increasing NF-kappa B activity in Wnt3a-, interleukin-1beta (IL-1 beta)-, and combined Wnt3a/IL-beta-treated cells. Wnt3a treatment increased the mRNA levels of catabolic markers (cyclooxygenase-2, interleukin-6, inducible nitric oxide synthase) to a much lesser degree than IL-1 beta treatment in human articular chondrocytes, and decreased the mRNA levels of matrix metalloproteinase-13 (MMP-13) and articular cartilage markers (aggrecan, type II collagen). Furthermore, Wnt3a decreased the mRNA levels of catabolic markers and MMP-13 in IL-1 beta-treated human articular chondrocytes. High expression of AnxA6 resulted in decreased mRNA levels of catabolic markers, and increased MMP-13 and articular cartilage marker mRNA levels in Wnt3a-treated human articular chondrocytes, whereas leading to increased mRNA levels of catabolic markers and MMP-13 inw human articular chondrocytes treated with IL-1 beta, or combined Wnt3a and IL-1 beta. Our findings define a novel role for AnxA6 in articular chondrocytes via its modulation of Wnt/beta-catenin and NF-kappa B signaling activities and the cross-talk between these two signaling pathways.	[Minashima, Takeshi; Kirsch, Thorsten] NYU, Sch Med, Musculoskeletal Res Ctr, Dept Orthopaed Surg, New York, NY 10016 USA; [Minashima, Takeshi] Kindai Univ Sch Med, Dept Physiol & Regenerat Med, Osaka, Japan	New York University	Kirsch, T (corresponding author), NYU, Sch Med, Musculoskeletal Res Ctr, Dept Orthopaed Surg, New York, NY 10016 USA.	thorsten.kirch@nyumc.org	Kirsch, Thorsten/GQP-1157-2022		National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R01AR064186]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064186] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by 1R01AR064186 to TK from National Institute of Arthritis and Musculoskeletal and Skin Diseases (https://www.niams.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiychuk EB, 2000, J CELL BIOL, V150, P1113, DOI 10.1083/jcb.150.5.1113; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bist P, 2011, ONCOGENE, V30, P3174, DOI 10.1038/onc.2011.28; Blom AB, 2010, CURR DRUG TARGETS, V11, P620; Campbell KA, 2013, ARTHRITIS RHEUM-US, V65, P3120, DOI 10.1002/art.38182; Fatimathas L, 2010, HISTOL HISTOPATHOL, V25, P527, DOI 10.14670/HH-25.527; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hawkins TE, 1999, MOL CELL BIOL, V19, P8028; Hayes M. J., 2007, V45, P1; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; Joiner DM, 2013, OSTEOARTHR CARTILAGE, V21, P1576, DOI 10.1016/j.joca.2013.05.019; Jonason JH, 2015, METHODS MOL BIOL, V1226, P11, DOI 10.1007/978-1-4939-1619-1_2; Kobayashi M, 2005, ARTHRITIS RHEUM-US, V52, P128, DOI 10.1002/art.20776; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Lietman C, 2018, JCI INSIGHT, V3, DOI DOI 10.1172/JD.INSIGHT.96308; Ma B, 2013, CALCIFIED TISSUE INT, V92, P399, DOI 10.1007/s00223-012-9675-5; Ma B, 2012, ARTHRITIS RHEUM-US, V64, P2589, DOI 10.1002/art.34425; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Nalesso G, 2011, J CELL BIOL, V193, P551, DOI 10.1083/jcb.201011051; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Pfander D, 2001, AM J PATHOL, V159, P1777, DOI 10.1016/S0002-9440(10)63024-6; Pritchard S, 2006, ARTHRITIS RHEUM-US, V54, P2164, DOI 10.1002/art.21941; Qu F, 2013, FRONT BIOSCI-LANDMRK, V18, P493, DOI 10.2741/4116; Rand JH, 2000, BBA-MOL CELL RES, V1498, P169, DOI 10.1016/S0167-4889(00)00093-8; Ruiz-Romero C, 2005, PROTEOMICS, V5, P3048, DOI 10.1002/pmic.200402106; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Tauriello DVF, 2012, P NATL ACAD SCI USA, V109, pE812, DOI 10.1073/pnas.1114802109; Usami Y, 2016, LAB INVEST, V96, P186, DOI 10.1038/labinvest.2015.142; van den Bosch MH, 2015, AM J PATHOL, V185, P1970, DOI 10.1016/j.ajpath.2015.03.013; VONDERMARK K, 1992, ARTHRITIS RHEUM-US, V35, P806, DOI 10.1002/art.1780350715; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279; Zhou YC, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0679-z; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	41	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197690	10.1371/journal.pone.0197690	http://dx.doi.org/10.1371/journal.pone.0197690			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771996	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900088
J	Perera, OP; Little, NS; Pierce, CA				Perera, Omaththage P.; Little, Nathan S.; Pierce, Calvin A., III			CRISPR/Cas9 mediated high efficiency knockout of the eye color gene Vermillion in Helicoverpa zea (Boddie)	PLOS ONE			English	Article							TRYPTOPHAN OXYGENASE; FUNCTIONAL-ANALYSIS; GUIDE RNA; ON-TARGET; GENOME; DROSOPHILA; MUTAGENESIS; SEQUENCE; PEST; IDENTIFICATION	Among various genome editing tools available for functional genomic studies, reagents based on clustered regularly interspersed palindromic repeats (CRISPR) have gained popularity due to ease and versatility. CRISPR reagents consist of ribonucleoprotein (RNP) complexes formed by combining guide RNA (gRNA) that target specific genomics regions and a CRISPR associated nuclease (Cas). The gRNA targeting specific gene sequences may be delivered as a plasmid construct that needs to be transcribed or as a synthetic RNA. The Cas nuclease can be introduced as a plasmid construct, mRNA, or purified protein. The efficiency of target editing is dependent on intrinsic factors specific to each species, the target gene sequence, and the delivery methods of CRISPR gRNA and the Cas nuclease. Although intrinsic factors affecting genome editing may not be altered in most experiments, the delivery method for CRISPR/Cas reagents can be optimized to produce the best results. In this study, the efficiency of genome editing by CRISPR/Cas system in the bollworm, Helicoverpa zea (Boddie), was evaluated using ribonucleoprotein (RNP) complexes assembled by binding synthetic gRNA with purified Cas9 nuclease engineered with nuclear localization signals to target the vermillion (eye color) gene. Mutation rates of adults emerging from embryos microinjected with 1, 2, or 4 mu M RNP complexes were compared using replicated experiments. Embryos injected with 2 or 4 mu M RNP complexes displayed significantly higher mutation rates (>88%) in surviving adults compared to those injected with 1 mu M. The hatch rate in embryos injected with RNP complexes and with injection buffer only (mock injections) was reduced by 19.8(+/- 5.2)% compared to noninjected control embryos, but did not differ significantly between injected embryos. Evaluation of potential off-target sites in H. zea genome did not identify any mutations. This study demonstrates that in vitro assembled synthetic RNP complexes can be used to obtain high genome editing rates in a reproducible manner in functional genomics or genetic manipulation studies.	[Perera, Omaththage P.; Little, Nathan S.; Pierce, Calvin A., III] USDA ARS, Southern Insect Management Res Unit, Stoneville, MS 38776 USA	United States Department of Agriculture (USDA)	Perera, OP (corresponding author), USDA ARS, Southern Insect Management Res Unit, Stoneville, MS 38776 USA.	op.perera@ars.usda.gov		Perera, Omaththage/0000-0002-0643-0066; Little, Nathan/0000-0003-1105-3733	USDA Agricultural Research Service [6066-22000-085-00D]	USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by USDA Agricultural Research Service project number 6066-22000-085-00D. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112; Beumer KJ, 2014, METHODS, V68, P29, DOI 10.1016/j.ymeth.2013.12.002; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Choo A, 2018, J APPL ENTOMOL, V142, P52, DOI 10.1111/jen.12411; Cui YB, 2017, ENTOMOL EXP APPL, V162, P124, DOI 10.1111/eea.12530; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Fabrick JA, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.15; FERRE J, 1986, BIOCHEM GENET, V24, P545, DOI 10.1007/BF00504334; Gasiunas Giedrius, 2012, Proc Natl Acad Sci U S A, V109, pE2579; Gokcezade J, 2014, G3-GENES GENOM GENET, V4, P2279, DOI 10.1534/g3.114.014126; Gore J, 2005, J ECON ENTOMOL, V98, P88, DOI 10.1603/0022-0493-98.1.88; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; GREEN MM, 1952, P NATL ACAD SCI USA, V38, P300, DOI 10.1073/pnas.38.4.300; Gundersen-Rindal D. E., 2017, Trends in Entomology, V13, P109; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439; HENDERSON CF, 1955, J ECON ENTOMOL, V48, P157, DOI 10.1093/jee/48.2.157; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jarjees EA, 2004, J INVERTEBR PATHOL, V85, P1, DOI 10.1016/j.jip.2003.12.001; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Khan SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40025; Kim K, 2017, GENOME RES, V27, P419, DOI 10.1101/gr.219089.116; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Koutroumpa FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29620; Lee CM, 2016, MOL THER, V24, P475, DOI 10.1038/mt.2016.1; Li F, 2016, BIOCHEM BIOPH RES CO, V469, P911, DOI 10.1016/j.bbrc.2015.12.081; Li XY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9212; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Lin SL, 2015, GENETICS, V201, P433, DOI 10.1534/genetics.115.181065; Livraghi L, 2017, ADV INSECT PHYSL, DOI [10.1534/genetics.113.152710, DOI 10.1534/GENETICS.113.152710]; Lorenzen MD, 2002, GENETICS, V160, P225; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Markert MJ, 2016, G3-GENES GENOM GENET, V6, P905, DOI 10.1534/g3.116.027029; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meccariello A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10347-5; Mircetic J, 2017, SMALL METHODS, V1, DOI 10.1002/smtd.201600052; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0402-6; Perera OP, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev137; Reid W, 2016, CURR OPIN INSECT SCI, V13, P43, DOI 10.1016/j.cois.2015.11.001; RYALL RL, 1974, INSECT BIOCHEM, V4, P47, DOI 10.1016/0020-1790(74)90041-9; SUMMERS KM, 1982, ADV INSECT PHYSIOL, V16, P119, DOI 10.1016/S0065-2806(08)60153-8; Sun D, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00608; Suresh B, 2017, METHODS MOL BIOL, V1507, P81, DOI 10.1007/978-1-4939-6518-2_7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang YJ, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34607; Taning CNT, 2017, J INSECT PHYSIOL, V98, P245, DOI 10.1016/j.jinsphys.2017.01.007; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; Venken KJT, 2016, WIRES DEV BIOL, V5, P233, DOI 10.1002/wdev.214; VISCONTINI M, 1961, HELV CHIM ACTA, V44, P1783, DOI 10.1002/hlca.19610440636; Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146; Zeng BS, 2016, INSECT BIOCHEM MOLEC, V72, P31, DOI 10.1016/j.ibmb.2016.03.006; Zhang LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11769; Zhang ZJ, 2015, J INSECT PHYSIOL, V79, P73, DOI 10.1016/j.jinsphys.2015.06.004; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003	66	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197567	10.1371/journal.pone.0197567	http://dx.doi.org/10.1371/journal.pone.0197567			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771955	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900075
J	Sheshadri, A; Shah, DP; Godoy, M; Erasmus, JJ; Song, J; Li, L; Evans, SE; Chemaly, RF; Dickey, BF; Ost, DE				Sheshadri, Ajay; Shah, Dimpy P.; Godoy, Myrna; Erasmus, Jeremy J.; Song, Juhee; Li, Liang; Evans, Scott E.; Chemaly, Roy F.; Dickey, Burton F.; Ost, David E.			Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; VENTILATOR-ASSOCIATED PNEUMONIA; COMPUTED-TOMOGRAPHY SCAN; HEMATOLOGICAL MALIGNANCIES; RADIOGRAPHIC RESOLUTION; CHEST RADIOGRAPHS; DISEASES-SOCIETY; CLINICAL-TRIALS; RISK-FACTORS; END-POINTS	Background Radiologic severity may predict adverse outcomes after lower respiratory tract infection (LRI). However, few studies have quantified radiologic severity of LRIs. We sought to evaluate whether a semi-quantitative scoring tool, the Radiologic Severity Index (RSI), predicted mortality after parainfluenza virus (PIV)-associated LRI. Methods We conducted a retrospective review of consecutively-enrolled adult patients with hematologic malignancy or hematopoietic stem cell transplantation and with PIV detected in nasal wash who subsequently developed radiologically-confirmed LRI. We measured RSI (range 0-72) in each chest radiograph during the first 30 days after LRI diagnosis. We used extended Cox proportional hazards models to identify factors associated with mortality after onset of LRI with all-cause mortality as our failure event. Results After adjustment for patient characteristics, each 1-point increase in RSI was associated with an increased hazard of death (HR 1.13, 95% confidence interval [CI] 1.05-1.21, p = 0.0008). Baseline RSI was not predictive of death, but both peak RSI and the change from baseline to peak RSI (delta-RSI) predicted mortality (odds ratio for mortality, peak: 1.11 [95%CI 1.04-1.18], delta-RSI: 1.14 [95%CI 1.06-1.22]). A delta-RSI of >= 19.5 was 89% sensitive and 91% specific in predicting 30-day mortality. Conclusions We conclude that the RSI offers precise, informative and reliable assessments of LRI severity. Progression of RSI predicts 30-day mortality after LRI, but baseline RSI does not. Our results were derived from a cohort of patients with PIV-associated LRI, but can be applied in validated in other populations of patients with LRI.	[Sheshadri, Ajay; Evans, Scott E.; Dickey, Burton F.; Ost, David E.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Shah, Dimpy P.; Chemaly, Roy F.] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA; [Godoy, Myrna; Erasmus, Jeremy J.] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA; [Song, Juhee; Li, Liang] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Shah, Dimpy P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health San Antonio	Sheshadri, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.	asheshadri@mdanderson.org	Sheshadri, Ajay/AAN-7427-2020; Ost, David E./AAT-9505-2021	Sheshadri, Ajay/0000-0002-8091-0180; Ost, David E./0000-0001-6351-5552; Evans, Scott/0000-0003-4503-0644	Pulmotect, Inc. (Houston, TX); National Institute of Allergy and Infectious Diseases [K23 AI117024]; National Cancer Institute (Cancer Center Support Grant) at the National Institutes of Health [P30 CA016672]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL123229] Funding Source: NIH RePORTER	Pulmotect, Inc. (Houston, TX); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (Cancer Center Support Grant) at the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by a sponsored research agreement with Pulmotect, Inc. (Houston, TX) and supported by a grant from the National Institute of Allergy and Infectious Diseases (K23 AI117024 to AS.) and the National Cancer Institute (Cancer Center Support Grant, P30 CA016672, Biostatistics Resource Group) at the National Institutes of Health to A.S. The sponsors and funding agencies had no role in the conception, design, conduct or analysis of the study and had no role in the preparation of the manuscript.	Abi-Dargham A, 2016, NAT MED, V22, P1248, DOI 10.1038/nm.4190; Allison P. D., 1995, SURVIVAL ANAL USING; Aujesky D, 2005, AM J MED, V118, P384, DOI 10.1016/j.amjmed.2005.01.006; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown SM, 2012, RESPIROLOGY, V17, P1207, DOI 10.1111/j.1440-1843.2012.02225.x; Bruns AHW, 2007, CLIN INFECT DIS, V45, P983, DOI 10.1086/521893; Buising KL, 2006, THORAX, V61, P419, DOI 10.1136/thx.2005.051326; Chalmers JD, 2011, CLIN INFECT DIS, V53, P503, DOI 10.1093/cid/cir463; Chemaly RF, 2012, BLOOD, V119, P2738, DOI 10.1182/blood-2011-08-371112; Claessens YE, 2015, AM J RESP CRIT CARE, V192, P974, DOI 10.1164/rccm.201501-0017OC; COX DR, 1972, J R STAT SOC B, V34, P187; Dignan FL, 2016, BRIT J HAEMATOL, V173, P380, DOI 10.1111/bjh.14027; El Solh AA, 2004, J AM GERIATR SOC, V52, P224, DOI 10.1111/j.1532-5415.2004.52059.x; Elemraid MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106051; Feng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093885; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Garcia-Vidal C, 2008, EUR RESPIR J, V32, P733, DOI 10.1183/09031936.00128107; Grieser C, 2012, EUR J RADIOL, V81, P389, DOI 10.1016/j.ejrad.2010.12.085; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hardak E, 2016, INFECTION, V44, P491, DOI 10.1007/s15010-016-0873-3; Hayden GE, 2009, J EMERG MED, V36, P266, DOI 10.1016/j.jemermed.2007.11.042; Heussel CP, 1997, AM J ROENTGENOL, V169, P1347, DOI 10.2214/ajr.169.5.9353456; Hirsch HH, 2013, CLIN INFECT DIS, V56, P258, DOI 10.1093/cid/cis844; Hopstaken RM, 2004, CLIN RADIOL, V59, P743, DOI 10.1016/j.crad.2004.01.011; Laessig KA, 2010, CLIN INFECT DIS, V51, pS117, DOI 10.1086/653059; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lisboa T, 2009, CHEST, V135, P165, DOI 10.1378/chest.08-1216; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mannu GS, 2013, EUR J INTERN MED, V24, P857, DOI 10.1016/j.ejim.2013.05.001; Menendez R, 2004, THORAX, V59, P960, DOI 10.1136/thx.2003.017756; Metersky ML, 2012, CHEST, V142, P476, DOI 10.1378/chest.11-2393; MITTL RL, 1994, AM J RESP CRIT CARE, V149, P630, DOI 10.1164/ajrccm.149.3.8118630; Muscedere JG, 2010, CLIN INFECT DIS, V51, pS120, DOI 10.1086/653060; Musher DM, 2008, CLIN INFECT DIS, V47, pS207, DOI 10.1086/591406; Neill AM, 1996, THORAX, V51, P1010, DOI 10.1136/thx.51.10.1010; Neuman MI, 2012, J HOSP MED, V7, P294, DOI 10.1002/jhm.955; Puig N, 2007, LEUKEMIA LYMPHOMA, V48, P2367, DOI 10.1080/10428190701694178; Roson B, 2004, ARCH INTERN MED, V164, P502, DOI 10.1001/archinte.164.5.502; Sampsonas F, 2011, CANCER-AM CANCER SOC, V117, P3424, DOI 10.1002/cncr.25905; Self WH, 2013, AM J EMERG MED, V31, P401, DOI 10.1016/j.ajem.2012.08.041; Seo S, 2014, CLIN INFECT DIS, V58, P1357, DOI 10.1093/cid/ciu134; Shah DP, 2016, CANCER LETT, V370, P358, DOI 10.1016/j.canlet.2015.11.014; Shindo Y, 2008, RESPIROLOGY, V13, P731, DOI 10.1111/j.1440-1843.2008.01329.x; Sibila O, 2013, J CRIT CARE, V28, P284, DOI 10.1016/j.jcrc.2012.09.010; Specchia G, 2003, LEUKEMIA LYMPHOMA, V44, P97, DOI 10.1080/1042819021000040297; Taylor E, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0103-y; Williams GJ, 2013, PEDIATR PULM, V48, P1195, DOI 10.1002/ppul.22806	48	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197418	10.1371/journal.pone.0197418	http://dx.doi.org/10.1371/journal.pone.0197418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771962	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900056
J	Fischer, D; Buchbinder, JH; Sundmacher, K; Lavrik, IN; Flassig, RJ				Fischer, Dennis; Buchbinder, Joern H.; Sundmacher, Kai; Lavrik, Inna N.; Flassig, Robert J.			A guide to automated apoptosis detection: How to make sense of imaging flow cytometry data	PLOS ONE			English	Article							SELECTION; QUANTIFICATION; INFORMATION	Imaging flow cytometry is a powerful experimental technique combining the strength of microscopy and flow cytometry to enable high-throughput characterization of cell populations on a detailed microscopic scale. This approach has an increasing importance for distinguishing between different cellular phenotypes such as proliferation, cell division and cell death. In the course of undergoing these different pathways, each cell is characterized by a high amount of properties. This makes it hard to filter the most relevant information for cell state discrimination. The traditional methods for cell state discrimination rely on dye based two-dimensional gating strategies ignoring information that is hidden in the high-dimensional property space. In order to make use of the information ignored by the traditional methods, we present a simple and efficient approach to distinguish biological states within a cell population based on machine learning techniques. We demonstrate the advantages and drawbacks of filter techniques combined with different classification schemes. These techniques are illustrated with two case studies of apoptosis detection in HeLa cells. Thereby we highlight (i) the aptitude of imaging flow cytometry regarding automated, label-free cell state discrimination and (ii) pitfalls that are frequently encountered. Additionally a MATLAB script is provided, which gives further insight regarding the computational work presented in this study.	[Fischer, Dennis; Sundmacher, Kai] Otto von Guericke Univ, Proc Syst Engn, Magdeburg, Germany; [Buchbinder, Joern H.; Lavrik, Inna N.] Otto von Guericke Univ, Translat Inflammat Res, Magdeburg, Germany; [Sundmacher, Kai; Flassig, Robert J.] Max Planck Inst Dynam Complex Tech Syst, Proc Syst Engn, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Max Planck Society	Flassig, RJ (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Proc Syst Engn, Magdeburg, Germany.	flassig@mpi-magdeburg.mpg.de	Lavrik, Inna N/C-1700-2009	Lavrik, Inna N/0000-0002-9324-309X; Flassig, Robert/0000-0002-7092-1046	Ministry of Sciences and Economic Affairs of Saxony-Anhalt (Research Centre Dynamic Systems: Biosystems Engineering) [MW-21LMS 5]; Federal Ministry of Education and Research [031A304, TPU - 0316170G]; Deutsche Forschungsgemeinschaft [LA 2386/6-1]; Russian Science Foundation [14-44-00011]; Russian Science Foundation [17-44-00002] Funding Source: Russian Science Foundation	Ministry of Sciences and Economic Affairs of Saxony-Anhalt (Research Centre Dynamic Systems: Biosystems Engineering); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	The study was funded by the following institutions: Ministry of Sciences and Economic Affairs of Saxony-Anhalt (Research Centre Dynamic Systems: Biosystems Engineering, MW-21LMS 5); Federal Ministry of Education and Research (eB10 project "AML" 031A304 and eB10 project "ImmunoQuant" - TPU - 0316170G); Deutsche Forschungsgemeinschaft (LA 2386/6-1); and Russian Science Foundation (14-44-00011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, TECHNICAL REPORT; Basiji DA, 2007, CLIN LAB MED, V27, P653, DOI 10.1016/j.cll.2007.05.008; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bergstra J. S., 2011, P 24 INT C NEUR INF, P2546, DOI DOI 10.1145/3065386; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Blanchet L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08035; Blasi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10256; Bolon-Canedo V, 2013, KNOWL INF SYST, V34, P483, DOI 10.1007/s10115-012-0487-8; Brown G, 2012, J MACH LEARN RES, V13, P27; Chattopadhyay PK, 2014, NAT IMMUNOL, V15, P128, DOI 10.1038/ni.2796; Chen C. - Y., 2016, SCI REPORTS, V6; Coroiu AM, 2016, INT C INTELL COMP CO, P135, DOI 10.1109/ICCP.2016.7737135; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Djuric N, 2013, J MACH LEARN RES, V14, P3813; Duda R.O., 2000, PATTERN CLASSIFICATI; Fan JQ, 2014, NATL SCI REV, V1, P293, DOI 10.1093/nsr/nwt032; France SL, 2012, INFORM SCIENCES, V184, P92, DOI 10.1016/j.ins.2011.07.048; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; Hastie T., 2003, ELEMENTS STAT LEARNI; Hennig H, 2017, METHODS, V112, P201, DOI 10.1016/j.ymeth.2016.08.018; Henry CM, 2013, METHODS, V61, P90, DOI 10.1016/j.ymeth.2013.01.008; Higuchi T, 2015, CANCER IMMUNOL RES, V3, P1257, DOI 10.1158/2326-6066.CIR-15-0044; Huang CM, 2007, COMPUT STAT DATA AN, V52, P335, DOI 10.1016/j.csda.2007.02.013; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Escalante HJ, 2009, J MACH LEARN RES, V10, P405; Kobayashi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12378-4; Lai QTK, 2016, OPT EXPRESS, V24, P28170, DOI 10.1364/OE.24.028170; Lavrik IN, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.160; LEWIS DD, 1992, SPEECH AND NATURAL LANGUAGE, P212; Lin WJ, 2013, BRIEF BIOINFORM, V14, P13, DOI 10.1093/bib/bbs006; Maillo J, 2015, IEEE TRUST BIG, P167, DOI 10.1109/Trustcom.2015.577; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; O'Neill K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003365; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pietkiewicz S, 2015, J IMMUNOL METHODS, V423, P99, DOI 10.1016/j.jim.2015.04.025; Pischel D, 2018, GUIDE AUTOMATED APOP, DOI [10.5281/zenodo.1220090, DOI 10.5281/ZENODO.1220090]; Rubbens P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169754; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Schmidt JH, 2015, J IMMUNOL METHODS, V423, P12, DOI 10.1016/j.jim.2015.04.026; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Wen YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184726; Zhang K., 2012, ARTIF INTELL STAT, P1425	44	13	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197208	10.1371/journal.pone.0197208	http://dx.doi.org/10.1371/journal.pone.0197208			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768460	gold, Green Published			2022-12-26	WOS:000432329200068
J	Ikawati, M; Kawaichi, M; Oka, C				Ikawati, Muthi; Kawaichi, Masashi; Oka, Chio			Loss of HtrA1 serine protease induces synthetic modulation of aortic vascular smooth muscle cells	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; HEAT-SHOCK PROTEASE; MARFAN-SYNDROME; MACULAR DEGENERATION; EXTRACELLULAR-MATRIX; SUBCORTICAL INFARCTS; MOUSE MODELS; IN-VITRO; APOPTOSIS; PROTEINS	Homozygous mutations of human HTRA1 cause cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). HtrA1(-/-) mice were examined for arterial abnormalities. Although their cerebral arteries were normal, the thoracic aorta was affected in HtrA1(-/-) mice. The number of vascular smooth muscle cells (VSMCs) in the aorta was increased in HtrA1(-/-) mice of 40 weeks or younger, but decreased thereafter. The cross-sectional area of the aorta was increased in HtrA1(-/-) mice of 40 weeks or older. Aortic VSMCs isolated from HtrA1(-/-) mice rapidly proliferated and migrated, produced high MMP9 activity, and were prone to oxidative stress-induced cell death. HtrA1(-/-) VSMCs expressed less smooth muscle alpha-actin, and more vimentin and osteopontin, and responded to PDGF-BB more strongly than wild type VSMCs, indicating that HtrA1(-/-) VSMCs were in the synthetic phenotype. The elastic lamina was disrupted, and collagens were decreased in the aortic media. Calponin in the media was decreased, whereas vimentin and osteopontin were increased, suggesting a synthetic shift of VSMCs in vivo. Loss of HtrA1 therefore skews VSMCs toward the synthetic phenotype, induces MMP9 expression, and expedites cell death. We propose that the synthetic modulation is the primary event that leads to the vascular abnormalities caused by HtrA1 deficiency.	[Ikawati, Muthi; Kawaichi, Masashi; Oka, Chio] Nara Inst Sci & Technol, Lab Gene Funct Anim, Nara, Japan; [Ikawati, Muthi] Univ Gadjah Mada, Fac Pharm, Dept Pharmaceut Chem, Sekip Utara, Yogyakarta, Indonesia	Nara Institute of Science & Technology; Gadjah Mada University	Oka, C (corresponding author), Nara Inst Sci & Technol, Lab Gene Funct Anim, Nara, Japan.	coka@bs.naist.jp	Ikawati, Muthi/GLV-5087-2022	Ikawati, Muthi/0000-0002-5968-0130; Oka, Chio/0000-0001-9352-461X				Arima K, 2003, NEUROPATHOLOGY, V23, P327, DOI 10.1046/j.1440-1789.2003.00519.x; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Beaufort N, 2014, P NATL ACAD SCI USA, V111, P16496, DOI 10.1073/pnas.1418087111; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Boyle JJ, 2002, ARTERIOSCL THROM VAS, V22, P1624, DOI 10.1161/01.ATV.0000033517.48444.1A; Bunton TE, 2001, CIRC RES, V88, P37, DOI 10.1161/01.RES.88.1.37; Cai B, 2015, NEUROL SCI, V36, P1387, DOI 10.1007/s10072-015-2121-5; Campioni M, 2010, MOL CANCER RES, V8, P1248, DOI 10.1158/1541-7786.MCR-09-0473; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Deckert V, 2013, AM J PATHOL, V183, P975, DOI 10.1016/j.ajpath.2013.05.018; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Emrich FC, 2015, ARTERIOSCL THROM VAS, V35, P146, DOI 10.1161/ATVBAHA.114.304364; Formichi P, 2009, J CELL PHYSIOL, V219, P494, DOI 10.1002/jcp.21695; Foucaud-Scheunemann C, 2003, FEMS MICROBIOL LETT, V224, P53, DOI 10.1016/S0378-1097(03)00419-1; Francis PJ, 2008, MOL VIS, V14, P1395; Granata A, 2017, NAT GENET, V49, P97, DOI 10.1038/ng.3723; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Gray F, 2007, J NEUROPATH EXP NEUR, V66, P597, DOI 10.1097/nen.0b013e318093e574; Hara K, 2009, NEW ENGL J MED, V360, P1729, DOI 10.1056/NEJMoa0801560; HART MN, 1980, HYPERTENSION, V2, P419, DOI 10.1161/01.HYP.2.4.419; Hasan MZ, 2015, DEV BIOL, V397, P89, DOI 10.1016/j.ydbio.2014.10.015; Hayashi K, 1999, J CELL BIOL, V145, P727, DOI 10.1083/jcb.145.4.727; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Ihalainen S, 2007, MOL MED, V13, P305, DOI 10.2119/2006-00069.Ihalainen; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06; MAEDA S, 1976, Folia Psychiatrica et Neurologica Japonica, V30, P165; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847; Metz RP, 2012, METHODS MOL BIOL, V843, P169, DOI 10.1007/978-1-61779-523-7_16; Muratoglu SC, 2013, ARTERIOSCL THROM VAS, V33, P2137, DOI 10.1161/ATVBAHA.113.301893; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Nataatmadja M, 2003, CIRCULATION, V108, P329, DOI 10.1161/01.cir.0000087660.82721.15; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Nie GY, 2003, MOL HUM REPROD, V9, P279, DOI 10.1093/molehr/gag036; Oide T, 2008, NEUROPATHOLOGY, V28, P132, DOI 10.1111/j.1440-1789.2007.00864.x; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; OWENS GK, 1995, PHYSIOL REV, V75, P487; Rauter H, 2003, MONATSH CHEM, V134, P1489, DOI 10.1007/s00706-003-0605-0; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Skorko-Glonek J, 1999, MOL GEN GENET, V262, P342, DOI 10.1007/s004380051092; SKORKOGLONEK J, 1995, J BIOL CHEM, V270, P11140, DOI 10.1074/jbc.270.19.11140; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Supanji, 2013, EXP EYE RES, V112, P79, DOI 10.1016/j.exer.2013.04.013; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Vaja V, 2009, EUR J PHARMACOL, V619, P85, DOI 10.1016/j.ejphar.2009.08.003; Verdura E, 2015, BRAIN, V138, P2347, DOI 10.1093/brain/awv155; Wong LSM, 2009, CARDIOVASC RES, V81, P244, DOI 10.1093/cvr/cvn337; Xu QB, 2004, AM J PATHOL, V165, P1, DOI 10.1016/S0002-9440(10)63270-1; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YOKOI S, 1985, CLIN NEUROPATHOL, V4, P165; Zhang H, 2013, MOL CELL BIOCHEM, V375, P11, DOI 10.1007/s11010-012-1512-7; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhu BH, 2001, EXP GERONTOL, V36, P111, DOI 10.1016/S0531-5565(00)00179-0	61	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196628	10.1371/journal.pone.0196628	http://dx.doi.org/10.1371/journal.pone.0196628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768431	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200037
J	Ma, JH; Ma, SY; Zou, HQ; Zhang, YZ; Chan, P; Ye, Z				Ma, Jinghong; Ma, Shaoyang; Zou, Haiqiang; Zhang, Yizhi; Chan, Piu; Ye, Zheng			Impaired serial ordering in nondemented patients with mild Parkinson's disease	PLOS ONE			English	Article							MONTREAL COGNITIVE ASSESSMENT; MENTAL-STATE-EXAMINATION; WORKING-MEMORY; TEMPORAL CONNECTIVES; DIAGNOSTIC-CRITERIA; TASK; COMPREHENSION; SUPERIOR; MOCA	The ability to arrange thoughts and actions in an appropriate serial order (the problem of serial order) is essential to complex behaviors such as language, reasoning and cognitive planning. Patients with Parkinson's disease (PD) perform poorly in tasks that rely on the successful rearrangement of working memory representations. We hypothesized that serial ordering is impaired in nondemented patients with mild PD. We recruited 49 patients with mild idiopathic PD (Hoehn and Yahr Scale 1-2.5) and 51 matched healthy adults. Nineteen patients had normal global cognition (PD-NC, Montreal Cognitive Assessment, MoCA >= 26/30) and thirty patients had mild cognitive impairment (PD-MCI, 21 <= MoCA <= 25). All participants underwent three working memory assessments: two experimental tests that require reordering random digits following a particular rule (adaptive digit ordering test and digit span backward test) and a control test that requires maintaining but no reordering (digit span forward test). PD-NC and PD-MCI patients performed significantly worse (with lower test scores and larger ordering costs) than healthy controls in both digit ordering and backward tests, although they performed normally in the forward test. The ordering cost increased as a function of age across groups, indicating an aging-related decline in the ability of serial ordering. However, individual patients' task performances were not correlated with their severity or duration of motor symptoms, or daily exposure to dopaminergic drugs. These results suggested that serial ordering deficits exist in early stages of PD, prior to subtle changes in global cognition and in parallel with motor symptoms.	[Ma, Jinghong; Chan, Piu] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Ma, Shaoyang; Ye, Zheng] Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China; [Ma, Shaoyang; Ye, Zheng] Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China; [Zou, Haiqiang] Guangzhou Mil Command PLA, Gen Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Zhang, Yizhi] Jilin Univ, Hosp 2, Dept Neurol, Changchun, Jilin, Peoples R China; [Ye, Zheng] CAS Ctr Excellence Brain Sci & Intelligence Techn, Shanghai, Peoples R China	Capital Medical University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Southern Theater Command General Hospital; Jilin University	Ye, Z (corresponding author), Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China.; Ye, Z (corresponding author), Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China.; Ye, Z (corresponding author), CAS Ctr Excellence Brain Sci & Intelligence Techn, Shanghai, Peoples R China.	yez@psych.ac.cn	Chan, Piu/I-4580-2016; Ye, Zheng/V-9575-2019	Chan, Piu/0000-0003-1346-881X; Ye, Zheng/0000-0003-1912-6992	Thousand Young Talents Program; National Natural Science Foundation of China [31771216]	Thousand Young Talents Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Thousand Young Talents Program (to Z.Y.) and the National Natural Science Foundation of China (31771216, to Z.Y.).	Al-Khaled M, 2012, Z NEUROPSYCHOL, V23, P97, DOI 10.1024/1016-264X/a000066; Borg C, 2008, BEHAV NEUROL, V19, P49, DOI 10.1155/2008/389181; Cools R, 2007, J NEUROSCI, V27, P5506, DOI 10.1523/JNEUROSCI.0601-07.2007; COOPER JA, 1992, BRAIN, V115, P1701, DOI 10.1093/brain/115.6.1701; D'Esposito M, 2015, ANNU REV PSYCHOL, V66, P115, DOI 10.1146/annurev-psych-010814-015031; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; De Belder M, 2017, J ALZHEIMERS DIS, V59, P1171, DOI 10.3233/JAD-170193; Dodds CM, 2009, PSYCHOPHARMACOLOGY, V207, P35, DOI 10.1007/s00213-009-1634-0; Dong YH, 2012, INT PSYCHOGERIATR, V24, P1749, DOI 10.1017/S1041610212001068; Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; Fama R, 2002, CORTEX, V38, P753, DOI 10.1016/S0010-9452(08)70042-X; Gabrieli JDE, 1996, NEUROPSYCHOLOGY, V10, P322, DOI 10.1037/0894-4105.10.3.321; Goldman JG, 2015, MOVEMENT DISORD, V30, P402, DOI 10.1002/mds.26084; Hanagasi HA, 2011, MOVEMENT DISORD, V26, P1851, DOI 10.1002/mds.23738; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Lewis SJG, 2005, NEUROPSYCHOLOGIA, V43, P823, DOI 10.1016/j.neuropsychologia.2004.10.001; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Minzenberg MJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1477, DOI 10.1038/sj.npp.1301534; Muller U, 2005, J PSYCHOPHARMACOL, V19, P21, DOI 10.1177/0269881105048888; Muller U, 2004, PSYCHOPHARMACOLOGY, V177, P161, DOI 10.1007/s00213-004-1926-3; NATSOPOULOS D, 1991, BRAIN LANG, V40, P444, DOI 10.1016/0093-934X(91)90142-N; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Shipley BA, 2002, NEUROPSYCHOLOGIA, V40, P1488, DOI 10.1016/S0028-3932(01)00195-6; Tinaz S, 2008, NEUROBIOL AGING, V29, P397, DOI 10.1016/j.neurobiolaging.2006.10.025; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Werheid K, 2002, ARCH CLIN NEUROPSYCH, V17, P547, DOI 10.1016/S0887-6177(01)00134-2; Ye Z, 2012, NEUROPSYCHOLOGIA, V50, P1794, DOI 10.1016/j.neuropsychologia.2012.04.004	28	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197489	10.1371/journal.pone.0197489	http://dx.doi.org/10.1371/journal.pone.0197489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF9WG	29768473	gold, Green Submitted, Green Published			2022-12-26	WOS:000432329200087
J	Pompilio, A; Crocetta, V; Savini, V; Petrelli, D; Di Nicola, M; Bucco, S; Amoroso, L; Bonomini, M; Di Bonaventura, G				Pompilio, Arianna; Crocetta, Valentina; Savini, Vincenzo; Petrelli, Dezemona; Di Nicola, Marta; Bucco, Silvia; Amoroso, Luigi; Bonomini, Mario; Di Bonaventura, Giovanni			Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; ANTIMICROBIAL RESISTANCE; REDUCED VIRULENCE; CYSTITIS; BACTEREMIA; PROSTATITIS; SPECTRUM; SEQUENCE; GENES; UROPATHOGENS	The present work set out to search for a virulence repertoire distinctive for Escherichia coli causing primitive acute pyelonephritis (APN). To this end, the virulence potential of 18 E. coli APN strains was genotypically and phenotypically assessed, comparatively with 19 strains causing recurrent cystitis (RC), and 16 clinically not significant (control, CO) strains. Most of the strains belong to phylogenetic group B1 (69.8%; p<0.01), and APN strains showed unique features, which are the presence of phylogroup A, and the absence of phylogroup B2 and non-typeable strains. Overall, the most dominant virulence factor genes (VFGs) were ecpA and fyuA (92.4 and 86.7%, respectively; p<0.05), and the mean number of VFGs was significantly higher in uropathogenic strains. Particularly, papAH and maIX were exclusive for uropathogenic strains. APN and RC strains showed a significantly higher prevalence of fyuA, usp, and ma/Xthan of CO strains. Compared to RC strains, APN ones showed a higher prevalence of iha, but a lower prevalence of iroN, cnf1, and kpsMT-II. Hierarchical cluster analysis showed a higher proportion of two gene clusters (ma/X and usp, and fyuA and ecpA) were detected in the APN and RC groups than in CO, whereas iutA and iha clusters were detected more frequently in APN strains. The motility level did not differ among the study-groups and phylogroups considered, although a higher proportion of swarming strains was observed in APN strains. Antibiotic-resistance rates were generally low except for ampicillin (37.7%), and were not associated with specific study- or phylogenetic groups. APN and RC strains produced more biofilm than CO strains. In APN strains, iha was associated with higher biofilm biomass formation, whereas iroN and KpSMT-K1 were associated with a lower amount of biofilm biomass. Further work is needed to grasp the virulence and fitness mechanisms adopted by E. coli causing APN, and hence develop new therapeutic and prophylactic approaches.	[Pompilio, Arianna; Crocetta, Valentina; Di Nicola, Marta; Di Bonaventura, Giovanni] G dAnnunzio Univ Chieti Pescara, Lab Clin Microbiol, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Pompilio, Arianna; Crocetta, Valentina; Di Bonaventura, Giovanni] G dAnnunzio Univ Chieti Pescara, Lab Clin Microbiol, Ctr Excellence Aging & Translat Med CeSI MeT, Chieti, Italy; [Savini, Vincenzo] Spirito Santo Hosp, Lab Clin Microbiol & Virol, Pescara, Italy; [Petrelli, Dezemona] Univ Camerino, Sch Pharm, Microbiol Unit, Camerino, Italy; [Bucco, Silvia; Amoroso, Luigi; Bonomini, Mario] G dAnnunzio Univ Chieti Pescara, Dept Med, Nephrol & Dialysis Unit, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Camerino; G d'Annunzio University of Chieti-Pescara	Pompilio, A (corresponding author), G dAnnunzio Univ Chieti Pescara, Lab Clin Microbiol, Dept Med Oral & Biotechnol Sci, Chieti, Italy.; Pompilio, A (corresponding author), G dAnnunzio Univ Chieti Pescara, Lab Clin Microbiol, Ctr Excellence Aging & Translat Med CeSI MeT, Chieti, Italy.	ariannapompilio@unich.it	Di Bonaventura, Giovanni/AAK-5850-2020; Petrelli, Dezemona/G-6048-2012; Pompilio, Arianna/AAL-8050-2021	Di Bonaventura, Giovanni/0000-0001-5850-2810; 	Universita di Chieti	Universita di Chieti	This work was supported by Universita di Chieti ex-60% anno 2016, Prof. Giovanni Di Bonaventura. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000586; Blackburn D, 2009, J CLIN MICROBIOL, V47, P1781, DOI 10.1128/JCM.00260-09; Buckles EL, 2009, J INFECT DIS, V199, P1689, DOI 10.1086/598524; Burman WJ, 2003, AM J MED, V115, P358, DOI 10.1016/S0002-9343(03)00372-3; Butler MT, 2010, P NATL ACAD SCI USA, V107, P3776, DOI 10.1073/pnas.0910934107; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; Delcaru C, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6020022; Ejrnaes K, 2011, VIRULENCE, V2, P528, DOI 10.4161/viru.2.6.18189; Er DK, 2015, MICROB PATHOGENESIS, V89, P188, DOI 10.1016/j.micpath.2015.10.014; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Foxman B, 2003, ANN EPIDEMIOL, V13, P144, DOI 10.1016/S1047-2797(02)00272-7; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Grude N, 2007, CLIN MICROBIOL INFEC, V13, P208, DOI 10.1111/j.1469-0691.2006.01584.x; Gupta K, 1999, INT J ANTIMICROB AG, V11, P305, DOI 10.1016/S0924-8579(99)00035-7; Gupta K, 2001, ANN INTERN MED, V135, P41, DOI 10.7326/0003-4819-135-1-200107030-00012; HAGBERG L, 1981, INFECT IMMUN, V31, P564, DOI 10.1128/IAI.31.2.564-570.1981; Hannan TJ, 2012, FEMS MICROBIOL REV, V36, P616, DOI 10.1111/j.1574-6976.2012.00339.x; HERZER PJ, 1990, J BACTERIOL, V172, P6175, DOI 10.1128/jb.172.11.6175-6181.1990; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Horcajada JP, 2005, J CLIN MICROBIOL, V43, P2962, DOI 10.1128/JCM.43.6.2962-2964.2005; Johnson JR, 2006, J INFECT DIS, V194, P1141, DOI 10.1086/507305; Johnson JR, 2005, J CLIN MICROBIOL, V43, P6064, DOI 10.1128/JCM.43.12.6064-6072.2005; Johnson JR, 2002, J INFECT DIS, V185, P1439, DOI 10.1086/340506; Johnson JR, 2000, INFECT IMMUN, V68, P3040, DOI 10.1128/IAI.68.5.3040-3047.2000; Johnson JR, 2005, J INFECT DIS, V191, P46, DOI 10.1086/426450; Johnson JR, 2000, J INFECT DIS, V181, P261, DOI 10.1086/315217; Jung YS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-102; Kanamaru S, 2006, INT J ANTIMICROB AG, V28, pS21, DOI 10.1016/j.ijantimicag.2006.05.006; Kudinha T, 2013, CLIN MICROBIOL INFEC, V19, pE173, DOI 10.1111/1469-0691.12123; Kudinha T, 2012, APPL ENVIRON MICROB, V78, P1198, DOI 10.1128/AEM.06921-11; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Liu F, 2017, MICROBIOL RES, V196, P69, DOI 10.1016/j.micres.2016.11.013; Lloyd AL, 2009, J BACTERIOL, V191, P3469, DOI 10.1128/JB.01717-08; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Magistro G, 2015, INT J MED MICROBIOL, V305, P435, DOI 10.1016/j.ijmm.2015.03.008; Martinez JA, 2006, J CLIN MICROBIOL, V44, P1468, DOI 10.1128/JCM.44.4.1468-1474.2006; Moreno E, 2005, DIAGN MICR INFEC DIS, V53, P93, DOI 10.1016/j.diagmicrobio.2005.05.015; Moulin-Schouleur M, 2006, J CLIN MICROBIOL, V44, P3484, DOI 10.1128/JCM.00548-06; Navidinia M, 2014, BRAZ J MICROBIOL, V45, P509, DOI 10.1590/S1517-83822014000200019; Ong CLY, 2008, J BACTERIOL, V190, P1054, DOI 10.1128/JB.01523-07; Ostblom A, 2011, APPL ENVIRON MICROB, V77, P2303, DOI 10.1128/AEM.02405-10; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Pompilio A, 2008, FEMS MICROBIOL LETT, V287, P41, DOI 10.1111/j.1574-6968.2008.01292.x; Pompilio A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-159; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Pruss BM, 2006, J BACTERIOL, V188, P3731, DOI 10.1128/JB.01780-05; Reisner A, 2006, J BACTERIOL, V188, P3572, DOI 10.1128/JB.188.10.3572-3581.2006; Rijavec M, 2008, J MED MICROBIOL, V57, P1329, DOI 10.1099/jmm.0.2008/002543-0; Robin F, 2008, CLIN MICROBIOL INFEC, V14, P148, DOI 10.1111/j.1469-0691.2007.01893.x; Sarkar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094786; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Soto SM, 2007, J UROLOGY, V177, P365, DOI 10.1016/j.juro.2006.08.081; Soto SM, 2006, CLIN MICROBIOL INFEC, V12, P1034, DOI 10.1111/j.1469-0691.2006.01543.x; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Subashchandrabose S, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.UTI-0015-2012; Swiecicki JM, 2013, INTEGR BIOL-UK, V5, P1490, DOI 10.1039/c3ib40130h; Talan DA, 2008, CLIN INFECT DIS, V47, P1150, DOI 10.1086/592250; TENNER SM, 1992, POSTGRAD MED, V91, P261; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Terlizzi ME, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01566; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Wang Y, 2011, FEMS MICROBIOL LETT, V316, P36, DOI 10.1111/j.1574-6968.2010.02189.x; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Yamamoto S, 2001, J UROLOGY, V165, P1347, DOI 10.1016/S0022-5347(01)69897-5; Zhou ML, 2015, APPL MICROBIOL BIOT, V99, P3797, DOI 10.1007/s00253-015-6533-1	68	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196260	10.1371/journal.pone.0196260	http://dx.doi.org/10.1371/journal.pone.0196260			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758033	Green Published, gold, Green Submitted			2022-12-26	WOS:000432082900010
J	Hager, NA; Krasowski, CJ; Mackie, TD; Kolb, AR; Needham, PG; Augustine, AA; Dempsey, A; Szent-Gyorgyi, C; Bruchez, MP; Bain, DJ; Kwiatkowski, AV; O'Donnell, AF; Brodsky, JL				Hager, Natalie A.; Krasowski, Collin J.; Mackie, Timothy D.; Kolb, Alexander R.; Needham, Patrick G.; Augustine, Andrew A.; Dempsey, Alison; Szent-Gyorgyi, Christopher; Bruchez, Marcel P.; Bain, Daniel J.; Kwiatkowski, Adam V.; O'Donnell, Allyson F.; Brodsky, Jeffrey L.			Select -arrestins control cell-surface abundance of the mammalian Kir2.1 potassium channel in a yeast model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin ligase; calcineurin; arrestin; vacuole; Saccharomyces cerevisiae; protein trafficking (Golgi); endocytosis; inward rectifying channel; protein adaptor; protein quality control; vacuole; yeast	GAP1 PERMEASE UBIQUITYLATION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; INTRACELLULAR TRAFFICKING; FUNCTIONAL EXPRESSION; REGULATE ENDOCYTOSIS; STRESS CONDITIONS; PLASMA-MEMBRANE; GLOBAL ANALYSIS; GENE DELETION	Protein composition at the plasma membrane is tightly regulated, with rapid protein internalization and selective targeting to the cell surface occurring in response to environmental changes. For example, ion channels are dynamically relocalized to or from the plasma membrane in response to physiological alterations, allowing cells and organisms to maintain osmotic and salt homeostasis. To identify additional factors that regulate the selective trafficking of a specific ion channel, we used a yeast model for a mammalian potassium channel, the K+ inward rectifying channel Kir2.1. Kir2.1 maintains potassium homeostasis in heart muscle cells, and Kir2.1 defects lead to human disease. By examining the ability of Kir2.1 to rescue the growth of yeast cells lacking endogenous potassium channels, we discovered that specific -arrestins regulate Kir2.1 localization. Specifically, we found that the Ldb19/Art1, Aly1/Art6, and Aly2/Art3 -arrestin adaptor proteins promote Kir2.1 trafficking to the cell surface, increase Kir2.1 activity at the plasma membrane, and raise intracellular potassium levels. To better quantify the intracellular and cell-surface populations of Kir2.1, we created fluorogen-activating protein fusions and for the first time used this technique to measure the cell-surface residency of a plasma membrane protein in yeast. Our experiments revealed that two -arrestin effectors also control Kir2.1 localization. In particular, both the Rsp5 ubiquitin ligase and the protein phosphatase calcineurin facilitated the -arrestin-mediated trafficking of Kir2.1. Together, our findings implicate -arrestins in regulating an additional class of plasma membrane proteins and establish a new tool for dissecting the trafficking itinerary of any membrane protein in yeast.	[Hager, Natalie A.; Krasowski, Collin J.; O'Donnell, Allyson F.] Duquesne Univ, Dept Biol Sci, 600 Forbes Ave, Pittsburgh, PA 15282 USA; [Mackie, Timothy D.; Kolb, Alexander R.; Needham, Patrick G.; Augustine, Andrew A.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Dempsey, Alison; Szent-Gyorgyi, Christopher; Bruchez, Marcel P.] Carnegie Mellon Univ, Mol Biosensor & Imaging Ctr, Pittsburgh, PA 15213 USA; [Bain, Daniel J.] Univ Pittsburgh, Dept Geol & Environm Sci, Pittsburgh, PA 15260 USA; [Kwiatkowski, Adam V.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15261 USA	Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	O'Donnell, AF (corresponding author), Duquesne Univ, Dept Biol Sci, 600 Forbes Ave, Pittsburgh, PA 15282 USA.; Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	odonne15@duq.edu; jbrodsky@pitt.edu	Bain, Daniel J/G-3055-2013	Hager, Natalie/0000-0002-7140-7380; O'Donnell, Allyson/0000-0003-0966-288X; Bain, Daniel/0000-0003-1979-7016	National Institutes of Health [R01 HL127711, R01 GM075061, P30 DK079307, U54-GM103529]; National Science Foundation (NSF) MCB CAREER Grant [1553143]; NSF EAR-IF [0948366]; Shurl and Kay Curci Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529, R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) MCB CAREER Grant(National Science Foundation (NSF)); NSF EAR-IF(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Shurl and Kay Curci Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL127711 (to A. V. K.), R01 GM075061 (to J. L. B. and A. F. O.), P30 DK079307 (to J. L. B.), and U54-GM103529 (to A. D., C. S.-G., and M. P. B). This work also was supported by National Science Foundation (NSF) MCB CAREER Grant 1553143 (to A. F. O.) and NSF EAR-IF 0948366 (to D. J. B.), a Pilot Grant from P30 DK079307 (to A. F. O.), and a grant from the Shurl and Kay Curci Foundation (to M. P. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai T, 2002, CIRCULATION, V105, P2592, DOI 10.1161/01.CIR.0000019906.35135.A3; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Aubry L, 2009, CURR GENOMICS, V10, P133, DOI 10.2174/138920209787847014; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Boeckstaens M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4101; Brachmann CB, 1998, YEAST, V14, P115; Brette F, 2003, CIRC RES, V92, P1182, DOI 10.1161/01.RES.0000074908.17214.FD; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Chen H, 1998, FEBS LETT, V422, P307, DOI 10.1016/S0014-5793(98)00028-3; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2; Crapeau M, 2014, J BIOL CHEM, V289, P22103, DOI 10.1074/jbc.M114.582320; Curran J, 2014, CIRC RES, V115, P68, DOI 10.1161/CIRCRESAHA.115.304149; CYERT MS, 1992, MOL CELL BIOL, V12, P3460, DOI 10.1128/MCB.12.8.3460; Dart C, 2001, J BIOL CHEM, V276, P20499, DOI 10.1074/jbc.M101425200; de Boer TP, 2010, ACTA PHYSIOL, V199, P243, DOI 10.1111/j.1748-1716.2010.02108.x; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Foote C, 2006, J CELL BIOL, V173, P615, DOI 10.1083/jcb.200510161; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649; Herrador A, 2013, J BIOL CHEM, V288, P16206, DOI 10.1074/jbc.C113.452250; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Ho HC, 2017, MOL BIOL CELL, V28, P1271, DOI 10.1091/mbc.E17-01-0008; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; KO CH, 1991, MOL CELL BIOL, V11, P4266, DOI 10.1128/MCB.11.8.4266; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Minear S, 2011, EUKARYOT CELL, V10, P1574, DOI 10.1128/EC.05163-11; Nakamura RL, 1998, METHOD ENZYMOL, V293, P89; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; O'Donnell AF, 2015, MOL CELL BIOL, V35, P939, DOI 10.1128/MCB.01183-14; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; O'Donnell AF, 2012, MOL CELL BIOL, V32, P4506, DOI 10.1128/MCB.01176-12; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; O'Donnell BM, 2017, J BIOL CHEM, V292, P12813, DOI 10.1074/jbc.M117.786376; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; Picones A, 2001, BIOPHYS J, V81, P2035, DOI 10.1016/S0006-3495(01)75853-5; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Pratt CP, 2015, BIOCONJUGATE CHEM, V26, P1963, DOI 10.1021/acs.bioconjchem.5b00409; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Prosser DC, 2016, JOVE-J VIS EXP, DOI 10.3791/54587; Prosser DC, 2015, J CELL SCI, V128, P4220, DOI 10.1242/jcs.175372; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Shiwarski DJ, 2017, MOL BIOL CELL, V28, P2202, DOI 10.1091/mbc.E17-01-0030; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Starita LM, 2012, PROTEOMICS, V12, P236, DOI 10.1002/pmic.201100166; Stimpson HEM, 2006, EMBO J, V25, P662, DOI 10.1038/sj.emboj.7600984; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Szent-Gyorgyi C, 2013, J MOL BIOL, V425, P4595, DOI 10.1016/j.jmb.2013.08.014; Szent-Gyorgyi C, 2008, NAT BIOTECHNOL, V26, P235, DOI 10.1038/nbt1368; Tan R, 2017, MOL CELL, V65, P818, DOI 10.1016/j.molcel.2017.01.015; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Tristani-Firouzi M, 2010, PFLUG ARCH EUR J PHY, V460, P289, DOI 10.1007/s00424-010-0820-6; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; VOLLAND C, 1994, FOLIA MICROBIOL, V39, P554, DOI 10.1007/BF02814106; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yan Q, 2015, ORG BIOMOL CHEM, V13, P2078, DOI 10.1039/c4ob02309a; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	94	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11006	11021		10.1074/jbc.RA117.001293	http://dx.doi.org/10.1074/jbc.RA117.001293			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784874	hybrid, Green Published			2022-12-26	WOS:000438882800014
J	Del Poggetto, E; Toto, A; Aloise, C; Di Piro, F; Gori, L; Malatesta, F; Gianni, S; Chiti, F; Bemporad, F				Del Poggetto, Edoardo; Toto, Angelo; Aloise, Chiara; Di Piro, Francesco; Gori, Ludovica; Malatesta, Francesco; Gianni, Stefano; Chiti, Fabrizio; Bemporad, Francesco			Stability of an aggregation-prone partially folded state of human profilin-1 correlates with aggregation propensity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); protein folding; protein misfolding; aggregation; amyloid; neurodegenerative disease; profilin; ALS; Lou Gehrig Disease; protein dynamics; protein self-assembly	AMYOTROPHIC-LATERAL-SCLEROSIS; INTERMEDIATE STATE; TRANSITION-STATES; PROTEIN; FRUSTRATION; MUTATIONS; BETA(2)-MICROGLOBULIN; IDENTIFICATION; DEGENERATION; MECHANISM	A set of missense mutations in the gene encoding profilin-1 has been linked to the onset of familial forms of ALS (fALS), also known as Lou Gehrig's disease. The pathogenic potential of these mutations is linked to the formation of intracellular inclusions of the mutant proteins and correlates with the mutation-induced destabilization of its native, fully folded state. However, the mechanism by which these mutations promote misfolding and self-assembly is yet unclear. Here, using temperature-jump and stopped-flow kinetic measurements, we show that, during refolding, WT profilin-1 transiently populates a partially folded (PF) state endowed with hydrophobic clusters exposed to the solvent and with no detectable secondary structure. We observed that this conformational state is marginally stable at neutral pH but becomes significantly populated at mildly acidic pH. Interestingly, the fALS-associated mutations did not cause a change in the refolding mechanism of profilin-1, but induced a stabilization of the PF state. In the presence of preformed profilin-1 aggregates, the PF state, unlike the unfolded and folded states, could interact with these aggregates via nonspecific hydrophobic interactions and also increase thioflavin-T fluorescence, revealing its amyloidogenic potential. Moreover, in the variants tested, we found a correlation between conformational stability of PF and aggregation propensity, defining this conformational state as an aggregation-prone folding intermediate. In conclusion, our findings indicate that mutation-induced stabilization of a partially folded state can enhance profilin-1 aggregation and thereby contribute to the pathogenicity of the mutations.	[Del Poggetto, Edoardo; Aloise, Chiara; Di Piro, Francesco; Gori, Ludovica; Chiti, Fabrizio; Bemporad, Francesco] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Viale GB Morgagni 50, I-50134 Florence, Italy; [Toto, Angelo; Malatesta, Francesco; Gianni, Stefano] Sapienza Univ Rome, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Gianni, Stefano] CNR, Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy; [Gianni, Stefano] CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy	University of Florence; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Fondazione Cenci Bolognetti; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Bemporad, F (corresponding author), Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Viale GB Morgagni 50, I-50134 Florence, Italy.	francesco.bemporad@unifi.it	Malatesta, Francesco/AAT-4757-2020; Toto, Angelo/AAV-9598-2021	Toto, Angelo/0000-0002-4620-3677; Bemporad, Francesco/0000-0002-0643-6249; Chiti, Fabrizio/0000-0002-1330-1289; Del Poggetto, Edoardo/0000-0002-3648-4399	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetto di Interesse "Invecchiamento"; Programma per Giovani Ricercatori "Rita Levi Montalcini" 2010; Sapienza University of Rome [C26A155S48, B52F16003410005, RP11715C34AEAC9B]	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetto di Interesse "Invecchiamento"(Ministry of Education, Universities and Research (MIUR)); Programma per Giovani Ricercatori "Rita Levi Montalcini" 2010; Sapienza University of Rome	This work was supported in part by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca, Progetto di Interesse "Invecchiamento" (to S. G.) and Programma per Giovani Ricercatori "Rita Levi Montalcini" 2010 (to F. B.) and Sapienza University of Rome, Grants C26A155S48, B52F16003410005, and RP11715C34AEAC9B (to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alkam D, 2017, CELL MOL LIFE SCI, V74, P967, DOI 10.1007/s00018-016-2372-1; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Boopathy S, 2015, P NATL ACAD SCI USA, V112, P7984, DOI 10.1073/pnas.1424108112; Brettle M, 2015, NEUROSCI LETT, V609, P223, DOI 10.1016/j.neulet.2015.09.034; Chen Y, 2013, ADV POROUS MATER, V1, P34, DOI 10.1166/apm.2013.1006; Chi CN, 2007, FEBS LETT, V581, P1109, DOI 10.1016/j.febslet.2007.02.011; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Del Poggetto E, 2016, BIOL CHEM, V397, P927, DOI 10.1515/hsz-2016-0154; Del Poggetto E, 2015, ACS CHEM BIOL, V10, P2553, DOI 10.1021/acschembio.5b00598; Del Poggetto E, 2015, SCI REP-UK, V5, DOI 10.1038/srep12332; Ferreiro DU, 2018, CURR OPIN STRUC BIOL, V48, P68, DOI 10.1016/j.sbi.2017.09.006; Finsterer J, 2014, EUR J MED GENET, V57, P103, DOI 10.1016/j.ejmg.2014.01.002; Freischmidt A, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0214-y; Geierhaas CD, 2008, PROTEIN ENG DES SEL, V21, P215, DOI 10.1093/protein/gzm092; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Gianni S, 2014, P NATL ACAD SCI USA, V111, P14141, DOI 10.1073/pnas.1405233111; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Parra RG, 2016, NUCLEIC ACIDS RES, V44, pW356, DOI 10.1093/nar/gkw304; Heidarsson PO, 2014, P NATL ACAD SCI USA, V111, P13069, DOI 10.1073/pnas.1401065111; Honda RP, 2015, STRUCTURE, V23, P1735, DOI 10.1016/j.str.2015.07.001; Ingre C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.009; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Karamanos TK, 2016, J AM CHEM SOC, V138, P6271, DOI 10.1021/jacs.6b02464; Krobath H, 2012, J MOL BIOL, V422, P705, DOI 10.1016/j.jmb.2012.06.020; Kullmann JA, 2012, NEUROSCIENCE, V223, P355, DOI 10.1016/j.neuroscience.2012.07.055; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; Matsukawa K, 2016, J BIOL CHEM, V291, P23464, DOI 10.1074/jbc.M116.729152; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Rennella E, 2017, BIOCHEMISTRY-US, V56, P692, DOI 10.1021/acs.biochem.6b01263; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sen Mojumdar S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01996-1; Smith BN, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.10.032; Stoppini M, 2015, J BIOL CHEM, V290, P9951, DOI 10.1074/jbc.R115.639799; Tanaka Y, 2016, PRION, V10, P283, DOI 10.1080/19336896.2016.1207033; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yang CX, 2016, P NATL ACAD SCI USA, V113, pE6209, DOI 10.1073/pnas.1605964113	45	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10303	10313		10.1074/jbc.RA118.002087	http://dx.doi.org/10.1074/jbc.RA118.002087			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29760185	Green Published, hybrid			2022-12-26	WOS:000437096700028
J	Tachibana, K; Yuzuriha, T; Tabata, R; Fukuda, S; Maegawa, T; Takahashi, R; Tanimoto, K; Tsujino, H; Nunomura, K; Lin, BZ; Matsuura, Y; Tanaka, T; Hamakubo, T; Sakai, J; Kodama, T; Kobayashi, T; Ishimoto, K; Miyachi, H; Doi, T				Tachibana, Keisuke; Yuzuriha, Tomohiro; Tabata, Ryotaro; Fukuda, Syohei; Maegawa, Takashi; Takahashi, Rika; Tanimoto, Keiichi; Tsujino, Hirofumi; Nunomura, Kazuto; Lin, Bangzhong; Matsuura, Yoshiharu; Tanaka, Toshiya; Hamakubo, Takao; Sakai, Juro; Kodama, Tatsuhiko; Kobayashi, Tadayuki; Ishimoto, Kenji; Miyachi, Hiroyuki; Doi, Takefumi			Discovery of peroxisome proliferator-activated receptor (PPAR alpha) activators with a ligand-screening system using a human PPAR-expressing cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peroxisome proliferator-activated receptor (PPAR); triglyceride; cell biology; transcription regulation; drug screening; chemical screening system; dyslipidemia; ligand; nuclear receptor; Tet-off system	RESPONSE ELEMENT; LIPID-METABOLISM; MICE; GENE; STEATOHEPATITIS; AGONISTS; LIVER; CARBOHYDRATE; SUPERFAMILY; MECHANISM	Peroxisome proliferator-activated receptor (PPAR) is a ligand-activated transcription factor that belongs to the superfamily of nuclear hormone receptors. PPAR is mainly expressed in the liver, where it activates fatty acid oxidation and lipoprotein metabolism and improves plasma lipid profiles. Therefore, PPAR activators are often used to treat patients with dyslipidemia. To discover additional PPAR activators as potential compounds for use in hypolipidemic drugs, here we established human hepatoblastoma cell lines with luciferase reporter expression from the promoters containing peroxisome proliferator-responsive elements (PPREs) and tetracycline-regulated expression of full-length human PPAR to quantify the effects of chemical ligands on PPAR activity. Using the established cell-based PPAR-activator screening system to screen a library of >12,000 chemical compounds, we identified several hit compounds with basic chemical skeletons different from those of known PPAR agonists. One of the hit compounds, a 1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid derivative we termed compound 3, selectively up-regulated PPAR transcriptional activity, leading to PPAR target gene expression both in vitro and in vivo. Of note, the half-maximal effective concentrations of the hit compounds were lower than that of the known PPAR ligand fenofibrate. Finally, fenofibrate or compound 3 treatment of high fructose-fed rats having elevated plasma triglyceride levels for 14 days indicated that compound 3 reduces plasma triglyceride levels with similar efficiency as fenofibrate. These observations raise the possibility that 1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid derivatives might be effective drug candidates for selective targeting of PPAR to manage dyslipidemia.	[Tachibana, Keisuke; Yuzuriha, Tomohiro; Tabata, Ryotaro; Fukuda, Syohei; Maegawa, Takashi; Takahashi, Rika; Tanimoto, Keiichi; Tsujino, Hirofumi; Nunomura, Kazuto; Lin, Bangzhong; Kobayashi, Tadayuki; Ishimoto, Kenji; Doi, Takefumi] Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan; [Yuzuriha, Tomohiro] Setsunan Univ, Fac Pharmaceut Sci, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan; [Matsuura, Yoshiharu] Osaka Univ, Res Inst Microbial Dis, Dept Mol Virol, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan; [Tanaka, Toshiya; Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan; [Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan; [Sakai, Juro] Univ Tokyo, Res Ctr Adv Sci & Technol, Div Metab Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan; [Miyachi, Hiroyuki] Univ Tokyo, Drug Discovery Initiat, Lead Explorat Unit, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	Osaka University; Setsunan University; Osaka University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Tachibana, K; Doi, T (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, 1-6 Yamadaoka, Suita, Osaka 5650871, Japan.	nya@phs.osaka-u.ac.jp; doi@phs.osaka-u.ac.jp		Sakai, Juro/0000-0003-4043-1035	JSPS KAKENHI [15H02896, 16K13044, 18H03190]; Lydia O'Leary Memorial Pias Dermatological Foundation; Takeda Science Foundation; Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) - Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED) [17am0101084j0001, JP18am0101123, JP18am0101084, JP18am0101085]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Lydia O'Leary Memorial Pias Dermatological Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) - Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by JSPS KAKENHI Grants 15H02896, 16K13044, and 18H03190; Lydia O'Leary Memorial Pias Dermatological Foundation; Takeda Science Foundation; the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) funded by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT); and the Japan Agency for Medical Research and Development (AMED) under Grants 17am0101084j0001, JP18am0101123, JP18am0101084, and JP18am0101085. The authors declare that they have no conflicts of interest with the contents of this article.	Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Ban S, 2011, BIOORGAN MED CHEM, V19, P3183, DOI 10.1016/j.bmc.2011.03.064; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Dubois V, 2017, J CLIN INVEST, V127, P1202, DOI 10.1172/JCI88894; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; Feng L, 2016, DIABETOLOGIA, V59, P1276, DOI 10.1007/s00125-016-3912-9; Fruchart JC, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-26; Fruchart JC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-82; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HERTZ R, 1995, J BIOL CHEM, V270, P13470, DOI 10.1074/jbc.270.22.13470; Huang PX, 2010, ANNU REV PHYSIOL, V72, P247, DOI 10.1146/annurev-physiol-021909-135917; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; LEE SST, 1995, MOL CELL BIOL, V15, P3012; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Markt P, 2007, J COMPUT AID MOL DES, V21, P575, DOI 10.1007/s10822-007-9140-0; Miyamoto T, 1997, J BIOL CHEM, V272, P7752, DOI 10.1074/jbc.272.12.7752; MIYATA KS, 1993, J BIOL CHEM, V268, P19169; Nakshatri H, 1998, NUCLEIC ACIDS RES, V26, P2491, DOI 10.1093/nar/26.10.2491; Nomura M, 2003, J MED CHEM, V46, P3581, DOI 10.1021/jm0205144; Park J, 1997, J LIPID RES, V38, P2529; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Raza-Iqbal S, 2015, J ATHEROSCLER THROMB, V22, P754, DOI 10.5551/jat.28720; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tachibana K, 2013, J BIOCHEM, V154, P265, DOI 10.1093/jb/mvt050; Tachibana K, 2009, BIOCHEM BIOPH RES CO, V389, P501, DOI 10.1016/j.bbrc.2009.09.018; Tachibana K, 2008, PPAR RES, V2008, DOI 10.1155/2008/102737; Tachibana K, 2008, FEBS LETT, V582, P3884, DOI 10.1016/j.febslet.2008.10.027; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a	38	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10333	10343		10.1074/jbc.RA118.002077	http://dx.doi.org/10.1074/jbc.RA118.002077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764933	Green Published, hybrid			2022-12-26	WOS:000437096700031
J	Schliemann, C; Kerkhoff, A; Hesse, P; Brockling, S; Hardes, J; Streitburger, A; Andreou, D; Gosheger, G; Elges, S; Wardelmann, E; Hartmann, W; Mesters, R; Lenz, G; Willich, N; Kriz, J; Eich, H; Berdel, WE; Kessler, T				Schliemann, Christoph; Kerkhoff, Andrea; Hesse, Paula; Broeckling, Sebastian; Hardes, Jendrik; Streitbuerger, Arne; Andreou, Dimosthenis; Gosheger, Georg; Elges, Sandra; Wardelmann, Eva; Hartmann, Wolfgang; Mesters, Rolf; Lenz, Georg; Willich, Normann; Kriz, Jan; Eich, Hans; Berdel, Wolfgang E.; Kessler, Torsten			Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; HIGH-RISK; EUROPEAN ORGANIZATION; PROGNOSTIC-FACTORS; OPEN-LABEL; TRIALS; DOXORUBICIN; IFOSFAMIDE; CHEMORADIOTHERAPY; EXTREMITY	Adjuvant therapy of local soft tissue sarcomas (STS) after wide surgical excision still is a topic under controversial scientific debate. In this single center report we have offered an adjuvant "sandwich" therapy protocol consisting of 4 cycles of doxorubicin (75 mg/m(2) i.v. over 1 h on day 1) followed by ifosfamide (5 g/m(2) i.v. over 24 h starting on day 1) and local radiotherapy scheduled between chemotherapy cycles 2 and 3 to 104 consecutive patients after wide surgical excision (R0) of histologically proven high-grade STS. After a mean follow-up of 39 months (range 5-194 months) relapse free survival (RFS) at 2 and 5 years was 68.1% (95% CI, 58.5-77.7%) and 61.2% (95% CI, 50.4-71.6%). When analyzing the 82 STS cases of the extremities only 2- and 5-year RFS was 74.0% (95% CI, 64.0-84.0%) and 65.3% (95% CI, 53.7-76.9%). By intent-to-treat analysis, the overall survival (OS) at 2 years was 87.3% (95% CI, 80.5-94.1%) and 75.6% (95% CI, 65.2-86.0%) at 5 years, while OS for STS of the extremities only cohort was 90.5% (95% CI, 83.7-97.3%) and 79.0% (95% CI, 68.4-89.6%), respectively. Tolerability of the treatment was good. This analysis demonstrates the feasibility of adjuvant chemoradiotherapy and reflects the results of the long lasting intensive multidisciplinary team approach at our "high-volume" sarcoma center. The long-term survival in our patients is among the highest reported and the low local and distant recurrence rate in high-risk STS is at least comparable to the published data.	[Schliemann, Christoph; Kerkhoff, Andrea; Hesse, Paula; Broeckling, Sebastian; Mesters, Rolf; Lenz, Georg; Berdel, Wolfgang E.; Kessler, Torsten] Univ Hosp Muenster, Dept Med A, Munster, Germany; [Hardes, Jendrik; Streitbuerger, Arne; Andreou, Dimosthenis; Gosheger, Georg] Univ Hosp Muenster, Dept Orthoped & Tumororthoped, Munster, Germany; [Elges, Sandra; Wardelmann, Eva; Hartmann, Wolfgang] Univ Hosp Muenster, Gerhard Domagk Inst Pathol, Munster, Germany; [Willich, Normann; Kriz, Jan; Eich, Hans] Univ Hosp Muenster, Dept Radiat Oncol, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Kessler, T (corresponding author), Univ Hosp Muenster, Dept Med A, Munster, Germany.	torstenkessler@uni-muenster.de	Kessler, Torsten/S-3319-2016; Hartmann, Wolfgang/G-1893-2017	Kessler, Torsten/0000-0001-7679-5362; Hartmann, Wolfgang/0000-0002-7609-5021				Afonso SL, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.10042; Brandts CH, 2012, CANCER CHEMOTH PHARM, V69, P613, DOI 10.1007/s00280-011-1731-8; Casali PG, 2014, ANN ONCOL, V25, P102, DOI 10.1093/annonc/mdu254; Cormier JN, 2004, J CLIN ONCOL, V22, P4567, DOI 10.1200/JCO.2004.02.057; Davis EJ, 2015, EUR J CANCER, V51, P1794, DOI 10.1016/j.ejca.2015.05.010; Eastley N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i436; Fletcher CDM, 2014, HISTOPATHOLOGY, V64, P2, DOI 10.1111/his.12267; Frustaci S, 2003, ONCOLOGY-BASEL, V65, P80, DOI 10.1159/000073366; Frustaci S, 2001, J CLIN ONCOL, V19, P1238, DOI 10.1200/JCO.2001.19.5.1238; Grimer RJ, 2006, ANN ROY COLL SURG, V88, P519, DOI 10.1308/003588406X130651; Gronchi A, 2017, LANCET ONCOL, V18, P812, DOI 10.1016/S1470-2045(17)30334-0; Gronchi A, 2012, J CLIN ONCOL, V30, P850, DOI 10.1200/JCO.2011.37.7218; Hong NJL, 2013, EUR J CANCER, V49, P875, DOI 10.1016/j.ejca.2012.10.002; Italiano A, 2014, CANCER-AM CANCER SOC, V120, P3361, DOI 10.1002/cncr.28885; Kasper B, 2013, EUR J CANCER, V49, P449, DOI 10.1016/j.ejca.2012.08.007; Kattan MW, 2002, J CLIN ONCOL, V20, P791, DOI 10.1200/JCO.2002.20.3.791; Le Cesne A, 2014, ANN ONCOL, V25, P2425, DOI 10.1093/annonc/mdu460; Lopez-Pousa A, 2016, CLIN TRANSL ONCOL, V18, P1213, DOI 10.1007/s12094-016-1574-1; Pervaiz N, 2008, CANCER-AM CANCER SOC, V113, P573, DOI 10.1002/cncr.23592; Posch F, 2017, CLIN ORTHOP RELAT R, V475, P1427, DOI 10.1007/s11999-017-5232-x; Saponara M, 2017, EUR J CANCER, V70, P1, DOI 10.1016/j.ejca.2016.09.030; Vlenterie M, 2016, EUR J CANCER, V58, P62, DOI 10.1016/j.ejca.2016.02.002; von Mehren M, 2016, J NATL COMPR CANC NE, V14, P758, DOI 10.6004/jnccn.2016.0078; Willeumier JJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012930; Woll PJ, 2012, LANCET ONCOL, V13, P1045, DOI 10.1016/S1470-2045(12)70346-7; Young RJ, 2014, EUR J CANCER, V50, P3178, DOI 10.1016/j.ejca.2014.10.004	26	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197315	10.1371/journal.pone.0197315	http://dx.doi.org/10.1371/journal.pone.0197315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787570	gold, Green Published, Green Submitted			2022-12-26	WOS:000432785700021
J	Kronenfeld, N; Baran, TZ; Berlin, M; Karra, N; Dinavitser, N; Cohen, R; Wiener, Y; Schwartzberg, E; Bercovitch, M				Kronenfeld, Nirit; Baran, Tomer Ziv; Berlin, Maya; Karra, Nour; Dinavitser, Natalie; Cohen, Rana; Wiener, Yifat; Schwartzberg, Eyal; Bercovitch, Matitiahu			Chronic use of psychotropic medications in breastfeeding women: Is it safe?	PLOS ONE			English	Article							HUMAN-MILK; FED INFANTS; MATERNAL DEPRESSION; ADVERSE-REACTIONS; PREGNANCY; CITALOPRAM; EXPOSURE; ANTIDEPRESSANTS; LACTATION; EXCRETION	Background Current knowledge regarding chronic use of psychotropic medications during breastfeeding is limited. The objective of this study was to evaluate the long-term effects of psychotropic monotherapy use during lactation on the breastfed infant. Materials and methods In this prospective study, we followed 280 infants whose mothers contacted the Drug Consultation Center (DCC) at Assaf Harofeh Medical Center between January 2011 and December 2015, seeking information regarding the chronic use of psychotropic medications during lactation. This group was compared with a group of 152 callers, who inquired evidence regarding the use of antibiotics compatible with breastfeeding. Information on adverse effects, physical measures and gross motor developmental milestone achievements of the breastfed infants was obtained during a follow-up telephone interview. At follow up, the median age of the infants in the Psychotropic-drug group was 20 (11-33) months versus 36 (20-48) months in the Antibiotic group (p < 0.001). The outcomes were compared between the groups followed by a propensity score matching to control for difference in baseline characteristics. Results At follow-up, no significant differences between infants in the two groups were observed with regard to height, weight, head circumference and weight-length ratio percentile (p = 0.339, p = 0.223, p = 0.738, p = 0.926, respectively). Children in both groups were, according to their parents, within the normal developmental range for all milestones, according to the Denver Developmental Scale. Use of psychotropic medications during breastfeeding was not significantly associated with adverse reactions. After propensity score matching (n = 120 pairs) to control for differences in baseline characteristics and the length of lactation, only one significant difference was reported, sleepiness in infants in the study group (7/120) and none in the comparison group (p = 0.008). Conclusions Chronic use of psychotropic monotherapy during lactation is associated with normal growth and gross motor developmental as by milestone achievements reported by parents. Sleepiness was reported, it seemed self-limited with no developmental effect.	[Kronenfeld, Nirit] Hebrew Univ Jerusalem, Dept Pharm, Jerusalem, Israel; [Kronenfeld, Nirit; Berlin, Maya; Karra, Nour; Dinavitser, Natalie; Cohen, Rana; Bercovitch, Matitiahu] Tel Aviv Univ, Sackler Sch Med, Assaf Harofeh Med Ctr, Dept Clin Pharmacol Unit, Tel Aviv, Israel; [Baran, Tomer Ziv] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel; [Wiener, Yifat] Tel Aviv Univ, Sackler Sch Med, Assaf Harofeh Med Ctr, Dept Obstet & Gynecol, Tel Aviv, Israel; [Schwartzberg, Eyal] Ben Gurion Univ Negev, Dept Pharm, Beer Sheva, Israel	Hebrew University of Jerusalem; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University	Bercovitch, M (corresponding author), Tel Aviv Univ, Sackler Sch Med, Assaf Harofeh Med Ctr, Dept Clin Pharmacol Unit, Tel Aviv, Israel.	mberkovitch@asaf.health.gov.il		Berlin, Maya/0000-0003-4731-742X				Anderson PO, 2016, CLIN PEDIATR, V55, P236, DOI 10.1177/0009922815594586; Anderson PO, 2003, CLIN PEDIATR, V42, P325, DOI 10.1177/000992280304200405; [Anonymous], 1988, STAT POWER ANAL BEHA; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Benyamini L, 2005, THER DRUG MONIT, V27, P499, DOI 10.1097/01.ftd.0000168294.25356.d0; Berkovitch M, 2000, NEW ENGL J MED, V343, P445, DOI 10.1056/NEJM200008103430616; Berle JO, 2004, J CLIN PSYCHIAT, V65, P1228, DOI 10.4088/JCP.v65n0911; Berlin CM, 2005, SEMIN FETAL NEONAT M, V10, P149, DOI 10.1016/j.siny.2004.09.016; CAPLAN HL, 1989, BRIT J PSYCHIAT, V154, P818, DOI 10.1192/bjp.154.6.818; COGILL SR, 1986, BMJ-BRIT MED J, V292, P1165, DOI 10.1136/bmj.292.6529.1165; Cohen LS, 1998, J CLIN PSYCHIAT, V59, P18; Committee on Healthcare for Underserved Women, 2013, OBSTET GYNECOL, V122, P423, DOI DOI 10.1097/01.AOG.0000433008.93971.6A; Gartner LM, 1997, PEDIATRICS, V100, P1035, DOI 10.1542/peds.100.6.1035; Gilad O, 2011, BREASTFEED MED, V6, P55, DOI 10.1089/bfm.2010.0027; Goldstein LH, 2009, BREASTFEED MED, V4, P197, DOI 10.1089/bfm.2008.0135; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE309, DOI 10.4088/JCP.12r07967; Hackett LP, 2006, EUR J CLIN PHARMACOL, V62, P633, DOI 10.1007/s00228-006-0140-0; Heikkinen T, 2002, CLIN PHARMACOL THER, V72, P184, DOI 10.1067/mcp.2002.126181; Hendrick V, 2001, BRIT J PSYCHIAT, V179, P163, DOI 10.1192/bjp.179.2.163; Hendrick V, 2001, BIOL PSYCHIAT, V50, P775, DOI 10.1016/S0006-3223(01)01197-0; Hill RC, 2000, J CLIN PSYCHOPHARM, V20, P285, DOI 10.1097/00004714-200004000-00036; ITO S, 1993, AM J OBSTET GYNECOL, V168, P1393, DOI 10.1016/S0002-9378(11)90771-6; Ito S, 2000, NEW ENGL J MED, V343, P118, DOI 10.1056/NEJM200007133430208; Jensen PN, 1997, THER DRUG MONIT, V19, P236, DOI 10.1097/00007691-199704000-00021; Jimenez-Solem E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063034; Kallen B, 2004, ARCH PEDIAT ADOL MED, V158, P312, DOI 10.1001/archpedi.158.4.312; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; Kieviet N, 2013, NEUROPSYCH DIS TREAT, V9, P1257, DOI 10.2147/NDT.S36394; Kristensen JH, 2007, BRIT J CLIN PHARMACO, V63, P322, DOI 10.1111/j.1365-2125.2006.02773.x; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Rampono J, 2000, BRIT J CLIN PHARMACO, V50, P263, DOI 10.1046/j.1365-2125.2000.00253.x; Rampono J, 2006, BRIT J CLIN PHARMACO, V62, P316, DOI 10.1111/j.1365-2125.2006.02659.x; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87; Yoshida K, 1997, J AFFECT DISORDERS, V43, P225, DOI 10.1016/S0165-0327(97)01433-X	34	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197196	10.1371/journal.pone.0197196	http://dx.doi.org/10.1371/journal.pone.0197196			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG2QJ	29782546	Green Submitted, gold, Green Published			2022-12-26	WOS:000432537100017
J	Liu, XY; Li, Y; Zhou, XG; Luo, K; Hu, LF; Liu, KL; Bai, LY				Liu, Xiangying; Li, Yu; Zhou, Xuguo; Luo, Kun; Hu, Lifeng; Liu, Kailin; Bai, Lianyang			Photocatalytic degradation of dimethoate in Bok choy using cerium-doped nano titanium dioxide	PLOS ONE			English	Article							WASTE-WATER; BRASSICA VEGETABLES; ACUTE TOXICITY; PHOTO-FENTON; CANCER RISK; HUMAN LIVER; DNA-DAMAGE; MALE-MICE; TIO2; MECHANISM	Dimethoate, a systemic insecticide, has been used extensively in vegetable production. Insecticide residues in treated vegetables, however, pose a potential risk to consumers. Photocatalytic degradation is a new alternative to managing pesticide residues. In this study, the degradation of dimethoate in Bok choy was investigated under the field conditions using cerium-doped nano titanium dioxide (TiO2/Ce) hydrosol as a photocatalyst. The results show that TiO2/Ce hydrosol can accelerate the degradation of dimethoate in Bok choy. Specifically, the application of TiO2/Ce hydrosol significantly increased the reactive oxygen species (ROS) contents in the treated Bok choy, which speeds up the degradation of dimethoate. Ultra-performance liquid chromatography coupled with mass spectrometry (UPLC-MS) analysis detected three major degradation products, including omethoate, 0,0, S-trimethyl thiophosphorothioate, and 1,2-Bis (acetyl-N-methyl-) methane disulfide. Two potential photodegradation pathways have been proposed based on the intermediate products. To understand the relationship between photodegradation and the molecular structure of target insecticides, we investigated the bond length, Mulliken atomic charge and frontier electron density of dimethoate using ab initio quantum analysis. These results suggest the P = S, P-S and S-C of dimethoate are the initiation sites for the photocatalytic reaction in Bok choy, which is consistent with our empirical data.	[Liu, Xiangying; Li, Yu; Zhou, Xuguo; Luo, Kun; Hu, Lifeng; Liu, Kailin; Bai, Lianyang] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Liu, Xiangying; Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA; [Liu, Xiangying; Bai, Lianyang] Collaborat Innovat Ctr Farmland Weeds Control, Loudi, Hunan, Peoples R China; [Bai, Lianyang] Hunan Acad Agr Sci, Biotechnol Res Ctr, Changsha, Hunan, Peoples R China	Hunan Agricultural University; University of Kentucky; Hunan Academy of Agricultural Sciences	Zhou, XG; Bai, LY (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.; Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.; Bai, LY (corresponding author), Collaborat Innovat Ctr Farmland Weeds Control, Loudi, Hunan, Peoples R China.; Bai, LY (corresponding author), Hunan Acad Agr Sci, Biotechnol Res Ctr, Changsha, Hunan, Peoples R China.	xuguozhou@uky.edu; bailianyang2005@aliyun.com			National Natural Science Foundation of China [31672043, 21003042]; Special Fund for Agro-scientific Research in the Public Interest, P.R. China [201303031]; China Postdoctoral Science Foundation [2015M582329]; Natural Science Funds of Hunan Province [2018JJ2165]; China Scholarship Council [201608430210]; Shen-Nong Visiting Scholar Funding Program of Hunan Agricultural University; Collaborative Innovation Center for Field Weeds Control [ZCFKP20141203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest, P.R. China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Funds of Hunan Province; China Scholarship Council(China Scholarship Council); Shen-Nong Visiting Scholar Funding Program of Hunan Agricultural University; Collaborative Innovation Center for Field Weeds Control	This work was supported by a grant from the National Natural Science Foundation of China (Award #: 31672043, 21003042), the Special Fund for Agro-scientific Research in the Public Interest, P.R. China (Award #: 201303031), China Postdoctoral Science Foundation funded project (Award #: 2015M582329), Natural Science Funds of Hunan Province (Award #: 2018JJ2165), China Scholarship Council (File No. 201608430210), Shen-Nong Visiting Scholar Funding Program of Hunan Agricultural University, and Collaborative Innovation Center for Field Weeds Control (ZCFKP20141203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2011, J ENVIRON MANAGE, V92, P311, DOI 10.1016/j.jenvman.2010.08.028; Amano T, 2010, SCI TOTAL ENVIRON, V408, P480, DOI 10.1016/j.scitotenv.2009.10.037; [Anonymous], 2013, AFR J BIOTECHNOL, DOI [10.5897/AJB12, DOI 10.5897/AJB12.2481, 10.5897/AJB12.2481]; Astiz M, 2013, TOXICOL APPL PHARM, V272, P263, DOI 10.1016/j.taap.2013.07.008; Bhatkhande DS, 2002, J CHEM TECHNOL BIOT, V77, P102, DOI 10.1002/jctb.532; BUDREAU CH, 1973, TOXICOL APPL PHARM, V26, P29, DOI 10.1016/0041-008X(73)90082-3; Buratti FA, 2007, TOXICOLOGY, V241, P33, DOI 10.1016/j.tox.2007.08.081; Charanpahari A, 2013, APPL SURF SCI, V282, P408, DOI 10.1016/j.apsusc.2013.05.144; Chen JQ, 2007, DESALINATION, V207, P87, DOI 10.1016/j.desal.2006.06.012; Chen JY, 2009, J APPL TOXICOL, V29, P330, DOI 10.1002/jat.1414; Chen XB, 2008, J AM CHEM SOC, V130, P5018, DOI 10.1021/ja711023z; DAUTERMAN WC, 1960, J AGR FOOD CHEM, V8, P115, DOI 10.1021/jf60108a013; DebMandal M, 2008, WORLD J MICROB BIOT, V24, P69, DOI 10.1007/s11274-007-9440-5; Dogan D, 2011, CHEMOSPHERE, V84, P39, DOI 10.1016/j.chemosphere.2011.02.087; Duan YM, 2010, BIOMATERIALS, V31, P894, DOI 10.1016/j.biomaterials.2009.10.003; Dunnill CW, 2011, DALTON T, V40, P1635, DOI 10.1039/c0dt00494d; Elahifard MR, 2007, J AM CHEM SOC, V129, P9552, DOI 10.1021/ja072492m; Evgenidou E, 2006, J HAZARD MATER, V137, P1056, DOI 10.1016/j.jhazmat.2006.03.042; Evgenidou E, 2005, J PHOTOCH PHOTOBIO A, V175, P29, DOI 10.1016/j.jphotochem.2005.04.021; Farag AT, 2007, REPROD TOXICOL, V23, P232, DOI 10.1016/j.reprotox.2006.12.003; FOX MA, 1990, TETRAHEDRON LETT, V31, P4533, DOI 10.1016/S0040-4039(00)97667-6; Ge YG, 2011, ENVIRON SCI TECHNOL, V45, P1659, DOI 10.1021/es103040t; Grisenti RE, 2000, PHYS REV LETT, V85, P2284, DOI 10.1103/PhysRevLett.85.2284; Kralj MB, 2007, WATER RES, V41, P4504, DOI 10.1016/j.watres.2007.06.016; Kristal AR, 2002, NUTR CANCER, V42, P1, DOI 10.1207/S15327914NC421_1; Larue C, 2014, J HAZARD MATER, V273, P17, DOI 10.1016/j.jhazmat.2014.03.014; Lee CM, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6924-y; Li R, 2010, INT BIODETER BIODEGR, V64, P51, DOI 10.1016/j.ibiod.2009.10.007; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Liu B, 2001, CHEMOSPHERE, V44, P1315, DOI 10.1016/S0045-6535(00)00506-3; Liu XY, 2015, J ENVIRON SCI HEAL B, V50, P331, DOI 10.1080/03601234.2015.1000177; Mahmoodzadeh H., 2013, J ORNAMENT PLANTS, V3, P25; Echavia GRM, 2009, CHEMOSPHERE, V76, P595, DOI 10.1016/j.chemosphere.2009.04.055; Miller RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030321, 10.1371/journal.pone.0033885]; Mishra YK, 2018, MATER TODAY, V21, P631, DOI 10.1016/j.mattod.2017.11.003; Nano-Plant Technology (NPL), 2002, METH ACC MET GROWTH, P1; Oller I, 2007, CATAL TODAY, V129, P69, DOI 10.1016/j.cattod.2007.06.055; Owolade O. F., 2008, Electronic Journal of Environmental, Agricultural and Food Chemistry, V7, P2942; OWolade Oluwaferanmi Fortune, 2008, Journal of Plant Protection Research, V48, P329, DOI 10.2478/v10045-008-0042-5; PARR RG, 1984, J AM CHEM SOC, V106, P4049, DOI 10.1021/ja00326a036; Priya DN, 2011, J HAZARD MATER, V195, P214, DOI 10.1016/j.jhazmat.2011.08.030; Sayim F, 2007, EXP TOXICOL PATHOL, V59, P237, DOI 10.1016/j.etp.2007.05.008; SENANAYAKE N, 1987, NEW ENGL J MED, V316, P761, DOI 10.1056/NEJM198703263161301; Serna-Galvis EA, 2016, SCI TOTAL ENVIRON, V541, P1431, DOI 10.1016/j.scitotenv.2015.10.029; Shang C, 2009, APPL CATAL B-ENVIRON, V89, P536, DOI 10.1016/j.apcatb.2009.01.020; Sharma Y, 2005, TOXICOLOGY, V206, P49, DOI 10.1016/j.tox.2004.06.062; Singh R. N., 2010, World Journal of Zoology, V5, P183; Sozer N, 2009, TRENDS BIOTECHNOL, V27, P82, DOI 10.1016/j.tibtech.2008.10.010; Sun XM, 2008, SCI TOTAL ENVIRON, V402, P123, DOI 10.1016/j.scitotenv.2008.04.038; Terry P, 2001, JAMA-J AM MED ASSOC, V285, P2975, DOI 10.1001/jama.285.23.2975; Tian F, 2014, CHEMOSPHERE, V103, P181, DOI 10.1016/j.chemosphere.2013.11.061; Tripathi KM, 2017, ACS SUSTAIN CHEM ENG, V5, P3982, DOI 10.1021/acssuschemeng.6b03182; Tripathi KM, 2017, ACS SUSTAIN CHEM ENG, V5, P2906, DOI 10.1021/acssuschemeng.6b01937; Tyagi A, 2016, RSC ADV, V6, P72423, DOI 10.1039/c6ra10488f; UCHIDA T, 1967, TOXICOL APPL PHARM, V10, P89, DOI 10.1016/0041-008X(67)90131-7; Undeger U, 2005, ARCH TOXICOL, V79, P169, DOI 10.1007/s00204-004-0616-6; Vidal A, 1999, APPL CATAL B-ENVIRON, V21, P259, DOI 10.1016/S0926-3373(99)00019-3; Xie JM, 2010, COLLOID SURFACE A, V372, P107, DOI 10.1016/j.colsurfa.2010.09.037; Yan ZQ, 2015, PLANT PHYSIOL BIOCH, V88, P53, DOI 10.1016/j.plaphy.2015.01.010; Zeng R, 2010, J RARE EARTH, V28, P353, DOI 10.1016/S1002-0721(10)60329-8; Zhang L, 2007, J HAZARD MATER, V149, P675, DOI 10.1016/j.jhazmat.2007.04.039; Zhang QZ, 2007, ENVIRON SCI TECHNOL, V41, P6109, DOI 10.1021/es0628001	62	4	5	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197560	10.1371/journal.pone.0197560	http://dx.doi.org/10.1371/journal.pone.0197560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771967	gold, Green Submitted, Green Published			2022-12-26	WOS:000432348900073
J	Akhtar, Z; Rishi, P; Srikanth, R; Rishi, E; Bhende, M; Raman, R				Akhtar, Zeeshan; Rishi, Pukhraj; Srikanth, Ramasubramanian; Rishi, Ekta; Bhende, Muna; Raman, Rajiv			Choroidal thickness in normal Indian subjects using Swept source optical coherence tomography	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; OCULAR PERFUSION-PRESSURE; HEALTHY JAPANESE SUBJECTS; SPECTRAL-DOMAIN; EYES; PROFILE	Aim To determine choroidal thickness in healthy Indian subjects using Swept source optical coherence tomography (SS-OCT). Methods In this prospective, observational, cross-sectional study; healthy Indian subjects (n=230) with no history of ocular and/or systemic disorders were enrolled in the study. Choroidal thickness was measured for 230 eyes using SS-OCT. Subjects were divided into six age groups. Main outcome measures were subfoveal choroidal thickness (SFCT) and macular choroidal thickness (MCT) up to 3 mm at 500-micron interval from the fovea was measured in eight different quadrants. Results The mean SFCT was 307 +/- 79 mu m and mean MCT was 285 +/- 75 mu m. No difference in the choroidal thickness was found among genders. Mean SFCT of the different age groups was 327 +/- 68 mu m (12-18 years), 364 +/- 70 mu m (18.1-30 years), 321 +/- 78 mu m (30.1-40 years), 304 +/- 79 mu m (40.1-50 years), 283 +/- 69 mu m (50.1-60 years) and 262 +/- 72 mu m (above 60 years; p<0.001; One way ANOVA). Mean macular choroidal thickness was 305 +/- 60 mu m, 342 +/- 61 mu m, 306 +/- 72 mu m, 282 +/- 79 mu m, 261 +/- 66 mu m, 238 +/- 68 mu m respectively (p<0.001; one way ANOVA). A significant weak negative correlation was found between age with SFCT (r=-0.368, p<0.001) and MCT (r=-0.40, p<0.001). No significant correlation was found with refractive error, axial length and ocular perfusion pressure. Conclusion This study showed that mean SFCT and MCT was 307 +/- 79 mu m and 285 +/- 75 mu m, respectively, among healthy Indian subjects. Mean CT was found to decrease with age, although there was no difference in CT between genders.	[Akhtar, Zeeshan; Rishi, Pukhraj; Rishi, Ekta; Bhende, Muna; Raman, Rajiv] Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India; [Akhtar, Zeeshan] Sankara Nethralaya, Elite Sch Optometry, Med Res Fdn, Madras, Tamil Nadu, India; [Akhtar, Zeeshan] Sankara Nethralaya, Srimathi Sundari Subramanian Dept Visual Psychoph, Madras, Tamil Nadu, India; [Srikanth, Ramasubramanian] Sankara Nethralaya, Sankara Nethralya Orbis Paediat Ophthalmol Learni, Madras, Tamil Nadu, India		Rishi, P (corresponding author), Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India.	docrishi@yahoo.co.in	Rishi, Pukhraj/AAZ-5296-2020; Raman, Rajiv/A-7234-2009	Raman, Rajiv/0000-0001-5842-0233; Bhende, Muna/0000-0002-9251-170X; Rishi, Pukhraj/0000-0001-5615-7734				Agawa T, 2011, GRAEF ARCH CLIN EXP, V249, P1485, DOI 10.1007/s00417-011-1708-7; Chhablani J, 2014, INDIAN J OPHTHALMOL, V62, P1060, DOI 10.4103/0301-4738.146711; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Copete S, 2014, BRIT J OPHTHALMOL, V98, P334, DOI 10.1136/bjophthalmol-2013-303904; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Esmaeelpour M, 2012, INVEST OPHTH VIS SCI, V53, P6803, DOI 10.1167/iovs.12-10314; Fong AHC, 2011, RETINA-J RET VIT DIS, V31, P502, DOI 10.1097/IAE.0b013e3182083beb; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Hamzah F, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-145; Hirata M, 2011, INVEST OPHTH VIS SCI, V52, P4971, DOI 10.1167/iovs.11-7729; Ho M, 2013, OPHTHALMOLOGY, V120, P1909, DOI 10.1016/j.ophtha.2013.02.005; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Kim M, 2012, INVEST OPHTH VIS SCI, V53, P7710, DOI 10.1167/iovs.12-10464; Li XQ, 2011, INVEST OPHTH VIS SCI, V52, P8438, DOI 10.1167/iovs.11-8108; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; Maruko I, 2010, OPHTHALMOLOGY, V117, P1792, DOI 10.1016/j.ophtha.2010.01.023; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Rishi P, 2013, EYE, V27, P1038, DOI 10.1038/eye.2013.106; Ruiz-Medrano J, 2014, INVEST OPHTH VIS SCI, V55, P3532, DOI 10.1167/iovs.14-13868; Ruiz-Moreno JM, 2013, INVEST OPHTH VIS SCI, V54, P353, DOI 10.1167/iovs.12-10863; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Wei WB, 2013, OPHTHALMOLOGY, V120, P175, DOI 10.1016/j.ophtha.2012.07.048	24	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197457	10.1371/journal.pone.0197457	http://dx.doi.org/10.1371/journal.pone.0197457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768485	Green Submitted, gold, Green Published			2022-12-26	WOS:000432329200084
J	Castillo, H; Li, XP; Schilkey, F; Smith, GB				Castillo, Hugo; Li, Xiaoping; Schilkey, Faye; Smith, Geoffrey B.			Transcriptome analysis reveals a stress response of Shewanella oneidensis deprived of background levels of ionizing radiation	PLOS ONE			English	Article							GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; DEINOCOCCUS-RADIODURANS; OXIDATIVE STRESS; OUTER-MEMBRANE; PROTEIN; GROWTH; MECHANISMS; RIBOSOME; EXPOSURE	Natural ionizing background radiation has exerted a constant pressure on organisms since the first forms of life appeared on Earth, so that cells have developed molecular mechanisms to avoid or repair damages caused directly by radiation or indirectly by radiation-induced reactive oxygen species (ROS). In the present study, we investigated the transcriptional effect of depriving Shewanella oneidensis cultures of background levels of radiation by growing the cells in a mine 655 m underground, thus reducing the dose rate from 72.1 to 0.9 nGy h(-1) from control to treatment, respectively. RNASeq transcriptome analysis showed the differential expression of 4.6 and 7.6% of the S. oneidensis genome during early- and late-exponential phases of growth, respectively. The greatest change observed in the treatment was the downregulation of ribosomal proteins (21% of all annotated ribosomal protein genes during early- and 14% during late-exponential) and tRNA genes (14% of all annotated tRNA genes in early-exponential), indicating a marked decrease in protein translation. Other significant changes were the upregulation of membrane transporters, implying an increase in the traffic of substrates across the cell membrane, as well as the up and downregulation of genes related to respiration, which could be interpreted as a response to insufficient oxidants in the cells. In other reports, there is evidence in multiple species that some ROS not just lead to oxidative stress, but act as signaling molecules to control cellular metabolism at the transcriptional level. Consistent with these reports, several genes involved in the metabolism of carbon and biosynthesis of amino acids were also regulated, lending support to the idea of a wide metabolic response. Our results indicate that S. oneidensis is sensitive to the withdrawal of background levels of ionizing radiation and suggest that a transcriptional response is required to maintain homeostasis and retain normal growth.	[Castillo, Hugo; Smith, Geoffrey B.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Li, Xiaoping] Oregon State Univ, Dept Bot & Plant Pathol, Hermiston, OR USA; [Schilkey, Faye] Natl Ctr Genome Resources, Santa Fe, NM USA	New Mexico State University; Oregon State University; National Center for Genome Resources (NCGR)	Castillo, H (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	hac141@nmsu.edu	Li, Xiaoping/AFQ-6148-2022	Li, Xiaoping/0000-0003-1288-6438	Department of Energy Office of Environmental Management [DE-EM0002423]	Department of Energy Office of Environmental Management	This work was supported by Department of Energy Office of Environmental Management, award #DE-EM0002423. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agafonov DE, 2001, EMBO REP, V2, P399; Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; AHMED M, 1995, J BACTERIOL, V177, P3904, DOI 10.1128/jb.177.14.3904-3910.1995; Aoki H, 2008, FEBS J, V275, P671, DOI 10.1111/j.1742-4658.2007.06228.x; Benz R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143557; Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Bosdriesz E, 2015, FEBS J, V282, P2029, DOI 10.1111/febs.13258; Brown SD, 2006, MOL CELL PROTEOMICS, V5, P1054, DOI 10.1074/mcp.M500394-MCP200; Cabello-Villegas J, 2005, NUCLEIC ACIDS RES, V33, P6961, DOI 10.1093/nar/gki1004; Castillo H, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00177; Castillo H, 2015, INT J RADIAT BIOL, V91, P749, DOI 10.3109/09553002.2015.1062571; Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Djokic T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15263; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; El Azzam, 2001, P NATL ACAD SCI USA, V98, P473, DOI [10.1073/pnas.011417098, DOI 10.1073/PNAS.011417098D:11149936]; Esch EI, 2005, NUCL INSTRUM METH A, V538, P516, DOI 10.1016/j.nima.2004.09.005; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Fratini E, 2015, RADIAT ENVIRON BIOPH, V54, P183, DOI 10.1007/s00411-015-0587-4; Fu XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096001; Gao HC, 2010, MICROB BIOTECHNOL, V3, P455, DOI 10.1111/j.1751-7915.2010.00181.x; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Gao WM, 2005, BIOELECTROMAGNETICS, V26, P558, DOI 10.1002/bem.20133; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; GIBERT I, 1990, FEMS MICROBIOL LETT, V68, P307, DOI 10.1016/S0378-1097(05)80059-X; Gorgoni B, 2016, NUCLEIC ACIDS RES, V44, P9231, DOI 10.1093/nar/gkw630; HAMEL E, 1972, J BIOL CHEM, V247, P805; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075610; Kawanishi M, 2012, J RADIAT RES, V53, P404, DOI 10.1269/jrr.11145; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; Kendall GM, 2013, LEUKEMIA, V27, P3, DOI 10.1038/leu.2012.151; Kim HW, 2016, APPL ENVIRON MICROB, V82, P2893, DOI 10.1128/AEM.00050-16; Lampe N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166364; Le CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep26828; Leaphart AB, 2006, J BACTERIOL, V188, P1633, DOI 10.1128/JB.188.4.1633-1642.2006; Lee SJ, 2004, MOL CELL, V14, P153, DOI 10.1016/S1097-2765(04)00202-3; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; Magoc T., 2011, EVOL BIOINFORM ONLIN, V9, P127; Marritt SJ, 2012, BIOCHEM J, V444, P465, DOI 10.1042/BJ20120197; Mc Laughlin JP, 2015, RADIAT PROT DOSIM, V167, P2, DOI 10.1093/rpd/ncv206; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; National Council on Radiation Protection and Measurements, 1987, 93 NAT COUNC RAD PRO; NEWMAN EB, 1995, ANNU REV MICROBIOL, V49, P747, DOI 10.1146/annurev.mi.49.100195.003531; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; NILSSON L, 1994, J BIOL CHEM, V269, P9460; NILSSON L, 1992, J BACTERIOL, V174, P921, DOI 10.1128/jb.174.3.921-929.1992; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; PLANEL H, 1987, HEALTH PHYS, V52, P571, DOI 10.1097/00004032-198705000-00007; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; Qiu XY, 2005, PHOTOCHEM PHOTOBIOL, V81, P1559, DOI 10.1562/2005-04-15-RA-490; Qiu XY, 2005, J BACTERIOL, V187, P3556, DOI 10.1128/JB.187.10.3556-3564.2005; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; RUSSELL JB, 1995, MICROBIOL REV, V59, P48, DOI 10.1128/MMBR.59.1.48-62.1995; Satta L, 2002, RADIAT ENVIRON BIOPH, V41, P217, DOI 10.1007/s00411-002-0159-2; SATTA L, 1995, MUTAT RES LETT, V347, P129, DOI 10.1016/0165-7992(95)00031-3; Smith Geoffrey Battle, 2011, Health Phys, V100, P263, DOI 10.1097/HP.0b013e318208cd44; Smith JT, 2012, BIOL LETTERS, V8, P594, DOI 10.1098/rsbl.2012.0150; Sorensen MA, 1998, J MOL BIOL, V280, P561, DOI 10.1006/jmbi.1998.1909; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Sun Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167156; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Thorne MC, 2003, J RADIOL PROT, V23, P29, DOI 10.1088/0952-4746/23/1/302; VANDERMEIDE PH, 1983, EUR J BIOCHEM, V130, P397; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; Zhong JY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005302	75	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196472	10.1371/journal.pone.0196472	http://dx.doi.org/10.1371/journal.pone.0196472			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768440	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200029
J	Depra, GD; da Graca, WJ; Pavanelli, CS; Avelino, GS; Oliveira, C				Depra, Gabriel de Carvalho; da Graca, Weferson Junio; Pavanelli, Carla Simone; Avelino, Gleisy Semencio; Oliveira, Claudio			Molecular phylogeny of Planaltina Bohlke (Characidae: Stevardiinae) and comments on the definition and geographic distribution of the genus, with description of a new species	PLOS ONE			English	Article							UPPER RIO-PARANA; CHARACIFORMES; TELEOSTEI; FISHES; OSTARIOPHYSI; RIVER	A molecular phylogeny of Planaltina, including the three previously described species and an undescribed species, is presented. The monophyly of the genus, included in Diapomini, is strongly supported. Its sister group, the remaining Diapomini, includes only species without modified caudal-fin squamation in the present analysis (species of Diapoma with caudal organs were not sampled). Creagrutus is sister to Planaltina plus remaining Diapomini instead of Planaltina being sister to Creagrutus plus Diapomini, as a previous analysis had suggested. Species of Planaltina form two clades: P. britskii plus the new species, with low support (< 50%); and P. myersi plus P. glandipedis, with higher support. Planaltina is rediagnosed from all Characidae based on the morphology of the caudal organ, the absence of a humeral spot and the presence of a complete lateral line. Comments on the caudal-fin squamation of Diapoma and Lepidocharax burnsi, on the type-series of L. burnsi and on the geographic distribution of Planaltina and Lepidocharax species are provided. Finally, a formal description of the aforementioned new species and a novel identification key to Planaltina are presented.	[Depra, Gabriel de Carvalho; da Graca, Weferson Junio; Pavanelli, Carla Simone] Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil; [da Graca, Weferson Junio] Univ Estadual Maringa, Dept Biol, Maringa, Parana, Brazil; [da Graca, Weferson Junio; Pavanelli, Carla Simone] Univ Estadual Maringa, Nucleo Pesquisas Limnol Ictiol & Aquicultura, Maringa, Parana, Brazil; [Avelino, Gleisy Semencio; Oliveira, Claudio] Univ Estadual Paulista Julio de Mesquite Filho, Inst Biociencias, Dept Morfol, Botucatu, SP, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual Paulista	Depra, GD (corresponding author), Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil.	gabrieldepra@gmail.com	Pavanelli, Carla/G-6399-2012; Oliveira, Claudio/D-7713-2012; Graca, Weferson/D-8358-2013	Pavanelli, Carla/0000-0003-4059-984X; Oliveira, Claudio/0000-0002-7010-8880; Graca, Weferson/0000-0002-8925-5629; Depra, Gabriel/0000-0002-5520-9763	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/26508-3]; Fundacao Araucaria (Secretaria da Ciencia, Tecnologia e Ensino Superior do Parana) [471/2013, 36204]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Araucaria (Secretaria da Ciencia, Tecnologia e Ensino Superior do Parana)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA)	We thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, cnpq.br) for scholarship to GCD and grants to CSP and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www.fapesp.br) for providing grant (proc. 2014/26508-3) to CO. WJG is partially supported by a research grant from the Fundacao Araucaria (Secretaria da Ciencia, Tecnologia e Ensino Superior do Parana, www.fappr.pr.gov.br; covenant #471/2013, protocol #36204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz HSV, 2009, NEOTROP ICHTHYOL, V7, P185, DOI 10.1590/S1679-62252009000200008; Alves CBM, 2005, AM FISH S S, V45, P587; Araujo NB, 2009, NEOTROP ICHTHYOL, V7, P31, DOI 10.1590/S1679-62252009000100005; Arcila D, 2013, COPEIA, P604, DOI 10.1643/CI-13-009; Azpelicueta MD, 2003, REV SUISSE ZOOL, V110, P581, DOI 10.5962/bhl.part.80200; Baicere-Silva CM, 2011, NEOTROP ICHTHYOL, V9, P377, DOI 10.1590/S1679-62252011005000014; Baumgartner G., 2012, PEIXES BAIXO RIO IGU; Bohlke J., 1954, Stanford Ichthyological Bulletin, V4, P265; Britski Heraldo A., 1997, Papeis Avulsos de Zoologia (Sao Paulo), V40, P231; Burns JR, 1996, COPEIA, P627; Casciotta Jorge R., 2004, Ichthyological Exploration of Freshwaters, V15, P61; de Oliveira CLC, 2012, NEOTROP ICHTHYOL, V10, P349, DOI 10.1590/S1679-62252012005000005; Ferreira KM, 2011, NEOTROP ICHTHYOL, V9, P281, DOI 10.1590/S1679-62252011000200005; Frota Augusto, 2016, Check List, V12, P1995; Frota A, 2016, BIOTA NEOTROP, V16, DOI 10.1590/1676-0611-BN-2015-0151; Gery J., 1977, CHARACOIDS WORLD; Graca WJ, 2007, PEIXES PLANFCIE INUN; IBGE, 2010, BRAS DF; IBGE, 2010, PLAN GO; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Jerep Fernando C., 2006, Zootaxa, V1372, P53; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Langeani F, 2005, COPEIA, P386; Li CH, 2008, SYST BIOL, V57, P519, DOI 10.1080/10635150802206883; Magalhaes C, 1958, NOVO DISTRITO FEDERA; Malabarba Luiz R., 2000, Ichthyological Exploration of Freshwaters, V11, P315; Mirande JM, 2013, NEOTROP ICHTHYOL, V11, P747, DOI 10.1590/S1679-62252013000400003; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Mariguela TC, 2013, MOL PHYLOGENET EVOL, V68, P23, DOI 10.1016/j.ympev.2013.03.011; Menezes NA, 2003, P BIOL SOC WASH, V116, P557; Menezes Naércio A., 2011, Pap. Avulsos Zool., V51, P59; Miller M.A., 2010, P GAT COMP ENV WORKS; Netto-Ferreira AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052098; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Pavanelli Carla Simone, 2007, Check List, V3, P58; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Santos Udson, 2015, Check List, V11, P1507; Shibatta OA, 2002, BACIA RIO TIBAGI, P403; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tagliacollo VA, 2012, MOL PHYLOGENET EVOL, V64, P297, DOI 10.1016/j.ympev.2012.04.007; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teran GE, 2014, ACTA ZOOLOGICA, V96, P335; Thomaz AT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0403-4; Vari R. P., 2001, SMITHSONIAN CONTRIBU, V613, P1, DOI DOI 10.5479/SI.00810282.613; Weitzman Stanley H., 1998, P171; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Zawadzki Claudio Henrique, 2008, Zootaxa, V1757, P31	50	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196291	10.1371/journal.pone.0196291	http://dx.doi.org/10.1371/journal.pone.0196291			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768420	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200020
J	King, JR; Kabbani, N				King, Justin R.; Kabbani, Nadine			Alpha 7 nicotinic receptors attenuate neurite development through calcium activation of calpain at the growth cone	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; ACH RECEPTORS; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; PROTEIN; CELLS; OUTGROWTH; FILOPODIA; GUIDANCE; SPECTRIN	The alpha 7 nicotinic acetylcholine receptor ( nAChR) is a ligand-gated ion channel that plays an important role in cellular calcium signaling contributing to synaptic development and plasticity, and is a key drug target for the treatment of neurodegenerative conditions such as Alzheimer's disease. Here we show that alpha 7 nAChR mediated calcium signals in differentiating PC12 cells activate the proteolytic enzyme calpain leading to spectrin breakdown, microtubule retraction, and attenuation in neurite growth. Imaging in growth cones confirms that alpha 7 activation decreases EB3 comet motility in a calcium dependent manner as demonstrated by the ability of alpha 7 nAChR, ryanodine, or IP3 receptor antagonists to block the effect of alpha 7 nAChR on growth. alpha 7 nAChR mediated EB3 comet motility, spectrin breakdown, and neurite growth was also inhibited by the addition of the selective calpain blocker calpeptin and attenuated by the expression of an alpha 7 subunit unable to bind G alpha q and activate calcium store release. The findings indicate that alpha 7 nAChRs regulate cytoskeletal dynamics through local calcium signals for calpain protease activity.	[King, Justin R.; Kabbani, Nadine] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA	George Mason University	Kabbani, N (corresponding author), George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA.	nkabbani@gmu.edu			Virginia Foundation for Healthy Youth	Virginia Foundation for Healthy Youth	This work was funded in part through an award from the Virginia Foundation for Healthy Youth to Nadine Kabbani. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117; ALETTA JM, 1988, J NEUROSCI, V8, P1425; Baudry M, 2015, BRAIN RES, V1621, P73, DOI 10.1016/j.brainres.2014.11.033; Borodinsky Laura N, 2006, Sci STKE, V2006, ppe22, DOI 10.1126/stke.3362006pe22; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; CHAN J, 1993, NEUROSCIENCE, V56, P441, DOI 10.1016/0306-4522(93)90344-F; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Fayuk D, 2007, J PHYSIOL-LONDON, V582, P597, DOI 10.1113/jphysiol.2007.135319; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Gomez-Varela D, 2013, J NEUROSCI, V 33, P17062, DOI 10.1523/JNEUROSCI.1482-13.2013; Gu ZL, 2012, J NEUROSCI, V32, P12337, DOI 10.1523/JNEUROSCI.2129-12.2012; Halff AW, 2014, J NEUROSCI, V34, P2051, DOI 10.1523/JNEUROSCI.2795-13.2014; HALLORAN MC, 1994, J NEUROSCI, V14, P2161; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; Hou ST, 2008, INT REV CEL MOL BIO, V267, P125, DOI 10.1016/S1937-6448(08)00603-5; Hruska M, 2007, J NEUROSCI, V27, P11501, DOI 10.1523/JNEUROSCI.3057-07.2007; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; Kano Y, 2002, CELL STRUCT FUNCT, V27, P393, DOI 10.1247/csf.27.393; KATER SB, 1991, J NEUROSCI, V11, P891; Kelly TAN, 2010, J NEUROSCI RES, V88, P3024, DOI 10.1002/jnr.22478; Kerstein PC, 2017, J NEUROSCI, V37, P1568, DOI 10.1523/JNEUROSCI.2769-16.2016; King JR, 2018, MOL PHARM, DOI [10.1124/M06117.111401, DOI 10.1124/M06117.111401]; King JR, 2016, J NEUROCHEM, V138, P532, DOI 10.1111/jnc.13660; King JR, 2015, J BIOL CHEM, V290, P20060, DOI 10.1074/jbc.M115.647040; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Liu M, 2010, J NEUROSCI, V30, P14896, DOI 10.1523/JNEUROSCI.3739-10.2010; Meur AML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004334; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; Nery AA, 2010, J MOL NEUROSCI, V41, P329, DOI 10.1007/s12031-010-9369-2; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Nordman JC, 2014, FASEB J, V28, P2995, DOI 10.1096/fj.14-251439; Nordman JC, 2014, J NEUROCHEM, V129, P649, DOI 10.1111/jnc.12641; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Peng HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5342; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Pinter M, 1994, NEUROSCI LETT, P170; REHDER V, 1992, J NEUROSCI, V12, P3175, DOI 10.1523/JNEUROSCI.12-08-03175.1992; Ribas VT, 2017, MOL NEUROBIOL, V54, P72, DOI 10.1007/s12035-015-9676-2; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; SEGUELA P, 1993, J NEUROSCI, V13, P596; SEUBERT P, 1987, SYNAPSE, V1, P20, DOI 10.1002/syn.890010105; To KCW, 2007, MOL CELL NEUROSCI, V36, P425, DOI 10.1016/j.mcn.2007.08.001; Vaisid T, 2009, INT J BIOCHEM CELL B, V41, P2450, DOI 10.1016/j.biocel.2009.07.010; VARNUMFINNEY B, 1994, J CELL BIOL, V127, P1071, DOI 10.1083/jcb.127.4.1071; VERNINO S, 1994, J NEUROSCI, V14, P5514; Wang YB, 2016, NEUROBIOL DIS, V93, P121, DOI 10.1016/j.nbd.2016.05.007; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wen ZX, 2004, NEURON, V43, P835, DOI 10.1016/j.neuron.2004.08.037; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yakel JL, 2014, J PHYSIOL-LONDON, V592, P4147, DOI 10.1113/jphysiol.2014.273896; Yakel JL, 2013, PFLUG ARCH EUR J PHY, V465, P441, DOI 10.1007/s00424-012-1200-1; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z; Zhao HK, 2013, NEUROSCI LETT, V551, P12, DOI 10.1016/j.neulet.2013.06.026; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0; Zhong CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082719; Zhong LR, 2013, DEV NEUROBIOL, V73, P487, DOI 10.1002/dneu.22071	60	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197247	10.1371/journal.pone.0197247	http://dx.doi.org/10.1371/journal.pone.0197247			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768467	Green Submitted, gold, Green Published			2022-12-26	WOS:000432329200070
J	Yaylali, E; Farnham, PG; Cohen, S; Purcell, DW; Hauck, H; Sansom, SL				Yaylali, Emine; Farnham, Paul G.; Cohen, Stacy; Purcell, David W.; Hauck, Heather; Sansom, Stephanie L.			Optimal allocation of HIV prevention funds for state health departments	PLOS ONE			English	Article							CONCURRENT SEXUAL PARTNERSHIPS; BEHAVIORAL SURVEILLANCE SYSTEM; UNITED-STATES; COST-EFFECTIVENESS; MEDICATION ADHERENCE; TESTING BEHAVIORS; INFECTED PATIENTS; PERCEIVED HEALTH; RISK; TRANSMISSION	Objective To estimate the optimal allocation of Centers for Disease Control and Prevention (CDC) HIV prevention funds for health departments in 52 jurisdictions, incorporating Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS Program funds, to improve outcomes along the HIV care continuum and prevent infections. Methods Using surveillance data from 2010 to 2012 and budgetary data from 2012, we divided the 52 health departments into 5 groups varying by number of persons living with diagnosed HIV (PLWDH), median annual CDC HIV prevention budget, and median annual HRSA expenditures supporting linkage to care, retention in care, and adherence to antiretroviral therapy. Using an optimization and a Bernoulli process model, we solved for the optimal CDC prevention budget allocation for each health department group. The optimal allocation distributed the funds across prevention interventions and populations at risk for HIV to prevent the greatest number of new HIV cases annually. Results Both the HIV prevention interventions funded by the optimal allocation of CDC HIV prevention funds and the proportions of the budget allocated were similar across health department groups, particularly those representing the large majority of PLWDH. Consistently funded interventions included testing, partner services and linkage to care and interventions for men who have sex with men (MSM). Sensitivity analyses showed that the optimal allocation shifted when there were differences in transmission category proportions and progress along the HIV care continuum. Conclusion The robustness of the results suggests that most health departments can use these analyses to guide the investment of CDC HIV prevention funds into strategies to prevent the most new cases of HIV.	[Yaylali, Emine; Farnham, Paul G.; Purcell, David W.; Sansom, Stephanie L.] Ctr Dis Prevent & Control CDC, Natl Ctr HIV Viral Hepatitis STD & TB Prevent NCH, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Cohen, Stacy; Hauck, Heather] US Hlth Resources & Serv Adm, HIV AIDS Bur, Rockville, MD 20857 USA; [Yaylali, Emine] Istanbul Tech Univ, Dept Ind Engn, Istanbul, Turkey	United States Health Resources & Service Administration (HRSA); Istanbul Technical University	Yaylali, E (corresponding author), Ctr Dis Prevent & Control CDC, Natl Ctr HIV Viral Hepatitis STD & TB Prevent NCH, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.; Yaylali, E (corresponding author), Istanbul Tech Univ, Dept Ind Engn, Istanbul, Turkey.	emine.yaylali@gmail.com	Yaylali, Emine/S-6288-2016	Yaylali, Emine/0000-0002-6707-9521; Cohen, Stacy/0000-0002-0475-1122				Adimora AA, 2002, EPIDEMIOLOGY, V13, P320, DOI 10.1097/00001648-200205000-00013; Ahrens K, 2007, JAIDS-J ACQ IMM DEF, V46, P479, DOI 10.1097/QAI.0b013e3181594c61; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2011, ENHANCED COMPREHENSI; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Baggaley RF, 2006, AIDS, V20, P805, DOI 10.1097/01.aids.0000218543.46963.6d; Barnett PG, 2009, DRUG ALCOHOL DEPEN, V100, P115, DOI 10.1016/j.drugalcdep.2008.09.017; Begley E, 2012, PUBLIC HEALTH REP, V127, P432, DOI 10.1177/003335491212700411; Bohl DD, 2009, SEX TRANSM INFECT, V85, P367, DOI 10.1136/sti.2009.036723; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Centers for Disease Control and Prevention, 2012, DHAP HIV FUND AW STA; Centers for Disease Control and Prevention, 2012, HIV TEST CDC FUND SI; Centers for Disease Control and Prevention, 2012, 3 CDCP; Centers for Disease Control and Prevention, 2013, 2 CDCP; Centers for Disease Control and Prevention, 2015, HIV SURV REP 2013; Centers for Disease Control and Prevention, NCHHSTP ATL CTR DIS; Centers for Disease Control and Prevention, 2016, TRENDS US HIV DIAGN; Centers for Disease Control and Prevention (CDC), 2013, HIV SURV REP 2011; Centers for Disease Control and Prevention (CDC), 2014, HIV SURV REP 2012; Chandra A, 2011, SEXUAL BEHAV SEXUAL; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Control CfD, 2006, MMWR-MORBID MORTAL W, V57, P1073; Farnham PG, 2013, JAIDS-J ACQ IMM DEF, V64, P183, DOI 10.1097/QAI.0b013e3182973966; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Freedberg KA, 2006, JAIDS-J ACQ IMM DEF, V43, pS113, DOI 10.1097/01.qai.0000248334.52072.25; Gardner LI, 2005, AIDS, V19, P423, DOI 10.1097/01.aids.0000161772.51900.eb; Gardner LI, 2014, CLIN INFECT DIS, V59, P725, DOI 10.1093/cid/ciu357; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Health Resources and Services Administration, 2020, RYAN WHIT HIV AIDS P; Herbenick D, 2010, J SEX MED, V7, P277, DOI 10.1111/j.1743-6109.2010.02010.x; Jenness SM, 2011, SUBST USE MISUSE, V46, P192, DOI 10.3109/10826084.2011.521467; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Kalichman SC, 2001, AM J PREV MED, V21, P84, DOI 10.1016/S0749-3797(01)00324-5; KELLY JA, 1991, AM J PUBLIC HEALTH, V81, P168, DOI 10.2105/AJPH.81.2.168; Lin F, 2016, AM J PREV MED, V50, P699, DOI 10.1016/j.amepre.2016.01.011; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Metsch L, 2007, 2007 NAT HIV PREV C; Reece M, 2010, J SEX MED, V7, P266, DOI 10.1111/j.1743-6109.2010.02017.x; Reece M, 2010, J SEX MED, V7, P291, DOI 10.1111/j.1743-6109.2010.02009.x; Rotheram-Borus MJ, 2004, JAIDS-J ACQ IMM DEF, V37, pS68, DOI 10.1097/01.qai.0000140604.57478.67; Sabah State Health Department, 2021, HLTH FACTS SAB 2019; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2005, AIDS CARE, V17, P927, DOI 10.1080/09540120500100635; Shrestha RK, 2015, JAIDS-J ACQ IMM DEF, V68, P345, DOI 10.1097/QAI.0000000000000462; Shrestha RK, 2011, AIDS EDUC PREV, V23, P49, DOI 10.1521/aeap.2011.23.3_supp.49; Shrestha RK, 2011, METHODS ESTIMATING C; Shrestha RK, 2012, ESTIMATING COMPREHEN; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wilton L, 2009, AIDS BEHAV, V13, P532, DOI 10.1007/s10461-009-9529-y; Wingood GM, 2004, JAIDS-J ACQ IMM DEF, V37, pS58, DOI 10.1097/01.qai.0000140603.57478.a9; Yaylali E, 2015, J PUBLIC HLTH MANAGE	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197421	10.1371/journal.pone.0197421	http://dx.doi.org/10.1371/journal.pone.0197421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF9WG	29768489	gold, Green Published, Green Submitted			2022-12-26	WOS:000432329200082
J	Du, YJ; Taylor, CG; Aukema, HM; Zahradka, P				Du, Youjia; Taylor, Carla G.; Aukema, Harold M.; Zahradka, Peter			Importance of extracellular matrix and growth state for the EA.hy926 endothelial cell response to polyunsaturated fatty acids	PLOS ONE			English	Article							SUBSTRATE STIFFNESS; ARACHIDONIC-ACID; N-3 PUFA; APOPTOSIS; INFLAMMATION; EXPRESSION	Consumption of different PUFAs (polyunsaturated fatty acids) can induce functional changes in blood vessels via endothelial cells, which interact with dietary factors in the circulation. The basement membrane that separates the endothelium from the smooth muscle cells of the medial layer can also influence the functional state of endothelial cells. However, the effect of basement membrane on the endothelial response to dietary PUFAs in relation to growth state (e.g. proliferation versus quiescence) has never been investigated. We therefore compared the viability (CCK kit) and proliferation (bromodeoxyuridine incorporation) of EA.hy926 endothelial cells grown on Matrigel or collagen versus non-coated plates. EA.hy926 viability and proliferation were also assessed after treatment with 0-150 mu M of PUFAs [linoleic acid (LA), arachidonic acid (AA), alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)]. Our study showed that only cells grown on Matrigel-coated plates reached quiescence after becoming confluent with a decreased level of MCM2 and p-cyclin D1 (T286), increased levels of p27kip1 and a low level of apoptosis and senescence. AA, EPA and DHA decreased the viability and proliferation of subconfluent cells grown on plastic dishes in a dose-dependent manner, while the presence of Matrigel made the cells resistant to these adverse effects. Confluent cell viability was less sensitive to higher concentrations of AA, EPA and DHA than subconfluent cells, and a significant increase in caspase-3 cleavage was only observed in confluent cells treated with DHA. Higher concentrations of AA, EPA and DHA suppressed DNA synthesis by both subconfluent and confluent cells, while precursor C18 PUFAs (LA and ALA) had no negative effects on viability and proliferation. Our study is the first to show that extracellular matrix and growth state are important factors in the EA.hy926 cell response to PUFAs, and that the mechanisms by which individual PUFAs operate may be growth state-dependent.	[Du, Youjia; Taylor, Carla G.; Zahradka, Peter] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Du, Youjia; Taylor, Carla G.; Aukema, Harold M.; Zahradka, Peter] St Boniface Albrechtsen Res, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB, Canada; [Taylor, Carla G.; Aukema, Harold M.; Zahradka, Peter] Univ Manitoba, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Zahradka, P (corresponding author), Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada.; Zahradka, P (corresponding author), St Boniface Albrechtsen Res, Canadian Ctr Agri Food Res Hlth & Med, Winnipeg, MB, Canada.; Zahradka, P (corresponding author), Univ Manitoba, Dept Food & Human Nutr Sci, Winnipeg, MB, Canada.	peterz@sbrc.ca		Aukema, Harold/0000-0002-6982-7239; Taylor, Carla G./0000-0003-3358-6418	Canadian Institutes of Health Research [MOP311856]; University of Manitoba Graduate Enhancement of Tri-Council Stipends (GETS) program; Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Manitoba Graduate Enhancement of Tri-Council Stipends (GETS) program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research MOP311856 (http://www.cihr-irsc.gc.ca/e/193.html) to HMA and the University of Manitoba Graduate Enhancement of Tri-Council Stipends (GETS) program (https://umanitoba.ca/faculties/graduate_studies/media/GETSGuidelines2017.pdf) to YD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funds from the Canadian Institutes of Health Research. YD had scholarship funding from the University of Manitoba Graduate Enhancement of Tri-Council Stipends (GETS) program. The authors have no conflicts of interest to declare.	Abeywardena MY, 2001, CARDIOVASC RES, V52, P361, DOI 10.1016/S0008-6363(01)00406-0; Artwohl M, 2004, FASEB J, V18, P146, DOI 10.1096/fj.03-0301fje; Artwohl M, 2008, J LIPID RES, V49, P2627, DOI 10.1194/jlr.M800393-JLR200; Barre D E, 2016, Endocr Regul, V50, P183, DOI 10.1515/enr-2016-0020; Birukova AA, 2013, MICROVASC RES, V87, P50, DOI 10.1016/j.mvr.2012.12.006; Chao CY, 2014, J AGR FOOD CHEM, V62, P4152, DOI 10.1021/jf5007165; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; DeCaterina R, 1996, LIPIDS, V31, pS57, DOI 10.1007/BF02637052; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Gousset-Dupont A, 2007, PROSTAG LEUKOTR ESS, V76, P131, DOI 10.1016/j.plefa.2006.11.005; Haberka M, 2011, CLIN NUTR, V30, P79, DOI 10.1016/j.clnu.2010.07.011; HENNIG B, 1984, ARTERIOSCLEROSIS, V4, P489, DOI 10.1161/01.ATV.4.5.489; Kim HJ, 2005, J CELL PHYSIOL, V204, P881, DOI 10.1002/jcp.20351; Labbe SM, 2011, DIABETES, V60, P408, DOI 10.2337/db10-0997; Meerarani P, 2000, AM J CLIN NUTR, V71, P81; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Oh PC, 2014, INT J CARDIOL, V176, P696, DOI 10.1016/j.ijcard.2014.07.075; Pla AF, 2001, CELL CALCIUM, V30, P235, DOI 10.1054/ceca.2001.0234; Pla AF, 2008, MOL CANCER RES, V6, P535, DOI 10.1158/1541-7786.MCR-07-0271; Ros E, 2004, CIRCULATION, V109, P1609, DOI 10.1161/01.CIR.0000124477.91474.FF; Schiano V, 2008, CLIN NUTR, V27, P241, DOI 10.1016/j.clnu.2007.11.007; Shen JH, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-90; SPECTOR AA, 1980, J CLIN INVEST, V65, P1003, DOI 10.1172/JCI109752; Stroka KM, 2011, BLOOD, V118, P1632, DOI 10.1182/blood-2010-11-321125; Su JJ, 2015, CELL SIGNAL, V27, P47, DOI 10.1016/j.cellsig.2014.10.003; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Veszelka S, 2013, J ALZHEIMERS DIS, V36, P487, DOI 10.3233/JAD-120163; Yang YC, 2013, J NUTR BIOCHEM, V24, P204, DOI 10.1016/j.jnutbio.2012.05.003; Yeh YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046889; Zanetti M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/791978	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197613	10.1371/journal.pone.0197613	http://dx.doi.org/10.1371/journal.pone.0197613			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763471	Green Published, Green Submitted, gold			2022-12-26	WOS:000432118800056
J	Lemaire, JB; Ewashina, D; Polachek, AJ; Dixit, J; Yiu, V				Lemaire, Jane B.; Ewashina, Darby; Polachek, Alicia J.; Dixit, Jaya; Yiu, Verna			Understanding how patients perceive physician wellness and its links to patient care: A qualitative study	PLOS ONE			English	Article							WORK-LIFE BALANCE; JOB-SATISFACTION; BURNOUT; HEALTH; PRACTITIONERS; INTERVENTIONS; OUTCOMES; COMMUNICATION; METAANALYSIS; POPULATION	Despite increased interest in physician wellness, little is known about patients' views on the topic. We explore patients' perceptions of physician wellness and how it links to patient care. This exploratory, qualitative study employed semi-structured interviews with a convenience sample of 20 patients from outpatient care settings in a western Canadian city. Using inductive thematic analysis, interview transcripts were independently coded by two authors and then discussed to ensure consensus and to abstract into higher-level themes. Three overarching premises were identified. First, patients notice cues that they interpret as signs of physician wellness. These include overt indicators, such as a physician's demeanor or physical appearance, along with a general impression about a physician's wellness. Second, patients form judgments based on what they notice, and these judgments affect patients' views about their care; feelings, such as trust, in their interactions with physicians; and actions, such as following care plans. Third, participants perceive a bi-directional link between physician wellness and patient care. Physician wellness impacts patient care, but physician wellness is also impacted by the care they provide and the challenges they face within the healthcare system. Patients' judgments regarding physician wellness may have important impacts on the doctor-patient relationship. Furthermore, patients appear to have a nuanced understanding about how physicians' work may put physicians at risk for being unwell. Patients may be powerful allies in supporting physician wellness initiatives focused on the shared responsibility of individual physicians, the medical profession, and healthcare organizations.	[Lemaire, Jane B.] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada; [Lemaire, Jane B.; Polachek, Alicia J.] Univ Calgary, Res & Innovat Ctr W21C, Cumming Sch Med, Calgary, AB, Canada; [Ewashina, Darby] Univ Calgary, Cumming Sch Med, Dept Psychiat, Calgary, AB, Canada; [Dixit, Jaya] Univ Calgary, Calgary, AB, Canada; [Yiu, Verna] Alberta Hlth Serv, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS)	Lemaire, JB (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada.; Lemaire, JB (corresponding author), Univ Calgary, Res & Innovat Ctr W21C, Cumming Sch Med, Calgary, AB, Canada.	lemaire@ucalgary.ca			Alberta Health Services	Alberta Health Services	Alberta Health Services (https://www.albertahealthservices.ca) provided funding for this research to the corresponding author. A member of Alberta Health Services (VY) was involved in the study by providing feedback on the study design and interpretation of the data. She was not involved in recruitment, data collection, or analysis of the raw data, but did review the paper and contribute to the decision to approve publication of the finished manuscript. The W21C Research and Innovation Center (www.w21c.org), University of Calgary provided in-kind support in the form of salaries, space, and administrative oversight for research staff involved in the project. The W21C had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Baldisseri MR, 2007, CRIT CARE MED, V35, pS106, DOI 10.1097/01.CCM.0000252918.87746.96; Berg B.L., 2012, QUALITATIVE RES METH, V8th; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Bryson EO, 2008, ANESTHESIOLOGY, V109, P905, DOI 10.1097/ALN.0b013e3181895bc1; Center C, 2003, JAMA-J AM MED ASSOC, V289, P3161, DOI 10.1001/jama.289.23.3161; Cornuz J, 2000, FAM PRACT, V17, P535, DOI 10.1093/fampra/17.6.535; Cruess RL, 2008, PERSPECT BIOL MED, V51, P579, DOI 10.1353/pbm.0.0045; De Vries AMM, 2014, PSYCHO-ONCOLOGY, V23, P375, DOI 10.1002/pon.3445; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Frank E, 2000, ARCH FAM MED, V9, P287, DOI 10.1001/archfami.9.3.287; Frank E, 2009, CAN FAM PHYSICIAN, V55; Frank E, 2013, CAN MED ASSOC J, V185, P649, DOI 10.1503/cmaj.121028; Goehring C, 2005, SWISS MED WKLY, V135, P101; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Halbesleben JRB, 2008, HEALTH CARE MANAGE R, V33, P29, DOI 10.1097/01.HMR.0000304493.87898.72; Hawton K, 2001, J EPIDEMIOL COMMUN H, V55, P296, DOI 10.1136/jech.55.5.296; Howe LC, 2017, J PERS SOC PSYCHOL, V112, P718, DOI 10.1037/pspi0000085; Lafreniere JP, 2016, J GEN INTERN MED, V31, P203, DOI 10.1007/s11606-015-3503-3; Lemaire JB, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3360; Lemaire JB, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-18; Linzer M, 2015, J GEN INTERN MED, V30, P1105, DOI 10.1007/s11606-015-3235-4; Panagioti M, 2017, JAMA INTERN MED, V177, P195, DOI 10.1001/jamainternmed.2016.7674; Perez HR, 2017, J HEALTHC QUAL, V39, P43, DOI 10.1097/JHQ.0000000000000016; Puhl RM, 2013, INT J OBESITY, V37, P1415, DOI 10.1038/ijo.2013.33; Ratanawongsa N, 2008, J GEN INTERN MED, V23, P1581, DOI 10.1007/s11606-008-0702-1; Sandelowski M, 1995, RES NURSING HLTH, V18; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Shanafelt TD, 2011, ARCH SURG-CHICAGO, V146, P54, DOI 10.1001/archsurg.2010.292; Tavakol M, 2014, MED TEACH, V36, P838, DOI 10.3109/0142159X.2014.915297; Thommasen HV, 2001, CAN FAM PHYSICIAN, V47, P737; Thompson WT, 2001, BRIT MED J, V323, P728, DOI 10.1136/bmj.323.7315.728; UALLACHAIN GN, 2008, IRISH MED J, V100, P489; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; Williams ES, 2007, HEALTH CARE MANAGE R, V32, P203, DOI 10.1097/01.HMR.0000281626.28363.59; Williams ES, 2003, HEALTH CARE MANAGE R, V28, P119, DOI 10.1097/00004010-200304000-00004	38	15	15	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196888	10.1371/journal.pone.0196888	http://dx.doi.org/10.1371/journal.pone.0196888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF7AA	29763443	gold, Green Published, Green Submitted			2022-12-26	WOS:000432118800017
J	Li, RR; Kowalski, PS; Morselt, HWM; Schepel, I; Jongman, RM; Aslan, A; Ruiters, MHJ; Zijlstra, JG; Molema, G; van Meurs, M; Kamps, JAAM				Li, Ranran; Kowalski, Piotr S.; Morselt, Henriette W. M.; Schepel, Ilona; Jongman, Rianne M.; Aslan, Adnan; Ruiters, Marcel H. J.; Zijlstra, Jan G.; Molema, Grietje; van Meurs, Matijs; Kamps, Jan A. A. M.			Endothelium-targeted delivery of dexamethasone by anti-VCAM-1 SAINT-O-Somes in mouse endotoxemia	PLOS ONE			English	Article							NF-KAPPA-B; SEPTIC SHOCK; SEPSIS; CELLS; SIRNA; GLUCOCORTICOSTEROIDS; HYDROCORTISONE; INFLAMMATION; MORTALITY; LIPOSOMES	Microvascular endothelial cells play a pivotal role in the pathogenesis of sepsis-induced inflammatory responses and multiple organ failure. Therefore, they represent an important target for pharmacological intervention in the treatment of sepsis. Glucocorticosteroids were widely used in the treatment of sepsis but vast evidence to support their systemic use is lacking. The limited effects of glucocorticoids in the treatment of sepsis may be explained by differential effects of drug initiated NF-kappa B inhibition in different cell types and insufficient drug delivery in target cells. The current study aimed therefore to investigate the effects of an endothelial targeted delivery of dexamethasone in a mouse model of endotoxemia induced by two consecutive i.p. injections of lipopolysaccharide (LPS). To achieve endothelial cell specific delivery of dexamethasone, we modified SAINT-O-Somes, a new generation of liposomes that contain the cationic amphiphile SAINT-C18 (1-methyl-4-(cis-9-dioleyl) methyl-pyridinium chloride, with antibodies against vascular cell adhesion molecule-1 (VCAM-1). In LPS challenged mice, the systemic administration of free dexamethasone had negligible effects on the microvascular inflammatory endothelial responses. Dexamethasone-loaded anti-VCAM-1 SAINT-O-Somes specifically localized at VCAM-1 expressing endothelial cells in the microvasculature of inflamed organs. This was associated with a marginal attenuation of the expression of a few pro-inflammatory genes in kidney and liver, while no effects in the lung were observed. This study reveals that, although local accumulation of the targeted drug was achieved, endothelial targeted dexamethasone containing anti-VCAM-1 SAINT-O-Somes exhibited marginal effects on inflammatory endothelial cell activation in a model of endotoxemia. Studies with more potent drugs encapsulated into anti-VCAM-1 SAINT-O-Somes will in the future reveal whether this delivery system can be further developed for efficacious endothelial directed delivery of drugs in the treatment of sepsis.	[Li, Ranran; Kowalski, Piotr S.; Morselt, Henriette W. M.; Schepel, Ilona; Jongman, Rianne M.; Aslan, Adnan; Ruiters, Marcel H. J.; Molema, Grietje; van Meurs, Matijs; Kamps, Jan A. A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect,Lab Endothelial Biomed & Vasc Drug, Groningen, Netherlands; [Jongman, Rianne M.; Aslan, Adnan; Zijlstra, Jan G.; van Meurs, Matijs] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands; [Jongman, Rianne M.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Kamps, JAAM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect,Lab Endothelial Biomed & Vasc Drug, Groningen, Netherlands.	j.a.a.m.kamps@umcg.nl	Li, Ranran/N-1948-2015; Kowalski, Piotr/AAF-7450-2021; Zijlstra, Jan/E-6782-2011	Kowalski, Piotr/0000-0001-8607-0189; Zijlstra, Jan/0000-0001-9079-0795; Molema, Grietje/0000-0002-4147-6676	Top Institute Pharma (TI Pharma project, The Netherlands) [D5-301]; University Medical Center Groningen, The Netherlands	Top Institute Pharma (TI Pharma project, The Netherlands); University Medical Center Groningen, The Netherlands(Netherlands Government)	This work was funded by the Top Institute Pharma (TI Pharma project D5-301, The Netherlands) and the University Medical Center Groningen, The Netherlands.	Adrian JE, 2010, J CONTROL RELEASE, V144, P341, DOI 10.1016/j.jconrel.2010.03.003; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-7; Asgeirdottir SA, 2008, AM J PHYSIOL-RENAL, V294, pF554, DOI 10.1152/ajprenal.00391.2007; Asgeirsdottir SA, 2012, AM J PHYSIOL-RENAL, V302, pF1630, DOI 10.1152/ajprenal.00400.2011; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Choi M, 2017, J AM SOC NEPHROL, V28, P3190, DOI 10.1681/ASN.2016060690; Howard MD, 2014, ANNU REV PHARMACOL, V54, P205, DOI 10.1146/annurev-pharmtox-011613-140002; KAMPS JAA, 2007, LIPOSOME TECHNOLOGY, V3, P127; Kamps JAAM, 1997, P NATL ACAD SCI USA, V94, P11681, DOI 10.1073/pnas.94.21.11681; Kowalski PS, 2014, J CONTROL RELEASE, V176, P64, DOI 10.1016/j.jconrel.2013.12.029; Kowalski PS, 2013, MOL PHARMACEUT, V10, P3033, DOI 10.1021/mp4001124; Kowalski PS, 2011, IUBMB LIFE, V63, P648, DOI 10.1002/iub.487; Marik PE, 2009, CHEST, V135, P181, DOI 10.1378/chest.08-1149; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; van Meurs M, 2008, SHOCK, V29, P291, DOI 10.1097/shk.0b013e318145a7c1; van Meurs M, 2011, ANESTHESIOLOGY, V115, P474, DOI 10.1097/ALN.0b013e318229a640; Volbeda M, 2015, INTENS CARE MED, V41, P1220, DOI 10.1007/s00134-015-3899-6; Xu C, 2014, KIDNEY INT, V85, P72, DOI 10.1038/ki.2013.286; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393	24	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196976	10.1371/journal.pone.0196976	http://dx.doi.org/10.1371/journal.pone.0196976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763440	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800021
J	Polycarpou-Schwarz, M; Gross, M; Mestdagh, P; Schott, J; Grund, SE; Hildenbrand, C; Rom, J; Aulmann, S; Sinn, HP; Vandesompele, J; Diederichs, S				Polycarpou-Schwarz, Maria; Gross, Matthias; Mestdagh, Pieter; Schott, Johanna; Grund, Stefanie E.; Hildenbrand, Catherina; Rom, Joachim; Aulmann, Sebastian; Sinn, Hans-Peter; Vandesompele, Jo; Diederichs, Sven			The cancer-associated microprotein CASIMO1 controls cell proliferation and interacts with squalene epoxidase modulating lipid droplet formation	ONCOGENE			English	Article							RIBOSOME PROFILING REVEALS; MEVALONATE PATHWAY; CHOLESTEROL-SYNTHESIS; MOLECULAR PORTRAITS; RNA; ACTIN; PEPTIDES; TRANSLATION; EXPRESSION; DISCOVERY	Breast cancer is a leading cause of cancer-related death in women. Small open reading frame (sORF)-encoded proteins or microproteins constitute a new class of molecules often transcribed from presumed long non-coding RNA transcripts (lncRNAs). The translation of some of these sORFs has been confirmed, but their cellular function and importance remains largely unknown. Here, we report the identification and characterization of a novel microprotein of 10 kDa, which we named Cancer-Associated Small Integral Membrane Open reading frame 1 (CASIMO1). CASIMO1 RNA is overexpressed predominantly in hormone receptor-positive breast tumors. Its knockdown leads to decreased proliferation in multiple breast cancer cell lines. Its loss disturbs the organization of the actin cytoskeleton, leads to inhibition of cell motility, and causes a G(0)/G(1) cell cycle arrest. The proliferation phenotype upon overexpression is observed only with CASIMO1 protein expression, but not with a non-translatable mutant attributing the effects to the sORF-derived protein rather than a lncRNA function. CASIMO1 microprotein interacts with squalene epoxidase (SQLE), a key enzyme in cholesterol synthesis and a known oncogene in breast cancer. Overexpression of CASIMO1 leads to SQLE protein accumulation without affecting its RNA levels and increased lipid droplet clustering, while knockdown of CASIMO1 decreased SQLE protein abundance and ERK phosphorylation downstream of SQLE. Importantly, SQLE knockdown mimicked the CASIMO1 knockdown phenotype and in turn SQLE overexpression fully rescued the effect of CASIMO1 knockdown. These findings establish CASIMO1 as the first functional microprotein that plays a role in carcinogenesis and is implicated in the cell lipid homeostasis.z	[Polycarpou-Schwarz, Maria; Gross, Matthias; Grund, Stefanie E.; Hildenbrand, Catherina; Diederichs, Sven] German Canc Res Ctr, Div RNA Biol & Canc, Heidelberg, Germany; [Polycarpou-Schwarz, Maria; Gross, Matthias; Aulmann, Sebastian; Sinn, Hans-Peter; Diederichs, Sven] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany; [Mestdagh, Pieter; Vandesompele, Jo] Ghent Univ Belgium, Ctr Med Genet, Ghent, Belgium; [Mestdagh, Pieter; Vandesompele, Jo] Ghent Univ Belgium, CRIG, Ghent, Belgium; [Schott, Johanna] Heidelberg Univ, Div Biochem 1, Ctr Biomed & Med Technol Mannheim CBTM, Med Fac Mannheim, Mannheim, Germany; [Schott, Johanna] Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Mannheim, Germany; [Rom, Joachim] Univ Hosp Heidelberg, Dept Obstet & Gynecol, Heidelberg, Germany; [Diederichs, Sven] Univ Freiburg, Div Canc Res, Dept Thorac Surg, Med Ctr, Freiburg, Germany; [Diederichs, Sven] Univ Freiburg, Fac Med, Freiburg, Germany; [Diederichs, Sven] German Canc Consortium DKTK, Partner Site Freiburg, Freiburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ghent University; Ghent University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Freiburg; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ)	Diederichs, S (corresponding author), German Canc Res Ctr, Div RNA Biol & Canc, Heidelberg, Germany.; Diederichs, S (corresponding author), Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany.; Diederichs, S (corresponding author), Univ Freiburg, Div Canc Res, Dept Thorac Surg, Med Ctr, Freiburg, Germany.; Diederichs, S (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.; Diederichs, S (corresponding author), German Canc Consortium DKTK, Partner Site Freiburg, Freiburg, Germany.	s.diederichs@dkfz.de	Sinn, Hans-Peter/C-5661-2008; Vandesompele, Jo/W-3411-2018; Diederichs, Sven/J-6237-2012	Sinn, Hans-Peter/0000-0003-2836-6699; Vandesompele, Jo/0000-0001-6274-0184; Gross, Matthias/0000-0003-0449-1591; Diederichs, Sven/0000-0001-7901-4752; Polycarpou-Schwarz, Maria/0000-0002-9125-6460; Mestdagh, Pieter/0000-0001-7821-9684	German Research Foundation [DFG Di 1421/7-1]; RNA@DKFZ Cross Program Topic	German Research Foundation(German Research Foundation (DFG)); RNA@DKFZ Cross Program Topic	We thank Drs. K. Boulay and A. Roth for helpful discussions and suggestions and for critical reading of the manuscript, S. Wiemann for helpful discussions, L. Chatel-Chaix (University of Heidelberg) and R. Pepperkok (EMBL Heidelberg) for antibodies and suggestions, V. Benes, T. Ivacevic, and S. Schmidt (EMBL Heidelberg, Genome Core Facility) for support with microarray performance and the DKFZ Light Microscopy and Flow Cytometry Core Facilities and the ZMBH Flow Cytometry & FACS Core Facility (University of Heidelberg) for technical support. Research in the Diederichs lab is supported by the German Research Foundation (DFG Di 1421/7-1) and the RNA@DKFZ Cross Program Topic. This work is part of the Ph.D. thesis of M.P.-S.	Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Bhattacharyya S, 2009, CLIN EXP METASTAS, V26, P535, DOI 10.1007/s10585-009-9253-z; Bi P, 2017, SCIENCE, V356, P323, DOI 10.1126/science.aam9361; Brar GA, 2015, NAT REV MOL CELL BIO, V16, P651, DOI 10.1038/nrm4069; Brown DN, 2016, SCI REP-UK, V6, DOI 10.1038/srep19435; Cabrera-Quio LE, 2016, RNA BIOL, V13, P1051, DOI 10.1080/15476286.2016.1218589; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chu Q, 2017, BIOCHEMISTRY-US, V56, P3299, DOI 10.1021/acs.biochem.7b00265; Couso JP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0765-3; Couso JP, 2017, NAT REV MOL CELL BIO, V18, P575, DOI 10.1038/nrm.2017.58; D'Lima NG, 2017, NAT CHEM BIOL, V13, P174, DOI [10.1038/NCHEMBIO.2249, 10.1038/nchembio.2249]; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gachet Y, 2001, NATURE, V412, P352, DOI 10.1038/35085604; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Gutschner T, 2011, GENOME RES, V21, P1944, DOI 10.1101/gr.122358.111; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hannus M, 2014, NUCLEIC ACIDS RES, V42, P8049, DOI 10.1093/nar/gku480; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Helms MW, 2008, BRIT J CANCER, V99, P774, DOI 10.1038/sj.bjc.6604556; Housman G, 2016, BBA-GENE REGUL MECH, V1859, P31, DOI 10.1016/j.bbagrm.2015.07.017; Inder KL, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012245; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Lambrechts A, 2004, INT J BIOCHEM CELL B, V36, P1890, DOI 10.1016/j.biocel.2004.01.024; Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009; Lee KG, 2007, CELL CYCLE, V6, P1487; Leucci E, 2016, NATURE, V531, P518, DOI 10.1038/nature17161; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Lluch-Senar M, 2015, MOL SYST BIOL, V11; Ma J, 2014, J PROTEOME RES, V13, P1757, DOI 10.1021/pr401280w; Mackowiak SD, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0742-x; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Miettinen TP, 2015, CELL REP, V13, P2610, DOI 10.1016/j.celrep.2015.11.045; Mullen PJ, 2016, NAT REV CANCER, V16, P718, DOI 10.1038/nrc.2016.76; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; RYDER NS, 1992, BRIT J DERMATOL, V126, P2, DOI 10.1111/j.1365-2133.1992.tb00001.x; RYDER NS, 1985, BIOCHEM J, V230, P765, DOI 10.1042/bj2300765; Saghatelianr A, 2015, NAT CHEM BIOL, V11, P909, DOI 10.1038/nchembio.1964; Schmid I., 2001, CURR PROTOC CYTOM; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Simigdala N, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0713-5; Skibinski A, 2015, ONCOGENE, V34, P5309, DOI 10.1038/onc.2014.475; Slavoff SA, 2014, J BIOL CHEM, V289, P10950, DOI 10.1074/jbc.C113.533968; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Sleator RD, 2010, GENE, V461, P1, DOI 10.1016/j.gene.2010.04.008; Staudt AC, 2011, EMBO REP, V12, P35, DOI 10.1038/embor.2010.196; Stevenson J, 2014, BIOCHEM J, V461, P435, DOI 10.1042/BJ20131404; Sui ZH, 2015, TUMOR BIOL, V36, P6173, DOI 10.1007/s13277-015-3301-x; Ta MT, 2012, FEBS J, V279, P4231, DOI 10.1111/febs.12015; Thurnher M, 2012, CLIN CANCER RES, V18, P3524, DOI 10.1158/1078-0432.CCR-12-0489; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; Zhang HY, 2014, THORAC CANCER, V5, P275, DOI 10.1111/1759-7714.12087; Zhang Q, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15664	69	74	78	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 23	2018	37	34					4750	4768		10.1038/s41388-018-0281-5	http://dx.doi.org/10.1038/s41388-018-0281-5			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GR3SE	29765154				2022-12-26	WOS:000442514400009
J	Balasuriya, N; Kunkel, MT; Liu, XG; Biggar, KK; Li, SSC; Newton, AC; O'Donoghue, P				Balasuriya, Nileeka; Kunkel, Maya T.; Liu, Xuguang; Biggar, Kyle K.; Li, Shawn S. -C.; Newton, Alexandra C.; O'Donoghue, Patrick			Genetic code expansion and live cell imaging reveal that Thr-308 phosphorylation is irreplaceable and sufficient for Akt1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; protein kinase B (PKB); protein phosphorylation; cell biology; cell signaling; enzyme; aminoacyl tRNA synthetase; transfer RNA (tRNA); genetic code expansion; phosphomimetics; phosphoseryl-tRNA synthetase (SepRS); tRNASep; activation loop; hydrophobic motif	PROTEIN-KINASE-B; RICTOR-MTOR COMPLEX; SIGNALING PATHWAY; SPATIOTEMPORAL DYNAMICS; HYDROPHOBIC DOMAIN; ESCHERICHIA-COLI; ACTIVATION LOOP; UP-REGULATION; TUMOR-GROWTH; LUNG-CANCER	The proto-oncogene Akt/protein kinase B (PKB) is a pivotal signal transducer for growth and survival. Growth factor stimulation leads to Akt phosphorylation at two regulatory sites (Thr-308 and Ser-473), acutely activating Akt signaling. Delineating the exact role of each regulatory site is, however, technically challenging and has remained elusive. Here, we used genetic code expansion to produce site-specifically phosphorylated Akt1 to dissect the contribution of each regulatory site to Akt1 activity. We achieved recombinant production of full-length Akt1 containing site-specific pThr and pSer residues for the first time. Our analysis of Akt1 site-specifically phosphorylated at either or both sites revealed that phosphorylation at both sites increases the apparent catalytic rate 1500-fold relative to unphosphorylated Akt1, an increase attributable primarily to phosphorylation at Thr-308. Live imaging of COS-7 cells confirmed that phosphorylation of Thr-308, but not Ser-473, is required for cellular activation of Akt. We found in vitro and in the cell that pThr-308 function cannot be mimicked with acidic residues, nor could unphosphorylated Thr-308 be mimicked by an Ala mutation. An Akt1 variant with pSer-308 achieved only partial enzymatic and cellular signaling activity, revealing a critical interaction between the -methyl group of pThr-308 and Cys-310 in the Akt1 active site. Thus, pThr-308 is necessary and sufficient to stimulate Akt signaling in cells, and the common use of phosphomimetics is not appropriate for studying the biology of Akt signaling. Our data also indicate that pThr-308 should be regarded as the primary diagnostic marker of Akt activity.	[Balasuriya, Nileeka; Liu, Xuguang; Biggar, Kyle K.; Li, Shawn S. -C.; O'Donoghue, Patrick] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [O'Donoghue, Patrick] Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada; [Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of California System; University of California San Diego	O'Donoghue, P (corresponding author), Univ Western Ontario, Dept Chem, London, ON N6A 5C1, Canada.; Newton, AC (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	anewton@ucsd.edu; patrick.odonoghue@uwo.ca		O'Donoghue, Patrick/0000-0002-9500-8640	Natural Sciences and Engineering Research Council of Canada [RGPIN 04282-2014]; Canada Foundation for Innovation [229917]; Ontario Research Fund [229917]; Canada Research Chairs [950-229917]; Canadian Cancer Society Research Institute Innovation [704324]; Canadian Breast Cancer Foundation; National Institutes of Health [R03 CA178524, R35 GM122523, R01 GM43154]; Ontario Graduate Scholarship; Banting Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [R03CA178524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R35GM122523] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Research Fund; Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Cancer Society Research Institute Innovation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Banting Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN 04282-2014 (to P. O.), Canada Foundation for Innovation Grant 229917 (to P. O.), Ontario Research Fund Grant 229917 (to P. O.), Canada Research Chairs 950-229917 (to P. O.), the Canadian Cancer Society Research Institute Innovation Grant 704324 (to P. O. and S. L.), the Canadian Breast Cancer Foundation (to S. L.), and National Institutes of Health Grants R03 CA178524 (to M. T. K.) and R35 GM122523 and R01 GM43154 (to A. C. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of an Ontario Graduate Scholarship.; Recipient of a Banting Postdoctoral Fellowship.	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andjelkovic M, 1999, MOL CELL BIOL, V19, P5061; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Antal CE, 2014, BIOCHEM SOC T, V42, P1477, DOI 10.1042/BST20140172; Antal CE, 2013, MOL CELL PROTEOMICS, V12, P3498, DOI 10.1074/mcp.R113.029819; Berndt N, 2010, CELL DEATH DIFFER, V17, P1795, DOI 10.1038/cdd.2010.63; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Dissmeyer N, 2011, METHODS MOL BIOL, V779, P93, DOI 10.1007/978-1-61779-264-9_6; Ebner M, 2017, MOL CELL, V65, P416, DOI 10.1016/j.molcel.2016.12.028; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Fabbro D, 1999, PROTEIN EXPRES PURIF, V17, P83, DOI 10.1006/prep.1999.1102; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; George S, 2016, FEBS LETT, V590, P1530, DOI 10.1002/1873-3468.12182; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Hassan B, 2013, SURG ONCOL CLIN N AM, V22, P641, DOI 10.1016/j.soc.2013.06.008; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; Iacovides DC, 2013, MOL CELL PROTEOMICS, V12, P3210, DOI 10.1074/mcp.M112.023119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Klein S, 2005, PROTEIN EXPRES PURIF, V41, P162, DOI 10.1016/j.pep.2005.01.003; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Kunkel Maya T, 2009, Curr Protoc Chem Biol, V1, P17; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lee S, 2013, ANGEW CHEM INT EDIT, V52, P5771, DOI 10.1002/anie.201300531; Liao Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07962-7; Lippa B, 2008, BIOORG MED CHEM LETT, V18, P3359, DOI 10.1016/j.bmcl.2008.04.034; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; LoRusso PM, 2016, J CLIN ONCOL, V34, P3803, DOI 10.1200/JCO.2014.59.0018; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Massihnia D, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0371-1; Munoz C, 2013, J MEMBRANE BIOL, V246, P189, DOI 10.1007/s00232-012-9520-9; Newton AC, 2014, ANNU REV PHARMACOL, V54, P537, DOI 10.1146/annurev-pharmtox-011112-140338; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Parker L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100631; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Reuveni H, 2002, BIOCHEMISTRY-US, V41, P10304, DOI 10.1021/bi0202530; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Steichen JM, 2012, J BIOL CHEM, V287, P14672, DOI 10.1074/jbc.M111.335091; Tang H, 2016, ONCOL REP, V36, P900, DOI 10.3892/or.2016.4901; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; Tobisawa T, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0621-6; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; TSUTAKAWA SE, 1995, J BIOL CHEM, V270, P26807, DOI 10.1074/jbc.270.45.26807; Turowec JP, 2010, METHOD ENZYMOL, V484, P471, DOI [10.1016/S0076-6879(10)84023-6, 10.1016/B978-0-12-381298-8.00023-X]; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; WALSH DA, 1968, J BIOL CHEM, V243, P3763; Warsi J, 2015, CELL PHYSIOL BIOCHEM, V37, P2454, DOI 10.1159/000438598; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Xiao J, 2017, ONCOL REP, V37, P2513, DOI 10.3892/or.2017.5484; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang YW, 2016, ONCOTARGET, V7, P59388, DOI 10.18632/oncotarget.10673; Zhang XL, 2006, J BIOL CHEM, V281, P13949, DOI 10.1074/jbc.M601384200; Zhuo DX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065679	68	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10744	10756		10.1074/jbc.RA118.002357	http://dx.doi.org/10.1074/jbc.RA118.002357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29773654	Green Published, hybrid			2022-12-26	WOS:000437828400029
J	Murthy, T; Bluemn, T; Gupta, AK; Reimer, M; Rao, S; Pillai, MM; Minella, AC				Murthy, Tushar; Bluemn, Theresa; Gupta, Abhishek K.; Reimer, Michael; Rao, Sridhar; Pillai, Manoj M.; Minella, Alex C.			Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; RNA splicing; chromatin; chromatin immunoprecipitation (ChiP); cyclin; cyclin-dependent kinase (CDK); phosphorylation; RNA splicing	CELL-DIFFERENTIATION; RING SIDEROBLASTS; CANCER GENES; HISTONE H1.4; BRANCH SITE; U2 SNRNP; PHOSPHORYLATION; SF3B1; TRANSCRIPTION; MUTATIONS	Splicing factor 3B1 (SF3B1) is a core splicing protein that stabilizes the interaction between the U2 snRNA and the branch point in the mRNA target during splicing. SF3B1 is heavily phosphorylated at its N terminus and a substrate of cyclin-dependent kinases (CDKs). Although SF3B1 phosphorylation coincides with splicing catalysis, the functional significance of SF3B1 phosphorylation is largely undefined. Here, we show that SF3B1 phosphorylation follows a dynamic pattern during cell cycle progression that depends on CDK activity. SF3B1 is known to interact with chromatin, and we found that SF3B1 maximally interacts with nucleosomes during G(1)/S and that this interaction requires CDK2 activity. In contrast, SF3B1 disassociates from nucleosomes at G(2)/M, coinciding with a peak in CDK1-mediated SF3B1 phosphorylation. Thus, CDK1 and CDK2 appear to have opposing roles in regulating SF3B1-nucleosome interactions. Importantly, these interactions were modified by the presence and phosphorylation status of linker histone H1, particularly the H1.4 isoform. Performing genome-wide analysis of SF3B1-chromatin binding in synchronized cells, we observed that SF3B1 preferentially bound exons. Differences in SF3B1 chromatin binding to specific sites, however, did not correlate with changes in RNA splicing, suggesting that the SF3B1-nucleosome interaction does not determine cell cycle-dependent changes to mRNA splicing. Our results define a cell cycle stage-specific interaction between SF3B1 and nucleosomes that is mediated by histone H1 and depends on SF3B1 phosphorylation. Importantly, this interaction does not seem to be related to SF3B1's splicing function and, rather, points toward its potential role as a chromatin modifier.	[Murthy, Tushar] Northwestern Univ, Driskill Grad Program, Chicago, IL 60611 USA; [Bluemn, Theresa; Reimer, Michael; Rao, Sridhar] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Bluemn, Theresa; Reimer, Michael; Rao, Sridhar; Minella, Alex C.] BloodCtr Wisconsin, Blood Res Inst, 8727 W Watertown Plank Rd, Milwaukee, WI 53213 USA; [Gupta, Abhishek K.; Pillai, Manoj M.] Yale Canc Ctr, Sect Hematol, New Haven, CT 06510 USA; [Gupta, Abhishek K.; Pillai, Manoj M.] Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA	Northwestern University; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Yale University; Yale University	Minella, AC (corresponding author), BloodCtr Wisconsin, Blood Res Inst, 8727 W Watertown Plank Rd, Milwaukee, WI 53213 USA.; Pillai, MM (corresponding author), Yale Canc Ctr, Sect Hematol, New Haven, CT 06510 USA.; Pillai, MM (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA.	manoj.pillai@yale.edu; aminella@me.com		Minella, Alex/0000-0001-6693-3362; Bluemn, Theresa/0000-0003-1296-2461	National Institutes of Health [R01 HL098608, R01HL103040, R01HL133406]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098608, R01HL104070, R01HL133406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL098608 (to A. C. M.) and R01HL103040 and R01HL133406 (to M. M. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boudrez A, 2002, J BIOL CHEM, V277, P31834, DOI 10.1074/jbc.M204427200; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Clurman BE, 1996, GENE DEV, V10, P1979, DOI 10.1101/gad.10.16.1979; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; de Almeida SF, 2011, NAT STRUCT MOL BIOL, V18, P977, DOI 10.1038/nsmb.2123; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez D, 2016, ELIFE, V5, DOI 10.7554/eLife.10288; Eto K, 2011, MOL CELL BIOCHEM, V355, P217, DOI 10.1007/s11010-011-0857-7; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hergeth SP, 2015, EMBO REP, V16, P1439, DOI 10.15252/embr.201540749; Herzel L, 2017, NAT REV MOL CELL BIO, V18, P637, DOI 10.1038/nrm.2017.63; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Kamieniarz K, 2012, GENE DEV, V26, P797, DOI 10.1101/gad.182014.111; Kesarwani AK, 2017, ONCOGENE, V36, P1123, DOI 10.1038/onc.2016.279; Kfir N, 2015, CELL REP, V11, P618, DOI 10.1016/j.celrep.2015.03.048; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee KY, 2012, J BIOL CHEM, V287, P11891, DOI 10.1074/jbc.M111.338467; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mupo A, 2017, LEUKEMIA, V31, P720, DOI 10.1038/leu.2016.251; Nuytten M, 2008, ONCOGENE, V27, P1449, DOI 10.1038/sj.onc.1210774; Obeng EA, 2016, CANCER CELL, V30, P404, DOI 10.1016/j.ccell.2016.08.006; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Seghezzi W, 1998, MOL CELL BIOL, V18, P4526, DOI 10.1128/MCB.18.8.4526; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Strikoudis A, 2016, NAT CELL BIOL, V18, P1127, DOI 10.1038/ncb3424; Thompson BJ, 2015, J EXP MED, V212, P723, DOI 10.1084/jem.20150002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Van Dessel N, 2010, NUCLEIC ACIDS RES, V38, P7500, DOI 10.1093/nar/gkq643; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zheng YP, 2010, J CELL BIOL, V189, P407, DOI 10.1083/jcb.201001148; Zlotorynski E, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.44	55	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10220	10234		10.1074/jbc.RA118.001654	http://dx.doi.org/10.1074/jbc.RA118.001654			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764937	Green Published, hybrid			2022-12-26	WOS:000437096700022
J	Pal, E; Korva, M; Rus, KR; Kejzar, N; Bogovic, P; Kurent, A; Avsic-Zupanc, T; Strle, F				Pal, Emil; Korva, Misa; Rus, Katarina Resman; Kejzar, Natasa; Bogovic, Petra; Kurent, Anica; Avsic-Zupanc, Tatjana; Strle, Franc			Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome	PLOS ONE			English	Article							NEPHROPATHIA-EPIDEMICA; HANTAVIRUS INFECTIONS; SLOVENIA; PUUMALA; DISEASE; REGION; LOAD	Background Information on the sequential appearance, duration, and magnitude of clinical and laboratory parameters in hemorrhagic fever with renal syndrome (HFRS) is limited. Methods Analysis of clinical and laboratory parameters obtained serially in 81 patients with HFRS, of whom 15 were infected with Dobrava virus and 66 with Puumala virus. Results The initial signs/symptoms, appearing on median day 1 of illness, were fever, headache, and myalgia. These were present in 86%, 65%, and 40% of patients and had a median duration of 4, 4, and 5.5 days, respectively. The signs/symptoms were followed by myopia (appearance on day 5), insomnia (day 6), oliguria/anuria (day 6), polyuria (day 9), and sinus bradycardia (day 9.5). These were present in 35%, 30%, 28%, 91%, and 35% of patients; their median duration was 2, 2, 2, 7, and 1 day, respectively. Laboratory abnormalities, including thrombocytopenia, elevated alanine aminotransferase, CRP, procalcitonin, creatinine, diminished glomerular filtration rate, and leukocytosis, were ascertained on admission to hospital or on the following day (day 5 or 6 of illness) and were established in 95%, 87%, 99%, 91%, 94%, 87%, and 55% of patients, and had a median duration of 4, 3, 7, 3, 9, 8, and 2 days, respectively. Comparison of patients infected with Dobrava and Puumala viruses found several differences in the frequency, magnitude, and duration of abnormalities, indicating that Dobrava virus causes the more severe HFRS. Conclusions In the majority of patients, the classic clinical distinction into febrile, hypotonic, oliguric, polyuric, and convalescent phases of illness is unclear.	[Pal, Emil] Murska Sobota Gen Hosp, Dept Infect Dis, Rakican, Slovenia; [Pal, Emil; Strle, Franc] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Korva, Misa; Rus, Katarina Resman; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Kejzar, Natasa] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia; [Bogovic, Petra; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Kurent, Anica] Novo Mesto Gen Hosp, Dept Infect Dis, Novo Mesto, Slovenia	University of Ljubljana; University of Ljubljana; University of Ljubljana; University Medical Centre Ljubljana	Strle, F (corresponding author), Univ Ljubljana, Fac Med, Ljubljana, Slovenia.; Strle, F (corresponding author), Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia.	franc.strle@kclj.si		AVSIC ZUPANC, TATJANA/0000-0001-6243-0688; Strle, Franc/0000-0003-4163-0503; Kejzar, Natasa/0000-0003-3069-9863; Korva, Misa/0000-0003-1501-1004	Slovenian Research Agency [P3-0296, P3-0083]; European Virus Archive goes Global (EVAg) project from the European Union Horizon research and innovation program [653316]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Virus Archive goes Global (EVAg) project from the European Union Horizon research and innovation program	This work was supported by the Slovenian Research Agency (grant numbers P3-0296 to FS and P3-0083 to TA), and by the European Virus Archive goes Global (EVAg) project that has received funding from the European Union Horizon 2020 research and innovation program under grant agreement no. 653316 to TA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avsic-Zupanc T, 2019, CLIN MICROBIOL INFEC, V21, pE6, DOI 10.1111/1469-0691.12291; Avsic-Zupanc T, 1999, CLIN INFECT DIS, V28, P860, DOI 10.1086/515185; AVSICZUPANC T, 1989, ACTA VIROL, V33, P327; Braun N, 2010, NEPHROL DIAL TRANSPL, V25, P2997, DOI 10.1093/ndt/gfq118; Cizman B, 1989, Adv Exp Med Biol, V252, P173; Connolly-Andersen AM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu027; Hautala N, 2011, BRIT J OPHTHALMOL, V95, P559, DOI 10.1136/bjo.2010.185413; Hepojoki J, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00727; Jereb M, 2011, SCAND J CLIN LAB INV, V71, P287, DOI 10.3109/00365513.2011.560675; Korva M, 2013, CLIN MICROBIOL INFEC, V19, pE358, DOI 10.1111/1469-0691.12218; Korva M, 2011, CLIN VACCINE IMMUNOL, V18, P1435, DOI 10.1128/CVI.05187-11; Kraigher A, 2012, EUROSURVEILLANCE, V17, P7; Krautkramer E, 2014, VIRUS RES, V187, P59, DOI 10.1016/j.virusres.2013.12.043; Krautkramer E, 2011, J VIROL, V85, P9811, DOI 10.1128/JVI.00568-11; Kruger DH, 2011, HUM VACCINES, V7, P685, DOI 10.4161/hv.7.6.15197; Kruger DH, 2001, MICROBES INFECT, V3, P1129, DOI 10.1016/S1286-4579(01)01474-5; Latus J, 2015, KIDNEY BLOOD PRESS R, V40, P22, DOI 10.1159/000368479; Latus J, 2015, EMERG INFECT DIS, V21, P76, DOI 10.3201/eid2101.140861; LEE JS, 1991, KIDNEY INT, V40, pS88; Markotic A, 2002, J MED VIROL, V66, P542, DOI 10.1002/jmv.2179; MUSTONEN J, 1994, SCAND J INFECT DIS, V26, P7, DOI 10.3109/00365549409008583; Pal E, 2005, WIEN KLIN WOCHENSCHR, V117, P398, DOI 10.1007/s00508-005-0359-2; Park KH, 2011, AM J TROP MED HYG, V84, P229, DOI 10.4269/ajtmh.2011.10-0024; Puljiz I, 2005, SCAND J INFECT DIS, V37, P594, DOI 10.1080/00365540510036606; Puljiz Ivan, 2003, Acta Med Croatica, V57, P347; Rasmuson J, 2011, EUR J CLIN MICROBIOL, V30, P685, DOI 10.1007/s10096-010-1141-6; Saksida A, 2008, J INFECT DIS, V197, P681, DOI 10.1086/527485; Saksida A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-142; Team RDC, 2012, R LANG ENV STAT COMP; Theiler G, 2012, CLIN MICROBIOL INFEC, V18, pE435, DOI 10.1111/j.1469-0691.2012.03997.x; Turcinov D, 2013, CLIN MICROBIOL INFEC, V19, P674, DOI 10.1111/j.1469-0691.2012.03994.x; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Zupanc TA, 2014, VIRUS RES, V187, P27, DOI 10.1016/j.virusres.2013.12.042	34	8	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197661	10.1371/journal.pone.0197661	http://dx.doi.org/10.1371/journal.pone.0197661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791494	Green Submitted, gold, Green Published			2022-12-26	WOS:000433077000050
J	Nahid, P; Jarlsberg, LG; Kato-Maeda, M; Segal, MR; Osmond, DH; Gagneux, S; Dobos, K; Gold, M; Hopewell, PC; Lewinsohn, DM				Nahid, P.; Jarlsberg, L. G.; Kato-Maeda, M.; Segal, M. R.; Osmond, D. H.; Gagneux, S.; Dobos, K.; Gold, M.; Hopewell, P. C.; Lewinsohn, D. M.			Interplay of strain and race/ethnicity in the innate immune response to M-tuberculosis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GLOBAL DISTRIBUTION; INFECTION; VIRULENT; DISEASE; SUSCEPTIBILITY; POLYMORPHISMS; EPIDEMIOLOGY; MACROPHAGES; RECOGNITION	Background The roles of host and pathogen factors in determining innate immune responses to M. tuberculosis are not fully understood. In this study, we examined host macrophage immune responses of 3 race/ethnic groups to 3 genetically and geographically diverse M. tuberculosis lineages. Methods Monocyte-derived macrophages from healthy Filipinos, Chinese and non-Hispanic White study participants (approximately 45 individuals/group) were challenged with M. tuberculosis whole cell lysates of clinical strains Beijing HN878 (lineage 2), Manila T31 (lineage 1), CDC1551 (lineage 4), the reference strain H37Rv (lineage 4), as well as with Toll-like receptor 2 agonist lipoteichoic acid (TLR2/LTA) and TLR4 agonist lipopolysaccharide (TLR4/LPS). Following overnight incubation, multiplex assays for nine cytokines: IL-113, IL-2, IL-6, IL-8, IL-10, IL-12p70, IFN gamma, TNF alpha, and GM-CSF, were batch applied to supernatants. Results Filipino macrophages produced less IL-1, IL-6, and more IL-8, compared to macrophages from Chinese and Whites. Race/ethnicity had only subtle effects or no impact on the levels of IL-10, IL-12p70, TNF alpha and GM-CSF. In response to the Toll-like receptor 2 agonist lipoteichoic acid (TLR2/LTA), Filipino macrophages again had lower IL-1 and IL-6 responses and a higher IL-8 response, compared to Chinese and Whites. The TLR2/LTA-stimulated Filipino macrophages also produced lower amounts of IL-10, TNFa and GM-CSF. Race/ethnicity had no impact on IL-12p70 levels released in response to TLR2/LTA. The responses to TLR4 agonist lipopolysaccharide (TLR4/LPS) were similar to the TLR2/LTA responses, for IL-1, IL-6, IL-8, and IL-10. However, TLR4/LPS triggered the release of less IL-12p70 from Filipino macrophages, and less TNF alpha from White macrophages. Conclusions Both host race/ethnicity and pathogen strain influence the innate immune response. Such variation may have implications for the development of new tools across TB therapeutics, immunodiagnostics and vaccines.	[Nahid, P.; Jarlsberg, L. G.; Kato-Maeda, M.; Hopewell, P. C.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Segal, M. R.; Osmond, D. H.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Gagneux, S.] Univ Basel, Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Dobos, K.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Gold, M.] Vet Affairs Portland Hlth Care Ctr, Dept Res, Portland, OR USA; [Lewinsohn, D. M.] Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA; [Lewinsohn, D. M.] Vet Affairs Portland Hlth Care Ctr, Dept Res, Portland, OR 97239 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Basel; Swiss Tropical & Public Health Institute; Colorado State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Nahid, P (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.; Lewinsohn, DM (corresponding author), Oregon Hlth & Sci Univ, Dept Pulm & Crit Care Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.; Lewinsohn, DM (corresponding author), Vet Affairs Portland Hlth Care Ctr, Dept Res, Portland, OR 97239 USA.	pnahid@ucsf.edu; lewinsod@ohsu.edu	Gagneux, Sebastien/ABE-7909-2020	Gagneux, Sebastien/0000-0001-7783-9048; Jarlsberg, Leah/0000-0001-6548-6337; Nahid, Payam/0000-0003-2811-1311	NIH [NHLBI K23HL092629]; National Center for Research Resources [KL2RR024130]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by NIH grants: NHLBI K23HL092629 (PN) and The National Center for Research Resources grant number KL2RR024130 (PN). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH.	Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428; Ahmed N, 2004, J CLIN MICROBIOL, V42, P3240, DOI 10.1128/JCM.42.7.3240-3247.2004; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Boisson-Dupuis S, 2015, IMMUNOL REV, V264, P103, DOI 10.1111/imr.12272; Boisson-Dupuis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018524; Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Cattamanchi A, 2006, INT J TUBERC LUNG D, V10, P297; Chun RF, 2010, J CLIN ENDOCR METAB, V95, P3368, DOI 10.1210/jc.2010-0195; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Coussens AK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003468; CROWLE AJ, 1990, INFECT IMMUN, V58, P632, DOI 10.1128/IAI.58.3.632-638.1990; Diggle P, 2013, ANAL LONGITUDINAL DA, Vxv; Divangahi M, 2018, AM J RESP CRIT CARE, V197, P427, DOI 10.1164/rccm.201707-1489PP; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Ferrand PE, 2002, MOL HUM REPROD, V8, P1031, DOI 10.1093/molehr/8.11.1031; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; HernandezPando R, 1997, IMMUNOLOGY, V90, P607, DOI 10.1046/j.1365-2567.1997.00193.x; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; Khatri B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052673; Kramnik I, 2000, P NATL ACAD SCI USA, V97, P8560, DOI 10.1073/pnas.150227197; Law K, 1996, AM J RESP CRIT CARE, V153, P799, DOI 10.1164/ajrccm.153.2.8564135; Lazarus R, 2002, IMMUNOL REV, V190, P9, DOI 10.1034/j.1600-065X.2002.19002.x; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Lucas Megan C, 2015, Methods Mol Biol, V1285, P47, DOI 10.1007/978-1-4939-2450-9_4; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 1999, J IMMUNOL, V162, P6740; Meyer CG, 2014, SEMIN IMMUNOL, V26, P445, DOI 10.1016/j.smim.2014.09.005; MUSSER JM, 1990, REV INFECT DIS, V12, P75; Mvubu NE, 2016, DEV COMP IMMUNOL, V65, P321, DOI 10.1016/j.dci.2016.07.022; Nahid P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010753; Pareek M, 2013, THORAX, V68, P221, DOI 10.1136/thoraxjnl-2012-201824; Portevin D, 2014, MICROBIOLOGYOPEN, V3, P823, DOI 10.1002/mbo3.193; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Rose G, 2013, GENOME BIOL EVOL, V5, P1849, DOI 10.1093/gbe/evt138; Sarkar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043170; Schorey JS, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0010-2016; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Shah JA, 2017, AM J RESP CRIT CARE, V196, P502, DOI [10.1164/rccm.201611-2346OC, 10.1164/rccm.201611-2346oc]; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Speeckaert M, 2006, CLIN CHIM ACTA, V372, P33, DOI 10.1016/j.cca.2006.03.011; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Subbian S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-60; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; Wan XH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175330; Wang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075090; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919; Zhang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063357	63	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0195392	10.1371/journal.pone.0195392	http://dx.doi.org/10.1371/journal.pone.0195392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787561	Green Published, gold, Green Accepted			2022-12-26	WOS:000432785700002
J	Piccirillo, E; Alegria, TGP; Discola, KF; Cussiol, JARR; Domingos, RM; de Oliveira, MA; de Rezende, L; Netto, LES; Amaral, ATD				Piccirillo, Erika; Alegria, Thiago G. P.; Discola, Karen F.; Cussiol, Jose A. R. R.; Domingos, Renato M.; de Oliveira, Marcos A.; de Rezende, Leandro; Netto, Luis E. S.; Amaral, Antonia T-do			Structural insights on the efficient catalysis of hydroperoxide reduction by Ohr: Crystallographic and molecular dynamics approaches	PLOS ONE			English	Article							RESISTANCE PROTEIN; ESCHERICHIA-COLI; FEATURES; GROMACS; SYSTEM; OSMC	Organic hydroperoxide resistance (Ohr) enzymes are highly efficient Cys-based peroxidases that play central roles in bacterial response to fatty acid hydroperoxides and peroxynitrite, two oxidants that are generated during host-pathogen interactions. In the active site of Ohr proteins, the conserved Arg (Arg19 in Ohr from Xylella fastidiosa) and Glu (Glu51 in Ohr from Xylella fastidiosa) residues, among other factors, are involved in the extremely high reactivity of the peroxidatic Cys (C-p) toward hydroperoxides. In the closed state, the thiolate of C-p is in close proximity to the guanidinium group of Arg19. Ohr enzymes can also assume an open state, where the loop containing the catalytic Arg is far away from C-p and Glu51. Here, we aimed to gain insights into the putative structural switches of the Ohr catalytic cycle. First, we describe the crystal structure of Ohr from Xylella fastidiosa (XfOhr) in the open state that, together with the previously described XfOhr structure in the closed state, may represent two snapshots along the coordinate of the enzyme-catalyzed reaction. These two structures were used for the experimental validation of molecular dynamics (MD) simulations. MD simulations employing distinct protonation states and in silico mutagenesis indicated that the polar interactions of Arg19 with Glu51 and C-p contributed to the stabilization of XfOhr in the closed state. Indeed, C-p oxidation to the disulfide state facilitated the switching of the Arg19 loop from the closed to the open state. In addition to the Arg19 loop, other portions of XfOhr displayed high mobility, such as a loop rich in Gly residues. In summary, we obtained a high correlation between crystallographic data, MD simulations and biochemical/enzymatic assays. The dynamics of the Ohr enzymes are unique among the Cys-based peroxidases, in which the active site Arg undergoes structural switches throughout the catalytic cycle, while C-p remains relatively static.	[Piccirillo, Erika; de Rezende, Leandro; Amaral, Antonia T-do] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, SP, Brazil; [Alegria, Thiago G. P.; Discola, Karen F.; Cussiol, Jose A. R. R.; Domingos, Renato M.; Netto, Luis E. S.] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil; [de Oliveira, Marcos A.] Univ Estadual Paulista, Inst Biociencias, Campus Litoral Paulista, Sao Vicente, SP, Brazil; [Cussiol, Jose A. R. R.] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Amaral, ATD (corresponding author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, SP, Brazil.; Netto, LES (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, SP, Brazil.	nettoles@ib.usp.br; atdamara@iq.usp.br	Netto, Luis/A-3783-2008; Piccirillo, Erika/P-5256-2016; de Oliveira, Marcos A/K-5746-2015; Piccirillo, Erika/L-5056-2019; Cussiol, José Renato/E-5142-2015; Amaral, Antonia/C-4423-2012	Netto, Luis/0000-0002-4250-9177; Piccirillo, Erika/0000-0003-4094-3102; de Oliveira, Marcos A/0000-0002-1192-7296; Cussiol, José Renato/0000-0001-5909-8215; Amaral, Antonia/0000-0003-2937-5255; Mateus Domingos, Renato/0000-0002-6928-4836; Alegria, Thiago Geronimo Pires/0000-0002-3086-4059	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Redox Processes in Biomedicine [13/07937-8]; FAPESP [2008/07971-3, 2009/12885-1, 2005/50056-6, 2014/01614-5, 2012/06633-2, 2016/12392-9]	Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Redox Processes in Biomedicine; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We want to thank the Fundacao de Amparo a Pesquisa no Estado de Sao Paulo (FAPESP), Brazil, and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil, for the grants to support this study. A.T-do A., L.E.S.N., and M.A.O. are under financial support of Grant 13/07937-8 (Redox Processes in Biomedicine. T.G.P.A., K.F.D., J.R.R.C., E.P. and A. T-do.A were recipients of fellowships from FAPESP (2008/07971-3; 2009/12885-1; 2005/50056-6; 2014/01614-5 and 2012/06633-2 and 2016/12392-9).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alegria TGP, 2017, P NATL ACAD SCI USA, V114, pE132, DOI 10.1073/pnas.1619659114; Atichartpongkul S, 2001, MICROBIOL-SGM, V147, P1775, DOI 10.1099/00221287-147-7-1775; Baldi P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00944; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; BENESCH RE, 1955, J AM CHEM SOC, V77, P5877, DOI 10.1021/ja01627a030; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BLESSING RH, 1995, ACTA CRYSTALLOGR A, V51, P33, DOI 10.1107/S0108767394005726; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Costa MGS, 2015, J CHEM THEORY COMPUT, V11, P2755, DOI 10.1021/acs.jctc.5b00003; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Flohe L, 2016, FREE RADICAL RES, V50, P126, DOI 10.3109/10715762.2015.1046858; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1993, JOINT CCP4 EESF EACM, P29; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; Meireles A, 2017, REDOX BIOL, V12, P600, DOI 10.1016/j.redox.2017.03.026; Meireles DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099492; Meunier-Jamin C, 2004, J BIOL CHEM, V279, P25830, DOI 10.1074/jbc.M312983200; Mongkolsuk S, 1998, J BACTERIOL, V180, P2636, DOI 10.1128/JB.180.10.2636-2643.1998; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson KJ, 2018, ANTIOXID REDOX SIGN, V28, P521, DOI 10.1089/ars.2016.6922; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Oliveira MA, 2006, J MOL BIOL, V359, P433, DOI 10.1016/j.jmb.2006.03.054; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccirillo E, 2016, J COMPUT AID MOL DES, V30, P251, DOI 10.1007/s10822-016-9901-8; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; R Core Team, 2013, R LANG ENV STAT COMP; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Sardi F, 2013, ANAL BIOCHEM, V435, P74, DOI 10.1016/j.ab.2012.12.017; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schrodinger L., 2013, PYMOL MOL GRAPHICS S; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Shin DH, 2004, ACTA CRYSTALLOGR D, V60, P903, DOI 10.1107/S0907444904005013; Sippel M, 2010, J CHEM INF MODEL, V50, P604, DOI 10.1021/ci900403s; Tairum Jr CA, 2016, SCI REPORTS, V6, P1, DOI [10.1038/srep33133, DOI 10.1038/SREP33133PMID:27629822]; Tobin DM, 2013, CURR OPIN PHARMACOL, V13, P641, DOI 10.1016/j.coph.2013.06.007; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	52	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							0196918	10.1371/journal.pone.0196918	http://dx.doi.org/10.1371/journal.pone.0196918			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782551	Green Published, gold, Green Submitted			2022-12-26	WOS:000432537100011
J	do Prado, RF; Esteves, GC; Santos, ELD; Bueno, DAG; Cairo, CAA; De Vasconcellos, LGO; Sagnori, RS; Tessarin, FBP; Oliveira, FE; De Oliveira, LD; Villaca-Carvalho, MFL; Henriques, VAR; Carvalho, YR; De Vasconcellos, LMR				do Prado, Renata Falchete; Esteves, Gabriela Campos; De Souza Santos, Evelyn Luzia; Griti Bueno, Daiane Acacia; Alves Cairo, Carlos Alberto; Oliveira De Vasconcellos, Luis Gustavo; Sagnori, Renata Silveira; Pereira Tessarin, Fernanda Bastos; Oliveira, Felipe Eduardo; De Oliveira, Luciane Dias; Lima Villaca-Carvalho, Maria Fernanda; Rodrigues Henriques, Vinicius Andre; Carvalho, Yasmin Rodarte; Reis De Vasconcellos, Luana Marotta			In vitro and in vivo biological performance of porous Ti alloys prepared by powder metallurgy	PLOS ONE			English	Article							TITANIUM-ALLOYS; BIOMEDICAL APPLICATIONS; BONE RESPONSE; EXPRESSION; SURFACE; CELLS; TI-13NB-13ZR; IMPLANTS; CYTOCOMPATIBILITY; OSSEOINTEGRATION	Titanium (Ti) and Ti-6 Aiuminium-4 Vanadium alloys are the most common materials in implants composition but beta type alloys are promising biomaterials because they present better mechanical properties. Besides the composition of biomaterial, many factors influence the performance of the biomaterial. For example, porous surface may modify the functional cellular response and accelerate osseointegration. This paper presents in vitro and in vivo evaluations of powder metallurgy-processed porous samples composed by different titanium alloys and pure Ti, aiming to show their potential for biomedical applications. The porous surfaces samples were produced with different designs to in vitro and in vivo tests. Samples were characterized with scanning electron microscopy (SEM), energy dispersive spectroscopy (EDS) and elastic modulus analyses. Osteogenic cells from newborn rat calvaria were plated on discs of different materials: G1-commercially pure Ti group (CpTi); G2-Ti-6AI-4V alloy; G3-Ti-13 Niobium-13 Zirconium alloy; G4-Ti-35 Niobium alloy; G5-Ti-35 Niobium-7 Zirconium-5 Tantalum alloy. Cell adhesion and viability, total protein content, alkaline phosphatase activity, mineralization nodules and gene expression (alkaline phosphatase, Runx-2, osteocalcin and osteopontin) were assessed. After 2 and 4 weeks of implantation in rabbit tibia, bone ingrowth was analyzed using micro-computed tomography (mu CT). EDS analysis confirmed the material production of each group. Metallographic and SEM analysis revealed interconnected pores, with mean pore size of 99,5 mu m and mean porosity of 42%, without significant difference among the groups (p > 0.05). The elastic modulus values did not exhibit difference among the groups (p > 0.05). Experimental alloys demonstrated better results than CpTi and Ti-6AI-4V, in gene expression and cytokines analysis, especially in early experimental periods. In conclusion, our data suggests that the experimental alloys can be used for biomedical application since they contributed to excellent cellular behavior and osseointegration besides presenting lower elastic modulus.	[do Prado, Renata Falchete; Esteves, Gabriela Campos; De Souza Santos, Evelyn Luzia; Griti Bueno, Daiane Acacia; Oliveira, Felipe Eduardo; De Oliveira, Luciane Dias; Lima Villaca-Carvalho, Maria Fernanda; Carvalho, Yasmin Rodarte; Reis De Vasconcellos, Luana Marotta] Sao Paulo State Univ, UNESP, Inst Sci & Technol, Dept Biosci & Oral Diag, Sao Jose Dos Campos, SP, Brazil; [Alves Cairo, Carlos Alberto; Rodrigues Henriques, Vinicius Andre] Praca Mal Ar Eduardo Gomes, Air & Space Inst, Div Mat, Sao Jose Dos Campos, SP, Brazil; [Oliveira De Vasconcellos, Luis Gustavo] Sao Paulo State Univ, UNESP, Inst Sci & Technol, Dept Prosthodont & Dent Mat, Sao Jose Dos Campos, SP, Brazil; [Sagnori, Renata Silveira] Univ Estadual Campinas, UNICAMP, Piracicaba Dent Sch, Dept Oral Diag, Piracicaba, SP, Brazil; [Pereira Tessarin, Fernanda Bastos] Sao Paulo State Univ, UNESP, Inst Sci & Technol, Dept Restorat Dent, Sao Jose Dos Campos, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual de Campinas; Universidade Estadual Paulista	do Prado, RF (corresponding author), Sao Paulo State Univ, UNESP, Inst Sci & Technol, Dept Biosci & Oral Diag, Sao Jose Dos Campos, SP, Brazil.	renatafalchete@hotmail.com	Henriques, Vinicius A.R./G-2465-2012; Prado, Renata/G-5066-2011; Cairo, Carlos/AAK-8799-2020; de Vasconcellos, Luana Marotta Reis/V-6606-2019; Cairo, Carlos Alberto Alves/G-2721-2012; Oliveira, Luciane D/O-5157-2018	Prado, Renata/0000-0001-5970-0464; Cairo, Carlos/0000-0003-4093-9365; de Vasconcellos, Luana Marotta Reis/0000-0003-4344-0578; Oliveira, Luciane D/0000-0001-9956-7768	FAPESP (Sao Paulo State Research Foundation) [2011/23662-3, 2012/20311-8]; FAPEPS [2012/22158-2, 2011/15342-9, 2012/13338-7, 2012/13324-6]	FAPESP (Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPEPS	This work was partially funded by the FAPESP (Sao Paulo State Research Foundation) grant no 2011/23662-3 and no 2012/20311-8. We also thank FAPEPS for the scholarships (2012/22158-2, 2011/15342-9, 2012/13338-7 and 2012/13324-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially funded by the FAPESP (Sao Paulo State Research Foundation) grant no 2011/23662-3 and no 2012/20311-8.; We also thank FAPEPS for the scholarships (2012/22158-2, 2011/15342-9, 2012/13338-7 and 2012/13324-6).	Bencharit S, 2014, CLIN IMPLANT DENT R, V16, P817, DOI 10.1111/cid.12059; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Bottino MC, 2008, MAT SCI ENG C-BIO S, V28, P223, DOI 10.1016/j.msec.2006.12.014; Bottino MC, 2009, J BIOMED MATER RES A, V88A, P689, DOI 10.1002/jbm.a.31912; Brentel Aline Scalone, 2006, J. Appl. Oral Sci., V14, P213, DOI 10.1590/S1678-77572006000300013; Capek J, 2013, MAT SCI ENG C-MATER, V33, P564, DOI 10.1016/j.msec.2012.10.002; Catelas I, 2003, BIOMATERIALS, V24, P4785, DOI 10.1016/S0142-9612(03)00378-8; Chen XB, 2009, ACTA BIOMATER, V5, P1808, DOI 10.1016/j.actbio.2009.01.015; Cordeiro JM, 2017, DENT MATER, V33, P1244, DOI 10.1016/j.dental.2017.07.013; de Andrade DP, 2015, MAT SCI ENG C-MATER, V56, P538, DOI 10.1016/j.msec.2015.07.026; de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8; de Vasconcellos LMR, 2010, MED ORAL PATOL ORAL, V15, pE407, DOI 10.4317/medoral.15.e407; Deporter D, 2014, CLIN ORAL IMPLAN RES, V25, pE189, DOI 10.1111/clr.12043; Dewidar MM, 2006, MET MATER INT, V12, P193, DOI 10.1007/BF03027531; do Prado RF, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5594-0; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Galli S, 2017, CLIN ORAL IMPLAN RES, V28, P1234, DOI 10.1111/clr.12947; Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Guo YY, 2013, INT J MOL MED, V31, P689, DOI 10.3892/ijmm.2013.1249; Hagihara K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29779; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Khan MA, 1999, BIOMATERIALS, V20, P631, DOI 10.1016/S0142-9612(98)00217-8; Lindner M, 2014, J BIOMED MATER RES A, V102, P3677, DOI 10.1002/jbm.a.35038; Liu XH, 2015, MAT SCI ENG C-MATER, V48, P256, DOI 10.1016/j.msec.2014.12.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma QL, 2014, BIOMATERIALS, V35, P9853, DOI 10.1016/j.biomaterials.2014.08.025; Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L; Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3; Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7; Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001; Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037; Okafor CC, 2006, J ORTHOP RES, V24, P461, DOI 10.1002/jor.20075; Osta B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00048; Oyonarte R, 2005, AM J ORTHOD DENTOFAC, V128, P173, DOI 10.1016/j.ajodo.2004.02.023; Park CH, 2011, CLIN ORAL IMPLAN RES, V22, P735, DOI 10.1111/j.1600-0501.2010.02053.x; Park JW, 2008, J BIOMED MATER RES B, V84B, P400, DOI 10.1002/jbm.b.30884; Park YJ, 2013, J DENT, V41, P1251, DOI 10.1016/j.jdent.2013.09.003; Peng W, 2016, BIOMED ENG ONLINE, V15, DOI [10.1186/s12938-016-0207-9, 10.1186/s12938-016-0277-8]; de Vasconcellos LMR, 2012, J MATER SCI-MATER M, V23, P357, DOI 10.1007/s10856-011-4515-0; de Vasconcellos LMR, 2008, MATER RES-IBERO-AM J, V11, P275, DOI 10.1590/S1516-14392008000300008; Rosa AL, 2009, CLIN ORAL IMPLAN RES, V20, P472, DOI 10.1111/j.1600-0501.2008.01662.x; Samuel S, 2010, J BIOMED MATER RES A, V94A, P1251, DOI 10.1002/jbm.a.32782; Santos DR, 2008, MAT SCI ENG A-STRUCT, V472, P193, DOI 10.1016/j.msea.2007.03.075; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055015; Sista S, 2013, MAT SCI ENG C-MATER, V33, P1573, DOI 10.1016/j.msec.2012.12.063; Teixeira LN, 2012, INT J ORAL MAX SURG, V41, P1097, DOI 10.1016/j.ijom.2012.02.020; Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293; Weng XJ, 2016, EXP THER MED, V12, P1323, DOI 10.3892/etm.2016.3472; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079289	51	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196169	10.1371/journal.pone.0196169	http://dx.doi.org/10.1371/journal.pone.0196169			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771925	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900009
J	Durairaj, R; Pageat, P; Bienboire-Frosini, C				Durairaj, Rajesh; Pageat, Patrick; Bienboire-Frosini, Cecile			Another cat and mouse game: Deciphering the evolution of the SCGB superfamily and exploring the molecular similarity of major cat allergen Fel d 1 and mouse ABP using computational approaches	PLOS ONE			English	Article							BINDING PROTEIN ABP; D-I; STEROID-BINDING; SALIVARY; UTEROGLOBIN; GENE; CELL; GENERATION; FAMILY; MEMBER	The mammalian secretoglobin (SCGB) superfamily contains functionally diverse members, among which the major cat allergen Fel d 1 and mouse salivary androgen-binding protein (ABP) display similar subunits. We searched for molecular similarities between Fel d 1 and ABP to examine the possibility that they play similar roles. We aimed to i) cluster the evolutionary relationships of the SCGB superfamily; ii) identify divergence patterns, structural overlap, and protein-protein docking between Fel d 1 and ABP dimers; and iii) explore the residual interaction between ABP dimers and steroid binding in chemical communication using computational approaches. We also report that the evolutionary tree of the SCGB superfamily comprises seven unique palm-like clusters, showing the evolutionary pattern and divergence time tree of Fel d 1 with 28 ABP paralogs. Three ABP subunits (A27, BG27, and BG26) share phylogenetic relationships with Fel d 1 chains. The Fel d 1 and ABP subunits show similarities in terms of sequence conservation, identical motifs and binding site clefts. Topologically equivalent positions were visualized through superimposition of ABP A27:BG27 (AB) and ABP A27:BG26 (AG) dimers on a heterodimeric Fel d 1 model. In docking, Fel d 1-ABP dimers exhibit the maximum surface binding ability of AG compared with that of AB dimers and the several polar interactions between ABP dimers with steroids. Hence, cat Fel d 1 is an ABP-like molecule in which monomeric chains 1 and 2 are the equivalent of the ABPA and ABPBG monomers, respectively. These findings suggest that the biological and molecular function of Fel d 1 is similar to that of ABP in chemical communication, possibly via pheromone and/or steroid binding.	[Durairaj, Rajesh; Bienboire-Frosini, Cecile] Res Inst Semiochem & Appl Ethol IRSEA, Dept Behav & Physiol Mech Adaptat MPCA, Apt, France; [Pageat, Patrick] Res Inst Semiochem & Appl Ethol IRSEA, Dept Semiochem Identificat & Analogs Design D ISC, Apt, France		Durairaj, R (corresponding author), Res Inst Semiochem & Appl Ethol IRSEA, Dept Behav & Physiol Mech Adaptat MPCA, Apt, France.	r.durairaj@group-irsea.com	Durairaj, Rajesh/N-9013-2018; BIENBOIRE-FROSINI, Cécile/J-9630-2019	Durairaj, Rajesh/0000-0002-3807-4174; BIENBOIRE-FROSINI, Cécile/0000-0002-7230-4471	Research Institute in Semiochemistry and Applied Ethology (IRSEA), APT, France	Research Institute in Semiochemistry and Applied Ethology (IRSEA), APT, France	DR gratefully thanks the Research Institute in Semiochemistry and Applied Ethology (IRSEA), APT, France for providing financial support for the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Austin CJ, 2004, EUR J BIOCHEM, V271, P2593, DOI 10.1111/j.1432-1033.2004.04188.x; Beier HM, 2000, ANN NY ACAD SCI, V923, P9; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bienboire-Frosini C, 2012, J INVEST ALLERG CLIN, V22, P270; Bienboire-Frosini C, 2012, VET J, V193, P162, DOI 10.1016/j.tvjl.2011.09.031; Bienboire-Frosini C, 2010, INT ARCH ALLERGY IMM, V152, P197, DOI 10.1159/000283024; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Bonnet B, 2018, BIOMED CENTRAL, V14, P860, DOI DOI 10.1186/S13223-018-0239-8; Callebaut I, 2000, ANN NY ACAD SCI, V923, P90; Carayol N, 2000, ALLERGY, V55, P570, DOI 10.1034/j.1398-9995.2000.00588.x; CHARPIN C, 1991, J ALLERGY CLIN IMMUN, V88, P77, DOI 10.1016/0091-6749(91)90303-6; Chaudhary V, 2016, SCI REP-UK, V6, DOI 10.1038/srep35156; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Chung AG, 2017, GENETICS, V205, P1517, DOI 10.1534/genetics.116.194571; Colpitts TL, 2000, ANN NY ACAD SCI, V923, P312; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; DABROWSKI AJ, 1990, J ALLERGY CLIN IMMUN, V86, P462, DOI 10.1016/S0091-6749(05)80200-3; Daniel JC, 2000, ANN NY ACAD SCI, V923, P1; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, P345; DeAndrade AD, 1996, CLIN EXP ALLERGY, V26, P178, DOI 10.1111/j.1365-2222.1996.tb00077.x; DLOUHY SR, 1987, GENETICS, V115, P535; DOMINGUEZ P, 1995, FEBS LETT, V376, P257, DOI 10.1016/0014-5793(95)01294-4; Emes RD, 2004, GENES, P1516, DOI [10.11014.2540304, DOI 10.1101/GR.2540304]; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gelly JC, 2011, NUCLEIC ACIDS RES, V39, pW18, DOI 10.1093/nar/gkr333; Glasgow BJ, 2002, ADV EXP MED BIOL, V506, P573; GRIFFITH IJ, 1992, GENE, V113, P263, DOI 10.1016/0378-1119(92)90405-E; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Irwin RS, 2013, CHEST, V143, P1, DOI 10.1378/chest.12-2762; Jackson Brian C., 2011, Human Genomics, V5, P691; Jamroz M, 2013, NUCLEIC ACIDS RES, V41, pW427, DOI 10.1093/nar/gkt332; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Kaiser L, 2003, J BIOL CHEM, V278, P37730, DOI 10.1074/jbc.M304740200; Kaiser L, 2007, J MOL BIOL, V370, P714, DOI 10.1016/j.jmb.2007.04.074; KARN RC, 1994, BIOCHEM GENET, V32, P271, DOI 10.1007/BF00555830; Karn RC, 1998, BIOCHEM GENET, V36, P105, DOI 10.1023/A:1018708404789; Karn RC, 1999, BIOCHEM GENET, V37, P187, DOI 10.1023/A:1018786622052; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; KARN RC, 1991, J HERED, V82, P453, DOI 10.1093/oxfordjournals.jhered.a111127; Karn RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115454; Karn RC, 2014, BIOCHEM SOC T, V42, P851, DOI 10.1042/BST20140042; Karn RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047697; Klug J, 2000, ANN NY ACAD SCI, V923, P348; Kristensen AK, 1997, BIOL CHEM, V378, P899; KRUSCHE C, 1994, ANN ANAT, V176, P23, DOI 10.1016/S0940-9602(11)80409-7; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laukaitis C.M., 2012, EVOLUTION HOUSE MOUS, P150, DOI [10.1017/CBO9781139044547.009, DOI 10.1017/CBO9781139044547.009]; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035898; Laukaitis CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-40; Laukaitis CM, 2005, BIOL J LINN SOC, V84, P493, DOI 10.1111/j.1095-8312.2005.00450.x; Laukaitis CM, 2003, MAMM GENOME, V14, P679, DOI 10.1007/s00335-003-2291-y; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; Ligabue-Braun R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132311; MORGENSTERN JP, 1991, P NATL ACAD SCI USA, V88, P9690, DOI 10.1073/pnas.88.21.9690; Mukerjhee A., 2000, ANN NY ACAD SCI, V932, P1; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Ni J, 2000, ANN NY ACAD SCI, V923, P25; Niimi T, 2001, MOL ENDOCRINOL, V15, P2021, DOI 10.1210/me.15.11.2021; OHMAN JL, 1977, J ALLERGY CLIN IMMUN, V60, P317, DOI 10.1016/0091-6749(77)90112-9; Pageat P, 2003, VET CLIN N AM-SMALL, V33, P187, DOI 10.1016/S0195-5616(02)00128-6; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; PARKER M, 1982, NATURE, V298, P92, DOI 10.1038/298092a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poupon A, 1999, THEOR CHEM ACC, V101, P2, DOI 10.1007/s002140050397; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tu JB, 2015, EVOL BIOINFORM, V11, DOI 10.4137/EBO.S25580; VAILES LD, 1994, J ALLERGY CLIN IMMUN, V93, P22, DOI 10.1016/0091-6749(94)90229-1; VANMILLIGEN FJ, 1990, INT ARCH ALLER A IMM, V92, P375, DOI 10.1159/000235168; Watson MA, 1996, CANCER RES, V56, P860; Zahradnik E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00076	75	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197618	10.1371/journal.pone.0197618	http://dx.doi.org/10.1371/journal.pone.0197618			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771985	Green Published, gold, Green Submitted			2022-12-26	WOS:000432348900079
J	Wagner, SG; Ziegler, M; Lowe, H; Kremling, A; Pfluger-Grau, K				Wagner, Sabine G.; Ziegler, Martin; Loewe, Hannes; Kremling, Andreas; Pflueger-Grau, Katharina			pTRA - A reporter system for monitoring the intracellular dynamics of gene expression	PLOS ONE			English	Article							EUROPEAN VECTOR ARCHITECTURE; FLUORESCENT PROTEIN; ESCHERICHIA-COLI; BIOLOGY; SEVA	The presence of standardised tools and methods to measure and represent accurately biological parts and functions is a prerequisite for successful metabolic engineering and crucial to understand and predict the behaviour of synthetic genetic circuits. Many synthetic gene networks are based on transcriptional circuits, thus information on transcriptional and translational activity is important for understanding and fine-tuning the synthetic function. To this end, we have developed a toolkit to analyse systematically the transcriptional and translational activity of a specific synthetic part in vivo. It is based on the plasmid pTRA and allows the assignment of specific transcriptional and translational outputs to the gene(s) of interest (GOI) and to compare different genetic setups. By this, the optimal combination of transcriptional strength and translational activity can be identified. The design is tested in a case study using the gene encoding the fluorescent mCherry protein as GOI. We show the intracellular dynamics of mRNA and protein formation and discuss the potential and shortcomings of the pTRA plasmid.	[Wagner, Sabine G.; Ziegler, Martin; Loewe, Hannes; Kremling, Andreas; Pflueger-Grau, Katharina] Tech Univ Munich, Fac Mech Engn, Syst Biotechnol, Garching, Germany; [Ziegler, Martin] Univ Stuttgart, Inst Biochem Engn, Stuttgart, Germany	Technical University of Munich; University of Stuttgart	Pfluger-Grau, K (corresponding author), Tech Univ Munich, Fac Mech Engn, Syst Biotechnol, Garching, Germany.	k.pflueger-grau@tum.de		Lowe, Hannes/0000-0003-3867-6391; Ziegler, Martin/0000-0003-2137-5234	German Federal Ministry of Education and Research (BMBF) with the Grant SysBioTerp [031A305A]	German Federal Ministry of Education and Research (BMBF) with the Grant SysBioTerp	This work was supported by the German Federal Ministry of Education and Research (BMBF) with the Grant SysBioTerp (Support Code 031A305A) to AK.	Borkowski O, 2016, CURR OPIN MICROBIOL, V33, P123, DOI 10.1016/j.mib.2016.07.009; de Lorenzo V, 2018, NEW BIOTECHNOL, V40, P170, DOI 10.1016/j.nbt.2017.05.001; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Filonov GS, 2015, CHEM BIOL, V22, P649, DOI 10.1016/j.chembiol.2015.04.018; Filonov GS, 2014, J AM CHEM SOC, V136, P16299, DOI 10.1021/ja508478x; Gawin A, 2017, MICROB BIOTECHNOL, V10, P702, DOI 10.1111/1751-7915.12701; Gorii-Moreno A, 2015, BIORXIV, DOI [10.1101/019927, DOI 10.1101/019927]; Hiller J, 2007, BIOTECHNOL LETT, V29, P1169, DOI 10.1007/s10529-007-9384-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martinez-Garcia E, 2015, NUCLEIC ACIDS RES, V43, pD1183, DOI 10.1093/nar/gku1114; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; RIESENBERG D, 1991, J BIOTECHNOL, V20, P17, DOI 10.1016/0168-1656(91)90032-Q; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Silva-Rocha R, 2013, NUCLEIC ACIDS RES, V41, pD666, DOI 10.1093/nar/gks1119; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6	15	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197420	10.1371/journal.pone.0197420	http://dx.doi.org/10.1371/journal.pone.0197420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29772009	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900057
J	Eckhardt, BL; Gagliardi, M; Iles, L; Evans, K; Ivan, C; Liu, XP; Liu, CG; Souza, G; Rao, A; Meric-Bernstam, F; Ueno, NT; Bartholomeusz, GA				Eckhardt, Bedrich L.; Gagliardi, Maria; Iles, LaKesla; Evans, Kurt; Ivan, Cristina; Liu, Xiuping; Liu, Chang-Gong; Souza, Glauco; Rao, Arvind; Meric-Bernstam, Funda; Ueno, Naoto T.; Bartholomeusz, Geoffrey A.			Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies	PLOS ONE			English	Article							3-DIMENSIONAL CELL-CULTURE; MAGNETIC-LEVITATION; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; COLORECTAL-CANCER; DRUG DEVELOPMENT; OVER-EXPRESSION; COCULTURE MODEL; ORGANOID MODELS; IN-VIVO	Inflammatory breast cancer (IBC) is a rare and aggressive presentation of invasive breast cancer with a 62% to 68% 5-year survival rate. It is the most lethal form of breast cancer, and early recognition and treatment is important for patient survival. Like non-inflammatory breast cancer, IBC comprises multiple subtypes, with the triple-negative subtype being over-represented. Although the current multimodality treatment regime of anthracycline-and taxane-based neoadjuvant therapy, surgery, and radiotherapy has improved the outcome of patients with triple-negative IBC, overall survival continues to be worse than in patients with non-inflammatory locally advanced breast cancer. Translation of new therapies into the clinics to successfully treat IBC has been poor, in part because of the lack of in vitro preclinical models that can accurately predict the response of the original tumor to therapy. We report the generation of a preclinical IBC patient-derived xenograft (PDX)-derived ex vivo (PDXEx) model and show that it closely replicates the tissue architecture of the original PDX tumor harvested from mice. The gene expression profile of our IBC PDXEx model had a high degree of correlation to that of the original tumor. This suggests that the process of generating the PDXEx model did not significantly alter the molecular signature of the original tumor. We demonstrate a high degree of similarity in drug response profile between a PDX mouse model and our PDXEx model generated from the same original PDX tumor tissue and treated with the same panel of drugs, indicating that our PDXEx model had high predictive value in identifying effective tumor-specific therapies. Finally, we used our PDXEx model as a platform for a robotic-based high-throughput drug screen of a 386-drug anti-cancer compound library. The top candidates identified from this drug screen all demonstrated greater therapeutic efficacy than the standard-of-care drugs used in the clinic to treat triple-negative IBC, doxorubicin and paclitaxel. Our PDXEx model is simple, and we are confident that it can be incorporated into a PDX mouse system for use as a first-pass screening platform. This will permit the identification of effective tumor-specific therapies with high predictive value in a resource-, time-, and cost-efficient manner.	[Eckhardt, Bedrich L.; Gagliardi, Maria; Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Eckhardt, Bedrich L.; Ueno, Naoto T.; Bartholomeusz, Geoffrey A.] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Iles, LaKesla; Ivan, Cristina; Liu, Xiuping; Liu, Chang-Gong; Bartholomeusz, Geoffrey A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Evans, Kurt; Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Souza, Glauco] Nano3D Biosci, Houston, TX USA; [Souza, Glauco] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Rao, Arvind] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Bartholomeusz, GA (corresponding author), Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA.; Bartholomeusz, GA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	gbarthol@mdanderson.org		Eckhardt, Bedrich/0000-0002-3402-3900; Ivan, Cristina/0000-0002-4848-0168	Avon Foundation grant [02-2015-067]; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Cancer Prevention and Research Institute of Texas [RP110532, RP150578]; American Cancer Society grant [RSG-16-005-01]; Cancer Center Support Grant from the National Cancer Institute [P30CA016672]	Avon Foundation grant; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Cancer Prevention and Research Institute of Texas; American Cancer Society grant(American Cancer Society); Cancer Center Support Grant from the National Cancer Institute	This work was supported by an Avon Foundation grant 02-2015-067 (https//www.avonfoundation.org/programs/breast-cancer/) to Geoffrey A. Bartholomeusz, the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic (https://www.mdanderson.org/research/departments-labs-institutes/programs-centers/Inflammatory-breast-cancer-research-program.html) to Geoffrey A. Bartholomeusz, Cancer Prevention and Research Institute of Texas grants RP110532 and RP150578 (www.cprit.state.tx.us) to Arvind Rao, an American Cancer Society grant RSG-16-005-01 (Cancerorg) to Arvind Rao, and a Cancer Center Support Grant P30CA016672 from the National Cancer Institute, which supports the Bioinformatics Shared Resource to Arvind Rao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeywardhana DY, 2016, J MED IMAG RADIAT ON, V60, P83, DOI 10.1111/1754-9485.12418; *ACS, 2007, CANC FACTS FIG 2007; Alpaugh ML, 1999, CANCER RES, V59, P5079; Anderson William F, 2005, Breast Dis, V22, P9; [Anonymous], 1993, AM VET MED ASS, V202, P229; Astashkina A, 2014, ADV DRUG DELIVER REV, V69, P1, DOI 10.1016/j.addr.2014.02.008; Bartholomesuz G, 2014, FRONTIERS IN RNAI, V1, P215; Becker JL, 2013, NAT REV CANCER, V13, P315, DOI 10.1038/nrc3507; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Broutier L, 2017, NAT MED, V23, P1424, DOI 10.1038/nm.4438; Buchsbaum RJ, 2016, CANCERS, V8, DOI 10.3390/cancers8020019; Cabioglu N, 2007, ANN ONCOL, V18, P1021, DOI 10.1093/annonc/mdm060; Cariati M, 2005, SURG ONCOL, V14, P133, DOI 10.1016/j.suronc.2005.07.004; Centenera MM, 2013, NAT REV UROL, V10, P483, DOI 10.1038/nrurol.2013.126; Costa R, 2017, ONCOTARGET, V8, P12417, DOI 10.18632/oncotarget.13778; Cristofanilli M, 2003, ONCOLOGIST, V8, P141, DOI 10.1634/theoncologist.8-2-141; Cristofanilli M, 2007, CANCER-AM CANCER SOC, V110, P1436, DOI 10.1002/cncr.22927; Cristofanilli M, 2016, LANCET ONCOL, V17, P544, DOI 10.1016/S1470-2045(16)00064-4; Dawood S, 2011, ANN ONCOL, V22, P515, DOI 10.1093/annonc/mdq345; Dawood S, 2011, ONCOLOGY, V25, P73; Dawood S, 2011, ONCOLOGY-NY, V25, P264; Dawood S, 2011, CANCER-AM CANCER SOC, V117, P1819, DOI 10.1002/cncr.25682; Dawood S, 2010, EXPERT REV ANTICANC, V10, P209, DOI [10.1586/era.09.90, 10.1586/ERA.09.90]; Desai A, 2014, RADIOTHER ONCOL, V110, P538, DOI 10.1016/j.radonc.2013.10.040; Desai PK, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051085; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P59, DOI 10.1016/S1040-8428(00)00076-7; Dong X, 2015, ONCOTARGET, V6, P1231, DOI 10.18632/oncotarget.2840; Evans KW, 2017, CLIN CANCER RES, V23, P6468, DOI 10.1158/1078-0432.CCR-17-0615; Fouad TM, 2015, BREAST CANCER RES TR, V152, P407, DOI 10.1007/s10549-015-3436-x; Fouad TM, 2014, ADV EXP MED BIOL, V816, P53, DOI 10.1007/978-3-0348-0837-8_3; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Giussani M, 2015, SEMIN CANCER BIOL, V35, P3, DOI 10.1016/j.semcancer.2015.09.012; Haisler WL, 2013, NAT PROTOC, V8, P1940, DOI 10.1038/nprot.2013.125; Hamm CA, 2016, MOL CANCER THER, V15, P1746, DOI 10.1158/1535-7163.MCT-15-0353; Hance KW, 2005, JNCI-J NATL CANCER I, V97, P966, DOI 10.1093/jnci/dji172; Hess MW, 2010, METHOD CELL BIOL, V96, P649, DOI 10.1016/S0091-679X(10)96027-5; Hurley J, 2006, J CLIN ONCOL, V24, P1831, DOI 10.1200/JCO.2005.02.8886; Hynds RE, 2013, STEM CELLS, V31, P417, DOI 10.1002/stem.1290; Iniesta MD, 2009, EXPERT OPIN PHARMACO, V10, P2987, DOI 10.1517/14656560903401638; Jaganathan H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06468; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Kim SJ, 2005, CLIN CANCER RES, V11, P8425, DOI 10.1158/1078-0432.CCR-05-0449; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Lamhamedi-Cherradi SE, 2014, ADV DRUG DELIVER REV, V79-80, P155, DOI 10.1016/j.addr.2014.07.012; Lee J, 2015, J CANCER, V6, P1306, DOI 10.7150/jca.13266; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Lee KW, 2005, CLIN IMAG, V29, P22, DOI 10.1016/j.clinimag.2004.03.006; Levine PH, 2008, SEMIN ONCOL, V35, P11, DOI 10.1053/j.seminoncol.2007.11.018; Li CP, 2012, ONCOTARGET, V3, P314, DOI 10.18632/oncotarget.463; Li J, 2011, ONCOLOGIST, V16, P1675, DOI 10.1634/theoncologist.2011-0196; Limentani SA, 2007, J CLIN ONCOL, V25, P1232, DOI 10.1200/JCO.2005.05.3306; Lin HC, 2016, J UROLOGY, V195, P788, DOI 10.1016/j.juro.2015.10.129; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Masuda H, 2014, ANN ONCOL, V25, P384, DOI 10.1093/annonc/mdt525; Matro JM, 2015, CLIN BREAST CANCER, V15, P1, DOI 10.1016/j.clbc.2014.05.005; Miki Y, 2012, J STEROID BIOCHEM, V131, P68, DOI 10.1016/j.jsbmb.2011.12.004; Molckovsky A, 2009, CAN FAM PHYSICIAN, V55, P25; Moro M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/568567; Natori A, 2013, CLIN BREAST CANCER, V13, P460, DOI 10.1016/j.clbc.2013.08.004; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Peery RC, 2017, DRUG DISCOV TODAY, V22, P1466, DOI 10.1016/j.drudis.2017.05.009; Ranga A, 2014, ADV DRUG DELIVER REV, V69, P19, DOI 10.1016/j.addr.2014.02.006; Robertson Fredika M, 2013, J Exp Ther Oncol, V10, P219; Robertson FM, 2010, CA-CANCER J CLIN, V60, P351, DOI 10.3322/caac.20082; Shah AN, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0443-7; Shiga K, 2015, CANCERS, V7, P2443, DOI 10.3390/cancers7040902; Souza GR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040683; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Suarez-Arroyo IJ, 2016, AM J CANCER RES, V6, P1720; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Timm DM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03000; Tsai CJJL, 2015, AM J CLIN ONCOL-CANC, V38, P242, DOI 10.1097/COC.0b013e3182937921; Tseng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep30640; Tseng H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13987; Tseng H, 2014, ACTA BIOMATER, V10, P173, DOI 10.1016/j.actbio.2013.09.003; Tseng H, 2013, TISSUE ENG PART C-ME, V19, P665, DOI [10.1089/ten.tec.2012.0157, 10.1089/ten.TEC.2012.0157]; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Van Laere SJ, 2013, CLIN CANCER RES, V19, P4685, DOI 10.1158/1078-0432.CCR-12-2549; van Uden DJP, 2015, CRIT REV ONCOL HEMAT, V93, P116, DOI 10.1016/j.critrevonc.2014.09.003; Vlachogiannis G, 2018, SCIENCE, V359, P920, DOI 10.1126/science.aao2774; Xie BY, 2016, CHINESE MED J-PEKING, V129, P2469, DOI 10.4103/0366-6999.191782; Yagi N, 2009, CANCER RES, V69, P6531, DOI 10.1158/0008-5472.CAN-08-3945; Yamasaki F, 2007, CANCER RES, V67, P5779, DOI 10.1158/0008-5472.CAN-06-3020; Yang WT, 2008, BREAST CANCER RES TR, V109, P417, DOI 10.1007/s10549-007-9671-z	89	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0195932	10.1371/journal.pone.0195932	http://dx.doi.org/10.1371/journal.pone.0195932			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768500	Green Submitted, gold, Green Published			2022-12-26	WOS:000432329200012
J	Rani, RHJ; Victoire, TAA				Rani, Hannah Jessie R.; Victoire, Aruldoss Albert T.			Training radial basis function networks for wind speed prediction using PSO enhanced differential search optimizer	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; BACK-PROPAGATION ALGORITHM; ARTIFICIAL NEURAL-NETWORKS; ECONOMIC-DISPATCH; BEE COLONY; HYBRID; EVOLUTION; MODEL	This paper presents an integrated hybrid optimization algorithm for training the radial basis function neural network (RBF NN). Training of neural networks is still a challenging exercise in machine learning domain. Traditional training algorithms in general suffer and trap in local optima and lead to premature convergence, which makes them ineffective when applied for datasets with diverse features. Training algorithms based on evolutionary computations are becoming popular due to their robust nature in overcoming the drawbacks of the traditional algorithms. Accordingly, this paper proposes a hybrid training procedure with differential search (DS) algorithm functionally integrated with the particle swarm optimization (PSO). To surmount the local trapping of the search procedure, a new population initialization scheme is proposed using Logistic chaotic sequence, which enhances the population diversity and aid the search capability. To demonstrate the effectiveness of the proposed RBF hybrid training algorithm, experimental analysis on publicly available 7 benchmark datasets are performed. Subsequently, experiments were conducted on a practical application case for wind speed prediction to expound the superiority of the proposed RBF training algorithm in terms of prediction accuracy.	[Rani, Hannah Jessie R.; Victoire, Aruldoss Albert T.] Anna Univ, Dept Elect & Elect Engn, Reg Campus, Coimbatore, Tamil Nadu, India	Anna University; Anna University of Technology Coimbatore	Victoire, TAA (corresponding author), Anna Univ, Dept Elect & Elect Engn, Reg Campus, Coimbatore, Tamil Nadu, India.	t.aruldoss@gmail.com	VICTOIRE, T ARULDOSS ALBERT/V-6247-2018	VICTOIRE, T ARULDOSS ALBERT/0000-0003-2274-1988; , Hannah Jessie Rani R/0000-0002-5449-104X				Alexandridis A, 2016, APPL SOFT COMPUT, V49, P485, DOI 10.1016/j.asoc.2016.08.032; Alexiadis MC, 1999, IEEE T ENERGY CONVER, V14, P836, DOI 10.1109/60.790962; Amrane Y, 2015, INT J ELEC POWER, V64, P551, DOI 10.1016/j.ijepes.2014.07.060; Bahrami S, 2014, ENERGY, V72, P434, DOI 10.1016/j.energy.2014.05.065; Broomhead D. S., 1988, Complex Systems, V2, P321; Caponetto R, 2003, IEEE T EVOLUT COMPUT, V7, P289, DOI 10.1109/TEVC.2003.810069; Chang GW, 2017, RENEW ENERG, V105, P301, DOI 10.1016/j.renene.2016.12.071; Chen ZY, 2016, INT J ARTIF INTELL T, V25, DOI 10.1142/S0218213016500044; Civicioglu P, 2012, COMPUT GEOSCI-UK, V46, P229, DOI 10.1016/j.cageo.2011.12.011; Coelho LS, 2006, IEEE T POWER SYST, V21, P989, DOI 10.1109/TPWRS.2006.873410; Fathi V, 2013, NEUROCOMPUTING, V111, P169, DOI 10.1016/j.neucom.2012.12.024; Gao WF, 2015, IEEE T CYBERNETICS, V45, P2827, DOI 10.1109/TCYB.2014.2387067; Grasso F, 2017, NEURAL PROCESS LETT, P1; Haque AU, 2012, RENEW SUST ENERG REV, V16, P4563, DOI 10.1016/j.rser.2012.05.042; Harpham C, 2004, NEURAL COMPUT APPL, V13, P193, DOI [10.1007/s00521-004-0404-5, 10.1007/S00521-004-0404-5]; Hu JM, 2015, ENERGY, V81, P563, DOI 10.1016/j.energy.2014.12.074; Ilonen J, 2003, NEURAL PROCESS LETT, V17, P93, DOI 10.1023/A:1022995128597; Jaddi NS, 2015, APPL SOFT COMPUT, V37, P71, DOI 10.1016/j.asoc.2015.08.002; Jaddi NS, 2015, INFORM SCIENCES, V294, P628, DOI 10.1016/j.ins.2014.08.050; Jafrasteh B, 2017, NEUROCOMPUTING, V235, P217, DOI 10.1016/j.neucom.2017.01.016; Kalogirou SA, 2000, APPL ENERG, V67, P17, DOI 10.1016/S0306-2619(00)00005-2; Lee CM, 2009, NEUROCOMPUTING, V73, P449, DOI 10.1016/j.neucom.2009.07.005; Li G, 2010, APPL ENERG, V87, P2313, DOI 10.1016/j.apenergy.2009.12.013; LIU Xiaoju, 2010, POWER SYSTEM TECHNOL, V12, P99; Lu JN, 2015, NEUROCOMPUTING, V152, P305, DOI 10.1016/j.neucom.2014.10.065; Meng K, 2009, IET GENER TRANSM DIS, V3, P325, DOI 10.1049/iet-gtd.2008.0328; Mirjalili S, 2014, INFORM SCIENCES, V269, P188, DOI 10.1016/j.ins.2014.01.038; More A, 2003, MAR STRUCT, V16, P35, DOI 10.1016/S0951-8339(02)00053-9; MUSAVI MT, 1992, NEURAL NETWORKS, V5, P595, DOI 10.1016/S0893-6080(05)80038-3; Neruda R, 2005, FUTURE GENER COMP SY, V21, P1131, DOI 10.1016/j.future.2004.03.013; Petkovic D, 2016, THEOR APPL CLIMATOL, V125, P555, DOI 10.1007/s00704-015-1522-y; Piotrowski AP, 2014, APPL SOFT COMPUT, V21, P382, DOI 10.1016/j.asoc.2014.03.039; Poitras G, 2011, WIND ENG, V35, P369, DOI 10.1260/0309-524X.35.3.369; Potter CW, 2006, IEEE T POWER SYST, V21, P965, DOI 10.1109/TPWRS.2006.873421; Rahnamayan S, 2008, IEEE T EVOLUT COMPUT, V12, P64, DOI 10.1109/TEVC.2007.894200; Ramasamy P, 2015, RENEW ENERG, V80, P338, DOI 10.1016/j.renene.2015.02.034; Ramirez-Rosado IJ, 2009, RENEW ENERG, V34, P1848, DOI 10.1016/j.renene.2008.11.014; Satapathy Sandeep Kumar, 2017, Informatics in Medicine Unlocked, V6, P1, DOI 10.1016/j.imu.2016.12.001; Selakov A, 2014, APPL SOFT COMPUT, V16, P80, DOI 10.1016/j.asoc.2013.12.001; Shang ZG, 2015, NEUROCOMPUTING, V148, P544, DOI 10.1016/j.neucom.2014.07.009; Shen W, 2011, KNOWL-BASED SYST, V24, P378, DOI 10.1016/j.knosys.2010.11.001; Sheta AF, 2001, INFORM SCIENCES, V133, P221, DOI 10.1016/S0020-0255(01)00086-X; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Sideratos G, 2012, IEEE T POWER SYST, V27, P1788, DOI 10.1109/TPWRS.2012.2187803; Subathra MSP, 2015, IEEE SYST J, V9, P1031, DOI 10.1109/JSYST.2013.2297471; Sun YJ, 2017, NEUROCOMPUTING, V261, P83, DOI 10.1016/j.neucom.2016.07.072; Victoire TAA, 2004, ELECTR POW SYST RES, V71, P51, DOI 10.1016/j.epsr.2003.12.017; Wang L, 2015, EXPERT SYST APPL, V42, P855, DOI 10.1016/j.eswa.2014.08.018; Wu JS, 2015, NEUROCOMPUTING, V148, P136, DOI 10.1016/j.neucom.2012.10.043; Yu SW, 2015, ENERG CONVERS MANAGE, V91, P176, DOI 10.1016/j.enconman.2014.11.059; Zeng J., 2011, IEEE PES GEN M, P1, DOI DOI 10.1109/PSCE.2011.5772573; Zhang JR, 2007, APPL MATH COMPUT, V185, P1026, DOI 10.1016/j.amc.2006.07.025	52	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196871	10.1371/journal.pone.0196871	http://dx.doi.org/10.1371/journal.pone.0196871			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768463	gold, Green Published			2022-12-26	WOS:000432329200050
J	Bindawas, SM; Vennu, V; Alfhadel, S; Al-Otaibi, AD; Binnasser, AS				Bindawas, Saad M.; Vennu, Vishal; Alfhadel, Saud; Al-Otaibi, Ali D.; Binnasser, Ahmad S.			Knee pain and health-related quality of life among older patients with different knee osteoarthritis severity in Saudi Arabia	PLOS ONE			English	Article							POPULATION-BASED COHORT; ASSOCIATION; DISABILITY; DOMAINS; IMPACT; VARY; HIP	Objective There is a lack of knowledge about health-related quality of life (HRQoL) in Saudi patients with musculoskeletal impairment, particularly among older adult populations. Thus, the current research aimed to determine the association of knee osteoarthritis (OA) severity with knee pain (KP) and HRQoL among older patients in Riyadh, Saudi Arabia. Methods In a multicenter cross-sectional study, we recruited 209 consecutive males and females aged >= 55 years with radiographically diagnosed knee OA from five hospitals across Riyadh, Saudi Arabia. According to the Kellgren & Lawrence classification, patients were classified into two groups: mild/moderate knee OA (n = 126) and severe knee OA (n = 83). KP and HRQoL were assessed using the pain visual analogue scale (VAS) and the 36-Item Short Form Health Survey (SF-36), respectively. A higher score on the pain VAS and the SF-36 represented worse KP and better HRQoL, respectively. Results Severe knee OA was significantly associated with an increased score of 3.47 (p <.0001) points on the pain VAS compared with the score reported by patients with mild/moderate knee OA. Additionally, it was significantly associated with reduced scores of 6.83 and 5.82 (both: p <.0001) points on the physical and mental composite summary subscales of the SF-36, respectively, compared with the scores of patients with mild/moderate knee OA, even after adjusting for all covariates. Conclusion Older patients with severe knee OA had significantly worse KP and reduced HRQoL compared to patients with mild/moderate knee conditions, even after controlling for confounders.	[Bindawas, Saad M.; Vennu, Vishal; Alfhadel, Saud; Al-Otaibi, Ali D.] King Saud Univ, Coll Appl Med Sci, Dept Rehabil Sci, Riyadh, Saudi Arabia; [Alfhadel, Saud] Gen Directorate Med Serv, Phys Therapy Dept, Riyadh, Saudi Arabia; [Al-Otaibi, Ali D.] Dawadmi Gen Hosp, Phys Therapy Dept, Riyadh, Saudi Arabia; [Binnasser, Ahmad S.] King Saud Univ, Coll Med, Dept Orthoped, Riyadh, Saudi Arabia	King Saud University; King Saud University	Bindawas, SM (corresponding author), King Saud Univ, Coll Appl Med Sci, Dept Rehabil Sci, Riyadh, Saudi Arabia.	sbindawas@ksu.edu.sa	Vennu, Vishal/ABG-4133-2021; Vennu, Vishal/E-5419-2019; Vennu, vishal/U-2661-2017; Bin Nasser, Ahmad/AAL-4444-2020; Vennu, Vishal/CAF-9545-2022	Vennu, Vishal/0000-0001-7616-3955; Vennu, Vishal/0000-0001-7616-3955; Vennu, vishal/0000-0001-7616-3955; Alfadhel, Saud/0000-0001-9184-0344	Deanship of Scientific Research at King Saud University [RG-1438-085]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciations to the Deanship of Scientific Research at King Saud University for funding this work through Research Group No. RG-1438-085. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan BM, 2014, MOD RHEUMATOL, V24, P166, DOI 10.3109/14397595.2013.854046; Almalki M., 2011, Eastern Mediterranean Health Journal, V17, P784; Alrushud AS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014537; Bindawas SM, 2015, RHEUMATOL INT, V35, P2095, DOI 10.1007/s00296-015-3309-y; Bindawas SM, 2015, J ORTHOP SPORT PHYS, V45, P128, DOI 10.2519/jospt.2015.5123; Bindawas SM, 2011, ETHNIC DIS, V21, P230; Coons SJ, 1998, MED CARE, V36, P428, DOI 10.1097/00005650-199803000-00018; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Neto EMD, 2011, REV BRAS REUMATOL, V51, P539; Farr Ii Jack, 2013, Open Orthop J, V7, P619, DOI 10.2174/1874325001307010619; Fayers P.M., 2013, QUALITY LIFE ASSESSM; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Homoud Al-Hazmi Ahmad, 2012, Niger Med J, V53, P213, DOI 10.4103/0300-1652.107556; Javaid MK, 2012, ARTHRITIS RHEUM-US, V64, P3246, DOI 10.1002/art.34594; Jhun HJ, 2013, J KOREAN MED SCI, V28, P1807, DOI 10.3346/jkms.2013.28.12.1807; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kiadaliri AA, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0525-4; Kon E, 2014, EUROPEAN SURG ORTHOP, P3371, DOI [10.1007/978-3-642-34746-7_120, DOI 10.1007/978-3-642-34746-7_120]; Laslett LL, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-168; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; McCarthy I, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-169; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Neogi T, 2010, OSTEOARTHR CARTILAGE, V18, P1250, DOI 10.1016/j.joca.2010.08.001; Pang J, 2015, INT J CLIN EXP MED, V8, P4472; Riddle DL, 2014, PHYS THER, V94, P490, DOI 10.2522/ptj.20130331; Sadosky AB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3121; Shimura Y, 2013, OSTEOARTHR CARTILAGE, V21, P1179, DOI 10.1016/j.joca.2013.05.014; Walker JL, 2016, DISABIL HEALTH J, V9, P510, DOI 10.1016/j.dhjo.2016.02.004; Wu MJ, 2015, EUR J HEALTH ECON, V16, P141, DOI 10.1007/s10198-013-0559-z; Xie F, 2006, OSTEOARTHR CARTILAGE, V14, P224, DOI 10.1016/j.joca.2005.09.009; Xie F, 2005, SEMIN ARTHRITIS RHEU, V34, P793, DOI 10.1016/j.semarthrit.2005.02.003; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	32	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196150	10.1371/journal.pone.0196150	http://dx.doi.org/10.1371/journal.pone.0196150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763420	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800006
J	Ravindra, KC; Ahrens, CC; Wang, Y; Ramseier, JY; Wishnok, JS; Griffith, LG; Grodzinsky, AJ; Tannenbaum, SR				Ravindra, Kodihalli C.; Ahrens, Caroline C.; Wang, Yang; Ramseier, Julie Y.; Wishnok, John S.; Griffith, Linda G.; Grodzinsky, Alan J.; Tannenbaum, Steven R.			Chemoproteomics of matrix metalloproteases in a model of cartilage degeneration suggests functional biomarkers associated with posttraumatic osteoarthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS; matrix metalloproteinase (MMP); osteoarthritis; peptidase; protein engineering; osteoarthritis; matrix metalloproteinase (MMP); ADAMTS; protein engineering; peptidase	IN-SITU ZYMOGRAPHY; SYNOVIAL FIBROBLASTS; MECHANICAL INJURY; PROTEASE ACTIVITY; BOVINE CARTILAGE; TISSUE INHIBITOR; GENE-EXPRESSION; COLLAGENASE; STROMELYSIN; ENDOMETRIOSIS	Active matrix metalloproteases (MMPs) play a significant role in the pathogenesis of many diseases including osteoarthritis (OA), which involves progressive proteolytic degradation of cartilage. Clinical success of OA interventions that target MMPs has been limited by a lack of information about the presence and activity of specific disease-related proteases. We therefore developed a chemoproteomics approach based on MS to characterize the release and activity of MMPs in an in vitro model of the early inflammatory phase of posttraumatic OA (PTOA). We designed and synthesized chemical activity-based probes (ABPs) to identify active MMPs in bovine cartilage explants cultured for 30 days with the proinflammatory cytokine, interleukin-1. Using these probes in an activity-based protein profiling-multidimensional identification technology (ABPP-MudPIT) approach, we identified active MMP-1, -2, -3, -7, -9, -12, and -13 in the medium after 10 days of culture, the time at which irreversible proteolysis of the collagen network in the explant was detected using proteolytic activation of FRET-quenched MMP substrates. Total MMP levels were quantified by shotgun proteomics, which, taken with ABPP-MudPIT data, indicated the presence of predominantly inactive MMPs in the culture medium. The selectivity of the ABPP-MudPIT approach was further validated by detection of specific endogenous MMPs activated de novo with 4-aminophenylmurcuric acetate. The utility of the new ABPP-MudPIT approach for detecting molecular biomarkers of PTOA disease initiation and potential targets for therapeutics motivates possible application in other diseases involving MMP activity.	[Ravindra, Kodihalli C.; Wang, Yang; Ramseier, Julie Y.; Wishnok, John S.; Griffith, Linda G.; Grodzinsky, Alan J.; Tannenbaum, Steven R.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Tannenbaum, Steven R.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Ahrens, Caroline C.; Griffith, Linda G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Griffith, Linda G.] MIT, Ctr Gynepathol Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Grodzinsky, Alan J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Grodzinsky, Alan J.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tannenbaum, SR (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Tannenbaum, SR (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	srt@mit.edu		Griffith, Linda/0000-0002-1801-5548	National Institutes of Health NIAMS Grant [AR060331]; National Science Scholarship, Agency for Science, Technology and Research, Singapore; National Institutes of Health [R01EB010246]; John and Karine Begg Fund; National Research Foundation; Singapore Infectious Disease IRG, Singapore-MIT Alliance for Research and Technology (SMART); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010246] Funding Source: NIH RePORTER	National Institutes of Health NIAMS Grant; National Science Scholarship, Agency for Science, Technology and Research, Singapore; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John and Karine Begg Fund; National Research Foundation; Singapore Infectious Disease IRG, Singapore-MIT Alliance for Research and Technology (SMART); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health NIAMS Grant AR060331 (to A. J. G.), National Science Scholarship, Agency for Science, Technology and Research, Singapore (to W. Y.), National Institutes of Health Grant R01EB010246 (to L. G. G.), the John and Karine Begg Fund (to L. G. G.), the National Research Foundation, and the Singapore Infectious Disease IRG, Singapore-MIT Alliance for Research and Technology (SMART). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Caescu C., 2010, BIOCHEM J, V424, P79; Chen CH, 2013, J AM CHEM SOC, V135, P1645, DOI 10.1021/ja307866z; CHIN JR, 1985, J BIOL CHEM, V260, P2367; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Dickinson SC, 2003, MATRIX BIOL, V22, P267, DOI 10.1016/S0945-053X(03)00034-9; Dozin B, 2002, MATRIX BIOL, V21, P449, DOI 10.1016/S0945-053X(02)00028-8; Freije JR, 2003, J CHROMATOGR A, V1009, P155, DOI 10.1016/S0021-9673(03)00920-8; Gartner CA, 2007, J PROTEOME RES, V6, P1482, DOI 10.1021/pr060605f; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; He Y, 2013, MATRIX BIOL, V32, P143, DOI 10.1016/j.matbio.2012.12.001; Kellogg BA, 2011, BIOCONJUGATE CHEM, V22, P717, DOI 10.1021/bc100480a; Keow JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043434; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Levin JI, 2004, CURR TOP MED CHEM, V4, P1289, DOI 10.2174/1568026043387935; Levy DE, 1998, J MED CHEM, V41, P199, DOI 10.1021/jm970494j; Li Y, 2015, OSTEOARTHR CARTILAGE, V23, P266, DOI 10.1016/j.joca.2014.11.006; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; Miller MA, 2016, CANCER DISCOV, V6, P382, DOI 10.1158/2159-8290.CD-15-0933; Miller MA, 2013, P NATL ACAD SCI USA, V110, pE2074, DOI 10.1073/pnas.1222387110; Miller MA, 2011, INTEGR BIOL-UK, V3, P422, DOI 10.1039/c0ib00083c; Milner JM, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2034; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Mungall BA, 2001, J BIOCHEM BIOPH METH, V47, P169, DOI 10.1016/S0165-022X(00)00126-3; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; Niphakis MJ, 2014, ANNU REV BIOCHEM, V83, P341, DOI 10.1146/annurev-biochem-060713-035708; OKADA Y, 1992, LAB INVEST, V66, P680; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Ravindra KC, 2015, CHEM RES TOXICOL, V28, P1903, DOI 10.1021/acs.chemrestox.5b00105; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Stevens AL, 2009, MOL CELL PROTEOMICS, V8, P1475, DOI 10.1074/mcp.M800181-MCP200; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; VINCENTI MP, 1994, ARTHRITIS RHEUM, V37, P1115, DOI 10.1002/art.1780370802; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yan SJ, 2003, VET PATHOL, V40, P227, DOI 10.1354/vp.40-3-227; Zeitvogel A, 2001, AM J PATHOL, V159, P1839, DOI 10.1016/S0002-9440(10)63030-1	44	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 20	2018	293	29					11459	11469		10.1074/jbc.M117.818542	http://dx.doi.org/10.1074/jbc.M117.818542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN8UL	29794029	Green Published, hybrid			2022-12-26	WOS:000439449700016
J	Du, H; Leng, JP; Wang, PC; Li, L; Wang, YS				Du, Hua; Leng, Jiapeng; Wang, Pengcheng; Li, Lin; Wang, Yinsheng			Impact of tobacco-specific nitrosamine-derived DNA adducts on the efficiency and fidelity of DNA replication in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA replication; DNA polymerase; mutagenesis; carcinogenesis; DNA adduct; DNA alkylation; N-nitrosamine; translesion synthesis; translesion synthesis polymerase	TRANSLESION SYNTHESIS POLYMERASES; TANDEM MASS-SPECTROMETRY; LUNG-CANCER; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; MUTAGENIC PROPERTIES; ESCHERICHIA-COLI; NEVER-SMOKERS; REV1 PROTEIN; IN-VIVO; REPAIR	The tobacco-derived nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N-nitrosonornicotine (NNN) are known human carcinogens. Following metabolic activation, NNK and NNN can induce a number of DNA lesions, including several 4-(3-pyridyl)-4-oxobut-1-yl (POB) adducts. However, it remains unclear to what extent these lesions affect the efficiency and accuracy of DNA replication and how their replicative bypass is influenced by translesion synthesis (TLS) DNA polymerases. In this study, we investigated the effects of three stable POB DNA adducts (O-2-POB-dT, O-4-POB-dT, and O-6-POB-dG) on the efficiency and fidelity of DNA replication in HEK293T human cells. We found that, when situated in a double-stranded plasmid, O-2-POB-dT and O-4-POB-dT moderately blocked DNA replication and induced exclusively TA (approximate to 14.9%) and TC (approximate to 35.2%) mutations, respectively. On the other hand, O-6-POB-dG slightly impeded DNA replication, and this lesion elicited primarily the GA transition (approximate to 75%) together with a low frequency of the GT transversion (approximate to 3%). By conducting replication studies in isogenic cells in which specific TLS DNA polymerases (Pols) were deleted by CRISPR-Cas9 genome editing, we observed that multiple TLS Pols, especially Pol and Pol , are involved in bypassing these lesions. Our findings reveal the cytotoxic and mutagenic properties of specific POB DNA adducts and unravel the roles of several TLS polymerases in the replicative bypass of these adducts in human cells. Together, these results provide important new knowledge about the biological consequences of POB adducts.	[Du, Hua; Leng, Jiapeng; Wang, Pengcheng; Li, Lin; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022	Wang, Pengcheng/0000-0003-4581-983X	National Institutes of Health [R01 ES025121]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES025121] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grant R01 ES025121. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Carlson ES, 2016, CHEM RES TOXICOL, V29, P2194, DOI 10.1021/acs.chemrestox.6b00384; CRESPI CL, 1991, CARCINOGENESIS, V12, P1197, DOI 10.1093/carcin/12.7.1197; Delaney JC, 2008, CHEM RES TOXICOL, V21, P232, DOI 10.1021/tx700292a; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; GERSON SL, 1988, CANCER RES, V48, P5368; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gowda ASP, 2016, CHEM RES TOXICOL, V29, P303, DOI 10.1021/acs.chemrestox.5b00468; Gowda ASP, 2012, CHEM RES TOXICOL, V25, P1195, DOI 10.1021/tx200483g; Guengerich FP, 2003, BIOCHEMISTRY-US, V42, P10965, DOI 10.1021/bi034937z; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Guza R, 2010, ACS SYM SER, V1041, P73; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Jasti VP, 2011, CHEM RES TOXICOL, V24, P1833, DOI 10.1021/tx200435d; Kotandeniya D, 2013, BIOCHEMISTRY-US, V52, P4075, DOI 10.1021/bi4004952; Lao YB, 2006, CHEM RES TOXICOL, V19, P674, DOI 10.1021/tx050351x; Lawrence CW, 2002, DNA REPAIR, V1, P425, DOI 10.1016/S1568-7864(02)00038-1; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leng JP, 2017, ANAL CHEM, V89, P9124, DOI 10.1021/acs.analchem.7b01857; Li L, 2009, CHEM RES TOXICOL, V22, P1464, DOI 10.1021/tx9001572; Liu D, 2013, J MOL CELL BIOL, V5, P204, DOI 10.1093/jmcb/mjs061; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Pauly GT, 2002, CHEM RES TOXICOL, V15, P165, DOI 10.1021/tx0101245; PETERSON LA, 1993, CANCER RES, V53, P2780; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pustovalova Y, 2016, BIOCHEMISTRY-US, V55, P2043, DOI 10.1021/acs.biochem.5b01282; RONAI ZA, 1993, CARCINOGENESIS, V14, P2419, DOI 10.1093/carcin/14.11.2419; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shopland DR, 1995, ENVIRON HEALTH PERSP, V103, P131, DOI 10.2307/3432300; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; TAKESHITA M, 1994, NUCLEIC ACIDS RES, V22, P1897, DOI 10.1093/nar/22.10.1897; Urban AM, 2012, CHEM RES TOXICOL, V25, P2167, DOI 10.1021/tx300245w; Wang LJ, 1999, CHEM RES TOXICOL, V12, P127, DOI 10.1021/tx980251+; Wang PC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv941; Weerasooriya S, 2015, DNA REPAIR, V35, P63, DOI 10.1016/j.dnarep.2015.09.023; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; You CJ, 2015, NAT PROTOC, V10, P1389, DOI 10.1038/nprot.2015.094; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; Yousefzadeh MJ, 2013, DNA REPAIR, V12, P1, DOI 10.1016/j.dnarep.2012.10.004; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Zhai QQ, 2014, NUCLEIC ACIDS RES, V42, P10529, DOI 10.1093/nar/gku748; Zhai QQ, 2014, CARCINOGENESIS, V35, P2002, DOI 10.1093/carcin/bgu085	45	22	23	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11100	11108		10.1074/jbc.RA118.003477	http://dx.doi.org/10.1074/jbc.RA118.003477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789427	Green Published, hybrid			2022-12-26	WOS:000438882800022
J	Tillet, E; Ouarne, M; Desroches-Castan, A; Mallet, C; Subileau, M; Didier, R; Lioutsko, A; Belthier, G; Feige, JJ; Bailly, S				Tillet, Emmanuelle; Ouarne, Marie; Desroches-Castan, Agnes; Mallet, Christine; Subileau, Mariela; Didier, Robin; Lioutsko, Anna; Belthier, Guillaume; Feige, Jean-Jacques; Bailly, Sabine			A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); angiogenesis; vascular biology; blood; liver; heterodimer	KINASE 1 ALK1; TGF-BETA; GROWTH; SPECIFICITY; RECEPTORS; FAMILY; IDENTIFICATION; ACTIVATION; COMPLEXES; SIGNALS	Bone morphogenetic protein 9 (BMP9) and BMP10 are the two high-affinity ligands for the endothelial receptor activin receptor-like kinase 1 (ALK1) and are key regulators of vascular remodeling. They are both present in the blood, but their respective biological activities are still a matter of debate. The aim of the present work was to characterize their circulating forms to better understand how their activities are regulated in vivo. First, by cotransfecting BMP9 and BMP10, we found that both can form a disulfide-bonded heterodimer in vitro and that this heterodimer is functional on endothelial cells via ALK1. Next, we developed an ELISA that could specifically recognize the BMP9-BMP10 heterodimer and which indicated its presence in both human and mouse plasma. In addition to using available Bmp9-KO mice, we generated a conditional Bmp10-KO mouse strain. The plasma from Bmp10-KO mice, similarly to that of Bmp9-KO mice, completely lacked the ability to activate ALK1-transfected 3T3 cells or phospho-Smad1-5 on endothelial cells, indicating that the circulating BMP activity is mostly due to the BMP9-BMP10 heterodimeric form. This result was confirmed in human plasma that had undergone affinity chromatography to remove BMP9 homodimer. Finally, we provide evidence that hepatic stellate cells in the liver could be the source of the BMP9-BMP10 heterodimer. Together, our findings demonstrate that BMP9 and BMP10 can heterodimerize and that this heterodimer is responsible for most of the biological BMP activity found in plasma.	[Tillet, Emmanuelle; Ouarne, Marie; Desroches-Castan, Agnes; Mallet, Christine; Subileau, Mariela; Didier, Robin; Lioutsko, Anna; Belthier, Guillaume; Feige, Jean-Jacques; Bailly, Sabine] Univ Grenoble Alpes, INSERM, CEA, BIG Biol Canc & Infect, F-38000 Grenoble, France; [Didier, Robin] Univ Nice, INSERM, C3M, F-06200 Nice, France; [Lioutsko, Anna] Univ Paris Sud 11, IDMIT, INSERM, CEA, F-92260 Fontenay Aux Roses, France; [Belthier, Guillaume] Univ Montpellier, INSERM, CNRS, IGF, F-34090 Montpellier, France	CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Tillet, E (corresponding author), CEA G, BCI, BIG, UMR1036, 17 Rue Martyrs, F-38054 Grenoble, France.	emmanuelle.tillet@cea.fr	Castan, Agnes/AAS-2580-2021; Feige, Jean-Jacques/M-8905-2017; Ouarné, Marie/ABB-2357-2021; Desroches-Castan, Agnes/AAA-4557-2019; bailly, sabine/G-3540-2013	Castan, Agnes/0000-0002-3301-9504; Feige, Jean-Jacques/0000-0002-1354-7692; Ouarné, Marie/0000-0003-4724-4363; bailly, sabine/0000-0003-1043-7030; Tillet, Emmanuelle/0000-0002-0076-8007; Subileau, Mariela/0000-0002-7759-8376	Fondation Maladies Rares (FMR)	Fondation Maladies Rares (FMR)	We thank Dr. D. Constam (Ecole Polytechnique Federale de Lausanne, Switzerland) for his gift of PCR3-furin plasmid, Dr. S. J. lee (Johns Hopkins University School of Medicine, Baltimore, MD) and Dr. T. Zimmers (Thomas Jefferson University, Philadelphia, PA) for providing Bmp9-KO mice, Dr. D. Metzger (IGBMC, Illkirch, France) for providing the Rosa26-CreER<SUP>T2</SUP> mouse, and the animal facility staff at Institut de Biosciences et Biotechnologies de Grenoble (BIG, Grenoble, France) for animal husbandry. We thank the Fondation Maladies Rares (FMR) for its financial support to the generation of Bmp10<SUP>lox/lox</SUP> mice.	Allendorph GP, 2007, BIOCHEMISTRY-US, V46, P12238, DOI 10.1021/bi700907k; AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Breitkopf-Heinlein K, 2017, GUT, V66, P939, DOI 10.1136/gutjnl-2016-313314; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Constam DB, 2014, SEMIN CELL DEV BIOL, V32, P85, DOI 10.1016/j.semcdb.2014.01.008; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; de Vinuesa AG, 2016, CYTOKINE GROWTH F R, V27, P65, DOI 10.1016/j.cytogfr.2015.12.005; Fuerer C, 2014, J BIOL CHEM, V289, P17854, DOI 10.1074/jbc.M114.550301; Guo J, 2012, CYTOKINE GROWTH F R, V23, P61, DOI 10.1016/j.cytogfr.2012.02.001; Hernandez Felicia, 2015, Hum Genome Var, V2, P15040, DOI 10.1038/hgv.2015.40; Herrera B, 2009, CANCER RES, V69, P9254, DOI 10.1158/0008-5472.CAN-09-2912; Hinck A. P., 2016, COLD SPRING HARBOR P, V8; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Isaacs MJ, 2010, MOL ENDOCRINOL, V24, P1469, DOI 10.1210/me.2009-0496; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; Jiang H, 2016, J BIOL CHEM, V291, P2954, DOI 10.1074/jbc.M115.683292; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kienast Y, 2016, J BIOL CHEM, V291, P3395, DOI 10.1074/jbc.M115.680009; Laux DW, 2013, DEVELOPMENT, V140, P3403, DOI 10.1242/dev.095307; Levet S, 2015, P NATL ACAD SCI USA, V112, pE3207, DOI 10.1073/pnas.1508386112; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Mahlawat P, 2012, BIOCHEMISTRY-US, V51, P6328, DOI 10.1021/bi300942x; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; Miller AF, 2000, J BIOL CHEM, V275, P17937, DOI 10.1074/jbc.275.24.17937; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mottershead DG, 2015, J BIOL CHEM, V290, P24007, DOI 10.1074/jbc.M115.671487; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Neuhaus H, 1999, MECH DEVELOP, V80, P181, DOI 10.1016/S0925-4773(98)00221-4; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sebald W, 2004, BIOL CHEM, V385, P697, DOI 10.1515/BC.2004.086; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shimmi O, 2005, DEV BIOL, V282, P70, DOI 10.1016/j.ydbio.2005.02.029; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Tanaka C, 2007, GENE DEV, V21, P3272, DOI 10.1101/gad.1623907; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Valera E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011167; Wohl AP, 2016, J BIOL CHEM, V291, P12732, DOI 10.1074/jbc.M115.704734; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Zhao B, 2018, J BIOL CHEM, V293, P1579, DOI 10.1074/jbc.M117.809657; Zinski J., 2017, COLD SPRING HARBOR P, V2017, DOI 1101/cshperspect.a033274	57	64	65	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10963	10974		10.1074/jbc.RA118.002968	http://dx.doi.org/10.1074/jbc.RA118.002968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789425	Green Published, hybrid			2022-12-26	WOS:000438882800010
J	Francis, JH; Levin, AM; Zabor, EC; Gobin, YP; Abramson, DH				Francis, Jasmine H.; Levin, Ariana M.; Zabor, Emily C.; Gobin, Y. Pierre; Abramson, David H.			Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival	PLOS ONE			English	Article							INTRAOCULAR RETINOBLASTOMA; INTRAARTERIAL CHEMOTHERAPY; BILATERAL RETINOBLASTOMA; EYES	Purpose To report associations between disease- and treatment-related variables and rates of recurrence-free survival and ocular survival in eyes treated with ophthalmic artery chemosurgery (OAC) for retinoblastoma. Design Pre-post study. Subjects All eyes treated with OAC for retinoblastoma at Memorial Sloan Kettering Cancer Center between May 2006 and February 2017. Methods This retrospective review included 452 retinoblastoma eyes treated with OAC. The Kaplan Meier method was used to estimate recurrence-free survival (RFS), progression-free survival (PFS) and ocular survival (OcS), and Cox regression was used to estimate hazard ratios. Eyes treated in the pre-intravitreous chemotherapy era were analyzed separately from eyes treated in the intravitreal era. Main outcome measures Recurrence-free survival, ocular survival, associations with risk of recurrence Results Disease and treatment characteristics were recorded over a median 23.6 month follow-up. One-year OcS, PFS and RFS were 96% (95% CI 93-99%), 88% (95% CI 88-94%) and 74% (95% CI 67-81%) in the pre-intravitreal era and 96% (95% CI 94-99%), 93% (95% CI 89-96%) and 78% (95% CI 72-83%) in the intravitreal era, respectively. Presence of vitreous seeds was associated with increased risk of recurrence in the pre-intravitreal era but not in the intravitreal era. Longer time interval between OAC sessions was associated with increased risk of recurrence and majority OAC access via the ophthalmic artery was associated with decreased risk of recurrence in both eras. Conclusions Approximately a quarter of eyes initially treated with ophthalmic artery chemosurgery develop recurrent disease, with the majority of recurrences within the first year following completion of OAC. Despite this, these eyes have a very good chance of salvage. In eyes with vitreous seeds at presentation, intravitreal injections are useful in minimizing future vitreous recurrence. Eyes that receive the majority of drug infusions via non-ophthalmic artery routes or greater interval between OAC are more likely to recur and might warrant closer monitoring.	[Francis, Jasmine H.; Zabor, Emily C.; Abramson, David H.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Francis, Jasmine H.; Levin, Ariana M.; Gobin, Y. Pierre; Abramson, David H.] Weill Cornell Med Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Francis, JH (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.; Francis, JH (corresponding author), Weill Cornell Med Ctr, New York, NY 10065 USA.	francij1@mskcc.org		Francis, Jasmine/0000-0002-7637-3108	Fund for Ophthalmic Knowledge; Research to Prevent Blindness; Cancer Center Support Grant [P30 CA008748]; Weill Cornell Medicine Areas of Concentration Program	Fund for Ophthalmic Knowledge; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Cancer Center Support Grant; Weill Cornell Medicine Areas of Concentration Program	This study was supported by The Fund for Ophthalmic Knowledge, Research to Prevent Blindness and Cancer Center Support Grant (P30 CA008748) and Weill Cornell Medicine Areas of Concentration Program.	Abdelhakim AH, 2017, BRIT J OPHTHALMOL, V101, P623, DOI 10.1136/bjophthalmol-2016-308591; Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146582; Abramson DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145436; Abramson DH, 2014, ANNU REV MED, V65, P171, DOI 10.1146/annurev-med-061312-123455; ABRAMSON DH, 1981, ARCH OPHTHALMOL-CHIC, V99, P1763; Abramson DH, 2015, JAMA OPHTHALMOL, V133, P1; Berry JL, 2013, PEDIATR BLOOD CANCER, V60, P688, DOI 10.1002/pbc.24303; Dunkel IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108692; Francis JH, 2017, OPHTHALMOLOGY, V124, P1548, DOI 10.1016/j.ophtha.2017.04.010; Ghassemi F, 2013, PEDIATR BLOOD CANCER, V60, P599, DOI 10.1002/pbc.24333; Gobin YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044322; Grigorovski N, 2014, INT J OPHTHALMOL-CHI, V7, P726, DOI 10.3980/j.issn.2222-3959.2014.04.26; Scelfo C, 2017, INT J OPHTHALMOL-CHI, V10, P961, DOI 10.18240/ijo.2017.06.20; STALLARD H B, 1955, Br J Ophthalmol, V39, P241, DOI 10.1136/bjo.39.4.241; Tuncer S, 2016, ACTA OPHTHALMOL, V94, pE644, DOI 10.1111/aos.13077	16	43	43	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197081	10.1371/journal.pone.0197081	http://dx.doi.org/10.1371/journal.pone.0197081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791475	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000030
J	Huang, YJ; Mitrousia, GK; Sidique, SNM; Qi, AM; Fitt, BDL				Huang, Yong-Ju; Mitrousia, Georgia K.; Sidique, Siti Nordahliawate M.; Qi, Aiming; Fitt, Bruce D. L.			Combining R gene and quantitative resistance increases effectiveness of cultivar resistance against Leptosphaeria maculans in Brassica napus in different environments	PLOS ONE			English	Article							PHOMA STEM CANKER; OILSEED RAPE; DURABLE RESISTANCE; FIELD-RESISTANCE; PLANT-PATHOGENS; MAJOR GENE; EPIDEMIOLOGY; POPULATIONS; CROPS; IDENTIFICATION	Using cultivar resistance against pathogens is one of the most economical and environmentally friendly methods for control of crop diseases. However, cultivar resistance can be easily rendered ineffective due to changes in pathogen populations or environments. To test the hypothesis that combining R gene-mediated resistance and quantitative resistance (QR) in one cultivar can provide more effective resistance than use of either type of resistance on its own, effectiveness of resistance in eight oilseed rape (Brassica napus) cultivars with different R genes and/or QR against Leptosphaeria maculans (phoma stem canker) was investigated in 13 different environments/sites over three growing seasons (2010/2011, 2011/2012 and 2012/2013). Cultivar Drakkar with no R genes and no QR was used as susceptible control and for sampling L. maculans populations. Isolates of L. maculans were obtained from the 13 sites in 2010/2011 to assess frequencies of avirulent alleles of different effector genes (AvrLm1, AvrLm4 or AvrLm7) corresponding to the resistance genes (RIm1, RIm4 or RIm7) used in the field experiments. Results of field experiments showed that cultivars DK Cabernet (RIm1 + QR) and Adriana (RIm4 + QR) had significantly less severe phoma stem canker than cultivars Capitol (RIm1) and Bilbao (RIm4), respectively. Results of controlled environment experiments confirmed the presence of Rim genes and/or QR in these four cultivars. Analysis of L. maculans populations from different sites showed that the mean frequencies of AvrLml (10%) and AvrLm4 (41 %) were less than that of AvrLm7 (100%), suggesting that RIm1 and RIm4 gene-mediated resistances were partially rendered ineffective while RIm7 resistance was still effective. Cultivar Excel (RIm7+ QR) had less severe canker than cultivar Roxet (RIm7), but the difference between them was not significant due to influence of the effective resistance gene RIm7. For the two cultivars with only QR, Es-Astrid (QR) had less severe stem canker than NK Grandia (QR). Analysis of the relationship between severity of stem canker and weather data among the 13 sites in the three growing seasons showed that increased severity of stem canker was associated with increased rainfall during the phoma leaf spot development stage and increased temperature during the stem canker development stage. Further analysis of cultivar response to environmental factors showed that cultivars with both an Rim gene and QR (e.g. DK Cabernet, Adriana and Excel) were less sensitive to a change in environment than cultivars with only Rim genes (e.g. Capitol, Bilbao) or only QR (e.g. DK Grandia). These results suggest that combining R gene and QR can provide effective, stable control of phoma stem canker in different environments.	[Huang, Yong-Ju; Mitrousia, Georgia K.; Sidique, Siti Nordahliawate M.; Qi, Aiming; Fitt, Bruce D. L.] Univ Hertfordshire, Sch Life & Med Sci, Ctr Agr Food & Environm Management, Hatfield, Herts, England; [Sidique, Siti Nordahliawate M.] Univ Malaysia Terengganu, Sch Food Sci & Technol, Lab Pest Dis & Microbial Biotechnol LAPDiM, Kuala Terengganu, Malaysia	University of Hertfordshire; Universiti Malaysia Terengganu	Huang, YJ (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Ctr Agr Food & Environm Management, Hatfield, Herts, England.	y.huang8@herts.ac.uk	Sidique, Siti Nordahliawate Mohamed/X-5726-2018; Qi, Aiming/AAH-7872-2021	Sidique, Siti Nordahliawate Mohamed/0000-0003-3231-4701; Qi, Aiming/0000-0002-0784-9520; Bruce D. L., Fitt/0000-0003-3981-6456	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB 1017585, M028348/1, P00489X/1]; Innovate UK [102100, 102641]; Agriculture, Horticulture Development Board (AHDB) [RD-2140021105]; Felix Cobbold Trust; Chadacre Agricultural Trust	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovate UK(UK Research & Innovation (UKRI)Innovate UK); Agriculture, Horticulture Development Board (AHDB); Felix Cobbold Trust; Chadacre Agricultural Trust	UK Biotechnology and Biological Sciences Research Council (BBSRC, BB 1017585, M028348/1 and P00489X/1), the Innovate UK (102100 and 102641), the Agriculture, Horticulture Development Board (AHDB) (RD-2140021105), Felix Cobbold Trust and the Chadacre Agricultural Trust provided funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balesdent MH, 2006, EUR J PLANT PATHOL, V114, P53, DOI 10.1007/s10658-005-2104-0; Balesdent MH, 2005, PHYTOPATHOLOGY, V95, P1061, DOI 10.1094/PHYTO-95-1061; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/nclimate1990, 10.1038/NCLIMATE1990]; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Brun H, 2010, NEW PHYTOL, V185, P285, DOI 10.1111/j.1469-8137.2009.03049.x; Carter HE, 2014, MOL PLANT PATHOL, V15, P513, DOI 10.1111/mpp.12106; Cruz CMV, 2000, P NATL ACAD SCI USA, V97, P13500, DOI 10.1073/pnas.250271997; Delourme R, 2006, EUR J PLANT PATHOL, V114, P41, DOI 10.1007/s10658-005-2108-9; Delourme R, 2014, INFECT GENET EVOL, V27, P490, DOI 10.1016/j.meegid.2013.12.019; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Ghanbarnia K, 2018, MOL PLANT PATHOL, V19, P1754, DOI 10.1111/mpp.12658; Hahn Matthias, 2014, Journal of Chemical Biology, V7, P133, DOI 10.1007/s12154-014-0113-1; Huang YJ, 2016, THEOR APPL GENET, V129, P169, DOI 10.1007/s00122-015-2620-z; Huang YJ, 2011, PLANT PATHOL, V60, P607, DOI 10.1111/j.1365-3059.2010.02416.x; Huang YJ, 2009, PLANT PATHOL, V58, P314, DOI 10.1111/j.1365-3059.2008.01957.x; Huang YJ, 2006, NEW PHYTOL, V170, P129, DOI 10.1111/j.1469-8137.2006.01651.x; Huang YJ, 2005, EUR J PLANT PATHOL, V111, P263, DOI 10.1007/s10658-004-4421-0; Huang YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084924; Hughes DJ, 2011, PEST MANAG SCI, V67, P1082, DOI 10.1002/ps.2151; Jestin C, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0356-8; Jestin C, 2011, MOL BREEDING, V27, P271, DOI 10.1007/s11032-010-9429-x; JOHNSON R, 1981, PHYTOPATHOLOGY, V71, P567, DOI 10.1094/Phyto-71-567; KOCH E, 1991, MOL PLANT MICROBE IN, V4, P341, DOI 10.1094/MPMI-4-341; Lo-Pelzer E, 2009, EUR J PLANT PATHOL, V125, P515, DOI 10.1007/s10658-009-9499-y; MacQueen A, 2016, J EXP BOT, V67, P2093, DOI 10.1093/jxb/erv530; Niks RE, 2015, ANNU REV PHYTOPATHOL, V53, P445, DOI 10.1146/annurev-phyto-080614-115928; Payne RW, 2011, GUIDE GENSTAT RELEAS; Pilet ML, 1998, THEOR APPL GENET, V96, P23, DOI 10.1007/s001220050704; Pilet ML, 2001, CROP SCI, V41, P197, DOI 10.2135/cropsci2001.411197x; Pilet-Nayel ML, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01838; Plissonneau C, 2016, NEW PHYTOL, V209, P1613, DOI 10.1111/nph.13736; Rouxel T, 2003, EUR J PLANT PATHOL, V109, P871, DOI 10.1023/A:1026189225466; Rouxel T, 2017, NEW PHYTOL, V214, P526, DOI 10.1111/nph.14411; Sprague SJ, 2006, EUR J PLANT PATHOL, V114, P33, DOI 10.1007/s10658-005-3683-5; Stachowiak A, 2006, EUR J PLANT PATHOL, V114, P67, DOI 10.1007/s10658-005-2931-z; Stall RE, 2009, ANNU REV PHYTOPATHOL, V47, P265, DOI 10.1146/annurev-phyto-080508-081752; Stotz HU, 2014, TRENDS PLANT SCI, V19, P491, DOI 10.1016/j.tplants.2014.04.009; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Stuthman DD, 2007, ADV AGRON, V95, P319, DOI 10.1016/S0065-2113(07)95004-X; Toscano-Underwood C, 2003, PLANT PATHOL, V52, P726, DOI 10.1111/j.1365-3059.2003.00930.x; West JS, 2001, PLANT PATHOL, V50, P10, DOI 10.1046/j.1365-3059.2001.00546.x; West JS, 1999, ANN APPL BIOL, V135, P535, DOI 10.1111/j.1744-7348.1999.tb00885.x; Zhang X, 2014, PLANT PATHOL, V63, P598, DOI 10.1111/ppa.12146; Zhang XH, 2016, EUR J PLANT PATHOL, V145, P659, DOI 10.1007/s10658-015-0819-0	45	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197752	10.1371/journal.pone.0197752	http://dx.doi.org/10.1371/journal.pone.0197752			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791484	gold, Green Submitted, Green Published			2022-12-26	WOS:000433077000058
J	El Kateb, A; Stalder, C; Ruggeberg, A; Neururer, C; Spangenberg, JE; Spezzaferri, S				El Kateb, Akram; Stalder, Claudio; Ruggeberg, Andres; Neururer, Christoph; Spangenberg, Jorge E.; Spezzaferri, Silvia			Impact of industrial phosphate waste discharge on the marine environment in the Gulf of Gabes (Tunisia)	PLOS ONE			English	Article							SEAGRASS POSIDONIA-OCEANICA; NITROGEN STABLE-ISOTOPE; ROCK-EVAL PYROLYSIS; ORGANIC-MATTER; GAFSA BASIN; DOLOMITE FORMATION; FRESH-WATER; PALEOENVIRONMENTAL CONDITIONS; PHOSPHORUS SPECIATION; SPATIAL-DISTRIBUTION	The marine environment in the Gulf of Gabes (southern Tunisia) is severely impacted by phosphate industries. Nowadays, three localities, Sfax, Skhira and Gabes produce phosphoric acid along the coasts of this Gulf and generate a large amount of phosphogypsum as a waste product. The Gabes phosphate industry is the major cause of pollution in the Gulf because most of the waste is directly discharged into the sea without preliminary treatment. This study investigates the marine environment in the proximity of the phosphate industries of Gabes and the coastal marine environment on the eastern coast of Djerba, without phosphate industry. This site can be considered as "pristine" and enables a direct comparison between polluted and "clean" adjacent areas. Phosphorous, by sequential extractions (SEDEX), Rock-Eval, C, H, N elemental analysis, and stable carbon isotope composition of sedimentary organic matter, X-ray diffraction (qualitative and quantitative analysis) were measured on sediments. Temperature, pH and dissolved oxygen were measured on the water close to the sea floor of each station to estimate environmental conditions. These analyses are coupled with video surveys of the sea floor. This study reveals clear differentiations in pollution and eutrophication in the investigated areas.	[El Kateb, Akram; Ruggeberg, Andres; Neururer, Christoph; Spezzaferri, Silvia] Univ Fribourg, Dept Geosci, Chemin Musee 6, Fribourg, Switzerland; [Stalder, Claudio] FOPH, Radiat Protect Div, Schwarzenburgstr 157, Bern, Switzerland; [Spangenberg, Jorge E.] Univ Lausanne, Inst Earth Surface Dynam IDYST, Lausanne, Switzerland	University of Fribourg; University of Lausanne	El Kateb, A (corresponding author), Univ Fribourg, Dept Geosci, Chemin Musee 6, Fribourg, Switzerland.	akram.elkateb@unifr.ch	Rüggeberg, Andres/ABE-9057-2021	Rüggeberg, Andres/0000-0003-2393-0625; El Kateb, Akram/0000-0002-0925-8097; Spangenberg, Jorge E./0000-0001-8636-6414	Swiss National Science Fondation (Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung) [200021-149589]	Swiss National Science Fondation (Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung)	This work was founded by the Swiss National Science Fondation (Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung) (http://www.snf.ch/en/Pages/default.aspx) with grant 200021-149589 for Akram El Kateb. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajam L, 2009, CONSTR BUILD MATER, V23, P3240, DOI 10.1016/j.conbuildmat.2009.05.009; Ajmal PY, 2014, J RADIOANAL NUCL CH, V300, P1; Al-Enezi E, 2014, J ENG RES-KUWAIT, V2, P1; Aloulou F, 2012, ENVIRON MONIT ASSESS, V184, P777, DOI 10.1007/s10661-011-2001-2; Anderson R., 2003, TREATISE GEOCHEMISTR, V6, P625, DOI [10.1016/b0-08-043751-6/06111-9, DOI 10.1016/B0-08-043751-6/06111-9]; Ayadi N, 2016, ENVIRON SCI POLLUT R, V23, P6414, DOI 10.1007/s11356-015-5872-x; Ayadi N, 2014, ARAB J GEOSCI, V8, P1; Baskerville WH, 1935, J PHYS CHEM-US, V39, P769, DOI 10.1021/j150366a004; Bathurst R.G.C., 1966, GEOL J, V5, P15, DOI DOI 10.1002/GJ.3350050104; Bathurst RG., 1972, CARBONATE SEDIMENTS, V12; Behar F, 2001, OIL GAS SCI TECHNOL, V56, P111, DOI 10.2516/ogst:2001013; Bejaoui B., 2004, B I NATN SCI TECH ME, V31, P103; BELAYOUNI H, 1990, ORG GEOCHEM, V15, P47, DOI 10.1016/0146-6380(90)90184-2; Belayouni H., 1984, ORG GEOCHEM, V6, P741, DOI [10.1016/0146-6380(84)90095-0, DOI 10.1016/0146-6380(84)90095-0]; Ben Amor R., 2003, B I SCI TECH, V30, P143; Ben Aoun Z, 2007, B I NATN SCI TECH ME, V34, P119; Ben Brahim M, 2010, MAR ENVIRON RES, V70, P411, DOI 10.1016/j.marenvres.2010.08.005; Ben Hassen A, 2009, CR GEOSCI, V341, P319, DOI 10.1016/j.crte.2009.02.001; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BERLAND BR, 1980, OCEANOL ACTA, V3, P135; Bontognali TRR, 2010, SEDIMENTOLOGY, V57, P824, DOI 10.1111/j.1365-3091.2009.01121.x; Bordovskiy O K, 1965, MAR GEOL, V3, P33, DOI [10.1016/0025-3227(65)90004-6, DOI 10.1016/0025-3227(65)90004-6]; Boughzala K, 2015, REV SCI MATERIAUX LA, V6, P11; Castany G., 1951, CARTE GEOLOGIQUE TUN; Cisse L., 2004, PHOSPHORUS RESBULL, V15, P21, DOI DOI 10.3363/PRB1992.15.0_21; Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986; COOPER LW, 1989, MAR ECOL PROG SER, V50, P225, DOI 10.3354/meps050225; Correll DL, 1998, J ENVIRON QUAL, V27, P261, DOI 10.2134/jeq1998.00472425002700020004x; Cotner JB, 1997, AQUAT MICROB ECOL, V13, P141, DOI 10.3354/ame013141; Dahri N., 2014, INT J SCI ENG, V7, P23; DARMOUL B, 1980, B I NATL SCI TECHNIQ, V7, P5; Darmouli B., 1988, Bulletin de l'Institut National Scientifique et Technique d'Oceanographie et de Peche de Salammbo, V15, P61; De la Rocha CL, 2003, TREATISE GEOCHEMISTR, V8, P1; DEAN WE, 1986, MAR GEOL, V70, P119, DOI 10.1016/0025-3227(86)90092-7; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; DELVAUX D, 1990, ORG GEOCHEM, V16, P175, DOI 10.1016/0146-6380(90)90038-2; El Afifi EM, 2009, J ENVIRON RADIOACTIV, V100, P407, DOI 10.1016/j.jenvrad.2009.01.005; El Kateb A, 2016, HELIYON, DOI [10.1016/j.heliyon.2016.900195, DOI 10.1016/J.HELIYON.2016.900195]; El Lakhrach H, 2012, MEDITERR MAR SCI, V13, P12, DOI 10.12681/mms.19; El Zrelli R, 2017, ENVIRON SCI POLLUT R, V24, P22214, DOI 10.1007/s11356-017-9856-x; El Zrelli R, 2015, MAR POLLUT BULL, V101, P922, DOI 10.1016/j.marpolbul.2015.10.047; ESPITALIE J, 1985, REV I FR PETROL, V40, P755, DOI 10.2516/ogst:1985045; Feki W, 2008, B I NATN SCIAEN TECH, V35, P105; Follmi KB, 1996, EARTH-SCI REV, V40, P55, DOI 10.1016/0012-8252(95)00049-6; Freudenthal T, 2001, GEOCHIM COSMOCHIM AC, V65, P1795, DOI 10.1016/S0016-7037(01)00554-3; Garcias-Bonet N, 2016, AQUAT BOT, V131, P57, DOI 10.1016/j.aquabot.2016.03.002; Gargouri D, 2011, ENVIRON MONIT ASSESS, V175, P519, DOI 10.1007/s10661-010-1548-7; GEARING JN, 1984, GEOCHIM COSMOCHIM AC, V48, P1089, DOI 10.1016/0016-7037(84)90199-6; Guo TZ, 2001, ENVIRON SCI TECHNOL, V35, P3967, DOI 10.1021/es010520+; Haridasan PP, 2002, J ENVIRON RADIOACTIV, V62, P287, DOI 10.1016/S0265-931X(02)00011-5; Hattab T, 2013, J MARINE SYST, V128, P159, DOI 10.1016/j.jmarsys.2013.04.017; Hayes JM, 1999, CHEM GEOL, V161, P103, DOI 10.1016/S0009-2541(99)00083-2; Hedges JI, 1997, ORG GEOCHEM, V27, P195, DOI 10.1016/S0146-6380(97)00066-1; Henchiri M, 2007, J AFR EARTH SCI, V49, P187, DOI 10.1016/j.jafrearsci.2007.09.001; Hrs-Brenko Mirjana, 2006, Acta Adriatica, V47, P49; Kassir LN, 2012, ENVIRON TECHNOL, V33, P873, DOI 10.1080/09593330.2011.601765; Katz B.J., 1983, ORG GEOCHEM, V4, P195, DOI [10.1016/0146-6380(83)90041-4, DOI 10.1016/0146-6380(83)90041-4]; Khan NS, 1991, HDB SEA LEVEL RES, P295; Khiari R, 2010, BIORESOURCE TECHNOL, V101, P775, DOI 10.1016/j.biortech.2009.08.079; Klein C., 2007, 23 EDITION MANUAL MI; Koched W, 2013, MEDITERR MAR SCI, V14, P5, DOI 10.12681/mms.314; Kocsis L, 2014, J AFR EARTH SCI, V100, P586, DOI 10.1016/j.jafrearsci.2014.07.024; Kocsis L, 2013, INT J EARTH SCI, V102, P1111, DOI 10.1007/s00531-012-0845-5; Lafargue E, 1998, REV I FR PETROL, V53, P421, DOI 10.2516/ogst:1998036; Laffite R, 1952, 19 C GEOL INT ALG; LANGFORD FF, 1990, AAPG BULL, V74, P799; Lepoint G, 2003, BOT MAR, V46, P555, DOI 10.1515/BOT.2003.058; Littke R., 1993, LECT NOTES EARTH SCI, V47; LUCOTTE M, 1994, CAN J EARTH SCI, V31, P14, DOI 10.1139/e94-003; Mauro L, 2013, MAR POLLUT BULL, V77, P45, DOI 10.1016/j.marpolbul.2013.10.036; MCARTHUR JM, 1985, GEOCHIM COSMOCHIM AC, V49, P23, DOI 10.1016/0016-7037(85)90188-7; McKenzie JA, 2009, SEDIMENTOLOGY, V56, P205, DOI 10.1111/j.1365-3091.2008.01027.x; Messaoudi I, 2009, ENVIRON MONIT ASSESS, V156, P551, DOI 10.1007/s10661-008-0504-2; MILLIMAN JD, 1994, DEEP-SEA RES PT II, V41, P797, DOI 10.1016/0967-0645(94)90049-3; Morse JW., 1990, GEOCHEMISTRY SEDIMEN, V48, P39, DOI [10.1016/s0070-4571(08)70331-5, DOI 10.1016/S0070-4571(08)70331-5]; MRABET A, 1981, SEDIMENTOLOGY, V28, P331, DOI 10.1111/j.1365-3091.1981.tb01684.x; Muller A, 1999, PALAEOGEOGR PALAEOCL, V145, P1, DOI 10.1016/S0031-0182(98)00094-7; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Notholt AJG, 2005, PHOSPHATE ROCK RESOU, V2; Nunez-Betelu L., 1994, MUNIBE CIENCIAS NATU, V46, P43; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; OUESLATI A, 1995, QUATERN INT, V30, P41; Ounis A, 2008, PALAEOGEOGR PALAEOCL, V268, P1, DOI 10.1016/j.palaeo.2008.07.005; PATIENCE RL, 1990, P OCEAN DRILLING PRO, V0112; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Peng JF, 2007, ECOL ENG, V31, P92, DOI 10.1016/j.ecoleng.2007.06.005; Perez-Lopez R, 2007, J HAZARD MATER, V148, P745, DOI 10.1016/j.jhazmat.2007.06.068; Rabaoui L, 2014, MEDITERR MAR SCI, V15, P45; Rekik A, 2012, MAR POLLUT BULL, V64, P336, DOI 10.1016/j.marpolbul.2011.11.005; RUTHERFORD PM, 1994, SCI TOTAL ENVIRON, V149, P1, DOI 10.1016/0048-9697(94)90002-7; Ruttenberg K C, 2012, Front Microbiol, V3, P274, DOI 10.3389/fmicb.2012.00274; Ruttenberg KC, 2011, GEOCHIM COSMOCHIM AC, V75, P4095, DOI 10.1016/j.gca.2010.10.033; Ruttenberg KC, 2009, LIMNOL OCEANOGR-METH, V7, P319, DOI 10.4319/lom.2009.7.319; RUTTENBERG KC, 1993, CHEM GEOL, V107, P405, DOI 10.1016/0009-2541(93)90220-D; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; Sassi AB, 1999, J AFR EARTH SCI, V29, P501; Schlitzer R., 2021, OCEAN DATA VIEW VS 5; Secrieru D., 2009, GEOECOMARINA, V15, P5, DOI DOI 10.5281/zenodo.57303; SHELDON RP, 1981, ANNU REV EARTH PL SC, V9, P251, DOI 10.1146/annurev.ea.09.050181.001343; Slomp CP, 1996, J MAR RES, V54, P1179, DOI 10.1357/0022240963213745; Slomp CP, 1996, MAR CHEM, V52, P55, DOI 10.1016/0304-4203(95)00078-X; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Snelgrove P, 1997, AMBIO, V26, P578; SONDERGAARD M, 1988, ENVIRON GEOL WATER S, V11, P115, DOI 10.1007/BF02587770; Tayibi H, 2009, J ENVIRON MANAGE, V90, P2377, DOI 10.1016/j.jenvman.2009.03.007; THORNTON SF, 1994, ESTUAR COAST SHELF S, V38, P219, DOI 10.1006/ecss.1994.1015; Tucker M E, 1990, INT ASS SEDIMENTOLOG, V1; Turner RE, 2003, MAR POLLUT BULL, V46, P1032, DOI 10.1016/S0025-326X(03)00049-3; van der Zee C, 2002, MAR GEOL, V185, P379, DOI 10.1016/S0025-3227(02)00189-5; VANCAPPELLEN P, 1991, GEOCHIM COSMOCHIM AC, V55, P1219; VASCONCELOS C, 1995, NATURE, V377, P220, DOI 10.1038/377220a0; Vizzini S, 2003, AQUAT BOT, V76, P195, DOI 10.1016/S0304-3770(03)00052-4; Vizzini S, 2002, ACTA OECOL, V23, P277, DOI 10.1016/S1146-609X(02)01156-6; Wali Ahmed, 2013, Environmental Research, Engineering and Management, V65, P20, DOI 10.5755/j01.erem.63.3.4865; Zaaboub N, 2014, ECOL ENG, V73, P115, DOI 10.1016/j.ecoleng.2014.09.017; Zairi M., 1999, B LABORATOIRES PONTS, P29; Zaouali Jeanne, 1994, Marine Life, V3, P47; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB	123	37	37	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197731	10.1371/journal.pone.0197731	http://dx.doi.org/10.1371/journal.pone.0197731			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771969	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900090
J	Zhao, W; Liu, WG; Liu, HP; Yi, XP; Hou, JL; Pei, YG; Liu, H; Feng, DY; Liu, LY; Li, WZ				Zhao, Wei; Liu, Wenguang; Liu, Huaping; Yi, Xiaoping; Hou, Jiale; Pei, Yigang; Liu, Hui; Feng, Deyun; Liu, Liyu; Li, Wenzheng			Preoperative prediction of microvascular invasion of hepatocellular carcinoma with IVIM diffusion-weighted MR imaging and Gd-EOB-DTPA-enhanced MR imaging	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; HEPATOBILIARY PHASE; TUMOR SIZE; RESECTION; RECURRENCE; SYSTEM; CANCER; GRADE	Microvascular invasion (MVI) is regarded as one of the independent risk factors for recurrence and poor prognosis of hepatocellular carcinoma (HCC). The presence of MVI in HCCs was evaluated on the basis of pathological reports of surgical specimens and was defined as tumor within a vascular space lined by endothelium that was visible only on microscopy. The aim of the study was to investigate the usefulness of intravoxel incoherent motion (IVIM) diffusion weighted (DW) magnetic resonance (MR) imaging in predicting MVI of HCC. Preoperative IVIM DW imaging and Gd-EOB-DTPA-enhanced MRI (DCE-MRI) of 51 patients were analyzed. Standard apparent diffusion coefficient (ADC), D (the true diffusion coefficient), D* (the pseudodiffusion coefficient) and f (the perfusion fraction), relative enhancement (RE) and radiological features were evaluated and analyzed. Univariate analysis revealed that HCCs with MVI had a higher portion of an irregular tumor shape than HCCs without MVI (p=0.009), the Standard ADC, D value were significantly lower in HCCs with MVI (p=0.022, p=0.007, respectively). Multivariate analysis revealed that an irregular shape (p=0.012) and D value <= 1.16x10(-3)mm(2)/sec (p=0.048) were independent predictors for MVI. Combining the two factors of an irregular shape and D value, a sensitivity of 94.4% and specificity of 63.6% for predicting MVI was obtained. In conclusion, we found that an irregular shape and D value <= 1.16x10(-3)mm(2)/sec may suggest the presence of MVI in HCCs.	[Zhao, Wei; Liu, Wenguang; Liu, Huaping; Yi, Xiaoping; Hou, Jiale; Pei, Yigang; Liu, Hui; Li, Wenzheng] Ctr South Univ, Xiangya Hosp, Dept Radiol, Changsha, Hunan, Peoples R China; [Zhao, Wei] Fudan Univ, Huadong Hosp, Dept Radiol, Shanghai, Peoples R China; [Feng, Deyun] Ctr South Univ, Dept Pathol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Liu, Liyu] Ctr South Univ, Ctr Mol Med, Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Fudan University; Central South University; Central South University	Li, WZ (corresponding author), Ctr South Univ, Xiangya Hosp, Dept Radiol, Changsha, Hunan, Peoples R China.	wenzheng727@163.com	Zhao, Wei/K-3724-2019	Zhao, Wei/0000-0002-8520-2087; yi, xiaoping/0000-0002-4220-1981	XiangYa Clinical Research Fund [2014L05]; Research Foundation of Education Bureau of Hunan Province,China [2017SK2010]	XiangYa Clinical Research Fund; Research Foundation of Education Bureau of Hunan Province,China	This work was supported by XiangYa Clinical Research Fund (Grant No. 2014L05) and the Research Foundation of Education Bureau of Hunan Province,China(Grant No. 2017SK2010) http://www.xiangya.com.cn/web/Content.aspx?chn=296&id=26676 http://www.hnst.gov.cn/xxgk/czxx/201709/t20170914 4507903.html.	Ariizumi S, 2011, J HEPATO-BIL-PAN SCI, V18, P575, DOI 10.1007/s00534-010-0369-y; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chan SC, 2012, HEPATOL INT, V6, P646, DOI 10.1007/s12072-011-9318-3; Chandarana H, 2011, AM J ROENTGENOL, V196, P1083, DOI 10.2214/AJR.10.4720; Chanyaputhipong J, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/489342; Clark HP, 2005, RADIOGRAPHICS, V25, pS3, DOI 10.1148/rg.25si055507; Fidelman N, 2012, LIVER TRANSPLANT, V18, P1131, DOI 10.1002/lt.23536; Gouw ASH, 2011, LIVER TRANSPLANT, V17, pS72, DOI 10.1002/lt.22368; Hemming AW, 2001, ANN SURG, V233, P652, DOI 10.1097/00000658-200105000-00009; Hirokawa F, 2014, HEPATOL RES, V44, P846, DOI 10.1111/hepr.12196; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Kim H, 2009, EUR RADIOL, V19, P1744, DOI 10.1007/s00330-009-1331-8; Kim KA, 2012, J MAGN RESON IMAGING, V35, P629, DOI 10.1002/jmri.22876; Kudo M, 2015, LIVER CANCER, V4, P39, DOI 10.1159/000367727; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1989, MAGNET RESON MED, V10, P324; McHugh PP, 2010, HPB, V12, P56, DOI 10.1111/j.1477-2574.2009.00128.x; Min JH, 2015, EUR J RADIOL, V84, P1036, DOI 10.1016/j.ejrad.2015.03.002; Muhi A, 2009, J MAGN RESON IMAGING, V30, P1005, DOI 10.1002/jmri.21931; Nasu K, 2009, AM J ROENTGENOL, V193, P438, DOI 10.2214/AJR.08.1424; Okamura S, 2016, DIGEST LIVER DIS, V48, P945, DOI 10.1016/j.dld.2016.05.020; Pawlik TM, 2005, LIVER TRANSPLANT, V11, P1086, DOI 10.1002/lt.20472; Poon RTP, 2002, ANN SURG, V235, P373, DOI 10.1097/00000658-200203000-00009; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Rodriguez-Peralvarez M, 2013, ANN SURG ONCOL, V20, P325, DOI 10.1245/s10434-012-2513-1; Schlichtemeier SM, 2016, EJSO-EUR J SURG ONC, V42, P1576, DOI 10.1016/j.ejso.2016.05.032; Shirabe K, 2007, J SURG ONCOL, V95, P235, DOI 10.1002/jso.20655; Shirabe K, 2014, LIVER INT, V34, P937, DOI 10.1111/liv.12459; Suh YJ, 2012, LIVER TRANSPLANT, V18, P1171, DOI 10.1002/lt.23502; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Verloh N, 2014, EUR RADIOL, V24, P1013, DOI 10.1007/s00330-014-3108-y; Wu TH, 2016, SURG TODAY, V46, P1275, DOI 10.1007/s00595-016-1320-x; Xu PJ, 2014, J GASTROEN HEPATOL, V29, P330, DOI 10.1111/jgh.12358; Zhao WC, 2013, EJSO-EUR J SURG ONC, V39, P858, DOI 10.1016/j.ejso.2013.04.003	34	30	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197488	10.1371/journal.pone.0197488	http://dx.doi.org/10.1371/journal.pone.0197488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771954	Green Submitted, gold, Green Published			2022-12-26	WOS:000432348900067
J	He, JF; Liang, YP; Li, LJ; Luo, YJ				He, Jiang-fu; Liang, Yun-pei; Li, Li-jia; Luo, Yong-jiang			Theoretical analysis and design of hydro-hammer with a jet actuator: An engineering application to improve the penetration rate of directional well drilling in hard rock formations	PLOS ONE			English	Article								Rapid horizontal directional well drilling in hard or fractured formations requires efficient drilling technology. The penetration rate of conventional hard rock drilling technology in horizontal directional well excavations is relatively low, resulting in multiple overgrinding of drill cuttings in bottom boreholes. Conventional drilling techniques with reamer or diamond drill bit face difficulties due to the long construction periods, low penetration rates, and high engineering costs in the directional well drilling of hard rock. To improve the impact energy and penetration rate of directional well drilling in hard formations, a new drilling system with a percussive and rotary drilling technology has been proposed, and a hydro-hammer with a jet actuator has also been theoretically designed on the basis of the impulse hydro-turbine pressure model. In addition, the performance parameters of the hydro-hammer with a jet actuator have been numerically and experimentally analyzed, and the influence of impact stroke and pumped flow rate on the motion velocity and impact energy of the hydro-hammer has been obtained. Moreover, the designed hydro-hammer with a jet actuator has been applied to hard rock drilling in a trenchless drilling program. The motion velocity of the hydro-hammer ranges from 1.2 m/s to 3.19 m/s with diverse flow rates and impact strokes, and the motion frequency ranges from 10 Hz to 22 Hz. Moreover, the maximum impact energy of the hydro-hammer is 407 J, and the pumped flow rate is 2.3 m(3)/min. Thus, the average penetration rate of the optimized hydro-hammer improves by over 30% compared to conventional directional drilling in hard rock formations.	[He, Jiang-fu; Liang, Yun-pei; Li, Li-jia; Luo, Yong-jiang] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing, Peoples R China; [He, Jiang-fu] Chongqing Univ, Postdoctoral Res Stn Mineral Engn, Chongqing, Peoples R China; [He, Jiang-fu; Liang, Yun-pei; Li, Li-jia; Luo, Yong-jiang] Chongqing Univ, Coll Resources & Environm Sci, Chongqing, Peoples R China	Chongqing University; Chongqing University; Chongqing University	Liang, YP (corresponding author), Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing, Peoples R China.; Liang, YP (corresponding author), Chongqing Univ, Coll Resources & Environm Sci, Chongqing, Peoples R China.	liangyunpei@cqu.edu.cn			National Natural Science Foundation of China [51674050]; National Science and Technology Major Project of China [2016ZX05043005, 2016ZX05045004]; State Key Research Development Program of China [2017YFC0804202, 2016YFC0801402, 2016YFC0801404]; China Postdoctoral Science Foundation [2017M612916]; Chongqing Postdoctoral Research Foundation [Xm2017068]; Fundamental Research Funds for the Central Universities [106112015CDJZR245520, 106112017CDJXY240001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of China; State Key Research Development Program of China(State Key Development Program for Basic Research of China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chongqing Postdoctoral Research Foundation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The research work was financially supported by the National Natural Science Foundation of China (51674050) to YPL, the National Science and Technology Major Project of China (Grant No. 2016ZX05043005 & 2016ZX05045004) to YPL, the State Key Research Development Program of China (Grant No. 2017YFC0804202, 2016YFC0801402 & 2016YFC0801404) to YPL, the Project funded by China Postdoctoral Science Foundation (Project NO. 2017M612916) to JFH, the Project funded by Chongqing Postdoctoral Research Foundation (Project NO. Xm2017068) to JFH, and the Fundamental Research Funds for the Central Universities (Project No. 106112015CDJZR245520 & 106112017CDJXY240001) to YJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalizad SA, 2012, ARCH MIN SCI, V57, P715, DOI 10.2478/v10267-012-0046-x; Altindag R., 2004, GEOTECH GEOL ENG, V22, P417, DOI [10.1023/B:GEGE.0000025043.92979.48, DOI 10.1023/B:GEGE.0000025043.92979.48]; [Anonymous], 2009, THESIS; [Anonymous], 2009, THESIS; Deniz T, 2016, TUNN UNDERGR SP TECH, V59, P37; Guan ZC, 2014, PETROL EXPLOR DEV+, V41, P678, DOI 10.1016/S1876-3804(14)60081-1; Hettiarachchi DSW, 2016, THESIS; HUSTRULID WA, 1972, INT J ROCK MECH MIN, V9, P431, DOI 10.1016/0148-9062(72)90007-1; Kahraman S, 2003, INT J ROCK MECH MIN, V40, P711, DOI 10.1016/S1365-1609(03)00063-7; Kolle J, 1999, COMP WATER JET ABRAS, P1; Lundberg B, 2001, INT J IMPACT ENG, V25, P345, DOI 10.1016/S0734-743X(00)00053-1; Mao WB, 2004, POWER ENERGY, V35, P1; Melamed Y, 1999, J ENERGY RESOUR TECH, V122, P1; MISHNAEVSKY LL, 1993, INT J ROCK MECH MIN, V30, P663, DOI 10.1016/0148-9062(93)91227-A; Mishnaevsky LL, 1995, INT J ROCK MECH MIN, V32, P763, DOI 10.1016/0148-9062(95)00027-E; Peng JM, 2004, THESIS; Pushmin P, 2015, IOP C SER EARTH ENV, V27, DOI 10.1088/1755-1315/27/1/012052; Sandvik Ab, 2000, ROCK DRILLING TOOL R; Simon R., 1964, INT J ROCK MECH MIN, V1, P397, DOI [10.1016/0148-9062(64)90006-3, DOI 10.1016/0148-9062(64)90006-3]; Tan F., 2005, THESIS; Tang JR, 2013, J MINING SAF ENG, V30, P621; Wu P, 2014, CHINA PETROLEUM MACH, V42, P18; Wu Z., 2002, THESIS	23	1	1	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196234	10.1371/journal.pone.0196234	http://dx.doi.org/10.1371/journal.pone.0196234			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768421	gold, Green Published, Green Submitted			2022-12-26	WOS:000432329200016
J	Krug, I; Behrens, M; Esselen, M; Humpf, HU				Krug, Isabel; Behrens, Matthias; Esselen, Melanie; Humpf, Hans-Ulrich			Transport of enniatin B and enniatin B1 across the blood-brain barrier and hints for neurotoxic effects in cerebral cells	PLOS ONE			English	Article							IN-VITRO; MYCOTOXINS BEAUVERICIN; FUSARIUM-AVENACEUM; MASS-SPECTROMETRY; CACO-2 CELLS; BIOAVAILABILITY; CYTOTOXICITY; MODEL; A(1); PIGS	Enniatins are common contaminants of food and feed and belong to the group of the "emerging" mycotoxins, which are produced by various Fusarium species. Although a wide range of toxic effects, like antibacterial, antifungal, insecticidal and cytotoxic properties, have been described in vitro, so far, no cases of mycotoxicosis connected to enniatins in vivo are reported. Among this group of mycotoxins, enniatin B and enniatin B1 are the most prevalent compounds and therefore are present in the human diet. Enniatins can reach systemic circulation, thus, the investigation of possible neurotoxic effects is of importance. Different cerebral cells were used to address effects on cell death having an impact on the blood-brain barrier. The influence of enniatin B and enniatin B1 on cellular viability was examined via Cell Counting kit-8 assay (CCK-8) in three different cell types of the blood-brain barrier: porcine brain capillary endothelial cells (PBCEC), human brain microvascular endothelial cells (HBMEC) and human astrocytoma cells (CCF-STTG1). CCF-STTG1 cells were more sensitive to enniatin B (IC50 = 8.9 mu M) and enniatin B1 (IC50 = 4.4 mu M) than both endothelial cell types. In CCF-STTG1 cells, caspase-3 activation and lactate dehydrogenase (LDH) release were evaluated. Both compounds did not induce any LDH release and only enniatin B increased caspase-3 activity as a marker for apoptosis. The transport kinetics of enniatin B and enniatin B1 across the blood-brain barrier in vitro were evaluated using PBCEC, cultivated on Transwell (R) filter inserts. Analysis of the apical and the basolateral compartment by high performance liquid chromatography-mass spectrometry revealed high influx rates for enniatin B and enniatin B1. Thus, both compounds can reach the brain parenchyma where neurotoxic effects cannot be ruled out.	[Krug, Isabel; Behrens, Matthias; Esselen, Melanie; Humpf, Hans-Ulrich] Westfalische Wilhelms Univ Munster, Inst Food Chem, Corrensstr 45, Munster, Germany	University of Munster	Humpf, HU (corresponding author), Westfalische Wilhelms Univ Munster, Inst Food Chem, Corrensstr 45, Munster, Germany.	humpf@wwu.de	Humpf, Hans-Ulrich/AAV-4845-2020	Behrens, Matthias/0000-0001-5425-8144				Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Behrens M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143640; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Devreese M, 2014, FOOD CHEM TOXICOL, V63, P161, DOI 10.1016/j.fct.2013.11.005; Devreese M, 2013, TALANTA, V106, P212, DOI 10.1016/j.talanta.2012.11.068; Dornetshuber R, 2007, CHEM RES TOXICOL, V20, P465, DOI 10.1021/tx600259t; European Medicines Agency, 2016, FUS CONT MED PROD OR; Faeste CK, 2011, DRUG METAB DISPOS, V39, P1768, DOI 10.1124/dmd.111.039529; Firakova S, 2007, PHARMAZIE, V62, P563, DOI 10.1691/ph.2007.8.7600; Franke H, 2000, BRAIN RES PROTOC, V5, P248, DOI 10.1016/S1385-299X(00)00020-9; Gerding J, 2014, MOL NUTR FOOD RES, V58, P2358, DOI 10.1002/mnfr.201400406; Gruber-Dorninger C, 2017, J AGR FOOD CHEM, V65, P7052, DOI 10.1021/acs.jafc.6b03413; Ivanova L, 2006, TOXICON, V47, P868, DOI 10.1016/j.toxicon.2006.02.012; Ivanova L, 2017, FOOD CHEM TOXICOL, V105, P506, DOI 10.1016/j.fct.2017.04.041; Jestoi M, 2008, CRIT REV FOOD SCI, V48, P21, DOI 10.1080/10408390601062021; LIUZZI VC, 2017, TOXINS, V9, DOI DOI 10.3390/T0XINS9020045; Meca G, 2012, TOXICON, V59, P1, DOI 10.1016/j.toxicon.2011.10.004; Meca G, 2011, FOOD CHEM TOXICOL, V49, P2464, DOI 10.1016/j.fct.2011.05.020; Osteresch B, 2017, ANAL BIOANAL CHEM, V409, P3369, DOI 10.1007/s00216-017-0279-9; Patabendige A, 2013, BRAIN RES, V1521, P1, DOI 10.1016/j.brainres.2012.06.057; Razafimanjato H, 2011, GLIA, V59, P1672, DOI 10.1002/glia.21214; Razafimanjato H, 2010, NEUROTOXICOLOGY, V31, P475, DOI 10.1016/j.neuro.2010.06.003; Rubert J, 2014, ANAL CHIM ACTA, V820, P39, DOI 10.1016/j.aca.2014.02.009; Taevernier L, 2016, TOXICOL LETT, V258, P175, DOI 10.1016/j.toxlet.2016.06.1741; Taevernier L, 2016, J EXPO SCI ENV EPID, V26, P277, DOI 10.1038/jes.2015.10; Taevernier L, 2015, INT J PHARMACEUT, V491, P144, DOI 10.1016/j.ijpharm.2015.06.029; Uhlig S, 2007, INT J FOOD MICROBIOL, V119, P17, DOI 10.1016/j.ijfoodmicro.2007.07.021; Watjen W, 2009, MOL NUTR FOOD RES, V53, P431, DOI 10.1002/mnfr.200700428; Weidner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060484; Wolff A, 2015, J PHARM SCI-US, V104, P2727, DOI 10.1002/jps.24329	31	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197406	10.1371/journal.pone.0197406	http://dx.doi.org/10.1371/journal.pone.0197406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768483	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200080
J	Ogata, H; Mitsuzuka, Y; Honma, N; Yoshida, M; Sumazaki, M; Saito, F; Kobayashi, M; Shibuya, K; Mikami, T; Kaneko, H				Ogata, Hideaki; Mitsuzuka, Yukio; Honma, Naoko; Yoshida, Miho; Sumazaki, Makoto; Saito, Fumi; Kobayashi, Masahiro; Shibuya, Kazutoshi; Mikami, Tetsuo; Kaneko, Hironori			Sonographic visualization of nipple blood flow can help differentiate Paget disease from benign eczematous nipple lesions	PLOS ONE			English	Article							BREAST; WOMEN; RISK; MRI	Purpose Paget disease of the breast is a rare cancer that originates from the nipple-areolar complex. It is often overlooked and misdiagnosed as benign chronic eczema of the nipple. We aimed to retrospectively verify whether blood flow analysis using Doppler sonography was useful for detecting the presence of Paget disease. Methods In this retrospective study, 12 patients with pathologically proven unilateral nipple eczematous lesions (seven with Paget disease and five with simple dermatitis) were included. Nipple blood flow signal was observed using Doppler sonography, and the detected blood flow signals were quantified using digitally recorded images. Quantified blood flow ratio and pathologically examined capillary density were evaluated between affected and unaffected nipples. Findings of mammography, grayscale sonography, and contrast-enhanced magnetic resonance imaging (CE-MRI) were reviewed. Results In patients with Paget disease, Doppler effects in the affected nipple were more clearly visible than those in the unaffected nipple. These effects were sufficiently visible to identify Paget disease. No obvious effects were observed in the affected and unaffected nipples of simple dermatitis. The quantified blood flow ratio and pathologically examined capillary density were significantly higher for the Paget lesion than those for the non-Paget lesion. The sensitivity of CE-MRI and Doppler sonography was markedly correlated, revealing blood flow changes in the nipple lesions of Paget disease. Conclusion Doppler sonography visualized the proliferation of blood vessels in Paget lesions. The visualization of increased nipple blood flow using Doppler sonography is a simple and low-cost method that provides useful data for identifying Paget disease during routine medical care.	[Ogata, Hideaki; Yoshida, Miho; Sumazaki, Makoto; Saito, Fumi; Kaneko, Hironori] Toho Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg Omori,Ota Ku, Tokyo, Japan; [Mitsuzuka, Yukio] Toho Univ, Omori Hosp, Med Ctr, Dept Clin Physiol,Ota Ku, Tokyo, Japan; [Honma, Naoko; Mikami, Tetsuo] Toho Univ, Sch Med, Dept Pathol, Ota Ku, Tokyo, Japan; [Kobayashi, Masahiro] Toho Univ, Sch Med, Dept Radiol, Ota Ku, Tokyo, Japan; [Shibuya, Kazutoshi] Toho Univ, Sch Med, Dept Surg Pathol, Ota Ku, Tokyo, Japan		Ogata, H (corresponding author), Toho Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg Omori,Ota Ku, Tokyo, Japan.	ogatah@med.toho-u.ac.jp						ASHIKARI R, 1970, CANCER, V26, P680, DOI 10.1002/1097-0142(197009)26:3<680::AID-CNCR2820260329>3.0.CO;2-P; Burke ET, 1998, RADIOGRAPHICS, V18, P1459, DOI 10.1148/radiographics.18.6.9821194; Catalano O, 2010, AM J ROENTGENOL, V194, P735, DOI 10.2214/AJR.09.2422; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Giovagnorio F, 1999, J ULTRAS MED, V18, P89; Gunhan-Bilgen I, 2006, EUR J RADIOL, V60, P256, DOI 10.1016/j.ejrad.2006.06.010; IKEDA DM, 1993, RADIOLOGY, V189, P89, DOI 10.1148/radiology.189.1.8396786; Karakas Cansu, 2011, J Carcinog, V10, P31, DOI 10.4103/1477-3163.90676; Kim HS, 2010, ARCH GYNECOL OBSTET, V282, P157, DOI 10.1007/s00404-009-1244-4; Kothari AS, 2002, CANCER, V95, P1, DOI 10.1002/cncr.10638; Lassau Nathalie, 2006, Cancer Imaging, V6, P24, DOI 10.1102/1470-7330.2006.0009; Lim HS, 2011, RADIOGRAPHICS, V31, P1973, DOI 10.1148/rg.317115070; Lohsiriwat V, 2012, ANN SURG ONCOL, V19, P1850, DOI 10.1245/s10434-012-2226-5; Moon JY, 2013, AM J ROENTGENOL, V201, P448, DOI 10.2214/AJR.12.9186; Morrogh M, 2008, J AM COLL SURGEONS, V206, P316, DOI 10.1016/j.jamcollsurg.2007.07.046; PAONE JF, 1981, CANCER, V48, P825, DOI 10.1002/1097-0142(19810801)48:3<825::AID-CNCR2820480326>3.0.CO;2-#; Rickard M T, 1995, Australas Radiol, V39, P27, DOI 10.1111/j.1440-1673.1995.tb00227.x; Trebska-McGowan K, 2013, GLAND SURG, V2, P137, DOI 10.3978/j.issn.2227-684X.2013.08.03; Ward KA, 1997, CLIN DERMATOL, V15, P45, DOI 10.1016/S0738-081X(96)00109-5; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007	20	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197156	10.1371/journal.pone.0197156	http://dx.doi.org/10.1371/journal.pone.0197156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768474	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200062
J	Martin-Canavate, R; Sonego, M; Sagrado, MJ; Escobar, G; Rivas, E; Ayala, S; Castaneda, L; Aparicio, P; Custodio, E				Martin-Canavate, Rocio; Sonego, Michela; Jose Sagrado, Maria; Escobar, Gustavo; Rivas, Estefanie; Ayala, Sandra; Castaneda, Luis; Aparicio, Pilar; Custodio, Estefania			Dietary patterns and nutritional status of HIV-infected children and adolescents in El Salvador: A cross-sectional study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SOCIOECONOMIC-STATUS; DISEASE; HEALTH; ASSOCIATION; PREVALENCE; EXERCISE	Introduction The present study aimed to assess the nutritional status, the dietary patterns and its associated factors in the HIV-infected population of children and adolescents on antiretroviral treatment at the El Salvador reference center for pediatric HIV care (CENID). Methods A cross-sectional survey was carried out between December 2010 and December 2011. Socio-demographic and clinical characteristics were collected from 307 children and adolescents aged 2-18 years and receiving antiretroviral therapy. Nutritional status was assessed by height-for-age, weight-for-height and body mass index-for-age. Dietary data was collected through a 24 hour recall, and through a weekly food frequency questionnaire. Dietary patterns were identified by principal component analysis. Bivariate and multivariable statistical methods were used to assess the factors associated with "high adherence" to the "healthy diet" pattern. Results More than a third of the study group (33.2%) were stunted, 3.3% were identified as being wasted, and 10% were overweight or obese. Their diets were predominantly based on a high consumption of cereals, beans, eggs and processed foods and a low consumption of fruits, vegetables and dairy products. Three dietary patterns were identified: "healthy diet", "high fat/sugar diet" and "low diversity diet". Being female (OR: 1.63; 95%Cl: 0.97-2.75), younger (OR: 2.37; 95%Cl: 1.28-4.36) and institutionalized (OR: 14.5; 95%Cl: 5.35-39.50) increased the odds to adhere to the "healthy diet" pattern. Conclusion Our findings reveal a high prevalence of stunting and overweight in HIV-infected children in El Salvador. Institutionalized children were more likely to adhere to a healthy dietary pattern whereas children in poverty were more likely to have less varied and healthy diets. These results highlight the need to assess the dietary patterns of HIV-infected children and adolescents in order to guide public policies to design healthy life style interventions for this population at risk.	[Martin-Canavate, Rocio; Jose Sagrado, Maria; Aparicio, Pilar; Custodio, Estefania] Inst Hlth Carlos III, Natl Ctr Trop Med, Madrid, Spain; [Sonego, Michela] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Sonego, Michela] Inst Hlth Carlos III, Natl Ctr Epidemiol, Madrid, Spain; [Jose Sagrado, Maria] Inst Hlth Carlos III, Natl Ctr Epidemiol, Field Epidemiol Training Program, Madrid, Spain; [Escobar, Gustavo; Rivas, Estefanie; Ayala, Sandra; Castaneda, Luis] Children Hosp Benjamin Bloom, Ctr Excelencia Ninos Inmunodeficiencias, San Salvador, El Salvador; [Custodio, Estefania] European Commiss Joint Res Ctr, Ispra, Italy	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; European Commission Joint Research Centre; EC JRC ISPRA Site	Custodio, E (corresponding author), Inst Hlth Carlos III, Natl Ctr Trop Med, Madrid, Spain.; Custodio, E (corresponding author), European Commiss Joint Res Ctr, Ispra, Italy.	estefania.custodio@ec.europa.eu			Agencia Espanola de Cooperacion y Desarrollo (AECID); Fundacion Inocencia; Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) Institute de Salud Carlos III [RD12/0018/0001]	Agencia Espanola de Cooperacion y Desarrollo (AECID); Fundacion Inocencia; Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) Institute de Salud Carlos III	The study was funded by the Agencia Espanola de Cooperacion y Desarrollo (AECID), la Fundacion Inocencia and the Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET) Institute de Salud Carlos III RD12/0018/0001.	[Anonymous], ENC NAC SAL IND MULT; [Anonymous], 2013, ENC MUND SAL ESC RES; [Anonymous], 2010, INF NC B PIK USNL M; Aranceta J, 2003, EUR J CLIN NUTR, V57, pS40, DOI 10.1038/sj.ejcn.1601813; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Asociacion Demografica Salvadorena, 2009, FESAL2008; Bermudez Odilia I., 2003, Cad. Saúde Pública, V19, pS87, DOI 10.1590/S0102-311X2003000700010; Boccara F, 2013, J AM COLL CARDIOL, V61, P511, DOI 10.1016/j.jacc.2012.06.063; Botros D, 2012, CURR HIV-AIDS REP, V9, P351, DOI 10.1007/s11904-012-0135-7; Chandra RK, 1997, AM J CLIN NUTR, V66, P460; Charakida M, 2005, CIRCULATION, V112, P103, DOI 10.1161/CIRCULATIONAHA.104.517144; Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479; de Lima LRA, 2013, J PEDIAT-BRAZIL, V89, P91, DOI 10.1016/j.jped.2013.02.014; de Pinho L, 2014, J PEDIAT-BRAZIL, V90, P267, DOI 10.1016/j.jped.2013.04.006; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Fernandez-Alvira JM, 2014, EUR J CLIN NUTR, V68, P811, DOI 10.1038/ejcn.2014.78; Fields-Gardner C, 2010, J AM DIET ASSOC, V110, P1105, DOI 10.1016/j.jada.2010.05.020; Fransen HP, 2014, J NUTR, V144, P1274, DOI 10.3945/jn.113.188680; Vilela AAF, 2014, CAD SAUDE PUBLICA, V30, P502, DOI 10.1590/0102-311X00167512; Fuster M, 2014, PUBLIC HEALTH NUTR, V17, P529, DOI 10.1017/S1368980013000426; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Groeneveld IF, 2007, REV PANAM SALUD PUBL, V22, P169, DOI 10.1590/S1020-49892007000800003; Instituto de Nutricion de Centroamerica y Panama A INCAP, 2011, AN SIT AL SALV; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kanjanavanit S, 2011, ANTIVIR THER, V16, P1351, DOI 10.3851/IMP1897; LaRowe TL, 2007, J AM DIET ASSOC, V107, P1124, DOI 10.1016/j.jada.2007.04.013; Li K., 2014, J GLOB HLTH; Mangili A, 2006, CLIN INFECT DIS, V42, P836, DOI 10.1086/500398; Miller TL, 1996, J NUTR, V126, pS2623, DOI 10.1093/jn/126.suppl_10.2623S; Ministerio de Salud de El Salvador, 2012, GUIA AL FAM SALV; Mwiru Ramadhani S, 2015, J Int Assoc Provid AIDS Care, V14, P172, DOI 10.1177/2325957413500852; National Institute of Statistics Spain, NAT HLTH SURV 2006 M; Pajuelo-Ramírez Jaime, 2013, Rev. perú. med. exp. salud publica, V30, P583; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Puthanakit T, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18575; Romieu I, 1997, AM J CLIN NUTR, V65, P1159; Sonego M, 2016, PEDIATR INFECT DIS J, V35, P1111, DOI 10.1097/INF.0000000000001244; Strehlau R, 2012, JAIDS-J ACQ IMM DEF, V60, P369, DOI 10.1097/QAI.0b013e318243760b; Swetha GK, 2015, INDIAN J MED RES, V141, P46; Tsiodras S, 2009, METABOLISM, V58, P854, DOI 10.1016/j.metabol.2009.02.012; Verweel G, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e25; Vreeman RC, 2015, J INT AIDS SOC, V18, P53, DOI 10.7448/IAS.18.7.20258; Whiting SJ, 2001, NUTR RES, V21, P1107, DOI 10.1016/S0271-5317(01)00324-4; WHO, WHO CHILD GROWTH STA; WHO, GUID INT APPR NUTR C	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196380	10.1371/journal.pone.0196380	http://dx.doi.org/10.1371/journal.pone.0196380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763418	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800008
J	Hansen, AT; Jensen, JMB; Hvas, AM; Christiansen, M				Hansen, Anette Tarp; Jensen, Jens Magnus Bernth; Hvas, Anne-Mette; Christiansen, Mette			The genetic component of preeclampsia: A whole-exome sequencing study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HYPERTENSIVE DISORDERS; REDUCTASE DEFICIENCY; RISK; PREGNANCY; VARIANTS; ECLAMPSIA; METAANALYSIS; RECURRENCE; REGISTRY	Preeclampsia is a major cause of maternal and perinatal deaths. The aetiology of preeclampsia is largely unknown but a polygenetic component is assumed. To explore this hypothesis, we performed an in-depth whole-exome sequencing study in women with (cases, N = 50) and without (controls, N = 50) preeclampsia. The women were identified in an unselected cohort of 2,545 pregnant women based on data from the Danish National Patient Registry and the Medical Birth Registry. Matching DNA was obtained from a biobank containing excess blood from routine antenatal care visits. Novogene performed the whole-exome sequencing blinded to preeclampsia status. Variants for comparison between cases and controls were filtered in the Ingenuity Variant Analysis software. We applied two different strategies; a disease association pane/approach, which included variants in single genes associated with established clinical risk factors for preeclampsia, and a gene pane/approach, which included biological pathways harbouring genes previously reported to be associated with preeclampsia. Variant variability was compared in cases and controls at the level of biological processes, signalling pathways, and in single genes. Regardless of the applied strategy and the level of variability examined, we consistently found positive correlations between variant numbers in cases and controls (all R-2 s>0.88). Contrary to what was expected, cases carried fewer variants in biological processes and signalling pathways than controls (all p-values <= 0.02). In conclusion, our findings challenge the hypothesis of a polygenetic aetiology for preeclampsia with a common network of susceptibility genes. The greater genetic diversity among controls may suggest a protective role of genetic diversity against the development of preeclampsia.	[Hansen, Anette Tarp; Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark; [Hansen, Anette Tarp] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark; [Hansen, Anette Tarp; Jensen, Jens Magnus Bernth; Hvas, Anne-Mette] Aarhus Univ, Dept Clin Med, Hlth, Aarhus, Denmark; [Jensen, Jens Magnus Bernth; Christiansen, Mette] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University	Hansen, AT (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark.; Hansen, AT (corresponding author), Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark.; Hansen, AT (corresponding author), Aarhus Univ, Dept Clin Med, Hlth, Aarhus, Denmark.	anette.tarp.hansen@dadlnet.dk	Bernth-Jensen, Jens Magnus/H-6694-2019	Christiansen, Mette/0000-0001-5158-3670; Hansen, Anette Tarp/0000-0001-6276-6579; Bernth Jensen, Jens Magnus/0000-0002-5004-7822	Danish Council for Independent Research [0602-021736]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The trial was funded by The Danish Council for Independent Research (Grant no: 0602-021736 FSS). The funder had no role in the design or conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, critical review, and final approval of the paper.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ark M, 2005, PLACENTA, V26, P81, DOI 10.1016/j.placenta.2004.03.012; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Behrens I, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3078; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Burda P, 2015, HUM MUTAT, V36, P611, DOI 10.1002/humu.22779; CHESLEY LC, 1986, BRIT J OBSTET GYNAEC, V93, P898, DOI 10.1111/j.1471-0528.1986.tb08006.x; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Fong FM, 2014, AM J EPIDEMIOL, V180, P335, DOI 10.1093/aje/kwu151; Hazelett DJ, 2016, CELL CYCLE, V15, P22, DOI 10.1080/15384101.2015.1120928; Ho LN, 2017, SCIENCE, V357, P707, DOI 10.1126/science.aam6607; Johnson MP, 2009, HUM GENET, V126, P655, DOI 10.1007/s00439-009-0714-x; Kaartokallio T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29085; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lin J, 2005, OBSTET GYNECOL, V105, P182, DOI 10.1097/01.AOG.0000146250.85561.e9; Loset M, 2014, PREGNANCY HYPERTENS, V4, P178, DOI 10.1016/j.preghy.2014.03.005; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; MacDorman MF, 2017, OBSTET GYNECOL, V129, P811, DOI [10.1097/AOG.0000000000001968, 10.1097/aog.0000000000001968]; Melamed N, 2012, J MATERN-FETAL NEO M, V25, P2248, DOI 10.3109/14767058.2012.684174; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roberge S., 2017, AM J OBSTET GYNECOL; Ros HS, 2000, AM J MED GENET, V91, P256; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; THORNTON JG, 1991, BRIT MED J, V303, P1241, DOI 10.1136/bmj.303.6812.1241; Tonetti C, 2003, EUR J PEDIATR, V162, P466, DOI 10.1007/s00431-003-1196-9; Tong X, 2011, EMBO REP, V12, P428, DOI 10.1038/embor.2011.49; Tooher J, 2017, HYPERTENSION, V70, P798, DOI 10.1161/HYPERTENSIONAHA.117.09246; Treloar SA, 2001, AM J OBSTET GYNECOL, V184, P374, DOI 10.1067/mob.2001.109400; Triche EW, 2014, J REPROD IMMUNOL, V101, P111, DOI 10.1016/j.jri.2013.06.004; Valenzuela FJ, 2012, J PREGNANCY, V2012, DOI [10.1155/2012/632732, DOI 10.1155/2012/632732]; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Williams PJ, 2011, BEST PRACT RES CL OB, V25, P405, DOI 10.1016/j.bpobgyn.2011.02.007; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yong HEJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128230; Yuan Q, 2016, P NATL ACAD SCI USA, V113, P8532, DOI 10.1073/pnas.1608859113	42	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197217	10.1371/journal.pone.0197217	http://dx.doi.org/10.1371/journal.pone.0197217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758065	Green Published, gold, Green Submitted			2022-12-26	WOS:000432082900036
J	Rostovtseva, TK; Gurnev, PA; Hoogerheide, DP; Rovini, A; Sirajuddin, M; Bezrukov, SM				Rostovtseva, Tatiana K.; Gurnev, Philip A.; Hoogerheide, David P.; Rovini, Amandine; Sirajuddin, Minhajuddin; Bezrukov, Sergey M.			Sequence diversity of tubulin isotypes in regulation of the mitochondrial voltage-dependent anion channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gating; tubulin; membrane protein; recombinant protein expression; protein engineering; protein-lipid interaction; mitochondrial transport; ion channel; permeability; membrane transport; beta-barrel channel; drift-diffusion model; engineered recombinant tubulin; peripheral membrane proteins; VDAC; C-terminal tail; gating charge; intrinsically disordered protein domains	III BETA-TUBULIN; POSTTRANSLATIONAL MODIFICATIONS; ALPHA-TUBULIN; CANCER-CELLS; PHOSPHOLIPID-VESICLES; PROXIMITY LIGATION; ION-CHANNEL; IN-SITU; VDAC; MEMBRANE	The microtubule protein tubulin is a heterodimer comprising / subunits, in which each subunit features multiple isotypes in vertebrates. For example, seven -tubulin and eight -tubulin isotypes in the human tubulin gene family vary mostly in the length and primary sequence of the disordered anionic carboxyl-terminal tails (CTTs). The biological reason for such sequence diversity remains a topic of vigorous enquiry. Here, we demonstrate that it may be a key feature of tubulin's role in regulation of the permeability of the mitochondrial outer membrane voltage-dependent anion channel (VDAC). Using recombinant yeast /-tubulin constructs with -CTTs, -CTTs, or both from various human tubulin isotypes, we probed their interactions with VDAC reconstituted into planar lipid bilayers. A comparative study of the blockage kinetics revealed that either -CTTs or -CTTs block the VDAC pore and that the efficiency of blockage by individual CTTs spans 2 orders of magnitude, depending on the CTT isotype. -Tubulin constructs, notably 3, blocked VDAC most effectively. We quantitatively described these experimental results using a physical model that accounted only for the number and distribution of charges in the CTT, and not for the interactions between specific residues on the CTT and VDAC pore. Based on these results, we speculate that the effectiveness of VDAC regulation by tubulin depends on the predominant tubulin isotype in a cell. Consequently, the fluxes of ATP/ADP through the channel could vary significantly, depending on the isotype, thus suggesting an intriguing link between VDAC regulation and the diversity of tubulin isotypes present in vertebrates.	[Rostovtseva, Tatiana K.; Gurnev, Philip A.; Rovini, Amandine; Bezrukov, Sergey M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Transport, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA; [Hoogerheide, David P.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Sirajuddin, Minhajuddin] Inst Stem Cell Biol & Regenerat Med, Bangalore 560065, Karnataka, India	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Standards & Technology (NIST) - USA; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Rostovtseva, TK (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Transport, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov	Hoogerheide, David P./AAB-3753-2019; rovini, amandine/W-1703-2019	Hoogerheide, David P./0000-0003-2918-1469; Rovini, Amandine/0000-0003-0483-9092; Sirajuddin, Minhajuddin/0000-0001-5742-2130	National Science Foundation (NSF) [ACI-1053575]; NSF [ACI-1445606]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are indebted to Jeff Abramson and Lucie Bergdoll (David Geffen School of Medicine, UCLA) for fruitful discussions. This study used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation (NSF) Grant ACI-1053575. Specifically, it was the Bridges system supported by NSF Award ACI-1445606, at the Pittsburgh Super-computing Center (PSC).	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ambjornsson T, 2002, J CHEM PHYS, V117, P4063, DOI 10.1063/1.1486208; BANERJEE A, 1988, J BIOL CHEM, V263, P3029; BERNIERVALENTIN F, 1983, J CELL BIOL, V97, P209, DOI 10.1083/jcb.97.1.209; Bickel T, 2001, EUR PHYS J E, V4, P33, DOI 10.1007/s101890170140; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Bode CJ, 2003, EMBO REP, V4, P94, DOI 10.1038/sj.embor.embor716; Bretteville A, 2017, METHODS MOL BIOL, V1523, P297, DOI 10.1007/978-1-4939-6598-4_18; BURGOYNE RD, 1988, EMBO J, V7, P2311, DOI 10.1002/j.1460-2075.1988.tb03074.x; Camara AKS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00460; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Colombini M, 1996, Ion Channels, V4, P169; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Doi M., 1988, THEORY POLYMER DYNAM, P8; FERREIRA A, 1992, J NEUROSCI RES, V32, P516, DOI 10.1002/jnr.490320407; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Hoogerheide DP, 2018, BIOPHYS J, V114, P772, DOI 10.1016/j.bpj.2017.12.019; Hoogerheide DP, 2017, P NATL ACAD SCI USA, V114, pE3622, DOI 10.1073/pnas.1619806114; Hoogerheide DP, 2017, NANOSCALE, V9, P183, DOI 10.1039/c6nr08145b; Hoogerheide DP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.248301; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Johnson V, 2011, BIOCHEMISTRY-US, V50, P8636, DOI 10.1021/bi2005174; Kienzle P., 2011, BUMPS VERSION 080; KLAUSNER RD, 1981, J BIOL CHEM, V256, P5879; KUMAR N, 1981, J BIOL CHEM, V256, P5886; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Luduena RF, 2013, INT REV CEL MOL BIO, V302, P41, DOI 10.1016/B978-0-12-407699-0.00002-9; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Mariani M, 2015, GENE, V563, P109, DOI 10.1016/j.gene.2015.03.061; Minoura I, 2013, FEBS LETT, V587, P3450, DOI 10.1016/j.febslet.2013.08.032; Monge C, 2008, MOL CELL BIOCHEM, V318, P147, DOI 10.1007/s11010-008-9865-7; Monje-Galvan V, 2016, BBA-BIOMEMBRANES, V1858, P1584, DOI 10.1016/j.bbamem.2016.02.018; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Noskov SY, 2016, BBA-BIOMEMBRANES, V1858, P1778, DOI 10.1016/j.bbamem.2016.02.026; Noskov SY, 2013, BIOCHEMISTRY-US, V52, P9246, DOI 10.1021/bi4011495; Nystrom Nicholas A, 2015, P 2015 XSEDE C SCI A; PALMIERI F, 1989, J BIOENERG BIOMEMBR, V21, P417, DOI 10.1007/BF00762514; Pamula MC, 2016, J CELL BIOL, V213, P425, DOI 10.1083/jcb.201603050; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N; Redeker V, 2010, METHOD CELL BIOL, V95, P77, DOI 10.1016/S0091-679X(10)95006-1; Roll-Mecak A, 2015, SEMIN CELL DEV BIOL, V37, P11, DOI 10.1016/j.semcdb.2014.09.026; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva TK, 2008, J BIOENERG BIOMEMBR, V40, P163, DOI 10.1007/s10863-008-9145-y; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2015, SPRINGER SER BIOPHYS, V18, P3, DOI 10.1007/978-3-319-20149-8_1; Rostovtseva TK, 2012, J BIOL CHEM, V287, P29589, DOI 10.1074/jbc.M112.378778; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; SCHATZ PJ, 1987, MOL CELL BIOL, V7, P3799, DOI 10.1128/MCB.7.10.3799; Sheldon KL, 2015, J BIOL CHEM, V290, P26784, DOI 10.1074/jbc.M115.678854; Shoshan-Barmatz V, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00154; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Ti SC, 2016, DEV CELL, V37, P72, DOI 10.1016/j.devcel.2016.03.003; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Valenstein ML, 2016, CELL, V164, P911, DOI 10.1016/j.cell.2016.01.019; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P292; Vemu A, 2016, J BIOL CHEM, V291, P12907, DOI 10.1074/jbc.C116.731133; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vrugt JA, 2009, INT J NONLIN SCI NUM, V10, P273, DOI 10.1515/IJNSNS.2009.10.3.273; Weinrich M, 2017, NANOSCALE, V9, P13291, DOI 10.1039/c7nr03926c; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yates B, 2017, NUCLEIC ACIDS RES, V45, pD619, DOI 10.1093/nar/gkw1033	72	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10949	10962		10.1074/jbc.RA117.001569	http://dx.doi.org/10.1074/jbc.RA117.001569			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29777059	Green Published, hybrid			2022-12-26	WOS:000438882800009
J	Wang, WH; Li, F; Xu, YM; Wei, JC; Zhang, YN; Yang, H; Gao, BX; Yu, GH; Fang, DY				Wang, Wenhui; Li, Fei; Xu, Yuanming; Wei, Juncheng; Zhang, Yana; Yang, Heeyoung; Gao, Beixue; Yu, Guohua; Fang, Deyu			JAK1-mediated Sirt1 phosphorylation functions as a negative feedback of the JAK1-STAT3 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Janus kinase (JAK); signal transduction; sirtuin 1 (SIRT1); STAT3; post-translational modification (PTM); JAK1; negative feedback	BREAST-CANCER CELLS; P53 ACETYLATION; LUNG-CANCER; DNA-DAMAGE; ACTIVATION; DEACETYLASE; TRANSFORMATION; TRANSCRIPTION; INHIBITION; EXPRESSION	The type III NAD-dependent histone deacetylase Sirt1 plays important roles in a variety of pathobiological functions through targeting either the acetylated histones or transcription factors. However, the molecular mechanisms underlying how the Sirt1 functions are regulated remain vague. Herein we identified that the Janus kinase 1 (JAK1) interacts with Sirt1 and catalyzes its phosphorylation at the tyrosine residues of 280 and 301, both of which are highly conserved and located in the histone deacetylase catalytic domain of Sirt1. IL-6 stimulation enhanced Sirt1 interaction with JAK1 and JAK1-mediated Sirt1 phosphorylation. Interestingly, JAK1-mediated Sirt1 phosphorylation did not alter Sirt1 deacetylase catalytic activity, but instead it is required for Sirt1 interaction with the downstream transcription factor STAT3. JAK1-mediated phosphorylation enhanced Sirt1 suppression of STAT3 acetylation and transcriptional activity. As a consequence, Sirt1 activation attenuates IL-6 activity in protecting cancer cells from chemotherapeutic drug-induced apoptosis. Our studies identify JAK1 as a previously unappreciated tyrosine kinase of Sirt1 and reveal a novel negative feedback of the JAK1-STAT3 pathway.	[Wang, Wenhui; Yu, Guohua] Wei Fang Peoples Hosp, Dept Oncol, Wei Fang 261041, Shandong, Peoples R China; [Wang, Wenhui; Li, Fei; Xu, Yuanming; Wei, Juncheng; Zhang, Yana; Yang, Heeyoung; Gao, Beixue; Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Zhang, Yana] Guangzhou Women & Childrens Med Ctr, Dept Otolaryngol Head & Neck Surg, Guangzhou 510623, Guangdong, Peoples R China	Northwestern University; Feinberg School of Medicine	Yu, GH (corresponding author), Wei Fang Peoples Hosp, Dept Oncol, Wei Fang 261041, Shandong, Peoples R China.; Fang, DY (corresponding author), 303 E Chicago Ave, Chicago, IL 60611 USA.	ghyry@126.com; fangd@northwestern.edu	xu, Yuanming/R-2226-2018; Wei, Juncheng/Q-1092-2019	xu, Yuanming/0000-0003-3137-5270; 	National Institutes of Health [R01 AI079056, AI108634, AR006634]; National Natural Science Foundation of China [81600784]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079056, R01AI108634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI079056, AI108634, and AR006634 (to D. F.) and the National Natural Science Foundation of China Grant 81600784 (to Y. Z.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Conrad E, 2016, CELL DEATH DIFFER, V23, P110, DOI 10.1038/cdd.2015.75; Conze D, 2001, CANCER RES, V61, P8851; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Gao BX, 2012, P NATL ACAD SCI USA, V109, P899, DOI 10.1073/pnas.1118462109; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Kong SY, 2012, IMMUNOL CELL BIOL, V90, P6, DOI 10.1038/icb.2011.102; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Lau AW, 2014, AM J CANCER RES, V4, P245; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yan HQ, 2014, CANCER SCI, V105, P1220, DOI 10.1111/cas.12478; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	37	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11067	11075		10.1074/jbc.RA117.001387	http://dx.doi.org/10.1074/jbc.RA117.001387			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789426	hybrid, Green Published			2022-12-26	WOS:000438882800019
J	Nithianantham, S; McNally, FJ; Al-Bassam, J				Nithianantham, Stanley; McNally, Francis J.; Al-Bassam, Jawdat			Structural basis for disassembly of katanin heterododecamers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; microtubule-associated protein (MAP); microtubule; mitosis; meiosis; tubulin	MICROTUBULE-SEVERING ACTIVITY; SPASTIC PARAPLEGIA; AAA ATPASE; PROTEIN; COMPLEX; CRYSTALLOGRAPHY; SOFTWARE; QUALITY; SYSTEM; PHENIX	The reorganization of microtubules in mitosis, meiosis, and development requires the microtubule-severing activity of katanin. Katanin is a heterodimer composed of an ATPase associated with diverse cellular activities (AAA) subunit and a regulatory subunit. Microtubule severing requires ATP hydrolysis by katanin's conserved AAA ATPase domains. Whereas other AAA ATPases form stable hexamers, we show that katanin forms only a monomer or dimers of heterodimers in solution. Katanin oligomers consistent with hexamers of heterodimers or heterododecamers were only observed for an ATP hydrolysis-deficient mutant in the presence of ATP. X-ray structures of katanin's AAA ATPase in monomeric nucleotide-free and pseudo-oligomeric ADP-bound states revealed conformational changes in the AAA subdomains that explained the structural basis for the instability of the katanin heterododecamer. We propose that the rapid dissociation of katanin AAA oligomers may lead to an autoinhibited state that prevents inappropriate microtubule severing or that cyclical disassembly into heterodimers may critically contribute to the microtubule-severing mechanism.	[Nithianantham, Stanley; McNally, Francis J.; Al-Bassam, Jawdat] Univ Calif Davis, Dept Mol Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Al-Bassam, J (corresponding author), Univ Calif Davis, Dept Mol Cellular Biol, Davis, CA 95616 USA.	jawdat@ucdavis.edu			National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205, S10OD021527]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110283, R01GM079421, P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021527] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Advanced Photon Source and Drs. K. Rajashankar, J. Schuermann, and D. Neau of the Northeastern Collaborative Access Team (NE-CAT) for the use of the 24-IDC and IDE beam lines to collect all the X-ray diffraction data for our crystallo-graphic studies. We thank our graduate student, Brian D. Cook, for help with SEC-MALS. This work is based upon research conducted at the NE-CAT beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). The Eiger 16M detector on 24-ID-E beam line is funded by a NIH-ORIP HEI grant (S10OD021527). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bailey ME, 2015, BIOPHYS J, V109, P2546, DOI 10.1016/j.bpj.2015.11.011; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLARKMAGUIRE S, 1994, J CELL BIOL, V126, P199, DOI 10.1083/jcb.126.1.199; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Han H, 2017, ELIFE, V6, DOI 10.7554/eLife.31324; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hu WF, 2014, NEURON, V84, P1240, DOI 10.1016/j.neuron.2014.12.017; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; Jiang K, 2017, NAT CELL BIOL, V19, P480, DOI 10.1038/ncb3511; Jiang K, 2014, DEV CELL, V28, P295, DOI 10.1016/j.devcel.2014.01.001; Joly N, 2016, DEVELOPMENT, V143, P3604, DOI 10.1242/dev.140830; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally FJ, 1998, MOL BIOL CELL, V9, P1847, DOI 10.1091/mbc.9.7.1847; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; Mishra-Gorur K, 2014, NEURON, V84, P1226, DOI 10.1016/j.neuron.2014.12.014; Monroe N, 2017, ELIFE, V6, DOI 10.7554/eLife.24487; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Powell HR, 2013, ACTA CRYSTALLOGR D, V69, P1195, DOI 10.1107/S0907444912048524; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Sharma N, 2007, J CELL BIOL, V178, P1065, DOI 10.1083/jcb.200704021; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Srayko M, 2000, GENE DEV, V14, P1072; Su M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700325; Sun S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16064; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Taylor JL, 2012, J STRUCT BIOL, V179, P133, DOI 10.1016/j.jsb.2012.03.002; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wohlever ML, 2017, MOL CELL, V67, P194, DOI 10.1016/j.molcel.2017.06.019; Zehr E, 2017, NAT STRUCT MOL BIOL, V24, P717, DOI 10.1038/nsmb.3448	48	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10590	10605		10.1074/jbc.RA117.001215	http://dx.doi.org/10.1074/jbc.RA117.001215			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29752405	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000437828400018
J	Kurasawa, Y; Hu, HQ; Zhou, Q; Li, ZY				Kurasawa, Yasuhiro; Hu, Huiqing; Zhou, Qing; Li, Ziyin			The trypanosome-specific protein CIF3 cooperates with the CIF1 protein to promote cytokinesis in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cell division; cytokinesis; parasite; Trypanosoma brucei; Aurora B kinase; kinetoplastid; polo-like kinase; sleeping sickness; trypanosomiasis; CIF1; CIF2; CIF3	POLO-LIKE KINASE; CELL MORPHOGENESIS; INITIATION; SEGREGATION; EXPRESSION; FLAGELLUM; ROLES; RING	Cytokinesis, the terminal step in cell division, in the protist human pathogen Trypanosoma brucei occurs along the longitudinal axis from the anterior tip of the new flagellum attachment zone (FAZ) toward the posterior cell tip. This process is regulated by a signaling cascade composed of the Polo-like kinase homolog TbPLK, the Aurora B kinase homolog TbAUK1, and the trypanosome-specific CIF1-CIF2 protein complex. However, the regulatory mechanism and the signaling pathway for this unusual mode of cytokinesis remain poorly understood. Here, we report another trypanosome-specific protein assembly, the CIF1-CIF3 complex, and its essential role in cytokinesis initiation. Through biochemical and genetic approaches, we demonstrate that CIF3 interacts with CIF1 in a TbPLK-dependent manner and maintains CIF1 localization at the new FAZ tip. Conversely, CIF1 maintains CIF3 stability at the new FAZ tip. We further show that TbPLK is required for CIF3 localization and that CIF3 is necessary for targeting TbAUK1 to the new FAZ tip during anaphase. These results suggest that two trypanosome-specific CIF1-containing protein complexes cooperate with the evolutionarily conserved Polo-like kinase and Aurora B kinase to promote cytokinesis in T. brucei.	[Kurasawa, Yasuhiro; Hu, Huiqing; Zhou, Qing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/I-6223-2019; Zhou, Qing/A-8296-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [AI101437, AI118736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101437, R01AI118736] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI101437 and AI118736. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; Cheffings TH, 2016, CURR BIOL, V26, pR719, DOI 10.1016/j.cub.2016.06.071; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hu HQ, 2017, J CELL SCI, V130, P4108, DOI 10.1242/jcs.207134; Hu HQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006146; Hu HQ, 2015, J BIOL CHEM, V290, P25012, DOI 10.1074/jbc.M115.674796; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Li Z, 2010, EUKARYOT CELL, V9, P705, DOI 10.1128/EC.00330-09; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Muller S, 2016, SEMIN CELL DEV BIOL, V53, P10, DOI 10.1016/j.semcdb.2015.10.037; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wickstead B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015020; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	26	18	18	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10275	10286		10.1074/jbc.RA118.003113	http://dx.doi.org/10.1074/jbc.RA118.003113			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764941	Green Published, hybrid			2022-12-26	WOS:000437096700026
J	Marciano, G; Da Vela, S; Tria, G; Svergun, DI; Byron, O; Huang, DT				Marciano, Gabriele; Da Vela, Stefano; Tria, Giancarlo; Svergun, Dmitri I.; Byron, Olwyn; Huang, Danny T.			Structure-specific recognition protein-1 (SSRP1) is an elongated homodimer that binds histones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						analytical ultracentrifugation; small-angle X-ray scattering (SAXS); histone chaperone; oligomerization; histone; H2A-H2B; H3-H4; homodimer; SSRP1	SMALL-ANGLE SCATTERING; DNA-POLYMERASE ALPHA; N-TERMINAL DOMAIN; CHAPERONE FACT; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; NUCLEOSOME REORGANIZATION; CHROMATIN; REPLICATION; SPT16	The histone chaperone complex facilitates chromatin transcription (FACT) plays important roles in DNA repair, replication, and transcription. In the formation of this complex, structure-specific recognition protein-1 (SSRP1) heterodimerizes with suppressor of Ty 16 (SPT16). SSRP1 also has SPT16-independent functions, but how SSRP1 functions alone remains elusive. Here, using analytical ultracentrifugation (AUC) and small-angle X-ray scattering (SAXS) techniques, we characterized human SSRP1 and that from the amoeba Dictyostelium discoideum and show that both orthologs form an elongated homodimer in solution. We found that substitutions in the SSRP1 pleckstrin homology domain known to bind SPT16 also disrupt SSRP1 homodimerization. Moreover, AUC and SAXS analyses revealed that SSRP1 homodimerization and heterodimerization with SPT16 (resulting in FACT) involve the same SSRP1 surface, namely the PH2 region, and that the FACT complex contains only one molecule of SSRP1. These observations suggest that SSRP1 homo- and heterodimerization might be mutually exclusive. Moreover, isothermal titration calorimetry analyses disclosed that SSRP1 binds both histones H2A-H2B and H3-H4 and that disruption of SSRP1 homodimerization decreases its histone-binding affinity. Together, our results provide evidence for regulation of SSRP1 by homodimerization and suggest a potential role for homodimerization in facilitating SPT16-independent functions of SSRP1.	[Marciano, Gabriele; Huang, Danny T.] Univ Glasgow, Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland; [Marciano, Gabriele; Huang, Danny T.] Univ Glasgow, Inst Canc Sci, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland; [Da Vela, Stefano; Tria, Giancarlo; Svergun, Dmitri I.] European Mol Biol Lab, Hamburg Outstn, EMBL DESY, Notkestr 85, D-22607 Hamburg, Germany; [Byron, Olwyn] Univ Glasgow, Sch Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Tria, Giancarlo] Maastricht Univ, Multimodal Imaging Inst, Div Nanoscopy, POB 616, NL-6200 MD Maastricht, Netherlands	Beatson Institute; University of Glasgow; University of Glasgow; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Glasgow; Maastricht University	Marciano, G (corresponding author), Univ Glasgow, Canc Res UK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.; Marciano, G (corresponding author), Univ Glasgow, Inst Canc Sci, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	gabriele.marciano@bioch.ox.ac.uk; d.huang@beatson.gla.ac.uk	Huang, Danny/AAM-3631-2021	Huang, Danny/0000-0002-6192-259X; Svergun, Dmitri/0000-0003-0830-5696; Marciano, Gabriele/0000-0003-2720-652X; TRIA, Giancarlo/0000-0003-4736-471X; Byron, Olwyn/0000-0001-7857-4520	Cancer Research UK [A23278]	Cancer Research UK(Cancer Research UK)	This work was supported in part by Cancer Research UK Grant A23278. The authors declare that they have no conflicts of interest with the contents of this article.	Akey CW, 2003, CURR OPIN STRUC BIOL, V13, P6, DOI 10.1016/S0959-440X(03)00002-2; Allain FHT, 1999, EMBO J, V18, P2563, DOI 10.1093/emboj/18.9.2563; Andrews AJ, 2008, J BIOL CHEM, V283, P32412, DOI 10.1074/jbc.M805918200; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Dam J, 2004, METHOD ENZYMOL, V384, P185; Fazly A, 2012, J BIOL CHEM, V287, P10753, DOI 10.1074/jbc.M112.347450; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Franke D, 2012, NUCL INSTRUM METH A, V689, P52, DOI 10.1016/j.nima.2012.06.008; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Hoffmann C, 2015, ACS CHEM BIOL, V10, P2753, DOI 10.1021/acschembio.5b00493; Hondele M, 2013, NATURE, V499, P111, DOI 10.1038/nature12242; Ikeda Y, 2011, DEV CELL, V21, P589, DOI 10.1016/j.devcel.2011.08.013; Kasai N, 2005, J BIOMOL NMR, V32, P83, DOI 10.1007/s10858-005-3662-3; Keller DM, 2002, J BIOL CHEM, V277, P50206, DOI 10.1074/jbc.M209820200; Kemble DJ, 2015, MOL CELL, V60, P294, DOI 10.1016/j.molcel.2015.09.008; Kemble DJ, 2013, J BIOL CHEM, V288, P10188, DOI 10.1074/jbc.C113.451369; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lambert SJ, 1999, ACTA CRYSTALLOGR D, V55, P1048, DOI 10.1107/S0907444999001912; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P99; Li YP, 2007, J BIOL CHEM, V282, P6936, DOI 10.1074/jbc.M603822200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marciano G, 2016, ACTA CRYSTALLOGR F, V72, P121, DOI 10.1107/S2053230X15024565; Masse JE, 2002, J MOL BIOL, V323, P263, DOI 10.1016/S0022-2836(02)00938-5; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Park YJ, 2008, NAT STRUCT MOL BIOL, V15, P957, DOI 10.1038/nsmb.1480; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Schlesinger MB, 2000, GENETICS, V155, P1593; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SMITH CA, 1988, BIOCHEM EDUC, V16, P104, DOI 10.1016/0307-4412(88)90075-1; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; Spencer JA, 1999, J BIOL CHEM, V274, P15686, DOI 10.1074/jbc.274.22.15686; Stuwe T, 2008, P NATL ACAD SCI USA, V105, P8884, DOI 10.1073/pnas.0712293105; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Svejstrup JQ, 2002, CURR OPIN GENET DEV, V12, P156, DOI 10.1016/S0959-437X(02)00281-2; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang Y, 2008, P NATL ACAD SCI USA, V105, P12206, DOI 10.1073/pnas.0802393105; Tsunaka Y, 2016, GENE DEV, V30, P673, DOI 10.1101/gad.274183.115; Tsunaka Y, 2009, J BIOL CHEM, V284, P24610, DOI 10.1074/jbc.M109.001958; VanDemark AP, 2008, J BIOL CHEM, V283, P5058, DOI 10.1074/jbc.M708682200; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winkler DD, 2011, J BIOL CHEM, V286, P41883, DOI 10.1074/jbc.M111.301465; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wittmeyer J, 1997, MOL CELL BIOL, V17, P4178, DOI 10.1128/MCB.17.7.4178; Xin H, 2009, MOL CELL, V35, P365, DOI 10.1016/j.molcel.2009.06.024; Zeng SX, 2010, MOL CELL BIOL, V30, P935, DOI 10.1128/MCB.01379-09; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zhang W., 2015, SCI REPORTS, V5, P1, DOI DOI 10.1038/SREP10791; Zunder RM, 2012, P NATL ACAD SCI USA, V109, pE144, DOI 10.1073/pnas.1119095109	65	8	9	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10071	10083		10.1074/jbc.RA117.000994	http://dx.doi.org/10.1074/jbc.RA117.000994			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764934	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000437096700012
J	Tempestini, A; Rysgaard, S; Dufresne, F				Tempestini, Astrid; Rysgaard, Soren; Dufresne, France			Species identification and connectivity of marine amphipods in Canada's three oceans	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; BIOLOGICAL IDENTIFICATIONS; DNA BARCODES; BIODIVERSITY; DELIMITATION; DIVERSITY; CRUSTACEA; ATLANTIC; TAXONOMY; ZOOPLANKTON	Monitoring the distribution of marine biodiversity is a crucial step to better assess the impacts of global changes. Arctic marine fauna is dominated by amphipods in terms of abundance and biomass. These peracarids are an important marine order of crustaceans but the number of species found in the different Canadian oceans is currently unknown. Furthermore, most species are difficult to identify due to poor taxonomic descriptions and morphological convergence. The aim of this study was to assess the species diversity of marine amphipods in the three Canadian oceans using DNA barcoding. To do so, we produced a database of DNA barcodes of amphipods from the three Canadian Oceans publicly available from the BOLD website to which we added 310 new sequences from the Canadian Arctic Archipelago. We first delimited amphipod species based on barcode gap detection techniques and tree based method (bPTP) and then compared the composition of amphipods among the three oceans in order to assess the influence of past transarctic exchanges on Arctic diversity. Our analysis of 2309 sequences which represent more than 250 provisional species revealed a high connectivity between the Atlantic and Arctic Oceans. Our results also suggest that a single threshold to delimitate species is not suitable for amphipods. This study highlights the challenges involved in species delimitation and the need to obtain complete barcoding inventories in marine invertebrates.	[Tempestini, Astrid; Dufresne, France] Univ Quebec & Rimouski, Dept Biol, Rimouski, PQ, Canada; [Tempestini, Astrid] Univ Quebec & Rimouski, Quebec Ocean, Rimouski, PQ, Canada; [Rysgaard, Soren] Univ Manitoba, Ctr Earth Observat Sci, Winnipeg, MB, Canada; [Rysgaard, Soren] Greenland Inst Nat Resources, Nuuk, Greenland; [Rysgaard, Soren] Aarhus Univ, Arctic Res Ctr, Aarhus, Denmark; [Dufresne, France] Univ Quebec & Rimouski, Ctr Etud Nord, Rimouski, PQ, Canada	University of Quebec; Universite du Quebec a Rimouski; University of Quebec; Universite du Quebec a Rimouski; University of Manitoba; Greenland Institute of Natural Resources; Aarhus University; University of Quebec; Universite du Quebec a Rimouski	Tempestini, A (corresponding author), Univ Quebec & Rimouski, Dept Biol, Rimouski, PQ, Canada.; Tempestini, A (corresponding author), Univ Quebec & Rimouski, Quebec Ocean, Rimouski, PQ, Canada.	astrid.tempestini@gmail.com		Rysgaard, Soren/0000-0003-1726-2958	Natural Sciences and Engineering Research Council of Canada [222948]; Canada Excellence Research Chair program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Excellence Research Chair program	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_fra.asp), 222948, to FD. SR was supported by the Canada Excellence Research Chair program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the officers and crew of the CCGS Amundsen during sampling efforts in 2011. We are also grateful to the Greenland Institute of Natural Resources in Nuuk, Greenland for providing samples. We thank Dr. A. Comeau for MOTHUR presentation. (SR) was supported by the Canada Excellence Research Chair program. We also thank Dr. K. Dionne, Dr N. Bierne, Dr. C. Nozais and Dr. A. Derry for comments on a previous version of this manuscript. We wish to thank the Canadian Healthy Ocean Network. We are grateful to Quebec Ocean and EnviroNord.	ANGEL MV, 1993, CONSERV BIOL, V7, P760, DOI 10.1046/j.1523-1739.1993.740760.x; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Archambault P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012182; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; Bluhm BA, 2011, OCEANOGRAPHY, V24, P232, DOI 10.5670/oceanog.2011.75; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Costa FO, 2009, SYST BIODIVERS, V7, P365, DOI 10.1017/S1477200009990120; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Coyer JA, 2011, J BIOGEOGR, V38, P756, DOI 10.1111/j.1365-2699.2010.02437.x; Cunningham Clifford W., 1998, P297; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; Darnis G, 2012, CLIMATIC CHANGE, V115, P179, DOI 10.1007/s10584-012-0483-8; Dionne Kaven, 2011, Diversity, V3, P390, DOI 10.3390/d3030390; Dodson JJ, 2007, MOL ECOL, V16, P5030, DOI 10.1111/j.1365-294X.2007.03559.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisner LB, 2014, DEEP-SEA RES PT II, V109, P157, DOI 10.1016/j.dsr2.2014.03.004; Fiser Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134384; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-171; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; Goetze E, 2005, EVOLUTION, V59, P2378; Goetze E, 2010, MOL ECOL, V19, P952, DOI 10.1111/j.1365-294X.2009.04520.x; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Hardy Sarah Mincks, 2011, Marine Biodiversity, V41, P195, DOI 10.1007/s12526-010-0056-x; Havermans C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074218; Heads M, 2005, BIOL J LINN SOC, V84, P675, DOI 10.1111/j.1095-8312.2005.00466.x; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Josefson AB, 2013, ARCTIC BIODIVERSITY; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kekkonen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122481; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King RA, 2011, INVERTEBR SYST, V25, P171, DOI 10.1071/IS10035; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kraft A, 2013, DEEP-SEA RES PT I, V73, P62, DOI 10.1016/j.dsr.2012.11.012; Kuklinski P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059152; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Layton KKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095003; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Lorz AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032365; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Martin J.W., 2001, UPDATED CLASSIFICATI, VVolume 39, P1; McLaughlin PA, 2005, COMMON SCI NAMES AQU; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Nelson RJ, 2009, MAR ECOL PROG SER, V381, P129, DOI 10.3354/meps07940; Nikula R, 2007, EVOLUTION, V61, P928, DOI 10.1111/j.1558-5646.2007.00066.x; Palsson S, 2009, POLAR BIOL, V32, P471, DOI 10.1007/s00300-008-0542-9; Peloso PLV, 2017, MITOCHONDRIAL DNA DN, P1; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Questel JM, 2016, J PLANKTON RES, V38, P610, DOI 10.1093/plankt/fbw025; Radulovici Adriana E., 2010, Diversity, V2, P450; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2007, DEEP-SEA RES PT II, V54, P1820, DOI 10.1016/j.dsr2.2007.07.009; Raupach MJ, 2015, ZOOKEYS, P53, DOI 10.3897/zookeys.539.6530; Raupach MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139421; Rawson PD, 2009, MAR BIOL, V156, P1857, DOI 10.1007/s00227-009-1218-x; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Serejo CS, 2009, ZOOTAXA, P440, DOI 10.11646/zootaxa.2260.1.24; Sirenko BI, 2001, LIST SPECIES FREE LI; Tempestini A, 2017, J CRUSTACEAN BIOL, P1; Trebitz AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12162; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Vainola R, 2008, HYDROBIOLOGIA, V595, P241, DOI 10.1007/s10750-007-9020-6; Vainola R, 2003, MAR BIOL, V143, P935, DOI 10.1007/s00227-003-1137-1; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Vinogradov M. E., 1996, HYPERIID AMPHIPODS A; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Wassmann P, 2015, PROG OCEANOGR, V139, P42, DOI 10.1016/j.pocean.2015.06.011; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Webb CO, 2010, BIODIVERS CONSERV, V19, P955, DOI 10.1007/s10531-010-9817-x; Wisz MS, 2015, NAT CLIM CHANGE, V5, P261, DOI [10.1038/nclimate2500, 10.1038/NCLIMATE2500]; Witt JDS, 2003, MOL ECOL, V12, P405, DOI 10.1046/j.1365-294X.2003.01728.x; Witt JDS, 2008, GEOL SOC AM SPEC PAP, V439, P103, DOI 10.1130/2008.2439(05); Young RG, 2017, GENOME, V60, P169, DOI 10.1139/gen-2015-0209; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	88	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197174	10.1371/journal.pone.0197174	http://dx.doi.org/10.1371/journal.pone.0197174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791459	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000034
J	Tinguely, P; Schwalbe, M; Fuss, T; Guensch, DP; Kohler, A; Baumgartner, I; Weber, S; Candinas, D				Tinguely, Pascale; Schwalbe, Marius; Fuss, Torsten; Guensch, Dominik P.; Kohler, Andreas; Baumgartner, Iris; Weber, Stefan; Candinas, Daniel			Multi-Operational Selective Computer-Assisted Targeting of hepatocellular carcinoma-Evaluation of a novel approach for navigated tumor ablation	PLOS ONE			English	Article							GUIDED RADIOFREQUENCY ABLATION; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; ELECTROMAGNETIC TRACKING SYSTEM; IN-VIVO; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-TUMORS; BIPLANE FLUOROSCOPY; MICROWAVE ABLATION; COMBINED THERAPY; EX-VIVO	Objective To facilitate precise local ablation of hepatocellular carcinoma (HCC) in a setting of combined ablation and transarterial chemoembolization (TACE), we evaluated accuracy and efficiency of a novel technique for navigated positioning of ablation probes using intrahepatic tumor referencing and electromagnetic (EM) guidance, in a porcine model. Methods An angiographic wire with integrated EM reference sensor at its tip was inserted via a trans arterial femoral access and positioned in the vicinity of artificial liver tumors. The resulting offset distance between the tumor center and the intrahepatic endovascular EM reference was calculated. Subsequently, EM tracked ablation probes were inserted percutaneously and navigated toward the tumor center, relying on continuous EM guidance via the intrahepatic reference. Targeting accuracy was assessed as the Euclidean distance between the tip of the ablation probe and the tumor center (Target Positioning Error, TPE). Procedural efficiency was assessed as time efforts for tumor referencing and tumor targeting. Results In 6 animals, 124 targeting measurements were performed with an offset distance < 30 mm (clinically most feasible position), resulting in a mean TPE of 2.9 +/- 1.6 mm. No significant correlation between the TPE and different intrahepatic offset distances (range 21 to 61 mm, n = 365) was shown as long as the EM reference was placed within the liver. However, the mean TPE increased when placing the EM reference externally on the animal skin (p < 0.01). TPE was similar when targeting under continuous ventilation or in apnea (p = 0.50). Mean time for tumor referencing and navigated targeting was 6.5 +/- 3.8 minutes and 14 +/- 8 seconds, respectively. Conclusion The proposed technique allows precise and efficient navigated positioning of ablation probes into liver tumors in the animal model. We introduce a simple approach suitable for combined ablation and TACE of HCC in a single treatment session.	[Tinguely, Pascale; Kohler, Andreas; Candinas, Daniel] Univ Bern, Bern Univ Hosp, Inselspital, Dept Visceral Surg & Med, Bern, Switzerland; [Schwalbe, Marius; Weber, Stefan] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland; [Fuss, Torsten; Baumgartner, Iris] Univ Bern, Bern Univ Hosp, Inselspital, Dept Clin & Intervent Angiol, Bern, Switzerland; [Guensch, Dominik P.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Anesthesiol & Pain Med, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Tinguely, P (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Visceral Surg & Med, Bern, Switzerland.	pascale.tinguely@insel.ch	Kohler, Andreas/H-2465-2018; Weber, Stefan/A-4418-2012	Kohler, Andreas/0000-0002-8033-7740; Weber, Stefan/0000-0002-0395-7102; Gunsch, Dominik/0000-0003-4127-4086	Research Grant for Young Investigators from the Inselspital University Hospital Bern	Research Grant for Young Investigators from the Inselspital University Hospital Bern	This work was supported by financial contribution from the Research Grant for Young Investigators from the Inselspital University Hospital Bern, awarded to Pascale Tinguely (PT), in June 2015.	Appelbaum L, 2013, ACAD RADIOL, V20, P209, DOI 10.1016/j.acra.2012.09.020; Banovac F, 2005, MED PHYS, V32, P2698, DOI 10.1118/1.1992267; Beyer LP, 2016, PEERJ, V4, DOI 10.7717/peerj.2277; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Condino S, 2012, INT J MED ROBOT COMP, V8, P300, DOI 10.1002/rcs.1417; Engstrand J, 2017, AM J ROENTGENOL, V208, P193, DOI 10.2214/AJR.15.15803; Franz AM, 2014, IEEE T MED IMAGING, V33, P1702, DOI 10.1109/TMI.2014.2321777; Goldberg SN, 2002, RADIOLOGY, V222, P797, DOI 10.1148/radiol.2223010861; Jiang GS, 2014, TUMOR BIOL, V35, P3405, DOI 10.1007/s13277-013-1449-9; Kang SG, 2009, J VASC INTERV RADIOL, V20, P1570, DOI 10.1016/j.jvir.2009.09.003; Kang TW, 2015, INVEST RADIOL, V50, P81, DOI 10.1097/RLI.0000000000000103; Kim JH, 2011, ANN SURG ONCOL, V18, P1624, DOI 10.1245/s10434-011-1673-8; Krucker J, 2007, J VASC INTERV RADIOL, V18, P1141, DOI 10.1016/j.jvir.2007.06.014; Krucker J, 2011, J VASC INTERV RADIOL, V22, P515, DOI 10.1016/j.jvir.2010.10.033; Krueger S, 2005, PHYS MED BIOL, V50, P581, DOI 10.1088/0031-9155/50/4/002; Lee MW, 2011, BRIT J RADIOL, V84, P691, DOI 10.1259/bjr/27559204; Lee MW, 2010, J ULTRAS MED, V29, P1305, DOI 10.7863/jum.2010.29.9.1305; Lencioni R, 2015, LIVER CANCER, V4, P208, DOI 10.1159/000367747; Levy EB, 2007, ACAD RADIOL, V14, P344, DOI 10.1016/j.acra.2006.12.004; Liu FY, 2012, EUR J RADIOL, V81, P1455, DOI 10.1016/j.ejrad.2011.03.057; Livraghi T, 2000, RADIOLOGY, V214, P761, DOI 10.1148/radiology.214.3.r00mr02761; Lu DSK, 2005, RADIOLOGY, V234, P954, DOI 10.1148/radiol.2343040153; Lu ZM, 2013, EUR J GASTROEN HEPAT, V25, P187, DOI 10.1097/MEG.0b013e32835a0a07; Maier-Hein L, 2008, MED PHYS, V35, P5385, DOI 10.1118/1.3002315; Manstad-Hulaas F, 2011, J ENDOVASC THER, V18, P230, DOI 10.1583/10-3301.1; Maurer CR, 1997, IEEE T MED IMAGING, V16, P447, DOI 10.1109/42.611354; Min JH, 2013, KOREAN J RADIOL, V14, P248, DOI 10.3348/kjr.2013.14.2.248; Morimoto M, 2010, CANCER-AM CANCER SOC, V116, P5452, DOI 10.1002/cncr.25314; Ni JY, 2013, WORLD J GASTROENTERO, V19, P3872, DOI 10.3748/wjg.v19.i24.3872; Patterson EJ, 1998, ANN SURG, V227, P559, DOI 10.1097/00000658-199804000-00018; Peng ZW, 2013, J CLIN ONCOL, V31, P426, DOI 10.1200/JCO.2012.42.9936; Penzkofer T, 2014, BIOMED ENG-BIOMED TE, V59, P153, DOI 10.1515/bmt-2013-0045; Peterhans Matthias, 2012, Critical Reviews in Biomedical Engineering, V40, P199, DOI 10.1615/CritRevBiomedEng.v40.i3.40; Poulin F, 2002, J BIOMECH, V35, P733, DOI 10.1016/S0021-9290(02)00036-2; Praktiknjo M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192897; Schwalbe M, 2018, MINIM INVASIV THER, V27, P51, DOI 10.1080/13645706.2017.1407798; Sindram D, 2015, HPB, V17, P87, DOI 10.1111/hpb.12315; Srimathveeravalli G, 2013, INT J COMPUT ASS RAD, V8, P15, DOI 10.1007/s11548-012-0745-y; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Venkatesan AM, 2011, RADIOLOGY, V260, P848, DOI 10.1148/radiol.11101985; Wang X, 2016, KOREAN J RADIOL, V17, P93, DOI 10.3348/kjr.2016.17.1.93; Widmann G, 2012, CARDIOVASC INTER RAD, V35, P570, DOI 10.1007/s00270-011-0200-4; Wood BJ, 2005, J VASC INTERV RADIOL, V16, P493, DOI 10.1097/01.RVI.0000148827.62296.B4; Yamakado K, 2010, AM J ROENTGENOL, V194, P530, DOI 10.2214/AJR.09.2917	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197914	10.1371/journal.pone.0197914	http://dx.doi.org/10.1371/journal.pone.0197914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791518	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000069
J	McMahon, G; Morse, CI; Winwood, K; Burden, A; Onambele, GL				McMahon, Gerard; Morse, Christopher I.; Winwood, Keith; Burden, Adrian; Onambele, Gladys L.			Gender associated muscle-tendon adaptations to resistance training	PLOS ONE			English	Article							HUMAN PATELLAR TENDON; GROWTH-FACTOR-I; EXERCISE-INDUCED CHANGES; MECHANICAL-PROPERTIES; SKELETAL-MUSCLE; COLLAGEN-SYNTHESIS; PROTEIN-SYNTHESIS; TRANSFORMING GROWTH-FACTOR-BETA-1; SEX; STIFFNESS	Purpose To compare the relative changes in muscle-tendon complex (MTC) properties following high load resistance training (RT) in young males and females, and determine any link with circulating TGF beta-1 and IGF-I levels. Methods Twenty-eight participants were assigned to a training group and subdivided by sex (T males [TM] aged 20 +/- 1 year, n = 8, T females [TF] aged 19 +/- 3 year, n = 8), whilst age-matched 6 males and 6 females were assigned to control groups (ConM/F). The training groups completed 8 weeks of resistance training (RT). MTC properties (Vastus Lateralis, VL) physiological cross-sectional area (pCSA), quadriceps torque, patella tendon stiffness [K], Young's modulus, volume, cross-sectional area, and length, circulating levels of TGF beta-1 and IGF-I were assessed at baseline and post RT. Results Post RT, there was a significant increase in the mechanical and morphological properties of the MTC in both training groups, compared to ConM/F (p<0.001). However, there were no significant sex-specific changes in most MTC variables. There were however significant sex differences in changes in K, with females exhibiting greater changes than males at lower MVC (Maximal Voluntary Contraction) force levels (10% p = 0.030 & 20% MVC p = 0.032) and the opposite effect seen at higher force levels (90% p = 0.040 & 100% MVC p = 0.044). There were significant increases (p<0.05) in IGF-I in both TF and TM following training, with no change in TGF beta-1. There were no gender differences (p>0.05) in IGF-I or TGF beta-1. Interestingly, pooled population data showed that TGF beta-1 correlated with K at baseline, with no correlations identified between IGF-I and MTC properties. Conclusions Greater resting TGF6-1 levels are associated with superior tendon mechanical properties. RT can impact opposite ends of the patella tendon force-elongation relationship in each sex.	[McMahon, Gerard] Ulster Univ, Sch Sport, Belfast, Antrim, North Ireland; [McMahon, Gerard; Morse, Christopher I.; Winwood, Keith; Burden, Adrian; Onambele, Gladys L.] Manchester Metropolitan Univ, Hlth Exercise & Act Living HEAL Res Ctr, Crewe, Cheshire, England	Ulster University; Manchester Metropolitan University	McMahon, G (corresponding author), Ulster Univ, Sch Sport, Belfast, Antrim, North Ireland.; McMahon, G (corresponding author), Manchester Metropolitan Univ, Hlth Exercise & Act Living HEAL Res Ctr, Crewe, Cheshire, England.	g.mcmahon@ulster.ac.uk	Onambélé-Pearson, Gladys Leopoldine/F-1679-2013; Morse, Christopher/AAE-7913-2022	Onambélé-Pearson, Gladys Leopoldine/0000-0002-1466-3265; Morse, Christopher/0000-0002-5261-2637; McMahon, Gerard/0000-0002-4852-9988; Winwood, Keith/0000-0002-8696-9976				Albracht K, 2013, EUR J APPL PHYSIOL, V113, P1605, DOI 10.1007/s00421-012-2585-4; Astill BD, 2017, J APPL PHYSIOL, V122, P361, DOI 10.1152/japplphysiol.00878.2016; BELL DG, 1986, MED SCI SPORT EXER, V18, P31; Bryant AL, 2008, J APPL PHYSIOL, V105, P1035, DOI 10.1152/japplphysiol.01281.2007; Doessing S, 2010, J PHYSIOL-LONDON, V588, P341, DOI 10.1113/jphysiol.2009.179325; Esformes JI, 2002, EUR J APPL PHYSIOL, V87, P90, DOI 10.1007/s00421-002-0592-6; Goodier HCJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0947-8; Grainger DJ, 2000, CYTOKINE GROWTH F R, V11, P133, DOI 10.1016/S1359-6101(99)00037-4; Hansen M, 2014, EXERC SPORT SCI REV, V42, P183, DOI 10.1249/JES.0000000000000026; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; Heinemeier K, 2003, EUR J APPL PHYSIOL, V90, P171, DOI 10.1007/s00421-003-0881-8; Hicks KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150848; Hicks KM, 2013, ACTA PHYSIOL, V209, P235, DOI 10.1111/apha.12159; Knobloch K, 2010, KNEE SURG SPORT TR A, V18, P648, DOI 10.1007/s00167-009-1006-7; Kubo K, 2003, EUR J APPL PHYSIOL, V88, P520, DOI 10.1007/s00421-002-0744-8; LeMoine JK, 2009, AM J PHYSIOL-REG I, V296, pR119, DOI 10.1152/ajpregu.90607.2008; Little D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096526; Lyras DN, 2010, ACTA ORTHOP BELG, V76, P380; Maffulli N, 2003, CLIN SPORT MED, V22, P675, DOI 10.1016/S0278-5919(03)00004-8; McMahon G, 2014, MUSCLE NERVE, V49, P108, DOI 10.1002/mus.23884; McMahon GE, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.91; Miller BF, 2007, J APPL PHYSIOL, V102, P541, DOI 10.1152/japplphysiol.00797.2006; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004; Nielsen RH, 2014, J APPL PHYSIOL, V116, P42, DOI 10.1152/japplphysiol.01084.2013; Onambele GNL, 2007, J ORTHOP RES, V25, P1635, DOI 10.1002/jor.20404; Onambele-Pearson GL, 2012, AGE, V34, P427, DOI 10.1007/s11357-011-9248-y; Pearson SJ, 2005, CHRONOBIOL INT, V22, P1013, DOI 10.1080/07420520500397900; Pearson SJ, 2006, MUSCLE NERVE, V33, P792, DOI 10.1002/mus.20529; Reeves ND, 2004, EUR J APPL PHYSIOL, V91, P116, DOI 10.1007/s00421-003-0961-9; Reeves ND, 2004, J APPL PHYSIOL, V96, P885, DOI 10.1152/japplphysiol.00688.2003; Seynnes OR, 2011, SCAND J MED SCI SPOR, V21, P39, DOI 10.1111/j.1600-0838.2011.01340.x; Sipila S, 2013, BIOGERONTOLOGY, V14, P231, DOI 10.1007/s10522-013-9425-8; Smith FW, 2002, SPORTS MED ARTHROSC, V10, P98, DOI 10.1097/00132585-200210010-00014; Sullivan BE, 2009, J APPL PHYSIOL, V106, P468, DOI 10.1152/japplphysiol.91341.2008; WAKEFIELD LM, 1995, CLIN CANCER RES, V1, P129; Westh E, 2008, SCAND J MED SCI SPOR, V18, P23, DOI 10.1111/j.1600-0838.2007.00638.x; Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005	38	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197852	10.1371/journal.pone.0197852	http://dx.doi.org/10.1371/journal.pone.0197852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787583	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000432785700053
J	Rahimnia, A; Rahimnia, AH; Mobasher-Jannat, A				Rahimnia, Alireza; Rahimnia, Amir-Hossein; Mobasher-Jannat, Abdolkarim			Clinical and functional outcomes of vascularized bone graft in the treatment of scaphoid non-union	PLOS ONE			English	Article							DISTAL RADIUS; AVASCULAR NECROSIS; SUPRARETINACULAR ARTERY; DISPLACED FRACTURES; WAIST FRACTURES; HERBERT SCREW; RECONSTRUCTION; MANAGEMENT; METAANALYSIS; FIXATION	Introduction Scaphoid non-union is a challenging and complex problem. Various methods have been proposed for the management of patients with scaphoid non-union and to reduce the risk of complications. In this study, our aim was to evaluate the clinical and functional outcomes of using a vascularized bone graft in the treatment of scaphoid non-union. Methods Patients with scaphoid non-union who underwent 1,2 intercompartmental supraretinacular artery pedicled vascularized bone graft between January 2005 and January 2011 were enrolled. The parameters assessed included clinical and functional outcomes, radiological measures, and potential risk factors. Results Forty-one patients were finally included. Thirty patients achieved union (73%) and 11 did not. Smoking was a significant risk factor for non-union after the surgery. In patients who achieved union, grip strength and radioulnar abduction were greater in comparison to that in patients who did not achieve union. Functional measures, including the Disabilities of Arm and Shoulder score and the Modified Mayo Wrist Score, improved in patients with scaphoid union. The scaphoid length also improved significantly postoperatively in these patients. Conclusion Surgical treatment of scaphoid non-union using vascularized bone graft led to a high union rate with good clinical and functional outcomes. Smoking is a risk factor for non-union, even with the use of a vascularized bone graft. Avascular necrosis was not associated with an increased risk for non-union.	[Rahimnia, Alireza] Baqiyatallah Univ Med Sci, Dept Med, Trauma Res Ctr, Tehran, Iran; [Rahimnia, Amir-Hossein] Univ Tehran Med Sci, Dept Med, Tehran, Iran; [Mobasher-Jannat, Abdolkarim] Baqiyatallah Univ Med Sci, Syst Biol & Poisonings Inst, Chem Injuries Res Ctr, Tehran, Iran	Baqiyatallah University of Medical Sciences (BMSU); Tehran University of Medical Sciences; Baqiyatallah University of Medical Sciences (BMSU)	Mobasher-Jannat, A (corresponding author), Baqiyatallah Univ Med Sci, Syst Biol & Poisonings Inst, Chem Injuries Res Ctr, Tehran, Iran.	karim.jannat@yahoo.com		Mobasher Jannat, abdolkarim/0000-0003-1657-8942; rahimnia, alireza/0000-0001-9063-8435; Rahimnia, Amirhossein/0000-0002-4451-4930				Al-Hadithy N, 2012, ACTA ORTHOP BELG, V78, P285; Alshryda S, 2012, SURG-J R COLL SURG E, V10, P218, DOI 10.1016/j.surge.2012.03.004; Bedi A, 2007, J HAND SURG-AM, V32A, P326, DOI 10.1016/j.jhsa.2007.01.002; Belsky MR, 2012, HAND CLIN, V28, P269, DOI 10.1016/j.hcl.2012.05.005; Bhat M, 2004, J BONE JOINT SURG BR, V86B, P705, DOI 10.1302/0301-620X.86B5.14374; Boyer MI, 1998, J HAND SURG-BRIT EUR, V23B, P686, DOI 10.1016/S0266-7681(98)80029-6; BRUNELLI GA, 1991, J HAND SURG-BRIT EUR, V16B, P148, DOI 10.1016/0266-7681(91)90165-K; Caporrino FA, 2014, J ORTHOP TRAUMA, V28, pE44, DOI 10.1097/BOT.0b013e3182a4a91a; Chang MA, 2006, J HAND SURG-AM, V31A, P387, DOI 10.1016/j.jhsa.2005.10.019; Dailiana ZH, 2006, J HAND SURG-AM, V31A, P397, DOI 10.1016/j.jhsa.2005.09.021; Dehghani Mohamad, 2014, Adv Biomed Res, V3, P185, DOI 10.4103/2277-9175.140094; DIAS JJ, 1989, J BONE JOINT SURG BR, V71, P307, DOI 10.1302/0301-620X.71B2.2925752; Dinah AF, 2007, INT ORTHOP, V31, P503, DOI 10.1007/s00264-006-0231-7; Ferguson DO, 2016, J HAND SURG-EUR VOL, V41, P492, DOI 10.1177/1753193415604778; Gabl M, 1999, J BONE JOINT SURG AM, V81A, P1414, DOI 10.2106/00004623-199910000-00006; Geissler WB, 2009, HAND CLIN, V25, P359, DOI 10.1016/j.hcl.2009.05.004; GELLMAN H, 1989, J BONE JOINT SURG AM, V71A, P354, DOI 10.2106/00004623-198971030-00007; GREEN DP, 1985, J HAND SURG-AM, V10A, P597, DOI 10.1016/S0363-5023(85)80191-X; Haisman JM, 2006, J BONE JOINT SURG AM, V88A, P2750, DOI 10.2106/00004623-200612000-00026; Hankins CL, 2011, J HAND SURG-AM, V36A, P583, DOI 10.1016/j.jhsa.2010.12.035; Hirche C, 2014, J HAND SURG-AM, V39, P423, DOI 10.1016/j.jhsa.2013.10.028; Ibrahim T, 2011, J HAND SURG-AM, V36A, P1759, DOI 10.1016/j.jhsa.2011.08.033; Inoue G, 1997, CLIN ORTHOP RELAT R, P99; JUDET R, 1972, REV CHIR ORTHOP, V58, P699; Kawamura K, 2008, J HAND SURG-AM, V33A, P988, DOI 10.1016/j.jhsa.2008.04.026; Konishi H, 2010, VASC MED, V15, P47, DOI 10.1177/1358863X09106326; KUHLMANN J N, 1986, Acta Orthopaedica Belgica, V52, P753; LANGHOFF O, 1988, J HAND SURG-BRIT EUR, V13B, P77, DOI 10.1016/0266-7681(88)90058-7; Malizos KN, 2001, J HAND SURG-BRIT EUR, V26, P330, DOI 10.1054/jhsb.2001.0570; Malizos KN, 2007, PLAST RECONSTR SURG, V119, P1513, DOI 10.1097/01.prs.0000256144.52654.da; Malizos Konstantinos N, 2017, Eur J Orthop Surg Traumatol, V27, P33, DOI 10.1007/s00590-016-1867-7; Malizos KN, 2009, J HAND MICROSURG, V1, P50, DOI 10.1007/s12593-009-0003-x; Malizos KN, 2010, J HAND SURG-AM, V35A, P1710, DOI 10.1016/j.jhsa.2010.08.006; Meisel Erin, 2017, Eur J Orthop Surg Traumatol, V27, P23, DOI 10.1007/s00590-016-1876-6; Merrell GA, 2002, J HAND SURG-AM, V27A, P685, DOI 10.1053/jhsu.2002.34372; Ozalp T, 2015, INJURY, V46, pS47, DOI 10.1016/j.injury.2015.05.032; Pinder RM, 2015, J HAND SURG-AM, V40, P1797, DOI 10.1016/j.jhsa.2015.05.003; Reigstad O, 2012, J ORTHOP TRAUMA, V26, P241, DOI 10.1097/BOT.0b013e31821f940a; Ribak S, 2010, INT ORTHOP, V34, P683, DOI 10.1007/s00264-009-0862-6; Schuind F, 2017, Eur J Orthop Surg Traumatol, V27, P3, DOI 10.1007/s00590-016-1886-4; Sendher R, 2013, ORTHOP CLIN N AM, V44, P107, DOI 10.1016/j.ocl.2012.09.003; Steinmann SP, 2002, J HAND SURG-AM, V27A, P391, DOI 10.1053/jhsu.2002.32077; Straw RG, 2002, J HAND SURG-BRIT EUR, V27B, P413, DOI 10.1054/jhsb.2002.0808; Sunagawa T, 2000, J HAND SURG-AM, V25A, P849, DOI 10.1053/jhsu.2000.8639; Tsai Tsung-Ting, 2002, Chang Gung Med J, V25, P321; Uerpairojkit C, 2000, J HAND SURG-BRIT EUR, V25B, P266, DOI 10.1054/jhsb.2000.0378; Van Tassel DC, 2010, J HAND SURG-AM, V35A, P1242, DOI 10.1016/j.jhsa.2010.05.017; Waitayawinyu T, 2009, J HAND SURG-AM, V34A, P387, DOI 10.1016/j.jhsa.2008.11.023; WARRENSMITH CD, 1988, J HAND SURG-BRIT EUR, V13B, P83, DOI 10.1016/0266-7681(88)90060-5; Werdin Frank, 2014, Eplasty, V14, pe24; Yuceturk A, 1997, J HAND SURG-BRIT EUR, V22B, P425, DOI 10.1016/S0266-7681(97)80420-2; ZAIDEMBERG C, 1991, J HAND SURG-AM, V16A, P474, DOI 10.1016/0363-5023(91)90017-6	52	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197768	10.1371/journal.pone.0197768	http://dx.doi.org/10.1371/journal.pone.0197768			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787613	Green Published, gold, Green Submitted			2022-12-26	WOS:000432785700044
J	Riento, K; Zhang, QF; Clark, J; Begum, F; Stephens, E; Wakelam, MJ; Nichols, BJ				Riento, Kirsi; Zhang, Qifeng; Clark, Jonathan; Begum, Farida; Stephens, Elaine; Wakelam, Michael J.; Nichols, Benjamin J.			Flotillin proteins recruit sphingosine to membranes and maintain cellular sphingosine-1-phosphate levels	PLOS ONE			English	Article							HISTONE DEACETYLASES; MAMMALIAN-CELLS; S1P GRADIENTS; FYN KINASE; PLASMA; MICRODOMAINS; ENDOCYTOSIS; DOMAIN; RAFTS; REGGIE-1/FLOTILLIN-2	Sphingosine-1-phosphate (S1P) is an important lipid signalling molecule. S1P is produced via intracellular phosphorylation of sphingosine (Sph). As a lipid with a single fatty alkyl chain, Sph may diffuse rapidly between cellular membranes and through the aqueous phase. Here, we show that the absence of microdomains generated by multimeric assemblies of flotillin proteins results in reduced S1P levels. Cellular phenotypes of flotillin knockout mice, including changes in histone acetylation and expression of Isg15, are recapitulated when S1P synthesis is perturbed. Flotillins bind to Sph in vitro and increase recruitment of Sph to membranes in cells. Ectopic re-localisation of flotillins within the cell causes concomitant redistribution of Sph. The data suggest that flotillins may directly or indirectly regulate cellular sphingolipid distribution and signalling.	[Riento, Kirsi; Begum, Farida; Stephens, Elaine; Nichols, Benjamin J.] MRC, Lab Mol Biol, Cambridge, England; [Zhang, Qifeng; Clark, Jonathan; Wakelam, Michael J.] Babraham Inst, Babraham Res Campus, Cambridge, England	MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Riento, K; Nichols, BJ (corresponding author), MRC, Lab Mol Biol, Cambridge, England.	kirsi@mrc-lmb.cam.ac.uk; ben@mrc-lmb.cam.ac.uk		Wakelam, Michael/0000-0003-4059-9276	BN Medical Research Council UK; MW Biotechnology and Biological Sciences Research Council UK; BBSRC [BBS/E/B/000C0431, BBS/E/B/000C0415, BBS/E/B/000C0411, BBS/E/B/000C0419] Funding Source: UKRI; MRC [MC_U105178778] Funding Source: UKRI	BN Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MW Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the BN Medical Research Council UK and MW Biotechnology and Biological Sciences Research Council UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; Bitsikas V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085217; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Choi JC, 2009, J IMMUNOL, V182, P6307, DOI 10.4049/jimmunol.0802454; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DCunha J, 1996, P NATL ACAD SCI USA, V93, P211, DOI 10.1073/pnas.93.1.211; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Frisz JF, 2013, P NATL ACAD SCI USA, V110, pE613, DOI 10.1073/pnas.1216585110; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; KHAN WA, 1991, BIOCHEM J, V278, P387, DOI 10.1042/bj2780387; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Ludwig A, 2010, J CELL BIOL, V191, P771, DOI 10.1083/jcb.201005140; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; MITOMA J, 1992, J BIOCHEM-TOKYO, V111, P20, DOI 10.1093/oxfordjournals.jbchem.a123712; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Nagesh PT, 2016, J VIROL, V90, P4614, DOI 10.1128/JVI.00126-16; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Olivera A, 2013, BBA-MOL CELL BIOL L, V1831, P193, DOI 10.1016/j.bbalip.2012.06.007; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Sasaki H, 2009, BIOPHYS J, V96, P2727, DOI 10.1016/j.bpj.2008.12.3926; Saslowsky DE, 2010, J CLIN INVEST, V120, P4399, DOI 10.1172/JCI42958; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Siow D, 2011, CRIT REV BIOCHEM MOL, V46, P365, DOI 10.3109/10409238.2011.580097; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Willinger T, 2014, J EXP MED, V211, P685, DOI 10.1084/jem.20131343; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wong M, 2014, SCIENCE, V346, P601, DOI 10.1126/science.1256898; Yasmin R, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/201703; Yatomi Y, 1997, J BIOCHEM, V121, P969; Young MM, 2016, CELL REP, V17, P1532, DOI 10.1016/j.celrep.2016.10.019	49	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197401	10.1371/journal.pone.0197401	http://dx.doi.org/10.1371/journal.pone.0197401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787576	Green Published, gold, Green Submitted			2022-12-26	WOS:000432785700026
J	Chang, CC; Chen, TL; Lin, CS; Chung, CL; Yeh, CC; Hu, CJ; Lane, HL; Liao, CC; Shih, CC				Chang, Chuen-Chau; Chen, Ta-Liang; Lin, Chao-Shun; Chung, Chi-Li; Yeh, Chun-Chieh; Hu, Chaur-Jong; Lane, Hsin-Long; Liao, Chien-Chang; Shih, Chun-Chuan			Decreased risk of pneumonia in stroke patients receiving acupuncture: A nationwide matched-pair retrospective cohort study	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; POSTSTROKE PAIN; ELECTROACUPUNCTURE; OUTCOMES; INJURY	Background Acupuncture treatment is common among stroke patients, but there is limited information available on whether acupuncture effectively prevents post-stroke pneumonia. The aim of this study was to analyze the differential risk of pneumonia after stroke between patients who did and did not receive acupuncture after discharge. Methods We used the Taiwan National Health Insurance Research Database to conduct a retrospective cohort study using propensity score matched-pairs of new stroke patients in 2000-2004 who did and did not receive acupuncture post-stroke. Both cohorts were followed up until the end of 2009 for new-onset pneumonia. After correcting for immortal time bias, the incidence and adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) of pneumonia associated with acupuncture use were calculated using multivariate Cox proportional hazard models. Results Overall, 12557 stroke patients with 12557 paired controls were included in the analysis; pneumonia was diagnosed in 6796 (27.1%). Stroke patients receiving acupuncture had a lower incidence of pneumonia than those without acupuncture (53.4 vs. 58.9 per 1000 person-years), with an adjusted HR of 0.86 (95% CI 0.82-0.90). The association between pneumonia risk and acupuncture use was significant in men (HR 0.92, 95% CI 0.86-0.98) and women (HR 0.79, 95% 0.70-0.82) and was also observed in every age group from 2079 years. Conclusion Stroke patients receiving acupuncture had a lower risk of pneumonia than those who did not. Further randomized control studies are needed to validate the protective effect of acupuncture on the risk of pneumonia among stroke patients.	[Chang, Chuen-Chau; Chen, Ta-Liang; Lin, Chao-Shun; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chang, Chuen-Chau; Chen, Ta-Liang; Lin, Chao-Shun; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Chang, Chuen-Chau; Chen, Ta-Liang; Lin, Chao-Shun; Liao, Chien-Chang] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Chung, Chi-Li] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei City, Taiwan; [Lane, Hsin-Long] I Shou Univ, Coll Med, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Liao, Chien-Chang] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Liao, Chien-Chang] Taipei Med Univ, Shuan Ho Hosp, Dept Anesthesiol, Taipei, Taiwan; [Shih, Chun-Chuan] Taipei Med Univ, PhD Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan	Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Taipei Medical University; I Shou University; China Medical University Taiwan; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Shih, CC (corresponding author), Taipei Med Univ, PhD Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan.	hwathai@seed.net.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	Taiwan's National Union of Chinese Medical Doctors' Association [UNCMA104-H-001]; Taiwan's Ministry of Science and Technology [MOST106-2320-B-214-003, MOST105-2629-B-038-001, MOST103-2320-B-214-010-MY2]	Taiwan's National Union of Chinese Medical Doctors' Association; Taiwan's Ministry of Science and Technology	This research was supported in part by Taiwans National Union of Chinese Medical Doctors Association (UNCMA104-H-001), Taiwans Ministry of Science and Technology (MOST106-2320-B-214-003; MOST105-2629-B-038-001; MOST103-2320-B-214-010-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2010, ANN NEUROL, V68, P503, DOI 10.1002/ana.22189; Beilin B, 2003, ANESTH ANALG, V97, P822, DOI 10.1213/01.ANE.0000078586.82810.3B; Burton CAC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008860.pub2; Byeon HS, 2011, J ALTERN COMPLEM MED, V17, P219, DOI 10.1089/acm.2010.0232; Cai HY, 2015, INT J CLIN EXP MED, V8, P14090; Chang CC, 2016, J ETHNOPHARMACOL, V177, P46, DOI 10.1016/j.jep.2015.11.028; Chau JPC, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00030; Chen C, 2013, NEUROLOGY, V80, pS27, DOI 10.1212/WNL.0b013e3182762569; Chuang SF, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0828-8; Ding SS, 2014, QJM-INT J MED, V107, P341, DOI 10.1093/qjmed/hct196; Du YH, 2011, NEUROL RES, V33, P101, DOI 10.1179/016164110X12714125204317; Feng R, 2014, AFR J TRADIT COMPLEM, V11, P25, DOI 10.4314/ajtcam.v11i3.5; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Geeganage C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000323.pub2; Hannawi Y, 2013, CEREBROVASC DIS, V35, P430, DOI 10.1159/000350199; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; Hsiu H, 2011, MICROVASC RES, V81, P289, DOI 10.1016/j.mvr.2011.03.001; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056736; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Lee GJ, 2010, NEUROL RES, V32, pS79, DOI 10.1179/016164109X12537002794200; Lee S, 2015, CLIN EXP PHARMACOL P, V42, P822, DOI 10.1111/1440-1681.12413; Li J, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-441; Liu YM, 2010, J NEUROIMMUNOL, V220, P25, DOI 10.1016/j.jneuroim.2009.12.005; MacPherson H, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001518; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Murthy SB, 2016, NEUROCRIT CARE, V25, P178, DOI 10.1007/s12028-016-0282-6; Neumann S, 2015, INT J MOL SCI, V16, P29029, DOI 10.3390/ijms161226141; Paolucci S, 2016, PAIN MED, V17, P924, DOI 10.1093/pm/pnv019; Shih CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089208; Shim R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010064; Vickers AJ, 2014, JAMA-J AM MED ASSOC, V311, P955, DOI 10.1001/jama.2013.285478; Wang Li-ping, 2006, Zhongguo Zhen Jiu, V26, P141; Weng SW, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010539; Weng SW, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1272-0; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Wolfe CDA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001033; Xie Y, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006076.pub2; Zhang SH, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003317.pub2; Zhang XZ, 2014, NEUROCHEM INT, V65, P23, DOI 10.1016/j.neuint.2013.12.004	40	6	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0196094	10.1371/journal.pone.0196094	http://dx.doi.org/10.1371/journal.pone.0196094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782526	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100003
J	Lashkari, K; Teague, G; Chen, H; Lin, YQ; Kumar, S; McLaughlin, MM; Lopez, FJ				Lashkari, Kameran; Teague, Gianna; Chen, Hong; Lin, Yong-Qing; Kumar, Sanjay; McLaughlin, Megan M.; LoPez, Francisco J.			A monoclonal antibody targeting amyloid beta (A beta) restores complement factor I bioactivity: Potential implications in age-related macular degeneration and Alzheimer's disease	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; HIGH-RISK; ACTIVATION; DRUSEN; DEPOSITS; PATHOGENESIS; RETINA; MODEL; VEGF; CFI	Activation of the alternative complement cascade has been implicated in the pathogenesis of age related macular degeneration (AMD) and Alzheimer's disease (AD). Amyloid beta (A beta), a component of drusen, may promote complement activation by inhibiting CFI bioactivity. We determined whether A beta reduced CFI bioactivity and whether antibodies against A beta including a monoclonal antibody, GSK933776 could restore CFI bioactivity. We also measured CFI bioactivity in plasma of subjects with AMD and AD. In support of the GSK933776 development program in AMD (geographic atrophy), we developed a quantitative assay to measure CFI bioactivity based on its ability to cleave C3b to iC3b, and repeated it in presence or absence of A beta and anti-A beta antibodies. Using this assay, we measured CFI bioactivity in plasma of 194 subjects with AMD, and in samples from subjects with AD that had been treated with GSK933776 as part of the GSK933776 development program in AD. A beta reduced the CFI bioactivity by 5-fold and pre-incubation with GSK933776 restored CFI bioactivity. In subjects with AMD, plasma CFI levels and bioactivity were not significantly different from non-AMD controls. However, we detected a positive linear trend, suggesting increasing activity with disease severity. In subjects with AD, we observed a 10% and 27% increase in overall CFI bioactivity after treatment with GSK933776 during the second and third dose. Our studies indicate that CFI enzymatic activity can be inhibited by A beta and be altered in proinflammatory diseases such as AMD and AD, in which deposition of A beta and activation of the alternative complement cascade are believed to play a key role in the disease process.	[Lashkari, Kameran; Teague, Gianna] Harvard Med Sch, Mass Eye & Ear, Schepens Eye Res Inst, Boston, MA USA; [Chen, Hong; Lin, Yong-Qing] Alliance Pharma, Malvern, PA USA; [Kumar, Sanjay; McLaughlin, Megan M.; LoPez, Francisco J.] GlaxoSmithKline, Alternat Discovery & Dev, King Of Prussia, PA USA	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Alliance Pharma Inc; GlaxoSmithKline	Lashkari, K (corresponding author), Harvard Med Sch, Mass Eye & Ear, Schepens Eye Res Inst, Boston, MA USA.	kameran_lashkari@meei.harvard.edu		Lashkari, Kameran/0000-0003-3855-0246	GlaxoSmithKline, King of Prussia [4100111]	GlaxoSmithKline, King of Prussia	This work was supported by Grant #4100111, GlaxoSmithKline, King of Prussia, PA. https://us.gsk.com. The funder provided study materials and consulted on design of some of the experiments. The funder provided support in the form of salaries for authors [HC, YL, SK, MMMcL, FJL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contribution section.	Alexander P, 2014, MOL VIS, V20, P1253; Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Andreasen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0098153; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BOX GEP, 1974, TECHNOMETRICS, V16, P385, DOI 10.2307/1267668; Catchpole I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065518; Crabb JW, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017194; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Ghosh K, 1998, J Biopharm Stat, V8, P645, DOI 10.1080/10543409808835266; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Koronyo-Hamaoui M, 2011, NEUROIMAGE, V54, pS204, DOI 10.1016/j.neuroimage.2010.06.020; Kurji KH, 2010, INVEST OPHTH VIS SCI, V51, P1151, DOI 10.1167/iovs.09-3622; Lambert NG, 2016, PROG RETIN EYE RES, V54, P64, DOI 10.1016/j.preteyeres.2016.04.003; Lashkari K, 2016, INVEST OPHTH VIS SCI, V57, P57; Liu RT, 2013, INVEST OPHTH VIS SCI, V54, P2225, DOI 10.1167/iovs.12-10849; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; Ratnayaka JA, 2015, EYE, V29, P1013, DOI 10.1038/eye.2015.100; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Saint-Geniez M, 2009, P NATL ACAD SCI USA, V106, P18751, DOI 10.1073/pnas.0905010106; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Seth A, 2008, INVEST OPHTH VIS SCI, V49, P743, DOI 10.1167/iovs.07-1072; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Tan PL, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0079-x; Team RC, 2013, R LANG ENV STAT COMP; Tsiftsoglou SA, 2004, J IMMUNOL, V173, P367, DOI 10.4049/jimmunol.173.1.367; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Wang JY, 2008, J IMMUNOL, V181, P712, DOI 10.4049/jimmunol.181.1.712; Wang JY, 2009, J CELL PHYSIOL, V220, P119, DOI 10.1002/jcp.21742; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Zhao YH, 2015, MOL NEUROBIOL, V52, P533, DOI 10.1007/s12035-014-8886-3	37	18	19	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0195751	10.1371/journal.pone.0195751	http://dx.doi.org/10.1371/journal.pone.0195751			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782502	gold, Green Published, Green Submitted			2022-12-26	WOS:000432537100002
J	Ramadan, S; Miyake, T; Yamaura, J; Inoue-Murayama, M				Ramadan, Sherif; Miyake, Takeshi; Yamaura, Junichi; Inoue-Murayama, Miho			LDHA gene is associated with pigeon survivability during racing competitions	PLOS ONE			English	Article							PERFORMANCE; HERITABILITY; POLYMORPHISM; BEHAVIOR; LACTATE	Pigeon racing is a popular sport worldwide. Pigeons are under continuous selection to improve speed, spatial orientation, and endurance during long flights. However, numerous genetic and non-genetic factors affect survivability and homing ability, making such traits difficult for breeders to control. Polymorphisms in the lactate dehydrogenase A gene (LDHA) likely affects pigeon racing and homing abilities, due to its role in physical and mental performance. Additionally, the adenylate cyclase activating polypeptide 1 gene (ADCYAP1) has been associated with physiological and behavioral shifts that occur during avian migration. In this study, we examined the association between LDHA and ADCYAP1 genotypes with pigeon survivability during racing competitions. Survivability was evaluated through the estimated breeding value (EBV) of each individual's total race distances during its athletic life. ADCYAP1 was not polymorphic among our samples, while LDHA genotypes were significantly associated with deviated EBV values of longer total race distance; individuals carrying the S+ genotype had higher EBV (i.e., greater survivability). Thus, the LDHA locus might be useful for marker-assisted selection, empowering breeders and trainers to maximize pigeon quality. Moreover, data obtained from breeding will also improve our understanding of the genetic mechanism underlying navigation and flight for wild migrating bird species.	[Ramadan, Sherif; Inoue-Murayama, Miho] Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan; [Ramadan, Sherif] Benha Univ, Fac Vet Med, Anim Wealth Dev Dept, Moshtohor, Egypt; [Miyake, Takeshi] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Yamaura, Junichi] Japan Racing Pigeon Assoc, Kashiwa, Chiba, Japan; [Inoue-Murayama, Miho] Natl Inst Environm Studies, Wildlife Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan	Kyoto University; Egyptian Knowledge Bank (EKB); Benha University; Kyoto University; National Institute for Environmental Studies - Japan	Inoue-Murayama, M (corresponding author), Kyoto Univ, Wildlife Res Ctr, Kyoto, Japan.; Inoue-Murayama, M (corresponding author), Natl Inst Environm Studies, Wildlife Genome Collaborat Res Grp, Tsukuba, Ibaraki, Japan.	mmurayama@wrc.kyoto-u.ac.jp	Ramadan, Sherif/AAY-5228-2020; ramadann, sherif/AAX-4992-2020	ramadann, sherif/0000-0001-5151-5520	JSPS KAKENHI [25290082, 25118005, 17H03624]; Kyoto University; Egyptian Ministry of Higher Education; Future Development Funding Program of Kyoto University Research Coordination Alliance	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kyoto University; Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF)); Future Development Funding Program of Kyoto University Research Coordination Alliance	This work was supported by JSPS KAKENHI Grant Numbers 25290082, 25118005, 17H03624 to MI-M, Kyoto University Supporting program for interaction-based initiative team studies (SPIRITS) to MI-M, and the Egyptian Ministry of Higher Education to SR. This work was supported by the Future Development Funding Program of Kyoto University Research Coordination Alliance. The funders had no role in the study.	Biro D, 2007, P NATL ACAD SCI USA, V104, P7471, DOI 10.1073/pnas.0701575104; Darwin C, 1859, ORIGIN SPECIES MEANS; Dixon A, 2002, ATTACKS BIRDS PREY R; Dybus A, 2006, J APPL GENETICS, V47, P63, DOI 10.1007/BF03194601; Gaspardy A., 2017, INT J AGR SCI FOOD T, V3, P9, DOI [10.17352/2455-815X.000016, DOI 10.17352/2455-815X.000016]; Henderson C. R., 1973, P AN BREED GEN S HON, P10; Herold C, 2015, HIPPOCAMPUS, V25, P1193, DOI 10.1002/hipo.22463; Jerolmack C, 2007, ANIMAL ARCHEOLOGY DO, P3; Levi W.M., 1963, THE PIGEON; Li SSL, 1998, ZOOL STUD, V37, P1; LIPP HP, 1983, COMP BIOCHEM PHYS A, V76, P743, DOI 10.1016/0300-9629(83)90136-6; MIYAKE T, 1999, COMPUTER PROGRAM GEN; Mueller JC, 2011, P ROY SOC B-BIOL SCI, V278, P2848, DOI 10.1098/rspb.2010.2567; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Oki H, 2007, J ANIM BREED GENET, V124, P185, DOI 10.1111/j.1439-0388.2007.00659.x; Palleroni A, 2005, NATURE, V434, P973, DOI 10.1038/434973b; Proia P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091450; Proskura WS, 2014, J POULT SCI, V51, P364, DOI 10.2141/jpsa.0130237; Proskura WS, 2015, ANIM GENET, V46, P586, DOI 10.1111/age.12328; Ramadan S, 2013, J POULT SCI, V50, P194, DOI 10.2141/jpsa.0120137; Ramadan S, 2011, J POULT SCI, V48, P79, DOI 10.2141/jpsa.010109; Rattenborg NC, 2004, PLOS BIOL, V2, P924, DOI 10.1371/journal.pbio.0020212; Riviere B. B., 1923, British Birds, V17, P118; Rohe R, 2001, ARCH TIERZUCHT, V44, P579, DOI 10.5194/aab-44-579-2001; Ruefenacht S, 2002, APPL ANIM BEHAV SCI, V79, P113, DOI 10.1016/S0168-1591(02)00134-X; Santoro C., 2015, SCI REPORTS, P5; Shapiro MD, 2013, CURR BIOL, V23, pR302, DOI 10.1016/j.cub.2013.01.063; Shin DH, 2015, ASIAN AUSTRAL J ANIM, V28, P771, DOI 10.5713/ajas.14.0008; Smith T., 2012, BRIT HOMING WORLD, V83, P67; Sobczynska Magdalena, 2003, Animal Science Papers and Reports, V21, P233; SORENSEN DA, 1995, GENET SEL EVOL, V27, P229, DOI 10.1051/gse:19950303; Tozaki T, 2012, J ANIM BREED GENET, V129, P402, DOI 10.1111/j.1439-0388.2011.00982.x; Tozaki T, 2012, ANIM GENET, V43, P42, DOI 10.1111/j.1365-2052.2011.02201.x; Valvona CJ, 2016, BRAIN PATHOL, V26, P3, DOI 10.1111/bpa.12299; van Hall G, 1999, P NUTR SOC, V58, P899, DOI 10.1017/S0029665199001202; Van Hall G, 2000, ACTA PHYSIOL SCAND, V168, P643, DOI 10.1046/j.1365-201x.2000.00716.x; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	38	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0195121	10.1371/journal.pone.0195121	http://dx.doi.org/10.1371/journal.pone.0195121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775483	Green Published, Green Submitted, gold			2022-12-26	WOS:000432521100005
J	Murgai, A; Altmeyer, S; Wiegand, S; Tylzanowski, P; Stricker, S				Murgai, Arunima; Altmeyer, Sara; Wiegand, Stephanie; Tylzanowski, Przemko; Stricker, Sigmar			Cooperation of BMP and IHH signaling in interdigital cell fate determination	PLOS ONE			English	Article							APICAL ECTODERMAL RIDGE; PHALANX-FORMING REGION; TGF-BETA-S; INDIAN HEDGEHOG; LIMB DEVELOPMENT; MOUSE LIMB; CHONDROCYTE PROLIFERATION; DEATH; NOGGIN; DIFFERENTIATION	The elaborate anatomy of hands and feet is shaped by coordinated formation of digits and regression of the interdigital mesenchyme (IM). A failure of this process causes persistence of interdigital webbing and consequently cutaneous syndactyly. Bone morphogenetic proteins (BMPs) are key inductive factors for interdigital cell death (ICD) in vivo. NOGGIN (NOG) is a major BMP antagonist that can interfere with BMP-induced ICD when applied exogenously, but its in vivo role in this process is unknown. We investigated the physiological role of NOG in ICD and found that Noggin null mice display cutaneous syndactyly and impaired interdigital mesenchyme specification. Failure of webbing regression was caused by lack of cell cycle exit and interdigital apoptosis. Unexpectedly, Noggin null mutants also exhibit increased Indian hedgehog (Ihh) expression within cartilage condensations that leads to aberrant extension of IHH downstream signaling into the interdigital mesenchyme. A converse phenotype with increased apoptosis and reduced cell proliferation was found in the interdigital mesenchyme of Ihh mutant embryos. Our data point towards a novel role for NOG in balancing Ihh expression in the digits impinging on digit-interdigit cross talk. This suggests a so far unrecognized physiological role for IHH in interdigital webbing biology.	[Murgai, Arunima; Altmeyer, Sara; Wiegand, Stephanie; Stricker, Sigmar] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Murgai, Arunima; Altmeyer, Sara; Wiegand, Stephanie; Stricker, Sigmar] Max Planck Inst Mol Genet, Dev & Dis Grp, Berlin, Germany; [Murgai, Arunima; Stricker, Sigmar] Charite, Campus Virchow Klinikum, Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany; [Tylzanowski, Przemko] Univ Leuven, Skeletal Biol & Engn Res Ctr, Dept Dev & Regenerat, Lab Dev & Stem Cell Biol, Leuven, Belgium; [Tylzanowski, Przemko] Med Univ Lublin, Dept Biochem & Mol Biol, Lublin, Poland	Free University of Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; KU Leuven; Medical University of Lublin	Stricker, S (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany.; Stricker, S (corresponding author), Max Planck Inst Mol Genet, Dev & Dis Grp, Berlin, Germany.; Stricker, S (corresponding author), Charite, Campus Virchow Klinikum, Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany.	sigmar.stricker@fu-berlin.de	Stricker, Sigmar/B-9169-2009	Stricker, Sigmar/0000-0002-7174-5363; Murgai, Arunima/0000-0001-9767-7402; Tylzanowski, Przemko/0000-0003-0769-559X	Deutsche Forschungsgemeinschaft [SFB577]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/), grant number SFB577 (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Chen YP, 1998, J EXP ZOOL, V282, P691; Choi KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037826; Cunningham TJ, 2011, DEV DYNAM, V240, P1142, DOI 10.1002/dvdy.22583; Dupe V, 1999, DEV BIOL, V208, P30, DOI 10.1006/dbio.1998.9176; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gao B, 2009, NATURE, V458, P1196, DOI 10.1038/nature07862; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Guha U, 2002, DEV BIOL, V249, P108, DOI 10.1006/dbio.2002.0752; Hernandez-Martinez R, 2011, DEV GROWTH DIFFER, V53, P245, DOI 10.1111/j.1440-169X.2010.01246.x; Hernandez-Martinez R, 2009, DEVELOPMENT, V136, P3669, DOI 10.1242/dev.041954; Kaltcheva MM, 2016, DEV BIOL, V411, P266, DOI 10.1016/j.ydbio.2015.12.016; Klopocki E, 2011, AM J HUM GENET, V88, P70, DOI 10.1016/j.ajhg.2010.11.006; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kuss P, 2009, J CLIN INVEST, V119, P146, DOI 10.1172/JCI36851; Lallemand Y, 2005, DEVELOPMENT, V132, P3003, DOI 10.1242/dev.01877; Lehmann K, 2007, AM J HUM GENET, V81, P388, DOI 10.1086/519697; Long FX, 2001, DEVELOPMENT, V128, P5099; Lorda-Diez CI, 2015, AGING-US, V7, P974, DOI 10.18632/aging.100844; Lorda-Diez CI, 2015, INT J DEV BIOL, V59, P55, DOI 10.1387/ijdb.150065jh; Lorda-Diez CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060423; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maatouk DM, 2009, DEV BIOL, V327, P516, DOI 10.1016/j.ydbio.2009.01.004; Macias D, 1997, DEVELOPMENT, V124, P1109; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; Merino R, 1999, DEVELOPMENT, V126, P5515; Minina E, 2001, DEVELOPMENT, V128, P4523; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Pizette S, 2001, DEVELOPMENT, V128, P4463; Pizette S, 1999, DEVELOPMENT, V126, P883; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rodriguez-Leon J, 1999, NAT CELL BIOL, V1, P125, DOI 10.1038/10098; Salas-Vidal E, 2001, DEV DYNAM, V220, P295, DOI 10.1002/dvdy.1108; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Seki K, 2004, J BIOL CHEM, V279, P18544, DOI 10.1074/jbc.M311592200; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stricker S, 2011, DEV DYNAM, V240, P990, DOI 10.1002/dvdy.22565; Sun X, 2002, NATURE, V418, P501, DOI 10.1038/nature00902; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Takahashi T, 2001, CLIN GENET, V60, P447, DOI 10.1034/j.1399-0004.2001.600607.x; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Tylzanowski P, 2006, DEV DYNAM, V235, P1599, DOI 10.1002/dvdy.20782; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wang CKL, 2004, DEV BIOL, V269, P109, DOI 10.1016/j.ydbio.2004.01.016; Weatherbee SD, 2006, P NATL ACAD SCI USA, V103, P15103, DOI 10.1073/pnas.0604934103; Will AJ, 2017, NAT GENET, V49, P1539, DOI 10.1038/ng.3939; Witte F, 2010, P NATL ACAD SCI USA, V107, P14211, DOI 10.1073/pnas.1009314107; Yokouchi Y, 1996, DEVELOPMENT, V122, P3725; Yuksel-Apak M, 2012, EUR J HUM GENET, V20, P639, DOI 10.1038/ejhg.2011.250; Zhao XL, 2010, DEV DYNAM, V239, P665, DOI 10.1002/dvdy.22188; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197535	10.1371/journal.pone.0197535	http://dx.doi.org/10.1371/journal.pone.0197535			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771958	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900071
J	Wang, XY; Li, YQ; Chen, YP; Lian, J; Luo, YQ; Niu, YY; Gong, XW				Wang, Xuyang; Li, Yuqiang; Chen, Yinping; Lian, Jie; Luo, Yongqing; Niu, Yayi; Gong, Xiangwen			Spatial pattern of soil organic carbon and total nitrogen, and analysis of related factors in an agro-pastoral zone in Northern China	PLOS ONE			English	Article							DIFFERENT LAND USES; LOESS PLATEAU; SEQUESTRATION; STOCKS; MATTER; REGION; PREDICTION; GRASSLAND; IRELAND; EROSION	The spatial pattern of soil organic carbon (SOC) and total nitrogen (TN) densities plays a profound important role in estimating carbon and nitrogen budgets. Naiman Banner located in northern China was chosen as research site, a total of 332 soil samples were taken in a depth of 100 cm from the low hilly land in the southern part, sandy land in the middle part and an alluvial plain in the northern part of the county. The results showed that SOC and TN density initially decreased and then increased from the north to the south, The highest densities, were generally in the south, with the lowest generally in the middle part. The SOC and TN densities in cropland were significantly greater than those in woodland and grassland in the alluvial plains and for Naiman as a whole. The woodland SOC and TN density were higher than those of grassland in the low hilly land, and higher densities of SOC and TN in grassland than woodland in the sandy land and low hilly land. There were significant differences in SOC and TN densities among the five soil types of Cambisols, Arenosols, Gleysols, Argosols, and Kastanozems. In addition, SOC and TN contents generally decreased with increasing soil depth, but increased below a depth of 40 cm in the Cambisols and became roughly constant at this depth in the Kastanozems. There is considerable potential to sequester carbon and nitrogen in the soil via the conversion of degraded sandy land into woodland and grassland in alluvial plain, and more grassland should be established in sandy land and low hilly land.	[Wang, Xuyang; Li, Yuqiang; Lian, Jie; Luo, Yongqing; Niu, Yayi; Gong, Xiangwen] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China; [Wang, Xuyang; Niu, Yayi; Gong, Xiangwen] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Yuqiang; Lian, Jie; Luo, Yongqing] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Naiman Desertificat Res Stn, Tongliao, Peoples R China; [Chen, Yinping] Lanzhou Jiaotong Univ, Sch Environm & Municipal Engn, Lanzhou, Gansu, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Lanzhou Jiaotong University	Li, YQ (corresponding author), Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Lanzhou, Gansu, Peoples R China.; Li, YQ (corresponding author), Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, Naiman Desertificat Res Stn, Tongliao, Peoples R China.	liyq@lzb.ac.cn			National Key Research and Development Program of China [2016YFC0500901]; One Hundred Person Project of the Chinese Academy of Sciences [Y551821]; National Natural Science Foundation of China [31640012, 31560161, 31260089]	National Key Research and Development Program of China; One Hundred Person Project of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key Research and Development Program of China (2016YFC0500901), One Hundred Person Project of the Chinese Academy of Sciences (Y551821), and the National Natural Science Foundation of China (grants 31640012, 31560161, and 31260089). All co-authors assisted with manuscript writing. Xuyang Wang, Yuqiang Li and Yinping Chen conceived and designed the experiment, and wrote this paper. Jie Lian and Yongqing Luo were responsible for the field investigation, Yayi Niu and Xiangwen Gong were responsible for the soil sampling, and laboratory analyses.	Agricultural Bureau of Naiman Banner Inner Mongolia, 1984, 2 SOIL SURV REP, V128; ANDERSON DW, 1981, SOIL SCI SOC AM J, V45, P767, DOI 10.2136/sssaj1981.03615995004500040018x; BIEDERBECK VO, 1994, SOIL BIOL BIOCHEM, V26, P1647, DOI 10.1016/0038-0717(94)90317-4; BURGESS TM, 1980, J SOIL SCI, V31, P333, DOI 10.1111/j.1365-2389.1980.tb02085.x; CAMPBELL CA, 1991, CAN J SOIL SCI, V71, P363, DOI 10.4141/cjss91-035; Carter M., 2007, SOIL SAMPLING METHOD, V2, P15, DOI [10.1201/9781420005271, DOI 10.1201/9781420005271]; Carter MR, 1997, CAN J SOIL SCI, V77, P205, DOI 10.4141/S96-111; Chappell A, 2016, AEOLIAN RES, V22, P107, DOI 10.1016/j.aeolia.2016.07.005; Chen HQ, 2009, J PLANT NUTR SOIL SC, V172, P32, DOI 10.1002/jpln.200700116; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Farage PK, 2007, SOIL TILL RES, V94, P457, DOI 10.1016/j.still.2006.09.006; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Gao P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083592; Gregorich EG, 2008, SOIL SAMPLING METHOD; GSP, 2011, EST GLOB SOIL PARTN; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kaushik G, 2014, AFR J AGRO, V2, P188; Khalil MI, 2013, GEODERMA, V193, P222, DOI 10.1016/j.geoderma.2012.10.005; Kucharik CJ, 2001, ECOSYSTEMS, V4, P237, DOI 10.1007/s10021\N001\N0007-2; Kumar S, 2012, GEODERMA, V189, P627, DOI 10.1016/j.geoderma.2012.05.022; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Lal R, 2009, LAND DEGRAD DEV, V20, P441, DOI 10.1002/ldr.934; Lal R, 2001, CLIMATIC CHANGE, V51, P35, DOI 10.1023/A:1017529816140; Li FR, 2007, EFFICACY EXCLOSURES; Li Y, 2010, GEODERMA, V159, P63, DOI 10.1016/j.geoderma.2010.06.017; Li YQ, 2014, CAN J SOIL SCI, V94, P9, DOI 10.4141/CJSS2013-074; Li YQ, 2013, AGR ECOSYST ENVIRON, V177, P75, DOI 10.1016/j.agee.2013.06.007; Lian J, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020211; Liu ZP, 2011, AGR ECOSYST ENVIRON, V142, P184, DOI 10.1016/j.agee.2011.05.002; Ma K, 2016, CATENA, V144, P102, DOI 10.1016/j.catena.2016.05.014; Mayes M. T., 2012, AGU FALL M; MCBRATNEY AB, 1982, AGRONOMIE, V2, P969, DOI 10.1051/agro:19821010; Mcbratney AB, 2006, EUR J SOIL SCI, V37, P617, DOI [10.11118.1385-2389.19864800392.4, DOI 10.1111/J.1385-2389.19864800392.X]; McGrath D, 2003, APPL GEOCHEM, V18, P1629, DOI 10.1016/S0883-2927(03)00045-3; Meng F.Q., 2014, GEODERMA REG, V1, P19, DOI [10.1016/j.geodrs.2014.05.001, DOI 10.1016/J.GEODRS.2014.05.001]; Nelson D. W., 1982, METHODS SOIL ANAL PA, P961; Nosetto MD, 2006, J ARID ENVIRON, V67, P142, DOI 10.1016/j.jaridenv.2005.12.008; Ouyang XJ, 2008, J ENVIRON SCI, V20, P1082, DOI 10.1016/S1001-0742(08)62153-1; SCHIMEL DS, 1986, PLANT SOIL, V93, P347, DOI 10.1007/BF02374285; Smith P, 2000, SOIL USE MANAGE, V16, P293, DOI 10.1111/j.1475-2743.2000.tb00214.x; Sun W, 2012, GEODERMA, V171, P16, DOI 10.1016/j.geoderma.2011.02.010; Wang K., 1989, J DESERT RES, V9, P33, DOI DOI 10.13287/J.1001-9332.201805.005; Wang SF, 2012, J ENVIRON SCI, V24, P387, DOI 10.1016/S1001-0742(11)60789-4; Wang YQ, 2009, PEDOSPHERE, V19, P486, DOI 10.1016/S1002-0160(09)60141-7; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; Wilson BR, 2011, SOIL USE MANAGE, V27, P437, DOI 10.1111/j.1475-2743.2011.00357.x; WRB, 2006, WORLD SOIL RESOURCES; [吴薇 Wu Wei], 2003, [中国沙漠, Journal of Desert Research], V23, P646; Xu Xinliang, 2015, 2015 LAND USE STATUS, V2015; Yuksek T, 2011, CATENA, V84, P47, DOI 10.1016/j.catena.2010.09.002; Zhao Zhong, 2000, Yingyong Shengtai Xuebao, V11, P37; Zhou RL, 2008, GEODERMA, V145, P370, DOI 10.1016/j.geoderma.2008.04.003; Zier U, 2002, COMPU GEOSCI, V28, P281, DOI [10.1016/S009873004(01)00101-7, DOI 10.1016/S009873004(01)00101-7]	55	6	6	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197451	10.1371/journal.pone.0197451	http://dx.doi.org/10.1371/journal.pone.0197451			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771979	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900061
J	Saul, MC; Stevenson, SA; Zhao, CJ; Driessen, TM; Eisinger, BE; Gammie, SC				Saul, Michael C.; Stevenson, Sharon A.; Zhao, Changjiu; Driessen, Terri M.; Eisinger, Brian E.; Gammie, Stephen C.			Genomic variants in an inbred mouse model predict mania-like behaviors	PLOS ONE			English	Article							BIPOLAR AFFECTIVE-DISORDER; WIDE SCAN; ARTIFICIAL SELECTION; LINKAGE; LOCI; RECEPTORS; GENES; POLYMORPHISMS; MODULATION; PROVIDES	Contemporary rodent models for bipolar disorders split the bipolar spectrum into complimentary behavioral endophenotypes representing mania and depression. Widely accepted mania models typically utilize single gene transgenics or pharmacological manipulations, but inbred rodent strains show great potential as mania models. Their acceptance is often limited by the lack of genotypic data needed to establish construct validity. In this study, we used a unique strategy to inexpensively explore and confirm population allele differences in naturally occurring candidate variants in a manic rodent strain, the Madison (MSN) mouse strain. Variants were identified using whole exome resequencing on a small population of animals. Interesting candidate variants were confirmed in a larger population with genotyping. We enriched these results with observations of locomotor behavior from a previous study. Resequencing identified 447 structural variants that are mostly fixed in the MSN strain relative to control strains. After filtering and annotation, we found 11 non-synonymous MSN variants that we believe alter protein function. The allele frequencies for 6 of these variants were consistent with explanatory variants for the Madison strain's phenotype. The variants are in the Npas2, Cp, Polr3c, Smarca4, Trpv1, and Slc5a7 genes, and many of these genes' products are in pathways implicated in human bipolar disorders. Variants in Smarca4 and Polr3c together explained over 40% of the variance in locomotor behavior in the Hsd: ICR founder strain. These results enhance the MSN strain's construct validity and implicate altered nucleosome structure and transcriptional regulation as a chief molecular system underpinning behavior.	[Saul, Michael C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Stevenson, Sharon A.; Zhao, Changjiu; Gammie, Stephen C.] Univ Wisconsin, Dept Integrat Biol, Madison, WI 53706 USA; [Driessen, Terri M.] Yale Univ, Sch Med, New Haven, CT USA; [Eisinger, Brian E.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Gammie, Stephen C.] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Wisconsin System; University of Wisconsin Madison; Yale University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gammie, SC (corresponding author), Univ Wisconsin, Dept Integrat Biol, Madison, WI 53706 USA.; Gammie, SC (corresponding author), Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA.	scgammie@wisc.edu	Saul, Michael C./N-9303-2019	Saul, Michael C./0000-0002-4916-8619	University of Wisconsin-Madison Department of Zoology; University of Wisconsin Madison Department of Zoology John T. Emlen Grant for Behavioral Research; NIH [R01 MH085642]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085642] Funding Source: NIH RePORTER	University of Wisconsin-Madison Department of Zoology; University of Wisconsin Madison Department of Zoology John T. Emlen Grant for Behavioral Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was funded by funds from the University of Wisconsin-Madison Department of Zoology to SCG, a University of Wisconsin Madison Department of Zoology John T. Emlen Grant for Behavioral Research to MCS, and NIH R01 MH085642 to SCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Jamra R, 2007, AM J HUM GENET, V81, P974, DOI 10.1086/521690; [Anonymous], 2013, DIAGN STAT MAN MENT; Bazalakova MH, 2007, GENES BRAIN BEHAV, V6, P411, DOI 10.1111/j.1601-183X.2006.00269.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brambilla C, 2012, DEPRESS RES TREAT, V2012, DOI [10.1155/2012/978962, DOI 10.1155/2012/978962]; Bruxel EM, 2013, PHARMACOGENOMICS J, V13, P476, DOI 10.1038/tpj.2012.25; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carta MG, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-52; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cohen OS, 2012, SCHIZOPHR RES, V142, P188, DOI 10.1016/j.schres.2012.09.015; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Detera-Wadleigh SD, 2011, PHARMACOPSYCHIATRY, V44, pS35, DOI 10.1055/s-0031-1275275; Einat H, 2006, J PSYCHOPHARMACOL, V20, P714, DOI 10.1177/0269881106060241; Ewald H, 2002, MOL PSYCHIATR, V7, P734, DOI 10.1038/sj.mp.4001074; Flaisher-Grinberg Shlomit, 2010, Front Psychiatry, V1, P10, DOI 10.3389/fpsyt.2010.00010; Gammie SC, 2006, BEHAV GENET, V36, P713, DOI 10.1007/s10519-006-9071-x; Gammie SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001974; Gershon ES, 2011, AM J PSYCHIAT, V168, P253, DOI 10.1176/appi.ajp.2010.10091340; Hiscock K.M., 2007, J MED BIOMED SCI, V1, P1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Johansson C, 2003, NEUROPSYCHOPHARMACOL, V28, P734, DOI 10.1038/sj.npp.1300121; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lefevre S, 2011, NAT STRUCT MOL BIOL, V18, P352, DOI 10.1038/nsmb.1996; Lev-Ran S, 2013, PSYCHIAT RES, V209, P459, DOI 10.1016/j.psychres.2012.12.014; Lisboa SF, 2012, NEUROPHARMACOLOGY, V62, P2455, DOI 10.1016/j.neuropharm.2012.02.008; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Neumann SA, 2006, BIOL PSYCHIAT, V60, P1155, DOI 10.1016/j.biopsych.2006.03.059; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pato CN, 2004, AM J MED GENET B, V127B, P30, DOI 10.1002/ajmg.b.30001; Saul MC, 2017, GENES BRAIN BEHAV, V16, P328, DOI 10.1111/gbb.12347; Saul MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072125; Saul MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038128; Schumacher J, 2005, AM J HUM GENET, V77, P1102, DOI 10.1086/498619; Scotti MAL, 2011, PHYSIOL BEHAV, V103, P376, DOI 10.1016/j.physbeh.2011.03.005; Serretti A, 2008, MOL PSYCHIATR, V13, P742, DOI 10.1038/mp.2008.29; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; Subtil-Rodriguez A, 2010, EMBO REP, V11, P751, DOI 10.1038/embor.2010.131; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; Tam GWC, 2009, BIOL PSYCHIAT, V66, P1005, DOI 10.1016/j.biopsych.2009.07.027; Virit O, 2008, KLIN PSIKOFARMAKOL B, V18, P282; Witkin JM, 2005, BEHAV PHARMACOL, V16, P315, DOI 10.1097/00008877-200509000-00005; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046254; Zombeck JA, 2011, BEHAV GENET, V41, P571, DOI 10.1007/s10519-010-9425-2	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197624	10.1371/journal.pone.0197624	http://dx.doi.org/10.1371/journal.pone.0197624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768498	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200097
J	Alvarez, S; Timler, CJ; Michalscheck, M; Paas, W; Descheemaeker, K; Tittonell, P; Andersson, JA; Groot, JCJ				Alvarez, Stephanie; Timler, Carl J.; Michalscheck, Mirja; Paas, Wim; Descheemaeker, Katrien; Tittonell, Pablo; Andersson, Jens A.; Groot, Jeroen C. J.			Capturing farm diversity with hypothesis-based typologies: An innovative methodological framework for farming system typology development	PLOS ONE			English	Article							WEST-AFRICA; SMALLHOLDER FARMS; SOUTHERN MALI; FAMILY FARMS; TRAJECTORIES; AGRICULTURE; HOUSEHOLDS; SCALE; VARIABILITY; ENVIRONMENT	Creating typologies is a way to summarize the large heterogeneity of smallholder farming systems into a few farm types. Various methods exist, commonly using statistical analysis, to create these typologies. We demonstrate that the methodological decisions on data collection, variable selection, data-reduction and clustering techniques can bear a large impact on the typology results. We illustrate the effects of analysing the diversity from different angles, using different typology objectives and different hypotheses, on typology creation by using an example from Zambia's Eastern Province. Five separate typologies were created with principal component analysis (PCA) and hierarchical clustering analysis (HCA), based on three different expert-informed hypotheses. The greatest overlap between typologies was observed for the larger, wealthier farm types but for the remainder of the farms there were no clear overlaps between typologies. Based on these results, we argue that the typology development should be guided by a hypothesis on the local agriculture features and the drivers and mechanisms of differentiation among farming systems, such as biophysical and socio-economic conditions. That hypothesis is based both on the typology objective and on prior expert knowledge and theories of the farm diversity in the study area. We present a methodological framework that aims to integrate participatory and statistical methods for hypothesis-based typology construction. This is an iterative process whereby the results of the statistical analysis are compared with the reality of the target population as hypothesized by the local experts. Using a well-defined hypothesis and the presented methodological framework, which consolidates the hypothesis through local expert knowledge for the creation of typologies, warrants development of less subjective and more contextualized quantitative farm typologies.	[Alvarez, Stephanie; Timler, Carl J.; Michalscheck, Mirja; Paas, Wim; Tittonell, Pablo; Groot, Jeroen C. J.] Wageningen Univ & Res, Farming Syst Ecol, Wageningen, Netherlands; [Paas, Wim; Descheemaeker, Katrien] Wageningen Univ & Res, Plant Prod Syst, Wageningen, Netherlands; [Andersson, Jens A.] CIMMYT Southern Africa, Harare, Zimbabwe	Wageningen University & Research; Wageningen University & Research	Groot, JCJ (corresponding author), Wageningen Univ & Res, Farming Syst Ecol, Wageningen, Netherlands.	jeroen.groot@wur.nl	Paas, Wim/W-8046-2019; descheemaeker, katrien/P-6605-2014; Andersson, Jens/G-7984-2011; Michalscheck, Mirja/AAJ-8223-2020	Paas, Wim/0000-0001-9025-1652; descheemaeker, katrien/0000-0003-0184-2034; Andersson, Jens/0000-0002-8124-3447; Michalscheck, Mirja/0000-0002-5121-6413; Tittonell, Pablo/0000-0002-0284-2514	United States Agency for International Development (USAID) as part of the US Government's Feed the Future Initiative; CGIAR Research program Humidtropics	United States Agency for International Development (USAID) as part of the US Government's Feed the Future Initiative(United States Agency for International Development (USAID)); CGIAR Research program Humidtropics(CGIAR)	The fieldwork of this study was conducted within the Africa RISING/SIMLEZA research-for-development program in Zambia that is led by the International Institute of Tropical Agriculture (IITA). The research was partly funded by the United States Agency for International Development (USAID; https://www.usaid.gov/) as part of the US Government's Feed the Future Initiative. The contents are the responsibility of the producing organizations and do not necessarily reflect the opinion of USAID or the U.S. Government. The CGIAR Research program Humidtropics and all the donors supported this research through their contributions to the CGIAR Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For a list of Fund donors please see: https://www.cgiar.org/funders/.	Alary V, 2016, AGR SYST, V144, P33, DOI 10.1016/j.agsy.2016.01.008; Alary V, 2002, REV ELEVAGE MED VET, V55; Albaladejo C, 1997, JOURN PROGR ENV VIE, P203; Andersen E, 2007, J ENVIRON MANAGE, V82, P353, DOI 10.1016/j.jenvman.2006.04.021; Andrieu N, 2015, AGR SYST, V136, P125, DOI 10.1016/j.agsy.2015.02.010; Aregheore EM, 2014, COUNTRY PASTURE FORA; Bidogeza JC, 2009, FOOD SECUR, V1, P321, DOI 10.1007/s12571-009-0029-8; Blazy JM, 2009, AGR SYST, V101, P30, DOI 10.1016/j.agsy.2009.02.004; Brossier J., 1977, EC RURALE, V122, P31, DOI 10.3406/ecoru.1977.2520; CAPILLON A., 1993, THESIS, V1; Chavez MD, 2010, SPAN J AGRIC RES, V8, P460, DOI 10.5424/sjar/2010082-1201; Chopin P, 2015, AGRON SUSTAIN DEV, V35, P325, DOI 10.1007/s13593-014-0250-5; Cortez-Arriola J, 2015, AGR SYST, V135, P66, DOI 10.1016/j.agsy.2014.12.005; Dossa LH, 2011, LANDSCAPE URBAN PLAN, V102, P197, DOI 10.1016/j.landurbplan.2011.04.005; Douxchamps S, 2016, REG ENVIRON CHANGE, V16, P1305, DOI 10.1007/s10113-015-0838-6; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ewert F, 2011, AGR ECOSYST ENVIRON, V142, P6, DOI 10.1016/j.agee.2011.05.016; Falconnier GN, 2015, AGR SYST, V139, P210, DOI 10.1016/j.agsy.2015.07.005; Giller KE, 2011, AGR SYST, V104, P191, DOI 10.1016/j.agsy.2010.07.002; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hauswirth D, 2015, CAH AGRIC, V24, P102, DOI 10.1684/agr.2015.0744; Iraizoz B, 2007, AGR SYST, V93, P143, DOI 10.1016/j.agsy.2006.05.002; JOLLIVET M, 1965, REV FR SOCIOL, V6, P33, DOI 10.2307/3319368; Kobrich C, 2003, AGR SYST, V76, P141, DOI 10.1016/S0308-521X(02)00013-6; KOSTROWICKI J, 1977, Agricultural Systems, V2, P33, DOI 10.1016/0308-521X(77)90015-4; Kostrowicki J, 1970, AGR TYPOLOGY SELECTE; Kuentz-Simonet V, 2013, J SFDS, V154, P37; Kuivanen KS, 2016, J RURAL STUD, V45, P184, DOI 10.1016/j.jrurstud.2016.03.015; Kuivanen KS, 2016, NJAS WAGENINGEN J LI; Kumar R., 2014, RES METHODOLOGY STEP, V4th; Landais E, 1998, AGR SYST, V58, P505, DOI 10.1016/S0308-521X(98)00065-1; Landais E., 1988, ETUD RURALES, V109, P125, DOI [10.3406/rural.1988.3226, DOI 10.3406/RURAL.1988.3226]; Larouche C., 2011, THESIS; Lau HD, 2001, REV ELEVAGE MED VET, V54; Laurent C., 1999, Agrekon, V38, P190; Leeuwis C, 2000, DEV CHANGE, V31, P931, DOI 10.1111/1467-7660.00184; Legendre R, 2005, DICT ACTUEL ED, V3eme; Malapit H.J., 2017, 1647 IFPRI; Mbetid-Bessane E, 2003, ACT C GAR CAM CIR PR; Michielsens CGJ, 2002, AQUAC RES, V33, P403, DOI 10.1046/j.1365-2109.2002.00686.x; Monicat F., 1992, Cahiers de la Recherche Developpement, P38; Moreno-Perez OM, 2011, AGR SYST, V104, P500, DOI 10.1016/j.agsy.2011.03.007; Mucha HJ, 2014, ARCH DATA SCI, V1; Mwijage NA, 2009, AFR J AGR RES, V4, P1410; Pacini GC, 2014, EXP AGR, V50, P376, DOI 10.1017/S0014479713000495; Perrot C., 1995, Economie Rurale, P35; Perrot C, 1993, CAHIERS RECHERCHE DE, P33; Reidsma P, 2011, LAND USE POLICY, V28, P604, DOI 10.1016/j.landusepol.2010.11.009; Reidsma P, 2010, EUR J AGRON, V32, P91, DOI 10.1016/j.eja.2009.06.003; Rey B., 1989, CAHIERS RECHERCHE DE, V23, P94; Righi E, 2011, AGR ECOSYST ENVIRON, V142, P63, DOI 10.1016/j.agee.2010.07.011; Rueff C, 2012, J SUSTAIN AGR, V36, P564, DOI 10.1080/10440046.2012.672547; Sanogo OM, 2010, CAH AGRIC, V19, P185, DOI 10.1684/agr.2010.0401; SCHONLAU M., 2002, STATA J, V3, P316; Simukoko H, 2007, VET PARASITOL, V147, P231, DOI 10.1016/j.vetpar.2007.04.005; Timler C, 2016, SUSTAINABLE INTENSIF; Tittonell P, 2010, AGR SYST, V103, P83, DOI 10.1016/j.agsy.2009.10.001; Tittonell P, 2014, AGR SYST, V126, P3, DOI 10.1016/j.agsy.2013.10.010; Valbuena D, 2015, REG ENVIRON CHANGE, V15, P1395, DOI 10.1007/s10113-014-0702-0; Vayssieres J, 2011, AGR SYST, V104, P146, DOI 10.1016/j.agsy.2010.05.008; WHATMORE S, 1987, SOCIOL RURALIS, V27, P21, DOI 10.1111/j.1467-9523.1987.tb00315.x; Zingore S, 2007, FIELD CROP RES, V101, P296, DOI 10.1016/j.fcr.2006.12.006	62	69	70	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0194757	10.1371/journal.pone.0194757	http://dx.doi.org/10.1371/journal.pone.0194757			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF7AA	29763422	gold, Green Published, Green Submitted			2022-12-26	WOS:000432118800001
J	Dietz, P; Quermann, A; van Poppel, MNM; Striegel, H; Schroter, H; Ulrich, R; Simon, P				Dietz, Pavel; Quermann, Anne; van Poppel, Mireille Nicoline Maria; Striegel, Heiko; Schroeter, Hannes; Ulrich, Rolf; Simon, Perikles			Physical and cognitive doping in university students using the unrelated question model (UQM): Assessing the influence of the probability of receiving the sensitive question on prevalence estimation	PLOS ONE			English	Article							RANDOMIZED-RESPONSE; ILLICIT USE; PRESCRIPTION STIMULANTS; COLLEGE-STUDENTS; DRUG-USE; SPORTS; TOPICS	Study objectives In order to increase the value of randomized response techniques (RRTs) as tools for studying sensitive issues, the present study investigated whether the prevalence estimate for a sensitive item (pi)over-cap, assessed with the unrelated questionnaire method (UQM) is influenced by changing the probability of receiving the sensitive question p. Material and methods A short paper-and-pencil questionnaire was distributed to 1.243 university students assessing the 12-month prevalence of physical and cognitive doping using two versions of the UQM with different probabilities for receiving the sensitive question (p approximate to 1/3 and p approximate to 2/3). Likelihood ratio tests were used to assess whether the prevalence estimates for physical and cognitive doping differed significantly between p approximate to 1/3 and p approximate to 2/3. The order of questions (physical doping and cognitive doping) as well as the probability of receiving the sensitive question (p approximate to 1/3 or p approximate to 2/3) were counterbalanced across participants. Statistical power analyses were performed to determine sample size. Results The prevalence estimate for physical doping with p approximate to 1/3 was 22.5% (95% CI: 10.8-34.1), and 12.8% (95% CI: 7.6-18.0) with p approximate to 2/3. For cognitive doping with p approximate to 1/3, the estimated prevalence was 22.5% (95% CI: 11.0-34.1), whereas it was 18.0% (95% CI: 12.5-23.5) with p approximate to 2/3. Likelihood-ratio tests revealed that prevalence estimates for both physical and cognitive doping, respectively, did not differ significantly under p approximate to 1/3 and p approximate to 2/3 (physical doping:chi(2) = 2.25, df = 1, p = 0.13; cognitive doping:chi(2) = 0.49, df = 1, p = 0.48). Bayes factors computed with the Savage-Dickey method favored the null ("the prevalence estimates are identical under p approximate to 1/3 and p approximate to 2/3") over the alternative ("the prevalence estimates differ under p approximate to 1/3 and p 2/3") hypothesis for both physical doping (BF = 2.3) and cognitive doping (BF = 5.3). Conclusion The present results suggest that prevalence estimates for physical and cognitive doping assessed by the UQM are largely unaffected by the probability for receiving the sensitive question p.	[Dietz, Pavel; van Poppel, Mireille Nicoline Maria] Karl Franzens Univ Graz, Inst Sports Sci, Res Grp Phys Act & Publ Hlth, Graz, Austria; [Dietz, Pavel] Karlsruhe Inst Technol, Inst Sports & Sports Sci, Working Grp Social & Hlth Sci Sport, Karlsruhe, Germany; [Quermann, Anne; Simon, Perikles] Johannes Gutenberg Univ Mainz, Inst Sports Sci, Dept Sports Med Rehabil & Dis Prevent, Mainz, Germany; [Quermann, Anne] Univ Leipzig, Fac Sport Sci, Inst Exercise & Publ Hlth, Leipzig, Germany; [Striegel, Heiko] Univ Tubingen, Dept Sports Med, Tubingen, Germany; [Schroeter, Hannes] German Inst Adult Educ, Bonn, Germany; [Ulrich, Rolf] Univ Tubingen, Dept Psychol, Tubingen, Germany	University of Graz; Helmholtz Association; Karlsruhe Institute of Technology; Johannes Gutenberg University of Mainz; Leipzig University; Eberhard Karls University of Tubingen; Deutsches Institut fur Erwachsenenbildung (DIE); Eberhard Karls University of Tubingen	Dietz, P (corresponding author), Karl Franzens Univ Graz, Inst Sports Sci, Res Grp Phys Act & Publ Hlth, Graz, Austria.; Dietz, P (corresponding author), Karlsruhe Inst Technol, Inst Sports & Sports Sci, Working Grp Social & Hlth Sci Sport, Karlsruhe, Germany.	pavel.dietz@uni-graz.at	Van Poppel, Mireille/AAL-8228-2020; Simon, Perikles D/B-2293-2013	Van Poppel, Mireille/0000-0001-5694-4324; Simon, Perikles D/0000-0002-7996-4034; Dietz, Pavel/0000-0002-8390-0594				Baruch Y, 1999, HUM RELAT, V52, P421, DOI 10.1023/A:1016905407491; Bassoli L, 2004, Minerva Pediatr, V56, P317; BORUCH RF, 1971, AM SOCIOL, V6, P308; DALTON DR, 1994, PERS PSYCHOL, V47, P817, DOI 10.1111/j.1744-6570.1994.tb01578.x; DeSantis AD, 2008, J AM COLL HEALTH, V56, P315, DOI 10.3200/JACH.57.3.315-324; Dickson-Swift V, 2009, QUAL RES, V9, P61, DOI 10.1177/1468794108098031; Dietz P, 2016, J SPORT SCI, V34, P1965, DOI 10.1080/02640414.2016.1149214; Dietz P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00520; Dietz P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078702; Dietz P, 2013, PHARMACOTHERAPY, V33, P44, DOI 10.1002/phar.1166; EDGELL SE, 1982, SOCIOL METHOD RES, V11, P89, DOI 10.1177/0049124182011001005; Elmir Rakime, 2011, Nurse Res, V19, P12; Enosh G, 2005, QUAL INQ, V11, P588, DOI 10.1177/1077800405275054; Fahie D, 2014, INT J QUAL METH, V13, P19, DOI 10.1177/160940691401300108; Fox J.A., 1986, RANDOMIZED RESPONSE; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P331, DOI 10.1055/s-0031-1286347; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-102; GOODRUM S., 2007, INT J SOC RES METHOD, V10, P249, DOI [DOI 10.1080/13645570701400976, 10.1080/13645570701400976]; GREENBERG BG, 1969, J AM STAT ASSOC, V64, P520, DOI 10.2307/2283636; Hall KM, 2005, J AM COLL HEALTH, V53, P167, DOI 10.3200/JACH.53.4.167-174; Hilbig BE, 2015, J RES PERS, V57, P72, DOI 10.1016/j.jrp.2015.04.003; Hoffmann A, 2017, BEHAV RES METHODS, V49, P1470, DOI 10.3758/s13428-016-0804-3; Lee R.M., 1993, DOING RES SENSITIVE; LEE RM, 1990, AM BEHAV SCI, V33, P510, DOI 10.1177/0002764290033005002; Lensvelt-Mulders GJLM, 2005, SOCIOL METHOD RES, V33, P319, DOI 10.1177/0049124104268664; Lensvelt-Mulders GJLM, 2005, QUAL QUANT, V39, P253, DOI 10.1007/s11135-004-0432-3; Lipscomb Martin, 2010, Nurse Res, V17, P49; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; MITCHELL W., 2008, INT J QUAL METH, V7, P31, DOI 10.1177/160940690800700403; Moshagen M, 2014, EXP PSYCHOL, V61, P48, DOI 10.1027/1618-3169/a000226; Moshagen M, 2012, BEHAV RES METHODS, V44, P222, DOI 10.3758/s13428-011-0144-2; Moshagen M, 2011, EUR J SOC PSYCHOL, V41, P638, DOI 10.1002/ejsp.793; Moshagen M, 2010, EPIDEMIOLOGY, V21, P379, DOI 10.1097/EDE.0b013e3181d61dbc; Ostapczuk M, 2009, EUR J SOC PSYCHOL, V39, P920, DOI 10.1002/ejsp.588; Pitsch W, 2007, EUR J SPORT SOC, V4, P89, DOI 10.1080/16138171.2007.11687797; Plummer M., 2016, RJAGS BAYESIAN GRAPH; Possick C, 2009, QUAL INQ, V15, P859, DOI 10.1177/1077800408330418; Raftery AE, 1999, SOCIOL METHOD RES, V27, P411, DOI 10.1177/0049124199027003005; Rasinski KA, 1999, APPL COGNITIVE PSYCH, V13, P465, DOI 10.1002/(SICI)1099-0720(199910)13:5<465::AID-ACP609>3.0.CO;2-Y; Schroter H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155765; SIEBER JE, 1988, AM PSYCHOL, V43, P49, DOI 10.1037/0003-066X.43.1.49; Simon P, 2006, ADDICTION, V101, P1640, DOI 10.1111/j.1360-0443.2006.01568.x; Sollund R., 2008, J SCANDINAVIAN STUDI, V9, P181, DOI [DOI 10.1080/14043850802450138, 10.1080/14043850802450138]; Striegel H, 2010, DRUG ALCOHOL DEPEN, V106, P230, DOI 10.1016/j.drugalcdep.2009.07.026; Sudman S, 1982, JOSSEY BASS SERIES S; Teter CJ, 2006, PHARMACOTHERAPY, V26, P1501, DOI 10.1592/phco.26.10.1501; Teter CJ, 2003, PHARMACOTHERAPY, V23, P609, DOI 10.1592/phco.23.5.609.34187; Thielmann I, 2016, JUDGM DECIS MAK, V11, P527; Ulrich R, 2012, PSYCHOL METHODS, V17, P623, DOI 10.1037/a0029314; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wagenmakers EJ, 2010, COGNITIVE PSYCHOL, V60, P158, DOI 10.1016/j.cogpsych.2009.12.001; Walls Paula, 2010, Nurse Res, V18, P26; WARNER SL, 1971, J AM STAT ASSOC, V66, P884, DOI 10.2307/2284247; WARNER SL, 1965, J AM STAT ASSOC, V60, P63, DOI 10.2307/2283137; Yesalis C E, 2001, AIDS Read, V11, P157; Yu JW, 2008, METRIKA, V67, P251, DOI 10.1007/s00184-007-0131-x	57	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197270	10.1371/journal.pone.0197270	http://dx.doi.org/10.1371/journal.pone.0197270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF7AA	29763428	Green Published, Green Submitted, gold			2022-12-26	WOS:000432118800033
J	Vorhagen, S; Kleefisch, D; Persa, OD; Graband, A; Schwickert, A; Saynisch, M; Leitges, M; Niessen, CM; Iden, S				Vorhagen, Susanne; Kleefisch, Dominik; Persa, Oana-Diana; Graband, Annika; Schwickert, Alexandra; Saynisch, Michael; Leitges, Michael; Niessen, Carien M.; Iden, Sandra			Shared and independent functions of aPKC lambda and Par3 in skin tumorigenesis	ONCOGENE			English	Article							POLARITY PROTEIN PAR3; NF-KAPPA-B; CELL POLARITY; EPIDERMAL HOMEOSTASIS; BREAST-CANCER; CARCINOGENESIS; STAT3; DIFFERENTIATION; COMPLEX; TUMORS	The polarity proteins Par3 and aPKC are key regulators of processes altered in cancer. Par3/aPKC are thought to dynamically interact with Par6 but increasing evidence suggests that aPKC and Par3 also exert complex-independent functions. Whereas aPKC. serves as tumor promotor, Par3 can either promote or suppress tumorigenesis. Here we asked whether and how Par3 and aPKC lambda genetically interact to control two-stage skin carcinogenesis. Epidermal loss of Par3, aPKC lambda, or both, strongly reduced tumor multiplicity and increased latency but inhibited invasion to similar extents, indicating that Par3 and aPKC lambda function as a complex to promote tumorigenesis. Molecularly, Par3/aPKC lambda cooperate to promote Akt, ERK and NF-kappa B signaling during tumor initiation to sustain growth, whereas aPKC lambda dominates in promoting survival. In the inflammatory tumorigenesis phase Par3/aPKC lambda cooperate to drive Stat3 activation and hyperproliferation. Unexpectedly, the reduced inflammatory signaling did not alter carcinogen-induced immune cell numbers but reduced IL-4 Receptor-positive stromal macrophage numbers in all mutant mice, suggesting that epidermal aPKC lambda and Par3 promote a tumor-permissive environment. Importantly, aPKC lambda also serves a distinct, carcinogen-independent role in controlling skin immune cell homeostasis. Collectively, our data demonstrates that Par3 and aPKC lambda cooperate to promote skin tumor initiation and progression, likely through sustaining growth, survival, and inflammatory signaling.	[Vorhagen, Susanne; Persa, Oana-Diana; Schwickert, Alexandra; Niessen, Carien M.] Univ Cologne, Dept Dermatol, Cologne, Germany; [Vorhagen, Susanne; Kleefisch, Dominik; Persa, Oana-Diana; Graband, Annika; Schwickert, Alexandra; Saynisch, Michael; Niessen, Carien M.; Iden, Sandra] Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Vorhagen, Susanne; Kleefisch, Dominik; Graband, Annika; Schwickert, Alexandra; Saynisch, Michael; Niessen, Carien M.; Iden, Sandra] Univ Cologne, CMMC, Cologne, Germany; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, N-0316 Oslo, Norway	University of Cologne; University of Cologne; University of Cologne; University of Oslo	Niessen, CM (corresponding author), Univ Cologne, Dept Dermatol, Cologne, Germany.; Niessen, CM; Iden, S (corresponding author), Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.; Niessen, CM; Iden, S (corresponding author), Univ Cologne, CMMC, Cologne, Germany.	carien.niessen@uni-koeln.de; sandra.iden@uk-koeln.de	Leitges, Michael/AAN-1953-2021; Iden, Sandra/ABB-2698-2021	Iden, Sandra/0000-0003-2333-9827; Leitges, Michael/0000-0003-4203-6995; Niessen, Carien M./0000-0002-4892-9391	joint German Research Foundation (DFG) grant [NIE-1234/4-1, ID79/1-1]; Koln Fortune grant [197/2013]; DFG [ID79/2-1, CRC829/A10, CRC829/A01 + A05, NIE-1234/6-1]; German Cancer Society;  [DFG-SFB832]	joint German Research Foundation (DFG) grant(German Research Foundation (DFG)); Koln Fortune grant; DFG(German Research Foundation (DFG)); German Cancer Society; 	We thank Martim Dias Gomes for mouse line maintenance, Julia Stinn, Emmi Wachsmuth, Soriba Letzian, and Annika Schmitz for technical assistance, and the UoC animal facilities and CECAD histology unit for important services. We acknowledge Walter Birchmeier and Shigeo Ohno for sharing mouse lines, and thank the Niessen, Iden, Wickstrom, and Bazzi laboratories for helpful discussions. This project was funded by a joint German Research Foundation (DFG) grant (NIE-1234/4-1 and ID79/1-1 to C.N. and S. I.), a DFG-SFB832 grant to CMN (A3) and a Koln Fortune grant to S. I. (#197/2013). Work in the Iden laboratory is also supported by the DFG (ID79/2-1, CRC829/A10). Work in the Niessen laboratory is supported by the DFG (CRC829/A01 + A05, NIE-1234/6-1) and the German Cancer Society.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Ali NJA, 2016, J INVEST DERMATOL, V136, P2406, DOI 10.1016/j.jid.2016.07.011; Bandyopadhyay G, 2004, MOL ENDOCRINOL, V18, P373, DOI 10.1210/me.2003-0087; Bonastre E, 2015, CANCER RES, V75, P1287, DOI 10.1158/0008-5472.CAN-14-2444; Campanale JP, 2017, J CELL SCI, V130, P1201, DOI 10.1242/jcs.188599; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Fang LH, 2007, CELL RES, V17, P100, DOI 10.1038/sj.cr.7310145; Forteza R, 2016, MOL BIOL CELL, V27, P2186, DOI 10.1091/mbc.E16-02-0086; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Godde NJ, 2014, EXP CELL RES, V328, P249, DOI 10.1016/j.yexcr.2014.08.036; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guyer RA, 2015, J BIOL CHEM, V290, P8457, DOI 10.1074/jbc.M114.621011; Hirose T, 2006, DEVELOPMENT, V133, P1389, DOI 10.1242/dev.02294; Hirose T, 2002, J CELL SCI, V115, P2485; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; Ishiuchi T, 2011, NAT CELL BIOL, V13, P860, DOI 10.1038/ncb2274; Kern F, 2011, BRIT J CANCER, V104, P229, DOI 10.1038/sj.bjc.6606009; Kim C, 2014, EMBO MOL MED, V6, P970, DOI 10.15252/emmm.201303541; Kojima Y, 2008, HUM PATHOL, V39, P824, DOI 10.1016/j.humpath.2007.11.001; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; McCreery MQ, 2015, NAT MED, V21, P1514, DOI 10.1038/nm.3979; Nakamura H, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2929-2; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Niessen MT, 2013, J CELL BIOL, V202, P887, DOI 10.1083/jcb.201307001; Nolan ME, 2008, CANCER RES, V68, P8201, DOI 10.1158/0008-5472.CAN-07-6567; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tervonen TA, 2011, ADV CANCER RES, V111, P97, DOI 10.1016/B978-0-12-385524-4.00003-9; Tran CS, 2014, CELL HOST MICROBE, V15, P636, DOI 10.1016/j.chom.2014.04.007; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Xue B, 2013, NAT CELL BIOL, V15, P189, DOI 10.1038/ncb2663; Yamanaka T, 2003, CURR BIOL, V13, P734, DOI 10.1016/S0960-9822(03)00244-6; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012	40	12	14	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 13	2018	37	37					5136	5146		10.1038/s41388-018-0313-1	http://dx.doi.org/10.1038/s41388-018-0313-1			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT3LT	29789715	hybrid, Green Published			2022-12-26	WOS:000444405300009
J	Tan, S; Li, H; Zhang, WJ; Shao, YY; Liu, Y; Guan, HY; Wu, J; Kang, YN; Zhao, JS; Yu, Q; Gu, YZ; Ding, KS; Zhang, M; Qian, WC; Zhu, Y; Cai, HY; Chen, CY; Lobie, PE; Zhao, XD; Sun, JL; Zhu, T				Tan, Sheng; Li, Hua; Zhang, Weijie; Shao, Yunying; Liu, Yuan; Guan, Haiyang; Wu, Jun; Kang, Yani; Zhao, Junsong; Yu, Qing; Gu, Yunzhao; Ding, Keshuo; Zhang, Min; Qian, Wenchang; Zhu, Yong; Cai, Huayong; Chen, Changyu; Lobie, Peter E.; Zhao, Xiaodong; Sun, Jielin; Zhu, Tao			NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression	ONCOGENE			English	Article							CLEAVAGE FACTOR-I; CANCER; REVEALS; CELLS; RECOGNITION; MECHANISM; TUMORS; SITES	Alternative polyadenylation (APA) is an important post-transcriptional regulatory mechanism and involved in many diseases, including cancer. CFIm25, a subunit of the cleavage factor I encoded by NUDT21, is required for 3'RNA cleavage and polyadenylation. Although it has been recently reported to be involved in glioblastoma tumor suppression, its roles and the underlying functional mechanism remain unclear in other types of cancer. In this study, we characterized NUDT21 in hepatocellular carcinoma (HCC). Reduced expression of NUDT21 was observed in HCC tissue compared to adjacent non-tumorous compartment. HCC patients with lower NUDT21 expression have shorter overall and disease-free survival times than those with higher NUDT21 expression after surgery. Knockdown of NUDT21 promotes HCC cell proliferation, metastasis, and tumorigenesis, whereas forced expression of NUDT21 exhibits the opposite effects. We then performed global APA site profiling analysis in HCC cells and identified considerable number of genes with shortened 3'UTRs upon the modulation of NUDT21 expression. In particular, we further characterized the NUDT21-regulated genes PSMB2 and CXXC5. We found NUDT21 knockdown increases usage of the proximal polyadenylation site in the PSMB2 and CXXC5 3'UTRs, resulting in marked increase in the expression of PSMB2 and CXXC5. Moreover, knockdown of PSMB2 or CXXC5 suppresses HCC cell proliferation and invasion. Taken together, our study demonstrated that NUDT21 inhibits HCC proliferation, metastasis and tumorigenesis, at least in part, by suppressing PSMB2 and CXXC5, and thereby provided a new insight into understanding the connection of HCC suppression and APA machinery.	[Tan, Sheng; Zhang, Weijie; Shao, Yunying; Liu, Yuan; Guan, Haiyang; Zhao, Junsong; Yu, Qing; Zhang, Min; Qian, Wenchang; Zhu, Yong; Cai, Huayong; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Li, Hua; Wu, Jun; Kang, Yani; Gu, Yunzhao] Shanghai Jiao Tong Univ, BioID Ctr, Sch Biomed Engn, Shanghai 200240, Peoples R China; [Ding, Keshuo] Anhui Med Univ, Dept Pathol, Meishan Rd, Hefei 230031, Anhui, Peoples R China; [Chen, Changyu] Anhui Med Univ, Affiliated Hosp 1, Meishan Rd, Hefei 230031, Anhui, Peoples R China; [Lobie, Peter E.] Tsinghua Univ, Precis Med & Healthcare Res Ctr, Tsinghua Berkeley Shenzhen Inst, Shenzhen 518055, Peoples R China; [Zhao, Xiaodong; Sun, Jielin] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Shanghai Jiao Tong University; Anhui Medical University; Anhui Medical University; Tsinghua University; Shanghai Jiao Tong University	Zhu, T (corresponding author), Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Innate Immun & Chron Dis, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.; Zhao, XD; Sun, JL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	xiaodongzhao@sjtu.edu.cn; jlsun@sjtu.edu.cn; zhut@ustc.edu.cn	Kang, Yani/AAQ-1503-2020; tan, sheng/GSN-2599-2022; Wu, Jun/GRS-5039-2022	Kang, Yani/0000-0002-6753-386X; Wu, Jun/0000-0002-3381-2561; LI, HUA/0000-0003-2153-2500; Zhang, Weijie/0000-0002-6462-6067	National Key Scientific Programme of China [2016YFC1302305]; National Natural Science Foundation of China [81672609, 31671299, 81502282, 81472494]; Shenzhen Development and Reform Commission Subject Construction Project [[2017] 1434]	National Key Scientific Programme of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Development and Reform Commission Subject Construction Project	This work was supported by The National Key Scientific Programme of China (2016YFC1302305), The National Natural Science Foundation of China (81672609, 31671299, 81502282, 81472494,) and the Shenzhen Development and Reform Commission Subject Construction Project [2017] 1434. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.	Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; Collavoli A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/757960; Coseno M, 2008, NUCLEIC ACIDS RES, V36, P3474, DOI 10.1093/nar/gkn079; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Erson-Bensan AE, 2016, MOL CANCER RES, V14, P507, DOI 10.1158/1541-7786.MCR-15-0489; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Gennarino VA, 2015, ELIFE, V4, DOI 10.7554/eLife.10782; Knappskog S, 2011, ANN ONCOL, V22, P2208, DOI 10.1093/annonc/mdq737; Lai DP, 2015, HUM MOL GENET, V24, P3410, DOI 10.1093/hmg/ddv089; Lembo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031129; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Llovet JM, 2014, NAT REV CLIN ONCOL, V11, P506, DOI 10.1038/nrclinonc.2014.136; Martin G, 2012, CELL REP, V1, P753, DOI 10.1016/j.celrep.2012.05.003; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miles WO, 2016, CANCER RES, V76, P7231, DOI 10.1158/0008-5472.CAN-16-0844; Morris AR, 2012, CLIN CANCER RES, V18, P5256, DOI 10.1158/1078-0432.CCR-12-0543; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Singh P, 2009, CANCER RES, V69, P9422, DOI 10.1158/0008-5472.CAN-09-2236; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605; Xia Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6274; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107	27	57	59	4	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 30	2018	37	35					4887	4900		10.1038/s41388-018-0280-6	http://dx.doi.org/10.1038/s41388-018-0280-6			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS0BA	29780166				2022-12-26	WOS:000443146000009
J	Garg, R; Blando, JM; Perez, CJ; Lal, P; Feldman, MD; Smyth, EM; Ricciotti, E; Grosser, T; Benavides, F; Kazanietz, MG				Garg, Rachana; Blando, Jorge M.; Perez, Carlos J.; Lal, Priti; Feldman, Michael D.; Smyth, Emer M.; Ricciotti, Emanuela; Grosser, Tilo; Benavides, Fernando; Kazanietz, Marcelo G.			COX-2 mediates pro-tumorigenic effects of PKC epsilon in prostate cancer	ONCOGENE			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; PROSTAGLANDIN RECEPTOR EP2; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; IN-VIVO; COLORECTAL-CANCER; CYCLOOXYGENASE-2 INHIBITORS; TRANSCRIPTION FACTORS; CELL-PROLIFERATION	The pro-oncogenic kinase PKC epsilon is overexpressed in human prostate cancer and cooperates with loss of the tumor suppressor Pten for the development of prostatic adenocarcinoma. However, the effectors driving PKC epsilon-mediated phenotypes remain poorly defined. Here, using cellular and mouse models, we showed that PKC epsilon overexpression acts synergistically with Pten loss to promote NF-kappa B activation and induce cyclooxygenase-2 (COX-2) expression, phenotypic traits which are also observed in human prostate tumors. Targeted disruption of PKC epsilon from prostate cancer cells impaired COX-2 induction and PGE(2) production. Notably, COX-2 inhibitors selectively killed prostate epithelial cells overexpressing PKC epsilon, and this ability was greatly enhanced by Pten loss. Long-term COX-2 inhibition markedly reduced adenocarcinoma formation, as well as angiogenesis in a mouse model of prostate-specific PKC epsilon expression and Pten loss. Overall, our results provide strong evidence for the involvement of the canonical NF-kappa B pathway and its target gene COX2 as PKC epsilon effectors, and highlight the potential of PKC epsilon as a useful biomarker for the use of COX inhibition for chemopreventive and/or chemotherapeutic purposes in prostate cancer.	[Garg, Rachana; Smyth, Emer M.; Ricciotti, Emanuela; Grosser, Tilo; Kazanietz, Marcelo G.] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Blando, Jorge M.] Univ Texas MD Anderson Canc Ctr, Immunopathol Lab, Dept Immunol, Houston, TX 77030 USA; [Perez, Carlos J.; Benavides, Fernando] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Perez, Carlos J.; Benavides, Fernando] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Lal, Priti; Feldman, Michael D.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Pennsylvania; Pennsylvania Medicine	Kazanietz, MG (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Ricciotti, Emanuela/AAH-2729-2019; Grosser, Tilo/A-1057-2007; Garg, Rachana/AAQ-9518-2020	Grosser, Tilo/0000-0001-8569-8396; Garg, Rachana/0000-0002-7808-1053	DHHS/NCI Cancer Center Support grant [P30 CA016672];  [R01-CA089202];  [R01-CA189765];  [R01-CA196232 (NIH)];  [PC130641 (DOD)];  [W81XWH-12-1-0009 (DOD)]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA189765, R01CA196232, R01CA089202] Funding Source: NIH RePORTER	DHHS/NCI Cancer Center Support grant; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01-CA089202, R01-CA189765, R01-CA196232 (NIH), and PC130641 (DOD) to M.G.K., and W81XWH-12-1-0009 (DOD) to R.G. This study made use of the Research Animal Support Facility at MD Anderson Cancer Center, Smithville, including Laboratory Animal Genetic Services and Mutant Mouse Pathology Services, which are supported by DHHS/NCI Cancer Center Support grant P30 CA016672.	Abedinpour P, 2011, PROSTATE, V71, P813, DOI 10.1002/pros.21297; Adhami VM, 2007, CLIN CANCER RES, V13, P1611, DOI 10.1158/1078-0432.CCR-06-2269; Armstrong AJ, 2012, LANCET ONCOL, V13, P443, DOI 10.1016/S1470-2045(12)70111-0; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; Cai Y, 2008, INT J CANCER, V123, P195, DOI 10.1002/ijc.23481; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Claudino RF, 2006, J PHARMACOL EXP THER, V318, P611, DOI 10.1124/jpet.106.102806; Dandekar DS, 2005, INT J CANCER, V115, P484, DOI 10.1002/ijc.20878; Denkert C, 2007, PROSTATE, V67, P361, DOI 10.1002/pros.20467; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Fernandez-Marcos PJ, 2009, P NATL ACAD SCI USA, V106, P12962, DOI 10.1073/pnas.0813055106; Finetti F, 2015, ENDOCR-RELAT CANCER, V22, P665, DOI 10.1530/ERC-15-0277; Fries S, 2006, GASTROENTEROLOGY, V130, P55, DOI 10.1053/j.gastro.2005.10.002; Garcia M, 2014, BJU INT, V113, pE164, DOI 10.1111/bju.12503; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Garg R, 2017, CELL REP, V19, P375, DOI 10.1016/j.celrep.2017.03.042; Garg R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067319; Garg R, 2012, J BIOL CHEM, V287, P37570, DOI 10.1074/jbc.M112.398925; Gorin MA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-9; Gowda R, 2012, CANCER BIOL THER, V13, P756, DOI 10.4161/cbt.20558; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gupta S, 2004, CANCER RES, V64, P3334, DOI 10.1158/0008-5472.CAN-03-2422; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Gutierrez-Uzquiza A, 2015, MOL CANCER RES, V13, P1336, DOI 10.1158/1541-7786.MCR-15-0111; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; Harris R. E., 2009, Inflammopharmacology, V17, P55, DOI 10.1007/s10787-009-8049-8; Harris Randall E, 2012, J Exp Pharmacol, V4, P91, DOI 10.2147/JEP.S23826; Henry WS, 2017, CANCER RES, V77, P790, DOI 10.1158/0008-5472.CAN-16-2400; Holden NS, 2008, CELL SIGNAL, V20, P1338, DOI 10.1016/j.cellsig.2008.03.001; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Howe LR, 2003, J MAMMARY GLAND BIOL, V8, P31, DOI 10.1023/A:1025731204719; Hu ZX, 2017, ONCOTARGETS THER, V10, P2893, DOI 10.2147/OTT.S134599; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; Jain K, 2014, CANCERS, V6, P860, DOI 10.3390/cancers6020860; Jain S, 2008, CANCER RES, V68, P7750, DOI 10.1158/0008-5472.CAN-07-6689; Jamal MS, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-4204; James ND, 2012, LANCET ONCOL, V13, P549, DOI 10.1016/S1470-2045(12)70088-8; Jiang JX, 2013, TRENDS PHARMACOL SCI, V34, P413, DOI 10.1016/j.tips.2013.05.003; Jiang JX, 2013, J PHARMACOL EXP THER, V344, P360, DOI 10.1124/jpet.112.200444; Jiao J, 2007, CANCER RES, V67, P6083, DOI 10.1158/0008-5472.CAN-06-4202; Kashiwagi E, 2014, PROSTATE CANCER P D, V17, P10, DOI 10.1038/pcan.2013.53; Kashiwagi E, 2013, ENDOCR-RELAT CANCER, V20, P431, DOI 10.1530/ERC-12-0344; Khor LY, 2007, LANCET ONCOL, V8, P912, DOI 10.1016/S1470-2045(07)70280-2; Kim BH, 2011, KOREAN J UROL, V52, P253, DOI 10.4111/kju.2011.52.4.253; Kirschenbaum A, 2000, UROLOGY, V56, P671, DOI 10.1016/S0090-4295(00)00674-9; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Lu ZG, 2009, CANCER RES, V69, P5927, DOI 10.1158/0008-5472.CAN-08-4786; Masferrer JL, 2000, CANCER RES, V60, P1306; Mesquita RFDS, 2014, MOL CELL BIOL, V34, P574, DOI 10.1128/MCB.01098-13; Narayanan BA, 2006, PROSTATE, V66, P257, DOI 10.1002/pros.20331; Narayanan BA, 2007, CLIN CANCER RES, V13, P5965, DOI 10.1158/1078-0432.CCR-07-0744; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; O'Callaghan G, 2015, BRIT J PHARMACOL, V172, P5239, DOI 10.1111/bph.13331; Ogino S, 2008, CLIN CANCER RES, V14, P8221, DOI 10.1158/1078-0432.CCR-08-1841; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Richardsen E, 2010, CANCER EPIDEMIOL, V34, P316, DOI 10.1016/j.canep.2010.03.019; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Terry MB, 2004, JAMA-J AM MED ASSOC, V291, P2433, DOI 10.1001/jama.291.20.2433; Tougeron D, 2014, CLIN CANCER RES, V20, P1087, DOI 10.1158/1078-0432.CCR-13-2563; Turturro SB, 2016, BREAST CANCER RES TR, V156, P33, DOI 10.1007/s10549-016-3729-8; Veitonmaki T, 2013, EUR J CANCER, V49, P938, DOI 10.1016/j.ejca.2012.09.030; Walter B, 2010, WORLD J UROL, V28, P745, DOI 10.1007/s00345-010-0567-x; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang HB, 2014, J BIOL CHEM, V289, P19823, DOI 10.1074/jbc.M114.548446; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Wu DQ, 2002, CANCER RES, V62, P2423; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Yoshimura R, 2000, CANCER-AM CANCER SOC, V89, P589, DOI 10.1002/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C; Zheng X, 2010, CANCER PREV RES, V3, P114, DOI 10.1158/1940-6207.CAPR-09-0059	73	34	36	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 23	2018	37	34					4735	4749		10.1038/s41388-018-0318-9	http://dx.doi.org/10.1038/s41388-018-0318-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GR3SE	29765153	Green Accepted			2022-12-26	WOS:000442514400008
J	Grun, D; Adhikary, G; Eckert, RL				Grun, Daniel; Adhikary, Gautam; Eckert, Richard L.			NRP-1 interacts with GIPC1 and alpha 6/beta 4-integrins to increase YAP1/Delta Np63 alpha-dependent epidermal cancer stem cell survival	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SKIN-CANCER; ISOFORM EXPRESSION; HIPPO PATHWAY; TUMOR-CELLS; NEUROPILIN-1; VEGF; CARCINOMA; ANGIOGENESIS; PROMOTE	We have identified an epidermal cancer stem (ECS) cell population that drives formation of rapidly growing and highly invasive and vascularized tumors. VEGF-A and neuropilin-1 (NRP-1) are highly expressed in ECS cell tumors and VEGF-A/NRP-1 interaction is required for ECS cell survival and tumor vascularization. We now identify a novel signaling cascade that is triggered by VEGF-A/NRP-1. We show that NRP-1 forms a complex with GIPC1 and alpha 6/beta 4-integrin to activate FAK/Src signaling, which leads to stabilization of a YAP1/Delta Np63 alpha to enhance ECS cell survival, invasion, and angiogenesis. Loss of NRP-1, GIPC1, alpha 6/beta 4-integrins, YAP1, or Delta Np63 alpha reduces these responses. Moreover, restoration of constituently active YAP1 or Delta Np63 alpha in NRP-1 null cells restores the ECS cell phenotype. Tumor xenograft experiments show that NRP-1 knockout ECS cells form small tumors characterized by reduced vascularization as compared to wild-type cells. The NRP-1 knockout tumors display signaling changes consistent with a role for the proposed signaling cascade. These studies suggest that VEGF-A interacts with NRP-1 and GIPC1 to regulate alpha 6/beta 4-integrin, FAK, Src, PI3K/PDK1, LATS1 signaling to increase YAP1/Delta Np63 alpha accumulation to drive ECS cell survival, angiogenesis, and tumor formation.	[Grun, Daniel; Adhikary, Gautam; Eckert, Richard L.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Dept Dermatol, Sch Med, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Reprod Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA.; Eckert, RL (corresponding author), Univ Maryland, Dept Dermatol, Sch Med, Baltimore, MD 21201 USA.; Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Reprod Biol, Baltimore, MD 21201 USA.; Eckert, RL (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.	reckert@umaryland.edu			NIH [CA131074, CA184027]; Greenebaum Comprehensive Cancer Center [P30 CA134274]; NATIONAL CANCER INSTITUTE [R01CA184027, R01CA131074, P30CA134274] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenebaum Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH (CA131074 and CA184027) to RLE and a pilot grant from the Greenebaum Comprehensive Cancer Center (P30 CA134274).	Adhikary G, 2015, CARCINOGENESIS, V36, P800, DOI 10.1093/carcin/bgv064; Adhikary G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084324; American Cancer Society, CANC FACTS FIG; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bickers DR, 2006, J AM ACAD DERMATOL, V55, P490, DOI 10.1016/j.jaad.2006.05.048; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bowden J, 2002, J CUTAN PATHOL, V29, P585, DOI 10.1034/j.1600-0560.2002.291003.x; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Casanova ML, 2002, CANCER RES, V62, P3402; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Djordjevic S, 2013, DRUG DISCOV TODAY, V18, P447, DOI 10.1016/j.drudis.2012.11.013; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Fisher ML, 2016, CANCER RES, V76, P7265, DOI 10.1158/0008-5472.CAN-16-2032; Fisher ML, 2016, MOL CARCINOGEN, V55, P2024, DOI 10.1002/mc.22448; Fisher ML, 2015, ONCOTARGET, V6, P20525, DOI 10.18632/oncotarget.3890; Fisher ML, 2015, MOL CANCER RES, V13, P1083, DOI 10.1158/1541-7786.MCR-14-0685-T; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Gray MJ, 2005, CANCER RES, V65, P3664, DOI 10.1158/0008-5472.CAN-04-2229; Grun D, 2016, ONCOGENE, V35, P4379, DOI 10.1038/onc.2015.507; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Jia H, 2010, BRIT J CANCER, V102, P541, DOI 10.1038/sj.bjc.6605539; Johnson KE, 2012, J SKIN CANCER, V2012, DOI 10.1155/2012/483439; Katoh M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.49; Kim J, 2017, J CLIN INVEST, V127, P3447, DOI 10.1172/JCI93825; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lampropoulou A, 2014, BIOCHEM SOC T, V42, P1623, DOI 10.1042/BST20140244; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Li M, 2004, CANCER-AM CANCER SOC, V101, P2341, DOI 10.1002/cncr.20634; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Man XY, 2006, MOL MED, V12, P127, DOI 10.2119/2006-00024.Man; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Shahrabi-Farahani S, 2016, AM J PATHOL, V186, P1055, DOI 10.1016/j.ajpath.2015.11.021; Siegle JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5511; Sniezek JC, 2004, LARYNGOSCOPE, V114, P2063, DOI 10.1097/01.mlg.0000149437.35855.4b; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Tani TT, 2001, J BIOL CHEM, V276, P36535, DOI 10.1074/jbc.M105785200; Thurfjell N, 2004, INT J ONCOL, V25, P27; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Wang XH, 2017, DEV CELL, V42, P462, DOI 10.1016/j.devcel.2017.08.002; Yang XH, 2006, BIOCHEM BIOPH RES CO, V349, P31, DOI 10.1016/j.bbrc.2006.07.213; Yoshida A, 2015, BIOL OPEN, V4, P1063, DOI 10.1242/bio.010918; Zhang GL, 2016, TUMOR BIOL, V37, P13777, DOI 10.1007/s13277-016-5138-3; Zhao Y, 2011, INT J DEV BIOL, V55, P477, DOI 10.1387/ijdb.103225yz; Zhu JW, 2012, INT J BIOCHEM CELL B, V44, P246, DOI 10.1016/j.biocel.2011.10.022	55	20	21	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 23	2018	37	34					4711	4722		10.1038/s41388-018-0290-4	http://dx.doi.org/10.1038/s41388-018-0290-4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GR3SE	29755126	Green Accepted			2022-12-26	WOS:000442514400006
J	Tang, JM; Li, YX; Sang, YZ; Yu, B; Lv, DG; Zhang, WW; Feng, HZ				Tang, Jianming; Li, Yanxin; Sang, Youzhou; Yu, Bo; Lv, Deguan; Zhang, Weiwei; Feng, Haizhong			LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling	ONCOGENE			English	Article							CELL-PROLIFERATION; POOR-PROGNOSIS; GASTRIC-CANCER; MYC; AMPLIFICATION; METASTASIS; EXPRESSION; INVASION; CATENIN; GENE	Recent molecularly targeted approach gains advance in breast cancer treatment. However, the estimated 5-year survival rate has not met the desired expectation for improvement, especially for patients with triple-negative breast cancer (TNBC). Here we report that the lncRNA PVT1 promotes KLF5/beta-catenin signaling to drive TNBC tumorigenesis. PVT1 is upregulated in clinical TNBC tumors. Using genetic approaches targeting PVT1 in TNBC cells, we found that PVT1 depletion inhibited cell proliferation, colony formation, and orthotopic xenograft tumor growth. Mechanistically, PVT1 binds with KLF5 and increases its stability via BAP1, which upregulates beta-catenin signaling, resulting in enhanced TNBC tumorigenesis. PVT1, KLF5, and beta-catenin were also revealed to be co-expressed in clinical TNBC samples. Our findings uncover a new singaling pathway to mediate TNBC, and provide PVT1 as a new target for improving treatment of TNBC.	[Tang, Jianming; Sang, Youzhou; Yu, Bo; Lv, Deguan; Zhang, Weiwei; Feng, Haizhong] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Renji Med Clin Stem Cell Res Ctr 10,State Key Lab, Shanghai 200127, Peoples R China; [Li, Yanxin] Shanghai Jiao Tong Univ, Pediat Translat Med Inst, Key Lab Pediat Hematol & Oncol, Shanghai Childrens Med Ctr,Minist Hlth,Sch Med, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Feng, HZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Renji Med Clin Stem Cell Res Ctr 10,State Key Lab, Shanghai 200127, Peoples R China.; Li, YX (corresponding author), Shanghai Jiao Tong Univ, Pediat Translat Med Inst, Key Lab Pediat Hematol & Oncol, Shanghai Childrens Med Ctr,Minist Hlth,Sch Med, Shanghai 200127, Peoples R China.	liyanxin@scmc.com.cn; Fenghaizhong@sjtu.edu.cn	Feng, Haizhong/E-5795-2017	Feng, Haizhong/0000-0003-3552-6865; Lv, Deguan/0000-0003-3142-9814; Tang, Jianming/0000-0003-3738-9761	National Natural Science Foundation of China [81372704, 81572467, 81470315, 81772663]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [2014024]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [20161310]; New Hundred Talent Program (Outstanding Academic Leader) at Shanghai Municipal Health Bureau [2017BR021]; State Key Laboratory of Oncogenes and Related Genes in China [91-17-25]; Technology Transfer Project of Science and Technology Department at Shanghai Jiao Tong University School of Medicine [ZT201701]; Shanghai Jiao Tong University School of Medicine Hospital Fund [14XJ10069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support; New Hundred Talent Program (Outstanding Academic Leader) at Shanghai Municipal Health Bureau; State Key Laboratory of Oncogenes and Related Genes in China; Technology Transfer Project of Science and Technology Department at Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine Hospital Fund	This work was supported in part by the National Natural Science Foundation of China (No. 81372704, 81572467 to H.F.; No. 81470315, 81772663 to Y.L.); the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (No. 2014024), Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support (No. 20161310), New Hundred Talent Program (Outstanding Academic Leader) at Shanghai Municipal Health Bureau (2017BR021), the State Key Laboratory of Oncogenes and Related Genes in China (No. 91-17-25), and Technology Transfer Project of Science and Technology Department at Shanghai Jiao Tong University School of Medicine (ZT201701) to H.F.; and Shanghai Jiao Tong University School of Medicine Hospital Fund (No. 14XJ10069) to Y.L.	Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Grampp S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13183; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Guo LL, 2015, CELL SIGNAL, V27, P961, DOI 10.1016/j.cellsig.2015.02.005; Iden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156274; Ishikawa ET, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2645; Jones RA, 2016, J CLIN INVEST, V126, P3739, DOI 10.1172/JCI81568; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kong R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0355-8; Li PD, 2017, ONCOTARGET, V8, P34164, DOI 10.18632/oncotarget.15878; Li WJ, 2017, J CLIN INVEST, V127, P3427, DOI 10.1172/JCI94233; Li Z, 2016, CELL DEATH DIFFER, V23, P583, DOI 10.1038/cdd.2015.125; Lin AF, 2017, NAT CELL BIOL, V19, P238, DOI 10.1038/ncb3473; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; Qin JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9471; Shi PG, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.10; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Takahashi Y, 2014, Br J Cancer, V110, P164, DOI 10.1038/bjc.2013.698; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Wan L, 2016, MOL CANCER THER, V15, P1082, DOI 10.1158/1535-7163.MCT-15-0707; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; WEBB E, 1984, NATURE, V312, P777, DOI 10.1038/312777a0; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xu MD, 2017, CLIN CANCER RES, V23, P2071, DOI 10.1158/1078-0432.CCR-16-0742; Zhang L, 2016, ONCOGENE, V35, P5641, DOI 10.1038/onc.2016.100; Zhou Q, 2016, ONCOTARGET, V7, P82620, DOI 10.18632/oncotarget.13012; Zhou W, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9557	33	101	108	4	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 23	2018	37	34					4723	4734		10.1038/s41388-018-0310-4	http://dx.doi.org/10.1038/s41388-018-0310-4			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GR3SE	29760406				2022-12-26	WOS:000442514400007
J	Knickelbein, K; Tong, JS; Chen, DS; Wang, YJ; Misale, S; Bardelli, A; Yu, J; Zhang, L				Knickelbein, Kyle; Tong, Jingshan; Chen, Dongshi; Wang, Yi-Jun; Misale, Sandra; Bardelli, Alberto; Yu, Jian; Zhang, Lin			Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer	ONCOGENE			English	Article							NF-KAPPA-B; ACQUIRED-RESISTANCE; RAS ONCOGENES; APOPTOSIS; THERAPY; INHIBITION; MUTATIONS; CETUXIMAB; MEK; PANITUMUMAB	Intrinsic and acquired resistance to anti-EGFR antibody therapy, frequently mediated by a mutant or amplified KRAS oncogene, is a significant challenge in the treatment of colorectal cancer (CRC). However, the mechanism of KRAS-mediated therapeutic resistance is not well understood. In this study, we demonstrate that clinically used anti-EGFR antibodies, including cetuximab and panitumumab, induce killing of sensitive CRC cells through p73-dependent transcriptional activation of the pro-apoptotic Bcl-2 family protein PUMA. PUMA induction and p73 activation are abrogated in CRC cells with acquired resistance to anti-EGFR antibodies due to KRAS alterations. Inhibition of aurora kinases preferentially kills mutant KRAS CRC cells and overcomes KRAS-mediated resistance to anti-EGFR antibodies in vitro and in vivo by restoring PUMA induction. Our results suggest that PUMA plays a critical role in meditating the sensitivity of CRC cells to anti-EGFR antibodies, and that restoration of PUMA-mediated apoptosis is a promising approach to improve the efficacy of EGFR-targeted therapy.	[Knickelbein, Kyle; Tong, Jingshan; Chen, Dongshi; Wang, Yi-Jun; Yu, Jian; Zhang, Lin] UMPC Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Knickelbein, Kyle; Tong, Jingshan; Chen, Dongshi; Wang, Yi-Jun; Yu, Jian; Zhang, Lin] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Misale, Sandra] Mem Sloan Kettering Canc, Program Mol Pharmacol, New York, NY 10065 USA; [Bardelli, Alberto] IRCCS, Candiolo Canc Inst FPO, I-10060 Candiolo, TO, Italy; [Bardelli, Alberto] IRCCS, Dept Oncol, I-10060 Candiolo, TO, Italy; [Yu, Jian] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; IRCCS Fondazione del Piemonte per l'Oncologia; IRCCS Fondazione del Piemonte per l'Oncologia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, L (corresponding author), UMPC Hillman Canc Ctr, Pittsburgh, PA 15213 USA.; Zhang, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.	zhanglx@upmc.edu	Zhang, Lin/A-7389-2009; Yu, Jian/A-8301-2009; Wang, Yixuan/GZK-6559-2022; Wang, Yin/HCI-9352-2022; wang, yi/GVT-8516-2022; wang, yixuan/GXW-2866-2022; Wang, Yijun/GXW-1763-2022; BARDELLI, Alberto/J-9721-2018	Zhang, Lin/0000-0003-0018-3903; Yu, Jian/0000-0002-4021-1000; Tong, Jingshan/0000-0003-1640-5769; BARDELLI, Alberto/0000-0003-1647-5070	U.S. National Institute of Health [R01CA106348, R01CA172136, R01CA203028, R01CA217141, U19AI068021, R01CA215481]; Cotswold Foundation; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine;  [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA172136, R01CA217141, P30CA047904, R01CA203028, R01CA106348, R01CA215481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085570] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cotswold Foundation; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank our lab members for critical reading. This work is supported by U.S. National Institute of Health grants (R01CA106348, R01CA172136, R01CA203028, and R01CA217141 to LZ; U19AI068021 and R01CA215481 to JY). KK was supported by a fellowship from the Cotswold Foundation and the Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine. This project used the UPMC Hillman Cancer Center shared facilities that were supported in part by award P30CA047904.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Banck MS, 2009, CLIN CANCER RES, V15, P7492, DOI 10.1158/1078-0432.CCR-09-0188; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Bhola PD, 2016, MOL CELL, V61, P695, DOI 10.1016/j.molcel.2016.02.019; Brown MF, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.104; Chen DS, 2014, ONCOTARGET, V5, P8107, DOI 10.18632/oncotarget.2440; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Conforti F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.27; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Del Poeta G, 2016, DRUG TODAY, V52, P249, DOI 10.1358/dot.2016.52.4.2470954; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dudgeon C, 2012, ONCOGENE, V31, P4848, DOI 10.1038/onc.2011.644; Giam M, 2008, ONCOGENE, V27, pS128, DOI 10.1038/onc.2009.50; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata AN, 2014, CANCER RES, V74, P3146, DOI 10.1158/0008-5472.CAN-13-3728; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kasper S, 2013, ONCOGENE, V32, P2873, DOI 10.1038/onc.2012.302; Knickelbein K, 2015, GENES DIS, V2, P4, DOI 10.1016/j.gendis.2014.10.002; Lee HJ, 2015, CELL RES, V25, P225, DOI 10.1038/cr.2015.8; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lu Y, 2007, CANCER RES, V67, P8240, DOI 10.1158/0008-5472.CAN-07-0589; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Martini M, 2012, NAT REV CLIN ONCOL, V9, P87, DOI 10.1038/nrclinonc.2011.164; Medico E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8002; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Misale S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9305; Misale S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007947; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Sun J, 2014, MOL CANCER THER, V13, P1298, DOI 10.1158/1535-7163.MCT-13-0846; Sun Q, 2009, ONCOGENE, V28, P2348, DOI 10.1038/onc.2009.108; Tsai KKC, 2003, CANCER RES, V63, P3418; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhang L, 2013, CURR COLORECT CANC R, V9, P331, DOI 10.1007/s11888-013-0188-z	44	26	26	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4599	4610		10.1038/s41388-018-0289-x	http://dx.doi.org/10.1038/s41388-018-0289-x			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29755130	Green Accepted			2022-12-26	WOS:000441736700008
J	Habtemichael, EN; Li, DT; Alcazar-Roman, A; Westergaard, XO; Li, MY; Petersen, MC; Li, HB; DeVries, SG; Li, E; Julca-Zevallos, O; Wolenski, JS; Bogan, JS				Habtemichael, Estifanos N.; Li, Don T.; Alcazar-Roman, Abel; Westergaard, Xavier O.; Li, Muyi; Petersen, Max C.; Li, Hanbing; DeVries, Stephen G.; Li, Eric; Julca-Zevallos, Omar; Wolenski, Joseph S.; Bogan, Jonathan S.			Usp25m protease regulates ubiquitin-like processing of TUG proteins to control GLUT4 glucose transporter translocation in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transporter type 4 (GLUT4); insulin; protein processing; adipocyte; membrane trafficking; protein translocation; proteolysis; kinesin; insulin resistance; ubiquitylation (ubiquitination)	DIET-INDUCED OBESITY; 3T3-L1 ADIPOCYTES; INSULIN ACTION; DEGRADATION SIGNAL; RECYCLING PATHWAY; STORAGE-VESICLES; SKELETAL-MUSCLE; ADIPOSE-TISSUE; CELL-SURFACE; INTERACTS	Insulin stimulates the exocytic translocation of specialized vesicles in adipocytes, which inserts GLUT4 glucose transporters into the plasma membrane to enhance glucose uptake. Previous results support a model in which TUG (Tether containing a UBX domain for GLUT4) proteins trap these GLUT4 storage vesicles at the Golgi matrix and in which insulin triggers endoproteolytic cleavage of TUG to translocate GLUT4. Here, we identify the muscle splice form of Usp25 (Usp25m) as a protease required for insulin-stimulated TUG cleavage and GLUT4 translocation in adipocytes. Usp25m is expressed in adipocytes, binds TUG and GLUT4, dissociates from TUG-bound vesicles after insulin addition, and colocalizes with TUG and insulin-responsive cargoes in unstimulated cells. Previous results show that TUG proteolysis generates the ubiquitin-like protein, TUGUL (for TUG ubiquitin-like). We now show that TUGUL modifies the kinesin motor protein, KIF5B, and that TUG proteolysis is required to load GLUT4 onto these motors. Insulin stimulates TUG proteolytic processing independently of phosphatidylinositol 3-kinase. In nonadipocytes, TUG cleavage can be reconstituted by transfection of Usp25m, but not the related Usp25a isoform, together with other proteins present on GLUT4 vesicles. In rodents with diet-induced insulin resistance, TUG proteolysis and Usp25m protein abundance are reduced in adipose tissue. These effects occur soon after dietary manipulation, prior to the attenuation of insulin signaling to Akt. Together with previous data, these results support a model whereby insulin acts through Usp25m to mediate TUG cleavage, which liberates GLUT4 storage vesicles from the Golgi matrix and activates their microtubule-based movement to the plasma membrane. This TUG proteolytic pathway for insulin action is independent of Akt and is impaired by nutritional excess.	[Habtemichael, Estifanos N.; Li, Don T.; Alcazar-Roman, Abel; Westergaard, Xavier O.; Li, Muyi; Petersen, Max C.; Li, Hanbing; DeVries, Stephen G.; Li, Eric; Julca-Zevallos, Omar; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA; [Li, Don T.; Julca-Zevallos, Omar; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Petersen, Max C.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Wolenski, Joseph S.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Li, Hanbing] Zhejiang Univ Technol, Inst Pharmacol, Dept Pharmaceut Sci, Hangzhou 310014, Zhejiang, Peoples R China	Yale University; Yale University; Yale University; Yale University; Zhejiang University of Technology	Bogan, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Li, Hanbing/W-3302-2019; Bogan, Jonathan S/A-1575-2010; Li, Don/F-5162-2018	Bogan, Jonathan S/0000-0001-6463-8466; Alcazar-Roman, Abel R./0000-0003-1668-1886; Li, Don/0000-0001-7547-4022	National Institutes of Health [P30 DK45735]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK115037, R01DK092661, F30DK104596, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Gerald Shulman, Dr. Nai-Wen Chi, Arielle Patterson, Vincent Calia-Bogan, and Roland Calia-Bogan for helpful discussions and assistance, and Dr. Gemma Marfany, Dr. Konstantin Kandror, and Dr. Gustav Lienhard for kindly sharing plasmids. This work used the Cell Biology Core of the Yale Diabetes Endocrinology Research Center (supported by National Institutes of Health Grant P30 DK45735) as well as services provided by the W. M. Keck Foundation Biotechnology Resource Laboratory at Yale University.	Belman JP, 2015, J BIOL CHEM, V290, P4447, DOI 10.1074/jbc.M114.603977; Belman JP, 2014, REV ENDOCR METAB DIS, V15, P55, DOI 10.1007/s11154-013-9276-2; Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bosch-Comas A, 2006, CELL MOL LIFE SCI, V63, P723, DOI 10.1007/s00018-005-5533-1; Brewer PD, 2016, J BIOL CHEM, V291, P773, DOI 10.1074/jbc.M115.694919; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Cui J, 2017, FASEB J, V31, P2533, DOI 10.1096/fj.201601103R; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Govers R, 2014, ADV CLIN CHEM, V66, P173, DOI 10.1016/B978-0-12-801401-1.00006-2; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Habtemichael EN, 2015, J BIOL CHEM, V290, P14454, DOI 10.1074/jbc.C115.639203; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Huang GR, 2013, MOL BIOL CELL, V24, P3115, DOI 10.1091/mbc.E12-10-0765; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; JOHNSON ES, 1992, EMBO J, V11, P497, DOI 10.1002/j.1460-2075.1992.tb05080.x; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Jun HS, 2008, OBESITY, V16, P1226, DOI 10.1038/oby.2008.220; Jung ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep08805; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Kawaguchi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45037; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-166; Lin DD, 2015, P NATL ACAD SCI USA, V112, P11324, DOI 10.1073/pnas.1509968112; Liu LB, 2007, DIABETES, V56, P1977, DOI 10.2337/db06-1100; Liu SJ, 2017, CELL REP, V18, P1005, DOI 10.1016/j.celrep.2016.12.086; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Loffler MG, 2013, J BIOL CHEM, V288, P20135, DOI 10.1074/jbc.M113.458075; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muretta JM, 2008, J BIOL CHEM, V283, P311, DOI 10.1074/jbc.M705756200; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Pan X, 2017, MOL BIOL CELL, V28, P1667, DOI 10.1091/mbc.E16-11-0777; Quan NH, 2017, FASEB J, V31, P4153, DOI 10.1096/fj.201700063R; Ren YJ, 2016, J BIOL CHEM, V291, P13206, DOI 10.1074/jbc.M116.718080; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Sebastian BM, 2005, AM J PHYSIOL-ENDOC M, V289, pE1077, DOI 10.1152/ajpendo.00296.2005; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2008, J BIOL CHEM, V283, P30311, DOI 10.1074/jbc.M805182200; Tettamanzi MC, 2006, PROTEIN SCI, V15, P498, DOI 10.1110/ps.051901806; Valero R, 2001, GENOME BIOL, V2; Vatner DF, 2015, P NATL ACAD SCI USA, V112, P1143, DOI 10.1073/pnas.1423952112; Xu DC, 2017, GENE DEV, V31, P1024, DOI 10.1101/gad.300889.117; Xu YK, 2016, J CELL SCI, V129, P2085, DOI 10.1242/jcs.174805; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Zhong HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080976; Zhong LL, 2016, DIABETOLOGIA, V59, P582, DOI 10.1007/s00125-015-3815-1	72	19	19	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10466	10486		10.1074/jbc.RA118.003021	http://dx.doi.org/10.1074/jbc.RA118.003021			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29773651	hybrid, Green Published			2022-12-26	WOS:000437828400008
J	Meikle, WG; Holst, N; Colin, T; Weiss, M; Carroll, MJ; McFrederick, QS; Barron, AB				Meikle, William G.; Holst, Niels; Colin, Theotime; Weiss, Milagra; Carroll, Mark J.; McFrederick, Quinn S.; Barron, Andrew B.			Using within-day hive weight changes to measure environmental effects on honey bee colonies	PLOS ONE			English	Article							FOOD SHORTAGE; POLLEN; TEMPERATURE; HEALTH; DIET	Patterns in within-day hive weight data from two independent datasets in Arizona and California were modeled using piecewise regression, and analyzed with respect to honey bee colony behavior and landscape effects. The regression analysis yielded information on the start and finish of a colony's daily activity cycle, hive weight change at night, hive weight loss due to departing foragers and weight gain due to returning foragers. Assumptions about the meaning of the timing and size of the morning weight changes were tested in a third study by delaying the forager departure times from one to three hours using screen entrance gates. A regression of planned vs. observed departure delays showed that the initial hive weight loss around dawn was largely due to foragers. In a similar experiment in Australia, hive weight loss due to departing foragers in the morning was correlated with net bee traffic (difference between the number of departing bees and the number of arriving bees) and from those data the payload of the arriving bees was estimated to be 0.02 g. The piecewise regression approach was then used to analyze a fifth study involving hives with and without access to natural forage. The analysis showed that, during a commercial pollination event, hives with previous access to forage had a significantly higher rate of weight gain as the foragers returned in the afternoon, and, in the weeks after the pollination event, a significantly higher rate of weight loss in the morning, as foragers departed. This combination of continuous weight data and piecewise regression proved effective in detecting treatment differences in foraging activity that other methods failed to detect.	[Meikle, William G.; Weiss, Milagra; Carroll, Mark J.] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA; [Holst, Niels] Aarhus Univ, Dept Agroecol, Forsogsvej 1, Slagelse, Denmark; [Colin, Theotime; Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [McFrederick, Quinn S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	United States Department of Agriculture (USDA); Aarhus University; Macquarie University; University of California System; University of California Riverside	Meikle, WG (corresponding author), USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA.	william.meikle@ars.usda.gov	Meikle, William/AAC-2481-2022; Colin, Theotime/AAW-7734-2020; McFrederick, Quinn/AAD-2858-2019	Meikle, William/0000-0002-1759-6950; McFrederick, Quinn/0000-0003-0740-6954; Holst, Niels/0000-0002-8414-6773; Barron, Andrew/0000-0002-8135-6628; Colin, Theotime/0000-0003-0223-4479	Almond Board of California [15-POLL14]; MQRES from Macquarie University	Almond Board of California; MQRES from Macquarie University	Three authors (WGM, MJC, QSM) received funding from grant no. 15-POLL14 from the Almond Board of California: www.almonds.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to warmly thank M. Heitlinger at the Santa Rita Experimental Range, M. Mcclaran at the University of Arizona, and S. Naranjo at USDA-ARS for use of the apiary sites in Arizona; A. Lawson and A. Novicki at California State University, Fresno, CA and Hiatt Honey Company for access to colonies in California; Olam International (almond orchards) for apiary sites in California; C. Ledbetter and J. Throne at the San Joaquin Valley Agricultural Sciences Center, USDA-ARS, Parlier, CA for valuable assistance with logistics; and G. Wardell and Wonderful Farms (Wonderful Pistachios and Almonds of California, USA) for apiary sites in California. We would also like to thank E. Beren, N. Brown, M. Giansiracusa, and I. Carstensen for valuable assistance in the field, and B.G. Rector, V. Ricigliano and two anonymous reviewers for improving the manuscript<SUP>.</SUP> Part of this research was funded by grant no. 15-POLL14 from the Almond Board of California to QSM, WGM, and MJC, by an MQRES scholarship from Macquarie University for TC.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Bayir R, 2016, INT J DISTRIB SENS N, V12, DOI 10.1177/1550147716678003; Bitondi MMG, 1996, J APICULT RES, V35, P27, DOI 10.1080/00218839.1996.11100910; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Buchmann S. L., 1990, Bee Science, V1, P40; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; CRAILSHEIM K, 1990, ZOOL JAHRB ALLG ZOOL, V94, P303; DUSTMANN JH, 1988, APIDOLOGIE, V19, P245, DOI 10.1051/apido:19880304; Gil-Lebrero S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010055; Hambleton JI, 1925, USDA DEP B, V1339; Human H, 2007, J INSECT PHYSIOL, V53, P649, DOI 10.1016/j.jinsphys.2007.04.002; JAY SC, 1964, CAN J ZOOLOG, V42, P455, DOI 10.1139/z64-039; KUNERT K, 1988, J APICULT RES, V27, P13, DOI 10.1080/00218839.1988.11100775; Mattila HR, 2007, ECOL ENTOMOL, V32, P496, DOI 10.1111/j.1365-2311.2007.00904.x; Maurizio A., 1950, BEE WORLD, V31, P9, DOI 10.1080/0005772X.1950.11094617; Meikle WG, 2006, J APICULT RES, V45, P39, DOI 10.1080/00218839.2006.11101311; Meikle WG, 2016, APIDOLOGIE, V47, P1, DOI 10.1007/s13592-015-0370-1; Meikle WG, 2015, APIDOLOGIE, V46, P10, DOI 10.1007/s13592-014-0298-x; Meikle WG, 2017, APIDOLOGIE, V48, P666, DOI 10.1007/s13592-017-0512-8; Meikle WG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168603; Meikle WG, 2008, APIDOLOGIE, V39, P694, DOI 10.1051/apido:2008055; Muggeo V.M., 2008, R NEWS, V8, P20; Rothman JA, 2018, MICROB ECOL, V76, P814, DOI 10.1007/s00248-018-1151-y; Sagili RR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1471, DOI 10.1007/s00265-007-0379-1; Schmickl T, 2003, INSECT SOC, V50, P174, DOI 10.1007/s00040-003-0644-x; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; Schmickl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188004; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Schulz DJ, 2002, INSECT SOC, V49, P50, DOI 10.1007/s00040-002-8279-x; Scofield HN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121731; Stalidzans E, 2017, J ECON ENTOMOL, V110, P13, DOI 10.1093/jee/tow282; THOENES SC, 1992, J APICULT RES, V31, P167, DOI 10.1080/00218839.1992.11101280; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Wood SN, 2001, BIOMETRICS, V57, P240, DOI 10.1111/j.0006-341X.2001.00240.x; Zacepins A., 2017, Agronomy Research, V15, P585	36	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197589	10.1371/journal.pone.0197589	http://dx.doi.org/10.1371/journal.pone.0197589			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791462	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000043
J	Silva-Brandao, KL; Peruchi, A; Seraphim, N; Murad, NF; Carvalho, RA; Farias, JR; Omoto, C; Consoli, FL; Figueira, A; Brandao, MM				Silva-Brandao, Karina Lucas; Peruchi, Aline; Seraphim, Noemy; Murad, Natalia Faraj; Carvalho, Renato Assis; Farias, Juliano Ricardo; Omoto, Celso; Consoli, Fernando Luis; Figueira, Antonio; Brandao, Marcelo Mendes			Loci under selection and markers associated with host plant and host-related strains shape the genetic structure of Brazilian populations of Spodoptera frugiperda (Lepidoptera, Noctuidae)	PLOS ONE			English	Article							FALL ARMYWORM LEPIDOPTERA; GLUTATHIONE-S-TRANSFERASE; BACILLUS-THURINGIENSIS; RICE STRAINS; HELICOVERPA-ARMIGERA; ECOLOGICAL SPECIATION; SMITH LEPIDOPTERA; CENTRAL COLOMBIA; TOOL SET; CORN	We applied the ddRAD genotyping-by-sequencing technique to investigate the genetic distinctiveness of Brazilian populations of the noctuid moth Spodoptera frugiperda, the fall armyworm (FAW), and the role of host-plant association as a source of genetic diversification. By strain-genotyping all field-collected individuals we found that populations collected from corn were composed primarily of corn-strain individuals, while the population collected from rice was composed almost entirely of rice-strain individuals. Outlier analyses indicated 1,184 loci putatively under selection (ca. 15% of the total) related to 194 different Gene Ontologies (GOs); the most numerous GOs were nucleotide binding, ATP binding, metal ion binding and nucleic-acid binding. The association analyses indicated 326 loci associated with the host plant, and 216 loci associated with the individual strain, including functions related to Bacillus thuringiensis and insecticide resistance. The genetic-structure analyses indicated a moderate level of differentiation among all populations, and lower genetic structure among populations collected exclusively from corn, which suggests that the population collected from rice has a strong influence on the overall genetic structure. Populations of S. frugiperda are structured partially due to the host plant, and pairs of populations using the same host plant are more genetically similar than pairs using different hosts. Loci putatively under selection are the main factors responsible for the genetic structure of these populations, which indicates that adaptive selection on important traits, including the response to control tactics, is acting in the genetic differentiation of FAW populations in Brazil.	[Silva-Brandao, Karina Lucas; Peruchi, Aline; Figueira, Antonio] Univ Sao Paulo, Ctr Energia Nucl Agr, Lab Melhoramento Plantas, Campus Luiz de Queiroz, Piracicaba, SP, Brazil; [Seraphim, Noemy] Inst Fed Educ Ciencia & Tecnol Sao Paulo, Campus Campinas CTI Renato Archer, Campinas, SP, Brazil; [Murad, Natalia Faraj] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Programa Posgrad Genet & Biol Mol, Campinas, SP, Brazil; [Carvalho, Renato Assis] Monsanto Brasil Ltda, Sao Paulo, SP, Brazil; [Farias, Juliano Ricardo] Inst Phytus, Dept Entomol, Rua Duque de Caxias, Santa Maria, RS, Brazil; [Omoto, Celso; Consoli, Fernando Luis] Univ Sao Paulo, Dept Entomol & Acarol, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Silva-Brandao, Karina Lucas; Brandao, Marcelo Mendes] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil	Universidade de Sao Paulo; Instituto Federal de Sao Paulo (IFSP); Universidade Estadual de Campinas; Monsanto; Universidade de Sao Paulo; Universidade Estadual de Campinas	Silva-Brandao, KL (corresponding author), Univ Sao Paulo, Ctr Energia Nucl Agr, Lab Melhoramento Plantas, Campus Luiz de Queiroz, Piracicaba, SP, Brazil.; Silva-Brandao, KL (corresponding author), Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil.	klsilva@gmail.com	Figueira, Antonio/D-5556-2011; BrandÃo, Marcelo/AAX-5691-2020; Murad, Natália Faraj/W-7707-2019; Omoto, Celso/D-9794-2012; Seraphim, Noemy/G-1813-2015; Silva-Brandao, Karina L/F-4955-2012; Consoli, Fernando Luis/D-5706-2012	Figueira, Antonio/0000-0001-8641-2556; Murad, Natália Faraj/0000-0001-7652-2567; Omoto, Celso/0000-0002-6432-830X; Seraphim, Noemy/0000-0002-8579-561X; Consoli, Fernando Luis/0000-0002-2287-0782	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Fapesp [2012/16266-7, 2011/00417-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq [403851/2013-0]; Monsanto do Brasil Ltda.; Institute Phytus	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Monsanto do Brasil Ltda.; Institute Phytus	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br); Fapesp, process 2012/16266-7 (Study design, data collection and analysis). This was a fellowship to KLSB. This work was also supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br); Fapesp, process 2011/00417-3 to MMB (Data collection and analysis was performed in the Thunder Computer Cluster). This work was also supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br); CNPq process # 403851/2013-0 to CO (Decision to publish.). Monsanto do Brasil Ltda. provided support in the form of salaries for RAC and in collecting field samples, and Institute Phytus provided support in the form of salaries for JRF and in collecting field samples. The two companies did not have any additional role in the study design and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acevedo FE, 2017, INSECT BIOCHEM MOLEC, V86, P81, DOI 10.1016/j.ibmb.2017.06.001; Adamczyk J. J. Jr., 1997, Journal of Cotton Science, V1, P21; Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Blackford M, 1996, J INSECT PHYSIOL, V42, P931, DOI 10.1016/0022-1910(96)00052-2; Blanco CA, 2016, CURR OPIN INSECT SCI, V15, P131, DOI 10.1016/j.cois.2016.04.012; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bown DP, 2004, EUR J BIOCHEM, V271, P2000, DOI 10.1111/j.1432-1033.2004.04113.x; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Brunet BMT, 2017, SYST ENTOMOL, V42, P317, DOI 10.1111/syen.12211; Busato G. R., 2008, Revista Brasileira de Agrociencia, V14, P273; Busato GR, 2004, NEOTROP ENTOMOL, V33, P709, DOI 10.1590/S1519-566X2004000600008; Busato GR, 2002, REV BRAS AGRO, V10, P317; BUSH GL, 1969, EVOLUTION, V23, P237, DOI 10.1111/j.1558-5646.1969.tb03508.x; Canas-Hoyos N, 2014, ANN ENTOMOL SOC AM, V107, P575, DOI 10.1603/AN12154; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; DEVARENNE TP, 1995, PHYTOCHEMISTRY, V40, P1125, DOI 10.1016/0031-9422(95)00435-A; Diez-Rodriguez Gabriela I., 2001, Neotropical Entomology, V30, P311, DOI 10.1590/S1519-566X2001000200016; Dinan L, 2017, COMPILATION LIT REPO; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dumas P, 2015, GENETICA, V143, P305, DOI 10.1007/s10709-015-9829-2; Dumas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122407; Dussex N, 2016, EVOLUTION, V70, P38, DOI 10.1111/evo.12826; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Emelianov I, 2004, P ROY SOC B-BIOL SCI, V271, P97, DOI 10.1098/rspb.2003.2574; EMELIANOV I, 1995, HEREDITY, V75, P416, DOI 10.1038/hdy.1995.154; Erion R, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00353; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang SM, 2012, B INSECTOL, V65, P265; Fatoretto JC, 2017, J INTEGR PEST MANAG, V8, DOI 10.1093/jipm/pmx011; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; Fouet C, 2017, INFECT GENET EVOL, V48, P27, DOI 10.1016/j.meegid.2016.12.006; Fritz ML, 2018, MOL ECOL, V27, P167, DOI 10.1111/mec.14430; Funk DJ, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P117; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; Murua MG, 2015, J ECON ENTOMOL, V108, P2305, DOI 10.1093/jee/tov203; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Glauser G, 2011, PLANT J, V68, P901, DOI 10.1111/j.1365-313X.2011.04740.x; Gouin A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10461-4; GOUSSAIN MARCIO M., 2002, Neotrop. entomol., V31, P305, DOI 10.1590/S1519-566X2002000200019; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Groman JD, 2000, J EVOLUTION BIOL, V13, P223, DOI 10.1046/j.1420-9101.2000.00159.x; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Heckel D., 2009, MOL BIOL GENETICS LE, P239; Ingber DA, 2018, J ECON ENTOMOL, V111, P361, DOI 10.1093/jee/tox311; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Juarez ML, 2014, ENTOMOL EXP APPL, V152, P182, DOI 10.1111/eea.12215; Kergoat GJ, 2012, MOL PHYLOGENET EVOL, V65, P855, DOI 10.1016/j.ympev.2012.08.006; KLUN JA, 1967, J ECON ENTOMOL, V60, P1529, DOI 10.1093/jee/60.6.1529; Kostaropoulos I, 2001, INSECT BIOCHEM MOLEC, V31, P313, DOI 10.1016/S0965-1748(00)00123-5; Lafont R, 1997, ARCH INSECT BIOCHEM, V35, P3, DOI 10.1002/(SICI)1520-6327(1997)35:1/2<3::AID-ARCH2>3.3.CO;2-M; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Juarez ML, 2012, J ECON ENTOMOL, V105, P573, DOI 10.1603/EC11184; Levy HC, 2002, FLA ENTOMOL, V85, P186, DOI 10.1653/0015-4040(2002)085[0186:SIOSFL]2.0.CO;2; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Lozier JD, 2016, ECOL EVOL, V6, P1075, DOI 10.1002/ece3.1928; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Machado V, 2008, ANN ENTOMOL SOC AM, V101, P619, DOI 10.1603/0013-8746(2008)101[619:MCOHSO]2.0.CO;2; Vlez-Arango AM, 2008, REV COLOMB ENTOMOL, V34, P145; Marion-Poll F, 2002, J INSECT PHYSIOL, V48, P467, DOI 10.1016/S0022-1910(02)00068-9; Martel C, 2003, HEREDITY, V90, P141, DOI 10.1038/sj.hdy.6800186; Martinelli S, 2007, B ENTOMOL RES, V97, P225, DOI 10.1017/S0007485307004944; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; MCPHERON BA, 1988, NATURE, V336, P64, DOI 10.1038/336064a0; Meagher RL, 2011, J INSECT BEHAV, V24, P337, DOI 10.1007/s10905-011-9259-7; Nagoshi RN, 2003, INSECT MOL BIOL, V12, P453, DOI 10.1046/j.1365-2583.2003.00429.x; Nagoshi RN, 2007, ANN ENTOMOL SOC AM, V100, P394, DOI 10.1603/0013-8746(2007)100[394:IACOFA]2.0.CO;2; Nagoshi RN, 2010, ANN ENTOMOL SOC AM, V103, P283, DOI 10.1603/AN09046; Nagoshi RN, 2008, FLA ENTOMOL, V91, P546; Nascimento A. M., 2014, BRAZILIAN J AGR SCI, V9, P215, DOI [10.5039/agraria.v9i2a3930, DOI 10.5039/AGRARIA.V9I2A3930]; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Negre V, 2006, BMC BIOINFORMATICS, P7; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Omoto C, 2013, MANEJO RESISTENCIA S; Ortego F, 1998, J INSECT PHYSIOL, V44, P95, DOI 10.1016/S0022-1910(97)00103-0; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; PASHLEY DP, 1992, ANN ENTOMOL SOC AM, V85, P400, DOI 10.1093/aesa/85.4.400; Pauchet Y, 2016, TOXINS, V8, DOI 10.3390/toxins8120362; Pearce SL, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0402-6; PITRE HN, 1983, J ECON ENTOMOL, V76, P463, DOI 10.1093/jee/76.3.463; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ragland GJ, 2017, MOL ECOL, V26, P3926, DOI 10.1111/mec.14178; Rasic G, 2015, EVOL APPL, V8, P901, DOI 10.1111/eva.12301; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ren FR, 2005, SYST BIOL, V54, P808, DOI 10.1080/10635150500354688; Ren XL, 2016, J ECON ENTOMOL, V109, P2281, DOI 10.1093/jee/tow193; Rios-Diez JD, 2011, J ECON ENTOMOL, V104, P1698, DOI 10.1603/EC11079; Roditakis E, 2017, INSECT BIOCHEM MOLEC, V80, P11, DOI 10.1016/j.ibmb.2016.11.003; Rodriguez-Almazan C, 2012, BIOCHEM J, V443, P711, DOI 10.1042/BJ20111579; Rostas M, 2007, J PEST SCI, V80, P35, DOI 10.1007/s10340-006-0151-8; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Saldamando CI, 2010, NEOTROP ENTOMOL, V39, P921, DOI 10.1590/S1519-566X2010000600012; Saldamando-Benjumea CI, 2014, J INSECT BEHAV, V27, P555, DOI 10.1007/s10905-014-9451-7; Silva-Brandao KL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4170-z; Silva-Brandao KL, 2015, EVOL APPL, V8, P476, DOI 10.1111/eva.12257; SLATKIN M, 1995, GENETICS, V139, P457; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Steinig EJ, 2016, MOL ECOL RESOUR, V16, P216, DOI 10.1111/1755-0998.12442; Stinchcombe JR, 2008, HEREDITY, V100, P158, DOI 10.1038/sj.hdy.6800937; Sun W, 2012, INT J BIOL SCI, V8, P125, DOI 10.7150/ijbs.8.125; Tay WT, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005534; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Wang GR, 2005, SCI CHINA SER C, V48, P346, DOI 10.1360/03yc0273; WHITFORD F, 1988, FLA ENTOMOL, V71, P234, DOI 10.2307/3495426; Wouters FC, 2016, J BRAZIL CHEM SOC, V27, P1379, DOI 10.5935/0103-5053.20160177; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yao JX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020301; Zhang HN, 2017, INSECT BIOCHEM MOLEC, V86, P41, DOI 10.1016/j.ibmb.2017.05.004	128	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197378	10.1371/journal.pone.0197378	http://dx.doi.org/10.1371/journal.pone.0197378			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787608	Green Submitted, Green Published, gold			2022-12-26	WOS:000432785700025
J	Neira, V; Allerson, M; Corzo, C; Culhane, M; Rendahl, A; Torremorell, M				Neira, Victor; Allerson, Matt; Corzo, Cesar; Culhane, Marie; Rendahl, Aaron; Torremorell, Montserrat			Detection of influenza A virus in aerosols of vaccinated and non-vaccinated pigs in a warm environment	PLOS ONE			English	Article							2011-2012 H3N2V; UNITED-STATES; RISK-FACTORS; SWINE; EFFICACY; H1N1; TRANSMISSION; TEMPERATURE; SURVEILLANCE; INFECTIONS	The 2009 influenza pandemic, the variant H3N2v viruses in agricultural fairs and the zoonotic poultry H5N9 infections in China have highlighted the constant threat that influenza A viruses (IAV) present to people and animals. In this study we evaluated the effect of IAV vaccination on aerosol shedding in pigs housed in warm environmental conditions. Thirty-six, three-week old weaned pigs were obtained from an IAV negative herd and were randomly allocated to one of 4 groups: 1) a homologous vaccine group, 2) a heterologous multivalent vaccine group, 3) a heterologous monovalent group and, 4) a non-vaccinated group. After vaccination pigs were challenged with the triple reassortant A/Sw/IA/00239/04 H1N1 virus. Environmental temperature and relative humidity were recorded throughout the study. Nasal swabs, oral fluids and air samples were collected daily. All samples were tested by RRT-PCR and virus isolation was attempted on positive samples. Average temperature and relative humidity throughout the study were 27 degrees C (80 degrees F) and 53%, respectively. A significantly higher proportion of infected pigs was detected in the non-vaccinated than in the vaccinated group. Lower levels of nasal virus shedding were found in vaccinated groups compared to non-vaccinated group and IAV was not detected in air samples of any of the vaccinated groups. In contrast, positive air samples were detected in the non-vaccinated group at 1, 2 and 3 days post infection although the overall levels were considered low most likely due to the elevated environmental temperature. In conclusion, both the decrease in shedding and the increase in environmental temperature may have contributed to the inability to detect airborne IAV in vaccinated pigs.	[Neira, Victor] Univ Chile, Fac Ciencias Vet & Pecuarias, Dept Med Prevent, Santiago, Chile; [Neira, Victor; Allerson, Matt; Corzo, Cesar; Culhane, Marie; Rendahl, Aaron; Torremorell, Montserrat] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	Universidad de Chile; University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA.	torr0033@umn.edu	Culhane, Marie/H-3143-2019; Ramirez, Victor Manuel Neira/M-8736-2013	Ramirez, Victor Manuel Neira/0000-0001-9062-9969; Rendahl, Aaron/0000-0001-5434-3592; Culhane, Marie/0000-0002-3547-7576	National Pork Board [11-038]	National Pork Board	This work has been supported by the National Pork Board (Grant no. # 11-038) to Montserrat Torremorell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerson MW, 2014, TRANSBOUND EMERG DIS, V61, P490, DOI 10.1111/tbed.12053; Allerson M, 2013, VACCINE, V31, P500, DOI 10.1016/j.vaccine.2012.11.023; Anderson TK, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00275-16; Anderson TK, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12193; Brockmeier SL, 2002, POLYMICROBIAL DISEASES, P231; Ciacci-Zanella JR, 2010, J VET DIAGN INVEST, V22, P3, DOI 10.1177/104063871002200102; Corzo CA, 2014, TRANSBOUND EMERG DIS, V61, P28, DOI 10.1111/j.1865-1682.2012.01367.x; Corzo CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071444; Corzo CA, 2013, VET J, V196, P171, DOI 10.1016/j.tvjl.2012.09.024; Corzo CA, 2013, EMERG INFECT DIS, V19, P954, DOI 10.3201/eid1906.121637; Corzo CA, 2012, J SWINE HEALTH PROD, V20, P283; Corzo CA, 2012, AVIAN DIS, V56, P488, DOI 10.1637/10037-121211-Reg.1; Direksin K, 2002, J VET DIAGN INVEST, V14, P169, DOI 10.1177/104063870201400215; Ducatez MF, 2011, MULTIPLE REASSORTMEN, V17, P1; Feng ZX, 2013, J VIROL, V87, P7655, DOI 10.1128/JVI.00804-13; Kitikoon P, 2013, INFLUENZA OTHER RESP, V7, P32, DOI 10.1111/irv.12189; Kyriakis CS, 2010, VET MICROBIOL, V144, P67, DOI 10.1016/j.vetmic.2009.12.039; Laskowski M, 2013, PREV MED, V57, P910, DOI 10.1016/j.ypmed.2013.04.011; Lee JH, 2007, CAN J VET RES, V71, P207; Lewis NS, 2016, ELIFE, V5, DOI 10.7554/eLife.12217; Loeffen WLA, 2011, VET MICROBIOL, V152, P304, DOI 10.1016/j.vetmic.2011.05.027; Loving CL, 2013, J VIROL, V87, P9895, DOI 10.1128/JVI.01038-13; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; Ma W, 2008, J MOL GENET MED J MO, V3, DOI [10.4172/1747-0862, DOI 10.4172/1747-0862]; Maes D, 2000, VET RES, V31, P313, DOI 10.1051/vetres:2000122; Mena I, 2016, ELIFE, V5, DOI 10.7554/eLife.16777; Neira V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146616; Pardo FOC, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00167; Poljak Z, 2008, CAN J VET RES, V72, P7; Reeth VK, 2012, DIS SWINE, V10th, P557; Romagosa A, 2012, INFLUENZA OTHER RESP, V6, P110, DOI 10.1111/j.1750-2659.2011.00276.x; Romagosa A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-120; Skowronski DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054015; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Van Reeth K, 2001, VACCINE, V19, P4479, DOI 10.1016/S0264-410X(01)00206-7; Van Reeth K, 2013, CURR TOP MICROBIOL, V370, P173, DOI 10.1007/82_2012_266; Vincent A, 2014, ZOONOSES PUBLIC HLTH, V61, P4, DOI 10.1111/zph.12049	41	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197600	10.1371/journal.pone.0197600	http://dx.doi.org/10.1371/journal.pone.0197600			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782527	Green Submitted, gold, Green Published			2022-12-26	WOS:000432537100034
J	Zhao, JJ; Okamoto, Y; Asano, Y; Ishimaru, K; Aki, S; Yoshioka, K; Takuwa, N; Wada, T; Inagaki, Y; Takahashi, C; Nishiuchi, T; Takuwa, Y				Zhao, Juanjuan; Okamoto, Yasuo; Asano, Yuya; Ishimaru, Kazuhiro; Aki, Sho; Yoshioka, Kazuaki; Takuwa, Noriko; Wada, Takashi; Inagaki, Yutaka; Takahashi, Chiaki; Nishiuchi, Takumi; Takuwa, Yoh			Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages	PLOS ONE			English	Article							ALTERNATIVELY ACTIVATED MACROPHAGES; INDUCED LUNG INJURY; MYOFIBROBLAST DIFFERENTIATION; FIBROTIC DISEASES; TISSUE-REPAIR; MICE; ANGIOGENESIS; PATHOGENESIS; FIBROBLASTS; MECHANISMS	Idiopathic pulmonary fibrosis is a devastating disease with poor prognosis. The pathogenic role of the lysophospholipid mediator sphingosine-1-phosphate and its receptor S1PR2 in lung fibrosis is unknown. We show here that genetic deletion of S1 pr2strikingly attenuated lung fibrosis induced by repeated injections of bleomycin in mice. We observed by using Slpr2(LacZ/+) mice that S1PR2 was expressed in alveolar macrophages, vascular endothelial cells and alveolar epithelial cells in the lung and that S1 PR2-expressing cells accumulated in the fibrotic legions. Bone marrow chimera experiments suggested that S1PR2 in bone marrow derived cells contributes to the development of lung fibrosis. Depletion of macrophages greatly attenuated lung fibrosis. Bleomycin administration stimulated the mRNA expression of the profibrotic cytokines IL-13 and IL-4 and the M2 markers including arginase 1, Fizz1/Retnia, Ccl17 and Ccl24 in cells collected from broncho-alveolar lavage fluids (BALF), and Slpr2deletion markedly diminished the stimulated expression of these genes. BALF cells from bleomycin administered wild-type mice showed a marked increase in phosphorylation of STAT6, a transcription factor which is activated downstream of IL-13, compared with saline administered wild-type mice. Interestingly, in bleomycin administered S1 pr(2-1-) mice, STAT6 phosphorylation in BALF cells was substantially diminished compared with wild-type mice. Finally, pharmacological S1PR2 blockade in S1pr2(+/+) mice alleviated bleomycin induced lung fibrosis. Thus, S1PR2 facilitates lung fibrosis through the mechanisms involving augmentation of IL-13 expression and its signaling in BALF cells, and represents a novel target for treating lung fibrosis.	[Zhao, Juanjuan; Okamoto, Yasuo; Asano, Yuya; Ishimaru, Kazuhiro; Aki, Sho; Yoshioka, Kazuaki; Takuwa, Noriko; Takuwa, Yoh] Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa, Japan; [Takuwa, Noriko] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Sch Med, Dept Nephrol & Lab Med, Kanazawa, Ishikawa, Japan; [Inagaki, Yutaka] Tokai Univ, Grad Sch Med, Ctr Matrix Biol & Med, Tokyo, Kanagawa, Japan; [Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Div Oncol & Mol Biol, Kanazawa, Ishikawa, Japan; [Nishiuchi, Takumi] Kanazawa Univ, Adv Sci Res Ctr, Div Funct Genom, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University; Tokai University; Kanazawa University; Kanazawa University	Takuwa, Y (corresponding author), Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa, Japan.	ytakuwa@med.kanazawa-u.ac.jp	Yoshioka, Kazuaki/G-1038-2013	Yoshioka, Kazuaki/0000-0002-8631-3846; Ishimaru, Kazuhiro/0000-0002-4706-316X; Nishiuchi, Takumi/0000-0001-9429-5396	Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science; JST	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST))	This work was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan, the Japan Society for the Promotion of Science, and grants for Core Research for Evolutional Science and Technology from JST.	Ballinger MN, 2015, J IMMUNOL, V194, P1894, DOI 10.4049/jimmunol.1402377; Baran CP, 2007, AM J RESP CRIT CARE, V176, P78, DOI 10.1164/rccm.200609-1279OC; Belperio JA, 2002, AM J RESP CELL MOL, V27, P419, DOI 10.1165/rcmb.2002-0009OC; Bohmer Frank-D, 2014, JAKSTAT, V3, pe28087, DOI 10.4161/jkst.28087; Cai Y, 2014, PLOS ONE, V9; Cui H, 2013, J ALLERGY CLIN IMMUN, V132, P1205, DOI 10.1016/j.jaci.2013.07.026; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Higashiyama R, 2009, GASTROENTEROLOGY, V137, P1459, DOI 10.1053/j.gastro.2009.07.006; Ikeda H, 2009, J LIPID RES, V50, P556, DOI 10.1194/jlr.M800496-JLR200; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Keller CD, 2007, AM J PATHOL, V170, P281, DOI 10.2353/ajpath.2007.060485; Kershaw NJ, 2013, BIOCHEM SOC T, V41, P1042, DOI 10.1042/BST20130077; Kolodsick JE, 2004, J IMMUNOL, V172, P4068, DOI 10.4049/jimmunol.172.7.4068; Kono Y, 2007, AM J RESP CELL MOL, V37, P395, DOI 10.1165/rcmb.2007-0065OC; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Liu TJ, 2004, J IMMUNOL, V173, P3425, DOI 10.4049/jimmunol.173.5.3425; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Milara J, 2012, THORAX, V67, P147, DOI 10.1136/thoraxjnl-2011-200026; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Murakami K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106792; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naganawa A, 2012, World Intellectual Property Organization Patent, Patent No. [WO2013047701, 2013047701]; Nie YJ, 2017, J IMMUNOL, V198, P4470, DOI 10.4049/jimmunol.1601503; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qi X, 2010, EUR J PHARMACOL, V634, P121, DOI 10.1016/j.ejphar.2010.02.038; Schwalm S, 2013, BBA-MOL CELL BIOL L, V1831, P239, DOI 10.1016/j.bbalip.2012.07.022; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Sobel K, 2013, J BIOL CHEM, V288, P14839, DOI 10.1074/jbc.M112.426726; Takuwa Y, 2013, BBA-MOL CELL BIOL L, V1831, P185, DOI 10.1016/j.bbalip.2012.06.008; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Tang YJ, 2014, AM J RESP CELL MOL, V51, P761, DOI 10.1165/rcmb.2013-0423OC; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Walford Hannah H, 2013, JAKSTAT, V2, pe25301, DOI 10.4161/jkst.25301; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907	49	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197604	10.1371/journal.pone.0197604	http://dx.doi.org/10.1371/journal.pone.0197604			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782549	Green Published, gold			2022-12-26	WOS:000432537100035
J	Kommerein, N; Doll, K; Stumpp, NS; Stiesch, M				Kommerein, Nadine; Doll, Katharina; Stumpp, Nico S.; Stiesch, Meike			Development and characterization of an oral multispecies biofilm implant flow chamber model	PLOS ONE			English	Article							MATERIALS IN-VITRO; BACTERIAL INTERACTIONS; DENTAL BIOFILM; PERI-IMPLANT; STREPTOCOCCI; COMMUNITIES; SALIVA; SITES; IDENTIFICATION; CIPROFLOXACIN	Peri-implant infections are the most common cause of implant failure in modern dental implantology. These are caused by the formation of biofilms on the implant surface and consist of oral commensal and pathogenic bacteria, which harm adjacent soft and hard tissues and may ultimately lead to implant loss. In order to improve the clinical situation, there has to be a better understanding of biofilm formation on abiotic surfaces. Therefore, we successfully developed a system to cultivate an oral multispecies biofilm model in a flow chamber system, optimized for the evaluation of biofilm formation on solid materials by direct microscopic investigation. The model contains four relevant oral bacterial species: Streptococcus oralis, Actinomyces naeslundii, Veillonella dispar and Porphyromonas gingivaiis in ratios similar to the native situation. The reliability of the developed "Hanoverian Oral Multispecies Biofilm Implant Flow Chamber" (HOBIC) model was verified. Biofilm volume and live/dead distribution within biofilms were determined by fluorescence staining and confocal laser scanning microcopy (CLSM). The individual species distribution was analyzed using quantitative real time PCR with propidium monoazide pretreatment (PMA-qRT-PCR) and by ureaNaCI fluorescence in situ hybridization (urea-NaCI-FISH). This in vitro model may be used to analyze biofilm formation on dental implants in more detail and to develop future implant systems with improved material properties.	[Kommerein, Nadine; Doll, Katharina; Stumpp, Nico S.; Stiesch, Meike] Hannover Med Sch, Clin Dent Prosthet & Biomed Mat Sci, Hannover, Germany	Hannover Medical School	Kommerein, N; Doll, K (corresponding author), Hannover Med Sch, Clin Dent Prosthet & Biomed Mat Sci, Hannover, Germany.	kommerein.nadine@mh-hannover.de; doll.Katharina@mh-hannover.de	Kommerein, Nadine/AAT-5392-2020	Kommerein, Nadine/0000-0001-5978-2965	Ministry of Lower Saxony [BIOFABRICATION FOR NIFE: VVVZN2860]; Volkswagen Stiftung [BIOFABRICATION FOR NIFE: VVVZN2860]	Ministry of Lower Saxony; Volkswagen Stiftung(Volkswagen)	The BIOFABRICATION FOR NIFE Initiative is financially supported by the Ministry of Lower Saxony and the Volkswagen Stiftung (both BIOFABRICATION FOR NIFE: VVVZN2860).	Alvarez G, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-1; Ammann TW, 2013, J PERIODONTAL RES, V48, P517, DOI 10.1111/jre.12034; Ammann TW, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-227; Astasov-Frauenhoffer M, 2014, J PERIODONTOL, V85, P349, DOI 10.1902/jop.2013.120733; Astasov-Frauenhoffer M, 2012, FEMS MICROBIOL LETT, V337, P31, DOI 10.1111/1574-6968.12007; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Blanc V, 2014, J PERIODONTAL RES, V49, P323, DOI 10.1111/jre.12110; Casado PL, 2011, IMPLANT DENT, V20, P226, DOI 10.1097/ID.0b013e3182199348; Chin MYH, 2006, EUR J ORTHODONT, V28, P1, DOI 10.1093/ejo/cji094; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cuadra-Saenz G, 2012, MICROBIOL-SGM, V158, P1783, DOI 10.1099/mic.0.057182-0; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Diaz PI, 2012, INFECT IMMUN, V80, P620, DOI 10.1128/IAI.05896-11; Dixon DR, 2004, J PERIODONTOL, V75, P1486, DOI 10.1902/jop.2004.75.11.1486; Doll K, 2016, J MICROBIOL METH, V130, P61, DOI 10.1016/j.mimet.2016.07.016; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Farkas R., 2005, STUDIE SITUATION MED; Foster JS, 2004, APPL ENVIRON MICROB, V70, P4340, DOI 10.1128/AEM.70.7.4340-4348.2004; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Hauser-Gerspach I, 2007, DENT MATER J, V26, P361, DOI 10.4012/dmj.26.361; Huang RJ, 2011, VIRULENCE, V2, P435, DOI 10.4161/viru.2.5.16140; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; IData Research Inc, 2017, EUROPE MARKET REPORT; Kolenbrander PE, 2006, PERIODONTOL 2000, V42, P47, DOI 10.1111/j.1600-0757.2006.00187.x; Kolenbrander PE, 2011, INT J ORAL SCI, V3, P49, DOI 10.4248/IJOS11025; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Kommerein N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173973; Lawson TS, 2012, LETT APPL MICROBIOL, V54, P263, DOI 10.1111/j.1472-765X.2011.03197.x; Li J, 2004, J APPL MICROBIOL, V97, P1311, DOI 10.1111/j.1365-2672.2004.02420.x; Meier R, 2008, J MATER SCI-MATER M, V19, P3249, DOI 10.1007/s10856-008-3457-7; Mombelli A, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2012.02541.x; Moran F J, 1998, Rev Esp Quimioter, V11, P52; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; NYVAD B, 1987, SCAND J DENT RES, V95, P369; Palmer RJ, 2014, PERIODONTOL 2000, V64, P20, DOI 10.1111/j.1600-0757.2012.00453.x; Paramonova E, 2009, J DENT RES, V88, P922, DOI 10.1177/0022034509344569; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Persson GR, 2014, CLIN IMPLANT DENT R, V16, P783, DOI 10.1111/cid.12052; Rath H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172095; RODGERS J, 1994, FEMS IMMUNOL MED MIC, V9, P109, DOI 10.1016/0928-8244(94)90063-9; Roehling S, 2017, J PERIODONTOL, V88, P298, DOI 10.1902/jop.2016.160245; Sanchez MC, 2011, J PERIODONTAL RES, V46, P252, DOI 10.1111/j.1600-0765.2010.01341.x; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schaumann S, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-157; Schlafer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041534; Schmidt JC, 2017, CLIN ORAL INVEST, V21, P1565, DOI 10.1007/s00784-016-1969-y; Socransky SS, 2002, J CLIN PERIODONTOL, V29, P260, DOI 10.1034/j.1600-051x.2002.290313.x; Sternberg C, 1999, APPL ENVIRON MICROB, V65, P4108; SUCI PA, 1994, ANTIMICROB AGENTS CH, V38, P2125, DOI 10.1128/AAC.38.9.2125; Tabanella G, 2009, CLIN IMPLANT DENT R, V11, P24, DOI 10.1111/j.1708-8208.2008.00088.x; Vrany JD, 1997, ANTIMICROB AGENTS CH, V41, P1352, DOI 10.1128/AAC.41.6.1352; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhao B, 2014, DENT MATER, V30, P716, DOI 10.1016/j.dental.2014.04.001; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x	59	29	29	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196967	10.1371/journal.pone.0196967	http://dx.doi.org/10.1371/journal.pone.0196967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771975	Green Submitted, gold, Green Published			2022-12-26	WOS:000432348900025
J	Kou, L; Zhang, LG; Zhang, KJ; Sun, JG; Han, QL; Jin, ZL				Kou, Liang; Zhang, Liguo; Zhang, Kejia; Sun, Jianguo; Han, Qilong; Jin, Zilong			A multi-focus image fusion method via region mosaic on Laplacian pyramids	PLOS ONE			English	Article							SHAPE	In this paper, a method named Region Mosaicking on Laplacian Pyramids (RMLP) is proposed to fuse multi-focus images that is captured by microscope. First, the Sum-ModifiedLaplacian is applied to measure the focus of multi-focus images. Then the density-based region growing algorithm is utilized to segment the focused region mask of each image. Finally, the mask is decomposed into a mask pyramid to supervise region mosaicking on a Laplacian pyramid. The region level pyramid keeps more original information than the pixel level. The experiment results show that RMLP has best performance in quantitative comparison with other methods. In addition, RMLP is insensitive to noise and can reduces the color distortion of the fused images on two datasets.	[Kou, Liang; Zhang, Liguo; Zhang, Kejia; Sun, Jianguo; Han, Qilong] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China; [Jin, Zilong] Nanjing Univ Informat Sci & Technol, Sch Comp & Software, Nanjing 210044, Jiangsu, Peoples R China	Harbin Engineering University; Nanjing University of Information Science & Technology	Zhang, LG (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin 150001, Heilongjiang, Peoples R China.	zhangliguo@hrbeu.edu.cn	zhang, ke/AAH-8217-2019	Zhang, Kejia/0000-0002-6204-3044	National Science Foundation of China [61501132, 61370084]; China Postdoctoral Science Foundation [2016M591515]; Heilongjiang Postdoctoral Sustentation Fund [LBH-Z14055]; Harbin Application Technology Research and Development Project [2016RAQXJ063, 2016RAXXJ013]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Sustentation Fund; Harbin Application Technology Research and Development Project	This work is supported by the National Science Foundation of China (Grant No. 61501132, Grant No. 61370084), the China Postdoctoral Science Foundation No. 2016M591515, the Heilongjiang Postdoctoral Sustentation Fund with No. LBH-Z14055, and Harbin Application Technology Research and Development Project (Grant No. 2016RAQXJ063, Grant No. 2016RAXXJ013).; This work is supported by the National Science Foundation of China (Grant No. 61501132, Grant No. 61370084), the China Postdoctoral Science Foundation No. 2016M591515, the Heilongjiang Postdoctoral Sustentation Fund with No. LBH-Z14055, Harbin Application Technology Research and Development Project (Grant No. 2016RAQXJ063, Grant No. 2016RAXXJ013).	Agarwala A, 2004, ACM T GRAPHIC, V23, P294, DOI 10.1145/1015706.1015718; Bai XZ, 2015, INFORM FUSION, V22, P105, DOI 10.1016/j.inffus.2014.05.003; Chabi N, 2014, MACHINE VISION IMAGE, P403; Chen Y, 2015, CHEM ENG SCI, V132, P1, DOI 10.1016/j.ces.2015.04.006; Dogan H., 2016, INT C EL EL ENG, P253; Dong YB, 2014, APPL MECH MATER, V525, P711, DOI 10.4028/www.scientific.net/AMM.525.711; Eckhorn R, 1990, NEURAL COMPUT, V2, P293, DOI 10.1162/neco.1990.2.3.293; Favaro P, 2008, IEEE T PATTERN ANAL, V30, P518, DOI 10.1109/TPAMI.2007.1175; Gayathri N, 2016, INT CONF COMMUN SYST, P173, DOI 10.1109/CSN.2016.7824009; Goshtasby AA, 2007, INFORM FUSION, V8, P114, DOI 10.1016/j.inffus.2006.04.001; Hariharan H, 2007, IEEE C COMP VIS PATT, V124, P1; Hariharan R, 2012, IEEE T IMAGE PROCESS, V21, P3323, DOI 10.1109/TIP.2012.2190612; Hu Y, 2016, IEEE T INF FOREN SEC, V11, P1549, DOI 10.1109/TIFS.2016.2541612; Huang W, 1990, NEURAL COMPUT, V2, P293; Jing HY, 2014, NASA ESA CONF, P135, DOI 10.1109/AHS.2014.6880169; Johnson JL, 1999, IEEE T NEURAL NETWOR, V10, P480, DOI 10.1109/72.761706; Kausar N, 2016, ENG APPL ARTIF INTEL, V55, P339, DOI 10.1016/j.engappai.2016.08.006; Kubota A, 2005, IEEE T IMAGE PROCESS, V14, P1848, DOI 10.1109/TIP.2005.854468; Lewis JJ, 2007, INFORM FUSION, V8, P119, DOI 10.1016/j.inffus.2005.09.006; Li H, MULTIFOCUS IMAGE FUS; Li Junhua, 2014, Biomed Res Int, V2014, P708364, DOI 10.1155/2014/708364; Li ST, 2017, INFORM FUSION, V33, P100, DOI 10.1016/j.inffus.2016.05.004; Ma ZL, 2016, NEUROCOMPUTING, V173, P1257, DOI 10.1016/j.neucom.2015.08.084; NAYAR SK, 1994, IEEE T PATTERN ANAL, V16, P824, DOI 10.1109/34.308479; Pajares G, 2004, PATTERN RECOGN, V37, P1855, DOI 10.1016/j.patcog.2004.03.010; Petrovic VS, 2004, IEEE T IMAGE PROCESS, V13, P228, DOI [10.1109/TIP.2004.823821, 10.1109/tip.2004.823821]; Pradnya PM, 2013, 2013 INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS AND SIGNAL PROCESSING (ISSP), P77, DOI 10.1109/ISSP.2013.6526878; Rockinger O, 1997, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL III, P288, DOI 10.1109/ICIP.1997.632093; Saha A, 2013, DIGIT SIGNAL PROCESS, V23, P1121, DOI 10.1016/j.dsp.2013.03.001; Shang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04184; Srivastava R, 2015, INT C CONT COMP, P497; Tian J, 2010, IEEE IMAGE PROC, P1205, DOI 10.1109/ICIP.2010.5651791; TOET A, 1989, PATTERN RECOGN LETT, V9, P245, DOI 10.1016/0167-8655(89)90003-2; Tsai DC, 2012, IEEE T IMAGE PROCESS, V21, P459, DOI 10.1109/TIP.2011.2164417; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang ZB, 2010, PATTERN RECOGN, V43, P2003, DOI 10.1016/j.patcog.2010.01.011; Wencheng Wang, 2011, Journal of Computers, V6, P2559, DOI 10.4304/jcp.6.12.2559-2566; Yang B, 2010, IEEE T INSTRUM MEAS, V59, P884, DOI 10.1109/TIM.2009.2026612; Yang H, 2016, J SIGNAL PROCESSING; Yang HF, 2015, INT CONF SOFTW ENG, P330, DOI 10.1109/ICSESS.2015.7339067; Yang Y, 2015, IEEE SENS J, V15, P2824, DOI 10.1109/JSEN.2014.2380153; Yin HP, 2016, NEUROCOMPUTING, V216, P216, DOI 10.1016/j.neucom.2016.07.039; Zhang YJ, 2009, DIGIT SIGNAL PROCESS, V19, P186, DOI 10.1016/j.dsp.2008.11.002; Zheng YH, 2015, J INTELL FUZZY SYST, V28, P961, DOI 10.3233/IFS-141378; Zhou Z, 2014, INFORM FUSION, V20, P60, DOI 10.1016/j.inffus.2013.11.005; Zhuo SJ, 2011, PATTERN RECOGN, V44, P1852, DOI 10.1016/j.patcog.2011.03.009	46	20	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0191085	10.1371/journal.pone.0191085	http://dx.doi.org/10.1371/journal.pone.0191085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771912	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900001
J	Lee, J; Echigoya, Y; Duddy, W; Saito, T; Aoki, Y; Takeda, S; Yokota, T				Lee, Joshua; Echigoya, Yusuke; Duddy, William; Saito, Takashi; Aoki, Yoshitsugu; Takeda, Shin'ichi; Yokota, Toshifumi			Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblasts	PLOS ONE			English	Article							DUCHENNE-MUSCULAR-DYSTROPHY; MUSCLE BIOPSY; MDX52 MICE; EXPRESSION; MORPHOLINO; ETEPLIRSEN; RESTORATION; DELETION; VIRUS; CELLS	Antisense-mediated exon skipping has made significant progress as a therapeutic platform in recent years, especially in the case of Duchenne muscular dystrophy (DMD). Despite FDA approval of eteplirsen-the first-ever antisense drug clinically marketed for DMD-exon skipping therapy still faces the significant hurdles of limited applicability and unknown truncated protein function. In-frame exon skipping of dystrophin exons 45-55 represents a significant approach to treating DMD, as a large proportion of patients harbor mutations within this "hotspot" region. Additionally, patients harboring dystrophin exons 45-55 deletion mutations are reported to have exceptionally mild to asymptomatic phenotypes. Here, we demonstrate that a cocktail of phosphorodiamidate morpholino oligomers can effectively skip dystrophin exons 45-55 in vitro in myotubes transdifferentiated from DMD patient fibroblast cells. This is the first report of substantive exons 45-55 skipping in DMD patient cells. These findings help validate the use of transdifferentiated patient fibroblast cells as a suitable cell model for dystrophin exon skipping assays and further emphasize the feasibility of dystrophin exons 45-55 skipping in patients.	[Lee, Joshua; Yokota, Toshifumi] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada; [Echigoya, Yusuke] Nihon Univ, Dept Vet Med, Fujisawa, Kanagawa, Japan; [Duddy, William] Ulster Univ, Northern Ireland Ctr Stratified Med, Altnagelvin Hosp Campus, Coleraine, Londonderry, North Ireland; [Saito, Takashi; Aoki, Yoshitsugu; Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo, Japan; [Yokota, Toshifumi] Friends Garrett Cumming Res & Muscular Dystrophy, Edmonton, AB, Canada	University of Alberta; Nihon University; Ulster University; National Center for Neurology & Psychiatry - Japan	Yokota, T (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada.; Yokota, T (corresponding author), Friends Garrett Cumming Res & Muscular Dystrophy, Edmonton, AB, Canada.	toshifumi@ualberta.ca	Duddy, William/S-9773-2019	Duddy, William/0000-0003-2239-9094; Aoki, MD, PhD, Yoshitsugu/0000-0002-9038-7506; Echigoya, Yusuke/0000-0003-1573-4819; Yokota, Toshifumi/0000-0001-7316-3546; , toshifumi/0000-0001-6672-6742	University of Alberta Faculty of Medicine and Dentistry; Friends of Garrett Cumming Research Chair Fund; HM Toupin Neurological Science Research Chair Fund; Muscular Dystrophy Canada; Canada Foundation for Innovation (CFI); Alberta Advanced Education and Technology (AET); Canadian Institutes of Health Research (CIHR); Jesse's Journey - The Foundation for Gene and Cell Therapy; Women and Children's Health Research Institute (WCHRI); Alberta Innovates Health Solutions (AIHS)	University of Alberta Faculty of Medicine and Dentistry(University of Alberta); Friends of Garrett Cumming Research Chair Fund; HM Toupin Neurological Science Research Chair Fund; Muscular Dystrophy Canada(Muscular Dystrophy Association); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Alberta Advanced Education and Technology (AET); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Jesse's Journey - The Foundation for Gene and Cell Therapy; Women and Children's Health Research Institute (WCHRI); Alberta Innovates Health Solutions (AIHS)	This work was supported by University of Alberta Faculty of Medicine and Dentistry, The Friends of Garrett Cumming Research Chair Fund, HM Toupin Neurological Science Research Chair Fund, Muscular Dystrophy Canada, Canada Foundation for Innovation (CFI), Alberta Advanced Education and Technology (AET), Canadian Institutes of Health Research (CIHR), Jesse's Journey - The Foundation for Gene and Cell Therapy, the Women and Children's Health Research Institute (WCHRI), and Alberta Innovates Health Solutions (AIHS).	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2017, NUCLEIC ACID THER, V27, P1, DOI 10.1089/nat.2016.0657; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Aoki Y, 2012, P NATL ACAD SCI USA, V109, P13763, DOI 10.1073/pnas.1204638109; Aslesh T, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010001; Beroud C, 2007, HUM MUTAT, V28, P196, DOI 10.1002/humu.20428; Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010; Duchenne, 1867, Br Med J, V2, P541; Echigoya Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120058; Echigoya Y, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2014.76; Flanigan KM, 2014, NEUROL CLIN, V32, P671, DOI 10.1016/j.ncl.2014.05.002; Heald AE, 2014, ANTIMICROB AGENTS CH, V58, P6639, DOI 10.1128/AAC.03442-14; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2011, AM J PATHOL, V179, P12, DOI 10.1016/j.ajpath.2011.03.050; Joyce NC, 2012, PHYS MED REH CLIN N, V23, P609, DOI 10.1016/j.pmr.2012.06.006; KOENIG M, 1989, AM J HUM GENET, V45, P498; Lee JJA, 2013, J PERS MED, V3, P144, DOI 10.3390/jpm3030144; Lim KRQ, 2017, DRUG DES DEV THER, V11, P533, DOI 10.2147/DDDT.S97635; Magri F, 2011, J NEUROL, V258, P1610, DOI 10.1007/s00415-011-5979-z; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Miller Colton M, 2016, RNA Dis, V3, DOI 10.14800/rd.1393; Moulton HM, 2010, BBA-BIOMEMBRANES, V1798, P2296, DOI 10.1016/j.bbamem.2010.02.012; Muntoni F, 2001, NEUROLOGY, V57, P574, DOI 10.1212/WNL.57.4.574; Nakamura A, 2017, J HUM GENET, V62, P459, DOI 10.1038/jhg.2016.152; Nakamura A, 2008, J CLIN NEUROSCI, V15, P757, DOI 10.1016/j.jocn.2006.12.012; Nakamura H, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-60; Niks EH, 2017, EXPERT OPIN BIOL TH, V17, P225, DOI 10.1080/14712598.2017.1271872; Paasuke R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8296150; Saito T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012239; Sazani P, 2011, INT J TOXICOL, V30, P313, DOI 10.1177/1091581811403505; Shen XL, 2018, NUCLEIC ACIDS RES, V46, P1584, DOI 10.1093/nar/gkx1239; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; van Vliet L, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-105; Wu B, 2010, GENE THER, V17, P132, DOI 10.1038/gt.2009.120; Wu B, 2011, MOL THER, V19, P576, DOI 10.1038/mt.2010.288; Yokota T, 2007, Acta Myol, V26, P179; Yokota T, 2012, NUCLEIC ACID THER, V22, P306, DOI 10.1089/nat.2012.0368; Yokota T, 2009, ARCH NEUROL-CHICAGO, V66, P32, DOI 10.1001/archneurol.2008.540	41	16	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197084	10.1371/journal.pone.0197084	http://dx.doi.org/10.1371/journal.pone.0197084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771942	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900028
J	Wang, SS; Zhang, Y; Xu, Q; Yuan, XY; Dai, WC; Shen, XK; Wang, ZX; Chang, GB; Wang, ZQ; Chen, GH				Wang, Shasha; Zhang, Yang; Xu, Qi; Yuan, Xiaoya; Dai, Wangcheng; Shen, Xiaokun; Wang, Zhixiu; Chang, Guobin; Wang, Zhiquan; Chen, Guohong			The differentiation of preadipocytes and gene expression related to adipogenesis in ducks (Anas platyrhynchos)	PLOS ONE			English	Article							ACID-BINDING PROTEIN; ADIPOCYTE DIFFERENTIATION; ADIPOSE-TISSUE; PPAR-GAMMA; TRANSCRIPTIONAL REGULATION; STROMAL CELLS; FAT; METABOLISM; REGULATOR; CULTURE	Meat quality is closely related to adipose tissues in ducks, and adipogenesis is controlled by a complex network of transcription factors tightly acting at different stages of differentiation especially in ducks. The aim of this study was to establish the preadipocyte in vitro culture system and understand the biological characteristics of expansion of duck adipocyte tissue at the cellular and molecular level. We isolated pre-adipocytes from the subcutaneous fat of three breeds of duck and differentiated them into mature adipocytes using a mixture of insulin, rosiglitazone, dexamethasone, 3-isobutyl-1-methylxanthine, and oleic acid over 0,2, 4, 6, and 8 days. Successful differentiation was confirmed from the development of lipid droplets and their response to Oil Red O, and increasing numbers of lipid droplets were stained red over time. The expression of key marker genes, including peroxisome proliferator activated receptor gamma (PPAR gamma), CCAT/enhancer binding protein-alpha (C/EBP alpha), adipocyte fatty acid binding protein 4 (FABP4), and fatty acid synthetase (FAS), gradually increased during pre-adipocyte differentiation. Furthermore, it was verified by interference experiments that the knockdown of PPAR gamma directly reduced lipid production. Meanwhile we analyzed the role of unsaturated fatty acids in the production of poultry fat using different concentrations of oleic acid and found that lipid droplet deposition was highest when the concentration of oleic acid was 300 mu M. We also compared the level of differentiated preadipocytes that were isolated from Jianchang ducks (fatty-meat duck), Cherry Valley ducks (lean-meat duck) and White-crested ducks (egg-producing duck). The proliferation and differentiation rate of pre-adipocytes derived from Jianchang ducks was higher than that of White-crested ducks. These results provide the foundation for further research into waterfowl adipogenesis.	[Wang, Shasha; Zhang, Yang; Xu, Qi; Yuan, Xiaoya; Wang, Zhixiu; Chang, Guobin; Chen, Guohong] Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Jiangsu, Peoples R China; [Dai, Wangcheng; Shen, Xiaokun] Waterfowl Inst Zhenjiang City, Dantu, Peoples R China; [Wang, Zhiquan] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada	Yangzhou University; University of Alberta	Chen, GH (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding & Mol Design Jiangs, Yangzhou, Jiangsu, Peoples R China.	ghchen@yzu.edu.cn	XU, Qi/AID-2262-2022	Wang, Shasha/0000-0002-2136-6576	National Natural Science Foundation of China [31601931]; Jiangsu Natural Science Foundation [BK20150439]; Jiangsu University Natural Foundation [16KJB230002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu University Natural Foundation	This research work was supported by the National Natural Science Foundation of China (no. 31601931); Jiangsu Natural Science Foundation (no. BK20150439); and Jiangsu University Natural Foundation (no. 16KJB230002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng BH, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160049; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Ding F, 2015, CYTOTECHNOLOGY, V67, P773, DOI 10.1007/s10616-014-9715-2; Ding F, 2014, ELECTRON J BIOTECHN, V17, P251, DOI 10.1016/j.ejbt.2014.08.001; Ding ST, 2000, J ANIM SCI, V78, P2127; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; He J, 2012, POULTRY SCI, V91, P2270, DOI 10.3382/ps.2012-02149; He YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070135; JENSEN CH, 1993, HUM REPROD, V8, P635, DOI 10.1093/oxfordjournals.humrep.a138110; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807; Matsubara Y, 2005, COMP BIOCHEM PHYS A, V141, P108, DOI 10.1016/j.cbpb.2005.04.013; McGown C, 2014, CLIN LIVER DIS, V18, P41, DOI 10.1016/j.cld.2013.09.012; Mitterberger MC, 2012, STEM CELL RES, V9, P35, DOI 10.1016/j.scr.2012.04.001; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Shi H, 2010, COMP BIOCHEM PHYS B, V157, P357, DOI 10.1016/j.cbpb.2010.08.005; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang F, 2011, MOL CELL BIOCHEM, V353, P267, DOI 10.1007/s11010-011-0795-4; Wang WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117843; Wang Y, 2008, POULTRY SCI, V87, P226, DOI 10.3382/ps.2007-00329; Yamada T, 2009, MEAT SCI, V81, P86, DOI 10.1016/j.meatsci.2008.06.022; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	29	11	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196371	10.1371/journal.pone.0196371	http://dx.doi.org/10.1371/journal.pone.0196371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771917	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900011
J	McCreesh, N; Andrianakis, I; Nsubuga, RN; Strong, M; Vernon, I; McKinley, TJ; Oakley, JE; Goldstein, M; Hayes, R; White, RG				McCreesh, Nicky; Andrianakis, Ioannis; Nsubuga, Rebecca N.; Strong, Mark; Vernon, Ian; McKinley, Trevelyan J.; Oakley, Jeremy E.; Goldstein, Michael; Hayes, Richard; White, Richard G.			Choice of time horizon critical in estimating costs and effects of changes to HIV programmes	PLOS ONE			English	Article							AFRICA; COHORT	Background Uganda changed its antiretroviral therapy guidelines in 2014, increasing the CD4 threshold for antiretroviral therapy initiation from 350 cells/mu l to 500 cells/mu l. We investigate what effect this change in policy is likely to have on HIV incidence, morbidity, and programme costs, and estimate the cost-effectiveness of the change over different time horizons. Methods We used a complex individual-based model of HIV transmission and antiretroviral therapy scale-up in Uganda. 100 model fits were generated by fitting the model to 51 demographic, sexual behaviour, and epidemiological calibration targets, varying 96 input parameters, using history matching with model emulation. An additional 19 cost and disability weight parameters were varied during the analysis of the model results. For each model fit, the model was run to 2030, with and without the change in threshold to 500 cells/mu l. Results The change in threshold led to a 9.7% (90% plausible range: 4.3%-15.0%) reduction in incidence in 2030, and averted 278,944 (118,452-502,790) DALYs, at a total cost of $28M (-$142M to +$195M). The cost per disability adjusted life year (DALY) averted fell over time, from $3238 (-$125 to +$29,969) in 2014 to $100 (-$499 to +$785) in 2030. The change in threshold was cost-effective (cost <3xUganda's per capita GDP per DALY averted) by 2018, and highly cost-effective (cost <Uganda's per capita GDP per DALY averted) by 2022, for more than 50% of parameter sets. Conclusions Model results suggest that the change in threshold is unlikely to have been cost-effective to date, but is likely to be highly cost-effective in Uganda by 2030. The time horizon needs to be chosen carefully when projecting intervention effects. Large amounts of uncertainty in our results demonstrates the need to comprehensively incorporate uncertainties in model parameterisation.	[McCreesh, Nicky; Andrianakis, Ioannis; Hayes, Richard; White, Richard G.] London Sch Hyg & Trop Med, London, England; [Nsubuga, Rebecca N.] MRC UVRI Res Unit AIDS, Entebbe, Uganda; [Strong, Mark; Oakley, Jeremy E.] Univ Sheffield, Sheffield, S Yorkshire, England; [Vernon, Ian; Goldstein, Michael] Univ Durham, Durham, England; [McKinley, Trevelyan J.] Exeter Univ, Exeter, Devon, England	University of London; London School of Hygiene & Tropical Medicine; University of Sheffield; Durham University; University of Exeter	McCreesh, N (corresponding author), London Sch Hyg & Trop Med, London, England.	Nicky.mccreesh@lshtm.ac.uk	White, Richard G/D-5407-2009; Strong, Mark/A-4638-2010	White, Richard G/0000-0003-4410-6635; Strong, Mark/0000-0003-1486-8233; McCreesh, Nicky/0000-0003-1409-8531; Hayes, Richard/0000-0002-1729-9892	Medical Research Council (UK) grant on Model Calibration [MR/J005088/1]; Medical Research Council (UK) [G0802414]; Bill and Melinda Gates Foundation [21675/ OPP1084276, 19790.01]; CDC/PEPFAR via the Aurum Institute [U2GPS0008111]; MRC Skills Development Fellowship [MR/N014693/1]; Biotechnology and Biological Sciences Research Council [BB/I012192/1]; Medical Research Council [K012126/1]; National Institute for Health Research Post Doctoral Research Fellowship [PDF-2012-05-258]; National Institute for Health Research (NIHR); BBSRC [BB/I012192/1] Funding Source: UKRI; MRC [G0601721, MR/J005088/1] Funding Source: UKRI	Medical Research Council (UK) grant on Model Calibration(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); CDC/PEPFAR via the Aurum Institute; MRC Skills Development Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Post Doctoral Research Fellowship; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council (UK) grant on Model Calibration (MR/J005088/1) to RGW. RGW is additionally funded by the Medical Research Council (UK) (G0802414), the Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium: Grants 21675/ OPP1084276 and Consortium to Respond Effectively to the AIDS/TB Epidemic 19790.01), and CDC/PEPFAR via the Aurum Institute (U2GPS0008111). NM is supported by an MRC Skills Development Fellowship (MR/N014693/1). TJM is supported by Biotechnology and Biological Sciences Research Council grant number BB/I012192/1. RH receives support from the Medical Research Council (K012126/1). MS is supported by a National Institute for Health Research Post Doctoral Research Fellowship (PDF-2012-05-258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This article presents independent research part funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Alistar SS, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-46; Andrianakis I, ANN APPL STAT; Andrianakis I, J UNCERTAINTY QUANTI; Andrianakis I, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003968; Asiki G, 2013, INT J EPIDEMIOL; Braithwaite RS, 2014, AIDS, V28, pS73, DOI 10.1097/QAD.0000000000000110; DeSA U, 2013, WORLD POP PROSP 2012; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Hontelez JAC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021919; Ishikawa N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090991; Kaleebu P, 2014, TROPICAL MED INT HLT; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; McCreesh N, 2017, BMC INFECT DIS, V17; McCreesh N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2664-6; McCreesh N, 2012, SEX TRANSM DIS, V39, P407, DOI 10.1097/OLQ.0b013e318254c84a; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; STD/AIDS Control Programme MoH, 2014, STAT ANT THER SERV U; STD/AIDS Control Programme MoH, 2010, STAT ANT THER SERV D; Uganda AIDS Commission, 2015, HIV AIDS UG COUNTR P; Uganda Ministry of Health, 2003, UG NAT ANT TREATM CA; Uganda Ministry of Health, 2013, ADD ANT TREATM GUID; Uganda Ministry of Health and ICF International, 2012, 2011 UG AIDS IND SUR; World Health Organisation, 2013, CONS GUID GEN HIV CA; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2002, SCAL ANT THER RES LT	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196480	10.1371/journal.pone.0196480	http://dx.doi.org/10.1371/journal.pone.0196480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768457	Green Accepted, gold, Green Published			2022-12-26	WOS:000432329200031
J	Motoyama, H; Kobayashi, A; Yokoyama, T; Shimizu, A; Sakai, H; Notake, T; Fukushima, K; Miyagawa, S				Motoyama, Hiroaki; Kobayashi, Akira; Yokoyama, Takahide; Shimizu, Akira; Sakai, Hiroshi; Notake, Tsuyoshi; Fukushima, Kentaro; Miyagawa, Shin-ichi			Treatment with specific soluble factors promotes the functional maturation of transcription factor-mediated, pancreatic transdifferentiated cells	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; GLUCAGON-LIKE PEPTIDE-1; BETA-CELLS; LIVER; GENERATION; DIFFERENTIATION; ENDODERM; PROGENITORS; HEPATOCYTES; HEPATECTOMY	Pancreatic lineage-specific transcription factors (TFs) display instructive roles in converting adult cells to endocrine pancreatic cells through a process known as transdifferentiation. However, little is known about potential factors capable of accelerating transdifferentiation following transduction to achieve the functional maturation of transdifferentiated cells. In this study, we demonstrated, using adult liver-derived progenitor cells, that soluble factors utilized in pancreatic differentiation protocols of pluripotent stem cells promote functional maturation of TFs-mediated transdifferentiated cells. Treatment with an N2 supplement in combination with three soluble factors (glucagon-like peptide-1 [GLP-1] receptor agonist, notch inhibitor, and transforming growth factor-beta [TGF-beta] inhibitor) enhanced liver-to-pancreas transdifferentiation based on the following findings: i) the incidence of c-peptide-positive cells increased by approximately 1.2-fold after the aforementioned treatment; ii) the cpeptide expression level in the treated cells increased by approximately 12-fold as compared with the level in the untreated cells; iii) the treated cells secreted insulin in a glucosedependent manner, whereas the untreated cells did not; and iv) transplantation of treatedtransdifferentiated cells into streptozotocin-induced immunodeficient diabetic mice led to the amelioration of hyperglycemia. These results suggest that treatment with specific soluble factors promotes the functional maturation of transdifferentiated cells. Our findings could facilitate the development of new modalities for cell-replacement therapy for patients with diabetes.	[Motoyama, Hiroaki; Kobayashi, Akira; Yokoyama, Takahide; Shimizu, Akira; Sakai, Hiroshi; Notake, Tsuyoshi; Fukushima, Kentaro; Miyagawa, Shin-ichi] Shinshu Univ, Dept Surg 1, Sch Med, Matsumoto, Nagano, Japan	Shinshu University	Motoyama, H (corresponding author), Shinshu Univ, Dept Surg 1, Sch Med, Matsumoto, Nagano, Japan.	motoyama@shinshu-u.ac.jp		Motoyama, Hiroaki/0000-0003-0882-2626	Japan Society for the Promotion of Science (Tokyo, Japan) [21390375, 22591516, 25462108]	Japan Society for the Promotion of Science (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by funding from Grant-in-Aid for Scientific Research to Shin-ichi Miyagawa (No.21390375, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-21390375/) and to Akira Kobayashi (No.22591516, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-22591516/) (No,25462108, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-25462108/) from the Japan Society for the Promotion of Science (Tokyo, Japan).	Akinci E, 2013, PLOS ONE, V8, DOI [10.1371/journatpone.0082424, DOI 10.1371/JOURNATPONE.0082424]; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Aviv V, 2009, J BIOL CHEM, V284, P33509, DOI 10.1074/jbc.M109.017608; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bai L, 2005, J ENDOCRINOL, V186, P343, DOI 10.1677/joe.1.06078; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cai J, 2010, J MOL CELL BIOL, V2, P50, DOI 10.1093/jmcb/mjp037; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Fukuda K, 2005, DEVELOPMENT, DOI [10.1111/j.1440-169X.2005.00815.x, DOI 10.1111/J.1440-169X.2005.00815.X]; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Hui HX, 2001, DIABETES, V50, P785, DOI 10.2337/diabetes.50.4.785; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kawasaki S, 2003, ANN SURG, V238, P84, DOI 10.1097/01.SLA.0000074984.83031.02; Kim S, 2007, LAB INVEST, V87, P702, DOI 10.1038/labinvest.3700561; Kobayashi A, 2010, BRIT J SURG, V97, P56, DOI 10.1002/bjs.6788; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Li WD, 2014, NAT BIOTECHNOL, V32, P1223, DOI 10.1038/nbt.3082; MAKUUCHI M, 1990, SURGERY, V107, P521; MATTHEWS DR, 1985, CLIN ENDOCRINOL, V23, P71, DOI 10.1111/j.1365-2265.1985.tb00185.x; Meivar-Levy I, 2015, BEST PRACT RES CL EN, V29, P873, DOI 10.1016/j.beem.2015.10.006; Motoyama H, 2009, BIOCHEM BIOPH RES CO, V385, P123, DOI 10.1016/j.bbrc.2009.04.146; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nostro MC, 2015, STEM CELL REP, V4, P591, DOI 10.1016/j.stemcr.2015.02.017; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Nostro MC, 2012, SEMIN CELL DEV BIOL, V23, P701, DOI 10.1016/j.semcdb.2012.06.010; Ogawa S, 2005, STEM CELLS, V23, P903, DOI 10.1634/stemcells.2004-0295; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pan FC, 2007, MECH DEVELOP, V124, P518, DOI 10.1016/j.mod.2007.06.003; Pandian GN, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-6; Park SR, 1999, BONE, V24, P549, DOI 10.1016/S8756-3282(99)00084-8; POITOUT V, 1995, DIABETES, V44, P306, DOI 10.2337/diabetes.44.3.306; RHODES CJ, 1994, DIABETES, V43, P511, DOI 10.2337/diabetes.43.4.511; Sakai H, 2010, BIOCHEM BIOPH RES CO, V403, P298, DOI 10.1016/j.bbrc.2010.11.021; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018; Spagnoli FM, 2008, DEVELOPMENT, V135, P451, DOI 10.1242/dev.008458; Tang DQ, 2006, LAB INVEST, V86, P83, DOI 10.1038/labinvest.3700368; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wiater E, 2012, MOL CELL ENDOCRINOL, V359, P23, DOI 10.1016/j.mce.2012.02.015; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	54	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197175	10.1371/journal.pone.0197175	http://dx.doi.org/10.1371/journal.pone.0197175			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768476	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200065
J	Shah, R; Kiriya, J; Shibanuma, A; Jimba, M				Shah, Richa; Kiriya, Junko; Shibanuma, Akira; Jimba, Masamine			Use of modern contraceptive methods and its association with QOL among Nepalese female migrants living in Japan	PLOS ONE			English	Article							UNINTENDED PREGNANCY; REPRODUCTIVE HEALTH; WOMEN; ABORTION; IMMIGRANTS; KNOWLEDGE; INFANT	Introduction Modern contraceptive use among migrants may be limited due to factors such as language barriers, socio-economic condition, and inadequate knowledge. Limited evidence is available on the factors associated with the use of modern contraceptive methods by migrants in Japan. Moreover, evidence remains scarce on the quality of life (QOL) of migrants in relation to contraceptive use. As the Nepalese migrant population in Japan is increasing, this study was conducted to address their sexual and reproductive health issues. Therefore, the objectives of this study were to examine the factors associated with the use of modern contraceptive methods and to explore the association between the use of modern contraceptive methods and QOL among married Nepalese female migrants in Japan. Methods This is a cross-sectional study conducted among 189 married Nepalese female migrants residing in five prefectures of Japan from August to October 2016. This study employed snowball sampling to recruit the migrants. Simple and multiple logistic analyses were used to examine the association between independent variables and the use of modern contraceptive methods. Similarly, multiple linear regression analysis was used to examine the association between the use of modern contraceptive methods and quality of life. Results Migrants who had higher knowledge of modern contraceptive methods were more likely to use them (Adjusted Odds Ratio [AOR] = 1.31; 95% Confidence Interval [CI]: 1.07, 1.60). The psychological domain scores were higher in those who used modern contraceptive methods (Coefficient [B] = 0.58; 95% CI: 0.05, 1.11). Conclusion This study highlights the importance of the knowledge of modern contraceptive methods to increase their use. Also, the use of modern contraceptive methods improves the psychological QOL domain scores of the migrants using them. These results suggest a need for sexual and reproductive health education for migrants, especially pertaining to modern contraceptive use.	[Shah, Richa; Kiriya, Junko; Shibanuma, Akira; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan	University of Tokyo	Shibanuma, A (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Tokyo, Japan.	shibanuma@m.u-tokyo.ac.jp	Shah, Richa/AAL-6051-2021; Shibanuma, Akira/C-7652-2016; Jimba, Masamine/AAF-5630-2020	Shah, Richa/0000-0002-3625-8228; Shibanuma, Akira/0000-0003-2058-1722; 	Asian Development Bank Japan Scholarship Program	Asian Development Bank Japan Scholarship Program	This study was supported by Asian Development Bank Japan Scholarship Program (http://www.adb.org/site/careers/japan-scholarship-program/main). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adanu RMK, 2009, INT J GYNECOL OBSTET, V106, P179, DOI 10.1016/j.ijgo.2009.03.036; Alvarez-Nieto C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0071-2; [Anonymous], 2015, TRENDS CONTR US WORL; Boerleider AW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-81; Caruso S, 2016, J ENDOCRINOL INVEST, V39, P923, DOI 10.1007/s40618-016-0460-6; Coleman PK, 2011, BRIT J PSYCHIAT, V199, P180, DOI 10.1192/bjp.bp.110.077230; Daher AM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-407; de Leon Siantz Mary Lou, 2013, Glob Adv Health Med, V2, P12, DOI 10.7453/gahmj.2013.065; DHITAL R, 2013, BMC WOMENS HEALTH, V13, DOI DOI 10.1186/14'72-68'74-13-22; Ghodsi Z, 2012, PROCD SOC BEHV, V46, P3031, DOI 10.1016/j.sbspro.2012.06.004; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Gissler M, 2009, ACTA OBSTET GYN SCAN, V88, P134, DOI 10.1080/00016340802603805; Grossman D, 2010, REPROD HEALTH MATTER, V18, P136, DOI 10.1016/S0968-8080(10)36534-7; IDRE, 2015, REGR STAT; Ip WY, 2011, J CLIN NURS, V20, P1685, DOI 10.1111/j.1365-2702.2010.03404.x; Jackson AV, 2017, SEMIN PERINATOL, V41, P273, DOI 10.1053/j.semperi.2017.04.003; Jacquemyn Y, 2012, CLIN EXP OBSTET GYN, V39, P181; Kessler K, 2010, FIELD ACTIONS SCI RE, P1; Keygnaert I, 2014, HEALTH POLICY, V114, P215, DOI 10.1016/j.healthpol.2013.10.007; Lindert J, 2009, SOC SCI MED, V69, P246, DOI 10.1016/j.socscimed.2009.04.032; Magalhaes L, 2010, J IMMIGR MINOR HEALT, V12, P132, DOI 10.1007/s10903-009-9280-5; Matsumoto Y, 2011, J OBSTET GYNAECOL RE, V37, P887, DOI 10.1111/j.1447-0756.2010.01461.x; Mengesha ZB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181421; Ministry of Health, 2016, NEPAL DEMOGRAPHIC HL; Ministry of Health and Population Government of Nepal., 2015, NEP HLTH SECT STRAT; Ministry of Health and Population New ERA ICF International Inc, 2012, NEP DEM HLTH SURV 20; Ministry of Health Labour and Welfare, 2007, ETHL GUID MED HLTH R; Ministry of Internal Affairs and Communication, 2016, JAP FIG; Murphy H, 2000, AUSTR WHOQOL INSTRUM; Ostrach B, 2013, J IMMIGR MINOR HEALT, V15, P262, DOI 10.1007/s10903-012-9680-9; Patel VV, 2012, J IMMIGR MINOR HEALT, V14, P767, DOI 10.1007/s10903-011-9555-5; Perez-Campos E, 2011, VALUE HEALTH, V14, P892, DOI 10.1016/j.jval.2011.08.1729; Rechel B., 2011, MIGRATION HLTH EUROP; Schwarz EB, 2008, CONTRACEPTION, V78, P204, DOI 10.1016/j.contraception.2008.04.120; Shaukat S, 2015, FWU J SOC SCI, V9, P101; Shrestha D R, 2012, J Nepal Health Res Counc, V10, P108; Southern DA, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-57; United Nations, 2015, TRENDS INT MIGR; United Nations, 2013, POP DYN REPR HLTH SU; Vangen S, 2008, BJOG-INT J OBSTET GY, V115, P1309, DOI 10.1111/j.1471-0528.2008.01832.x; World Health Organization, 2010, EQUI HLTH; World Health Organization, 2010, GEND WOM PRIM HLTH C; World Health Organization (WHO), 2009, MENTAL HLTH ASPECTS; Yadav S, 2010, QUAL LIFE RES, V19, P157, DOI 10.1007/s11136-009-9574-z; Yamanaka K, 2005, GLOBAL NETW, V5, P337, DOI 10.1111/j.1471-0374.2005.00123.x; Yoshitake N, 2016, QUAL LIFE RES, V25, P3147, DOI 10.1007/s11136-016-1352-0	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197243	10.1371/journal.pone.0197243	http://dx.doi.org/10.1371/journal.pone.0197243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF9WG	29768459	gold, Green Published, Green Submitted			2022-12-26	WOS:000432329200069
J	Pasteuning-Vuhman, S; Putker, K; Tanganyika-de Winter, CL; Boertje-van der Meulen, JW; van Vliet, L; Overzier, M; Plomp, JJ; Aartsma-Rus, A; van Putten, M				Pasteuning-Vuhman, S.; Putker, K.; Tanganyika-de Winter, C. L.; Boertje-van der Meulen, J. W.; van Vliet, L.; Overzier, M.; Plomp, J. J.; Aartsma-Rus, A.; van Putten, M.			Natural disease history of the dy(2J) mouse model of laminin alpha 2 (merosin)-deficient congenital muscular dystrophy	PLOS ONE			English	Article							MUSCLE ATROPHY; CHAIN; INHIBITION; EXPRESSION; MICE; FIBROSIS; MOTOR	Merosin deficient congenital muscular dystrophy 1A (MDC1A) is a very rare autosomal recessive disorder caused by mutations in the LAMA2 gene leading to severe and progressive muscle weakness and atrophy. Although over 350 causative mutations have been identified for MDC1A, no treatment is yet available. There are many therapeutic approaches in development, but the lack of natural history data of the mouse model and standardized outcome measures makes it difficult to transit these pre-clinical findings to clinical trials. Therefore, in the present study, we collected natural history data and assessed pre-clinical outcome measures for the dy(2J)/dy(2J) mouse model using standardized operating procedures available from the TREAT-NMD Alliance. Wild type and dy(2J)/dy(2J) mice were subjected to five different functional tests from the age of four to 32 weeks. Non-tested control groups were taken along to assess whether the functional test regime interfered with muscle pathology. Respiratory function, body weights and creatine kinase levels were recorded. Lastly, skeletal muscles were collected for further histopathological and gene expression analyses. Muscle function of dy(2J)/dy(2J) mice was severely impaired at four weeks of age and all mice lost the ability to use their hind limbs. Moreover, respiratory function was altered in dy(2J)/dy(2J) mice. Interestingly, the respiration rate was decreased and declined with age, whereas the respiration amplitude was increased in dy(2J)/dy(2J) mice when compared to wild type mice. Creatine kinase levels were comparable to wild type mice. Muscle histopathology and gene expression analysis revealed that there was a specific regional distribution pattern of muscle damage in dy(2J)/dy(2J) mice. Gastrocnemius appeared to be the most severely affected muscle with a high proportion of atrophic fibers, increased fibrosis and inflammation. By contrast, triceps was affected moderately and diaphragm only mildly. Our study presents a complete natural history dataset which can be used in setting up standardized studies in dy(2J)/dy(2J) mice.	[Pasteuning-Vuhman, S.; Putker, K.; Tanganyika-de Winter, C. L.; Boertje-van der Meulen, J. W.; van Vliet, L.; Overzier, M.; Aartsma-Rus, A.; van Putten, M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Plomp, J. J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Putten, M (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	M.van_Putten@lumc.n1		Aartsma-Rus, Annemieke/0000-0003-1565-654X; Overzier, Maurice/0000-0002-8143-4884; van Putten, Maaike/0000-0002-0683-8897	ZonMw [113302001]; NeurOmics (FP7) [2012-305121]; AFM [20251]	ZonMw(Netherlands Organization for Health Research and Development); NeurOmics (FP7); AFM(Association Francaise contre les Myopathies)	The work was supported by grants from ZonMw (project 113302001) and NeurOmics (FP7, grant agreement 2012-305121) and AFM (grant number 20251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2014, JOVE-J VIS EXP, DOI 10.3791/51303; Allamand V, 2002, EUR J HUM GENET, V10, P91, DOI 10.1038/sj.ejhg.5200743; Carmignac V, 2011, HUM MOL GENET, V20, P4891, DOI 10.1093/hmg/ddr427; Carter RJ, 1999, J NEUROSCI, V19, P3248; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Durbeej M, 2015, CURR TOP MEMBR, V76, P31, DOI 10.1016/bs.ctm.2015.05.002; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Elbaz M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.60; Festing Michael F W, 2002, ILAR J, V43, P244; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Morales MG, 2013, CELL TISSUE RES, V353, P173, DOI 10.1007/s00441-013-1642-6; Gawlik KI, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-9; Geranmayeh F, 2010, NEUROMUSCULAR DISORD, V20, P241, DOI 10.1016/j.nmd.2010.02.001; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Muntoni F, 2003, Neuromuscul Disord, V13, P579, DOI 10.1016/S0960-8966(03)00072-5; Nevo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018049; Nevo Y, 2010, MUSCLE NERVE, V42, P218, DOI 10.1002/mus.21706; Pasteuning-Vuhman S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182704; Rom O, 2016, FREE RADICAL BIO MED, V98, P218, DOI 10.1016/j.freeradbiomed.2015.12.031; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; van der Pijl EM, 2016, EUR J NEUROSCI, V43, P1623, DOI 10.1111/ejn.13249; van Putten M, 2010, NEUROMUSCULAR DISORD, V20, P273, DOI 10.1016/j.nmd.2010.02.004; Xiong H, 2015, CLIN GENET, V87, P233, DOI 10.1111/cge.12366; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Yu QF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078318, 10.1371/journal.pone.0059627]; Yuan L, 2015, ONCOL REP, V33, P2261, DOI 10.3892/or.2015.3845	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197388	10.1371/journal.pone.0197388	http://dx.doi.org/10.1371/journal.pone.0197388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763467	Green Submitted, Green Published, gold			2022-12-26	WOS:000432118800046
J	Sato, T; Hatano, M; Iwasaki, Y; Maki, H; Saito, A; Minatsuki, S; Inaba, T; Amiya, E; Fujio, K; Watanabe, M; Yamamoto, K; Komuro, I				Sato, Tatsuyuki; Hatano, Masaru; Iwasaki, Yukiko; Maki, Hisataka; Saito, Akihito; Minatsuki, Shun; Inaba, Toshiro; Amiya, Eisuke; Fujio, Keishi; Watanabe, Masafumi; Yamamoto, Kazuhiko; Komuro, Issei			Prevalence of primary Sjogren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension	PLOS ONE			English	Article							CONNECTIVE-TISSUE DISEASE; AMERICAN-COLLEGE; CLINICAL CHARACTERISTICS; CLASSIFICATION CRITERIA; ANTINUCLEAR ANTIBODIES; DIAGNOSIS; SURVIVAL; CONSENSUS	Background The prevalence of pulmonary arterial hypertension (PAH) in primary Sjogren's syndrome (SS) had been reported to be rare. However, recent studies using echocardiography as a screening method showed conflicting results, and the true prevalence is still unclear. Since diagnosing primary SS is difficult because of its heterogeneous nature, a number of patients with primary-SS-associated PAH may be misdiagnosed with idiopathic PAH, losing their chance to undergo immunosuppressive therapy. Therefore, we sought to elucidate the prevalence of primary SS among patients who initially present with PAH. Methods From our prospective institutional PAH database, 40 consecutive patients without any obvious cause of PAH at the time of PAH diagnosis were identified. We retrospectively evaluated the prevalence of primary SS diagnosed during or after the initial assessment of PAH. Results During the initial assessment, one patient was diagnosed with primary-SS-associated PAH. Among the 25 patients who were initially diagnosed with idiopathic PAH, five were diagnosed with primary SS during their course of the disease. Of the five patients, three had key signs suggesting primary SS and were probably underdiagnosed at the time of initial evaluation. The remaining two patients, who were finally diagnosed with primary SS, did not have any specific signs suggesting primary SS at the time of initial evaluation but showed positive conversion of their autoantibodies during the course of PAH. Conclusion The prevalence of primary-SS-associated PAH may be relatively high among patients who undergo initial evaluation for PAH. Furthermore, primary-SS-associated PAH may be underdiagnosed with routine evaluation for the primary cause of PAH. Clinicians should pay specific attention and carefully evaluate the possibility of primary SS in patients with PAH.	[Sato, Tatsuyuki; Maki, Hisataka; Saito, Akihito; Minatsuki, Shun; Inaba, Toshiro; Amiya, Eisuke; Watanabe, Masafumi; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Hatano, Masaru] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan; [Iwasaki, Yukiko; Fujio, Keishi; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Yamamoto, Kazuhiko] RIKEN Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo; RIKEN	Hatano, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo, Japan.	hatanoma@pg8.so-net.ne.jp	Sato, Tatsuyuki/V-8183-2019; Amiya, Eisuke/O-4981-2019	Sato, Tatsuyuki/0000-0002-9229-9016; Amiya, Eisuke/0000-0003-2810-8040	Chugai Pharmaceuticals; Bristol-Myers Squibb; AbbVie; Astellas; Mitsubishi-Tanabe; Eisai; Daiichi-Sankyo; Pfizer; Takeda; Ayumi; UCB; Janssen; Taisho Toyama; Aurinia; Eli-Lilly	Chugai Pharmaceuticals; Bristol-Myers Squibb(Bristol-Myers Squibb); AbbVie(AbbVie); Astellas(Astellas Pharmaceuticals); Mitsubishi-Tanabe(Mitsubishi Tanabe Pharma Corporation); Eisai(Eisai Co Ltd); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Ayumi; UCB(UCB Pharma SA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Taisho Toyama; Aurinia; Eli-Lilly(Eli Lilly)	The authors received no specific funding for this work. The authors would like to disclose the following: Masaru Hatano received endowment from Bayer, GlaxoSmithKline, and Nippon Shinyaku; and honoraria from Bayer, Pfizer, Actelion, and Nippon Shinyaku. Keishi Fujio may benefit from a patent belonging to Chugai Pharmaceuticals (B cell activation inhibitor, and therapeutic agent for autoimmune diseases: PCT/JP2015/065466). This does not alter our adherence to PLOS ONE policies on sharing data and materials. Keishi Fujio received research grants from Chugai Pharmaceuticals, Bristol-Myers Squibb, AbbVie, Astellas, Mitsubishi-Tanabe, Eisai, Daiichi-Sankyo, Pfizer, and Takeda; and received travel grants and honoraria from Chugai Pharmaceuticals, Bristol-Myers Squibb, Daiichi-Sankyo, Mitsubishi-Tanabe, Pfizer, Ayumi, Eisai, AbbVie, UCB, Janssen, Taisho Toyama, Aurinia, Astellas, Eli-Lilly, and Takeda. Masafumi Watanabe received endowment from Takeda. Kazuhiko Yamamoto received honoraria from AbbVie, Astellas Pharma, Ayumi Pharmaceutical, Bristol-Myers Squibb, Chugai Pharmaceutical, Eisai, Janssen Pharmaceutical, Mitsubishi Tanabe Pharma, Ono Pharmaceutical, Takeda Pharmaceutical, and UCB Japan.	Baronaite R, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/534759; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Bertoni M, 2005, CLIN RHEUMATOL, V24, P431, DOI 10.1007/s10067-004-1071-8; Brito-Zeron P, 2017, ANN RHEUM DIS, V76, P1042, DOI 10.1136/annrheumdis-2016-209952; Cavagna L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004827; Chung L, 2010, CHEST, V138, P1383, DOI 10.1378/chest.10-0260; Copple SS, 2011, AM J CLIN PATHOL, V135, P678, DOI 10.1309/AJCP6R8EELGODAYW; Dong-fang L, 2010, CHIN MED J, V123, P3252; Faria AC, 2005, J RHEUMATOL, V32, P1267; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Hao YJ, 2014, EUR RESPIR J, V44, P963, DOI 10.1183/09031936.00182813; HEDGPETH MT, 1988, ANN RHEUM DIS, V47, P251, DOI 10.1136/ard.47.3.251; Humbert M, 2007, EUR RESPIR J, V30, P338, DOI 10.1183/09031936.00138706; Kassan SS, 2004, ARCH INTERN MED, V164, P1275, DOI 10.1001/archinte.164.12.1275; Kobak S, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/710401; Kurumagawa T, 2005, RESPIROLOGY, V10, P86, DOI 10.1111/j.1440-1843.2005.00627.x; Launay D, 2007, MEDICINE, V86, P299, DOI 10.1097/MD.0b013e3181579781; Meroni PL, 2010, ANN RHEUM DIS, V69, P1420, DOI 10.1136/ard.2009.127100; Papageorgiou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116189; Peene I, 2000, CLIN RHEUMATOL, V19, P291, DOI 10.1007/s100670070048; Rasmussen A, 2014, ANN RHEUM DIS, V73, P31, DOI 10.1136/annrheumdis-2013-203845; Reina D, 2016, REUMATOL CLIN, V12, P201, DOI [10.1016/j.reuma.2015.09.003, 10.1016/j.reumae.2015.09.009]; Satoh M, 2017, ENDOCR J, V64, P1173, DOI 10.1507/endocrj.EJ17-0155; Satoh M, 2010, CIRC J, V74, P371, DOI 10.1253/circj.CJ-09-0369; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Shiboski CH, 2017, ARTHRITIS RHEUMATOL, V69, P35, DOI 10.1002/art.39859; Shirai Y, 2012, RHEUMATOLOGY, V51, P1846, DOI 10.1093/rheumatology/kes140; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sugimoto K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184990; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tobon GJ, 2011, INT J CLIN RHEUMATOL, V6, P291; Tsuboi H, 2013, MOD RHEUMATOL, V23, P219, DOI 10.1007/s10165-012-0812-9; Yazdany J, 2013, ARTHRIT CARE RES, V65, P329, DOI 10.1002/acr.21930; Zhao JL, 2017, INT J CARDIOL, V236, P432, DOI 10.1016/j.ijcard.2017.01.097	34	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197297	10.1371/journal.pone.0197297	http://dx.doi.org/10.1371/journal.pone.0197297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763424	Green Submitted, Green Published, gold			2022-12-26	WOS:000432118800037
J	Cardoso, R; Ruas, CF; Giacomin, RM; Ruas, PM; Ruas, EA; Barbieri, RL; Rodrigues, R; Goncalves, LSA				Cardoso, Rafaella; Ruas, Claudete F.; Giacomin, Renata M.; Ruas, Paulo M.; Ruas, Eduardo A.; Barbieri, Rosa L.; Rodrigues, Rosana; Goncalves, Leandro S. A.			Genetic variability in Brazilian Capsicum baccatum germplasm collection assessed by morphological fruit traits and AFLP markers	PLOS ONE			English	Article							CHILI-PEPPERS CAPSICUM; DOMESTICATED CAPSICUM; AGRONOMIC TRAITS; ANNUUM L.; ACCESSIONS; DIVERSITY; SOLANACEAE	Capsicum baccatum is one of the main pepper species grown and consumed in South America. In Brazil, it is commonly cultivated by family farmers, using mostly the genotypes bishop's hat genotypes (locally cambuci) and red chili pepper (dedo-de-moca). This study had the objective of characterizing 116 C. baccatum accessions from different regions of Brazil, based on morphological fruit descriptors and AFLP (Amplified Fragment Length Polymorphisms) markers. Broad phenotypic variability among the C. baccatum accessions was detected when using morphological fruit descriptors. The Ward modified location model (Ward-MLM) discriminated five groups, based mainly on fruit shape. Six combinations of AFLP primers detected polymorphism in 97.93% of the 2466 identified bands, indicating the high genetic variability in the accessions. The UPGMA coincided with the Bayesian clustering analysis and three large groups were formed, separating the wild variety C. baccatum var. praetermissum from the other accessions. There was no relation between genetic distance and geographical origin of the accessions, probably due to the intense exchange of fruits and seeds between farmers. Morphological descriptors used together with AFLP markers proved efficient in detecting the levels of genetic variability among the accessions maintained in the germplasm collections. These results can be used as an additional source of helpful information to be exploited in C. baccatum breeding programs.	[Cardoso, Rafaella; Ruas, Claudete F.; Giacomin, Renata M.; Ruas, Paulo M.; Ruas, Eduardo A.] Univ Estadual Londrina, Biol Dept, Londrina, Parana, Brazil; [Barbieri, Rosa L.] Embrapa Clima Temperado, Pelotas, RS, Brazil; [Rodrigues, Rosana] Univ Estadual Norte Fluminense, Plant Breeding Dept, Campos Dos Goytacazes, RJ, Brazil; [Goncalves, Leandro S. A.] Univ Estadual Londrina, Agron Dept, Londrina, Parana, Brazil	Universidade Estadual de Londrina; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual do Norte Fluminense; Universidade Estadual de Londrina	Goncalves, LSA (corresponding author), Univ Estadual Londrina, Agron Dept, Londrina, Parana, Brazil.	leandrosag@uel.br	Barbieri, Rosa L./W-7280-2018; Rodrigues, Rosana/C-4152-2013; Goncalves, Leandro/J-5505-2017	Barbieri, Rosa L./0000-0001-8420-9546; Rodrigues, Rosana/0000-0002-8180-7265; Goncalves, Leandro/0000-0001-9700-9375; Giacomin, Renata/0000-0003-1568-2107	Fundacao Araucaria CNPq	Fundacao Araucaria CNPq	This work was supported by Fundacao Araucaria CNPq.	Albrecht E, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-68; Albrecht E, 2012, GENET RESOUR CROP EV, V59, P517, DOI 10.1007/s10722-011-9700-y; [Anonymous], GENET RESOUR CROP EV; [Anonymous], **DATA OBJECT**, DOI DOI 10.0.HTTPS://CRAN.R-PR0JECT.0RG/PACKAGE=TABLE0NE; [Anonymous], 2008, GENET MOL RES; Baba VY, 2016, GENET RESOUR CROP EV, V63, P1371, DOI 10.1007/s10722-015-0325-4; Barbe TD, 2010, EUPHYTICA, V173, P337, DOI 10.1007/s10681-009-0089-z; Bharath SM, 2014, PLANT GENET RESOUR-C, V12, P48, DOI 10.1017/S1479262113000245; BOSLAND PW., 1999, PEPPERS VEGETABLE SP; CARVALHO S. I. C., 2006, PIMENTAS GENERO CAPS; Carvalho SIC, 2017, GENET MOL RES, V16; Costa F. R. da, 2006, Crop Breeding and Applied Biotechnology, V6, P18; D'Arcy W. G., 1974, Baileya, V19, P93; Dewitt D, 2006, COMPLETE CHILE PEPPE; do Rego ER, 2011, GENET RESOUR CROP EV, V58, P909, DOI 10.1007/s10722-010-9628-7; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ESHBAUGH WH, 1970, BRITTONIA, V22, P31, DOI 10.2307/2805720; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Finger FL, 2010, GENET MOL RES, V9, P1852, DOI 10.4238/vol9-3gmr891; Franco J, 1998, CROP SCI, V38, P1688, DOI 10.2135/cropsci1998.0011183X003800060045x; Geleta LF, 2005, BIODIVERS CONSERV, V14, P2361, DOI 10.1007/s10531-004-1669-9; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; HEISER CHARLES B., 1958, BRITTONIA, V10, P194, DOI 10.2307/2804950; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunziker A.T., 2001, GENERA SOLANACEAE; Ibiza VP, 2012, GENET RESOUR CROP EV, V59, P1077, DOI 10.1007/s10722-011-9744-z; *IPGRI, 1995, DESCR CAPS; Jarret RL, 2007, HORTSCIENCE, V42, P1303, DOI 10.21273/HORTSCI.42.5.1303; Krishnamurthy SL, 2015, INDIAN J BIOTECHNOL, V14, P49; Lannes SD, 2007, SCI HORTIC-AMSTERDAM, V112, P266, DOI 10.1016/j.scienta.2006.12.029; Leite PSS., 2016, GENET MOL RES, V15, P1, DOI [10.4238/gmr.15048482, DOI 10.4238/GMR.15048482]; Moscone EA, 2007, ACTA HORTIC, P137, DOI 10.17660/ActaHortic.2007.745.5; NEITZKE R. S., 2008, MAGISTRA CRUZ ALMAS, V20, P249; Neitzke RS, 2010, HORTIC BRAS, V28, P47, DOI 10.1590/S0102-05362010000100009; Ortiz R, 2010, SCI HORTIC-AMSTERDAM, V126, P186, DOI 10.1016/j.scienta.2010.07.007; Perry L, 2007, SCIENCE, V315, P986, DOI 10.1126/science.1136914; Rego ER, 2011, BRAZILIAN MAG ORNAM, V16, P165; Rivera A, 2016, SCI HORTIC-AMSTERDAM, V203, P1, DOI 10.1016/j.scienta.2016.03.006; Rodrigues R, 2012, HORTIC BRAS, V30, P226, DOI 10.1590/S0102-05362012000200008; *SAS I, 2000, SAS ONL DOC; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Silva CQ, 2010, HORTIC BRAS, V33, P63; Sreelathakumary I., 2004, INDIAN J HORTIC, V61, P137; Sudre CP, 2010, GENET MOL RES, V9, P283, DOI 10.4238/vol9-1gmr698; Villela JCB, 2014, HORTIC BRAS, V32, P131, DOI 10.1590/S0102-0536201400020002; Vos P, 1995, NUCLEIC ACIDS RES, V44, P388	48	21	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196468	10.1371/journal.pone.0196468	http://dx.doi.org/10.1371/journal.pone.0196468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758023	Green Published, gold, Green Submitted			2022-12-26	WOS:000432082900012
J	Glasset, B; Herbin, S; Granier, SA; Cavalie, L; Lafeuille, E; Guerin, C; Ruimy, R; Casagrande-Magne, F; Levast, M; Chautemps, N; Decousser, JW; Belotti, L; Pelloux, I; Robert, J; Brisabois, A; Ramarao, N				Glasset, Benjamin; Herbin, Sabine; Granier, Sophie A.; Cavalie, Laurent; Lafeuille, Emilie; Guerin, Cyprien; Ruimy, Raymond; Casagrande-Magne, Florence; Levast, Marion; Chautemps, Nathalie; Decousser, Jean-Winoc; Belotti, Laure; Pelloux, Isabelle; Robert, Jerome; Brisabois, Anne; Ramarao, Nalini			Bacillus cereus, a serious cause of nosocomial infections: Epidemiologic and genetic survey	PLOS ONE			English	Article							BACTEREMIA; VIRULENCE; IDENTIFICATION; THURINGIENSIS; MENINGITIS; PNEUMONIA; LEUKEMIA; TOXINS	Bacillus cereus is the 2nd most frequent bacterial agent responsible for food-borne out-breaks in France and the 3rd in Europe. In addition, local and systemic infections have been reported, mainly describing individual cases or single hospital setting. The real incidence of such infection is unknown and information on genetic and phenotypic characteristics of the incriminated strains is generally scarce. We performed an extensive study of B. cereus strains isolated from patients and hospital environments from nine hospitals during a 5-year study, giving an overview of the consequences, sources and pathogenic patterns of B. cereus clinical infections. We demonstrated the occurrence of several hospital-cross-contaminations. Identical B. cereus strains were recovered from different patients and hospital environments for up to 2 years. We also clearly revealed the occurrence of inter hospital contaminations by the same strain. These cases represent the first documented events of nosocomial epidemy by B. cereus responsible for intra and inter hospitals contaminations. Indeed, contamination of different patients with the same strain of B. cereus was so far never shown. In addition, we propose a scheme for the characterization of B. cereus based on biochemical properties and genetic identification and highlight that main genetic signatures may carry a high pathogenic potential. Moreover, the characterization of antibiotic resistance shows an acquired resistance phenotype for rifampicin. This may provide indication to adjust the antibiotic treatment and care of patients.	[Glasset, Benjamin; Ramarao, Nalini] Univ Paris Saclay, Micalis Inst, AgroParisTech, INRA, Jouy En Josas, France; [Glasset, Benjamin; Herbin, Sabine; Granier, Sophie A.; Brisabois, Anne] Univ Paris Est, Anses, Lab Food Safety, Maisons Alfort, France; [Cavalie, Laurent] Univ Toulouse, CHU Toulouse, Serv Bacteriol Hyg, IRSD,INSERM,INRA,ENVT,UPS, Toulouse, France; [Lafeuille, Emilie; Robert, Jerome] UPMC Univ Paris 06, Sorbonne Univ, Inserm, U1135,Ctr Immunol Malad Infect CIMI Paris, Paris, France; [Lafeuille, Emilie; Robert, Jerome] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Lab Bacteriol Hyg, Paris, France; [Guerin, Cyprien] Univ Paris Saclay, AgroParisTech, INRA, MaiAGE, Jouy En Josas, France; [Ruimy, Raymond; Casagrande-Magne, Florence] CHU Nice, Lab Bacteriol, Nice, France; [Levast, Marion; Chautemps, Nathalie] Hop Chambery, Lab Biol Med, Chambery, France; [Decousser, Jean-Winoc] Hop Univ Paris Sud Antoine Beclere, Lab Hyg, Clamart, France; [Belotti, Laure] CHU Strasbourg, Lab Hyg Hosp, Strasbourg, France; [Pelloux, Isabelle] CHU Grenoble, Lab Bacteriol, Grenoble, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Securite Aliments; Ecole Nationale Veterinaire d'Alfort (ENVA); CHU de Toulouse; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Ramarao, N (corresponding author), Univ Paris Saclay, Micalis Inst, AgroParisTech, INRA, Jouy En Josas, France.	nalini.ramarao@inra.fr	ROBERT, Jérôme/C-3993-2011; Rama Rao, Nalini/GRR-7800-2022; Granier, Sophie A./H-6796-2019; , DECOUSSER/AFM-9917-2022; Ruimy, Raymond/P-6068-2016	ROBERT, Jérôme/0000-0002-9380-0570; Granier, Sophie A./0000-0001-9676-2402; Ruimy, Raymond/0000-0002-7179-662X; Guerin, Cyprien/0000-0001-6102-7002				Arnaout MK, 1999, J PEDIAT HEMATOL ONC, V21, P431, DOI 10.1097/00043426-199909000-00018; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Auger S, 2009, APPL ENVIRON MICROB, V75, P6616, DOI 10.1128/AEM.00155-09; BEECHER DJ, 1994, APPL ENVIRON MICROB, V60, P1646, DOI 10.1128/AEM.60.5.1646-1651.1994; Benusic MA, 2015, CAN J INFECT DIS MED, V26, P103, DOI 10.1155/2015/482309; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Bouillaut L, 2005, APPL ENVIRON MICROB, V71, P8903, DOI 10.1128/AEM.71.12.8903-8910.2005; Callegan MC, 2005, INVEST OPHTH VIS SCI, V46, P3233, DOI 10.1167/iovs.05-0410; Clinical and Laboratory Standards Institute (CLSI), 2010, METH ANT DIL DISK SU; Decousser JW, 2013, AM J INFECT CONTROL, V41, P918, DOI 10.1016/j.ajic.2013.01.043; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Ehling-Schulz M, 2006, FEMS MICROBIOL LETT, V260, P232, DOI 10.1111/j.1574-6968.2006.00320.x; Evreux F, 2007, ARCH PEDIATRIE, V14, P365, DOI 10.1016/j.arcped.2007.01.009; Frankard J, 2004, EUR J CLIN MICROBIOL, V23, P725, DOI 10.1007/s10096-004-1180-y; Gaur AH, 2001, CLIN INFECT DIS, V32, P1456, DOI 10.1086/320154; Glasset B., 2016, EUROSURVEILLANCE, V21, P48, DOI DOI 10.2807/1560-7917.ES.2016.21.48.30413; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; Guillemet E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055085; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Guinebretiere MH, 2002, J CLIN MICROBIOL, V40, P3053, DOI 10.1128/JCM.40.8.3053-3056.2002; Hilliard NJ, 2003, J CLIN MICROBIOL, V41, P3441, DOI 10.1128/JCM.41.7.3441-3444.2003; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ikeda M, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0104-2; INVS, 2016, COLL FOOD POIS INVS; Kato K, 2016, EUR J CLIN MICROBIOL, V35, P875, DOI 10.1007/s10096-016-2618-8; Lotte R, 2017, EMERG INFECT DIS, V23, P845, DOI 10.3201/eid2305.161788; Marston CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156987; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; Ramarao N, 2012, EMC BIOL MED, V7, P1; Ramarao N., 2015, MOL MED MICROBIOL, V2, P1041, DOI [10.1016/B978-0-12-397169-2.00059-7, DOI 10.1016/B978-0-12-397169-2.00059-7]; Ramarao N, 2014, AM J INFECT CONTROL, V42, P694, DOI 10.1016/j.ajic.2014.01.025; Ramarao N, 2013, TOXINS, V5, P1119, DOI 10.3390/toxins5061119; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Sasahara T, 2011, EUR J CLIN MICROBIOL, V30, P219, DOI 10.1007/s10096-010-1072-2; Shah M, 2015, IDCases, V2, P120, DOI 10.1016/j.idcr.2015.10.003; Tran SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022876; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Tran SL, 2010, J BACTERIOL, V192, P2638, DOI 10.1128/JB.01315-09; Veysseyre F, 2015, MED MALADIES INFECT, V45, P436, DOI 10.1016/j.medmal.2015.09.011; Wright WF, 2016, CLIN MED RES	42	59	61	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0194346	10.1371/journal.pone.0194346	http://dx.doi.org/10.1371/journal.pone.0194346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791442	gold, Green Submitted, Green Published			2022-12-26	WOS:000433077000002
J	Parisi, F; Rousian, M; Koning, IV; Willemsen, SP; de Vries, JHM; Steegers, EAP; Steegers-Theunissen, RPM				Parisi, Francesca; Rousian, Melek; Koning, Irene, V; Willemsen, Sten P.; de Vries, Jeanne H. M.; Steegers, Eric A. P.; Steegers-Theunissen, Regine P. M.			Periconceptional maternal dairy-rich dietary pattern is associated with prenatal cerebellar growth	PLOS ONE			English	Article							PROTEIN-MALNUTRITION; IMPACT; VALIDATION; ULTRASOUND; NUTRITION; FOLATE; BIRTH	Background Maternal nutrition during pregnancy has been related to intrauterine brain development and neurodevelopmental disabilities in adult life. We aim to investigate associations between periconceptional maternal dietary patterns and prenatal cerebellar growth from the first trimester onwards. Materials and methods 126 women with singleton non-malformed pregnancies were enrolled before 8 weeks of gestation in the Rotterdam periconceptional cohort between 2013 and 2015. Periconceptional maternal dietary patterns were extracted from food frequency questionnaires and associated with blood biomarkers and micronutrient intakes. Serial two-dimensional and three-dimensional ultrasound scans were performed at 9, 11, 22, 26 and 32 weeks of gestation for transcerebellar diameter (TCD) measurement. Linear mixed models were estimated to investigate associations between periconceptional maternal dietary patterns and longitudinal TCD measurements as a function of gestational age. Results We performed a median of 4 scans per pregnancy, resulting in 570 total datasets. The success rate of TCD measurements was 87% (range 65-100%), depending on gestational age. The Mediterranean, Western, egg-rich and dairy-rich dietary patterns were extracted, explaining 37.2% of the overall variance of food intake in this population. The dairy-rich dietary pattern was positively associated with cerebellar growth trajectories (beta = 0.02 (95% CI: 0.01; 0.03) root mm, p = 0.01). Maternal strong adherence to this dietary pattern increased TCD measurements by 0.8 standard deviation scores (SDs) compared to weak adherence, reflected in increased TCD estimates of 0.44 mm at 9 weeks (+6.8%), 0.88 mm at 22 weeks (+3.6%), and 1.17 mm at 32 weeks (+2.8%). No significant associations were detected for the Mediterranean, Western and egg-rich dietary patterns. Conclusions This study shows a positive association between periconceptional maternal adherence to a dairy-rich dietary pattern and human prenatal TCD measurements as a proxy of cerebellar growth. Next step is the investigation of the impact on neurodevelopmental outcomes in the offspring.	[Parisi, Francesca; Rousian, Melek; Koning, Irene, V; Willemsen, Sten P.; Steegers, Eric A. P.; Steegers-Theunissen, Regine P. M.] Univ Med Ctr, Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands; [Willemsen, Sten P.] Univ Med Ctr, Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [de Vries, Jeanne H. M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Steegers-Theunissen, Regine P. M.] Univ Med Ctr, Erasmus MC, Div Neonatol, Dept Pediat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research; Erasmus University Rotterdam; Erasmus MC	Steegers-Theunissen, RPM (corresponding author), Univ Med Ctr, Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands.; Steegers-Theunissen, RPM (corresponding author), Univ Med Ctr, Erasmus MC, Div Neonatol, Dept Pediat, Rotterdam, Netherlands.	r.steegers@erasmusmc.nl	Parisi, Francesca/AAB-7065-2019	Parisi, Francesca/0000-0003-2017-7869	Department of Obstetrics and Gynaecology of the Erasmus MC University Medical Centre, Rotterdam, The Netherlands	Department of Obstetrics and Gynaecology of the Erasmus MC University Medical Centre, Rotterdam, The Netherlands	This study was funded by the Department of Obstetrics and Gynaecology of the Erasmus MC University Medical Centre, Rotterdam, The Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 2005, NEUROIMAGE, V28, P39, DOI 10.1016/j.neuroimage.2005.06.013; Allin MPG, 2016, SEMIN FETAL NEONAT M, V21, P333, DOI 10.1016/j.siny.2016.06.003; Barua S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00168; Bonatto F, 2006, NEUROSCI LETT, V406, P281, DOI 10.1016/j.neulet.2006.07.052; Cace IB, 2011, MED HYPOTHESES, V76, P514, DOI 10.1016/j.mehy.2010.12.005; Crozier SR, 2009, J NUTR, V139, P1956, DOI 10.3945/jn.109.109579; de Zeeuw P, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.12; Handmaker NS, 2006, ALCOHOL CLIN EXP RES, V30, P892, DOI 10.1111/j.1530-0277.2006.00104.x; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Hunter DS, 2016, PHYSIOL BEHAV, V164, P233, DOI 10.1016/j.physbeh.2016.06.005; Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008; Koning IV, 2017, HUM REPROD, V32, P1230, DOI 10.1093/humrep/dex079; Koning IV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141089; Marques AH, 2015, BRAIN RES, V1617, P28, DOI 10.1016/j.brainres.2014.10.051; Montag AC, 2016, ALCOHOL CLIN EXP RES, V40, P2418, DOI 10.1111/acer.13232; Netherlands Nutrition Centre, 2011, NEVO TAB NED VOED 20; Nuttall JR, 2017, NUTR NEUROSCI, V20, P209, DOI [10.1080/1028415X.2015.1103437, 10.1080/1028415x.2015.1103437]; Pierson CR, 2016, SEMIN FETAL NEONAT M, V21, P305, DOI 10.1016/j.siny.2016.04.006; Ramirez-Zea M, 2005, PUBLIC HEALTH NUTR, V8, P1213, DOI 10.1079/PHN2005807; Ranade SC, 2012, BRIT J NUTR, V107, P1167, DOI 10.1017/S0007114511004119; ROBINSON HP, 1973, BMJ-BRIT MED J, V4, P28, DOI 10.1136/bmj.4.5883.28; Rousian M, 2013, REPROD SCI, V20, P899, DOI 10.1177/1933719112468950; Shpyleva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113712; Siebelink E, 2011, BRIT J NUTR, V106, P274, DOI 10.1017/S0007114511000067; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1311, DOI 10.1079/PHN2002407; Steegers-Theunissen RPM, 2016, INT J EPIDEMIOL, V45, P374, DOI 10.1093/ije/dyv147; Steegers-Theunissen RPM, 2013, HUM REPROD UPDATE, V19, P640, DOI 10.1093/humupd/dmt041; Suren P, 2013, JAMA-J AM MED ASSOC, V309, P570, DOI 10.1001/jama.2012.155925; van Uitert EM, 2014, BJOG-INT J OBSTET GY, V121, P821, DOI 10.1111/1471-0528.12592; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Vinkesteijn ASM, 2000, ULTRASOUND OBST GYN, V15, P47, DOI 10.1046/j.1469-0705.2000.00024.x; Yu Y, 2017, ENVIRON TOXICOL, V32, P1241, DOI 10.1002/tox.22320	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197901	10.1371/journal.pone.0197901	http://dx.doi.org/10.1371/journal.pone.0197901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791504	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000068
J	Edelsberg, J; Weycker, D; Atwood, M; Hamilton-Fairley, G; Jett, JR				Edelsberg, John; Weycker, Derek; Atwood, Mark; Hamilton-Fairley, Geoffrey; Jett, James R.			Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules	PLOS ONE			English	Article							NATURAL-HISTORY; METAANALYSIS; PROBABILITY; VALIDATION; STRATEGIES; MALIGNANCY; GUIDELINES; MANAGEMENT; UTILITY; GROWTH	Objective Patients who have incidentally detected pulmonary nodules and an estimated intermediate risk (5-60%) of lung cancer frequently are followed via computed tomography (CT) surveillance to detect nodule growth, despite guidelines for a more aggressive diagnostic strategy. We examined the cost-effectiveness of an autoantibody test (AABT) Early Cancer Detection Test-Lung (EarIyCDT-LungTM) as an aid to early diagnosis of lung cancer among such patients. Methods We developed a decision-analytic model to evaluate use of the AABT versus CT surveillance alone. In the model, patients with a positive AABT because they are at substantially enhanced risk of lung cancer are assumed to go directly to biopsy, resulting in diagnosis of lung cancer in earlier stages than under current guidelines (a beneficial stage shift). Patients with a negative AABT, and those scheduled for CT surveillance alone, are assumed to have periodic CT screenings to detect rapid growth and thus to have their lung cancers diagnosed on average at more advanced stages. Results Among 1,000 patients who have incidentally detected nodules 8-30 mm, have an intermediate-risk of lung cancer, and are evaluated by CT surveillance alone, 95 (9.5%) are assumed to have lung cancer (local, 73.6%; regional, 22.0%; distant, 4.4%). With use of the AABT set at a sensitivity/specificity of 41%/93% (stage shift = 10.8%), although expected costs would be higher by $949,442 ($949 per person), life years would be higher by 53 (0.05 per person), resulting in a cost per life-year gained of $18,029 and a cost per quality-adjusted life year (QALY) gained of $24,330. With use of the AABT set at a sensitivity/specificity of 28%/98% (stage shift = 7.4%), corresponding cost-effectiveness ratios would be $18,454 and $24,833. Conclusions Under our base-case assumptions, and reasonable variations thereof, using AABT as an aid in the early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules who are estimated to be at intermediate risk of lung cancer and are scheduled for CT surveillance alone is likely to be a cost-effective use of healthcare resources.	[Edelsberg, John; Weycker, Derek; Atwood, Mark] Policy Anal Inc, Brookline, MA 02445 USA; [Hamilton-Fairley, Geoffrey] Oncimmune Ltd, Nottingham, England; [Jett, James R.] Oncimmune LLC, Napa, CA USA	Policy Analysis Inc	Weycker, D (corresponding author), Policy Anal Inc, Brookline, MA 02445 USA.	dweycker@pai2.com			Oncimmune Inc; Oncimmune Inc.	Oncimmune Inc; Oncimmune Inc.	Funding for this research was provided by Oncimmune Inc. to Policy Analysis Inc. (PAI). GHF and JJ are employed by, and own stock in, Oncimmune Inc. Oncimmune Inc. provided support in the form of salaries for authors GHF and JJ, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JE, DW, and MA are employed by Policy Analysis Inc. Policy Analysis Inc. provided support in the form of salaries for authors JE, DW, and MA, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Adams PF, 2006, VITAL HLTH STAT, V10, P230; Agency for Healthcare Research and Quality, 2014, HEALTHC COST UT PROJ; [Anonymous], MED RES BAS REL VALV; Arias E., 2004, NATL VITAL STAT REPO, V2007, P56; Black WC, 2014, NEW ENGL J MED, V371, P1793, DOI 10.1056/NEJMoa1312547; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Chapman CJ, 2012, TUMOR BIOL, V33, P1319, DOI 10.1007/s13277-012-0379-2; David G, 2012, MINIM INVASIVE SURG, V2012, DOI 10.1155/2012/760292; Deppen SA, 2014, ANN THORAC SURG, V98, P1214, DOI 10.1016/j.athoracsur.2014.05.025; Deppen SA, 2014, JAMA-J AM MED ASSOC, V312, P1227, DOI 10.1001/jama.2014.11488; Detterbeck FC, 2008, J THORAC ONCOL, V3, P781, DOI 10.1097/JTO.0b013e31817c9230; Fry WA, 1996, CANCER, V77, P1947, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1947::AID-CNCR27>3.0.CO;2-Z; Gould MK, 2015, AM J RESP CRIT CARE, V192, P1208, DOI 10.1164/rccm.201505-0990OC; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Gould MK, 2003, ANN INTERN MED, V138, P724, DOI 10.7326/0003-4819-138-9-200305060-00009; Gulack BC, 2016, ANN THORAC SURG, V102, P1814, DOI 10.1016/j.athoracsur.2016.06.032; Healey GF, 2017, J CANC THERAPY, V8, P506, DOI DOI 10.4236/JCT.2017.85043; Healey GF, 2013, J THORAC DIS, V5, P618, DOI 10.3978/j.issn.2072-1439.2013.08.65; Iaccarino JM, 2017, CHEST, V152, P232, DOI 10.1016/j.chest.2017.03.009; Jett J, 2017, J THORAC ONCOL, V12, pS2169; Jett JR, 2014, LUNG CANCER, V83, P51, DOI 10.1016/j.lungcan.2013.10.008; Lam S, 2011, CANCER PREV RES, V4, P1126, DOI 10.1158/1940-6207.CAPR-10-0328; MacMahon H, 2017, RADIOLOGY, V284, P228, DOI 10.1148/radiol.2017161659; Memoli JSW, 2012, CHEST, V142, P385, DOI 10.1378/chest.11-1764; Murray A, 2010, ANN ONCOL, V21, P1687, DOI 10.1093/annonc/mdp606; National Cancer Institute, SEER CANC STAT REV 1; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Oncimmune, AB ONC; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Plevritis SK, 2006, JAMA-J AM MED ASSOC, V295, P2374, DOI 10.1001/jama.295.20.2374; Raz DJ, 2007, CHEST, V132, P193, DOI 10.1378/chest.06-3096; Schultz EM, 2008, J THORAC ONCOL, V3, P422, DOI 10.1097/JTO.0b013e318167146b; STEELE JD, 1973, J THORAC CARDIOV SUR, V65, P140; Sturza J, 2010, MED DECIS MAKING, V30, P685, DOI 10.1177/0272989X10369004; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Tanner NT, 2017, CHEST, V152, P263, DOI 10.1016/j.chest.2017.01.018; Tanner NT, 2015, CHEST, V148, P1405, DOI 10.1378/chest.15-0630; Veronesi G, 2015, EUR RESPIR J, V45, P501, DOI 10.1183/09031936.00066514; Vollset SE, 2006, ANN INTERN MED, V10, P230; Wiener RS, 2014, JAMA INTERN MED, V174, P871, DOI 10.1001/jamainternmed.2014.561; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003	41	25	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197826	10.1371/journal.pone.0197826	http://dx.doi.org/10.1371/journal.pone.0197826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787590	gold, Green Published, Green Submitted			2022-12-26	WOS:000432785700050
J	Pavanello, S; Varesco, L; Gismondi, V; Bruzzi, P; Bolognesi, C				Pavanello, Sofia; Varesco, Liliana; Gismondi, Viviana; Bruzzi, Paolo; Bolognesi, Claudia			Leucocytes telomere length and breast cancer risk/susceptibility: A case-control study	PLOS ONE			English	Article							BRCA2 MUTATION CARRIERS; INCIDENT COLORECTAL-CARCINOMA; CIGARETTE-SMOKING; PREDISPOSITION FACTOR; BLADDER-CANCER; RISK; ASSOCIATION; LYMPHOCYTES; INSTABILITY; DYSFUNCTION	Background Telomere length in peripheral blood leukocytes (PBL-TL) was proposed as a biomarker of cancer risk. Recent scientific evidence suggested PBL-TL plays a diverse role in different cancers. Inconsistent results were obtained on PBL-TL in relation to breast cancer risk and specifically to the presence of BRCA1 and BRCA2 mutations. The aim of the present case control study was to analyse the correlation between family history of breast cancer or presence of a BRCA mutation and PBL-TL in the hypothesis that TL is a modifier of cancer risk. Methods PBL-TL was measured using the real-time quantitative PCR method in DNA for 142 cases and 239 controls. All the women enrolled were characterized for cancer family history. A subgroup of 48 women were classified for the presence of a BRCA mutation. PBL-TL were summarized as means and standard deviations, and compared by standard analysis of variance. A multivariable Generalised Linear Model was fitted to the data with PBL-TL as the dependent variable, case/control status and presence of a BRCA/VUS mutation as factors, and age in 4 strata as a covariate. Results Age was significantly associated with decreasing PBL-TL in controls (p = 0.01), but not in BC cases. The telomere length is shorter in cases than in controls after adjusting for age. No effect on PBL-TL of BM I, smoke nor of the most common risk factors for breast cancer was observed. No association between PBL-TL and family history was detected both in BC cases and controls. In the multivariate model, no association was observed between BRCA mutation and decreased PBL-TL. A statistically significant interaction (p = 0.031) between case-control status and a BRCA-mutationNUS was observed, but no effect was detected for the interaction of cancer status and BRCA or VUS. Conclusion Our study fails to provide support to the hypothesis that PBL-TL is associated with the risk of hereditary BC, or that is a marker of inherited mutations in BRCA genes.	[Pavanello, Sofia] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Unit Occupat Med, Padua, Italy; [Varesco, Liliana; Gismondi, Viviana] Osped Policlin San Martino, Unit Hereditary Canc, Genoa, Italy; [Bruzzi, Paolo] Osped Policlin San Martino, Unit Clin Epidemiol, Genoa, Italy; [Bolognesi, Claudia] Osped Policlin San Martino, Unit Environm Carcinogenesis, Genoa, Italy	University of Padua	Bolognesi, C (corresponding author), Osped Policlin San Martino, Unit Environm Carcinogenesis, Genoa, Italy.	claudia.bolognesi@hsanmartino.it	Bruzzi, Paolo/AAU-3363-2021; Varesco, Liliana/AAF-6521-2019	Varesco, Liliana/0000-0003-4871-6668; Pavanello, Sofia/0000-0002-5229-9900; Gismondi, Viviana/0000-0002-1115-0325	Italian Association for Research on Cancer (AIRC) [IG 5706 2008]	Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association for Research on Cancer (AIRC), Project IG 5706 2008. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Astuti Y, 2017, ENVIRON RES, V158, P480, DOI 10.1016/j.envres.2017.06.038; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Ballal RD, 2009, J BIOL CHEM, V284, P36083, DOI 10.1074/jbc.M109.025825; Banerjee B, 2008, BREAST CANCER RES TR, V107, P25, DOI 10.1007/s10549-007-9530-y; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Benitez-Buelga C, 2015, BREAST CANCER RES TR, V149, P385, DOI 10.1007/s10549-014-3246-6; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boccardi V, 2014, AGEING RES REV, V15, P1, DOI 10.1016/j.arr.2013.12.006; Bolognesi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112354; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Feldser DM, 2003, NAT REV CANCER, V3, P623, DOI 10.1038/nrc1142; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Gramatges MM, 2010, CANCER EPIDEM BIOMAR, V19, P605, DOI 10.1158/1055-9965.EPI-09-0896; Han JL, 2009, J INVEST DERMATOL, V129, P415, DOI 10.1038/jid.2008.238; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Hou LF, 2009, CANCER EPIDEM BIOMAR, V18, P3103, DOI 10.1158/1055-9965.EPI-09-0347; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Killick E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086659; Kim S, 2011, CANCER CAUSE CONTROL, V22, P1061, DOI 10.1007/s10552-011-9778-8; Latifovic L, 2016, CANCER EPIDEM BIOMAR, V25, P374, DOI 10.1158/1055-9965.EPI-14-1364; Lee IM, 2010, CLIN CHEM LAB MED, V48, P259, DOI 10.1515/CCLM.2010.049; Lin JG, 2014, DNA REPAIR, V20, P142, DOI 10.1016/j.dnarep.2014.01.012; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Martinez-Delgado B, 2013, BREAST CANCER RES TR, V141, P231, DOI 10.1007/s10549-013-2696-6; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Michor F, 2005, PHILOS T R SOC B, V360, P631, DOI 10.1098/rstb.2004.1617; Milne RL, 2016, ENDOCR-RELAT CANCER, V23, pT69, DOI 10.1530/ERC-16-0277; Min J, 2012, J BIOL CHEM, V287, P5091, DOI 10.1074/jbc.M111.278994; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Muezzinler A, 2014, OBES REV, V15, P192, DOI 10.1111/obr.12126; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Pavanello S, 2010, CARCINOGENESIS, V31, P216, DOI 10.1093/carcin/bgp278; Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880; Pooley KA, 2014, CANCER EPIDEM BIOMAR, V23, P1018, DOI 10.1158/1055-9965.EPI-13-0635-T; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Qu SM, 2013, AM J EPIDEMIOL, V177, P617, DOI 10.1093/aje/kws291; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Shen J, 2007, CANCER RES, V67, P5538, DOI 10.1158/0008-5472.CAN-06-3490; Shen J, 2009, INT J CANCER, V124, P1637, DOI 10.1002/ijc.24105; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Thorvaldsdottir B, 2017, CANCER EPIDEM BIOMAR, V26, P1248, DOI 10.1158/1055-9965.EPI-16-0946; von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184; Webb CJ, 2013, COLD SPRING HARB PER, V5, DOI [10.1101/cshperspect.a012666.2013, DOI 10.1101/CSHPERSPECT.A012666.2013]; Weischer M, 2013, JNCI-J NATL CANCER I, V105, P459, DOI 10.1093/jnci/djt016; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Zee RYL, 2009, CANCER EPIDEM BIOMAR, V18, P2280, DOI 10.1158/1055-9965.EPI-09-0360; Zheng YL, 2011, HUM MOL GENET, V20, P378, DOI 10.1093/hmg/ddq461; Zhu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep22243	59	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197522	10.1371/journal.pone.0197522	http://dx.doi.org/10.1371/journal.pone.0197522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782524	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100029
J	Silva, IAL; Conceiceao, N; Gagnon, E; Brown, JP; Cancela, ML; Michou, L				Silva, Iris A. L.; Conceiceao, Natercia; Gagnon, Edith; Brown, Jacques P.; Cancela, M. Leonor; Michou, Laetitia			Molecular effect of an OPTN common variant associated to Paget's disease of bone	PLOS ONE			English	Article							KAPPA-B ACTIVATION; GENETIC-HETEROGENEITY; TRANSCRIPTION FACTOR; AUTOPHAGY RECEPTOR; CHROMOSOME 18Q; OPTINEURIN; IDENTIFICATION; BINDING; LINKAGE; LOCUS	Paget's disease of bone (PDB) is a chronic bone disorder and although genetic factors appear to play an important role in its pathogenesis, to date PDB causing mutations were identified only in the Sequestosome 1 (SQSTM1) gene at the PDB3 locus. PDB6 locus, also previously linked to PDB, contains several candidate genes for metabolic bone diseases. We focused our analysis in the most significantly associated variant with PDB, within the Optineurin (OPTN) gene, i.e. the common variant rs1561570. Although it was previously shown to be strongly associated with PDB in several populations, its contribution to PDB pathogenesis remains unclear. In this study we have shown that rs1561570 may contribute to PDB since its Tallele results in the loss of a methylation site in patients' DNA, leading to higher levels of OPTN gene expression and a corresponding increase in protein levels in patients' osteoclasts. This increase in OPTN expression leads to higher levels of NF-KB translocation into the nucleus and increasing expression of its target genes, which may contribute to the overactivity of osteoclasts observed in PDB. We also reported a tendency for a more severe clinical phenotype in the presence of a haplotype containing the rs1561570 T allele, which appear to be re-enforced with the presence of the SQSTM1/P392L mutation. In conclusion, our work provides novel insight towards understanding the functional effects of this variant, located in OPTN intron 7, and its implication in the contribution to PDB pathogenesis.	[Silva, Iris A. L.; Conceiceao, Natercia; Cancela, M. Leonor] Univ Algarve, Dept Biomed Sci & Med, Faro, Portugal; [Silva, Iris A. L.; Conceiceao, Natercia; Cancela, M. Leonor] Univ Algarve, Algarve Biomed Ctr, Faro, Portugal; [Silva, Iris A. L.; Conceiceao, Natercia; Cancela, M. Leonor] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal; [Gagnon, Edith; Brown, Jacques P.; Michou, Laetitia] Univ Laval, CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Michou, Laetitia] Univ Laval, Dept Med, Div Rheumatol, Quebec City, PQ, Canada; [Michou, Laetitia] Univ Laval, CHU Quebec, Dept Rheumatol, Quebec City, PQ, Canada; [Silva, Iris A. L.] Univ Lisbon, BioISI Biosyst & Integrat Sci Inst, Fac Sci, Lisbon, Portugal	Universidade do Algarve; Universidade do Algarve; Universidade do Algarve; Laval University; Laval University; Laval University; BIOISI; Universidade de Lisboa	Cancela, ML (corresponding author), Univ Algarve, Dept Biomed Sci & Med, Faro, Portugal.; Cancela, ML (corresponding author), Univ Algarve, Algarve Biomed Ctr, Faro, Portugal.; Cancela, ML (corresponding author), Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal.; Michou, L (corresponding author), Univ Laval, CHU Quebec, Res Ctr, Quebec City, PQ, Canada.; Michou, L (corresponding author), Univ Laval, Dept Med, Div Rheumatol, Quebec City, PQ, Canada.; Michou, L (corresponding author), Univ Laval, CHU Quebec, Dept Rheumatol, Quebec City, PQ, Canada.	lcancela@ualg.pt; laetitia.michou@crchudequebec.ulaval.ca	Cancela, M. Leonor/F-4665-2012; Conceição, Natércia/F-1737-2011; Silva, Iris/U-5740-2017	Cancela, M. Leonor/0000-0003-3114-6662; Silva, Iris/0000-0002-8062-5558; Conceicao, Natercia/0000-0002-5057-0912; Brown, Jacques/0000-0003-1910-788X; Michou, Laetitia/0000-0002-8364-4164	national funds from Foundation for Science and Technology (FCT) [UID/Multi/04326/2013]; Canadian Institutes for Health Research, Canada [MOP130457]; CHU de Quebec Foundation; Canadian Foundation for Innovation; Fonds de recherche du Quebec-sante; Laval University; CHU de Quebec-Universite Laval Research Centre; FCT [SFRH/BD/77227/2011, SFRH/BPD/111898/2015]; Fonds de recherche Quebec-Sante (FRQ-S), Quebec, Canada	national funds from Foundation for Science and Technology (FCT); Canadian Institutes for Health Research, Canada(Canadian Institutes of Health Research (CIHR)); CHU de Quebec Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de recherche du Quebec-sante(Fonds de la Recherche en Sante du Quebec); Laval University; CHU de Quebec-Universite Laval Research Centre; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fonds de recherche Quebec-Sante (FRQ-S), Quebec, Canada	This research was supported in part by national funds from Foundation for Science and Technology (FCT) through project UID/Multi/04326/2013 to MLC and by Canadian Institutes for Health Research (MOP130457 to LM), Canada, CHU de Quebec Foundation, Canadian Foundation for Innovation, Fonds de recherche du Quebec-sante, Laval University and CHU de Quebec-Universite Laval Research Centre. The authors would also like to acknowledge the CHU de Quebec-Universite Laval Research Centre (CHUL) Gene Expression Platform, Quebec, Canada for the quantitative real-time PCR measurements and the Centre of Marine Sciences (CCMAR), Faro, Portugal for the use of the sequencing platform. IS and NC were supported by doctoral and post-doctoral fellowships (SFRH/BD/77227/2011 and SFRH/BPD/111898/2015, respectively) from FCT. LM is supported by a career award from the Fonds de recherche Quebec-Sante (FRQ-S), Quebec, Canada. All the funders cited above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagha OME, 2010, NAT GENET, V42, P520, DOI 10.1038/ng.562; Altman RD, 2000, J BONE MINER RES, V15, P461, DOI 10.1359/jbmr.2000.15.3.461; Beranger GE, 2007, J BONE MINER RES, V22, P975, DOI 10.1359/JBMR.070406; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; David JP, 2001, J CELL PHYSIOL, V188, P89, DOI 10.1002/jcp.1099; FOTINO M, 1977, TRANSPLANT P, V9, P1867; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Good DA, 2002, AM J HUM GENET, V70, P517, DOI 10.1086/338658; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Haslam SI, 1998, J BONE MINER RES, V13, P911, DOI 10.1359/jbmr.1998.13.6.911; Hernandez HG, 2013, BIOTECHNIQUES, V55, P181, DOI 10.2144/000114087; Hocking L, 2000, BONE, V26, P577, DOI 10.1016/S8756-3282(00)00278-7; Hocking LJ, 2001, AM J HUM GENET, V69, P1055, DOI 10.1086/323798; Hrasovec S, 2013, DIS MARKERS, V34, P93, DOI [10.1155/2013/427890, 10.3233/DMA-120948]; Inoue D, 1997, J BIOL CHEM, V272, P25386, DOI 10.1074/jbc.272.40.25386; Itzstein C, 2000, BIOCHEM BIOPH RES CO, V268, P201, DOI 10.1006/bbrc.2000.2097; Iwamoto K, 2011, GENOME RES, V21, P688, DOI 10.1101/gr.112755.110; Journo C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000521; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Laurin N, 2001, AM J HUM GENET, V69, P528, DOI 10.1086/322975; Lorenzo J, 2007, OSTEOIMMUNOLOGY INTE; Lucas GJA, 2008, J BONE MINER RES, V23, P58, DOI 10.1359/JBMR.071004; Meena NP, 2016, FEBS LETT, V590, P1498, DOI 10.1002/1873-3468.12176; Michou L, 2012, BONE, V51, P720, DOI 10.1016/j.bone.2012.06.028; MORALESPIGA AA, 1995, J BONE MINER RES, V10, P663; Munitic I, 2013, J IMMUNOL, V191, P6231, DOI 10.4049/jimmunol.1301696; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nasr R, 2006, BLOOD, V107, P4021, DOI 10.1182/blood-2005-09-3572; Obaid R, 2015, CELL REP, P1; Osawa T, 2011, NEUROPATHOLOGY, V31, P569, DOI 10.1111/j.1440-1789.2011.01199.x; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; ROODMAN GD, 1992, J CLIN INVEST, V89, P46, DOI 10.1172/JCI115584; Shen WC, 2015, AUTOPHAGY, V11, P685, DOI 10.4161/auto.36098; Silva IAL, 2018, BBA-MOL BASIS DIS, V1864, P143, DOI 10.1016/j.bbadis.2017.10.008; Slowicka K, 2016, TRENDS IMMUNOL, V37, P621, DOI 10.1016/j.it.2016.07.002; Slowicka K, 2016, EUR J IMMUNOL, V46, P971, DOI 10.1002/eji.201545863; Swarup G, 2013, GLAUCOMA BASIC CLIN; Van Staa TP, 2002, J BONE MINER RES, V17, P465, DOI 10.1359/jbmr.2002.17.3.465; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Yao GQ, 2005, CALCIFIED TISSUE INT, V76, P371, DOI 10.1007/s00223-004-0099-8; Zeller T, 2010, GENETICS THE TRANSCR, V5	45	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197543	10.1371/journal.pone.0197543	http://dx.doi.org/10.1371/journal.pone.0197543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782529	gold, Green Published, Green Submitted			2022-12-26	WOS:000432537100031
J	Zaslona, JL; O'Keeffe, KM; Signal, TL; Gander, PH				Zaslona, Jennifer L.; O'Keeffe, Karyn M.; Signal, T. Leigh; Gander, Philippa H.			Shared responsibility for managing fatigue: Hearing the pilots	PLOS ONE			English	Article							ULTRA-LONG-RANGE; IN-FLIGHT SLEEP; CREW; PERFORMANCE	In commercial aviation, fatigue is defined as a physiological state of reduced mental or physical performance capability resulting from sleep loss, extended wakefulness, circadian phase, and/or workload. The International Civil Aviation Organisation mandates that responsibility for fatigue risk management is shared between airline management, pilots, and support staff. However, to date, the majority of research relating to fatigue mitigations in long range operations has focused on the mitigations required or recommended by regulators and operators. Little research attention has been paid to the views or operational experience of the pilots who use these (or other) mitigations. This study focused on pilots' views and experiences of in-flight sleep as the primary fatigue mitigation on long range flights. It also sought information about other fatigue mitigation strategies they use. Thematic analysis was used to explore written comments from diary and survey data collected during long range and ultra-long range trips (N = 291 pilots on three different aircraft types, 17 different out-and-back trips, and four airlines based on three continents). The findings indicate that the recommended fatigue mitigation strategies on long-haul flights (particularly in-flight sleep) are effective and well-utilised, consistent with quantitative findings from the same trips. Importantly however, the analyses also highlight areas that require further investigation, including flight preparation strategies in relation to the uncertainty of in-flight break allocation. There were two strategies for sleep prior to a flight: maximising sleep if pilots were expecting later breaks in the flight; or minimising sleep if they were expecting breaks earlier or at unfavourable times in the circadian cycle. They also provide a broader view of the factors that affect the amount and quality of pilots' in-flight sleep, about which evidence has previously been largely anecdotal. The study underscores the value of including the views and experience of pilots in fatigue risk management.	[Zaslona, Jennifer L.; O'Keeffe, Karyn M.; Signal, T. Leigh; Gander, Philippa H.] Massey Univ, Sleep Wake Res Ctr, Wellington, New Zealand	Massey University	Zaslona, JL (corresponding author), Massey Univ, Sleep Wake Res Ctr, Wellington, New Zealand.	J.Zaslona@massey.ac.nz	O'Keeffe, Karyn M/I-1772-2013; Zaslona, Jennifer/ABB-5969-2020	O'Keeffe, Karyn M/0000-0003-1588-3638; Zaslona, Jennifer/0000-0002-6954-1150	Commonwealth Scholarship; Commonwealth Scholarship Commission	Commonwealth Scholarship; Commonwealth Scholarship Commission	Jennifer Zaslona was funded by a doctoral scholarship awarded by the Commonwealth Scholarship and Fellowship Plan provided by the Commonwealth Scholarship Commission. All other authors received no specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; Braun V., 2022, THEMATIC ANAL PRACTI; Braun V., 2012, THEMATIC ANAL, P57, DOI 10.1037/13620-004; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Dawson D, 2017, ACCIDENT ANAL PREV, V99, P465, DOI 10.1016/j.aap.2015.10.011; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Gander PH, 2015, J SLEEP RES, V24, P110, DOI 10.1111/jsr.12197; Gander PH, 2014, AVIAT SPACE ENVIR MD, V85, P833, DOI 10.3357/ASEM.3963.2014; Gander PH, 2013, J SLEEP RES, V22, P697, DOI 10.1111/jsr.12071; Holmes A, 2012, ACCIDENT ANAL PREV, V45, P27, DOI 10.1016/j.aap.2011.09.021; International Civil Aviation Organization, 2015, FAT MAN GUID AIRL OP; International Civil Aviation Organization, 2012, FAT RISK MAN SYST MA; International Civil Aviation Organization, 2016, MAN OV FAT MAN APPR, V2nd; Muzet A, 2007, SLEEP MED REV, V11, P135, DOI 10.1016/j.smrv.2006.09.001; NICHOLSON AN, 1987, ERGONOMICS, V30, P1033, DOI 10.1080/00140138708965993; Pascoe PA, 1995, DRACHSANCR95002; Pascoe PA, 1994, 778 RAF IAM; Roach GD, 2011, APPL ERGON, V42, P214, DOI 10.1016/j.apergo.2010.06.016; Rosekind MR, 2000, NASATM200209611 AM R; Signal TL, 2014, AVIAT SPACE ENVIR MD, V85, P1199, DOI 10.3357/ASEM.4034.2014; Signal TL, 2013, SLEEP, V36, P109, DOI 10.5665/sleep.2312; Signal TL, 2005, AVIAT SPACE ENVIR MD, V76, P1058; Signal TL, 2004, PHASE 3 ULTRALONG RA; Simons RM, 1994, RD3194A NETH AER MED; Simons RM, 1994, RD3194 NETH AER MED; Spencer MB, 2000, DERACHSPPDCR00008 CI; Wu L., 2012, THESIS; Zaslona JL, 2016, THESIS	29	14	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0195530	10.1371/journal.pone.0195530	http://dx.doi.org/10.1371/journal.pone.0195530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782533	gold, Green Submitted, Green Published			2022-12-26	WOS:000432537100001
J	Wojas, LE; Podkowa, PW; Osiejuk, TS				Wojas, Lucyna Ewa; Podkowa, Pawel Wojciech; Osiejuk, Tomasz Stanislaw			A nocturnal rail with a simple territorial call eavesdrops on interactions between rivals	PLOS ONE			English	Article							CORNCRAKE CREX-CREX; COMMUNICATION-NETWORKS; PUBLIC INFORMATION; MALES; EXPERIENCE; NEIGHBORS; PIGEONS	The behaviour of most animals has evolved in a communication network environment, in which signals produced by senders are perceived by many intended and unintended receivers. In this study, we tested whether the corncrake (Crex crex), a nocturnal rail species with innate (non-learned) calls, is able to eavesdrop on the interactions of conspecific males and how this eavesdropping affects subsequent responses by the eavesdropper to territorial intrusion. In the first step, simulated aggressive or neutral interactions between male dyads were presented to a focal male. In the second step, the calls of winning, losing or neutral males from the first step were played within the territory of the focal male. We measured behavioural and vocal responses of focal males. We found that corncrakes eavesdropped on signal exchange between rivals. Males often began responding to distant aggressive interactions during the eavesdropping phase, and they responded strongly during the intrusion phase of the experiments. The response was significantly weaker to playback of males from neutral interactions than to those involved in aggressive interactions, and we found no differences between the responses to Winners and Losers entering a focal male territory.	[Wojas, Lucyna Ewa; Osiejuk, Tomasz Stanislaw] Adam Mickiewicz Univ, Dept Behav Ecol, Poznan, Poland; [Podkowa, Pawel Wojciech] Adam Mickiewicz Univ, Dept Avian Biol & Ecol, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University	Wojas, LE (corresponding author), Adam Mickiewicz Univ, Dept Behav Ecol, Poznan, Poland.	lwojas@amu.edu.pl	Podkowa, Paweł/Y-1121-2018	Podkowa, Paweł/0000-0001-8148-9968	Polish National Science Centre grant Preludium [2012/07/N/NZ8/00062]; State Committee for Scientific Research [3 P04C 083 25]; Ministry of Science and Higher Education of the Republic of Poland under the Leading National Research Centre (KNOW) program	Polish National Science Centre grant Preludium; State Committee for Scientific Research(Polish State Committee for Scientific Research); Ministry of Science and Higher Education of the Republic of Poland under the Leading National Research Centre (KNOW) program(Ministry of Science and Higher Education, Poland)	Study was financially supported by the Polish National Science Centre grant Preludium no. 2012/07/N/NZ8/00062 to LEW. Part of equipment was purchased from the State Committee for Scientific Research grant no. 3 P04C 083 25 to TSO. Funding for the open access charge: Ministry of Science and Higher Education of the Republic of Poland, from the quality promoting subsidy, under the Leading National Research Centre (KNOW) program for the years 2014-2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2003, NATURE, V422, P483, DOI 10.1038/422483a; Aquiloni L, 2008, CURR BIOL, V18, pR462, DOI 10.1016/j.cub.2008.04.006; Aquiloni L, 2010, ANIM BEHAV, V79, P265, DOI 10.1016/j.anbehav.2009.09.024; Beecher MD, 2017, ANIM BEHAV, V124, P233, DOI 10.1016/j.anbehav.2016.09.001; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Budka M, 2015, J ORNITHOL, V156, P481, DOI 10.1007/s10336-014-1149-2; Budka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104031; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; Budka M, 2013, J ORNITHOL, V154, P685, DOI 10.1007/s10336-013-0933-8; Budka Michal, 2012, Ornis Polonica, V53, P165; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; de Kort SR, 2009, BEHAV ECOL, V20, P200, DOI 10.1093/beheco/arn135; EASON P, 1992, J ANIM ECOL, V61, P411, DOI 10.2307/5332; Fitzsimmons LP, 2008, BEHAV ECOL, V19, P824, DOI 10.1093/beheco/arn036; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Gotz T, 2006, BIOL LETTERS, V2, P5, DOI 10.1098/rsbl.2005.0407; Green Rhys E., 1997, Vogelwelt, V118, P117; Gregg J.D., 2007, INT J COMP PSYCHOL, V20, P65, DOI DOI 10.5070/P4201009979; Jones BC, 2011, ANIM BEHAV, V81, P1203, DOI 10.1016/j.anbehav.2011.03.003; LEIMAR O, 1984, J THEOR BIOL, V111, P475, DOI 10.1016/S0022-5193(84)80235-0; McCullagh P, 1989, GEN LINEAR MODELS; McGregor Peter K., 2000, Acta Ethologica, V2, P71, DOI 10.1007/s102110000015; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P79; McGregor PK, 2005, ANIMAL COMMUNICATION; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Mennill DJ, 2003, NATURWISSENSCHAFTEN, V90, P577, DOI 10.1007/s00114-003-0479-3; Mesterton-Gibbons M, 2007, B MATH BIOL, V69, P1255, DOI 10.1007/s11538-006-9151-3; Mouterde SC, 2012, ANIM BEHAV, V83, P605, DOI 10.1016/j.anbehav.2011.11.032; Naguib M, 1999, P ROY SOC B-BIOL SCI, V266, P537, DOI 10.1098/rspb.1999.0669; Naguib M, 2004, BEHAV ECOL, V15, P1011, DOI 10.1093/beheco/arh108; Nakamura T, 2003, LEARN BEHAV, V31, P307; Ophir AG, 2004, ANIM BEHAV, V68, P1221, DOI 10.1016/j.anbehav.2003.12.023; Osiejuk TS, 2004, ANIM BIOL, V54, P207, DOI 10.1163/1570756041445218; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Otter KA, 2001, J AVIAN BIOL, V32, P338, DOI 10.1111/j.0908-8857.2001.320408.x; Peake TM, 1998, IBIS, V140, P120, DOI 10.1111/j.1474-919X.1998.tb04548.x; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; Peake TM, 2001, P ROY SOC B-BIOL SCI, V268, P1183, DOI 10.1098/rspb.2001.1648; Plath Martin, 2011, Communicative & Integrative Biology, V4, P276, DOI 10.4161/cib.4.3.14916; Rek P, 2013, BEHAV PROCESS, V99, P121, DOI 10.1016/j.beproc.2013.07.009; Rek P, 2013, ANIM BEHAV, V86, P451, DOI 10.1016/j.anbehav.2013.05.042; Rek P, 2011, BEHAV PROCESS, V86, P323, DOI 10.1016/j.beproc.2011.01.011; Rek P, 2010, BEHAV ECOL, V21, P1203, DOI 10.1093/beheco/arq143; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Schaeffer Norbert, 1999, Oekologie der Voegel, V21, P1; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Sprau P, 2012, ANIM BEHAV, V83, P961, DOI 10.1016/j.anbehav.2012.01.015; Stephan C, 2013, ANIM BEHAV, V85, P605, DOI 10.1016/j.anbehav.2012.12.023; Taylor B, 1998, RAILS GUIDE RAILS CR, P320; Templeton CN, 2010, P ROY SOC B-BIOL SCI, V277, P447, DOI 10.1098/rspb.2009.1491; Toth CA, 2012, BEHAV ECOL, V23, P836, DOI 10.1093/beheco/ars038; Valone TJ, 2007, BEHAV ECOL SOCIOBIOL, V62, P1, DOI 10.1007/s00265-007-0439-6; Webster MM, 2013, ANIM BEHAV, V86, P75, DOI 10.1016/j.anbehav.2013.04.014; YDENBERG RC, 1988, ANIM BEHAV, V36, P343, DOI 10.1016/S0003-3472(88)80004-6	58	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197368	10.1371/journal.pone.0197368	http://dx.doi.org/10.1371/journal.pone.0197368			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG2KJ	29775465	Green Published, Green Submitted, gold			2022-12-26	WOS:000432521100015
J	Coello, Y; Quesque, F; Gigliotti, MF; Ott, L; Bruyelle, JL				Coello, Yann; Quesque, Francois; Gigliotti, Maria-Francesca; Ott, Laurent; Bruyelle, Jean-Luc			Idiosyncratic representation of peripersonal space depends on the success of one's own motor actions, but also the successful actions of others !	PLOS ONE			English	Article							TOOL-USE OBSERVATION; FAR SPACE; INTERPERSONAL SPACE; PRECENTRAL GYRUS; FRONTAL-CORTEX; SOCIAL-CONTEXT; FMRI REVEALS; REWARD; PERCEPTION; ATTENTION	Peripersonal space is a multisensory representation of the environment around the body in relation to the motor system, underlying the interactions with the physical and social world. Although changing body properties and social context have been shown to alter the functional processing of space, little is known about how changing the value of objects influences the representation of peripersonal space. In two experiments, we tested the effect of modifying the spatial distribution of reward-yielding targets on manual reaching actions and peripersonal space representation. Before and after performing a target-selection task consisting of manually selecting a set of targets on a touch-screen table, participants performed a twoalternative forced-choice reachability-judgment task. In the target-selection task, half of the targets were associated with a reward (change of colour from grey to green, providing 1 point), the other half being associated with no reward (change of colour from grey to red, providing no point). In Experiment 1, the target-selection task was performed individually with the aim of maximizing the point count, and the distribution of the reward-yielding targets was either 50%, 25% or 75% in the proximal and distal spaces. In Experiment 2, the target-selection task was performed in a social context involving cooperation between two participants to maximize the point count, and the distribution of the reward-yielding targets was 50% in the proximal and distal spaces. Results showed that changing the distribution of the reward-yielding targets or introducing the social context modified concurrently the amplitude of self-generated manual reaching actions and the representation of peripersonal space. Moreover, a decrease of the amplitude of manual reaching actions caused a reduction of peripersonal space when resulting from the distribution of reward-yielding targets, while this effect was not observed in a social interaction context. In that case, the decreased amplitude of manual reaching actions was accompanied by an increase of peripersonal space representation, which was not due to the mere presence of a confederate (control experiment). We conclude that reward-dependent modulation of objects values in the environment modifies the representation of peripersonal space, when resulting from either self-generated motor actions or observation of motor actions performed by a confederate.	[Coello, Yann; Quesque, Francois; Gigliotti, Maria-Francesca; Ott, Laurent; Bruyelle, Jean-Luc] Univ Lille, CNRS, UMR 9193, SCALab,Sci Cognit & Sci Affect, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille	Coello, Y (corresponding author), Univ Lille, CNRS, UMR 9193, SCALab,Sci Cognit & Sci Affect, Lille, France.	yann.coello@univ-lille.fr	Quesque, Francois/AAF-2948-2019	Quesque, Francois/0000-0001-7954-8316	French National Research Agency [ANR-11-EQPX-0023]; European funds through the program FEDER SCV-IrDIVE; University of Lille; Region Hauts-de-France	French National Research Agency(French National Research Agency (ANR)); European funds through the program FEDER SCV-IrDIVE; University of Lille; Region Hauts-de-France(Region Hauts-de-France)	This work was funded by the French National Research Agency (ANR-11-EQPX-0023) and also supported by European funds through the program FEDER SCV-IrDIVE to YC. FQ was supported by a PhD grant from the University of Lille and Region Hauts-de-France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the French National Research Agency (ANR-11-EQPX-0023) and also supported by European funds through the program FEDER SCV-IrDIVE to YC. FQ was supported by a PhD grant from the University of Lille and Region Hauts-de-France. The authors are grateful to John M. Belmont, Ph.D., for his helpful comments on the manuscript.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Aimola L, 2013, BEHAV NEUROL, V27, P245, DOI [10.1155/2013/198460, 10.3233/BEN-2012-110243]; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andersen RA, 2009, NEURON, V63, P568, DOI 10.1016/j.neuron.2009.08.028; Anderson BA, 2013, J VISION, V13, DOI 10.1167/13.3.7; Anderson BA, 2012, ATTEN PERCEPT PSYCHO, V74, P1183, DOI 10.3758/s13414-012-0325-9; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Azzi JCB, 2012, P NATL ACAD SCI USA, V109, P2126, DOI 10.1073/pnas.1111715109; Baess P, 2015, EXP BRAIN RES, V233, P105, DOI 10.1007/s00221-014-4092-9; Balcetis E, 2010, PSYCHOL SCI, V21, P147, DOI 10.1177/0956797609356283; Bartolo A., 2017, CORTEX, P30168; Bartolo A, 2014, EUR J NEUROSCI, V40, P3807, DOI 10.1111/ejn.12742; Bartolo A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00003; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bhanji JP, 2014, WIRES COGN SCI, V5, P61, DOI 10.1002/wcs.1266; Bourgeois J, 2014, ACTA PSYCHOL, V148, P91, DOI 10.1016/j.actpsy.2014.01.008; Bourgeois J, 2012, ATTEN PERCEPT PSYCHO, V74, P1268, DOI 10.3758/s13414-012-0316-x; Brown SBRE, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00033; Brozzoli C, 2014, NEUROSCIENTIST, V20, P122, DOI 10.1177/1073858413511153; Brozzoli C, 2009, NEUROREPORT, V20, P913, DOI 10.1097/WNR.0b013e32832c0b9b; Camara E, 2013, EXP BRAIN RES, V230, P291, DOI 10.1007/s00221-013-3654-6; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chelazzi L, 2013, VISION RES, V85, P58, DOI 10.1016/j.visres.2012.12.005; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Clery J, 2015, NEUROPSYCHOLOGIA, V70, P313, DOI 10.1016/j.neuropsychologia.2014.10.022; Coello Y., 2016, FDN EMBODIED COGNITI, P198, DOI DOI 10.4324/9781315751979; Coello Y, 2012, COGN PROCESS, V13, pS131, DOI 10.1007/s10339-012-0470-z; Coello Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002862; Cooke DF, 2004, J NEUROPHYSIOL, V91, P1648, DOI 10.1152/jn.00955.2003; Costantini M, 2014, EXP BRAIN RES, V232, P3233, DOI 10.1007/s00221-014-4012-z; Costantini M, 2011, NEUROPSYCHOLOGIA, V49, P2658, DOI 10.1016/j.neuropsychologia.2011.05.013; Costantini M, 2010, EXP BRAIN RES, V207, P95, DOI 10.1007/s00221-010-2435-8; COWEY A, 1994, NEUROPSYCHOLOGIA, V32, P1059, DOI 10.1016/0028-3932(94)90152-X; de Vignemont F, 2015, NEUROPSYCHOLOGIA, V70, P327, DOI 10.1016/j.neuropsychologia.2014.11.018; Delevoye Y., 2010, PERCEPTION ACTION CO, P217, DOI DOI 10.1093/ACPR0F:0S0/9780199551118.003.0012; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; di Pellegrino G, 2015, NEUROPSYCHOLOGIA, V66, P126, DOI 10.1016/j.neuropsychologia.2014.11.011; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dotsch D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00077; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Frischen A, 2009, COGNITION, V111, P212, DOI 10.1016/j.cognition.2009.02.003; Fujii N, 2009, SOC NEUROSCI-UK, V4, P73, DOI 10.1080/17470910802046230; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; Gawronski B, 2005, SOC COGNITION, V23, P182, DOI 10.1521/soco.23.2.182.65627; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P2621, DOI 10.1016/j.neuropsychologia.2005.09.011; Graziano MSA, 2000, EXP BRAIN RES, V135, P259, DOI 10.1007/s002210000518; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; Hickey C, 2012, CURR BIOL, V22, pR219, DOI 10.1016/j.cub.2012.02.007; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; Hughes G, 2011, NEUROIMAGE, V56, P1632, DOI 10.1016/j.neuroimage.2011.02.057; Hunley SB, 2017, EXP PSYCHOL, V64, P49, DOI 10.1027/1618-3169/a000350; Iachini T, 2016, J ENVIRON PSYCHOL, V45, P154, DOI 10.1016/j.jenvp.2016.01.004; Iachini T, 2015, ACTA PSYCHOL, V161, P131, DOI 10.1016/j.actpsy.2015.09.003; Iachini T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111511; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jiang YHV, 2015, ATTEN PERCEPT PSYCHO, V77, P50, DOI 10.3758/s13414-014-0747-7; Klaes C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002774; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P1229, DOI 10.3758/APP.72.5.1229; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Lebrecht S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00107; Lourenco SF, 2011, COGNITION, V119, P448, DOI 10.1016/j.cognition.2011.02.009; Madlon-Kay S, 2013, NEUROIMAGE, V70, P66, DOI 10.1016/j.neuroimage.2012.12.001; Maranesi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08956-1; Moratti S, 2011, J NEUROSCI, V31, P17278, DOI 10.1523/JNEUROSCI.2917-11.2011; Nandrino JL, 2017, EUR EAT DISORD REV, V25, P179, DOI 10.1002/erv.2506; Noel JP, 2017, SCHIZOPHR RES, V179, P8, DOI 10.1016/j.schres.2016.09.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pezzulo G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00800; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Prinz W., 1990, RELATIONSHIPS PERCEP, DOI DOI 10.1037/xlm0000474; Quesque F, 2017, PSYCHOL RES-PSYCH FO, V81, P709, DOI 10.1007/s00426-016-0782-1; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Rudebeck PH, 2008, J NEUROSCI, V28, P13775, DOI 10.1523/JNEUROSCI.3541-08.2008; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Sambo CF, 2012, J NEUROSCI, V32, P12921, DOI 10.1523/JNEUROSCI.0607-12.2012; Sambo CF, 2013, J NEUROSCI, V33, P14225, DOI 10.1523/JNEUROSCI.0706-13.2013; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2015, PHYSIOL REV, V95, P853, DOI 10.1152/physrev.00023.2014; Sirigu A, 2016, DIALOGUES CLIN NEURO, V18, P45; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Szpak A, 2015, NEUROPSYCHOLOGIA, V70, P462, DOI 10.1016/j.neuropsychologia.2014.10.008; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Teneggi C, 2013, CURR BIOL, V23, P406, DOI 10.1016/j.cub.2013.01.043; Theeuwes J, 2012, VISION RES, V74, P80, DOI 10.1016/j.visres.2012.07.024; Valdes-Conroy B, 2014, NEUROPSYCHOLOGIA, V59, P27, DOI 10.1016/j.neuropsychologia.2014.04.009; Vesper C, 2017, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.02039; Vuilleumier P, 1998, ANN NEUROL, V43, P406, DOI 10.1002/ana.410430324; Wamain Yannick, 2016, Cortex, V74, P20, DOI 10.1016/j.cortex.2015.10.006; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107; Xu-Wilson M, 2009, EXP BRAIN RES, V196, P475, DOI 10.1007/s00221-009-1879-1	106	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							eOl96874	10.1371/journal.pone.0196874	http://dx.doi.org/10.1371/journal.pone.0196874			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG0DP	29771982	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900021
J	Lara, W; Bogino, S; Bravo, F				Lara, Wilson; Bogino, Stella; Bravo, Felipe			Multilevel analysis of dendroclimatic series with the R-package BIOdry	PLOS ONE			English	Article							GENERAL-MODEL; TREE-RINGS; GROWTH; DENDROCHRONOLOGY; FORESTS; CLIMATE; TIME; ECOLOGY; DECLINE	The R-package BIOdry allows to model and compare fluctuations of Tree-ring Width (TRW) and climate, or dendroclimatic fluctuations, while accounting for source variability. The package eases multilevel modeling and multivariate comparison in dendroclimatic analysis using the nlme and ecodist packages, respectively. For implementing such libraries, the in-package algorithms transform the dendroclimatic fluctuations into Multilevel Dendroclimatic Data Series and maintain categorical variables and time units in the outputs. The dendroclimatic modeling is developed with two functions: modelFrame and muleMan. The first function binds core-level cumulative TRWs to the processed data sets and subtracts trends in TRWs by fitting multilevel log-linear growth formulas or multilevel linear formulas. modelFrame can also model within-group fluctuations in dendroclimatic variables other than tree-radial increments such as aridity indices or allometric components of tree growth: e.g. diameters at breast height over bark, tree basal areas, total tree biomass, among other. The second function compares fluctuations in modelFrame objects that share outermost categorical variable and annual records. Here, we use BlOdry to model dendroclimatic relationships in northern and east-central Spain to illustrate future users in the implementation of the package for modeling ecological relationships in space and time.	[Lara, Wilson; Bravo, Felipe] UVA INIA, Sustainable Forest Management Res Inst, Avda Madrid S-N, Palencia 34071, Spain; [Lara, Wilson] Temple Univ, Coll Liberal Arts, Dept Geog & Urban Studies, 316 Gladfelter Hall,115 W Polett Walk, Philadelphia, PA 19122 USA; [Bogino, Stella] Univ Nacl San Luis, Dept Ciencias Agr, Ave 25 Mayo 384, RA-5730 Villa Mercedes, San Luis, Argentina	Universidad de Valladolid; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Universidad Nacional de San Luis	Lara, W (corresponding author), UVA INIA, Sustainable Forest Management Res Inst, Avda Madrid S-N, Palencia 34071, Spain.; Lara, W (corresponding author), Temple Univ, Coll Liberal Arts, Dept Geog & Urban Studies, 316 Gladfelter Hall,115 W Polett Walk, Philadelphia, PA 19122 USA.	wilarhen@gmail.com	Bravo, Felipe/C-5073-2009	Bravo, Felipe/0000-0001-7348-6695; Lara Henao, Wilson/0000-0003-3527-1380	Colombian Government (Colciencias) within the framework of the National Program for Doctoral Studies Abroad [568]; FORMIXING project - Spanish Ministry of Economy, Industry and Competitiveness [AGL2014-51964-C2-1-R]	Colombian Government (Colciencias) within the framework of the National Program for Doctoral Studies Abroad(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); FORMIXING project - Spanish Ministry of Economy, Industry and Competitiveness	This research has been supported through funds from the Colombian Government (Colciencias) within the framework of the National Program for Doctoral Studies Abroad (Year 2012, Number 568) to WL (URL: http://legadoweb.colciencias.gov.co/convocatoria/convocatoria-nacional-para-estudios-de-doctorado-en-el-exterior-o-2012-conformaci-n-de-). This study was also financed by the FORMIXING project (AGL2014-51964-C2-1-R) funded by the Spanish Ministry of Economy, Industry and Competitiveness to FB (URL: http://www.mineco.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been supported through funds from the Colombian Government (Colciencias) within the framework of the National Program for Doctoral Studies Abroad (Year 2012, Number 568). This study was also financed by the FORMIXING project (AGL2014-51964-C2-1-R) funded by the Spanish Ministry of Economy, Industry and Competitiveness. Our thanks to the researchers at the UVa-INIA Sustainable Forest Management Research Institute for their assistance in core sampling and for their ideas related to the development of the algorithm; in particular Cristobal Ordonez, Ana de Luca, Jose Riofrio, and Cristina Prieto. Many thanks to Andy Bunn (Western Washington University), Ignacio del Valle (National University of Colombia) and Victor Gutierrez-Velez (Temple University) for their valuable suggestions. Finally, we want to thank the anonymous reviewers, as well as Ben Bon-Lamberty (Academic Editor of PLOS ONE), for their suggestions and comments.	Battipaglia G, 2009, FOREST ECOL MANAG, V257, P820, DOI 10.1016/j.foreco.2008.10.015; Bogino SM, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008025; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boswijk G, 2014, QUATERNARY SCI REV, V90, P128, DOI 10.1016/j.quascirev.2014.02.022; Bowman DMJS, 2013, TRENDS PLANT SCI, V18, P11, DOI 10.1016/j.tplants.2012.08.005; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Bunn AG, 2010, DENDROCHRONOLOGIA, V28, P251, DOI 10.1016/j.dendro.2009.12.001; Carrer M, 2015, TREE PHYSIOL; Cocozza C., 2014, ECOHYDROLOGY, V8, P1; Cook E.R., 1996, GUIDE COMPUTER PROGR; Cook ER, 2011, DEV PALEOENVIRON RES, V11, P77, DOI 10.1007/978-1-4020-5725-0_4; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Crawley MJ, 2013, R BOOK, P557; De Micco V, 2014, DENDROCHRONOLOGIA, V32, P1, DOI 10.1016/j.dendro.2013.06.001; Farmer G.T., 2013, CLIMATE CHANGE SCI M, V1; Foster JR, 2014, OECOLOGIA, V175, P363, DOI 10.1007/s00442-014-2881-2; Fritts H. C., 1976, TREE RINGS CLIMATE; Galecki A, 2013, SPRINGER TEXTS IN ST; Garcia-Lopez JM, 2012, ECOL INDIC, V18, P73, DOI 10.1016/j.ecolind.2011.10.004; Gerhart LM, 2014, BIOGEOCHEMISTRY, V120, P1, DOI 10.1007/s10533-014-9988-8; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Green P, 2016, METHODS ECOL EVOL, V7, P493, DOI 10.1111/2041-210X.12504; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; Guijarro J.A., 2011, USERS GUIDE CLIMATOL; Hughes Malcolm K., 2002, Dendrochronologia, V20, P95, DOI 10.1078/1125-7865-00011; Hughes MK, 2011, DEV PALEOENVIRON RES, V11, P1, DOI 10.1007/978-1-4020-5725-0; Hurlbert S. H., 2003, ECOLOGY, V84, P810, DOI DOI 10.1890/0012-9658(2003)084[0810:DAAUIU]2.0.CO;2; Jia Z, 2009, AGR WATER MANAGE, V96, P1339, DOI 10.1016/j.agwat.2009.04.006; Jones MD, 2016, J TORREY BOT SOC, V143, P239, DOI 10.3159/TORREY-D-15-00053; Jorgensen SE, 2016, ECOL MODEL, V319, P112, DOI 10.1016/j.ecolmodel.2015.08.007; Kanatjev AG, 2014, INSTRUM EXP TECH+, V57, P214, DOI 10.1134/S0020441214020080; Kempes CP, 2008, J ARID ENVIRON, V72, P350, DOI 10.1016/j.jaridenv.2007.07.009; King DA, 2005, ECOL MODEL, V185, P77, DOI 10.1016/j.ecolmodel.2004.11.017; Lara W, 2013, AGR FOREST METEOROL, V178, P140, DOI 10.1016/j.agrformet.2013.04.017; Legendre P, 2000, J STAT COMPUT SIM, V67, P37, DOI 10.1080/00949650008812035; Legendre P, 2012, DEVELOPMENTS IN ENVI, V24; Lei Y.C., 2004, NONLINEAR ANAL-MODEL, V9, P65, DOI [DOI 10.15388/NA.2004.9.1.15171, 10.15388/na.2004.9.1.15171]; Manrique E, 2000, CLIMATIC CHANGE, V44, P123; Martinelli N, 2004, GLOBAL PLANET CHANGE, V40, P129, DOI 10.1016/S0921-8181(03)00103-6; Metsaranta JM, 2009, FORESTRY, V82, P163, DOI 10.1093/forestry/cpn051; Mishra A. K., 2010, J HYDROL, V391, P202, DOI [DOI 10.1016/J.JHYDROL.2010.07.012, 10.1016/j.jhydrol.2010.07.012, DOI 10.1016/j.jhydrol.2010.07.012]; Nehrbass-Ahles C, 2014, GLOBAL CHANGE BIOL, V20, P2867, DOI 10.1111/gcb.12599; Oksanen J., 2015, MULTIVARIATE ANAL EC; Oswald SA, 2012, METHODS ECOL EVOL, V3, P1073, DOI 10.1111/j.2041-210X.2012.00231.x; Peters RL, 2014, GLOBAL CHANGE BIOL; Petrillo M, 2016, BIOGEOSCIENCES, V13, P1537, DOI 10.5194/bg-13-1537-2016; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pommerening A, 2016, ECOL MODEL, V320, P383, DOI 10.1016/j.ecolmodel.2015.10.015; Regent Instruments Canada Inc, 2009, WINDENDRO TREE RING; Sanogo K, 2016, POTENTIAL OF DENDROC; Shi PJ, 2016, ECOL MODEL, V320, P177, DOI 10.1016/j.ecolmodel.2015.09.012; Shumway R.H., 2006, TIME SERIES ANAL ITS; Speer JH, 2010, FUNDAMENTALS TREE RI; Stillwell R, 2016, EVOLUTION; Stow CA, 2006, ECOLOGY, V87, P1472, DOI 10.1890/0012-9658(2006)87[1472:ABATRB]2.0.CO;2; Tjorve E, 2010, J THEOR BIOL, V267, P417, DOI 10.1016/j.jtbi.2010.09.008; Touchan R, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/044020; Troupin D, 2006, MOL ECOL, V15, P3617, DOI 10.1111/j.1365-294X.2006.03047.x; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; VONBERTALANFFY L, 1950, SCIENCE, V111, P23, DOI 10.1126/science.111.2872.23; Voor Tech Consulting, 2008, MEAS J2X; Walter H., 1985, VEGETATION EARTH ECO; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wu YL, 2017, J PLANT ECOL, V10, P415, DOI 10.1093/jpe/rtw076; ZEIDE B, 1993, FOREST SCI, V39, P594, DOI 10.1093/forestscience/39.3.594	67	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196923	10.1371/journal.pone.0196923	http://dx.doi.org/10.1371/journal.pone.0196923			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771934	Green Published, gold, Green Submitted			2022-12-26	WOS:000432348900023
J	Rabani, S; Sardarinia, M; Akbarpour, S; Azizi, F; Khalili, D; Hadaegh, F				Rabani, SeyedHossein; Sardarinia, Mahsa; Akbarpour, Samaneh; Azizi, Fereidoun; Khalili, Davood; Hadaegh, Farzad			12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; SECONDARY PREVENTION; KIDNEY-DISEASE; COLLABORATIVE METAANALYSIS; MYOCARDIAL-INFARCTION; HEART-DISEASE; MORTALITY; PREVALENCE; STROKE; INDIVIDUALS	Background To examine the trend of cardiovascular diseases (CVD) risk factors among a Middle Eastern population with prevalent CVD during a median follow up of 12 years. Methods Patients with prevalent CVD (n = 282, men = 167), with a mean age of 60.76 years were evaluated in four study phases of the TLGS (Tehran lipid glucose study), 2002-2005, 2005-2008, 2008-2011, and 2011-2014. Trends of CVD risk factors were estimated using generalized estimation equation (GEE) models, by adjusting for gender, age and propensity scores. Result The adjusted prevalence of general and central adiposity, diabetes and physical inactivity at baseline was 25.18, 60.14, 25.03 and 43.74%, respectively and had increasing trends during the study period, reaching 41.32, 66.74, 43.20 and 50.32%, respectively, at the last visit. Although systolic, but not diastolic blood pressure, decreased from 134.88 to 129.86 mmHg, the prevalence of hypertension did not decrease(64.21% vs 68%, p value = 0.326). The prevalence of low high density lipoprotein cholesterol (HDL-C), hypertriglyceridemia and high non-HDL-C at baseline was 74.54, 59.89 and 96.53%, respectively, and showed improved trends reaching 44.87, 47.12 and 96.06% respectively; however, the favorable trend was not observed for high low density cholesterol. Significant increasing trends were observed in the consumption of anti-hypertensive, lipid and glucose lowering medications, but not for aspirin. The prevalence of current smoking (11.05 vs 16.83%, p value = 0.042) and chronic kidney disease (44.16 vs 51.65%, p value = 0.054) increased during follow up. Conclusion Except for lipid profile status, dangerous trends for other CVD risk factors were demonstrated among CVD patients, which can be a harbinger for high rates of CVD mortality; these findings highlight the need for urgent implementation of multicomponent interventions to control CVD risk factors among these patients.	[Rabani, SeyedHossein; Sardarinia, Mahsa; Akbarpour, Samaneh; Khalili, Davood; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Akbarpour, Samaneh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	fzhadaegh@endocrine.ac.ir	hadaegh, farzad/K-2460-2017; Khalili, Davood/T-2913-2017; Azizi, Fereidoun/ABD-4136-2021	Khalili, Davood/0000-0003-4956-1039; Azizi, Fereidoun/0000-0002-6470-2517; Hadaegh, Farzad/0000-0002-8935-2744; hadaegh, farzad/0000-0002-0352-8666	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by grant No. 121 from the National Research Council of the Islamic Republic of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Asgari S, 2016, INT J ENDOCRINOL MET, V14, DOI 10.5812/ijem.37018; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Baber U, 2013, AM HEART J, V166, P373, DOI 10.1016/j.ahj.2013.05.008; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Chen YQ, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-52; Colantonio LD, 2017, JAMA CARDIOL, V2, P890, DOI 10.1001/jamacardio.2017.0911; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Committee IPAQR, 2005, GUID DAT PROC AN INT; Conn VS, 2009, AM J PREV MED, V37, P330, DOI 10.1016/j.amepre.2009.06.008; Critchley J, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD003041.PUB2, 10.1002/14651858.CD003041.pub2]; De Vera MA, 2014, BRIT J CLIN PHARMACO, V78, P684, DOI 10.1111/bcp.12339; Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Gigliotti A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-327; Gupta R, 2004, J AM COLL CARDIOL, V44, P1343, DOI 10.1016/j.jacc.2004.06.058; Hadaegh F, 2009, INT J OBESITY, V33, P1437, DOI 10.1038/ijo.2009.180; Hadaegh F, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-84; Hosseini V, 2016, IRAN STUD-UK, V49, P1029, DOI 10.1080/00210862.2016.1241587; Inker LA, 2013, NEPHROL DIAL TRANSPL, V28, P1390, DOI 10.1093/ndt/gft003; Jahangiri-Noudeh Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112639; Kheirandish M, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-20; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Koohpayehzadeh J, 2014, INT J PUBLIC HEALTH, V59, P231, DOI 10.1007/s00038-013-0529-3; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Lee Moo-Sik, 2014, J Prev Med Public Health, V47, P216, DOI 10.3961/jpmph.2014.47.4.216; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lindholm LH, 2007, LANCET, V370, P720, DOI 10.1016/S0140-6736(07)61356-7; Lloyd-Jones DM, 2017, J AM COLL CARDIOL, V70, P1785, DOI 10.1016/j.jacc.2017.07.745; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; Mariscalco G, 2017, CIRCULATION, V135, P850, DOI 10.1161/CIRCULATIONAHA.116.022840; Mohammadifard N, 2013, ARYA ATHEROSCLER, V9, P29; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Muntner P, 2006, AM J EPIDEMIOL, V163, P913, DOI 10.1093/aje/kwj124; Nilsson PM, 2012, HYPERTENSION, V59, P8, DOI 10.1161/HYPERTENSIONAHA.111.182774; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; Oreopoulos A, 2008, OBESITY, V16, P442, DOI 10.1038/oby.2007.36; Organization WH, 2003, HLTH DEV PHYS ACT SP; Ovbiagele B, 2013, STROKE, V44, P3223, DOI 10.1161/STROKEAHA.113.002463; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Rosolova H, 2017, PHYSIOL RES, V66, pS77, DOI 10.33549/physiolres.933598; Sardarinia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167623; Sidney S, 2016, JAMA CARDIOL, V1, P594, DOI 10.1001/jamacardio.2016.1326; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stuntz Mark, 2017, Prev Med Rep, V5, P183, DOI 10.1016/j.pmedr.2016.12.023; Szummer K, 2010, J INTERN MED, V268, P40, DOI 10.1111/j.1365-2796.2009.02204.x; Thompson AM, 2011, JAMA-J AM MED ASSOC, V305, P913, DOI 10.1001/jama.2011.250; Tohidi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045304; Torabi P, 2004, 12 NUTR C TABR IR; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	57	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0195543	10.1371/journal.pone.0195543	http://dx.doi.org/10.1371/journal.pone.0195543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768511	Green Submitted, gold, Green Published			2022-12-26	WOS:000432329200008
J	Zaidi, S; Bouam, A; Bessas, A; Hezil, D; Ghaoui, H; Ait-Oudhia, K; Drancourt, M; Bitam, I				Zaidi, Sara; Bouam, Amar; Bessas, Amina; Hezil, Djamila; Ghaoui, Hicham; Ait-Oudhia, Khatima; Drancourt, Michel; Bitam, Idir			Urinary shedding of pathogenic Leptospira in stray dogs and cats, Algiers: A prospective study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REACTION ASSAY; SEROLOGICAL SURVEY; RISK-FACTORS; EARLY-DIAGNOSIS; CANINE URINE; ANTIBODIES; INFECTION; PCR; GRIPPOTYPHOSA	Background Leptospirosis is an important worldwide zoonosis. This disease is caused by pathogenic species of the genus Leptospira which are maintained in the environment via chronic renal infection of carrier animals which can be asymptomatic excretors of the organisms in their urines and become a source of infection for humans and other hosts. The prevalence of animal leptospirosis in Algiers, Algeria, is unknown. Methodology/principal findings Real-time PCR and standard PCR and sequencing were used to detect pathogenic Leptospira organisms in the urines of stray dogs and cats in Algiers. In the presence of appropriate controls, none of the 107 cat urine samples were positive while 5/104 (4.8%) canine urine samples (asymptomatic mixed-breed dogs, three females and two males) were positive in two real-time PCR assays targeting the rrs and hsp genes. The positivity of these samples was confirmed by partial PCR-sequencing of the rpoB gene which yielded 100% sequence similarity with Leptospira interrogans reference sequence. In this study, L. interrogans prevalence was significantly higher in dogs aged < one year (16.46% - 29.41%) than in adults (0%) (P value = 0.0001) and then in the overall dog population (2.68% -4.8%) (P = 0.0007). Conclusions/significance These results suggest that dogs are maintenance hosts for zoonotic leptospirosis in Algiers, Algeria. To face this situation, effective canine vaccination strategies and raising public health awareness are mandatory. Further investigations incorporating a larger sample in more localities will be undertaken to document the epidemiology of urban animal leptospirosis in Algeria at large.	[Zaidi, Sara; Bessas, Amina; Hezil, Djamila; Ghaoui, Hicham; Ait-Oudhia, Khatima] Ecole Natl Super Vet, Algiers, Algeria; [Bouam, Amar; Ghaoui, Hicham; Drancourt, Michel] Aix Marseille Univ, IHU Mediterranee Infect, MEPHI, IRD, Marseille, France; [Bitam, Idir] ESSAIA, El Harrach, Alger, Algeria; [Bitam, Idir] Aix Marseille Univ, IRD, VITROME, IHU Mediterranee Infect, Marseille, France	Ecole Nationale Superieure Veterinaire; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Drancourt, M (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, MEPHI, IRD, Marseille, France.	michel.drancourt@univ-amu.fr		BOUAM, Amar/0000-0001-8470-4459; Ait-Oudhia, Khatima/0000-0002-2514-5615	Fondation Mediterranee Infection, Marseille, France; French Government under the "Investissements d'avenir" (Investments for the Future) program [10-IAHU-03]	Fondation Mediterranee Infection, Marseille, France; French Government under the "Investissements d'avenir" (Investments for the Future) program(French National Research Agency (ANR))	AB benefits from a PhD grant from the Fondation Mediterranee Infection, Marseille, France. This work was supported by the French Government under the "Investissements d'avenir" (Investments for the Future) program managed by the Agence Nationale de la Recherche (ANR, fr: National Agency for Research), (reference: Mediterranee Infection 10-IAHU-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afiri M, 2013, Med Sante Trop, V23, P234, DOI 10.1684/mst.2013.0203; Agunloye CA, 1996, J SMALL ANIM PRACT, V37, P126, DOI 10.1111/j.1748-5827.1996.tb02360.x; Appelt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088376; Arbour J, 2012, J AM ANIM HOSP ASSOC, V48, P256, DOI 10.5326/JAAHA-MS-5748; Aubry P, 1975, Bull Soc Pathol Exot Filiales, V68, P370; Azocar-Aedo Lucia, 2014, Animals (Basel), V4, P612, DOI 10.3390/ani4040612; BAL AE, 1994, J CLIN MICROBIOL, V32, P1894, DOI 10.1128/JCM.32.8.1894-1898.1994; Branger C, 2005, FEMS MICROBIOL LETT, V243, P437, DOI 10.1016/j.femsle.2005.01.007; Brown CA, 1996, J AM VET MED ASSOC, V209, P1265; Brown PD, 2011, INT J OCCUP ENV MED, V2, P47; BROWN PD, 1995, J MED MICROBIOL, V43, P110, DOI 10.1099/00222615-43-2-110; Bryant TN, 2000, STAT CONFIDENCE, P49; Cai HY, 2002, J VET DIAGN INVEST, V14, P164, DOI 10.1177/104063870201400214; Calderon A, 2014, TROP ANIM HEALTH PRO, V46, P427, DOI 10.1007/s11250-013-0508-y; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Chan KW, 2014, VECTOR-BORNE ZOONOT, V14, P118, DOI 10.1089/vbz.2013.1324; Davis MA, 2008, ZOONOSES PUBLIC HLTH, V55, P436, DOI 10.1111/j.1863-2378.2008.01137.x; Delaude A, 2017, PREV VET MED, V141, P48, DOI 10.1016/j.prevetmed.2017.04.008; Desvars A, 2013, EPIDEMIOL INFECT, V141, P1154, DOI 10.1017/S0950268812002075; DICKESON D, 1993, AUST VET J, V70, P389, DOI 10.1111/j.1751-0813.1993.tb00823.x; DONATIEN A., 1951, ARCH INST PASTEUR ALGERIE, V29, P20; dos Santos LF, 2017, TROP ANIM HEALTH PRO, V49, P1715, DOI 10.1007/s11250-017-1382-9; Felt SA, 2011, AM J TROP MED HYG, V84, P420, DOI 10.4269/ajtmh.2011.10-0393; Fink JM, 2015, J VET DIAGN INVEST, V27, P159, DOI 10.1177/1040638715571360; Fraune CK, 2013, JAVMA-J AM VET MED A, V242, P1373, DOI 10.2460/javma.242.10.1373; Gay N, 2014, INT J ENV RES PUB HE, V11, P4316, DOI 10.3390/ijerph110404316; Harkin KR, 2003, J AM VET MED ASSOC, V222, P1230, DOI 10.2460/javma.2003.222.1230; Harkin KR, 2003, J AM VET MED ASSOC, V222, P1224, DOI 10.2460/javma.2003.222.1224; Hartmann K, 2013, J FELINE MED SURG, V15, P576, DOI 10.1177/1098612X13489217; Jamshidi S, 2009, IRAN J MICROBIOL, V1, P32; Klopfleisch R, 2010, EMERGING PULMONARY H, DOI [10.4061/2010/928541, DOI 10.4061/2010/928541]; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x; Langston CE, 2003, VET CLIN N AM-SMALL, V33, P791, DOI 10.1016/S0195-5616(03)00026-3; Lapointe C, 2013, CAN VET J, V54, P497; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Llewellyn JR, 2016, BERL MUNCH TIERARZTL, V129, P251, DOI 10.2376/0005-9366-129-15061; Millan J, 2009, VECTOR-BORNE ZOONOT, V9, P549, DOI 10.1089/vbz.2008.0081; Monahan AM, 2009, J APPL MICROBIOL, V107, P707, DOI 10.1111/j.1365-2672.2009.04220.x; Munoz-Zanzi C, 2014, INT J ENV RES PUB HE, V11, P6666, DOI 10.3390/ijerph110706666; Musso D, 2013, J MICROBIOL IMMUNOL, V46, P245, DOI 10.1016/j.jmii.2013.03.001; Mylonakis ME, 2005, VET REC, V156, P615, DOI 10.1136/vr.156.19.615; Oliveira ST, 2012, ACTA SCI VET, V40; Patterson MJ, 1996, MED MICROBIOLOGY; Ramírez Díaz Mario H., 2015, Rev. electrón. investig. educ. cienc., V10, P59; Renaud C, 2013, VET J, V196, P126, DOI 10.1016/j.tvjl.2012.10.002; Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116; Rodriguez J, 2014, J VET INTERN MED, V28, P284, DOI 10.1111/jvim.12287; Rojas P, 2010, EUR J CLIN MICROBIOL, V29, P1305, DOI 10.1007/s10096-010-0991-2; SanT'Anna R, 2017, EPIDEMIOL INFECT, V145, P1852, DOI 10.1017/S0950268817000632; Scanziani E, 2002, J SMALL ANIM PRACT, V43, P154, DOI 10.1111/j.1748-5827.2002.tb00048.x; Smythe LD, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-13; Thaipadunpanit J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016236; Viau EJ, 2011, J WATER HEALTH, V9, P637, DOI 10.2166/wh.2011.064; Vicari Domenico, 2007, Rev Cubana Med Trop, V59, P61; Villumsen S, 2012, J MICROBIOL METH, V91, P184, DOI 10.1016/j.mimet.2012.06.009; Ward MP, 2002, J AM VET MED ASSOC, V220, P53, DOI 10.2460/javma.2002.220.53; Weis S, 2017, J FELINE MED SURG, V19, P470, DOI 10.1177/1098612X16634389; Xu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089507; Zakeri S, 2010, INFECT GENET EVOL, V10, P273, DOI 10.1016/j.meegid.2010.01.001	60	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197068	10.1371/journal.pone.0197068	http://dx.doi.org/10.1371/journal.pone.0197068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768448	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200055
J	Luk, B; Veeraragavan, S; Engevik, M; Balderas, M; Major, A; Runge, J; Luna, RA; Versalovic, J				Luk, Berkley; Veeraragavan, Surabi; Engevik, Melinda; Balderas, Miriam; Major, Angela; Runge, Jessica; Luna, Ruth Ann; Versalovic, James			Postnatal colonization with human "infant-type" Bifidobacterium species alters behavior of adult gnotobiotic mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MODULATES BRAIN-DEVELOPMENT; GUT MICROBIOTA; IMPACT; AUTOIMMUNITY; MATURATION; DEFICITS; ANXIETY; MODEL	Accumulating studies have defined a role for the intestinal microbiota in modulation of host behavior. Research using gnotobiotic mice emphasizes that early microbial colonization with a complex microbiota (conventionalization) can rescue some of the behavioral abnormalities observed in mice that grow to adulthood completely devoid of bacteria (germ-free mice). However, the human infant and adult microbiomes vary greatly, and effects of the neonatal microbiome on neurodevelopment are currently not well understood. Microbe-mediated modulation of neural circuit patterning in the brain during neurodevelopment may have significant long-term implications that we are only beginning to appreciate. Modulation of the host central nervous system by the early-life microbiota is predicted to have pervasive and lasting effects on brain function and behavior. We sought to replicate this early microbe-host interaction by colonizing gnotobiotic mice at the neonatal stage with a simplified model of the human infant gut microbiota. This model consortium consisted of four "infant-type" Bifidobacterium species known to be commensal members of the human infant microbiota present in high abundance during postnatal development. Germ-free mice and mice neonatally-colonized with a complex, conventional murine microbiota were used for comparison. Motor and non-motor behaviors of the mice were tested at 6-7 weeks of age, and colonization patterns were characterized by 16S ribosomal RNA gene sequencing. Adult germ-free mice were observed to have abnormal memory, sociability, anxiety-like behaviors, and motor performance. Conventionalization at the neonatal stage rescued these behavioral abnormalities, and mice colonized with Bifidobacterium spp. also exhibited important behavioral differences relative to the germ-free controls. The ability of Bifidobacterium spp. to improve the recognition memory of both male and female germ-free mice was a prominent finding. Together, these data demonstrate that the early-life gut microbiome, and human "infant-type" Bifidobacterium species, affect adult behavior in a strongly sex-dependent manner, and can selectively recapitulate the results observed when mice are colonized with a complex microbiota.	[Luk, Berkley; Engevik, Melinda; Balderas, Miriam; Major, Angela; Runge, Jessica; Luna, Ruth Ann; Versalovic, James] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Luk, Berkley; Engevik, Melinda; Balderas, Miriam; Runge, Jessica; Luna, Ruth Ann; Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Luk, Berkley] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Veeraragavan, Surabi] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Balderas, Miriam; Runge, Jessica; Luna, Ruth Ann; Versalovic, James] Texas Childrens Hosp, Texas Childrens Microbiome Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Versalovic, J (corresponding author), Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA.; Versalovic, J (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.; Versalovic, J (corresponding author), Texas Childrens Hosp, Texas Childrens Microbiome Ctr, Houston, TX 77030 USA.	jamesv@bcm.edu	Engevik, Mindy/P-9725-2018	Engevik, Mindy/0000-0002-9742-9932; Luck, Berkley/0000-0001-5996-876X	Texas Children's Hospital (Houston, Texas, USA); National Institutes of Health; Texas Medical Center Digestive Disease Center [P30 DK56338]; National Cancer Institute [U01 CM 70930]; BioGaia AB (Stockholm, Sweden); Baylor College of Medicine IDDRC Grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54HD083092]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	Texas Children's Hospital (Houston, Texas, USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Medical Center Digestive Disease Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BioGaia AB (Stockholm, Sweden); Baylor College of Medicine IDDRC Grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from Texas Children's Hospital (Houston, Texas, USA), the National Institutes of Health to James Versalovic including the Texas Medical Center Digestive Disease Center (P30 DK56338), National Cancer Institute (U01 CM 70930), and unrestricted research support from BioGaia AB (Stockholm, Sweden) to James Versalovic. The project was supported in part by Baylor College of Medicine IDDRC Grant Number U54HD083092 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2014, NEUROGASTROENT MOTIL, V26, P510, DOI 10.1111/nmo.12295; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204; Arentsen T, 2017, MOL PSYCHIATR, V22, P257, DOI 10.1038/mp.2016.182; Arentsen Tim, 2015, Microbial Ecology in Health and Disease, V26, P29719, DOI 10.3402/mehd.v26.29719; Bercik P, 2012, NEUROGASTROENT MOTIL, V24, P405, DOI 10.1111/j.1365-2982.2012.01906.x; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bercik P, 2010, GASTROENTEROLOGY, V139, P2102, DOI 10.1053/j.gastro.2010.06.063; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; De Palma G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8735; De Palma G, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6397; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Desbonnet L, 2008, J PSYCHIATR RES, V43, P164, DOI 10.1016/j.jpsychires.2008.03.009; Di Gioia D, 2014, APPL MICROBIOL BIOT, V98, P563, DOI 10.1007/s00253-013-5405-9; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Foster JA, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv114; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Haghikia A, 2015, IMMUNITY, V43, P817, DOI 10.1016/j.immuni.2015.09.007; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hildebrand F, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-30; Hoban AE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.42; Hoban AE, 2017, MOL PSYCHIATR, DOI [10.1038/mp.2017.100PMID:28507320, DOI 10.1038/MP.2017.100PMID:28507320]; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Jasarevic E, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0122; Komada M, 2008, JOVE-J VIS EXP, DOI [10.3791/1088PMID:19229173, DOI 10.3791/1088PMID:19229173]; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Luczynski P, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw020; Lyte M, 2014, GUT MICROBES, V5, P381, DOI 10.4161/gmic.28682; MacFabe Derrick F., 2015, Microbial Ecology in Health and Disease, V26, P28177, DOI 10.3402/mehd.v26.28177; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Marzban H, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00450; Matsuki T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11939; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; Moeller AH, 2016, SCIENCE, V353, P380, DOI 10.1126/science.aaf3951; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Neuman H, 2015, FEMS MICROBIOL REV, V39, P509, DOI 10.1093/femsre/fuu010; Nishino R, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12110; Ogbonnaya ES, 2015, BIOL PSYCHIAT, V78, pE7, DOI 10.1016/j.biopsych.2014.12.023; Pokusaeva K, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12904; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RODGERS RJ, 1995, PHARMACOL BIOCHEM BE, V52, P297, DOI 10.1016/0091-3057(95)00138-M; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Saulnier DM, 2013, GUT MICROBES, V4, P17, DOI 10.4161/gmic.22973; Savignac HM, 2015, BEHAV BRAIN RES, V287, P59, DOI 10.1016/j.bbr.2015.02.044; Savignac HM, 2014, NEUROGASTROENT MOTIL, V26, P1615, DOI 10.1111/nmo.12427; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Shevelkin AV, 2014, REV NEUROSCIENCE, V25, P177, DOI 10.1515/revneuro-2013-0049; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Tognini P, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00025; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	70	42	44	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196510	10.1371/journal.pone.0196510	http://dx.doi.org/10.1371/journal.pone.0196510			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763437	Green Published, Green Submitted, gold			2022-12-26	WOS:000432118800012
J	Khajuria, C; Ivashuta, S; Wiggins, E; Flagel, L; Moar, W; Pleau, M; Miller, K; Zhang, YJ; Ramaseshadri, P; Jiang, CJ; Hodge, T; Jensen, P; Chen, M; Gowda, A; McNulty, B; Vazquez, C; Bolognesi, R; Haas, J; Head, G; Clark, T				Khajuria, Chitvan; Ivashuta, Sergey; Wiggins, Elizabeth; Flagel, Lex; Moar, William; Pleau, Michael; Miller, Kaylee; Zhang, Yuanji; Ramaseshadri, Parthasarathy; Jiang, Changjian; Hodge, Tracey; Jensen, Peter; Chen, Mao; Gowda, Anilkumar; McNulty, Brian; Vazquez, Cara; Bolognesi, Renata; Haas, Jeffrey; Head, Graham; Clark, Thomas			Development and characterization of the first dsRNA-resistant insect population from western corn rootworm, Diabrotica virgifera virgifera LeConte	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; COLEOPTERA-CHRYSOMELIDAE; INTERFERENCE; SURVIVAL; GENES	The use of dsRNA to control insect pests via the RNA interference (RNAi) pathway is being explored by researchers globally. However, with every new class of insect control compounds, the evolution of insect resistance needs to be considered, and understanding resistance mechanisms is essential in designing durable technologies and effective resistance management strategies. To gain insight into insect resistance to dsRNA, a field screen with subsequent laboratory selection was used to establish a population of DvSnf7 dsRNA-resistant western corn rootworm, Diabrotica virgifera virgifera, a major maize insect pest. WCR resistant to ingested DvSnf7 dsRNA had impaired luminal uptake and resistance was not DvSnf7 dsRNA-specific, as indicated by cross resistance to all other dsRNAs tested. No resistance to the Bacillus thuringiensis Cry3Bb1 protein was observed. DvSnf7 dsRNA resistance was inherited recessively, located on a single locus, and autosomal. Together these findings will provide insights for dsRNA deployment for insect pest control.	[Khajuria, Chitvan; Ivashuta, Sergey; Wiggins, Elizabeth; Flagel, Lex; Moar, William; Pleau, Michael; Miller, Kaylee; Zhang, Yuanji; Ramaseshadri, Parthasarathy; Jiang, Changjian; Hodge, Tracey; Jensen, Peter; Chen, Mao; Gowda, Anilkumar; McNulty, Brian; Vazquez, Cara; Bolognesi, Renata; Haas, Jeffrey; Head, Graham; Clark, Thomas] Monsanto Co, 700 Chesterfield Pkwy West, Chesterfield, MO 63017 USA	Monsanto	Khajuria, C (corresponding author), Monsanto Co, 700 Chesterfield Pkwy West, Chesterfield, MO 63017 USA.	chitvan.khajuria@monsanto.com		Head, Graham/0000-0003-0521-0616	Monsanto	Monsanto	All authors are Monsanto employees, and Monsanto accepted no outside funding for this research represented in this manuscript. The funder (Monsanto) provided support in the form of salaries for all authors, and also played a role in the design, data analysis and the decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], SAS SOFTW REL 9 4 TS; Armstrong TA, 2013, J AGR FOOD CHEM, V61, P12557, DOI 10.1021/jf4031458; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cappelle K, 2016, INSECT MOL BIOL, V25, P315, DOI 10.1111/imb.12222; Cullen EM, 2013, J INTEGR PEST MANAG, V4, pD1, DOI 10.1603/IPM13012; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Fishilevich E, 2016, PEST MANAG SCI, V72, P1652, DOI 10.1002/ps.4324; Fishilevich E, 2016, INSECT BIOCHEM MOLEC, V71, P58, DOI 10.1016/j.ibmb.2016.02.004; Flagel LE, 2015, G3-GENES GENOM GENET, V5, P399, DOI 10.1534/g3.114.016485; Gassmann AJ, 2016, J ECON ENTOMOL, V109, P1872, DOI 10.1093/jee/tow110; Gassmann AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI 10.1073/pnas.1317179111; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Girard C, 1998, INSECT BIOCHEM MOLEC, V28, P229, DOI 10.1016/S0965-1748(98)00027-7; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Head GP, 2017, PEST MANAG SCI, V73, P1883, DOI 10.1002/ps.4554; Ivashuta S, 2015, RNA, V21, P840, DOI 10.1261/rna.048116.114; Jakka SRK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27860; James C., 2015, EXECUTIVE SUMMARY; Jensen Peter D, 2013, GM Crops Food, V4, P90, DOI 10.4161/gmcr.25285; Khajuria C, 2015, INSECT BIOCHEM MOLEC, V63, P54, DOI 10.1016/j.ibmb.2015.05.011; Kourti A, 2017, BIOL CONTROL PEST VE; Levine Eli, 2002, American Entomologist, V48, P94; Li XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep08700; Meihls LN, 2008, P NATL ACAD SCI USA, V105, P19177, DOI 10.1073/pnas.0805565105; Meinke LJ, 1998, J ECON ENTOMOL, V91, P594, DOI 10.1093/jee/91.3.594; Moar W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169175; National Academies of Sciences E Medicine., 2017, GEN ENG CROPS EXP PR; Ni M, 2017, PLANT BIOTECHNOL J, V15, P1204, DOI 10.1111/pbi.12709; Parimi S, 2006, CROP PROT, V25, P269, DOI 10.1016/j.cropro.2005.04.017; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rangasamy M, 2012, PEST MANAG SCI, V68, P587, DOI 10.1002/ps.2301; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; Tabashnik BE, 2017, NAT BIOTECHNOL, V35, P926, DOI 10.1038/nbt.3974; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Wu YH, 2011, IEEE ACM T COMPUT BI, V8, P381, DOI 10.1109/TCBB.2010.35; Xiao D, 2015, INSECT BIOCHEM MOLEC, V60, P68, DOI 10.1016/j.ibmb.2015.03.009; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zukoff SN, 2016, J ECON ENTOMOL, V109, P1387, DOI 10.1093/jee/tow073	43	88	90	9	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197059	10.1371/journal.pone.0197059	http://dx.doi.org/10.1371/journal.pone.0197059			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758046	gold, Green Submitted, Green Published			2022-12-26	WOS:000432082900023
J	Meleder, V; Jesus, B; Barnett, A; Barille, L; Lavaud, J				Meleder, Vona; Jesus, Bruno; Barnett, Alexandre; Barille, Laurent; Lavaud, Johann			Microphytobenthos primary production estimated by hyperspectral reflectance	PLOS ONE			English	Article							WATER MARINE HABITATS; CHLOROPHYLL FLUORESCENCE; ENERGY-DISSIPATION; EUROPEAN ESTUARY; BENTHIC DIATOMS; ECOLOGICAL ROLE; TAGUS ESTUARY; SECRET GARDEN; HIGH LIGHT; BIOMASS	The use of remote sensing techniques allows monitoring of photosynthesis at the ecosystem level and improves our knowledge of plant primary productivity. The main objective of the current study was to develop a remote sensing based method to measure microphytobenthos (MPB) primary production from intertidal mudflats. This was achieved by coupling hyperspectral radiometry (reflectance, rho and second derivative, delta delta) and PAM-fluorometry (non-sequential light curves, NSLC) measurements. The latter allowed the estimation of primary production using a light use efficiency parameter (LUE) and electron transport rates (ETR) whereas rho allowed to estimate pigment composition and optical absorption cross-section (a*). Five MPB species representative of the main growth forms: epipelic (benthic motile), epipsammic (benthic motile and non motile) and tychoplanktonic (temporarily resuspended in the water column) were submitted to increasing light intensities from dark to 1950 mu mol photons.m(-2).s(-1). Different fluorescence patterns were observed for the three growth-forms and were linked to their xanthophyll cycle (de-epoxydation state). After spectral reflectance measurements, a* was retrieved using a radiative transfer model and several radiometric indices were tested for their capacity to predict LUE and ETR measured by PAM-fluorometry. Only one radiometric index was not species or growth-form specific, i.e. delta delta(496/508). This index was named MPBLUE and could be used to predict LUE and ETR. The applicability of this index was tested with simulated bands of a wide variety of hyperspectral sensors at spectral resolutions between 3 and 15 nm of Full Width at Half Maximum (FWHM).	[Meleder, Vona; Jesus, Bruno; Barille, Laurent] Univ Nantes, Mer Mol Sante MMS EA 2160, Nates, France; [Jesus, Bruno] Campo Grande Univ Lisboa, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal; [Barnett, Alexandre; Lavaud, Johann] Univ La Rochelle, Inst Littoral & Environm, CNRS, Littoral Environm & Soc LIENSs UMR 7266, 2 Rue Olympe Gouges, La Rochelle, France; [Barnett, Alexandre] Natl Univ Ireland, Bot & Plant Sci, Galway, Ireland; [Lavaud, Johann] Univ Laval, Takuvik UMI 3376, Dept Biol, CNRS, Pavillon Alexandre Vachon, Quebec City, PQ, Canada	Nantes Universite; BIOISI; Universidade de Lisboa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Ollscoil na Gaillimhe-University of Galway; Laval University	Meleder, V (corresponding author), Univ Nantes, Mer Mol Sante MMS EA 2160, Nates, France.	vona.meleder@univ-nantes.fr	Jesus, Bruno/B-5441-2011; Lavaud, Johann/N-6185-2014	Jesus, Bruno/0000-0002-2047-3783; Lavaud, Johann/0000-0002-4704-2502; Barille, Laurent/0000-0001-5138-2684; Meleder, Vona/0000-0002-1874-1929	Centre National de la Recherche Scientifique-CNRS; Region Poitou-Charentes; French consortium CPER-Littoral; Region Pays de la Loire; Fondation de France	Centre National de la Recherche Scientifique-CNRS(Centre National de la Recherche Scientifique (CNRS)); Region Poitou-Charentes(Region Nouvelle-Aquitaine); French consortium CPER-Littoral; Region Pays de la Loire(Region Pays de la Loire); Fondation de France(Fondation de France)	This work is supported by the Centre National de la Recherche Scientifique-CNRS (sabbatical and EC2CO grant to VM), the Region Poitou-Charentes (Ph.D. grant to AB), the French consortium CPER-Littoral (to JL), the Region Pays de la Loire (Atlantic Micro-algae program to VM) and the Fondation de France (grant 'Quels littoraux pour demain ?' to JL and VM); the Planetology and Geodynamic laboratory (UMR 6112, University of Nantes-CNRS) for supplying the ASD FieldSpec3spectrometer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett A, 2015, ISME J, V9, P32, DOI 10.1038/ismej.2014.105; Benyoucef I, 2014, ESTUAR COAST SHELF S, V136, P43, DOI 10.1016/j.ecss.2013.11.007; Blanchard GF, 1997, J PHYCOL, V33, P723, DOI 10.1111/j.0022-3646.1997.00723.x; Blommaert L, 2017, LIMNOL OCEANOGR; Brito AC, 2013, CONT SHELF RES, V66, P83, DOI 10.1016/j.csr.2013.07.004; Cartaxana P, 2011, J EXP MAR BIOL ECOL, V405, P120, DOI 10.1016/j.jembe.2011.05.027; Combe JP, 2005, REMOTE SENS ENVIRON, V98, P371, DOI 10.1016/j.rse.2005.07.010; Consalvey M, 2005, DIATOM RES, V20, P1; Consalvey M, 2004, PHOTOSYNTH RES, V81, P91, DOI 10.1023/B:PRES.0000028397.86495.b5; Davoult D, 2009, HYDROBIOLOGIA, V620, P163, DOI 10.1007/s10750-008-9626-3; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Guarini J.M., 2006, FUNCTIONING MICROPHY, P187; GUILLARD RRL, 1982, CULTURE MARINE INVER, P108; Hamels I, 1998, EUR J PROTISTOL, V34, P308, DOI 10.1016/S0932-4739(98)80058-8; Huete A, 2016, REMOTE SENS HBK, V2, P3, DOI 10.1201/b19355-61; Jesus B, 2014, REMOTE SENS ENVIRON, V140, P196, DOI 10.1016/j.rse.2013.08.040; Jesus B, 2009, CONT SHELF RES, V29, P1624, DOI 10.1016/j.csr.2009.05.006; Jesus B, 2008, J PHYCOL, V44, P1349, DOI 10.1111/j.1529-8817.2008.00583.x; Juneau P, 2015, J EXP MAR BIOL ECOL, V463, P95, DOI 10.1016/j.jembe.2014.11.003; Kazemipour F, 2012, REMOTE SENS ENVIRON, V127, P1, DOI 10.1016/j.rse.2012.08.016; Kazemipour F, 2011, J QUANT SPECTROSC RA, V112, P131, DOI 10.1016/j.jqsrt.2010.08.029; Kromkamp J., 2006, FUNCTIONING MICROPHY, P9; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2014, ADV PHOTOSYNTH RESP, V40, P421, DOI 10.1007/978-94-017-9032-1_20; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; Laviale M, 2015, ENVIRON MICROBIOL, V17, P3662, DOI 10.1111/1462-2920.12728; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Lohr M, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P2313; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Magney TS, 2017, NEW PHYTOL, V215, P1594, DOI 10.1111/nph.14662; Meleder V, 2003, REMOTE SENS ENVIRON, V88, P386, DOI 10.1016/j.rse.2003.08.009; Meleder V, 2010, ENVIRON SCI ENG TECH, P71; Meleder V, 2003, CR BIOL, V326, P377, DOI 10.1016/S1631-0691(03)00125-2; Meleder V, 2007, J PHYCOL, V43, P1177, DOI 10.1111/j.1529-8817.2007.00423.x; Meleder V, 2013, J PHOTOCH PHOTOBIO B, V129, P115, DOI 10.1016/j.jphotobiol.2013.10.005; Migne A, 2002, MAR BIOL, V140, P865, DOI 10.1007/s00227-001-0741-1; Migne A, 2007, J PHYCOL, V43, P864, DOI 10.1111/j.1529-8817.2007.00379.x; Miller DC, 1996, ESTUARIES, V19, P202, DOI 10.2307/1352225; OLAIZOLA M, 1994, J PHYCOL, V30, P606, DOI 10.1111/j.0022-3646.1994.00606.x; Parson W., 2003, ADV PHOTOSYNTHESIS R, P83; Paterson D. M., 2001, V151, P105; Perkins R, 2011, DEV APPL PHYCOLOGY, V4; Perkins RG, 2006, MAR BIOL, V149, P703, DOI 10.1007/s00227-005-0222-z; PINCKNEY J, 1993, ESTUARIES, V16, P887, DOI 10.2307/1352447; Ribeiro L, 2003, ACTA OECOL, V24, pS117, DOI 10.1016/S1146-609X(03)00012-2; Ribeiro L, 2013, J PHYCOL, V49, P258, DOI 10.1111/jpy.12031; Roy S., 2011, PHYTOPLANKTON PIGMEN; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Ryu JH, 2014, OCEAN COAST MANAGE, V102, P458, DOI 10.1016/j.ocecoaman.2014.03.003; Saburova MA, 1995, MAR ECOL PROG SER, V129, P229, DOI 10.3354/meps129229; Serodio J, 2003, J PHYCOL, V39, P33; Serodio J, 2011, PHOTOSYNTH RES, V108, P61, DOI 10.1007/s11120-011-9654-0; Underwood GJC, 1999, ADV ECOL RES, V29, P93; van der Wal D, 2010, ECOSYSTEMS, V13, P338, DOI 10.1007/s10021-010-9322-9; WILHELM C, 1990, PLANT PHYSIOL BIOCH, V28, P293	56	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197093	10.1371/journal.pone.0197093	http://dx.doi.org/10.1371/journal.pone.0197093			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758047	Green Published, Green Submitted, gold			2022-12-26	WOS:000432082900025
J	Choi, S; Snider, JM; Olakkengil, N; Lambert, JM; Anderson, AK; Ross-Evans, JS; Cowart, LA; Snider, AJ				Choi, Songhwa; Snider, Justin M.; Olakkengil, Nicole; Lambert, Johana M.; Anderson, Andrea K.; Ross-Evans, Jessica S.; Cowart, L. Ashley; Snider, Ashley J.			Myristate-induced endoplasmic reticulum stress requires ceramide synthases 5/6 and generation of C14-ceramide in intestinal epithelial cells	FASEB JOURNAL			English	Article						ER stress; IL-6; XBP1	INFLAMMATORY-BOWEL-DISEASE; UNFOLDED PROTEIN RESPONSE; SPHINGOSINE KINASE 1; FREE FATTY-ACIDS; ER STRESS; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; SKELETAL-MUSCLE; DIETARY-FAT; APOPTOSIS	Saturated fatty acids (SFAs) have been shown to induce endoplasmic reticulum (ER) stress and chronic inflammatory responses, as well as alter sphingolipid metabolism. Disruptions in ER stress and sphingolipid metabolism have also been implicated in intestinal inflammation. Therefore, to elucidate the roles of SFAs in ER stress and inflammation in intestinal epithelial cells, we examined myristate (C14:0) and palmitate (C16:0). Myristate, but not palmitate, induced ER stress signaling, including activation of inositol-requiring enzyme 1 (IRE1) and X-box binding protein 1 (XBP1) signaling. Myristate significantly increased C14-ceramide levels, whereas palmitate increased several long-chain ceramides. To define the role of ceramide synthases (CerSs) in myristate-induced ER stress, we used the pharmacologic inhibitor, fumonisin B1 (FB1), and small interfering RNA (siRNA) for CerS5 and 6, the primary isoforms that are involved in C14-ceramide generation. FB1 and siRNA for CerS5 or 6 suppressed myristate-induced C14-ceramide generation and XBP1 splicing (XBP1s). Moreover, increased XBP1s induced the downstream expression of IL-6 in a CerS5/6-dependent manner. In addition, a myristate-enriched milk fat-based diet, but not a lard-based diet, increased C14-ceramide, XBP1s, and IL-6 expression in vivo. Taken together, our data suggest that myristate modulates ER stress and cytokine production in the intestinal epithelium via CerS5/6 and C14-ceramide generation.Choi, S., Snider, J. M., Olakkengil, N., Lambert, J. M., Anderson, A. K., Ross-Evans, J. S., Cowart, L. A., Snider, A. J. Myristate-induced endoplasmic reticulum stress requires ceramide synthases 5/6 and generation of C14-ceramide in intestinal epithelial cells.	[Choi, Songhwa; Snider, Justin M.; Olakkengil, Nicole] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA; [Choi, Songhwa; Snider, Justin M.; Snider, Ashley J.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Snider, Ashley J.] SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA; [Lambert, Johana M.; Anderson, Andrea K.; Cowart, L. Ashley] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA; [Lambert, Johana M.; Anderson, Andrea K.; Ross-Evans, Jessica S.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Cowart, L. Ashley] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Snider, Ashley J.] Northport Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Virginia Commonwealth University; Medical University of South Carolina; Hunter Holmes McGuire Veterinary Affairs Medical Center	Snider, AJ (corresponding author), SUNY Stony Brook, 100 Nicolls Rd.,Hlth Sci Ctr,L15-023, Stony Brook, NY 11794 USA.	ashley.snider@stonybrookmedicine.edu		Olakkengil, Nicole/0000-0002-3128-008X	Veteran's Administration Career Development Award; U.S. National Institutes of Health (NIH), National Cancer Institute [P01-CA097132]; NIH, National Heart, Lung, and Blood Institute [R01-HL117233]; Department of Veteran's Affairs Merit Grant [I01BX000200]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117233] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000200] Funding Source: NIH RePORTER	Veteran's Administration Career Development Award; U.S. National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veteran's Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Lina M. Obeid for expertise and suggestions for examining CerS, and Yusuf A. Hannun for expert advice in sphingolipid biology (both from the Stony Brook University School of Medicine). The authors also thank the Stony Brook University Lipidomics Shared Resource Core for lipid analysis. This work was supported by the Veteran's Administration Career Development Award (to A.J.S.); U.S. National Institutes of Health (NIH), National Cancer Institute Grant P01-CA097132 (to A.J.S.); NIH, National Heart, Lung, and Blood Institute Grant R01-HL117233; and the Department of Veteran's Affairs Merit Grant I01BX000200 (to L.A.C.). The contents do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government. The authors declare no conflicts of interest.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bogaert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025589; Cheng CY, 2017, J MANUF SYST, V42, P1, DOI 10.1016/j.jmsy.2016.10.005; Choi S., 2015, MEDIAT INFLAMM, V2015; Contreras C, 2014, CELL REP, V9, P366, DOI 10.1016/j.celrep.2014.08.057; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Espaillat MP, 2018, FASEB J, V32, P2339, DOI 10.1096/fj.201700585R; Garg AD, 2012, TRENDS MOL MED, V18, P589, DOI 10.1016/j.molmed.2012.06.010; Geng T, 2013, DIABETOLOGIA, V56, P2078, DOI 10.1007/s00125-013-2973-2; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hernandez-Corbacho MJ, 2015, J BIOL CHEM, V290, P25356, DOI 10.1074/jbc.M115.658658; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kim S, 2015, J IMMUNOL, V194, P4498, DOI 10.4049/jimmunol.1401399; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Liu Z, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-71; Lovejoy JC, 2001, METABOLISM, V50, P86, DOI 10.1053/meta.2001.19440; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Negroni A, 2014, DIGEST LIVER DIS, V46, P788, DOI 10.1016/j.dld.2014.05.013; Nestel PJ, 2008, J AM COLL NUTR, V27, p735S, DOI 10.1080/07315724.2008.10719751; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park MA, 2008, CANCER BIOL THER, V7, P1648, DOI 10.4161/cbt.7.10.6623; Ross JS, 2013, J BIOL CHEM, V288, P22193, DOI 10.1074/jbc.M113.477786; Russo SB, 2013, J BIOL CHEM, V288, P13397, DOI 10.1074/jbc.M112.428185; Russo SB, 2012, J CLIN INVEST, V122, P3919, DOI 10.1172/JCI63888; Snider AJ, 2012, PROSTAG OTH LIPID M, V99, P124, DOI 10.1016/j.prostaglandins.2012.08.003; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wang K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.36; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Williams BL, 2006, J VIROL, V80, P8613, DOI 10.1128/JVI.00836-06; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yasuda S, 2003, J BIOL CHEM, V278, P4176, DOI 10.1074/jbc.M209602200; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	47	19	19	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5724	5736		10.1096/fj.201800141R	http://dx.doi.org/10.1096/fj.201800141R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29768040	Bronze, Green Published			2022-12-26	WOS:000447972500043
J	Yu, M; Li, WJ; Wang, QQ; Wang, Y; Lu, F				Yu, Min; Li, Wenjing; Wang, Qianqian; Wang, Yan; Lu, Fei			Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; REV-ERB-BETA; ORPHAN NUCLEAR RECEPTORS; NEWLY-DIAGNOSED GLIOBLASTOMA; RECURRENT GLIOBLASTOMA; GENE-EXPRESSION; GROWTH-ARREST; CANCER-CELLS; CROSS-TALK; PHASE-II	Nuclear receptor NR1D2 is originally characterized as the repressor of genes involved in circadian rhythm. Recently, it is documented that NR1D2 is overexpressed in various cancers. However, the pathways and biological functions that NR1D2 involved in cancers remain poorly understood. Here, we reported that NR1D2 was abundant in human glioblastoma (GBM) tissue and cell lines but not primary human astrocytes. Silencing of NR1D2 changed the morphology of GBM cells, inhibited cell proliferation and motility, whereas had no effects on apoptosis. Importantly, based on RNA-seq and ChIP assay, we identified receptor tyrosine kinase AXL as a new transcriptional target of NR1D2 in GBM cells. AXL mediated partially the regulatory effects of NR1D2 on PI3K/AKT axis and promoted proliferation, migration, and invasion of GBM cells. Besides, NR1D2 knockdown remarkably impaired the maturation of focal adhesion and assembly of F-actin, along with downregulated p-FAK, and proteins involved in actin nucleation and polymerization (p-Rac1/Cdc42, WAVE and PFN2). Moreover, NR1D2 had more targets other than AXL to regulate epithelial-to-mesenchymal transition and cell motility in GBM cells. Altogether, our findings uncover a GBM-promoting role of NR1D2 and provide the rationale for targeting NR1D2 as a potential therapeutic approach.	[Yu, Min; Li, Wenjing; Wang, Qianqian; Lu, Fei] Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China; [Wang, Yan] Qingdao Univ, Qingdao Municipal Hosp, Dept Cardiol, Qingdao 266011, Peoples R China	Peking University; University Town of Shenzhen; Qingdao Municipal Hospital; Qingdao University	Lu, F (corresponding author), Peking Univ, Shenzhen Grad Sch, Key Lab Chem Genom, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China.	lufei@pkusz.edu.cn		Wang, Qianqian/0000-0003-4919-1998; Li, Wenjing/0000-0001-9151-9219	Natural Science Foundation of Guangdong Province [2014A030313779]; Shenzhen basic research program [JCYJ20160527100529884, JCYJ20170818085657917]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen basic research program	This work was supported by grants from Natural Science Foundation of Guangdong Province (grant no. 2014A030313779), Shenzhen basic research program (grant no. JCYJ20160527100529884 and JCYJ20170818085657917). We thank Dr. Hui Zhang for the kind gift of U-373 MG cell line.	Alexander BM, 2017, J CLIN ONCOL, V35, P2402, DOI 10.1200/JCO.2017.73.0119; Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Axelrod H, 2014, ONCOTARGET, V5, P1, DOI 10.18632/oncotarget.2422; BELLOSTA P, 1995, MOL CELL BIOL, V15, P614; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Chamberlain MC, 2017, J NEURO-ONCOL, V133, P561, DOI 10.1007/s11060-017-2466-0; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; De Mei C, 2015, ONCOGENE, V34, P2597, DOI 10.1038/onc.2014.203; Debruyne DN, 2016, ONCOGENE, V35, P3681, DOI 10.1038/onc.2015.434; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; Gilbert MR, 2017, J NEURO-ONCOL, V131, P193, DOI 10.1007/s11060-016-2288-5; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Iser IC, 2017, MED RES REV, V37, P271, DOI 10.1002/med.21408; Kubelt C, 2015, INT J ONCOL, V46, P2515, DOI 10.3892/ijo.2015.2944; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Li Stephen Yt, 2013, Spermatogenesis, V3, pe25385; Mahabir R, 2014, NEURO-ONCOLOGY, V16, P671, DOI 10.1093/neuonc/not239; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meng J, 2014, ONCOTARGET, V5, P4683, DOI 10.18632/oncotarget.2088; Ott M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047663; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qi DD, 2016, CELL CYCLE, V15, P2009, DOI 10.1080/15384101.2016.1192729; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan SN, 2009, BIOCHEM BIOPH RES CO, V388, P654, DOI 10.1016/j.bbrc.2009.08.045; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Rankin EB, 2016, CANCERS, V8, DOI 10.3390/cancers8110103; Raspe E, 2001, J BIOL CHEM, V276, P2865, DOI 10.1074/jbc.M004982200; Siripala AD, 2007, CELL, V128, P1014, DOI 10.1016/j.cell.2007.02.021; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Weathers SP, 2016, J NEURO-ONCOL, V129, P487, DOI 10.1007/s11060-016-2195-9; Wick W, 2016, CLIN CANCER RES, V22, P4797, DOI 10.1158/1078-0432.CCR-15-3153; Wilson C, 2014, CANCER RES, V74, P5878, DOI 10.1158/0008-5472.CAN-14-1009; Wong GS, 2013, BRIT J CANCER, V108, P755, DOI 10.1038/bjc.2012.592; Yan YR, 2014, NEUROPATHOLOGY, V34, P128, DOI 10.1111/neup.12062; Yin F, 2014, MOL CELL BIOL, V34, P158, DOI 10.1128/MCB.00631-13; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343	47	29	30	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 30	2018	37	35					4838	4853		10.1038/s41388-018-0319-8	http://dx.doi.org/10.1038/s41388-018-0319-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS0BA	29773903				2022-12-26	WOS:000443146000006
J	Feng, LF; Vujicic, S; Dietrich, ME; Litbarg, N; Setty, S; Antoni, A; Rauch, J; Levine, JS				Feng, Lanfei; Vujicic, Snezana; Dietrich, Michael E.; Litbarg, Natalia; Setty, Suman; Antoni, Angelika; Rauch, Joyce; Levine, Jerrold S.			Repeated exposure of epithelial cells to apoptotic cells induces the specific selection of an adaptive phenotype: Implications for tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; epithelial cell; innate immunity; cancer biology; B-cell lymphoma 2 (Bcl-2) family; cell death; cell proliferation; cell signaling; tumor microenvironment; directed evolution	TUMOR-ASSOCIATED MACROPHAGES; CYTOCHROME-C; SIGNALING EVENTS; BID CLEAVAGE; GRANZYME-B; IN-VITRO; DEATH; PROLIFERATION; GROWTH; CANCER	The consequences of apoptosis extend beyond the mere death of the cell. We have shown that receptor-mediated recognition of apoptotic target cells by viable kidney proximal tubular epithelial cells (PTECs) inhibits PTEC proliferation, growth, and survival. Here, we tested the hypothesis that continual exposure to apoptotic targets can induce a phenotypic change in responding PTECs, as in other instances of natural selection. In particular, we demonstrate that repeated exposure to apoptotic targets leads to emergence of a PTEC line (denoted BU.MPTSEL) resistant to apoptotic target-induced death. Resistance is exquisitely specific. Not only are BU.MPTSEL responders fully resistant to apoptotic target-induced death (approximate to 85% survival versus <10% survival of nonselected cells) but do so while retaining sensitivity to all other target-induced responses, including inhibition of proliferation and growth. Moreover, the resistance of BU.MPTSEL responders is specific to target-induced apoptosis, as apoptosis in response to other suicidal stimuli occurs normally. Comparison of the signaling events induced by apoptotic target exposure in selected versus nonselected responders indicated that the acquired resistance of BU.MPTSEL cells lies in a regulatory step affecting the generation of the pro-apoptotic protein, truncated BH3 interacting-domain death agonist (tBID), most likely at the level of BID cleavage by caspase-8. This specific adaptation has especial relevance for cancer, in which the prominence and persistence of cell death entail magnification of the post-mortem effects of apoptotic cells. Just as cancer cells acquire specific resistance to chemotherapeutic agents, we propose that cancer cells may also adapt to their ongoing exposure to apoptotic targets.	[Feng, Lanfei; Vujicic, Snezana; Dietrich, Michael E.; Litbarg, Natalia; Levine, Jerrold S.] Univ Illinois, Dept Med, Sect Nephrol, 840 South Wood St,MC-793, Chicago, IL 60612 USA; [Setty, Suman] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Feng, Lanfei; Vujicic, Snezana; Litbarg, Natalia; Levine, Jerrold S.] Jesse Brown Vet Affairs Hosp, Dept Med, Sect Nephrol, Chicago, IL 60612 USA; [Antoni, Angelika] Kutztown Univ Penn, Dept Biol, Kutztown, PA 19530 USA; [Rauch, Joyce] McGill Univ, Hlth Ctr, Res Inst, Div Rheumatol,Dept Med, Montreal, PQ H4A 3J1, Canada	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Pennsylvania State System of Higher Education (PASSHE); Kutztown University - Pennsylvania; McGill University	Levine, JS (corresponding author), Univ Illinois, Dept Med, Sect Nephrol, 840 South Wood St,MC-793, Chicago, IL 60612 USA.	jslevine@uic.edu			Section of Nephrology, University of Illinois at Chicago; Division of Rheumatology, McGill University; Department of Medicine, McGill University; Research Institute of the McGill University Health Centre	Section of Nephrology, University of Illinois at Chicago; Division of Rheumatology, McGill University; Department of Medicine, McGill University; Research Institute of the McGill University Health Centre	This work was supported, in whole or in part, by institutional funds from Dr. Jose A. Arruda and the Section of Nephrology, University of Illinois at Chicago (to J. S. L. and N. L.), and funding from the Division of Rheumatology and the Department of Medicine, McGill University, and the Research Institute of the McGill University Health Centre (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Barry M, 2000, MOL CELL BIOL, V20, P3781, DOI 10.1128/MCB.20.11.3781-3794.2000; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Birge RB, 2008, CELL DEATH DIFFER, V15, P1096, DOI 10.1038/cdd.2008.58; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Byun JS, 2013, AM J PATHOL, V182, P1055, DOI 10.1016/j.ajpath.2013.01.009; Chaurio R, 2013, AUTOIMMUNITY, V46, P317, DOI 10.3109/08916934.2012.754433; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Cristofanon S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.163; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Cvetanovic M, 2006, J BIOL CHEM, V281, P20055, DOI 10.1074/jbc.M603920200; Devitt A, 2011, J LEUKOCYTE BIOL, V90, P447, DOI 10.1189/jlb.0211095; Djudjaj S, 2016, KIDNEY INT, V89, P792, DOI 10.1016/j.kint.2015.10.015; Donato AL, 2014, J INVEST DERMATOL, V134, P1686, DOI 10.1038/jid.2014.18; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Erlanson M, 1997, ACTA ONCOL, V36, P17, DOI 10.3109/02841869709100725; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Feltham R, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2016.83; Flavahan WA, 2017, SCIENCE, V357, DOI 10.1126/science.aal2380; Ford CA, 2015, CURR BIOL, V25, P577, DOI 10.1016/j.cub.2014.12.059; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gall JM, 2011, KIDNEY INT, V79, P1207, DOI 10.1038/ki.2010.532; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gregory CD, 2016, ADV EXP MED BIOL, V930, P51, DOI 10.1007/978-3-319-39406-0_3; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardwick JM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008722; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; Huang Q, 2011, NAT MED, V17, P860, DOI 10.1038/nm.2385; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Knott A, 2005, CANCER BIOL THER, V4, P532, DOI 10.4161/cbt.4.5.1658; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mao P, 2013, ONCOL LETT, V5, P1615, DOI 10.3892/ol.2013.1223; Medina CB, 2016, CELL DEATH DIFFER, V23, P979, DOI 10.1038/cdd.2016.13; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naumann I, 2011, CLIN CANCER RES, V17, P3204, DOI 10.1158/1078-0432.CCR-10-2451; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Parnaik R, 2000, CURR BIOL, V10, P857, DOI 10.1016/S0960-9822(00)00598-4; Patel VA, 2015, J BIOL CHEM, V290, P22352, DOI 10.1074/jbc.M115.667345; Patel VA, 2012, J BIOL CHEM, V287, P13761, DOI 10.1074/jbc.M112.350843; Patel VA, 2010, J BIOL CHEM, V285, P1829, DOI 10.1074/jbc.M109.018440; Peter C, 2010, APOPTOSIS, V15, P1007, DOI 10.1007/s10495-010-0472-1; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Reiners JJ, 2002, CELL DEATH DIFFER, V9, P934, DOI 10.1038/sj.cdd.4401048; Reiter I, 1999, J IMMUNOL, V163, P1730; REVESZ L, 1956, NATURE, V178, P1391, DOI 10.1038/1781391a0; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; SASAKI K, 1993, CYTOMETRY, V14, P876, DOI 10.1002/cyto.990140805; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Shoshan-Barmatz V, 2015, BBA-BIOMEMBRANES, V1848, P2547, DOI 10.1016/j.bbamem.2014.10.040; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Soki FN, 2014, J BIOL CHEM, V289, P24560, DOI 10.1074/jbc.M114.571620; Stanford JC, 2014, J CLIN INVEST, V124, P4737, DOI 10.1172/JCI76375; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Sutton VR, 2003, IMMUNITY, V18, P319, DOI 10.1016/S1074-7613(03)00050-5; Suzanne M, 2013, CELL DEATH DIFFER, V20, P669, DOI 10.1038/cdd.2013.11; Ucker David S., 2009, P163, DOI 10.1007/978-1-4020-9292-3_6; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Vajjhala PR, 2015, J BIOL CHEM, V290, P29217, DOI 10.1074/jbc.M115.687731; Van der Hauwaert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066750; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Voss JJLP, 2017, CELL DEATH DIFFER, V24, P971, DOI 10.1038/cdd.2016.132; Vujicic S, 2016, JOVE-J VIS EXP, DOI 10.3791/54980; Yaacoub K, 2016, CANCER LETT, V378, P150, DOI 10.1016/j.canlet.2016.05.012; Zhang WH, 2005, CANCER RES, V65, P11529, DOI 10.1158/0008-5472.CAN-05-2718; Zinkel SS, 2013, ONCOGENE, V32, P3213, DOI 10.1038/onc.2012.454; Zitvogel L, 2010, CELL, V140, P798, DOI 10.1016/j.cell.2010.02.015	85	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10245	10263		10.1074/jbc.RA117.001290	http://dx.doi.org/10.1074/jbc.RA117.001290			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769319	Green Published, hybrid			2022-12-26	WOS:000437096700024
J	de Barros, IL; Costa, L; Bezerra, B; Gomes, R; Morais, N; Strunz, CMC; Novaes, M; Gebara, OCE; Pedrosa, RP; Nicolau, JC				de Barros, Isly L.; Costa, Laura; Bezerra, Bento; Gomes, Rafael; Morais, Natanael; Strunz, Celia M. C.; Novaes, Moacir; Gebara, Otavio C. E.; Pedrosa, Rodrigo Pinto; Nicolau, Jose C.			Predictors of subclinical carotid atherosclerosis in middle-aged women	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; RISK-FACTORS; CARDIOVASCULAR RISK; DISEASE; ASSOCIATION; PREMENOPAUSAL; PREVALENCE; HEART	Background Traditional strategies for primary cardiovascular prevention have been insufficient in reducing the high rates of coronary ischemic events in women, probably because these women are often stratified into low-risk groups. However, cardiovascular diseases continue to be the main cause of morbidity and mortality in women worldwide. We hypothesized that carotid atherosclerosis (CA) is common in middle-aged women. Methods We prospectively evaluated asymptomatic peri- and post-menopausal women with no cardiovascular diseases or the use of hormone therapy from two gynecologic clinics. All the patients underwent full clinical and laboratory evaluation and underwent a B-mode ultrasound for carotid evaluations. The presence of CA was defined as the presence of plaque and/or carotid intima-media thickness (CIMT)>1.00 mm. We performed logistic regression to evaluate independent predictors of CA. Results We studied 823 women (age: 54.4 +/- 5.4 years; body mass index-BMI: 28.5 +/- 4.9 kg/m(2); diabetes:10%; hypertension: 58%). The prevalence of CA was 12.7% for the entire population and 11% for the low-risk sub-group as defined by a Framingham risk score <5%. In the multivariate model, age: odds ratio (OR) = 1.54, 95% confidence interval (CI) = 1.25-1.89,p<0.001; current smoker status: OR = 2.69, 95% CI = 1.48-4.91, p = 0.001; total cholesterol: OR = 1.13, 95% CI = 1.03-1.24, p = 0.008; and systolic blood pressure: OR = 1.01, 95% CI = 1.00-1.02, p = 0.030 remained independently associated with CA. Conclusion Subclinical CA is common among asymptomatic middle-aged women, and traditional risk factors are independently associated with CA. These findings are particularly relevant for improving cardiovascular health in women.	[de Barros, Isly L.; Morais, Natanael; Strunz, Celia M. C.; Nicolau, Jose C.] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Coracao InCor, Sao Paulo, Brazil; [de Barros, Isly L.; Bezerra, Bento; Novaes, Moacir] Univ Pernambuco, HUOC, Recife, Pe, Brazil; [de Barros, Isly L.; Gomes, Rafael; Pedrosa, Rodrigo Pinto] Univ Pernambuco, Pronto Socorro Cardiol Pernambuco PROCAPE, Recife, Pe, Brazil; [Costa, Laura] Univ Pernambuco, CISAM, Recife, Pe, Brazil; [Gebara, Otavio C. E.] Hosp Santa Paula, Cardiol Dept, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE)	de Barros, IL (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Inst Coracao InCor, Sao Paulo, Brazil.; de Barros, IL (corresponding author), Univ Pernambuco, HUOC, Recife, Pe, Brazil.; de Barros, IL (corresponding author), Univ Pernambuco, Pronto Socorro Cardiol Pernambuco PROCAPE, Recife, Pe, Brazil.	isly.lucena@gmail.com	Strunz, Celia Maria Cassaro/L-4117-2019; Nicolau, Jose C/E-1487-2012; Strunz, Celia/G-5562-2011; Gebara, Otavio C. E./D-1542-2013; Pedrosa, Rodrigo P/G-4593-2013	Strunz, Celia Maria Cassaro/0000-0002-9766-1184; Nicolau, Jose C/0000-0002-9680-3689; Strunz, Celia/0000-0002-9766-1184; Gebara, Otavio C. E./0000-0003-4089-3520; 	Pernambuco State Foundation for Science and Technology (FACEPE) [APQ-1386-400/08]	Pernambuco State Foundation for Science and Technology (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was supported by the Pernambuco State Foundation for Science and Technology (FACEPE) [APQ-1386-400/08].	BONITHONKOPP C, 1991, ARTERIOSCLER THROMB, V11, P966, DOI 10.1161/01.ATV.11.4.966; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Grewal J, 2008, ATHEROSCLEROSIS, V197, P435, DOI 10.1016/j.atherosclerosis.2007.06.020; Hartley L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009874.pub2; Hunt KJ, 2001, ULTRASOUND MED BIOL, V27, P357, DOI 10.1016/S0301-5629(00)00353-7; Lloyd GWL, 2009, MATURITAS, V63, P28, DOI 10.1016/j.maturitas.2009.02.002; Lorenzo C, 2007, DIABETES CARE, V30, P8, DOI 10.2337/dc06-1414; Maas AHEM, 2011, EUR HEART J, V32, P1362, DOI 10.1093/eurheartj/ehr048; Mattioli AV, 2017, NUTR METAB CARDIOVAS, V27, P985, DOI 10.1016/j.numecd.2017.09.011; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; O'Leary DH, 2010, EUR HEART J, V31, P1682, DOI 10.1093/eurheartj/ehq185; PRATI P, 1992, STROKE, V23, P1705, DOI 10.1161/01.STR.23.12.1705; Rayburn WF, 1997, J REPROD MED, V42, P585; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072; Soules M R, 2001, Menopause, V8, P402, DOI 10.1097/00042192-200111000-00004; Sun Y, 2002, ATHEROSCLEROSIS, V164, P89, DOI 10.1016/S0021-9150(02)00017-5; Sutton-Tyrrell K, 1998, STROKE, V29, P1116, DOI 10.1161/01.STR.29.6.1116; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Tremollieres FA, 2004, MENOPAUSE, V11, P323, DOI 10.1097/01.GME.0000094393.59028.88; van den Oord SCH, 2013, ATHEROSCLEROSIS, V228, P1, DOI 10.1016/j.atherosclerosis.2013.01.025; Weber M, 2011, AM HEART J, V162, P81, DOI [10.1016/j.ahj.2011.04.007, 10.1016/j.ahj.2011.07.029]; Yu RHY, 2009, MATURITAS, V63, P233, DOI 10.1016/j.maturitas.2009.03.022	25	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197582	10.1371/journal.pone.0197582	http://dx.doi.org/10.1371/journal.pone.0197582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791465	Green Submitted, Green Published, gold			2022-12-26	WOS:000433077000042
J	Atalell, KA; Tebeje, NB; Ekubagewargies, DT				Atalell, Kendalem Asmare; Tebeje, Nigusie Birhan; Ekubagewargies, Daniale Tekelia			Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study	PLOS ONE			English	Article							RISK-FACTORS; MDR-TB; HIV; CHALLENGES; IMPACT	Background Tuberculosis (TB) is the leading cause of death in Human immunodeficiency virus (HIV) infected children globally. The aims of this study were to determine the mortality rate and to identify the predictors of mortality among TB/HIV co-infected children at University of Gondar Comprehensive Specialized Hospital. Method A retrospective follow-up study was conducted among TB/HIV co-infected children from February 2005 to March 2017. A Kaplan Meier curve was used to estimate the median survival time. Bivariate and multivariable Cox proportional hazards models were fitted to identify the predictors of mortality. Results A total of 271 TB/HIV co-infected children were included in the analysis. Of these, 38 (14.02%) children were died during the follow-up period. This gives a total of 1167.67 child years of observations. The overall mortality rate was 3.27(95%Cl: 2.3-4.5) per 100 child years. The independent predictors of time to death were age 1-5 years (as compared to age <1 year) (AHR = 0.3; 95%Cl:0.09-0.98)), being anemic (AHR = 2.6; 95%Cl:1.24-5.3), cotrimoxazole preventive therapy (CPT) non-users (AHR = 4.1; 95%Cl:1.4-16.75), isoniazid preventive therapy(IPT) non-users (AHR = 2.95; 95%Cl:1.16-7.5), having extra pulmonary tuberculosis(EPTB) (AHR = 2.43; 95%Cl:1.1-5.3)) and fair or poor adherence to Anti-Retroviral Therapy (ART)(AHR = 3.5; 95%Cl:1.7-7.5). Conclusion Mortality rate among TB/HIV co-infected children was high at University of Gondar Comprehensive Specialized Hospital. Age, extra-pulmonary tuberculosis, anemia, adherence, CPT and IPT were the independent predictors of mortality.	[Atalell, Kendalem Asmare; Ekubagewargies, Daniale Tekelia] Univ Gondar, Sch Nursing, Dept Pediat & Child Hlth Nursing, Coll Med & Hlth Sci, Gondar, Ethiopia; [Tebeje, Nigusie Birhan] Univ Gondar, Sch Nursing, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar	Atalell, KA (corresponding author), Univ Gondar, Sch Nursing, Dept Pediat & Child Hlth Nursing, Coll Med & Hlth Sci, Gondar, Ethiopia.	kedasmar@gmail.com		Atalell, Kendalem Asmare/0000-0003-1127-3592	University of Gondar	University of Gondar	The funding organization was University of Gondar.r The authors would like to thank the University of Gondar for financial support that made this study possible. They would also like to thank the data collectors for their tolerance and collaboration during the work.	Adejumo OA, 2016, J TROP PEDIATRICS, V62, P131, DOI 10.1093/tropej/fmv089; Bakeera-Kitaka S, 2011, INT J TUBERC LUNG D, V15, P1082, DOI 10.5588/ijtld.10.0538; Buck WC, 2013, INT J TUBERC LUNG D, V17, P1389, DOI 10.5588/ijtld.13.0030; Chamla DD, 2015, J INT AIDS SOC, V18, P46, DOI 10.7448/IAS.18.7.20251; Ebonyi Augustine O, 2016, Germs, V6, P139, DOI 10.11599/germs.2016.1099; Hesseling AC, 2005, ARCH DIS CHILD, V90, P1171, DOI 10.1136/adc.2004.070466; Hicks RM, 2014, INT J TUBERC LUNG D, V18, P1074, DOI 10.5588/ijtld.14.0231; Isaakidis P, 2015, INT J TUBERC LUNG D, V19, P969, DOI 10.5588/ijtld.15.0123; Isaakidis P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068869; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Jeena PM, 2002, INT J TUBERC LUNG D, V6, P672; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Liestol K, 2009, INT J EPIDEMIOL, V38, P427, DOI 10.1093/ije/dyn347; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Madhi SA, 2014, IMPACT HIV 1 COINFEC; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Manosuthi W, 2011, INDIAN PEDIATR, V48, P937, DOI 10.1007/s13312-011-0146-2; Ramos JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-215; Marais BJ, 2007, J INFECT DIS, V196, pS76, DOI 10.1086/518659; Marais BJ, 2011, PAEDIATR RESPIR REV, V12, P39, DOI 10.1016/j.prrv.2010.09.002; Mwiru RS, 2013, J INT ASS PROVIDERS; Nwokeukwu HI, 2013, CASE REP MED, V2013, DOI 10.1155/2013/756152; Palme IB, 2002, PEDIATR INFECT DIS J, V21, P1053, DOI 10.1097/00006454-200211000-00016; Paulson T, 2013, NATURE, V502, pS2, DOI 10.1038/502S2a; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Salvadori N, 2017, J PEDIAT INF DIS SOC; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; Venturini E, 2014, BMC INFECTIOUS DISEA, V14, P1; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2015, END TB STRAT IMPL EN; World Health Organization, 2015, US HIGH BURD COUNTR; Yumo HA, 2011, PAN AFR MED J, V10; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	34	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197145	10.1371/journal.pone.0197145	http://dx.doi.org/10.1371/journal.pone.0197145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787596	Green Published, Green Submitted, gold			2022-12-26	WOS:000432785700013
J	Scherz, B; Rabl, R; Flunkert, S; Rohler, S; Neddens, J; Taub, N; Temmel, M; Panzenboeck, U; Niederkofler, V; Zimmermann, R; Hutter-Paier, B				Scherz, Barbara; Rabl, Roland; Flunkert, Stefanie; Rohler, Siegfried; Neddens, Joerg; Taub, Nicole; Temmel, Magdalena; Panzenboeck, Ute; Niederkofler, Vera; Zimmermann, Robert; Hutter-Paier, Birgit			mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; TDP-43 TRANSGENIC MICE; DNA-BINDING PROTEIN-43; NUCLEAR FACTOR TDP-43; CYTOPLASMIC INCLUSIONS; NEURONAL INCLUSIONS; RODENT MODELS; CFTR EXON-9; SPINAL-CORD	Transgenic mouse models are indispensable tools to mimic human diseases and analyze the effectiveness of related new drugs. For a long time amyotrophic lateral sclerosis (ALS) research depended on only a few mouse models that exhibit a very strong and early phenotype, e.g. SOD1 mice, resulting in a short treatment time window. By now, several models are available that need to be characterized to highlight characteristics of each model. Here we further characterized the mThy1-hTDP-43 transgenic mouse model TAR6/6 that overexpresses wild type human TARDBP, also called TDP-43, under control of the neuronal Thy-1 promoter presented by Wils and colleagues, 2010, by using biochemical, histological and behavioral readouts. Our results show that TAR6/6 mice exhibit a strong TDP-43 expression in the hippocampus, spinal cord, hypothalamus and medulla oblongata. Apart from prominent protein expression in the nucleus, TDP-43 protein was found at lower levels in the cytosol of transgenic mice. Additionally, we detected insoluble TDP-43 in the cortex, motoneuron loss, and increased neuroinflammation in the central nervous system of TAR6/6 animals. Behavioral analyses revealed early motor deficits in the clasping- and wire suspension test as well as decreased anxiety in the elevated plus maze. Further motor tests showed differences at later time points compared to non-transgenic littermates, thus allowing the observation of onset and severity of such deficits. Together, TAR6/6 mice are a valuable tool to test new ALS/FTLD drugs that target TDP-43 expression and insolubility, neuroinflammation, motoneuron loss or other TDP-43 related downstream signaling pathways since these mice exhibit a later pathology as previously used ALS/FTLD mouse models.	[Scherz, Barbara; Rabl, Roland; Flunkert, Stefanie; Neddens, Joerg; Taub, Nicole; Temmel, Magdalena; Niederkofler, Vera; Hutter-Paier, Birgit] QPS Austria GmbH, Grambach, Austria; [Scherz, Barbara; Zimmermann, Robert] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Rohler, Siegfried; Panzenboeck, Ute] Med Univ Graz, Inst Pathophysiol & Immunol, Graz, Austria	University of Graz; Medical University of Graz	Hutter-Paier, B (corresponding author), QPS Austria GmbH, Grambach, Austria.	Birgit.hutter-paier@qps.com		Zimmermann, Robert/0000-0002-7354-870X; Flunkert, Stefanie/0000-0003-3806-3907; Schider, Nicole/0000-0002-3579-3667; Panzenbock, Ute/0000-0002-0545-6758	Austrian FFG: Forschungspartnerschaften, Industrienahe Dissertationen [847249]; QPS Austria GmbH; Austrian FFG	Austrian FFG: Forschungspartnerschaften, Industrienahe Dissertationen; QPS Austria GmbH; Austrian FFG	The authors greatly thank the whole research team of QPS Austria GmbH for their technical support. This work was supported by the Austrian FFG: Forschungspartnerschaften, Industrienahe Dissertationen: #847249 as well as QPS Austria GmbH. The Austrian FFG provided support in the form of part of the salary of BS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. QPS Austria GmbH provided support in the form of part or full salaries of BS, RR, SF, JN, NT, MT, VN, BHP. As QPS employees, these authors had main roles in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ali FE, 2005, J PEPT SCI, V11, P353, DOI 10.1002/psc.626; Amschl D, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-6; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Franceschini AD, 2015, NEUROREHABILITATION, V36, P127, DOI 10.3233/NRE-141200; Gendron TF, 2011, J MOL NEUROSCI, V45, P486, DOI 10.1007/s12031-011-9610-7; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Gordon PH, 2013, AGING DIS, V4, P295, DOI 10.14336/AD.2013.0400295; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; HARTIKAINEN P, 1993, J NEURAL TRANSM-PARK, V6, P127, DOI 10.1007/BF02261006; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Jovicic A, 2016, J NEUROCHEM, V138, P134, DOI 10.1111/jnc.13642; Kurt A, 2007, CNS DRUGS, V21, P279, DOI 10.2165/00023210-200721040-00003; LANGMORE SE, 1994, J SPEECH HEAR RES, V37, P28, DOI 10.1044/jshr.3701.28; Lant SB, 2014, NEUROPATH APPL NEURO, V40, P686, DOI 10.1111/nan.12092; Lattante S, 2013, HUM MUTAT, V34, P812, DOI 10.1002/humu.22319; Marconi A, 2012, AMYOTROPH LATERAL SC, V13, P452, DOI 10.3109/17482968.2012.696658; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Olney RK, 2005, NEUROLOGY, V65, P1774, DOI 10.1212/01.wnl.0000188759.87240.8b; Otsuki M, 2010, J NEUROL, V257, P1148, DOI 10.1007/s00415-010-5480-0; Pasquarelli N, 2017, BEHAV BRAIN RES, V333, P35, DOI 10.1016/j.bbr.2017.06.018; Raaphorst J, 2014, EUR J NEUROL; Rabl R, 2016, J NEUROSCI METH, V274, P125, DOI 10.1016/j.jneumeth.2016.10.006; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Sager TN, 2010, BEHAV BRAIN RES, V208, P444, DOI 10.1016/j.bbr.2009.12.014; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Shan X, 2010, P NATL ACAD SCI USA, V107, P16325, DOI 10.1073/pnas.1003459107; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Swarup V, 2011, BRAIN, V134, P2610, DOI 10.1093/brain/awr159; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Tsao W, 2012, BRAIN RES, V1462, P26, DOI 10.1016/j.brainres.2012.04.031; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Xu YF, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-73; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	50	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197674	10.1371/journal.pone.0197674	http://dx.doi.org/10.1371/journal.pone.0197674			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787578	Green Submitted, Green Published, gold			2022-12-26	WOS:000432785700033
J	Schneider, AC; Seichter, HA; Neupert, S; Hochhaus, AM; Smarandache-Wellmann, CR				Schneider, Anna C.; Seichter, Henriette A.; Neupert, Susanne; Hochhaus, A. Maren; Smarandache-Wellmann, Carmen R.			Profiling neurotransmitters in a crustacean neural circuit for locomotion	PLOS ONE			English	Article							TERMINAL ABDOMINAL-GANGLION; PATTERN-GENERATING CIRCUITS; GAMMA-AMINOBUTYRIC-ACID; LOBSTER NERVOUS-SYSTEM; SWIMMERET SYSTEM; STOMATOGASTRIC SYSTEM; PROCAMBARUS-CLARKII; LIMB MOVEMENTS; MOTOR-NEURONS; COORDINATING INTERNEURONS	Locomotor systems are widely used to study rhythmically active neural networks. These networks have to be coordinated in order to produce meaningful behavior. The crayfish swimmeret system is well suited to investigate such coordination of distributed neural oscillators because the neurons and their connectivity for generating and especially for coordinating the motor output are identified. The system maintains a fixed phase lag between the segmental oscillators, independent of cycle period. To further the understanding of the system's plasticity for keeping the phase lag fixed, we profiled the neurotransmitters used by the Coordinating Neurons, which are necessary and sufficient for coordination of the segmental oscillators. We used a combination of electrophysiological, immunohistochemical, and mass spectrometric methods. This arrangement of methods ensured that we could screen for several specific neurotransmitters, since a single method is often not suitable for all neurotransmitters of interest. In a first step, to preselect neurotransmitter candidates, we investigated the effect of substances known to be present in some swimmeret system neurons on the motor output and coordination. Subsequently, we demonstrated electrophysiologically that the identified synapse between the Coordinating Neurons and their target is mainly chemical, but neither glutamate antagonist nor Y-aminobutyric acid antagonist application affected this synapse. With immunohistochemical experiments, we provide strong evidence that the Coordinating Neurons are not serotonergic. Single-cell MALDI-TOF mass spectrometry with subsequent principal component analysis identified acetylcholine as the putative neurotransmitter for both types of Coordinating Neurons.	[Schneider, Anna C.; Seichter, Henriette A.; Hochhaus, A. Maren; Smarandache-Wellmann, Carmen R.] Univ Cologne, Inst Zool, Emmy Noether Grp, Anim Physiol, Cologne, Germany; [Neupert, Susanne] Univ Cologne, Inst Zool, Anim Physiol, Cologne, Germany	University of Cologne; University of Cologne	Smarandache-Wellmann, CR (corresponding author), Univ Cologne, Inst Zool, Emmy Noether Grp, Anim Physiol, Cologne, Germany.	carmen.wellmann@uni-koeln.de		Schneider, Anna C./0000-0002-1270-836X	DFG [NE 911/3]; DFG Emmy Noether Program [SM 206/3-1]; University of Cologne Advanced Researcher Group Grant [ZUK 81/1]	DFG(German Research Foundation (DFG)); DFG Emmy Noether Program(German Research Foundation (DFG)); University of Cologne Advanced Researcher Group Grant	This work was supported by DFG NE 911/3 to Susanne Neupert, DFG Emmy Noether Program SM 206/3-1 (http://gepris.dfg.de/gepris/projekt/164334465) to Carmen R Smarandache-Wellmann, and University of Cologne Advanced Researcher Group Grant ZUK 81/1 (http://exzellenz.uni-koeln.de/11599.html) to Carmen R Smarandache-Wellmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aonuma H, 1999, J COMP NEUROL, V410, P677; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; BARKER DL, 1972, J PHYSIOL-LONDON, V226, P205, DOI 10.1113/jphysiol.1972.sp009981; BELTZ BS, 1983, J NEUROSCI, V3, P585; BRAUN G, 1995, J NEUROPHYSIOL, V73, P880, DOI 10.1152/jn.1995.73.2.880; BRAUN G, 1994, J COMP NEUROL, V350, P272, DOI 10.1002/cne.903500210; BRAUN G, 1993, J NEUROPHYSIOL, V70, P2391, DOI 10.1152/jn.1993.70.6.2391; Cattaert D, 1998, EUR J NEUROSCI, V10, P3737, DOI 10.1046/j.1460-9568.1998.00384.x; CATTAERT D, 1994, J NEUROPHYSIOL, V72, P1622, DOI 10.1152/jn.1994.72.4.1622; CHRACHRI A, 1990, J NEUROSCI, V10, P707; ELMANIRA A, 1994, J NEUROPHYSIOL, V71, P1088, DOI 10.1152/jn.1994.71.3.1088; FLOREY E, 1960, J GEN PHYSIOL, V43, P509, DOI 10.1085/jgp.43.3.509; FLOREY E, 1973, J COMP PHYSIOL, V83, P1, DOI 10.1007/BF00694568; HILDEBRAND JG, 1974, J NEUROCHEM, V23, P951, DOI 10.1111/j.1471-4159.1974.tb10747.x; HUGHES GM, 1960, J EXP BIOL, V37, P657; IKEDA K, 1964, COMP BIOCHEM PHYSIOL, V12, P107, DOI 10.1016/0010-406X(64)90053-2; Jones SR, 2003, J NEUROSCI, V23, P3457; JULLIEN A, 1948, CR HEBD ACAD SCI, V226, P1396; Klein AN, 2000, NEUROSCI LETT, V289, P37, DOI 10.1016/S0304-3940(00)01262-3; LeGal P, 2017, NEUROBIOLOGY MOTOR C; Lioe H, 2009, J AM SOC MASS SPECTR, V20, P238, DOI 10.1016/j.jasms.2008.09.017; MARDER E, 1978, J PHYSIOL-LONDON, V280, P213, DOI 10.1113/jphysiol.1978.sp012381; MARDER E, 1984, J NEUROPHYSIOL, V51, P1345, DOI 10.1152/jn.1984.51.6.1345; MARDER E, 1974, NATURE, V251, P730, DOI 10.1038/251730a0; MARDER E, 1976, J PHYSIOL-LONDON, V257, P63, DOI 10.1113/jphysiol.1976.sp011356; Mulloney B, 2003, J NEUROSCI, V23, P5953; MULLONEY B, 1990, J COMP NEUROL, V291, P383, DOI 10.1002/cne.902910306; Mulloney B, 2006, J NEUROPHYSIOL, V95, P850, DOI 10.1152/jn.00939.2005; Mulloney B, 2003, J COMP NEUROL, V466, P366, DOI 10.1002/cne.10885; Mulloney B, 2003, MICROSC RES TECHNIQ, V60, P253, DOI 10.1002/jemt.10265; MULLONEY B, 1987, J NEUROPHYSIOL, V58, P584, DOI 10.1152/jn.1987.58.3.584; Mulloney B, 1997, J NEUROSCI, V17, P1860; Mulloney B, 2007, J NEUROPHYSIOL, V98, P405, DOI 10.1152/jn.00345.2007; Mulloney B, 2007, J NEUROPHYSIOL, V97, P436, DOI 10.1152/jn.00580.2006; Mulloney B, 2012, PROG NEUROBIOL, V96, P242, DOI 10.1016/j.pneurobio.2012.01.002; NAGAYAMA T, 1993, J COMP NEUROL, V332, P155, DOI 10.1002/cne.903320203; Nagayama T, 2004, J COMP NEUROL, V474, P123, DOI 10.1002/cne.20124; Namba H, 1999, J NEUROPHYSIOL, V81, P2437, DOI 10.1152/jn.1999.81.5.2437; Neupert S, 2010, METHODS MOL BIOL, V615, P137, DOI 10.1007/978-1-60761-535-4_11; PEARLSTEIN E, 1994, EUR J NEUROSCI, V6, P1445, DOI 10.1111/j.1460-9568.1994.tb01006.x; Persike M, 2010, ANAL CHEM, V82, P922, DOI 10.1021/ac902130h; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seichter HA, 2014, JOVE-J VIS EXP, DOI 10.3791/52109; Sherff CM, 1996, J NEUROSCI, V16, P2839; Smarandache C, 2009, J NEUROSCI, V29, P9351, DOI 10.1523/JNEUROSCI.1744-09.2009; Smarandache-Wellmann C, 2014, J NEUROSCI, V34, P5627, DOI 10.1523/JNEUROSCI.2670-13.2014; Smarandache-Wellmann C, 2014, J NEUROSCI, V34, P793, DOI 10.1523/JNEUROSCI.2642-13.2014; Swensen AM, 2000, J EXP BIOL, V203, P2075; TAKEUCHI A, 1964, J PHYSIOL-LONDON, V170, P296, DOI 10.1113/jphysiol.1964.sp007332; TAKEUCHI A, 1969, J PHYSIOL-LONDON, V205, P377, DOI 10.1113/jphysiol.1969.sp008972; TAKEUCHI A, 1965, J PHYSIOL-LONDON, V177, P225, DOI 10.1113/jphysiol.1965.sp007588; Tschuluun N, 2009, J EXP BIOL, V212, P3605, DOI 10.1242/jeb.033621; Tschuluun N, 2001, J NEUROSCI, V21, P7859, DOI 10.1523/JNEUROSCI.21-19-07859.2001; Ushizawa T, 1996, J COMP PHYSIOL A, V179, P1; Weller Cynthia, 2015, J Undergrad Neurosci Educ, V13, pA74; Zhang C, 2017, J MATH BIOL, V74, P1627, DOI 10.1007/s00285-016-1066-5	57	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197781	10.1371/Journal.pone.0197781	http://dx.doi.org/10.1371/Journal.pone.0197781			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787606	gold, Green Published, Green Submitted			2022-12-26	WOS:000432785700045
J	Cui, XC; Niu, YY; Zheng, XW; Han, YS				Cui, Xinchun; Niu, Yuying; Zheng, Xiangwei; Han, Yingshuai			An optimized digital watermarking algorithm in wavelet domain based on differential evolution for color image	PLOS ONE			English	Article							SCHEME	In this paper, a new color watermarking algorithm based on differential evolution is proposed. A color host image is first converted from RGB space to YIQ space, which is more suitable for the human visual system. Then, apply three-level discrete wavelet transformation to luminance component Y and generate four different frequency sub-bands. After that, perform singular value decomposition on these sub-bands. In the watermark embedding process, apply discrete wavelet transformation to a watermark image after the scrambling encryption processing. Our new algorithm uses differential evolution algorithm with adaptive optimization to choose the right scaling factors. Experimental results show that the proposed algorithm has a better performance in terms of invisibility and robustness.	[Cui, Xinchun; Han, Yingshuai] Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao, Shandong, Peoples R China; [Niu, Yuying] Peony Dist Lib Heze City, Heze, Shandong, Peoples R China; [Zheng, Xiangwei] Shandong Normal Univ, Sch Informat Sci & Engn, Jinan, Shandong, Peoples R China	Qufu Normal University; Shandong Normal University	Cui, XC (corresponding author), Qufu Normal Univ, Sch Informat Sci & Engn, Rizhao, Shandong, Peoples R China.	cuixinchun@qfnu.edu.cn		cui, xinchun/0000-0002-5445-2139	Humanities and social sciences Foundation of Ministry of education [11YJCZH021, 15YJCZH111]; National Natural Science Foundation of China [61373149]	Humanities and social sciences Foundation of Ministry of education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Humanities and social sciences Foundation of Ministry of education, No. 11YJCZH021, and No. 15YJCZH111, https://xm.sinoss.net/indexAction!to_index.action, Dr. Xinchun Cui; and National Natural Science Foundation of China, No.61373149, http://www.nsfc.gov.cn/, Dr. Xiangwei Zheng.	Ali Musrrat, 2013, 2013 IEEE Symposium on Differential Evolution (SDE), P99, DOI 10.1109/SDE.2013.6601448; Ali M, 2014, SIGNAL PROCESS, V94, P545, DOI 10.1016/j.sigpro.2013.07.024; Aslantas V, 2009, OPT COMMUN, V282, P769, DOI 10.1016/j.optcom.2008.11.024; Basturk A, 2009, EXPERT SYST APPL, V36, P2645, DOI 10.1016/j.eswa.2008.01.082; Chen Rong-Yuan, 2010, Acta Automatica Sinica, V36, P392, DOI 10.3724/SP.J.1004.2010.00392; Cui XC, 2006, LECT NOTES CONTR INF, V344, P810; Cui XC, 2011, IEICE T INF SYST, VE94D, P155, DOI 10.1587/transinf.E94.D.155; Gong H, 2012, THESIS ZHEJIANG U CO; Hu GS, 2004, BASIC COURSE MODERN; Hua G, 2015, IEEE-ACM T AUDIO SPE, V23, P227, DOI 10.1109/TASLP.2014.2387385; Jiang Li, 2014, Journal of Huazhong University of Science and Technology (Natural Science Edition), V42, P121, DOI 10.13245/j.hust.140624; Jiang YM, 2010, IEEE J OCEANIC ENG, V35, P59, DOI 10.1109/JOE.2009.2025904; Lampinen J., 1999, TECH REP; Lei B., 2013, 9 INT C INF COMM SIG, P1; Liang F., 2011, J COMPUTATIONAL INFO, V6, P2013; Nasir IA, 2013, LECT NOTES ENG COMP, P2238; Pereira S, 2011, SIGNAL PROCESS, V91, p1251 ; Priya RL, 2015, 2014 INTERNATIONAL CONFERENCE ON MEDICAL IMAGING, M-HEALTH & EMERGING COMMUNICATION SYSTEMS (MEDCOM), P30; RUAN QQ, 2001, DIGITAL IMAGE PROCES; Storn RM, 2006, DIFFERENTIAL EVOLUTI; SUN C. G., 2012, THESIS; Vahedi E, 2012, DIGIT SIGNAL PROCESS, V22, P153, DOI 10.1016/j.dsp.2011.08.006; [王文辉 Wang Wenhui], 2011, [计算机应用与软件, Computer Applications and Software], V28, P277; Wang Y, 2010, INFORM SCIENCES, V180, P2405, DOI 10.1016/j.ins.2010.02.015; Wei Zhenggang, 1999, Acta Electronica Sinica, V27, P79; Xiang LL, 2014, INFORM STUDIES THEOR, V37, p28 ; [杨启文 YANG QiWen], 2008, [模式识别与人工智能, Pattern Recognition and Artificial Intelligence], V21, P506; Yang YX, 2007, BASIC COURSE DIGITAL; Zhang LB, 2013, DOCUMENT INFORM KNOW, p122 	29	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0196306	10.1371/journal.pone.0196306	http://dx.doi.org/10.1371/journal.pone.0196306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782490	Green Published, gold, Green Submitted			2022-12-26	WOS:000432537100005
J	Kemppainen, M; Lahesmaa-Korpinen, AM; Kauppi, P; Virtanen, M; Virtanen, SM; Karikoski, R; Gissler, M; Kirjavainen, T				Kemppainen, Mari; Lahesmaa-Korpinen, Anna-Maria; Kauppi, Paula; Virtanen, Martti; Virtanen, Suvi M.; Karikoski, Riitta; Gissler, Mika; Kirjavainen, Turkka			Maternal asthma is associated with increased risk of perinatal mortality	PLOS ONE			English	Article							CONGENITAL-MALFORMATIONS; PREGNANT-WOMEN; OUTCOMES; THERAPY; DRUGS; METAANALYSIS; PREVALENCE; MANAGEMENT; SEVERITY; SYMPTOMS	Background Asthma is the most common chronic disease during pregnancy and it may have influence on pregnancy outcome. Objectives Our goal was to assess the association between maternal asthma and the perinatal risks as well as possible effects of asthma medication. Methods The study was based on a nationwide Finnish register-based cohort between the years 1996 and 2012 in the Drug and Pregnancy Database. The register data comprised 962 405 singleton live and stillbirths, 898 333 (93.3%) pregnancies in mothers with neither confirmed asthma nor use of asthma medication (controls), and 26 674 (2.8%) pregnancies with confirmed maternal asthma. 71% of mothers with asthma used asthma medication. The diagnosis of asthma was based on the mothers' right for subsidised medication which is carefully evaluated by strict criteria including pulmonary function testing. Odds ratio was used in comparison. Premature birth (PB), low birth weight, small for gestational age (SGA), neonatal death were the main outcome measures. Results Maternal asthma was associated with adjusted odds ratios (aORs) for perinatal mortality 1.24 (95% CI 1.05 to 1.46), preterm birth 1.18 (1.11 to 1.25), low birth weight 1.29 (1.21 to 1.37), fetal growth restriction (SGA) 1.32, (1.24 to 1.40), and asphyxia 1.09 (1.02 to 1.17). Asthma treatment reduced the increased risk of preterm birth aOR 0.85 (95% CI 0.76 to 0.96) but mothers with treated asthma had higher risks of fetal growth restriction (SGA) aOR 1.26 (1.10 to 1.45), and asphyxia aOR 1.37 (1.17 to 1.61) than mothers with untreated asthma. Conclusion Asthma is associated with increased risks of perinatal mortality, preterm birth, low birth weight, fetal growth restriction (SGA), and asphyxia. Asthma treatment reduces the risk of preterm delivery, but it does not seem to reduce other complications such as perinatal mortality.	[Kemppainen, Mari; Kirjavainen, Turkka] Helsinki Univ Hosp, Childrens Hosp, Dept Paediat, Helsinki, Finland; [Lahesmaa-Korpinen, Anna-Maria; Gissler, Mika] Natl Inst Hlth & Welf, Informat Serv Dept, Unit Stat & Registers, Helsinki, Finland; [Kauppi, Paula] Univ Helsinki, Resp Med & Allergol, Helsinki, Finland; [Kauppi, Paula] Helsinki Univ Cent Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Virtanen, Martti] Nord Casemix Ctr, Helsinki, Finland; [Virtanen, Suvi M.] Natl Inst Hlth & Welf, Unit Nutr, Helsinki, Finland; [Virtanen, Suvi M.] Univ Tampere, Hlth Sci Ctr, Ctr Child Hlth Res, Tampere, Finland; [Virtanen, Suvi M.] Tampere Univ Hosp, Tampere, Finland; [Virtanen, Suvi M.] Pirkanmaa Hosp Dist, Sci Ctr, Tampere, Finland; [Karikoski, Riitta] Reg State Adm Agencies, Tampere, Finland; [Gissler, Mika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med, Stockholm, Sweden	University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Tampere University; Tampere University; Tampere University Hospital; Pirkanmaa Hospital District; Karolinska Institutet	Kemppainen, M (corresponding author), Helsinki Univ Hosp, Childrens Hosp, Dept Paediat, Helsinki, Finland.	mari.kemppainen@helsinki.fi	Virtanen, Suvi/AAP-1922-2021; Kauppi, Paula/AAX-9525-2020	Kauppi, Paula/0000-0002-1065-330X; Kirjavainen, Turkka/0000-0002-0043-5093; Virtanen, Suvi/0000-0001-8928-0878; Gissler, Mika/0000-0001-8254-7525	Fimea Finnish Medicines Agency	Fimea Finnish Medicines Agency	Drugs and Pregnancy database is a collaboration by THL National Institute for Health and Welfare, Kela Social Insurance Institution and Fimea Finnish Medicines Agency (main funder). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author(s) received no specific funding for this work.	Alexander S, 1998, OBSTET GYNECOL, V92, P435, DOI 10.1016/S0029-7844(98)00191-4; Artama M, 2011, PHARMACOEPIDEM DR S, V20, P729, DOI 10.1002/pds.2159; Bracken MB, 2003, OBSTET GYNECOL, V102, P739, DOI 10.1016/S0029-7844(03)00621-5; Breton MC, 2009, THORAX, V64, P101, DOI 10.1136/thx.2008.102970; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Cossette B, 2013, THORAX, V68, P724, DOI 10.1136/thoraxjnl-2012-203122; Demissie K, 1998, PEDIATRICS, V102, P84, DOI 10.1542/peds.102.1.84; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Kainu A, 2013, PRIM CARE RESP J, V22, P64, DOI 10.4104/pcrj.2013.00002; Kallen B, 2007, EUR J CLIN PHARMACOL, V63, P363, DOI 10.1007/s00228-006-0257-1; Kallen B, 2007, EUR J CLIN PHARMACOL, V63, P383, DOI 10.1007/s00228-006-0259-z; Kallen B, 2007, EUR J CLIN PHARMACOL, V63, P375, DOI 10.1007/s00228-006-0258-0; Kauppi P, 2013, THORAX, V68, P292, DOI 10.1136/thoraxjnl-2011-201028; Kwon HL, 2006, IMMUNOL ALLERGY CLIN, V26, P29, DOI 10.1016/j.iac.2005.11.002; Meher S, 2014, BJOG-INT J OBSTET GY, V121, P1188, DOI 10.1111/1471-0528.12593; Mendola P, 2014, J ALLERGY CLIN IMMUN, V133, P85, DOI 10.1016/j.jaci.2013.06.012; Mendola P, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.007; Murphy VE, 2013, BJOG-INT J OBSTET GY, V120, P812, DOI 10.1111/1471-0528.12224; Murphy VE, 2011, BJOG-INT J OBSTET GY, V118, P1314, DOI 10.1111/j.1471-0528.2011.03055.x; Olesen C, 2001, RESPIRATION, V68, P256, DOI 10.1159/000050507; Palmsten K, 2016, J ALLER CL IMM-PRACT, V4, P310, DOI 10.1016/j.jaip.2015.11.019; PERLOW JH, 1992, AM J OBSTET GYNECOL, V167, P963, DOI 10.1016/S0002-9378(12)80020-2; Powell H, 2011, LANCET, V378, P983, DOI 10.1016/S0140-6736(11)60971-9; Rejno G, 2018, J ALLER CL IMM-PRACT, V6, P916, DOI 10.1016/j.jaip.2017.07.036; Rejno G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104755; Sankilampi U, 2013, ANN MED, V45, P446, DOI 10.3109/07853890.2013.803739; Schatz M, 2006, AM J OBSTET GYNECOL, V194, P120, DOI 10.1016/j.ajog.2005.06.028; STENIUSAARNIALA B, 1988, THORAX, V43, P12, DOI 10.1136/thx.43.1.12; SteniusAarniala BSM, 1996, THORAX, V51, P411, DOI 10.1136/thx.51.4.411; Tamasi L, 2010, MULTIDISCIP RESP MED, V5, P259, DOI 10.1186/2049-6958-5-4-259; Zhang J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.058	31	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197593	10.1371/journal.pone.0197593	http://dx.doi.org/10.1371/journal.pone.0197593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775476	Green Submitted, gold, Green Published			2022-12-26	WOS:000432521100020
J	Sharp, PA; Clarkson, R; Hussain, A; Weeks, RJ; Morison, IM				Sharp, Paul A.; Clarkson, Rachel; Hussain, Ahmed; Weeks, Robert J.; Morison, Ian M.			DNA methylation of hepatic iron sensing genes and the regulation of hepcidin expression	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR 2; HEREDITARY HEMOCHROMATOSIS PROTEIN; INTESTINAL EPITHELIAL-CELLS; MYELODYSPLASTIC SYNDROMES; HORMONE HEPCIDIN; MICE LEADS; HFE; OVERLOAD; SERUM; MACROPHAGES	Production of the iron regulatory peptide hepcidin is tightly controlled by a network of proteins in hepatocytes that sense levels of iron in the circulation (as diferric-transferrin) and in tissues (in ferritin). Human studies show high variability in the normal range of serum hepcidin levels. We have postulated that this may, in part, be related to inter-individual variability in the expression of genes in the iron sensing pathway, potentially governed by epigenetic factors. Here, we have investigated whether genes encoding hepatic iron sensing proteins and hepcidin are regulated by DNA methylation. Experiments were performed on two human hepatoma cell lines, HepG2 cells and Huh7 cells. Basal expression of TFR2 and HAMP was significantly lower in Huh7 cells compared with HepG2 cells. Analysis of bisulphite-converted DNA from Huh7 cells revealed partial methylation of TFR2 (alpha transcript), which could result in gene silencing. Demethylation using 5-aza-2'-deoxycitidine (AZA) increased TFR2 mRNA expression in Huh7. PCR analysis of bisulphite-converted HAMP promoter DNA, using methylation-specific primers, revealed no differences between cell lines. However, HAMP mRNA expression in Huh7 was increased by AZA treatment, suggesting that methylation of one or more iron sensing genes may indirectly influence HAMP expression. Our study provides evidence that DNA methylation might control expression of HAMP and other hepatic iron sensing genes, and indicates that epigenetic influences on iron homeostasis warrant further investigation.	[Sharp, Paul A.; Clarkson, Rachel; Hussain, Ahmed] Kings Coll London, Sch Life Course Sci, Dept Nutr Sci, London, England; [Weeks, Robert J.; Morison, Ian M.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand	University of London; King's College London; University of Otago	Sharp, PA (corresponding author), Kings Coll London, Sch Life Course Sci, Dept Nutr Sci, London, England.	paul.a.sharp@kcl.ac.uk	Weeks, Robert J/A-6876-2012; Morison, Ian/A-1236-2008	Weeks, Robert J/0000-0003-0474-9089; Hussain, Ahmed/0000-0003-2246-1791; Morison, Ian/0000-0003-3616-0025; Sharp, Paul Anthony/0000-0003-3400-6702	Dunedin School of Medicine	Dunedin School of Medicine	This work was funded by the Dunedin School of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Armitage AE, 2011, BLOOD, V118, P4129, DOI 10.1182/blood-2011-04-351957; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Braliou GG, 2008, J HEPATOL, V48, P801, DOI 10.1016/j.jhep.2007.12.021; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Chaston T, 2008, GUT, V57, DOI 10.1136/gut.2007.131722; Chaston TB, 2011, AM J PHYSIOL-CELL PH, V300, pC888, DOI 10.1152/ajpcell.00121.2010; Chatterjee A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17328; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137; Chung B, 2007, J NUTR, V137, P2366, DOI 10.1093/jn/137.11.2366; Chung B, 2009, J NUTR, V139, P1457, DOI 10.3945/jn.108.102905; Corradini E, 2011, GASTROENTEROLOGY, V141, P1907, DOI 10.1053/j.gastro.2011.06.077; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Di Savino A, 2017, BRIT J HAEMATOL, V176, P491, DOI 10.1111/bjh.13968; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012; Forejtnikova H, 2010, BLOOD, V116, P5357, DOI 10.1182/blood-2010-04-281360; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Gkouvatsos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085530; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Gu SC, 2015, CANCER INVEST, V33, P98, DOI 10.3109/07357907.2014.1001895; Handley S, 2017, BIOANALYSIS, V9, P541, DOI 10.4155/bio-2016-0286; Jiang Y, 2009, BLOOD, V113, P1315, DOI 10.1182/blood-2008-06-163246; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kawabata H, 2001, BLOOD, V98, P2714, DOI 10.1182/blood.V98.9.2714; Khan C, 2012, THER ADV HEMATOL, V3, P355, DOI 10.1177/2040620712464882; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kroot JJC, 2009, ANAL BIOCHEM, V389, P124, DOI 10.1016/j.ab.2009.03.039; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matak P, 2009, HAEMATOL-HEMATOL J, V94, P773, DOI 10.3324/haematol.2008.003400; Mena NP, 2008, AM J PHYSIOL-GASTR L, V294, pG192, DOI 10.1152/ajpgi.00122.2007; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nai A, 2015, BLOOD, V125, P1170, DOI 10.1182/blood-2014-08-596254; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakamaki T, 2004, BRIT J HAEMATOL, V125, P42, DOI 10.1111/j.1365-2141.2004.04866.x; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Pelucchi S, 2009, HAEMATOL-HEMATOL J, V94, P276, DOI 10.3324/haematol.13576; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Ramey G, 2009, HAEMATOL-HEMATOL J, V94, P765, DOI 10.3324/haematol.2008.003541; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Rapisarda C, 2010, AM J PHYSIOL-GASTR L, V299, pG778, DOI 10.1152/ajpgi.00157.2010; Rishi G, 2016, AM J HEMATOL, V91, P812, DOI 10.1002/ajh.24417; Rivera S, 2005, BLOOD, V106, P2196, DOI 10.1182/blood-2005-04-1766; Roetto A, 2010, BLOOD, V115, P3382, DOI 10.1182/blood-2009-09-240960; Sonnweber T, 2014, GUT, V63, P1951, DOI 10.1136/gutjnl-2013-305317; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Tesfay L, 2015, CANCER RES, V75, P2254, DOI 10.1158/0008-5472.CAN-14-2465; Udali S, 2017, EUR J CLIN INVE 1213, DOI [10.1111/eci, DOI 10.1111/ECI]; Vecchi C, 2010, HEPATOLOGY, V51, P654, DOI 10.1002/hep.23410; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Yamaji S, 2004, BLOOD, V104, P2178, DOI 10.1182/blood-2004-03-0829	62	6	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197863	10.1371/journal.pone.0197863	http://dx.doi.org/10.1371/journal.pone.0197863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771984	Green Submitted, gold, Green Published			2022-12-26	WOS:000432348900105
J	Marshall, AL; Jenkins, S; Oxentenko, AS; Lee, AI; Siegel, MD; Katz, JT; Vyas, JM; Del Valle, J; Mikhael, JR				Marshall, Ariela L.; Jenkins, Sarah; Oxentenko, Amy S.; Lee, Alfred, I; Siegel, Mark D.; Katz, Joel T.; Vyas, Jatin M.; Del Valle, John; Mikhael, Joseph R.			Internal medicine trainees' knowledge and confidence in using the American Society of Hematology Choosing Wisely guidelines in hemostasis, thrombosis, and non-malignant hematology	PLOS ONE			English	Article							CARE; PHYSICIANS; RESIDENTS; CAMPAIGN; COST	Background Several specialty societies participate in the Choosing Wisely (CW) campaign in an attempt to reduce waste in health care spending. We surveyed internal medicine (IM) residents with an objective of classifying knowledge of and confidence in using the American Society of Hematology (ASH) CW principles in hemostasis, thrombosis, and non-malignant hematology. Methods Multi-institutional study of IM residents at 5 academic training programs in the United States. A 10-question, case-based multiple choice test, with each question accompanied by a 5-point Likert-scale confidence assessment, was distributed electronically. Responses were summarized with frequencies and percentages or medians and ranges, as appropriate. Two sample t-tests or Wilcoxon rank-sum tests were used to compare confidence and knowledge scores. Results Of 892 IM residents, 174 (19.5%) responded to all questions. Overall, residents answered a median of 7 of 10 questions correctly (range 2-10) and median resident confidence in their responses was 3.1 (on a 5-point scale). Correct responses were significantly associated with higher confidence for all but one question. Having a hematology rotation experience was significantly associated with more correct responses and with higher confidence (p=0.001 and p<0.001, respectively). Conclusions IM residents at several academic hospitals have variable knowledge of ASH-CW guidelines in thrombosis and hemostasis/non-malignant hematology. Residents who have done hematology rotations, particularly a hematology consult rotation, were more likely to answer questions correctly and to be more confident that their answers were correct. Adequate clinical exposure and training in cost-effective care is essential to train clinicians who are cost-conscious in any specialty.	[Marshall, Ariela L.] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA; [Marshall, Ariela L.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Jenkins, Sarah] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Oxentenko, Amy S.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Lee, Alfred, I; Siegel, Mark D.] Yale Sch Med, Div Hematol, New Haven, CT USA; [Katz, Joel T.] Brigham & Womens Hosp, Dept Internal Med, 75 Francis St, Boston, MA 02115 USA; [Vyas, Jatin M.] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [Del Valle, John] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Mikhael, Joseph R.] Mayo Clin, Div Hematol & Med Oncol, Dept Med, Phoenix, AZ USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic Phoenix	Marshall, AL (corresponding author), Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA.; Marshall, AL (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.	marshall.ariela@mayo.edu	Vyas, Jatin/Q-1627-2016	Vyas, Jatin/0000-0002-9985-9565; Marshall, Ariela/0000-0001-7388-0422				Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Caverzagie KJ, 2013, ANN INTERN MED, V158, P557, DOI 10.7326/0003-4819-158-7-201304020-00593; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; Greene SE, 2015, AM J EMERG MED, V33, P853, DOI 10.1016/j.ajem.2015.03.067; Hicks CW, 2017, AM J SURG, V214, P571, DOI 10.1016/j.amjsurg.2017.06.020; Hicks LK, 2016, AM J HEMATOL, V91, P787, DOI 10.1002/ajh.24412; Hicks LK, 2014, BLOOD, V124, P3524, DOI 10.1182/blood-2014-09-599399; Hom J, 2017, POSTGRAD MED J; Iams W, 2016, ACAD MED, V91, P813, DOI 10.1097/ACM.0000000000001149; Kauf TL, 2009, AM J HEMATOL, V84, P323, DOI 10.1002/ajh.21408; Levinson W, 2015, BMJ QUAL SAF, V24, P167, DOI 10.1136/bmjqs-2014-003821; Malhotra A, 2016, BRIT J SPORT MED, V50, P826, DOI 10.1136/bjsports-2016-h2308rep; Nanwa N, 2011, PHARMACOECONOMICS, V29, P511, DOI 10.2165/11584330-000000000-00000; Neuss M, 2017, J ONCOL PRACT, V13, P135, DOI 10.1200/JOP.2016.017954; Patel MS, 2014, JAMA INTERN MED, V174, P470, DOI 10.1001/jamainternmed.2013.13222; Rocque GB, 2017, J ONCOL PRACT, V13, P43, DOI 10.1200/JOP.2016.015396; Shah N, 2015, ACAD MED, V90, P624, DOI 10.1097/ACM.0000000000000631; Willis MH, 2016, ACAD RADIOL, V23, P1309, DOI 10.1016/j.acra.2016.01.020; Wolfson D, 2016, HEALTHCARE-J DEL SCI, V4, P240, DOI 10.1016/j.hjdsi.2016.05.004	19	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197414	10.1371/journal.pone.0197414	http://dx.doi.org/10.1371/journal.pone.0197414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768480	gold, Green Published, Green Submitted			2022-12-26	WOS:000432329200081
J	Ma, JJ; Ma, LY; Zhang, H; Zhang, ZQ; Wang, YQ; Li, K; Chen, XM				Ma, Jinju; Ma, Liyi; Zhang, Hong; Zhang, Zhongquan; Wang, Youqiong; Li, Kai; Chen, Xiaoming			Policosanol fabrication from insect wax and optimization by response surface methodology	PLOS ONE			English	Article							RICE BRAN WAX; NORMAL-HEXACOSANOL; SUGAR-CANE; WHITE WAX; EXTRACTION; DELIVERY; ALCOHOLS	Background Insect wax is a famous biological resource for the role in economic production in China. Insect wax is a good source of policosanol, which may is a candidate supplement in foodstuff and pharmaceuticals that has important physiological activities. Therefore, this work aims to investigate a high-yield and rapid method for policosanol fabrication from insect wax. Results The conditions for policosanol fabrication were optimized as follows: an oil bath temperature of 112.7 degrees C and reductant dosage of 0.97 g (used for the reduction of 10.00 g of insect wax). The yield of policosanol reached 83.20%, which was 4 times greater than that of existing methods, such as saponification. The total content of policosanol obtained under the optimal conditions reached 87%. In other words, a high yield of policosanol was obtained from insect wax (723.84 mg/g), that was 55 times higher than that generated from beeswax-brown via saponification. The concentrations of metal residues in policosanol were within the limits of the European Union regulations and EFSA stipulation. The LD50 values for oral doses of insect wax and policosanol were both > 5 g/kg. Conclusion Policosanol was fabricated via solvent-free reduction from insect wax using LiAlH4 at a high yield. The fabrication conditions were optimized. Policosanol and insect wax showed high security, which made them potential candidates as supplements in foods, pharmaceuticals and cosmetics. The rapid and high-yield method has great potential for commercial manufacturing of policosanol.	[Ma, Jinju; Ma, Liyi; Zhang, Hong; Zhang, Zhongquan; Wang, Youqiong; Li, Kai; Chen, Xiaoming] Chinese Acad Forestry, Res Inst Resources Insects, Kunming, Yunnan, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF	Ma, LY; Zhang, H (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Kunming, Yunnan, Peoples R China.	linhuashi510@outlooK.com; kmzhhong@163.com			Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB2018SY025]; National High Technology Research and Development Program of China (863 Program) [2014AA021801]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was financially supported by the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (CAFYBB2018SY025) http://www.caf.ac.cn/, and National High Technology Research and Development Program of China (863 Program) (2014AA021801) http://program.most.gov.cn/.	Abul Kalam M, 2013, J BIOMED MATER RES A, V101, P1813, DOI 10.1002/jbm.a.34453; ARRUZAZABALA ML, 1993, THROMB RES, V69, P321, DOI 10.1016/0049-3848(93)90030-R; BORG J, 1991, J NEUROSCI RES, V29, P62, DOI 10.1002/jnr.490290107; BORG J, 1990, BRAIN RES, V518, P295, DOI 10.1016/0006-8993(90)90985-K; Bravo LG, 2002, MIXTURE PRIMARY FATT; Chen H., 2003, STUDY ISOLATION PURI; Chen XJ, 2011, STUDY PREPARATION AP; Chen XM, 2009, CHINESE WHITE WAX SC, P29; Cherif AO, 2010, J AGR FOOD CHEM, V58, P12143, DOI 10.1021/jf1030345; Cravotto G, 2004, EUR J LIPID SCI TECH, V106, P147, DOI 10.1002/ejlt.200300914; DAMGE C, 1995, EUR J PHARMACOL, V274, P133, DOI 10.1016/0014-2999(94)00720-R; Duan QF, 2005, J CHEM IND FOR PROD, V39, p42 ; Europe U- UNECf, GLOB HARM SYST CLASS; European Food Safety Authority, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2157; Fang H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151149; Francini-Pesenti F, 2008, COMPLEMENT THER MED, V16, P61, DOI 10.1016/j.ctim.2007.08.003; Hou WC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162139; Hou XY., 2011, J ANHUI AGR SCI, V39, P2817; Irmak S, 2006, FOOD CHEM, V95, P312, DOI 10.1016/j.foodchem.2005.01.009; LIPNICK RL, 1995, FOOD CHEM TOXICOL, V33, P223, DOI 10.1016/0278-6915(94)00136-C; Liu YF, 2008, INT J FOOD SCI TECH, V43, P763, DOI 10.1111/j.1365-2621.2006.01232.x; Lung Tsuen-ni, 2004, AGR HIST CHINA, P18; Lupi FR, 2013, FOOD FUNCT, V4, P1512, DOI 10.1039/c3fo60259a; Markrack G., POLICOSANOL DIETARY; MOOSBRUGGER I, 1992, INT J IMMUNOPHARMACO, V14, P293, DOI 10.1016/0192-0561(92)90042-J; Motwani SK, 2008, EUR J PHARM BIOPHARM, V68, P513, DOI 10.1016/j.ejpb.2007.09.009; OECD, 2001, GUID TEST CHEM 420 A; OECD, 2004, LEACH SOIL COL OECD, DOI [10.1787/9789264070561-en, DOI 10.1787/9789264070561-EN]; Pandolsook S, 2017, J FOOD ENG, DOI [10.1016/j.jfoodeng.2017.07.022, DOI 10.1016/J.JFOODENG.2017.07.022]; Qin Y, 2009, J ETHNOPHARMACOL, V126, P543, DOI 10.1016/j.jep.2009.08.047; Taylor JC, 2003, NUTRITION, V19, P192, DOI 10.1016/S0899-9007(02)00869-9; Wang MF, 2007, J AGR FOOD CHEM, V55, P5552, DOI 10.1021/jf063623q; Wang T, 2010, ACTA PHARMACOL SIN, V31, P765, DOI 10.1038/aps.2010.69; Wang ZD, 2017, BIOMED PHARMACOTHER, V89, P438, DOI 10.1016/j.biopha.2017.02.036; Yang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035719; Yang P, 2011, AFR J MICROBIOL RES, V5, P1246; Zheng YA, 2011, CHEM ENG J, V171, P1201, DOI 10.1016/j.cej.2011.05.026; ZHU J, 2008, J S W U NATL NATURAL, V34, P144	38	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197343	10.1371/journal.pone.0197343	http://dx.doi.org/10.1371/journal.pone.0197343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763430	Green Submitted, gold, Green Published			2022-12-26	WOS:000432118800039
J	Marjonen, H; Toivonen, M; Lahti, L; Kaminen-Ahola, N				Marjonen, Heidi; Toivonen, Mia; Lahti, Laura; Kaminen-Ahola, Nina			Early prenatal alcohol exposure alters imprinted gene expression in placenta and embryo in a mouse model	PLOS ONE			English	Article							REDUCED DNA METHYLATION; ETHANOL EXPOSURE; GROWTH; H19; CONSUMPTION; BEHAVIOR; MIR-675; REGION; FOLATE; SEX	Prenatal alcohol exposure (PAE) can harm the embryonic development and cause life-long consequences in offspring's health. To clarify the molecular mechanisms of PAE we have used a mouse model of early alcohol exposure, which is based on maternal ad libitum ingestion of 10% (v/v) ethanol for the first eight days of gestation (GD 0.5-8.5). Owing to the detected postnatal growth-restricted phenotype in the offspring of this mouse model and both prenatal and postnatal growth restriction in alcohol-exposed humans, we focused on imprinted genes Insulin-like growth factor 2 (Igf2), H19, Small Nuclear Ribonucleoprotein Polypeptide N (Snrpn) and Paternally expressed gene 3 (Peg3), which all are known to be involved in embryonic and placental growth and development. We studied the effects of alcohol on DNA methylation level at the Igf2/H19 imprinting control region (ICR), Igf2 differentially methylated region 1, Snrpn ICR and Peg3 ICR in 9.5 embryonic days old (E9.5) embryos and placentas by using MassARRAY EpiTYPER. To determine alcohol-induced alterations globally, we also examined methylation in long interspersed nuclear elements (Line-1) in E9.5 placentas. We did not observe any significant alcohol-induced changes in DNA methylation levels. We explored effects of PAE on gene expression of E9.5 embryos as well as E9.5 and E16.5 placentas by using quantitative PCR. The expression of growth promoter gene Igf2 was decreased in the alcohol-exposed E9.5 and E16.5 placentas. The expression of negative growth controller H19 was significantly increased in the alcohol exposed E9.5 embryos compared to controls, and conversely, a trend of decreased expression in alcohol-exposed E9.5 and E16.5 placentas were observed. Furthermore, increased Snrpn expression in alcohol-exposed E9.5 embryos was also detected. Our study indicates that albeit no alterations in the DNA methylation levels of studied sequences were detected by EpiTYPER, early PAE can affect the expression of imprinted genes in both developing embryo and placenta.	[Marjonen, Heidi; Toivonen, Mia; Kaminen-Ahola, Nina] Univ Helsinki, Dept Med & Clin Genet, Med, Helsinki, Finland; [Lahti, Laura] Univ Helsinki, Dept Biol & Environm Sci, Div Genet, Helsinki, Finland	University of Helsinki; University of Helsinki	Kaminen-Ahola, N (corresponding author), Univ Helsinki, Dept Med & Clin Genet, Med, Helsinki, Finland.	nina.kaminen@helsinki.fi		Kaminen-Ahola, Nina/0000-0003-1255-4716; Lahti, Laura/0000-0003-2929-1975	Academy of Finland [258304]; Finnish Foundation for Alcohol Studies; Finnish Cultural Foundation; Yrjo Jahnsson Foundation	Academy of Finland(Academy of Finland); Finnish Foundation for Alcohol Studies; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Yrjo Jahnsson Foundation	Funded by The Academy of Finland (258304) (N.K.-A.), The Finnish Foundation for Alcohol Studies (N.K.-A. and H.M.), Finnish Cultural Foundation (N.K.-A. and H.M.), Yrjo Jahnsson Foundation (N.K.-A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AM, 2003, ALCOHOL CLIN EXP RES, V27, P2009, DOI 10.1097/01.ALC.0000100940.95053.72; Bartolomei Marisa S, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a002592; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Chang SY, 2013, J CELL BIOCHEM, V114, P1549, DOI 10.1002/jcb.24496; Chiavegatto S, 2012, BRAIN BEHAV, V2, P365, DOI 10.1002/brb3.58; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Downing C, 2011, ALCOHOL, V45, P65, DOI 10.1016/j.alcohol.2010.07.006; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Haggarty P, 2013, AM J CLIN NUTR, V97, P94, DOI 10.3945/ajcn.112.042572; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Haycock PC, 2009, BIOL REPROD, V81, P618, DOI 10.1095/biolreprod.108.074682; Hoyme HE, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4256; Kaminen-Ahola N, 2010, BIRTH DEFECTS RES A, V88, P818, DOI 10.1002/bdra.20729; Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Lambert JF, 2000, J NEUROSCI METH, V95, P127, DOI 10.1016/S0165-0270(99)00157-0; Laufer BI, 2013, DIS MODEL MECH, V6, P977, DOI 10.1242/dmm.010975; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liang F, 2014, NEUROPHARMACOLOGY, V81, P126, DOI 10.1016/j.neuropharm.2014.01.025; Liu YL, 2009, EPIGENETICS-US, V4, P500, DOI 10.4161/epi.4.7.9925; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loke YJ, 2015, J DEV ORIG HLTH DIS, V6, P115, DOI 10.1017/S2040174415000161; Marjonen H, 2017, HUM REPROD OPEN, V2017, DOI 10.1093/hropen/hox014; Marjonen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124931; Masemola ML, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00085; MCCLEARN GE, 1959, Q J STUD ALCOHOL, V20, P691; Morita S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085477; Nelissen ECM, 2013, HUM REPROD, V28, P1117, DOI 10.1093/humrep/des459; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; PADMANABHAN R, 1988, DRUG ALCOHOL DEPEN, V22, P91, DOI 10.1016/0376-8716(88)90042-7; Portales-Casamar E, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0074-4; Sharp GC, 2018, EPIGENOMICS-UK, V10, P27, DOI 10.2217/epi-2017-0095; Soejima H, 2013, J HUM GENET, V58, P402, DOI 10.1038/jhg.2013.51; Stouder C, 2011, REPROD TOXICOL, V31, P507, DOI 10.1016/j.reprotox.2011.02.009; Susiarjo M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003401; Tarnowski M, 2015, INT J ONCOL, V46, P2241, DOI 10.3892/ijo.2015.2906; Tobi EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037933; Vega MCS, 2013, BEHAV BRAIN RES, V252, P326, DOI 10.1016/j.bbr.2013.06.003; Verona RI, 2008, MOL CELL BIOL, V28, P71, DOI 10.1128/MCB.01534-07; Wang ZY, 2010, FERTIL STERIL, V93, P2729, DOI 10.1016/j.fertnstert.2010.03.025; White V, 2018, PEDIATR RES, V83, P183, DOI 10.1038/pr.2017.221; Wu MY, 2006, GENESIS, V44, P12, DOI 10.1002/gene.20179; Zhang JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-478	50	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197461	10.1371/journal.pone.0197461	http://dx.doi.org/10.1371/journal.pone.0197461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763474	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800054
J	Moran, F; Olmos, A; Lotos, L; Predajna, L; Katis, N; Glasa, M; Maliogka, V; Ruiz-Garcia, AB				Moran, Felix; Olmos, Antonio; Lotos, Leonidas; Predajna, Lukas; Katis, Nikolaos; Glasa, Miroslav; Maliogka, Varvara; Ruiz-Garcia, Ana B.			A novel specific duplex real-time RT-PCR method for absolute quantitation of Grapevine Pinot gris virus in plant material and single mites	PLOS ONE			English	Article							1ST REPORT	Grapevine Pinot gris virus (GPGV) is a widely distributed grapevine pathogen that has been associated to the grapevine leaf mottling and deformation disease. With the aim of better understanding the disease epidemiology and providing efficient control strategies a specific and quantitative duplex TaqMan real-time RT-PCR assay has been developed. This method has allowed reliable quantitation of the GPGV titer ranging from 30 up to 3 x 10(8) transcript copies, with a detection limit of 70 viral copies in plant material. The assay targets a grapevine internal control that reduces the occurrence of false negative results, thus increasing the diagnostic sensitivity of the technique. Viral isolates both associated and non-associated to symptoms from Greece, Slovakia and Spain have been successfully detected. The method has also been applied to the absolute quantitation of GPGV in its putative transmission vector Colomerus vitis. Moreover, the viral titer present in single mites has been determined. In addition, in the current study a new polymorphism in the GPGV genome responsible for a shorter movement protein has been found. A phylogenetic study based on this genomic region has shown a high variability among Spanish isolates and points to a different evolutionary origin of this new polymorphism. The methodology here developed opens new possibilities for basic and epidemiological studies as well as for the establishment of efficient control strategies.	[Moran, Felix; Olmos, Antonio; Ruiz-Garcia, Ana B.] IVIA, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain; [Lotos, Leonidas; Katis, Nikolaos; Maliogka, Varvara] Aristotle Univ Thessaloniki, Fac Agr Forestry & Nat Environm, Sch Agr, Plant Pathol Lab, Thessaloniki, Greece; [Predajna, Lukas; Glasa, Miroslav] Slovak Acad Sci, Biomed Res Ctr, Inst Virol, Dubravska Cesta 9, Bratislava, Slovakia	Aristotle University of Thessaloniki; Slovak Academy of Sciences	Ruiz-Garcia, AB (corresponding author), IVIA, Ctr Protecc Vegetal & Biotecnol, Valencia, Spain.	ana.belen.ruiz@uv.es	Predajna, Lukas/AAL-5425-2021; Morán, Félix/U-9613-2019; Ruiz-Garcia, Ana Belen/ABB-1915-2021; Glasa, Miroslav/AAC-3814-2019; Maliogka, Varvara/ABC-6161-2020; Olmos, Antonio/C-1570-2013	Morán, Félix/0000-0001-5850-1527; Ruiz-Garcia, Ana Belen/0000-0001-5704-2138; Glasa, Miroslav/0000-0002-8495-7971; Maliogka, Varvara/0000-0001-5714-2710; Olmos, Antonio/0000-0001-8406-7963; Predajna, Lukas/0000-0002-1026-8479	Institute Nacional de Investigaciones Agrarias (INIA) [RTA-2014-00061, INIA E-RTA2017-00009]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [734736]; COST Action [FA1407]; Scientific Grant Agency of the Ministry of Education [VEGA2/0036/16]; Slovak Academy of Sciences	Institute Nacional de Investigaciones Agrarias (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa); COST Action(European Cooperation in Science and Technology (COST)); Scientific Grant Agency of the Ministry of Education; Slovak Academy of Sciences(Slovak Academy of Sciences)	This work was supported by the projects Institute Nacional de Investigaciones Agrarias (INIA) RTA-2014-00061 and INIA E-RTA2017-00009. Also, it has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 734736. The research was conducted within the framework of COST Action FA1407. LP and MG were also supported by the grant VEGA2/0036/16 from the Scientific Grant Agency of the Ministry of Education and Slovak Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Avogadro A., 1811, J PHYS-PARIS, V73, P58; Becker N, 2015, SCI REP-UK, V5, DOI 10.1038/srep17696; Bertazzon N, 2017, PLANT PATHOL, V66, P949, DOI 10.1111/ppa.12639; Bertazzon N, 2016, ARCH VIROL, V161, P711, DOI 10.1007/s00705-015-2718-2; Bertolini E, 2008, EUR J PLANT PATHOL, V120, P177, DOI 10.1007/s10658-007-9206-9; Bertolini E, 2010, EUR J PLANT PATHOL, V128, P283, DOI 10.1007/s10658-010-9663-4; Beuve M, 2015, PLANT DIS, V99, P293, DOI 10.1094/PDIS-10-14-1008-PDN; Beuve M, 2007, J VIROL METHODS, V141, P117, DOI 10.1016/j.jviromet.2006.11.042; Borges AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111399; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Glasa M, 2014, ARCH VIROL, V159, P2103, DOI 10.1007/s00705-014-2031-5; Gualandri V, 2017, EUR J PLANT PATHOL, V147, P21, DOI 10.1007/s10658-016-0989-4; Malagnini V, 2016, ARCH VIROL, V161, P2595, DOI 10.1007/s00705-016-2935-3; Fajardo TVM, 2017, AUSTRALAS PLANT DIS, V12, DOI 10.1007/s13314-017-0270-5; Olmos A, 2005, J VIROL METHODS, V128, P151, DOI 10.1016/j.jviromet.2005.05.011; Osman F, 2007, J VIROL METHODS, V141, P22, DOI 10.1016/j.jviromet.2006.11.035; Ruiz-Garcia AB, 2017, PLANT DIS, V101, P1070, DOI [10.1094/PDIS-12-16-1858-PDN, 10.1094/pdis-12-16-1858-pdn]; Saldarelli P, 2015, PHYTOPATHOLOGY, V105, P555, DOI 10.1094/PHYTO-09-14-0241-R; Saldarelli P, 2017, GRAPEVINE VIRUSES MO, P351, DOI DOI 10.1007/978-3-319-57706-7_17; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Velasco L, 2014, PLANT DIS, V98, P395, DOI 10.1094/PDIS-04-13-0433-RE; Wu Q, 2017, VIRUS GENES, V53, P935, DOI 10.1007/s11262-017-1475-6	24	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197237	10.1371/journal.pone.0197237	http://dx.doi.org/10.1371/journal.pone.0197237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763449	Green Published, gold			2022-12-26	WOS:000432118800031
J	Rockenbach, MF; Correa, CCG; Heringer, AS; Freitas, ILJ; Santa-Catarina, C; do Amaral, AT; Silveira, V				Rockenbach, Mathias F.; Correa, Caio C. G.; Heringer, Angelo S.; Freitas, Ismael L. J.; Santa-Catarina, Claudete; do Amaral-Junior, Antonio T.; Silveira, Vanildo			Differentially abundant proteins associated with heterosis in the primary roots of popcorn	PLOS ONE			English	Article							NONADDITIVE GENE-EXPRESSION; PROTEOMIC ANALYSIS; MAIZE; ENZYME; SYNTHETASE; PATTERNS; HYBRIDS; DEHYDROGENASE; PURIFICATION; IMPROVEMENT	Although heterosis has significantly contributed to increases in worldwide crop production, the molecular mechanisms regulating this phenomenon are still unknown. In the present study, we used a comparative proteomic approach to explore hybrid vigor via the proteome of both the popcorn L54 female and P8 male genotypes and the resultant UENF/UEM01 hybrid cross. To analyze the differentially abundant proteins involved in heterosis, we used the primary roots of these genotypes to analyze growth parameters and extract proteins. The results of the growth parameter analysis showed that the mid- and best-parent heterosis were positive for root length and root dry matter but negative for root fresh matter, seedling fresh matter, and protein content. The comparative proteomic analysis identified 1343 proteins in the primary roots of hybrid UENF/UEM01 and its parental lines; 220 proteins were differentially regulated in terms of protein abundance. The mass spectrometry proteomic data are available via ProteomeXchange with identifier "PXD009436". A total of 62 regulated proteins were classified as nonadditive, of which 53.2% were classified as high parent abundance (+), 17.8% as above-high parent abundance (+ +), 16.1% as below-low parent abundance (- -), and 12.9% as low parent abundance (-). A total of 22 biological processes were associated with nonadditive proteins; processes involving translation, ribosome biogenesis, and energy-related metabolism represented 45.2% of the nonadditive proteins. Our results suggest that heterosis in the popcorn hybrid UENF/UEM01 at an early stage of plant development is associated with an up-regulation of proteins related to synthesis and energy metabolism.	[Rockenbach, Mathias F.; Correa, Caio C. G.; Heringer, Angelo S.; Silveira, Vanildo] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, CBB, Lab Biotecnol, Av Alberto Lamego, Campos Dos Goytacazes, RJ, Brazil; [Rockenbach, Mathias F.; Correa, Caio C. G.; Heringer, Angelo S.; Silveira, Vanildo] Univ Estadual N Fluminen, Setor Genom & Prote, Unidade Biol Integrat, Campos dos Goytacazes, RJ, Brazil; [Freitas, Ismael L. J.; do Amaral-Junior, Antonio T.] Univ Estadual N Fluminen, CCTA, Lab Melhoramento Genet Vegetal, Campos dos Goytacazes, RJ, Brazil; [Santa-Catarina, Claudete] Univ Estadual N Fluminen, CBB, Lab Biol Celular & Tecidual, Campos dos Goytacazes, RJ, Brazil	Universidade Estadual do Norte Fluminense	Silveira, V (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, CBB, Lab Biotecnol, Av Alberto Lamego, Campos Dos Goytacazes, RJ, Brazil.; Silveira, V (corresponding author), Univ Estadual N Fluminen, Setor Genom & Prote, Unidade Biol Integrat, Campos dos Goytacazes, RJ, Brazil.; do Amaral, AT (corresponding author), Univ Estadual N Fluminen, CCTA, Lab Melhoramento Genet Vegetal, Campos dos Goytacazes, RJ, Brazil.	amaraljr@uenf.br; vanildo@uenf.br	Heringer, Angelo S/M-8275-2014; do Amaral, Antônio Teixeira/AAD-6291-2021; Correa, Caio Cezar Guedes/GQA-7450-2022; Correa, Caio Cezar Guedes/AAD-7149-2020; Heringer, Angelo/S-3033-2019; FREITAS, ISMAEL/AAP-3679-2021; Silveira, Vanildo/E-8887-2011; Santa-Catarina, Claudete/L-5531-2014	Heringer, Angelo S/0000-0002-2723-7353; do Amaral, Antônio Teixeira/0000-0003-4831-7878; Correa, Caio Cezar Guedes/0000-0002-0579-0270; Correa, Caio Cezar Guedes/0000-0002-0579-0270; Heringer, Angelo/0000-0002-2723-7353; FREITAS, ISMAEL/0000-0002-8138-7846; Silveira, Vanildo/0000-0001-5697-6932; Santa-Catarina, Claudete/0000-0002-1669-660X	Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) [E26/201.574/2014, E26/202.761/2017]; National Council for Scientific and Technological Development (CNPq) [454451/2014-8, 305415/2016-6, 401182/2016-9]; CNPq; Improvement of Higher Education Personnel (CAPES)	Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: E26/201.574/2014-Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) - VS; 454451/2014-8 and 305415/2016-6-National Council for Scientific and Technological Development (CNPq) - VS; 401182/2016-9-National Council for Scientific and Technological Development (CNPq)-ATAJ; E26/202.761/2017- Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)-ATAJ. Scholarships were provided by CNPq to MFR and by the Improvement of Higher Education Personnel (CAPES) to CCGC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AT, 2010, GENET MOL RES, V9, P340, DOI 10.4238/vol9-1gmr702; Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; BARNETT WE, 1967, P NATL ACAD SCI USA, V57, P1775, DOI 10.1073/pnas.57.6.1775; Cabral P. D. S., 2015, Australian Journal of Crop Science, V9, P256; Canovas FM, 2004, PROTEOMICS, V4, P285, DOI 10.1002/pmic.200300602; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'Auria JC, 2007, FEBS LETT, V581, P872, DOI 10.1016/j.febslet.2007.01.060; Dahal D, 2016, J PROTEOME RES, V15, P2445, DOI 10.1021/acs.jproteome.5b01120; Dahal D, 2012, PLANT J, V72, P70, DOI 10.1111/j.1365-313X.2012.05056.x; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; de Mendiburu FM, 2016, PACKAGE AGRICOLAE R; Falconer D.S., 1996, INTRO QUANTITATIVE G, V4th, P480; Kurosawa RDF, 2018, BRAGANTIA, V77, P36, DOI 10.1590/1678-4499.2017035; Freitas ILJ, 2014, GENET MOL RES, V13, P518, DOI 10.4238/2014.January.21.21; Freitas Junior S. de P., 2009, Crop Breeding and Applied Biotechnology, V9, P1; Fridman E, 2015, PLANT SCI, V232, P35, DOI 10.1016/j.plantsci.2014.11.014; Fu ZY, 2011, PROTEOMICS, V11, P1462, DOI 10.1002/pmic.201000481; Goff SA, 2011, NEW PHYTOL, V189, P923, DOI 10.1111/j.1469-8137.2010.03574.x; HELLER W, 1985, PLANTA, V165, P284, DOI 10.1007/BF00395052; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Hoecker N, 2006, THEOR APPL GENET, V112, P421, DOI 10.1007/s00122-005-0139-4; Hoecker N, 2008, GENETICS, V179, P1275, DOI 10.1534/genetics.108.088278; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Hubel F, 1996, PLANT PHYSIOL, V112, P1429, DOI 10.1104/pp.112.4.1429; Kamphorst SH, 2016, GENETICS MOL RES, V15; Kurosawa RNF, 2016, TROP PLANT PATHOL, V41, P415, DOI 10.1007/s40858-016-0112-6; LABOURE AM, 1993, BIOCHEM J, V295, P413, DOI 10.1042/bj2950413; Lam KC, 2007, GENOME, V50, P1001, DOI 10.1139/G07-077; Li KP, 2007, PROTEOMICS, V7, P1501, DOI 10.1002/pmic.200600960; Lopez-Castillo LM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01817; Ma J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158028; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Marcon C, 2013, J PROTEOMICS, V93, P295, DOI 10.1016/j.jprot.2013.04.015; Marcon C, 2010, J PROTEOME RES, V9, P6511, DOI 10.1021/pr100718d; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Mohayeji M, 2014, J PROTEOMICS, V99, P101, DOI 10.1016/j.jprot.2014.01.028; Nakajima J, 2001, J BIOL CHEM, V276, P25797, DOI 10.1074/jbc.M100744200; Nanjo Y, 2012, J PROTEOME RES, V11, P372, DOI 10.1021/pr200701y; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; R CT, 2017, R FDN STAT COMP; Rasmusson AG, 2004, ANNU REV PLANT BIOL, V55, P23, DOI 10.1146/annurev.arplant.55.031903.141720; Reis RS, 2016, J PROTEOMICS, V130, P170, DOI 10.1016/j.jprot.2015.09.029; Sauter C, 2000, J MOL BIOL, V299, P1313, DOI 10.1006/jmbi.2000.3791; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Schwantes IA, 2017, TROP PLANT PATHOL, V42, P70, DOI 10.1007/s40858-017-0136-6; SHULL GH, 1948, GENETICS, V33, P439; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Thelen JJ, 1999, J BIOL CHEM, V274, P21769, DOI 10.1074/jbc.274.31.21769; Turchetto-Zolet AC, 2009, MOL GENET GENOMICS, V281, P87, DOI 10.1007/s00438-008-0396-4; Vale EM, 2016, SCI HORTIC-AMSTERDAM, V209, P178, DOI 10.1016/j.scienta.2016.06.031; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Xing JW, 2016, BBA-PROTEINS PROTEOM, V1864, P908, DOI 10.1016/j.bbapap.2015.12.007	56	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197114	10.1371/journal.pone.0197114	http://dx.doi.org/10.1371/journal.pone.0197114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758068	Green Submitted, Green Published, gold			2022-12-26	WOS:000432082900029
J	Rossow, L; Veitl, S; Vorlova, S; Wax, JK; Kuhn, AE; Maltzahn, V; Upcin, B; Karl, F; Hoffmann, H; Gatzner, S; Kallius, M; Nandigama, R; Scheld, D; Irmak, S; Herterich, S; Zernecke, A; Ergun, S; Henke, E				Rossow, Leonie; Veitl, Simona; Vorlova, Sandra; Wax, Jacqueline K.; Kuhn, Anja E.; Maltzahn, Verena; Upcin, Berin; Karl, Franziska; Hoffmann, Helene; Gaetzner, Sabine; Kallius, Matthias; Nandigama, Rajender; Scheld, Daniela; Irmak, Ster; Herterich, Sabine; Zernecke, Alma; Ergun, Sueleyman; Henke, Erik			LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy	ONCOGENE			English	Article							LYSYL OXIDASE; TUMOR ANGIOGENESIS; DRUG-DELIVERY; DOUBLE-BLIND; PHASE-II; DOXORUBICIN; IMPROVES; COMBINATION; SIMTUZUMAB; INHIBITION	The potential of altering the tumor ECM to improve drug response remains fairly unexplored. To identify targets for modification of the ECM aiming to improve drug response and overcome resistance, we analyzed expression data sets from pre-treatment patient cohorts. Cross-evaluation identified a subset of chemoresistant tumors characterized by increased expression of collagens and collagen-stabilizing enzymes. We demonstrate that strong collagen expression and stabilization sets off a vicious circle of self-propagating hypoxia, malignant signaling, and aberrant angiogenesis that can be broken by an appropriate auxiliary intervention: Interfering with collagen stabilization by inhibition of lysyl oxidases significantly enhanced response to chemotherapy in various tumor models, even in metastatic disease. Inhibition of collagen stabilization by itself can reduce or enhance tumor growth depending on the tumor type. The mechanistical basis for this behavior is the dependence of the individual tumor on nutritional supply on one hand and on high tissue stiffness for FAK signaling on the other.	[Rossow, Leonie; Veitl, Simona; Wax, Jacqueline K.; Kuhn, Anja E.; Maltzahn, Verena; Upcin, Berin; Karl, Franziska; Hoffmann, Helene; Kallius, Matthias; Nandigama, Rajender; Ergun, Sueleyman; Henke, Erik] Univ Wurzburg, Inst Anat & Cell Biol 2, Koellikerstr 6, D-97070 Wurzburg, Germany; [Vorlova, Sandra; Karl, Franziska; Hoffmann, Helene; Zernecke, Alma] Univ Klinikum Wurzburg, Inst Expt Biomed, Josef Schneider Str 2, D-97082 Wurzburg, Germany; [Upcin, Berin; Irmak, Ster] Bilgi Univ, Sch Hlth Sci, TR-34440 Beyoglu Istanbul, Turkey; [Gaetzner, Sabine] Univ Wurzburg, Inst Tissue Engn, Roentgenring 11, D-97070 Wurzburg, Germany; [Kallius, Matthias; Henke, Erik] Grad Sch Life Sci, Josef Schneider Str 2, D-97082 Wurzburg, Germany; [Scheld, Daniela; Herterich, Sabine] Univ Klinikum Wurzburg, Zent Lab, Josef Schneider Str 2, D-97082 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; Istanbul Bilgi University; University of Wurzburg; University of Wurzburg	Henke, E (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol 2, Koellikerstr 6, D-97070 Wurzburg, Germany.; Henke, E (corresponding author), Grad Sch Life Sci, Josef Schneider Str 2, D-97082 Wurzburg, Germany.	erik.henke@uni-wuerzburg.de	Henke, Erik/AAG-7053-2020	Henke, Erik/0000-0003-2380-2682; Nandigama, Rajender/0000-0002-7344-4732	DFG [HE3565/2-1, HE3565/3-1]	DFG(German Research Foundation (DFG))	We thank Prof. Almut Schulze (Institute for Biochemistry and Molecular Biology, Universitat Wurzburg) and Afsar Barlas (MCCF, Memorial Sloan-Kettering Cancer Center) for helpful discussion. We especially want to acknowledge the tremendous help of Erna Kleinschroth (Institute for Anatomy and Cell Biology II) with histological procedures. Funding was provided by the DFG (Grant Nos. HE3565/2-1 and HE3565/3-1 to EH).	Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Baker AM, 2013, CANCER RES, V73, P583, DOI 10.1158/0008-5472.CAN-12-2447; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Benson AB, 2017, ONCOLOGIST, V22, P241, DOI 10.1634/theoncologist.2017-0024; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Curnis F, 2002, J CLIN INVEST, V110, P475, DOI 10.1172/JCI200215223; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DiChiara AS, 2016, ACS CHEM BIOL, V11, P1408, DOI 10.1021/acschembio.5b01083; Eikenes L, 2004, CANCER RES, V64, P4768, DOI 10.1158/0008-5472.CAN-03-1472; Eisinger-Mathason TSK, 2013, CANCER DISCOV, V3, P1190, DOI 10.1158/2159-8290.CD-13-0118; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Escorcia FE, 2010, CANCER RES, V70, P9277, DOI 10.1158/0008-5472.CAN-10-2029; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feres EJ, 1995, J BIOL CHEM, V270, P30797, DOI 10.1074/jbc.270.51.30797; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Guo HF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02859-z; HARRISON K, 1978, J NUCL MED, V19, P84; Hecht JR, 2017, ONCOLOGIST, V22, P243, DOI 10.1634/theoncologist.2016-0479; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lankelma J, 1999, CLIN CANCER RES, V5, P1703; Le Calve B, 2016, ONCOTARGET, V7, P32100, DOI 10.18632/oncotarget.8527; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Marturano JE, 2013, P NATL ACAD SCI USA, V110, P6370, DOI 10.1073/pnas.1300135110; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Naba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014647; Netti PA, 2000, CANCER RES, V60, P2497; Pepin KM, 2014, MAGN RESON MED, V71, P1834, DOI 10.1002/mrm.24825; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rohrig F, 2017, ONCOGENE, V36, P1, DOI 10.1038/onc.2016.182; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Samani A, 2007, PHYS MED BIOL, V52, P1565, DOI 10.1088/0031-9155/52/6/002; Schutze F, 2015, SCI REP-UK, V5, DOI 10.1038/srep17576; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Shah NR, 2014, GYNECOL ONCOL, V134, P104, DOI 10.1016/j.ygyno.2014.04.044; Shapiro IM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008639; Simon R, 2007, CANCER INFORM, V3, P11; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Walser R, 2013, EUR CELLS MATER, V26, P222, DOI 10.22203/eCM.v026a16; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Xie J, 2012, INT ORTHOP, V36, P207, DOI 10.1007/s00264-011-1261-3; Xu XJ, 2008, BIOINFORMATICS, V24, P137, DOI 10.1093/bioinformatics/btm541; Zaffryar-Eilot S, 2013, CARCINOGENESIS, V34, P2370, DOI 10.1093/carcin/bgt241	54	42	43	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 6	2018	37	36					4921	4940		10.1038/s41388-018-0320-2	http://dx.doi.org/10.1038/s41388-018-0320-2			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS6QR	29780168	Green Published, hybrid			2022-12-26	WOS:000443823600002
J	Li, XY; Wang, LQ; Fang, P; Sun, Y; Jiang, XH; Wang, H; Yang, XF				Li, Xinyuan; Wang, Luqiao; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng			Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; lysophospholipid; metabolism; endothelial cell; atherosclerosis; immunometabolism; lysophosphatidylcholine; lysophosphatidylinositol; RNA-Seq; transdifferentiation	ACUTE CORONARY SYNDROME; PHOSPHOLIPASE A(2) INHIBITOR; RANDOMIZED CLINICAL-TRIAL; MESENCHYMAL TRANSITION; ATHEROSCLEROTIC PLAQUE; VASCULAR INFLAMMATION; CARDIOVASCULAR EVENTS; DISEASE; VARESPLADIB; METABOLISM	Innate immune cells express danger-associated molecular pattern (DAMP) receptors, T-cell costimulation/coinhibition receptors, and major histocompatibility complex II (MHC-II). We have recently proposed that endothelial cells can serve as innate immune cells, but the molecular mechanisms involved still await discovery. Here, we investigated whether human aortic endothelial cells (HAECs) could be transdifferentiated into innate immune cells by exposing them to hyperlipidemia-up-regulated DAMP molecules, i.e. lysophospholipids. Performing RNA-seq analysis of lysophospholipid-treated HAECs, we found that lysophosphatidylcholine (LPC) and lysophosphatidylinositol (LPI) regulate largely distinct gene programs as revealed by principal component analysis. Metabolically, LPC up-regulated genes that are involved in cholesterol biosynthesis, presumably through sterol regulatory element-binding protein 2 (SREBP2). By contrast, LPI up-regulated gene transcripts critical for the metabolism of glucose, lipids, and amino acids. Of note, we found that LPC and LPI both induce adhesion molecules, cytokines, and chemokines, which are all classic markers of endothelial cell activation, in HAECs. Moreover, LPC and LPI shared the ability to transdifferentiate HAECs into innate immune cells, including induction of potent DAMP receptors, such as CD36 molecule, T-cell costimulation/coinhibition receptors, and MHC-II proteins. The induction of these innate-immunity signatures by lysophospholipids correlated with their ability to induce up-regulation of cytosolic calcium and mitochondrial reactive oxygen species. In conclusion, lysophospholipids such as LPC and LPI induce innate immune cell transdifferentiation in HAECs. The concept of prolonged endothelial activation, discovered here, is relevant for designing new strategies for managing cardiovascular diseases.	[Li, Xinyuan; Wang, Luqiao; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Ctr Metab Dis Res, MERB 1059,3500 North Broad St, Philadelphia, PA 19140 USA; [Li, Xinyuan; Wang, Luqiao; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Ctr Cardiovasc Res, MERB 1059,3500 North Broad St, Philadelphia, PA 19140 USA; [Li, Xinyuan; Wang, Luqiao; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Ctr Thrombosis Res, Philadelphia, PA 19140 USA; [Li, Xinyuan; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Li, Xinyuan; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Microbiol, Philadelphia, PA 19140 USA; [Li, Xinyuan; Fang, Pu; Sun, Yu; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Immunol, Philadelphia, PA 19140 USA; [Wang, Luqiao] Kunming Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Kunming 650031, Yunnan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Kunming Medical University	Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Metab Dis Res, MERB 1059,3500 North Broad St, Philadelphia, PA 19140 USA.; Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Cardiovasc Res, MERB 1059,3500 North Broad St, Philadelphia, PA 19140 USA.	xfyang@temple.edu	Li, Xinyuan/Z-6299-2019; Li, Xinyuan/B-1139-2015; SUN, YU/ABE-7355-2021	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367; SUN, YU/0000-0002-0877-7186; wang, luqiao/0000-0003-0263-9492	NHLBI, National Institutes of Health [HL131460, HL132399, HL138749, HL130233, HL110764, HL117654]; NIDDK, National Institutes of Health [DK104116, DK113775]; American Heart Association Scientist Development Grant [17SDG33671051]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132399, R01HL138749, R01HL131460, R01HL130233, R01HL117654, R01HL110764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104116, R01DK113775] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grants HL131460, HL132399, HL138749, HL130233, HL110764, and HL117654 from the NHLBI, National Institutes of Health and Grants DK104116 and DK113775 from the NIDDK, National Institutes of Health (to X.-F. Y. and H. W.) and American Heart Association Scientist Development Grant 17SDG33671051 (to P. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Beiting DP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cheng JL, 2017, ADV EXP MED BIOL, V982, P359, DOI 10.1007/978-3-319-55330-6_20; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Drzazga A, 2017, BIOCHEM BIOPH RES CO, V489, P242, DOI 10.1016/j.bbrc.2017.05.145; Du FY, 2012, FRONT BIOSCI-LANDMRK, V17, P2327, DOI 10.2741/4055; Dushkin MI, 2012, BIOCHEMISTRY-MOSCOW+, V77, P327, DOI 10.1134/S0006297912040025; Evrard SM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11853; Fang P, 2014, DIABETES, V63, P4275, DOI 10.2337/db14-0809; Ferrer LM, 2016, J CARDIOVASC TRANSL, V9, P135, DOI 10.1007/s12265-016-9683-3; Filadi R, 2017, CELL CALCIUM, V62, P1, DOI 10.1016/j.ceca.2017.01.003; Fraser H, 2009, J CARDIOVASC PHARM, V53, P60, DOI 10.1097/FJC.0b013e318195bfbc; Fu HF, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0440-0; Gaber T, 2017, NAT REV RHEUMATOL, V13, P267, DOI 10.1038/nrrheum.2017.37; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jang C, 2013, NATURE, V500, P409, DOI 10.1038/nature12549; Ke XY, 2008, FRONT BIOSCI-LANDMRK, V13, P3986, DOI 10.2741/2986; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Langston PK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00061; Li XY, 2018, ARTERIOSCL THROM VAS, V38, P599, DOI 10.1161/ATVBAHA.117.310626; Li XY, 2019, CYTOKINE, V122, DOI 10.1016/j.cyto.2017.06.003; Li XY, 2017, CAN J PHYSIOL PHARM, V95, P247, DOI 10.1139/cjpp-2016-0515; Li XY, 2016, ARTERIOSCL THROM VAS, V36, P1090, DOI 10.1161/ATVBAHA.115.306964; Li YF, 2016, FRONT BIOSCI-LANDMRK, V21, P178, DOI 10.2741/4383; Li YF, 2016, FRONT BIOSCI-LANDMRK, V21, P70, DOI 10.2741/4377; Li YF, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0130-8; Mai JT, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-61; Man K, 2017, CELL METAB, V25, P11, DOI 10.1016/j.cmet.2016.08.016; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Monroy MA, 2015, FRONT BIOSCI-LANDMRK, V20, P784, DOI 10.2741/4337; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; O'Donoghue ML, 2014, JAMA-J AM MED ASSOC, V312, P1006, DOI 10.1001/jama.2014.11061; Packard RRS, 2009, SEMIN IMMUNOPATHOL, V31, P5, DOI 10.1007/s00281-009-0153-8; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Rosenson RS, 2010, J AM COLL CARDIOL, V56, P1079, DOI 10.1016/j.jacc.2010.06.015; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Sha XJ, 2015, J BIOL CHEM, V290, P19307, DOI 10.1074/jbc.M115.663286; Shao Y, 2018, ANTIOXID REDOX SIGN, V28, P973, DOI 10.1089/ars.2017.7069; Shao Y, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0080-6; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Virtue A, 2017, J BIOL CHEM, V292, P1267, DOI 10.1074/jbc.M116.739839; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Wang X, 2016, J CARDIOVASC TRANSL, V9, P343, DOI 10.1007/s12265-016-9700-6; White HD, 2014, NEW ENGL J MED, V370, P1702, DOI 10.1056/NEJMoa1315878; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Xi H, 2016, CIRC RES, V118, P1525, DOI 10.1161/CIRCRESAHA.116.308501; Xiao H, 2013, CIRCULATION, V128, P632, DOI 10.1161/CIRCULATIONAHA.113.002714; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Xu KM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00045; Yamashita A, 2013, PROSTAG OTH LIPID M, V107, P103, DOI 10.1016/j.prostaglandins.2013.05.004; Yang WY, 2015, BURNS TRAUMA, V3, DOI 10.1186/s41038-015-0001-0; Yang XF, 2006, INT J IMMUNOPATH PH, V19, P853, DOI 10.1177/039463200601900415; Yin Y, 2015, ARTERIOSCL THROM VAS, V35, P804, DOI 10.1161/ATVBAHA.115.305282; Yin Y, 2013, FRONT BIOSCI-LANDMRK, V18, P638, DOI 10.2741/4127	59	48	49	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11033	11045		10.1074/jbc.RA118.002752	http://dx.doi.org/10.1074/jbc.RA118.002752			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29769317	Green Published, hybrid			2022-12-26	WOS:000438882800016
J	Qin, LY; Sankaran, B; Aminzai, S; Casteel, DE; Kim, C				Qin, Liying; Sankaran, Banumathi; Aminzai, Sahar; Casteel, Darren E.; Kim, Choel			Structural basis for selective inhibition of human PKG I by the balanol-like compound N46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); protein kinase G (PKG); inhibitor; crystal structure; drug design; ATP competitive inhibitor; inhibitor specificity; nonopioid analgesics; protein-ligand complex	DEPENDENT PROTEIN-KINASE; CRYSTAL-STRUCTURE; PAIN HYPERSENSITIVITY; CATALYTIC SUBUNIT; CGMP-BINDING; NERVE INJURY; ACTIVATION; COMPLEX; SPECIFICITY; REVEALS	Activation of protein kinase G (PKG) I in nociceptive neurons induces long-term hyperexcitability that causes chronic pain. Recently, a derivative of the fungal metabolite balanol, N46, has been reported to inhibit PKG I with high potency and selectivity and attenuate thermal hyperalgesia and osteoarthritic pain. Here we determined co-crystal structures of the PKG I C-domain and cAMP-dependent protein kinase (PKA) C, each bound with N46, at 1.98 and 2.65 , respectively. N46 binds the active site with its external phenyl ring, specifically interacting with the glycine-rich loop and the C helix. Phe-371 at the PKG I glycine-rich loop is oriented parallel to the phenyl ring of N46, forming a strong -stacking interaction, whereas the analogous Phe-54 in PKA C rotates 30 degrees and forms a weaker interaction. Structural comparison revealed that steric hindrance between the preceding Ser-53 and the propoxy group of the phenyl ring may explain the weaker interaction with PKA C. The analogous Gly-370 in PKG I, however, causes little steric hindrance with Phe-371. Moreover, Ile-406 on the C helix forms a hydrophobic interaction with N46 whereas its counterpart in PKA, Thr-88, does not. Substituting these residues in PKG I with those in PKA C increases the IC50 values for N46, whereas replacing these residues in PKA C with those in PKG I reduces the IC50, consistent with our structural findings. In conclusion, our results explain the structural basis for N46-mediated selective inhibition of human PKG I and provide a starting point for structure-guided design of selective PKG I inhibitors.	[Qin, Liying; Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA; [Aminzai, Sahar; Casteel, Darren E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Diego; Baylor College of Medicine	Kim, C (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Casteel, DE (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Kim, C (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA.	dcasteel@ucsd.edu; ckim@bcm.edu			National Institutes of Health [S10OD021832]; Howard Hughes Medical Institute; NIGMS, National Institutes of Health National [P30 GM124169-01]; Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161, P30GM124169] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS, National Institutes of Health National; Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Andrey Kovalevsky and Friedrich W. Herberg for critical reading of the manuscript. We also thank Paul Leonard (MD Anderson Cancer Center) for assistance with the initial screening of the PKG I-N46 complex crystals and Ying-Ju Sung (Geisinger Commonwealth School of Medicine) for kindly providing N46. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health; the NIGMS, National Institutes of Health; and the Howard Hughes Medical Institute. The ALS-ENABLE beamlines are supported in part by NIGMS, National Institutes of Health National Grant P30 GM124169-01. The Advanced Light Source is a Department of Energy Office of Science User Facility under Contract DE-AC02-05CH11231. The Pilatus detector was funded under National Institutes of Health Grant S10OD021832.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berndt N, 2017, CURR OPIN CHEM BIOL, V39, P126, DOI 10.1016/j.cbpa.2017.06.015; Boric M, 2014, J CHEM NEUROANAT, V61-62, P140, DOI 10.1016/j.jchemneu.2014.09.004; Burkhardt M, 2000, J BIOL CHEM, V275, P33536, DOI 10.1074/jbc.M005670200; BUTT E, 1990, FEBS LETT, V263, P47, DOI 10.1016/0014-5793(90)80702-K; Butt Elke, 2009, V191, P409, DOI 10.1007/978-3-540-68964-5_17; Campbell JC, 2017, ACS CHEM BIOL, V12, P2388, DOI 10.1021/acschembio.7b00369; Campbell JC, 2017, FEBS LETT, V591, P221, DOI 10.1002/1873-3468.12505; Council of Economic Advisers, 2017, UND COST OP CRIS; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Fountas A, 2015, TRENDS ENDOCRIN MET, V26, P643, DOI 10.1016/j.tem.2015.09.003; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Gangadharan V, 2017, MOL PAIN, V13, DOI 10.1177/1744806917701743; Gustafsson AB, 1999, MOL PHARMACOL, V56, P377, DOI 10.1124/mol.56.2.377; Hedegaard Holly, 2017, NCHS Data Brief, P1; HIDAKA H, 1992, ANNU REV PHARMACOL, V32, P377, DOI 10.1146/annurev.pharmtox.32.1.377; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hofmann Franz, 2013, Methods Mol Biol, V1020, P17, DOI 10.1007/978-1-62703-459-3_2; Kalyanaraman H, 2017, J BIOL CHEM, V292, P8262, DOI 10.1074/jbc.C117.787358; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; KOIDE K, 1995, CHEM BIOL, V2, P601, DOI 10.1016/1074-5521(95)90124-8; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Luo C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001283; Marsico F, 2017, J CARDIOVASC MED, V18, pe40, DOI 10.2459/JCM.0000000000000443; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Narayana N, 1999, BIOCHEMISTRY-US, V38, P2367, DOI 10.1021/bi9820659; Office of the Surgeon General, 2016, FAC ADD AM SURG GEN; Ono-Saito N, 1999, PHARMACOL THERAPEUT, V82, P123, DOI 10.1016/S0163-7258(98)00070-9; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Rummans TA, 2018, MAYO CLIN PROC, V93, P344, DOI 10.1016/j.mayocp.2017.12.020; Ryan SA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-4129; Setyawan J, 1999, MOL PHARMACOL, V56, P370, DOI 10.1124/mol.56.2.370; Sung YJ, 2006, NEUROSCIENCE, V141, P697, DOI 10.1016/j.neuroscience.2006.04.033; Sung YJ, 2017, PAIN, V158, P822, DOI 10.1097/j.pain.0000000000000832; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; Wagner J, 2009, J MED CHEM, V52, P6193, DOI 10.1021/jm901108b; Walitt B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138024; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Wolfertstetter S, 2013, PHARMACEUTICALS, V6, P269, DOI 10.3390/ph6020269	46	7	7	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10985	10992		10.1074/jbc.RA118.002427	http://dx.doi.org/10.1074/jbc.RA118.002427			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29769318	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000438882800012
J	Zhu, WY; Tomberg, J; Knilans, KJ; Anderson, JE; McKinnon, KP; Sempowski, GD; Nicholas, RA; Duncan, JA				Zhu, Weiyan; Tomberg, Joshua; Knilans, Kayla J.; Anderson, James E.; McKinnon, Karen P.; Sempowski, Gregory D.; Nicholas, Robert A.; Duncan, Joseph A.			Properly folded and functional PorB from Neisseria gonorrhoeae inhibits dendritic cell stimulation of CD4(+) T cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE VESICLES; IMMUNE-RESPONSES; MENINGITIDIS; ACTIVATION; TLR2; RESISTANCE; PROTEINS; INVASION; BLEBS; ROLES	Neisseria gonorrhoeae is an exclusive human pathogen that evades the host immune system through multiple mechanisms. We have shown that N. gonorrhoeae suppresses the capacity of antigen-presenting cells to induce CD4(+) T cell proliferation. In this study, we sought to determine the gonococcal factors involved in this adaptive immune suppression. We show that suppression of the capacity of antigen-pulsed dendritic cells to induce T cell proliferation is recapitulated by administration of a high-molecular-weight fraction of conditioned medium from N. gonorrhoeae cultures, which includes outer membrane vesicles that are shed during growth of the bacteria. N. gonorrhoeae PorB is the most abundant protein in N. gonorrhoeae-derived vesicles, and treatment of dendritic cells with purified recombinant PorB inhibited the capacity of the cells to stimulate T cell proliferation. This immunosuppressive feature of purified PorB depended on proper folding of the protein. PorB from N. gonorrhoeae, as well as other Neisseria species and other Gram-negative bacterial species, are known to activate host Toll-like receptor 2 (TLR2) signaling. Published studies have demonstrated that purified Neisseria PorB forms proteinacious nanoparticles, termed proteosomes, when detergent micelles are removed. Unlike folded, detergent-solubilized PorB, PorB proteosomes stimulate immune responses. We now demonstrate that the formation of PorB proteosomes from structurally intact PorB eliminates the immunosuppressive property of the protein while enhancing TLR2 stimulation. These findings suggest that gonococcal PorB present in shed outer membrane vesicles plays a role in suppression of adaptive immune responses to this immune-evasive pathogen.	[Zhu, Weiyan; Anderson, James E.; Duncan, Joseph A.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Tomberg, Joshua; Knilans, Kayla J.; Nicholas, Robert A.; Duncan, Joseph A.] Univ N Carolina, Dept Pharmacol, CB 7365,4046 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Sempowski, Gregory D.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA; [McKinnon, Karen P.; Nicholas, Robert A.] Univ N Carolina, Dept Microbiol & Immunol, CB 7365,4046 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [McKinnon, Karen P.; Duncan, Joseph A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nicholas, RA (corresponding author), Univ N Carolina, Dept Pharmacol, CB 7365,4046 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Nicholas, RA (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, CB 7365,4046 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.; Duncan, JA (corresponding author), Univ N Carolina, Dept Med, CB 7030,8341B Med & Biomol Res Bldg, Chapel Hill, NC 27599 USA.; Duncan, JA (corresponding author), Univ N Carolina, Dept Pharmacol, CB 7030,8341B Med & Biomol Res Bldg, Chapel Hill, NC 27599 USA.	nicholas@med.unc.edu; jaduncan@med.unc.edu		Duncan, Joseph/0000-0002-4438-2018; Sempowski, Gregory/0000-0003-0391-6594	Burroughs Wellcome Fund Career Awards for Medical Scientists; National Institutes of Health [U19-AI031496, U19-AI113170-01, UC6-AI058607]; NIGMS [R01-GM066861]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031496, UC6AI058607, U19AI113170, T32AI007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066861] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Awards for Medical Scientists; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the Burroughs Wellcome Fund Career Awards for Medical Scientists (to J. A. D.) and the National Institutes of Health through the following grants and contracts: U19-AI031496 (Southeastern Sexually Transmitted Infection Cooperative Research Center) (to J. A. D. and G. D. S.); U19-AI113170-01 (Atlantic Coast Sexually Transmitted Infection Cooperative Research Center) (to J. A. D., G. D. S., and R. A. N.); UC6-AI058607 (Regional Biocontainment Laboratory at Duke University Medical Center) (to G. D. S.); and NIGMS Grant R01-GM066861 (to R. A. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JE, 2003, MOL MICROBIOL, V48, P1325, DOI 10.1046/j.1365-2958.2003.03496.x; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Boulton IC, 2002, NAT IMMUNOL, V3, P229, DOI 10.1038/ni769; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 2001, J BIOL CHEM, V276, P17413, DOI 10.1074/jbc.M010609200; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Duluc D, 2013, MUCOSAL IMMUNOL, V6, P626, DOI 10.1038/mi.2012.104; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Faulstich M, 2015, CELL MICROBIOL, V17, P241, DOI 10.1111/cmi.12361; Fox K K, 1999, Curr Opin Urol, V9, P65, DOI 10.1097/00042307-199901000-00011; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; Jerse AE, 2013, SEX TRANSM INFECT, V89, P63, DOI 10.1136/sextrans-2013-051225; JOHNSTON KH, 1974, J BACTERIOL, V119, P250, DOI 10.1128/JB.119.1.250-257.1974; Kattner C, 2014, J STRUCT BIOL, V185, P440, DOI 10.1016/j.jsb.2013.12.006; Katz AR, 2012, CLIN INFECT DIS, V54, P841, DOI 10.1093/cid/cir929; Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629; Lappann M, 2013, J BACTERIOL, V195, P4425, DOI 10.1128/JB.00625-13; Liu XP, 2008, VACCINE, V26, P786, DOI 10.1016/j.vaccine.2007.11.080; Liu Y, 2014, MUCOSAL IMMUNOL, V7, P165, DOI 10.1038/mi.2013.36; Liu YR, 2011, MBIO, V2, DOI 10.1128/mBio.00095-11; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Massari P, 2005, PROTEIN EXPRES PURIF, V44, P136, DOI 10.1016/j.pep.2005.04.021; Massari P, 2003, CELL MICROBIOL, V5, P99, DOI 10.1046/j.1462-5822.2003.00257.x; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Mosaheb MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00225; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Murshid A, 2015, CYTOKINE, V75, P256, DOI 10.1016/j.cyto.2015.02.009; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Olesky M, 2006, J BACTERIOL, V188, P2300, DOI 10.1128/JB.188.7.2300-2308.2006; Platt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082171; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Rouquette-Loughlin CE, 2017, MBIO, V8, DOI 10.1128/mBio.00449-17; Shafer WM, 2002, J ENDOTOXIN RES, V8, P47, DOI 10.1179/096805102125000083; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Singleton TE, 2005, J IMMUNOL, V174, P3545, DOI 10.4049/jimmunol.174.6.3545; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Toussi DN, 2012, INFECT IMMUN, V80, P3417, DOI 10.1128/IAI.00683-12; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/FMB.12.117, 10.2217/fmb.12.117]; van Vliet SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000625; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x; WETZLER LM, 1992, INFECT IMMUN, V60, P39, DOI 10.1128/IAI.60.1.39-43.1992; Yu QG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056705; Zhang YL, 2015, ONCOTARGET, V6, P19936, DOI 10.18632/oncotarget.4582; Zhu WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041260; Zughaier S, 2006, VACCINE, V24, P1291, DOI 10.1016/j.vaccine.2005.09.039	49	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11218	11229		10.1074/jbc.RA117.001209	http://dx.doi.org/10.1074/jbc.RA117.001209			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29752412	Green Published, hybrid			2022-12-26	WOS:000438882800032
J	Li, XL; Wu, CL; Shen, Y; Wang, K; Tang, L; Zhou, M; Yang, M; Pan, TY; Liu, XH; Xu, WM				Li, Xiaoliang; Wu, Chunlian; Shen, Ying; Wang, Ke; Tang, Li; Zhou, Mi; Yang, Ming; Pan, Tianying; Liu, Xinghui; Xu, Wenming			Ten-eleven translocation 2 demethylates the MMP9 promoter, and its down-regulation in preeclampsia impairs trophoblast migration and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; pregnancy; placenta; metalloprotease; DNA demethylation; preeclampsia; pregnancy complication; TET2; trophoblast; MMP9; methylation	DNA METHYLATION; HTR8/SVNEO INVASION; TET2 FUNCTION; MATRIX-METALLOPROTEINASE-9; HYPERMETHYLATION; EXPRESSION; CONTRIBUTES; PREVENTION; PLACENTA	Preeclampsia is the most common clinical disorder in pregnancy and might result from disordered uterine environments caused by epigenetic modifications, including deregulation of DNA methylation/demethylation. Recent research has indicated that 5-hydroxymethylcytosine (5hmC), a DNA base derived from 5-methylcytosine (5mC) via oxidation by ten-eleven translocation (TET) enzymes, is involved in DNA methylation-related plasticity. Here, we report that TET2 expression and 5hmC abundance are significantly altered in the placentas from preeclampsia patients. shRNA-mediated TET2 knockdown (shTET2) reduced trophoblast migration and invasion when cultured in Matrigel. Both real-time PCR of matrix metalloproteinase (MMP)-related transcripts and a human angiogenesis antibody array indicated that TET2 knockdown in trophoblasts inhibits the expression of MMP transcript, of which MMP9 represented one of the most significant TET2 downstream targets. Using an established shTET2 HTR-8/SVneo cell model, we further confirmed alterations of 5hmC levels and MMP9 expression at both mRNA and protein levels. In particular, we found that TET2 bound to and removed 5mC modifications at the MMP9 promoter region. Interestingly, in TET2 knockdown cells, both MMP9 expression and the compromised trophoblast phenotype could be rescued by vitamin C, an activator of TET enzyme activity. Finally, TET2 expression correlated with MMP9 levels in placenta samples from the preeclampsia patients, indicating that TET2 deregulation is critically involved in the pathogenesis of preeclampsia through down-regulation of MMP9 expression. Our findings highlight a critical role of TET2 in regulating trophoblast cell migration through demethylation at the MMP9 promoter, and suggest that down-regulation of the TET2-MMP9-mediated pathway contributes to preeclampsia pathogenesis.	[Li, Xiaoliang; Shen, Ying; Wang, Ke; Tang, Li; Zhou, Mi; Yang, Ming; Pan, Tianying; Xu, Wenming] Sichuan Univ, West China Univ Hosp 2, Joint Lab Reprod Med,Minist Educ, SCU CUHK,Key Lab Obstet Gynecol & Pediat Dis & Bi, Chengdu 610041, Sichuan, Peoples R China; [Li, Xiaoliang; Shen, Ying; Wang, Ke; Tang, Li; Zhou, Mi; Yang, Ming; Pan, Tianying; Liu, Xinghui; Xu, Wenming] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol Dis, Chengdu 610041, Sichuan, Peoples R China; [Li, Xiaoliang; Wu, Chunlian] China West Normal Univ, Minist Educ, Key Lab Southwest China Wildlife Resource Conserv, Nanchong 637009, Peoples R China	Sichuan University; Sichuan University; China West Normal University	Xu, WM (corresponding author), 3duan 17, Chengdu 610041, Sichuan, Peoples R China.	Xinghuiliu@163.com; xuwenming@scu.edu.cn	shen, ying/HHS-5635-2022	Xu, wenming/0000-0002-3686-229X	Natural Science Foundation of China [81300494, 81471463]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China Grants 81300494 and 81471463. The authors declare that they have no conflicts of interest with the contents of this article.	Abad C, 2012, HYPERTENS PREGNANCY, V31, P427, DOI 10.3109/10641955.2012.690058; Agathocleous M, 2017, NATURE, V549, P476, DOI 10.1038/nature23876; An J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.5; Anderson CM, 2014, BIOL RES NURS, V16, P409, DOI 10.1177/1099800413508645; Azami M, 2017, INT J REPROD BIOMED, V15, P273; Bowman RL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026518; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P531, DOI 10.1038/nrneph.2014.103; Chinnathambi V, 2013, HYPERTENSION, V61, P647, DOI 10.1161/HYPERTENSIONAHA.111.00486; Cimmino L, 2017, CELL, V170, P1079, DOI 10.1016/j.cell.2017.07.032; Cudmore M, 2007, CIRCULATION, V115, P1789, DOI 10.1161/CIRCULATIONAHA.106.660134; Duraisamy AJ, 2017, INVEST OPHTH VIS SCI, V58, P6440, DOI 10.1167/iovs.17-22706; Fan M, 2016, CELL PHYSIOL BIOCHEM, V38, P1319, DOI 10.1159/000443076; Gao WL, 2011, HYPERTENS RES, V34, P655, DOI 10.1038/hr.2011.9; Kowluru RA, 2016, LAB INVEST, V96, P1040, DOI 10.1038/labinvest.2016.78; Ling L, 2013, J MOL ENDOCRINOL, V50, P279, DOI 10.1530/JME-12-0172; Lio CW, 2016, ELIFE, V5, DOI 10.7554/eLife.18290; Liu H, 2014, PLACENTA, V35, P981, DOI 10.1016/j.placenta.2014.09.016; Logan Philip C., 2013, Frontiers in Genetics, V4, P265, DOI 10.3389/fgene.2013.00265; Lorquet S, 2010, ACTA CLIN BELG, V65, P237, DOI 10.1179/acb.2010.051; Martin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141294; Nelissen ECM, 2011, HUM REPROD UPDATE, V17, P397, DOI 10.1093/humupd/dmq052; Palei ACT, 2013, CURR DRUG TARGETS, V14, P325; Peng B, 2016, MOL HUM REPROD, V22, P119, DOI 10.1093/molehr/gav070; Plaks V, 2013, P NATL ACAD SCI USA, V110, P11109, DOI 10.1073/pnas.1309561110; Pushpakumar S, 2015, FASEB J, V29, P4713, DOI 10.1096/fj.15-272443; Qu K, 2017, INT J BIOL MACROMOL, V98, P637, DOI 10.1016/j.ijbiomac.2017.02.025; Rahat B, 2016, EPIGENOMICS-UK, V8, P767, DOI 10.2217/epi.16.7; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Shorey-Kendrick LE, 2017, AM J RESP CRIT CARE, V196, P745, DOI 10.1164/rccm.201610-2141OC; Takayama K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9219; Tan Q, 2016, CLIN ENDOCRINOL, V85, P54, DOI 10.1111/cen.13047; Tanaka S, 2014, INT J DEV BIOL, V58, P231, DOI 10.1387/ijdb.140053st; Tang L, 2017, REPRODUCTION, V153, pR27, DOI 10.1530/REP-16-0287; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; White WM, 2013, HYPERTENS PREGNANCY, V32, P257, DOI 10.3109/10641955.2013.796970; Yang M, 2016, PLACENTA, V41, P62, DOI 10.1016/j.placenta.2016.03.007; Yang Y, 2015, PLACENTA, V36, P587, DOI 10.1016/j.placenta.2015.01.201; Zhang JL, 2016, WOUND REPAIR REGEN, V24, P489, DOI 10.1111/wrr.12426; Zhang YW, 2017, MOL CELL, V65, P323, DOI 10.1016/j.molcel.2016.12.013; Zhu LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134119	41	32	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10059	10070		10.1074/jbc.RA117.001265	http://dx.doi.org/10.1074/jbc.RA117.001265			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29773648	hybrid, Green Published			2022-12-26	WOS:000437096700011
J	Sasaki, T; Kuboyama, A; Mita, M; Murata, S; Shimizu, M; Inoue, J; Mori, K; Sato, R				Sasaki, Takashi; Kuboyama, Ayane; Mita, Moeko; Murata, Shotaro; Shimizu, Makoto; Inoue, Jun; Mori, Kazutoshi; Sato, Ryuichiro			The exercise-inducible bile acid receptor Tgr5 improves skeletal muscle function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						skeletal muscle; bile acid; muscle hypertrophy; exercise; unfolded protein response (UPR); endoplasmic reticulum stress (ER stress); transcription regulation; muscle cell differentiation; TGR5	UNFOLDED PROTEIN RESPONSE; STRESS; HYPERTROPHY; IMPACT; MASS; CHOLESTEROL; ANTIOBESITY; ACTIVATION; RESISTANCE; INHIBITION	TGR5 (also known as G protein-coupled bile acid receptor 1, GPBAR1) is a G protein-coupled bile acid receptor that is expressed in many diverse tissues. TGR5 is involved in various metabolic processes, including glucose metabolism and energy expenditure; however, TGR5's function in skeletal muscle is not fully understood. Using both gain- and loss-of-function mouse models, we demonstrate here that Tgr5 activation promotes muscle cell differentiation and muscle hypertrophy. Both young and old transgenic mice with muscle-specific Tgr5 expression exhibited increased muscle strength. Moreover, we found that Tgr5 expression is increased by the unfolded protein response (UPR), which is an adaptive response required for maintenance of endoplasmic reticulum (ER) homeostasis. Both ER stress response element (ERSE)- and unfolded protein response element (UPRE)-like sites are present in the 5 upstream region of the Tgr5 gene promoter and are essential for Tgr5 expression by Atf6 (activating transcription factor 6), a well known UPR-activated transcriptional regulator. We observed that in the skeletal muscle of mice, exercise-induced UPR increases Tgr5 expression, an effect that was abrogated in Atf6 KO mice, indicating that Atf6 is essential for this response. These findings indicate that the bile acid receptor Tgr5 contributes to improved muscle function and provide an additional explanation for the beneficial effects of exercise on skeletal muscle activity.	[Sasaki, Takashi; Kuboyama, Ayane; Mita, Moeko; Murata, Shotaro; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo 1138657, Japan; [Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutri Life Sci Lab, Tokyo 1138657, Japan; [Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; [Sato, Ryuichiro] Japan Agcy Med Res & Dev, CREST, AMED, Tokyo 1000004, Japan	University of Tokyo; University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo 1138657, Japan.; Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutri Life Sci Lab, Tokyo 1138657, Japan.; Sato, R (corresponding author), Japan Agcy Med Res & Dev, CREST, AMED, Tokyo 1000004, Japan.	aroysato@mail.ecc.u-tokyo.ac.jp	Mori, Kazutoshi/AAW-5449-2020	Sasaki, Takashi/0000-0002-3352-0753	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP15H05781, JP16K18699]; LOTTE Foundation; Cross-ministerial Strategic Innovation Promotion Program [14533567]; Japanese Agency for Medical Research and Development (AMED-CREST) [16gm0910008h0001]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); LOTTE Foundation; Cross-ministerial Strategic Innovation Promotion Program; Japanese Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant JP15H05781 (to R. S.) and JP16K18699 (to T. S.), research grants from the LOTTE Foundation (to M. S.), Cross-ministerial Strategic Innovation Promotion Program Grant 14533567 (to R. S.), and the Japanese Agency for Medical Research and Development (AMED-CREST) Grant 16gm0910008h0001 (to R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Benoit B, 2017, NAT MED, V23, P990, DOI 10.1038/nm.4363; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Bohnert KR, 2016, FASEB J, V30, P3053, DOI 10.1096/fj.201600250RR; Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Cao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28676; Chen M, 2009, AM J PHYSIOL-CELL PH, V296, pC930, DOI 10.1152/ajpcell.00443.2008; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Horiba T, 2015, BIOCHEM BIOPH RES CO, V463, P846, DOI 10.1016/j.bbrc.2015.06.022; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kim HJ, 2011, MED SCI SPORT EXER, V43, P18, DOI 10.1249/MSS.0b013e3181e4c5d1; KIM YS, 1992, LIFE SCI, V50, P397, DOI 10.1016/0024-3205(92)90374-X; Kliewer SA, 2015, DIGEST DIS, V33, P327, DOI 10.1159/000371670; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Ono E, 2011, BIOCHEM BIOPH RES CO, V410, P677, DOI 10.1016/j.bbrc.2011.06.055; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Potthoff MJ, 2013, AM J PHYSIOL-GASTR L, V304, pG371, DOI 10.1152/ajpgi.00400.2012; Rajagopal S, 2013, AM J PHYSIOL-GASTR L, V304, pG527, DOI 10.1152/ajpgi.00388.2012; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Ryall JG, 2007, J GERONTOL A-BIOL, V62, P813, DOI 10.1093/gerona/62.8.813; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sasaki T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179226; Sasaki T, 2014, AM J PHYSIOL-ENDOC M, V306, pE1085, DOI 10.1152/ajpendo.00691.2013; Sato H, 2007, BIOCHEM BIOPH RES CO, V362, P793, DOI 10.1016/j.bbrc.2007.06.130; Sato R, 2013, VITAM HORM, V91, P425, DOI 10.1016/B978-0-12-407766-9.00018-3; Stewart R, 2013, P NATL ACAD SCI USA, V110, P117, DOI 10.1073/pnas.1212676110; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tontonoz P, 2015, MOL CELL BIOL, V35, P1125, DOI 10.1128/MCB.00715-14; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Vassileva G, 2010, J ENDOCRINOL, V205, P225, DOI 10.1677/JOE-10-0009; Velazquez-Villegas LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02068-0; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Worthmann A, 2017, NAT MED, V23, P839, DOI 10.1038/nm.4357; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	49	34	35	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10322	10332		10.1074/jbc.RA118.002733	http://dx.doi.org/10.1074/jbc.RA118.002733			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29773650	Green Published, hybrid			2022-12-26	WOS:000437096700030
J	Kazmiruk, TN; Kazmiruk, VD; Bendell, LI				Kazmiruk, T. N.; Kazmiruk, V. D.; Bendell, L., I			Abundance and distribution of microplastics within surface sediments of a key shellfish growing region of Canada	PLOS ONE			English	Article							MARINE-ENVIRONMENT; BRITISH-COLUMBIA; PLASTIC DEBRIS; PACIFIC-OCEAN; BIOAVAILABILITY; AQUACULTURE; POLLUTION; INDUSTRY; PELLETS; METALS	The abundance and distribution of microplastics within 5 sediment size classes (>5000 mu m, 1000-5000 mu m, 250-1000 mu m, 250-0.63 mu m and <0.63 mu m) were determined for 16 sites within Lambert Channel and Baynes Sound, British Columbia, Canada. This region is Canada's premier growing area for the Pacific oyster (Crassostrea gigas). Microplastics were found at all sampling locations indicating widespread contamination of this region with these particles. Three types of microplastics were recovered: microbeads, which occurred in the greatest number (up to 25000/kg dry sediment) and microfibers and microfragments, which were much less in number compared with microbeads and occurred in similar amounts (100-300/kg dry sediment). Microbeads were recovered primarily in the <0.63 mu m and 250-0.63 mu m sediment size class, whereas microfragments and microfibers were generally identified in all 5 sediment size classes. Abundance and distribution of the three types of microplastics were spatially dependent with principal component analysis (PCA) indicating that 84 percent of the variation in abundance and distribution was due to the presence of high numbers of microbeads at three locations within the study region. At these sites, microbeads expressed as a percent component of the sediment by weight was similar to key geochemical components that govern trace metal behavior and availability to benthic organisms. Microbeads have been shown to accumulate metals from the aquatic environment, hence in addition to the traditional geochemical components such as silt and organic matter, microplastics also need to be considered as a sediment component that can influence trace metal geochemistry. Our findings have shown that BC's premier oyster growing region is highly contaminated with microplastics, notably microbeads. It would be prudent to assess the degree to which oysters from this region are ingesting microplastics. If so, it would have direct implications for Canada's oyster farming industry with respect to the health of the oyster and the quality of product that is being farmed and sets an example for other shellfish growing regions of the world.	[Kazmiruk, T. N.; Kazmiruk, V. D.; Bendell, L., I] Simon Fraser Univ, Dept Biol Sci, Ecotoxicol Res Grp, Burnaby, BC, Canada	Simon Fraser University	Bendell, LI (corresponding author), Simon Fraser Univ, Dept Biol Sci, Ecotoxicol Res Grp, Burnaby, BC, Canada.	bendell@sfu.ca			Centre of Coastal Science and Management, Faculty of Environment, Simon Fraser University; Centre for Coastal Science and Management at Simon Fraser University	Centre of Coastal Science and Management, Faculty of Environment, Simon Fraser University; Centre for Coastal Science and Management at Simon Fraser University	Funding was provided by the Centre of Coastal Science and Management, Faculty of Environment, Simon Fraser University (LIB).; We thank the Centre for Coastal Science and Management at Simon Fraser University for funding this study. The authors gratefully acknowledge Shelley McKeachie, Morley McKeachie, Barbara Mills, Rollande McKinley, and Angela Robinson for their logistical support, painstaking efforts in ensuring reliability of the data and encouragement in the field on the Denman Island. The authors would also like to thank Dr.'s Mattsson and Bisgrove from SFU for providing us with necessary equipment and assisting us with making photo-catalogue of microplastic particles. A thank you to Cam Young for the use of his hot needle for microplastic identification.	Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; [Anonymous], 2011, 09426 WORL PARS CAN; Arthur C., 2009, P INT RES WORKSH OCC; Ashton K, 2010, MAR POLLUT BULL, V60, P2050, DOI 10.1016/j.marpolbul.2010.07.014; Avio CG, 2015, ENVIRON POLLUT, V198, P211, DOI 10.1016/j.envpol.2014.12.021; Bendell LI, 2015, MAR POLLUT BULL, V91, P22, DOI 10.1016/j.marpolbul.2014.12.043; Bendell LI, 2014, AQUACULTURE, V433, P384, DOI 10.1016/j.aquaculture.2014.06.027; Bendell LI, 2011, J COAST CONSERV, V15, P417, DOI 10.1007/s11852-010-0101-8; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Claessens M, 2011, MAR POLLUT BULL, V62, P2199, DOI 10.1016/j.marpolbul.2011.06.030; Clague J. J, 1976, 7621 GEOL SURV CAN; Cluzard M, 2015, ARCH ENVIRON CON TOX, V69, P310, DOI 10.1007/s00244-015-0156-5; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Davidson K, 2016, ARCH ENVIRON CON TOX, V71, P147, DOI 10.1007/s00244-016-0286-4; De Witte B, 2014, MAR POLLUT BULL, V85, P146, DOI 10.1016/j.marpolbul.2014.06.006; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Desforges JPW, 2014, MAR POLLUT BULL, V79, P94, DOI 10.1016/j.marpolbul.2013.12.035; Doyle MJ, 2011, MAR ENVIRON RES, V71, P41, DOI 10.1016/j.marenvres.2010.10.001; Environment and Climate Change Canada, 2015, MICR A SCI SUMM; Gorley C.K., 2006, GETTING STARTED PRIM; Hanke G, 2013, MSFD GES TECHNICAL S; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Holmes LA, 2012, ENVIRON POLLUT, V160, P42, DOI 10.1016/j.envpol.2011.08.052; Jamieson GS, 2501125 SCI ADV SECR; Jang M, 2016, ENVIRON SCI TECHNOL, V50, P4951, DOI 10.1021/acs.est.5b05485; Klein S, 2015, ENVIRON SCI TECHNOL, V49, P6070, DOI 10.1021/acs.est.5b00492; Li JN, 2015, ENVIRON POLLUT, V207, P190, DOI 10.1016/j.envpol.2015.09.018; Liebezeit G, 2012, B ENVIRON CONTAM TOX, V89, P213, DOI 10.1007/s00128-012-0642-7; LUCAS Z, 1992, MAR POLLUT BULL, V24, P192, DOI 10.1016/0025-326X(92)90529-F; Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025; Mudroch P., 1997, MANUAL PHYSICOCHEMIC; Napper IE, 2015, MAR POLLUT BULL, V99, P178, DOI 10.1016/j.marpolbul.2015.07.029; National Oceanic and Atmospheric Administration, 2015, DET MICR MAR ENV; Phuong NN, 2016, ENVIRON POLLUT, V211, P111, DOI 10.1016/j.envpol.2015.12.035; Plastics Europe, 2017, PLAST FACTS 2017, P44; Plastics Europe. Plastics the Facts, 2012, PLAST FACTS AN EUR P, P34; Puyate Y. T., 2007, J APPL SCI RES, V3, P2056; Rocha-Santos T, 2015, TRAC-TREND ANAL CHEM, V65, P47, DOI 10.1016/j.trac.2014.10.011; Rochman CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085433; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Sussarellu R, 2016, P NATL ACAD SCI USA, V113, P2430, DOI 10.1073/pnas.1519019113; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Zhang C, 2014, ENVIRON INT, V73, P270, DOI 10.1016/j.envint.2014.08.010	43	35	36	5	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196005	10.1371/journal.pone.0196005	http://dx.doi.org/10.1371/journal.pone.0196005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791448	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000010
J	Neal, S; Channon, AA; Chintsanya, J				Neal, Sarah; Channon, Andrew Amos; Chintsanya, Jesman			The impact of young maternal age at birth on neonatal mortality: Evidence from 45 low and middle income countries	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; ADOLESCENT PREGNANCY; TEENAGE PREGNANCY; INFANT-MORTALITY; OUTCOMES; HEALTH; TRENDS; DEATHS; GROWTH; RISK	Objectives This study explores the impact of early motherhood on neonatal mortality, and how this differs between countries and regions. It assesses whether the risk of neonatal mortality is greater for younger adolescent mothers compared with mothers in later adolescence, and explores if differences reflect confounding socio-economic and health care utilisation factors. It also examines how the risks differ for first or subsequent pregnancies. Methods The analysis uses 64 Demographic and Health Surveys collected between 2005 and 2015 from 45 countries to explore the relationship between adolescent motherhood (disaggregated as <16 years, 16/17 years and 18/19 years) and neonatal mortality. Both unadjusted bivariate association and logistic regression are used. Regional level multivariate models that adjust for a range of socio-economic, demographic and health service utilisation variables are estimated. Further stratified models are created to examine the excess risk for first and subsequent births separately. Findings The risk of neonatal mortality in all regions was markedly greater for infants with mothers under 16 years old, although there was marked heterogeneity in patterns between regions. Adjusting for socio-economic, demographic and health service utilisation variables did not markedly change the odds ratios associated with age. The increased risks associated with adolescent motherhood are lowest for first births. Conclusion Our findings particularly highlight the importance of reducing adolescent births among the youngest age group as a strategy for addressing the problem of neonatal mortality, as well ensuring pregnant adolescents have access to quality maternal health services to protect the health of both themselves and their infants. The regional differences in increased risk are a novel finding which requires more exploration.	[Neal, Sarah; Channon, Andrew Amos] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [Chintsanya, Jesman] Univ Malawi, Chancellor Coll, Zomba, Malawi	University of Southampton; University of Malawi	Neal, S (corresponding author), Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England.	S.Neal@soton.ac.uk		Neal, Sarah/0000-0003-1812-7221; Chintsanya, Jesman/0000-0002-0262-9668; Channon, Andrew/0000-0003-4855-0418	British Academy [511537101]	British Academy	This work was supported by a British Academy Postdoctoral Fellowship 511537101 (SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshina N, 2003, HIGH IS INFANT MORTA; [Anonymous], WHO AD PREGN; Atuyambe Lynn, 2005, Afr Health Sci, V5, P304; Atuyambe Lynn, 2008, Reprod Health, V5, P13, DOI 10.1186/1742-4755-5-13; Bilano VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091198; Chen XK, 2008, J CLIN EPIDEMIOL, V61, P688, DOI 10.1016/j.jclinepi.2007.08.009; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; Cowden AJ, 2001, J ADOLESCENT HEALTH, V29, P37, DOI 10.1016/S1054-139X(01)00217-8; Ezeh OK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-521; FRASER AM, 1995, NEW ENGL J MED, V332, P1113, DOI 10.1056/NEJM199504273321701; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Glassman A, 2012, 295 CTR GLOB DEV; Granja ACL, 2001, J ADOLESCENT HEALTH, V28, P303, DOI 10.1016/S1054-139X(00)00205-6; Haider BA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3443; Hardy J. B., 1991, ADOLESCENT PREGNANCY; Hayward CE, 2012, AM J PHYSIOL-ENDOC M, V302, pE233, DOI 10.1152/ajpendo.00192.2011; Iacobelli S, 2012, J MATERN-FETAL NEO M, P1; Igras SM, 2014, GLOB PUBLIC HEALTH, V9, P555, DOI 10.1080/17441692.2014.908230; Kozuki N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S2; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Leppalahti S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003225; Mahy M, 2003, DHS COMP REPORTS; Malqvist M, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.5724; Markovitz BP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-79; Mekonnen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-483; Neal S., 2012, 25 ESRC CTR POP CHAN; Neal S, 2012, ACTA OBSTET GYN SCAN, V91, P1114, DOI 10.1111/j.1600-0412.2012.01467.x; Neal SE, 2015, INT PERSPECT SEX R H, V41, P210, DOI 10.1363/4121015; Neal SE, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-13; Neal SE, 2015, UNION AFRICAN POPULA; Okusanya BO, 2013, J MATERN-FETAL NEO M, V26, P885, DOI 10.3109/14767058.2013.765851; Rani M, 2004, INT FAM PLAN PERSPEC, V30, P110, DOI 10.1363/3011004; Reynolds H, 2006, INT FAMILY PLANNING; Scholl T O, 1989, Paediatr Perinat Epidemiol, V3, P357, DOI 10.1111/j.1365-3016.1989.tb00524.x; SCHOLL TO, 1994, AM J CLIN NUTR, V60, P183, DOI 10.1093/ajcn/60.2.183; Sharma V, 2008, ARCH PEDIAT ADOL MED, V162, P828, DOI 10.1001/archpedi.162.9.828; Smith GCS, 2001, BRIT MED J, V323, P476, DOI 10.1136/bmj.323.7311.476; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Taylor S, 2015, LANCET, V386, P1213, DOI 10.1016/S0140-6736(15)00300-1; Temin M, 2010, ISSUES SCI TECHNOL, V26, P33; The DHS Program, QUAL INF PLAN MON IM; Thomas F, 2001, HUM BIOL, V73, P271, DOI 10.1353/hub.2001.0029; UNDESA, UN DEP EC SOC AFF ST; UNFPA WHO UNAIDS, 2004, SEEN NOT HEARD VER Y; UNICEF, 2011, STAT WORLDS CHILDR 2; UNICEF, 2016, UNICEF DAT; Walker N., 2016, REPROD MATERNAL NEWB, V2; Wort UU, 2006, ACTA OBSTET GYN SCAN, V85, P949, DOI 10.1080/00016340600756870	49	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0195731	10.1371/journal.pone.0195731	http://dx.doi.org/10.1371/journal.pone.0195731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0FF	29791441	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000433077000005
J	Berardi, R; Torniai, M; Partelli, S; Rubini, C; Pagliaretta, S; Savini, A; Polenta, V; Santoni, M; Giampieri, R; Onorati, S; Barucca, F; Murrone, A; Bianchi, F; Falconi, M				Berardi, Rossana; Torniai, Mariangela; Partelli, Stefano; Rubini, Corrado; Pagliaretta, Silvia; Savini, Agnese; Polenta, Vanessa; Santoni, Matteo; Giampieri, Riccardo; Onorati, Sofia; Barucca, Federica; Murrone, Alberto; Bianchi, Francesca; Falconi, Massimo			Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms	PLOS ONE			English	Article							FACTOR GENE POLYMORPHISMS; CELL CARCINOMA; 1ST-LINE SUNITINIB; PROGNOSTIC-FACTORS; TUMOR PROGRESSION; CANCER; ANGIOGENESIS; SURVIVAL; RISK; SUSCEPTIBILITY	Angiogenesis represents a key event in cancer development, leading to local invasion e metastatization, and might be considered a basic feature in gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) with a high expression of angiogenic molecules. We aimed to analyze the prognostic and predictive role of angiogenic factors in GEP-NENs through the analysis of single nucleotide polymorphisms (SNPs) of VEGF-A, VEGFR2 and VEGFR3. The genomic DNA of 58 consecutive patients with GEP-NENs treated at our Institution was extracted from peripheral blood. Two SNPs were identified respectively in VEGFA (rs2010963G>C, rs699947A>C), VEGFR-2 (rs2305948C>T, rs1870377T>A), and VEGFR-3 (rs307821T>C, rs307826C>A) gene. Gene polymorphisms were determined by Real-Time PCR using TaqMan assays. Median age was 57 years (range 24-79 years); 32 patients were male and 77.5% of NENs were localized in the pancreas. The allele frequency of VEGFR-2 rs2305948T and of VEGF-A rs2010963C showed a trend of higher frequency than in general population (12.1% vs. 8.0% and 34.5% vs. 31.2%, respectively). Three out SNPs (VEGF-A rs699947C, VEGF-A rs2010963GC and VEGFR-3 rs307821C) showed a correlation with an increased risk of disease relapse. Moreover median PFS changes according to the presence of 0-1 SNPs (20.7% of cases; 61.9 months), 2 SNPs (25.9%; 49.2 months) and 3 SNPs (53.4%; 27.8 months) (p = 0.034). Results suggest, for the first time, that specific SNPs in VEGF-A and VEGFR-3 correlate with poor prognosis in GEP-NENs. The identification of this new prognostic factor might be helpful in order to optimize the management of these heterogeneous neoplasms.	[Berardi, Rossana; Torniai, Mariangela; Pagliaretta, Silvia; Savini, Agnese; Santoni, Matteo; Giampieri, Riccardo; Onorati, Sofia; Barucca, Federica; Murrone, Alberto; Bianchi, Francesca] Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Ancona, Clin Oncol Med, Ancona, Italy; [Partelli, Stefano] Univ Vitae & Salute, Osped San Raffaele IRCCS, Chirurg Pancreas, Milan, Italy; [Rubini, Corrado; Falconi, Massimo] Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Ancona, Deparment Neurosci, Sect Pathol Anat & Histopathol, Ancona, Italy; [Polenta, Vanessa] Azienda Osped Univ Osped Riuniti Ancona, Dipartimento Chirurg Gen, Ancona, Italy	Marche Polytechnic University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Marche Polytechnic University	Berardi, R (corresponding author), Univ Politecn Marche, Azienda Osped Univ Osped Riuniti Ancona, Clin Oncol Med, Ancona, Italy.	r.berardi@univpm.it	Berardi, Rossana/AAC-5216-2022; Falconi, Massimo/K-2194-2016; Torniai, Mariangela/N-6327-2019; Berardi, Rossana/AAC-5758-2022	Berardi, Rossana/0000-0002-9529-2960; Falconi, Massimo/0000-0001-9654-7243; 				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berardi R, 2015, ONCOTARGET, V6, P19305, DOI 10.18632/oncotarget.4191; Beuselinck B, 2013, BRIT J CANCER, V108, P887, DOI 10.1038/bjc.2012.548; Chen HY, 2012, J MOL NEUROSCI, V47, P448, DOI 10.1007/s12031-012-9705-9; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fraenkel M, 2014, ENDOCR-RELAT CANCER, V21, pR153, DOI 10.1530/ERC-13-0125; Garcia-Carbonero R, 2014, CANCER METAST REV, V33, P343, DOI 10.1007/s10555-013-9469-x; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Giampieri R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25195; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Grande E, 2015, ANN ONCOL, V26, P1987, DOI 10.1093/annonc/mdv252; Grimm C, 2011, INT J GYNECOL CANCER, V21, P597, DOI 10.1097/IGC.0b013e318214557c; Halfdanarson TR, 2015, CURR CLIN PHARMACOL, V10, P305, DOI 10.2174/1574884710666151020100211; Janardhan B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131190; Jang MJ, 2013, MOL CARCINOGEN, V52, P60, DOI 10.1002/mc.21980; Kammerer PW, 2010, J ORAL PATHOL MED, V39, P786, DOI 10.1111/j.1600-0714.2010.00904.x; Karamysheva AF, 2008, BIOCHEMISTRY-US, V73, P935; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kuiper P, 2011, WORLD J GASTROENTERO, V17, P219, DOI 10.3748/wjg.v17.i2.219; Li R, 2011, INT J CANCER, V128, P166, DOI 10.1002/ijc.25306; Lin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075123; Masago K, 2009, CANCER SCI, V100, P1917, DOI 10.1111/j.1349-7006.2009.01253.x; Meadows KN, 2001, J BIOL CHEM, V276, P49289, DOI 10.1074/jbc.M108069200; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Pape UF, 2008, ENDOCR-RELAT CANCER, V15, P1083, DOI 10.1677/ERC-08-0017; Pavel ME, 2005, CLIN ENDOCRINOL, V62, P434, DOI 10.1111/j.1365-2265.2005.02238.x; Pinato DJ, 2014, BRIT J CANCER, V110, P115, DOI 10.1038/bjc.2013.682; Poncet G, 2009, J SURG RES, V154, P68, DOI 10.1016/j.jss.2008.03.055; Rindi G., 2010, WHO CLASSIFICATION T, pS13; Scartozzi M, 2013, BRIT J CANCER, V108, P1126, DOI 10.1038/bjc.2012.501; Scartozzi M, 2014, INT J CANCER, V135, P1247, DOI 10.1002/ijc.28772; Tamburrino D, 2016, BEST PRACT RES CL EN, V30, P93, DOI 10.1016/j.beem.2015.10.003; Vaziri SAJ, 2010, CURR ONCOL REP, V12, P102, DOI 10.1007/s11912-010-0085-4; Wang K, 2011, CYTOKINE, V56, P167, DOI 10.1016/j.cyto.2011.06.018; Wang ZW, 2015, SEMIN CANCER BIOL, V35, pS224, DOI 10.1016/j.semcancer.2015.01.001; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Yadav L, 2015, J CLIN DIAGN RES, V9, pXE1, DOI 10.7860/JCDR/2015/12016.6135; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zachary I, 2001, AM J PHYSIOL-CELL PH, V280, pC1375, DOI 10.1152/ajpcell.2001.280.6.C1375; Zhang J, 2007, CANCER, V109, P1478, DOI 10.1002/cncr.22554; Zhou LP, 2011, GENET MOL RES, V10, P3674, DOI 10.4238/2011.October.31.13	44	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197035	10.1371/journal.pone.0197035	http://dx.doi.org/10.1371/journal.pone.0197035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787601	Green Submitted, gold, Green Published			2022-12-26	WOS:000432785700011
J	Kutsuna, R; Tomida, J; Morita, Y; Kawamura, Y				Kutsuna, Ryo; Tomida, Junko; Morita, Yuji; Kawamura, Yoshiaki			Paraclostridium bifermentans exacerbates pathosis in a mouse model of ulcerative colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SULFATE-REDUCING BACTERIA; GENOME-WIDE ASSOCIATION; REGULATORY T-CELLS; CHAIN FATTY-ACIDS; CLOSTRIDIUM-BIFERMENTANS; CROHNS-DISEASE; COMMENSAL BACTERIA; GUT MICROBIOTA; HUMAN FECES	Although it has been recognized that intestinal bacteria play an important role in the pathology of human ulcerative colitis (UC), specific pathogenic bacteria for UC have not been identified. We investigated the influence of Paraclostridium bifermentans PAGU1678 strain on the pathology of a UC mouse model and found it increased UC pathosis scores such as loose and bloody stools, reduced diversity of fecal flora, disappearance of the crypt structure of distal colon tissue, destruction of intestinal epithelial cells, and atrophy of the colon. Furthermore, we observed an increase in COX-2, TNF-alpha, IL-6, IL-1, and IL-17 expression and a decrease in Foxp3 and SOCS3 expression, as inflammation-related factors and inflammatory cytokines, a decrease in the concentration of short chain fatty acids (acetic acid, propionic acid, and butyric acid) in feces, and an increase of intestinal mucosal myeloperoxidase activity. These results suggest that P. bifermentans PAGU1678 is a pathology-exacerbating factor in a mouse model of UC. This study is the first to demonstrate exacerbation of the pathological condition in a mouse model of UC by a single bacterial strain.	[Kutsuna, Ryo; Tomida, Junko; Morita, Yuji; Kawamura, Yoshiaki] Aichi Gakuin Univ, Grad Sch Pharmaceut Sci, Dept Microbiol, Nagoya, Aichi, Japan; [Morita, Yuji] Meiji Pharmaceut Univ, Sch Pharm, Dept Infect Control Sci, Tokyo, Japan	Aichi Gakuin University; Meiji Pharmaceutical University	Kawamura, Y (corresponding author), Aichi Gakuin Univ, Grad Sch Pharmaceut Sci, Dept Microbiol, Nagoya, Aichi, Japan.	kawamura@dpc.agu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25460177, 21590138]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (https://www.jsps.go.jp/j-grantsinaid/index.html) grant numbers 25460177 and 21590138 to YK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andoh A, 2012, J GASTROENTEROL, V47, P1298, DOI 10.1007/s00535-012-0605-0; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Bousvaros A, 2005, INFLAMM BOWEL DIS, V11, P833, DOI 10.1097/01.MIB.0000175905.00212.2c; Choudhary S, 2001, DIGEST DIS SCI, V46, P2222, DOI 10.1023/A:1011975218006; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; GIBSON GR, 1993, GUT, V34, P437, DOI 10.1136/gut.34.4.437; Gourgue-Jeannot C, 2006, CAN J MICROBIOL, V52, P924, DOI 10.1139/W06-053; HAGUE A, 1995, INT J CANCER, V60, P400, DOI 10.1002/ijc.2910600322; Hale A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw095; Hayashi A, 2013, CELL HOST MICROBE, V13, P711, DOI 10.1016/j.chom.2013.05.013; Hegazy SK, 2010, WORLD J GASTROENTERO, V16, P4145, DOI 10.3748/wjg.v16.i33.4145; Hisamatsu T, 2013, PHARMACOL THERAPEUT, V137, P283, DOI 10.1016/j.pharmthera.2012.10.008; Hong SW, 2016, J MICROBIOL BIOTECHN, V26, P1057, DOI 10.4014/jmb.1512.12035; Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9; Islam MS, 2008, BRIT J PHARMACOL, V154, P812, DOI 10.1038/bjp.2008.137; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jyothsna TSS, 2016, INT J SYST EVOL MICR, V66, P1268, DOI 10.1099/ijsem.0.000874; Kanda T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159705; Kawamura Y, 2012, JAPANESE J BACTERIOL, V67, P106; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lindsay JO, 2006, GUT, V55, P348, DOI 10.1136/gut.2005.074971; Liu YW, 2011, INT IMMUNOPHARMACOL, V11, P2159, DOI 10.1016/j.intimp.2011.09.013; Loubinoux J, 2002, FEMS MICROBIOL ECOL, V40, P107, DOI 10.1111/j.1574-6941.2002.tb00942.x; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MISRA DP, 1980, THORAX, V35, P310, DOI 10.1136/thx.35.4.310; Mitsuoka T, 1996, Asia Pac J Clin Nutr, V5, P2; Miyamoto M, 2003, J IMMUNOL, V170, P4665, DOI 10.4049/jimmunol.170.9.4665; Ohkusa T, 2009, J MED MICROBIOL, V58, P535, DOI 10.1099/jmm.0.005801-0; Pitcher MCL, 2000, GUT, V46, P64, DOI 10.1136/gut.46.1.64; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P1008, DOI 10.1056/NEJM199110033251406; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; ROEDIGER WEW, 1993, GASTROENTEROLOGY, V104, P802, DOI 10.1016/0016-5085(93)91016-B; SCANLAN DR, 1994, J CLIN MICROBIOL, V32, P2867, DOI 10.1128/JCM.32.11.2867-2868.1994; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; SMART SJ, 1994, AM J PHYSIOL, V266, pL238, DOI 10.1152/ajplung.1994.266.3.L238; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545; Torii T, 2010, ANN CLIN BIOCHEM, V47, P447, DOI 10.1258/acb.2010.010047; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Zhang HQ, 2009, WORLD J GASTROENTERO, V15, P1821, DOI 10.3748/wjg.15.1821	51	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197668	10.1371/journal.pone.0197668	http://dx.doi.org/10.1371/journal.pone.0197668			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782507	Green Published, gold, Green Submitted			2022-12-26	WOS:000432537100039
J	Tsukamoto, Y; Ikeda, S; Uwai, K; Taguchi, R; Chayama, K; Sakaguchi, T; Narita, R; Yao, WL; Takeuchi, F; Otakaki, Y; Watashi, K; Wakita, T; Kato, H; Fujita, T				Tsukamoto, Yuta; Ikeda, Sotaro; Uwai, Koji; Taguchi, Riho; Chayama, Kazuaki; Sakaguchi, Takemasa; Narita, Ryo; Yao, Wan-Ling; Takeuchi, Fumihiko; Otakaki, Yukie; Watashi, Koichi; Wakita, Takaji; Kato, Hiroki; Fujita, Takashi			Rosmarinic acid is a novel inhibitor for Hepatitis B virus replication targeting viral epsilon RNA-polymerase interaction	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; RIG-I; DERIVATIVES; HELICASE; STRATEGY; BLOCKING; CELLS	Current therapeutics for hepatitis B virus (HBV) patients such as nucleoside analogs (NAs) are effective; however, new antiviral drugs against HBV are still desired. Since the interaction between the epsilon (c) sequence of HBV pregenomic RNA and viral polymerase (Pot) is a key step in the HBV replication cycle, we aimed to identify small compounds for its inhibition, and established a pull-down assay system for the detection of c-RNA-binding-Pol. Screening showed that 5 out of 3,965 compounds inhibited c-Pol binding, and we identified rosmarinic acid, which exhibited specificity, as a potential antiviral agent. In order to examine the anti-HBV effects of rosmarinic acid, HBV-infected primary human hepatocytes from a humanized mouse liver were treated with rosmarinic acid. The rosmarinic acid treatment decreased HBV components including the amounts of extracellular HBV DNA with negligible cytotoxicity. We also investigated the combined effects of rosmarinic acid and the NA, lamivudine. rosmarinic acid slightly enhanced the anti-HBV activity of lamivudine, suggesting that the HBV replication step targeted by rosmarinic acid is distinct from that of NA. We analyzed an additional 25 rosmarinic acid derivatives, and found that 5 also inhibited c-Pol. Structural comparisons between these derivatives implied that the "two phenolic hydroxyl groups at both ends" and the "caffeic acid-like structure" of rosmarinic acid are critical for the inhibition of c-Pol binding. Collectively, our results demonstrate that rosmarinic acid inhibits HBV replication in HBV-infected cells by specifically targeting c-Pol binding.	[Tsukamoto, Yuta; Ikeda, Sotaro; Narita, Ryo; Yao, Wan-Ling; Takeuchi, Fumihiko; Otakaki, Yukie; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Lab Mol Genet, Kyoto, Japan; [Tsukamoto, Yuta; Kato, Hiroki] Univ Bonn, Univ Hosp Bonn, Inst Mol Med, Bonn, Germany; [Ikeda, Sotaro; Yao, Wan-Ling; Takeuchi, Fumihiko; Otakaki, Yukie; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Immunol, Kyoto, Japan; [Uwai, Koji; Taguchi, Riho] Muroran Inst Technol, Grad Sch Engn, Div Sustainable & Environm Engn, Muroran, Hokkaido, Japan; [Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Sakaguchi, Takemasa] Hiroshima Univ, Grad Sch Biomed Sci, Dept Virol, Hiroshima, Japan; [Narita, Ryo] Aarhus Univ, Dept Mol Biol & Genet, Ctr Struct Biol, Aarhus, Denmark; [Watashi, Koichi; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Watashi, Koichi] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba, Japan; [Watashi, Koichi] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan	Kyoto University; University of Bonn; Kyoto University; Muroran Institute of Technology; Hiroshima University; Hiroshima University; Hiroshima University; Aarhus University; National Institute of Infectious Diseases (NIID); Tokyo University of Science; Japan Science & Technology Agency (JST)	Fujita, T (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Lab Mol Genet, Kyoto, Japan.; Fujita, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Immunol, Kyoto, Japan.	tfujita@virus.kyoto-u.ac.jp	chayama, Kazuaki/G-2917-2019; Sakaguchi, Takemasa/H-1488-2019	Sakaguchi, Takemasa/0000-0002-3754-1252; TSUKAMOTO, Yuta/0000-0002-0773-7190; Chayama, Kazuaki/0000-0002-5530-5341; YAO, WAN-LING/0000-0001-6193-9247	Ministry of Health, Labour and Welfare/Japan Agency for Medical Research and Development (AMED) [17fk0310107h0001, 17fk0310109h0001]	Ministry of Health, Labour and Welfare/Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	The work was supported by The Ministry of Health, Labour and Welfare/Japan Agency for Medical Research and Development (AMED) for research on the innovative development and the practical application of new drugs for hepatitis B, Grant number: 17fk0310107h0001 to TF and 17fk0310109h0001 to HK (URL: https://www.amed.go.dp/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTENSCHLAGER R, 1992, EMBO J, V11, P3413, DOI 10.1002/j.1460-2075.1992.tb05420.x; Bloom K, 2013, MOL THER, V21, P1889, DOI 10.1038/mt.2013.170; Cai CW, 2014, ANTIVIR RES, V108, P48, DOI 10.1016/j.antiviral.2014.05.007; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; Cheng ZK, 2015, VIROL SIN, V30, P261, DOI 10.1007/s12250-015-3584-5; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Delaney WE, 2002, ANTIMICROB AGENTS CH, V46, P3057, DOI 10.1128/AAC.46.9.3057-3060.2002; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Hu Y, 2013, ANTIVIR RES, V99, P221, DOI 10.1016/j.antiviral.2013.06.007; Katen SP, 2010, ACS CHEM BIOL, V5, P1125, DOI 10.1021/cb100275b; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Leong CR, 2016, ONCOTARGET, DOI [10.18632/oncotarget.1190711907, DOI 10.18632/ONCOTARGET.1190711907]; Lin L, 2008, J VIROL, V82, P2305, DOI 10.1128/JVI.02147-07; Lin SR, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.38; Liu YJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006296; Lu GF, 2015, ANTIMICROB AGENTS CH, V59, P1070, DOI 10.1128/AAC.04617-14; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ogura N, 2014, BIOCHEM BIOPH RES CO, V452, P315, DOI 10.1016/j.bbrc.2014.08.029; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Schoneweis K, 2018, ANTIVIR RES, V149, P26, DOI 10.1016/j.antiviral.2017.10.022; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seeger C, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.68; Stray SJ, 2006, J MOL RECOGNIT, V19, P542, DOI 10.1002/jmr.801; Taguchi R, 2017, EUR J MED CHEM, V138, P1066, DOI 10.1016/j.ejmech.2017.07.026; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tavis JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003125; Volz T, 2013, J HEPATOL, V58, P861, DOI 10.1016/j.jhep.2012.12.008; Wang YX, 2012, J VIROL, V86, P10079, DOI 10.1128/JVI.00816-12; Watanabe N, 1997, EMBO J, V16, P3609, DOI 10.1093/emboj/16.12.3609; Yao WL, 2017, INT IMMUNOL, DOI [10.1093/intimm/dxx0123066062, DOI 10.1093/INTIMM/DXX0123066062]; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	35	26	28	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197664	10.1371/journal.pone.0197664	http://dx.doi.org/10.1371/journal.pone.0197664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782545	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100038
J	Liu, YL; Zhang, BH; Wen, XP; Zhang, SL; Wei, YY; Lu, QW; Liu, Z; Wang, KB; Liu, F; Peng, RH				Liu, Yuling; Zhang, Baohong; Wen, Xinpeng; Zhang, Shulin; Wei, Yangyang; Lu, Quanwei; Liu, Zhen; Wang, Kunbo; Liu, Fang; Peng, Renhai			Construction and characterization of a bacterial artificial chromosome library for Gossypium mustelinum	PLOS ONE			English	Article							GENETIC DIVERSITY; GENOME; COTTON; MAP; IDENTIFICATION; INTEGRATION; HIRSUTUM; DNA	A bacterial artificial chromosome (BAC) library for G. mustelinum Miers ex G. Watt (AD(4)) was constructed. Intact nuclei from G. mustelinum (AD(4)) were used to isolate high molecular weight DNA, which was partially cleaved with Hind III and cloned into pSMART BAC (Hind III) vectors. The BAC library consisted of 208,182 clones arrayed in 542 384-microtiter plates, with an average insert size of 121.72 kb ranging from 100 to 150 kb. About 2% of the clones did not contain inserts. Based on an estimated genome size of 2372 Mb for G. mustelinum, the BAC library was estimated to have a total coverage of 10.50 x genome equivalents. The high capacity library of G. mustelinum will serve as a giant gene resource for map-based cloning of quantitative trait loci or genes associated with important agronomic traits or resistance to Verticillium wilt, physical mapping and comparative genome analysis.	[Liu, Yuling; Wen, Xinpeng; Zhang, Shulin; Wei, Yangyang; Lu, Quanwei; Liu, Zhen; Peng, Renhai] Anyang Inst Technol, Anyang, Henan, Peoples R China; [Zhang, Baohong] East Carolina Univ, Dept Biol, Greenville, NC USA; [Wang, Kunbo; Liu, Fang; Peng, Renhai] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Anyang Institute of Technology; University of North Carolina; East Carolina University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Peng, RH (corresponding author), Anyang Inst Technol, Anyang, Henan, Peoples R China.; Liu, F; Peng, RH (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	liufcri@163.com; aydxprh@163.com		Peng, Renhai/0000-0001-7916-2288; Wen, Xinpeng/0000-0002-2589-0893	National Natural Science Foundation of China [31471548]; State Key Laboratory of Cotton Biology Open Fund [CB2017A06]; National Key Research and Development Program [2016YFD0100203]; PhD Scientific Research Fund of Anyang Institute of Technology [BSJ2016005]; Key Scientific Research Project of Higher Education in Henan Province [18B210001]; Science and Technology Development Program of Henan Province [182102110048]; Innovation Scientists and Technicians Troop Construction Projects of Henan Province [184200510009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Cotton Biology Open Fund; National Key Research and Development Program; PhD Scientific Research Fund of Anyang Institute of Technology; Key Scientific Research Project of Higher Education in Henan Province; Science and Technology Development Program of Henan Province; Innovation Scientists and Technicians Troop Construction Projects of Henan Province	This work was sponsored by a grant from the National Natural Science Foundation of China (No. 31471548)(Renhai Peng), State Key Laboratory of Cotton Biology Open Fund (No. CB2017A06)(Yuling Liu), National Key Research and Development Program (2016YFD0100203)(Renhai Peng), PhD Scientific Research Fund of Anyang Institute of Technology (BSJ2016005)(Yuling Liu), Key Scientific Research Project of Higher Education in Henan Province (18B210001)(Yuling Liu), Science and Technology Development Program of Henan Province (182102110048), and Innovation Scientists and Technicians Troop Construction Projects of Henan Province (184200510009) (Renhai Peng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was sponsored by the National Natural Science Foundation of China (31471548), National Key Research and Development Program (2016YFD0100203), Innovation Scientists and Technicians Troop Construction Projects of Henan Province (184200510009), Science and Technology Development Program of Henan Province (182102110048), Key Scientific Research Project of Higher Education in Henan Province (18B210001).	Beier S, 2016, PLANT BIOTECHNOL J, V14, P1511, DOI 10.1111/pbi.12511; Bohra A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-56; Cui XL, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0106-y; Dong JM, 1999, BACTERIAL ARTIFICIAL; Fryxell P.A., 1992, RHEEDEA, V2, P108; Gan YM, 2012, GENES GENET SYST, V87, P233, DOI 10.1266/ggs.87.233; Gao HY, 2013, CHINESE SCI BULL, V58, P3199, DOI 10.1007/s11434-013-5864-5; Grover CE, 2015, GENET RESOUR CROP EV, V62, P103, DOI 10.1007/s10722-014-0138-x; Grover CE, 2015, MOL PHYLOGENET EVOL, V92, P45, DOI 10.1016/j.ympev.2015.05.023; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Hu Y, 2009, J INTEGR PLANT BIOL, V51, P107, DOI 10.1111/j.1744-7909.2008.00773.x; Hu Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457137; Hulse-Kemp AM, 2015, G3-GENES GENOM GENET, V5, P1095, DOI 10.1534/g3.115.017749; Jiang LK, 2016, MAR BIOTECHNOL, V18, P49, DOI 10.1007/s10126-015-9666-4; Ling P, 2005, GENOME, V48, P1028, DOI [10.1139/g05-078, 10.1139/G05-078]; Liu F, 2015, GENET MOL RES, V14, P16975, DOI 10.4238/2015.December.15.3; Liu YL, 2017, COMP CYTOGENET, V11, P405, DOI 10.3897/CompCytogen.v11i2.12824; Liu YL, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0235-y; Schulte D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-247; Wang BH, 2016, G3-GENES GENOM GENET, V6, P1673, DOI 10.1534/g3.116.029116; [汪保华 Wang Baohua], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P45; Wang K, 2008, GENETICS, V178, P1117, DOI 10.1534/genetics.107.083576; Wang K, 2010, CHROMOSOMA, V119, P255, DOI 10.1007/s00412-009-0254-0; Wang KB, 2014, CHINA COTTON, V41, P6; [王坤波 WANG Kunbo], 2007, [棉花学报, Cotton Science], V19, P354; Wang XF, 2006, GENOME, V49, P1393, DOI 10.1139/G06-113; [王省芬 WANG Xingfen], 2006, [棉花学报, Cotton Science], V18, P200; WENDEL JF, 1994, PLANT SYST EVOL, V192, P49, DOI 10.1007/BF00985907; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Wendel JF, 2015, AGRON MONOGR, V57, P25, DOI 10.2134/agronmonogr57.2013.0020; Wu Q, 2013, J INTEGR PLANT BIOL, V55, P654, DOI 10.1111/jipb.12084; [武亚磊 Wu Yalei], 2016, [分子植物育种, Molecular Plant Breeding], V14, P2172; Yin JM, 2006, J INTEGR PLANT BIOL, V48, P219, DOI 10.1111/j.1744-7909.2006.00169.x-i1; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; [郑拥民 Zheng Yongmin], 2004, [河北农业大学学报, Journal of Agricultural University of Hebei], V27, P17	36	2	4	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196847	10.1371/journal.pone.0196847	http://dx.doi.org/10.1371/journal.pone.0196847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771937	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900020
J	Oliveira, RC; Pralle, RS; de Resende, LC; Nova, CHPC; Caprarulo, V; Jendza, JA; Troescher, A; White, HM				Oliveira, Rafael Caputo; Pralle, Ryan S.; de Resende, Lucas C.; Nova, Carlos Henrique P. C.; Caprarulo, Valentina; Jendza, Joshua A.; Troescher, Arnulf; White, Heather M.			Prepartum supplementation of conjugated linoleic acids (CLA) increased milk energy output and decreased serum fatty acids and beta-hydroxybutyrate in early lactation dairy cows	PLOS ONE			English	Article							TRANS-OCTADECENOIC ACIDS; REPRODUCTIVE-PERFORMANCE; SUBCLINICAL KETOSIS; POSTPARTUM; CATTLE; LIVER; RESPONSES; SYSTEM; PERIOD	Prepartum supplementation with conjugated linoleic acid (CLA) may influence lipolysis and hyperketonemia in dairy cows. The objective of this study was to examine the effect of prepartum CLA supplementation on lactation performance and serum fatty acids (FA) and beta-hydroxybutyrate (BHB) in early lactation dairy cows, and secondarily on reproductive performance. Multiparous cows were enrolled in the study at 18 days prior to expected calving date, and randomly assigned 100 g/day of Lutrell Pure (BASF, Ludwigshafen, Germany; 75% FA), providing 10 g/day of each CLA isomer (trans-10 cis-12 and cis-9 trans-11 CLA) or equivalent amount of rumen inert fatty acids as control (78 g/day of Energy Booster 100; Milk Specialties Global, Eden Prairie, MN). Treatments were top dressed daily to individual cows from enrollment to calving and all cows were offered the same ration. Blood samples were collected on the first day of supplementation, 10 days prepartum, and 1, 7, 14, and 30 days postpartum. Hyperketonemia was defined as serum BHB >= 1.2 mM. Milk yield was recorded daily until 60 days postpartum and averaged weekly. Milk samples were obtained weekly for component analysis. Prepartum CLA supplementation tended to increase serum concentration of cis-9, trans-11 CLA and increased trans-10, cis-12 CLA prepartum. Cows supplemented with CLA had increased milk protein yield and tended to have increased milk fat yield and milk yield, which together resulted in greater energy content of milk. Cows supplemented with CLA had lower serum FA on day 1 and 7 postpartum and overall lower serum BHB postpartum, which resulted in decreased prevalence of hyperketonemia on day 14 postpartum. There were no differences in body condition score change, other health disorders, or reproductive outcomes by treatment. Together, these findings indicate that prepartum CLA supplementation may be a plausible strategy to positively influence postpartum performance.	[Oliveira, Rafael Caputo; Pralle, Ryan S.; White, Heather M.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [de Resende, Lucas C.] Univ Fed Lavras, Dept Med Vet, Lavras, MG, Brazil; [Nova, Carlos Henrique P. C.] State Univ Northern Rio de Janeiro, Dept Anim Sci, Campos Dos Goytacazes, RJ, Brazil; [Caprarulo, Valentina] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Jendza, Joshua A.] BASF, Florham Pk, NJ USA; [Troescher, Arnulf] BASF, Lampertheim, Hesse, Germany	University of Wisconsin System; University of Wisconsin Madison; Universidade Federal de Lavras; University of Milan; BASF; BASF	White, HM (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	heather.white@wisc.edu	Pralle, Ryan/AAM-4463-2021; CAPRARULO, VALENTINA/ABB-8785-2020	Pralle, Ryan/0000-0001-9803-1152; CAPRARULO, VALENTINA/0000-0003-3691-4608	Wisconsin Alumni Research Foundation (WARF)	Wisconsin Alumni Research Foundation (WARF)	This research was partially funded by gifts from the Wisconsin Alumni Research Foundation (WARF; warf.org) received by HMW. Lutrell Pure product was provided by BASF Corporation (basf.com).	Bernal-Santos G, 2003, J DAIRY SCI, V86, P3218, DOI 10.3168/jds.S0022-0302(03)73925-3; Castaneda-Gutierrez E, 2007, J DAIRY SCI, V90, P4253, DOI 10.3168/jds.2007-0117; Chandler TL, 2017, ANIM FEED SCI TECH, V224, P90, DOI 10.1016/j.anifeedsci.2016.12.008; CRAIG MC, 1972, ARCH BIOCHEM BIOPHYS, V152, P619, DOI 10.1016/0003-9861(72)90258-5; Csillik Z, 2017, J DAIRY SCI, V100, P5888, DOI 10.3168/jds.2016-12124; de Veth MJ, 2009, J DAIRY SCI, V92, P2662, DOI 10.3168/jds.2008-1845; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Esposito G, 2013, S AFR J ANIM SCI, V43, pS33, DOI 10.4314/sajas.v43i5.6; Galamb E, 2017, J ANIM PHYSIOL AN N, V101, P1026, DOI 10.1111/jpn.12544; Harvatine KJ, 2011, J DAIRY SCI, V94, P6047, DOI 10.3168/jds.2011-4657; He M, 2011, J DAIRY SCI, V94, P2481, DOI 10.3168/jds.2010-3755; Herdt TH, 2000, VET CLIN N AM-FOOD A, V16, P215, DOI 10.1016/S0749-0720(15)30102-X; Lima FS, 2012, VET J, V193, P140, DOI 10.1016/j.tvjl.2011.09.019; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; Moore CE, 2004, J DAIRY SCI, V87, P1886, DOI 10.3168/jds.S0022-0302(04)73347-0; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Petzold M, 2013, ARCH ANIM NUTR, V67, P185, DOI 10.1080/1745039X.2013.793049; Rutherford AJ, 2016, J DAIRY SCI, V99, P4808, DOI 10.3168/jds.2015-10154; Schepers AJ, 1997, J DAIRY SCI, V80, P1833, DOI 10.3168/jds.S0022-0302(97)76118-6; Selberg KT, 2004, J DAIRY SCI, V87, P158, DOI 10.3168/jds.S0022-0302(04)73153-7; Souza AH, 2008, THERIOGENOLOGY, V70, P208, DOI 10.1016/j.theriogenology.2008.03.014; Toledo MZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189117; Tyburczy C, 2008, J DAIRY SCI, V91, P3850, DOI 10.3168/jds.2007-0893; VOLPE JJ, 1973, ANNU REV BIOCHEM, V42, P21, DOI 10.1146/annurev.bi.42.070173.000321; von Soosten D, 2011, J DAIRY SCI, V94, P2859, DOI 10.3168/jds.2010-3851; WIGGANS GR, 1986, J DAIRY SCI, V69, P2935, DOI 10.3168/jds.S0022-0302(86)80749-4; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6	27	11	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197733	10.1371/journal.pone.0197733	http://dx.doi.org/10.1371/journal.pone.0197733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29772023	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900091
J	Rozenberg, K; Rosenzweig, T				Rozenberg, Konstantin; Rosenzweig, Tovit			Sarcopoterium spinosum extract improved insulin sensitivity in mice models of glucose intolerance and diabetes	PLOS ONE			English	Article							HIGH-FAT-DIET; MEDICINAL-PLANTS; NONALCOHOLIC STEATOHEPATITIS; ETHNOBOTANICAL SURVEY; GENETIC ARCHITECTURE; SKELETAL-MUSCLE; OBESITY; RESISTANCE; MECHANISMS; COMPLICATIONS	Background The glucose lowering properties of Sarcopoterium spinosum, a traditional medicinal plant, were previously validated by us using KK-Ay mice as a genetic model for type 2 diabetes (T2D). Objective To clarify the effects of Sarcopoterium spinosum extract (SSE) on diet-induced glucose intolerance and to investigate SSE effects on carbohydrate and lipid metabolism in target tissues of both high-fat-diet (HFD)-fed and KK-Ay mice. Results Mice were given SSE (70 mg/day) for 6 weeks. SSE improved glucose tolerance and insulin sensitivity in HFD-fed mice as was demonstrated previously in KK-Ay mice. Higher insulin sensitivity was validated by lower serum insulin and activation of the insulin signaling cascade in skeletal muscle and liver of SSE-treated mice in both models. H&E staining of the livers demonstrated lower severity of steatosis in SSE-treated mice. Several model-specific effects of SSE were observed-mRNA expression of proinflammatory genes and CD36 was reduced in SSE-treated KK-Ay mice. Hepatic mRNA expression of PEPCK was also reduced in SSE-treated KK-Ay mice, while other genes involved in carbohydrates and lipid metabolism were not affected. HFD-fed mice treated by SSE had elevated hepatic glycogen stores. Gluconeogenic gene expression was not affected, while GCK expression was increased. HFD-induced hepatic steatosis was not affected by SSE. However, while genes involved in lipid metabolism were downregulated by HFD, this was not found in HFD-fed mice given SSE, demonstrating an expression profile which is similar to that of standard diet-fed mice. Conclusion Our study supports the insulin sensitizing activity of SSE and suggests that this extract might improve other manifestations of the metabolic syndrome.	[Rosenzweig, Tovit] Ariel Univ, Dept Mol Biol, Ariel, Israel; Ariel Univ, Dept Nutr Studies, Ariel, Israel	Ariel University; Ariel University	Rosenzweig, T (corresponding author), Ariel Univ, Dept Mol Biol, Ariel, Israel.	tovitro@ariel.ac.il	Rosenzweig, Tovit/AAG-4216-2019	Rosenzweig, Tovit/0000-0002-1706-0136	Israeli Ministry of Agriculture and Rural Development; Diabest botanical Drug Ltd.	Israeli Ministry of Agriculture and Rural Development; Diabest botanical Drug Ltd.	This work was supported by the Israeli Ministry of Agriculture and Rural Development and Diabest botanical Drug Ltd. which provided research materials in addition to financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qura'n S, 2009, J ETHNOPHARMACOL, V123, P45, DOI 10.1016/j.jep.2009.02.031; Ali-Shtayeh MS, 2000, J ETHNOPHARMACOL, V73, P221, DOI 10.1016/S0378-8741(00)00316-0; Bachrach ZY, 2007, ISR J PLANT SCI, V55, P111, DOI 10.1560/IJPS.55.1.111; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bhupathiraju SN, 2016, CIRC RES, V118, P1723, DOI 10.1161/CIRCRESAHA.115.306825; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Centers for Disease C Prevention, 2004, MMWR MORB MORTAL WKL, V53, P1066; Chamorro-Garcia R, 2014, CURR OPIN PHARMACOL, V19, P153, DOI 10.1016/j.coph.2014.10.010; Chaturvedi N, 2007, DIABETES RES CLIN PR, V76, pS3, DOI 10.1016/j.diabres.2007.01.019; Claeson P, 2014, J ETHNOPHARMACOL, V158, P463, DOI 10.1016/j.jep.2014.07.017; DAFNI A, 1984, J ETHNOPHARMACOL, V10, P295, DOI 10.1016/0378-8741(84)90017-5; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Elyasiyan U, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1860-7; Franks PW, 2016, SCIENCE, V354, P69, DOI 10.1126/science.aaf5094; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Heo HS, 2013, MOL CELLS, V36, P25, DOI 10.1007/s10059-013-2336-3; Huang MA, 2005, AM J GASTROENTEROL, V100, P1072, DOI 10.1111/j.1572-0241.2005.41334.x; Hung HY, 2012, NAT PROD REP, V29, P580, DOI 10.1039/c2np00074a; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kaser S, 2005, GUT, V54, P117, DOI 10.1136/gut.2003.037010; Khunti K, 2010, DIABETES OBES METAB, V12, P474, DOI 10.1111/j.1463-1326.2009.01186.x; Labaronne E, 2017, J NUTR BIOCHEM, V45, P83, DOI 10.1016/j.jnutbio.2017.04.001; Lake A, 2006, J R SOC PROMO HEALTH, V126, P262, DOI 10.1177/1466424006070487; Lam DW, 2012, CURR OPIN ENDOCRINOL, V19, P93, DOI 10.1097/MED.0b013e328350583a; Lu BB, 2014, DIABETES, V63, P2935, DOI 10.2337/db13-1531; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Marles RJ, 1995, PHYTOMEDICINE, V2, P137, DOI 10.1016/S0944-7113(11)80059-0; Mishra A, 2012, J CLIN EXP HEPATOL, V2, P135, DOI 10.1016/S0973-6883(12)60102-9; Mohlke KL, 2015, HUM MOL GENET, V24, pR85, DOI 10.1093/hmg/ddv264; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nascimento EBM, 2006, DIABETES, V55, P3221, DOI 10.2337/db05-1390; Osei-Assibey G, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001538; Prabhakar PK, 2008, CURR DIABETES REV, V4, P291, DOI 10.2174/157339908786241124; Qi Lu, 2012, Curr Nutr Rep, V1, P222; Ravussin E, 2000, EUR J PHARMACOL, V410, P131, DOI 10.1016/S0014-2999(00)00811-6; Rozenberg K, 2014, J ETHNOPHARMACOL; Samad A, 2009, CURR DIABETES REV, V5, P102, DOI 10.2174/157339909788166837; Sampson SR, 2010, APOPTOSIS, V15, P1165, DOI 10.1007/s10495-010-0517-5; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Smirin P, 2010, J ETHNOPHARMACOL, V129, P10, DOI 10.1016/j.jep.2010.02.021; Sonntag D, 2015, NUTRIENTS, V7, P8565, DOI 10.3390/nu7105414; Tumova J, 2016, PHYSIOL RES, V65, P193, DOI 10.33549/physiolres.932993; Vida M, 2015, DIS MODEL MECH, V8, P721, DOI 10.1242/dmm.019166; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6	46	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196736	10.1371/journal.pone.0196736	http://dx.doi.org/10.1371/journal.pone.0196736			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768504	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200044
J	Ji, XM; Qian, J; Rahman, SMJ; Siska, PJ; Zou, Y; Harris, BK; Hoeksema, MD; Trenary, IA; Heidi, C; Eisenberg, R; Rathmell, JC; Young, JD; Massion, PP				Ji, Xiangming; Qian, Jun; Rahman, S. M. Jamshedur; Siska, Peter J.; Zou, Yong; Harris, Bradford K.; Hoeksema, Megan D.; Trenary, Irina A.; Heidi, Chen; Eisenberg, Rosana; Rathmell, Jeffrey C.; Young, Jamey D.; Massion, Pierre P.			xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression	ONCOGENE			English	Article							GLUTAMATE TRANSPORTER SLC7A11; CYSTINE/GLUTAMATE ANTIPORTER; GLUTAMINASE EXPRESSION; OXIDATIVE-STRESS; CIGARETTE-SMOKE; GROWTH; APOPTOSIS; INHIBITION; OVEREXPRESSION; SENSITIVITY	Many tumors increase uptake and dependence on glucose, cystine or glutamine. These basic observations on cancer cell metabolism have opened multiple new diagnostic and therapeutic avenues in cancer research. Recent studies demonstrated that smoking could induce the expression of xCT (SLC7A11) in oral cancer cells, suggesting that overexpression of xCT may support lung tumor progression. We hypothesized that overexpression of xCT occurs in lung cancer cells to satisfy the metabolic requirements for growth and survival. Our results demonstrated that 1) xCT was highly expressed at the cytoplasmic membrane in non-small cell lung cancer (NSCLC), 2) the expression of xCT was correlated with advanced stage and predicted a worse 5-year survival, 3) targeting xCT transport activity in xCT overexpressing NSCLC cells with sulfasalazine decreased cell proliferation and invasion in vitro and in vivo and 4) increased dependence on glutamine was observed in xCT overexpressed normal airway epithelial cells. These results suggested that xCT regulate metabolic requirements during lung cancer progression and be a potential therapeutic target in NSCLC.	[Ji, Xiangming; Qian, Jun; Rahman, S. M. Jamshedur; Zou, Yong; Harris, Bradford K.; Hoeksema, Megan D.; Massion, Pierre P.] Vanderbilt Univ, Canc Early Detect & Prevent Initiat, Div Allergy Pulm & Crit Care Med, Vanderbilt Ingram Canc Ctr,Sch Med, Nashville, TN 37232 USA; [Ji, Xiangming] Georgia State Univ, Byrdine F Lewis Sch Nursing & Hlth Profess, Dept Nutr, Atlanta, GA 30302 USA; [Siska, Peter J.; Rathmell, Jeffrey C.] Univ Hosp Regensburg, Dept Internal Med 3, D-93053 Regensburg, Germany; [Trenary, Irina A.; Young, Jamey D.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Heidi, Chen] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; [Eisenberg, Rosana] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Massion, Pierre P.] Tennessee Valley Healthcare Syst, Vet Affairs, Nashville, TN 37212 USA	Vanderbilt University; University System of Georgia; Georgia State University; University of Regensburg; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Massion, PP (corresponding author), Vanderbilt Univ, Canc Early Detect & Prevent Initiat, Div Allergy Pulm & Crit Care Med, Vanderbilt Ingram Canc Ctr,Sch Med, Nashville, TN 37232 USA.; Massion, PP (corresponding author), Tennessee Valley Healthcare Syst, Vet Affairs, Nashville, TN 37212 USA.	pierre.massion@vanderbilt.edu		Siska, Peter/0000-0002-1521-6213	NCI [CA102353]; DoD [W81XWH-11-2-0161]; FAMRI foundation [YFEL141014]; NATIONAL CANCER INSTITUTE [R01CA102353, R01CA217987] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DoD(United States Department of Defense); FAMRI foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant CA102353 and DoD W81XWH-11-2-0161 to PPM. This work was also supported by FAMRI foundation YFEL141014 to XJ.	Baek S, 2012, CLIN CANCER RES, V18, P5427, DOI 10.1158/1078-0432.CCR-12-0214; Chen RS, 2009, ONCOGENE, V28, P599, DOI 10.1038/onc.2008.414; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Chung WJ, 2009, J NEUROCHEM, V110, P182, DOI 10.1111/j.1471-4159.2009.06129.x; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Dai ZY, 2007, J MED CHEM, V50, P1896, DOI 10.1021/jm060960h; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guan J, 2009, CANCER CHEMOTH PHARM, V64, P463, DOI 10.1007/s00280-008-0894-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassanein M, 2013, CLIN CANCER RES, V19, P560, DOI 10.1158/1078-0432.CCR-12-2334; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Kobayashi S, 2012, FREE RADICAL BIO MED, V53, P2197, DOI 10.1016/j.freeradbiomed.2012.09.040; Liu RQ, 2007, MOL PHARMACOL, V72, P1637, DOI 10.1124/mol.107.039644; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Lobo C, 2000, BIOCHEM J, V348, P257, DOI 10.1042/0264-6021:3480257; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Murphy TA, 2013, BIOTECHNOL BIOENG, V110, P1748, DOI 10.1002/bit.24836; Murphy TA, 2013, METAB ENG, V15, P206, DOI 10.1016/j.ymben.2012.07.008; Nagaraj NS, 2006, TOXICOL LETT, V165, P182, DOI 10.1016/j.toxlet.2006.03.008; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Qian J, 2015, P NATL ACAD SCI USA, V112, P3469, DOI 10.1073/pnas.1421975112; Qian J, 2009, MOL CANCER THER, V8, P101, DOI 10.1158/1535-7163.MCT-08-0973; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Shih AY, 2001, BIOCHEM BIOPH RES CO, V282, P1132, DOI 10.1006/bbrc.2001.4703; Shroff EH, 2015, P NATL ACAD SCI USA, V112, P6539, DOI 10.1073/pnas.1507228112; Singh JA, 2004, ARTHRIT RHEUM-ARTHR, V51, P952, DOI 10.1002/art.20827; Siska PJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93411; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhu JC, 2009, NAT METHODS, V6, P239, DOI 10.1038/nmeth0409-239	46	138	150	5	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 6	2018	37	36					5007	5019		10.1038/s41388-018-0307-z	http://dx.doi.org/10.1038/s41388-018-0307-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS6QR	29789716	Green Published, hybrid			2022-12-26	WOS:000443823600008
J	Rada, M; Nallanthighal, S; Cha, J; Ryan, K; Sage, J; Eldred, C; Ullo, M; Orsulic, S; Cheon, DJ				Rada, Miran; Nallanthighal, Sameera; Cha, Jennifer; Ryan, Kerry; Sage, Jessica; Eldred, Catherine; Ullo, Maria; Orsulic, Sandra; Cheon, Dong-Joo			Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer	ONCOGENE			English	Article							NF-KAPPA-B; CELL LUNG-CANCER; EXTRACELLULAR-MATRIX; LINKED INHIBITOR; GENE SIGNATURE; ACTIVATION; PROMOTES; COL11A1; SRC; CHEMORESISTANCE	Although, cisplatin resistance is a major challenge in the treatment of ovarian cancer, the precise mechanisms underlying cisplatin resistance are not fully understood. Collagen type XI alpha 1 (COL11A1), a gene encoding a minor fibrillar collagen of the extracellular matrix, is identified as one of the most upregulated genes in cisplatin-resistant ovarian cancer and recurrent ovarian cancer. However, the exact functions of COL11A1 in cisplatin resistance are unknown. Here we demonstrate that COL11A1 binds to integrin alpha 1 beta 1 and discoidin domain receptor 2 (DDR2) and activates downstream signaling pathways to inhibit cisplatin-induced apoptosis in ovarian cancer cells. Mechanistically, we show that COL11A1 activates Src-PI3K/Akt-NF-kB signaling to induce the expression of three inhibitor apoptosis proteins (IAPs), including XIAP, BIRC2, and BIRC3. Genetic and pharmacological inhibition of XIAP, BIRC2, and BIRC3 is sufficient to restore cisplatin-induced apoptosis in ovarian cancer cells in the presence of COL11A1 in ovarian cancer cells and xenograft mouse models, respectively. We also show that the components of COL11A1-integrin alpha 1 beta 1/DDR2-Src-PI3K/Akt-NF-kB-IAP signaling pathway serve as poor prognosis markers in ovarian cancer patients. Taken together, our results suggest novel mechanisms by which COL11A1 confers cisplatin resistance in ovarian cancer. Our study also uncovers IAPs as promising therapeutic targets to reduce cisplatin resistance in ovarian cancer, particularly in recurrent ovarian cancer expressing high levels of COL11A1.	[Rada, Miran; Nallanthighal, Sameera; Cha, Jennifer; Ryan, Kerry; Sage, Jessica; Eldred, Catherine; Ullo, Maria; Cheon, Dong-Joo] Albany Med Coll, Dept Regenerat & Canc Cell Biol, Albany, NY 12208 USA; [Cha, Jennifer] Rensselaer Polytech Inst, Sch Sci, Troy, NY 12180 USA; [Orsulic, Sandra] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA	Albany Medical College; Rensselaer Polytechnic Institute; Cedars Sinai Medical Center	Cheon, DJ (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, Albany, NY 12208 USA.	cheond@mail.amc.edu	Rada, Miran/AFC-7022-2022; Rada, Miran/AAO-8034-2021	Rada, Miran/0000-0002-8220-7982; 	Albany Medical College; Ovarian Cancer Research Fund Ann Schreiber Mentored Investigator Award; AACR Gertrude B. Elion Cancer Research Award	Albany Medical College; Ovarian Cancer Research Fund Ann Schreiber Mentored Investigator Award; AACR Gertrude B. Elion Cancer Research Award	We thank Drs. Robert C. Bast, Michael DiPersio, and Paula McKeown-Longo for insightful discussions and critical readings of the manuscript; Dr. Nikki Cheng for CAF cells. D.-J.C. is supported by the startup fund from the Albany Medical College, the Ovarian Cancer Research Fund Ann Schreiber Mentored Investigator Award, and the AACR Gertrude B. Elion Cancer Research Award.	Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Asselin E, 2001, CANCER RES, V61, P1862; Cai Q, 2011, J MED CHEM, V54, P2714, DOI 10.1021/jm101505d; Castells M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.384; Cheon DJ, 2014, BIOMARK MED, V8, P523, DOI 10.2217/bmm.14.16; Cheon DJ, 2014, CLIN CANCER RES, V20, P711, DOI 10.1158/1078-0432.CCR-13-1256; Chien J, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00251; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Cohen E, 2013, ANTICANCER RES, V33, P379; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Garcia-Pravia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078327; Godwin P, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00120; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hatton O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042610; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Ikeda K, 2002, J BIOL CHEM, V277, P19206, DOI 10.1074/jbc.M201078200; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Janzen DM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8956; Jia DY, 2016, CANCER LETT, V382, P203, DOI 10.1016/j.canlet.2016.09.001; Jin H, 2015, ONCOL RES, V22, P167, DOI 10.3727/096504015X14298122915664; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; KLEMAN JP, 1992, EUR J BIOCHEM, V210, P329, DOI 10.1111/j.1432-1033.1992.tb17425.x; Konecny GE, 2009, BRIT J CANCER, V101, P1699, DOI 10.1038/sj.bjc.6605381; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Li JL, 2001, ENDOCRINOLOGY, V142, P370, DOI 10.1210/en.142.1.370; Li WY, 2011, J THORAC ONCOL, V6, P1801, DOI 10.1097/JTO.0b013e318226b4a6; Pistritto G, 2016, AGING-US, V8, P603, DOI 10.18632/aging.100934; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Pramanik KC, 2013, CARCINOGENESIS, V34, P2061, DOI 10.1093/carcin/bgt154; Raglow Z, 2015, CANCER LETT, V357, P448, DOI 10.1016/j.canlet.2014.12.011; Sasaki H, 2000, CANCER RES, V60, P5659; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Shen LH, 2016, ONCOL REP, V36, P877, DOI 10.3892/or.2016.4869; Sherman-Baust CA, 2003, CANCER CELL, V3, P377, DOI 10.1016/S1535-6108(03)00058-8; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Teng P-N, 2013, BRIT J CANCER, V110, P123; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang WM, 2016, CELL, V165, P1092, DOI 10.1016/j.cell.2016.04.009; Wu WS, 2016, ONCOTARGET, V7, P52281, DOI 10.18632/oncotarget.10739; Wu YH, 2014, ONCOGENE, V33, P3432, DOI 10.1038/onc.2013.307; Wu YH, 2015, ONCOTARGET, V6, P23748, DOI 10.18632/oncotarget.4250; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209	50	53	53	2	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 30	2018	37	35					4809	4820		10.1038/s41388-018-0297-x	http://dx.doi.org/10.1038/s41388-018-0297-x			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS0BA	29769618				2022-12-26	WOS:000443146000004
J	Huang, L; Liu, J; Zhang, XO; Sibley, K; Najjar, SM; Lee, MM; Wu, Q				Huang, Lei; Liu, Jehnan; Zhang, Xiao-Ou; Sibley, Katelyn; Najjar, Sonia M.; Lee, Mary M.; Wu, Qiong			Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; fatty acid oxidation; signaling; mitochondria; Akt PKB; mitochondrial biogenesis; non-alcoholic fatty liver; PGC-1; PPAR; PRMT5	CELL LUNG-CANCER; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; AKT PHOSPHORYLATION; LIPOGENIC PATHWAY; CYCLE PROGRESSION; SIGNALING CASCADE; GENE-EXPRESSION; MESSENGER-RNA	Protein arginine methyltransferase 5 (PRMT5) regulates gene expression either transcriptionally by symmetric dimethylation of arginine residues on histones H4R3, H3R8, and H2AR3 or at the posttranslational level by methylation of nonhistone target proteins. Although emerging evidence suggests that PRMT5 functions as an oncogene, its role in metabolic diseases is not well-defined. We investigated the role of PRMT5 in promoting high-fat-induced hepatic steatosis. A high-fat diet up-regulated PRMT5 levels in the liver but not in other metabolically relevant tissues such as skeletal muscle or white and brown adipose tissue. This was associated with repression of master transcription regulators involved in mitochondrial biogenesis. In contrast, lentiviral short hairpin RNA-mediated reduction of PRMT5 significantly decreased phosphatidylinositol 3-kinase/AKT signaling in mouse AML12 liver cells. PRMT5 knockdown or knockout decreased basal AKT phosphorylation but boosted the expression of peroxisome proliferator-activated receptor (PPAR) and PGC-1 with a concomitant increase in mitochondrial biogenesis. Moreover, by overexpressing an exogenous WT or enzyme-dead mutant PRMT5 or by inhibiting PRMT5 enzymatic activity with a small-molecule inhibitor, we demonstrated that the enzymatic activity of PRMT5 is required for regulation of PPAR and PGC-1 expression and mitochondrial biogenesis. Our results suggest that targeting PRMT5 may have therapeutic potential for the treatment of fatty liver.	[Huang, Lei; Lee, Mary M.; Wu, Qiong] Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA 01655 USA; [Liu, Jehnan; Najjar, Sonia M.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res, Toledo, OH 43606 USA; [Zhang, Xiao-Ou] Univ Massachusetts, Med Sch, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Sibley, Katelyn] Worcester Polytech Inst, Dept Biochem, Worcester, MA 01609 USA; [Najjar, Sonia M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; University of Toledo; University of Massachusetts System; University of Massachusetts Worcester; Worcester Polytechnic Institute; University System of Ohio; Ohio University	Lee, MM; Wu, Q (corresponding author), Univ Massachusetts, Med Sch, Dept Pediat, Worcester, MA 01655 USA.	mary.lee@umassmemorial.org; joae.wu@umassmed.edu	Huang, Lei/H-7658-2019; Najjar, Sonia M/GXW-2217-2022; Zhang, Xiao-Ou/J-6229-2014	Lee, Mary Min-chin/0000-0003-1985-4594; Huang, Lei/0000-0002-0568-0645; Zhang, Xiao-Ou/0000-0002-2027-1313	University of Massachusetts Medical School internal funds and National Institutes of Health [R01-DK054254, R01-DK083850, R01HL112248]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083850, R01DK054254] Funding Source: NIH RePORTER	University of Massachusetts Medical School internal funds and National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by University of Massachusetts Medical School internal funds and National Institutes of Health Grants R01-DK054254, R01-DK083850, and R01HL112248. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Byrne CD, 2009, CLIN SCI, V116, P539, DOI 10.1042/CS20080253; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen M, 2014, J BIOL CHEM, V289, P24325, DOI 10.1074/jbc.M114.577494; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Gulla A, 2018, LEUKEMIA, V32, P996, DOI 10.1038/leu.2017.334; Han CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0098759; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Herst PM, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00296; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kanamaluru D, 2011, MOL CELL BIOL, V31, P1540, DOI 10.1128/MCB.01212-10; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kim SM, 2017, ONCOTARGET, V8, P46273, DOI 10.18632/oncotarget.17695; Kim SP, 2003, DIABETES, V52, P2453, DOI 10.2337/diabetes.52.10.2453; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; LeBlanc SE, 2016, NUCLEIC ACIDS RES, V44, P5133, DOI 10.1093/nar/gkw129; LeBlanc SE, 2012, MOL ENDOCRINOL, V26, P583, DOI 10.1210/me.2011-1162; Lewis GF, 2002, ENDOCR REV, V23, P201, DOI 10.1210/er.23.2.201; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lien EC, 2016, RECENT RESULTS CANC, V207, P39, DOI 10.1007/978-3-319-42118-6_3; Liu L, 2016, CANCER RES, V76, P1260, DOI 10.1158/0008-5472.CAN-15-1766; Luyckx FH, 2000, DIABETES METAB, V26, P98; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513; MILLAR SE, 1995, DEVELOPMENT, V121, P3223; Moussa NM, 1999, OBES RES, V7, P506, DOI 10.1002/j.1550-8528.1999.tb00440.x; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rengasamy M, 2017, NUCLEIC ACIDS RES, V45, P11106, DOI 10.1093/nar/gkx727; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Sanchis-Gomar F, 2014, CURR PHARM DESIGN, V20, P5619, DOI 10.2174/1381612820666140306095106; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Sidiropoulos KG, 2007, ARCH BIOCHEM BIOPHYS, V465, P380, DOI 10.1016/j.abb.2007.06.029; Veiga FM, 2017, BIOCHIMIE, V140, P106, DOI 10.1016/j.biochi.2017.07.003; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; Soliman GA, 2011, CELL CYCLE, V10, P861, DOI 10.4161/cc.10.6.14930; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Wolff GL, 1999, PHYSIOL GENOMICS, V1, P151, DOI 10.1152/physiolgenomics.1999.1.3.151; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Yamauchi Y, 2011, CANCER RES, V71, P4989, DOI 10.1158/0008-5472.CAN-10-4108; Zivkovic AM, 2007, AM J CLIN NUTR, V86, P285, DOI 10.1093/ajcn/86.2.285	72	22	22	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10884	10894		10.1074/jbc.RA118.002377	http://dx.doi.org/10.1074/jbc.RA118.002377			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29773653	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000438882800004
J	Yu, SY; Ito, SJ; Wada, I; Hosokawa, N				Yu, Shangyu; Ito, Shinji; Wada, Ikuo; Hosokawa, Nobuko			ER-resident protein 46 (ERp46) triggers the mannose-trimming activity of ER degradation-enhancing -mannosidase-like protein 3 (EDEM3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); endoplasmic-reticulum-associated protein degradation (ERAD); ER quality control; N-linked glycosylation; protein complex; alpha-mannosidase; EDEM3; ERp46	RETICULUM-ASSOCIATED DEGRADATION; DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; PDI FAMILY; GLYCOPROTEINS; ISOMERASE; ROLES; PEROXIREDOXIN; PROTEOSTASIS	Protein folding in the cell is regulated by several quality-control mechanisms. Correct folding of glycoproteins in the endoplasmic reticulum (ER) is tightly monitored by the recognition of glycan signals by lectins in the ER-associated degradation (ERAD) pathway. In mammals, mannose trimming from N-glycans is crucial for disposal of misfolded glycoproteins. The mannosidases responsible for this process are ER mannosidase I and ER degradation-enhancing -mannosidase-like proteins (EDEMs). However, the molecular mechanism of mannose removal by EDEMs remains unclear, partly owing to the difficulty of reconstituting mannosidase activity in vitro. Here, our analysis of EDEM3-mediated mannose-trimming activity on a misfolded glycoprotein revealed that ERp46, an ER-resident oxidoreductase, associates stably with EDEM3. This interaction, which depended on the redox activity of ERp46, involved formation of a disulfide bond between the cysteine residues of the ERp46 redox-active sites and the EDEM3 -mannosidase domain. In a defined in vitro system consisting of recombinant proteins purified from HEK293 cells, the mannose-trimming activity of EDEM3 toward the model misfolded substrate, the glycoprotein T-cell receptor locus (TCR), was reconstituted only when ERp46 had established a covalent interaction with EDEM3. On the basis of these findings, we propose that disposal of misfolded glycoproteins through mannose trimming is tightly connected to redox-mediated regulation in the ER.	[Yu, Shangyu; Hosokawa, Nobuko] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Mol & Cellular Biol, Kyoto 6068507, Japan; [Ito, Shinji] Kyoto Univ, Grad Sch Med, Med Res Support Ctr, Kyoto 6068501, Japan; [Wada, Ikuo] Fukushima Med Univ, Sch Med, Inst Biomed Sci, Dept Cell Sci, Fukushima 9601295, Japan	Kyoto University; Kyoto University; Fukushima Medical University	Hosokawa, N (corresponding author), Kyoto Univ, Lab Mol & Cellular Biol, Inst Frontier Life & Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto, Kyoto 6068507, Japan.	nobukoh@infront.kyoto-u.ac.jp			Institute for Molecular Science (IMS); Scientific Research C of KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mizutani Foundation for Glycosciences	Institute for Molecular Science (IMS)(National Institutes of Natural Sciences (NINS) - JapanInstitute for Molecular Science (IMS)); Scientific Research C of KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Mizutani Foundation for Glycosciences	This work was supported by a Joint Research grant from the Institute for Molecular Science (IMS); Scientific Research C of KAKENHI from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and the Mizutani Foundation for Glycosciences (to N. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Aikawa J, 2012, GLYCOCONJUGATE J, V29, P35, DOI 10.1007/s10719-011-9362-1; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Araki K, 2013, J CELL BIOL, V202, P861, DOI 10.1083/jcb.201303027; Benham AM, 2012, ANTIOXID REDOX SIGN, V16, P781, DOI 10.1089/ars.2011.4439; Benyair R, 2015, SEMIN CELL DEV BIOL, V41, P99, DOI 10.1016/j.semcdb.2014.11.006; Benyair R, 2015, MOL BIOL CELL, V26, P172, DOI 10.1091/mbc.E14-06-1152; Berner N, 2018, ANNU REV BIOCHEM, V87, P751, DOI 10.1146/annurev-biochem-062917-012749; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Caramelo JJ, 2015, FEBS LETT, V589, P3379, DOI 10.1016/j.febslet.2015.07.021; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Fujimori T, 2017, GENES CELLS, V22, P684, DOI 10.1111/gtc.12506; Fujimori T, 2013, FEBS J, V280, P1563, DOI 10.1111/febs.12157; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2010, GLYCOBIOLOGY, V20, P651, DOI 10.1093/glycob/cwq013; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kojima R, 2014, STRUCTURE, V22, P431, DOI 10.1016/j.str.2013.12.013; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Liu YC, 2016, P NATL ACAD SCI USA, V113, pE4015, DOI 10.1073/pnas.1608795113; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Ninagawa S, 2014, J CELL BIOL, V206, P347, DOI 10.1083/jcb.201404075; Pfeiffer A, 2016, J BIOL CHEM, V291, P12195, DOI 10.1074/jbc.M115.703256; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Sakoh-Nakatogawa M, 2009, J BIOL CHEM, V284, P11815, DOI 10.1074/jbc.M900813200; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02456; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Shepherd C, 2014, BIOCHEM J, V461, P107, DOI 10.1042/BJ20140234; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	43	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10663	10674		10.1074/jbc.RA118.003129	http://dx.doi.org/10.1074/jbc.RA118.003129			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29784879	Green Published, hybrid			2022-12-26	WOS:000437828400023
J	Chen, YT; Chang, IYF; Liu, H; Ma, CP; Kuo, YP; Shih, CT; Shih, YH; Kang, L; Tan, BCM				Chen, Yi-Tung; Chang, Ian Yi-Feng; Liu, Hsuan; Ma, Chung-Pei; Kuo, Yu-Ping; Shih, Chieh-Tien; Shih, Ying-Hsin; Kang, Lin; Tan, Bertrand Chin-Ming			Tumor-associated intronic editing of HNRPLL generates a novel splicing variant linked to cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA editing; alternative splicing; exonic splicing enhancer; cell proliferation; tumor cell biology	FACTOR SRSF1; RNA; GENE; ADENOSINE; TRANSCRIPTION; TRANSLATION; MUTATIONS; STABILITY; REVEALS; COMPLEX	Processing of the eukaryotic transcriptome is a dynamic regulatory mechanism that confers genetic diversity, and splicing and adenosine to inosine (A-to-I) RNA editing are well-characterized examples of such processing. Growing evidence reveals the cross-talk between the splicing and RNA editing, but there is a paucity of substantial evidence for its mechanistic details and contribution in a physiological context. Here, our findings demonstrate that tumor-associated differential RNA editing, in conjunction with splicing machinery, regulates the expression of variants of HNRPLL, a gene encoding splicing factor. We discovered an HNRPLL transcript variant containing an additional exon 12A (E12A), which is a substrate of ADAR1 and ADAR2. Adenosine deaminases acting on RNA (ADAR) direct deaminase-dependent expression of the E12A transcript, and ADAR-mediated regulation of E12A is largely splicing-based, and does not affect the stability or nucleocytoplasmic distribution of the transcript. Furthermore, ADAR-mediated modification of exon 12A generates an enhancer for the oncogenic splicing factor SRSF1 and consequently promotes the frequency of alternative splicing. Gene expression profiling by RNA-seq revealed that E12A acts distinctly from HNRPLL and regulates a set of growth-related genes, such as cyclin CCND1 and growth factor receptor TGFBR1. Accordingly, silencing E12A expression leads to impaired clonogenic ability and enhanced sensitivity to doxorubicin, thus highlighting the significance of this alternative isoform in tumor cell survival. In summary, we present the interplay of RNA editing and splicing as a regulatory mechanism of gene expression and also its physiological relevance. These findings extend our understanding of transcriptional dynamics and provide a mechanistic explanation to the link of RNA editors to tumorigenesis.	[Chen, Yi-Tung; Ma, Chung-Pei; Kuo, Yu-Ping; Shih, Chieh-Tien; Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan; [Chen, Yi-Tung; Ma, Chung-Pei; Kuo, Yu-Ping; Shih, Chieh-Tien; Shih, Ying-Hsin; Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Dept Biomed Sci, Coll Med, 259 Wen Hwa First Rd, Taoyuan 333, Taiwan; [Chang, Ian Yi-Feng; Liu, Hsuan; Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Mol Med Res Ctr, Taoyuan 333, Taiwan; [Liu, Hsuan] Chang Gung Mem Hosp, Dept Biochem, Coll Med, Taoyuan 333, Taiwan; [Liu, Hsuan] Chang Gung Mem Hosp, Div Colon & Rectal Surg, Lin Kou Med Ctr, Taoyuan 333, Taiwan; [Kang, Lin] Edward Via Coll Osteopath Med, Blacksburg, VA 24060 USA; [Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Lin Kou Med Ctr, Dept Neurosurg, Taoyuan 333, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tan, BCM (corresponding author), Chang Gung Mem Hosp, Grad Inst Biomed Sci, Coll Med, Taoyuan 333, Taiwan.; Tan, BCM (corresponding author), Chang Gung Mem Hosp, Dept Biomed Sci, Coll Med, 259 Wen Hwa First Rd, Taoyuan 333, Taiwan.	btan@mail.cgu.edu.tw	Kang, Lin/AAA-2260-2019; Chang, Ian/U-3571-2019	Kang, Lin/0000-0002-9186-9574; Chang, Ian/0000-0001-5840-2051; Tan, Bertrand/0000-0002-2218-7115; Chen, Yi-Tung/0000-0001-9715-648X	Ministry of Science and Technology of Taiwan [MOST105-2320-B-182-017, MOST104-2320-B-182-029-MY3, MOST105-2314-B-182-061-MY4, MOST103-2632-B-182-001, MOST104-2632-B-182-001, MOST105-2632-B-182-001]; Chang Gung Memorial Hospital [CMRPD1F0571, CMRPD1C0843, CMRPD3E0153, CMRPD1F0442, BMRP960]; National Health Research Institute of Taiwan [NHRI-EX105-10321SI]; Ministry of Education of Taiwan	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan); Ministry of Education of Taiwan(Ministry of Education, Taiwan)	This work was supported by Ministry of Science and Technology of Taiwan Grants MOST105-2320-B-182-017 (to H. L.), MOST104-2320-B-182-029-MY3, and MOST105-2314-B-182-061-MY4 (to B. C.-M. T.), MOST103-2632-B-182-001, MOST104-2632-B-182-001, and MOST105-2632-B-182-001, Chang Gung Memorial Hospital Grants CMRPD1F0571 (to H. L.), CMRPD1C0843, CMRPD3E0153, CMRPD1F0442, and BMRP960(to B. C-M. T.), National Health Research Institute of Taiwan Grant NHRI-EX105-10321SI, and a grant from the Ministry of Education of Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Anantharaman A, 2017, NUCLEIC ACIDS RES, V45, P4189, DOI 10.1093/nar/gkw1304; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Choudhury Y, 2012, J CLIN INVEST, V122, P4059, DOI 10.1172/JCI62925; Das S, 2012, CELL REP, V1, P110, DOI 10.1016/j.celrep.2011.12.001; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Gumireddy K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10715; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hsieh CL, 2014, CELL DEATH DIFFER, V21, P707, DOI 10.1038/cdd.2013.197; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Licht K, 2016, NUCLEIC ACIDS RES, V44, P6398, DOI 10.1093/nar/gkw325; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nakano M, 2017, J BIOL CHEM, V292, P4873, DOI 10.1074/jbc.M117.775684; Nasim MT, 2006, NAT PROTOC, V1, P1022, DOI 10.1038/nprot.2006.148; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Ota H, 2013, CELL, V153, P575, DOI 10.1016/j.cell.2013.03.024; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Raitskin O, 2001, P NATL ACAD SCI USA, V98, P6571, DOI 10.1073/pnas.111153798; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Salton M, 2016, TRENDS MOL MED, V22, P28, DOI 10.1016/j.molmed.2015.11.005; Salton M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8103; Slavov D, 2000, GENE, V250, P53, DOI 10.1016/S0378-1119(00)00175-X; Wang IX, 2013, CELL REP, V5, P849, DOI 10.1016/j.celrep.2013.10.002; Wang LL, 2016, CANCER CELL, V30, P750, DOI 10.1016/j.ccell.2016.10.005; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Wang T, 2013, NUCLEIC ACIDS RES, V41, P4743, DOI 10.1093/nar/gkt178; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Yang CC, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.12; Yang CC, 2012, EMBO J, V31, P1739, DOI 10.1038/emboj.2012.24; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zipeto MA, 2015, TRENDS MOL MED, V21, P549, DOI 10.1016/j.molmed.2015.07.001	52	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10158	10171		10.1074/jbc.RA117.001197	http://dx.doi.org/10.1074/jbc.RA117.001197			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769310	Green Published, hybrid			2022-12-26	WOS:000437096700018
J	Yan, T; Zhang, AL; Shi, FF; Chang, F; Mei, J; Liu, YJ; Zhu, YC				Yan, Ting; Zhang, Ailiang; Shi, Fangfang; Chang, Fei; Mei, Jie; Liu, Yongjian; Zhu, Yichao			Integrin v3-associated DAAM1 is essential for collagen-induced invadopodia extension and cell haptotaxis in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; actin; invadopodia; migration; integrin; DAAM1; haptotaxis; integrin v3; invadopodia; RHOA	EXTRACELLULAR-MATRIX; BETA-3 INTEGRIN; ACTIN DYNAMICS; PROTEIN DAAM1; ACTIVATION; MIGRATION; INVASION; COMPLEX; RHOA	The formin protein dishevelled-associated activator of morphogenesis 1 (DAAM1) polymerizes straight actin filaments and mediates migration of cancer cells. However, how DAAM1 governs cell haptotaxis in response to collagen remains unexplored in breast cancer cells. We hypothesized that DAAM1 mediates invadopodia extension and cell haptotaxis in response to type IV collagen in association with integrin receptors. Using Boyden chamber membranes coated with type IV collagen, we show here that type IV collagen activates both DAAM1 and Ras homolog family member A (RHOA) and promotes haptotaxis of MDA-MB-231 and MDA-MB-453 breast cancer cells, a process abolished by treatment with the integrin v3 inhibitor cyclo(-RGDfK). shRNA-mediated knockdown of DAAM1 or a dominant-negative DAAM1 mutation (N-DAAM1) significantly decreased collagen-induced RHOA activity and the assembly of stress fibers, invadopodia extension, and cell haptotaxis. Immunoprecipitation and pulldown assays revealed that integrin v3 is associated with, but only indirectly binds to, the C-terminal DAD domain of DAAM1 in mammalian cells. Blockade of RHOA activation with a specific inhibitor (CCG-1423) or via a dominant-negative RHOA mutation (RHOA-N19) suppressed collagen-induced invadopodia extension and haptotaxis of the MDA-MB-231 and MDA-MB-453 cells. Immunoblotting and immunofluorescence assays indicated high DAAM1 and RHOA expression in invadopodia, which was abolished by cyclo(-RGDfK) treatment or DAAM1 knockdown. These findings have uncovered an integrin v3/DAAM1/RHOA signaling pathway for type IV collagen-induced invadopodia extension and haptotaxis in breast cancer cells. Targeting this pathway may be a means for reducing invasiveness and metastasis of breast cancer.	[Yan, Ting] Nanjing Med Univ, Safety Assessment & Res Ctr Drug Pesticide & Vet, Nanjing 211166, Jiangsu, Peoples R China; [Chang, Fei; Mei, Jie; Liu, Yongjian; Zhu, Yichao] Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China; [Zhu, Yichao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China; [Zhang, Ailiang] Soochow Univ, Affiliated Hosp 3, Dept Spine Surg, Changzhou 213003, Peoples R China; [Shi, Fangfang] Southeast Univ, Zhongda Hosp, Dept Oncol, Nanjing 210009, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Soochow University - China; Southeast University - China	Zhu, YC (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing 211166, Jiangsu, Peoples R China.; Zhu, YC (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.	zhuyichao@njmu.edu.cn	Liu, Yong/GWQ-6163-2022; Mei, Jie/W-1298-2019	Mei, Jie/0000-0001-7799-8129	National Natural Science Foundation of China [81472703]; Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents; Southeast University [2242017K3DN41]; Nanjing Medical University [2242017K3DN41]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents; Southeast University; Nanjing Medical University	This work was supported by National Natural Science Foundation of China Grant 81472703 (to Y. Z.), a sponsorship of the Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents (to Y. Z.), and Joint Research Project of Southeast University and Nanjing Medical University Grant 2242017K3DN41 (to F. S. and Y. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Debruyne PR, 2002, ONCOGENE, V21, P6740, DOI 10.1038/sj.onc.1205729; Demircioglu F, 2016, CURR OPIN CELL BIOL, V42, P121, DOI 10.1016/j.ceb.2016.07.008; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Guillabert-Gourgues A, 2016, MOL BIOL CELL, V27, P941, DOI 10.1091/mbc.E14-08-1332; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Higashi T, 2008, J BIOL CHEM, V283, P8746, DOI 10.1074/jbc.M707839200; Hynes RO, 2014, NAT REV MOL CELL BIO, V15, P761, DOI 10.1038/nrm3908; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Flamini MI, 2017, HORM CANCER-US, V8, P16, DOI 10.1007/s12672-016-0280-3; Jacob A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00004; Kerkhoff E, 2011, EUR J CELL BIOL, V90, P922, DOI 10.1016/j.ejcb.2010.10.011; Kwakwa KA, 2017, CANCERS, V9, DOI 10.3390/cancers9070084; Li WT, 2016, INT J ONCOL, V48, P1155, DOI 10.3892/ijo.2016.3319; Liu JJ, 2013, CELL SIGNAL, V25, P447, DOI 10.1016/j.cellsig.2012.10.012; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Lu YY, 2016, MOL MED REP, V14, P3429, DOI 10.3892/mmr.2016.5635; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Moilanen JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45057; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nair MG, 2016, EXP CELL RES, V346, P137, DOI 10.1016/j.yexcr.2016.05.015; Nishimura T, 2016, J CELL BIOL, V215, P559, DOI 10.1083/jcb.201603107; Oudin MJ, 2016, MOL BIOL CELL, V27, P3085, DOI 10.1091/mbc.E16-04-0212; Oudin MJ, 2016, CANCER DISCOV, V6, P516, DOI 10.1158/2159-8290.CD-15-1183; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Pelaez R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181579; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Santiago-Medina M, 2016, CANCER DISCOV, V6, P474, DOI 10.1158/2159-8290.CD-16-0231; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Wang Yingchun, 2007, Sci STKE, V2007, ppl4, DOI 10.1126/stke.4002007pl4; Zeltz C, 2016, J CELL SCI, V129, P1284, DOI 10.1242/jcs.188672; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823	36	27	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10172	10185		10.1074/jbc.RA117.000327	http://dx.doi.org/10.1074/jbc.RA117.000327			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29752407	Green Published, hybrid			2022-12-26	WOS:000437096700019
J	Ernst, DC; Borchert, AJ; Downs, DM				Ernst, Dustin C.; Borchert, Andrew J.; Downs, Diana M.			Perturbation of the metabolic network in Salmonella enterica reveals cross-talk between coenzyme A and thiamine pathways	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; BIOSYNTHETIC-PATHWAY; GENE; TYPHIMURIUM; EXPRESSION; RESISTANCE; TRANSPOSITION; TRANSDUCTION; MUTAGENESIS; PROMOTERS	Microorganisms respond to a variety of metabolic perturbations by repurposing or recruiting pathways to reroute metabolic flux and overcome the perturbation. Elimination of the 2-dehydropantoate 2-reductase, PanE, both reduces total coenzyme A (CoA) levels and causes a conditional HMP-P auxotrophy in Salmonella enterica. CoA or acetyl-CoA has no demonstrable effect on the HMP-P synthase, ThiC, in vitro. Suppressors aimed at probing the connection between the biosynthesis of thiamine and CoA contained mutations in the gene encoding the ilvC transcriptional regulator, ilvY. These mutations may help inform the structure and mechanism of action for the effector-binding domain, as they represent the first sequenced substitutions in the effector-binding domain of IlvY that cause constitutive expression of ilvC. Since IlvC moonlights as a 2-dehydropantoate 2-reductase, the resultant increase in ilvC transcription increased synthesis of CoA. This study failed to identify mutations overcoming the need for CoA for thiamine synthesis in S. enterica panE mutants, suggesting that a more integrated approach may be necessary to uncover the mechanism connecting CoA and ThiC activity in vivo.	[Ernst, Dustin C.; Borchert, Andrew J.; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Ernst, Dustin C.] Univ Calif San Diego, Ctr Circadian Biol, San Diego, CA 92103 USA	University System of Georgia; University of Georgia; University of California System; University of California San Diego	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dmdowns@uga.edu	Borchert, Andrew John/AAH-5655-2021	Borchert, Andrew John/0000-0003-1435-3643	National Institutes of Health [GM095837]; NIH [GM095837]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by GM095837 from competitive grants program at the National Institutes of Health to DMD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by GM095837 from competitive grants program at the NIH to DMD. Lauren D. Palmer isolated and characterized ThiC variants and performed growth analyses reported in Table 2. The authors thank Jorge Escalante-Semerena for use of the Applied Biosystems 7500 Fast Real Time PCR system.	Ahmed KD., 1989, THESIS; Allen S, 2002, J BACTERIOL, V184, P6130, DOI 10.1128/JB.184.22.6130-6137.2002; ALLRED JB, 1969, ANAL BIOCHEM, V29, P293, DOI 10.1016/0003-2697(69)90312-1; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Bazurto JV, 2015, J BACTERIOL, V197, P2821, DOI 10.1128/JB.00282-15; BIEL AJ, 1981, J BACTERIOL, V146, P718, DOI 10.1128/JB.146.2.718-724.1981; Borchert AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13030-x; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; CHAN RK, 1972, VIROLOGY, V50, P883, DOI 10.1016/0042-6822(72)90442-4; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Czapski TR, 2014, GENE, V547, P91, DOI 10.1016/j.gene.2014.06.033; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Downs DM, 2006, ANNU REV MICROBIOL, V60, P533, DOI 10.1146/annurev.micro.60.080805.142308; DOWNS DM, 1994, J BACTERIOL, V176, P4858, DOI 10.1128/jb.176.16.4858-4864.1994; ELLIOTT T, 1988, MOL GEN GENET, V213, P332, DOI 10.1007/BF00339599; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Flynn JM, 2013, MOL MICROBIOL, V89, P751, DOI 10.1111/mmi.12313; Frodyma M, 2000, J BACTERIOL, V182, P236, DOI 10.1128/JB.182.1.236-240.2000; Frodyma ME, 1998, J BIOL CHEM, V273, P5572, DOI 10.1074/jbc.273.10.5572; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heng Sean S J, 2011, ISRN Microbiol, V2011, P469053, DOI 10.5402/2011/469053; Kim J, 2012, P NATL ACAD SCI USA, V109, pE2856, DOI 10.1073/pnas.1208509109; Koenigsknecht MJ, 2010, TRENDS MICROBIOL, V18, P240, DOI 10.1016/j.tim.2010.03.003; Lambrecht JA, 2013, ACS CHEM BIOL, V8, P242, DOI 10.1021/cb300364k; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Gomez NC, 2008, BIOCHEMISTRY-US, V47, P9054, DOI 10.1021/bi8010253; Palmer LD, 2014, J BACTERIOL, V196, P3964, DOI 10.1128/JB.02159-14; Palmer LD, 2013, J BIOL CHEM, V288, P30693, DOI 10.1074/jbc.M113.500280; Palmer LD, 2012, J BACTERIOL, V194, P6088, DOI 10.1128/JB.01361-12; PRIMERANO DA, 1983, J BACTERIOL, V153, P259, DOI 10.1128/JB.153.1.259-269.1983; Rhee KY, 1999, P NATL ACAD SCI USA, V96, P14294, DOI 10.1073/pnas.96.25.14294; ROLFES RJ, 1988, J BIOL CHEM, V263, P19649; ROLFES RJ, 1988, J BIOL CHEM, V263, P19653; Ruangprasert A, 2010, J MOL BIOL, V404, P568, DOI 10.1016/j.jmb.2010.09.053; Russell DA, 2004, J BACTERIOL, V186, P5576, DOI 10.1128/JB.186.17.5576-5584.2004; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Song KJ, 2017, APPL MICROBIOL BIOT, V101, P4581, DOI 10.1007/s00253-017-8242-4; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; Stead MB, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks680; Sun S, 2009, GENETICS, V182, P1183, DOI 10.1534/genetics.109.103028; Taylor JL, 2012, MOL MICROBIOL, V83, P457, DOI 10.1111/j.1365-2958.2011.07919.x; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; WEK RC, 1988, J MOL BIOL, V203, P643, DOI 10.1016/0022-2836(88)90199-4; ZHOU GC, 1994, J BIOL CHEM, V269, P6784	45	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197703	10.1371/journal.pone.0197703	http://dx.doi.org/10.1371/journal.pone.0197703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791499	Green Submitted, Green Published, gold			2022-12-26	WOS:000433077000057
J	Awan, I; Aziz, W; Shah, IH; Habib, N; Alowibdi, JS; Saeed, S; Nadeem, MSA; Shah, SAA				Awan, Imtiaz; Aziz, Wajid; Shah, Imran Hussain; Habib, Nazneen; Alowibdi, Jalal S.; Saeed, Sharjil; Nadeem, Malik Sajjad Ahmed; Shah, Syed Ahsin Ali			Studying the dynamics of interbeat interval time series of healthy and congestive heart failure subjects using scale based symbolic entropy analysis	PLOS ONE			English	Article							MULTISCALE ENTROPY; APPROXIMATE ENTROPY; COMPLEXITY; CLASSIFICATION; ORGANIZATION; SIGNALS; KERNEL	Considerable interest has been devoted for developing a deeper understanding of the dynamics of healthy biological systems and how these dynamics are affected due to aging and disease. Entropy based complexity measures have widely been used for quantifying the dynamics of physical and biological systems. These techniques have provided valuable information leading to a fuller understanding of the dynamics of these systems and underlying stimuli that are responsible for anomalous behavior. The single scale based traditional entropy measures yielded contradictory results about the dynamics of real world time series data of healthy and pathological subjects. Recently the multiscale entropy (MSE) algorithm was introduced for precise description of the complexity of biological signals, which was used in numerous fields since its inception. The original MSE quantified the complexity of coarse-grained time series using sample entropy. The original MSE may be unreliable for short signals because the length of the coarse-grained time series decreases with increasing scaling factor tau however, MSE works well for long signals. To overcome the drawback of original MSE, various variants of this method have been proposed for evaluating complexity efficiently. In this study, we have proposed multiscale normalized corrected Shannon entropy (MNCSE), in which instead of using sample entropy, symbolic entropy measure NCSE has been used as an entropy estimate. The results of the study are compared with traditional MSE. The effectiveness of the proposed approach is demonstrated using noise signals as well as interbeat interval signals from healthy and pathological subjects. The preliminary results of the study indicate that MNCSE values are more stable and reliable than original MSE values. The results show that MNCSE based features lead to higher classification accuracies in comparison with the MSE based features.	[Awan, Imtiaz; Aziz, Wajid; Saeed, Sharjil; Nadeem, Malik Sajjad Ahmed; Shah, Syed Ahsin Ali] Univ Azad Jammu & Kashmir, Dept Comp Sci & Informat Technol, Muzaffarabad, Azad Kashmir, Pakistan; [Aziz, Wajid; Alowibdi, Jalal S.] Univ Jeddah, Fac Comp & IT, Dept Comp Sci, Jeddah, Saudi Arabia; [Shah, Imran Hussain] Univ Bath, Dept Econ, Bath, Avon, England; [Habib, Nazneen] Univ Azad Jammu & Kashmir, Dept Sociol & Rural Dev, Muzaffarabad, Azad Kashmir, Pakistan	University of Azad Jammu & Kashmir; University of Jeddah; University of Bath; University of Azad Jammu & Kashmir	Shah, IH (corresponding author), Univ Bath, Dept Econ, Bath, Avon, England.	i.h.shah@bath.ac.uk	Shah, Imran/W-6547-2019	Shah, Imran/0000-0002-3662-4128	University of Bath	University of Bath	The open access fees for this work were funded by the University of Bath. The authors received no specific funding for this work.	Abbasi AQ, 2014, J SIGNAL PROCESS SYS, V74, P417, DOI 10.1007/s11265-013-0836-1; Ahmed MU, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061918; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; American Heart Association (AHA), CLASS HEART FAIL; An SJ, 2007, PATTERN RECOGN, V40, P2154, DOI 10.1016/j.patcog.2006.12.015; Azami H, 2017, MED BIOL ENG COMPUT, V55, P2037, DOI 10.1007/s11517-017-1647-5; Aziz W, 2005, PROCEEDINGS OF THE INMIC 2005: 9TH INTERNATIONAL MULTITOPIC CONFERENCE - PROCEEDINGS, P368; Aziz W, 2006, EUR J APPL PHYSIOL, V98, P30, DOI 10.1007/s00421-006-0226-5; Aziz W, 2014, ACTA BIOL HUNG, V65, P252, DOI 10.1556/ABiol.65.2014.3.2; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Camm AJ, 1996, CIRCULATION, V93, P1043; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, COMPUT CARDIOL, V29, P137, DOI 10.1109/CIC.2002.1166726; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; DAW CS, 1995, PHYS REV LETT, V75, P2308, DOI 10.1103/PhysRevLett.75.2308; Eguia MC, 2000, PHYS REV E, V62, P7111, DOI 10.1103/PhysRevE.62.7111; Valencia JF, 2009, IEEE T BIO-MED ENG, V56, P2202, DOI 10.1109/TBME.2009.2021986; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Guzman-Vargas L, 2008, NAT HAZARD EARTH SYS, V8, P855, DOI 10.5194/nhess-8-855-2008; Hampton JR, 2013, THE ECG MADE EASY; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Humeau-Heurtier A, 2014, ENTROPY-SWITZ, V16, P5777, DOI 10.3390/e16115777; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Moody GB, 2011, IEEE ENG MED BIO, P8327, DOI 10.1109/IEMBS.2011.6092053; Nadeem MSA, 2010, JMLR WORKSH CONF PRO, V8, P65; Nikulin VV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.089803; Niu H, 2015, COMMUN NONLINEAR SCI, V22, P375, DOI 10.1016/j.cnsns.2014.08.038; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Wu HT, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/231762; Wu SD, 2013, ENTROPY-SWITZ, V15, P1069, DOI 10.3390/e15031069; Yu J, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19100557	37	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196823	10.1371/journal.pone.0196823	http://dx.doi.org/10.1371/journal.pone.0196823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771977	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900019
J	Frank, SL; Yang, JB				Frank, Stefan L.; Yang, Jinbiao			Lexical representation explains cortical entrainment during speech comprehension	PLOS ONE			English	Article							LANGUAGE; EVOLUTION; BRAIN	Results from a recent neuroimaging study on spoken sentence comprehension have been interpreted as evidence for cortical entrainment to hierarchical syntactic structure. We present a simple computational model that predicts the power spectra from this study, even though the model's linguistic knowledge is restricted to the lexical level, and word-level representations are not combined into higher-level units (phrases or sentences). Hence, the cortical entrainment results can also be explained from the lexical properties of the stimuli, without recourse to hierarchical syntax.	[Frank, Stefan L.; Yang, Jinbiao] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands; [Yang, Jinbiao] NYU Shanghai, Inst Brain & Cognit Sci, Shanghai, Peoples R China	Radboud University Nijmegen; NYU Shanghai	Frank, SL (corresponding author), Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands.	s.frank@let.ru.nl	Yang, Jinbiao/ABC-9682-2020; Frank, Stefan/U-5209-2018	Frank, Stefan/0000-0002-7026-711X; Yang, Jinbiao/0000-0001-9337-0243	Netherlands Organisation for Scientific Research (NWO) [024.001.006]; Netherlands Organisation for Scientific Research [024.001.006]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We are very grateful to Nai Ding for sharing his data and to Jona Sassenhagen, Tal Linzen, and two anonymous reviewers for their comments on earlier versions of this paper. The research presented here was funded by the Netherlands Organisation for Scientific Research (NWO) Gravitation Grant 024.001.006 to the Language in Interaction Consortium.; This work funded by the Netherlands Organisation for Scientific Research (www.nwo.nl) Gravitation Grant 024.001.006 to the Language in Interaction Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews M, 2009, PSYCHOL REV, V116, P463, DOI 10.1037/a0016261; Baroni M., 2014, LINGUISTIC ISSUES LA, V9, P5, DOI DOI 10.33011/LILT.V9I.1321; Bellegarda JR, 2016, COMPUT SPEECH LANG, V35, P163, DOI 10.1016/j.csl.2015.07.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berwick RC, 2013, TRENDS COGN SCI, V17, P89, DOI 10.1016/j.tics.2012.12.002; Coecke B., 2010, LINGUIST ANAL; Ding N, 2016, NAT NEUROSCI, V19, P158, DOI 10.1038/nn.4186; Frank SL, 2017, LANG COGN NEUROSCI, V32, P1192, DOI 10.1080/23273798.2017.1323109; Frank SL, 2012, P ROY SOC B-BIOL SCI, V279, P4522, DOI 10.1098/rspb.2012.1741; Hale JT, 2011, COGNITIVE SCI, V35, P399, DOI 10.1111/j.1551-6709.2010.01145.x; Jackendoff R, 2017, PSYCHON B REV, V24, P219, DOI 10.3758/s13423-016-1073-y; Li J, 2016, P WORKSH COMP LING L, P186; Mandera P, 2017, J MEM LANG, V92, P57, DOI 10.1016/j.jml.2016.04.001; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; Martin AE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000663; Mikolov T., 2013, P ICLR WORKSH; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Rotaru AS, COGNITIVE SCI; Sanford AJ, 2002, TRENDS COGN SCI, V6, P382, DOI 10.1016/S1364-6613(02)01958-7; Schafer R., 2015, P 3 WORKSHOP CHALLEN, P28; Wehbe L., 2014, P 2014 C EMP METH NA, DOI 10.3115/v1/D14-1030; Wehbe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112575; Zhou H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00274	23	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197304	10.1371/journal.pone.0197304	http://dx.doi.org/10.1371/journal.pone.0197304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG0DP	29771964	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900047
J	Some, JW; Jones, AD				Some, Jerome W.; Jones, Andrew D.			The influence of crop production and socioeconomic factors on seasonal household dietary diversity in Burkina Faso	PLOS ONE			English	Article							NUTRITIONAL-STATUS; FOOD SECURITY; FARMING HOUSEHOLDS; RURAL BANGLADESH; WOMEN; VARIETY; SCORES; URBAN; INDICATORS; ADEQUACY	Households in low-income settings are vulnerable to seasonal changes in dietary diversity because of fluctuations in food availability and access. We assessed seasonal differences in household dietary diversity in Burkina Faso, and determined the extent to which household socioeconomic status and crop production diversity modify changes in dietary diversity across seasons, using data from the nationally representative 2014 Burkina Faso Continuous Multisectoral Survey (EMC). A household dietary diversity score based on nine food groups was created from household food consumption data collected during four rounds of the 2014 EMC. Plot-level crop production data, and data on household assets and education were used to create variables on crop diversity and household socioeconomic status, respectively. Analyses included data for 10,790 households for which food consumption data were available for at least one round. Accounting for repeated measurements and controlling for the complex survey design and confounding covariates using a weighted multilevel model, household dietary diversity was significantly higher during both lean seasons periods, and higher still during the harvest season as compared to the post-harvest season (mean: post-harvest: 4.76 (se(0.04)); beginning of lean: 5.13 ((SE) 0.05); end of lean: 5.21 ((sE) 0.05); harvest: 5.72 ((SE) 0.04)), but was not different between the beginning and the end of lean season. Seasonal differences in household dietary diversity were greater among households with higher food expenditures, greater crop production, and greater monetary value of crops sale (P < 0.05). Seasonal changes in household dietary diversity in Burkina Faso may reflect nutritional differences among agricultural households, and may be modified both by households' socioeconomic status and agricultural characteristics.	[Some, Jerome W.; Jones, Andrew D.] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Some, JW (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA.	joserweb@yahoo.fr	McIntyre, Lauren/AAC-8416-2020	SOME, JEROME/0000-0001-5955-9747	Innovative Methods and Metrics for Agriculture and Nutrition Actions (IMMANA) research initiative - UK Department for International Development (DFID)	Innovative Methods and Metrics for Agriculture and Nutrition Actions (IMMANA) research initiative - UK Department for International Development (DFID)	This study was supported by a grant through the Innovative Methods and Metrics for Agriculture and Nutrition Actions (IMMANA) research initiative funded by the UK Department for International Development (DFID) and coordinated by the Leverhulme Centre for Integrative Research on Agriculture and Health (LCIRAH) (ADJ). The funder had no role in the design, analysis or writing of this article.	Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Arsenault JE, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.53; Becquey E, 2012, BRIT J NUTR, V107, P1860, DOI 10.1017/S0007114511005071; BENEFICE E, 1984, ECOL FOOD NUTR, V14, P229, DOI 10.1080/03670244.1984.9990790; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BRANCA F, 1993, EUR J CLIN NUTR, V47, P840; Christiaensen L, 2011, J DEV ECON, V96, P239, DOI 10.1016/j.jdeveco.2010.10.006; FAO and FHI 360, 2016, MIN DIET DIV WOM GUI; Ferro-luzzi A., 2001, SEASONAL UNDERNUTRIT; FEWS NET, 2010, LIV ZON PROF REP BUR; Frongillo EA, 2006, J NUTR, V136, P1409; Gillespie S, 2012, IFPRI DISCUSS PAP; GUTHRIE HA, 1981, J AM DIET ASSOC, V78, P240; Harris-Fry H, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0022-0; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; Hatloy A, 2000, PUBLIC HEALTH NUTR, V3, P57, DOI 10.1017/S1368980000000628; Hoddinott J., 2002, 136 IFPRIFCND; Jalloh A, 2013, W AFRICAN AGR CLIMAT, DOI [10.1016/S0140-6736(13)60937-X, DOI 10.1016/S0140-6736(13)60937-X]; Jones AD, 2017, J NUTR, V147, P86, DOI 10.3945/jn.116.235879; Jones AD, 2014, FOOD POLICY, V46, P1, DOI 10.1016/j.foodpol.2014.02.001; KANT AK, 1995, J AM COLL NUTR, V14, P358; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Keding GB, 2012, FOOD SECUR, V4, P129, DOI 10.1007/s12571-011-0163-y; Kennedy G., 2013, GUID MEAS HOUS IND D; Koppmair S, 2017, PUBLIC HEALTH NUTR, V20, P325, DOI [10.1017/S1368980016002135, 10.1017/s1368980016002135]; Lykke AM, 2002, ECOL FOOD NUTR, V41, P119, DOI 10.1080/03670240214492; Martin-Prevel Y, 2017, DEV DICHOTOMOUS INDI, V1; Mayanja M, 2015, ECOL FOOD NUTR, V54, P529, DOI 10.1080/03670244.2015.1041135; Ministere de l'Economie et des Finances, 2014, TABL BORD EC 4 TRIM; Ng'endo M, 2016, ECOL FOOD NUTR, V55, P403, DOI 10.1080/03670244.2016.1200037; Onyango A, 1998, INT J EPIDEMIOL, V27, P484, DOI 10.1093/ije/27.3.484; Savy M, 2005, EUR J CLIN NUTR, V59, P703, DOI 10.1038/sj.ejcn.1602135; Savy M, 2006, J NUTR, V136, P2625, DOI 10.1093/jn/136.10.2625; Sibhatu KT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186406; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Sibhatu KT, 2018, FARM PRODUCTION DIVE; Som? L., 2013, W AFRICAN AGR CLIMAT, P79; Stevens B, 2017, PUBLIC HEALTH NUTR, V20, P121, DOI [10.1017/S136898001600183X, 10.1017/s136898001600183x]; Steyn NP, 2006, PUBLIC HEALTH NUTR, V9, P644, DOI 10.1079/PHN2005912; Teokul W, 1986, FOOD NUTR B, V8; Van Liere M. J., 1995, Food and Nutrition Bulletin, V16, P147; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Working Group on Infant and Young Child Feeding Indicators, 2007, 360 FANTAFHI WORK GR; World Health Organization, 1996, PREP US FOOD BAS DET	44	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0195685	10.1371/journal.pone.0195685	http://dx.doi.org/10.1371/journal.pone.0195685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771910	Green Submitted, gold, Green Published			2022-12-26	WOS:000432348900005
J	Tejera-Parrado, C; Jesus, S; Lopez-Ruiz, A; Buiza-Rueda, D; Bonilla-Toribio, M; Bernal-Bernal, I; Perinan, MT; Vargas-Gonzalez, L; Gomez-Garre, P; Mir, P				Tejera-Parrado, Cristina; Jesus, Silvia; Lopez-Ruiz, Adrian; Buiza-Rueda, Dolores; Bonilla-Toribio, Marta; Bernal-Bernal, Inmaculada; Teresa Perinan, Maria; Vargas-Gonzalez, Laura; Gomez-Garre, Pilar; Mir, Pablo			TMEM230 in Parkinson's disease in a southern Spanish population	PLOS ONE			English	Article							CHINESE PATIENTS; GENETIC-ANALYSIS; MUTATIONS; RARE	TMEM230 has been associated with autosomal dominant Parkinson's disease (PD). Subsequent studies have remained negative, and none of previous described mutation has been reported anymore. We investigated the implication of this gene in the PD in a population of 703 PD patients and 695 unrelated healthy controls from southern Spain. Thirteen variants were found, twelve of them observed only in controls or in patients and controls, and one (c.190A>G) observed only in one patient. Subsequent analysis of this variant indicates that probably it is not pathogenic. In addition, we found a variation in the 3'-UTR (rs183551373) and related with the miRNA hsa-miR-4299 but it was observed only in healthy controls. Our results suggest that variants in TMEM230 gene are not associated with the development of PD.	[Tejera-Parrado, Cristina; Jesus, Silvia; Lopez-Ruiz, Adrian; Buiza-Rueda, Dolores; Bonilla-Toribio, Marta; Bernal-Bernal, Inmaculada; Teresa Perinan, Maria; Vargas-Gonzalez, Laura; Gomez-Garre, Pilar; Mir, Pablo] Univ Seville, Inst Biomed Sevilla IBiS, Unidad Trastornos Movimiento,CSIC, Serv Neurol & Neurofisiol Clin,Hosp Univ Virgen d, Seville, Spain; [Gomez-Garre, Pilar; Mir, Pablo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBERNED	Gomez-Garre, P; Mir, P (corresponding author), Univ Seville, Inst Biomed Sevilla IBiS, Unidad Trastornos Movimiento,CSIC, Serv Neurol & Neurofisiol Clin,Hosp Univ Virgen d, Seville, Spain.; Gomez-Garre, P; Mir, P (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	mgomez-ibis@us.es; pmir@us.es	Termine, Cristinano/AAB-8366-2022; Gómez-Garre, Pilar/AAG-8048-2020; Mir, Pablo/C-8662-2013	Gómez-Garre, Pilar/0000-0002-0437-6182; Mir, Pablo/0000-0003-1656-302X; Perinan, Maria Teresa/0000-0001-7412-7440; Tejera-Parrado, Cristina/0000-0001-8001-5621	Spanish Ministry of Economy and Competitiveness - Institute de Salud Carlos-III (ISCIII) [PI14/01823, PI16/01575]; Fondo Europeo de Desarrollo Regional (FEDER); Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685]; Consejeria de Salud y Bienestar Social de la Junta de Andalucia [PI-0437-2012, PI-0471-2013]; Sociedad Andaluza de Neurologia to Pablo Mir; Jacques and Gloria Gossweiler Foundation; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena; "Miguel Servet" (ISCIII-FEDER) programme; "Nicolas Monardes" (Andalusian Ministry of Health) programme; "Juan Rodes" programme (from ISCIII-FEDER); VPPI-US from the Universidad de Sevilla	Spanish Ministry of Economy and Competitiveness - Institute de Salud Carlos-III (ISCIII); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia(Junta de Andalucia); Consejeria de Salud y Bienestar Social de la Junta de Andalucia; Sociedad Andaluza de Neurologia to Pablo Mir; Jacques and Gloria Gossweiler Foundation; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); "Miguel Servet" (ISCIII-FEDER) programme; "Nicolas Monardes" (Andalusian Ministry of Health) programme; "Juan Rodes" programme (from ISCIII-FEDER); VPPI-US from the Universidad de Sevilla	This study was supported by grants from the Spanish Ministry of Economy and Competitiveness [PI14/01823 to Pilar Gomez-Garre, PI16/01575 to Pablo Mir] co-founded by the Institute de Salud Carlos-III (ISCIII) and by Fondo Europeo de Desarrollo Regional (FEDER), the Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685], the Consejeria de Salud y Bienestar Social de la Junta de Andalucia [PI-0437-2012, PI-0471-2013], the Sociedad Andaluza de Neurologia to Pablo Mir, the Jacques and Gloria Gossweiler Foundation to Pablo Mir, the Fundacion Alicia Koplowitz to Pablo Mir, and the Fundacion Mutua Madrilena. Pilar Gomez-Garre was supported by the "Miguel Servet" (from ISCIII-FEDER) and "Nicolas Monardes" (from Andalusian Ministry of Health) programmes. Silvia Jesus was supported by the "Juan Rodes" programme (from ISCIII-FEDER). Cristina Tejera-Parrado was supported by VPPI-US from the Universidad de Sevilla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann H, 2017, PARKINSONISM RELAT D, V35, P100, DOI 10.1016/j.parkreldis.2016.12.015; Buongarzone G, 2017, PARKINSONISM RELAT D, V39, P87, DOI 10.1016/j.parkreldis.2017.03.007; Conedera SA, 2018, PARKINSONISM RELAT D, V48, P107, DOI 10.1016/j.parkreldis.2017.12.020; Deng HX, 2016, NAT GENET, V48, P733, DOI 10.1038/ng.3589; Fan TS, 2017, AM J MED GENET B, V174, P751, DOI 10.1002/ajmg.b.32576; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Giri A, 2017, NEUROBIOL AGING, V50, DOI 10.1016/j.neurobiolaging.2016.10.004; He YC, 2017, MOVEMENT DISORD, V32, P301, DOI 10.1002/mds.26875; Ibanez L, 2017, NEUROBIOL AGING, V56, DOI 10.1016/j.neurobiolaging.2017.03.014; Ma DR, 2017, NEUROBIOL AGING, V58, DOI 10.1016/j.neurobiolaging.2017.06.011; Quadri M, 2017, MOVEMENT DISORD, V32, P302, DOI 10.1002/mds.26900; Shi CH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01398-9; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; Wei QQ, 2018, MOL NEUROBIOL, V55, P2851, DOI 10.1007/s12035-017-0542-2; Wu HW, 2017, PARKINSONISM RELAT D, V36, P105, DOI 10.1016/j.parkreldis.2016.12.021; Yan WQ, 2017, NEUROBIOL AGING, V49, DOI 10.1016/j.neurobiolaging.2016.10.007; Yang XL, 2017, MOVEMENT DISORD, V32, P800, DOI 10.1002/mds.26996	17	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197271	10.1371/journal.pone.0197271	http://dx.doi.org/10.1371/journal.pone.0197271			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771939	Green Submitted, gold, Green Published			2022-12-26	WOS:000432348900041
J	Chang, RC; Hail-Jares, K; Zheng, H; He, N; Bouey, JZH				Chang, Ruth C.; Hail-Jares, Katie; Zheng, Huang; He, Na; Bouey, Jennifer Z. H.			Mitigating circumstances: A model-based analysis of associations between risk environment and infrequent condom use among Chinese street-based sex workers	PLOS ONE			English	Article							FEMALE ENTERTAINMENT WORKERS; SKILLS IMB MODEL; HIV PREVENTION; MALE CLIENTS; YUNNAN PROVINCE; MAINLAND CHINA; SELF-EFFICACY; UNSAFE SEX; HIV/AIDS; INTERVENTION	Background Little is known about how freelance street-based sex workers navigate condom use while soliciting. Traditional behavioural model may fail to account for the complex risk environment that most street-based sex workers work within. We examine first the association of self-efficacy and the infrequent condom use, then we investigated the roles of clients and venues frequented on this association. Method Using a purposive chain-referral sampling method, we surveyed 248 street-based sex workers in Shanghai. The survey focused on sex workers HIV risk factors, sex work patterns, HIV knowledge, and related HIV self-efficacy. Clients types and behaviours, and characteristics of the venues frequented by these commercial sex workers were also collected. We conducted a series of multiple logistic regression models to explore how the association between a sex worker's self-efficacy with infrequent condom use change as client and venue characteristics were added to the models. Results We find that within the basic model, low self-efficacy was marginally associated with infrequent condom use (54.9% vs. 45.1%, AOR = 1.70, 95% CI = 0.95-3.03). As client- and venue- characteristics were added, the associations between self-efficacy and condom use were strengthened (AOR = 2.10 95% CI = 1.12-3.91 and 2.54 95% CI = 1.24-5.19 respectively). Those who reported middle-tiered income were more likely to report infrequent condom use compared to their peers of high income (AOR = 3.92 95% CI = 1.32-11.70) whereas such difference was not found between low income and high income sex workers. Visiting multiple venues and having migrant workers as clients were also associated with infrequent condom use. Conclusion Our findings suggest sex worker's self-efficacy matters in their HIV risk behaviours only when environment characteristics were adjusted. Risk environment for street-based sex workers are complex. Programming addressing behavioural changes among female sex workers should adopt holistic, multilevel models with the consideration of risk environments.	[Chang, Ruth C.; Bouey, Jennifer Z. H.] Georgetown Univ, Sch Nursing & Hlth Studies, Dept Int Hlth, Washington, DC 20057 USA; [Hail-Jares, Katie] Griffith Univ, Griffith Criminol Inst, Mt Gravatt, Qld, Australia; [Zheng, Huang] Shanghai CSW&MSM Ctr, Xinjian St, Shanghai, Peoples R China; [He, Na] Fudan Univ, Dept Epidemiol, Shanghai, Peoples R China	Georgetown University; Griffith University; Fudan University	Bouey, JZH (corresponding author), Georgetown Univ, Sch Nursing & Hlth Studies, Dept Int Hlth, Washington, DC 20057 USA.	Jennifer.bouey@georgetown.edu		Hail-Jares, Katie/0000-0003-3732-1935	National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD-066362]	National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Data collection is funded by a research grant from National Institute of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-066362).	Aliabadi N, 2015, AIDS EDUC PREV, V27, P522, DOI 10.1521/aeap.2015.27.6.522; Anderson ES, 2006, ANN BEHAV MED, V31, P70, DOI 10.1207/s15324796abm3101_11; [Anonymous], 2004, DEVICES; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Benotsch EG, 2007, J COMMUN HEALTH, V32, P343, DOI 10.1007/s10900-007-9054-8; Bharat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068043; Blankenship KM, 2010, SEX TRANSM INFECT, V86, pI69, DOI 10.1136/sti.2009.038653; Chen XS, 2012, SEX TRANSM DIS, V39, P868, DOI 10.1097/OLQ.0b013e318264c3ba; Chen XS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-111; Chen XS, 2000, SEX TRANSM DIS, V27, P138, DOI 10.1097/00007435-200003000-00003; Cheng SSY, 2010, AIDS CARE, V22, P606, DOI 10.1080/09540120903311441; China Health and Family Planning Commission, 2015, CHIN AIDS RESP PROGR; Choi SYP, 2008, SEX TRANSM DIS, V35, P141, DOI 10.1097/OLQ.0b013e31815407c3; Choi SYP, 2007, CULT HEALTH SEX, V9, P489, DOI 10.1080/13691050701220446; Cornish F, 2006, J COMMUNITY APPL SOC, V16, P301, DOI 10.1002/casp.866; Cornman DH, 2007, SOC SCI MED, V64, P1572, DOI 10.1016/j.socscimed.2006.11.011; Dai W, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2385-y; Deering KN, 2013, JAIDS-J ACQ IMM DEF, V63, P522, DOI 10.1097/QAI.0b013e3182968d39; Eades M., 2004, US NEWS WORLD REP, P56; Evans C, 2010, GLOB PUBLIC HEALTH, V5, P449, DOI 10.1080/17441690902942472; FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455; Gaikwad SS, 2012, J EPIDEMIOL COMMUNIT, V66, DOI [10.1080/09540120500466937, DOI 10.1080/09540120500466937]; Ghimire L, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-42; Gil VE, 1996, SOC SCI MED, V42, P141, DOI 10.1016/0277-9536(95)00064-X; Grau LE, 2013, PREV SCI, V14, P400, DOI 10.1007/s11121-012-0301-6; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; Hao C, 2014, CULT HEALTH SEX, V16, P47, DOI 10.1080/13691058.2013.826820; Hong Y, 2007, SEX HEALTH, V4, P99, DOI 10.1071/SH06063; Hong Y, 2011, AIDS CARE, V23, P54, DOI 10.1080/09540121.2011.554526; Hong Y, 2009, AIDS CARE, V21, P212, DOI 10.1080/09540120801932165; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Kang'ethe S. M., 2015, Journal of Human Ecology, V49, P211; Ma QQ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4891-6; Rachakulla HK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S1; Ramesh BA, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000343762.54831.5c; Remez, 2005, STD RAT SOAR CHIN 3, DOI [10.1080/17441690902942472, DOI 10.1080/17441690902942472]; Rogers SJ, 2002, AIDS EDUC PREV, V14, P217, DOI 10.1521/aeap.14.3.217.23892; Safika I, 2013, CULT HEALTH SEX, V15, P598, DOI 10.1080/13691058.2013.776112; Scambler G, 2008, SOC SCI MED, V66, P1848, DOI 10.1016/j.socscimed.2008.01.002; Sgaier SK, 2012, SEX TRANSM INFECT, V88, P240, DOI 10.1136/sextrans-2011-050382; Suiming P., 2017, REALISTIC RESPONSE C; Svenson GR, 2002, AIDS EDUC PREV, V14, P515, DOI 10.1521/aeap.14.8.515.24111; UN Women, FEM HIV AIDS; Volkmann T, 2014, ARCH SEX BEHAV, V43, P719, DOI 10.1007/s10508-013-0149-2; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wee S, 2004, SEX TRANSM INFECT, V80, P310, DOI 10.1136/sti.2003.008342; WHO, WPRO HIV STIS; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046786; Xia GM, 2005, AIDS EDUC PREV, V17, P143, DOI 10.1521/aeap.17.3.143.62904; Yang C, 2010, SEX TRANSM INFECT, V86, P559, DOI 10.1136/sti.2009.041731; Yang HM, 2005, SEX TRANSM DIS, V32, P572, DOI 10.1097/01.olq.0000175418.48665.95; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang X, 2013, INT J STD AIDS, V24, P555, DOI 10.1177/0956462412473959; Yang XS, 2006, AIDS EDUC PREV, V18, P333, DOI 10.1521/aeap.2006.18.4.333; Yang XS, 2010, AIDS EDUC PREV, V22, P69, DOI 10.1521/aeap.2010.22.1.69; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; Zeng H, 2016, HEALTH SOC CARE COMM, V24, pE173, DOI 10.1111/hsc.12266; Zeng H, 2015, INT J ENV RES PUB HE, V12, P855, DOI 10.3390/ijerph120100855; Zhao R, 2008, AIDS CARE, V20, P782, DOI 10.1080/09540120701694030; Zhu J, 2018, INT J STD AIDS, V29, P424, DOI 10.1177/0956462417730258; Zhu V., 2017, SUSTAINABILITY, V9	61	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0195982	10.1371/journal.pone.0195982	http://dx.doi.org/10.1371/journal.pone.0195982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF7AA	29763416	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800005
J	Lee, MB; Kim, HJ; Woo, EJ; Kwon, OI				Lee, Mun Bae; Kim, Hyung Joong; Woo, Eung Je; Kwon, Oh In			Anisotropic conductivity tensor imaging for transcranial direct current stimulation (tDCS) using magnetic resonance diffusion tensor imaging (MR-DTI)	PLOS ONE			English	Article							CURRENT-DENSITY; FLUX DENSITY; IN-VIVO; MREIT; DEPRESSION; BRAIN; COEFFICIENT; TRIAL; WATER; PAIN	Transcranial direct current stimulation (tDCS) is a widely used non-invasive brain stimulation technique by applying low-frequency weak direct current via electrodes attached on the head. The tDCS using a fixed current between 1 and 2 mA has relied on computational modelings to achieve optimal stimulation effects. Recently, by measuring the tDCS current induced magnetic field using an MRI scanner, the internal current pathway has been successfully recovered. However, up to now, there is no technique to visualize electrical properties including the electrical anisotropic conductivity, effective extracellular ion-concentration, and electric field using only the tDCS current in-vivo. By measuring the apparent diffusion coefficient (ADC) and the magnetic flux density induced by the tDCS, we propose a method to visualize the electrical properties. We reconstruct the scale parameter, which connects the anisotropic conductivity tensor to the diffusion tensor of water molecules, by introducing a repetitive scheme called the diffusion tensor J-substitution algorithm using the recovered current density and the measured ADCs. We investigate the proposed method to explain why the iterative scheme converges to the internal conductivity. We verified the proposed method with an anesthetized canine brain to visualize electrical properties including the electrical properties by tDCS current.	[Lee, Mun Bae; Kwon, Oh In] Konkuk Univ, Dept Math, Seoul, South Korea; [Kim, Hyung Joong; Woo, Eung Je] Kyung Hee Univ, Dept Biomed Engn, Seoul, South Korea	Konkuk University; Kyung Hee University	Kwon, OI (corresponding author), Konkuk Univ, Dept Math, Seoul, South Korea.	oikwon@konkuk.ac.kr	Woo, Eung Je/ABH-6442-2020		National Research Foundation of Korea (NRF) - Korean government (MEST) [2015R1D1A1A09058104, 2016R1A2B4014534, 2017R1D1A1B03028754, 2017R1A2A1A05001330]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean government (MEST) (No. 2015R1D1A1A09058104, 2016R1A2B4014534, 2017R1D1A1B03028754, 2017R1A2A1A05001330).	Alonzo A, 2013, J AFFECT DISORDERS, V150, P91, DOI 10.1016/j.jad.2013.02.027; Bennabi D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00159; Brunoni AR, 2017, NEW ENGL J MED, V376, P2523, DOI 10.1056/NEJMoa1612999; Brunoni AR, 2016, BRIT J PSYCHIAT, V208, P522, DOI 10.1192/bjp.bp.115.164715; CHENEVERT TL, 1990, RADIOLOGY, V177, P401, DOI 10.1148/radiology.177.2.2217776; CLEVELAND GG, 1976, BIOPHYS J, V16, P1043, DOI 10.1016/S0006-3495(76)85754-2; Degirmenci E, 2007, PHYS MED BIOL, V52, P7229, DOI 10.1088/0031-9155/52/24/003; DeLano MC, 2000, AM J NEURORADIOL, V21, P1830; Goksu C, 2018, NEUROIMAGE, V171, P26, DOI 10.1016/j.neuroimage.2017.12.075; HASHIN Z, 1962, J APPL PHYS, V33, P3125, DOI 10.1063/1.1728579; Jeong WC, 2017, IEEE T MED IMAGING, V36, P124, DOI 10.1109/TMI.2016.2598546; Jog MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34385; Kwon OI, 2014, PHYS MED BIOL, V59, P2955, DOI 10.1088/0031-9155/59/12/2955; Le Bihan Denis, 1995, P5; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Loo CK, 2010, INT J NEUROPSYCHOPH, V13, P61, DOI 10.1017/S1461145709990411; Luedtke K, 2012, CLIN J PAIN, V28, P452, DOI 10.1097/AJP.0b013e31823853e3; Nam HS, 2010, PHYS MED BIOL, V55, P2743, DOI 10.1088/0031-9155/55/9/021; Nam HS, 2010, IEEE T MED IMAGING, V29, P781, DOI 10.1109/TMI.2009.2036440; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Palm U, 2016, TRANSCRANIAL DIRECT; Park C, 2007, PHYS MED BIOL, V52, P3001, DOI 10.1088/0031-9155/52/11/005; SCOTT GC, 1991, IEEE T MED IMAGING, V10, P362, DOI 10.1109/42.97586; Sekino M, 2009, BIOELECTROMAGNETICS, V30, P489, DOI 10.1002/bem.20505; SEN AK, 1989, PHYS REV B, V39, P4504, DOI 10.1103/PhysRevB.39.4504; Seo JK, 2011, SIAM REV, V53, P40, DOI 10.1137/080742932; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Wang YJ, 2016, J PSYCHIATR RES, V79, P1, DOI 10.1016/j.jpsychires.2016.04.001; Zaghi S, 2011, RESTOR NEUROL NEUROS, V29, P439, DOI 10.3233/RNN-2011-0615; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197063	10.1371/journal.pone.0197063	http://dx.doi.org/10.1371/journal.pone.0197063			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763453	Green Published, gold			2022-12-26	WOS:000432118800024
J	AlMenhalil, EA; Khalid, K; Iyanna, S				AlMenhalil, Entesar Ali; Khalid, Khalizani; Iyanna, Shilpa			Testing the psychometric properties of the Environmental Attitudes Inventory on undergraduate students in the Arab context: A test-retest approach	PLOS ONE			English	Article							ECOLOGICAL PARADIGM; BEHAVIOR; SCALE; EDUCATION; ISSUES; NEP	The Environmental Attitudes Inventory (EAI) was developed to evaluate the multidimensional nature of environmental attitudes; however, it is based on a dataset from outside the Arab context. This study reinvestigated the construct validity of the EAI with a new dataset and confirmed the feasibility of applying it in the Arab context. One hundred and forty-eight subjects in Study 1 and 130 in Study 2 provided valid responses. An exploratory factor analysis (EFA) was used to extract a new factor structure in Study 1, and confirmatory factor analysis (CFA) was performed in Study 2. Both studies generated a seven-factor model, and the model fit was discussed for both the studies. Study 2 exhibited satisfactory model fit indices compared to Study 1. Factor loading values of a few items in Study 1 affected the reliability values and average variance extracted values, which demonstrated low discriminant validity. Based on the results of the EFA and CFA, this study showed sufficient model fit and suggested the feasibility of applying the EAI in the Arab context with a good construct validity and internal consistency.	[AlMenhalil, Entesar Ali] Abu Dhabi Univ, Coll Business Adm, Abu Dhabi, U Arab Emirates; [Khalid, Khalizani] Abu Dhabi Univ, Coll Business Adm, Dept Management, Abu Dhabi, U Arab Emirates; [Iyanna, Shilpa] Abu Dhabi Univ, Coll Business Adm, Dept Mkt, Abu Dhabi, U Arab Emirates	Abu Dhabi University; Abu Dhabi University; Abu Dhabi University	Khalid, K (corresponding author), Abu Dhabi Univ, Coll Business Adm, Dept Management, Abu Dhabi, U Arab Emirates.	khalizani.khalid@adu.ac.ae	Khalid, Khalizani/AAZ-8618-2021	Khalid, Khalizani/0000-0002-8485-1616				ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Amburgey JW, 2012, ENVIRON BEHAV, V44, P235, DOI 10.1177/0013916511402064; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; [Anonymous], 2012, BERSKSHIRE ENCY SUST; Arbuckle J. L., 2014, AMOS VERSION 23 0 CO; Biasutti M, 2017, ENVIRON EDUC RES, V23, P214, DOI 10.1080/13504622.2016.1146660; BLAIKIE NWH, 1992, SOC SCI QUART, V73, P144; Bogner FX, 1999, EUR PSYCHOL, V4, P139, DOI 10.1027//1016-9040.4.3.139; Boyer P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040750; Bronfman NC, 2015, SUSTAINABILITY-BASEL, V7, P14133, DOI 10.3390/su71014133; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Chankrajang T, 2017, ECOL ECON, V131, P434, DOI 10.1016/j.ecolecon.2016.09.015; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Chen XD, 2011, ENVIRON CONSERV, V38, P45, DOI 10.1017/S037689291000086X; Cho E, 2016, ORGAN RES METHODS, V19, P651, DOI 10.1177/1094428116656239; Collins A, 2017, J SUSTAIN TOUR, V25, P148, DOI 10.1080/09669582.2016.1189922; De Leeuw A, 2015, J ENVIRON PSYCHOL, V42, P128, DOI 10.1016/j.jenvp.2015.03.005; Dean AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159063; DiBenedetto C. A., 2016, Journal of Agricultural Education, V57, P167; DUNLAP RE, 1978, J ENVIRON EDUC, V9, P10, DOI 10.1080/00958964.1978.10801875; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Dunlap RE, 2008, J ENVIRON EDUC, V40, P3, DOI 10.3200/JOEE.40.1.3-18; Erdogan N, 2009, AFR J AGR RES, V4, P1023; Evans-Lacko S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091053; Ferreira MC, 2015, PSICOL-REFLEX CRIT, V28, P340, DOI 10.1590/1678-7153.201528214; Fetscherin M, 2008, J ELECTRON COMMER RE, V9, P231; Field A.P., 2020, DISCOVERING STAT USI, V4th; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Geng LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127247; Lopez AG, 2008, PSICOTHEMA, V20, P623; Gravetter F, 2014, ESSENTIAL STAT BEHAV; Grendstad G, 2003, ACTA SOCIOL, V46, P289; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Harraway J, 2012, J ENVIRON EDUC, V43, P177, DOI 10.1080/00958964.2011.634450; Hawcroft LJ, 2010, J ENVIRON PSYCHOL, V30, P143, DOI 10.1016/j.jenvp.2009.10.003; Hebel F.L., 2014, INT J ENV SCI ED, V9, P329, DOI [DOI 10.12973/IJESE.2014.218A, 10.12973/ijese.2014.218a]; Hiramatsu A, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010024; Hope ALB, 2014, TECHNOL SOC, V38, P48, DOI 10.1016/j.techsoc.2014.02.003; Huddart E, 2009, HUM ECOL REV, V16, P151; Kagesten A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157805; Kenny DA, 2015, SOCIOL METHOD RES, V44, P486, DOI 10.1177/0049124114543236; Khan A., 2012, ASIA PACIFIC J MANAG, V8, P389, DOI DOI 10.1177/2319510X13477966; Khew JYT, 2014, HUM ECOL, V42, P979, DOI 10.1007/s10745-014-9709-x; Kim H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/2696019; Kim T.-H., 2004, FINANC RES LETT, V1, P56, DOI [DOI 10.1016/S1544-6123(03)00003-5, 10.1016/S1544-6123(03)00003-5]; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Koc I, 2016, INT J ENV SCI ED, V11, P5925; Kormos C, 2015, ENVIRON BEHAV, V47, P479, DOI 10.1177/0013916513520416; Krech D., 1948, THEORY PROBLEMS SOCI; Lonnqvist JE, 2015, J ECON BEHAV ORGAN, V119, P254, DOI 10.1016/j.jebo.2015.08.003; Lu JF, 2017, REHABIL PSYCHOL, V62, P110, DOI 10.1037/rep0000138; Lundmark C., 2007, ENVIRON EDUC RES, V13, P329, DOI DOI 10.1080/13504620701430448; Mamady K, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/9305768; Milfont T. L., 2006, MEDIO AMBIENTE COMPO, V7, P29; Milfont TL, 2010, J APPL SOC PSYCHOL, V40, P2791, DOI 10.1111/j.1559-1816.2010.00681.x; Milfont TL, 2010, J ENVIRON PSYCHOL, V30, P80, DOI 10.1016/j.jenvp.2009.09.001; Milfont Taciano L., 2009, Environmentalist, V29, P263, DOI 10.1007/s10669-008-9192-2; Newman TP, 2016, ENVIRON EDUC RES, V22, P153, DOI 10.1080/13504622.2014.999227; Olli E, 2001, ENVIRON BEHAV, V33, P181, DOI 10.1177/0013916501332002; Pannucci CJ, 2010, PLAST RECONSTR SURG, V126, P619, DOI 10.1097/PRS.0b013e3181de24bc; Petty R. E., 1998, HDB SOCIAL PSYCHOL, P323; Pooley JA, 2000, ENVIRON BEHAV, V32, P711, DOI 10.1177/0013916500325007; Raykov T, 1998, APPL PSYCH MEAS, V22, P375, DOI 10.1177/014662169802200407; Root D, 2003, 19 ANN ARCOM C 3 5 S, V2, P623; Russell DW, 2002, PERS SOC PSYCHOL B, V28, P1629, DOI 10.1177/014616702237645; Sammalisto K, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8060510; Satorra A., 1994, LATENT VARIABLES ANA, P399, DOI DOI 10.2307/2291370; Sayles JS, 2010, ECOL SOC, V15; Schroder T, 2017, J ENVIRON PSYCHOL, V52, P136, DOI 10.1016/j.jenvp.2016.03.007; Schultz PW, 2004, J ENVIRON PSYCHOL, V24, P31, DOI 10.1016/S0272-4944(03)00022-7; Schwarz N, 2007, SOC COGNITION, V25, P638, DOI 10.1521/soco.2007.25.5.638; Shephard K, 2009, BRIT J EDUC TECHNOL, V40, P386, DOI 10.1111/j.1467-8535.2008.00927.x; Sircova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117612; Sousa E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154440; SPSS Inc, 2009, PASW STAT WIND VERS; Sutton SG, 2015, INT J SUST HIGHER ED, V16, P16, DOI 10.1108/IJSHE-03-2013-0027; Tam KP, 2014, SOC COGNITION, V32, P276, DOI 10.1521/soco.2014.32.3.276; Tsoi KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163406; Turaga RMR, 2010, ANN NY ACAD SCI, V1185, P211, DOI 10.1111/j.1749-6632.2009.05163.x; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; WICKER AW, 1969, J SOC ISSUES, V25, P41, DOI 10.1111/j.1540-4560.1969.tb00619.x; Wu JZ, 2016, IEEE PHOTONICS J, V8, DOI 10.1109/JPHOT.2016.2514495; Xue W., 2015, INT J ENV SCI DEV, V6, P547, DOI [10.7763/IJESD.2015.V6.654, DOI 10.7763/IJESD.2015.V6.654]; Ziegler M, 2015, EUR J PSYCHOL ASSESS, V31, P231, DOI 10.1027/1015-5759/a000309; Ziegler M, 2014, EUR J PSYCHOL ASSESS, V30, P239, DOI 10.1027/1015-5759/a000228; Zsoka A, 2013, J CLEAN PROD, V48, P126, DOI 10.1016/j.jclepro.2012.11.030	86	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0195250	10.1371/journal.pone.0195250	http://dx.doi.org/10.1371/journal.pone.0195250			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF6MZ	29758021	Green Submitted, Green Published, gold			2022-12-26	WOS:000432082900002
J	Burger, J; Zappalorti, RT; Gochfeld, M				Burger, Joanna; Zappalorti, Robert T.; Gochfeld, Michael			Hatchling survival to breeding age in Northern Pine Snakes (Pituophis melanoleucus) in the New Jersey Pine Barrens: Human effects on recruitment from 1986 to 2017	PLOS ONE			English	Article							INCUBATION-TEMPERATURE; PINESNAKES PITUOPHIS; LIFE-HISTORY; REPRODUCTIVE SUCCESS; CHEMICAL CUES; GROWTH-RATES; HABITAT USE; BODY-SIZE; BEHAVIOR; HIBERNACULA	To conserve threatened/endangered species, we need to understand the factors contributing to reproductive success and recruitment to reproductive stage. Obtaining this information is difficult for snakes because they are secretive, are not easy to locate at the same stage each year, and are sometimes sparsely distributed. We determined nest fate, hatchling growth and survival to age 5 years, and recruitment to breeding age of Northern Pine Snakes (Pituophis melanoleucus) in New Jersey Pine Barrens from 1986 to 2017. Pine Snakes are 'threatened' in New Jersey and in other states, and are at risk because of increased human population, habitat loss, predation, and poaching. Age of first-breeding was 4-years, based on snout-vent length of gravid and laying females, and snout-vent length of females followed as hatchlings to 5-years. Mean clutch size (+/- 1 SE) was 9.5 +/- 0.3 (N = 53). The annual percent of nests in which eggs hatched averaged 25% (N = 288 nests), and varied among 5-year periods (5% to 30%/year). Of lab-reared hatchlings released into natal nests (N = 90), 26% (2015) and 32% (2016) reached hibernacula excavated in 2016 and 2017. The sex ratio of hatchlings reaching hibernation sites (N = 181) between 1986 and 2015 was skewed toward females (74/106, 59% females), and varied among 5-year periods (47-75% females). Once hatchlings reached a hibernaculum, there was a sex-related difference in survival. For hatchlings reaching a monitored hibernaculum, survival to 3-years was 35% in females and 40% in males, and to 4-years was 25% in females and 33% in males. Using these data, only 10% of females reached 3 years (first possible breeding age), and 7% survived to 4-years. Methodological problems with determining survival rates during these early critical years are discussed.	[Burger, Joanna; Gochfeld, Michael] Rutgers State Univ, Div Life Sci, Piscataway, NJ 08854 USA; [Zappalorti, Robert T.] Herpetol Associates Inc, Pemberton, NJ USA	Rutgers State University New Brunswick	Burger, J (corresponding author), Rutgers State Univ, Div Life Sci, Piscataway, NJ 08854 USA.	burger@biology.rutgers.edu			Tiko Fund; Herpetological Associates, Inc.; Rutgers University	Tiko Fund; Herpetological Associates, Inc.; Rutgers University	Limited financial support for the field work, data management, and analysis was from the Tiko Fund, Herpetological Associates, Inc., and Rutgers University. The funders provided support in the form of salaries for authors [JB, MG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews R.M., 1982, Biology of Reptilia, V13, P273; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Baron JP, 2010, J ANIM ECOL, V79, P640, DOI 10.1111/j.1365-2656.2010.01661.x; Blouin-Demers G, 2002, J ZOOL, V256, P1, DOI 10.1017/S0952836902000018; Bronikowski AM, 1999, ECOLOGY, V80, P2314, DOI 10.1890/0012-9658(1999)080[2314:TEEOLH]2.0.CO;2; Bronikowski AM, 2000, EVOLUTION, V54, P1760; Brown GP, 1997, CAN J ZOOL, V75, P424, DOI 10.1139/z97-052; Brown GP, 2005, ECOLOGY, V86, P2763, DOI 10.1890/04-1805; Brown WS, 2007, COPEIA, P656; Burger J, 1998, BEHAV ECOL SOCIOBIOL, V43, P11, DOI 10.1007/s002650050461; BURGER J, 1988, AM NAT, V132, P492, DOI 10.1086/284867; Burger J, 1998, ANIM BEHAV, V56, P547, DOI 10.1006/anbe.1998.0809; BURGER J, 1991, BEHAV ECOL SOCIOBIOL, V28, P297; BURGER J, 1989, BEHAV ECOL SOCIOBIOL, V24, P201, DOI 10.1007/BF00295199; BURGER J, 1990, COPEIA, P1160, DOI 10.2307/1446505; BURGER J, 1991, J HERPETOL, V25, P152, DOI 10.2307/1564642; BURGER J, 1989, J HERPETOL, V23, P68, DOI 10.2307/1564318; BURGER J, 1988, J HERPETOL, V22, P425, DOI 10.2307/1564337; BURGER J, 1992, J HERPETOL, V26, P259, DOI 10.2307/1564879; BURGER J, 1989, J CHEM ECOL, V15, P799, DOI 10.1007/BF01015178; BURGER J, 1987, COMP BIOCHEM PHYS A, V87, P727, DOI 10.1016/0300-9629(87)90390-2; BURGER J, 1986, COPEIA, P116; BURGER J, 1988, HERPETOLOGICA, V44, P48; BURGER J, 1992, BEHAV ECOL SOCIOBIOL, V30, P331; Burger J, 2013, NATURAL SCI, V5, P52; Burger J, 2011, NO PINESNAKE PITUOPH, P1; Burger J., 2000, HERP NATURAL HIST, V7, P59, DOI DOI 10.1038/S41514-017-0013-Z; Burger J, 2017, AMPHIB REPTILE CONSE, V11, P17; Burger J, 2016, HERPETOL CONSERV BIO, V11, P304; Burger J, 2015, J HERPETOL, V49, P245, DOI 10.1670/12-265; Burger J, 2012, J HERPETOL, V46, P596, DOI 10.1670/11-100; Burger Joanna, 2007, Urban Ecosystems, V10, P275, DOI 10.1007/s11252-007-0022-y; Burger Joanna, 2007, Urban Ecosystems, V10, P193, DOI 10.1007/s11252-007-0019-6; Charlesworth B., 1994, EVOLUTION AGE STRUCT, V2nd ed, edited by C. Cannings, F. C. Hoppensteadt, and L. A. Segel.; Charlesworth B, 1990, GENETIC EFFECTS AGIN, VII, P21; Conant R., 1998, FIELD GUIDE REPTILES, V3rd; de Buffrenil V, 2002, J HERPETOL, V36, P419, DOI 10.2307/1566186; DUNHAM AE, 1985, AM NAT, V126, P231, DOI 10.1086/284411; ELBIN SB, 1994, WILDLIFE SOC B, V22, P677; FITCH HS, 1949, AM MIDL NAT, V41, P513, DOI 10.2307/2421774; FORD NB, 1994, FUNCT ECOL, V8, P91, DOI 10.2307/2390116; Fornasiero S, 2016, ACTA HERPETOL, V11, P135, DOI 10.13128/Acta_Herpetol-18695; Forsman A, 1996, OECOLOGIA, V108, P669, DOI 10.1007/BF00329041; Gerald GW, 2006, J HERPETOL, V40, P503, DOI 10.1670/0022-1511(2006)40[503:MAARSO]2.0.CO;2; Gibbons JW, 1976, SPECIAL REV EXPT AGI, P454; Golden DM, 2009, STATUS ASSESSMENT NO; GREGORY PT, 1994, J ZOOL, V232, P313, DOI 10.1111/j.1469-7998.1994.tb01575.x; Hyslop NL, 2012, POPUL ECOL, V54, P145, DOI 10.1007/s10144-011-0292-3; IMLER RH, 1945, J WILDLIFE MANAGE, V9, P265, DOI 10.2307/3796368; Iverson JB, 2008, J HERPETOL, V42, P501, DOI 10.1670/07-030.1; Krause MA, 2003, J ZOOL, V261, P399, DOI 10.1017/S0952836903004321; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; National Wildlife Federation (NWF), 2017, LOUIS PIN SNAK; Parker, 1980, COMP ECOLOGY 2 COLUB; PARKER W S, 1973, Herpetologica, V29, P319; PARKER W S, 1987, P253; Rodriguez-Robles JA, 2000, MOL PHYLOGENET EVOL, V14, P35, DOI 10.1006/mpev.1999.0698; Roff Derek A., 1992; SCUDDER RM, 1985, DEV PSYCHOBIOL, V18, P203; SHINE R, 1992, EVOLUTION, V46, P62, DOI 10.1111/j.1558-5646.1992.tb01985.x; SHINE R, 1990, AM NAT, V135, P278, DOI 10.1086/285043; Shine R, 2003, P ROY SOC B-BIOL SCI, V270, P995, DOI 10.1098/rspb.2002.2307; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Taylor EN, 2005, J EXP ZOOL PART A, V303A, P598, DOI 10.1002/jez.a.189; Warner DA, 2014, INTEGRAT COMPAR BIOL; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Zappalorti R. T., 2011, ENV IND, V6, P17; Zappalorti R, 2015, HERPETOLOGICA, V71, P26, DOI 10.1655/HERPETOLOGICA-D-13-00035; Zappalorti RT, 2014, J TOXICOL ENV HEAL A, V77, P1285, DOI 10.1080/15287394.2014.934497; ZAPPALORTI RT, 1985, ENVIRON CONSERV, V12, P358, DOI 10.1017/S0376892900034500; Zuffi M. A. L., 2007, THESIS	73	3	3	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0195676	10.1371/journal.pone.0195676	http://dx.doi.org/10.1371/journal.pone.0195676			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758024	gold, Green Published, Green Submitted			2022-12-26	WOS:000432082900003
J	Cholewinska, E; Ognik, K; Fotschki, B; Zdunczyk, Z; Juskiewicz, J				Cholewinska, Ewelina; Ognik, Katarzyna; Fotschki, Bartosz; Zdunczyk, Zenon; Juskiewicz, Jerzy			Comparison of the effect of dietary copper nanoparticles and one copper (II) salt on the copper biodistribution and gastrointestinal and hepatic morphology and function in a rat model	PLOS ONE			English	Article							GOLD NANOPARTICLES; SILVER NANOPARTICLES; OXIDE NANOPARTICLES; OXIDATIVE STRESS; TOXICITY; LIVER; METABOLISM; PARAMETERS; WILSON; BRAIN	The aim of the study was to investigate the effect of two forms (CuCO3 (CuS); and Cu nanoparticles (CuNP)) and dosages (standard 6.5 mg/kg (H), half of the standard (L)) of additional dietary Cu administered to growing rats on gastrointestinal and hepatic function and morphology. Copper in the form of CuNP vs CuS caused lower Cu faecal/urinal excretion and increased Cu accumulation in the brain tissue. Hepatic high-grade hydropic degeneration and necrotic lesions were observed only in the CuNP-H animals. In the lower gut, the dietary application of CuNP stifled bacterial enzymatic activity of caecal gut microbiota and resulted in lower SCFA production. That diminishing effect of CuNP on caecal microbiota activity was accompanied by a relative increase in the secretion of glycoside hydrolases by bacterial cells. The results showed that in comparison to Cu from CuCO3, Cu nanoparticles to a greater extent were absorbed from the intestine, accumulated in brain tissue, exerted antimicrobial effect in the caecum, and at higher dietary dose caused damages in the liver of rats.	[Cholewinska, Ewelina; Ognik, Katarzyna] Univ Life Sci Lublin, Fac Biol Anim Sci & Bioecon, Dept Biochem & Toxicol, Lublin, Poland; [Fotschki, Bartosz; Zdunczyk, Zenon; Juskiewicz, Jerzy] Polish Acad Sci, Inst Anim Reprod & Food Res, Div Food Sci, Olsztyn, Poland	University of Life Sciences in Lublin; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Juskiewicz, J (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Div Food Sci, Olsztyn, Poland.	j.juskiewicz@pan.olsztyn.pl	Ognik, Katarzyna/T-9316-2018; FOTSCHKI, Bartosz/Q-4275-2019; FOTSCHKI, Bartosz/H-7172-2017; JUSKIEWICZ, Jerzy/H-7193-2017; ZDUNCZYK, Zenon/H-7272-2017	Ognik, Katarzyna/0000-0003-4393-4092; Cholewinska, Ewelina/0000-0003-0437-4766; FOTSCHKI, Bartosz/0000-0002-9727-7481; JUSKIEWICZ, Jerzy/0000-0003-0068-5970; ZDUNCZYK, Zenon/0000-0002-0640-7552	KNOW Consortium: "Healthy Animal - Safe Food" (Ministry of Sciences and Higher Education) [Dec: 05-1/KNOW2/2015]	KNOW Consortium: "Healthy Animal - Safe Food" (Ministry of Sciences and Higher Education)	The article processing charge was covered by the KNOW Consortium: "Healthy Animal - Safe Food" (Ministry of Sciences and Higher Education; Dec: 05-1/KNOW2/2015).	Aburto EM, 2001, CAN J VET RES, V65, P97; Aghamirkarimi S, 2017, GLOB J ENVIRON SCI M, V3, P323, DOI 10.22034/gjesm.2017.03.03.009; Akomolafe RO, 2014, AFR J ENV SCI TECHNO, V8, P158; Al-Naimi RA, 2010, AL ANBAR J VET SCI, V3, P1; Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; [Anonymous], 2017, GLOB J NANOMED; Arnal N, 2014, NUTRITION, V30, P96, DOI 10.1016/j.nut.2013.06.009; Assadi Z, 2018, J MOL LIQ, V250, P375, DOI 10.1016/j.molliq.2017.12.031; Atta AH, 2011, WORLD APPL SCI J, V12, P1469; Azam A, 2012, INT J NANOMED, V7, P3527, DOI 10.2147/IJN.S29020; Bari A, 2017, ACTA BIOMATER, V55, P493, DOI 10.1016/j.actbio.2017.04.012; Bauerly KA, 2005, AM J PHYSIOL-GASTR L, V288, pG1007, DOI 10.1152/ajpgi.00210.2004; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Cholewinska E, 2018, J TRACE ELEM MED BIO, V48, P111, DOI 10.1016/j.jtemb.2018.03.017; Cisternas FA, 2005, BIOMETALS, V18, P541, DOI 10.1007/s10534-005-1244-1; Das P., 2014, J NANOMED NANOTECHNO, V5, P235; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; Dizaj SM, 2014, MAT SCI ENG C-MATER, V44, P278, DOI 10.1016/j.msec.2014.08.031; Doudi M, 2014, NANOMED J, V1, P331, DOI 10.7508/NMJ.2015.05.007; Festa RA, 2011, CURR BIOL, V21, pR877, DOI 10.1016/j.cub.2011.09.040; Fuentealba IC, 2000, J TOXICOL-CLIN TOXIC, V38, P709, DOI 10.1081/CLT-100102384; Gangadoo S, 2016, TRENDS FOOD SCI TECH, V58, P115, DOI 10.1016/j.tifs.2016.10.013; Glod D., 2014, ZYWNOSC NAUKA TECHNO, V5, P36; Gnanavel V, 2017, J PHOTOCH PHOTOBIO B, V171, P133, DOI 10.1016/j.jphotobiol.2017.05.001; Gugolek A, 2015, J EXP ZOOL PART A, V323, P637, DOI 10.1002/jez.1954; Gupta A, 2009, FUTURE MED CHEM, V1, P1125, DOI 10.4155/FMC.09.84; Gupta V., 2013, SCI INT, V1, P167, DOI DOI 10.5567/SCIINTL.2013.167.174; Gupta Yugantak Raj, 2016, Aquaculture and Fisheries, V1, P15, DOI 10.1016/j.aaf.2016.09.003; Han XY, 2012, BIOL TRACE ELEM RES, V145, P355, DOI 10.1007/s12011-011-9191-x; Huster D, 2007, MOL BIOSYST, V3, P816, DOI 10.1039/b711118p; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Jia HY, 2009, J AM CHEM SOC, V131, P40, DOI 10.1021/ja808033w; Jo MR, 2015, NANOMATERIALS-BASEL, V5, P835, DOI 10.3390/nano5020835; Jurgonski A, 2013, NUTRITION, V29, P898, DOI 10.1016/j.nut.2012.11.006; Juskiewicz J, 2004, WORLD POULTRY SCI J, V60, P177, DOI [10.1079/WPS200311, 10.1079/WPS20040013]; Kumar V, 2015, J TRACE ELEM MED BIO, V29, P269, DOI 10.1016/j.jtemb.2014.06.004; Lee IC, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0169-x; Lee IC, 2016, INT J NANOMED, V11, P2883, DOI 10.2147/IJN.S106346; Liu Y, 2009, J NANOSCI NANOTECHNO, V9, P6335, DOI 10.1166/jnn.2009.1320; Lorincz Matthew T, 2018, Handb Clin Neurol, V147, P279, DOI 10.1016/B978-0-444-63233-3.00018-X; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mahapatra O, 2008, J EXP NANOSCI, V3, P185, DOI 10.1080/17458080802395460; Majewski M, 2017, PHARMACOL REP, V69, P1282, DOI 10.1016/j.pharep.2017.06.001; Mohammad yari A.T.R.S., 2014, J BIOL TODAYS WORLD, V6, P124, DOI DOI 10.15412/J.JBTW.01030601; Montenegro L, 2011, DRUG DEV IND PHARM, V37, P737, DOI 10.3109/03639045.2010.539231; Ognik K, 2016, CZECH J ANIM SCI, V61, P450, DOI 10.17221/80/2015-CJAS; Ognik K, 2016, POULTRY SCI, V95, P2045, DOI 10.3382/ps/pew200; Ozcelik D, 2009, BIOL TRACE ELEM RES, V127, P45, DOI 10.1007/s12011-008-8219-3; Ozkul H, 2011, J ANIM VET ADV, V10, P1373; Pal A, 2013, BIOL TRACE ELEM RES, V153, P257, DOI 10.1007/s12011-013-9665-0; Pietroiusti A, 2016, TOXICOL APPL PHARM, V299, P90, DOI 10.1016/j.taap.2015.12.017; Rowland I. R., 1995, HUMAN COLONIC BACTER, P155; Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10; Seol Ja-Kyung, 2015, [Journal of Preventive Veterinary Medicine, 예방수의학회지], V39, P3; Shahbazi MA, 2013, BIOMATERIALS, V34, P7776, DOI 10.1016/j.biomaterials.2013.06.052; Shameli K, 2011, INT J NANOMED, V6, P331, DOI 10.2147/IJN.S16964; Shi MingLei, 2013, Chinese Journal of Animal Nutrition, V25, P1843; Shukla S, 2015, IIS U J SC TECH, V4, P41; Skalska J, 2016, FOOD CHEM TOXICOL, V97, P307, DOI 10.1016/j.fct.2016.09.026; Tomaszewska E, 2017, J TRACE ELEM MED BIO, V42, P103, DOI 10.1016/j.jtemb.2017.05.002; Tomaszewska E, 2016, BIOL TRACE ELEM RES, V171, P185, DOI 10.1007/s12011-015-0522-1; Tomaszewska E, 2014, B VET I PULAWY, V58, P479, DOI 10.2478/bvip-2014-0073; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; Wijmenga C, 2004, P NUTR SOC, V63, P31, DOI 10.1079/PNS2003316; Yah CS, 2013, BIOMED RES-INDIA, V24, P400; Zdunczyk Z, 2004, ARCH ANIM NUTR, V58, P89, DOI 10.1080/00039420310001656703; Zhao JY, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2493-0	67	45	46	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197083	10.1371/journal.pone.0197083	http://dx.doi.org/10.1371/journal.pone.0197083			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758074	gold, Green Submitted, Green Published			2022-12-26	WOS:000432082900024
J	Yuan, S; Sharma, AK; Richart, A; Lee, J; Kim, BE				Yuan, Sai; Sharma, Anuj Kumar; Richart, Alexandria; Lee, Jaekwon; Kim, Byung-Eun			CHCA-1 is a copper-regulated CTR1 homolog required for normal development, copper accumulation, and copper-sensing behavior in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans (C; elegans); copper; copper transport; intestine; metal homeostasis; CHCH-1; copper avoidance	C. ELEGANS; TRANSPORTER CTR1; AVOIDANCE-BEHAVIOR; IRON-METABOLISM; ASH NEURONS; IN-VIVO; YEAST; GENE; CELLS; HCTR1	Copper plays key roles in catalytic and regulatory biochemical reactions essential for normal growth, development, and health. Dietary copper deficiencies or mutations in copper homeostasis genes can lead to abnormal musculoskeletal development, cognitive disorders, and poor growth. In yeast and mammals, copper is acquired through the activities of the CTR1 family of high-affinity copper transporters. However, the mechanisms of systemic responses to dietary or tissue-specific copper deficiency remain unclear. Here, taking advantage of the animal model Caenorhabditis elegans for studying whole-body copper homeostasis, we investigated the role of a C. elegans CTR1 homolog, CHCA-1, in copper acquisition and in worm growth, development, and behavior. Using sequence homology searches, we identified 10 potential orthologs to mammalian CTR1. Among these genes, we found that chca-1, which is transcriptionally up-regulated in the intestine and hypodermis of C. elegans during copper deficiency, is required for normal growth, reproduction, and maintenance of systemic copper balance under copper deprivation. The intestinal copper transporter CUA-1 normally traffics to endosomes to sequester excess copper, and we found here that loss of chca-1 caused CUA-1 to mislocalize to the basolateral membrane under copper overload conditions. Moreover, animals lacking chca-1 exhibited significantly reduced copper avoidance behavior in response to toxic copper conditions compared with WT worms. These results establish that CHCA-1-mediated copper acquisition in C. elegans is crucial for normal growth, development, and copper-sensing behavior.	[Yuan, Sai; Sharma, Anuj Kumar; Richart, Alexandria; Kim, Byung-Eun] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Kim, Byung-Eun] Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA; [Lee, Jaekwon] Univ Nebraska, Dept Biochem, Redox Biol Ctr, Lincoln, NE 68588 USA; [Sharma, Anuj Kumar] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Nebraska System; University of Nebraska Lincoln; Princeton University	Kim, BE (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.; Kim, BE (corresponding author), Univ Maryland, Biol Sci Grad Program, College Pk, MD 20742 USA.	bekim@umd.edu	Sharma, Anuj/G-3043-2011	Sharma, Anuj/0000-0001-5061-9731; Yuan, Sai/0000-0002-4089-5780	National Institutes of Health [DK074797]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079209, R01DK110195, R01DK074797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Kim laboratory for helpful suggestions, technical assistance, and critical reading of this manuscript. We thank members of Dr. Iqbal Hamza's laboratory (University of Maryland, College Park) for technical assistance and expertise in C. elegans genetics and cell biology as well as for discussions regarding the work, and Dr. Tamara Korolnek for critical reading of this manuscript. The COPAS Biosort instrument was purchased from funds supported by National Institutes of Health Grant DK074797 (to I.H.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Anderson CP, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00113; Anderson JL, 2010, J HERED, V101, pS62, DOI 10.1093/jhered/esq003; Aoki I, 2015, CURR OPIN NEUROBIOL, V34, P117, DOI 10.1016/j.conb.2015.03.011; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Block E, 2017, NAT PROD REP, V34, P529, DOI 10.1039/c7np00016b; Bousquet-Moore D, 2010, J NEUROSCI RES, V88, P2535, DOI 10.1002/jnr.22404; BRENNER S, 1974, GENETICS, V77, P71; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chen CY, 2012, J BIOL CHEM, V287, P9601, DOI 10.1074/jbc.M111.307694; Chun H, 2017, J BIOL CHEM, V292, P1, DOI 10.1074/jbc.M116.760876; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Du M, 2009, ENVIRON TOXICOL PHAR, V27, P314, DOI 10.1016/j.etap.2008.11.011; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Frooninckx Lotte, 2012, Front Endocrinol (Lausanne), V3, P167, DOI 10.3389/fendo.2012.00167; Gaetke LM, 2014, ARCH TOXICOL, V88, P1929, DOI 10.1007/s00204-014-1355-y; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; Guo M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6655; Hao LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020995; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Husson SJ, 2007, J NEUROCHEM, V102, P246, DOI 10.1111/j.1471-4159.2007.04474.x; IMAGAWA M, 1990, BIOCHEM J, V268, P237, DOI 10.1042/bj2680237; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kuo YM, 2001, P NATL ACAD SCI USA, V98, P6836, DOI 10.1073/pnas.111057298; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2000, GENE, V254, P87, DOI 10.1016/S0378-1119(00)00287-0; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Mackenzie NC, 2004, GENE, V328, P113, DOI 10.1016/j.gene.2003.11.019; Mak HY, 2012, J LIPID RES, V53, P28, DOI 10.1194/jlr.R021006; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2013, J BIOL CHEM, V288, P18035, DOI 10.1074/jbc.M112.442426; Mitani S, 2009, EXP ANIM TOKYO, V58, P351, DOI 10.1538/expanim.58.351; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nose Y, 2006, CELL METAB, V4, P235, DOI 10.1016/j.cmet.2006.08.009; Nose Y, 2010, J BIOL CHEM, V285, P32385, DOI 10.1074/jbc.M110.143826; Ohrvik H, 2014, ANN NY ACAD SCI, V1314, P32, DOI 10.1111/nyas.12371; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; Ohrvik H, 2016, J BIOL CHEM, V291, P13905, DOI 10.1074/jbc.M116.731281; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Ooi CE, 1996, EMBO J, V15, P3515, DOI 10.1002/j.1460-2075.1996.tb00720.x; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Wakabayashi T, 1998, FEBS LETT, V440, P141, DOI 10.1016/S0014-5793(98)01431-8; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	63	5	5	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10911	10925		10.1074/jbc.RA118.003503	http://dx.doi.org/10.1074/jbc.RA118.003503			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29784876	Green Published, hybrid			2022-12-26	WOS:000438882800006
J	Robinson, P; Liu, X; Sparrow, A; Patel, S; Zhang, YH; Casadei, B; Watkins, H; Redwood, C				Robinson, Paul; Liu, Xing; Sparrow, Alexander; Patel, Suketu; Zhang, Yin-Hua; Casadei, Barbara; Watkins, Hugh; Redwood, Charles			Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling, and stimulate Ca2+-dependent signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyopathy; troponin; tropomyosin; Ca2+; calmodulin-dependent protein kinase II (CaMKII); extracellular-signal-regulated kinase (ERK); NFAT transcription factor; SERCA	RAT VENTRICULAR MYOCYTES; MYOSIN HEAVY-CHAIN; CARDIAC TROPONIN-C; ALPHA-TROPOMYOSIN; DILATED CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY; MOUSE MODEL; CONTRACTILITY; BINDING; HEART	Mutations in thin filament regulatory proteins that cause hypertrophic cardiomyopathy (HCM) increase myofilament Ca2+ sensitivity. Mouse models exhibit increased Ca2+ buffering and arrhythmias, and we hypothesized that these changes are primary effects of the mutations (independent of compensatory changes) and that increased Ca2+ buffering and altered Ca2+ handling contribute to HCM pathogenesis via activation of Ca2+-dependent signaling. Here, we determined the primary effects of HCM mutations on intracellular Ca2+ handling and Ca2+-dependent signaling in a model system possessing Ca2+-handling mechanisms and contractile protein isoforms closely mirroring the human environment in the absence of potentially confounding remodeling. Using adenovirus, we expressed HCM-causing variants of human troponin-T, troponin-I, and -tropomyosin (R92Q, R145G, and D175N, respectively) in isolated guinea pig left ventricular cardiomyocytes. After 48 h, each variant had localized to the I-band and comprised approximate to 50% of the total protein. HCM mutations significantly lowered the K-d of Ca2+ binding, resulting in higher Ca2+ buffering of mutant cardiomyocytes. We observed increased diastolic [Ca2+] and slowed Ca2+ reuptake, coupled with a significant decrease in basal sarcomere length and slowed relaxation. HCM mutant cells had higher sodium/calcium exchanger activity, sarcoplasmic reticulum Ca2+ load, and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) activity driven by Ca2+/calmodulin-dependent protein kinase II (CaMKII) phosphorylation of phospholamban. The ryanodine receptor (RyR) leak/load relationship was also increased, driven by CaMKII-mediated RyR phosphorylation. Altered Ca2+ homeostasis also increased signaling via both calcineurin/NFAT and extracellular signal-regulated kinase pathways. Altered myofilament Ca2+ buffering is the primary initiator of signaling cascades, indicating that directly targeting myofilament Ca2+ sensitivity provides an attractive therapeutic approach in HCM.	[Robinson, Paul; Liu, Xing; Sparrow, Alexander; Patel, Suketu; Zhang, Yin-Hua; Casadei, Barbara; Watkins, Hugh; Redwood, Charles] Univ Oxford, Radcliffe Dept Med, Cardiovasc Med Div, Oxford OX3 9DU, England; [Zhang, Yin-Hua] Seoul Natl Univ, Coll Med, Ischem Hypox Dis Inst, Dept Physiol Biomed Sci, Seoul 110799, South Korea; [Zhang, Yin-Hua] Yanbian Univ Hosp, Yanji 133000, Jilin, Peoples R China; [Zhang, Yin-Hua] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9NT, Lancs, England	University of Oxford; Seoul National University (SNU); Yanbian University; University of Manchester	Robinson, P (corresponding author), John Radcliffe Hosp, Cardiovasc Med Div, Level 6 West Wing,Headley Way, Oxford OX3 9DU, England.	paulr@well.ox.ac.uk		Sparrow, Alexander/0000-0002-3354-3314; Casadei, Barbara/0000-0002-6801-1617	British Heart Foundation Programme Grant [RG/12/16/29939]; British Heart Foundation Centre of Research Excellence (Oxford, UK)	British Heart Foundation Programme Grant; British Heart Foundation Centre of Research Excellence (Oxford, UK)	The work is supported by British Heart Foundation Programme Grant RG/12/16/29939 and the British Heart Foundation Centre of Research Excellence (Oxford, UK). The authors declare that they have no conflicts of interest with the contents of this article.	Ashrafian H, 2003, TRENDS GENET, V19, P263, DOI 10.1016/S0168-9525(03)00081-7; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bing W, 1997, BIOCHEM BIOPH RES CO, V236, P760, DOI 10.1006/bbrc.1997.7045; Bode EF, 2011, J PHYSIOL-LONDON, V589, P4723, DOI 10.1113/jphysiol.2011.211052; Burton D, 2002, BIOCHEM J, V362, P443, DOI 10.1042/0264-6021:3620443; Coppini R, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003565; Coppini R, 2013, CIRCULATION, V127, P575, DOI 10.1161/CIRCULATIONAHA.112.134932; Davis J, 2007, CIRC RES, V100, P1494, DOI 10.1161/01.RES.0000268412.34364.50; Davis J, 2016, CELL, V165, P1147, DOI 10.1016/j.cell.2016.04.002; Davis J, 2012, J MOL CELL CARDIOL, V53, P446, DOI 10.1016/j.yjmcc.2012.05.018; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; ELLINGSEN O, 1993, AM J PHYSIOL, V265, pH747, DOI 10.1152/ajpheart.1993.265.2.H747; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Feng W, 2012, MOL PHARMACOL, V82, P993, DOI 10.1124/mol.112.079707; Haim TE, 2007, J MOL CELL CARDIOL, V42, P1098, DOI 10.1016/j.yjmcc.2007.03.906; Hamdani N, 2013, CARDIOVASC RES, V97, P464, DOI 10.1093/cvr/cvs353; Helassa N, 2016, SCI REP-UK, V6, DOI 10.1038/srep38276; Helms AS, 2016, CIRCULATION, V134, P1738, DOI 10.1161/CIRCULATIONAHA.115.020086; Jian Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005046; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lowey S, 2002, TRENDS CARDIOVAS MED, V12, P348, DOI 10.1016/S1050-1738(02)00181-0; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1996, CIRCULATION, V94, P588; Martins AS, 2015, CIRC-CARDIOVASC GENE, V8, P653, DOI 10.1161/CIRCGENETICS.114.000957; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; O'Hanlon R, 2010, J AM COLL CARDIOL, V56, P867, DOI 10.1016/j.jacc.2010.05.010; ONEILL SC, 1990, J PHYSIOL-LONDON, V430, P519, DOI 10.1113/jphysiol.1990.sp018305; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Rice R, 2010, J MOL CELL CARDIOL, V48, P979, DOI 10.1016/j.yjmcc.2009.11.018; Robertson IM, 2009, J BIOL CHEM, V284, P23012, DOI 10.1074/jbc.M109.021352; Robinson P, 2002, J BIOL CHEM, V277, P40710, DOI 10.1074/jbc.M203446200; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Schober T, 2012, CIRC RES, V111, P170, DOI 10.1161/CIRCRESAHA.112.270041; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Smith GA, 2000, BIOCHEM J, V346, P393, DOI 10.1042/0264-6021:3460393; STEMMER P, 1989, LIFE SCI, V44, P1231, DOI 10.1016/0024-3205(89)90319-6; Tadano N, 2010, BRIT J PHARMACOL, V161, P1034, DOI 10.1111/j.1476-5381.2010.00942.x; Tardiff JC, 2016, CIRCULATION, V134, P1749, DOI 10.1161/CIRCULATIONAHA.116.025455; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Trafford AW, 1999, PFLUG ARCH EUR J PHY, V437, P501, DOI 10.1007/s004240050808; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; WILLIAMS DA, 1985, NATURE, V318, P558, DOI 10.1038/318558a0; Witt CC, 2001, J BIOL CHEM, V276, P5353, DOI 10.1074/jbc.M008691200; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	49	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10487	10499		10.1074/jbc.RA118.002081	http://dx.doi.org/10.1074/jbc.RA118.002081			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29760186	Green Published, hybrid			2022-12-26	WOS:000437828400009
J	Assis, DS; Dos Santos, IA; Ramos, FN; Barrios-Rojas, KE; Majer, JD; Vilela, EF				Assis, Diego Santana; Dos Santos, Iracenir Andrade; Ramos, Flavio Nunes; Barrios-Rojas, Katty Elena; Majer, Jonathan David; Vilela, Evaldo Ferreira			Agricultural matrices affect ground ant assemblage composition inside forest fragments	PLOS ONE			English	Article							HABITAT FRAGMENTATION; LANDSCAPE STRUCTURE; SPECIES RICHNESS; CLEAR-CUT; LAND-USE; EDGE; CONSEQUENCES; BIODIVERSITY; COMMUNITIES; COFFEE	The establishment of agricultural matrices generally involves deforestation, which leads to fragmentation of the remaining forest. This fragmentation can affect forest dynamics both positively and negatively. Since most animal species are affected, certain groups can be used to measure the impact of such fragmentation. This study aimed to measure the impacts of agricultural crops (matrices) on ant communities of adjacent lower montane Atlantic rainforest fragments. We sampled nine forest fragments at locations surrounded by different agricultural matrices, namely: coffee (3 replicates); sugarcane (3); and pasture (3). At each site we installed pitfall traps along a 500 m transect from the interior of the matrix to the interior of the fragment (20 pitfall traps-25 m apart). Each transect was partitioned into four categories: interior of the matrix; edge of the matrix; edge of the fragment; and interior of the fragment. For each sample site, we measured ant species richness and ant community composition within each transect category. Ant richness and composition differed between fragments and matrices. Each sample location had a specific composition of ants, probably because of the influence of the nature and management of the agricultural matrices. Species composition in the coffee matrix had the highest similarity to its corresponding fragment. The variability in species composition within forest fragments surrounded by pasture was greatest when compared with forest fragments surrounded by sugarcane or, to a lesser extent, coffee. Functional guild composition differed between locations, but the most representative guild was 'generalist' both in the agricultural matrices and forest fragments. Our results are important for understanding how agricultural matrices act on ant communities, and also, how these isolated forest fragments could act as an island of biodiversity in an 'ocean of crops'.	[Assis, Diego Santana; Barrios-Rojas, Katty Elena; Vilela, Evaldo Ferreira] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Dos Santos, Iracenir Andrade] Univ Fed Oeste Para, Ctr Formacao Interdisciplinar, Santarem, Para, Brazil; [Ramos, Flavio Nunes] Univ Fed Alfenas, Inst Ciencias Nat, Alfenas, MG, Brazil; [Majer, Jonathan David] Univ Western Australia, Sch Biol Sci, Perth, WA, Australia; [Majer, Jonathan David] Curtin Univ, Sch Mol & Life Sci, Perth, WA, Australia; [Assis, Diego Santana; Barrios-Rojas, Katty Elena] Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil	Universidade Federal de Vicosa; Universidade Federal do Oeste do Para; Universidade Federal de Alfenas; University of Western Australia; Curtin University; Universidade de Sao Paulo	Assis, DS (corresponding author), Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil.; Assis, DS (corresponding author), Univ Sao Paulo, Dept Biol, Fac Filosofia Ciencias & Letras Ribeirao Preto, Ribeirao Preto, SP, Brazil.	diegoassis@usp.br	Ramos, Flavio N/D-6268-2013; Assis, Diego Santana/AAB-6174-2019	Ramos, Flavio N/0000-0001-6689-3575; Assis, Diego Santana/0000-0002-8131-2617	Empresa Brasileira de Pesquisa Agropecuaria; EMBRAPA-Amazonia Oriental; Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)/Vale Company [RDP-00104-10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472250/2010-8]	Empresa Brasileira de Pesquisa Agropecuaria(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); EMBRAPA-Amazonia Oriental(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)/Vale Company(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The project was supported by Empresa Brasileira de Pesquisa Agropecuaria, EMBRAPA-Amazonia Oriental, Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)/Vale Company (RDP-00104-10), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (472250/2010-8) provided grant to study design, data collection and analysis, and preparation of the manuscript. Moreover, Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES) also provided scholarships to DSA and IAS.; We thank the Universidade Federal de Alfenas for logistic support and also Lais Matias, Felipe Esteves, Alexandre Casadei, Carla Padua and Aline Constantino for help with the field work. We also thank the anonymous reviewers for their help to improve this manuscript. We also thank the farm owners for permission to enter and collect ants. Finally, we thank to Empresa Brasileira de Pesquisa Agropecuaria, EMBRAPA-Amazonia Oriental, Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)/Vale Company (RDP-00104-10), Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico (CNPq) (472250/2010-8) for providing funding for study design, data collection and analysis, and prepatation of the manuscript. Moreover, the Comissao de Aperfeicoamento de Pessoal do Nivel Superior (CAPES) also provided scholarships to DSA and IAS.	Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1995, NEW GEN CATALOGUE AN; [Anonymous], [No title captured]; [Anonymous], 2013, AGR FOREST METEOROL, DOI DOI 10.1016/j.agrformet.2013.03.008; Banks SC, 2007, CAN J ZOOL, V85, P1065, DOI 10.1139/Z07-094; Bates D., 2007, R PACKAGE VERSION, P74, DOI DOI 10.18637/JSS.V067.I01; Bolker B, 2015, R DEV CORE TEAM BBML; Bolton B., 1994, IDENTIFICATION GUIDE; Bretz F., 2016, MULTIPLE COMP USING; Brown KS, 1997, J INSECT CONSERV, V1, P25, DOI 10.1023/A:1018422807610; Carneiro MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164814; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; CHEN JQ, 1993, AGR FOREST METEOROL, V63, P219, DOI 10.1016/0168-1923(93)90061-L; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DANUNCIACAO PER, 2013, INT J ECOL, V2013, pNIL1, DOI DOI 10.1155/2013/183726; De la Mora A, 2013, BIODIVERS CONSERV, V22, P871, DOI 10.1007/s10531-013-0454-z; Deikumah JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074852; Delabie Jacques H.C., 2000, Curtin University of Technology School of Environmental Biology Bulletin, V18, P1; Devictor V, 2007, CONSERV BIOL, V21, P741, DOI 10.1111/j.1523-1739.2007.00671.x; Dias NS, 2008, IHERINGIA SER ZOOL, V98, P136, DOI 10.1590/S0073-47212008000100017; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Donald PF, 2006, J APPL ECOL, V43, P209, DOI 10.1111/j.1365-2664.2006.01146.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Duelli P, 2003, AGR ECOSYST ENVIRON, V98, P87, DOI 10.1016/S0167-8809(03)00072-0; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Estavillo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082369; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2017, ANNU REV ECOL EVOL S, V48, P1, DOI 10.1146/annurev-ecolsys-110316-022612; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Garcia-Martinez MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172464; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gomes APC, 2005, SUMMA PHYTOPATHOL BR, V261, P29; Gotelli NJ, 2013, ECOSIMR 1 00; Herve M., 2017, RVAIDEMEMOIRE DIVERS; Hillebrand H, 2018, J APPL ECOL, V55, P169, DOI 10.1111/1365-2664.12959; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Lassau SA, 2004, ECOGRAPHY, V27, P157, DOI 10.1111/j.0906-7590.2004.03675.x; LAWTON JH, 1983, ANNU REV ENTOMOL, V28, P23, DOI 10.1146/annurev.en.28.010183.000323; Lustig A, 2017, LANDSCAPE ECOL, V32, P2311, DOI 10.1007/s10980-017-0570-3; Magura T, 2017, ECOL EVOL, V7, P1009, DOI 10.1002/ece3.2722; MAJER JD, 1983, ENVIRON MANAGE, V7, P375, DOI 10.1007/BF01866920; MALCOLM JR, 1994, ECOLOGY, V75, P2438, DOI 10.2307/1940897; Marasas ME, 2001, APPL SOIL ECOL, V18, P61, DOI 10.1016/S0929-1393(01)00148-2; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Melo MM, 2016, BIOTA NEOTROP, V16, DOI 10.1590/1676-0611-BN-2015-0088; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; Moreira AA, 2004, J APPL ENTOMOL, V128, P204, DOI 10.1111/j.1439-0418.2004.00839.x; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Muriel SB, 2009, CONSERV BIOL, V23, P948, DOI 10.1111/j.1523-1739.2009.01213.x; O'Hara B., 2017, THE VEGAN PACKAGE; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Olff H, 2002, LANDSCAPE URBAN PLAN, V58, P83, DOI 10.1016/S0169-2046(01)00211-0; Olivetti D, 2015, CIENC AGROTEC, V39, P58, DOI 10.1590/S1413-70542015000100007; Philpott SM, 2008, J ANIM ECOL, V77, P505, DOI 10.1111/j.1365-2656.2008.01358.x; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; R Foundation for Statistical Computing, 2016, R LANG ENV STAT COMP; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; ROSENBERG DM, 1986, ENVIRON MANAGE, V10, P773, DOI 10.1007/BF01867730; Sabu TK, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.9801; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; SOS Mata Atlantica, 2014, ATL DOS REM FLOR MAT; Spiesman BJ, 2008, LANDSCAPE ECOL, V23, P313, DOI 10.1007/s10980-007-9186-3; Stork NE, 2017, CONSERV BIOL, V31, P924, DOI 10.1111/cobi.12883; Tagwireyi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124807; Wiescher PT, 2012, OECOLOGIA, V169, P1063, DOI 10.1007/s00442-012-2262-7; [No title captured]	75	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197697	10.1371/journal.pone.0197697	http://dx.doi.org/10.1371/journal.pone.0197697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791493	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000056
J	Conceicao, AA; Neto, CBS; Ribeiro, JAD; de Siqueira, FG; Miller, RNG; Mendonca, S				Conceicao, Aparecido Almeida; Soares Neto, Clemente Batista; de Aquino Ribeiro, Jose Antonio; de Siqueira, Felix Goncalves; Gerard Miller, Robert Neil; Mendonca, Simone			Development of an RP-UHPLC-PDA method for quantification of free gossypol in cottonseed cake and fungal-treated cottonseed cake	PLOS ONE			English	Article							WHITE-ROT FUNGI; TERPENOID ALDEHYDES; SPECTROPHOTOMETRIC DETERMINATION; MICROBIAL FERMENTATION; GROWTH-PERFORMANCE; MEAL; DETOXIFICATION; HEMIGOSSYPOL; INHIBITION; BINDING	Cottonseed cake biomass, which is a residue of oil extraction, is potentially appropriate for use as animal feed, given the high mineral, fibre and protein content. The presence of free gossypol, however, a toxic pigment in the glands of the cotton plant, limits use of this biomass for monogastric livestock. A promising method to detoxify cottonseed cake relies on fermentation by fungi, which can eliminate up to 100% of gossypol. In order to quantify trace levels of free gossypol in different cotton materials, including cottonseed cake treated with macrofungi, a simple and rapid chromatographic detection method was developed and validated. Under optimized conditions, extraction was performed using 70% acetone. The extract was then analysed by Ultra High -Performance Liquid Chromatography (UHPLC), with gradient elution on a C18 reverse phase column KINETEX (R) (100 x 2.10 mm, 2.6 pm). Methanol-0.1% TFA aqueous solution was employed as mobile phase and PDA detection conducted at 254 nm. The optimized method was validated by analysis of specificity, linearity and range, limit of detection, limit of quantification, precision and accuracy. Detection and quantification limits were observed at 0.2 and 0.5 mu g/mL, respectively. With good reproducibility, with precision (RSD)<10% and recovery greater than 94%, the developed assay was appropriate for quantification of low quantities of free gossypol. The validated method was successfully applied to determine trace levels of free gossypol cottonseed treated with a macrofungus.	[Conceicao, Aparecido Almeida] Univ Fed Bahia, Inst Multidisciplinar Saude, Vitoria Da Conquista, Ba, Brazil; [Conceicao, Aparecido Almeida; Soares Neto, Clemente Batista; de Aquino Ribeiro, Jose Antonio; de Siqueira, Felix Goncalves; Mendonca, Simone] Embrapa Agroenergia, Brasilia, DF, Brazil; [Soares Neto, Clemente Batista; Gerard Miller, Robert Neil] Univ Brasilia, Brasilia, DF, Brazil	Universidade Federal da Bahia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia	Mendonca, S (corresponding author), Embrapa Agroenergia, Brasilia, DF, Brazil.	simone.mendonca@embrapa.br	Siqueira, Felix/F-9910-2012; Miller, Robert Neil Gerard/C-6272-2013; de Aquino, Jose Antonio/AAD-9152-2020	Siqueira, Felix/0000-0001-5239-4994; Miller, Robert Neil Gerard/0000-0002-5798-4552; Ribeiro, Jose Antonio de Aquino/0000-0001-9374-8736; Mendonca, Simone/0000-0002-3647-6989	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [404786/2013-8, 307035/2013-1]; Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	SM, FGS, JAAR and AAC received Introduction funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - (www.cnpq.br) (404786/2013-8); RNGM received funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - (www.cnpq.br) (307035/2013-1); MC was supported by fellowship from Fundacao de Amparo a Pesquisa do Estado da Bahia (http://www.fapesb.ba.gov.br/) and CBSN was supported by fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(CAPES) (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUDONIA SA, 1981, J CHROMATOGR, V206, P606, DOI 10.1016/S0021-9673(00)88933-5; ADMASU A, 1984, ANAL CHEM, V56, P30, DOI 10.1021/ac00265a010; Alexander J, 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.908; AOCS, 1999, 8A99 AOCS BA, P1; AOCS, 2009, 758 AOCS BA; Benedict CR, 2006, PHYTOCHEMISTRY, V67, P356, DOI 10.1016/j.phytochem.2005.11.015; Benson CG, 2001, J AGR FOOD CHEM, V49, P2181, DOI 10.1021/jf0010836; BOTSOGLOU NA, 1991, J AGR FOOD CHEM, V39, P478, DOI 10.1021/jf00003a010; BOTSOGLOU NA, 1991, J CHROMATOGR, V587, P333, DOI 10.1016/0021-9673(91)85179-J; BOTTGER GT, 1964, J ECON ENTOMOL, V57, P283, DOI 10.1093/jee/57.2.283; Briggs H. M., 1946, JOUR AGRIC RES, V73, P167; Brubaker CL, 1996, AUST J BOT, V44, P601, DOI 10.1071/BT9960601; Cai C, 2011, AQUACULT NUTR, V17, P353, DOI 10.1111/j.1365-2095.2010.00801.x; Cai YF, 2004, J BIOSCIENCES, V29, P67, DOI 10.1007/BF02702563; Carruth FE, 1918, J AM CHEM SOC, V40, P647, DOI 10.1021/ja02237a008; CHAMKASEM N, 1988, J AM OIL CHEM SOC, V65, P1601, DOI 10.1007/BF02912562; Chandrashekar R., 2013, International Journal of Herbal Medicine, V1, P53; Cheeke PR., 1998, NATURAL TOXICANS FEE; Coutinho EM, 2000, CONTRACEPTION, V61, P61, DOI 10.1016/S0010-7824(99)00117-1; DANKE RJ, 1965, J NUTR, V87, P493, DOI 10.1093/jn/87.4.493; Du L, 2004, J ECON ENTOMOL, V97, P1278, DOI 10.1603/0022-0493-97.4.1278; Fackler K, 2006, ENZYME MICROB TECH, V39, P1476, DOI 10.1016/j.enzmictec.2006.03.043; Gaber MM, 2012, J AQUAC RES DEV, V3, P3, DOI [10.4172/2155-9546.1000151, DOI 10.4172/2155-9546.1000151]; GADELHA ICN, 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1155/2014/231635; Gallup WD, 1927, IND ENG CHEM, V19, P726, DOI 10.1021/ie50210a027; Gao W, 2013, MOL CELL PROTEOMICS, V12, P3690, DOI 10.1074/mcp.M113.031013; Girmay Z, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0265-1; Halverson JO, 1934, IND ENG CHEM ANAL ED, V6, P356, DOI 10.1021/ac50091a025; Hron RJ, 1996, J AM OIL CHEM SOC, V73, P199, DOI 10.1007/BF02523895; HRON RJ, 1990, J AM OIL CHEM SOC, V67, P182, DOI 10.1007/BF02539622; ICH, 2005, INT C HARM TECHN REQ, P1; IKEDA M, 1990, ANDROLOGIA, V22, P409; Jayasinghe Chandana, 2008, Mycobiology, V36, P114, DOI 10.4489/MYCO.2008.36.2.114; Karishma R, 2016, RES J BIOTECHNOL, V11, P70; Kaya S, 2009, ASIAN J CHEM, V21, P1897; Khalaf M. A., 2008, International Journal of Agriculture and Biology, V10, P185; Knutsen HK, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.4850; Kovacic P, 2003, CURR MED CHEM, V10, P2711, DOI 10.2174/0929867033456369; Kruve A, 2015, ANAL CHIM ACTA, V870, P8, DOI 10.1016/j.aca.2015.02.016; LEE CYG, 1982, MOL CELL BIOCHEM, V47, P65; Lee KJ, 2002, J CHROMATOGR B, V779, P313, DOI 10.1016/S1570-0232(02)00402-6; Lim SJ, 2011, J WORLD AQUACULT SOC, V42, P494, DOI 10.1111/j.1749-7345.2011.00491.x; Lin HX, 2012, J PHARMACEUT BIOMED, V66, P371, DOI 10.1016/j.jpba.2012.03.029; LIU FK, 1981, J AM OIL CHEM SOC, V58, pA93, DOI 10.1007/BF02672199; Liu JG, 2008, PHYTOCHEMISTRY, V69, P3038, DOI 10.1016/j.phytochem.2008.06.007; Camara ACL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143708; Lyman CM, 1943, IND ENG CHEM, V15, P489, DOI 10.1021/i560120a005; Menaul P., 1922, P OKLA ACAD SCI, V2, P68; MOHAMED SS, 1993, GRASAS ACEITES, V44, P279, DOI 10.3989/gya.1993.v44.i4-5.1080; MOORE AT, 1961, J AM OIL CHEM SOC, V38, P156, DOI 10.1007/BF02641241; MORGAN SE, 1989, VET CLIN N AM-FOOD A, V5, P251, DOI 10.1016/S0749-0720(15)30975-0; Nie CX, 2015, TURK J VET ANIM SCI, V39, P350, DOI 10.3906/vet-1410-65; NOMEIR AA, 1985, J AM OIL CHEM SOC, V62, P87, DOI 10.1007/BF02541497; NOMEIR AA, 1982, J AM OIL CHEM SOC, V59, P546, DOI 10.1007/BF02636320; PONS WA, 1949, J AM OIL CHEM SOC, V26, P671, DOI 10.1007/BF02651512; PONS WA, 1956, J AM OIL CHEM SOC, V33, P324, DOI 10.1007/BF02639344; Rajarathnam S, 2001, WORLD J MICROB BIOT, V17, P221, DOI 10.1023/A:1016603510901; REDDY CA, 1995, CURR OPIN BIOTECH, V6, P320, DOI 10.1016/0958-1669(95)80054-9; ROYER RE, 1983, FEBS LETT, V157, P28, DOI 10.1016/0014-5793(83)81109-0; ROYER RE, 1988, J PHARM SCI, V77, P237, DOI 10.1002/jps.2600770311; Santos JEP, 2005, J DAIRY SCI, V88, P3563, DOI 10.3168/jds.S0022-0302(05)73041-1; SMITH FH, 1968, J AM OIL CHEM SOC, V45, P903, DOI 10.1007/BF02540182; SMITH FH, 1958, J AM OIL CHEM SOC, V35, P261, DOI 10.1007/BF02640107; STIPANOVIC RD, 1988, J AGR FOOD CHEM, V36, P509, DOI 10.1021/jf00081a026; Sun ZT, 2008, ANN MICROBIOL, V58, P683, DOI 10.1007/BF03175575; Taleuzzaman M., 2015, AUSTIN J ANAL PHARM, V2, P1056; Uzal FA, 2005, J VET DIAGN INVEST, V17, P626, DOI 10.1177/104063870501700622; VEECH JA, 1977, J NEMATOL, V9, P225; Viana PG, 2011, DESEMPENHO AVALIAC C; Wagner TA, 2012, J AGR FOOD CHEM, V60, P2594, DOI 10.1021/jf2051366; WANG JM, 1992, J REPROD FERTIL, V95, P277; WANG MZ, 1987, J ETHNOPHARMACOL, V20, P1, DOI 10.1016/0378-8741(87)90112-7; Wang X, 2009, ADV FOOD NUTR RES, V58, P215, DOI 10.1016/S1043-4526(09)58006-0; Waqas Ahmad, 2011, Pakistan Journal of Nutrition, V10, P509; Xie YongFang, 2012, Agricultural Science & Technology - Hunan, V13, P44; Yang X, 2011, AFR J MICROBIOL RES, V5, P3066; Yu F, 1996, J SCI FOOD AGR, V72, P263, DOI 10.1002/(SICI)1097-0010(199610)72:2&lt;263::AID-JSFA653&gt;3.0.CO;2-1; Zhang Wen-ju, 2006, J Zhejiang Univ Sci B, V7, P690, DOI 10.1631/jzus.2006.B0690; Zhang WJ, 2007, ANIM FEED SCI TECH, V135, P176, DOI 10.1016/j.anifeedsci.2006.06.003	79	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196164	10.1371/journal.pone.0196164	http://dx.doi.org/10.1371/journal.pone.0196164			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791447	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000012
J	Kurisu, A; Suga, H; Prochazka, Z; Suzuki, K; Oguri, K; Inoue, T				Kurisu, Akane; Suga, Hisami; Prochazka, Zdenek; Suzuki, Kojiro; Oguri, Kazumasa; Inoue, Tetsunori			Potential technique for improving the survival of victims of tsunamis	PLOS ONE			English	Article							PREVENTION	We investigated a method for surviving tsunamis that involved the use of personal flotation devices (PFDs). In our work, we succeeded in numerically demonstrating that the heads of all the dummies wearing PFDs remained on the surface and were not dragged underwater after the artificial tsunami wave hit them. In contrast, the heads of all the dummies not wearing PFDs were drawn underwater immediately; these dummies were subsequently entrapped in a vortex. The results of our series of experiments are important as a first step to preventing the tragedies caused by tsunamis.	[Kurisu, Akane] Setagaya Ku, Tokyo, Japan; [Suga, Hisami] Japan Agcy Marine Earth Sci & Technol, Dept Biogeochem, Yokosuka, Kanagawa, Japan; [Prochazka, Zdenek] Natl Inst Technol, Oita Coll, Dept Informat Engn, Oita, Oita, Japan; [Suzuki, Kojiro] Port & Airport Res Inst, Coastal & Ocean Engn Dept, Yokosuka, Kanagawa, Japan; [Oguri, Kazumasa] Japan Agcy Marine Earth Sci & Technol, Dept Marine Biodivers, Yokosuka, Kanagawa, Japan; [Inoue, Tetsunori] Port & Airport Res Inst, Marine Informat & Tsunami Dept, Yokosuka, Kanagawa, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Port & Airport Research Institute; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Port & Airport Research Institute	Kurisu, A (corresponding author), Setagaya Ku, Tokyo, Japan.	kurisu.akane@peach.plala.or.jp		Oguri, Kazumasa/0000-0002-1695-455X	Japan Society for the Promotion of Science [16H03147]; Japan Society for the Promotion of Science (JSPS) [16H03147]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (B) (16H03147) (TI KS HS KO), https://www.isps.go.jp/english/e-grants/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staff of the Maritime Structures Research Group, Port and Airport Research Institute (PARI), for their help with experiments. This study was financially supported by a Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI) (B) (16H03147). Four anonymous reviewers are thanked for the constructive criticism that helped to improve the quality of the manuscript.	Barwood MJ, 2014, AVIAT SPACE ENVIR MD, V85, P960, DOI 10.3357/ASEM.3991.2014; Cyranoski D, 2012, NATURE, V484, P296, DOI 10.1038/484296a; Cyranoski D, 2011, NATURE, V471, P556, DOI 10.1038/471556a; Dominey-Howes D, 2010, NATURE, V464, P350, DOI 10.1038/464350a; Doocy S., 2013, PLOS CURR DISASTERS, V2013, P16; Duputel Z, 2012, GEOPHYS J INT, V189, P1125, DOI 10.1111/j.1365-246X.2012.05419.x; Giesbrecht G.G., 2006, HYPOTHERMIA FROSTBIT; Giesbrecht GG, 2000, AVIAT SPACE ENVIR MD, V71, P733; Golden FS, 1997, BRIT J ANAESTH, V79, P214, DOI 10.1093/bja/79.2.214; Gusman AR, 2014, PURE APPL GEOPHYS, V171, P1409, DOI 10.1007/s00024-013-0680-z; Hirata N, 2013, REPORT EVALUATION EA; Japan National Police Agency, 2012, SHOUTEN FOCUS, V281; Jasper R, 2017, HEALTH PROMOT J AUST, V28, P156, DOI 10.1071/HE16070; Kanamori H., 1972, Physics of the Earth and Planetary Interiors, V5, P129, DOI 10.1016/0031-9201(72)90082-9; Katada T, 2016, J DISASTER RES, V11, P845, DOI 10.20965/jdr.2016.p0845; Kazama M, 2012, SOILS FOUND, V52, P780, DOI 10.1016/j.sandf.2012.11.003; Leavy JE, 2015, J COMMUN HEALTH, V40, P725, DOI 10.1007/s10900-015-9991-6; Monastersky R, 2012, NATURE, V483, P144, DOI 10.1038/483144a; Nakamura T, 2017, J JAPAN SOC CIVIL B1, V73; Nishikiori N, 2006, BMJ-BRIT MED J, V332, P334, DOI 10.1136/bmj.38693.465023.7C; Normilie D., 2011, SCIENCE; Prince SJD, 2012, COMPUTER VISION MODE; Rodriguez H., 2006, DISASTER PREVENTION, V15, P163, DOI [10.1108/09653560610654310, DOI 10.1108/09653560610654310]; Roy N, 2006, PREHOSP DISASTER MED, V21, P310, DOI 10.1017/S1049023X00003939; SHIMAZAKI K, 1980, GEOPHYS RES LETT, V7, P279, DOI 10.1029/GL007i004p00279; Szpilman D, 2012, NEW ENGL J MED, V366, P2102, DOI 10.1056/NEJMra1013317; TIPTON MJ, 1991, J APPL PHYSIOL, V70, P317, DOI 10.1152/jappl.1991.70.1.317; van Beeck EF, 2005, B WORLD HEALTH ORGAN, V83, P853; Wilkerson JA, 1986, HYPOTHERMIA FROSTBIT; YABE T, 1991, J PHYS SOC JPN, V60, P2105, DOI 10.1143/JPSJ.60.2105; Yokota Y, 2016, NATURE, V534, P374, DOI 10.1038/nature17632	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197498	10.1371/journal.pone.0197498	http://dx.doi.org/10.1371/journal.pone.0197498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791490	gold, Green Published			2022-12-26	WOS:000433077000041
J	Morrison, SA; Yoong, D; Hart, TA; MacPherson, P; Bogoch, I; Sivarajah, V; Gough, K; Naccarato, M; Tan, DHS				Morrison, Steven A.; Yoong, Deborah; Hart, Trevor A.; MacPherson, Paul; Bogoch, Isaac; Sivarajah, Vishalini; Gough, Kevin; Naccarato, Mark; Tan, Darrell H. S.			High prevalence of syndemic health problems in patients seeking post-exposure prophylaxis for sexual exposures to HIV	PLOS ONE			English	Article							MENTAL-HEALTH; PREEXPOSURE PROPHYLAXIS; RISK BEHAVIOR; PSYCHOSOCIAL PROBLEMS; EMPIRICAL TESTS; MINORITY STRESS; BISEXUAL ADULTS; UNITED-STATES; GAY MEN; PREVENTION	Introduction The standard clinical approach to non-occupational HIV post-exposure prophylaxis (nPEP) focuses on biomedical aspects of the intervention, but may overlook co-occurring or `syndemic' psychosocial problems that reinforce future vulnerability to HIV. We therefore sought to determine the prevalence of syndemic health problems in a cohort of Ontario nPEP patients, and explored the relationship between syndemic burden and HIV risk. Methods Between 07/2013-08/2016, we distributed a self-administered questionnaire to patients presenting to three clinics in Toronto and Ottawa seeking nPEP for sexual HIV exposures. We used validated screening tools to estimate the prevalence of depression (CES-D score >= 16), harmful alcohol use (AUDIT >= 8), problematic drug use (DUDIT >= 6 men/>= 2 women), and sexual compulsivity (SCS >= 24) among men who have sex with men (MSM) respondents. In exploratory analyses, we examined the relationships between syndemic conditions using univariable logistic regression models, and the relationship between syndemic count (total number of syndemic conditions per participant) and HIV risk, as estimated by the HIRI-MSM score, using linear regression models. Results The 186 MSM included in the analysis had median age 31 (IQR = 26-36), including 87.6% having a college/undergraduate degree or higher. Overall, 53.8% screened positive for depression, 34.4% for harmful alcohol use, 30.1% for problematic drug use, and 16.1% for sexual compulsivity. Most participants (74.2%) had at least one syndemic condition and 46.8% had more than one. Exploratory analyses suggested positive associations between depression and harmful alcohol use (OR = 2.11, 95%Cl = 1.13, 3.94) and between harmful alcohol use and problematic drug use (OR = 1.22, 95%Cl = 0.65, 2.29). Syndemic count was associated with increased HIRI-MSM risk scores in univariable (2.2, 95%Cl = 1.0, 3.3 per syndemic condition) and multivariable (2.1, 95%Cl = 0.6, 3.6) linear regression models. Conclusions The prevalence of syndemic conditions in MSM seeking nPEP for sexual exposure is alarmingly high, and is associated with underlying HIV risk. Routine screening for these conditions may identify opportunities for intervention and could alleviate future vulnerability to HIV.	[Morrison, Steven A.; Sivarajah, Vishalini; Gough, Kevin; Tan, Darrell H. S.] St Michaels Hosp, Div Infect Dis, Toronto, ON, Canada; [Yoong, Deborah; Naccarato, Mark] St Michaels Hosp, Dept Pharm, Toronto, ON, Canada; [Hart, Trevor A.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Hart, Trevor A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [MacPherson, Paul] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada; [Bogoch, Isaac; Tan, Darrell H. S.] Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada; [Bogoch, Isaac; Gough, Kevin; Tan, Darrell H. S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Tan, Darrell H. S.] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Toronto Metropolitan University; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Tan, DHS (corresponding author), St Michaels Hosp, Div Infect Dis, Toronto, ON, Canada.; Tan, DHS (corresponding author), Toronto Gen Hosp, Div Infect Dis, Toronto, ON, Canada.; Tan, DHS (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Tan, DHS (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada.	Darrell.tan@gmail.com	Bogoch, Isaac/AAS-9631-2020	Tan, Darrell/0000-0002-3069-2875	Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario [SMHAIF-055]	Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario	This work was supported by the Innovation Fund of the Alternative Funding Plan for the Academic Health Sciences Centres of Ontario (Grant number: SMHAIF-055; URL: https://ifpoc.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterbergh RCA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2474-x; [Anonymous], DRUG USE DISORDER ID; [Anonymous], 2000, SEX ADDICT COMPULSIV, DOI [10.1080/10720160008400205, DOI 10.1080/10720160008400205]; [Anonymous], 2013, MENTAL SUBSTANCE USE; [Anonymous], 2001, AUDIT ALCOHOL USE DI; [Anonymous], CAN C HIV AIDS RES E; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Brown JL, 2014, CURR HIV-AIDS REP, V11, P363, DOI 10.1007/s11904-014-0228-6; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P468; Chan ACH, 2013, INT J STD AIDS, V24, P393, DOI 10.1177/0956462412472826; Chang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6; Cochran SD, 2003, J CONSULT CLIN PSYCH, V71, P53, DOI 10.1037/0022-006X.71.1.53; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; COMSTOCK GW, 1976, PSYCHOL MED, V6, P551, DOI 10.1017/S0033291700018171; Derbyshire KL, 2015, J BEHAV ADDICT, V4, P37, DOI 10.1556/2006.4.2015.003; Ferlatte O, 2014, AIDS BEHAV, V18, P1256, DOI 10.1007/s10461-013-0639-1; Gallagher T, 2014, LGBT HEALTH, V1, P218, DOI 10.1089/lgbt.2013.0046; Guadamuz TE, 2014, AIDS BEHAV, V18, P2089, DOI 10.1007/s10461-014-0826-8; Halkitis PN, 2013, AM PSYCHOL, V68, P261, DOI 10.1037/a0032746; Halkitis PN, 2010, AM PSYCHOL, V65, P752, DOI 10.1037/0003-066X.65.8.752; Halkitis PN, 2003, ARCH SEX BEHAV, V32, P351, DOI 10.1023/A:1024095016181; Herrick AL, 2013, AM J PUBLIC HEALTH, V103, P79, DOI 10.2105/AJPH.2012.300810; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Hook JN, 2010, J SEX MARITAL THER, V36, P227, DOI 10.1080/00926231003719673; Jain S, 2016, AIDS BEHAV, V20, P1556, DOI 10.1007/s10461-015-1021-2; KALICHMAN SC, 1994, J PERS ASSESS, V62, P385, DOI 10.1207/s15327752jpa6203_1; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Leal L, 2016, AIDS RES HUM RETROV, V32, P1016, DOI 10.1089/aid.2016.0062; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Mimiaga MJ, 2015, JAIDS-J ACQ IMM DEF, V68, P329, DOI 10.1097/QAI.0000000000000475; Moore DM, 2012, CAN J PUBLIC HEALTH, V103, P142, DOI 10.1007/BF03404220; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; Otis MD, 1996, J HOMOSEXUAL, V30, P93, DOI 10.1300/J082v30n03_05; Pachankis JE, 2015, HEALTH PSYCHOL, V34, P829, DOI 10.1037/hea0000180; Pantalone DW, 2016, SOC PERSONAL PSYCHOL, V10, P109, DOI 10.1111/spc3.12234; Parsons JT, 2012, AM J PUBLIC HEALTH, V102, P156, DOI 10.2105/AJPH.2011.300284; Ploderl M, 2015, INT REV PSYCHIATR, V27, P367, DOI 10.3109/09540261.2015.1083949; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Schwartz D.R., 2016, PSYCHOL SEX ORIENTAT, V3, P313, DOI DOI 10.1037/SGD0000180; Siemieniuk RAC, 2015, AIDS PATIENT CARE ST, V29, P431, DOI 10.1089/apc.2015.0014; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; SINGER M, 1994, SOC SCI MED, V39, P931, DOI 10.1016/0277-9536(94)90205-4; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Smith DK, 2012, JAIDS-J ACQ IMM DEF, V60, P421, DOI 10.1097/QAI.0b013e318256b2f6; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Stall R, 2015, SOC SCI MED, V145, P129, DOI 10.1016/j.socscimed.2015.07.016; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Tan DHS, 2016, J GAY LESBIAN MENT H, V20, P13, DOI 10.1080/19359705.2015.1105765; Theodore JL, 2013, J HOMOSEXUAL, V60, P558, DOI 10.1080/00918369.2013.760304; Tsai AC, 2016, AIDS BEHAV, V20, P423, DOI 10.1007/s10461-015-1260-2; Tsai AC, 2015, SOC SCI MED, V139, P26, DOI 10.1016/j.socscimed.2015.06.024; Tulloch TG, 2015, ARCH SEX BEHAV, V44, P1879, DOI 10.1007/s10508-015-0479-3; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Wilton J, 2017, JAIDS-J ACQ IMM DEF, V76, pE58, DOI 10.1097/QAI.0000000000001472; Wilton J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20777; Yi H, 2011, J SEX RES, V48, P62, DOI 10.1080/00224490903487570	61	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197998	10.1371/journal.pone.0197998	http://dx.doi.org/10.1371/journal.pone.0197998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0FF	29791514	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000073
J	Amarilyo, G; Pillar, N; Ben-Zvi, I; Weissglas-Volkov, D; Zalcman, J; Harel, L; Livneh, A; Shomron, N				Amarilyo, Gil; Pillar, Nir; Ben-Zvi, Ilan; Weissglas-Volkov, Daphna; Zalcman, Jonatan; Harel, Liora; Livneh, Avi; Shomron, Noam			Analysis of microRNAs in familial Mediterranean fever	PLOS ONE			English	Article							CELLS; DISEASE; ALPHA	Objectives Although Familial Mediterranean fever (FMF) is categorized as autosomal recessive, frequent exceptions to this model exist and therefore we aimed to search epigenetic modifications in this disease. Methods Ten M694V homozygous FMF patients (the most severe phenotype) were recruited for this study. Patients with inflammatory flare were excluded. Total RNA was extracted from peripheral blood, and microRNA expression profiled using NanoString nCounter technology. These patients were compared to 10 healthy age- and sex-matched controls. Results Seven hundred nighty-eight mature human miRNAs were probed, 103 of which had expression levels above the negative control probes. Seven miRNAs showed significant differences in expression in samples from FMF patients compared to healthy controls: four miRNAs were upregulated (miR-144-3p, miR-21-5p, miR-4454, and miR-451a), and three were downregulated (miR-107, let-7d-5p, and miR-148b-3p). Conclusion In this pilot study, we identified epigenetic modifications in clinically quiescent FMF patients. More studies are required for exploration of their contribution to FMF pathogenesis and their potential role as clinical biomarkers.	[Amarilyo, Gil; Harel, Liora] Schneider Childrens Med Ctr Israel, Dept Pediat Rheumatol, Petah Tiqwa, Israel; [Amarilyo, Gil; Pillar, Nir; Ben-Zvi, Ilan; Weissglas-Volkov, Daphna; Zalcman, Jonatan; Harel, Liora; Livneh, Avi; Shomron, Noam] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Ben-Zvi, Ilan; Livneh, Avi] Chaim Sheba Med Ctr, Dept Internal Med F, Tel Hashomer, Israel	Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Shomron, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	nshomron@post.tau.ac.il	Ben-Zvi, Ilan/ABE-7114-2021	Ben-Zvi, Ilan/0000-0002-9160-3098	Wladimir Schreiber Foundation for Medical Research at Sackler Faculty of Medicine, Tel Aviv University; Novartis Inc.	Wladimir Schreiber Foundation for Medical Research at Sackler Faculty of Medicine, Tel Aviv University; Novartis Inc.	This study was supported by research grants from the Wladimir Schreiber Foundation for Medical Research at Sackler Faculty of Medicine, Tel Aviv University, and Novartis Inc. The funders do not have any role in the study design; collection, analysis, and interpretation of data; writing of the paper; and/or decision to submit for publication. There is no potential financial and non-financial conflict of interest related to this manuscript between the funders and the authors.	Aldea A, 2004, AM J MED GENET A, V124A, P67, DOI 10.1002/ajmg.a.20296; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Berkun Y, 2012, CLIN EXP RHEUMATOL, V30, pS90; Booth DR, 2000, QJM-INT J MED, V93, P217, DOI 10.1093/qjmed/93.4.217; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Cheng J, 2017, INFLAMMATION, V40, P676, DOI 10.1007/s10753-017-0514-8; Ciancio G, 2017, CLIN EXP RHEUMATOL, V35, P113; Gao WQ, 2016, P NATL ACAD SCI USA, V113, pE4857, DOI 10.1073/pnas.1601700113; Gershoni-Baruch R, 2001, EUR J HUM GENET, V9, P634, DOI 10.1038/sj.ejhg.5200672; Hennessy EJ, 2011, J BIOL CHEM, V286, P25531, DOI 10.1074/jbc.M111.256206; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Marek-Yagel D, 2009, ARTHRITIS RHEUM-US, V60, P1862, DOI 10.1002/art.24570; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Polytarchou C, 2015, INFLAMM BOWEL DIS, V21, P2533, DOI 10.1097/MIB.0000000000000547; Rosenberger CM, 2012, J IMMUNOL, V189, P5965, DOI 10.4049/jimmunol.1201437; ter Haar N, 2013, ANN RHEUM DIS, V72, P678, DOI 10.1136/annrheumdis-2011-201268; Wada T., 2017, MOD RHEUMATOL, V6, P1; Wu C, 2016, ONCOTARGET, V7, P85876, DOI 10.18632/oncotarget.13042; Xue XC, 2014, EUR J IMMUNOL, V44, P673, DOI 10.1002/eji.201343717; Zhou F, 2014, BBA-GENE REGUL MECH, V1839, P344, DOI 10.1016/j.bbagrm.2014.01.006	20	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197829	10.1371/journal.pone.0197829	http://dx.doi.org/10.1371/journal.pone.0197829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787577	gold, Green Submitted, Green Published			2022-12-26	WOS:000432785700051
J	Farashahi, S; Rowe, K; Aslami, Z; Gobbini, MI; Soltani, A				Farashahi, Shiva; Rowe, Katherine; Aslami, Zohra; Gobbini, Maria Ida; Soltani, Alireza			Influence of learning strategy on response time during complex value-based learning and choice	PLOS ONE			English	Article							VISUAL-SEARCH; MODELS; SALIENCE; VISION	Measurements of response time (RT) have long been used to infer neural processes underlying various cognitive functions such as working memory, attention, and decision making. However, it is currently unknown if RT is also informative about various stages of value based choice, particularly how reward values are constructed. To investigate these questions, we analyzed the pattern of RT during a set of multi-dimensional learning and decision making tasks that can prompt subjects to adopt different learning strategies. In our experiments, subjects could use reward feedback to directly learn reward values associated with possible choice options (object-based learning). Alternatively, they could learn reward values of options' features (e.g. color, shape) and combine these values to estimate reward values for individual options (feature-based learning). We found that RT was slower when the difference between subjects' estimates of reward probabilities for the two alternative objects on a given trial was smaller. Moreover, RT was overall faster when the preceding trial was rewarded or when the previously selected object was present. These effects, however, were mediated by an interaction between these factors such that subjects were faster when the previously selected object was present rather than absent but only after unrewarded trials. Finally, RT reflected the learning strategy (i.e. object-based or feature-based approach) adopted by the subject on a trial-by-trial basis, indicating an overall faster construction of reward value and/or value comparison during object-based learning. Altogether, these results demonstrate that the pattern of RT can be informative about how reward values are learned and constructed during complex value-based learning and decision making.	[Farashahi, Shiva; Rowe, Katherine; Aslami, Zohra; Gobbini, Maria Ida; Soltani, Alireza] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Gobbini, Maria Ida] Univ Bologna, Sch Med, Dipartimento Med Specialist Diagnost & Sperimenta, Bologna, Italy	Dartmouth College; University of Bologna	Soltani, A (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA.	soltani@dartmouth.edu		Rowe, Katherine/0000-0002-1780-043X; Farashahi, Shiva/0000-0002-8771-4609; Soltani, Alireza/0000-0003-4386-8486	NSF EPSCoR (RII Track-2 FEC) grant	NSF EPSCoR (RII Track-2 FEC) grant	This work was supported by NSF EPSCoR (RII Track-2 FEC) grant to A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; BREITMEYER BG, 1975, VISION RES, V15, P1411, DOI 10.1016/0042-6989(75)90200-X; Clithero J. A., 2016, RESPONSE TIMES EC LO; Clithero JA, 2016, IMPROVING OUT SAMPLE; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Farashahi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01874-w; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Hickey C, 2015, NEURON, V85, P512, DOI 10.1016/j.neuron.2014.12.049; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Jocham G, 2016, NEURON, V90, P177, DOI 10.1016/j.neuron.2016.02.018; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Khorsand P, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00155; Konovalov A., 2017, REVEALED INDIFFERENC; Krummenacher J, 2001, PERCEPT PSYCHOPHYS, V63, P901, DOI 10.3758/BF03194446; Krummenacher J, 2010, VISION RES, V50, P1382, DOI 10.1016/j.visres.2010.04.006; Lee D, 2012, ANNU REV NEUROSCI, V35, P287, DOI 10.1146/annurev-neuro-062111-150512; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Luce RD, 1986, RESPONSE TIMES THEIR; MOYER RS, 1976, COGNITIVE PSYCHOL, V8, P228, DOI 10.1016/0010-0285(76)90025-6; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Niv Y, 2015, J NEUROSCI, V35, P8145, DOI 10.1523/JNEUROSCI.2978-14.2015; Pleskac TJ, 2010, PSYCHOL REV, V117, P864, DOI 10.1037/a0019737; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Seo H, 2007, CEREB CORTEX, V17, pI110, DOI 10.1093/cercor/bhm064; Soltani A, 2006, J NEUROSCI, V26, P3731, DOI 10.1523/JNEUROSCI.5159-05.2006; Soltani A, 2008, CURR OPIN NEUROBIOL, V18, P209, DOI 10.1016/j.conb.2008.07.003; Soltani A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002607; Spiliopoulos L, 2016, BCD RESPONSE TIME AN; STERNBERG S, 1969, AM SCI, V57, P421; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka Y, 1996, VISION RES, V36, P2125, DOI 10.1016/0042-6989(95)00272-3; Theeuwes J, 2012, VISION RES, V74, P80, DOI 10.1016/j.visres.2012.07.024; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; TYNAN PD, 1982, VISION RES, V22, P61, DOI 10.1016/0042-6989(82)90167-5; Unsworth N, 2005, MEM COGNITION, V33, P213, DOI 10.3758/BF03195310; Van Opstal F, 2008, PSYCHON B REV, V15, P419, DOI 10.3758/PBR.15.2.419; Wolfe JM, 2013, J VISION, V13, DOI 10.1167/13.3.10; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197263	10.1371/journal.pone.0197263	http://dx.doi.org/10.1371/journal.pone.0197263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG6DG	29787566	Green Published, Green Submitted, gold			2022-12-26	WOS:000432785700018
J	Feng, Y; Feng, YM; Wang, SM; Xu, F; Zhang, XH; Zhang, CY; Jia, YY; Yang, WR; Xia, XS; Yin, JZ				Feng, Yue; Feng, Yue-Mei; Wang, Songmei; Xu, Fang; Zhang, Xuehui; Zhang, Chunyue; Jia, Yuanyuan; Yang, Wanru; Xia, Xueshan; Yin, Jianzhong			High seroprevalence of hepatitis E virus in the ethnic minority populations in Yunnan, China	PLOS ONE			English	Article							HIGH PREVALENCE; BLOOD-DONORS; TRANSMISSION; ANTIBODIES; INFECTION	Hepatitis E virus (HEV) infection is relatively high in the southern regions of China. Yunnan, located in southwestern China, has the highest number of ethnic groups. However, HEV infection in the ethnic population is largely unknown. Therefore, we aimed to investigate the seropositive rate, risk factor, and clinical impact of HEV infection in the ethnic groups of Yunnan. We recruited 1912 individuals from four minority groups in three prefectures of Yunnan province. Epidemiological records on potential risk factors for exposure to HEV and blood biochemical index were analyzed. All the serum samples were tested for anti-HEV IgM/IgG by enzyme-linked immunosorbent assay, and the IgM-positive samples were subjected to nested reverse transcription-PCR to detect HEV RNA. Overall, 1273 individuals (66.58%) were positive for anti-HEV IgG, 16 (0.84%) for anti-HEV IgM, and 64 (3.35%) for anti-HEV IgG and IgM both; none of them had detectable HEV RNA. Multivariate analysis revealed a strong statistical association between ethnic origin and HEV IgG seroprevalence. Anti-HEV IgG reactivity in the Hani ethnic (82.3%; 401/487) population was higher than that in the Naxi (71.9%, 340/473), Bulang (65.1%; 302/464), and Wa (60.2%; 294/488) ethnic populations (p < 0.0001). Older age and male sex were independently associated with the risk of past HEV infection. Moreover, anti-HEV IgG-positive individuals showed significantly higher levels of total and direct bilirubin and alanine amino transferase but significantly lower levels of globulin and low-density lipoprotein, than the respective levels in anti-HEV IgG-negative individuals. Thus, the seroprevalence of HEV infection is high in the ethnic populations of Yunnan, China. It is therefore necessary to increase the surveillance of specific risk groups and raise awareness about the possible infectious diseases to help limit the HEV transmission here.	[Feng, Yue; Zhang, Chunyue; Jia, Yuanyuan; Yang, Wanru; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Feng, Yue-Mei; Wang, Songmei; Xu, Fang; Zhang, Xuehui; Yin, Jianzhong] Kunming Med Univ, Res Inst Nutr & Food Sci, Kunming, Yunnan, Peoples R China; [Feng, Yue-Mei; Wang, Songmei; Xu, Fang; Zhang, Xuehui; Yin, Jianzhong] Yunnan Key Lab Nutr & Food Safety, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology; Kunming Medical University	Xia, XS (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.; Yin, JZ (corresponding author), Kunming Med Univ, Res Inst Nutr & Food Sci, Kunming, Yunnan, Peoples R China.; Yin, JZ (corresponding author), Yunnan Key Lab Nutr & Food Safety, Kunming, Yunnan, Peoples R China.	oliverxia2000@aliyun.com; yinjianzhong2005@sina.com		Feng, Yue/0000-0002-2718-0836	Key Project of Yunnan Education Department [2015Z073]; Applied Basic Research Key Project of Yunnan [2014FZ008]; Yunnan provincial innovation team project [2015HC030]; National key R&D Program of China [2017YFC0907302]	Key Project of Yunnan Education Department; Applied Basic Research Key Project of Yunnan; Yunnan provincial innovation team project; National key R&D Program of China	This work was funded by the Key Project of Yunnan Education Department, 2015Z073, Yue-Mei Feng (data collection and analysis), Applied Basic Research Key Project of Yunnan, 2014FZ008, Jianzhong Yin (decision to publish), Yunnan provincial innovation team project, 2015HC030, Xueshan Xia (preparation of the manuscript), and National key R&D Program of China, 2017YFC0907302, Jianzhong Yin (data collection and analysis).	Alvarado-Esquivel C, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.16876; Ankcorn MJ, 2017, TRANSFUSION MED, V27, P84, DOI 10.1111/tme.12405; Bazerbachi F, 2016, GASTROENTEROL REP, V4, P1, DOI 10.1093/gastro/gov042; Debing Y, 2016, J HEPATOL, V65, P200, DOI 10.1016/j.jhep.2016.02.045; Gu GY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1308-y; Huang F, 2016, HEPATOLOGY, V64, P350, DOI 10.1002/hep.28668; Kamar N, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.86; Kang YH, 2017, J MED VIROL, V89, P872, DOI 10.1002/jmv.24693; Khuroo MS, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090253; Lee JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067180; Liang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088106; Liu P, 2013, EMERG INFECT DIS, V19, P559, DOI 10.3201/eid1904.120827; Long FY, 2017, J MED VIROL, V89, P1981, DOI 10.1002/jmv.24843; Mellgren A, 2017, J CLIN VIROL, V88, P39, DOI 10.1016/j.jcv.2017.01.005; Mirazo S, 2014, HEPATIC MED-EVID RES, V6, P45, DOI 10.2147/HMER.S63417; Passos-Castilho AM, 2017, BRAZ J INFECT DIS, V21, P535, DOI 10.1016/j.bjid.2017.05.004; Pavio N, 2017, VET RES, V48, DOI 10.1186/s13567-017-0483-9; Ren FR, 2014, TRANSFUSION, V54, P910, DOI 10.1111/trf.12530; Shalimar, 2013, J CLIN EXP HEPATOL, V3, P213, DOI 10.1016/j.jceh.2013.08.009; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P95, DOI 10.1016/j.trstmh.2004.12.005; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P89, DOI 10.1016/j.trstmh.2005.05.019; van Gageldonk-Lafeber AB, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2160-4; Wang MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161089; Yamada H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136903; Yoon Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-517; Zeng H, 2017, AIDS, V31, P2019, DOI [10.1097/QAD.0000000000001585, 10.1097/qad.0000000000001585]; Zeng MY, 2017, ZOONOSES PUBLIC HLTH, V64, P684, DOI 10.1111/zph.12377; Zhou X, 2017, J INFECT DIS, V215, P1197, DOI 10.1093/infdis/jix079	28	4	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197577	10.1371/journal.pone.0197577	http://dx.doi.org/10.1371/journal.pone.0197577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787589	gold, Green Published, Green Submitted			2022-12-26	WOS:000432785700031
J	Mottaleb, KA; Singh, PK; Sonder, K; Kruseman, G; Tiwari, TP; Barma, NCD; Malaker, PK; Braun, HJ; Erenstein, O				Mottaleb, Khondoker Abdul; Singh, Pawan Kumar; Sonder, Kai; Kruseman, Gideon; Tiwari, Thakur Prasad; Barma, Naresh C. D.; Malaker, Paritosh Kumar; Braun, Hans-Joachim; Erenstein, Olaf			Threat of wheat blast to South Asia's food security: An ex-ante analysis	PLOS ONE			English	Article							TRITICUM PATHOTYPE; CLIMATE ANALOGS; RESISTANCE; EMERGENCE; SYSTEMS; AFRICA	New biotic stresses have emerged around the globe over the last decades threatening food safety and security. In 2016, scientists confirmed the presence of the devastating wheat blast disease in Bangladesh, South Asia-its first occurrence outside South America. Severely blast-affected wheat fields had their grain yield wiped out. This poses a severe threat to food security in a densely-populated region with millions of poor inhabitants where wheat is a major staple crop and per capita wheat consumption has been increasing. As an ex ante impact assessment, this study examined potential wheat-blast scenarios in Bangladesh, India, and Pakistan. Based on the agro-climatic conditions in the epicenter, where the disease was first identified in Bangladesh in 2016, this study identified the correspondingly vulnerable areas in India, Pakistan and Bangladesh amounting to 7 million ha. Assuming a conservative scenario of 5-10% for blast-induced wheat production loss, this study estimated the annual potential wheat loss across the sampled countries to be 0.89-1.77 million tons, equivalent to USD 132-264 million. Such losses further threaten an already-precarious national food security, putting pressure on wheat imports and wheat prices. The study is a call for action to tackle the real wheat-blast threat in South Asia.	[Mottaleb, Khondoker Abdul; Kruseman, Gideon; Erenstein, Olaf] CIMMYT, Int Maize & Wheat Improvement Ctr, Socioecon Program, Texcoco, Mexico; [Singh, Pawan Kumar; Braun, Hans-Joachim] CIMMYT, Global Wheat Program, Texcoco, Mexico; [Sonder, Kai] CIMMYT, Geog Informat Syst Unit, Texcoco, Mexico; [Tiwari, Thakur Prasad] CIMMYT, Country Representat, Dhaka, Bangladesh; [Barma, Naresh C. D.; Malaker, Paritosh Kumar] Wheat Res Ctr, Bari, Bangladesh	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Kruseman, G (corresponding author), CIMMYT, Int Maize & Wheat Improvement Ctr, Socioecon Program, Texcoco, Mexico.	g.kruseman@cgiar.org	Kruseman, Gideon/S-6377-2016; Mottaleb, Khondoker A./I-1103-2019	Kruseman, Gideon/0000-0002-3392-4176; Mottaleb, Khondoker A./0000-0002-2666-1152; Sonder, Kai/0000-0001-9672-5361; Singh, Pawan/0000-0003-4610-3120; Erenstein, Olaf/0000-0002-7491-5786	CGIAR research program on WHEAT agro-food systems; Australian Center for International Agriculture Research (ACIAR) [CIM/2016/170]	CGIAR research program on WHEAT agro-food systems(CGIAR); Australian Center for International Agriculture Research (ACIAR)	This paper was supported by the CGIAR research program on WHEAT agro-food systems to GK and Australian Center for International Agriculture Research (ACIAR) CIM/2016/170 to PKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAPO (Asociacion de Productores de Oleaginosas y Trigo), 2012, MAN REC TECN CULT TR, P120; [Anonymous], 2017, HINDU BUSINESS LINE; Bangladesh Bureau of Statistics (BBS), 2014, EST WHEAT 2013 14; Berry P, 2014, CABI CLIM CHANGE SER, V4, P78, DOI 10.1079/9781780641973.0078; Burke MB, 2009, GLOBAL ENVIRON CHANG, V19, P317, DOI 10.1016/j.gloenvcha.2009.04.003; Callaway E, 2016, NATURE, V532, P421, DOI 10.1038/532421a; Castroagudin VL, 2015, PHYTOPATHOLOGY, V105, P284, DOI 10.1094/PHYTO-06-14-0184-R; Chowdhury AK, 2017, INDIAN J GENET PL BR, V77, P1, DOI 10.5958/0975-6906.2017.00001.3; Council SI., 2016, J WHEAT RES, V8, P1, DOI DOI 10.1201/9780429470554-1; Cruz CD, 2016, CROP SCI, V56, P990, DOI 10.2135/cropsci2015.07.0410; Cruz CD, 2016, PLANT DIS, V100, P1979, DOI 10.1094/PDIS-09-15-1006-RE; Das S., 2017, FINANCIAL EXPRESS; Duveiller E, 2011, PHYTOPATHOLOGY, V101, pS220; Duveiller E., 2016, WORLD WHEAT BOOK, V3, P1107; Erenstein O, 2011, AGR SYST, V104, P42, DOI 10.1016/j.agsy.2010.09.004; FAO, 2011, STAT WORLDS FOR; FAO (Food and Agriculture Organization of the United Nations), 2016, FAOSTAT CROP LIV PRO; FAO (Food and Agriculture Organization of the United Nations), 2016, WHEAT BLAST S UNPUB; Farman M, 2017, PLANT DIS, V101, P684, DOI 10.1094/PDIS-05-16-0700-RE; Goulart ACP., 1990, FITOPATOL BRAS, V15, P359; Government of India, 2017, CROP PROD STAT SEL S; Government of Sindh (Pakistan), 2016, FIN EST WHEAT CROP S; Igarashi S., 1986, FITOPATOL BRAS, V11, P351; Islam MT, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0309-7; Kellett J, 2015, LAND USE POLICY, V44, P54, DOI 10.1016/j.landusepol.2014.11.022; Leibing C, 2013, FORESTS, V4, P155, DOI 10.3390/f4010155; Maciel J. L. N., 2011, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V6, P1, DOI 10.1079/PAVSNNR20116050; Malaker PK, 2016, PLANT DIS, V100, P2330, DOI 10.1094/PDIS-05-16-0666-PDN; Mason NM, 2015, DEV POLICY REV, V33, P581, DOI 10.1111/dpr.12129; Mottaleb KA, 2018, EUR J DEV RES, V30, P252, DOI 10.1057/s41287-017-0096-1; Maciel JLN, 2014, PHYTOPATHOLOGY, V104, P95, DOI 10.1094/PHYTO-11-12-0294-R; Pugh TAM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12608; Ramirez-Villegas J., 2011, 12 CGIAR RES PROGR C; Sadat A.M., 2017, PLANT PATHOLOGY J, V33, P103, DOI [10.5423/PPJ.RW.09.2016.0179, DOI 10.5423/PPJ.RW.09.2016.0179]; Thornton PK, 2011, PHILOS T R SOC A, V369, P117, DOI 10.1098/rsta.2010.0246; Timsina J, 2001, FIELD CROP RES, V69, P93, DOI 10.1016/S0378-4290(00)00143-X; United Nations, 2015, WORLD POP AG 2015; Urashima AS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P267, DOI 10.1007/978-1-4020-9500-9_27; Webb LB, 2013, AUST J GRAPE WINE R, V19, P331, DOI 10.1111/ajgw.12045; World Bank, 2017, WORLD DEV IND 2017 P; World Bank, 2016, WORLD DEV IND AR LAN	41	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197555	10.1371/journal.pone.0197555	http://dx.doi.org/10.1371/journal.pone.0197555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782528	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100032
J	Ariz-Extreme, I; Hub, JS				Ariz-Extreme, Igor; Hub, Jochen S.			Assigning crystallographic electron densities with free energy calculations-The case of the fluoride channel Flue	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; POLARIZABLE FORCE-FIELD; FINITE-SIZE CORRECTIONS; ARTIFICIAL PERIODICITY; COMPUTER-SIMULATIONS; SELECTIVITY FILTER; MEMBRANE-PROTEIN; IONIC-SOLVATION; BASIS-SETS; VALIDATION	Approximately 90% of the structures in the Protein Data Bank (PDB) were obtained by X-ray crystallography or electron microscopy. Whereas the overall quality of structure is considered high, thanks to a wide range of tools for structure validation, uncertainties may arise from density maps of small molecules, such as organic ligands, ions or water, which are non-covalently bound to the biomolecules. Even with some experience and chemical intuition, the assignment of such disconnected electron densities is often far from obvious. In this study, we suggest the use of molecular dynamics (MD) simulations and free energy calculations, which are well-established computational methods, to aid in the assignment of ambiguous disconnected electron densities. Specifically, estimates of (i) relative binding affinities, for instance between an ion and water, (ii) absolute binding free energies, i.e., free energies for transferring a solute from bulk solvent to a binding site, and (iii) stability assessments during equilibrium simulations may reveal the most plausible assignments. We illustrate this strategy using the crystal structure of the fluoride specific channel (Flue), which contains five disconnected electron densities previously interpreted as four fluoride and one sodium ion. The simulations support the assignment of the sodium ion. In contrast, calculations of relative and absolute binding free energies as well as stability assessments during free MD simulations suggest that four of the densities represent water molecules instead of fluoride. The assignment of water is compatible with the loss of these densities in the nonconductive F82I/F85I mutant of Flue. We critically discuss the role of the ion force fields for the calculations presented here. Overall, these findings indicate that MD simulations and free energy calculations are helpful tools for modeling water and ions into crystallographic density maps.	[Ariz-Extreme, Igor; Hub, Jochen S.] Univ Gottingen, Inst Microbiol & Genet, Gottingen, Germany; [Hub, Jochen S.] Saarland Univ, Theoret Phys, Saarbrucken, Germany	University of Gottingen; Saarland University	Hub, JS (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Gottingen, Germany.; Hub, JS (corresponding author), Saarland Univ, Theoret Phys, Saarbrucken, Germany.	jochen.hub@physik.uni-saarland.de	Hub, Jochen/M-6230-2015	Hub, Jochen/0000-0001-7716-1767; Ariz-Extreme, Igor/0000-0002-8470-0850	Deutsche Forschungsgemeinschaft [HU 1971-1/1, HU 1971-3/1]; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB)	This study was supported by the Deutsche Forschungsgemeinschaft (grant numbers HU 1971-1/1, HU 1971-3/1) to JSH (URL: www.dfg.de). IA was supported by the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Piotr Neumann for investigating the anomalous signal of fluoride in the Fluc structure, and we thank Randy Stockbridge for insightful discussions. This study was supported by the Deutsche Forschungsgemeinschaft (grant numbers HU 1971-1/1, HU 1971-3/1) to JSH. IA was additionally supported by the Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB). The simulations were in part performed with resources provided by the North-German Supercomputing Alliance (HLRN).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreini C, 2013, NUCLEIC ACIDS RES, V41, pD312, DOI 10.1093/nar/gks1063; Andrejasic M, 2008, ACTA CRYSTALLOGR D, V64, P1093, DOI 10.1107/S0907444908027388; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Botos I, 2001, FEBS LETT, V509, P90, DOI 10.1016/S0014-5793(01)03113-1; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhary J, 2013, J PHYS CHEM B, V117, P9142, DOI 10.1021/jp402860e; Cooper DR, 2011, EXPERT OPIN DRUG DIS, V6, P771, DOI 10.1517/17460441.2011.585154; Cordomi A, 2012, J CHEM THEORY COMPUT, V8, P948, DOI 10.1021/ct200491c; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; FERGUSON DM, 1991, J MED CHEM, V34, P2654, DOI 10.1021/jm00112a048; Figueirido F, 1997, J PHYS CHEM B, V101, P5622, DOI 10.1021/jp970882x; FIGUEIRIDO F, 1995, J CHEM PHYS, V103, P6133, DOI 10.1063/1.470721; Harder E, 2006, J CHEM THEORY COMPUT, V2, P1587, DOI 10.1021/ct600180x; Hermans J, 1997, J AM CHEM SOC, V119, P2707, DOI 10.1021/ja963568+; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hodgman C. D., 1960, HDB CHEM PHYS; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hub JS, 2017, J CHEM THEORY COMPUT, V13, P2352, DOI 10.1021/acs.jctc.7b00106; Hub JS, 2014, J CHEM THEORY COMPUT, V10, P381, DOI 10.1021/ct400626b; Hummer G, 1998, J PHYS CHEM A, V102, P7885, DOI 10.1021/jp982195r; Hummer G, 1997, J CHEM PHYS, V107, P9275, DOI 10.1063/1.475219; Hummer G, 1996, J PHYS CHEM-US, V100, P1206, DOI 10.1021/jp951011v; Hunenberger PH, 1999, BIOPHYS CHEM, V78, P69, DOI 10.1016/S0301-4622(99)00007-1; Hunenberger PH, 1999, J CHEM PHYS, V110, P1856, DOI 10.1063/1.477873; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Jungwirth P, 2008, ANNU REV PHYS CHEM, V59, P343, DOI 10.1146/annurev.physchem.59.032607.093749; Kastenholz MA, 2004, J PHYS CHEM B, V108, P774, DOI 10.1021/jp0350924; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Kleywegt GJ, 2000, ACTA CRYSTALLOGR D, V56, P249, DOI 10.1107/S0907444999016364; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Kratochvil HT, 2016, SCIENCE, V353, P1040, DOI 10.1126/science.aag1447; Lamoureux G, 2006, J PHYS CHEM B, V110, P3308, DOI 10.1021/jp056043p; Lamoureux G, 2006, CHEM PHYS LETT, V418, P245, DOI 10.1016/j.cplett.2005.10.135; Lamoureux G, 2003, J CHEM PHYS, V119, P3025, DOI 10.1063/1.1589749; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Last NB, 2016, ELIFE, V5, DOI 10.7554/eLife.18767; Lemkul JA, 2016, CHEM REV, V116, P4983, DOI 10.1021/acs.chemrev.5b00505; Lemkul JA, 2015, J COMPUT CHEM, V36, P1473, DOI 10.1002/jcc.23937; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luo Y, 2010, J PHYS CHEM LETT, V1, P183, DOI 10.1021/jz900079w; Macdonald CB, 2017, CURR OPIN STRUC BIOL, V45, P142, DOI 10.1016/j.sbi.2017.04.003; Malde AK, 2011, J COMPUT AID MOL DES, V25, P1, DOI 10.1007/s10822-010-9397-6; Malde AK, 2009, J AM CHEM SOC, V131, P3848, DOI 10.1021/ja9002124; McGreevy R, 2016, METHODS, V100, P50, DOI 10.1016/j.ymeth.2016.01.009; McGreevy R, 2014, ACTA CRYSTALLOGR D, V70, P2344, DOI 10.1107/S1399004714013856; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morozenko A, 2016, PROTEINS, V84, P1347, DOI 10.1002/prot.25081; Nam KH, 2010, BIOCHEM BIOPH RES CO, V391, P1131, DOI 10.1016/j.bbrc.2009.12.038; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rembert KB, 2012, J AM CHEM SOC, V134, P10039, DOI 10.1021/ja301297g; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Sakane S, 1998, J PHYS CHEM B, V102, P5673, DOI 10.1021/jp9808227; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Sridhar A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172743; Stockbridge RB, 2015, NATURE, V525, P548, DOI 10.1038/nature14981; Stockbridge RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6120; Stockbridge RB, 2013, ELIFE, V2, DOI 10.7554/eLife.01084; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; TROPSHA A, 1992, PROTEIN ENG, V5, P29, DOI 10.1093/protein/5.1.29; Turman DL, 2017, J GEN PHYSIOL, V149, P511, DOI 10.1085/jgp.201611747; Turman DL, 2015, P NATL ACAD SCI USA, V112, P5697, DOI 10.1073/pnas.1505301112; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; van Maaren PJ, 2001, J PHYS CHEM B, V105, P2618, DOI [10.1021/jp003843l, 10.1021/jp0038431]; Vermaas JV, 2016, J CHEM INF MODEL, V56, P1112, DOI 10.1021/acs.jcim.6b00103; Vrbka L, 2006, P NATL ACAD SCI USA, V103, P15440, DOI 10.1073/pnas.0606959103; Weichenberger CX, 2006, BIOINFORMATICS, V22, P1397, DOI 10.1093/bioinformatics/btl128; Weichenberger CX, 2013, ACTA CRYSTALLOGR F, V69, P195, DOI 10.1107/S1744309112044387; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Wlodawer A, 2013, FEBS J, V280, P5705, DOI 10.1111/febs.12495; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yoo JJ, 2012, J PHYS CHEM LETT, V3, P45, DOI 10.1021/jz201501a; Yu HB, 2010, J CHEM THEORY COMPUT, V6, P774, DOI 10.1021/ct900576a; Zheng H, 2017, ACTA CRYSTALLOGR D, V73, P223, DOI 10.1107/S2059798317001061; Zheng JJ, 2011, THEOR CHEM ACC, V128, P295, DOI 10.1007/s00214-010-0846-z; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022	95	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196751	10.1371/journal.pone.0196751	http://dx.doi.org/10.1371/journal.pone.0196751			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771936	Green Published, gold, Green Submitted			2022-12-26	WOS:000432348900016
J	Dassanayake, RP; Falkenberg, SM; Register, KB; Samorodnitsky, D; Nicholson, EM; Reinhardt, TA				Dassanayake, Rohana P.; Falkenberg, Shollie M.; Register, Karen B.; Samorodnitsky, Daniel; Nicholson, Eric M.; Reinhardt, Timothy A.			Antimicrobial activity of bovine NK-lysin-derived peptides on Mycoplasma bovis	PLOS ONE			English	Article							BISON BISON-BISON; CATTLE; GRANULYSIN; CELLS; MEMBRANE; INFECTIONS; PNEUMONIAE; CERAGENINS; MECHANISM; MOLECULE	Antimicrobial peptides (AMPs) are a diverse group of molecules which play an important role in the innate immune response. Bovine NK-lysins, a type of AMP, have been predominantly found in the granules of cytotoxic T-lymphocytes and NK-cells. Bovine NK-lysinderived peptides demonstrate antimicrobial activity against various bacterial pathogens, including several involved in bovine respiratory disease complex (BRDC) in cattle; however, such studies are yet to be performed with one important contributor to the BRDC, Mycoplasma bovis. Therefore, the goal of this study was to assess the antimicrobial activity of bovine NK-lysin-derived peptides on M. bovis. Thirty-mer synthetic peptides corresponding to the functional region helices 2 and 3 of bovine NK-lysins NK1, NK2A, NK2B, and NK2C were evaluated for killing activity on M. bovis isolates. Among four peptides, NK2A and NK2C showed the highest antimicrobial activity against the M. bovis isolates tested. All four NK-lysin peptides induced rapid plasma membrane depolarization in M. bovis at two concentrations tested. However, based on propidium iodide uptake, only NK2A and NK2C appeared capable of causing structural damage to M. bovis plasma membrane. Confocal microscopy, flow cytometry, and transmission electron microscopy further suggested NK-lysin-induced damage to the plasma membrane. Taken together, the findings in this study suggest that plasma membrane depolarization alone was insufficient to induce lethality, but disruption/permeabilization of the M. bovis plasma membrane was the cause of lethality.	[Dassanayake, Rohana P.; Falkenberg, Shollie M.; Register, Karen B.; Reinhardt, Timothy A.] ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA; [Samorodnitsky, Daniel; Nicholson, Eric M.] ARS, Virus & Pr Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Dassanayake, RP (corresponding author), ARS, Ruminant Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	rohana.dassanayake@ars.usda.gov	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509	USDA; USDA/ARS National Animal Disease Center [5030-32000-116-00D]	USDA(United States Department of Agriculture (USDA)); USDA/ARS National Animal Disease Center	This research was conducted at a USDA research facility and all funding was provided through internal USDA research dollars. This project is an intramural project of the USDA/ARS National Animal Disease Center (5030-32000-116-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclaimer: Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer.	Ageitos JM, 2017, BIOCHEM PHARMACOL, V133, P117, DOI 10.1016/j.bcp.2016.09.018; Andersson M, 1996, VET IMMUNOL IMMUNOP, V54, P123, DOI 10.1016/S0165-2427(96)05677-2; Bechinger B, 1999, BBA-BIOMEMBRANES, V1462, P157, DOI 10.1016/S0005-2736(99)00205-9; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Brender JR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00195; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Caswell Jeff L., 2007, Animal Health Research Reviews, V8, P161, DOI 10.1017/S1466252307001351; Chen JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158882; Chen JF, 2015, P NATL ACAD SCI USA, V112, pE7223, DOI 10.1073/pnas.1519374113; Confer Anthony W., 2009, Animal Health Research Reviews, V10, P145, DOI 10.1017/S1466252309990193; Dahl J, 1993, Subcell Biochem, V20, P167; Dassanayake RP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183610; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Dyer N, 2008, J VET DIAGN INVEST, V20, P369, DOI 10.1177/104063870802000321; Earley B, 2017, ANIMAL, V11, P486, DOI 10.1017/S1751731116001622; Endsley JJ, 2004, J IMMUNOL, V173, P2607, DOI 10.4049/jimmunol.173.4.2607; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RF, 2010, ANTIMICROB AGENTS CH, V54, P3708, DOI 10.1128/AAC.00380-10; Gelhaus C, 2008, ANTIMICROB AGENTS CH, V52, P1713, DOI 10.1128/AAC.01342-07; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hata A, 2001, VIRAL IMMUNOL, V14, P125, DOI 10.1089/088282401750234501; Heuvelink A, 2016, VET MICROBIOL, V189, P1, DOI 10.1016/j.vetmic.2016.04.012; Jacobs T, 2003, ANTIMICROB AGENTS CH, V47, P607, DOI 10.1128/AAC.47.2.607-613.2003; Jeyaseelan Samithamby, 2002, Animal Health Research Reviews, V3, P69, DOI 10.1079/AHRR200242; Kornspan JD, 2012, J LIPIDS, V2012, DOI 10.1155/2012/640762; Kuwano K, 2006, CURR MICROBIOL, V52, P435, DOI 10.1007/s00284-005-0215-7; Lee SH, 2013, VET PARASITOL, V197, P113, DOI 10.1016/j.vetpar.2013.04.020; Lu XD, 2004, MICROB PATHOGENESIS, V37, P253, DOI 10.1016/j.micpath.2004.08.001; Lv YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Maunsell FP, 2011, J VET INTERN MED, V25, P772, DOI 10.1111/j.1939-1676.2011.0750.x; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Park HJ, 2013, FEBS LETT, V587, P3321, DOI 10.1016/j.febslet.2013.08.016; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Pena S V, 1997, Semin Immunol, V9, P117, DOI 10.1006/smim.1997.0061; Pena SV, 1997, J IMMUNOL, V158, P2680; Register KB, 2015, VET MICROBIOL, V175, P92, DOI 10.1016/j.vetmic.2014.11.002; Register KB, 2013, J VET DIAGN INVEST, V25, P541, DOI 10.1177/1040638713495029; Senyurek I, 2009, ANTIMICROB AGENTS CH, V53, P2499, DOI 10.1128/AAC.01679-08; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; Soehnlen MK, 2011, J VET DIAGN INVEST, V23, P547, DOI 10.1177/1040638711404155; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tani K, 2011, MICROBIOL IMMUNOL, V55, P582, DOI 10.1111/j.1348-0421.2011.00353.x; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Vizioli J, 2002, TRENDS PARASITOL, V18, P475, DOI 10.1016/S1471-4922(02)02428-5; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	47	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197677	10.1371/journal.pone.0197677	http://dx.doi.org/10.1371/journal.pone.0197677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771981	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900087
J	Paul, M; Bhadra, A				Paul, Manabi; Bhadra, Anindita			The great Indian joint families of free-ranging dogs	PLOS ONE			English	Article							CANIS-FAMILIARIS; DOMESTIC DOGS; EVOLUTION; SEX; BEHAVIOR; CARE; DOMINANCE; DISPERSAL; SEASON; SIZE	Cooperative breeding is an excellent example of cooperation in social groups. Domestic dogs have evolved from cooperatively hunting and breeding ancestors but have adapted to a facultatively social scavenging lifestyle on streets, and solitary living in human homes. Pets typically breed and reproduce under human supervision, but free-ranging dogs can provide insights into the natural breeding ecology of dogs. We conducted a five year-long field based behavioural study on parental care of free-ranging dogs in India. 23 mother-litter units, belonging to 15 groups were observed, which revealed the presence of widespread allo-parenting by both adult males and females. While all the females were known to be related to the pups receiving care, the relatedness with the males could not be determined. Hence, we coined the term "putative father" for caregiving males. Allomothers provided significantly less care than the mothers, but the putative fathers showed comparable levels of care with the mothers. Mothers invested more effort in nursing and allogrooming, while the putative fathers played and protected more. Our observations provide support for both the "benefit-of-philopatry" and "assured fitness returns" hypotheses. Free-ranging dogs are not cooperative breeders like wolves but are rather communal breeders; their breeding biology bearing interesting similarities with the human joint family system. This breeding strategy is likely to have played an important role in increasing pup survival in a stochastic environment and helping to adapt to living among humans during the domestication of dogs.	[Paul, Manabi; Bhadra, Anindita] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Behav & Ecol Lab, Mohanpur, India	Indian Institute of Science Education & Research (IISER) - Kolkata	Bhadra, A (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Behav & Ecol Lab, Mohanpur, India.	abhadra@iiserkol.ac.in		Bhadra, Anindita/0000-0002-3717-9732	Council of Scientific & Industrial Research, India [37 (1399)/ 10/ EMR-II]; Science and Engineering Research Board, India [SB/YS/LS-38/2013, SB/WEA-005/2013]	Council of Scientific & Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Science and Engineering Research Board, India	This project has been supported by the funds received by AB from Council of Scientific & Industrial Research, India (http://www.csir.res.in/), Project no. 37 (1399)/ 10/ EMR-II and Science and Engineering Research Board, India (http://serbonline.in/SERB/HomePage.do), Project no. SB/YS/LS-38/2013 and SB/WEA-005/2013. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ANDELT WF, 1979, J MAMMAL, V60, P568, DOI 10.2307/1380098; [Anonymous], 1877, DIFFERENT FORMS FLOW; Bell MBV, 2012, P ROY SOC B-BIOL SCI, V279, P619, DOI 10.1098/rspb.2011.1093; Bergmuller R, 2007, BEHAV PROCESS, V76, P61, DOI 10.1016/j.beproc.2007.07.001; Bhadra A, 2016, ETHOL ECOL EVOL, V28, P427, DOI 10.1080/03949370.2015.1076526; Bhadra A, 2014, J ETHOL, V32, P15, DOI 10.1007/s10164-013-0388-7; BOITANI L, 1995, ETHOL ECOL EVOL, V7, P49, DOI 10.1080/08927014.1995.9522969; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Butler JRA, 2004, BIOL CONSERV, V115, P369, DOI 10.1016/S0006-3207(03)00152-6; Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Cant MA, 2010, P ROY SOC B-BIOL SCI, V277, P2219, DOI 10.1098/rspb.2009.2097; DANIELS TJ, 1989, J MAMMAL, V70, P754, DOI 10.2307/1381709; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Dickinson Janis L., 2004, P48, DOI 10.1017/CBO9780511606816.004; Fisher RA, 1930, GENETICAL THEORY NAT; GADAGKAR R, 1990, PHILOS T ROY SOC B, V329, P17, DOI 10.1098/rstb.1990.0146; Gilchrist JS, 2004, BEHAV ECOL SOCIOBIOL, V57, P119, DOI 10.1007/s00265-004-0837-y; GOULD L, 1992, FOLIA PRIMATOL, V58, P72, DOI 10.1159/000156611; Groos K, 1898, THE PLAY OF ANIMALS; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hayes LD, 2000, ANIM BEHAV, V59, P677, DOI 10.1006/anbe.1999.1390; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Kleiman D., 1968, International Zoo Yearbook, V8, P3, DOI 10.1111/j.1748-1090.1968.tb00419.x; Kleiman D.G., 1981, P347; Lord K, 2013, BEHAV PROCESS, V92, P131, DOI 10.1016/j.beproc.2012.10.009; Lukas D, 2012, P ROY SOC B-BIOL SCI, V279, P2151, DOI 10.1098/rspb.2011.2468; Majumder SS, 2014, ACTA ETHOL, V17, P1, DOI 10.1007/s10211-013-0158-0; Moehlman PD, 1979, NATURE, DOI [10.1038/27382a0, DOI 10.1038/27382A0]; MURRAY MG, 1985, BEHAV ECOL SOCIOBIOL, V16, P151, DOI 10.1007/BF00295149; O'Farrell V., 1995, THE DOMESTIC DOG; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Pal S.K., 2011, International Journal of Zoology, V2011, P1, DOI 10.1155/2011/314216; Pal SK, 1998, APPL ANIM BEHAV SCI, V61, P123, DOI 10.1016/S0168-1591(98)00185-3; Pal SK, 2005, APPL ANIM BEHAV SCI, V90, P31, DOI 10.1016/j.applanim.2004.08.002; Pal SK, 1998, APPL ANIM BEHAV SCI, V59, P331, DOI 10.1016/S0168-1591(98)00108-7; Paul M, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160583; Paul M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170590; Paul M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19641; Paul M, 2014, J ETHOL, V32, P75, DOI 10.1007/s10164-014-0396-2; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; Range F, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01582; Schmidt PA, 1997, AM NAT, V150, P513, DOI 10.1086/286079; Sen Majumder S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143501; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; STACEY PB, 1991, AM NAT, V137, P831, DOI 10.1086/285196; Team RC, 2014, R LANG ENV STAT COMP; Van Schaik CP, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P3; Vanak AT, 2009, MAMMAL REV, V39, P265, DOI 10.1111/j.1365-2907.2009.00148.x; WILKINSON GS, 1992, BEHAV ECOL SOCIOBIOL, V31, P225; ZIMEN E, 1976, Z TIERPSYCHOL, V40, P300	53	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197328	10.1371/journal.pone.0197328	http://dx.doi.org/10.1371/journal.pone.0197328			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771960	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900050
J	Alcover, EA; Jaume-i-Capo, A; Moya-Alcover, B				Amengual Alcover, Esperanca; Jaume-i-Capo, Antoni; Moya-Alcover, Biel			PROGame: A process framework for serious game development for motor rehabilitation therapy	PLOS ONE			English	Article							IMPROVEMENT; CHILDREN	Serious game development for rehabilitation therapy is becoming increasingly popular because of the motivational advantages that these types of applications provide. Consequently, the need for a common process framework for this category of software development has become increasingly evident. The goal is to guarantee that products are developed and validated by following a coherent and systematic method that leads to high-quality serious games. This paper introduces a new process framework for the development of serious games for motor rehabilitation therapy. We introduce the new model and demonstrate its application for the development of a serious game for the improvement of the balance and postural control of adults with cerebral palsy. The development of this application has been facilitated by two technological transfer contracts and is being exploited by two different organizations. According to clinical measurements, patients using the application improved from high fall risk to moderate fall risk. We believe that our development strategy can be useful not only for motor rehabilitation therapy, but also for the development of serious games in many other rehabilitation areas.	[Amengual Alcover, Esperanca; Jaume-i-Capo, Antoni; Moya-Alcover, Biel] Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Spain	Universitat de les Illes Balears	Alcover, EA (corresponding author), Univ Balearic Isl, Dept Math & Comp Sci, Palma De Mallorca, Spain.	eamengual@uib.es	Amengual, Esperança/L-7065-2014; Jaume-i-Capó, Antoni/I-4053-2015; Moya-Alcover, Gabriel/L-3129-2018	Amengual, Esperança/0000-0002-0699-6684; Jaume-i-Capó, Antoni/0000-0003-3312-5347; Moya-Alcover, Gabriel/0000-0002-3412-5499	Ministerio de Economia, Industria y Competitividad (MINECO); Agencia Estatal de Investigacion (AEI); European Regional Development Funds (ERDF, EU) [TIN2016-81143R, TIN2015-67149-C3-2-R]	Ministerio de Economia, Industria y Competitividad (MINECO); Agencia Estatal de Investigacion (AEI); European Regional Development Funds (ERDF, EU)	We acknowledge the Ministerio de Economia, Industria y Competitividad (MINECO), the Agencia Estatal de Investigacion (AEI) and the European Regional Development Funds (ERDF, EU) for its support to the projects TIN2016-81143R (MINECO/AEI/ERDF, EU) and TIN2015-67149-C3-2-R (MINECO/AEI/ERDF, EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amengual E, 2007, 14 EUR SOFTW PROC IM, P11; Broetz D, 2013, NEUROREHABILITATION, V33, P377, DOI 10.3233/NRE-130967; Burke JW, 2009, VISUAL COMPUT, V25, P1085, DOI 10.1007/s00371-009-0387-4; Finch E, 2002, PHYS REHABILITATION; Flores E., 2008, P 2008 INT C ADV COM, P381, DOI [10.1145/1501750.1501839, DOI 10.1145/1501750.1501839]; Friedman L.M., 2015, BLINDING FUNDAMENTAL, V5, DOI DOI 10.1371/journal.pmed.1002711; Humphrey W., 1989, MANAGING SOFTWARE PR; Humphrey WS, 1993, INTRO SOFTWARE PROCE; Jaume-i-Capo A, 2014, SCI WORLD J, DOI 10.1155/2014/964576; Jaume-i-Capo A, 2014, STUD COMPUT INTELL, V536, P12, DOI 10.1007/978-3-642-45432-5_2; Jaume-i-Capo A, 2014, IEEE T NEUR SYS REH, V22, P419, DOI 10.1109/TNSRE.2013.2279155; Kappel G, 2005, WEB ENG; King LA, 2009, PHYS THER, V89, P384, DOI 10.2522/ptj.20080214; Mesquida AL, 2012, INFORM SOFTWARE TECH, V54, P239, DOI 10.1016/j.infsof.2011.11.002; Maclean N, 2002, STROKE, V33, P444, DOI 10.1161/hs0202.102367; Mas A, 2010, COMM COM INF SC, V99, P290; MOYAAALCOVER B, 2011, P 13 INT ACM SIGAC C, P297; Pichaco AM, 2003, SERP'03: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING RESEARCH AND PRACTICE, VOLS 1 AND 2, P693; Pirovano M, 2016, ENTERTAIN COMPUT, V14, P55, DOI 10.1016/j.entcom.2015.10.002; Pressman R, 2000, WEB ENG SOFTWARE ENG; Pressman R.S., 2015, SOFTWARE ENG PRACTIT, V8; Pressman RS, 1998, IEEE SOFTWARE, V15, P104, DOI 10.1109/MS.1998.714869; Pries K.H., 2010, SCRUM PROJECT MANAGE; Reyes-Amaro A., 2012, P E HLTH ENV C MIDDL, P127; Reyes-Amaro A., 2012, JACCES, V2, P62; Salem Y, 2009, NEUROREHABILITATION, V24, P307, DOI 10.3233/NRE-2009-0483; Sandlund M, 2009, DEV MED CHILD NEUROL, V51, P173, DOI 10.1111/j.1469-8749.2008.03184.x; Sommerville I, 2016, SOFTWARE ENG PEARSON; Turk M, 2004, COMMUN ACM, V47, P61, DOI 10.1145/962081.962107; Van Vliet H., 1993, SOFTWARE ENG PRINCIP, V3; Woollacott Marjorie Hines, 2005, Neural Plasticity, V12, P211, DOI 10.1155/NP.2005.211; Wulf G, 2010, RES Q EXERCISE SPORT, V81, P425	32	17	17	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197383	10.1371/journal.pone.0197383	http://dx.doi.org/10.1371/journal.pone.0197383			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF9WG	29768472	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200078
J	Frasca, D; Diaz, A; Romero, M; Thaller, S; Blomberg, BB				Frasca, Daniela; Diaz, Alain; Romero, Maria; Thaller, Seth; Blomberg, Bonnie B.			Secretion of autoimmune antibodies in the human subcutaneous adipose tissue	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CLASS SWITCH RECOMBINATION; T-BET EXPRESSION; BODY-MASS INDEX; B-CELLS; INSULIN-RESISTANCE; HUMAN OBESITY; TRANSCRIPTION FACTOR; FACTOR-ALPHA; INFLAMMATION	The adipose tissue (AT) contributes to systemic and B cell intrinsic inflammation, reduced B cell responses and secretion of autoimmune antibodies. In this study we show that adipocytes in the human obese subcutaneous AT (SAT) secrete several pro-inflammatory cytokines and chemokines, which contribute to the establishment and maintenance of local and systemic inflammation, and consequent suboptimal immune responses in obese individuals, as we have previously shown. We also show that pro-inflammatory chemokines recruit immune cells expressing the corresponding receptors to the SAT, where they also contribute to local and systemic inflammation, secreting additional pro-inflammatory mediators. Moreover, we show that the SAT generates autoimmune antibodies. During the development of obesity, reduced oxygen and consequent hypoxia and cell death lead to further release of pro-inflammatory cytokines, "self" protein antigens, cell-free DNA and lipids. All these stimulate class switch and the production of autoimmune IgG antibodies which have been described to be pathogenic. In addition to hypoxia, we have measured cell cytotoxicity and DNA damage mechanisms, which may also contribute to the release of "self" antigens in the SAT. All these processes are significantly elevated in the SAT as compared to the blood. We definitively found that fat-specific IgG antibodies are secreted by B cells in the SAT and that B cells express mRNA for the transcription factor T-bet and the membrane marker CD11c, both involved in the production of autoimmune IgG antibodies. Finally, the SAT also expresses RNA for cytokines known to promote Germinal Center formation, iso-type class switch, and plasma cell differentiation. Our results show novel mechanisms for the generation of autoimmune antibody responses in the human SAT and allow the identification of new pathways to possibly manipulate in order to reduce systemic inflammation and autoantibody production in obese individuals.	[Frasca, Daniela; Diaz, Alain; Romero, Maria; Blomberg, Bonnie B.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Thaller, Seth] Univ Miami, Miller Sch Med, Div Plast & Reconstruct Surg, Dept Surg, Miami, FL 33136 USA; [Blomberg, Bonnie B.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Frasca, D (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	dfrasca@med.miami.edu	Thaller, Seth/AAO-1801-2020		National Institutes of Health [R56 AG32576, R21 AG042826, R21 AI096446]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG032576, R01AG023717, R21AG042826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study has been supported by the following National Institutes of Health awards: R56 AG32576 (DF/BBB), R21 AG042826 (DF/BBB), R21 AI096446 (BBB/DF).	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Alcaide ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153045; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Apovian CM, 2012, CIRCULATION, V125, P1178, DOI 10.1161/CIRCULATIONAHA.111.022541; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Belanger S, 2016, NAT IMMUNOL, V17, P1135, DOI 10.1038/ni.3561; Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casas R, 2014, ENDOCR METAB IMMUNE, V14, P245, DOI 10.2174/1871530314666140922153350; Cho SH, 2016, NATURE, V537, P234, DOI 10.1038/nature19334; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Frasca D, 2017, CELL IMMUNOL, V321, P68, DOI 10.1016/j.cellimm.2017.04.007; Frasca D, 2017, MECH AGEING DEV, V162, P91, DOI 10.1016/j.mad.2017.01.004; Frasca D, 2016, OBESITY, V24, P615, DOI 10.1002/oby.21383; Grant Ryan, 2013, Methods Mol Biol, V1040, P195, DOI 10.1007/978-1-62703-523-1_15; Grant RW, 2015, OBESITY, V23, P512, DOI 10.1002/oby.21003; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Havenith SHC, 2014, INT IMMUNOL, V26, P183, DOI 10.1093/intimm/dxt058; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kwon B, 2014, BBA-MOL CELL RES, V1843, P1402, DOI 10.1016/j.bbamcr.2014.04.004; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Lawler HM, 2016, J CLIN ENDOCR METAB, V101, P1422, DOI 10.1210/jc.2015-4125; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu Y, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1438-2; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; McCall KD, 2010, J ENDOCRINOL, V207, P343, DOI 10.1677/JOE-09-0370; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Myles A, 2017, CELL IMMUNOL, V321, P3, DOI 10.1016/j.cellimm.2017.09.004; Naradikian MS, 2016, J IMMUNOL, V197, P1023, DOI 10.4049/jimmunol.1600522; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; Nielsen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031959; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Raval Forum M, 2013, Discoveries (Craiova), V1, pe6; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Santore MT, 2002, AM J PHYSIOL-LUNG C, V282, pL727, DOI 10.1152/ajplung.00281.2001; Schweiger M, 2014, METHOD ENZYMOL, V538, P171, DOI 10.1016/B978-0-12-800280-3.00010-4; Setty AR, 2007, ARCH INTERN MED, V167, P1670, DOI 10.1001/archinte.167.15.1670; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Strbo N, 2016, AM J REPROD IMMUNOL, V75, P134, DOI 10.1111/aji.12458; Suurmond J, 2015, J CLIN INVEST, V125, P2194, DOI 10.1172/JCI78084; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tarazona R, 2015, METHODS MOL BIOL, V1343, P9, DOI 10.1007/978-1-4939-2963-4_2; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Tse E, 2015, J INTERF CYTOK RES, V35, P392, DOI 10.1089/jir.2014.0165; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Zamboni M, 2014, MECH AGEING DEV, V136, P129, DOI 10.1016/j.mad.2013.11.008; Zhang Y, 2016, IMMUNOL REV, V270, P8, DOI 10.1111/imr.12396	68	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197472	10.1371/journal.pone.0197472	http://dx.doi.org/10.1371/journal.pone.0197472			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768501	gold, Green Submitted, Green Published			2022-12-26	WOS:000432329200086
J	Wiedeman, J; Mensa-Wilmot, K				Wiedeman, Justin; Mensa-Wilmot, Kojo			A fixable probe for visualizing flagella and plasma membranes of the African trypanosome	PLOS ONE			English	Article							ALTERNATIVE OXIDASE; DNA-REPLICATION; BRUCEI; PROTEIN; ENDOCYTOSIS; MORPHOGENESIS; BIOGENESIS; MICROSCOPY	The protozoan Trypanosoma brucei sp. cause diseases in humans and animals. Studies of T. brucei cell biology have revealed unique features, such as major endocytic events being limited to a single region, and mitochondrial genome segregation mediated via basal bodies. Further understanding of trypanosome cell biology can be facilitated with super-resolution fluorescence microscopy. Lack of a plasma membrane probe for fixed trypanosomes remains a persistent problem in need of a working solution. Herein, we report protocols developed using mCLING in super-resolution structured illumination fluorescence microscopy (SR-SIM). mCLING comprehensively labels flagellar membranes, including nascent intracellular stages. To extend its usefulness for trypanosome biology we optimized mCLING in combination with organelle-specific antibodies for immunofluorescence of basal bodies or mitochondria. Then in work with live trypanosomes, we demonstrated internalization of mCLING into endocytic stations that overlap with LysoTracker in acidic organelles. Greater detail of the intracellular location of mCLING was obtained with SR-SIM after pulsing trypanosomes with the probe, and allowing continuous uptake of fluorescent concanavalin A (ConA) destined for lysosomes. In most cases, ConA and mCLING vesicles were juxtaposed but not coincident. A video of the complete image stack at the 15 min time point shows zones of mCLING staining surrounding patches of ConA, consistent with persistence of mCLING in membranes of compartments that contain luminal ConA. In summary, these studies establish mCLING as a versatile trypanosome membrane probe compatible with super-resolution microscopy that can be used for detailed analysis of flagellar membrane biogenesis. In addition, mCLING can be used for immunofluorescence in fixed, permeabilized trypanosomes. Its robust staining of the plasma membrane eliminates a need to overlay transmitted light images on fluorescence pictures obtained from widefield, confocal, or super-resolution microscopy.	[Wiedeman, Justin; Mensa-Wilmot, Kojo] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Wiedeman, Justin; Mensa-Wilmot, Kojo] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Mensa-Wilmot, K (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.; Mensa-Wilmot, K (corresponding author), Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.	mensawil@uga.edu			NIAID [R01AI124046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124046, R01AI126311] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021719] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIAID grant # R01AI124046 to KM-W. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre J, 2014, J BIOL CHEM, V289, P464, DOI 10.1074/jbc.M113.509521; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Begejo EEB, 2015, J NAT SCI RES, V5, P117; Boehm CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006063; BRICKMAN MJ, 1995, J CELL SCI, V108, P3611; Chaudhuri M, 1998, MOL BIOCHEM PARASIT, V95, P53, DOI 10.1016/S0166-6851(98)00091-7; Chen Y, 2016, HISTOCHEM CELL BIOL, V146, P255, DOI 10.1007/s00418-016-1451-6; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Field MC, 2004, MICROSC MICROANAL, V10, P621, DOI 10.1017/S1431927604040942; Gaffield MA, 2006, NAT PROTOC, V1, P2916, DOI 10.1038/nprot.2006.476; Glover L, 2016, P NATL ACAD SCI USA, V113, P7225, DOI 10.1073/pnas.1600344113; Hall B, 2004, MOL BIOCHEM PARASIT, V138, P67, DOI 10.1016/j.molbiopara.2004.07.007; Hamilton V, 2014, EUKARYOT CELL, V13, P539, DOI 10.1128/EC.00312-13; Heilemann M, 2010, J BIOTECHNOL, V149, P243, DOI 10.1016/j.jbiotec.2010.03.012; HENLEY GL, 1978, Z PARASITENKD, V55, P181, DOI 10.1007/BF00390368; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hu HQ, 2015, EUKARYOT CELL, V14, P898, DOI 10.1128/EC.00083-15; Hughes L, 2013, J CELL SCI, V126, P5748, DOI 10.1242/jcs.139139; Kaufmann D, 2012, BIOCHEM BIOPH RES CO, V419, P698, DOI 10.1016/j.bbrc.2012.02.082; Kawahara J, 1997, POLYMER MODIFICATION, P119; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Lacomble S, 2010, J CELL SCI, V123, P2884, DOI 10.1242/jcs.074161; McDonald NA, 2017, ELIFE, V6, DOI [10.7554/eLife.28865, 10.7554/eLife.28865.001]; Morgan GW, 2005, MOL CELL BIOL, V25, P3774, DOI 10.1128/MCB.25.9.3774-3783.2005; Revelo NH, 2014, J CELL BIOL, V205, P591, DOI 10.1083/jcb.201402066; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sullenberger C, 2017, MOL PHARMACOL, V91, P482, DOI 10.1124/mol.116.106906; Trikin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005586; Tulloch LB, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005886; Vollert CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep17322; WOODWARD R, 1990, J CELL SCI, V95, P49	32	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197541	10.1371/journal.pone.0197541	http://dx.doi.org/10.1371/journal.pone.0197541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768499	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200092
J	Bowman, NM; Akialis, K; Cave, G; Barrera, R; Apperson, CS; Meshnick, SR				Bowman, Natalie M.; Akialis, Kristin; Cave, Grayson; Barrera, Roberto; Apperson, Charles S.; Meshnick, Steven R.			Pyrethroid insecticides maintain repellent effect on knock-down resistant populations of Aedes aegypti mosquitoes	PLOS ONE			English	Article							RTS,S/AS01 MALARIA VACCINE; AEGYPTI DIPTERA-CULICIDAE; LONE STAR TICK; YELLOW-FEVER OUTBREAK; PERSONAL PROTECTION; PRESSURIZED SPRAYS; IXODES-RICINUS; BEHAVIORAL-RESPONSES; RESIDUAL ACTIVITY; CONTROLLED-TRIAL	Pyrethroid-treated clothing is commonly worn for protection against mosquitoes; pyrethroids are both insecticides and repellents. Pyrethroid resistance has become increasingly common in Aedes aegypti, the vector of dengue, Zika, and other arboviruses, but it is not clear whether resistance is associated with reductions in repellency. In order to determine whether long-lasting permethrin impregnated (LLPI) clothing is protective, we used Aedes aegypti from New Orleans, LA (pyrethroid-sensitive) and San Juan, PR (resistant) to measure both lethality and repellency. PCR and Sanger sequencing were used to confirm resistance status by detecting mutations in the kdr gene at positions 1016 and 1534. Arm-incage trials of 100 Aedes aegypti females from both populations were performed for 10 minutes to bare arm or an arm clothed in untreated military camouflage or military camouflage impregnated with deltamethrin, permethrin, or etofenprox. Trials were repeated 4-5 times on different days. Number of landings, number of blood meals, and immediate and 24-hour mortality were recorded. Mortality was extremely low in all trials. Compared to untreated cloth, mosquitoes demonstrated a trend towards a 2%-63% reduction in landings and a statistically significant 78-100% reduction in blood feeding on pyrethroid-treated cloth for most insecticides. Effects were observed in both pyrethroid-sensitive and pyrethroid-resistant mosquito populations. Our data show that kdr mutations are associated with pyrethroid resistance but are likely not the only contributors. Pyrethroids appear to maintain repellent effect against resistant mosquitoes. This finding suggests that even in places where pyrethroid resistance is widespread, permethrin still has a role for use as a repellent on clothing to protect against mosquito bites.	[Bowman, Natalie M.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Akialis, Kristin; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Cave, Grayson; Apperson, Charles S.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA; [Barrera, Roberto] Ctr Dis Control & Prevent, San Juan, PR USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; Centers for Disease Control & Prevention - USA	Bowman, NM (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA.	nbowman@med.unc.edu		Bowman, Natalie/0000-0003-4260-8009	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI113197] Funding Source: NIH RePORTER; NIAID NIH HHS [K23 AI113197] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Achee NL, 2009, J AM MOSQUITO CONTR, V25, P156, DOI 10.2987/08-5831.1; Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Agossa FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145207; Agramonte NM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005954; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P345; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P186; Banks SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004109; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Chattopadhyay P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-284; Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060; EVANS SR, 1990, J MED ENTOMOL, V27, P829, DOI 10.1093/jmedent/27.5.829; Faulde M, 2008, INT J MED MICROBIOL, V298, P321, DOI 10.1016/j.ijmm.2007.11.007; Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008; Faulde MK, 2006, MIL MED, V171, P472, DOI 10.7205/MILMED.171.6.472; Faulde MK, 2003, J MED ENTOMOL, V40, P935, DOI 10.1603/0022-2585-40.6.935; Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004; Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Jordan RA, 2012, J MED ENTOMOL, V49, P101, DOI 10.1603/ME10241; Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197; Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/s1473-3099(16)30513-8, 10.1016/S1473-3099(16)30513-8]; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LANE RS, 1989, EXP APPL ACAROL, V6, P343, DOI 10.1007/BF01193304; Lardeux F, 2008, T ROY SOC TROP MED H, V102, P485, DOI 10.1016/j.trstmh.2008.02.006; Londono-Renteria B, 2015, AM J TROP MED HYG, V93, P869, DOI 10.4269/ajtmh.15-0130; Manda H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002074; Mharakurwa S, 2011, P NATL ACAD SCI USA, V108, P18796, DOI 10.1073/pnas.1116162108; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Miller NJ, 2011, J MED ENTOMOL, V48, P327, DOI 10.1603/ME10158; Miot Helio Amante, 2008, Dermatol Online J, V14, P1; Most B, 2017, PARASITOL RES, V116, P677, DOI 10.1007/s00436-016-5333-6; MOUNT GA, 1983, J ECON ENTOMOL, V76, P529, DOI 10.1093/jee/76.3.529; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805; Otshudiema JO, 2017, MMWR-MORBID MORTAL W, V66, P335, DOI 10.15585/mmwr.mm6612a5; Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Sathantriphop S, 2014, J MED ENTOMOL, V51, P1182, DOI 10.1603/ME13191; Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577; SCHRECK CE, 1982, J ECON ENTOMOL, V75, P1059, DOI 10.1093/jee/75.6.1059; SCHRECK CE, 1982, J MED ENTOMOL, V19, P143, DOI 10.1093/jmedent/19.2.143; SCHRECK CE, 1986, J MED ENTOMOL, V23, P396, DOI 10.1093/jmedent/23.4.396; Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005; Stell FM, 2013, MED VET ENTOMOL, V27, P284, DOI 10.1111/j.1365-2915.2012.01048.x; Thanispong K, 2009, J MED ENTOMOL, V46, P1407, DOI 10.1603/033.046.0622; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; Trexler JD, 2003, J MED ENTOMOL, V40, P841, DOI 10.1603/0022-2585-40.6.841; Vaughn MF, 2014, AM J PREV MED, V46, P473, DOI 10.1016/j.amepre.2014.01.008; Vaughn MF, 2011, VECTOR-BORNE ZOONOT, V11, P869, DOI 10.1089/vbz.2010.0158; Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wallace JW, 2016, VECTOR-BORNE ZOONOT, V16, P302, DOI 10.1089/vbz.2015.1887; Witting-Bissinger BE, 2008, J MED ENTOMOL, V45, P891, DOI 10.1603/0022-2585(2008)45[891:NARBIA]2.0.CO;2; World Health Organization, 2006, PEST THEIR APPL CONT; Wu JT, 2016, LANCET, V388, P2904, DOI 10.1016/S0140-6736(16)31838-4; Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658; Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005	61	23	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196410	10.1371/journal.pone.0196410	http://dx.doi.org/10.1371/journal.pone.0196410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763445	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800010
J	Calvo, M; Romero, D; Le Rolle, V; Behar, N; Gomis, P; Mabo, P; Hernandez, AI				Calvo, Mireia; Romero, Daniel; Le Rolle, Virginie; Behar, Nathalie; Gomis, Pedro; Mabo, Philippe; Hernandez, Alfredo, I			Multivariate classification of Brugada syndrome patients based on autonomic response to exercise testing	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ST-SEGMENT ELEVATION; BUNDLE-BRANCH BLOCK; RISK STRATIFICATION; VENTRICULAR-FIBRILLATION; RATE RECOVERY; DYSFUNCTION; PREVENTION; MANAGEMENT; MARKER	Ventricular arrhythmias in Brugada syndrome (BS) typically occur at rest and especially during sleep, suggesting that changes in the autonomic modulation may play an important role in arrhythmogenesis. The autonomic response to exercise and subsequent recovery was evaluated on 105 patients diagnosed with BS (twenty-four were symptomatic), by means of a time-frequency heart rate variability (HRV) analysis, so as to propose a novel predictive model capable of distinguishing symptomatic and asymptomatic BS populations. During incremental exercise, symptomatic patients showed higher HFnu values, probably related to an increased parasympathetic modulation, with respect to asymptomatic subjects. In addition, those extracted HRV features best distinguishing between populations were selected using a two-step feature selection approach, so as to build a linear discriminant analysis (LDA) classifier. The final features subset included one third of the total amount of extracted autonomic markers, mostly acquired during incremental exercise and active recovery, thus evidencing the relevance of these test segments in BS patients classification. The derived predictive model showed an improved performance with respect to previous works in the field (AUC= 0.92 +/- 0.01; Se= 0.91 +/- 0.06; Sp= 0.90 +/- 0.05). Therefore, based on these findings, some of the analyzed HRV markers and the proposed model could be useful for risk stratification in Brugada syndrome.	[Calvo, Mireia; Romero, Daniel; Le Rolle, Virginie; Behar, Nathalie; Mabo, Philippe; Hernandez, Alfredo, I] Univ Rennes, CHU Rennes, Inserm, LTSI UMR 1099, Rennes, France; [Calvo, Mireia; Gomis, Pedro] Univ Politecn Cataluna, Dept ESAII, CREB, Barcelona, Spain; [Gomis, Pedro] CIBER Bioengn Biomat & Nanomed, Zaragoza, Spain	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universitat Politecnica de Catalunya; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Le Rolle, V (corresponding author), Univ Rennes, CHU Rennes, Inserm, LTSI UMR 1099, Rennes, France.	virginie.lerolle@univ-rennes1.fr	Le Rolle, Virginie/AAQ-7010-2020; Hernández, Alfredo I/K-4933-2015; Gomis, Pedro/I-8740-2014	Le Rolle, Virginie/0000-0003-1068-5587; Hernández, Alfredo I/0000-0003-0765-2311; Gomis, Pedro/0000-0002-2058-7115; ROMERO PEREZ, DANIEL/0000-0001-5269-9667	French Ministry of Health (Programme Hospitalier de Recherche Clinique - PHRC Regional) [ID RCB 2007-A00887-46, 07/28-645]; la Caixa Foundation; Lefoulon-Delalande Foundation; la Caixa Foundation (Spain); Lefoulon-Delalande Foundation (France); French Ministry of Health (Programme Hospitalier de Recherche Clinique - PHRC Regional)	French Ministry of Health (Programme Hospitalier de Recherche Clinique - PHRC Regional); la Caixa Foundation(La Caixa Foundation); Lefoulon-Delalande Foundation; la Caixa Foundation (Spain)(La Caixa Foundation); Lefoulon-Delalande Foundation (France); French Ministry of Health (Programme Hospitalier de Recherche Clinique - PHRC Regional)	This work was supported by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique - PHRC Regional); ID RCB 2007-A00887-46 and reference 07/28-645. MC thanks la Caixa Foundation (URL: https://obrasociallacaixa.org/el/educacion-becas/becas-de-posgrado/europa/descripcion-del-programa) and Daniel Romero acknowledges Lefoulon-Delalande Foundation (URL: http://lefoulon-delalande.institut-de-france.fr/presentation-des-bourses-de-recherche) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the French Ministry of Health (Programme Hospitalier de Recherche Clinique - PHRC Regional). Mireia Calvo thanks la Caixa Foundation (Spain) and Daniel Romero acknowledges Lefoulon-Delalande Foundation (France) for financial support. The authors thank David Matelot for his valuable technical assistance.	Amin AS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P531, DOI 10.1161/CIRCEP.109.862441; Antzelevitch C, 2005, CIRCULATION, V111, P659, DOI 10.1161/01.CIR.0000152479.54298.51; Auger F, 1996, TIME FREQUENCY TOOLB; Bailon R, 2007, P ANN INT IEEE EMBS, P6675; Bailon R, 2006, IEEE T BIO-MED ENG, V53, P1273, DOI 10.1109/TBME.2006.871888; Behar N, 2017, EUROPACE, V19, P1730, DOI 10.1093/europace/euw224; Bigi MAB, 2008, EUROPACE, V10, P821, DOI 10.1093/europace/eum272; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Brugada J, 1998, CIRCULATION, V97, P457; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Calvo M, 2017, PHYSIOL MEAS, V38, P387, DOI 10.1088/1361-6579/aa513c; Camm AJ, 1996, EUR HEART J, V17, P354; COSTA AH, 1995, IEEE T SIGNAL PROCES, V43, P2283, DOI 10.1109/78.469860; Dumont J, 2010, IEEE T BIO-MED ENG, V57, P607, DOI 10.1109/TBME.2008.2002157; FOX SM, 1968, B NEW YORK ACAD MED, V44, P950; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; He HB, 2008, IEEE IJCNN, P1322, DOI 10.1109/IJCNN.2008.4633969; Hermida JS, 2003, EUR HEART J, V24, P2061, DOI 10.1016/j.ehj.2003.08.019; Hlawatsch F, 1992, IEEE SIGNAL PROC MAG, V9, P21, DOI 10.1109/79.127284; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Kawazoe H, 2016, HEART RHYTHM, V13, P1947, DOI 10.1016/j.hrthm.2016.07.009; Kies P, 2004, CIRCULATION, V110, P3017, DOI 10.1161/01.CIR.0000146920.35020.44; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kostopoulou A, 2010, J CARDIOVASC ELECTR, V21, P773, DOI 10.1111/j.1540-8167.2009.01702.x; Krittayaphong R, 2003, EUR HEART J, V24, P1771, DOI 10.1016/j.ehj.2003.06.005; Kuncheva L I, 2004, COMBINING PATTERN CL; Lauer MS, 1996, CIRCULATION, V93, P1520, DOI 10.1161/01.CIR.93.8.1520; Makimoto H, 2010, J AM COLL CARDIOL, V56, P1576, DOI 10.1016/j.jacc.2010.06.033; Masrur S, 2015, CLIN CARDIOL, V38, P323, DOI 10.1002/clc.22386; Matsuo K, 1999, EUR HEART J, V20, P465, DOI 10.1053/euhj.1998.1332; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Mitchell JH, 2013, EXP PHYSIOL, V98, P867, DOI 10.1113/expphysiol.2012.071001; Moody G.B., 1986, COMPUT CARDIOL, V13, P507; Nakazawa K, 2003, CIRC J, V67, P511; Orini M, 2010, IEEE ENG MED BIO, P1630, DOI 10.1109/IEMBS.2010.5626877; Paul M, 2011, PACE, V34, P1147, DOI 10.1111/j.1540-8159.2011.03127.x; Pierre B, 2007, PACE, V30, pS188; Priori SG, 2015, EUROPACE, V17, P1601, DOI 10.1093/europace/euv319; Priori SG, 2013, EUROPACE, V15, P1389, DOI 10.1093/europace/eut272; Probst V, 2010, CIRCULATION, V121, P635, DOI 10.1161/CIRCULATIONAHA.109.887026; Romero D, 2016, COMPUT CARDIOL CONF, V43, P205; SAVIN WM, 1982, J APPL PHYSIOL, V53, P1572, DOI 10.1152/jappl.1982.53.6.1572; Subramanian M, 2017, J CARDIOVASC ELECTR, V28, P677, DOI 10.1111/jce.13205; Tokuyama T, 2014, J CARDIOL, V64, P133, DOI 10.1016/j.jjcc.2013.12.001; Wichter T, 2002, CIRCULATION, V105, P702, DOI 10.1161/hc0602.103677	46	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197367	10.1371/journal.pone.0197367	http://dx.doi.org/10.1371/journal.pone.0197367			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763454	Green Published, gold			2022-12-26	WOS:000432118800042
J	Wissel, K; Brandes, G; Putz, N; Angrisani, GL; Thieleke, J; Lenar, T; Durisin, M				Wissel, Kirsten; Brandes, Gudrun; Puetz, Nils; Angrisani, Gian Luigi; Thieleke, Jan; Lenar, Thomas; Durisin, Martin			Platinum corrosion products from electrode contacts of human cochlear implants induce cell death in cell culture models	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; HEARING-LOSS; IN-VITRO; NANOPARTICLES; TOXICITY; GOLD; DISSOLUTION; INHIBITION; MECHANISMS; CISPLATIN	Despite the technological progress made with cochlear implants (CI), impedances and their diagnosis remain a focus of interest. Increases in impedance have been related to technical defects of the electrode as well as inflammatory and/or fibrosis along the electrode. Recent studies have demonstrated highly increased impedances as the result of corroded platinum (Pt) electrode contacts. This in vitro study examined the effects of Pt ions and compounds generated by corrosion of the electrode contacts of a human CI on cell metabolism. Since traces of solid Pt in surrounding cochlear tissues have been reported, the impact of commercially available Pt nanoparticles (Pt-NP, size 3 nm) on the cell culture model was also determined. For this purpose, the electrode contacts were electrically stimulated in a 0.5% aqueous NaCl solution for four weeks and the mass fraction of the platinum dissolute (Pt-Diss) was determined by mass spectrometry (ICP-MS). Metabolic activity of the murine fibroblasts (NIH 3T3) and the human neuroblastoma (SH-SY5Y) cells was determined using the WST-1 assay following exposure to Pt-Diss and Pt-NP. It was found that 5-50 mu g/ml of the Pt NP did not affect the viability of both cell types. In contrast, 100 mu g/ml of the nanoparticles caused significant loss in metabolic activity. Furthermore, transmission electron microscopy (TEM) revealed mitochondrial swelling in both cell types indicating cytotoxicity. Additionally, TEM demonstrated internalized Pt-NP in NIH 3T3 cells in a concentration dependent manner, whereas endocytosis in SH-SY5Y cells was virtually absent. In comparison with the Pt-NP, the corrosion products (Pt-Diss) with concentrations between 1.64 mu g/ ml and 8.2 mu g/ml induced cell death in both cell lines in a concentration dependent manner. TEM imaging revealed both mitochondrial disintegration and swelling of the endoplasmic reticulum, suggesting that Pt ions trigger cytotoxicity in both NIH 3T3 and SH-SY5Y cell lines by interacting with the respiratory chain.	[Wissel, Kirsten; Puetz, Nils; Lenar, Thomas; Durisin, Martin] Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany; [Wissel, Kirsten; Lenar, Thomas] NIFE, Cluster Excellence Hearing All 4, Hannover, Germany; [Brandes, Gudrun] Hannover Med Sch, Ctr Anat & Cell Biol, Inst Neuroanat & Cell Biol, Hannover, Germany; [Puetz, Nils] Tech Univ Dresden, Biotechnol Ctr, Dresden, Germany; [Angrisani, Gian Luigi] Leibniz Univ Hannover, Inst Mat Sci, Hannover, Germany; [Thieleke, Jan] Leibniz Univ Hannover, Inst Inorgan Chem, Hannover, Germany	Hannover Medical School; Hannover Medical School; Technische Universitat Dresden; Leibniz University Hannover; Leibniz University Hannover	Wissel, K (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany.; Wissel, K (corresponding author), NIFE, Cluster Excellence Hearing All 4, Hannover, Germany.	wissel.kirsten@mh-hannover.de			Deutsche Forschungsgemeinschaft [240032230]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant by the Deutsche Forschungsgemeinschaft, 240032230, recipients: Martin Durisin and Thomas Lenarz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, 109935 ISO; [Anonymous], 32645 DIN; [Anonymous], 3840251201509 DIN, DOI [10.1006/abbi.1993.1311, DOI 10.1006/ABBI.1993.1311]; Artelt S, 1999, SCI TOTAL ENVIRON, V228, P219, DOI 10.1016/S0048-9697(99)00049-2; Asharani PV, 2011, NANOTOXICOLOGY, V5, P43, DOI 10.3109/17435390.2010.489207; Asharani PV, 2010, NANOMEDICINE-UK, V5, P51, DOI [10.2217/nnm.09.85, 10.2217/NNM.09.85]; Barrese JC, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026003; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bierer JA, 2010, TRENDS AMPLIF, V14, P84, DOI 10.1177/1084713810375249; BRUMMER SB, 1977, BRAIN BEHAV EVOLUT, V14, P10, DOI 10.1159/000124611; Clark A, 2011, J NANOPART RES, V13, P5547, DOI 10.1007/s11051-011-0544-3; Clark G M, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P40; Clark Graeme M, 2014, Cochlear Implants Int, V15 Suppl 2, pS1, DOI 10.1179/1754762814Y.0000000087; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Durisin Martin, 2011, Cochlear Implants Int, V12, P228, DOI 10.1179/1754762810Y.0000000007; Elder A, 2007, ADV MATER, V19, P3124, DOI 10.1002/adma.200701962; Eshraghi AA, 2006, ANAT REC PART A, V288A, P473, DOI 10.1002/ar.a.20305; Gehrke H, 2011, ARCH TOXICOL, V85, P799, DOI 10.1007/s00204-010-0636-3; Gencoglu A, 2009, LAB CHIP, V9, P1866, DOI 10.1039/b820126a; George S, 2011, ACS NANO, V5, P1805, DOI 10.1021/nn102734s; Hashimoto M, 2016, EUR J ORAL SCI, V124, P68, DOI 10.1111/eos.12235; Hashimoto M, 2016, J BIOMED MATER RES A, V104, P209, DOI 10.1002/jbm.a.35557; Hebert C, 2014, CARBON, V71, P27, DOI 10.1016/j.carbon.2013.12.083; Hibbert DB, 2000, BIOMATERIALS, V21, P2177, DOI 10.1016/S0142-9612(00)00146-0; Horie M, 2012, CHEM RES TOXICOL, V25, P605, DOI 10.1021/tx200470e; Horie M, 2011, METALLOMICS, V3, P1244, DOI 10.1039/c1mt00060h; Huang CQ, 2001, ANN BIOMED ENG, V29, P791, DOI 10.1114/1.1397793; Jia H, 2013, ANN OTO RHINOL LARYN, V122, P33, DOI 10.1177/000348941312200107; Kajita M, 2007, FREE RADICAL RES, V41, P615, DOI 10.1080/10715760601169679; Kumar GP, 2014, INT J PHARMACEUT, V471, P146, DOI 10.1016/j.ijpharm.2014.05.033; Lenarz T, 2013, CURR PHARM BIOTECHNO, V14, P112; MCHARDY J, 1980, BIOMATERIALS, V1, P129, DOI 10.1016/0142-9612(80)90034-4; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Musa S, 2011, ANAL CHEM, V83, P4012, DOI 10.1021/ac103037u; Nadol JB, 2004, OTOL NEUROTOL, V25, P257, DOI 10.1097/00129492-200405000-00010; Nadol Joseph B, 2006, Adv Otorhinolaryngol, V64, P31, DOI 10.1159/000094643; Nadol JB, 2014, HEARING RES, V318, P11, DOI 10.1016/j.heares.2014.09.007; Nam KY, 2014, J ADV PROSTHODONT, V6, P207, DOI 10.4047/jap.2014.6.3.207; Neuburger J, 2009, INT J AUDIOL, V48, P233, DOI 10.1080/14992020802600808; O'Malley JT, 2017, OTOL NEUROTOL, V38, P970, DOI 10.1097/MAO.0000000000001454; Osterauer R, 2009, CHEMOSPHERE, V77, P975, DOI 10.1016/j.chemosphere.2009.08.033; PASCOE JM, 1974, BIOCHEM PHARMACOL, V23, P1345, DOI 10.1016/0006-2952(74)90354-2; Pelka J, 2009, CHEM RES TOXICOL, V22, P649, DOI 10.1021/tx800354g; Piret G, 2015, BIOMATERIALS, V53, P173, DOI 10.1016/j.biomaterials.2015.02.021; ROBBLEE LS, 1980, BIOMATERIALS, V1, P135, DOI 10.1016/0142-9612(80)90035-6; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Rosenberg B. B., 1971, PLATIN MET REV, V15, P42; Sawosz E, 2010, INT J NANOMED, V5, P631, DOI 10.2147/IJN.S12361; Schacht J, 2012, ANAT REC, V295, P1837, DOI 10.1002/ar.22578; SHEPHERD RK, 1985, BIOMATERIALS, V6, P237, DOI 10.1016/0142-9612(85)90019-5; Somdas MA, 2007, AUDIOL NEURO-OTOL, V12, P277, DOI 10.1159/000103208; Sorensen SN, 2016, ENVIRON SCI TECHNOL, V50, P10635, DOI 10.1021/acs.est.6b01072; Spiers Kathryn, 2016, Cochlear Implants Int, V17, P129, DOI 10.1080/14670100.2016.1157943; Wang HS, 2005, MATER CHEM PHYS, V94, P449, DOI 10.1016/j.matchemphys.2005.05.005; Watanabe A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/45/455105; Wilk M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147552; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005; Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1; Zhang L, 2006, BIOCHEMISTRY-US, V45, P8959, DOI 10.1021/bi060027g; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001	60	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196649	10.1371/journal.pone.0196649	http://dx.doi.org/10.1371/journal.pone.0196649			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763442	Green Published, gold			2022-12-26	WOS:000432118800014
J	Gatton, ML; Ciketic, S; Barnwell, JW; Cheng, Q; Chiodini, PL; Incardona, S; Bell, D; Cunningham, J; Gonzalez, IJ				Gatton, Michelle L.; Ciketic, Sadmir; Barnwell, John W.; Cheng, Qin; Chiodini, Peter L.; Incardona, Sandra; Bell, David; Cunningham, Jane; Gonzalez, Iveth J.			An assessment of false positive rates for malaria rapid diagnostic tests caused by non-Plasmodium infectious agents and immunological factors	PLOS ONE			English	Article							RHEUMATOID-FACTOR; ASSAY	Background Malaria rapid diagnostic tests (RDTs) can produce false positive (FP) results in patients with human African trypanosomiasis and rheumatoid factor (RF), but specificity against other infectious agents and immunological factors is largely unknown. Low diagnostic specificity caused by cross-reactivity may lead to over-estimates of the number of malaria cases and over-use of antimalarial drugs, at the cost of not diagnosing and treating the true underlying condition. Methods Data from the WHO Malaria RDT Product Testing Programme was analysed to assess FP rates of 221 RDTs against four infectious agents (Chagas, dengue, Leishmaniasis and Schistosomiasis) and four immunological factors (anti-nuclear antibody, human anti-mouse antibody (HAMA), RF and rapid plasma regain). Only RDTs with a FP rate against clean negative samples less than 10% were included. Paired t-tests were used to compare product-specific FP rates on clean negative samples and samples containing non-Plasmodium infectious agents and immunological factors. Results Forty (18%) RDTs showed no FP results against any tested infectious agent or immunological factor. In the remaining RDTs significant and clinically relevant increases in FP rates were observed for samples containing HAMA and RF (P<0.001). There were significant correlations between product-matched FP rates for RF and HAMA on all RDT test bands P<0.001), and FP rates for each infectious agent and immunological factor were also correlated between test bands of combination RDTs (P <= 0.002). Conclusions False positive results against non-Plasmodium infectious agents and immunological factors does not appear to be a universal property of malaria RDTs. However, since many malaria RDTs have elevated FP rates against HAMA and RF positive samples practitioners may need to consider the possibility of false positive results for malaria in patients with conditions that stimulate HAMA or RF.	[Gatton, Michelle L.; Ciketic, Sadmir] Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia; [Barnwell, John W.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Cheng, Qin] Australian Def Force Malaria & Infect Dis Inst, Drug Resistance & Diagnost, Brisbane, Qld, Australia; [Chiodini, Peter L.] Hosp Trop Dis, London, England; [Chiodini, Peter L.] London Sch Hyg & Trop Med, London, England; [Incardona, Sandra; Bell, David; Gonzalez, Iveth J.] FIND, Geneva, Switzerland; [Cunningham, Jane] WHO, Global Malaria Programme, Geneva, Switzerland; [Bell, David] Global Good Fund, Intellectual Ventures Lab, Bellevue, WA USA	Queensland University of Technology (QUT); Centers for Disease Control & Prevention - USA; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Foundation For Innovative New Diagnostics; World Health Organization; Intellectual Ventures	Gatton, ML (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Brisbane, Qld, Australia.	m.gatton@qut.edu.cn	Cheng, Qin/AAO-2198-2020; Gatton, Michelle/H-3139-2019	Cheng, Qin/0000-0001-7776-4437; Gatton, Michelle/0000-0003-1188-609X	Australian Department of Foreign Affairs and Trade (DFAT); UK Department for International Development (DFID); Bill and Melinda Gates Foundation; UNITAID; UCL Hospitals' Infection, Immunity and Inflammation research theme	Australian Department of Foreign Affairs and Trade (DFAT)(Australian Government); UK Department for International Development (DFID); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UNITAID; UCL Hospitals' Infection, Immunity and Inflammation research theme	This work was supported by the Australian Department of Foreign Affairs and Trade (DFAT), UK Department for International Development (DFID), The Bill and Melinda Gates Foundation, and UNITAID. PLC is supported by UCL Hospitals' Infection, Immunity and Inflammation research theme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEBAJO AO, 1994, J RHEUMATOL, V21, P968; Andreoli A, 2015, AM J TROP MED HYG, V92, P834, DOI 10.4269/ajtmh.13-0757; Antonescu C, 1998, BLOOD, V92, P3486, DOI 10.1182/blood.V92.9.3486; Gillet P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002180; Global Malaria Programme, 2016, REC SEL CRIT PROC MA; Grobusch MP, 1999, LANCET, V353, P297, DOI 10.1016/S0140-6736(05)74930-8; Iqbal J, 2000, J CLIN MICROBIOL, V38, P1184, DOI 10.1128/JCM.38.3.1184-1186.2000; Kricka LJ, 1999, CLIN CHEM, V45, P942; Laferi H, 1997, NEW ENGL J MED, V337, P1635, DOI 10.1056/NEJM199711273372219; Lee JH, 2014, J CLIN MICROBIOL, V52, P3784, DOI 10.1128/JCM.01797-14; Leshem E, 2011, J CLIN MICROBIOL, V49, P2331, DOI 10.1128/JCM.00307-11; Meatherall B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-377; Mills LA, 2010, AM J TROP MED HYG, V82, P145, DOI 10.4269/ajtmh.2010.09-0408; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; WHO Prequalication Team, 2017, TECHN SPEC SER SUBM; World Health Organization, 2017, DEPRESSION; World Health Organization, 2014, MAL RAP DIAGN TEST P	17	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197395	10.1371/journal.pone.0197395	http://dx.doi.org/10.1371/journal.pone.0197395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758050	Green Published, gold, Green Accepted			2022-12-26	WOS:000432082900044
J	Ge, LX; Yap, CW; Heng, BH				Ge, Lixia; Yap, Chun Wei; Heng, Bee Hoon			Sex differences in associations between multimorbidity and physical function domains among community-dwelling adults in Singapore	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-CARE GROUP; OLDER-ADULTS; DISABILITY INSTRUMENT; DIABETES-MELLITUS; CHRONIC DISEASES; PREVALENCE; PEOPLE; RISK; EPIDEMIOLOGY	Objectives The aims of the study were to identify the associations between multimorbidity and specific physical function domains among community-dwelling adults in Singapore, and to examine sex differences in the associations. Methods This study was conducted using baseline data of 1,940 participants in the Population Health Index Survey conducted in the Central Region of Singapore from November 2015 to November 2016. Physical function was assessed using the Function Component of the Late-life Function and Disability Instrument and compared between men and women. Multiple linear regressions were conducted to examine associations between multimorbidity and different physical function domains for all participants, and in men and women separately. Results The prevalence of multimorbidity in the study population was 35.0% for adults aged 21 years and above, with no differences between men and women. Multimorbidity was associated with reduced upper extremity function, basic and advanced lower extremity function, and overall function in men and women after adjusting for demographic factors. Multimorbidity had a stronger association with advanced lower extremity function and overall physical function in women than in men. Conclusions The findings of this study indicate that multimorbidity is associated with physical function domains in men and women, and in particular advanced lower extremity for women. Effective community-based interventions need to be implemented to preserve physical function in individuals with multimorbidity to keep them functionally independent and physically active in the community. Additional focus on advanced lower extremity function for women is needed.	[Ge, Lixia; Yap, Chun Wei; Heng, Bee Hoon] Natl Healthcare Grp Pte Ltd, Hlth Serv & Outcomes Res, Singapore, Singapore		Ge, LX (corresponding author), Natl Healthcare Grp Pte Ltd, Hlth Serv & Outcomes Res, Singapore, Singapore.	lixia_ge@nhg.com.sg	GE, LIXIA/ABA-5474-2020; Yap, Chun Wei/B-2587-2010	GE, LIXIA/0000-0001-8080-7020; Yap, Chun Wei/0000-0002-2004-3492	National Healthcare Group Pte Ltd	National Healthcare Group Pte Ltd	This work was supported by National Healthcare Group Pte Ltd in the form of salaries for all authors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts S, 2012, J PSYCHOSOM RES, V73, P211, DOI 10.1016/j.jpsychores.2012.05.014; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beauchamp MK, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-12; Beenakker KGM, 2010, AGEING RES REV, V9, P431, DOI 10.1016/j.arr.2010.05.005; Buttery AK, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0377-0; Debigare R, 2008, J APPL PHYSIOL, V105, P751, DOI 10.1152/japplphysiol.90336.2008a; Formiga F, 2005, J AM GERIATR SOC, V53, P1836, DOI 10.1111/j.1532-5415.2005.53528_4.x; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Franssen FME, 2002, MED SCI SPORT EXER, V34, P1570, DOI 10.1097/00005768-200210000-00007; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Garcia-Olmos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032141; Garin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111498; Ge LX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182145; Griffith L, 2010, AGE AGEING, V39, P738, DOI 10.1093/ageing/afq105; Haley SM, 2002, J GERONTOL A-BIOL, V57, pM217, DOI 10.1093/gerona/57.4.M217; Heng BH, 2010, ANN ACAD MED SINGAP, V39, P348; Hu Y, 2016, J EPIDEMIOL COMMUN H, V70, P1128, DOI 10.1136/jech-2015-206548; IJzerman TH, 2012, DIABETES RES CLIN PR, V95, P345, DOI 10.1016/j.diabres.2011.10.026; Jette A. M., 2006, LATE LIFE FDI MANUAL; Jindai K, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160174; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kuo HK, 2005, J AM GERIATR SOC, V53, P1154, DOI 10.1111/j.1532-5415.2005.53368.x; Kupzyk KA, 2016, J NURS MEAS, V24, P323, DOI 10.1891/1061-3749.24.2.323; LaPier TK, 2012, PHYSIOTHER CAN, V64, P53, DOI 10.3138/ptc.2010-30; Liu JJ, 2016, DIABETIC MED, V33, P332, DOI 10.1111/dme.13020; Loza E, 2009, SEMIN ARTHRITIS RHEU, V38, P312, DOI 10.1016/j.semarthrit.2008.01.004; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Oksuzyan A, 2014, EUR J EPIDEMIOL, V29, P243, DOI 10.1007/s10654-014-9893-4; Padilla J, 2008, J NEPHROL, V21, P550; Painter P, 1999, ADV RENAL REPLACE TH, V6, P110, DOI 10.1016/S1073-4449(99)70028-2; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Picco L, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1421-7; Smith SM, 2007, BRIT J GEN PRACT, V57, P268; Stenholm S, 2015, J GERONTOL A-BIOL, V70, P330, DOI 10.1093/gerona/glu113; Subramaniam M, 2014, GEN HOSP PSYCHIAT, V36, P375, DOI 10.1016/j.genhosppsych.2014.03.002; Sugimoto H., 2014, HEALTH, V6, P792, DOI DOI 10.4236/HEALTH.2014.68101; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Tinetti ME, 2004, AM J MED, V116, P179, DOI 10.1016/j.amjmed.2003.09.031; Toh MPHS, 2009, ANN ACAD MED SINGAP, V38, P546; Tseng LA, 2014, J GERONTOL A-BIOL, V69, P93, DOI 10.1093/gerona/glt027; Walker V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169282; Wang LL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-016-0580-x; Wei MY, 2016, AM J EPIDEMIOL, V184, P357, DOI 10.1093/aje/kwv456; Welmer AK, 2012, AGING CLIN EXP RES, V24, P480, DOI 10.3275/8584	48	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197443	10.1371/journal.pone.0197443	http://dx.doi.org/10.1371/journal.pone.0197443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF6MZ	29758072	gold, Green Published, Green Submitted			2022-12-26	WOS:000432082900049
J	Zhao, CH; Li, YT; Qiu, W; He, FX; Zhang, WM; Zhao, D; Zhang, ZW; Zhang, EB; Ma, P; Liu, YQ; Ma, L; Yang, FM; Wang, YW; Shu, YQ				Zhao, Chenhui; Li, Yongting; Qiu, Wen; He, Fengxia; Zhang, Weiming; Zhao, Dan; Zhang, Zhiwei; Zhang, Erbao; Ma, Pei; Liu, Yiqian; Ma, Ling; Yang, Fengming; Wang, Yingwei; Shu, Yongqian			C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation	ONCOGENE			English	Article							RAT THY-1 NEPHRITIS; GLOMERULAR MESANGIAL CELLS; PROMOTES PROLIFERATION; COMPLEMENT-SYSTEM; ANAPHYLATOXIN C5A; CARCINOMA-CELLS; COLON-CANCER; EXPRESSION; GROWTH; PROGRESSION	Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, and multiple evidence has confirmed that C5a production is elevated in NSCLC microenvironment. Although NSCLC cell proliferation induced by C5a has been reported, the involved mechanism has not been elucidated. In this study, we examined the proliferation-related genes (i.e., KLF5, GCN5, and GDF15) and C5a receptor (C5aR) expression in tumor tissues as well as C5a concentration in plasma of NSCLC patients, and then determined the roles of KLF5, GCN5, and GDF15 in C5a-triggered NSCLC cell proliferation and the related mechanism both in vitro and in vivo. Our results found that the expression of KLF5, GCN5, GDF15, C5aR, and C5a was significantly upregulated in NSCLC patients. Mechanistic exploration in vitro revealed that C5a could facilitate A549 cell proliferation through increasing KLF5, GCN5, and GDF15 expression. Besides, KLF5 and GCN5 could form a complex, binding to GDF15 promoter in a KLF5-dependent manner and leading to GDF15 gene transcription. More importantly, GCN5-mediated KLF5 acetylation contributing to GDF15 gene transcription and cell proliferation upon C5a stimulation, the region (-103 to + 58 nt) of GDF15 promoter which KLF5 could bind to, and two new KLF5 lysine sites (K335 and K391) acetylated by GCN5 were identified for the first time. Furthermore, our experiment in vivo demonstrated that the growth of xenograft tumors in BALB/c nude mice was greatly suppressed by the silence of KLF5, GCN5, or GDF15. Collectively, these findings disclose that C5a-driven KLF5-GCN5-GDF15 axis had a critical role in NSCLC proliferation and might serve as targets for NSCLC therapy.	[Zhao, Chenhui; Ma, Pei; Liu, Yiqian; Ma, Ling; Yang, Fengming; Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Li, Yongting; Qiu, Wen; Zhao, Dan; Zhang, Zhiwei; Wang, Yingwei] Nanjing Med Univ, Dept Immunol, Nanjing, Jiangsu, Peoples R China; [He, Fengxia] Nanjing Med Univ, Affiliated Hosp 2, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Zhang, Weiming] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Zhang, Erbao] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Zhang, Erbao] Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Shu, YQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	shuyqtg@126.com	Ma, Pei/ABD-6343-2021; Shu, Yongqian/ABD-5698-2021	He, Fengxia/0000-0002-1695-3127	National Natural Science Foundations of China [81272532, 81472626, 81672896]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundations of China (Nos. 81272532, 81472626, and 81672896). We thank Fuqiang Wang for technical assistance.	Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Bruzzese F, 2014, CANCER RES, V74, P3408, DOI 10.1158/0008-5472.CAN-13-2259; Cai KM, 2014, ONCOL REP, V32, P2260, DOI 10.3892/or.2014.3420; Carrillo-Garcia C, 2014, DEVELOPMENT, V141, P773, DOI 10.1242/dev.096131; Chen L, 2013, J BIOL CHEM, V288, P14510, DOI 10.1074/jbc.M113.458737; Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Du C, 2016, FEBS LETT, V590, P408, DOI 10.1002/1873-3468.12069; Griner SE, 2013, BIOCHEM PHARMACOL, V85, P46, DOI 10.1016/j.bcp.2012.10.007; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; He FX, 2016, J MOL CELL BIOL, V8, P477, DOI 10.1093/jmcb/mjw021; Hou M, 2017, CELL PHYSIOL BIOCHEM, V43, P1767, DOI 10.1159/000484063; Imamura T, 2016, BREAST CANCER-TOKYO, V23, P876, DOI 10.1007/s12282-015-0654-3; Jia L, 2016, ONCOGENE, V35, P2040, DOI 10.1038/onc.2015.263; Kadara H, 2006, CANCER BIOL THER, V5, P518, DOI 10.4161/cbt.5.5.2602; Kaypee S, 2016, PHARMACOL THERAPEUT, V162, P98, DOI 10.1016/j.pharmthera.2016.01.011; Kikuchi H, 2005, GENE, V347, P83, DOI 10.1016/j.gene.2004.12.007; Kim JS, 2005, MOL CANCER THER, V4, P487; Li Q, 2014, CELL PHYSIOL BIOCHEM, V33, P1, DOI 10.1159/000356645; Li XC, 2014, INT J ONCOL, V45, P1507, DOI 10.3892/ijo.2014.2544; Liu K, 2015, INT J MOL SCI, V16, P21897, DOI 10.3390/ijms160921897; Liu T, 2003, CANCER RES, V63, P5034; Lu Y, 2014, ONCOL REP, V32, P2817, DOI 10.3892/or.2014.3489; Maeda Y, 2015, ONCOL REP, V33, P1844, DOI 10.3892/or.2015.3800; Majaz S, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0114-6; Mamidi S, 2017, IMMUNOBIOLOGY, V222, P45, DOI 10.1016/j.imbio.2015.11.008; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2009, CANCER RES, V69, P6367, DOI 10.1158/0008-5472.CAN-09-1918; Nitta H, 2014, ONCOL REP, V32, P1715, DOI 10.3892/or.2014.3341; Noritsugu K, 2017, BIOCHEM BIOPH RES CO, V489, P455, DOI 10.1016/j.bbrc.2017.05.170; Pandey MK, 2017, NATURE, V543, P108, DOI 10.1038/nature21368; Piao CM, 2015, J BIOL CHEM, V290, P10667, DOI 10.1074/jbc.M114.612622; Qiu W, 2012, J PATHOL, V226, P619, DOI 10.1002/path.3011; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Sayegh ET, 2014, CANCER MED-US, V3, P747, DOI 10.1002/cam4.241; Takabayashi T, 2004, SURGERY, V135, P544, DOI 10.1016/j.surg.2003.09.010; Tanno T, 2014, BLOOD, V123, P725, DOI 10.1182/blood-2013-08-524025; Towner LD, 2016, J BIOL CHEM, V291, P14927, DOI 10.1074/jbc.M115.708446; Tu M, 2014, MOL MED REP, V10, P663, DOI 10.3892/mmr.2014.2317; Urakawa N, 2015, LAB INVEST, V95, P491, DOI 10.1038/labinvest.2015.36; Vadrevu SK, 2014, CANCER RES, V74, P3454, DOI 10.1158/0008-5472.CAN-14-0157; Wan JH, 2015, NUCLEIC ACIDS RES, V43, P3591, DOI 10.1093/nar/gkv238; Wang JC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003830; Wang L, 2014, CANCER RES, V74, P4720, DOI 10.1158/0008-5472.CAN-14-0960; Wang YG, 2017, NATURE, V552, P273, DOI 10.1038/nature25003; Yin YW, 2015, GENE EXPRESSION, V16, P187, DOI 10.3727/105221615X14399878166230; Zhang EB, 2017, NUCLEIC ACIDS RES, V45, P3086, DOI 10.1093/nar/gkw1247; Zhang H, 2017, ONCOGENE, V36, P5609, DOI 10.1038/onc.2017.163; Zhang J, 2014, FASEB J, V28, P1511, DOI 10.1096/fj.13-242693; Zheng X, 2018, ONCOGENE, V37, P502, DOI 10.1038/onc.2017.354	50	39	47	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 30	2018	37	35					4821	4837		10.1038/s41388-018-0298-9	http://dx.doi.org/10.1038/s41388-018-0298-9			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS0BA	29773900	Green Published, hybrid			2022-12-26	WOS:000443146000005
J	Zhou, X; Li, GH; An, SQ; Li, WX; Yang, HH; Guo, YC; Dai, Z; Dai, SX; Zheng, JJ; Huang, JF; Iavarone, A; Zhao, XD				Zhou, Xia; Li, Gonghua; An, Sanqi; Li, Wen-Xing; Yang, Huihui; Guo, Yicheng; Dai, Zhi; Dai, Shaoxing; Zheng, Junjuan; Huang, Jingfei; Iavarone, Antonio; Zhao, Xudong			A new method of identifying glioblastoma subtypes and creation of corresponding animal models	ONCOGENE			English	Article							ONCOGENE ACTIVATION; CO-DELETION; MUTATIONS; GENE; GLIOMAS; IDH1; CANCER; DEFINE; 1P/19Q	Glioblastoma (GBM) accounts for up to 50% of brain parenchymal tumors. It is the most malignant type of brain cancer with very poor survival and limited remedies. Cancer subtyping is important for cancer research and therapy. Here, we report a new subtyping method for GBM based on the genetic alterations of CDKN2A and TP53 genes. CDKN2A and TP53 are the most frequently mutated genes with mutation rates of 60 and 30%, respectively. We found that patients with deletion of CDKN2A possess worse survival than those with TP53 mutation. Interestingly, survival of patients with both TP53 mutation and CDKN2A deletion is no worse than for those with only one of these genetic alterations, but similar to those with TP53 mutation alone. Next, we investigated differences in the gene expression profile between TP53 and CDKN2A samples. Consistent with the survival data, the samples with both TP53 mutation and CDKN2A deletion showed a gene expression profile similar to those samples with TP53 mutation alone. Finally, we found that activation of RAS pathway plus Cdkn2a/b silencing can induce GBM, in a similar way to tumor induction by RAS activation plus TP53 silencing. In conclusion, we show that the genetic alterations of CDKN2A and TP53 may be used to stratify GBM, and the new animal models matching this stratification method were generated.	[Zhou, Xia; An, Sanqi; Yang, Huihui; Dai, Zhi; Zhao, Xudong] Chinese Acad Sci, Kunming Inst Zool, Key Lab Bioact Peptides Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Zhou, Xia; An, Sanqi; Yang, Huihui; Guo, Yicheng; Dai, Zhi; Dai, Shaoxing; Zheng, Junjuan; Huang, Jingfei; Zhao, Xudong] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650204, Yunnan, Peoples R China; [Li, Gonghua; An, Sanqi; Li, Wen-Xing; Guo, Yicheng; Dai, Shaoxing; Zheng, Junjuan; Huang, Jingfei] Chinese Acad Sci, Kunming Inst Zool, Lab Evolutionary & Funct Genom, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Li, Wen-Xing] Anhui Univ, Inst Hlth Sci, Hefei 230601, Anhui, Peoples R China; [Iavarone, Antonio] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Zhao, Xudong] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming 650223, Yunnan, Peoples R China; [Zhao, Xudong] Soochow Univ, Coll Pharmaceut Sci, KIZ SU Joint Lab Anim Model & Drug Dev, Suzhou 215000, Jiangsu, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Anhui University; Columbia University; Chinese Academy of Sciences; Soochow University - China	Zhao, XD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Bioact Peptides Yunnan Prov, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.; Huang, JF; Zhao, XD (corresponding author), Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650204, Yunnan, Peoples R China.; Huang, JF (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Lab Evolutionary & Funct Genom, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China.; Iavarone, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.; Zhao, XD (corresponding author), Chinese Acad Sci, Kunming Primate Res Ctr, Kunming 650223, Yunnan, Peoples R China.; Zhao, XD (corresponding author), Soochow Univ, Coll Pharmaceut Sci, KIZ SU Joint Lab Anim Model & Drug Dev, Suzhou 215000, Jiangsu, Peoples R China.	huangjf@mail.kiz.ac.cn; ai2102@cumc.columbia.edu; zhaoxudong@mail.kiz.ac.cn	Dai, shaoxing/ABA-8699-2020	zhao, zhao xu dong/0000-0001-9126-7365; Li, Wen-Xing/0000-0001-9984-8439; Li, Gong-Hua/0000-0002-9311-6613; Guo, Yicheng/0000-0001-5357-660X; Iavarone, Antonio/0000-0002-0683-4634	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA 01040403]; National Natural Science Foundation of China (NSFC) [81171960]; Top Talents Program of Yunnan Province China [2012HA014]; Yunnan Applied Basic Research Projects [2013FA020]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Top Talents Program of Yunnan Province China; Yunnan Applied Basic Research Projects	We thank Dr. Dong Yang and Qiu Tu for the useful advice. We also thank Yujie Xia for technical assistance with the histological analysis. This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA 01040403), the National Natural Science Foundation of China (NSFC, 81171960), the Top Talents Program of Yunnan Province China (2012HA014) to XZ, and Yunnan Applied Basic Research Projects (2013FA020).	Arvold ND, 2014, CLIN INTERV AGING, V9, P357, DOI 10.2147/CIA.S44259; Bhowmick DA, 2004, CANCER RES, V64, P1220, DOI 10.1158/0008-5472.CAN-03-3137; Boots-Sprenger SHE, 2013, MODERN PATHOL, V26, P922, DOI 10.1038/modpathol.2012.166; Brennan CW, 2014, CELL, V157, P753, DOI 10.1016/j.cell.2014.04.004; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Costa BM, 2010, CANCER RES, V70, P453, DOI 10.1158/0008-5472.CAN-09-2189; Dong SM, 2005, J NEUROPATH EXP NEUR, V64, P948, DOI 10.1097/01.jnen.0000186940.14779.90; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geraerts M, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-34; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Helseth R, 2010, ACTA NEUROL SCAND, V122, P159, DOI 10.1111/j.1600-0404.2010.01350.x; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Ichimura K, 1996, ONCOGENE, V13, P1065; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Kato H, 2000, CLIN CANCER RES, V6, P3937; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Liu YC, 2013, IEEE T CYBERNETICS, V43, P982, DOI 10.1109/TSMCB.2012.2220543; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Marusyk Andriy, 2010, Biochim Biophys Acta, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Mischel PS, 2003, J NEUROPATH EXP NEUR, V62, P542; Mistry M, 2015, J CLIN ONCOL, V33, P1015, DOI 10.1200/JCO.2014.58.3922; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Noushmehr Houtan, 2010, Cancer Cell, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Popova SN, 2014, HISTOPATHOLOGY, V64, P365, DOI 10.1111/his.12252; Qian WF, 2010, TRENDS GENET, V26, P425, DOI 10.1016/j.tig.2010.07.002; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rothschild G, 2006, MOL CELL BIOL, V26, P4351, DOI 10.1128/MCB.01743-05; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stancheva G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/654727; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Tu Q, 2018, ONCOGENE, V37, P128, DOI 10.1038/onc.2017.316; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vogazianou AP, 2010, NEURO-ONCOLOGY, V12, P664, DOI 10.1093/neuonc/nop075; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010	50	2	2	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 30	2018	37	35					4781	4791		10.1038/s41388-018-0305-1	http://dx.doi.org/10.1038/s41388-018-0305-1			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS0BA	29769617				2022-12-26	WOS:000443146000002
J	Okura, T; Nakamura, R; Fujioka, Y; Kawamoto-Kitao, S; Ito, Y; Matsumoto, K; Shoji, K; Sumi, K; Matsuzawa, K; Izawa, S; Ueta, E; Kato, M; Imamura, T; Taniguchi, S; Yamamoto, K				Okura, Tsuyoshi; Nakamura, Risa; Fujioka, Yohei; Kawamoto-Kitao, Sonoko; Ito, Yuichi; Matsumoto, Kazuhisa; Shoji, Kyoko; Sumi, Keisuke; Matsuzawa, Kazuhiko; Izawa, Shoichiro; Ueta, Etsuko; Kato, Masahiko; Imamura, Takeshi; Taniguchi, Shin-ichi; Yamamoto, Kazuhiro			CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance-A preliminary research	PLOS ONE			English	Article							BETA-CELL FUNCTION; HOMEOSTASIS MODEL ASSESSMENT; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; SENSITIVITY; SECRETION; CLAMP; ASSOCIATION; PEPTIDE; RATES	Background Increased hepatic insulin clearance (HIC) is important in the pathophysiology of type 2 diabetes mellitus (T2DM). The aim of this study is to analyze an effective insulin resistance (IR) index that is minimally affected by HIC. Methods Our study involved 20 participants with T2DM and 21 healthy participants without diabetes (Non-DM). Participants underwent a meal tolerance test from which plasma glucose, insulin and serum C-peptide immunoreactivity (CPR) were measured, and HOMA-IR and HIC were calculated. Participants then underwent a hyperinsulinemic-euglycemic clamp from which the glucose disposal rate (GDR) was measured. Results The index CPR-IR = 20/(fasting CPR x fasting plasma glucose) was correlated more strongly with GDR, than was HOMA-IR, and CPR-IR could be used to estimate GDR. In T2DM participants with HIC below the median, HOMA-IR and CPR-IR were equally well correlated with GDR. In T2DM with high HIC, CPR-IR correlated with GDR while HOMA-IR did not. In Non-DM, CPR-IR and HOMA-IR were equally well correlated with GDR regardless of HIC. The mean HIC value in T2DM was significantly higher than that of Non-DM. Conclusions CPR-IR could be a simple and effective index of insulin resistance for patients with type 2 diabetes that is minimally affected by HIC.	[Okura, Tsuyoshi; Nakamura, Risa; Fujioka, Yohei; Kawamoto-Kitao, Sonoko; Ito, Yuichi; Matsumoto, Kazuhisa; Shoji, Kyoko; Sumi, Keisuke; Matsuzawa, Kazuhiko; Izawa, Shoichiro; Kato, Masahiko; Yamamoto, Kazuhiro] Tottori Univ, Dept Mol Med & Therapeut, Div Cardiovasc Med Endocrinol & Metab, Fac Med, Yonago, Tottori, Japan; [Ueta, Etsuko] Tottori Univ, Sch Hlth Sci, Fac Med, Yonago, Tottori, Japan; [Imamura, Takeshi] Tottori Univ, Div Mol Pharmacol, Fac Med, Yonago, Tottori, Japan; [Taniguchi, Shin-ichi] Tottori Univ, Dept Reg Med, Fac Med, Yonago, Tottori, Japan	Tottori University; Tottori University; Tottori University; Tottori University	Okura, T (corresponding author), Tottori Univ, Dept Mol Med & Therapeut, Div Cardiovasc Med Endocrinol & Metab, Fac Med, Yonago, Tottori, Japan.	ohkura@med.tottori-u.ac.jp		Okura, Tsuyoshi/0000-0003-3713-6617	JSPS KAKENHI [16K08935, 26870373]; Japan Diabetes Foundation; Japan Association for Diabetes Education and Care; Tottori University Faculty of Medicine Research Grant; Tottori University Hospital Research Grant; MSD research grant	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Diabetes Foundation; Japan Association for Diabetes Education and Care; Tottori University Faculty of Medicine Research Grant; Tottori University Hospital Research Grant; MSD research grant	This work was supported by a JSPS KAKENHI Grant-in-Aid for Scientific Research (C) grant number 16K08935 (2016-2019), JSPS KAKENHI Grant-in-Aid for Young Scientists (B) grant number 26870373 (2014-2015), the Japan Diabetes Foundation (2013), grants for young researchers from the Japan Association for Diabetes Education and Care (2013, 2014), Tottori University Faculty of Medicine Research Grant (2013) and Tottori University Hospital Research Grant (2013). This work also supported by the MSD research grant (2013, 2015).	Ahren B, 2005, DIABETOLOGIA, V48, P2140, DOI 10.1007/s00125-005-1915-z; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Anderwald C, 2007, DIABETES CARE, V30, P2374, DOI 10.2337/dc07-0422; [Anonymous], 2016, SAMPL SIZ CALC; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chiu KC, 2000, DIABETES CARE, V23, P1353, DOI 10.2337/diacare.23.9.1353; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; EATON RP, 1983, J CLIN ENDOCR METAB, V56, P1294, DOI 10.1210/jcem-56-6-1294; EATON RP, 1980, J CLIN ENDOCR METAB, V51, P520, DOI 10.1210/jcem-51-3-520; Ekholm E, 2017, ENDOCR PRACT, V23, P258, DOI 10.4158/EP161323.OR; Funakoshi S, 2008, DIABETES RES CLIN PR, V82, P353, DOI 10.1016/j.diabres.2008.09.010; Hsu WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028311; KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262; Kang ES, 2005, METABOLISM, V54, P206, DOI 10.1016/j.metabol.2004.08.014; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kawamori R, 1998, DIABETES RES CLIN PR, V41, P35, DOI 10.1016/S0168-8227(98)00056-4; Kodama K, 2013, DIABETES CARE, V36, P1789, DOI 10.2337/dc12-1235; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; National Institutes of Diabetes and Digestive and Kidney Diseases, 1999, HBA1C CONV; Ohkura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-21; Pivovarova O, 2013, DIABETES CARE, V36, P3779, DOI 10.2337/dc12-1203; POLONSKY KS, 1986, J CLIN INVEST, V77, P98, DOI 10.1172/JCI112308; Sakurai Y, 2011, J DIABETES INVEST, V2, P310, DOI 10.1111/j.2040-1124.2010.00091.x; Sato F, 2007, J CLIN ENDOCR METAB, V92, P3326, DOI 10.1210/jc.2006-2384; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Tamaki M, 2009, ISLETS, V1, P124, DOI 10.4161/isl.1.2.9433; Uwaifo GI, 2002, DIABETES CARE, V25, P2081, DOI 10.2337/diacare.25.11.2081; Viskochil R, 2017, J APPL PHYSIOL, V123, P243, DOI 10.1152/japplphysiol.00790.2016; Yoshino Gen, 2006, Journal of the Japan Diabetes Society, V49, P361	32	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197663	10.1371/journal.pone.0197663	http://dx.doi.org/10.1371/journal.pone.0197663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791512	gold, Green Submitted, Green Published			2022-12-26	WOS:000433077000051
J	Spead, O; Verreet, T; Donelson, CJ; Poulain, FE				Spead, Olivia; Verreet, Tine; Donelson, Cory J.; Poulain, Fabienne E.			Characterization of the caspase family in zebrafish	PLOS ONE			English	Article							NON-APOPTOTIC ROLES; PROGRAMMED CELL-DEATH; AXON DEGENERATION; DECREASED APOPTOSIS; GENOME DUPLICATION; ANIMAL DEVELOPMENT; ACTIVE CASPASE-3; BERGMANN GLIA; EVOLUTION; DIFFERENTIATION	First discovered for their role in mediating programmed cell death and inflammatory responses, caspases have now emerged as crucial regulators of other cellular and physiological processes including cell proliferation, differentiation, migration, and survival. In the developing nervous system, for instance, the non-apoptotic functions of caspases have been shown to play critical roles in the formation of neuronal circuits by regulating axon outgrowth, guidance and pruning. How caspase activity is spatially and temporally maintained at sub-lethal levels within cells remains however poorly understood, especially in vivo. Thanks to its transparency and accessibility, the zebrafish offers the unique ability to directly visualize caspase activation in vivo. Yet, detailed information about the caspase family in zebrafish is lacking. Here, we report the identification and characterization of 19 different caspase genes in zebrafish, and show that caspases have diverse expression profiles from cleavage to larval stages, suggesting highly specialized and/or redundant functions during embryonic development.	[Spead, Olivia; Verreet, Tine; Donelson, Cory J.; Poulain, Fabienne E.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Poulain, FE (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	fpoulain@mailbox.sc.edu		POULAIN, Fabienne/0000-0002-7867-748X	National Institutes of Health [R00NS083714]; University of South Carolina; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS083714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant award R00NS083714 from the National Institutes of Health to FEP (https://grants.nih.gov/grants/oer.htm) and startup funds from the University of South Carolina to FEP (https://www.sc.eda/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Bell RAV, 2017, CELL DEATH DIFFER, V24, P1359, DOI 10.1038/cdd.2017.37; Bergmann A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3145re8; Burgon P. G., 2017, SEMIN CELL DEV BIOL; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Campbell DS, 2013, J CELL BIOL, V203, P657, DOI 10.1083/jcb.201303072; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Connolly PF, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00149; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; Deshmukh, 2017, SEMIN CELL DEV BIOL; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Eckhart L, 2005, J BIOL CHEM, V280, P35077, DOI 10.1074/jbc.C500282200; Eckhart L, 2008, MOL BIOL EVOL, V25, P831, DOI 10.1093/molbev/msn012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Gulyaeva NV, 2003, J NEUROSCI RES, V73, P853, DOI 10.1002/jnr.10730; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Huang WB, 2010, FISH SHELLFISH IMMUN, V28, P587, DOI 10.1016/j.fsi.2009.12.016; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Inohara N, 2000, CELL DEATH DIFFER, V7, P509, DOI 10.1038/sj.cdd.4400679; Keller N., 2018, SEMIN CELL DEV BIOL; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuo CT, 2006, NEURON, V51, P283, DOI 10.1016/j.neuron.2006.07.014; Kuranaga E, 2011, DEV GROWTH DIFFER, V53, P137, DOI 10.1111/j.1440-169X.2010.01237.x; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Masumoto J, 2003, J BIOL CHEM, V278, P4268, DOI 10.1074/jbc.M203944200; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mukherjee A, 2017, CELL DEATH DIFFER, V24, P1411, DOI 10.1038/cdd.2017.64; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Ohsawa S, 2010, P NATL ACAD SCI USA, V107, P13366, DOI 10.1073/pnas.0910488107; Oomman S, 2006, BRAIN RES, V1078, P19, DOI 10.1016/j.brainres.2006.01.041; Oomman S, 2005, DEV BRAIN RES, V160, P130, DOI 10.1016/j.devbrainres.2005.07.010; Perez-Garijo A, 2017, SEMIN CELL DEV BIOL; Pompeiano M, 2000, J COMP NEUROL, V423, P1; Poulain FE, 2013, NEURON, V78, P49, DOI 10.1016/j.neuron.2013.02.005; Poulain FE, 2010, METHOD CELL BIOL, V100, P3, DOI 10.1016/B978-0-12-384892-5.00001-3; Rotschafer SE, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00084; Sakamaki K, 2009, J FISH BIOL, V74, P727, DOI 10.1111/j.1095-8649.2009.02184.x; Sakamaki K, 2015, BIOESSAYS, V37, P767, DOI 10.1002/bies.201500010; Sakata S, 2007, GENE, V396, P134, DOI 10.1016/j.gene.2007.03.010; Salvesen GS, 2014, SEMIN IMMUNOL, V26, P246, DOI 10.1016/j.smim.2014.03.005; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Stepanichev MY, 2005, NEUROSCIENCE, V136, P579, DOI 10.1016/j.neuroscience.2005.08.010; Takle H, 2006, COMP BIOCHEM PHYS B, V144, P188, DOI 10.1016/j.cbpb.2006.02.006; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Unsain N, 2015, NEURON, V88, P461, DOI 10.1016/j.neuron.2015.08.029; Unsain N, 2013, CELL REP, V4, P751, DOI 10.1016/j.celrep.2013.07.015; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westphal D, 2010, J BIOL CHEM, V285, P42046, DOI 10.1074/jbc.M110.177147; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Williams DW, 2006, NAT NEUROSCI, V9, P1234, DOI 10.1038/nn1774; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Xu LQ, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-60; Xue YL, 2006, AM J HUM GENET, V78, P659, DOI 10.1086/503116; Yamaguchi Y, 2015, DEV CELL, V32, P478, DOI 10.1016/j.devcel.2015.01.019; Yang J, 2013, NEURON, V80, P1175, DOI 10.1016/j.neuron.2013.08.034	67	19	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197966	10.1371/journal.pone.0197966	http://dx.doi.org/10.1371/journal.pone.0197966			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791492	Green Submitted, Green Published, gold			2022-12-26	WOS:000433077000071
J	Moura, BD; Ferreira, ND; DosSantos, MF; Janini, MER				Moura, Brenda de Souza; Ferreira, Natalia dos Reis; DosSantos, Marcos F.; Rangel Janini, Maria Elisa			Changes in the vibration sensitivity and pressure pain thresholds in patients with burning mouth syndrome	PLOS ONE			English	Article							VISUAL ANALOG SCALE; QUESTIONNAIRE; DISORDERS; UPDATE	Objective To investigate the presence of changes in vibration detection and pressure pain threshold in patients with burning-mouth syndrome (BMS). Design of the study Case-control study. The sample was composed of 30 volunteers, 15 with BMS and 15 in the control group. The pressure-pain threshold (PPT) and vibration-detection threshold (VDT) were examined. The clinical evaluation was complemented with the McGill Pain Questionnaire (MPQ), Douleur Neuropathique 4 (DN4) and Beck Depression and Anxiety Inventories (BDI and BAI, respectively). Results BMS subjects showed a statistically significant higher PPT in the tongue (p = 0.002), right (p = 0.001) and left (p = 0.004) face, and a significant reduction of the VDT in the tongue (p = 0.013) and right face (p = 0.030). Significant differences were also found when comparing the PPT and the VDT of distinct anatomical areas. However, a significant interaction (group x location) was only for the PPT. BMS subjects also showed significantly higher levels of depression (p = 0.01), as measured by the BDI, compared to controls; and a significant inverse correlation between the VDT in the left face and anxiety levels was detected. Conclusions The study of somatosensory changes in BMS and its correlations with the clinical features as well as the levels of anxiety and depression expands current understanding of the neuropathic origin and the possible contribution of psychogenic factors related to this disease.	[Moura, Brenda de Souza; Rangel Janini, Maria Elisa] Univ Fed Rio de Janeiro, Fac Odontol, Dept Patol & Diagnost Oral, Rio De Janeiro, Brazil; [Moura, Brenda de Souza; Ferreira, Natalia dos Reis; DosSantos, Marcos F.] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Radiol, Rio De Janeiro, Brazil; [DosSantos, Marcos F.] Univ Fed Rio de Janeiro, ICB, LMC, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	DosSantos, MF (corresponding author), Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Radiol, Rio De Janeiro, Brazil.; DosSantos, MF (corresponding author), Univ Fed Rio de Janeiro, ICB, LMC, Rio De Janeiro, Brazil.	santosmfh@gmail.com	Moura, Brenda/M-5359-2018; DosSantos, Marcos/E-8913-2014; DosSantos, Marcos/AAR-7308-2020	Moura, Brenda/0000-0003-1550-7907; DosSantos, Marcos/0000-0002-5997-9693; DosSantos, Marcos/0000-0002-5997-9693				[Anonymous], 2005, ORAL SURG ORAL MED O, V99, P48, DOI [10.1016/j.tripleo.2004.01.021, DOI 10.1016/J.TRIPLEO.2004.01.021]; Bergdahl M, 1999, J ORAL PATHOL MED, V28, P350; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Braud A, 2013, J OROFAC PAIN, V27, P235, DOI 10.11607/jop.1038; Charleston L, 2013, CURR PAIN HEADACHE R, V17, P336, DOI 10.1007/s11916-013-0336-9; Cruccu G, 2004, EUR J NEUROL, V11, P153, DOI 10.1111/j.1468-1331.2004.00791.x; de Siqueira SRDT, 2013, OR SURG OR MED OR PA, V115, pE37, DOI 10.1016/j.oooo.2013.02.014; de Souza FTA, 2012, J PSYCHOSOM RES, V72, P142, DOI 10.1016/j.jpsychores.2011.11.008; Forssell H, 2015, J ORAL REHABIL, V42, P300, DOI 10.1111/joor.12256; Forssell H, 2002, PAIN, V99, P41, DOI 10.1016/S0304-3959(02)00052-0; Girden ER, 1992, QUANTITATIVE APPL SO, V07; Gremeau-Richard C, 2010, PAIN, V149, P27, DOI 10.1016/j.pain.2009.11.016; GRUSHKA M, 1987, PAIN, V28, P169, DOI 10.1016/0304-3959(87)90114-X; GRUSHKA M, 1987, ORAL SURG ORAL MED O, V63, P30, DOI 10.1016/0030-4220(87)90336-7; Gurvits GE, 2013, WORLD J GASTROENTERO, V19, P665, DOI 10.3748/wjg.v19.i5.665; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Heo JY, 2015, J ORAL FACIAL PAIN H, V29, P177, DOI 10.11607/ofph.1326; Jaaskelainen SK, 2012, CLIN NEUROPHYSIOL, V123, P71, DOI 10.1016/j.clinph.2011.07.054; Jaaskelainen SK, 1997, PAIN, V73, P455, DOI 10.1016/S0304-3959(97)00140-1; LAMEY PJ, 1988, BRIT MED J, V296, P1243, DOI 10.1136/bmj.296.6631.1243; Lauria G, 2005, PAIN, V115, P332, DOI 10.1016/j.pain.2005.03.028; Maffei Laura, 2014, J Diabetes Sci Technol, V8, P621, DOI 10.1177/1932296814527818; Malik Rohit, 2012, J Midlife Health, V3, P36, DOI 10.4103/0976-7800.98816; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Mo XY, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0565-x; Paes FAA, 2009, THESIS; Pigg M, 2010, PAIN, V148, P220, DOI 10.1016/j.pain.2009.10.024; Pimenta C A, 1996, Rev Esc Enferm USP, V30, P473; Puhakka A, 2016, ORAL DIS, V22, P338, DOI 10.1111/odi.12454; Puhakka AP, 2010, CLIN NEUROPHYSIOL, V121, pS230; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Scala A, 2003, CRIT REV ORAL BIOL M, V14, P275, DOI 10.1177/154411130301400405; Shearer A, 2003, DIABETES CARE, V26, P2305, DOI 10.2337/diacare.26.8.2305; Taiminen T, 2011, SCAND J PAIN, V2, P155, DOI 10.1016/j.sjpain.2011.06.004; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197834	10.1371/journal.pone.0197834	http://dx.doi.org/10.1371/journal.pone.0197834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782537	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100046
J	Frederick, TE; Peng, JW				Frederick, Thomas E.; Peng, Jeffrey W.			A gratuitous beta-Lactamase inducer uncovers hidden active site dynamics of the Staphylococcus aureus BIaR1 sensor domain	PLOS ONE			English	Article							TRIPLE-RESONANCE EXPERIMENTS; N-ZETA-DECARBOXYLATION; NMR-SPECTROSCOPY; BLAR1 PROTEIN; SIGNAL-TRANSDUCTION; ACINETOBACTER-BAUMANNII; ANTIBIOTIC-RESISTANCE; CHEMICAL-EXCHANGE; METHICILLIN; FLEXIBILITY	Increasing evidence shows that active sites of proteins have non-trivial conformational dynamics. These dynamics include active site residues sampling different local conformations that allow for multiple, and possibly novel, inhibitor binding poses. Yet, active site dynamics garner only marginal attention in most inhibitor design efforts and exert little influence on synthesis strategies. This is partly because synthesis requires a level of atomic structural detail that is frequently missing in current characterizations of conformational dynamics. In particular, while the identity of the mobile protein residues may be clear, the specific conformations they sample remain obscure. Here, we show how an appropriate choice of ligand can significantly sharpen our abilities to describe the interconverting binding poses (conformations) of protein active sites. Specifically, we show how 2-(2'-carboxyphenyl)-benzoyl-6-aminopenicillanic acid (CBAP) exposes otherwise hidden dynamics of a protein active site that binds p-lactam antibiotics. When CBAP acylates (binds) the active site serine of the p-lactam sensor domain of BIaR1 (BIaRS), it shifts the time scale of the active site dynamics to the slow exchange regime. Slow exchange enables direct characterization of inter-converting protein and bound ligand conformations using NMR methods. These methods include chemical shift analysis, 2-d exchange spectroscopy, off-resonance ROESY of the bound ligand, and reduced spectral density mapping. The active site architecture of BlaRs is shared by many beta-lactamases of therapeutic interest, suggesting CBAP could expose functional motions in other p-lactam binding proteins. More broadly, CBAP highlights the utility of identifying chemical probes common to structurally homologous proteins to better expose functional motions of active sites.	[Frederick, Thomas E.; Peng, Jeffrey W.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Peng, Jeffrey W.] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Frederick, Thomas E.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	University of Notre Dame; University of Notre Dame; Washington University (WUSTL)	Peng, JW (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Peng, JW (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.	Jeffrey.W.Peng.6@nd.edu			National Institutes of Health [GM085109-01A1, T32GM075762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM085109-01A1 (to JWP) and T32GM075762 (to TEF).	Archer GL, 2001, SCIENCE, V291, P1915, DOI 10.1126/science.1059671; Archer Gordon L., 1994, Trends in Microbiology, V2, P343, DOI 10.1016/0966-842X(94)90608-4; BETTINGER GE, 1970, J BACTERIOL, V104, P283, DOI 10.1128/JB.104.1.283-288.1970; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; Borbulevych O, 2011, J BIOL CHEM, V286, P31466, DOI 10.1074/jbc.M111.252189; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Cavanagh J., 2010, PROTEIN NMR SPECTROS; Cha J, 2007, J AM CHEM SOC, V129, P3834, DOI 10.1021/ja070472e; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Chen K, 2011, J MAGN RESON, V213, P151, DOI 10.1016/j.jmr.2011.09.042; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; Connelly PR, 2011, NAT CHEM, V3, P692, DOI 10.1038/nchem.1121; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAYIE KT, 1994, J MAGN RESON SER A, V111, P121, DOI 10.1006/jmra.1994.1236; De Luca F, 2011, P NATL ACAD SCI USA, V108, P18424, DOI 10.1073/pnas.1110530108; DESVAUX H, 1994, J MAGN RESON SER A, V108, P219, DOI 10.1006/jmra.1994.1114; DESVAUX H, 1995, J MAGN RESON SER A, V113, P47, DOI 10.1006/jmra.1995.1054; Ernst R.R., 1990, PRINCIPLES NUCL MAGN; Falagas ME, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-24; Ferrage F, 2010, J MAGN RESON, V207, P294, DOI 10.1016/j.jmr.2010.09.014; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Fleming A, 1929, B WORLD HEALTH ORGAN, V79, P780; Frederick TE, 2014, BIOCHEMISTRY-US, V53, P10, DOI 10.1021/bi401552j; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Goffin C, 2002, MICROBIOL MOL BIOL R, V66, P702, DOI 10.1128/MMBR.66.4.702-738.2002; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; Gomes JANF, 2001, CHEM REV, V101, P1349, DOI 10.1021/cr990323h; Grein F, 2002, J PHYS CHEM A, V106, P3823, DOI 10.1021/jp0122124; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; Hanique S, 2004, J BIOL CHEM, V279, P14264, DOI 10.1074/jbc.M313488200; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kay LE, 2016, J MOL BIOL, V428, P323, DOI 10.1016/j.jmb.2015.11.028; Keller R., COMPUTER AIDED RESON; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kovermann M, 2017, P NATL ACAD SCI USA, V114, P6298, DOI 10.1073/pnas.1700919114; Kumarasiri M, 2012, J BIOL CHEM, V287, P8232, DOI 10.1074/jbc.M111.333179; LEGGATE J, 1968, J BACTERIOL, V96, P2110, DOI 10.1128/JB.96.6.2110-2117.1968; Lisi GP, 2016, PROG NUCL MAG RES SP, V92-93, P1, DOI 10.1016/j.pnmrs.2015.11.001; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Llarrull LI, 2012, BIOCHEMISTRY-US, V51, P4642, DOI 10.1021/bi300429p; Llarrull LI, 2011, J BIOL CHEM, V286, P38148, DOI 10.1074/jbc.M111.288985; Llarrull LI, 2009, ANTIMICROB AGENTS CH, V53, P4051, DOI 10.1128/AAC.00084-09; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Mitchell JM, 2015, BIOCHEMISTRY-US, V54, P1976, DOI 10.1021/bi501547k; MONTELIONE GT, 1989, J AM CHEM SOC, V111, P3096, DOI 10.1021/ja00190a072; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Mulder FAA, 1998, J MAGN RESON, V131, P351, DOI 10.1006/jmre.1998.1380; Palmer AG, 2014, J MAGN RESON, V241, P3, DOI 10.1016/j.jmr.2014.01.008; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; Peng JW, 2002, BIOCHEMISTRY-US, V31, P8571; Press W. H., 1992, ART SCI COMPUTING; RICHMOND MH, 1967, J MOL BIOL, V26, P357, DOI 10.1016/0022-2836(67)90305-1; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Staude MW, 2016, BIOCHEMISTRY-US, V55, P6535, DOI 10.1021/acs.biochem.6b00806; Staude MW, 2015, BIOCHEMISTRY-US, V54, P1600, DOI 10.1021/bi501463k; Teague SJ, 2003, NAT REV DRUG DISCOV, V2, P527, DOI 10.1038/nrd1129; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Wishart DS, 2001, METHOD ENZYMOL, V338, P3	64	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197241	10.1371/journal.pone.0197241	http://dx.doi.org/10.1371/journal.pone.0197241			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771929	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900038
J	Dziewulska, K; Pilarska, M				Dziewulska, Katarzyna; Pilarska, Malwina			Inhibitory effect of K+ ions and influence of other ions and osmolality on the spermatozoa motility of European burbot (Lota lota L.)	PLOS ONE			English	Article							SEMINAL PLASMA COMPOSITION; PADDLEFISH POLYODON-SPATHULA; WHITEFISH COREGONUS-LAVARETUS; TROUT SALVELINUS-FONTINALIS; FRESH-WATER FISH; TRUTTA M. TRUTTA; SPERM MOTILITY; RAINBOW-TROUT; SALMO-TRUTTA; MEMBRANE HYPERPOLARIZATION	Background In fish with external fertilization, two main start-up mechanisms of the path that blocks or activates the spermatozoan motility apparatus are known. The main factor managing the path is osmolality or potassium ion. In burbot from the European and North American population, contradictory findings regarding the factors influencing the onset of spermatozoa motility were reported. The objective of the current study was to determine the effect of potassium and osmolality on the spermatozoa activation of European burbot, Lota lota (Actinopterygii, Gadiformes, Lotidae). Moreover, the influence of pH, as well as sodium ion concentrations on spermatozoa motility was investigated. Seven parameters characterising motility were traced by means of computer-assisted sperm analysis (CASA). Principal findings The spermatozoa of European burbot are K+ ion-sensitive. A 6-mM KCl solution significantly decreased motility, and above 12-mM (50 mOsm kg(-1)) totally ceased spermatozoa movement. Sucrose and Na+ solutions inhibited spermatozoa movement only at concentrations > 450-480 mOsm kg(-1). Greater differences in the percentage of motile sperm between individuals were noted in solutions containing high concentrations of chemicals triggering sperm motility. The optimum osmolality for spermatozoa motility is in the range of 100-200 mOsm kg(-1). The burbot spermatozoa were motile over a wide range of pH values with the best activation at pH 9. Conclusion It was demonstrated that the spermatozoa of European burbot are inhibited by K+ ions similarly as in North American burbot. Other electrolyte and non-electrolyte solutions inhibit spermatozoa movement only if their osmolality is greater than that of the physiological osmolality of seminal plasma. The data provided on basic knowledge of burbot spermatozoa allow to ensure appropriate conditions during artificial reproduction and scientific research.	[Dziewulska, Katarzyna; Pilarska, Malwina] Univ Szczecin, Fac Biol, Dept Gen Zool, Szczecin, Poland; [Dziewulska, Katarzyna] Univ Szczecin, Ctr Mol Biol & Biotechnol, Szczecin, Poland	University of Szczecin; University of Szczecin	Dziewulska, K (corresponding author), Univ Szczecin, Fac Biol, Dept Gen Zool, Szczecin, Poland.; Dziewulska, K (corresponding author), Univ Szczecin, Ctr Mol Biol & Biotechnol, Szczecin, Poland.	katarzyna.dziewulska@usz.edu.p		Dziewulska, Katarzyna/0000-0001-7439-8398	Ministry of Science and Higher Education, Poland	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	Ministry of Science and Higher Education, Poland to KD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAS GH, 1991, AQUACULTURE, V95, P125, DOI 10.1016/0044-8486(91)90079-M; Alavi SMH, 2007, THERIOGENOLOGY, V68, P276, DOI 10.1016/j.theriogenology.2007.05.045; Alavi SMH, 2011, COMP BIOCHEM PHYS A, V160, P166, DOI 10.1016/j.cbpa.2011.05.026; Alavi SMH, 2010, THERIOGENOLOGY, V74, P317, DOI 10.1016/j.theriogenology.2010.02.017; Alavi SMH, 2009, THERIOGENOLOGY, V72, P32, DOI 10.1016/j.theriogenology.2009.01.015; Alavi SMH, 2009, COMP BIOCHEM PHYS A, V153, P430, DOI 10.1016/j.cbpa.2009.04.001; Alavi SMH, 2008, AQUAT LIVING RESOUR, V21, P75, DOI 10.1051/alr:2008011; Alavi SMH, 2006, CELL BIOL INT, V30, P1, DOI 10.1016/j.cellbi.2005.06.004; Alavi SMH, 2005, CELL BIOL INT, V29, P101, DOI 10.1016/j.cellbi.2004.11.021; Alavi SMH, 2004, REPRODUCTION, V128, P819, DOI 10.1530/rep.1.00244; Alavi SMH, 2004, AQUAC RES, V35, P1238, DOI 10.1111/j.1365-2109.2004.01132.x; BAYNES SM, 1981, J FISH BIOL, V19, P259, DOI 10.1111/j.1095-8649.1981.tb05830.x; BILLARD R, 1986, REPROD NUTR DEV, V26, P877, DOI 10.1051/rnd:19860601; BILLARD R, 1992, J EXP ZOOL, V261, P122, DOI 10.1002/jez.1402610203; BOITANO S, 1992, CELL MOTIL CYTOSKEL, V21, P74, DOI 10.1002/cm.970210109; BOITANO S, 1991, J CELL SCI, V98, P343; Bozkurt Y, 2009, ISR J AQUACULT-BAMID, V61, P307; Butts IAE, 2013, COMP BIOCHEM PHYS A, V166, P147, DOI 10.1016/j.cbpa.2013.05.011; Cejko BI, 2010, AQUAC RES, V41, P804, DOI 10.1111/j.1365-2109.2009.02357.x; Christ SA, 1996, J FISH BIOL, V48, P1210, DOI 10.1111/j.1095-8649.1996.tb01815.x; CHRISTEN R, 1987, EUR J BIOCHEM, V166, P667, DOI 10.1111/j.1432-1033.1987.tb13565.x; Ciereszko A, 2010, J APPL ICHTHYOL, V26, P665, DOI 10.1111/j.1439-0426.2010.01536.x; Cosson J, 2008, J APPL ICHTHYOL, V24, P460, DOI 10.1111/j.1439-0426.2008.01151.x; Cosson J, 1996, FOLIA ZOOL, V45, P361; Cosson J, 2010, J FISH BIOL, V76, P240, DOI 10.1111/j.1095-8649.2009.02504.x; COSSON MP, 1991, CELL MOTIL CYTOSKEL, V20, P55, DOI 10.1002/cm.970200107; Dadras H, 2017, 6 INT WORKSH BIOL FI, V09, p[4, 99]; Dadras H, 2017, AQUAC RES, V48, P729, DOI 10.1111/are.13049; Dietrich GJ, 2007, ADV LIMNOL, V60, P159; Dietrich GJ, 2010, FISH PHYSIOL BIOCHEM, V36, P419, DOI 10.1007/s10695-009-9311-0; DUPLINSKY PD, 1982, T AM FISH SOC, V111, P768, DOI 10.1577/1548-8659(1982)111&lt;768:SMONPA&gt;2.0.CO;2; Dziewulska K, 2008, J APPL ICHTHYOL, V24, P497, DOI 10.1111/j.1439-0426.2008.01133.x; Dziewulska K, 2013, THERIOGENOLOGY, V79, P48, DOI 10.1016/j.theriogenology.2012.09.008; Froese R, 2017, FISHBASE WORLD WIDE; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; GATTI JL, 1990, J CELL PHYSIOL, V143, P546, DOI 10.1002/jcp.1041430320; Hatef A, 2007, AQUAC RES, V38, P1175, DOI 10.1111/j.1365-2109.2007.01784.x; HAYASHI H, 1987, J BIOL CHEM, V262, P16692; He SY, 2004, THERIOGENOLOGY, V61, P1487, DOI 10.1016/j.theriogenology.2003.08.015; Hu J., 2009, WORLD C COMP SCI INF, V5, P702, DOI DOI 10.HTTPS://D0I.0RG/10.1016/J.THERI0GEN0L0GY.2009.05.009; Hulak M, 2008, CYBIUM, V32, P189; HWANG PC, 1969, J FISH RES BOARD CAN, V26, P413, DOI 10.1139/f69-040; Inaba K, 1998, J CELL SCI, V111, P1105; Ingermann RL, 2002, J EXP BIOL, V205, P2885; Keith P, 2002, AQUAT CONSERV, V12, P169, DOI 10.1002/aqc.502; Kho KH, 2004, J MICROBIOL BIOTECHN, V14, P456; Kho KH, 2003, J MICROBIOL BIOTECHN, V13, P833; Kho KH, 2001, ZOOL SCI, V18, P919, DOI 10.2108/zsj.18.919; Koldras M, 1996, AQUAT LIVING RESOUR, V9, P337, DOI 10.1051/alr:1996036; Koldras Malgorzata, 1997, Polskie Archiwum Hydrobiologii, V44, P49; Kowalski RK, 2006, AQUACULTURE, V261, P760, DOI 10.1016/j.aquaculture.2006.08.038; Krasznai Z, 2000, P NATL ACAD SCI USA, V97, P2052, DOI 10.1073/pnas.040558097; Krasznai Z, 2003, CELL MOTIL CYTOSKEL, V55, P232, DOI 10.1002/cm.10125; KRASZNAI Z, 1995, AQUACULTURE, V129, P123, DOI 10.1016/0044-8486(94)00234-F; KRUGER JCD, 1984, J FISH BIOL, V24, P263, DOI 10.1111/j.1095-8649.1984.tb04797.x; Lahnsteiner F, 1997, J APPL ICHTHYOL, V13, P113, DOI 10.1111/j.1439-0426.1997.tb00110.x; Lahnsteiner F, 2002, FISH PHYSIOL BIOCHEM, V27, P49, DOI 10.1023/B:FISH.0000021792.97913.2e; Lahnsteiner F, 1996, FISH PHYSIOL BIOCHEM, V15, P167, DOI 10.1007/BF01875596; Lahnsteiner F, 1998, AQUACULTURE, V163, P163, DOI 10.1016/S0044-8486(98)00243-9; LAHNSTEINER F, 1995, J FISH BIOL, V47, P492, DOI 10.1111/j.1095-8649.1995.tb01917.x; Lahnsteiner F, 2014, FISH PHYSIOL BIOCHEM, V40, P469, DOI 10.1007/s10695-013-9858-7; Lin F, 1996, T AM FISH SOC, V125, P187, DOI 10.1577/1548-8659(1996)125&lt;0187:COMSIU&gt;2.3.CO;2; Lin F, 1996, T AM FISH SOC, V125, P195, DOI 10.1577/1548-8659(1996)125&lt;0195:COMSIE&gt;2.3.CO;2; Linhart O, 1999, J FISH BIOL, V55, P1344, DOI 10.1111/j.1095-8649.1999.tb02080.x; Linhart O, 2003, J APPL ICHTHYOL, V19, P177, DOI 10.1046/j.1439-0426.2003.00470.x; LINHART O, 1995, J FISH BIOL, V47, P902, DOI 10.1111/j.1095-8649.1995.tb06011.x; Linhart O, 2002, REPRODUCTION, V124, P713, DOI 10.1530/rep.0.1240713; Linhart O, 2000, AQUAT LIVING RESOUR, V13, P455, DOI 10.1016/S0990-7440(00)01068-8; MARSHALL WS, 1989, GEN COMP ENDOCR, V75, P118, DOI 10.1016/0016-6480(89)90016-6; MARSHALL WS, 1986, CAN J ZOOL, V64, P1827, DOI 10.1139/z86-272; Morisawa M, 2008, J APPL ICHTHYOL, V24, P362, DOI 10.1111/j.1439-0426.2008.01126.x; MORISAWA M, 1979, COMP BIOCHEM PHYS A, V64, P325, DOI 10.1016/0300-9629(79)90451-1; MORISAWA M, 1987, J EXP ZOOL, V242, P199, DOI 10.1002/jez.1402420211; MORISAWA M, 1982, NATURE, V295, P703, DOI 10.1038/295703a0; MORISAWA M, 1985, BIOMED RES-TOKYO, V6, P181; MORISAWA M, 1985, ZOOL SCI, V2, P605; MORISAWA M, 1980, SCIENCE, V210, P1145, DOI 10.1126/science.7444445; MORISAWA M, 1983, J EXP BIOL, V107, P105; MORISAWA M, 1983, J EXP BIOL, V107, P95; MORISAWA S, 1988, J EXP BIOL, V136, P13; Morita M, 2006, COMP BIOCHEM PHYS A, V143, P361, DOI 10.1016/j.cbpa.2005.12.020; Morita M, 2003, J EXP BIOL, V206, P913, DOI 10.1242/jeb.00153; MUNKITTRICK KR, 1987, AQUACULTURE, V64, P147, DOI 10.1016/0044-8486(87)90350-4; ODA S, 1993, CELL MOTIL CYTOSKEL, V25, P171, DOI 10.1002/cm.970250206; Paragamian VL, 2008, AM FISH S S, V59, P213; PERCHEC G, 1993, J APPL ICHTHYOL, V9, P129, DOI 10.1111/j.1439-0426.1993.tb00389.x; Poupard GP, 1997, J REPROD FERTIL, V110, P315, DOI 10.1530/jrf.0.1100315; Rosengrave P, 2009, COMP BIOCHEM PHYS A, V152, P123, DOI 10.1016/j.cbpa.2008.09.009; SCHIEMER F, 1989, Regulated Rivers Research and Management, V4, P397, DOI 10.1002/rrr.3450040407; TAKAI H, 1995, J CELL SCI, V108, P1175; Tan-Fermin JD, 1999, AQUACULTURE, V171, P323, DOI 10.1016/S0044-8486(98)00402-5; TANIMOTO S, 1988, DEV GROWTH DIFFER, V30, P117; TANIMOTO S, 1994, MOL REPROD DEV, V39, P409, DOI 10.1002/mrd.1080390409; Toth GP, 1997, AQUACULTURE, V154, P337, DOI 10.1016/S0044-8486(97)00066-5; Van Houdt JK, 2003, MOL PHYLOGENET EVOL, V29, P599, DOI 10.1016/S1055-7903(03)00133-7; Van Houdt JKJ, 2005, MOL ECOL, V14, P2445, DOI 10.1111/j.1365-294X.2005.02590.x; Witkowski Andrzej, 2009, Chronmy Przyrode Ojczysta, V65, P33; Wojtczak M, 2007, ADV LIMNOL, V60, P171; Worthington T, 2010, AQUAT CONSERV, V20, P371, DOI 10.1002/aqc.1113; Zilli L, 2017, AQUACULTURE, V472, P73, DOI 10.1016/j.aquaculture.2016.03.043; Zilli L, 2011, THERIOGENOLOGY, V76, P737, DOI 10.1016/j.theriogenology.2011.04.006; Zuccarelli MD, 2007, J FISH BIOL, V70, P178, DOI 10.1111/j.1095-8649.2006.01293.x	102	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196415	10.1371/journal.pone.0196415	http://dx.doi.org/10.1371/journal.pone.0196415			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768446	gold, Green Submitted, Green Published			2022-12-26	WOS:000432329200025
J	Leschak, CJ; Eisenberge, NI				Leschak, Carrianne J.; Eisenberge, Naomi, I			The role of social relationships in the link between olfactory dysfunction and mortality	PLOS ONE			English	Article							BULB REMOVAL; HUMAN ODOR; IDENTIFICATION; RECOGNITION; AGGRESSION; RESPONSES; BEHAVIOR; SUPPORT; HEALTH	Recent work suggests that olfactory dysfunction is a strong predictor of five-year mortality in older adults. Based on past work showing: 1) that olfactory dysfunction impairs social functioning and 2) that social ties are linked with mortality, the current work explored whether impairments in social life mediated the relationship between olfactory dysfunction and mortality. Additionally, based on work showing gender differences in the social consequences of olfactory dysfunction, gender was assessed as a potential moderator of this association. Social network size mediated the olfactory-mortality link for females. To probe what feature of social networks was driving this effect, we investigated two subcomponents of social life: emotional closeness (e.g., perceived social support, loneliness) and physical closeness (e.g., physical contact, in-person socializing with others). Physical closeness significantly mediated the olfactory-mortality link for females, even after controlling for social network size. Emotional closeness did not mediate this link. Possible mechanisms underlying this relationship are discussed.	[Leschak, Carrianne J.; Eisenberge, Naomi, I] Univ Calif Los Angeles, Dept Psychol, 405 Hilgard Ave, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Eisenberge, NI (corresponding author), Univ Calif Los Angeles, Dept Psychol, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	neisenbe@ucla.edu		Leschak, Carrianne/0000-0002-5930-8566				ALEXANDER G, 1977, APPL ANIM ETHOL, V3, P127, DOI 10.1016/0304-3762(77)90021-9; Boesveldt S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45118; Brand G, 2001, Q J EXP PSYCHOL-B, V54, P259, DOI 10.1080/02724990143000045; CHEAL ML, 1971, PSYCHOL REP, V29, P195, DOI 10.2466/pr0.1971.29.1.195; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; Croy I, 2013, BIOL PSYCHOL, V92, P292, DOI 10.1016/j.biopsycho.2012.11.008; DEVOR M, 1972, AM ZOOL, V12, P653; Ditzen B, 2007, PSYCHONEUROENDOCRINO, V32, P565, DOI 10.1016/j.psyneuen.2007.03.011; FERREIRA A, 1987, BEHAV NEUROSCI, V101, P709, DOI 10.1037/0735-7044.101.5.709; Field T., 2012, PSYCHOLOGY, V3, P467, DOI [10.4236/psych.2012.36066, DOI 10.4236/PSYCH.2012.36066]; Goldstein P, 2016, J PAIN, V17, P1049, DOI 10.1016/j.jpain.2016.06.007; HOFER MA, 1984, PSYCHOSOM MED, V46, P183, DOI 10.1097/00006842-198405000-00001; HOLD B, 1977, Z TIERPSYCHOL, V43, P225; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Keller A, 2013, BMC EAR NOSE THROAT, V13, DOI 10.1186/1472-6815-13-8; KIRKPATRICK B, 1994, PHYSIOL BEHAV, V55, P885, DOI 10.1016/0031-9384(94)90075-2; Lubke KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094314; Lundstrom JN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00597; Macfarlane A, 1975, Ciba Found Symp, P103; McGann JP, 2017, SCIENCE, V356, DOI 10.1126/science.aam7263; Mueller C, 2006, AM J RHINOL, V20, P113, DOI 10.1177/194589240602000121; MURPHY MR, 1976, BRAIN RES, V113, P95, DOI 10.1016/0006-8993(76)90009-3; MURPHY MR, 1970, SCIENCE, V167, P302, DOI 10.1126/science.167.3916.302; Olsson SB, 2006, J CHEM ECOL, V32, P1635, DOI 10.1007/s10886-006-9098-8; Pinto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107541; PORTER RH, 1981, PHYSIOL BEHAV, V27, P493, DOI 10.1016/0031-9384(81)90337-1; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Rstudio Team, 2019, RSTUDIO INTEGRATED D; Schaal B, 1998, BIOL NEONATE, V74, P266, DOI 10.1159/000014033; Tingley D, 2014, J STAT SOFTW, V59; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; VARENDI H, 1994, LANCET, V344, P989, DOI 10.1016/S0140-6736(94)91645-4; VONSTRALENDORFF F, 1982, NATURWISSENSCHAFTEN, V69, P553; White AM, 2009, AM J PUBLIC HEALTH, V99, P1872, DOI 10.2105/AJPH.2008.146894; WILLIAMS JR, 1992, PHYSIOL BEHAV, V52, P635, DOI 10.1016/0031-9384(92)90390-N; Zou LQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25026; [No title captured]	38	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196708	10.1371/journal.pone.0196708	http://dx.doi.org/10.1371/journal.pone.0196708			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF9WG	29768447	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200042
J	Ehrlich, H; Shaala, LA; Youssef, DTA; Zoltowska-Aksamitowska, S; Tsurkan, M; Galli, R; Meissner, H; Wysokowski, M; Petrenko, I; Tabachnick, KR; Ivanenko, VN; Bechmann, N; Joseph, Y; Jesionowski, T				Ehrlich, Hermann; Shaala, Lamiaa A.; Youssef, Diaa T. A.; Zoltowska-Aksamitowska, Sonia; Tsurkan, Mikhail; Galli, Roberta; Meissner, Heike; Wysokowski, Marcin; Petrenko, Iaroslav; Tabachnick, Konstantin R.; Ivanenko, Viatcheslav N.; Bechmann, Nicole; Joseph, Yvonne; Jesionowski, Teofil			Discovery of chitin in skeletons of non-verongiid Red Sea demosponges	PLOS ONE			English	Article							EXTREME BIOMIMETIC APPROACH; MARINE SPONGES; BETA-CHITIN; PORIFERAN CHITIN; 1ST EVIDENCE; PART II; IDENTIFICATION; SCAFFOLDS; CHITOSAN; CHEMISTRY	Marine demosponges (Porifera: Demospongiae) are recognized as first metazoans which have developed over millions of years of evolution effective survival strategies based on unique metabolic pathways to produce both biologically active secondary metabolites and biopolymer-based stiff skeletons with 3D architecture. Up to date, among marine demosponges, only representatives of the Verongiida order have been known to synthetize biologically active substances as well as skeletons made of structural polysaccharide chitin. This work, to our knowledge, demonstrates for the first time that chitin is an important structural component within skeletons of non-verongiid demosponges Acamus wolffgangi and Echinoclathria gibbosa collected in the Red Sea. Calcofluor white staining, FTIR and Raman analysis, ESI-MS, SEM, and fluorescence microscopy as well as a chitinase digestion assay were applied in order to confirm, with strong evidence, the finding of alpha-chitin in the skeleton of both species. We suggest that, the finding of chitin within these representatives of Poecilosclerida order is a promising step in the evaluation of these sponges as novel renewable sources for both biologically active metabolites and chitin, which are of prospective application for pharmacology and biomedicine.	[Ehrlich, Hermann; Petrenko, Iaroslav] TU Bergakad Freiberg, Inst Expt Phys, Freiberg, Germany; [Shaala, Lamiaa A.] King Abdulaziz Univ, King Fahd Med Res Ctr, Nat Prod Unit, Jeddah, Saudi Arabia; [Shaala, Lamiaa A.] Suez Canal Univ, Suez Canal Univ Hosp, Ismailia, Egypt; [Youssef, Diaa T. A.] Suez Canal Univ, Fac Pharm, Dept Pharmacognosy, Ismailia, Egypt; [Youssef, Diaa T. A.] King Abdulaziz Univ, Fac Pharm, Dept Nat Prod, Jeddah 6, Saudi Arabia; [Zoltowska-Aksamitowska, Sonia; Wysokowski, Marcin; Jesionowski, Teofil] Poznan Univ Tech, Fac Chem Technol, Inst Chem Technol & Engn, Poznan, Poland; [Tsurkan, Mikhail] Leibniz Inst Polymer Res Dresden, Dresden, Germany; [Galli, Roberta] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Anesthesiol & Intens Care Med, Clin Sensoring & Monitoring, Dresden, Germany; [Meissner, Heike] Tech Univ Dresden, Fac Med, Dept Prosthet Dent, Dresden, Germany; [Meissner, Heike] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Tabachnick, Konstantin R.] Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow, Russia; [Ivanenko, Viatcheslav N.] Lomonosov Moscow State Univ, Biol Fac, Dept Invertebrate Zool, Moscow, Russia; [Bechmann, Nicole] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Fac Med Carl Gustav Carus, Inst Clin Chem & Lab Med, Dresden, Germany; [Joseph, Yvonne] TU Bergakad Freiberg, Inst Elect & Sensor Mat, Freiberg, Germany	Technical University Freiberg; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Suez Canal University; King Abdulaziz University; Poznan University of Technology; Leibniz Institut fur Polymerforschung Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Russian Academy of Sciences; Shirshov Institute of Oceanology; Lomonosov Moscow State University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technical University Freiberg	Ehrlich, H (corresponding author), TU Bergakad Freiberg, Inst Expt Phys, Freiberg, Germany.	hermann.ehrlich@physik.tu-freiberg.de	Ivanenko, Viatcheslav N/B-8198-2008; Wysokowski, Marcin/J-3528-2015; Shaala, Lamiaa A/H-9827-2012; Youssef, Diaa TA/H-9813-2012; Youssef, Diaa/ADU-7200-2022; Jesionowski, Teofil/N-1623-2014; shaala, lamiaa/AAD-9815-2019; Petrenko, Iaroslav/I-1133-2016; Joseph, Yvonne/D-9505-2011; Ehrlich, Hermann/I-5481-2015; Tsurkan, Mikhail V/G-4068-2014; Bechmann, Nicole/J-3867-2019; Tabachnick, Konstantin/ABI-1399-2020	Ivanenko, Viatcheslav N/0000-0003-1255-0491; Wysokowski, Marcin/0000-0003-0624-2716; Shaala, Lamiaa A/0000-0002-1866-8258; Youssef, Diaa/0000-0003-2217-4039; Jesionowski, Teofil/0000-0002-7808-8060; Petrenko, Iaroslav/0000-0003-2150-3486; Joseph, Yvonne/0000-0003-0697-9646; Ehrlich, Hermann/0000-0003-4951-3555; Tsurkan, Mikhail V/0000-0003-4000-3890; 	German Research Foundation (DFG) [HE 394/3-2]; PUT Research Grant [03/32/DSPB/0806]; Foundation for Polish Science [START 097.2017]; Deutscher Akademischer Austauschdienst (DAAD); Erasmus Plus programs; Russian Foundation for Basic Research [15-29-02601]; Russian Science Foundation [14-50-00029]	German Research Foundation (DFG)(German Research Foundation (DFG)); PUT Research Grant; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Erasmus Plus programs; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was partially supported by German Research Foundation (DFG) Project HE 394/3-2 and PUT Research Grant no. 03/32/DSPB/0806. M.W. is grateful for financial support from Foundation for Polish Science - START 097.2017, and S.Z.A. for support from Deutscher Akademischer Austauschdienst (DAAD) as well as Erasmus Plus programs. Research of V.N.I was supported by the Russian Foundation for Basic Research (grant no. 15-29-02601). Literature and taxonomical data analysis were supported by the Russian Science Foundation (grant no. 14-50-00029).	Abdelhameed RF, 2017, J PHARM SCI RES, V9, p1324 ; Anastopoulos I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010114; Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008; [Anonymous], 2013, Patent no. CN, Patent No. 201310296865; Bak Michal, 2017, Polim Med, V47, P43, DOI 10.17219/pim/75653; Bo M, 2012, INT J BIOL MACROMOL, V51, P129, DOI 10.1016/j.ijbiomac.2012.04.016; Brunner E, 2009, J STRUCT BIOL, V168, P539, DOI 10.1016/j.jsb.2009.06.018; Brunner E, 2011, ANGEW CHEMIE D INT E, V48, p9724 ; CARTER GT, 1978, J AM CHEM SOC, V100, P4302, DOI 10.1021/ja00481a049; Connors MJ, 2012, J STRUCT BIOL, V177, P314, DOI 10.1016/j.jsb.2011.12.019; Deguchi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11907; Ehrlich H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03497; Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P132, DOI 10.1016/j.ijbiomac.2010.05.007; Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P141, DOI 10.1016/j.ijbiomac.2010.05.009; Ehrlich H., BIOMIMETIC BIOMATERI; Ehrlich H, 2011, Two or Three-Dimensional Cleaned Chitin Skeleton of Dictyoceratid Sponges, Method for the Production and Use Thereof, Patent No. [2011023531 A2, 2011023531, WO2011023531 A2]; Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P473, DOI 10.1002/jez.b.21174; Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156; Ehrlich H, 2018, MAR DRUGS, V16, DOI 10.3390/md16030079; Ehrlich H, 2017, INT J BIOL MACROMOL, V104, P1706, DOI 10.1016/j.ijbiomac.2017.01.141; Ehrlich H, 2016, ADV OPT MATER, V4, P1608, DOI 10.1002/adom.201600454; Ehrlich H, 2013, J STRUCT BIOL, V183, P474, DOI 10.1016/j.jsb.2013.06.015; Ehrlich H, 2008, J NANOMATER, V2008, DOI 10.1155/2008/623838; Ehrlich H, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0339; Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521; Ehrlich H, 2010, CHEM MATER, V22, P1462, DOI 10.1021/cm9026607; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Fontana A, 2001, J NAT PROD, V64, P131, DOI 10.1021/np0002435; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Guggolz T, 2015, J MORPHOL, V276, P1433, DOI 10.1002/jmor.20432; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Cuong HN, 2016, INT J BIOL MACROMOL, V93, P442, DOI 10.1016/j.ijbiomac.2016.08.085; HOOPER J N A, 1987, Memoirs of the Queensland Museum, V25, P71; Hooper J.N.A., 2002, SYSTEMA PORIFERA GUI, P412; Hooper JNA, 1928, SYSTEMA PORIFERA GUI, p403 ; Jesionowski T, 2018, MAR DRUGS, V16, DOI 10.3390/md16030088; Kaya M, 2017, CARBOHYD POLYM, V176, P177, DOI 10.1016/j.carbpol.2017.08.076; Keller C., 1889, ZEITS WISS ZOOL, V51, P399; Kitamura A, 1999, TETRAHEDRON, V55, P2487, DOI 10.1016/S0040-4020(99)00022-8; Kumirska J, 2010, MAR DRUGS, V8, P1567, DOI 10.3390/md8051567; Lavall RL, 2007, BIORESOURCE TECHNOL, V98, P2465, DOI 10.1016/j.biortech.2006.09.002; Lehnert Helmut, 2006, Zootaxa, V1250, P1; LI HY, 1993, TETRAHEDRON LETT, V34, P5733, DOI 10.1016/S0040-4039(00)73846-9; Aguilar-Camacho JM, 2013, SCI MAR, V77, P677, DOI 10.3989/scimar.03800.06A; Merzendorfer H, 2011, EUR J CELL BIOL, V90, P759, DOI 10.1016/j.ejcb.2011.04.014; Mohamed GA, 2014, PHYTOCHEM LETT, V9, P51, DOI 10.1016/j.phytol.2014.04.008; Mutsenko VV, 2017, INT J BIOL MACROMOL, V104, P1955, DOI 10.1016/j.ijbiomac.2017.03.161; Mutsenko VV, 2017, INT J BIOL MACROMOL, V104, P1966, DOI 10.1016/j.ijbiomac.2017.03.116; Petrenko I, 2017, INT J BIOL MACROMOL, V104, P1626, DOI 10.1016/j.ijbiomac.2017.01.084; Philibert T, 2017, APPL BIOCHEM BIOTECH, V181, P1314, DOI 10.1007/s12010-016-2286-2; Rudi A, 1995, J NAT PROD, V58, P1702, DOI 10.1021/np50125a009; Schleuter D, 2013, CARBOHYD POLYM, V92, P712, DOI 10.1016/j.carbpol.2012.08.090; Singh R, 2017, INT WOUND J, V14, P1276, DOI 10.1111/iwj.12797; Stepniak I, 2016, RSC ADV, V6, P4007, DOI 10.1039/c5ra22047e; Ueoka R, 2009, TOXICON, V53, P680, DOI 10.1016/j.toxicon.2009.02.008; van Soest R.W.M., 1991, Beaufortia, V42, P49; Von Kolliker A, 1864, FEINERE BAU PROTOZOE; Wysokowski M, 2017, MATER CHEM PHYS, V188, P115, DOI 10.1016/j.matchemphys.2016.12.038; Wysokowski M, 2015, NANO RES, V8, P2288, DOI 10.1007/s12274-015-0739-5; Wysokowski M, 2015, POLYMERS-BASEL, V7, P235, DOI 10.3390/polym7020235; Wysokowski M, 2014, PALEOBIOLOGY, V40, P529, DOI 10.1666/13083; Wysokowski M, 2013, FRONT MATER SCI, V7, P248, DOI 10.1007/s11706-013-0212-x; Wysokowski M, 2013, INT J BIOL MACROMOL, V62, P94, DOI 10.1016/j.ijbiomac.2013.08.039; Yosief T, 1998, J NAT PROD, V61, P491, DOI 10.1021/np970407q; Zakrzewski AC, 2014, GENOME BIOL EVOL, V6, P316, DOI 10.1093/gbe/evu011; Zoltowska-Aksamitowska S, 2018, INT J BIOL MACROMOL, V112, P1021, DOI 10.1016/j.ijbiomac.2018.02.071; Zoltowska-Aksamitowska S, 2018, MAR DRUGS, V16, DOI 10.3390/md16020068	67	24	24	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0195803	10.1371/journal.pone.0195803	http://dx.doi.org/10.1371/journal.pone.0195803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763421	Green Published, Green Submitted, gold			2022-12-26	WOS:000432118800004
J	Ferreira, JPA; Miranda, I; Sousa, VB; Pereira, H				Ferreira, Joana P. A.; Miranda, Isabel; Sousa, Vicelina B.; Pereira, Helena			Chemical composition of barks from Quercus faginea trees and characterization of their lipophilic and polar extracts	PLOS ONE			English	Article							WOOD DENSITY COMPONENTS; ANTIOXIDANT ACTIVITY; CELLULAR STRUCTURE; BETULA-PENDULA; CERRIS BARK; RING WIDTH; AGE TRENDS; CORK; OAK; GROWTH	The bark from Quercus faginea mature trees from two sites was chemically characterized for the first time. The barks showed the following composition: ash 14.6%, total extractives 13.2%, suberin 2.9% and lignin 28.2%. The polysaccharides were composed mainly of glucose and xylose (50.3% and 35.1% of all monosaccharides respectively) with 4.8% of uronic acids. The suberin composition was: omega-hydroxyacids 46.3% of total compounds, alpha,omega-alkanoic diacids 22.3%, alkanoic acids 5.9%, alkanols 6.7% and aromatics 6.9% (ferulic acid 4.0%). Polar extracts (ethanol-water) had a high phenolic content of 630.3 mg of gallic acid equivalents (GAE)/g of extract, condensed tannins 220.7 mg of catechin equivalents (CE)/g extract, and flavonoids 207.7 mg CE/g of extract. The antioxidant activity was very high corresponding to 1567 mg Trolox equivalents/g of extract, and an IC50 of 2.63 mu g extract/ml. The lipophilic extracts were constituted mainly by glycerol and its derivatives (12.3% of all compounds), alkanoic acids (27.8%), sterols (11.5%) and triterpenes (17.8%). In view of an integrated valorization, Quercus faginea barks are interesting sources of polar compounds including phenols and polyphenols with possible interesting bioactivities, while the sterols and triterpenes contained in the lipophilic extracts are also valuable bioactive compounds or chemical intermediates for specific high-value market niches, such as cosmetics, pharmaceuticals and biomedicine.	[Ferreira, Joana P. A.; Miranda, Isabel; Sousa, Vicelina B.; Pereira, Helena] Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal	Universidade de Lisboa	Ferreira, JPA (corresponding author), Univ Lisbon, Ctr Estudos Florestais, Inst Super Agron, Lisbon, Portugal.	jpferreira@isa.ulisboa.pt	Pereira, Helena/V-5236-2019; Ferreira, Joana/I-6369-2019; Sousa, Vicelina/B-3067-2016	Pereira, Helena/0000-0002-5393-4443; Ferreira, Joana/0000-0002-7637-3466; Sousa, Vicelina/0000-0003-4221-0041; Miranda, Isabel/0000-0003-0280-5219	project OAKWOODS - Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/AGR-AAM/69077/2006]; Strategic Project of Centro de Estudos Florestais [UID/AGR/00239/2013]; national funding from FCT; FCT [SFRH /BPD/ 97970/2013]	project OAKWOODS - Fundacao para a Ciencia e a Tecnologia (FCT); Strategic Project of Centro de Estudos Florestais; national funding from FCT; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The sampling was supported by the project OAKWOODS (PTDC/AGR-AAM/69077/2006) funded by Fundacao para a Ciencia e a Tecnologia (FCT). We thank Jose L. Louzada for providing the samples from Site 1 and Sofia Knapic for project management. We also thank Joaquina Silva and Lidia Silva for help with the chemical analysis. This work was supported by the Strategic Project (UID/AGR/00239/2013) of Centro de Estudos Florestais, by the national funding from FCT. The third author acknowledges a post-doc scholarship by FCT (SFRH /BPD/ 97970/2013).	Abdalla S, 2014, BIORESOURCES, V9, P3396; Balaban M, 2001, HOLZFORSCHUNG, V55, P478, DOI 10.1515/HF.2001.079; Baptista I, 2013, IND CROP PROD, V50, P166, DOI 10.1016/j.indcrop.2013.07.004; Barij N, 2011, IAWA J, V32, P25, DOI 10.1163/22941932-90000040; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Chu J-H, 1958, HUA HSUEH HSUEH PAO, V22, P128; Clermont LP, 1961, PULP PAPER MAGAZINE, V62, P511; Corcuera L, 2004, IAWA J, V25, P185, DOI 10.1163/22941932-90000360; Cotillas M, 2009, FOREST ECOL MANAG, V258, P1677, DOI 10.1016/j.foreco.2009.07.033; Dedrie M, 2015, IND CROP PROD, V70, P316, DOI 10.1016/j.indcrop.2015.03.071; Dickison W.C., 2000, INTEGRATIVE PLANT AN; Domingues RMA, 2011, IND CROP PROD, V33, P158, DOI 10.1016/j.indcrop.2010.10.006; EGLINTON G, 1968, PHYTOCHEMISTRY, V7, P313, DOI 10.1016/S0031-9422(00)86330-X; Fabiao A., 1996, Annali dell'Istituto Sperimentale per la Selvicoltura, V27, P77; Ferreira J, 2016, IND CROP PROD, V94, P638, DOI 10.1016/j.indcrop.2016.09.038; Ferreira JPA, 2017, J WOOD CHEM TECHNOL, V37, P10, DOI 10.1080/02773813.2016.1224248; Ferreira JPA, 2015, IND CROP PROD, V74, P998, DOI 10.1016/j.indcrop.2015.05.065; Gan RY, 2010, J MED PLANTS RES, V4, P2438; Graca J, 2000, J AGR FOOD CHEM, V48, P5476, DOI 10.1021/jf0006123; Graca J, 2004, IAWA J, V25, P325, DOI 10.1163/22941932-90000369; Guenther E., 1952, ESSENTIAL OILS, V5, P254; Iqbal Erum, 2015, Journal of King Saud University Science, V27, P224, DOI 10.1016/j.jksus.2015.02.003; Villaverde JJ, 2016, BIORESOURCES, V11, P5618; Knapic S, 2007, ANN FOREST SCI, V64, P211, DOI 10.1051/forest:2006105; Knapic S, 2011, CAN J FOREST RES, V41, P1212, DOI [10.1139/X11-038, 10.1139/x11-038]; KOLATTUKUDY PE, 1974, LIPIDS, V9, P682, DOI 10.1007/BF02532176; KULL U, 1972, Z PFLANZENPHYSIOL, V68, P55, DOI 10.1016/S0044-328X(72)80009-6; Lourenco A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01612; Menon V, 2012, PROG ENERG COMBUST, V38, P522, DOI 10.1016/j.pecs.2012.02.002; MILLER DP, 1992, AM J ENOL VITICULT, V43, P333; Miranda I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179268; Miranda I, 2016, IND CROP PROD, V82, P81, DOI 10.1016/j.indcrop.2015.12.003; Miranda I, 2013, J WOOD SCI, V59, P1, DOI 10.1007/s10086-012-1300-8; Miranda I, 2013, IND CROP PROD, V41, P299, DOI 10.1016/j.indcrop.2012.04.024; Miranda I, 2012, IND CROP PROD, V36, P395, DOI 10.1016/j.indcrop.2011.10.035; Montserrat-Marti G, 2009, TREES-STRUCT FUNCT, V23, P787, DOI 10.1007/s00468-009-0320-5; Morison JIL, 1999, PLANT CELL ENVIRON, V22, P659, DOI 10.1046/j.1365-3040.1999.00443.x; Mota GS, 2016, IND CROP PROD, V90, P65, DOI 10.1016/j.indcrop.2016.06.014; Nunes E, 1999, ANN FOREST SCI, V56, P479, DOI 10.1051/forest:19990604; Pazhe A, 2012, LATVIAN J CHEM, V51, P415, DOI 10.2478/v10161-012-0025-8; PEREIRA H, 1988, WOOD SCI TECHNOL, V22, P211, DOI 10.1007/BF00386015; PEREIRA H, 1992, IAWA BULL, V13, P389, DOI 10.1163/22941932-90001294; Pereira H, 2015, BIORESOURCES, V10, P6207; PETTERSEN RC, 1984, ADV CHEM SER, P57; Puech J.-L, 1978, THESIS; Quilho T, 2013, TURK J BOT, V37, P561, DOI 10.3906/bot-1201-54; Reboredo F, 2014, J FORESTRY RES, V25, P249, DOI 10.1007/s11676-014-0456-z; Santos SAO, 2012, IND CROP PROD, V39, P120, DOI 10.1016/j.indcrop.2012.02.003; Santos SAO, 2010, IND CROP PROD, V31, P521, DOI 10.1016/j.indcrop.2010.02.001; Sartori C, 2016, HOLZFORSCHUNG, V70, P819, DOI 10.1515/hf-2015-0258; Sen A, 2015, J SUPERCRIT FLUID, V97, P247, DOI 10.1016/j.supflu.2014.12.008; Sen A, 2011, IND CROP PROD, V34, P929, DOI 10.1016/j.indcrop.2011.02.015; Sen A, 2010, IND CROP PROD, V31, P417, DOI 10.1016/j.indcrop.2010.01.002; SESHADRI TR, 1971, PHYTOCHEMISTRY, V10, P897, DOI 10.1016/S0031-9422(00)97169-3; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sousa VB, 2013, WOOD FIBER SCI, V45, P405; Sousa VB, 2016, FOREST SYST, V25, DOI 10.5424/fs/2016251-08411; Sousa VB, 2014, IAWA J, V35, P293, DOI 10.1163/22941932-00000067; Touati R, 2015, IND CROP PROD, V76, P936, DOI 10.1016/j.indcrop.2015.07.074	60	24	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197135	10.1371/journal.pone.0197135	http://dx.doi.org/10.1371/journal.pone.0197135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763441	Green Submitted, gold, Green Published			2022-12-26	WOS:000432118800026
J	MacLaren, RD; Wisniewski, K; MacLaren, C				MacLaren, Ronald David; Wisniewski, Kathryn; MacLaren, Christina			Environmental concentrations of metformin exposure affect aggressive behavior in the Siamese fighting fish, Betta splendens	PLOS ONE			English	Article							PERSONAL CARE PRODUCTS; MINNOWS PIMEPHALES-PROMELAS; GLUCOSE-HOMEOSTASIS; RAINBOW-TROUT; ENDOCRINE DISRUPTION; XIPHOPHORUS-VARIATUS; FEMALE PREFERENCES; ANTIDIABETIC DRUG; WASTE-WATER; DORSAL FIN	Metformin, the medicine most commonly prescribed for treatment of Type II diabetes, is among the most abundant pharmaceuticals being introduced into the environment. Pharmaceuticals are increasingly found in wastewater and surface waters around the world, often due to incomplete metabolism in humans and subsequent excretion in human waste. Risk analyses and exposure studies have raised concerns about potential negative impacts of pharmaceuticals at current environmental levels. Results of the present study indicate that metformin at concentrations in the range of what has been documented in freshwater systems and waste-water effluent (40 mu g/L) affects aggressive behavior in adult male Betta splendens. Subjects exhibited less aggression toward a male dummy stimulus after four weeks exposure to metformin-treated water when compared to behavior measured immediately prior to their exposure, and in comparison to a separate cohort of un-exposed control fish. This effect persisted after 20 weeks exposure as well. Subjects exposed to metformin at a concentration twice that currently observed in nature (80 mu g/L) exhibited an even more substantial reduction in aggressive behaviors compared to controls and pre-exposure measurements than those observed in the low-dose treatment group. Such changes in behavior have the potential to affect male fitness and possibly impact the health of natural populations of aquatic organisms exposed to the drug.	[MacLaren, Ronald David; Wisniewski, Kathryn; MacLaren, Christina] Merrimack Coll, Dept Biol, N Andover, MA 01845 USA	Merrimack College	MacLaren, RD (corresponding author), Merrimack Coll, Dept Biol, N Andover, MA 01845 USA.	maclarenr@merrimack.edu			Merrimack College Faculty Development Grants; Murray Fellowship	Merrimack College Faculty Development Grants; Murray Fellowship	This study was supported in part by 2016 and 2017 Merrimack College Faculty Development Grants and the 2016 Murray Fellowship. All three forms of funding are internal and include no grant numbers or funds from external sources requiring references to funder's websites. The funders (Merrimack College) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Aukidy M, 2012, SCI TOTAL ENVIRON, V438, P15, DOI 10.1016/j.scitotenv.2012.08.061; Beitel SC, 2014, AQUAT TOXICOL, V152, P273, DOI 10.1016/j.aquatox.2014.04.013; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Blair BD, 2013, CHEMOSPHERE, V93, P2116, DOI 10.1016/j.chemosphere.2013.07.057; Blair BD, 2013, SCI TOTAL ENVIRON, V444, P515, DOI 10.1016/j.scitotenv.2012.11.103; Boyd GR, 2003, SCI TOTAL ENVIRON, V311, P135, DOI 10.1016/S0048-9697(03)00138-4; BRONSTEIN PM, 1982, ANIM LEARN BEHAV, V10, P145, DOI 10.3758/BF03212262; BRONSTEIN PM, 1983, J COMP PSYCHOL, V97, P135; BRONSTEIN PM, 1984, J COMP PSYCHOL, V98, P421, DOI 10.1037/0735-7036.98.4.421; Clotfelter ED, 2007, PHARMACOL BIOCHEM BE, V87, P222, DOI 10.1016/j.pbb.2007.04.018; Dzieweczynski TL, 2012, PHYSIOL BEHAV, V107, P92, DOI 10.1016/j.physbeh.2012.06.007; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Fatta-Kassinos D, 2011, ANAL BIOANAL CHEM, V399, P251, DOI 10.1007/s00216-010-4300-9; Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3; Lattier DL, 2002, ENVIRON TOXICOL CHEM, V21, P2385, DOI 10.1897/1551-5028(2002)021<2385:EIVGTQ>2.0.CO;2; Lynn SE, 2007, ADV PHYSIOL EDUC, V31, P358, DOI 10.1152/advan.00024.2007; MacLaren RD, 2008, BEHAVIOUR, V145, P897, DOI 10.1163/156853908784089289; MacLaren RD, 2013, BEHAV PROCESS, V92, P99, DOI 10.1016/j.beproc.2012.10.013; MacLaren RD, 2011, BEHAV PROCESS, V87, P197, DOI 10.1016/j.beproc.2011.03.006; MacLaren RD, 2004, ETHOLOGY, V110, P363, DOI 10.1111/j.1439-0310.2004.00974.x; MacLaren RD, 2012, ENVIRON BIOL FISH, V93, P105, DOI 10.1007/s10641-011-9896-x; Majidano SA, 2012, CHROMATOGRAPHIA, V75, P1311, DOI 10.1007/s10337-012-2321-6; Muncke J, 2006, ENVIRON TOXICOL CHEM, V25, P2734, DOI 10.1897/05-683R.1; Niemuth NJ, 2015, ENVIRON TOXICOL CHEM, V34, P291, DOI 10.1002/etc.2793; Oosterhuis M, 2013, SCI TOTAL ENVIRON, V442, P380, DOI 10.1016/j.scitotenv.2012.10.046; Panserat S, 2009, AM J PHYSIOL-REG I, V297, pR707, DOI 10.1152/ajpregu.00120.2009; Polakof S, 2011, AM J PHYSIOL-REG I, V300, pR166, DOI 10.1152/ajpregu.00619.2010; Polakof S, 2009, AM J PHYSIOL-REG I, V297, pR1769, DOI 10.1152/ajpregu.00369.2009; Polakof S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020228; Rowland WJ, 1999, ENVIRON BIOL FISH, V56, P285, DOI 10.1023/A:1007517720723; Scheurer M, 2012, WATER RES, V46, P4790, DOI 10.1016/j.watres.2012.06.019; Schmid T, 2002, TOXICOL LETT, V131, P65, DOI 10.1016/S0378-4274(02)00043-7; Sokal R. R., 1981, BIOMETRY; Tang T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub5; Weinberger J, 2014, AQUAT TOXICOL, V151, P77, DOI 10.1016/j.aquatox.2013.10.012; WINBERG S, 1992, J COMP PHYSIOL A, V170, P93; [No title captured], DOI DOI 10.1017/S1464793104006517	37	28	28	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197259	10.1371/journal.pone.0197259	http://dx.doi.org/10.1371/journal.pone.0197259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF7AA	29763426	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800032
J	Almagor, J; Temkin, E; Benenson, I; Fallach, N; Carmeli, Y				Almagor, Jonatan; Temkin, Elizabeth; Benenson, Itzhak; Fallach, Noga; Carmeli, Yehuda		DRIVE-AB Consortium	The impact of antibiotic use on transmission of resistant bacteria in hospitals: Insights from an agent-based model	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS COLONIZATION; LENGTH-OF-STAY; BETA-LACTAMASE; RISK-FACTORS; VANCOMYCIN; ENTEROCOCCI; PNEUMONIAE; INFECTION; EXPOSURE; PROGRAM	Extensive antibiotic use over the years has led to the emergence and spread of antibiotic resistant bacteria (ARB). Antibiotic resistance poses a major threat to public health since for many infections antibiotic treatment is no longer effective. Hospitals are focal points for ARB spread. Antibiotic use in hospitals exerts selective pressure, accelerating the spread of ARB. We used an agent-based model to explore the impact of antibiotics on the transmission dynamics and to examine the potential of stewardship interventions in limiting ARB spread in a hospital. Agents in the model consist of patients and health care workers (HCW). The transmission of ARB occurs through contacts between patients and HCW and between adjacent patients. In the model, antibiotic use affects the risk of transmission by increasing the vulnerability of susceptible patients and the contagiousness of colonized patients who are treated with antibiotics. The model shows that increasing the proportion of patients receiving antibiotics increases the rate of acquisition non-linearly. The effect of antibiotics on the spread of resistance depends on characteristics of the antibiotic agent and the density of antibiotic use. Antibiotic's impact on the spread increases when the bacterial strain is more transmissible, and decreases as resistance prevalence rises. The individual risk for acquiring ARB increases in parallel with antibiotic density both for patients treated and not treated with antibiotics. Antibiotic treatment in the hospital setting plays an important role in determining the spread of resistance. Interventions to limit antibiotic use have the potential to reduce the spread of resistance, mainly by choosing an agent with a favorable profile in terms of its impact on patient's vulnerability and contagiousness. Methods to measure these impacts of antibiotics should be developed, standardized, and incorporated into drug development programs and approval packages.	[Almagor, Jonatan; Benenson, Itzhak] Tel Aviv Univ, Dept Geog & Human Environm, Lab Geosimulat & Spatial Anal, Tel Aviv, Israel; [Almagor, Jonatan; Temkin, Elizabeth; Fallach, Noga; Carmeli, Yehuda] Tel Aviv Sourasky Med Ctr, Dept Epidemiol & Prevent Med, Tel Aviv, Israel; [Carmeli, Yehuda] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Almagor, J (corresponding author), Tel Aviv Univ, Dept Geog & Human Environm, Lab Geosimulat & Spatial Anal, Tel Aviv, Israel.; Almagor, J (corresponding author), Tel Aviv Sourasky Med Ctr, Dept Epidemiol & Prevent Med, Tel Aviv, Israel.	yonialmagor@hotmail.com	Benenson, Itzhak/R-3666-2016; Jonatan, Almagor/GSJ-2926-2022	Benenson, Itzhak/0000-0003-0704-0673; Jonatan, Almagor/0000-0002-1781-8533	Innovative Medicines Initiative Joint Undertaking [115618]; European Union	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission)	The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no115618 [Driving re-investment in R&D and responsible antibiotic use - DRIVE-AB] to Yehuda Carmeli, resources of which are composed of financial contributions from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. This work does not necessarily represent the view of all DRIVE-AB partners.	Ajao AO, 2013, INFECT CONT HOSP EP, V34, P453, DOI 10.1086/670216; Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Bar-Yoseph H, 2016, J ANTIMICROB CHEMOTH, V71, P2729, DOI 10.1093/jac/dkw221; Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118; Bertollo LG, AM J INFECT CONTROL; Calfee DP, 2003, CLIN INFECT DIS, V37, P326, DOI 10.1086/376624; Carling P, 2003, INFECT CONT HOSP EP, V24, P699, DOI 10.1086/502278; Carmeli Y, 2002, EMERG INFECT DIS, V8, P802, DOI 10.3201/eid0808.010418; Cheng VCC, 2008, J HOSP INFECT, V70, P27, DOI 10.1016/j.jhin.2008.05.019; D'Agata EMC, 2005, J INFECT DIS, V192, P2004, DOI 10.1086/498041; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; De Angelis G, 2011, J HOSP INFECT, V78, P86, DOI 10.1016/j.jhin.2011.02.003; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Drees M, 2008, INFECT CONT HOSP EP, V29, P709, DOI 10.1086/589582; European Centre for Disease Prevention and Control, 2013, POINT PREV SURV HEAL; Foster KR, 2006, PLOS MED, V3, P177, DOI 10.1371/journal.pmed.0030029; Freitas AR, 2016, J ANTIMICROB CHEMOTH, V71, P3351, DOI 10.1093/jac/dkw312; Fridkin SK, 2001, ANN INTERN MED, V135, P175, DOI 10.7326/0003-4819-135-3-200108070-00009; Friedman ND, 2016, CLIN MICROBIOL INFEC, V22, P416, DOI 10.1016/j.cmi.2015.12.002; Graffunder EM, 2005, J ANTIMICROB CHEMOTH, V56, P139, DOI 10.1093/jac/dki180; Huang SS, 2003, CLIN INFECT DIS, V36, P281, DOI 10.1086/345955; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; Hugonnet S, 2004, CURR OPIN INFECT DIS, V17, P329, DOI 10.1097/01.qco.0000136931.83167.d2; Kardas-Sloma L, 2013, ANTIMICROB AGENTS CH, V57, P4410, DOI 10.1128/AAC.00711-13; Kardas-Sloma L, 2011, ANTIMICROB AGENTS CH, V55, P4888, DOI 10.1128/AAC.01626-10; Lee BY, 2013, J AM MED INFORM ASSN, V20, pE139, DOI 10.1136/amiajnl-2012-001107; Lepper PM, 2002, ANTIMICROB AGENTS CH, V46, P2920, DOI 10.1128/AAC.46.9.2920-2925.2002; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Marschall J, 2006, INFECT CONT HOSP EP, V27, P1206, DOI 10.1086/507917; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; McBryde ES, 2004, J HOSP INFECT, V58, P104, DOI 10.1016/j.jhin.2004.06.010; Morgan DJ, 2010, INFECT CONT HOSP EP, V31, P716, DOI 10.1086/653201; O'Fallon E, 2009, CLIN INFECT DIS, V48, P1375, DOI 10.1086/598194; ONeill J., 2014, REV ANTIMICROB RESIS; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Passaretti CL, 2013, CLIN INFECT DIS, V56, P27, DOI 10.1093/cid/cis839; Paterson DL, 2006, CLIN INFECT DIS, V42, pS90, DOI 10.1086/499407; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Poirel L, 2002, ANTIMICROB AGENTS CH, V46, P4038, DOI 10.1128/AAC.46.12.4038-4040.2002; Polk RE, 2004, CLIN INFECT DIS, V39, P497, DOI 10.1086/422647; Porco TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046505; Rahal JJ, 1998, JAMA-J AM MED ASSOC, V280, P1233, DOI 10.1001/jama.280.14.1233; Scanvic A, 2001, CLIN INFECT DIS, V32, P1393, DOI 10.1086/320151; Schechner V, 2013, CLIN MICROBIOL INFEC, V19, P451, DOI 10.1111/j.1469-0691.2012.03888.x; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Shalit I, 2008, J ANTIMICROB CHEMOTH, V62, P196, DOI 10.1093/jac/dkn150; Shenoy ES, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-177; Snyder GM, 2008, INFECT CONT HOSP EP, V29, P583, DOI 10.1086/588701; Stone PW, 2003, INFECT CONT HOSP EP, V24, P601, DOI 10.1086/502253; Tacconelli E, 2009, ANTIMICROB AGENTS CH, V53, P4264, DOI 10.1128/AAC.00431-09; Teillant A, 2015, LANCET INFECT DIS, V15, P1429, DOI 10.1016/S1473-3099(15)00270-4; Temime L, 2009, P NATL ACAD SCI USA, V106, P18420, DOI 10.1073/pnas.0900974106; Wang JR, 2011, AM J INFECT CONTROL, V39, P763, DOI 10.1016/j.ajic.2010.11.012; WORLD HEALTH ORGANIZATION, 2014, ANT RES GLOB REP SUR, p[ix, xi]	55	28	29	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197111	10.1371/journal.pone.0197111	http://dx.doi.org/10.1371/journal.pone.0197111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758063	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000432082900028
J	Glynn, JR; Sunny, BS; DeStavola, B; Dube, A; Chihana, M; Price, AJ; Crampin, AC				Glynn, Judith R.; Sunny, Bindu S.; DeStavola, Bianca; Dube, Albert; Chihana, Menard; Price, Alison J.; Crampin, Amelia C.			Early school failure predicts teenage pregnancy and marriage: A large population-based cohort study in northern Malawi	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SEXUAL-BEHAVIOR; SOUTH-AFRICA; EDUCATIONAL-ATTAINMENT; REPRODUCTIVE HEALTH; KENYA; COUNTRIES; DROPOUT; TRENDS; RISK	Background School dropout has been linked to early pregnancy and marriage but less is known about the effect of school performance. We aimed to assess whether school performance influenced age at sexual debut, pregnancy and marriage, and from what age school drop-out and performance were associated with these later life events. Methods Data from 2007-2016 from a demographic surveillance site in northern Malawi with annual updating of schooling status and grades, and linked sexual behaviour surveys, were analysed to assess the associations of age-specific school performance (measured as age-for-grade) and status (in or out of school) on subsequent age at sexual debut, pregnancy and marriage. Landmark analysis with Cox regression was used to estimate hazard ratios of sexual debut, pregnancy and marriage by schooling at selected (landmark) ages, controlling for socio-economic factors. Results Information on at least one outcome was available for >16,000 children seen at ages 10-18. Sexual debut was available on a subset aged >= 15 by 2011. For girls, being out of school was strongly associated with earlier sexual debut, pregnancy and marriage. For example, using schooling status at age 14, compared to girls in primary, those who had dropped out had adjusted hazard ratios of subsequent sexual debut, pregnancy and marriage of 5.39 (95% CI 3.27-8.86), 2.39 (1.82-3.12), and 2.76 (2.08-3.67) respectively. For boys, the equivalent association with sexual debut was weak, 1.92 (0.81-4.55), but that with marriage was strong, 3.74 (2.28-6.11), although boys married later. Being overage-for-grade was not associated with sexual debut for girls or boys. For girls, being overage-for-grade from age 10 was associated with earlier pregnancy and marriage (e.g. adjusted hazard ratio 2.84 (1.32-6.17) for pregnancy and 3.19 (1.47-6.94) for marriage, for those >= 3 years overage compared to those on track at age 10). For boys, overage-for-grade was associated with earlier marriage from age 12, with stronger associations at older ages (e.g. adjusted hazard ratio 2.41 (1.56-3.70) for those >= 3 years overage compared to those on track at age 14). For girls >= 3 years overage at age 14, 39% were pregnant before they were 18, compared to 18% of those who were on track. The main limitation was the use of reported ages of sexual debut, pregnancy and marriage. Conclusions School progression at ages as young as 10 can predict teenage pregnancy and marriage, even after adjusting for socio-economic factors. Early education interventions may reduce teenage pregnancy and marriage as well as improving learning.	[Glynn, Judith R.; Sunny, Bindu S.; DeStavola, Bianca; Price, Alison J.; Crampin, Amelia C.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Dube, Albert; Chihana, Menard; Price, Alison J.; Crampin, Amelia C.] Malawi Epidemiol & Intervent Res Unit, Chilumba, Malawi	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Glynn, JR (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	Judith.glynn@lshtm.ac.uk	; Sunny, Boris Rodriguez/Y-3173-2018	Glynn, Judith/0000-0001-9325-4576; Sunny, Boris Rodriguez/0000-0002-8616-8183; Price, Alison/0000-0002-3891-3337; De Stavola, Bianca Lucia/0000-0001-7853-0528	Wellcome Trust [079828/Z/06/C, 098610/Z/12/Z]; UK Economic and Social Research Council [ES/L013967/1]; ESRC [ES/L013967/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Data collection was funded by The Wellcome Trust (grant numbers 079828/Z/06/Cand 098610/Z/12/Z to ACC and JRG) (wellcome.ac.uk). The analysis and write-up was funded by the UK Economic and Social Research Council (grant number ES/L013967/1 to JRG) (esrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Clark S, 2009, J MARRIAGE FAM, V71, P396, DOI 10.1111/j.1741-3737.2009.00607.x; Crampin AC, 2012, INT J EPIDEMIOL, V41, P676, DOI 10.1093/ije/dys088; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Duflo E, 2011, ED HIV EARLY FERTILI; Favara M., 2016, 146 YOUNG LIV; Friedlander E., 2016, LITERACY BOOST RWAND; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Glynn JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022840; Glynn JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015334; Grant MJ, 2015, POPUL DEV REV, V41, P409, DOI 10.1111/j.1728-4457.2015.00066.x; Grant MJ, 2008, STUD FAMILY PLANN, V39, P369, DOI 10.1111/j.1728-4465.2008.00181.x; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hunt FM., 2008, DROPPING OUT SCH CRO; Jukes MCH, 2017, J RES EDUC EFF, V10, P449, DOI 10.1080/19345747.2016.1221487; Kendall N., 2015, ED ADOLESCENT GIRLS, P23; Kim J, 2015, STUD FAMILY PLANN, V46, P263, DOI 10.1111/j.1728-4465.2015.00029.x; Lam D, 2013, STUD FAMILY PLANN, V44, P147, DOI 10.1111/j.1728-4465.2013.00350.x; Lloyd CB, 2000, COMP EDUC REV, V44, P113, DOI 10.1086/447600; Lloyd CB, 2008, POP STUD-J DEMOG, V62, P1, DOI 10.1080/00324720701810840; Marteleto L, 2008, STUD FAMILY PLANN, V39, P351, DOI 10.1111/j.1728-4465.2008.00180.x; McConnell C, 2016, KEEPING GIRLS SCH SI; Mmari K, 2009, GLOB PUBLIC HEALTH, V4, P350, DOI 10.1080/17441690701664418; Ndaruhutse Susy, 2008, GRADE REPETITION PRI; Office National Statistics, 2015, MAL MDG ENDL SURV 20; Schafer MJ, 2006, SOCIOL QUART, V47, P665, DOI 10.1111/j.1533-8525.2006.00062.x; Snilstveit B., 2015, 3IE SYSTEMATIC REV, V24; Speizer IS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4039-8; Sunny BS, 2017, INT J EDUC DEV, V52, P68, DOI 10.1016/j.ijedudev.2016.10.004; Timaeus IM, 2015, STUD FAMILY PLANN, V46, P143, DOI 10.1111/j.1728-4465.2015.00021.x; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; World Bank, 2010, WOR BANK WORK PAPER, P1, DOI 10.1596/978-0-8213-8198-4; Zuilkowski SS, 2012, AIDS CARE, V24, P562, DOI 10.1080/09540121.2011.630351	33	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196041	10.1371/journal.pone.0196041	http://dx.doi.org/10.1371/journal.pone.0196041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF6MZ	29758040	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000432082900004
J	Ordonez, AA; Pokkali, S; Kim, S; Carr, B; Klunk, MH; Tong, L; Saini, V; Chang, YS; McKevitt, M; Smith, V; Gossage, DL; Jain, SK				Ordonez, Alvaro A.; Pokkali, Supriya; Kim, Sunhwa; Carr, Brian; Klunk, Mariah H.; Tong, Leah; Saini, Vikram; Chang, Yong S.; McKevitt, Matthew; Smith, Victoria; Gossage, David L.; Jain, Sanjay K.			Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; MATRIX METALLOPROTEINASES; PULMONARY TUBERCULOSIS; VACCINE DEVELOPMENT; MOUSE MODEL; MICE; MATRIX-METALLOPROTEINASE-9; IMMUNOGLOBULIN; CAVITATION	Matrix metalloproteinase (MMP)-9 is a zinc-dependent protease associated with early immune responses to Mycobacterium tuberculosis infection, macrophage recruitment and granuloma formation. We evaluated whether adjunctive inhibition of MMP-9 could improve the response to standard TB treatment in a mouse model that develops necrotic lesions. Six weeks after an aerosol infection with M. tuberculosis, C3HeB/FeJ mice received standard TB treatment (12 weeks) comprising rifampin, isoniazid and pyrazinamide alone or in combination with either anti-MMP-9 antibody, etanercept (positive control) or isotype antibody (negative control) for 6 weeks. Anti-MMP-9 and the isotype control had comparable high serum exposures and expected terminal half-life. The relapse rate in mice receiving standard TB treatment was 46.6%. Compared to the standard TB treatment, relapse rates in animals that received adjunctive treatments with anti-MMP-9 antibody or etanercept were significantly decreased to 25.9% (P= 0.006) and 29.8% (P = 0.019) respectively, but were not different from the arm that received the isotype control antibody (25.9%). Immunostaining demonstrated localization of MMP-9 primarily in macrophages in both murine and human lung tissues infected with M. tuberculosis, suggesting the importance of MMP-9 in TB pathogenesis. These data suggest that the relapse rates in M. tuberculosis-infected mice may be non-specifically improved by administration of antibodies in conjunction with standard TB treatments. Future studies are needed to evaluate the mechanism(s) leading to improved outcomes with adjunctive antibody treatments.	[Ordonez, Alvaro A.; Pokkali, Supriya; Klunk, Mariah H.; Saini, Vikram; Chang, Yong S.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21205 USA; [Ordonez, Alvaro A.; Pokkali, Supriya; Klunk, Mariah H.; Saini, Vikram; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Baltimore, MD 21205 USA; [Ordonez, Alvaro A.; Pokkali, Supriya; Klunk, Mariah H.; Saini, Vikram; Chang, Yong S.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Kim, Sunhwa; Carr, Brian; Tong, Leah; McKevitt, Matthew; Smith, Victoria; Gossage, David L.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Kim, Sunhwa] Merck Res Labs, San Francisco, CA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Gilead Sciences; Merck & Company	Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21205 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Baltimore, MD 21205 USA.; Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	sjain5@jhmi.edu	Saini, Vikram/S-3145-2019; Ordonez, Alvaro/AAC-9996-2022; Pokkali, Supriya/T-2825-2017	Ordonez, Alvaro/0000-0002-8571-0655; Pokkali, Supriya/0000-0002-6209-1679; Saini, Vikram/0000-0002-5632-0009; Jain, Sanjay/0000-0001-9620-7070	Gilead Sciences, Inc. [15120275]	Gilead Sciences, Inc.(Gilead Sciences)	This work was supported by a grant (15120275) to Johns Hopkins University (S.K.J.) by Gilead Sciences, Inc. (www.gilead.com), who had an active role in the study design, data collection and analysis, and preparation of the manuscript.	Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Alvarez N, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-S1-S3; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Bekker LG, 1998, J INFECT DIS, V178, P580, DOI 10.1086/517479; Blackmore TK, 2008, CLIN INFECT DIS, V47, pE83, DOI 10.1086/592695; Collins HL, 2001, IMMUNOLOGY, V103, P1, DOI 10.1046/j.1365-2567.2001.01236.x; Cymer F., 2017, BIOLOGICALS; Davis SL, 2009, ANTIMICROB AGENTS CH, V53, P4879, DOI 10.1128/AAC.00789-09; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P533, DOI 10.1016/j.smim.2014.10.002; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Harper J, 2012, J INFECT DIS, V205, P595, DOI 10.1093/infdis/jir786; Hrabec E, 2002, INT J TUBERC LUNG D, V6, P713; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Kubler A, 2015, J PATHOL, V235, P431, DOI 10.1002/path.4432; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Marshall DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127063; MUTHUSWAMY P, 1995, CHEST, V107, P1621, DOI 10.1378/chest.107.6.1621; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Olivares N, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx118; Olivares N, 2013, PATHOG DIS, V69, P176, DOI 10.1111/2049-632X.12069; Olivares N, 2009, TUBERCULOSIS, V89, P218, DOI 10.1016/j.tube.2009.02.003; Ong CWM, 2014, AM J RESP CRIT CARE, V190, P9, DOI 10.1164/rccm.201311-2106PP; Ordonez AA, 2014, CURR MOL MED, V14, P385, DOI 10.2174/1566524013666131118112431; Ordonez AA, 2016, DIS MODEL MECH, V9, P779, DOI 10.1242/dmm.025643; Ordonez AA, 2015, ANTIMICROB AGENTS CH, V59, P642, DOI 10.1128/AAC.04180-14; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Price NM, 2001, J IMMUNOL, V166, P4223, DOI 10.4049/jimmunol.166.6.4223; Reljic R, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P457; Roy E, 2005, INFECT IMMUN, V73, P6101, DOI 10.1128/IAI.73.9.6101-6109.2005; Salgame P, 2011, J CLIN INVEST, V121, P1686, DOI 10.1172/JCI57423; Sheen P, 2009, EUR RESPIR J, V33, P134, DOI 10.1183/09031936.00127807; Singh S, 2014, ANTIMICROB AGENTS CH, V58, P4657, DOI 10.1128/AAC.02141-13; Skerry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039680; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wallis RS, 2009, CLIN INFECT DIS, V48, P1429, DOI 10.1086/598504; Wallis RS, 2004, AIDS, V18, P257, DOI 10.1097/00002030-200401230-00015; Wallis RS, 2005, CLIN INFECT DIS, V41, P201, DOI 10.1086/430914; WHO, 2018, GLOB TB REP 2017	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197474	10.1371/journal.pone.0197474	http://dx.doi.org/10.1371/journal.pone.0197474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758082	Green Published, Green Submitted, gold			2022-12-26	WOS:000432082900051
J	Jia, XT; Min, L; Zhu, ST; Zhang, ST; Huang, XF				Jia, Xueting; Min, Li; Zhu, Shengtao; Zhang, Shutian; Huang, Xiaofeng			Loss of sonic hedgehog gene leads to muscle development disorder and megaesophagus in mice	FASEB JOURNAL			English	Article						esophagus; muscle transdifferentiation; proliferation; developmental biology	CELL; GROWTH; PROLIFERATION; MORPHOGENESIS; ESOPHAGUS; MATURATION; MYOGENESIS; TRACHEA; LUNG	Sonic hedgehog (Shh) is crucial for organogenesis in the foregut. This study investigated the function of Shh at the late-gestational stage; during which, the esophagus continues to differentiate. We established cytokeratin 14 (CK14)-Cre;Shh(fl/fl) mice in which the down-regulation of Shh in the epithelium occurred at approximately the same time as esophageal muscle conversion. Hematoxylin and eosin and immunohistochemical staining, with antibodies against keratin 14, Shh, patched 1 (Ptch1), Gli1, proliferating cell nuclear antigen (PCNA), -smooth muscle actin (SMA), high-molecular-weight caldesmon (hCD), myogenin, paired box 7 (Pax7), 3-tubulin, and protein gene product 9.5 (PGP9.5), was performed to detect specific tissue dysplasia. Organ culture was conducted in vitro, and total mRNA was extracted to determine the transcriptional dysregulation. The esophagus of CK14-Cre;Shh(fl/fl) mice developed into an independent tube with an obvious dilatation at postnatal d 0.5. The number of cell layers and the expression of PCNA were decreased in mutant mice, compared with those in wild-type mice. The expression of hCD declined progressively in the middle, distal, and lower esophageal sphincter levels of the mutant esophagus from embryonic d 17.5, compared with the expression in wild-type littermates. Pax7 accumulation and myogenin reduction in mutant mice indicated that esophageal skeletal-myoblast progression was blocked. RNA sequencing analysis revealed a significant down-regulation of genes involved in proliferation and muscular motivation in CK14-Cre;Shh(fl/fl) mice. Thus, loss of Shh at the late-gestational stage leads to megaesophagus with reduced proliferation and a muscle development disorder in mice.Jia, X., Min, L., Zhu, S., Zhang, S., Huang, X. Loss of sonic hedgehog gene leads to muscle development disorder and megaesophagus in mice.	[Jia, Xueting; Min, Li; Zhu, Shengtao; Zhang, Shutian] Capital Med Univ, Dept Gastroenterol,Beijing Digestive Dis Ctr, Beijing Key Lab Precancerous Les Digest Dis, Beijing Friendship Hosp,Natl Clin Res Ctr Dig Dis, 95 Yongan Rd, Beijing, Peoples R China; [Jia, Xueting; Huang, Xiaofeng] Capital Med Univ, Beijing Friendship Hosp, Dept Stomatol, 95 Yongan Rd, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhang, ST (corresponding author), Capital Med Univ, Dept Gastroenterol,Beijing Digestive Dis Ctr, Beijing Key Lab Precancerous Les Digest Dis, Beijing Friendship Hosp,Natl Clin Res Ctr Dig Dis, 95 Yongan Rd, Beijing, Peoples R China.; Huang, XF (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Stomatol, 95 Yongan Rd, Beijing, Peoples R China.	zhangshutian@ccmu.edu.cn; huangxf1998@163.com	Min, Li/AAG-2088-2021; Jia, Xueting/AAG-5054-2020; Min, Li/T-8107-2018	Min, Li/0000-0001-9595-5536; Min, Li/0000-0001-9595-5536	National Natural Science Foundation of China [81170943]; Natural Science Foundation of Beijing Municipality [7162053]; Funding Program for Excellent Talents of Beijing [2017000021469G212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Funding Program for Excellent Talents of Beijing	The authors thank Yang Chai (University of Southern California, Los Angeles, Los Angeles, CA, USA), for providing CK14-Cre and Shh<SUP>fl/fl</SUP> transgenic mice, and Dr. Guangyong Chen (Capital Medical University, Beijing, China) for technical assistance with histologic analysis. In addition, the authors thank Qiping Luo (Ant Financial Services Group, Beijing, China) for his kind support in figure preparation. This work was supported by the National Natural Science Foundation of China (81170943), the Natural Science Foundation of Beijing Municipality (7162053 to X.H.), and the Funding Program for Excellent Talents of Beijing (2017000021469G212 to L.M.). The authors declare no conflicts of interest.	Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bren-Mattison Y, 2011, DEV BIOL, V356, P486, DOI 10.1016/j.ydbio.2011.06.002; Buller NVJA, 2015, GASTROENTEROLOGY, V148, P170, DOI 10.1053/j.gastro.2014.10.006; Cao M, 2010, DIFFERENTIATION, V79, P244, DOI 10.1016/j.diff.2010.02.002; Dassule HR, 2000, DEVELOPMENT, V127, P4775; DeSouza KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053675; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dionyssiou MG, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-7; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feng R, 2012, VITAM HORM, V88, P473, DOI 10.1016/B978-0-12-394622-5.00021-3; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; Huber PAJ, 1997, INT J BIOCHEM CELL B, V29, P1047, DOI 10.1016/S1357-2725(97)00004-6; Ioannides AS, 2003, J PEDIATR SURG, V38, P29, DOI 10.1053/jpsu.2003.50005; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Kahane N, 2013, DEVELOPMENT, V140, P1740, DOI 10.1242/dev.092726; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Lees C, 2005, GASTROENTEROLOGY, V129, P1696, DOI 10.1053/j.gastro.2005.05.010; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Nagy N, 2016, DEVELOPMENT, V143, P264, DOI 10.1242/dev.128132; NEUHUBER WL, 2006, ADV ANAT EMBRYOL CEL, V185, P1; Palmieri O, 2016, SCI REP-UK, V6, DOI 10.1038/srep31549; Parakati R, 2013, J BIOL CHEM, V288, P13876, DOI 10.1074/jbc.M113.457648; Parkin CA, 2008, AM J PHYSIOL-GASTR L, V294, pG363, DOI 10.1152/ajpgi.00457.2007; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Rishniw M, 2009, CELLS TISSUES ORGANS, V189, P410, DOI 10.1159/000155225; Romer AI, 2013, J CELL BIOL, V201, P309, DOI 10.1083/jcb.201301005; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Sumiyoshi H, 2004, J CELL BIOL, V166, P591, DOI 10.1083/jcb.200402054; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; van Dop WA, 2013, GUT, V62, P348, DOI 10.1136/gutjnl-2011-301141; Wang DH, 2014, J CLIN INVEST, V124, P3767, DOI 10.1172/JCI66603; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Yang CC, 2012, EMBO J, V31, P1739, DOI 10.1038/emboj.2012.24; Yu WY, 2005, DEV BIOL, V284, P157, DOI 10.1016/j.ydbio.2005.04.042; Zhao WF, 2000, DEV DYNAM, V219, P10, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1029>3.0.CO;2-2; Zizer E, 2010, GASTROENTEROLOGY, V139, P1344, DOI 10.1053/j.gastro.2010.06.041	43	3	3	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5703	5715		10.1096/fj.201701581R	http://dx.doi.org/10.1096/fj.201701581R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29768039	Bronze			2022-12-26	WOS:000447972500041
J	Cogan, DP; Baraquet, C; Harwood, CS; Nair, SK				Cogan, Dillon P.; Baraquet, Claudine; Harwood, Caroline S.; Nair, Satish K.			Structural basis of transcriptional regulation by CouR, a repressor of coumarate catabolism, in Rhodopseudomonas palustris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-ANTIBIOTIC-RESISTANCE; MULTIDRUG EFFLUX OPERON; CRYSTAL-STRUCTURE; DNA-BINDING; STRUCTURE REFINEMENT; MARR; MECHANISM; INSIGHTS; PROTEIN; IDENTIFICATION	The MarR family transcriptional regulator CouR, from the soil bacterium Rhodopseudomonas palustris CGA009, has recently been shown to negatively regulate a p-coumarate catabolic operon. Unlike most characterized MarR repressors that respond to small metabolites at concentrations in the millimolar range, repression by CouR is alleviated by the 800-Da ligand p-coumaroyl-CoA with high affinity and specificity. Here we report the crystal structures of ligand-free CouR as well as the complex with p-coumaroyl-CoA, each to 2.1-angstrom resolution, and the 2.85-angstrom resolution cocrystal structure of CouR bound to an oligonucleotide bearing the cognate DNA operator sequence. In combination with binding experiments that uncover specific residues important for ligand and DNA recognition, these structures provide glimpses of a MarR family repressor in all possible states, providing an understanding of the molecular basis of DNA binding and the conformation alterations that accompany ligand-induced dissociation for activation of the operon.	[Cogan, Dillon P.; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cogan, Dillon P.; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Baraquet, Claudine; Harwood, Caroline S.] Univ Washington, Sch Med, Dept Microbiol, Washington, DC 98195 USA; [Baraquet, Claudine] Univ Toulon & Var, Lab MAPIEM, F-83014 Toulon 9, France	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Washington; Universite de Toulon	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Nair, SK (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.; Nair, SK (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	s-nair@life.illinois.edu	Nair, Satish/AAY-2510-2021; Claudine, Baraquet/AAY-4483-2021	Baraquet, Claudine/0000-0002-0173-7501; Harwood, Caroline/0000-0003-4450-5177; Cogan, Dillon/0000-0003-4563-2397				Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Birukou I, 2014, NUCLEIC ACIDS RES, V42, P2774, DOI 10.1093/nar/gkt1215; Chang YM, 2010, P NATL ACAD SCI USA, V107, P8617, DOI 10.1073/pnas.0913302107; Davies C, 2000, STRUCTURE, V8, P185, DOI 10.1016/S0969-2126(00)00094-0; Davis JR, 2013, NUCLEIC ACIDS RES, V41, P3888, DOI 10.1093/nar/gkt009; Dolan KT, 2011, J BIOL CHEM, V286, P22178, DOI 10.1074/jbc.M111.245258; Duval V, 2013, J BACTERIOL, V195, P3341, DOI 10.1128/JB.02224-12; Edwards TE, 2011, ACTA CRYSTALLOGR F, V67, P1032, DOI 10.1107/S1744309111004349; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao YR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01705-4; Hao ZY, 2014, NAT CHEM BIOL, V10, P21, DOI [10.1038/NCHEMBIO.1380, 10.1038/nchembio.1380]; Haque MM, 2009, J BACTERIOL, V191, P5409, DOI 10.1128/JB.00240-09; Hirakawa H, 2012, J BACTERIOL, V194, P1960, DOI 10.1128/JB.06817-11; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Kaatz GW, 2006, ANTIMICROB AGENTS CH, V50, P1276, DOI 10.1128/AAC.50.4.1276-1281.2006; Kim Y, 2016, J BIOL CHEM, V291, P13243, DOI 10.1074/jbc.M115.712067; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Liu GJ, 2017, J AM CHEM SOC, V139, P1598, DOI 10.1021/jacs.6b11438; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Otani H, 2016, NUCLEIC ACIDS RES, V44, P595, DOI 10.1093/nar/gkv955; Perez-Rueda E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195332; Phattarasukol S, 2012, APPL ENVIRON MICROB, V78, P6812, DOI 10.1128/AEM.01418-12; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vivoli M, 2014, JOVE-J VIS EXP, DOI 10.3791/51809; Xiong Y, 2018, METHODS MOL BIOL, V1754, P223, DOI 10.1007/978-1-4939-7717-8_13	31	8	8	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 27	2018	293	30					11727	11735		10.1074/jbc.RA118.003561	http://dx.doi.org/10.1074/jbc.RA118.003561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GO6FP	29794028	Green Published, hybrid			2022-12-26	WOS:000440134500006
J	Phatarphekar, A; Su, Q; Eun, SH; Chen, X; Rokita, SE				Phatarphekar, Abhishek; Su, Qi; Eun, Suk Ho; Chen, Xin; Rokita, Steven E.			The importance of a halotyrosine dehalogenase for Drosophila fertility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; reproduction; reductase; flavoprotein; tyrosine; dehalogenase; halotyrosine	IODOTYROSINE DEIODINASE; THYROID-HORMONES; TERMINAL DIFFERENTIATION; MALE GERMLINE; IN-VIVO; METABOLISM; GENE; MELANOGASTER; EVOLUTIONARY; IODINE	The ability of iodotyrosine deiodinase to salvage iodide from iodotyrosine has long been recognized as critical for iodide homeostasis and proper thyroid function in vertebrates. The significance of its additional ability to dehalogenate bromo- and chlorotyrosine is less apparent, and none of these functions could have been anticipated in invertebrates until recently. Drosophila, as most arthropods, contains a deiodinase homolog encoded by CG6279, now named condet (cdt), with a similar catalytic specificity. However, its physiological role cannot be equivalent because Drosophila lacks a thyroid and its associated hormones, and no requirement for iodide or halotyrosines has been reported for this species. We have now applied CRISPR/Cas9 technology to generate Drosophila strains in which the cdt gene has been either deleted or mutated to identify its biological function. As previously shown in larvae, expression of cdt is primarily limited to the fat body, and we now report that loss of cdt function does not enhance sensitivity of the larvae to the toxic effects of iodotyrosine. In adult flies by contrast, expression is known to occur in testes and is detected at very high levels in this tissue. The importance of cdt is most evident in the decrease in fertility observed when either males or females carry a deletion or mutation of cdt. Therefore, dehalogenation of a halotyrosine appears essential for efficient reproduction in Drosophila and likely contributes to a new pathway for controlling viability in arthropods.	[Phatarphekar, Abhishek; Su, Qi; Rokita, Steven E.] Johns Hopkins Univ, Dept Chem, Charles & 34Th St, Baltimore, MD 21218 USA; [Eun, Suk Ho; Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Rokita, SE (corresponding author), 3400 N Charles St, Baltimore, MD 21218 USA.	rokita@jhu.edu	Rokita, Steven E/C-4793-2009	Phatarphekar, Abhishek/0000-0002-2657-1157	National Institutes of Health [AI119540]; David and Lucile Packard Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant AI119540 (to S. R.), grants from the David and Lucile Packard Foundation (to X. C.), and a Faculty Scholar award from Howard Hughes Medical Institute (to X. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; Akiva E, 2017, P NATL ACAD SCI USA, V114, pE9549, DOI 10.1073/pnas.1706849114; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Bobyk KD, 2015, BIOCHEMISTRY-US, V54, P4487, DOI 10.1021/acs.biochem.5b00410; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; Chen D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004797; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Crockford SJ, 2009, INTEGR COMP BIOL, V49, P155, DOI 10.1093/icb/icp053; DICKHOFF WW, 1983, AM ZOOL, V23, P697; Eales JG, 1997, P SOC EXP BIOL MED, V214, P302; Eun SH, 2013, DEVELOPMENT, V140, P23, DOI 10.1242/dev.086397; Flatt T, 2006, INTEGR COMP BIOL, V46, P777, DOI 10.1093/icb/icl034; Forhead AJ, 2014, J ENDOCRINOL, V221, pR87, DOI 10.1530/JOE-14-0025; Friedman JE, 2006, J BIOL CHEM, V281, P2812, DOI 10.1074/jbc.M510365200; Gan QA, 2010, CELL RES, V20, P763, DOI 10.1038/cr.2010.64; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; HARTMANN N, 1950, H-S Z PHYSIOL CHEM, V285, P1, DOI 10.1515/bchm2.1950.285.1-3.1; Heifetz Y, 2010, THERIOGENOLOGY, V73, P723, DOI 10.1016/j.theriogenology.2009.11.001; Heyland A, 2005, J EXP BIOL, V208, P4355, DOI 10.1242/jeb.01877; Heyland A, 2004, EVOL DEV, V6, P382, DOI 10.1111/j.1525-142X.2004.04047.x; Heyland A, 2006, J EXP ZOOL PART B, V306B, P551, DOI 10.1002/jez.b.21113; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; Hu JM, 2015, J BIOL CHEM, V290, P590, DOI 10.1074/jbc.M114.605964; HUNT S, 1984, METHOD ENZYMOL, V107, P413; Ingavat N, 2017, BIOCHEMISTRY-US, V56, P1130, DOI 10.1021/acs.biochem.6b01308; JOHNSON KS, 1992, ANAL CHEM, V64, pA1065, DOI 10.1021/ac00046a001; Mani AR, 2007, J BIOL CHEM, V282, P29114, DOI 10.1074/jbc.M704270200; Mani AR, 2016, FREE RADICAL BIO MED, V90, P243, DOI 10.1016/j.freeradbiomed.2015.11.030; McCall AS, 2014, CELL, V157, P1380, DOI 10.1016/j.cell.2014.05.009; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; McTamney PM, 2009, J AM CHEM SOC, V131, P14212, DOI 10.1021/ja906642n; Moreno JC, 2008, NEW ENGL J MED, V358, P1811, DOI 10.1056/NEJMoa0706819; Morris CA, 2009, NAT PROTOC, V4, P1807, DOI 10.1038/nprot.2009.192; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Phatarphekar A, 2016, PROTEIN SCI, V25, P2187, DOI 10.1002/pro.3044; Phatarphekar A, 2014, MOL BIOSYST, V10, P86, DOI 10.1039/c3mb70398c; Piper MDW, 2014, NAT METHODS, V11, P100, DOI [10.1038/NMETH.2731, 10.1038/nmeth.2731]; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; ROCHE J, 1953, BIOCHIM BIOPHYS ACTA, V12, P570, DOI 10.1016/0006-3002(53)90189-9; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Ryuda M, 2008, J INSECT PHYSIOL, V54, P1440, DOI 10.1016/j.jinsphys.2008.08.006; Schulz Cordula, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4764; SILVERSTONE M, 1978, GEN COMP ENDOCR, V34, P132, DOI 10.1016/0016-6480(78)90203-4; Sun ZD, 2017, ARCH BIOCHEM BIOPHYS, V632, P77, DOI 10.1016/j.abb.2017.07.019; Tata JR, 1999, BIOCHIMIE, V81, P359, DOI 10.1016/S0300-9084(99)80082-0; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Valverde-R C, 2004, INT REV CYTOL, V234, P143, DOI 10.1016/S0074-7696(04)34004-0; Wang LS, 2014, RSC ADV, V4, P57350, DOI 10.1039/c4ra09833a; WHEELER BM, 1950, J EXP ZOOL, V115, P83, DOI 10.1002/jez.1401150106; White-Cooper H, 2000, DEVELOPMENT, V127, P5463; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Xie J, 2015, CELL, V163, P920, DOI 10.1016/j.cell.2015.10.002	54	2	3	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10314	10321		10.1074/jbc.RA118.003364	http://dx.doi.org/10.1074/jbc.RA118.003364			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29764939	Green Published, hybrid			2022-12-26	WOS:000437096700029
J	Barrios-de Pedro, S; Poyato-Ariza, FJ; Moratalla, JJ; Buscalioni, AD				Barrios-de Pedro, Sandra; Jose Poyato-Ariza, Francisco; Joaquin Moratalla, Jose; Buscalioni, Angela D.			Exceptional coprolite association from the Early Cretaceous continental Lagerstatte of Las Hoyas, Cuenca, Spain	PLOS ONE			English	Article							DINOSAUR COPROLITES; VERTEBRATE COPROLITES; TRIASSIC COPROLITES; LAMETA FORMATION; IBERIAN RANGES; FOOD-WEB; PRESERVATION; TAPHONOMY; FECES; INDIA	Coprolites are some of the most abundant fossils at the Las Hoyas site, a well-known Early Cretaceous Konservat-Lagerstatte located in Cuenca, central Spain. The coprolite association is described, introducing taphonomic features and sedimentological properties. This study is based on a subsample of 433 fossils selected from some 2000 specimens collected. The taphonomic features of the coprolites show that their integrity, absence of desiccation marks, and volume are congruent with faeces produced and deposited in an aquatic ecosystem, which were immediately covered by microbial mats. The highest abundance of coprolites, 96%, occurs in layers linked to the presence of microbial mats. Consequently, it is likely that coprolites are taphonomically autochthonous. A dichotomous key has been made in order to delimit the morphotypes. The key is based on (1) presence/absence of spiral marks, (2) morphology of coprolite ends, including polarity, expansion, and surface, and (3) overall shape, outline, diameter, and constrictions. Twelve different morphotypes are distinguished: spiral, circular, irregular, elongated, rosary, ellipsoidal, cylinder, bump-headed lace, fir-tree, cone, straight lace, and thin lace. The association is dominated by thin-lace and cylinder morphotypes. The sizes, inclusions, and EDX analyses indicate that the Las Hoyas coprolites correspond mostly to carnivorous producers with ichthyophagous diets, as crocodiles, urodelans and different kind of fishes.	[Barrios-de Pedro, Sandra; Jose Poyato-Ariza, Francisco; Buscalioni, Angela D.] Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, Edificio Biol, Madrid, Spain; [Joaquin Moratalla, Jose] Inst Geol & Minero Espana, Museo Geominero, Madrid, Spain	Autonomous University of Madrid	Barrios-de Pedro, S (corresponding author), Univ Autonoma Madrid, Dept Biol, Unidad Paleontol, Edificio Biol, Madrid, Spain.	sandra.barrios@uam.es	Buscalioni, Angela D./AAA-5874-2019	Barrios-de Pedro, Sandra/0000-0003-0123-0660	Spanish Ministerio de Economia y Competitividad (MINECO) [CGL2013-42643P, BES2014-070985]	Spanish Ministerio de Economia y Competitividad (MINECO)	This work is financed by the Spanish Ministerio de Economia y Competitividad (MINECO) thorough the project CGL2013-42643P, and the PhD grant BES2014-070985, associated to this project. http://www.idi.mineco.gob.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altig R, 2007, FRESHWATER BIOL, V52, P386, DOI 10.1111/j.1365-2427.2006.01694.x; [Anonymous], 1997, ENCY DINOSAURS; Ash SA., 1978, GEOLOGY PALEONTOLOGY, P75; Bailleul A, 2011, CR PALEVOL, V10, P367, DOI 10.1016/j.crpv.2011.05.002; Bajdek P, 2014, PALAEOGEOGR PALAEOCL, V411, P1, DOI 10.1016/j.palaeo.2014.06.013; Bertrand C.E., 1903, MEMOIRE MUSEE ROYAL, V1, P1; Briggs D. E. G., 2016, HOYAS CRETACEOUS WET, P216; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; Buatois L., 2011, ICHNOLOGY ORGANISM S; Buatois LA, 2000, FACIES, V43, P145, DOI 10.1007/BF02536988; Buatois Luis Alberto, 2007, P285, DOI 10.1016/B978-044452949-7/50143-1; Buatois Luis Alberto, 1995, Ichnos, V4, P151; Buckland W. F., 1835, T GEOLOGICAL SOC LON, Viii, P223; Buscalioni AD, 2008, CRETACEOUS RES, V29, P687, DOI 10.1016/j.cretres.2008.02.004; Buscalioni AD, 2010, J IBER GEOL, V36, P297, DOI 10.5209/rev_JIGE.2010.v36.n2.13; Buscalioni A.D, 2016, HOYAS CRETACEOUS WET, P232; Buscalioni Angela D., 2016, Bulletin of the New Mexico Museum of Natural History and Science, P51; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Chin K, 2003, PALAIOS, V18, P286, DOI 10.1669/0883-1351(2003)018<0286:RPOUMT>2.0.CO;2; Chin K, 1996, PALAIOS, V11, P280, DOI 10.2307/3515235; Chin K, 2007, PALAIOS, V22, P554, DOI 10.2110/palo.2006.p06-087r; Chin Karen, 2002, Paleontological Society Papers, V8, P43; de Gibert JM, 1999, PALAEONTOLOGY, V42, P409, DOI 10.1111/1475-4983.00079; Dieguez C., 1995, BIOSTRATIGRAPHY HOYA, P77; EDWARDS P, 1974, Contributions to Geology University of Wyoming, V13, P67; Eriksson ME, 2011, LETHAIA, V44, P455, DOI 10.1111/j.1502-3931.2010.00257.x; Francischini H, 2018, LETHAIA, V51, P389, DOI 10.1111/let.12251; Fregenal-Martinez M.A., 2000, AAPG STUDIES GEOLOGY, V46, P303; Fregenal-Martinez MA, 2015, 31 IAS M SED KRAK PO, P367; Fregenal-Martinez MA, 2013, KARSTIC HABITAT SPEL, P1175; Fregenal-Martinez MA., 2016, HOYAS CRETACEOUS WET, P14; Fregenal-Martinez M, 2017, REV SOC GEOL ESPANA, V30, P113; Gaiser EE, 2011, CRIT REV ENV SCI TEC, V41, P92, DOI 10.1080/10643389.2010.531192; Ghosh P, 2003, CRETACEOUS RES, V24, P743, DOI 10.1016/j.cretres.2003.08.002; Gibert J.M. de, 2016, HOYAS CRETACEOUS WET, P195; Gill FL, 2009, QUATERNARY RES, V72, P284, DOI 10.1016/j.yqres.2009.06.006; Gupta NS, 2008, CRETACEOUS RES, V29, P1, DOI 10.1016/j.cretres.2006.12.009; Hansen BB, 2015, SPECIAL PUBLICATION; Hantschel W, 1968, Mem Geol Soc America, V108, P1; Hollocher KT, 2010, PALAIOS, V25, P132, DOI 10.2110/palo.2008.p08-132r; Hollocher TC, 2001, PALAIOS, V16, P547, DOI 10.2307/3515628; Hunt A.P., 2018, LATE TRIASSIC WORLD, V46, P447, DOI DOI 10.1007/978-3-319-68009-5_12; Hunt Adrian P., 2012, Bulletin of the New Mexico Museum of Natural History and Science, P153; Hunt Adrian P., 1994, P221; Hunt Adrian R., 2012, Bulletin of the New Mexico Museum of Natural History and Science, P5; Iniesto M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25716; Iniesto M, 2015, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2015.00051; Iniesto M, 2013, PALAIOS, V28, P56, DOI 10.2110/palo.2011.p11-099r; JAIN SL, 1983, PALAEONTOLOGY, V26, P813; Khosla A, 2015, PALAEOGEOGR PALAEOCL, V418, P90, DOI 10.1016/j.palaeo.2014.11.003; Knaust D, 2010, LETHAIA, V43, P344, DOI 10.1111/j.1502-3931.2009.00196.x; LADLE M, 1980, HYDROBIOLOGIA, V74, P161, DOI 10.1007/BF00014568; Luo M, 2017, PALAEOGEOGR PALAEOCL, V474, P232, DOI 10.1016/j.palaeo.2016.06.001; Milan Jesper, 2012, Bulletin of the New Mexico Museum of Natural History and Science, V57, P235; Milan Jesper, 2012, Bulletin of the New Mexico Museum of Natural History and Science, P65; Moratalla JJ, 2017, PALAEONTOL ELECTRON, V20, DOI 10.26879/770; Moratalla JJ, 1995, GEOBIOS-LYON, V28, P777, DOI 10.1016/S0016-6995(95)80074-3; Niedzwiedzki G, 2016, PALAEOGEOGR PALAEOCL, V464, P5, DOI 10.1016/j.palaeo.2016.04.003; Northwood C, 2005, PALAEONTOLOGY, V48, P49, DOI 10.1111/j.1475-4983.2004.00432.x; Ounis A, 2008, PALAEOGEOGR PALAEOCL, V268, P1, DOI 10.1016/j.palaeo.2008.07.005; Owocki K, 2012, PALAIOS, V27, P867, DOI 10.2110/palo.2012.p12-017r; Penalver E, 2010, PALAEOGEOGR PALAEOCL, V297, P683, DOI 10.1016/j.palaeo.2010.09.017; Poinar G, 2006, PARASITOLOGY, V133, P245, DOI 10.1017/S0031182006000138; Poyato-Ariza F., 2016, HOYAS CRETACEOUS WET, P114; Poyato-Ariza FJ, 1998, PALAEOGEOGR PALAEOCL, V144, P65, DOI 10.1016/S0031-0182(98)00085-6; Richter G, 2005, PALAEOGEOGR PALAEOCL, V223, P147, DOI 10.1016/j.palaeo.2005.04.002; Rodriguez-de la Rosa RA, 1998, PALAEOGEOGR PALAEOCL, V142, P231, DOI 10.1016/S0031-0182(98)00052-2; Saba GK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00716; SCHMITZ M, 1991, Palaeontologische Zeitschrift, V65, P199; Schwimmer DR, 2015, PALAIOS, V30, P707, DOI 10.2110/palo.2015.019; Segesdi M, 2017, CRETACEOUS RES, V74, P87, DOI 10.1016/j.cretres.2017.02.010; Spagna P., 2012, BERNISSART DINOSAURS, P87; Stevens CE., 1995, COMP PHYSL VERTEBRAT, DOI 10.1086/416640; THULBORN RA, 1991, PALAEOGEOGR PALAEOCL, V83, P341, DOI 10.1016/0031-0182(91)90060-5; Vajda V, 2016, PALAEOGEOGR PALAEOCL, V464, P134, DOI 10.1016/j.palaeo.2016.02.036; Van del Valk AG, 2006, BIOL FRESHWATER WETL; Viitasalo M, 1999, LIMNOL OCEANOGR, V44, P1388, DOI 10.4319/lo.1999.44.6.1388; Wotton RS, 2001, BIOSCIENCE, V51, P537, DOI 10.1641/0006-3568(2001)051[0537:FIAE]2.0.CO;2; Zaton M, 2015, PALAEOGEOGR PALAEOCL, V430, P21, DOI 10.1016/j.palaeo.2015.04.009; Zaton M, 2014, PALAEOGEOGR PALAEOCL, V394, P1, DOI 10.1016/j.palaeo.2013.11.019	80	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196982	10.1371/journal.pone.0196982	http://dx.doi.org/10.1371/journal.pone.0196982			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791478	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000027
J	Bjerregaard-Andersen, M; Lund, N; Joergensen, ASP; Jepsen, FS; Unger, HW; Mane, M; Rodrigues, A; Bergstrom, S; Berm, CS				Bjerregaard-Andersen, Morten; Lund, Najaaraq; Joergensen, Anne Sofie Pinstrup; Jepsen, Frida Starup; Unger, Holger Werner; Mane, Mama; Rodrigues, Amabelia; Bergstrom, Steffan; Berm, Christine Stabell			Stillbirths in urban Guinea-Bissau: A hospital and community-based study	PLOS ONE			English	Article							EARLY NEONATAL-MORTALITY; NEWBORN MORTALITY; RISK-FACTORS; BABIES; HEALTH; PRIORITIES; PREGNANCY; CHILDREN; AUDIT; RATES	Background Stillbirth rates remain high in many low-income settings, with fresh (intrapartum) stillbirths accounting for a large part due to limited obstetrical care. We aimed to determine the stillbirth rate and identify potentially modifiable factors associated with stillbirth in urban Guinea-Bissau. Methods The study was carried out by the Bandim Health Project (BHP), a Health and Demographic Surveillance System site in the capital Bissau. We assessed stillbirth rates in a hospital cohort consisting of all deliveries at the maternity ward at the National Hospital Simao Men des (HNSM), and in a community cohort, which only included women from the BHP area. Stillbirth was classified as fresh (FSB) if fetal movements were reported on the day of delivery. Results From October 1 2007 to April 15 2013, a total of 38164 deliveries were registered at HNSM, among them 3762 stillbirths (99/1000 births). Excluding deliveries referred to the hospital from outside the capital (9.6%), the HNSM stillbirth rate was 2786/34490 births (81/1000). During the same period, 15462 deliveries were recorded in the community cohort. Of these, 768 were stillbirths (50/1000). Of 11769 hospital deliveries among women from Bissau with data on fetal movement, 866 (74/1000) were stillbirths, and 609 (70.3%) of these were FSB, i.e. potentially preventable. The hospital FSB rate was highest in the evening from 4 pm to midnight (P = 0.04). In the community cohort, antenatal care (ANC) attendance correlated strongly with stillbirth reduction; the stillbirth rate was 71/1000 if the mother attended no ANC consultations vs. 36/1000 if she attended >= 7 consultations (P<0.001). Conclusion In Bissau, the stillbirth rate is alarmingly high. The majority of stillbirths are preventable FSB. Improving obstetrical training, labour management (including sufficient intrapartum monitoring and timely intervention) and hospital infrastructure is urgently required. This should be combined with proper community strategies and additional focus on antenatal care.	[Bjerregaard-Andersen, Morten; Lund, Najaaraq; Joergensen, Anne Sofie Pinstrup; Jepsen, Frida Starup; Unger, Holger Werner; Rodrigues, Amabelia; Berm, Christine Stabell] INDEPTH Network, Bandim Hlth Project, Apartado 861, Bissau 1004, Guinea Bissau; [Bjerregaard-Andersen, Morten; Lund, Najaaraq; Joergensen, Anne Sofie Pinstrup; Jepsen, Frida Starup; Berm, Christine Stabell] Statens Serum Inst, Res Ctr Vitamins & Vaccines CVIVA, Copenhagen, Denmark; [Bjerregaard-Andersen, Morten] Hosp Southwest Denmark, Dept Endocrinol, Esbjerg, Denmark; [Unger, Holger Werner] Univ Melbourne, Doherty Inst, Dept Med, Melbourne, Vic, Australia; [Unger, Holger Werner] Edinburgh Royal Infirm, Simpson Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Mane, Mama] Natl Hosp Simao Mendes, Dept Matern, Bissau, Guinea Bissau; [Bergstrom, Steffan] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Berm, Christine Stabell] Univ Southern Denmark, Inst Clin Res, Odense Univ Hosp, OPEN, Odense, Denmark	Statens Serum Institut; University of Melbourne; Royal Infirmary of Edinburgh; Karolinska Institutet; University of Southern Denmark; Odense University Hospital	Bjerregaard-Andersen, M (corresponding author), INDEPTH Network, Bandim Hlth Project, Apartado 861, Bissau 1004, Guinea Bissau.; Bjerregaard-Andersen, M (corresponding author), Statens Serum Inst, Res Ctr Vitamins & Vaccines CVIVA, Copenhagen, Denmark.; Bjerregaard-Andersen, M (corresponding author), Hosp Southwest Denmark, Dept Endocrinol, Esbjerg, Denmark.	mban@dadlnet.dk		Bjerregaard-Andersen, Morten/0000-0002-4128-5714	Danish National Research Foundation through CVIVA [DNRF108]; Odense University Hospital; Karen Elise Jensen's foundation; Danish Council for Strategic Research; University of Southern Denmark; CVIVA; European Research Council [ERC-2009-StG-243149]	Danish National Research Foundation through CVIVA; Odense University Hospital; Karen Elise Jensen's foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); University of Southern Denmark; CVIVA; European Research Council(European Research Council (ERC)European Commission)	The data collection was supported by the Danish National Research Foundation through CVIVA (DNRF108), Odense University Hospital and Karen Elise Jensen's foundation. MB-A was funded by the Danish Council for Strategic Research, University of Southern Denmark, Odense University Hospital and CVIVA. CSB has received a starting grant from the European Research Council (ERC-2009-StG-243149). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminu M, 2014, BJOG-INT J OBSTET GY, V121, P141, DOI 10.1111/1471-0528.12995; Andargie G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-168; Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; Bjerregaard-Andersen M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-140; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Briand V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047352; BUGALHO A, 1993, GYNECOL OBSTET INVES, V36, P239, DOI 10.1159/000292637; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2469, DOI 10.1001/jama.2011.1798; Chalumeau M, 2002, INT J EPIDEMIOL, V31, P661, DOI 10.1093/ije/31.3.661; Chou D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4255; Ekure EN, 2011, NIGER J CLIN PRACT, V14, P88, DOI 10.4103/1119-3077.79271; Engmann C, 2012, TROP MED INT HEALTH, V17, P272, DOI 10.1111/j.1365-3156.2011.02931.x; Engmann C, 2009, INT J GYNECOL OBSTET, V105, P112, DOI 10.1016/j.ijgo.2008.12.012; Ezugwu EC, 2011, INT J GYNECOL OBSTET, V115, P164, DOI 10.1016/j.ijgo.2011.05.028; French R, 1998, BRIT J OBSTET GYNAEC, V105, P827, DOI 10.1111/j.1471-0528.1998.tb10226.x; Gold KJ, 2014, INT J GYNECOL OBSTET, V125, P223, DOI 10.1016/j.ijgo.2013.12.006; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Hoj L, 2002, BJOG-INT J OBSTET GY, V109, P792, DOI 10.1111/j.1471-0528.2002.01259.x; Jammeh A, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/186867; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S2; Mbaruku G, 2009, INT J GYNECOL OBSTET, V106, P85, DOI 10.1016/j.ijgo.2009.04.008; MCCLURE EM, 2006, OBSTETRICS, V94, P82, DOI DOI 10.1016/J.IJGO.2006.03.023; Mondal D, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0220-4; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Olusanya BO, 2009, ACTA OBSTET GYN SCAN, V88, P1243, DOI 10.3109/00016340903287474; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Rao A, 2004, BEST PRACT RES CL OB, V18, P557, DOI 10.1016/j.bpobgyn.2004.04.007; Reddy UM, 2007, OBSTET GYNECOL, V110, P1151, DOI 10.1097/01.AOG.0000287616.71602.d0; Royal College of Obstetricians and Gynaecologists, 2011, GREEN TOP GUID RED F; Shah A, 2009, INT J GYNECOL OBSTET, V107, P191, DOI 10.1016/j.ijgo.2009.08.013; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Smith GCS, 2015, OBSTET GYNAECOL, V17, P183, DOI 10.1111/tog.12197; Sodemann M, 2004, ACTA PAEDIATR, V93, P959, DOI [10.1080/08035250410025564, 10.1111/j.1651-2227.2004.tb02696.x]; Spector JM, 2008, B WORLD HEALTH ORGAN, V86, P315, DOI 10.2471/BLT.07.049924; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; United Nations Development Programme, 2016, HUM DEV IND; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; Winje BA, 2016, BJOG-INT J OBSTET GY, V123, P886, DOI 10.1111/1471-0528.13802; World Health Organization, 2016, GUIN BISS COUNTR PRO; Yakoob MY, 2010, SEMIN PERINATOL, V34, P387, DOI 10.1053/j.semperi.2010.09.010; Yoshida S, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010508	45	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197680	10.1371/journal.pone.0197680	http://dx.doi.org/10.1371/journal.pone.0197680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791501	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000054
J	Koch, SAJ; Alexy, U; Diederichs, T; Buyken, AE; Rossbach, S				Koch, Stefanie A. J.; Alexy, Ute; Diederichs, Tanja; Buyken, Anette E.; Rossbach, Sarah			The relevance of restrained eating behavior for circadian eating patterns in adolescents	PLOS ONE			English	Article							GERMAN HEALTH INTERVIEW; BODY-MASS INDEX; RANDOMIZED CONTROLLED-TRIAL; DIETARY RESTRAINT; FOOD-INTAKE; ENERGY-INTAKE; NORMAL-WEIGHT; CHRONOBIOLOGICAL ASPECTS; CAUSAL ROLE; CHILDREN	Background Restrained Eating, i.e. the tendency to restrict dietary intake to control body-weight, often emerges during adolescence and may result in changes in circadian eating patterns. Objective The objective of the present investigation was to determine the cross-sectional relevance of restrained eating for characteristics of circadian eating pattern in adolescents and whether changes in restrained eating are accompanied by concurrent changes in circadian eating pattern over the course of adolescence. Methods Two questionnaires assessing restrained eating (Score 0-30) with parallel 3-day weighed dietary records from two different time points were available from 209 (male:101, female:108) 11-18 year old adolescents of the DONALD study. Mixed linear regression models were used to analyze whether restrained eating was associated with eating occasion frequency, snack frequency and morning and evening energy intake [in % of daily energy intake, %E]. Linear regression models were used to examine whether changes in restrained eating were associated with changes in the mentioned variables. Results Among girls, greater restrained eating was cross-sectionally associated with higher morning energy intake (p = 0.03). Further, there was a tendency towards lower evening energy intake with higher levels of restrained eating for the whole sample (p = 0.06). No cross-sectional associations were found with eating occasion or snack frequency. Each one-point increase in restrained eating during adolescence was related to a concurrent decrease in eating occasion frequency by 0.04 (95% CI-0.08;-0.01, p = 0.02) and in evening energy intake by 0.36%E (95% CI-0.70;-0.03, p = 0.04). A tendency towards decreasing snack frequency with increasing restrained eating was observed (beta =-0.03, 95% CI-0.07; 0.00, p = 0.07). No association was found between changes in restrained eating and concurrent changes in morning energy intake. Conclusion We found indications for cross-sectional and prospective associations between restrained eating and chronobiological aspects of food intake in adolescents. Our results suggest that restrained eating should be considered a relevant determinant of circadian eating patterns.	[Koch, Stefanie A. J.; Alexy, Ute; Diederichs, Tanja; Buyken, Anette E.; Rossbach, Sarah] Univ Bonn, Fac Agr, Dept Nutr & Food Sci, DONALD Study,Nutr Epidemiol, Bonn, North Rhine Wes, Germany; [Diederichs, Tanja; Buyken, Anette E.] Univ Paderborn, Inst Nutr Consumpt & Hlth, Fac Nat Sci, Publ Hlth Nutr, Paderborn, North Rhine Wes, Germany	University of Bonn; University of Paderborn	Alexy, U (corresponding author), Univ Bonn, Fac Agr, Dept Nutr & Food Sci, DONALD Study,Nutr Epidemiol, Bonn, North Rhine Wes, Germany.	alexy@uni-bonn.de		Koch, Stefanie/0000-0001-7399-7188; Alexy, Ute/0000-0002-1488-5175	Ministry of Science and Research of North Rhine Westphalia, Germany; German Research Foundation [AL1794/1-1]	Ministry of Science and Research of North Rhine Westphalia, Germany; German Research Foundation(German Research Foundation (DFG))	The DONALD Study is financially supported by the Ministry of Science and Research of North Rhine Westphalia, Germany. This analysis was funded by the German Research Foundation (http://www.dfg.de/) (AL1794/1-1) to Dr. Ute Alexy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anschutz DJ, 2009, APPETITE, V53, P119, DOI 10.1016/j.appet.2009.03.016; Asbeck I, 2002, PUBLIC HEALTH NUTR, V5, P683, DOI 10.1079/PHN2002337; Babio N, 2008, NUTR HOSP, V23, P27; Barkmann C, 2011, KLINISCH PSYCHIAT RA; Betts JA, 2016, P NUTR SOC, V75, P464, DOI 10.1017/S0029665116000318; Betts JA, 2014, AM J CLIN NUTR, V100, P539, DOI 10.3945/ajcn.114.083402; Birch L, 2007, CAN J DIET PRACT RES, V68, pS51, DOI DOI 10.1097/MD; Bisset S, 2007, PUBLIC HEALTH NUTR, V10, P780, DOI 10.1017/S1368980007249626; Bo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108467; Boland WA, 2013, APPETITE, V70, P47, DOI 10.1016/j.appet.2013.06.085; Braet C, 2000, INT J OBESITY, V24, P314, DOI 10.1038/sj.ijo.0801129; Braet C, 2008, J HEALTH PSYCHOL, V13, P733, DOI 10.1177/1359105308093850; Buyken AE, 2012, BUNDESGESUNDHEITSBLA, V55, P875, DOI 10.1007/s00103-012-1503-6; Buyken AE, 2010, DIABETOLOGIA, V53, P406, DOI 10.1007/s00125-009-1629-8; Buyken AE, 2007, AM J CLIN NUTR, V86, P980, DOI 10.1093/ajcn/86.4.980; Buyken AE, 2009, AM J CLIN NUTR, V89, P221, DOI 10.3945/ajcn.2008.26733; Cagampang FR, 2012, BRIT J NUTR, V108, P381, DOI 10.1017/S0007114512002139; Carper JL, 2000, APPETITE, V35, P121, DOI 10.1006/appe.2000.0343; Chowdhury EA, 2016, AM J CLIN NUTR, V103, P747, DOI 10.3945/ajcn.115.122044; Dannigkeit N, 2005, Z GESUNDHEITSPSYCHOL, V13, P79; de Castro JM, 2004, J NUTR, V134, P104, DOI 10.1093/jn/134.1.104; DECASTRO JM, 1995, PHYSIOL BEHAV, V57, P287, DOI 10.1016/0031-9384(94)00229-X; Diederichs T, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110716; DiSantis KI, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-89; Edmunds H, 1999, INT J EAT DISORDER, V25, P435, DOI 10.1002/(SICI)1098-108X(199905)25:4&lt;435::AID-EAT8&gt;3.0.CO;2-3; Ekmekcioglu C, 2011, OBES REV, V12, P14, DOI 10.1111/j.1467-789X.2010.00716.x; Eng S, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-27; Field AE, 2003, PEDIATRICS, V112, P900, DOI 10.1542/peds.112.4.900; Francis LA, 2005, HEALTH PSYCHOL, V24, P548, DOI 10.1037/0278-6133.24.6.548; Franzen S., 1997, KINDH ENTWICKL, V6, P116; Garaulet M, 2010, ADV DRUG DELIVER REV, V62, P967, DOI 10.1016/j.addr.2010.05.005; Grunert SC., 1989, DIAGNOSTICA, V2, P167; Gunther ALB, 2007, GEZUGELTES ESSVERHAL, P456; HEATHERTON TF, 1988, J ABNORM PSYCHOL, V97, P19, DOI 10.1037/0021-843X.97.1.19; Herbold NH, 2000, CURR OPIN PEDIATR, V12, P303, DOI 10.1097/00008480-200008000-00003; HERMAN CP, 1975, J PERS, V43, P647, DOI 10.1111/j.1467-6494.1975.tb00727.x; Holling H, 2007, BUNDESGESUNDHEITSBLA, V50, P794, DOI 10.1007/s00103-007-0242-6; Johnson F, 2012, INT J OBESITY, V36, P665, DOI 10.1038/ijo.2011.156; Kirkwood BR, 2003, ESSENTIAL MED STAT; Kroke A, 2004, EUR J NUTR, V43, P45, DOI 10.1007/s00394-004-0445-7; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kuijer R, 2008, APPETITE, V51, P506, DOI 10.1016/j.appet.2008.03.014; Kurth BM, 2007, BUNDESGESUNDHEITSBLA, V50, P533, DOI 10.1007/s00103-007-0214-x; LAESSLE RG, 1989, J ABNORM PSYCHOL, V98, P504, DOI 10.1037/0021-843X.98.4.504; Lattimore PJJ, 2003, BRIT J HEALTH PSYCH, V8, P451, DOI 10.1348/135910703770238301; Leblanc V, 2012, EAT BEHAV, V13, P162, DOI 10.1016/j.eatbeh.2011.12.002; Lee H, 2011, J ADOLESCENT HEALTH, V49, P601, DOI 10.1016/j.jadohealth.2011.04.019; Leech RM, 2015, AM J CLIN NUTR, V102, P1229, DOI 10.3945/ajcn.115.114660; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; Li RW, 2010, PEDIATRICS, V125, pE1386, DOI 10.1542/peds.2009-2549; Libuda L, 2014, BRIT J NUTR, V111, P141, DOI 10.1017/S0007114513002031; Longnecker MP, 1997, APPETITE, V29, P55, DOI 10.1006/appe.1997.0094; Lopez ALO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156320; Lucassen EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056519; Maffeis C, 2000, INT J OBESITY, V24, P75, DOI 10.1038/sj.ijo.0801088; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Maukonen M, 2017, OBESITY, V25, P608, DOI 10.1002/oby.21747; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Fernandez-Alvira JM, 2015, BRIT J NUTR, V113, P517, DOI 10.1017/S0007114514003663; Munkholm A, 2016, J ADOLESCENT HEALTH, V58, P533, DOI 10.1016/j.jadohealth.2016.01.006; Munkholm A, 2016, APPETITE, V101, P46, DOI 10.1016/j.appet.2016.02.020; Munoz JSG, 2017, EUR J CLIN NUTR, V71, P736, DOI 10.1038/ejcn.2016.182; Neumark-Sztainer D, 2012, J ADOLESCENT HEALTH, V50, P80, DOI 10.1016/j.jadohealth.2011.05.010; Oosterman JE, 2015, AM J PHYSIOL-REG I, V308, pR337, DOI 10.1152/ajpregu.00322.2014; Pietrowsky R, 2003, APPETITE, V40, P285, DOI 10.1016/S0195-6663(03)00012-6; Price M, 2015, APPETITE, V95, P203, DOI 10.1016/j.appet.2015.07.006; Reutrakul S, 2014, CHRONOBIOL INT, V31, P64, DOI 10.3109/07420528.2013.821614; Roenneberg T, 2007, SLEEP MED REV, V11, P429, DOI 10.1016/j.smrv.2007.07.005; Roenneberg T, 2016, CURR BIOL, V26, pR432, DOI 10.1016/j.cub.2016.04.011; Rolland-Cachera MF, 2000, EUR J CLIN NUTR, V54, pS41, DOI 10.1038/sj.ejcn.1600983; Rossbach S, 2017, EUR J NUTR, V56, P2507, DOI 10.1007/s00394-016-1286-x; Roth M, 1998, Z MED PSYCHOL, P158; Schaumberg K, 2016, CLIN OBES, V6, P89, DOI 10.1111/cob.12134; Schubert E, 2008, APPETITE, V51, P501, DOI 10.1016/j.appet.2008.03.018; Shunk JA, 2004, APPETITE, V42, P241, DOI 10.1016/j.appet.2003.11.007; Shunk JA, 2004, J AM DIET ASSOC, V104, P1120, DOI 10.1016/j.jada.2004.04.031; Sichert-Hellert W, 2007, J FOOD COMPOS ANAL, V20, P63, DOI 10.1016/j.jfca.2006.05.004; Snoek HM, 2008, HEALTH PSYCHOL, V27, P753, DOI 10.1037/0278-6133.27.6.753; Snoek HM, 2013, APPETITE, V67, P81, DOI 10.1016/j.appet.2013.03.014; Snoek HM, 2009, APPETITE, V52, P461, DOI 10.1016/j.appet.2008.12.009; Story M, 2002, J AM DIET ASSOC, V102, pS40, DOI 10.1016/S0002-8223(02)90421-9; Stroebe W, 2002, PSYCHOL RUNDSCH, V53, P14, DOI 10.1026//0033-3042.53.1.14; Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514; Tani Y, 2015, APPETITE, V92, P66, DOI 10.1016/j.appet.2015.04.071; The NS, 2010, JAMA-J AM MED ASSOC, V304, P2042, DOI 10.1001/jama.2010.1635; Timlin MT, 2008, PEDIATRICS, V121, pE638, DOI 10.1542/peds.2007-1035; TUSCHENCAFFIER B, 2005, DIAGNOSTIK ESSSTORUN; TUSCHL RJ, 1990, APPETITE, V14, P9, DOI 10.1016/0195-6663(90)90050-I; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Wang JB, 2014, J HUM NUTR DIET, V27, P255, DOI 10.1111/jhn.12141; WARDLE J, 1986, APPETITE, V7, P209, DOI 10.1016/S0195-6663(86)80026-5; WARDLE J, 1987, BEHAV RES THER, V25, P179, DOI 10.1016/0005-7967(87)90044-1; Watanabe Yoko, 2014, J Rural Med, V9, P51, DOI 10.2185/jrm.2887; Wijtzes AI, 2016, J PEDIATR-US, V168, P118, DOI 10.1016/j.jpeds.2015.09.039	94	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197131	10.1371/journal.pone.0197131	http://dx.doi.org/10.1371/journal.pone.0197131			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0FF	29791516	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000031
J	Nusca, A; Miglionico, M; Proscia, C; Ragni, L; Carassiti, M; Pepe, FL; Di Sciascio, G				Nusca, Annunziata; Miglionico, Marco; Proscia, Claudio; Ragni, Laura; Carassiti, Massimiliano; Pepe, Francesca Lassandro; Di Sciascio, Germano			Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions	PLOS ONE			English	Article							EARLY URINARY BIOMARKER; INDUCED NEPHROPATHY; CARDIOVASCULAR EVENTS; ANGIOPLASTY; DISEASE; DAMAGE; NGAL	Contrast-induced acute kidney injury (CI-AKI) is a serious complication during percutaneous coronary interventions (PCI). Currently, the diagnosis of CI-AKI relies on serum creatinine (SCr) that is however affected by several limitations potentially leading to delayed or missed diagnoses. In this study we examined the diagnostic accuracy of a "bedside" measurement of plasma Neutrophil Gelatinase-Associated Lipocalin (NGAL) in the early detection of CI-AKI in 97 patients undergoing elective PCI. The overall incidence of CI-AKI was 3%. A significant positive correlation was observed between 6-hours NGAL and post-PCI SCr (r = 0.339, p = 0.004) and a significant negative correlation between 6-hours NGAL and post-PCI CrCI (r = -0.303, p = 0.010). In patients with post-PCI SCr increase > 0.24 mg/dl (median SCr absolute increase), delta NGAL 0-6 hours and 6-hours NGAL values were higher compared with patients with SCr elevation below the defined threshold (p = 0.049 and p = 0.056). The ROC analysis showed that a 6 hours NGAL value > 96 ng/ml significantly predicted an absolute SCr increase > 0.24 mg/dl after contrast exposure with sensitivity of 53% and specificity of 74% (AUC 0.819, 95% CI: 0.656 to 0.983, p = 0.005). The use of bedside NGAL assessment may significantly hasten diagnosis and treatment of CI-AKI, with remarkable clinical prognostic consequences.	[Nusca, Annunziata; Miglionico, Marco; Proscia, Claudio; Ragni, Laura; Pepe, Francesca Lassandro; Di Sciascio, Germano] Campus Biomed Univ Rome, Unit Cardiac Sci, Rome, Italy; [Carassiti, Massimiliano] Campus Biomed Univ Rome, Unit Anesthesiol Crit Care & Pain Med, Rome, Italy	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy	Nusca, A (corresponding author), Campus Biomed Univ Rome, Unit Cardiac Sci, Rome, Italy.	a.nusca@unicampus.it	Ragni, Laura/AAA-7704-2020; Nusca, Annunziata/GLT-9798-2022	di sciascio, germano/0000-0003-0862-3619; Nusca, Annunziata/0000-0002-5616-3197				Bachorzewska-Gajewska H, 2006, AM J NEPHROL, V26, P287, DOI 10.1159/000093961; Briguori C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/568738; Bu DX, 2006, AM J PATHOL, V169, P2245, DOI 10.2353/ajpath.2006.050706; Cheng JM, 2014, ARTERIOSCL THROM VAS, V34, P1078, DOI 10.1161/ATVBAHA.114.303486; Fokkema ML, 2013, J AM COLL CARDIOL, V61, P1222, DOI 10.1016/j.jacc.2013.01.007; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Hirsch R, 2007, PEDIATR NEPHROL, V22, P2089, DOI 10.1007/s00467-007-0601-4; Lindberg S, 2012, J AM COLL CARDIOL, V60, P339, DOI 10.1016/j.jacc.2012.04.017; Marenzi G, 2004, J AM COLL CARDIOL, V44, P1780, DOI 10.1016/j.jacc.2004.07.043; Marques FZ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005971; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; McCullough PA, 2006, AM J CARDIOL, V98, p5K, DOI 10.1016/j.amjcard.2006.01.019; McCullough PA, 2013, CONTRIB NEPHROL, V182, P13, DOI 10.1159/000349963; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nickolas TL, 2012, J AM COLL CARDIOL, V59, P246, DOI 10.1016/j.jacc.2011.10.854; Padhy M, 2014, CLIN CHIM ACTA, V435, P48, DOI 10.1016/j.cca.2014.04.016; Patti G, 2011, AM J CARDIOL, V108, P1, DOI 10.1016/j.amjcard.2011.03.001; Quintavalle C, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002673; Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33; Rudnick MR, 2008, CLIN J AM SOC NEPHRO, V3, P261, DOI 10.2215/CJN.04951107; Shapiro NI, 2010, ANN EMERG MED, V56, P52, DOI 10.1016/j.annemergmed.2010.02.010; Soto K, 2013, CLIN J AM SOC NEPHRO, V8, P2053, DOI 10.2215/CJN.12181212; Szummer K, 2010, AM HEART J, V159, P979, DOI 10.1016/j.ahj.2010.03.028; Tasanarong A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-270; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669; Zimarino M, 2013, CARDIOVASC REVASCULA, V14, P32, DOI 10.1016/j.carrev.2012.10.006; Zografos T, 2009, AM J CARDIOL, V104, P917, DOI 10.1016/j.amjcard.2009.05.023	33	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197833	10.1371/journal.pone.0197833	http://dx.doi.org/10.1371/journal.pone.0197833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791495	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000064
J	Sutton, MY; Zhou, W; Frazier, EL				Sutton, Madeline Y.; Zhou, Wen; Frazier, Emma L.			Unplanned pregnancies and contraceptive use among HIV-positive women in care	PLOS ONE			English	Article							UNINTENDED PREGNANCIES; RECOMMENDATIONS; ELIMINATION	Among 230,360 women with diagnosed HIV in the United States (U.S.), similar to 8,500 give birth annually, and unplanned pregnancies (as with HIV-negative women) are prevalent. However, unplanned pregnancies and contraceptive use among HIV-positive women have been understudied. To examine unplanned pregnancies and contraceptive use among HIV-positive women, we used 2013-2014 data from the Medical Monitoring Project (MMP), an HIV surveillance system that produces national estimates for HIV-positive adults in care in the U.S. (Pregnancy outcome dates were from years 1986-2015 for this cohort of women who were interviewed during 2013-2014; median year of reported pregnancy outcome was year 2003). Women in HIV care and diagnosed with HIV before age 45 (reproductive age) were included. We calculated adjusted prevalence ratios (aPR) of unplanned pregnancies with 95% confidence intervals (CI). For women who were aged 18-44 years at time of interview, we computed weighted prevalences of contraceptive use (previous 12 months) by method, including permanent (i.e., sterilization), short-acting (i.e., pills, depo-progesterone acetate (DMPA)), long-acting reversible contraceptives (LARC) (i.e., implants), and barriers (i.e., condoms). Six hundred seventy-one women met criteria for the unplanned pregnancy analysis; median age at HIV diagnosis = 24.6 years, and 78.1% (CI:74.5-81.7) reported >= 1 unplanned pregnancy. Women reporting unplanned pregnancies were more likely to be non-Hispanic white (aPR = 1.20; CI 1.05-1.38) or non-Hispanic black (aPR = 1.14; CI 1.01-1.28) than Hispanic, to be above the poverty level (aPR = 1.09; CI 1.01-1.18), and to have not received care from an OB/GYN in the year before interview (aPR = 1.13; CI 1.04-1.22). Among 1,142 total pregnancies, 795 (69.6%) were live births; 70 (7.8%) were born HIV-positive; 42 (60%) of those born HIV-positive were unplanned pregnancies. For the contraceptives analysis (n = 957 women who were aged 18-44 at time of interview), 90.5% reported using at least one contraceptive, including 59.7% reporting barrier methods, 29.9% reporting permanent sterilization, and 22.8% reporting short-term methods in the previous year. LARC was used by only 5.3% of women. Women who reported use of LARC or DMPA were more likely to be aged 18-29 years (aPR = 3.08; CI 1.61-5.89) or 30-39 years (aPR = 2.86; CI 1.76-4.63) compared with women aged 40-44 years. Unplanned pregnancies were prevalent and LARC use was low; prevention efforts should strengthen pregnancy planning and contraceptive awareness for HIV-positive women during clinical visits.	[Sutton, Madeline Y.; Zhou, Wen; Frazier, Emma L.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA; [Sutton, Madeline Y.] Morehouse Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30310 USA; [Zhou, Wen] ICF, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Morehouse School of Medicine	Sutton, MY (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA 30333 USA.; Sutton, MY (corresponding author), Morehouse Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30310 USA.	msutton@cdc.gov		Sutton, Madeline/0000-0002-6023-3936	Centers for Disease Control and Prevention [PS09-937]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for the Medical Monitoring Project (MMP) is provided to participating U.S. jurisdictions by a cooperative agreement (PS09-937) from the Centers for Disease Control and Prevention. The contractor (ICF)provided support in the form of salaries for author W.Z., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abma J.C., 2012, NATL HLTH STAT REPOR; Blumenthal PD, 2011, HUM REPROD UPDATE, V17, P121, DOI 10.1093/humupd/dmq026; Bradley H, 17 HIV; Centers for Disease Control and Prevention, 2015, HIV SURV WOM 2015; Centers for Disease Control and Prevention, 2010, DIST PUBL HLTH RES P; Centers for Disease Control and Prevention, 2016, HIV SURV REP, V27; Curtis KM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6504a1; Daniels K, 2015, NAT HLTH STAT REPORT; Dauby N, 2016, NEW ENGL J MED, V375, P193, DOI 10.1056/NEJMc1604016; Finer BF, 2016, NEW ENGL J MED, V374, P843, DOI [10.1056/NaNsa1506575, DOI 10.1056/NANSA1506575]; Fox J, 2016, JAMA-J AM MED ASSOC, V316, P815, DOI 10.1001/jama.2016.8800; Haddad LB, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.08.006; Iachan Ronaldo, 2016, Open AIDS J, V10, P164, DOI 10.2174/1874613601610010164; Jamieson DJ, 2007, AM J OBSTET GYNECOL, V197, pS26, DOI 10.1016/j.ajog.2007.03.087; Kikuchi K, 2011, BIOSCI TRENDS, V5, P255, DOI 10.5582/bst.2011.v5.6.255; Loutfy MR, 2012, HIV MED, V13, P107, DOI 10.1111/j.1468-1293.2011.00946.x; Luzuriaga K, 2016, NEW ENGL J MED, V374, P761, DOI 10.1056/NEJMra1505256; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Momplaisir FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132262; Nesheim S, 2012, PEDIATRICS, V130, P738, DOI 10.1542/peds.2012-0194; Rahangdale L, 2014, JAIDS-J ACQ IMM DEF, V65, P306, DOI 10.1097/QAI.0000000000000014; RAO JNK, 1992, BIOMETRICS, V48, P577, DOI 10.2307/2532311; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Sun MY, 2012, OBSTET GYNECOL, V120, P783, DOI 10.1097/AOG.0b013e318269c8bb; Sutton MY, 2014, JAIDS-J ACQ IMM DEF, V65, P350, DOI 10.1097/QAI.0000000000000054; Swain CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160775; Taylor AW, 2017, JAMA PEDIAT; U.S. Department of Health and Human Services, 2013 HHS POV GUID; Whitmore SK, 2012, PEDIATRICS, V129, pE74, DOI 10.1542/peds.2010-3691	29	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197216	10.1371/journal.pone.0197216	http://dx.doi.org/10.1371/journal.pone.0197216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771940	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900036
J	Yun, KS; Hurwitz, AA; Perantoni, AO				Yun, Kangsun; Hurwitz, Arthur A.; Perantoni, Alan O.			Constitutive metanephric mesenchyme-specific expression of interferon-gamma causes renal dysplasia by regulating Sall 1 expression	PLOS ONE			English	Article							IN-UTERO; KIDNEY DEVELOPMENT; NEPHRON NUMBER; MOUSE; EXPOSURE; DIFFERENTIATION; PROGENITORS; MORPHOGENESIS; VIRUS; IDENTIFICATION	Transplacental viral and parasitic infections have been shown to initiate an innate response in the mammalian embryo by increasing the expression of pro-inflammatory cytokines such as interferon-gamma (Ifng). However, the developmental consequences of an activated innate immunity and, in particular, the effects of induction of Ifng expression independent of infection have been largely overlooked. Here, we demonstrate in vivo that the conditional overexpression of Ifng in metanephric mesenchymal (MM) progenitors results in renal agenesis or hypoplasia. Cell death was observed in and around the MM region of E10.5-11.5 mutants where Ifng was constitutively expressed during early kidney development and resulted in a retardation of branching morphogenesis. Furthermore, isolated mutant or normal Ifng-treated metanephroi replicated this phenotype in culture, demonstrating the inherent nature of the aberrant morphogenesis. The expression of renal progenitor marker Sall 1 was significantly decreased in the MM of mutant kidneys, suggesting that a reduction in Sal may be the cause of cell death in the MM during early kidney development and that, in turn, retards UB branching in the mutants. Therefore, the aberrant induction of Ifng expression, as part of an innate immune response, may contribute to renal agenesis or hypoplasia during early metanephric development by regulating the MM progenitor population.	[Yun, Kangsun; Perantoni, Alan O.] NCI, NIH, Canc & Dev Biol Lab, Frederick, MD 21701 USA; [Hurwitz, Arthur A.] NCI, NIH, Lab Mol Immunoregulat, Frederick, MD 21701 USA; [Hurwitz, Arthur A.] Agenus Inc, Lexington, MA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Agenus Inc	Perantoni, AO (corresponding author), NCI, NIH, Canc & Dev Biol Lab, Frederick, MD 21701 USA.	perantoa@mail.nih.gov			National Cancer Institute, Center for Cancer Research [ZIA BC 005093]; NATIONAL CANCER INSTITUTE [ZIABC005093] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, Center for Cancer Research intramural funding under project # ZIA BC 005093 (AOP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Athanassakis I, 1996, AM J REPROD IMMUNOL, V36, P111; Basta JM, 2014, DEVELOPMENT, V141, P1047, DOI 10.1242/dev.095851; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Cale CM, 1998, INT J DEV BIOL, V42, P663; Cale CM, 2000, NEPHROL DIAL TRANSPL, V15, P173, DOI 10.1093/ndt/15.2.173; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Chi X, 2009, GENESIS, V47, P61, DOI 10.1002/dvg.20452; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Diwan BA, 2009, DIFFERENTIATION, V77, P424, DOI 10.1016/j.diff.2008.12.003; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; EGWUAGU CE, 1994, DEV BIOL, V166, P557, DOI 10.1006/dbio.1994.1337; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Entrican G, 2002, J COMP PATHOL, V126, P79, DOI 10.1053/jcpa.2001.0539; Faa G, 2012, J CELL PHYSIOL, V227, P1257, DOI 10.1002/jcp.22985; Galinsky R, 2011, AM J PHYSIOL-RENAL, V301, pF280, DOI 10.1152/ajprenal.00066.2011; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Kanda S, 2014, J AM SOC NEPHROL, V25, P2584, DOI 10.1681/ASN.2013080896; Kiefer SM, 2010, DEVELOPMENT, V137, P3099, DOI 10.1242/dev.037812; Kitagaki J, 2011, DEVELOPMENT, V138, P5369, DOI 10.1242/dev.051888; LaFerla FM, 2000, J MOL NEUROSCI, V15, P45, DOI 10.1385/JMN:15:1:45; Li Y, 2014, GENE DEV, V28, P2597, DOI 10.1101/gad.253302.114; Little M, 2010, CURR TOP DEV BIOL, V90, P193, DOI 10.1016/S0070-2153(10)90005-7; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Loh HS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-42; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; Mao CP, 2010, AM J NEPHROL, V31, P141, DOI 10.1159/000259901; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Naiman N, 2017, DEV CELL, V41, P349, DOI 10.1016/j.devcel.2017.04.022; Nathanson S, 2000, J AM SOC NEPHROL, V11, P874, DOI 10.1681/ASN.V115874; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Ohmori T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15676; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Palis J, 1999, DEVELOPMENT, V126, P5073; Pawitwar SS, 2017, J NEUROIMMUNE PHARM; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Qiao XT, 2007, GASTROENTEROLOGY, V133, P1989, DOI 10.1053/j.gastro.2007.09.031; Rostovsky I, 2015, J VIROL, V89, P2182, DOI 10.1128/JVI.02908-14; Ruteshouser EC, 2008, GENE CHROMOSOME CANC, V47, P461, DOI 10.1002/gcc.20553; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Sajithlal G, 2005, DEV BIOL, V284, P323, DOI 10.1016/j.ydbio.2005.05.029; Schoneboom BA, 2000, J NEUROIMMUNOL, V109, P132, DOI 10.1016/S0165-5728(00)00290-3; Senegas A, 2009, INT J PARASITOL, V39, P481, DOI 10.1016/j.ijpara.2008.08.009; Singh RR, 2007, AM J PHYSIOL-RENAL, V293, pF548, DOI 10.1152/ajprenal.00156.2007; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Truchet S, 2001, MOL REPROD DEV, V60, P319, DOI 10.1002/mrd.1094; Uchiyama Y, 2010, P NATL ACAD SCI USA, V107, P9240, DOI 10.1073/pnas.0913748107; Wang H, 2010, CELL SIGNAL, V22, P1717, DOI 10.1016/j.cellsig.2010.06.012; Wang J., 2004, J REMOTE SENS, V8, P4; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Winyard P, 2008, SEMIN FETAL NEONAT M, V13, P142, DOI 10.1016/j.siny.2007.10.009; WORRAD DM, 1995, DEVELOPMENT, V121, P2949; Yun KS, 2014, HUM MOL GENET, V23, P6807, DOI 10.1093/hmg/ddu397; Zhu YP, 2016, REPROD TOXICOL, V61, P109, DOI [10.10164.reprotos.2016.04.007, DOI 10.1016/J.REPROTOS.2016.04.007]	58	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197356	10.1371/journal.pone.0197356	http://dx.doi.org/10.1371/journal.pone.0197356			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771971	Green Submitted, gold, Green Published			2022-12-26	WOS:000432348900052
J	Kelly, RS; Lasky-Su, J; Yeung, SCJ; Stone, RM; Caterino, JM; Hagan, SC; Lyman, GH; Baden, LR; Glotzbecker, BE; Coyne, CJ; Baugh, CW; Pallin, DJ				Kelly, Rachel S.; Lasky-Su, Jessica; Yeung, Sai-Ching J.; Stone, Richard M.; Caterino, Jeffrey M.; Hagan, Sean C.; Lyman, Gary H.; Baden, Lindsey R.; Glotzbecker, Brett E.; Coyne, Christopher J.; Baugh, Christopher W.; Pallin, Daniel J.			Integrative omics to detect bacteremia in patients with febrile neutropenia	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; HOST RNA SIGNATURE; CANCER 2010 UPDATE; ANTIMICROBIAL AGENTS; BIOMARKER DISCOVERY; AMERICAN SOCIETY; MULTIPLEX PCR; METABOLOMICS; SEPSIS	Background Cancer chemotherapy-associated febrile neutropenia (FN) is a common condition that is deadly when bacteremia is present. Detection of bacteremia depends on culture, which takes days, and no accurate predictive tools applicable to the initial evaluation are available. We utilized metabolomics and transcriptomics to develop multivariable predictors of bacteremia among FN patients. Methods We classified emergency department patients with FN and no apparent infection at presentation as bacteremic (cases) or not (controls), according to blood culture results. We assessed relative metabolite abundance in plasma, and relative expression of 2,560 immunology and cancer-related genes in whole blood. We used logistic regression to identify multivariable predictors of bacteremia, and report test characteristics of the derived predictors. Results For metabolomics, 14 bacteremic cases and 25 non-bacteremic controls were available for analysis; for transcriptomics we had 7 and 22 respectively. A 5-predictor metabolomic model had an area under the receiver operating characteristic curve of 0.991 (95% CI: 0.972,1.000), 100% sensitivity, and 96% specificity for identifying bacteremia. Pregnenolone steroids were more abundant in cases and carnitine metabolites were more abundant in controls. A 3-predictor gene expression model had corresponding results of 0.961 (95% CI: 0.896,1.000), 100%, and 86%. Genes involved in innate immunity were differentially expressed. Conclusions Classifiers derived from metabolomic and gene expression data hold promise as objective and accurate predictors of bacteremia among FN patients without apparent infection at presentation, and can provide insights into the underlying biology. Our findings should be considered illustrative, but may lay the groundwork for future biomarker development.	[Kelly, Rachel S.; Lasky-Su, Jessica] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Kelly, Rachel S.; Lasky-Su, Jessica; Stone, Richard M.; Baden, Lindsey R.; Glotzbecker, Brett E.; Baugh, Christopher W.; Pallin, Daniel J.] Harvard Med Sch, Boston, MA 02115 USA; [Yeung, Sai-Ching J.] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, Houston, TX 77030 USA; [Stone, Richard M.; Baden, Lindsey R.; Glotzbecker, Brett E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Caterino, Jeffrey M.] Ohio State Univ, Sch Med, Wexner Med Ctr, Dept Emergency Med, Columbus, OH 43210 USA; [Hagan, Sean C.; Baugh, Christopher W.; Pallin, Daniel J.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Lyman, Gary H.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Lyman, Gary H.] Univ Washington, Sch Med, Seattle, WA USA; [Coyne, Christopher J.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Coyne, Christopher J.] Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; University System of Ohio; Ohio State University; Harvard University; Brigham & Women's Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego	Pallin, DJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Pallin, DJ (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.	dpallin@bwh.harvard.edu	Pallin, Daniel J/H-6382-2013; kelly, rachel/H-4505-2017; Baugh, Christopher William/AAJ-3688-2021; Lyman, Gary H/K-5227-2019; Yeung, Sai-Ching/AAI-6178-2021; Yeung, Sai-Ching/AAP-8079-2020	Pallin, Daniel J/0000-0002-8517-9702; kelly, rachel/0000-0003-3023-1822; Baugh, Christopher William/0000-0002-2360-1891; Lyman, Gary H/0000-0002-0823-8086; Yeung, Sai-Ching/0000-0001-5170-0822; 	Harvard University Milton Award; R01 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health, Integrative metabolomics of asthma severity NHLBI [1R01HL123915-01]; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA066996] Funding Source: NIH RePORTER	Harvard University Milton Award; R01 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health, Integrative metabolomics of asthma severity NHLBI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the Harvard University Milton Award to CWB and DJP. JL-S was supported by an R01 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health, entitled Integrative metabolomics of asthma severity NHLBI 1R01HL123915-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, HUM MOL GENET, V19, P2739, DOI 10.1093/hmg/ddq155; Alexander J, 2017, SURG ENDOSC, V31, P1361, DOI 10.1007/s00464-016-5121-5; Baron EJ, 2013, CLIN INFECT DIS, V57, pE22, DOI 10.1093/cid/cit278; Baugh CW, 2017, ACAD EMERG MED, V24, P83, DOI 10.1111/acem.13079; Baughmd CW, 2016, AM J EMERG MED, V34, P1704, DOI 10.1016/j.ajem.2016.05.047; Bitar Roger A, 2015, Perm J, V19, P37, DOI 10.7812/TPP/14-188; Blighe K, 2017, AM J CLIN NUTR, V106, P1092, DOI 10.3945/ajcn.117.158220; Cazalis MA, 2014, INTENS CARE MED EXP, V2, DOI 10.1186/s40635-014-0020-3; Coyne CJ, 2017, ANN EMERG MED, V69, P755, DOI 10.1016/j.annemergmed.2016.11.007; Day E, 2014, CLIN ONCOL-UK, V26, P516, DOI 10.1016/j.clon.2014.05.003; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Druml W, 2001, AM J CLIN NUTR, V73, P908; Famularo G, 2004, ANN NY ACAD SCI, V1033, P132, DOI 10.1196/annals.1320.012; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Freifeld AG, 2011, CLIN INFECT DIS, V52, P427, DOI 10.1093/cid/ciq147; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Girard L, 2016, CLIN CANCER RES, V22, P4880, DOI 10.1158/1078-0432.CCR-15-2900; Guo LN, 2015, P NATL ACAD SCI USA, V112, pE4901, DOI 10.1073/pnas.1508425112; Herberg JA, 2016, JAMA-J AM MED ASSOC, V316, P835, DOI 10.1001/jama.2016.11236; Hotson AN, 2009, J IMMUNOL, V182, P7558, DOI 10.4049/jimmunol.0803666; HTGMolecular, 2017, HTG EDGESEQ ONC BIOM; Idelevich E, 2015, MED MICROBIOL IMMUN, V204, P585, DOI 10.1007/s00430-014-0385-7; Kaforou M, 2017, JAMA-J AM MED ASSOC, V317, P1577, DOI 10.1001/jama.2017.1365; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Khashana A, 2016, ACTA PAEDIATR, V105, P154, DOI 10.1111/apa.13257; Koen N, 2016, ADV PROTEIN CHEM STR, V102, P53, DOI 10.1016/bs.apcsb.2015.09.003; Lathia N, 2010, CANCER-AM CANCER SOC, V116, P742, DOI 10.1002/cncr.24773; Leite HP, 2016, J THORAC DIS, V8, pE552, DOI 10.21037/jtd.2016.05.37; NANNI G, 1985, JPEN-PARENTER ENTER, V9, P483, DOI 10.1177/0148607185009004483; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; NOLAN A, 2009, PLOS ONE, V4, DOI DOI 10.1371/J0URNAL.P0NE.0006600; Pacchiarotta T, 2012, BIOANALYSIS, V4, P919, DOI [10.4155/bio.12.61, 10.4155/BIO.12.61]; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Reers Y, 2016, DIAGN MICR INFEC DIS, V85, P413, DOI 10.1016/j.diagmicrobio.2016.04.024; Rhee EP, 2012, CLIN CHEM, V58, P139, DOI 10.1373/clinchem.2011.169573; Richter ME, 2016, INFECTION, V44, P175, DOI 10.1007/s15010-015-0830-6; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robles AI, 2017, LUNG CANCER, V107, P50, DOI 10.1016/j.lungcan.2016.06.003; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Thursky KA, 2015, CURR OPIN INFECT DIS, V28, P505, DOI 10.1097/QCO.0000000000000202; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; van Rensburg IC, 2015, BIOMARK MED, V9, P483, DOI 10.2217/bmm.15.16; Weycker D, 2014, J ONCOL PHARM PRACT, V20, P190, DOI 10.1177/1078155213492450; Wilson JX, 2009, BIOFACTORS, V35, P5, DOI 10.1002/biof.7; Yanagihara K, 2010, CRIT CARE, V14, DOI 10.1186/cc9234	46	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197049	10.1371/journal.pone.0197049	http://dx.doi.org/10.1371/journal.pone.0197049			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768470	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200053
J	Liu, HG; Yi, R; Wang, C; Zhao, P; Zhang, MY; Xu, SW; Bao, J				Liu, Honggui; Yi, Ran; Wang, Chao; Zhao, Peng; Zhang, Mingyue; Xu, Shiwen; Bao, Jun			Behavior and physiology of two different sow breeds in a farrowing environment during late 35-day lactation	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ALPHA TNF-ALPHA; CHRONIC STRESS; PSYCHOLOGICAL STRESS; EMOTIONAL STATES; RESPONSES; PIGS; WELFARE; ACTIVATION; CORTISOL	To improve the overall welfare levels of sows and to reduce stress levels at late 35-day lactation, we selected targeted behavioral indicators that might be associated with stress. Therefore, we monitored and evaluated the adaptive capability of two different breeds of sows to the farrowing environment. In this study, Damin sows (Large White x Min pig sows, n = 20) and Large White sows (n = 20) were farrowed in individual pens. Saliva was collected and tested for cortisol density at -15 min, and then at +15, 30, 60, 90, 120, 180 and 240 min after an adrenocorticotropic hormone (ACTH) stimulation test conducted at 20, 27 and 34 d post-partum. The postures, including ventral and lateral recumbency to other postures, defecating, urinating, sham-chewing and bar-biting behavior, were observed by video from 07:00 to 09:00 and from 13:00 to 15:00 on the 7th day of each week from the 3rd to the 5th week post-parturition. In addition, the concentrations of salivary interleukin (IL)-6, tumor necrosis factor (TNF)-alpha and secretory immunoglobulin (SIgA) were assayed after the observed behaviors. The results showed no significant difference between Damin sows and Large White sows in terms of behaviors at the 3rd week. Additionally, there were no significant differences between Damin and Large White sows in terms of the behaviors of ventral recumbency and bar-biting with the exception of lateral recumbency to other postures, sham-chewing, defecation and urination in the fifth week. Meanwhlie, there was significant difference between two breeds in term of ventral recumbency at the 4th week. The result of the ACTH test showed a significant difference between the Damin and Large White sows by the 27th and 34th days postpartum (P<0.01). In addition, the serological concentrations of IL-6 and TNF-alpha were not significantly different between the two breeds at the 3rd week post-partum. However, these indicators were significantly different at the 5th week postpartum (P = 0.000, and P = 0.003, respectively). The SIgA concentrations in saliva were significantly different between breeds at the 3rd week postpartum (P<0.01). In conclusion, both breeds of sows maybe in a state of stress after the 4th week postpartum. However, the Damin sows may be better than the Large White sows in terms of adapting to this farrowing environment.	[Liu, Honggui; Yi, Ran; Wang, Chao; Zhao, Peng; Zhang, Mingyue; Bao, Jun] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Liu, Honggui] Minist Agr, Key Lab Swine Facil Engn, Harbin, Heilongjiang, Peoples R China; [Xu, Shiwen] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China; Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Liu, HG; Bao, J (corresponding author), Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China.; Liu, HG (corresponding author), Minist Agr, Key Lab Swine Facil Engn, Harbin, Heilongjiang, Peoples R China.	liuhonggui1312@163.com; bjunneau@163.com		Yi, Ran/0000-0001-5738-1914; Liu, Honggui/0000-0002-0376-3623	Earmarked Fund for China Agriculture Research System [CARS-35]; Province Science Foundation of Hei Longjiang in China [C2016016, 2017RAQXJ062]; National Nature Science Foundation of China [31472131]	Earmarked Fund for China Agriculture Research System; Province Science Foundation of Hei Longjiang in China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Earmarked Fund for China Agriculture Research System (grant no. CARS-35) to JB, the Province Science Foundation of Hei Longjiang in China (project nos. C2016016 and 2017RAQXJ062) to HGL and National Nature Science Foundation of China (31472131) to JB.	AGUILERA G, 1994, FRONT NEUROENDOCRIN, V15, P321, DOI 10.1006/frne.1994.1013; ARELLANO PE, 1992, APPL ANIM BEHAV SCI, V35, P157, DOI 10.1016/0168-1591(92)90006-W; AXELROD J, 1984, SCIENCE, V224, P452, DOI 10.1126/science.6143403; Besedovsky HO, 2000, Z RHEUMATOL, V59, P26, DOI 10.1007/s003930070014; Boonstra R, 2005, J MAMMAL, V86, P236, DOI 10.1644/BHE-001.1; Borell EHV, 2001, BIOL STRESS ITS APPL; BROOM DM, 1986, BRIT VET J, V142, P524, DOI 10.1016/0007-1935(86)90109-0; Brosschot JF, 1998, PSYCHOSOM MED, V60, P359, DOI 10.1097/00006842-199805000-00024; Cantorna MT, 2000, ARCH BIOCHEM BIOPHYS, V377, P135, DOI 10.1006/abbi.2000.1765; Chandrashekara S, 2007, J PSYCHOSOM RES, V63, P65, DOI 10.1016/j.jpsychores.2007.03.001; Chapinal N, 2010, J VET BEHAV, V5, P82, DOI 10.1016/j.jveb.2009.09.046; Chrousos, 2000, J ALLERGY CLIN IMMUN, V106, P275, DOI DOI 10.1067/MAI.2000.110163; Cook NJ, 1996, CAN J ANIM SCI, V76, P329, DOI 10.4141/cjas96-049; CRONIN GM, 1991, APPL ANIM BEHAV SCI, V32, P117, DOI 10.1016/S0168-1591(05)80036-X; Cui SQ, 2011, APPL ANIM BEHAV SCI, V131, P40, DOI 10.1016/j.applanim.2011.01.011; Damm BI, 2005, APPL ANIM BEHAV SCI, V90, P3, DOI 10.1016/j.applanim.2004.08.008; DeRijk R, 1997, J CLIN ENDOCR METAB, V82, P2182, DOI 10.1210/jc.82.7.2182; Dhabhar FS, 2002, BRAIN BEHAV IMMUN, V16, P785, DOI 10.1016/S0889-1591(02)00036-3; DILLON KM, 1985, INT J PSYCHIAT MED, V15, P13, DOI 10.2190/R7FD-URN9-PQ7F-A6J7; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Franczak A, 2012, THERIOGENOLOGY, V77, P155, DOI 10.1016/j.theriogenology.2011.07.029; Fraser D., 1974, Applied Animal Ethology, V1, P3, DOI 10.1016/0304-3762(74)90003-0; Gonyou HW, 1998, CAN J ANIM SCI, V78, P517, DOI 10.4141/A98-023; HARBUZ MS, 1992, J ENDOCRINOL, V134, P327, DOI 10.1677/joe.0.1340327; Hurnik JF., 1995, DICT FARM ANIMAL BEH; JANSSENS CJJG, 1995, EUR J ENDOCRINOL, V132, P479, DOI 10.1530/eje.0.1320479; Jarvis S, 2006, PHYSIOL BEHAV, V87, P345, DOI 10.1016/j.physbeh.2005.10.004; JOHNSON EO, 1992, NEUROSCI BIOBEHAV R, V16, P115, DOI 10.1016/S0149-7634(05)80175-7; LAWRENCE AB, 1993, J ANIM SCI, V71, P2815, DOI 10.2527/1993.71102815x; LEVI L, 1965, PSYCHOSOM MED, V27, P80, DOI 10.1097/00006842-196501000-00009; Liu H, 2013, INT J MATER FORM, P1, DOI DOI 10.1371/J0URNAL.P0NE.0055389; Maes M, 1999, NEUROPSYCHOBIOLOGY, V39, P1, DOI 10.1159/000026552; Marshall GD, 2000, ALLERGY ASTHMA PROC, V21, P241, DOI 10.2500/108854100778248917; Mason GJ, 1993, FORMS STEREOTYPIC BE; Mendl M, 2004, ANIM WELFARE, V13, pS17; Mendl M, 1997, BEHAVIOUR, V134, P643, DOI 10.1163/156853997X00016; MORMEDE P, 1988, PHYSIOL BEHAV, V43, P577, DOI 10.1016/0031-9384(88)90211-9; Pajor EA, 1999, APPL ANIM BEHAV SCI, V65, P105, DOI 10.1016/S0168-1591(99)00046-5; Peters ML, 1999, PSYCHOSOM MED, V61, P513, DOI 10.1097/00006842-199907000-00016; Pignatelli D, 2000, ENDOCR RES, V26, P537, DOI 10.3109/07435800009048567; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schrader L, 1999, PHYSIOL BEHAV, V66, P775, DOI 10.1016/S0031-9384(99)00015-3; Spoolder HAM, 1997, LIVESTOCK PRODUCTION, V47, P51; Tuchscherer M, 2009, RES VET SCI, V87, P380, DOI 10.1016/j.rvsc.2009.04.010; Valros A, 2003, LIVEST PROD SCI, V79, P155, DOI 10.1016/S0301-6226(02)00154-9; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; Wang XB, 2002, J ANIM SCI VET SCI, V1, P12; Watanuki Shigeki, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P135, DOI 10.2114/jpa.24.135; Zaldivar F, 2006, J APPL PHYSIOL, V100, P1124, DOI 10.1152/japplphysiol.00562.2005	50	4	4	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197152	10.1371/journal.pone.0197152	http://dx.doi.org/10.1371/journal.pone.0197152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758053	Green Submitted, gold, Green Published			2022-12-26	WOS:000432082900033
J	Zhang, Z; Liu, J; Wang, YY; Tan, X; Zhao, WN; Xing, XX; Qiu, YL; Wang, R; Jin, MH; Fan, GW; Zhang, P; Zhong, YX; Kong, DX				Zhang, Zhe; Liu, Jie; Wang, Yingying; Tan, Xiao; Zhao, Wennan; Xing, Xiaoxue; Qiu, Yuling; Wang, Ran; Jin, Meihua; Fan, Guanwei; Zhang, Ping; Zhong, Yuxu; Kong, Dexin			Phosphatidylinositol 3-kinase and isoforms play key roles in metastasis of prostate cancer DU145 cells	FASEB JOURNAL			English	Article						PI3K isoform; inhibitor; antimetastatic; migration; invasion	PIK3CA GENE; SELECTIVE INHIBITORS; OVARIAN-CANCER; BREAST-CANCER; PI3K; PATHWAY; GROWTH; BONE; P110-ALPHA; MIGRATION	Metastasis is the main cause of the lethality of prostate cancer. Class I phosphatidylinositol 3-kinases (PI3Ks), which contain 4 isoforms, , , , and , are known to play important roles in cell growth, migration, invasion, and so on. However, the respective role of each PI3K isoform in cancer cell migration and invasion remains unknown. In a study that aimed to elucidate the respective role of the 4 PI3K isoforms, we investigated the change in migratory and invasive ability of DU145 cells after treatment with each PI3K isoform-specific inhibitor. Both migration and invasion of DU145 cells were potently blocked by each of the PI3K inhibitors (GSK2636771 and TGX221) and PI3K inhibitors (CAL101 and IC87114) while not obviously affected by PI3K inhibitor BYL719 or PI3K inhibitor AS252424. Furthermore, knocking down PI3K or PI3K isoform led to a significant decrease in migration of DU145. The results suggest that PI3K and PI3K play key roles in prostate cancer cell migration, while PI3K and PI3K might be redundant. Oral administration of GSK2636771 (100 mg/kg) and CAL101 (30 mg/kg) inhibited tumor growth in bone, an experimental model by intratibia injection of DU145 cells, with improved bone structure and bone mineral density analyzed by micro-computed tomography. Tissue staining indicated reduction of metastatic DU145 cells and osteoclasts in the bones of GSK2636771- and CAL101-treated mice compared to the untreated group. In summary, our results indicated the distinct roles of 4 PI3K isoforms in the migration of prostate cancer DU145 cells, and they demonstrated the in vitro and in vivo antimetastatic effect of PI3K-isoform specific inhibitors, most of which are in clinical trials.Zhang, Z., Liu, J., Wang, Y., Tan, X., Zhao, W., Xing, X., Qiu, Y., Wang, R., Jin, M., Fan, G., Zhang, P., Zhong, Y., Kong, D. Phosphatidylinositol 3-kinase and isoforms play key roles in metastasis of prostate cancer DU145 cells.	[Zhang, Zhe; Liu, Jie; Wang, Yingying; Tan, Xiao; Zhao, Wennan; Qiu, Yuling; Wang, Ran; Jin, Meihua; Kong, Dexin] Tianjin Med Univ, Tianjin Key Lab Technol Enabling Dev Clin Therape, Sch Pharmaceut Sci, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China; [Zhang, Ping] Tianjin Med Univ, Dept Anat & Histol, Sch Basic Med Sci, Tianjin, Peoples R China; [Tan, Xiao; Zhong, Yuxu] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, 27 Taiping Rd, Beijing 100850, Peoples R China; [Xing, Xiaoxue; Fan, Guanwei] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Academy of Military Medical Sciences - China; Tianjin University of Traditional Chinese Medicine	Kong, DX (corresponding author), Tianjin Med Univ, Tianjin Key Lab Technol Enabling Dev Clin Therape, Sch Pharmaceut Sci, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.; Zhong, YX (corresponding author), Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, 27 Taiping Rd, Beijing 100850, Peoples R China.	yuxuzhong2008@aliyun.com; kongdexin@tmu.edu.cn	Kong, Dexin/AAL-8336-2020; guanwei, fan/M-8193-2019; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; wang, yi/GVT-8516-2022; FAN, GUANWEI/GWV-6480-2022		National Natural Science Foundation of China [81373441, 81673464, 81672809, 81602614]; Major Project of Tianjin for New Drug Development [17ZXXYSY00050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Project of Tianjin for New Drug Development	The authors thank J. Li (School of Basic Medical Sciences, Tianjin Medical University) for technical assistance with the histologic analysis. This study was supported by grants from the National Natural Science Foundation of China (81373441, 81673464, 81672809, 81602614) and a grant from Major Project of Tianjin for New Drug Development (17ZXXYSY00050). The authors declare no conflicts of interest.	Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Bitting RL, 2013, ENDOCR-RELAT CANCER, V20, pR83, DOI 10.1530/ERC-12-0394; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Del Prete A, 2004, EMBO J, V23, P3505, DOI 10.1038/sj.emboj.7600361; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kong D, 2009, EUR J CANCER, V45, P857, DOI 10.1016/j.ejca.2008.12.007; Kretschmann KL, 2012, CANCER METAST REV, V31, P579, DOI 10.1007/s10555-012-9378-4; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; Liu DQ, 2015, BONE, V81, P620, DOI 10.1016/j.bone.2015.09.012; Liu H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8949; Mateo J, 2017, CLIN CANCER RES, V23, P5981, DOI 10.1158/1078-0432.CCR-17-0725; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Okkenhaug K, 2002, SCIENCE, V297, P1031; Ost P, 2015, EUR UROL, V67, P852, DOI 10.1016/j.eururo.2014.09.004; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Saudemont A, 2009, P NATL ACAD SCI USA, V106, P5795, DOI 10.1073/pnas.0808594106; Schwartz S, 2015, CANCER CELL, V27, P109, DOI 10.1016/j.ccell.2014.11.008; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shugg RPP, 2013, J BIOL CHEM, V288, P35346, DOI 10.1074/jbc.M113.507525; Simmons JK, 2015, VET PATHOL, V52, P827, DOI 10.1177/0300985815586223; Simmons JK, 2014, PROSTATE, V74, P1251, DOI 10.1002/pros.22838; Smith GC, 2013, FEBS J, V280, P5337, DOI 10.1111/febs.12428; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Tzenaki N, 2012, FASEB J, V26, P2498, DOI 10.1096/fj.11-198192; Wang X, 2015, ACTA PHARMACOL SIN, V36, P1170, DOI 10.1038/aps.2015.71; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Whyte DB, 2006, BIOCHEM BIOPH RES CO, V340, P469, DOI 10.1016/j.bbrc.2005.12.025; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103; Zhao WN, 2017, ACTA PHARM SIN B, V7, P27, DOI 10.1016/j.apsb.2016.07.006; Zhao WN, 2013, INT J MOL SCI, V14, P13577, DOI 10.3390/ijms140713577; Zhou QX, 2016, INT J BIOL SCI, V12, P631, DOI 10.7150/ijbs.14878	44	20	20	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5967	5975		10.1096/fj.201800183R	http://dx.doi.org/10.1096/fj.201800183R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29792732	Bronze			2022-12-26	WOS:000447172000017
J	Ding, J; Yeh, CR; Sun, Y; Lin, CY; Chou, JS; Ou, ZY; Chang, CS; Qi, J; Yeh, SY				Ding, Jie; Yeh, Chiuan-Ren; Sun, Yin; Lin, Changyi; Chou, Joshua; Ou, Zhenyu; Chang, Chawnshang; Qi, Jun; Yeh, Shuyuan			Estrogen receptor beta promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network	ONCOGENE			English	Article							LONG NONCODING RNA; RESISTANT PROSTATE-CANCER; ANDROGEN-RECEPTOR; ER-BETA; PROGNOSTIC MARKER; TARGETED THERAPY; SIGNALING AXIS; BREAST-CANCER; HOTAIR; EXPRESSION	Recent studies indicated that the estrogen receptor beta (ER beta) could affect the progression of prostate and bladder tumors, however, its roles in the renal cell carcinoma (RCC), remain to be elucidated. Here, we provide clinical evidence that ER beta expression is correlated in a negative manner with the overall survival/disease-free survival in RCC patients. Mechanism dissection revealed that targeting ER beta with ER beta-shRNA and stimulating the transactivation of ER beta with 17 beta-estradiol or environmental endocrine disrupting chemicals, all resulted in altering the lncRNA HOTAIR expression. The ER beta-modulated HOTAIR is able to function via antagonizing several microRNAs, including miR-138, miR-200c, miR-204, or miR-217 to impact various oncogenes, including ADAM9, CCND2, EZH2, VEGFA, VIM, ZEB1, and ZEB2, to promote RCC proliferation and invasion. Together, the identification of the ER beta-HOTAIR axis may provide us new biomarkers and/or therapeutic targets to better suppress RCC progression in the future.	[Ding, Jie; Qi, Jun] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai 200092, Peoples R China; [Ding, Jie; Yeh, Chiuan-Ren; Sun, Yin; Lin, Changyi; Chou, Joshua; Ou, Zhenyu; Chang, Chawnshang; Yeh, Shuyuan] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Ding, Jie; Yeh, Chiuan-Ren; Sun, Yin; Lin, Changyi; Chou, Joshua; Ou, Zhenyu; Chang, Chawnshang; Yeh, Shuyuan] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA	Shanghai Jiao Tong University; University of Rochester; University of Rochester	Qi, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai 200092, Peoples R China.; Yeh, SY (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Yeh, SY (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.	qijun@xinhuamed.com.cn; shuyuan_yeh@URMC.rochester.edu	Jie, Ding/ABD-8973-2021	Chang, Chawnshang/0000-0001-8510-3516	URMC Urology Department Research fund; George Whipple Professorship Endowment	URMC Urology Department Research fund; George Whipple Professorship Endowment	This work was partially supported by URMC Urology Department Research fund and George Whipple Professorship Endowment.	Batistatou A, 2006, J NEURO-ONCOL, V77, P17, DOI 10.1007/s11060-005-9005-0; Chiyomaru T, 2014, J BIOL CHEM, V289, P12550, DOI 10.1074/jbc.M113.488593; Chiyomaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070372; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Finley DS, 2011, ONCOLOGIST, V16, P4, DOI 10.1634/theoncologist.2011-S2-04; Fujimura T, 2001, BIOCHEM BIOPH RES CO, V289, P692, DOI 10.1006/bbrc.2001.6038; Gertz J, 2012, GENOME RES, V22, P2153, DOI 10.1101/gr.135681.111; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hajjari M, 2015, CANCER BIOL MED, V12, P1, DOI 10.7497/j.issn.2095-3941.2015.0006; Hall JM, 2013, MOL CARCINOGEN, V52, P715, DOI 10.1002/mc.21913; Hibino S, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.17; HOBISCH A, 1995, CANCER RES, V55, P3068; Hsu I, 2014, CARCINOGENESIS, V35, P651, DOI 10.1093/carcin/bgt348; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kartha RV, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00008; Klotz LV, 2012, LANGENBECK ARCH SURG, V397, P569, DOI 10.1007/s00423-012-0946-4; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kontovinis LF, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-82; Lee HW, 2012, PATHOL INT, V62, P735, DOI 10.1111/pin.12001; Li J, 2015, TUMOR BIOL, V36, P3611, DOI 10.1007/s13277-014-2998-2; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Liu L, 2016, BJU INT, V117, P351, DOI 10.1111/bju.12702; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12188, DOI 10.1073/pnas.0804701105; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Perkel JM, 2013, BIOTECHNIQUES, V54, P301, DOI 10.2144/000114037; Powles T, 2016, EUR UROL, V70, P705, DOI 10.1016/j.eururo.2016.06.009; Powles T, 2016, EUR UROL, V69, P4, DOI 10.1016/j.eururo.2015.10.017; Qin J, 2014, J CLIN INVEST, V124, P5013, DOI 10.1172/JCI76412; Rapisarda A, 2012, ADV CANCER RES, V114, P237, DOI 10.1016/B978-0-12-386503-8.00006-5; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sorensen KP, 2013, BREAST CANCER RES TR, V142, P529, DOI 10.1007/s10549-013-2776-7; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Verkasalo PK, 2001, BRIT J NUTR, V86, P415, DOI 10.1079/BJN2001424; Wagener N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-524; Wang XG, 2015, MOL CANCER RES, V13, P1567, DOI 10.1158/1541-7786.MCR-15-0128; Xu ZQ, 2015, CLIN TRANSL ONCOL, V17, P41, DOI 10.1007/s12094-014-1195-5; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yoon JH, 2014, SEMIN CELL DEV BIOL, V34, P9, DOI 10.1016/j.semcdb.2014.05.015; Younes M, 2011, ARCH PATHOL LAB MED, V135, P63, DOI 10.1043/2010-0448-RAR.1; Yu CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056667; Zheng JC, 2013, ONCOL LETT, V5, P1583, DOI 10.3892/ol.2013.1236; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051	49	80	81	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 13	2018	37	37					5037	5053		10.1038/s41388-018-0175-6	http://dx.doi.org/10.1038/s41388-018-0175-6			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT3LT	29789714				2022-12-26	WOS:000444405300001
J	Berns, K; Caumanns, JJ; Hijmans, EM; Gennissen, AMC; Severson, TM; Evers, B; Wisman, GBA; Meersma, GJ; Lieftink, C; Beijersbergen, RL; Itamochi, H; van der Zee, AGJ; de Jong, S; Bernards, R				Berns, Katrien; Caumanns, Joseph J.; Hijmans, E. Marielle; Gennissen, Annemiek M. C.; Severson, Tesa M.; Evers, Bastiaan; Wisman, G. Bea A.; Meersma, Gert Jan; Lieftink, Cor; Beijersbergen, Roderick L.; Itamochi, Hiroaki; van der Zee, Ate G. J.; de Jong, Steven; Bernards, Rene			ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors	ONCOGENE			English	Article							COLON-CANCER; RESISTANCE; ACTIVATION; LANDSCAPE; MYC	Current treatment for advanced stage ovarian clear cell cancer is severely hampered by a lack of effective systemic therapy options, leading to a poor outlook for these patients. Sequencing studies revealed that ARID1A is mutated in over 50% of ovarian clear cell carcinomas. To search for a rational approach to target ovarian clear cell cancers with ARID1A mutations, we performed kinome-centered lethality screens in a large panel of ovarian clear cell carcinoma cell lines. Using the largest OCCC cell line panel established to date, we show here that BRD2 inhibition is predominantly lethal in ARID1A mutated ovarian clear cell cancer cells. Importantly, small molecule inhibitors of the BET (bromodomain and extra terminal domain) family of proteins, to which BRD2 belongs, specifically inhibit proliferation of ARID1A mutated cell lines, both in vitro and in ovarian clear cell cancer xenografts and patient-derived xenograft models. BET inhibitors cause a reduction in the expression of multiple SWI/SNF members including ARID1B, providing a potential explanation for the observed lethal interaction with ARID1A loss. Our data indicate that BET inhibition may represent a novel treatment strategy for a subset of ARID1A mutated ovarian clear cell carcinomas.	[Berns, Katrien; Hijmans, E. Marielle; Gennissen, Annemiek M. C.; Severson, Tesa M.; Evers, Bastiaan; Lieftink, Cor; Beijersbergen, Roderick L.; Bernards, Rene] Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Berns, Katrien; Hijmans, E. Marielle; Gennissen, Annemiek M. C.; Severson, Tesa M.; Evers, Bastiaan; Lieftink, Cor; Beijersbergen, Roderick L.; Bernards, Rene] Netherlands Canc Inst, Oncode Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Caumanns, Joseph J.; Wisman, G. Bea A.; Meersma, Gert Jan; van der Zee, Ate G. J.] Univ Groningen, Univ Med Ctr Groningen, Canc Res Ctr Groningen, Gynaecol Oncol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands; [Itamochi, Hiroaki] Iwate Med Univ, Sch Med, Dept Obstet & Gynaecol, Morioka, Iwate 0208505, Japan; [de Jong, Steven] Univ Groningen, Univ Med Ctr Groningen, Canc Res Ctr Groningen, Med Oncol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Groningen; Iwate Medical University; University of Groningen	Berns, K; Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.; Berns, K; Bernards, R (corresponding author), Netherlands Canc Inst, Oncode Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	k.berns@nki.nl; r.bernards@nki.nl		Beijersbergen, Roderick/0000-0003-0116-4130	Dutch Cancer Society (KWF) [RUG2012-5477]; Cancer Genomics Center Netherlands through the Netherlands Organization for Scientific Research (NWO)	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Cancer Genomics Center Netherlands through the Netherlands Organization for Scientific Research (NWO)	We thank pathologist E.W. Duiker from UMCG for her contributions on OCCC pathology, H. Maat (Department of Experimental Hematology, UMCG) for her help with ChIP experiments, the people from the Genomics Core Facility of the Netherlands Cancer Institute for their technical support, and members of the Bernards lab for their helpful discussions. This research was supported by grants from the Dutch Cancer Society (KWF, RUG2012-5477) and the Cancer Genomics Center Netherlands through the Netherlands Organization for Scientific Research (NWO).	Alkema NG, 2015, SCI REP-UK, V5, DOI 10.1038/srep14495; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bitler BG, 2017, NAT CELL BIOL, V19, P962, DOI 10.1038/ncb3582; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Braicu EI, 2011, BRIT J CANCER, V105, P1818, DOI 10.1038/bjc.2011.455; Cheung KL, 2017, MOL CELL, V65, P1068, DOI 10.1016/j.molcel.2016.12.022; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis GV, 1996, GENE DEV, V10, P261, DOI 10.1101/gad.10.3.261; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Khursheed M, 2013, BRIT J CANCER, V108, P2056, DOI 10.1038/bjc.2013.200; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Marcotte R, 2016, CELL, V164, P293, DOI 10.1016/j.cell.2015.11.062; Miller RE, 2016, MOL CANCER THER, V15, P1472, DOI 10.1158/1535-7163.MCT-15-0554; Murakami R, 2017, AM J PATHOL, V187, P2246, DOI 10.1016/j.ajpath.2017.06.012; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Prat J, 2012, ANN ONCOL, V23, P111, DOI 10.1093/annonc/mds300; Shao Q, 2014, CANCER RES, V74, P7090, DOI 10.1158/0008-5472.CAN-14-0305; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068	29	52	54	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 16	2018	37	33					4611	4625		10.1038/s41388-018-0300-6	http://dx.doi.org/10.1038/s41388-018-0300-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GQ5OV	29760405	Green Published, hybrid			2022-12-26	WOS:000441736700009
J	Lasala, M; Corradi, J; Bruzzone, A; Esandi, MD; Bouzat, C				Lasala, Matias; Corradi, Jeremias; Bruzzone, Ariana; del Carmen Esandi, Maria; Bouzat, Cecilia			A human-specific, truncated 7 nicotinic receptor subunit assembles with full-length 7 and forms functional receptors with different stoichiometries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); patch clamp; Cys-loop receptor; channel activation; receptor structure-function; ion channel; 7 receptor; single-channel recording	CYS-LOOP RECEPTORS; AGONIST BINDING-SITES; X-RAY-STRUCTURE; ACETYLCHOLINE-RECEPTORS; SINGLE-CHANNEL; ION-CHANNEL; ALLOSTERIC MODULATION; INFLAMMATORY-RESPONSE; DELETION POLYMORPHISM; PARTIAL DUPLICATION	The cholinergic 7 nicotinic receptor gene, CHRNA7, encodes a subunit that forms the homopentameric 7 receptor, involved in learning and memory. In humans, exons 5-10 in CHRNA7 are duplicated and fused to the FAM7A genetic element, giving rise to the hybrid gene CHRFAM7A. Its product, dup7, is a truncated subunit lacking part of the N-terminal extracellular ligand-binding domain and is associated with neurological disorders, including schizophrenia, and immunomodulation. We combined dup7 expression on mammalian cells with patch clamp recordings to understand its functional role. Transfected cells expressed dup7 protein, but they exhibited neither surface binding of the 7 antagonist -bungarotoxin nor responses to acetylcholine (ACh) or to an allosteric agonist that binds to the conserved transmembrane region. To determine whether dup7 assembles with 7, we generated receptors comprising 7 and dup7 subunits, one of which was tagged with conductance substitutions that report subunit stoichiometry and monitored ACh-elicited channel openings in the presence of a positive allosteric 7 modulator. We found that 7 and dup7 subunits co-assemble into functional heteromeric receptors, which require at least two 7 subunits for channel opening, and that dup7's presence in the pentameric arrangement does not affect the duration of the potentiated events compared with that of 7. Using an 7 subunit mutant, we found that activation of (7)(2)(dup7)(3) receptors occurs through ACh binding at the 7/7 interfacial binding site. Our study contributes to the understanding of the modulation of 7 function by the human specific, duplicated subunit, associated with human disorders.	[Lasala, Matias; Corradi, Jeremias; Bruzzone, Ariana; del Carmen Esandi, Maria; Bouzat, Cecilia] Univ Nacl Sur, CONICET, Dept Biol Bioquim & Farm, Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Bouzat, C (corresponding author), CONICET Bahia Blanca, Inst Invest Bioquim Bahia Blanca INIBIBB, Camino La Carrindanga Km 7, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	inbouzat@criba.edu.ar		Lasala, Matias/0000-0002-0085-6621	Universidad Nacional del Sur (UNS); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina	Universidad Nacional del Sur (UNS); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Universidad Nacional del Sur (UNS) (to C.B. and M.C.E.), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) (to C.B. and J.C.), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Argentina (to C.B.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Andersen ND, 2016, NEUROPHARMACOLOGY, V107, P189, DOI 10.1016/j.neuropharm.2016.02.032; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Bartos M, 2009, MOL NEUROBIOL, V40, P236, DOI 10.1007/s12035-009-8084-x; Benfante R, 2011, J NEUROIMMUNOL, V230, P74, DOI 10.1016/j.jneuroim.2010.09.008; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Bouzat C, 2018, J PHYSIOL-LONDON, V596, P1847, DOI 10.1113/JP275101; Bouzat C, 2018, BRIT J PHARMACOL, V175, P1789, DOI 10.1111/bph.13770; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Chatzidaki A, 2015, BIOCHEM PHARMACOL, V97, P408, DOI 10.1016/j.bcp.2015.07.028; Chen DN, 1998, J NEUROCHEM, V70, P349; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Corradi J, 2016, MOL PHARMACOL, V90, P288, DOI 10.1124/mol.116.104240; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Costantini TW, 2015, MOL MED, V21, P323, DOI 10.2119/molmed.2015.00018; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; daCosta CJB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9057; daCosta CJB, 2013, P NATL ACAD SCI USA, V110, P6595, DOI 10.1073/pnas.1301909110; daCosta CJB, 2011, J NEUROSCI, V31, P13870, DOI 10.1523/JNEUROSCI.2652-11.2011; Dang XT, 2015, FASEB J, V29, P2292, DOI 10.1096/fj.14-268037; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Flomen RH, 2013, EUR J HUM GENET, V21, P76, DOI 10.1038/ejhg.2012.81; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; GOTTI C, 1995, EUR J NEUROSCI, V7, P2083, DOI 10.1111/j.1460-9568.1995.tb00630.x; Gu SY, 2016, NEURON, V89, P948, DOI 10.1016/j.neuron.2016.01.018; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Kabbani N, 2013, BIOESSAYS, V35, P1025, DOI 10.1002/bies.201300082; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lendvai B, 2013, BRAIN RES BULL, V93, P86, DOI 10.1016/j.brainresbull.2012.11.003; Locke DP, 2005, CYTOGENET GENOME RES, V108, P73, DOI 10.1159/000080804; Mazzaferro S, 2017, J BIOL CHEM, V292, P2729, DOI 10.1074/jbc.M116.764183; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Murray TA, 2012, MOL PHARMACOL, V81, P175, DOI 10.1124/mol.111.074088; Nielsen BE, 2018, CELL MOL LIFE SCI, V75, P2457, DOI 10.1007/s00018-017-2741-4; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Puskar NL, 2011, J BIOL CHEM, V286, P14618, DOI 10.1074/jbc.M110.206565; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Tsetlin V, 2007, LIFE SCI, V80, P2202, DOI 10.1016/j.lfs.2007.01.007; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	58	14	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10707	10717		10.1074/jbc.RA117.001698	http://dx.doi.org/10.1074/jbc.RA117.001698			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29784875	Green Published, hybrid			2022-12-26	WOS:000437828400026
J	Jha, B; Kumar, D; Sharma, A; Dwivedy, A; Singh, R; Biswal, BK				Jha, Bhavya; Kumar, Deepak; Sharma, Arun; Dwivedy, Abhisek; Singh, Ramandeep; Biswal, Bichitra Kumar			Identification and structural characterization of a histidinol phosphate phosphatase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; tuberculosis; histidine; phosphatase; inhibitor	IMIDAZOLEGLYCEROLPHOSPHATE DEHYDRATASE; SECONDARY-STRUCTURE; ESCHERICHIA-COLI; BIOSYNTHESIS; SEQUENCE; EXPRESSION; ALIGNMENT; CLONING; PATHWAY; FAMILY	The absence of a histidine biosynthesis pathway in humans, coupled with histidine essentiality for survival of the important human pathogen Mycobacterium tuberculosis (Mtb), underscores the importance of the bacterial enzymes of this pathway as major antituberculosis drug targets. However, the identity of the mycobacterial enzyme that functions as the histidinol phosphate phosphatase (HolPase) of this pathway remains to be established. Here, we demonstrate that the enzyme encoded by the Rv3137 gene, belonging to the inositol monophosphatase (IMPase) family, functions as the Mtb HolPase and specifically dephosphorylates histidinol phosphate. The crystal structure of Rv3137 in apo form enabled us to dissect its distinct structural features. Furthermore, the holo-complex structure revealed that a unique cocatalytic multizinc-assisted mode of substrate binding and catalysis is the hallmark of Mtb HolPase. Interestingly, the enzyme-substrate complex structure unveiled that although monomers possess individual catalytic sites they share a common product-exit channel at the dimer interface. Furthermore, target-based screening against HolPase identified several small-molecule inhibitors of this enzyme. Taken together, our study unravels the missing enzyme link in the Mtb histidine biosynthesis pathway, augments our current mechanistic understanding of histidine production in Mtb, and has helped identify potential inhibitors of this bacterial pathway.	[Jha, Bhavya; Kumar, Deepak; Dwivedy, Abhisek; Biswal, Bichitra Kumar] Natl Inst Immunol, Struct & Funct Biol Lab, Aruna Asaf Ali Marg, Delhi 110007, India; [Sharma, Arun; Singh, Ramandeep] Translat Hlth Sci & Technol Inst, Vaccine & Infect Dis Res Ctr, Faridabad 121001, Haryana, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Biswal, BK (corresponding author), Natl Inst Immunol, Struct & Funct Biol Lab, Aruna Asaf Ali Marg, Delhi 110007, India.	bbiswal@nii.ac.in	Dwivedy, Abhisek/AAV-4406-2021; Kumar, Deepak/AAB-7660-2022	Kumar, Deepak/0000-0001-5868-2057; Jha, Bhavya/0000-0002-0944-4279; Biswal, Bichitra/0000-0002-5927-3244; Singh, Ramandeep/0000-0003-2705-3826; Dwivedy, Abhisek/0000-0001-9745-8138	Department of Biotechnology (DBT), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by the Department of Biotechnology (DBT), Government of India, for X-ray data collection at synchrotron beamlines BM14 and ID30B of the European Synchrotron Radiation Facility, Grenoble, France. The authors declare that they have no conflicts of interest with the contents of this article.	Ahangar MS, 2013, ACTA CRYSTALLOGR D, V69, P2461, DOI 10.1107/S0907444913022579; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BAZZICALUPO M, 1987, MOL GEN GENET, V206, P76, DOI 10.1007/BF00326539; Castellani M, 2010, J BIOL CHEM, V285, P502, DOI 10.1074/jbc.M109.072959; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHIARIOTTI L, 1986, MOL GEN GENET, V202, P42, DOI 10.1007/BF00330514; Cho Y, 2003, J BIOL CHEM, V278, P8333, DOI 10.1074/jbc.M212124200; Cho Y, 2008, J MED CHEM, V51, P5984, DOI 10.1021/jm800328v; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Due AV, 2011, P NATL ACAD SCI USA, V108, P3554, DOI 10.1073/pnas.1015996108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Ghodge SV, 2013, BIOCHEMISTRY-US, V52, P1101, DOI 10.1021/bi301496p; Hogbom M, 2005, MOL CELL PROTEOMICS, V4, P827, DOI 10.1074/mcp.T400023-MCP200; Javid-Majd F, 2008, ACTA CRYSTALLOGR D, V64, P627, DOI 10.1107/S0907444908007105; Jiang JW, 2016, AQUAC RES, V47, P1269, DOI 10.1111/are.12586; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulis-Horn RK, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1069-4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Li W., 2016, FASEB J S, V30; Lunardi J, 2013, CURR TOP MED CHEM, V13, P2866, DOI 10.2174/15680266113136660203; MANO J, 1993, PLANT PHYSIOL, V103, P733, DOI 10.1104/pp.103.3.733; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marineo S, 2008, CURR MICROBIOL, V56, P6, DOI 10.1007/s00284-007-9014-7; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mormann S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-205; Movahedzadeh F, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-50; Murima P, 2014, CHEM BIOL, V21, P1423, DOI 10.1016/j.chembiol.2014.08.020; Nasir N, 2016, SCI REP-UK, V6, DOI 10.1038/srep18880; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parish T, 2003, J BACTERIOL, V185, P6702, DOI 10.1128/JB.185.22.6702-6706.2003; PARKER AR, 1994, GENE, V145, P135, DOI 10.1016/0378-1119(94)90336-0; Petersen LN, 2010, PLANT PHYSIOL, V152, P1186, DOI 10.1104/pp.109.150805; Poon BK, 2010, ACTA CRYSTALLOGR D, V66, P503, DOI 10.1107/S0907444910001502; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruszkowski M, 2016, J BIOL CHEM, V291, P9960, DOI 10.1074/jbc.M115.708727; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SEELIG GF, 1980, J BIOL CHEM, V255, P9589; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; STAPLES MA, 1979, J BIOL CHEM, V254, P1395; Sydor AM, 2013, BIOCHEMISTRY-US, V52, P1788, DOI 10.1021/bi301600z; TADA S, 1994, PLANT PHYSIOL, V105, P579, DOI 10.1104/pp.105.2.579; VALLEE BL, 1993, P NATL ACAD SCI USA, V90, P2715, DOI 10.1073/pnas.90.7.2715; Wellington S, 2017, NAT CHEM BIOL, V13, P943, DOI [10.1038/NCHEMBIO.2420, 10.1038/nchembio.2420]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045	57	6	6	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10102	10118		10.1074/jbc.RA118.002299	http://dx.doi.org/10.1074/jbc.RA118.002299			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29752410	Green Published, hybrid			2022-12-26	WOS:000437096700014
J	Dayeh, MA; Livadiotis, G; Elaydi, S				Dayeh, Maher A.; Livadiotis, George; Elaydi, Saber			A discrete mathematical model for the aggregation beta-Amyloid	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; PRECURSOR-PROTEIN; FIBRIL EXTENSION; OLIGOMERS; PROTOFIBRILLAR; TOXICITY; ETIOLOGY	Dementia associated with the Alzheimer's disease is thought to be correlated with the conversion of the beta - Amyloid (A beta) peptides from soluble monomers to aggregated oligomers and insoluble fibrils. We present a discrete-time mathematical model for the aggregation of A beta monomers into oligomers using concepts from chemical kinetics and population dynamics. Conditions for the stability and instability of the equilibria of the model are established. A formula for the number of monomers that is required for producing oligomers is also given. This may provide compound designers a mechanism to inhibit the A beta aggregation.	[Dayeh, Maher A.; Livadiotis, George] Southwest Res Inst, Dept Space Res, San Antonio, TX 78238 USA; [Elaydi, Saber] Trinity Univ, Dept Math, San Antonio, TX 78212 USA	Southwest Research Institute; Trinity University	Dayeh, MA (corresponding author), Southwest Res Inst, Dept Space Res, San Antonio, TX 78238 USA.	maldayeh@swri.edu			King Abdul Aziz University, SAU	King Abdul Aziz University, SAU	This work was supported by a grant from King Abdul Aziz University, SAU. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from King Abdul Aziz University, SAU.	[Anonymous], 1957, FISHERY INVESTIGATIO; Beyreuther K, 1991, BRAIN PATHOL, V1, P241, DOI 10.1111/j.1750-3639.1991.tb00667.x; Brauer F., 2012, MATH MODELS POPULATI, V40; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; FRASER PE, 1991, J NEUROSCI RES, V28, P474, DOI 10.1002/jnr.490280404; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hao WR, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0348-2; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kumar S, 2011, AGING, V3; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Livadiotis G, 2017, ALZHEIMERS DIS, V6, P75; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Malinchik SB, 1998, BIOPHYS J, V74, P537, DOI 10.1016/S0006-3495(98)77812-9; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Naiki H, 1996, LAB INVEST, V74, P374; Ni CL, 2011, FASEB J, V25, P1390, DOI 10.1096/fj.10-175539; Ortega JM, 1987, U SERIES MATH, VXII; Pallitto MM, 2001, BIOPHYS J, V81, P1805, DOI 10.1016/S0006-3495(01)75831-6; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Pryor NE, 2012, INT J MOL SCI, V13, P3038, DOI 10.3390/ijms13033038; Puri IK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015176; Purves D., 2012, NEUROSCIENCE, V5th, P713; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Wang Xiao-Ping, 2008, Neurosci Bull, V24, P105, DOI 10.1007/s12264-008-0105-7; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003235	51	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196402	10.1371/journal.pone.0196402	http://dx.doi.org/10.1371/journal.pone.0196402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791461	gold, Green Published, Green Submitted			2022-12-26	WOS:000433077000016
J	Vaidya, M; Bacchus, M; Sugaya, K				Vaidya, Manjusha; Bacchus, Michael; Sugaya, Kiminobu			Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker	PLOS ONE			English	Article							STEM-CELLS; LUNG	NANOG has been demonstrated to play an essential role in the maintenance of embryonic stem cells, and its pseudogene, NANOGP8, is suggested to promote the cancer stem cell phenotype. As the roles of these genes are intimately involved with glioblastoma multiforme progression and exosomes are critical in intercellular communication, we conducted a detailed analysis of the association of the NANOG gene family with exosomes to identify diagnostic markers for cancer. Exosomes were precipitated from conditioned culture media from various cell lines, and NANOG gene fragments were directly amplified without DNA isolation using multiple primer sets. The use of the enzymes AIwNI and Smal with restriction fragment length polymorphism analysis functioned to distinguish NANOGP8 from other NANOG family members. Collectively, results suggest that the NANOG DNA associated with exosomes is not full length and that mixed populations of the NANOG gene family exist. Furthermore, sequence analysis of exosomal DNA amplified with a NANOGP8 specific primer set frequently showed an insertion of a 22 bp sequence into the 3' UTR. The occurrence rate of this insertion was significantly higher in exosomal DNA clones from cancer cells as compared to normal cells. We have detected mixed populations of NANOG DNA associated with exosomes and have identified preferential modulations in the sequences from cancer samples. Our findings, coupled with the properties of exosomes, may allow for the detection of traditionally inaccessible cancers (i.e. GBM) through minimally invasive techniques. Further analysis of exosomal DNA sequences of NANOG and other embryonic stemness genes (OCT3/4, SOX2, etc.) may establish a robust collection of exosome based diagnostic markers, and further elucidate the mechanisms of cancer formation, progression, and metastasis.	[Vaidya, Manjusha; Bacchus, Michael; Sugaya, Kiminobu] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Sugaya, K (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	kaugaya@ucf.edu			The Wrenn Trust [2210-4202]; Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research [6901-7005]; preclinical test of Alzheimer's disease treatment in human 3D brain in vitro model; Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer's disease	The Wrenn Trust; Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research; preclinical test of Alzheimer's disease treatment in human 3D brain in vitro model; Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer's disease	This work was supported by The Wrenn Trust (grant number 2210-4202), preclinical test of Alzheimer's disease treatment in human 3D brain in vitro model, Principal Investigator (KS); The Florida Department of Health Ed and Ethel Moore Alzheimer's Disease Research (grant number 6901-7005), Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer's disease, Principal Investigator, (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady S, 2010, INT J DEV BIOL, V54, P1743, DOI 10.1387/ijdb.103192sa; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; CITRON M, 1991, CANCER RES, V51, P4131; Combs SE, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-115; Edgar JR, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0268-z; Field M, 2010, EMBRYONIC STEM CELL, P151; Garcia-Romero N, 2017, ONCOTARGET, V8, P1416, DOI 10.18632/oncotarget.13635; Jeter CR, 2015, STEM CELLS, V33, P2381, DOI 10.1002/stem.2007; Krama A F, 2016, IDH1 2 MUTATION MGMT, P194; Kregel S, 2014, PROSTATE, V74, P1530, DOI 10.1002/pros.22870; Liu Z, 2016, ONCOL LETT, V12, P2507, DOI 10.3892/ol.2016.4923; Page RL, 2009, CLONING STEM CELLS, V11, P417, DOI 10.1089/clo.2009.0015; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rider MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23978; Rodrigo JP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11709-9; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Virant-Klun I, 2017, INT J GYNECOLOGICAL, V27; Volk N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019391; Wang R, 2017, MOL ONCOL, V11, P1023, DOI 10.1002/1878-0261.12071; Whiteside TL, 2016, ADV CLIN CHEM, V74, P103, DOI 10.1016/bs.acc.2015.12.005; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	22	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197782	10.1371/journal.pone.0197782	http://dx.doi.org/10.1371/journal.pone.0197782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787607	Green Published, Green Submitted, gold			2022-12-26	WOS:000432785700046
J	Flores, CE; Deferrari, G; Collado, L; Escobar, J; Schiavini, A				Flores, Celina E.; Deferrari, Guillermo; Collado, Leonardo; Escobar, Julio; Schiavini, Adrian			Spatial abundance models and seasonal distribution for guanaco (Lama guanicoe) in central Tierra del Fuego, Argentina	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DISTRIBUTION PATTERNS; PARTIAL MIGRATION; HABITAT USE; MOVEMENTS; PATAGONIA; POPULATION; MANAGEMENT; LANDSCAPE; DENSITY	Spatially explicit modelling allows to estimate population abundance and predict species' distribution in relation to environmental factors. Abiotic factors are the main determinants of a herbivore's response to environmental heterogeneity on large spatiotemporal scales. We assessed the influence of elevation, geographic location and distance to the coast on the seasonal abundance and distribution of guanaco (Lama guanicoe) in central Tierra del Fuego, by means of spatially explicit modelling. The estimated abundance was 23,690 individuals for the non-breeding season and 33,928 individuals for the breeding season. The factors influencing distribution and abundance revealed to be the elevation for the non breeding season, and the distance to the coast and geographic location for the breeding season. The southwest of the study area presented seasonal abundance variation and the southeast and northeast presented high abundance during both seasons. The elevation would be the driving factor of guanaco distribution, as individuals move to lower areas during the non-breeding season and ascend to high areas during the breeding season. Our results confirm that part of the guanaco population performs seasonal migratory movements and that the main valleys present important wintering habitats for guanacos as well as up-hill zones during summer. This type of study would help to avoid problems of scale mismatch and achieve better results in management actions and is an example of how to assess important seasonal habitats from evaluations of abundance and distribution patterns.	[Flores, Celina E.; Deferrari, Guillermo; Escobar, Julio; Schiavini, Adrian] Consejo Nacl Invest Cient & Tecn, CADIC, Ctr Austral Invest Cient, Ushuaia, Tierra Del Fueg, Argentina; [Collado, Leonardo] Secretaria Ambiente Desarrollo Sostenible & Cambi, Direcc Gen Bosques, Ushuaia, Tierra Del Fueg, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Flores, CE (corresponding author), Consejo Nacl Invest Cient & Tecn, CADIC, Ctr Austral Invest Cient, Ushuaia, Tierra Del Fueg, Argentina.	celiflores1@gmail.com		Schiavini, Adrian Carlos Miguel/0000-0001-6621-4827	Fondo para la Investigacion Cientifica y Tecnologica (FONCYT-ANPCYT) [PICT-2011-1329]; Proyectos Federales de Innovacion Productiva [SCTIP 1198/06]; Consejo Nacional de Investigaciones Cientificas y Tecnicas	Fondo para la Investigacion Cientifica y Tecnologica (FONCYT-ANPCYT)(FONCyT); Proyectos Federales de Innovacion Productiva; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work received support from Fondo para la Investigacion Cientifica y Tecnologica (FONCYT-ANPCYT, PICT-2011-1329), www.agencia.mincyt.gob.ar/, Proyectos Federales de Innovacion Productiva (SCTIP 1198/06), www.cofecyt.mincyt.gob.ar/, and Consejo Nacional de Investigaciones Cientificas y Tecnicas, www.conicet.gov.ar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes P, 2010, MAMMALIA, V74, P57, DOI 10.1515/MAMM.2009.071; ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Baldi R, 2001, OECOLOGIA, V129, P561, DOI 10.1007/s004420100770; Baldi R, 2006, SECRETARIA AMBIENTE; Baldi R, 2010, GUANACO MANAGEMENT P, P266; Baldi Ricardo, 1997, Mastozoologia Neotropical, V4, P5; Bolger DT, 2008, ECOL LETT, V11, P63; Bonino N., 1991, Turrialba, V41, P452; Bonino Never, 1994, Ecologia Austral, V4, P79; Buckland S.T., 2001, pi; Collado Leonardo, 2008, Bosque (Valdivia), V29, P85; Coronato A., 2014, CAZADORES MAR TIERRA, P43; Coronato AMJ, 2008, DEV QUATER SCI, V11, P13, DOI 10.1016/S1571-0866(07)10003-8; D'Eon RG, 2005, J MAMMAL, V86, P736, DOI 10.1644/1545-1542(2005)086[0736:MDSMAM]2.0.CO;2; Dellabianca NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163441; Delsink A, 2013, BIOL CONSERV, V167, P116, DOI 10.1016/j.biocon.2013.07.035; DEVRIES MFW, 1995, CONSERV BIOL, V9, P25; Dicko AH, 2014, P NATL ACAD SCI USA, V111, P10149, DOI 10.1073/pnas.1407773111; DURANT SM, 1988, AFR J ECOL, V26, P257, DOI 10.1111/j.1365-2028.1988.tb00978.x; EDWARDS R. Y., 1956, JOUR WILDLIFE MANAGEMENT, V20, P159, DOI 10.2307/3797420; Flockhart D, 2017, GLOBAL CHANGE BIOL; Franklin WL, 1997, WILDLIFE SOC B, V25, P65; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Gaudry W, 2015, J MAMMAL, V96, P502, DOI 10.1093/jmammal/gyv055; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; Radovani NI, 2015, ORYX, V49, P42, DOI 10.1017/S0030605312001226; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; Jathanna D, 2003, J ZOOL, V261, P285, DOI 10.1017/S0952836903004278; Johnson CJ, 2005, ENVIRON CONSERV, V32, P117, DOI 10.1017/S0376892905002171; Johnson CJ, 2004, LANDSCAPE ECOL, V19, P869, DOI 10.1007/s10980-004-0246-7; Kanaji Y, 2017, DEEP-SEA RES PT II, V140, P151, DOI 10.1016/j.dsr2.2016.05.014; Kinnaird MF, 2012, CONSERV BIOL, V26, P1026, DOI 10.1111/j.1523-1739.2012.01942.x; Lendrum PE, 2014, MAMM BIOL, V79, P369, DOI 10.1016/j.mambio.2014.05.005; Livraghi EC, 2012, OVEJEROS FIN MUNDO R; Mainali KP, 2015, GLOBAL CHANGE BIOL, V21, P4464, DOI 10.1111/gcb.13038; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; MCNAUGHTON SJ, 1988, BIOSCIENCE, V38, P794, DOI 10.2307/1310789; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Montes C, 2000, MASTOZOOL NEOTROP, V7, P5; Moraga CA, 2015, ORYX, V49, P30, DOI 10.1017/S0030605312001238; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Murray K, 2009, ECOLOGY, V90, P348, DOI 10.1890/07-1929.1; Mysterud A, 2011, OIKOS, V120, P1817, DOI 10.1111/j.1600-0706.2010.19439.x; Ogutu JO, 2010, ECOL MONOGR, V80, P241, DOI 10.1890/09-0439.1; Oliva G, 2001, GANADERIA OVINA SUST, P17, DOI DOI 10.3989/AEAMER.1998.V55.I2.351; Ortega IM, 1995, REV CHIL HIST NAT, V68, P489; Osland MJ, 2017, ECOL MONOGR, V87, P341, DOI 10.1002/ecm.1248; Pepin D, 2008, ECOL RES, V23, P1005, DOI 10.1007/s11284-008-0468-2; Raedeke K.J., 1979, POPULATION DYNAMICS; Redfern JV, 2005, J ARID ENVIRON, V63, P406, DOI 10.1016/j.jaridenv.2005.03.016; Rushton SP, 2004, J APPL ECOL, V41, P193, DOI 10.1111/j.0021-8901.2004.00903.x; Sakari T., 1992, ACTA BOT FENN, V145, P1; Schroeder NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085960; SEAGLE SW, 1992, LANDSCAPE ECOL, V7, P229, DOI 10.1007/BF00131254; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Smit IPJ, 2007, BIOL CONSERV, V136, P85, DOI 10.1016/j.biocon.2006.11.009; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Spiegel O, 2017, ECOL LETT, V20, P3, DOI 10.1111/ele.12708; Suzuki N, 2008, BIODIVERS CONSERV, V17, P2197, DOI 10.1007/s10531-007-9281-4; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Travaini A, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-014-0097-0; Tucker B., 1991, RANGIFER, V11, P160, DOI [10.7557/2.11.4.1010, DOI 10.7557/2.11.4.1010]; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Williams R, 2006, ECOL SOC, V11; Winiarski KJ, 2013, MAR ECOL PROG SER, V492, P273, DOI 10.3354/meps10492; Young JK, 2004, J MAMMAL, V85, P72, DOI 10.1644/1545-1542(2004)085<0072:TFOMGI>2.0.CO;2; Zeng ZG, 2008, J WILDLIFE MANAGE, V72, P611, DOI 10.2193/2007-197; Zubillaga M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115307	73	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197814	10.1371/journal.pone.0197814	http://dx.doi.org/10.1371/journal.pone.0197814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782523	gold, Green Published, Green Submitted			2022-12-26	WOS:000432537100045
J	Kim, S; Choi, KH; Yun, J				Kim, Soyoung; Choi, Ki Hwan; Yun, Jaesuk			Exploration of alternative test methods to evaluate phototoxicity of ophthalmic agents by using Statens Seruminstitut Rabbit Cornea cell lines and 3D human reconstituted cornea models	PLOS ONE			English	Article							IN-VITRO ASSESSMENT; RISK-ASSESSMENT; 3T3 NRU; SKIN; CYTOTOXICITY; VALIDATION; ASSAY; PERMEABILITY; PREDICTION; RADIATION	Many chemicals have been reported to induce phototoxicity. The absorbance of light energy within the sunlight range is a common characteristic of phototoxicity. The 3T3 NRU photo toxicity test (PT) in 3T3 mouse skin fibroblasts has been used to identify the phototoxic potential induced by excited chemicals after exposure to ultra violet (UV). However, as phototoxicity may occur in ocular cells, it is necessary to develop a more suitable test for cornea -derived cells. In this study, we attempted to establish a new in vitro PT method in rabbit corneal cell lines (SIRC). We evaluated five ophthalmic agents, ciprofloxacin, levofloxacin, lomefloxacin, norfloxacin, and tetracycline, for their cytotoxic potential and in vitro phototoxicity. The results obtained using 3D human corneal models revealed that the UV-induced eye tissue toxicity by the test substances showed good correlation with those obtained using the in vitro phototoxicity test. However, the results from the 3D PT for ciprofloxacin, norfloxacin, and tetracycline in the 3D human cornea model were only partially comparable. Therefore, we suggest the SIRC cell line as a new phototoxicity test model; however, a sequential testing strategy, such as 3D PT, was also proposed to obtain relevant information for topical eye agents.	[Kim, Soyoung; Choi, Ki Hwan] MFDS, Natl Inst Food & Drug Safety Evaluat NIFDS, OHTAC 187, Osongsaengmyong 2 Ro, Cheongju, Chungbuk, South Korea; [Kim, Soyoung; Yun, Jaesuk] Wonkwang Univ, Coll Pharm, Iksan, Jeonbuk, South Korea	Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation; Wonkwang University	Yun, J (corresponding author), Wonkwang Univ, Coll Pharm, Iksan, Jeonbuk, South Korea.	actpot2863@wku.ac.kr	Yun, Jaesuk/Q-2993-2016	Yun, Jaesuk/0000-0002-3093-8919	Ministry of Food and Drug Safety [13181MFDS635]; Wonkwang University	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); Wonkwang University	This research was supported by a grant (13181MFDS635) from Ministry of Food and Drug Safety in 2014 to KHC and Wonkwang University in 2017 to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2007, PHOTOCHEM PHOTOBIOL, V83, P1226, DOI 10.1562/2006-10-12-RA-1059; Ayaki M, 2008, CLIN EXP OPHTHALMOL, V36, P553, DOI 10.1111/j.1442-9071.2008.01803.x; Ayaki M, 2011, J OLEO SCI, V60, P139, DOI 10.5650/jos.60.139; COHEN C, 1994, TOXICOL IN VITRO, V8, P669, DOI 10.1016/0887-2333(94)90040-X; de Avila RI, 2017, TOXICOL IN VITRO, V45, P386, DOI 10.1016/j.tiv.2017.04.001; EPSTEIN S, 1968, ARCH DERMATOL, V98, P354, DOI 10.1001/archderm.98.4.354; Food Drug Administration H.H.S, 2015, NOTICE FED REG, V80, P4282; Goskonda VR, 2000, PHARM DEV TECHNOL, V5, P409, DOI 10.1081/PDT-100100557; Goskonda VR, 1999, J PHARM SCI, V88, P180, DOI 10.1021/js980362t; Henry B, 2009, J PHOTOCH PHOTOBIO B, V96, P57, DOI 10.1016/j.jphotobiol.2009.04.005; Jirova D, 2005, TOXICOL IN VITRO, V19, P931, DOI 10.1016/j.tiv.2005.06.013; Jones PA, 2003, TOXICOL IN VITRO, V17, P703, DOI 10.1016/S0887-2333(03)00101-2; Jung KM, 2011, TOXICOL IN VITRO, V25, P403, DOI 10.1016/j.tiv.2010.10.019; Kandarova H, 2006, TOXICOL IN VITRO, V20, P547, DOI 10.1016/j.tiv.2005.11.008; Kleinman MH, 2010, REGUL TOXICOL PHARM, V58, P224, DOI 10.1016/j.yrtph.2010.06.013; Kloskowski T, 2010, PULM PHARMACOL THER, V23, P373, DOI 10.1016/j.pupt.2010.02.005; Lynch AM, 2011, EXP TOXICOL PATHOL, V63, P209, DOI 10.1016/j.etp.2009.12.001; MARTIN JP, 1987, J BACTERIOL, V169, P2516, DOI 10.1128/jb.169.6.2516-2522.1987; Matsumura Y, 2004, TOXICOL APPL PHARM, V195, P298, DOI 10.1016/j.taap.2003.08.019; Moore DE, 2002, DRUG SAFETY, V25, P345, DOI 10.2165/00002018-200225050-00004; Netzaff F, 2005, EUR J PHARM BIOPHARM, V60, P167, DOI 10.1016/j.ejpb.2005.03.004; Neumann NJ, 2005, J PHOTOCH PHOTOBIO B, V79, P25, DOI 10.1016/j.jphotobiol.2004.11.014; Onoue S, 2006, PHARM RES, V23, P156, DOI 10.1007/s11095-005-8497-9; Onoue S, 2008, J PHARMACEUT BIOMED, V47, P967, DOI 10.1016/j.jpba.2008.03.026; Peters B, 2002, ATLA-ALTERN LAB ANIM, V30, P415, DOI 10.1177/026119290203000405; Rai V, 2011, TOXICOL IN VITRO, V25, P538, DOI 10.1016/j.tiv.2010.11.017; SPIELMANN H, 1994, TOXICOL IN VITRO, V8, P793, DOI 10.1016/0887-2333(94)90069-8; Spielmann H, 1998, TOXICOL IN VITRO, V12, P305, DOI 10.1016/S0887-2333(98)00006-X; Spielmann H, 2000, ATLA-ALTERN LAB ANIM, V28, P777, DOI 10.1177/026119290002800603; Spielmann H, 2008, EXP TOXICOL PATHOL, V60, P225, DOI 10.1016/j.etp.2008.01.012; Spielmann Horst, 1994, ALTEX, V11, P22; VIAN L, 1995, TOXICOL IN VITRO, V9, P185, DOI 10.1016/0887-2333(94)00200-E; WAGAI N, 1992, ARCH TOXICOL, V66, P392, DOI 10.1007/BF02035128	33	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0196735	10.1371/journal.pone.0196735	http://dx.doi.org/10.1371/journal.pone.0196735			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782497	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100007
J	Burman, O; Marsella, G; Di Clemente, A; Cervo, L				Burman, Oliver; Marsella, Gerardo; Di Clemente, Angelo; Cervo, Luigi			The effect of exposure to low frequency electromagnetic fields (EMF) as an integral part of the housing system on anxiety-related behaviour, cognition and welfare in two strains of laboratory mouse	PLOS ONE			English	Article							DEPRESSION-LIKE BEHAVIOR; OBJECT RECOGNITION TASK; STATIC MAGNETIC-FIELD; WHOLE-BODY EXPOSURE; SOCIAL RECOGNITION; SPATIAL MEMORY; ANIMAL-MODELS; MALE RATS; MICE; PERFORMANCE	Electromagnetic field (EMF) technology has the potential to improve scientific data capture and welfare assessment by allowing automated data collection from individual cages. However, it is important to determine any impact that a new technology itself may have on animal welfare, and previous studies have found contrasting results of EMF on laboratory rodent anxiety-like behaviour and cognition. We therefore investigated whether there was an effect of low frequency EMF experienced continuously over a six-week period, as an integral part of the animal housing system, on measures of mouse anxiety-related behaviour, cognition and welfare. We housed mice (N = 80) of two strains (BALB/cAnNCrl and C57BL/6NCrI) separately in Individually Ventilated Cages (IVCs) in groups of four, either with the EMF plate turned 'on' or 'off' (n = 5). Some measures, e.g. food and water utilisation, were collected at regular intervals, whereas measures of anxiety-like behaviour (e.g. open field test) and cognitive performance (novel-object recognition test) were collected only at the end of the study. We found expected strong strain differences in most measures, e.g. latency to leave the starting square in an open field test, with C57BU6NCrl mice moving away sooner, and interactions between strain and time for those measures recorded at more than one time point, e.g. significant weight gain over time for both strains, but with BALB/cAnNCrl mice weighing more. However, we found no significant effects of treatment (EMF 'on'/'off') for any of the measures collected. These results indicate that, for the measures recorded here, there was no measurable impact on the behaviour and welfare of low frequency EMF exposure experienced continuously over a six-week period. Housing systems that include EMF monitoring technology may therefore be suitable for use without influencing either animal welfare or scientific outcomes.	[Burman, Oliver] Univ Lincoln, Sch Life Sci, Lincoln, England; [Marsella, Gerardo] IRCCS Ist Ric Farmacol Mario Negri, Anim Care Unit, Milan, Italy; [Di Clemente, Angelo; Cervo, Luigi] IRCCS Ist Ric Farmacol Mario Negri, Expt Psychopharmacol, Milan, Italy	University of Lincoln; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Burman, O (corresponding author), Univ Lincoln, Sch Life Sci, Lincoln, England.	oburman@lincoln.ac.uk	Di Clemente, Angelo/ABD-5929-2020; Cervo, Luigi/AAA-8081-2020	Di Clemente, Angelo/0000-0001-7982-291X; Cervo, Luigi/0000-0003-1314-1876	Istituto di Ricerche Farmacologiche "Mario Negri" - IRCCS, Milan, Italy	Istituto di Ricerche Farmacologiche "Mario Negri" - IRCCS, Milan, Italy	This study was sponsored by the Istituto di Ricerche Farmacologiche "Mario Negri" - IRCCS, Via La Masa, 19, 20156 Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammari M, 2008, ELECTROMAGN BIOL MED, V27, P185, DOI [10.1080/15368370802072158, 10.1016/15368370802072158]; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Bains RS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00106; Balducci C, 2014, J NEUROSCI, V34, P14022, DOI 10.1523/JNEUROSCI.0284-14.2014; Bernal-Mondragon C, 2017, NEUROL RES, V39, P165, DOI 10.1080/01616412.2016.1252875; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Burman O, 2014, PHYSIOL BEHAV, V124, P92, DOI 10.1016/j.physbeh.2013.10.019; Cosquer B, 2005, BEHAV BRAIN RES, V156, P65, DOI 10.1016/j.bbr.2004.05.007; Hashish AH, 2008, ECOTOX ENVIRON SAFE, V71, P895, DOI 10.1016/j.ecoenv.2007.10.002; Hawkins P, 2011, DEFINING IMPLEMENTIN; Jadidi M, 2007, NEUROBIOL LEARN MEM, V88, P387, DOI 10.1016/j.nlm.2007.07.010; Kitaoka K, 2013, BIOELECTROMAGNETICS, V34, P43, DOI 10.1002/bem.21743; Liu TT, 2008, NEUROSCI LETT, V434, P12, DOI 10.1016/j.neulet.2008.01.019; Mineur YS, 2006, BEHAV BRAIN RES, V175, P43, DOI 10.1016/j.bbr.2006.07.029; O'Leary TP, 2013, BEHAV GENET, V43, P34, DOI 10.1007/s10519-012-9572-8; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Recordati C, 2015, J AM ASS LAB ANIMAL, V54, P666; Rostami A, 2016, J LASERS MED SCI, V7, P120, DOI 10.15171/jlms.2016.20; Salunke BP, 2015, PHYSIOL BEHAV, V140, P32, DOI 10.1016/j.physbeh.2014.12.019; Salunke BP, 2014, ELECTROMAGN BIOL MED, V33, P312, DOI 10.3109/15368378.2013.839453; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Sutcliffe JS, 2007, BEHAV BRAIN RES, V177, P117, DOI 10.1016/j.bbr.2006.10.029; Tang XD, 2002, BEHAV BRAIN RES, V136, P555, DOI 10.1016/S0166-4328(02)00228-0; Vazquez-Garcia M, 2004, PHYSIOL BEHAV, V82, P685, DOI 10.1016/j.physbeh.2004.06.004; Webster AJF, 1998, NATURWISSENSCHAFTEN, V85, P262, DOI 10.1007/s001140050496	26	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197054	10.1371/journal.pone.0197054	http://dx.doi.org/10.1371/journal.pone.0197054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771983	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000432348900027
J	Alonso, F; Teran, GE; Calvino, P; Garcia, I; Cardoso, Y; Garcia, G				Alonso, Felipe; Enrique Teran, Guillermo; Calvino, Pablo; Garcia, Ignacio; Cardoso, Yamila; Garcia, Graciela			An endangered new species of seasonal killifish of the genus Austrolebias (Cyprinodontiformes: Aplocheiloidei) from the Bermejo river basin in the Western Chacoan Region	PLOS ONE			English	Article							ANNUAL FISH; RIVULIDAE; DIVERSIFICATION; BIOGEOGRAPHY; SPECIATION; EVOLUTION	Austrolebias wichi, new species, is herein described from seasonal ponds of the Bermejo river basin in the Western Chacoan district in northwestern Argentina. This species was found in a single pond, a paleochannel of the Bermejo River, which is seriously disturbed by soybean plantations surrounding it. Despite intensive sampling in the area, this species was only registered in this pond where it was relatively scarce. Therefore, we consider this species as critically endangered. This species is the sister species of A. patriciae in our phylogenetic analyses and is similar, in a general external aspect, to A. varzeae and A. carvalhoi. It can be distinguished among the species of Austrolebias by its unique color pattern in males. Additionally, from A. varzeae by presenting a supraorbital band equal or longer than the infraorbital band (vs. shorter) and from A. patriciae by the convex dorsal profile of head (vs. concave). Further diagnostic characters and additional comments on its ecology and reproduction are provided.	[Alonso, Felipe] Consejo Nacl Invest Cient & Tecn, Inst Bio & Geociencias NOA IBIGEO, 9 Julio 14, Rosario De Lerma, Provincia De Sa, Argentina; [Alonso, Felipe; Enrique Teran, Guillermo; Calvino, Pablo; Garcia, Ignacio] GICK, Berisso, Buenos Aires, Argentina; [Enrique Teran, Guillermo] Fdn Miguel Lillo, UEL, CONICET, Miguel Lillo 251, San Miguel De Tucuman, Tucuman, Argentina; [Garcia, Ignacio] UNLP, CONICET, Inst Limnol Dr Raul Ringuelet ILPLA, La Plata, Buenos Aires, Argentina; [Cardoso, Yamila] UNLP, CONICET, Fac Ciencias Nat & Museo, Lab Sistemat & Biol Evolut, La Plata, Buenos Aires, Argentina; [Garcia, Graciela] Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Universidad de la Republica, Uruguay	Alonso, F (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Bio & Geociencias NOA IBIGEO, 9 Julio 14, Rosario De Lerma, Provincia De Sa, Argentina.; Alonso, F (corresponding author), GICK, Berisso, Buenos Aires, Argentina.	felipealonso@gmail.com	Alonso, Felipe/AAA-5717-2020	Alonso, Felipe/0000-0001-7227-2732; Garcia, Ignacio/0000-0002-0454-2603; Teran, Guillermo/0000-0002-3795-3345; Cardoso, Yamila P./0000-0003-3497-4359				Alonso Felipe, 2016, Check List, V12, P1945; [Anonymous], 2008, CATALOG APLOCHEILOID; Arias M., 1996, ESTADISTICAS CLIMATO; Belote DF, 1998, REPROD BEHAV PATTERN; Braga Liliana, 1999, Physis Seccion A los Oceanos y sus Organismos, V57, P11; Bressane Nielsen Dalton Tavares, 2015, Aqua, V21, P172; Costa WJEM, 2017, VERTEBR ZOOL, V67, P139; Costa WJEM, 2017, MOL PHYLOGENET EVOL, V116, P61, DOI 10.1016/j.ympev.2017.07.020; Costa WJEM, 2014, ICHTHYOL EXPLOR FRES, V25, P97; Costa Wilson J.E.M., 2001, Ichthyological Exploration of Freshwaters, V12, P333; Costa WJEM, 2010, J BIOGEOGR, V37, P1995, DOI 10.1111/j.1365-2699.2010.02339.x; Costa WJEM, 2006, ZOOTAXA, P1; Costa WJEM, 1995, PEARL KILLIFISHES CY; Evans BJ, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170351; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; Garcia D, 2008, NEOTROP ICHTHYOL, V6, P243, DOI 10.1590/S1679-62252008000200012; Garcia G, 2014, GENETICA, V142, P87, DOI 10.1007/s10709-014-9756-7; Garcia G, 2002, BIOL J LINN SOC, V76, P49, DOI 10.1111/j.1095-8312.2002.tb01713.x; Garcia G, 2001, CHROMOSOME RES, V9, P437, DOI 10.1023/A:1011664009509; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2014, CLADISTICS, V30, P260, DOI 10.1111/cla.12047; Hales J, 2017, CHACO FRESHWATER ECO; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huber Jean H., 1995, Killi-Contact, V23, P1; IUCN Red List, 2001, CAT CRIT VERS 3 1 IU; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Loureiro M, 2008, ZOOTAXA, P1; Morrone JJ, 2014, CLADISTICS, V30, P202, DOI 10.1111/cla.12039; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Roxo FF, 2017, ZOOTAXA, V4294, P226, DOI 10.11646/zootaxa.4294.2.6; TAYLOR W R, 1985, Cybium, V9, P107; Thompson AW, 2017, J FISH BIOL, V91, P126, DOI 10.1111/jfb.13332; Volcan MV, 2017, ZOOTAXA, V4338, P141, DOI 10.11646/zootaxa.4338.1.7; Volcan Matheus Vieira, 2014, Aqua, V20, P161; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Worsham MLD, 2017, ECOL EVOL, V7, P10278, DOI 10.1002/ece3.3474	39	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196261	10.1371/journal.pone.0196261	http://dx.doi.org/10.1371/journal.pone.0196261			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768422	gold, Green Published, Green Submitted			2022-12-26	WOS:000432329200017
J	Luo, NF; Liu, J; Chen, Y; Li, H; Hu, ZY; Abbott, GW				Luo, Nanfu; Liu, Jin; Chen, Yan; Li, Huan; Hu, Zhaoyang; Abbott, Geoffrey W.			Remote ischemic preconditioning STAT3-dependently ameliorates pulmonary ischemia/reperfusion injury	PLOS ONE			English	Article							ACUTE LUNG INJURY; REPERFUSION INJURY; SIGNALING PATHWAYS; SALVAGE KINASE; TRANSPLANTATION; HUMANS; SITE	The lungs are highly susceptible to injury, including ischemia/reperfusion (I/R) injury. Pulmonary I/R injury can occur when correcting conditions such as primary pulmonary hypertension, and is also relatively common after lung transplantation or other cardiothoracic surgery. Methods to reduce pulmonary I/R injury are urgently needed to improve outcomes following procedures such as lung transplantation. Remote liver ischemic preconditioning (RLIPC) is an effective cardioprotective measure, reducing damage caused by subsequent cardiac I/R injury, but little is known about its potential role in pulmonary protection. Here, we analyzed the efficacy and mechanistic basis of RLIPC in a rat model of pulmonary I/R injury. RLIPC reduced lung I/R injury, lessening structural damage, inflammatory cytokine production and apoptosis. In addition, RLIPC preserved pulmonary function compared to controls following lung I/R injury. RLIPC stimulated phosphorylation of pulmonary STAT3, a component of the SAFE signaling pathway, but not phosphorylation of RISK pathway signaling proteins. Accordingly, STAT3 inhibition using AG490 eliminated the pulmonary protection afforded by RLIPC. Our data demonstrate for the first time that RLIPC protects against pulmonary I/R injury, via a signaling pathway requiring STAT3 phosphorylation.	[Luo, Nanfu; Liu, Jin; Chen, Yan; Li, Huan; Hu, Zhaoyang] Sichuan Univ, West China Hosp, Lab Anesthesiol & Crit Care Med, Translat Neurosci Ctr, Chengdu, Sichuan, Peoples R China; [Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Bioelect Lab, Dept Physiol & Biophys, Irvine, CA 92717 USA	Sichuan University; University of California System; University of California Irvine	Hu, ZY (corresponding author), Sichuan Univ, West China Hosp, Lab Anesthesiol & Crit Care Med, Translat Neurosci Ctr, Chengdu, Sichuan, Peoples R China.; Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Bioelect Lab, Dept Physiol & Biophys, Irvine, CA 92717 USA.	zyhu@hotmail.com; abbottg@uci.edu		Abbott, Geoffrey/0000-0003-4552-496X; Liu, Jin/0000-0002-2026-2513	National Natural Science Foundation of China [81670300]; University of California, Irvine School of Medicine Setup Funds	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of California, Irvine School of Medicine Setup Funds(University of California System)	This study was supported by grant No. 81670300 (to ZH) from the National Natural Science Foundation of China, and University of California, Irvine School of Medicine Setup Funds (to GWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Chen H, 2018, CARDIOVASC RES, V114, P679, DOI 10.1093/cvr/cvy014; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; den Hengst WA, 2010, AM J PHYSIOL-HEART C, V299, pH1283, DOI 10.1152/ajpheart.00251.2010; Fiser SM, 2002, ANN THORAC SURG, V73, P1041, DOI 10.1016/S0003-4975(01)03606-2; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Garcia-de-la-Asuncion J, 2015, EUR J CARDIO-THORAC, V48, pE37, DOI 10.1093/ejcts/ezv207; Gent S, 2017, AM J PHYSIOL-HEART C, V312, pH478, DOI 10.1152/ajpheart.00749.2016; Hausenloy DJ, 2011, ANTIOXID REDOX SIGN, V14, P893, DOI 10.1089/ars.2010.3360; Hausenloy DJ, 2005, TRENDS CARDIOVAS MED, V15, P69, DOI 10.1016/j.tcm.2005.03.001; Heusch G, 2012, CIRC RES, V110, P111, DOI 10.1161/CIRCRESAHA.111.259556; Hu ZY, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0537-3; Hu ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165123; Hu ZY, 2016, CARDIOVASC RES, V110, P227, DOI 10.1093/cvr/cvw048; Kreisel D, 2011, J CLIN INVEST, V121, P265, DOI 10.1172/JCI42596; Laubach VE, 2016, CURR OPIN ORGAN TRAN, V21, P246, DOI 10.1097/MOT.0000000000000304; Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019; Lecour S, 2009, J MOL CELL CARDIOL, V46, P607, DOI 10.1016/j.yjmcc.2009.01.003; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Lin E, 2014, J HEART LUNG TRANSPL, V33, P1139, DOI 10.1016/j.healun.2014.04.022; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Morciano G, 2017, ADV EXP MED BIOL, V982, P169, DOI 10.1007/978-3-319-55330-6_9; Peralta C, 1999, HEPATOLOGY, V30, P1481, DOI 10.1002/hep.510300622; Porteous MK, 2015, CURR OPIN ORGAN TRAN, V20, P506, DOI 10.1097/MOT.0000000000000232; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Song SQ, 2015, INT J CLIN EXP MED, V8, P14953; Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; TEMPLETON AW, 1967, DIS CHEST, V51, P166, DOI 10.1378/chest.51.2.166; Walters J, 2009, BIOCHEM J, V424, P335, DOI 10.1042/BJ20090825; Weyker PD, 2013, SEMIN CARDIOTHORAC V, V17, P28, DOI 10.1177/1089253212458329; YAN SF, 1995, J BIOL CHEM, V270, P11463, DOI 10.1074/jbc.270.19.11463; Yang S, 1985, J APPL PHYSIOL, DOI [10.1152/jappiphysiol.00862, DOI 10.1152/JAPPIPHYSIOL.00862.2016]; Zhao YR, 2016, J PHYSIOL SCI, V66, P229, DOI 10.1007/s12576-015-0418-z	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196186	10.1371/journal.pone.0196186	http://dx.doi.org/10.1371/journal.pone.0196186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768493	gold, Green Published			2022-12-26	WOS:000432329200015
J	Mohan, M; Keller, S; Nicolson, A; Biswas, S; Smith, D; Farah, JO; Eldridge, P; Wieshmann, U				Mohan, Midhun; Keller, Simon; Nicolson, Andrew; Biswas, Shubhabrata; Smith, David; Farah, Jibril Osman; Eldridge, Paul; Wieshmann, Udo			The long-term outcomes of epilepsy surgery	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; INITIALLY SEIZURE-FREE; ANTIEPILEPTIC DRUGS; SURGICAL-TREATMENT; FOLLOW-UP; LOBECTOMY; PREDICTORS; ADULTS; METAANALYSIS; RECURRENCE	Objective Despite modern anti-epileptic drug treatment, approximately 30% of epilepsies remain medically refractory and for these patients, epilepsy surgery may be a treatment option. There have been numerous studies demonstrating good outcome of epilepsy surgery in the short to median term however, there are a limited number of studies looking at the long-term outcomes. The aim of this study was to ascertain the long-term outcome of resective epilepsy surgery in a large neurosurgery hospital in the U.K. Methods This a retrospective analysis of prospectively collected data. We used the 2001 International League Against Epilepsy (ILAE) classification system to classify seizure freedom and Kaplan-Meier survival analysis to estimate the probability of seizure freedom. Results We included 284 patients who underwent epilepsy surgery (178 anterior temporal lobe resections, 37 selective amygdalohippocampectomies, 33 temporal lesionectomies, 36 extratemporal lesionectomies), and had a prospective median follow-up of 5 years (range 1-27). Kaplan-Meier estimates showed that 47% (95% CI 40-58) remained seizure free (apart from simple partial seizures) at 5 years and 38% (95% CI 31-45) at 10 years after surgery. 74% (95% CI 69-80) had a greater than 50% seizure reduction at 5 years and 70% (95% CI 64-77) at 10 years. Patients who had an amygdalohippocampectomy were more likely to have seizure recurrence than patients who had an anterior temporal lobe resection (p = 0.006) and temporal lesionectomy (p = 0.029). There was no significant difference between extra temporal and temporal lesionectomies. Hippocampal sclerosis was associated with a good outcome but declined in relative frequency over the years. Conclusion The vast majority of patients who were not seizure free experienced at least a substantial and long-lasting reduction in seizure frequency. A positive long-term outcome after epilepsy surgery is possible for many patients and especially those with hippocampal sclerosis or those who had anterior temporal lobe resections.	[Mohan, Midhun; Keller, Simon; Nicolson, Andrew; Biswas, Shubhabrata; Smith, David; Farah, Jibril Osman; Eldridge, Paul; Wieshmann, Udo] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England; [Keller, Simon] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England	Walton Centre; University of Liverpool	Wieshmann, U (corresponding author), Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.	udo.wieshmann@thewaltoncentre.nhs.uk	Morden, Frances/AAY-4233-2020	Keller, Simon/0000-0001-5247-9795; , Midhun/0000-0002-1865-8623				Asztely F, 2007, J NEUROL NEUROSUR PS, V78, P605, DOI 10.1136/jnnp.2006.098244; Aull-Watschinger S, 2008, EPILEPSIA, V49, P1308, DOI 10.1111/j.1528-1167.2008.01732.x; BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; Bien CG, 2013, J NEUROL NEUROSUR PS, V84, P54, DOI 10.1136/jnnp-2011-301763; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Di Gennaro G, 2014, EPILEPSY RES, V108, P945, DOI 10.1016/j.eplepsyres.2014.03.010; Duncan JS, 1997, BRAIN, V120, P339, DOI 10.1093/brain/120.2.339; Dupont S, 2006, EPILEPSIA, V47, P2115, DOI 10.1111/j.1528-1167.2006.00852.x; Edelvik A, 2013, NEUROLOGY, V81, P1244, DOI 10.1212/WNL.0b013e3182a6ca7b; Elsharkawy AE, 2008, J NEUROSURG, V108, P676, DOI 10.3171/JNS/2008/108/4/0676; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Engel J, 2012, JAMA-J AM MED ASSOC, V307, P922, DOI 10.1001/jama.2012.220; Fauser S, 2015, EPILEPSIA, V56, P66, DOI 10.1111/epi.12876; Foldvary N, 2000, NEUROLOGY, V54, P630, DOI 10.1212/WNL.54.3.630; FOY PM, 1992, J NEUROL NEUROSUR PS, V55, P753, DOI 10.1136/jnnp.55.9.753; French JA, 2004, NEUROLOGY, V62, P1261, DOI 10.1212/01.WNL.0000123695.22623.32; Gao L, 2013, EPILEPSY RES, V103, P31, DOI 10.1016/j.eplepsyres.2012.06.005; Giulioni M, 2013, J NEUROSURG, V119, P37, DOI 10.3171/2013.3.JNS122132; Gowers WR, 1901, MANUAL DIS NERVOUS S; Hemb M, 2013, J NEUROL NEUROSUR PS, V84, P800, DOI 10.1136/jnnp-2012-304038; Hess EJ, 2016, EPILEPSIA, V57, P1617, DOI 10.1111/epi.13499; Hu WH, 2013, J NEUROSURG, V119, P1089, DOI 10.3171/2013.8.JNS121854; JACOBY A, 1993, EPILEPSY RES, V16, P207, DOI 10.1016/0920-1211(93)90081-H; Jeha LE, 2006, NEUROLOGY, V66, P1938, DOI 10.1212/01.wnl.0000219810.71010.9b; Jeha LE, 2007, BRAIN, V130, P574, DOI 10.1093/brain/awl364; Jehi L, 2013, EPILEPSY CURR, V13, P166, DOI 10.5698/1535-7597-13.4.166; Josephson CB, 2013, NEUROLOGY, V80, P1669, DOI 10.1212/WNL.0b013e3182904f82; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keller SS, 2017, BRAIN, V140, P68, DOI 10.1093/brain/aww280; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; Lazow SP, 2012, EPILEPSIA, V53, P1746, DOI 10.1111/j.1528-1167.2012.03582.x; LI LM, 1995, J NEUROL NEUROSUR PS, V59, P384, DOI 10.1136/jnnp.59.4.384; Luyken C, 2003, EPILEPSIA, V44, P822, DOI 10.1046/j.1528-1157.2003.56102.x; Malmgren K, 2017, SEIZURE-EUR J EPILEP, V44, P217, DOI 10.1016/j.seizure.2016.10.015; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; Marson AG, 2001, EPILEPSY RES, V46, P259, DOI 10.1016/S0920-1211(01)00287-X; Mathon B, 2017, EPILEPSIA, V58, P1473, DOI 10.1111/epi.13831; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; McIntosh AM, 2012, EPILEPSIA, V53, P970, DOI 10.1111/j.1528-1167.2012.03430.x; Menon R, 2012, NEUROLOGY, V79, P770, DOI 10.1212/WNL.0b013e3182644f7d; Niemeyer P, 1958, TEMPORAL LOBE EPILEP, P461; Paglioli E, 2004, EPILEPSIA, V45, P1383, DOI 10.1111/j.0013-9580.2004.22204.x; Phi JH, 2009, CANCER-AM CANCER SOC, V115, P5771, DOI 10.1002/cncr.24666; Ramesha KN, 2011, EPILEPSIA, V52, P917, DOI 10.1111/j.1528-1167.2010.02891.x; Rathore C, 2011, EPILEPSIA, V52, P627, DOI 10.1111/j.1528-1167.2010.02890.x; Sander JWAS, 1996, J NEUROL NEUROSUR PS, V61, P433, DOI 10.1136/jnnp.61.5.433; Schramm J, 2012, ACTA NEUROCHIR, V154, P1603, DOI 10.1007/s00701-012-1408-z; Schwartz TH, 2006, EPILEPSIA, V47, P567, DOI 10.1111/j.1528-1167.2006.00469.x; Selwa LM, 2003, EPILEPSIA, V44, P1568, DOI 10.1111/j.0013-9580.2003.15003.x; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; SIEGEL AM, 1990, EPILEPSY RES, V6, P56, DOI 10.1016/0920-1211(90)90009-K; Simasathien T, 2013, ANN NEUROL, V73, P646, DOI 10.1002/ana.23862; Sommer W, 1880, ARCHIV F R PSYCHIATR, V10, P631, DOI [10.1007/BF02224538, DOI 10.1007/BF02224538]; Spencer SS, 2005, NEUROLOGY, V65, P912, DOI 10.1212/01.wnl.0000176055.45774.71; SPERLING MR, 1995, NEUROLOGY, V45, P970, DOI 10.1212/WNL.45.5.970; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Tonini C, 2004, EPILEPSY RES, V62, P75, DOI 10.1016/j.eplepsyres.2004.08.006; Veith G, 1982, ERGEBNISSE MORPHOLOG; Vinken PJ, 1974, HDB CLIN NEUROLOGY; West S, 2016, EPILEPTIC DISORD, V18, P113, DOI 10.1684/epd.2016.0825; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; WIESER HG, 1985, ELECTROEN CLIN NEURO, V61, P314, DOI 10.1016/0013-4694(85)91098-3; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; Wieshmann UC, 2003, J NEUROL NEUROSUR PS, V74, P466, DOI 10.1136/jnnp.74.4.466; Wieshmann UC, 2003, EUR NEUROL, V49, P3, DOI 10.1159/000067019; Yoon HH, 2003, NEUROLOGY, V61, P445, DOI 10.1212/01.WNL.0000081226.51886.5B	67	46	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196274	10.1371/journal.pone.0196274	http://dx.doi.org/10.1371/journal.pone.0196274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768433	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200018
J	Demsiss, W; Seid, A; Fiseha, T				Demsiss, Wondmagegn; Seid, Abdurahaman; Fiseha, Temesgen			Hepatitis B and C: Seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast Ethiopia	PLOS ONE			English	Article							VIRUS-INFECTION; CARE WORKERS; GLOBAL EPIDEMIOLOGY; VACCINATION STATUS; BODY-FLUIDS; PREVENTION; INJURIES; BURDEN; UNIVERSITY; ATTITUDES	Background Health care professionals, especially medical students, are at greater risk of contracting hepatitis B and C virus infections due to their occupational exposure to percutaneous injuries and other body fluids. The aim of this study was to determine the seroprevalence of hepatitis B and C virus infections among medicine and health science students in Northeast Ethiopia and to assess their knowledge and practice towards the occupational risk of viral hepatitis. Methods A cross-sectional study was conducted among a total of 408 medicine and health science students during the period from March to September 2017. A pre-coded self-administered questionnaire was used to collect data on students' socio- demographic characteristics, knowledge and practice of hepatitis B and C infections. Blood samples were collected and screened for hepatitis B surface antigen (HBsAg) and anti-HCV antibodies. SPSS version 20 statistical software was used for data analysis. Results The seroprevalence of HBV infection was 4.2% (95% CI 2.5 to 6.1%) and 0.7% (95% CI 0.0 to 1.7%) for HCV. Older age (AOR = 15.72, 95% CI 1.57-157.3) and exposure to needlestick injury (AOR = 3.43, 95% CI 1.10-10.73) were associated with a higher risk of HBV infection. Majority of the students (80.1%) had an adequate knowledge about hepatitis B and C infection, mode of transmission and preventive measures. Only 50.0% of students had safe practice towards occupational risk of viral hepatitis infection. Almost half (49.8%) of students experienced a needlestick injury; of which, 53.2% reported the incidence, and only 39.4% had screening test result for viral hepatitis. Conclusion A high seroprevalence but poor practice of hepatitis B and C virus infection was found in the study area despite their good knowledge towards occupational risk of viral hepatitis infection.	[Demsiss, Wondmagegn; Seid, Abdurahaman; Fiseha, Temesgen] Wollo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Dessie, Ethiopia	University of Gondar	Demsiss, W (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Dessie, Ethiopia.	wonde1980@gmail.com		Demsiss, Wondmagegn/0000-0003-3263-3673	Wollo University	Wollo University	This work was supported by the Wollo University (WWW.WU.edu.et) provided financial assistance for this study to WD. The confirmation is available at http://wollouniversity.education/colleges/college-of-medicine-and-health-science/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdela Abdnur, 2016, BMC Res Notes, V9, P410, DOI 10.1186/s13104-016-2216-y; Ahmad I, 2010, GOMAL J MED SCI, V8, P102; Al-Ajlan A., 2011, Eastern Mediterranean Health Journal, V17, P759; Alo M.N., 2013, EUR J EXP BIOL, V3, P666; Alqahtani JM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-577; Askarian Mehrdad, 2006, Indian J Med Sci, V60, P227; Atlam S.A., 2016, INT J RES MED SCI, V4, P749; Belyhun Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2090-1; Bhattarai Suraj, 2014, BMC Res Notes, V7, P774, DOI 10.1186/1756-0500-7-774; Ciorlia Luiz A.S., 2005, Braz J Infect Dis, V9, P384, DOI 10.1590/S1413-86702005000500005; Coppola N, 2016, WORLD J HEPATOL, V8, P273, DOI 10.4254/wjh.v8.i5.273; Deuffic-Burban S, 2011, J CLIN VIROL, V52, P4, DOI 10.1016/j.jcv.2011.05.016; de Souza-Borges FRF, 2014, REV INST MED TROP SP, V56, P157, DOI 10.1590/S0036-46652014000200012; Francois G., 2008, Southern African Journal of Epidemiology & Infection, V23, P24; Geberemicheal A, 2013, J ENV OCCUP SCI, V2, P9, DOI DOI 10.5455/JEOS.20130220105759; Ghahramani F., 2006, Hepatitis Monthly, V6, P59; Hussain JS, 2012, J CONT DENT, V2, P1; Ibrahim Nazir, 2014, Hepat Res Treat, V2014, P131920, DOI 10.1155/2014/131920; Khan N, 2010, J PAK MED ASSOC, V60, P450; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lemoine M, 2015, J HEPATOL, V62, P469, DOI 10.1016/j.jhep.2014.10.008; Mesfin YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079642; Nagandla K, 2015, INT ARCH MED, V8, P1; Noubiap JJN, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-148; Odusanya OO, 2007, T ROY SOC TROP MED H, V101, P465, DOI 10.1016/j.trstmh.2006.08.001; Okeke E N, 2008, Niger J Med, V17, P330; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Pido B, 2005, AFR HEALTH SCI, V5, P92; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Saleem T, 2010, J PAK MED ASSOC, V60, P151; Shahbaz T, 2014, PAK J MED HEALTH SCI, V8, P789; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Swati Chouhan, 2008, Hepatitis B Annual, V5, P102; Tarantola A, 2006, AM J INFECT CONTROL, V34, P367, DOI 10.1016/j.ajic.2004.11.011; World Health Organization, 2016, GLOB HLTH SECT STRAT	35	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196539	10.1371/journal.pone.0196539	http://dx.doi.org/10.1371/journal.pone.0196539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763447	Green Submitted, gold, Green Published			2022-12-26	WOS:000432118800013
J	Skeie, E; Koch, AM; Harthug, S; Fosse, U; Sygnestveit, K; Nilsen, RM; Tangvik, RJ				Skeie, Eli; Koch, Anne Mette; Harthug, Stig; Fosse, Unni; Sygnestveit, Kari; Nilsen, Roy Miodini; Tangvik, Randi J.			A positive association between nutritional risk and the incidence of surgical site infections: A hospital-based register study	PLOS ONE			English	Article							PREVALENCE; OUTCOMES; IMPACT; GUIDELINES; MORBIDITY; MORTALITY; SURGERY	Surgical site infections (SSI) are amongst the most common health care-associated infections and have adverse effects for patient health and for hospital resources. Although surgery guidelines recognize poor nutritional status to be a risk factor for SSI, they do not tell how to identify this condition. The screening tool Nutritional Risk Screening 2002 is commonly used at hospitals to identify patients at nutritional risk. We investigated the association between nutritional risk and the incidence of SSI among 1194 surgical patients at Haukeland University Hospital (Bergen, Norway). This current study combines data from two mandatory hospital-based registers: a) the incidence of SSI within 30 days after surgery, and b) the point-prevalence of patients at nutritional risk. Patients with more than 30 days between surgery and nutritional risk screening were excluded. Associations were assessed using logistic regression, and the adjusted odds ratio included age (continuous), gender (male/female), type of surgery (acute/elective) and score from The American Society of Anesthesiologists Physical Status Classification System. There was a significant higher incidence of SSI among patients at nutritional risk (11.8%), as compared to those who were not (7.0%) (p = 0.047). Moreover, the incidence of SSI was positively associated with the prevalence of nutritional risk in both simple (OR 1.76 (95% CI: 1.04, 2.98)) and adjusted (OR 1.81 (95% CI: 1.04, 3.16)) models. Answering "yes" to the screening questions regarding reduced dietary intake and weight loss was significantly associated with the incidence of SSI (respectively OR 2.66 (95% CI: 1.59, 4.45) and OR 2.15 (95% CI: 1.23, 3.76)). In conclusion, we demonstrate SSI to occur more often among patients at nutritional risk as compared to those who are not at nutritional risk. Future studies should investigate interventions to prevent both SSI and nutritional risk among surgical patients.	[Skeie, Eli; Koch, Anne Mette; Harthug, Stig; Fosse, Unni; Sygnestveit, Kari; Nilsen, Roy Miodini; Tangvik, Randi J.] Haukeland Hosp, Dept Res & Dev, Bergen, Norway; [Harthug, Stig] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Nilsen, Roy Miodini] Western Norway Univ Appl Sci, Fac Hlth & Social Sci, Bergen, Norway; [Tangvik, Randi J.] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Western Norway University of Applied Sciences; University of Bergen	Skeie, E (corresponding author), Haukeland Hosp, Dept Res & Dev, Bergen, Norway.	eli.skeie@helse-bergen.no	Harthug, Stig/GPS-8569-2022; Harthug, Stig/AAG-2688-2020	Nilsen, Roy Miodini/0000-0002-6340-4593	Helse Vest [HV1200]	Helse Vest	The work conducted by Eli Skeie was funded by Helse Vest (HV1200, www.helse-vest.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Anesthesiologists. ASo, 2014, AM SOC AN ASA PHYS S; Anthony PS, 2008, NUTR CLIN PRACT, V23, P373, DOI 10.1177/0884533608321130; Badia JM, 2017, J HOSP INFECT, V96, P1, DOI 10.1016/j.jhin.2017.03.004; Care NCfCiH, 2011, NOMESCO CLASS SURG P; Delgado-Rodriguez M, 1999, J HOSP INFECT, V41, P203, DOI 10.1016/S0195-6701(99)90017-8; Demling RH., 2009, EPLASTY, V9, P9; European Centre for Disease Prevention and Control, 2013, POINT PREV SURV HEAL; Folkehelseinstituttet, INF ETT KIR; Gillis C, 2015, ANESTHESIOLOGY, V123, P1455, DOI 10.1097/ALN.0000000000000795; HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Korol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083743; Kwag SJ, 2014, ANN SURG TREAT RES, V86, P206, DOI 10.4174/astr.2014.86.4.206; Lower HL, 2015, AM J INFECT CONTROL, V43, P323, DOI 10.1016/j.ajic.2014.12.013; Lower HL, 2013, AM J INFECT CONTROL, V41, P591, DOI 10.1016/j.ajic.2012.09.005; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Meijers JMM, 2010, NUTRITION, V26, P432, DOI 10.1016/j.nut.2009.06.012; omsorgsdepartementet H- o, 1996, LOV VERN MOT SMITTS; Shinkawa H, 2013, SURG TODAY, V43, P276, DOI 10.1007/s00595-012-0350-2; Tang HW, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006795; Tangvik RJ, 2012, EUR J CLIN NUTR, V66, P388, DOI 10.1038/ejcn.2011.149; Tangvik RJ, 2015, CLIN NUTR, V34, P705, DOI 10.1016/j.clnu.2014.08.001; Tangvik RJ, 2014, CLIN NUTR, V33, P634, DOI 10.1016/j.clnu.2013.09.008; Tarrant RC, 2015, EUR SPINE J, V24, P281, DOI 10.1007/s00586-014-3622-2; Weimann A, 2017, CLIN NUTR, V36, P623, DOI 10.1016/j.clnu.2017.02.013; Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033; WHO, 2009, GUID SAF SURV 2009; Zhou W, 2013, SURG ENDOSC, V27, P2569, DOI 10.1007/s00464-013-2790-1	31	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197344	10.1371/journal.pone.0197344	http://dx.doi.org/10.1371/journal.pone.0197344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763425	Green Submitted, Green Published, gold			2022-12-26	WOS:000432118800040
J	Vijayaraghavan, J; Kumar, V; Krishnan, NP; Kaufhold, RT; Zeng, XM; Lin, J; van den Akker, F				Vijayaraghavan, Jagamya; Kumar, Vijay; Krishnan, Nikhil P.; Kaufhold, Ross T.; Zeng, Ximin; Lin, Jun; van den Akker, Focco			Structural studies and molecular dynamics simulations suggest a processive mechanism of exolytic lytic transglycosylase from Campylobacter jejuni	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; CELL-SEPARATION; DOMAIN LINKERS; PROTEIN; BINDING; BULGECIN; SHAPE; ANTIBIOTICS; NUCLEOTIDE; HYDROLASE	The bacterial soluble lytic transglycosylase (LT) breaks down the peptidoglycan (PG) layer during processes such as cell division. We present here crystal structures of the soluble LT Cj0843 from Campylobacter jejuni with and without bulgecin A inhibitor in the active site. Cj0843 has a doughnut shape similar but not identical to that of E. coli SLT70. The C-terminal catalytic domain is preceded by an L-domain, a large helical U-domain, a flexible linker, and a small N-terminal NU-domain. The flexible linker allows the NU-domain to reach over and complete the circular shape, using residues conserved in the Epsilonproteobacteria LT family. The inner surface of the Cj0843 doughnut is mostly positively charged including a pocket that has 8 Arg/Lys residues. Molecular dynamics simulations with PG strands revealed a potential functional role for this pocket in anchoring the negatively charged terminal tetrapeptide of the PG during several steps in the reaction including homing and aligning the PG strand for exolytic cleavage, and subsequent ratcheting of the PG strand to enhance processivity in degrading PG strands.	[Vijayaraghavan, Jagamya; Kumar, Vijay; Krishnan, Nikhil P.; Kaufhold, Ross T.; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Zeng, Ximin; Lin, Jun] Univ Tennessee, Inst Agr, Knoxville, TN 37901 USA	Case Western Reserve University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	van den Akker, F (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu	Kumar, Vijay/ABA-4191-2021	Kaufhold, Ross/0000-0002-2589-2709; Krishnan, Nikhil/0000-0002-3755-6120; Kumar, Vijay/0000-0002-2741-8891	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the SSRL, SLAG National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. This work was supported in part by an allocation of computing time from the Ohio Supercomputer Cluster (OSC) and using the CWRU high-performance computer cluster.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alemka A, 2013, INFECT IMMUN, V81, P1674, DOI 10.1128/IAI.01370-12; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bae J, 2014, ANTIMICROB AGENTS CH, V58, P7573, DOI 10.1128/AAC.04066-14; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; Bonis M, 2012, MICROB DRUG RESIST, V18, P230, DOI 10.1089/mdr.2011.0231; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Burkinshaw BJ, 2015, J BIOL CHEM, V290, P10406, DOI 10.1074/jbc.M115.639013; Cerveny L, 2013, INFECT IMMUN, V81, P629, DOI 10.1128/IAI.01035-12; Chaput C, 2007, J BACTERIOL, V189, P422, DOI 10.1128/JB.01270-06; Chatterjee C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019208; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; Cho H, 2014, CELL, V159, P1300, DOI 10.1016/j.cell.2014.11.017; Cloud KA, 2004, J BACTERIOL, V186, P7811, DOI 10.1128/JB.186.22.7811-7814.2004; Dik DA, 2017, CRIT REV BIOCHEM MOL, V52, P503, DOI 10.1080/10409238.2017.1337705; Ebina T, 2009, BIOPOLYMERS, V92, P1, DOI 10.1002/bip.21105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fibriansah G, 2012, BIOCHEMISTRY-US, V51, P9164, DOI 10.1021/bi300900t; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Gumbart JC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003475; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Herlihey FA, 2014, J BIOL CHEM, V289, P31029, DOI 10.1074/jbc.M114.603944; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jorgenson MA, 2014, MOL MICROBIOL, V93, P113, DOI 10.1111/mmi.12643; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelly J, 2006, J BACTERIOL, V188, P2427, DOI 10.1128/JB.188.7.2427-2434.2006; Korsak D, 2005, ANTIMICROB AGENTS CH, V49, P1404, DOI 10.1128/AAC.49.4.1404-1409.2005; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Kuhle B, 2015, NUCLEIC ACIDS RES, V43, P9994, DOI 10.1093/nar/gkv930; Lee M, 2016, ACS CHEM BIOL, V11, P2936, DOI 10.1021/acschembio.6b00756; Lee M, 2013, J AM CHEM SOC, V135, P3311, DOI 10.1021/ja309036q; Lipski A, 2015, GLYCOBIOLOGY, V25, P319, DOI 10.1093/glycob/cwu113; Lommatzsch J, 1997, J BACTERIOL, V179, P5465, DOI 10.1128/jb.179.17.5465-5470.1997; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAKAO M, 1986, ANTIMICROB AGENTS CH, V30, P414, DOI 10.1128/AAC.30.3.414; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reid CW, 2004, FEBS LETT, V574, P73, DOI 10.1016/j.febslet.2004.08.006; ROMEIS T, 1993, FEMS MICROBIOL LETT, V111, P141; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Tu QV, 2008, J MED MICROBIOL, V57, P795, DOI 10.1099/jmm.0.47752-0; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; van Asselt EJ, 2000, BIOCHEMISTRY-US, V39, P1924, DOI 10.1021/bi992161p; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Viollier PH, 2003, MOL MICROBIOL, V49, P331, DOI 10.1046/j.1365-2958.2003.03576.x; Vivoli M, 2014, JOVE-J VIS EXP, DOI 10.3791/51809; Williams AH, 2017, ANTIBIOTICS-BASEL, V6, DOI 10.3390/antibiotics6010008; Yu YC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-52; Zeng XM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01292; Zeng XM, 2014, J ANTIMICROB CHEMOTH, V69, P1215, DOI 10.1093/jac/dkt515	68	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197136	10.1371/journal.pone.0197136	http://dx.doi.org/10.1371/journal.pone.0197136			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758058	gold, Green Published, Green Submitted			2022-12-26	WOS:000432082900031
J	Wang, XP; Guo, H; Li, Y; Wang, HX; He, J; Mu, LT; Hu, YH; Ma, JL; Yan, YZ; Li, SG; Ding, YS; Zhang, M; Niu, Q; Liu, JM; Zhang, JY; Ma, RL; Guo, SX				Wang, Xinping; Guo, Heng; Li, Yu; Wang, Haixia; He, Jia; Mu, Lati; Hu, Yunhua; Ma, Jiaolong; Yan, Yizhong; Li, Shugang; Ding, Yusong; Zhang, Mei; Niu, Qiang; Liu, Jiaming; Zhang, Jingyu; Ma, Rulin; Guo, Shuxia			Interactions among genes involved in reverse cholesterol transport and in the response to environmental factors in dyslipidemia in subjects from the Xinjiang rural area	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; COMBINATORIAL APPROACH; COMPLEX TRAIT; HEART-DISEASE; RISK-FACTOR; ASSOCIATION; POLYMORPHISMS; POPULATIONS	Gene-gene and gene-environment interactions may be partially responsible for dyslipidemia, but studies investigating interactions in the reverse cholesterol transport system (RCT) are limited. We explored these interactions in a Xinjiang rural population by genotyping five SNPs using SNPShot technique in APOA1, ABCA1, and LCAT, which are involved in the RCT (690 patients, 743 controls). We conducted unconditional logistical regression analysis to evaluate associations and generalized multifactor dimensionality reduction to evaluate interactions. Results revealed significant differences in rs670 and rs2292318 allele frequencies between cases and controls (P<0.025). rs670 G allele carriers were more likely to develop dyslipidemia than A allele carriers (OR = 1.315, OR 95% CI: 1.067-2.620; P= 0.010). rs2292318 T allele carriers were more likely to develop dyslipidemia than A allele carriers (OR = 1.264, OR 95% CI: 1.037-1.541; P= 0.020). Gene-gene interaction model APOA1rs670-ABCA1rs1800976-ABCA1rs4149313-LCATrs1109166 (P = 0.0107) and gene-environment interaction model ABCA1rs1800976-ABCA1rs4149313-LCATrs1109166-obesity-smoking were optimal dyslipidemia predictors (P= 0.0107) and can interact (4). Differences in A-C-A-C-A and G-G-G-T-G haplotype frequencies were observed (P<0.05). Serum lipid profiles could be partly attributed to RCT gene polymorphisms. Thus, dyslipidemia is influenced by APOA1, ABCA1, LCAT, environmental factors, and their interactions.	[Wang, Xinping; Guo, Heng; Li, Yu; Wang, Haixia; Mu, Lati; Hu, Yunhua; Ma, Jiaolong; Yan, Yizhong; Li, Shugang; Ding, Yusong; Zhang, Mei; Liu, Jiaming; Zhang, Jingyu; Ma, Rulin; Guo, Shuxia] Shihezi Univ, Sch Med, Dept Publ Hlth, Shihezi, Peoples R China; [He, Jia; Niu, Qiang] Shihezi Univ, Sch Med, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Peoples R China	Shihezi University; Shihezi University	Ma, RL; Guo, SX (corresponding author), Shihezi Univ, Sch Med, Dept Publ Hlth, Shihezi, Peoples R China.	marulin@126.com; pge888@sina.com	Wang, Xin/AAN-8435-2021; Zhang, Jing/GWZ-7332-2022; Wang, Xin/GYU-1129-2022	Wang, Xin/0000-0002-4457-7376; 	National Natural Science Foundation of China [81560551]; National Natural Science Foundation of Shihezi University [0305KX0161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shihezi University	This research was supported by grants from the National Natural Science Foundation of China (No. 81560551) and the National Natural Science Foundation of Shihezi University (0305KX0161).	Al Rashdan I, 2010, ANGIOLOGY, V61, P42, DOI 10.1177/0003319709333226; AlNuaim AR, 1997, DIABETES RES CLIN PR, V36, P181, DOI 10.1016/S0168-8227(97)00041-7; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; Bauerfeind A, 2006, HUM HERED, V61, P123, DOI 10.1159/000093773; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; D'Agostino RB, 2000, AM HEART J, V139, P272, DOI 10.1016/S0002-8703(00)90236-9; Davignon J, 1996, ATHEROSCLEROSIS, V124, pS57, DOI 10.1016/0021-9150(96)05858-3; Egana-Gorrono L, 2013, AIDS, V27, P529, DOI 10.1097/QAD.0b013e32835d0da1; Ergen A, 2008, IN VIVO, V22, P187; FIELDING CJ, 1995, J LIPID RES, V36, P211; Frommlet F, 2012, FINDING MISSING HERI; Gibbons GH, 2004, CIRCULATION, V109, P47, DOI 10.1161/01.CIR.0000133440.86427.26; Guo SX, 2015, INT J ENV RES PUB HE, V12, P15979, DOI 10.3390/ijerph121215036; Hata Y, 2000, J Atheroscler Thromb, V7, P177; Homma Y, 1990, MED TREATMENT HYPERL, V18, P1105; Huang P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/231515; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jackson RT, 2002, EUR J CLIN NUTR, V56, P709, DOI 10.1038/sj.ejcn.1601379; JEENAH M, 1990, MOL BIOL MED, V7, P233; Jimenez S, 2013, GENE ENV INTERACTION; Kamboh MI, 1999, GENET EPIDEMIOL, V16, P205, DOI 10.1002/(SICI)1098-2272(1999)16:2<205::AID-GEPI7>3.0.CO;2-P; Klos KLE, 2006, ARTERIOSCL THROM VAS, V26, P1828, DOI 10.1161/01.ATV.0000231523.19199.45; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Lander E, 1994, NAT GENET, V12, P356; Lee M, 2001, ATHEROSCLEROSIS, V159, P381, DOI 10.1016/S0021-9150(01)00513-5; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; MILLER GJ, 1975, LANCET, V1, P16; Organization WH Organization WH, 1999, WHO TECH REP SER, V894, pi; Pare G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286; Rao CS, 2013, J CLIN DIAGN RES, V7, P31, DOI 10.7860/JCDR/2012/5086.2663; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schmitz G, 2000, CURR OPIN LIPIDOL, V11, P493, DOI 10.1097/00041433-200010000-00007; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shioji K, 2004, J HUM GENET, V49, P141, DOI 10.1007/s10038-004-0124-9; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; Toshiaki O, 2016, J AM HEART ASS CARDI, V5; Vardarli AT, 2017, ANATOL J CARDIOL, V17, P313, DOI 10.14744/AnatolJCardiol.2016.7142; WHO Federation WH Organization WS, 2012, GLOBAL ATLAS CARDIOV; Xu HM, 2016, CURR GENOMICS, V17, P396, DOI 10.2174/1389202917666160513102612; YAO MH, 2016, INT J ENV RES PUB HE, V13; Yin RX, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-123; Yin RX, 2008, J AM DIET ASSOC, V108, P970, DOI 10.1016/j.jada.2008.03.010; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5; Zhou JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042881; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	49	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196042	10.1371/journal.pone.0196042	http://dx.doi.org/10.1371/journal.pone.0196042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758034	gold, Green Published, Green Submitted			2022-12-26	WOS:000432082900005
J	Dutta, A; Pattanaik, S; Choudhury, R; Nanda, P; Sahu, S; Panigrahi, R; Padhi, BK; Sahoo, KC; Mishra, PR; Panigrahi, P; Lekharu, D; Stevens, RH				Dutta, Ambarish; Pattanaik, Sarthak; Choudhury, Rajendra; Nanda, Pritish; Sahu, Suvanand; Panigrahi, Rajendra; Padhi, Bijaya K.; Sahoo, Krushna Chandra; Mishra, P. R.; Panigrahi, Pinaki; Lekharu, Daisy; Stevens, Robert H.			Impact of involvement of non-formal health providers on TB case notification among migrant slum-dwelling populations in Odisha, India	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; XPERT(R) MTB/RIF; IN-DIFFERENCES; URBAN SLUMS; RISK GROUPS; ACCESS	Background Migrant labourers living in the slums of urban and industrial patches across India make up a key sub-population so far controlling Tuberculosis (TB) in the country is concerned. This is because many TB patients from these communities-remain under reached by the Revised National Tuberculosis Control Programme (RNTCP) of India. This marginalized community usually seeks early-stage healthcare from "friendly neighbourhood" non-formal health providers (NFHPs). Because, RNTCP has limited capacity to involve the NFHPs, an implementation research project was conceived, whereby an external partner would engage with the NFHPs to enable them to identify early TB symptomatics from this key sub-population who would be then tested using Xpert MTB/RIF technology. Diagnosed TB cases among them would be referred promptly to RNTCP for treatment. This paper aimed to describe the project and its impact. Methods Adopting a quasi-experimental before-after design, four RNTCP units from two major urban-industrial areas of Odisha were selected for intervention, which spanned five quarters and covered 151,400 people, of which 30% were slum-dwelling migrants. Two similar units comprised the control population. The hypothesis was, reaching the under reached in the intervention area through NFHPs would increase TB notification from these traditionally under-notifying units. RNTCP notification data during intervention was compared with pre-intervention era, adjusted for contemporaneous changes in control population Results The project detected 488 Xpert(+) TB cases, of whom 466 were administered RNTCP treatment. This translated into notification of additional 198 new bacteriologically positive cases to RNTCP, a 30% notification surge, after adjustment for 2% decline in control. This meant an average quarterly increase in notification of 41.20(20.08, 62.31; p<0.001) cases. The increase was immediate, evident from the rise in level in the time series analysis by 50.42 (10.28, 90.55; p = 0.02) cases. Conclusion Engagement with NFHPs contributed to an increase in TB notification to RNTCP from key under reached, slum-dwelling migrant populations.	[Dutta, Ambarish; Pattanaik, Sarthak; Choudhury, Rajendra; Nanda, Pritish; Padhi, Bijaya K.; Sahoo, Krushna Chandra; Mishra, P. R.] Asian Inst Publ Hlth, Bhubaneswar, India; [Sahu, Suvanand] Stop TB Partnership, Geneva, Switzerland; [Panigrahi, Rajendra] WHO RNTCP Tech Assistance Network, Bhubaneswar, Odisha, India; [Panigrahi, Pinaki] Univ Nebraska Med Ctr, Omaha, NE USA; [Dutta, Ambarish] Publ Hlth Fdn India Bhubaneswar, Indian Inst Publ Hlth, Bhubaneswar, India	University of Nebraska System; University of Nebraska Medical Center	Dutta, A (corresponding author), Asian Inst Publ Hlth, Bhubaneswar, India.; Dutta, A (corresponding author), Publ Hlth Fdn India Bhubaneswar, Indian Inst Publ Hlth, Bhubaneswar, India.	ambarish.dutta@iiphb.org	Sahoo, Krushna Chandra/AAF-2813-2020; Padhi, Bijaya Kumar/AAW-2384-2021; Padhi, Bijaya K/E-7102-2010	Padhi, Bijaya Kumar/0000-0002-2828-2375; Padhi, Bijaya K/0000-0002-2828-2375; Dutta, Ambarish/0000-0002-4019-7472	TB REACH unit of STOP TB Partnership	TB REACH unit of STOP TB Partnership	Although the project was funded by TB REACH unit of STOP TB Partnership, which is hosted by UNOPS, they had no say in the analysis of the data and preparation of the manuscript. The project ended with account reconciliation on 31st Mar'2016.	Adams AM, 2015, HEALTH POLICY PLANN, V30, pi32, DOI 10.1093/heapol/czu094; [Anonymous], 2015, KEY POPULATIONS BRIE; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Creswell J, 2015, INT J TUBERC LUNG D, V19, P545, DOI 10.5588/ijtld.14.0775; Crown WH, 2014, APPL HEALTH ECON HEA, V12, P7, DOI 10.1007/s40258-013-0075-4; Das J, 2015, LANCET INFECT DIS, V15, P1305, DOI 10.1016/S1473-3099(15)00077-8; Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766; Fatima R, 2014, INT J TUBERC LUNG D, V18, P1099, DOI 10.5588/ijtld.14.0001; Friedrich SO, 2013, LANCET RESP MED, V1, P462, DOI 10.1016/S2213-2600(13)70119-X; Hanrahan CF, 2015, INT J TUBERC LUNG D, V19, P811, DOI 10.5588/ijtld.15.0013; Islam QS, 2014, INT HEALTH, V6, P225, DOI 10.1093/inthealth/ihu025; Kaboru Berthollet Bwira, 2011, World Health Popul, V12, P5; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Khanal S, 2016, PUBLIC HEALTH ACTION, V6, P136, DOI 10.5588/pha.16.0015; Marimuthu Palaniappan, 2016, Indian J Tuberc, V63, P167, DOI 10.1016/j.ijtb.2016.08.007; McNerney R, 2015, CURR OPIN PULM MED, V21, P304, DOI 10.1097/MCP.0000000000000161; Ministry of Health & Family Welfare Government of India, 2016, REV NAT TB CONTR PRO; Mullan Z, 2014, LANCET GLOB HEALTH, V2, pE182, DOI 10.1016/S2214-109X(14)70214-1; Murrison LB, 2016, INT J TUBERC LUNG D, V20, P544, DOI 10.5588/ijtld.15.0423; Onyeneho NG, 2010, J HEALTH POPUL NUTR, V28, P567, DOI 10.3329/jhpn.v28i6.6605; Oppong JR, 2015, AFR GEOGR REV, V34, P182, DOI 10.1080/19376812.2014.910815; R Core Team, 2016, R FDN STAT COMP; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Stop TB Partnership, 2015, STOP TB PARTNERSHIP; Sudhinaraset M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0585-7; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; The Global Fund, 2014, KEY POP ACT PLAN 201; UN-Habitat, 2013, STAT WORLD CIT 2012; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Wells WA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001842; WHO, 2015, GLOB TUB REP 2016; World Health Organization, 2014, TB REACH 3 MILL; Zhou HX, 2016, APPL HEALTH ECON HEA, V14, P419, DOI 10.1007/s40258-016-0249-y	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196067	10.1371/journal.pone.0196067	http://dx.doi.org/10.1371/journal.pone.0196067			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791449	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000011
J	Meroni, E; Stakenborg, N; Gomez-Pinilla, PJ; De Hertogh, G; Goverse, G; Matteoli, G; Verheijden, S; Boeckxstaens, GE				Meroni, Elisa; Stakenborg, Nathalie; Gomez-Pinilla, Pedro J.; De Hertogh, Gert; Goverse, Gera; Matteoli, Gianluca; Verheijden, Simon; Boeckxstaens, Guy E.			Functional characterization of oxazolone-induced colitis and survival improvement by vagus nerve stimulation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MURINE MODEL; ULCERATIVE-COLITIS; VAGAL INNERVATION; CROHNS-DISEASE; CELLS; ACTIVATION; PATHWAY; SEPSIS; HMGB1	Background Oxazolone-induced colitis has been frequently used in literature as a model of IBD, but insights into the underlying immune response and pathological features are surprisingly still very limited. Vagus nerve stimulation (VNS) has proven to be effective in innate and Th1/Th17 predominant inflammatory models, including pre-clinical models of colitis, however to what extent VNS is also effective in ameliorating Th2-driven colitis remains to be studied. In the present study, we therefore further characterized the immune response in oxazolone-induced colitis and investigated the potential therapeutic effect of VNS. Methods Colitis was induced in Balb/c mice by cutaneous sensitization with 3% oxazolone followed by intracolonic administration of 1% oxazolone 7 days later. To evaluate the effect of VNS on the development of Th2-driven colitis, VNS and sham-treated mice were challenged with 1% oxazolone. Results Intracolonic oxazolone administration resulted in a severe destruction of the colonic mucosa and a rapid drop in body temperature leading to a 65% mortality rate at day 5. Severe infiltration of neutrophils and monocytes was detected 6h after oxazolone administration which was associated with a Th2-type inflammatory response. VNS significantly improved survival rate which correlated with decreased levels of HMGB1 and reduced colonic (iI6 and cxcii mRNA) and serum cytokine levels (IL-6, TNF alpha and CXCL1) compared to sham treated mice. Conclusions Oxazolone-induced colitis rather represents a model of sepsis and, at best, may resemble a severe type of ulcerative colitis, associated with early and severe mucosal damage and a high mortality rate. VNS reduces colonic inflammation and improves survival in this model, supporting the anti-inflammatory properties of VNS, even in an aggressive model as oxazolone-induced colitis.	[Meroni, Elisa; Stakenborg, Nathalie; Gomez-Pinilla, Pedro J.; Goverse, Gera; Matteoli, Gianluca; Verheijden, Simon; Boeckxstaens, Guy E.] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium; [De Hertogh, Gert] Katholieke Univ Leuven, Dept Imaging & Pathol, Translat Cell & Tissue Res, Leuven, Belgium	KU Leuven; KU Leuven	Boeckxstaens, GE (corresponding author), Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium.	guy.boeckxstaens@kuleuven.be	Boeckxstaens, Guy/AAP-2502-2020	Matteoli, Gianluca/0000-0002-2902-4976	European Research Council (ERC) Advanced Grant [340101]; Flanders Fund for Innovation by Science and Technology (IWT-TBM) [110699]; Research Foundation-Flanders (FWO): Odysseus program [G.0905.07]; FWO grant [G.0566.12N]; FWO [G.0D83.17N]	European Research Council (ERC) Advanced Grant(European Research Council (ERC)); Flanders Fund for Innovation by Science and Technology (IWT-TBM); Research Foundation-Flanders (FWO): Odysseus program; FWO grant(FWO); FWO(FWO)	This work was supported by the European Research Council (ERC) Advanced Grant (ERC-2013-Adg: 340101 Cholstim) to GEB. GEB is also supported by Flanders Fund for Innovation by Science and Technology (IWT-TBM; 110699), and Research Foundation-Flanders (FWO): Odysseus program (G.0905.07) and FWO grant (G.0566.12N). PJGP, GG and SV are supported by a postdoctoral research fellowship of FWO. GM is supported by a FWO grant (G.0D83.17N).	[Anonymous], 2017, J INTERN MED, DOI DOI 10.1111/joim.12611; Beekwilder JP, 2010, J CLIN NEUROPHYSIOL, V27, P130, DOI 10.1097/WNP.0b013e3181d64d8a; BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; BERTHOUD HR, 1990, J COMP NEUROL, V301, P65, DOI 10.1002/cne.903010107; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Danese S, 2009, GASTROEN CLIN BIOL, V33, pS217, DOI 10.1016/S0399-8320(09)73157-4; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Di Giovangiulio M, 2016, MOL MED, V22, P464, DOI 10.2119/molmed.2016.00062; Farro G, 2017, GUT, V66, P2098, DOI 10.1136/gutjnl-2016-313144; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; Ghia JE, 2006, GASTROENTEROLOGY, V131, P1122, DOI 10.1053/j.gastro.2006.08.016; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG711, DOI 10.1152/ajpgi.00240.2007; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; Jin HF, 2017, AM J PHYSIOL-GASTR L, V313, pG192, DOI 10.1152/ajpgi.00254.2016; Kennedy RJ, 2000, BRIT J SURG, V87, P1346, DOI 10.1046/j.1365-2168.2000.01615.x; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P6102, DOI 10.3748/wjg.v12.i38.6102; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Nolte T, 2013, CLIN EXP IMMUNOL, V172, P349, DOI 10.1111/cei.12057; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Peters EG, 2015, NEUROGASTROENT MOTIL, V27, P743, DOI 10.1111/nmo.12579; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Stakenborg N, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13075; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Sun P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069424; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wedlake L, 2014, INFLAMM BOWEL DIS, V20, P576, DOI 10.1097/01.MIB.0000437984.92565.31; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zhu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100167	43	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197487	10.1371/journal.pone.0197487	http://dx.doi.org/10.1371/journal.pone.0197487			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791477	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000040
J	Sasaki, D; Matsuura, K; Seta, H; Haraguchi, Y; Okano, T; Shimizu, T				Sasaki, Daisuke; Matsuura, Katsuhisa; Seta, Hiroyoshi; Haraguchi, Yuji; Okano, Teruo; Shimizu, Tatsuya			Contractile force measurement of human induced pluripotent stem cell-derived cardiac cell sheet-tissue	PLOS ONE			English	Article							FUNCTIONAL 3-DIMENSIONAL TISSUES; ENGINEERED HUMAN MYOCARDIUM; IN-VITRO; CARDIOMYOCYTE SHEETS; HUMAN ATRIAL; MATURATION; HEART; FABRICATION; GRAFTS; LONG	We have developed our original tissue engineering technology "cell sheet engineering" utilizing temperature-responsive culture dishes. The cells are confluently grown on a temperature-responsive culture dish and can be harvested as a cell sheet by lowering temperature without enzymatic digestion. Cell sheets are high-cell-density tissues similar to actual living tissues, maintaining their structure and function. Based on this "cell sheet engineering", we are trying to create functional cardiac tissues from human induced pluripotent stem cells, for regenerative therapy and in vitro drug testing. Toward this purpose, it is necessary to evaluate the contractility of engineered cardiac cell sheets. Therefore, in the present study, we developed a contractile force measurement system and evaluated the contractility of human iPSC-derived cardiac cell sheet-tissues. By attaching the cardiac cell sheets on fibrin gel sheets, we created dynamically beating cardiac cell sheet-tissues. They were mounted to the force measurement system and the contractile force was measured stably and clearly. The absolute values of contractile force were around 1 mN, and the mean force value per cross-sectional area was 3.3 mN/mm(2). These values are equivalent to or larger than many previously reported values, indicating the functionality of our engineered cardiac cell sheets. We also confirmed that both the contractile force and beating rate were significantly increased by the administration of adrenaline, which are the physiologically relevant responses for cardiac tissues. In conclusion, the force measurement system developed in the present study is valuable for the evaluation of engineered cardiac cell sheet-tissues, and for in vitro drug testing as well.	[Sasaki, Daisuke; Matsuura, Katsuhisa; Haraguchi, Yuji; Okano, Teruo; Shimizu, Tatsuya] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Seta, Hiroyoshi] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University	Shimizu, T (corresponding author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan.	shimizu.tatsuya@twmu.ac.jp	Tatsuya, Shimizu/AAN-5675-2021	Okano, Teruo/0000-0002-4470-9842	Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology "Innovation Center for Fusion of Advanced Technologies to Realize Regenerative Medicines" from the Ministry of Educati; Japan Agency for Medical Research and Development (AMED) [JP17im0302706]	Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology "Innovation Center for Fusion of Advanced Technologies to Realize Regenerative Medicines" from the Ministry of Educati; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Formation of Innovation Center for Fusion of Advanced Technologies in the Special Coordination Funds for Promoting Science and Technology "Innovation Center for Fusion of Advanced Technologies to Realize Regenerative Medicines" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (http://www.mext.go. jp/en/). This work was also supported by Japan Agency for Medical Research and Development (AMED, https://www.amed.go/ip/en/index.html) under Grant Number JP17im0302706.	Black LD, 2009, TISSUE ENG PT A, V15, P3099, DOI [10.1089/ten.tea.2008.0502, 10.1089/ten.TEA.2008.0502]; Burridge PW, 2014, AM J TRANSL RES, V6, P724; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Egami M, 2014, ARCH PHARM RES, V37, P96, DOI 10.1007/s12272-013-0299-8; Feinberg AW, 2012, BIOMATERIALS, V33, P5732, DOI 10.1016/j.biomaterials.2012.04.043; Foldes G, 2011, J MOL CELL CARDIOL, V50, P367, DOI 10.1016/j.yjmcc.2010.10.029; Guo L, 2011, TOXICOL SCI, V123, P281, DOI 10.1093/toxsci/kfr158; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Hasegawa A, 2017, J BIOMED MATER RES B, V105, P481, DOI 10.1002/jbm.b.33566; HASENFUSS G, 1991, CIRC RES, V68, P836, DOI 10.1161/01.RES.68.3.836; Himel HD, 2012, HEART RHYTHM, V9, P2077, DOI 10.1016/j.hrthm.2012.08.035; Isenberg BC, 2008, BIOMATERIALS, V29, P2565, DOI 10.1016/j.biomaterials.2008.02.023; Iwata T, 2015, J TISSUE ENG REGEN M, V9, P343, DOI 10.1002/term.1785; Jackman CP, 2016, BIOMATERIALS, V111, P66, DOI 10.1016/j.biomaterials.2016.09.024; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kawatou M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01125-y; Kikuchi T, 2014, BIOMATERIALS, V35, P2428, DOI 10.1016/j.biomaterials.2013.12.014; Kim C, 2010, STEM CELLS DEV, V19, P783, DOI 10.1089/scd.2009.0349; Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107; Komae H, 2017, J TISSUE ENG REGEN M, V11, P926, DOI 10.1002/term.1995; Kubo H, 2007, BIOMATERIALS, V28, P3508, DOI 10.1016/j.biomaterials.2007.04.016; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lind JU, 2017, NAT MATER, V16, P303, DOI [10.1038/NMAT4782, 10.1038/nmat4782]; Lu TY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3307; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Masumoto H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29933; Matsuura K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21747; Matsuura K, 2012, BIOCHEM BIOPH RES CO, V425, P321, DOI 10.1016/j.bbrc.2012.07.089; MORANO I, 1991, CIRC RES, V68, P614, DOI 10.1161/01.RES.68.2.614; Moss RL, 2002, CIRC RES, V90, P11, DOI 10.1161/res.90.1.11; MULIERI LA, 1992, CIRCULATION, V85, P1743, DOI 10.1161/01.CIR.85.5.1743; Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Owaki T, 2014, BIOTECHNOL J, V9, P904, DOI 10.1002/biot.201300432; Parrag IC, 2012, BIOTECHNOL BIOENG, V109, P813, DOI 10.1002/bit.23353; Piroddi N, 2007, PFLUG ARCH EUR J PHY, V454, P63, DOI 10.1007/s00424-006-0181-3; Ruan JL, 2016, CIRCULATION, V134, P1557, DOI 10.1161/CIRCULATIONAHA.114.014998; Ruf T, 1998, CARDIOVASC RES, V40, P580, DOI 10.1016/S0008-6363(98)00164-3; Sakaguchi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01316; Sasagawa T, 2010, BIOMATERIALS, V31, P1646, DOI 10.1016/j.biomaterials.2009.11.036; Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Scott CW, 2014, TOXICOL SCI, V142, P331, DOI 10.1093/toxsci/kfu186; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; Sekine H, 2006, CIRCULATION, V114, pI87, DOI 10.1161/CIRCULATIONAHA.105.000273; Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406; Sekiya S, 2006, BIOCHEM BIOPH RES CO, V341, P573, DOI 10.1016/j.bbrc.2005.12.217; Seta H, 2017, SCI REP-UK, V7, DOI 10.1038/srep45499; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje; Takahashi H, 2011, BIOMATERIALS, V32, P8830, DOI 10.1016/j.biomaterials.2011.08.006; Takeda M, 2017, TISSUE ENG PART C-ME, DOI [10.1089/ten.TEC.2017.0247, DOI 10.1089/TEN9TEC.2017.0247]; Tiburcy M, 2017, CIRCULATION, V135, P1832, DOI 10.1161/CIRCULATIONAHA.116.024145; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Turnbull IC, 2014, FASEB J, V28, P644, DOI 10.1096/fj.13-228007; van der Velden J, 1998, CARDIOVASC RES, V38, P414, DOI 10.1016/S0008-6363(98)00019-4; Wanjare M, 2017, BIOMATER SCI-UK, V5, P1567, DOI 10.1039/c7bm00323d; Wiegerinck RF, 2009, PEDIATR RES, V65, P414, DOI 10.1203/PDR.0b013e318199093c; Williams C, 2009, ADV MATER, V21, P2161, DOI 10.1002/adma.200801027; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yang XL, 2014, J MOL CELL CARDIOL, V72, P296, DOI 10.1016/j.yjmcc.2014.04.005; Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026	68	55	56	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0198026	10.1371/journal.pone.0198026	http://dx.doi.org/10.1371/journal.pone.0198026			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791489	Green Submitted, Green Published, gold			2022-12-26	WOS:000433077000075
J	Vengust, M; Knapic, T; Weese, JS				Vengust, Modest; Knapic, Tea; Weese, J. Scott			The fecal bacterial microbiota of bats; Slovenia	PLOS ONE			English	Article							COMMUNITIES; DIVERSITY; HEALTHY; CAVE; IDENTIFICATION; VARIABILITY; RESERVOIRS; DYSBIOSIS; STORAGE	Methods Fecal samples were collected from 92 bats in Slovenia, consisting of 12 different species, and the bacterial microbiota was assessed via next generation sequencing of the 16S rRNA gene V4 region. Results Sequences were assigned to 28 different phyla, but only Proteobacteria, Firmicutes, Bacteroidetes and Actinobacteria accounted for >= 1% of sequences. One phylum (Proteobacteria), one class (Gammaproteobacteria), three orders (Pseudomonadales, Lactobacillales, Bacillales), four families (Enterobacteriaceae, Pseudomonadaceae, Staphylococcaceae, Carnobacteriaceae), and five genera (Pseudomonas, Staphylococcus, Carnobacterium, an unclassified Enterobacteriaceae, Acinetobacter) accounted for 50% of sequences. There were no significant differences in the relative abundances of any phyla between bat species, but various differences were noted at lower taxonomic levels, such as Enterobacteriaceae (P= 0.007, most abundant in M. blythii), Pseudomonadaceae (P= 0.007, most abundant in Rhinolophus hipposideros) and Chlamydiaceae (P= 0.04, most abundant in Myotis myotis). There were significant differences in richness between species in both adults and juveniles/subadults, but there was no impact of sex on any alpha diversity index. When only adults are considered, there were significant differences in community membership between M. blythii and M. emarginatus (P = 0.011), and M. blythii and R. hipposideros (P = 0.004). There were also significant differences in community structure between M. blythii and M. emarginatus (P = 0.025), and M. blythii and R. hipposideros (P = 0.026). When adults of the four main species were compared, 14 OTUs were identified as differentially abundant using LEfSe. Only one difference was identified when comparing R. hipposideros adults and juvenile/subadults, with Klebsiella over-represented in the younger bats. Conclusions Bats have a complex and diverse microbiota with a high relative abundance of Proteobacteria. The relevance of this difference is unclear and requires further study. Differences in the microbiota were observed between bat species, perhaps reflecting different diets and environmental exposures.	[Vengust, Modest] Univ Ljubljana, Vet Fac, Ljubljana, Slovenia; [Knapic, Tea] Slovenian Museum Nat Hist, Ljubljana, Slovenia; [Weese, J. Scott] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada	University of Ljubljana; University of Guelph	Weese, JS (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada.	jsweese@uoguelph.ca			Slovenian National Research Agency [P4-0053]; Ministry of the Environment and Spatial Planning [JN4310/2014]; Canadian Natural Sciences and Engineering Research Council	Slovenian National Research Agency(Slovenian Research Agency - Slovenia); Ministry of the Environment and Spatial Planning; Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was financed with the support of Slovenian National Research Agency (Grant no. P4-0053) and Ministry of the Environment and Spatial Planning (JN4310/2014). Additional support was provided by the Canadian Natural Sciences and Engineering Research Council (Discovery Grant)(http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financed with the support of Slovenian National Research Agency (Grant no. P4-0053) and Ministry of the Environment and Spatial Planning (JN4310/2014). Additional support was provided by the Canadian Natural Sciences and Engineering Research Council. The authors thank Primoz Presetnik, Monika Podgorelec and Jasmina Kotnik for their assistance with sample collection.	Nunez-Diaz JA, 2017, INT MICROBIOL, V20, P31, DOI 10.2436/20.1501.01.283; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Banskar S, 2016, MICROBIOL RES, V182, P99, DOI 10.1016/j.micres.2015.10.006; Barton HA, 2007, INT J SPELEOL, V36, P93, DOI 10.5038/1827-806X.36.2.5; Broekaert K, 2013, FOOD MICROBIOL, V36, P123, DOI 10.1016/j.fm.2013.04.009; Brook CE, 2015, TRENDS MICROBIOL, V23, P172, DOI 10.1016/j.tim.2014.12.004; Carrillo-Araujo M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00447; Cauchie E, 2017, INT J FOOD MICROBIOL, V247, P70, DOI 10.1016/j.ijfoodmicro.2016.10.012; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Costa MC, 2016, EQUINE VET J, V48, P681, DOI 10.1111/evj.12532; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Daniel DS, 2013, MICROBIOL RES, V168, P485, DOI 10.1016/j.micres.2013.04.001; del Rio MDS, 2017, INT J FOOD MICROBIOL, V251, P67, DOI 10.1016/j.ijfoodmicro.2017.03.023; Dietrich M, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw284; Dietz C., 2009, BATS BRITAIN EUROPE; Dou S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169851; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elzinga SE, 2016, J EQUINE VET SCI, V44, P9, DOI 10.1016/j.jevs.2016.05.010; Garcia-Mazcorro JF, 2012, MICROBIOLOGYOPEN, V1, P340, DOI 10.1002/mbo3.36; Gomez DE, 2017, J VET INTERN MED, V31, P928, DOI 10.1111/jvim.14695; Hamm PS, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03057-16; Handl S, 2013, FEMS MICROBIOL ECOL, V84, P332, DOI 10.1111/1574-6941.12067; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Holman DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15557; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Hoyt JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121329; Hutterer R., 2005, BAT MIGRATIONS EUROP; Kaakoush NO, 2012, J CLIN MICROBIOL, V50, P3258, DOI 10.1128/JCM.01396-12; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kohl C, 2014, VIRUSES-BASEL, V6, P3110, DOI 10.3390/v6083110; Konya T, 2014, ENVIRON RES, V131, P25, DOI 10.1016/j.envres.2014.02.005; Kunz T. H, 1990, ECOLOGICAL BEHAV MET, P1; Malinicova L, 2017, ACTA CHIROPTEROL, V19, P211, DOI 10.3161/15081109ACC2017.19.1.017; de Almeida MLM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167108; Moratelli R, 2015, MEM I OSWALDO CRUZ, V110, P1, DOI 10.1590/0074-02760150048; O'Shea TJ, 2014, EMERG INFECT DIS, V20, P741, DOI 10.3201/eid2005.130539; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Pasic L, 2010, FEMS MICROBIOL ECOL, V71, P50, DOI 10.1111/j.1574-6941.2009.00789.x; Presetnik P, 2015, OFFICIAL MONITORING; Quan PL, 2013, P NATL ACAD SCI USA, V110, P8194, DOI 10.1073/pnas.1303037110; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoster A, 2016, EQUINE VET J, V48, P595, DOI 10.1111/evj.12479; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Slifierz MJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0512-7; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-210; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; Wang LF, 2011, CURR OPIN VIROL, V1, P649, DOI 10.1016/j.coviro.2011.10.013; Weese JS, 2014, EQUINE VET J, V46, P654, DOI 10.1111/evj.12295; Wu YC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00244	53	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196728	10.1371/journal.pone.0196728	http://dx.doi.org/10.1371/journal.pone.0196728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791473	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000021
J	Kahsay, ZH; Tegegne, D; Mohammed, E; Kiros, G				Kahsay, Znabu Hadush; Tegegne, Dessie; Mohammed, Ebrahim; Kiros, Getachew			Application of individual behavioral models to predict willingness to use modern contraceptives among pastoralist women in Afar region, Northern Ethiopia	PLOS ONE			English	Article							PERCEPTIONS; PREGNANCY; WORLDWIDE	Background Use of modern contraceptive methods reduces the risk of unwanted pregnancy, and is influenced by individual-level factors. Willingness to use modern contraceptive methods maybe a useful metric when considering health outcomes as it could predict health behaviors. Therefore, the current study aimed to assess the willingness of women to use modern contraceptives in Afar pastoralist communities. Methods A community-based cross-sectional study was conducted from May 1 to 30, 2016. Three hundred forty-five women of childbearing age (15-49 years) were systematically sampled with proportionate allocation from seven randomly selected kebeles (neighborhoods) in Aballa District of Afar Region, Ethiopia. All women meeting the inclusion criteria in each selected household were interviewed at home using a semi-structured questionnaire. Construct validity was assured using factor analysis. A combination of individual behavioral models were applied in order to measure willingness to use modern contraceptive methods. Multiple logistic regressions were utilized to identify factors associated with willingness to use contraceptive at P-value of less than 0.05. Results Three hundred twenty-two women participated in the study, for a response rate of 93.3%. The mean age of respondents was 27 (6) years. About one-third (N = 106, 32.9%) of the participants reported that they were willing to use modern contraceptives. Orthodox Christians (AOR = 4.22, 95% CI 1.94-8.92), women aged 19 or older at first marriage (AOR = 2.89, 95% CI 1.16-7.23), and women who had never experienced a stillbirth (AOR = 3.85, 95%Cl 1.37-10.78) were more likely to report being willing to use modern contraceptives. Additionally, perceived severity of an unwanted pregnancy (AOR = 1.71, 95% CI 1.57-1.93) and perceived self-efficacy to use contraceptives (AOR = 1.26, 95% CI 1.17-1.65) were positively associated with the willingness. Women who had never had an abortion were less likely to express willingness to use modern contraceptives (AOR = 0.41, 95% CI 0.19-0.92) and perceived importance of cultural and religious norms (AOR = 0.85, 95% CI 0.62-0.90) was also negatively associated with willingness. Conclusions The majority of women in this study were not willing to use modern contraceptive methods. A previous pregnancy outcome of stillbirth was associated with reduced willingness, while a prior abortion was associated with increased willingness. Perceived severity of unwanted pregnancy and higher self-efficacy surrounding contraceptive use were strong predictors of increased willingness to use contraceptives. Religious and cultural norms also appear to influence perception towards modern contraception. Thus, involvement of cultural and religious leaders and consideration of a woman's reproductive history are recommended when designing health education messages on contraception for Afar pastoralist women.	[Kahsay, Znabu Hadush] Mekelle Univ, Sch Publ Hlth, Hlth Educ & Behav Sci Unit, Mekelle, Ethiopia; [Tegegne, Dessie] Debre Tabor Univ, Dept Med Lab Sci, Debre Tabor, Ethiopia; [Mohammed, Ebrahim] Samara Univ, Dept Publ Hlth, Coll Hlth Sci, Samara, Ethiopia; [Kiros, Getachew] Jimma Univ, Dept Hlth Educ & Behav Sci, Jimma, Ethiopia	Mekelle University; Samara University; Jimma University	Kahsay, ZH (corresponding author), Mekelle Univ, Sch Publ Hlth, Hlth Educ & Behav Sci Unit, Mekelle, Ethiopia.	hadiszinabu@gmail.com		Afework, Dessie/0000-0003-3469-017X	Samara University	Samara University	Samara University funded the study as small scale research in recurrent budget for 2015.; We would like to thank Samara University for financial support and study participants for their participation in the study. The authors want to thank Mr. Haftu Kahsay (BA, MSc, Ph.D. fellow in literature) for his immense support in copy-editing the manuscript mainly for English usage.	Abraham C., PREDICTING HLTH BEHA, P28; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Ajzen I., 1988, ATTITUDES PERSONALIT; Alemayehu M, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0321-7; [Anonymous], 2014, ETHIOPIAN MINI ETHIO; [Anonymous], 2007, 2007 CENS; Askew I, 2012, REV EVIDENCE IDENTIF; Babalola S, 2015, DEMOGR RES, P33; Bartholomew LK, 2011, PLANNING HLTH PROMOT; Belda SS, 2017, BMC HEALTH SERV RES, V17, P1, DOI [10.1186/s12913-016-1943-z, DOI 10.1186/S12913-016-1943-Z]; Cates W, 2010, CONTRACEPTION, V81, P460, DOI 10.1016/j.contraception.2010.01.002; Central Statistical Agency, 2011, ETH DEM HLTH SURV; Central Statistical Authority, 2016, ETH DEM HLTH SURV 20; County M, 2016, SOCIO EC CULTURAL BA, V6, P12; El Shiekh B, 2015, PASTORALISM, V5, DOI 10.1186/s13570-015-0041-x; Ernest H., 2011, Exchange on HIV/AIDS, Sexuality and Gender, P9; Frohwirth L, 2013, SOC SCI MED, V99, P18, DOI 10.1016/j.socscimed.2013.10.010; Kokeb L, 2015, J FAM MED DIS PREV, V1, DOI DOI 10.23937/2469-5793/1510022; Lakew Y, 2013, GEOGRAPHICAL VARIATI, P1; Lee T, 2014, J CLIN NURS, V23, P1086, DOI 10.1111/jocn.12348; Ministry of finance and economic development and UNICEF in Ethiopia, 2012, UNICEF ETH PROGR AB; Muhindo R, 2015, INT J POPULATION RES; Onega, 2001, ED THEOR MOD PRINC C; Poverty P. Constrained Agency, 2012, CONSTRAINED AGENCY P; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Serizawa A, 2014, INT J NURS STUD, V51, P572, DOI 10.1016/j.ijnurstu.2013.08.007; Shiferaw A, ASSESSMENT POST ABOR; Singh S, 2009, ADDING IT COSTS BENE; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Srikanthan A, 2008, J OBSTET GYNAECOL CA, V30, P129, DOI 10.1016/S1701-2163(16)32736-0; Tewodros Tewodros DM, THESIS; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; United Nations (UN), 2008, WORLD CONTR US 2007	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197366	10.1371/journal.pone.0197366	http://dx.doi.org/10.1371/journal.pone.0197366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG6DG	29787587	Green Published, Green Submitted, gold			2022-12-26	WOS:000432785700024
J	Shin, JW; Jeong, HS; Kwon, HJ; Song, KS; Kim, J				Shin, Jong Wook; Jeong, Hye Seon; Kwon, Hyon-Jo; Song, Kyu Sang; Kim, Jei			High red blood cell composition in clots is associated with successful recanalization during intra-arterial thrombectomy	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; SUCCESSFUL REVASCULARIZATION; ENDOVASCULAR TREATMENT; REPERFUSION; STANDARDS; SUBTYPE; IMPACT; TRIAL	We evaluated the composition of individual clots retrieved during intra-arterial thrombectomy in relation to recanalization success, stroke subtype, and the presence of clot signs on initial brain images. We analyzed clot and interventional data from 145 retrieval trials performed for 37 patients (69.5 +/- 14.0 years, 20 men, large artery atherosclerosis, n = 7; cardioembolism, n = 22; undetermined etiology, n = 8) who had undergone intra-arterial thrombectomy. Rates of clot retrieval and successful recanalization (Arterial Occlusive Lesion score of 2-3) for separate retrieval trials were evaluated. The area occupied by red blood cell (RBC), fibrin/platelets, and white blood cell (WBC) was measured from digitized images of hematoxylin-eosin stained clots. Compositional differences were compared according to recanalization success, stroke subtype, and the presence of hyperdense clot sign on initial computed tomography and/or blooming artifact on magnetic resonance image. Of the 145 total retrieval trials (3.4 +/- 2.4 times per patient), clot was retrieved in 93 trials (64%), while recanalization was successful in 73 (50%). Fibrin/platelets (63%) occupied the greatest area in retrieved clots, followed by RBCs (33%) and WBCs (4%). Clots retrieved from successful recanalization exhibited higher RBC composition (37%) than those retrieved from non-recanalization trials (20%, p = 0.001). RBC composition was higher in cardioembolic stroke (38%) rather than large artery atherosclerosis (23%) and undetermined etiology (26%, p = 0.01). Clots exhibiting clot signs (40%) had higher RBC composition than those without clot signs (19%, p = 0.001). RBC-rich clots were associated with successful recanalization of intra-arterial thrombectomy, cardioembolic stroke, and the presence of clot-signs on initial brain images.	[Shin, Jong Wook; Jeong, Hye Seon; Kwon, Hyon-Jo; Kim, Jei] Chungnam Natl Univ Hosp, Daejeon Chungnam Reg Cerebrovasc Ctr, Daejeon, South Korea; [Shin, Jong Wook; Jeong, Hye Seon; Kim, Jei] Chungnam Natl Univ, Hosp & Sch Med, Dept Neurol, Daejeon, South Korea; [Kwon, Hyon-Jo] Chungnam Natl Univ, Hosp & Sch Med, Dept Neurosurg, Daejeon, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Hosp & Sch Med, Dept Pathol, Daejeon, South Korea	Chungnam National University; Chungnam National University Hospital; Chungnam National University; Chungnam National University; Chungnam National University	Kim, J (corresponding author), Chungnam Natl Univ Hosp, Daejeon Chungnam Reg Cerebrovasc Ctr, Daejeon, South Korea.; Kim, J (corresponding author), Chungnam Natl Univ, Hosp & Sch Med, Dept Neurol, Daejeon, South Korea.	jeikim@cnu.ac.kr		Kwon, Hyon-Jo/0000-0003-1077-2461	Research Fund of Chungnam National University	Research Fund of Chungnam National University	The present study was supported by a Research Fund of Chungnam National University 2016 (for Jei Kim, MD).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ahn SH, 2016, INT J STROKE, V11, P1036, DOI 10.1177/1747493016641965; Asif KS, 2014, J NEUROINTERV SURG, V6, P505, DOI 10.1136/neurintsurg-2013-010792; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Boeckh-Behrens T, 2016, CLIN NEURORADIOL, V26, P189, DOI 10.1007/s00062-014-0347-x; Boeckh-Behrens T, 2016, STROKE, V47, P1864, DOI 10.1161/STROKEAHA.116.013105; de Matos LL, 2010, BIOMARK INSIGHTS, V5, P9; Gersh KC, 2009, THROMB HAEMOSTASIS, V102, P1169, DOI 10.1160/TH09-03-0199; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hashimoto T, 2016, STROKE, V47, P3035, DOI 10.1161/STROKEAHA.116.015228; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Jeong HS, 2015, J STROKE, V17, P76, DOI 10.5853/jos.2015.17.1.76; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Kim SK, 2015, AM J NEURORADIOL, V36, P1756, DOI 10.3174/ajnr.A4402; Liebeskind DS, 2014, STROKE, V45, P2036, DOI 10.1161/STROKEAHA.114.004781; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Mazighi M, 2012, STROKE, V43, P2998, DOI 10.1161/STROKEAHA.112.658849; Meurer WJ, 2017, J EMERG MED, V52, P255, DOI 10.1016/j.jemermed.2016.10.004; Mokin M, 2015, J NEUROINTERV SURG, V7, P104, DOI 10.1136/neurintsurg-2013-011017; Niesten JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088882; Puig J, 2012, AM J NEURORADIOL, V33, P90, DOI 10.3174/ajnr.A2878; Ribo M, 2013, J NEUROINTERV SURG, V5, P70, DOI 10.1136/neurintsurg-2012-010438; Roth C, 2010, STROKE, V41, P2559, DOI 10.1161/STROKEAHA.110.592071; Simons N, 2015, J NEURORADIOLOGY, V42, P86, DOI 10.1016/j.neurad.2014.01.124; Tomsick T, 2007, AM J NEURORADIOL, V28, P382; Yaziji H, 2006, ADV ANAT PATHOL, V13, P238, DOI 10.1097/01.pap.0000213041.39070.2f; Yoo AJ, 2017, J STROKE, V19, P121, DOI 10.5853/jos.2017.00752; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	28	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197492	10.1371/journal.pone.0197492	http://dx.doi.org/10.1371/journal.pone.0197492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782513	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100025
J	Bhatt, M; Mistri, P; Joshi, I; Ram, H; Raval, R; Thoota, S; Patel, A; Ravel, D; Bhargava, P; Soni, S; Bagatharia, S; Joshi, M				Bhatt, Meghna; Mistri, Pankti; Joshi, Ishita; Ram, Hemal; Raval, Rinni; Thoota, Sruthi; Patel, Ankur; Ravel, Dhrupa; Bhargava, Poonam; Soni, Subhash; Bagatharia, Snehal; Joshi, Madhvi			Molecular survey of basidiomycetes and divergence time estimation: An Indian perspective	PLOS ONE			English	Article							DNA; PHYLOGENY; REGION; FUNGI; REEVALUATION; EVOLUTION; MUSHROOM; LUCIDUM; PODAXIS	This study outlines the biodiversity of mushrooms of India. It reveals the molecular biodiversity and divergence time estimation of basidiomycetes from Gujarat, India. A total of 267 mushrooms were collected from 10 locations across the state. 225 ITS sequences were generated belonging to 105 species, 59 genera and 29 families. Phylogenetic analysis of Agaricaceae reveals monophyletic Glade of Podaxis differentiating it from Coprinus. Further, the ancient nature of Podaxis supports the hypothesis that gasteroid forms evolved from secotioid forms. Members of Polyporaceae appeared polyphyletic. Further, our results of a close phylogenetic relationship between Trametes and Lenziteslead us to propose that the genera Trametes may by enlarged to include Lenzites. The tricholomatoid Glade shows a clear demarcation for Entolomataceae. However, Lyophyllaceae and Tricholomataceae could not be distinguished clearly. Distribution studies of the mushrooms showed omnipresence of Ganoderma and Schizophyllum. Further, divergence time estimation shows that Dacrymycetes evolved in the Neoproterozoic Era and Hymenochaetales diverged from Agaricomycetes during the Silurian period.	[Bhatt, Meghna; Mistri, Pankti; Joshi, Ishita; Ram, Hemal; Raval, Rinni; Thoota, Sruthi; Patel, Ankur; Ravel, Dhrupa; Bagatharia, Snehal] Govt Gujarat, Gujarat State Biotechnol Mission, Dept Sci & Technol, Gandhinagar, Gujarat, India; [Bhargava, Poonam; Soni, Subhash; Joshi, Madhvi] Govt Gujarat, Dept Sci & Technol, Gujarat Biotechnol Res Ctr, Gandhinagar, Gujarat, India		Joshi, M (corresponding author), Govt Gujarat, Dept Sci & Technol, Gujarat Biotechnol Res Ctr, Gandhinagar, Gujarat, India.	madhvimicrobio@gmail.com			Department of Science and Technology, Government of Gujarat, India	Department of Science and Technology, Government of Gujarat, India(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	This work was supported by the Department of Science and Technology, Government of Gujarat, India.; This work was supported by the Department of Science and Technology, Government of Gujarat, India.	Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Berbee ML, 2001, MYCOTA, V7, P229; Bilgrami KS, 1981, FUNGI OF INDIA 2; Butler E, 1960, THE FUNGI OF INDIA; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eby John, 2011, World Applied Sciences Journal, V15, P304; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Geml Jozsef, 2004, Mycological Progress, V3, P157, DOI 10.1007/s11557-006-0086-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hasan S., 2012, INT J APPL RES STUD, V1, P1; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Hibbett DS, 2004, SYST BIOL, V53, P889, DOI 10.1080/10635150490522610; Hibbett DS, 1997, AM J BOT, V84, P981, DOI 10.2307/2446289; Kavina C, 1936, ATLAS CHAMPIGNONS EU, VIII, P624; Keirle MR, 2004, FUNGAL DIVERS, V15, P33; Kirk PM., 2008, DICT FUNGI, V10th ed; Ko KS, 1999, FEMS MICROBIOL LETT, V170, P181, DOI 10.1111/j.1574-6968.1999.tb13372.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Manoharachary C, 2005, CURR SCI INDIA, V89, P58; Matheny PB, 2009, J BIOGEOGR, V36, P577, DOI 10.1111/j.1365-2699.2008.02055.x; McLaughlin DJ, 2009, TRENDS MICROBIOL, V17, P488, DOI 10.1016/j.tim.2009.08.001; Medina-Ortiz AJ, 2017, MYCOKEYS, P17, DOI 10.3897/mycokeys.20.11570; Moncalvo JM, 1995, MYCOL RES, V99, P1489, DOI 10.1016/S0953-7562(09)80798-3; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Osmundson TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062419; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Rajchenberg M, 2011, MYCOLOGIA, V103, P677, DOI 10.3852/10-310; Razaq A, 2016, MYCOSPHERE, V7, P525, DOI 10.5943/mycosphere/7/4/11; Ricardo Garcia-Sandoval, 2011, MYCOLOGIA, V103, P510, DOI [10.3852/10.209, DOI 10.3852/10.209]; Sarbhoy A. K., 1996, FUNGI INDIA 1982 199; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Singh M.P., 2007, FOREST ENV BIODIVERS; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tang AMC, 2009, FUNGAL DIVERS, V34, P127; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Vellinga Else C., 2003, Mycological Progress, V2, P305, DOI 10.1007/s11557-006-0068-x; Wang DM, 2009, BOT STUD, V50, P451; Wang L, 1998, MED MYCOL, V36, P153, DOI 10.1080/02681219880000231; Wang L, 2000, J CLIN MICROBIOL, V38, P1352, DOI 10.1128/JCM.38.4.1352-1358.2000; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Welti S, 2012, FUNGAL DIVERS, V55, P47, DOI 10.1007/s13225-011-0149-2; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	46	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197306	10.1371/journal.pone.0197306	http://dx.doi.org/10.1371/journal.pone.0197306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771956	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900048
J	Muthukrishnan, R; Davis, AS; Jordan, NR; Forester, JD				Muthukrishnan, Ranjan; Davis, Adam S.; Jordan, Nicholas R.; Forester, James D.			Invasion complexity at large spatial scales is an emergent property of interactions among landscape characteristics and invader traits	PLOS ONE			English	Article							MISCANTHUS-X-GIGANTEUS; FRAGMENTED LANDSCAPES; UNITED-STATES; HABITAT FRAGMENTATION; BIOLOGICAL INVASIONS; PLANT INVASION; ECONOMIC COSTS; SPREAD; DISPERSAL; MANAGEMENT	Invasion potential should be part of the evaluation of candidate species for any species introduction. However, estimating invasion risks remains a challenging problem, particularly in complex landscapes. Certain plant traits are generally considered to increase invasive potential and there is an understanding that landscapes influence invasions dynamics, but little research has been done to explore how those drivers of invasions interact. We evaluate the relative roles of, and potential interactions between, plant invasiveness traits and landscape characteristics on invasions with a case study using a model parameterized for the potentially invasive biomass crop, Miscanthus * giganteus. Using that model we simulate invasions on 1000 real landscapes to evaluate how landscape characteristics, including both composition and spatial structure, affect invasion outcomes. We conducted replicate simulations with differing strengths of plant invasiveness traits (dispersal ability, establishment ability, population growth rate, and the ability to utilize dispersal corridors) to evaluate how the importance of landscape characteristics for predicting invasion patterns changes depending on the invader details. Analysis of simulations showed that the presence of highly suitable habitat (e.g., grasslands) is generally the strongest determinant of invasion dynamics but that there are also more subtle interactions between landscapes and invader traits. These effects can also vary between different aspects of invasion dynamics (short vs. long time scales and population size vs. spatial extent). These results illustrate that invasions are complex emergent processes with multiple drivers and effective management needs to reflect the ecology of the species of interest and the particular goals or risks for which efforts need to be optimized.	[Muthukrishnan, Ranjan; Forester, James D.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Davis, Adam S.] USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL USA; [Jordan, Nicholas R.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities	Muthukrishnan, R (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	mrunj@umn.edu		Davis, Adam/0000-0002-7196-1197; Muthukrishnan, Ranjan/0000-0002-7001-6249	United States Department of Agriculture-National Institute of Food and Agriculture [2012-67013]; National Science Foundation Division of Environmental Biology grant [1145200]; USDA-NIFA [2012-67013]; NSF DEB grant [1145200]	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Science Foundation Division of Environmental Biology grant; USDA-NIFA(United States Department of Agriculture (USDA)); NSF DEB grant	This work was funded by United States Department of Agriculture-National Institute of Food and Agriculture (https://nifa.usda.gov) grant #2012-67013 to NRJ, ASD and JDF. JDF was supported by National Science Foundation (https://www.nsf.gov) Division of Environmental Biology grant #1145200 to attend a workshop on Bayesian modeling. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by USDA-NIFA grant #2012-67013 to NRJ, ASD and JDF. JDF was supported by NSF DEB grant #1145200 to attend a workshop on Bayesian modeling. We are grateful for computational resources from the University of Minnesota Supercomputing Institute.	Andrew ME, 2010, ECOL APPL, V20, P593, DOI 10.1890/09-0034.1; [Anonymous], 2014, R LANG ENV STAT COMP; Barros C, 2016, DIVERS DISTRIB, V22, P1266, DOI 10.1111/ddi.12487; Bartuszevige AM, 2006, ECOGRAPHY, V29, P213, DOI 10.1111/j.2006.0906-7590.04359.x; Cardille J, 2005, BIOSCIENCE, V55, P983, DOI 10.1641/0006-3568(2005)055[0983:MCSPAS]2.0.CO;2; Caswell H, 2007, ECOL LETT, V10, P1, DOI 10.1111/j.1461-0248.2006.01001.x; Catford JA, 2011, DIVERS DISTRIB, V17, P1099, DOI 10.1111/j.1472-4642.2011.00794.x; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Coutts SR, 2011, BIOL INVASIONS, V13, P1649, DOI 10.1007/s10530-010-9922-5; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Cushman SA, 2008, ECOL INDIC, V8, P691, DOI 10.1016/j.ecolind.2007.12.002; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; Deckers B, 2005, ECOGRAPHY, V28, P99, DOI 10.1111/j.0906-7590.2005.04054.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Ezard THG, 2010, J APPL ECOL, V47, P515, DOI 10.1111/j.1365-2664.2010.01801.x; Gallien L, 2010, DIVERS DISTRIB, V16, P331, DOI 10.1111/j.1472-4642.2010.00652.x; Gilbert MA, 2014, J THEOR BIOL, V349, P135, DOI 10.1016/j.jtbi.2014.01.024; Hargis CD, 1998, LANDSCAPE ECOL, V13, P167, DOI 10.1023/A:1007965018633; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Heaton EA, 2013, BIOFUEL BIOPROD BIOR, V7, P702, DOI 10.1002/bbb.1429; Homer C, 2004, PHOTOGRAMM ENG REM S, V70, P829, DOI 10.14358/PERS.70.7.829; Hooten MB, 2015, ECOL MONOGR, V85, P3, DOI 10.1890/14-0661.1; Johnson LE, 2001, ECOL APPL, V11, P1789, DOI 10.1890/1051-0761(2001)011[1789:ODOAIS]2.0.CO;2; Kupfer JA, 2012, PROG PHYS GEOG, V36, P400, DOI 10.1177/0309133312439594; Levine JM, 2006, ECOL LETT, V9, P1005, DOI 10.1111/j.1461-0248.2006.00949.x; Lewis MA, 2000, J MATH BIOL, V41, P387, DOI 10.1007/s002850000050; Lloret F, 2005, J ECOL, V93, P512, DOI 10.1111/j.1365-2745.2005.00979.x; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McGarigal K., 2012, TECH REP; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Muthukrishnan R, 2015, ECOL MODEL, V317, P6, DOI 10.1016/j.ecolmodel.2015.08.022; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pittman SE, 2015, BIOL INVASIONS, V17, P3247, DOI 10.1007/s10530-015-0950-z; Plummer M, 2014, RJAGS BAYESIAN GRAPH; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Pysek P, 2005, ECOSCIENCE, V12, P302, DOI 10.2980/i1195-6860-12-3-302.1; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Rouget M, 2001, PLANT ECOL, V152, P79, DOI 10.1023/A:1011412427075; Schulte LA, 2017, P NATL ACAD SCI USA, V114; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Taylor CM, 2004, J APPL ECOL, V41, P1049, DOI 10.1111/j.0021-8901.2004.00979.x; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Travis JMJ, 2004, ANIM CONSERV, V7, P321, DOI 10.1017/S1367943004001507; TURNER MG, 1995, ECOL APPL, V5, P12, DOI 10.2307/1942046; Uden DR, 2015, BIOL INVASIONS, V17, P2831, DOI 10.1007/s10530-015-0914-3; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Vila M, 2011, LANDSCAPE ECOL, V26, P461, DOI 10.1007/s10980-011-9585-3; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; With KA, 2004, RISK ANAL, V24, P803, DOI 10.1111/j.0272-4332.2004.00480.x; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x	53	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0195892	10.1371/journal.pone.0195892	http://dx.doi.org/10.1371/journal.pone.0195892			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771923	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900007
J	Bernstein, SF; Rehkopf, D; Tuljapurkar, S; Horvitz, CC				Bernstein, Shayna Fae; Rehkopf, David; Tuljapurkar, Shripad; Horvitz, Carol C.			Poverty dynamics, poverty thresholds and mortality: An age-stage Markovian model	PLOS ONE			English	Article							UNITED-STATES; HEALTH; INCOME; RISK	Recent studies have examined the risk of poverty throughout the life course, but few have considered how transitioning in and out of poverty shape the dynamic heterogeneity and mortality disparities of a cohort at each age. Here we use state-by-age modeling to capture individual heterogeneity in crossing one of three different poverty thresholds (defined as 1x, 2x or 3x the "official" poverty threshold) at each age. We examine age-specific state structure, the remaining life expectancy, its variance, and cohort simulations for those above and below each threshold. Survival and transitioning probabilities are statistically estimated by regression analyses of data from the Health and Retirement Survey RAND data-set, and the National Longitudinal Survey of Youth. Using the results of these regression analyses, we parameterize discrete state, discrete age matrix models. We found that individuals above all three thresholds have higher annual survival than those in poverty, especially for mid-ages to about age 80. The advantage is greatest when we classify individuals based on 1x the "official" poverty threshold. The greatest discrepancy in average remaining life expectancy and its variance between those above and in poverty occurs at mid-ages for all three thresholds. And fewer individuals are in poverty between ages 40-60 for all three thresholds. Our findings are consistent with results based on other data sets, but also suggest that dynamic heterogeneity in poverty and the transience of the poverty state is associated with income-related mortality disparities (less transience, especially of those above poverty, more disparities). This paper applies the approach of age-by-stage matrix models to human demography and individual poverty dynamics. In so doing we extend the literature on individual poverty dynamics across the life course.	[Bernstein, Shayna Fae; Horvitz, Carol C.] Univ Miami, Dept Biol, ITME, Coral Gables, FL 33124 USA; [Rehkopf, David] Stanford Univ, Sch Med, Div Primary Care & Populat Hlth, Stanford, CA USA; [Tuljapurkar, Shripad] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Miami; Stanford University; Stanford University	Bernstein, SF (corresponding author), Univ Miami, Dept Biol, ITME, Coral Gables, FL 33124 USA.	shayna@bio.miami.edu		Tuljapurkar, Shripad/0000-0001-5549-4245; Rehkopf, David/0000-0002-7597-6513				Adler N, 1994, SOCIOECONOMIC STATUS; Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Backlund E, 1996, ANN EPIDEMIOL, V6, P12, DOI 10.1016/1047-2797(95)00090-9; Bane M, 1985, J HUMAN RESOURCES, V21; Benzeval M, 2001, SOC SCI MED, V52, P1371, DOI 10.1016/S0277-9536(00)00244-6; Boe C., 1998, N AM ACTUAR J, V2, P13, DOI DOI 10.1080/10920277.1998.10595752; Bureau of Labor Statistics USDoL, 2012, NAT LONG SURV YOUTH; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2012, THEOR ECOL-NETH, V5, P403, DOI 10.1007/s12080-011-0132-2; Caswell H, 2009, OIKOS, V118, P1763, DOI 10.1111/j.1600-0706.2009.17620.x; Cellini SR, 2008, J POLICY ANAL MANAG, V27, P577, DOI 10.1002/pam.20337; Charles Hokayem, 2014, CURRENT POPULATION R, P60; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Chetty R, 2014, Q J ECON, V129, P1553, DOI 10.1093/qje/qju022; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DeNavas-Walt C., 2014, CURR POPUL REP, V2015, pP60; Edwards AN, 2014, CURRENT POPULATION R, P70; Engelman M, 2014, DEMOGR RES, V30, P1367, DOI 10.4054/DemRes.2014.30.48; Fujiwara M, 2002, ECOLOGY, V83, P3257, DOI 10.2307/3072076; Gillespie DOS, 2014, DEMOGRAPHY, V51, P1003, DOI 10.1007/s13524-014-0287-8; Haughton J, 2009, HDB POVERTY INEQUALI, P273; Hokayem CUSCB, 2014, FACTORS INFLUENCING; Islam MA, 2006, APPL MATH MODEL, V30, P477, DOI 10.1016/j.apm.2005.05.006; Islam MA, 2004, INT J STAT SCI, V3, P241; Keyfitz N, 2005, STAT BIOL HEALTH, P1, DOI 10.1007/b139042; KEYFITZ N, 1968, INTRO MATH POPULATIO; KORN EL, 1979, BIOMETRICS, V35, P795, DOI 10.2307/2530111; Kot M, 2001, ELEMENTS MATH ECOLOG, DOI 10.1017/CBO9780511608520; Lawless JF, 2015, LIFETIME DATA ANAL, V21, P160, DOI 10.1007/s10985-014-9310-z; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Lumley T., 2014, SURVEY ANAL COMPLEX; Marmot M, 2002, HEALTH AFFAIR, V21, P31, DOI 10.1377/hlthaff.21.2.31; McDonough P, 2010, SOC SCI MED, V70, P251, DOI 10.1016/j.socscimed.2009.10.001; Metcalf CJE, 2012, THEOR POPUL BIOL, V82, P275, DOI 10.1016/j.tpb.2011.12.001; Moldoff M, 2014, RAND HRS DATA DOCUME; MUENZ LR, 1985, BIOMETRICS, V41, P91, DOI 10.2307/2530646; Neilson C, 2008, J LAT AM STUD, V40, P251, DOI 10.1017/S0022216X08003982; Osowole O. I., 2012, MATH THEORY MODELING, V2, P45; Rank MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133513; Rank MR, 2010, FAM SOC, V91, P337, DOI 10.1606/1044-3894.4032; Rank MR, 2001, J POLICY ANAL MANAG, V20, P737, DOI 10.1002/pam.1026; Rehkopf DH, 2010, SOC SCI MED, V71, P431, DOI 10.1016/j.socscimed.2010.03.045; Rehkopf DH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-383; ROGERS A, 1980, ENVIRON PLANN A, V12, P489, DOI 10.1068/a120489; ROGERS RG, 1992, DEMOGRAPHY, V29, P287, DOI 10.2307/2061732; Roth G, 2016, METHODS ECOL EVOL, V7, P1438, DOI 10.1111/2041-210X.12622; Sacker A, 2007, AM J PUBLIC HEALTH, V97, P812, DOI 10.2105/AJPH.2006.092320; Sandoval DA, 2009, DEMOGRAPHY, V46, P717, DOI 10.1353/dem.0.0082; SCHOEN R, 1988, ANNU REV SOCIOL, V14, P341; Seneta E., 1981, NONNEGATIVE MATRICES; SORLIE PD, 1995, AM J PUBLIC HEALTH, V85, P949, DOI 10.2105/AJPH.85.7.949; Steiner UK, 2012, EXP GERONTOL, V47, P773, DOI 10.1016/j.exger.2012.05.015; Stevens AH, 1999, J HUM RESOUR, V34, P557, DOI 10.2307/146380; Tuljapurkar S, 2010, ANN NY ACAD SCI, V1204, P65, DOI 10.1111/j.1749-6632.2010.05519.x; van Daalen S, 2015, DEMOGR RES, V33, P561, DOI 10.4054/DemRes.2015.33.20; Willekens F, 2014, DEMOGR RES, V31, P381, DOI 10.4054/DemRes.2014.31.14; Yang XW, 2007, STAT METHODS MED RES, V16, P347, DOI 10.1177/0962280206071843; Yu L, 2010, STAT MED, V29, P639, DOI 10.1002/sim.3828	58	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0195734	10.1371/journal.pone.0195734	http://dx.doi.org/10.1371/journal.pone.0195734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF9WG	29768416	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200009
J	Hodzic, A; Lavtar, P; Ristanovic, M; Novakovic, I; Dotlic, J; Peterlin, B				Hodzic, Alenka; Lavtar, Polona; Ristanovic, Momcilo; Novakovic, Ivana; Dotlic, Jelena; Peterlin, Borut			Genetic variation in the CLOCK gene is associated with idiopathic recurrent spontaneous abortion	PLOS ONE			English	Article							SHIFT WORK; CIRCADIAN-RHYTHMS; MISCARRIAGE; POLYMORPHISM; MUTATION; CYCLE; RISK	Physiological studies in animals and human support an important role of circadian system in reproduction. The aim of this study was to investigate the potential association of CLOCK gene polymorphisms with idiopathic recurrent spontaneous abortion (IRSA). We performed a case-control study. The study group consisted of 268 women with a history of three or more idiopathic recurrent spontaneous abortions and 284 women with at least two live births and no history of pathologic pregnancies all from Slovenia and Serbia. Two SNPs in the CLOCK gene were chosen and genotyped. The results showed a statistically significant difference in genotype distribution between the two groups in the CLOCK gene for rs6850524 and rs11932595. Our analysis showed that G allele under dominant model (GG+GC/CC) for rs6850524 (p = 2.10(-4), OR = 2.28, 95% CI = 1.46-3.56) as well as G allele under dominant model (GA+AA/AA) for rs11932595 (p = 0.04, OR = 1.47, 95% CI = 1.01-2.04) might be risk factors against IRSA. Our data suggest that genetic variability in the CLOCK gene is associated with IRSA warranting further confirmation and mechanistic investigations.	[Hodzic, Alenka; Lavtar, Polona; Peterlin, Borut] Univ Med Ctr Ljubljana, Clin Inst Med Genet, Ljubljana, Slovenia; [Ristanovic, Momcilo; Novakovic, Ivana] Univ Belgrade, Med Fac, Inst Human Genet, Belgrade, Serbia; [Dotlic, Jelena] Univ Belgrade, Fac Med, Clin Ctr Serbia, Clin Obstet & Gynecol, Belgrade, Serbia	University Medical Centre Ljubljana; University of Belgrade; Clinical Centre of Serbia; University of Belgrade	Peterlin, B (corresponding author), Univ Med Ctr Ljubljana, Clin Inst Med Genet, Ljubljana, Slovenia.	borut.peterlin@guest.arnes.si			Slovenian Research Agency [P3-0326]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported by grant P3-0326 from the Slovenian Research Agency.	Amano T, 2016, THERIOGENOLOGY, V86, P1670, DOI 10.1016/j.theriogenology.2016.05.027; Boden MJ, 2006, REPRODUCTION, V132, P379, DOI 10.1530/rep.1.00614; Daher S, 2012, AM J REPROD IMMUNOL, V67, P341, DOI 10.1111/j.1600-0897.2012.01123.x; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fernandez RC, 2016, SEMIN REPROD MED, V34, P74, DOI 10.1055/s-0036-1571354; Gamble Karen L, 2013, Front Endocrinol (Lausanne), V4, P92, DOI 10.3389/fendo.2013.00092; Grajewski B, 2015, EPIDEMIOLOGY, V26, P192, DOI 10.1097/EDE.0000000000000225; Hodzic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059220; Kim KH, 2015, J PSYCHOSOM OBST GYN, V36, P148, DOI 10.3109/0167482X.2015.1089229; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kovanen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010007; Li RW, 2015, CELL PHYSIOL BIOCHEM, V37, P911, DOI 10.1159/000430218; Li TC, 2002, HUM REPROD UPDATE, V8, P463, DOI 10.1093/humupd/8.5.463; Little J, 2009, EUR J CLIN INVEST, V39, P247, DOI 10.1111/j.1365-2362.2009.02125.x; Marino JL, 2008, EPIDEMIOLOGY, V19, P477, DOI 10.1097/EDE.0b013e31816b7378; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Qiu CF, 2016, INT J MOL EPIDEMIOL, V7, P32; Rull Kristiina, 2012, Frontiers in Genetics, V3, P34, DOI 10.3389/fgene.2012.00034; Stocker LJ, 2014, OBSTET GYNECOL, V124, P99, DOI 10.1097/AOG.0000000000000321; Sukumaran S, 2010, ADV DRUG DELIVER REV, V62, P904, DOI 10.1016/j.addr.2010.05.009; Summa KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037668; Toth B, 2010, J REPROD IMMUNOL, V85, P25, DOI 10.1016/j.jri.2009.12.006; Waddell BJ, 2012, PLACENTA, V33, P533, DOI 10.1016/j.placenta.2012.03.008	25	11	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196345	10.1371/journal.pone.0196345	http://dx.doi.org/10.1371/journal.pone.0196345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768442	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200022
J	Koklic, T; Pintaric, S; Zdovc, I; Golob, M; Umek, P; Mehle, A; Dobeic, M; Strancar, J				Koklic, Tilen; Pintaric, Stefan; Zdovc, Irena; Golob, Majda; Umek, Polona; Mehle, Alma; Dobeic, Martin; Strancar, Janez			Photocatalytic disinfection of surfaces with copper doped TiO2 nanotube coatings illuminated by ceiling mounted fluorescent light	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES STRAINS; LOGNORMAL-DISTRIBUTION; ANTIMICROBIAL ACTIVITY; SEMICONDUCTOR POWDERS; BACTERIAL-POPULATIONS; PROCESSING PLANTS; MICROBIAL-CELLS; MECHANISM; NANOPARTICLES; PRODUCTS	High economic burden is associated with foodborne illnesses. Different disinfection methods are therefore employed in food processing industry; such as use of ultraviolet light or usage of surfaces with copper-containing alloys. However, all the disinfection methods currently in use have some shortcomings. In this work we show that copper doped TiO2 nanotubes deposited on existing surfaces and illuminated with ceiling mounted fluorescent lights can retard the growth of Listeria Innocua by 80% in seven hours of exposure to the fluorescent lights at different places in a food processing plant or in the laboratory conditions with daily reinocuation and washing. The disinfection properties of the surfaces seem to depend mainly on the temperature difference of the surface and the dew point, where for the maximum effectiveness the difference should be about 3 degrees celsius. The TiO2 nanotubes have a potential to be employed for an economical and continuous disinfection of surfaces.	[Koklic, Tilen; Umek, Polona; Mehle, Alma; Strancar, Janez] Jozef Stefan Inst, Ljubljana, Slovenia; [Koklic, Tilen; Pintaric, Stefan; Zdovc, Irena; Umek, Polona; Dobeic, Martin; Strancar, Janez] NAMASTE Ctr Excellence, Ljubljana, Slovenia; [Pintaric, Stefan; Zdovc, Irena; Golob, Majda; Dobeic, Martin] Univ Ljubljana, Vet Fac, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Strancar, J (corresponding author), Jozef Stefan Inst, Ljubljana, Slovenia.; Dobeic, M; Strancar, J (corresponding author), NAMASTE Ctr Excellence, Ljubljana, Slovenia.; Dobeic, M (corresponding author), Univ Ljubljana, Vet Fac, Ljubljana, Slovenia.	Martin.Dobeic@vf.uni-lj.si; janez.strancar@ijs.si			Slovenian Research Agency; NAMASTE Centre of Excellence, Institute for research and development of Advanced Materials and Technologies for the Future	Slovenian Research Agency(Slovenian Research Agency - Slovenia); NAMASTE Centre of Excellence, Institute for research and development of Advanced Materials and Technologies for the Future	Javna Agencija za Raziskovalno Dejavnost RS, P1-0060, to Janez Strancar. Work was funded by Slovenian Research Agency grant 'Experimental biophysics of complex systems and imaging in biomedicine', and by NAMASTE Centre of Excellence, Institute for research and development of Advanced Materials and Technologies for the Future. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg JM, 2009, RELATIONSHIP PH ZETA; BEST M, 1990, APPL ENVIRON MICROB, V56, P377, DOI 10.1128/AEM.56.2.377-380.1990; Bintsis T, 2000, J SCI FOOD AGR, V80, P637, DOI 10.1002/(SICI)1097-0010(20000501)80:6<637::AID-JSFA603>3.0.CO;2-1; Buchalska M, 2015, ACS CATAL, V5, P7424, DOI 10.1021/acscatal.5b01562; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Ditta IB, 2008, APPL MICROBIOL BIOT, V79, P127, DOI 10.1007/s00253-008-1411-8; Dobeic M., 2015, XVII International Congress on Animal Hygiene 2015, "Animal Hygiene and Welfare in Livestock Production - The First Step to Food Hygiene", Proceedings, June 7-11, 2015, Kosice, Slovakia, P99; Doroghazi JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002910; Dunlop PSM, 2010, J PHOTOCH PHOTOBIO A, V216, P303, DOI 10.1016/j.jphotochem.2010.07.004; Emeline AV, 2005, J PHYS CHEM B, V109, P18515, DOI 10.1021/jp0523367; European Food Safety Authority, FOOD BORN ZOON DIS; Foster HA, 2010, J PHOTOCH PHOTOBIO A, V216, P283, DOI 10.1016/j.jphotochem.2010.09.017; Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7; FRANK SN, 1977, J PHYS CHEM-US, V81, P1484, DOI 10.1021/j100530a011; FUJISHIMA A, 1975, J ELECTROCHEM SOC, V122, P1487, DOI 10.1149/1.2134048; Fujishima A., 2000, J PHOTOCHEM PHOTOB C, V1, P1, DOI [10.1016/s1389-5567(00)00002-2, DOI 10.1016/S1389-5567(00)00002-2]; Garvas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129577; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Herrmann JM, 2010, J PHOTOCH PHOTOBIO A, V216, P85, DOI 10.1016/j.jphotochem.2010.05.015; HIRANO SS, 1982, APPL ENVIRON MICROB, V44, P695, DOI 10.1128/AEM.44.3.695-700.1982; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; JANZEN EG, 1971, ACCOUNTS CHEM RES, V4, P31, DOI 10.1021/ar50037a005; Kakuma Y, 2015, PHYS CHEM CHEM PHYS, V17, P18691, DOI 10.1039/c5cp02004b; KOCH AL, 1966, J THEOR BIOL, V12, P276, DOI 10.1016/0022-5193(66)90119-6; Koklic T, PLOS ONE UNPUB; Kostaki M, 2012, APPL ENVIRON MICROB, V78, P2586, DOI 10.1128/AEM.07099-11; Leyland NS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24770; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Lock N, 2013, DALTON T, V42, P9555, DOI 10.1039/c3dt00122a; Long M, 2014, FOOD CONTROL, V39, P68, DOI 10.1016/j.foodcont.2013.10.033; LOPER JE, 1984, PHYTOPATHOLOGY, V74, P1454, DOI 10.1094/Phyto-74-1454; Lunden JM, 2002, J FOOD PROTECT, V65, P1129, DOI 10.4315/0362-028X-65.7.1129; Lunden JM, 2000, J FOOD PROTECT, V63, P1204, DOI 10.4315/0362-028X-63.9.1204; MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211, DOI 10.1111/j.1574-6968.1985.tb00864.x; Nyachuba DG, 2010, NUTR REV, V68, P257, DOI 10.1111/j.1753-4887.2010.00286.x; Ojeniyi B, 2000, EPIDEMIOL INFECT, V125, P303, DOI 10.1017/S0950268899004483; Qiu XQ, 2012, ACS NANO, V6, P1609, DOI 10.1021/nn2045888; Rakic-Martinez M, 2011, APPL ENVIRON MICROB, V77, P8714, DOI 10.1128/AEM.05941-11; Ramaswamy Vidhya, 2007, Journal of Microbiology Immunology and Infection, V40, P4; Sato T, 2006, BIOCHEM ENG J, V30, P199, DOI 10.1016/j.bej.2006.04.002; Scharff RL, 2012, J FOOD PROTECT, V75, P123, DOI 10.4315/0362-028X.JFP-11-058; Sunada K, 2003, ENVIRON SCI TECHNOL, V37, P4785, DOI 10.1021/es034106g; Thevenot D, 2006, J APPL MICROBIOL, V101, P7, DOI 10.1111/j.1365-2672.2006.02962.x; Thevenot D, 2005, INT J FOOD MICROBIOL, V102, P85, DOI 10.1016/j.ijfoodmicro.2004.12.008; Umek P, 2008, J PHYS CHEM C, V112, P15311, DOI 10.1021/jp805005k; Umek P, 2007, J NANOSCI NANOTECHNO, V7, P3502, DOI 10.1166/jnn.2007.838; Wei XJ, 2014, APPL SURF SCI, V290, P274, DOI 10.1016/j.apsusc.2013.11.067; Wu B, 2010, SCI TOTAL ENVIRON, V408, P1755, DOI 10.1016/j.scitotenv.2009.11.004; Xin BF, 2008, APPL SURF SCI, V254, P2569, DOI 10.1016/j.apsusc.2007.09.002; Yi J, 2012, J PHYS CHEM C, V116, P10090, DOI 10.1021/jp301405e; You M, 2010, CRYST GROWTH DES, V10, P983, DOI 10.1021/cg9012944; Zhang J, 2014, J PHYS CHEM C, V118, P10824, DOI 10.1021/jp501214m; Zhang J, 2013, J PHYS CHEM C, V117, P1383, DOI 10.1021/jp3105166	53	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197308	10.1371/journal.pone.0197308	http://dx.doi.org/10.1371/journal.pone.0197308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768464	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200075
J	Kumar, V; Webb, JM; Gregory, A; Denis, M; Meixner, DD; Bayat, M; Whaley, DH; Fatemi, M; Alizad, A				Kumar, Viksit; Webb, Jeremy M.; Gregory, Adriana; Denis, Max; Meixner, Duane D.; Bayat, Mandi; Whaley, Dana H.; Fatemi, Mostafa; Alizad, Azra			Automated and real-time segmentation of suspicious breast masses using convolutional neural network	PLOS ONE			English	Article							ULTRASOUND SEGMENTATION; LEVEL; US	In this work, a computer-aided tool for detection was developed to segment breast masses from clinical ultrasound (US) scans. The underlying Multi U-net algorithm is based on convolutional neural networks. Under the Mayo Clinic Institutional Review Board protocol, a prospective study of the automatic segmentation of suspicious breast masses was performed. The cohort consisted of 258 female patients who were clinically identified with suspicious breast masses and underwent clinical US scan and breast biopsy. The computer-aided detection tool effectively segmented the breast masses, achieving a mean Dice coefficient of 0.82, a true positive fraction (TPF) of 0.84, and a false positive fraction (FPF) of 0.01. By avoiding positioning of an initial seed, the algorithm is able to segment images in real time (13-55 ms per image), and can have potential clinical applications. The algorithm is at par with a conventional seeded algorithm, which had a mean Dice coefficient of 0.84 and performs significantly better (P < 0.0001) than the original U-net algorithm.	[Kumar, Viksit; Bayat, Mandi; Fatemi, Mostafa] Mayo Clin, Dept Physiol & Biomed Engn, Coll Med & Sci, Rochester, MN USA; [Webb, Jeremy M.; Gregory, Adriana; Denis, Max; Meixner, Duane D.; Whaley, Dana H.; Alizad, Azra] Mayo Clin, Dept Radiol, Coll Med & Sci, Rochester, MN 55905 USA; [Denis, Max] Phys & Life Sci Solut LLC, Randolph, MA USA	Mayo Clinic; Mayo Clinic	Alizad, A (corresponding author), Mayo Clin, Dept Radiol, Coll Med & Sci, Rochester, MN 55905 USA.	alizad.azra@mayo.edu		Fatemi, Mostafa/0000-0002-6603-9077; Kumar, Viksit/0000-0003-0056-5223	National Cancer Institute [R01CA148994, R01CA148994-S1, R01CA168575, R01CA195527, R01CA174723]; NATIONAL CANCER INSTITUTE [R01CA148994] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by grants R01CA148994, R01CA148994-S1, R01CA168575, R01CA195527, and R01CA174723 from the National Cancer Institute.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Cary TW, 2005, MED PHYS, V32, P3318, DOI 10.1118/1.2012967; Chang RF, 2005, BREAST CANCER RES TR, V89, P179, DOI 10.1007/s10549-004-2043-z; Chang RF, 2003, ULTRASOUND MED BIOL, V29, P1571, DOI 10.1016/S0301-5629(03)00992-X; Checka CM, 2012, AM J ROENTGENOL, V198, pW292, DOI 10.2214/AJR.10.6049; Chen DR, 2003, ULTRASOUND MED BIOL, V29, P1017, DOI 10.1016/S0301-5629(03)00059-0; Committee ACoRB-R Radiology ACo, 1998, RADIOLOGY ACO; Cui J, 2009, MED PHYS, V36, P1553, DOI 10.1118/1.3110069; Drukker K, 2002, MED PHYS, V29, P1438, DOI 10.1118/1.1485995; Guliato D, 1998, 1998 P 20 ANN INT C; JACKSON VP, 1993, RADIOLOGY, V188, P297, DOI 10.1148/radiology.188.2.8327668; Jamieson AR, 2012, SPIE MED IMAGING 201; Keating NL, 2015, JAMA-J AM MED ASSOC, V314, P1569, DOI 10.1001/jama.2015.13086; Krizhevsky A., 2012, NEURIPS, P1106; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Li CM, 2010, IEEE T IMAGE PROCESS, V19, P3243, DOI 10.1109/TIP.2010.2069690; Liu B, 2010, PATTERN RECOGN, V43, P2028, DOI 10.1016/j.patcog.2010.01.002; Liu Y, 2012, J DIGIT IMAGING, V25, P580, DOI 10.1007/s10278-011-9450-6; Maas A.L., 2013, P ICML; Madabhushi A, 2003, IEEE T MED IMAGING, V22, P155, DOI 10.1109/TMI.2002.808364; Raza S, 2010, RADIOGRAPHICS, V30, P1199, DOI 10.1148/rg.305095144; Ronneberger O., 2015, INT C MED IM COMP CO, P234; Shulman LN, 2010, J ONCOL, V2010, DOI 10.1155/2010/595167; Siegel RL, 2016, CA CANC J CLIN, V2015; Sippel S, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-72; Skaane P, 1998, AM J ROENTGENOL, V170, P109, DOI 10.2214/ajr.170.1.9423610; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tian JW, 2012, ULTRASOUND MED BIOL, V38, P119, DOI 10.1016/j.ultrasmedbio.2011.09.011; Tieleman T, 2012, COURSERA NEURAL NETW, V4; Wirth MA, 2004, COMP ROB VIS 2004 P; Zhang Q, 2016, ULTRASONICS, V72, P150, DOI 10.1016/j.ultras.2016.08.004; Zhu SC, 1996, IEEE T PATTERN ANAL, V18, P884, DOI 10.1109/34.537343	32	23	23	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0195816	10.1371/journal.pone.0195816	http://dx.doi.org/10.1371/journal.pone.0195816			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768415	gold, Green Submitted, Green Published			2022-12-26	WOS:000432329200010
J	van Oostrom, SH; Engelfriet, PM; Verschuren, WMM; Schipper, M; Wouters, IM; Boezen, M; Smit, HA; Kerstjens, HAM; Picavet, HSJ				van Oostrom, Sandra H.; Engelfriet, Peter M.; Verschuren, W. M. Monique; Schipper, Maarten; Wouters, Inge M.; Boezen, Marike; Smit, Henriette A.; Kerstjens, Huib A. M.; Picavet, H. Susan J.			Aging-related trajectories of lung function in the general population-The Doetinchem Cohort Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; REFERENCE VALUES; NATURAL-HISTORY; COMPUTED-TOMOGRAPHY; SMOKING-CESSATION; GLOBAL BURDEN; BODY-MASS; ALL-CAUSE; SPIROMETRY	The objective of this study was to explore trajectories of lung function decline with age in the general population, and to study the effect of sociodemographic and life style related risk factors, in particular smoking and BMI. For this purpose, we used data from the Doetinchem Cohort Study (DCS) of men and women, selected randomly from the general population and aged 20-59 years at inclusion in 1987-1991, and followed until the present. Participants in the DCS are assessed every five years. Spirometry has been performed as part of this assessment from 1994 onwards. Participants were included in this study if spirometric measurement of FEV1, which in this study was the main parameter of interest, was acceptable and reproducible on at least one measurement round, leading to the inclusion of 5727 individuals (3008 females). Statistical analysis revealed three typical trajectories. The majority of participants followed a trajectory that closely adhered to the Global Lung Initiative Reference values (94.9% of men and 96.4% of women). Two other trajectories showed a more pronounced decline. Smoking and the presence of respiratory complaints were the best predictors of a trajectory with stronger decline. A greater BMI over the follow-up period was associated with a more unfavorable FEV1 course both in men (beta = -0.027 (SD = 0.002); P < 0.001) and in women (beta = -0.008 (SD = 0.001); P < 0.001). Smokers at baseline who quit the habit during follow-up, showed smaller decline in FEV1 in comparison to persistent smokers, independent of BMI change (In men beta = -0.074 (SD = 0.020); P < 0.001. In women beta = -0.277 (SD = 0.068); P < 0.001). In conclusion, three typical trajectories of age-related FEV1 decline could be distinguished. Change in the lifestyle related risk factors, BMI and smoking, significantly impact aging-related decline of lung function. Identifying deviant trajectories may help in early recognition of those at risk of a diagnosis of lung disease later in life.	[van Oostrom, Sandra H.; Engelfriet, Peter M.; Verschuren, W. M. Monique; Schipper, Maarten; Picavet, H. Susan J.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Wouters, Inge M.] Univ Utrecht, IRAS, Div Environm Epidemiol, Utrecht, Netherlands; [Boezen, Marike] Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Kerstjens, Huib A. M.] Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Groningen	Engelfriet, PM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	peter.engelfriet@rivm.nl	Kerstjens, Huib/N-4754-2017	Kerstjens, Huib/0000-0001-7705-7927; engelfriet, peter/0000-0001-7221-3599; Picavet, Susan/0000-0002-6895-165X; Wouters, Inge M./0000-0001-7834-9390	Netherlands' Ministry of Health, Welfare and Sport	Netherlands' Ministry of Health, Welfare and Sport	The Doetinchem Cohort Study is funded by the Netherlands' Ministry of Health, Welfare and Sport. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2016, EUR RESPIR J, V47, P410, DOI 10.1183/13993003.01359-2015; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bottai M, 2002, EUR RESPIR J, V20, P665, DOI 10.1183/09031936.02.01282001; Brown WJ, 2012, DEV EVIDENCE BASED P; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; BURROWS B, 1987, NEW ENGL J MED, V317, P1309, DOI 10.1056/NEJM198711193172103; Celli BR, 2015, EUR RESPIR J, V45, P879, DOI 10.1183/09031936.00009015; Chinn DJ, 1996, THORAX, V51, P699, DOI 10.1136/thx.51.7.699; Colak Y, 2015, COPD, V12, P5, DOI 10.3109/15412555.2014.933955; Copley SJ, 2012, J THORAC IMAG, V27, P366, DOI 10.1097/RTI.0b013e31825148c9; ENRIGHT PL, 1991, AM REV RESPIR DIS, V143, P1215, DOI 10.1164/ajrccm/143.6.1215; Faner R, 2012, AM J RESP CRIT CARE, V186, P306, DOI 10.1164/rccm.201202-0282PP; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fragoso CAV, 2015, AM J RESP CRIT CARE, V192, P817, DOI 10.1164/rccm.201503-0463OC; Fukuchi Yoshinosuke, 2009, Proc Am Thorac Soc, V6, P570, DOI 10.1513/pats.200909-099RM; GLINDMEYER HW, 1982, AM REV RESPIR DIS, V125, P544, DOI 10.1164/arrd.1982.125.5.544; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Islam JY, 2015, AM J RESP CRIT CARE, V192, P134, DOI 10.1164/rccm.201412-2142PP; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Jones RCM, 2014, LANCET RESP MED, V2, P267, DOI 10.1016/S2213-2600(14)70008-6; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Luoto JA, 2016, EUR RESPIR J, V47, P461, DOI 10.1183/13993003.00635-2015; Maciewicz Rose A, 2009, Proc Am Thorac Soc, V6, P614, DOI 10.1513/pats.200908-094RM; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; McClean KM, 2008, THORAX, V63, P649, DOI 10.1136/thx.2007.086801; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Ochs-Balcom HM, 2006, CHEST, V129, P853, DOI 10.1378/chest.129.4.853; Oelsner EC, 2014, ANN INTERN MED, V161, P863, DOI 10.7326/M13-2570; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Pols MA, 1997, PREV MED, V26, P37, DOI 10.1006/pmed.1996.9995; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Postma DS, 2015, LANCET, V385, P899, DOI 10.1016/S0140-6736(14)60446-3; Proust-Lima C, 2007, STAT MED, V26, P2229, DOI 10.1002/sim.2659; Proust-Lima Cecile, 2015, ESTIMATION EXTENDED; Putman RK, 2016, JAMA-J AM MED ASSOC, V315, P672, DOI 10.1001/jama.2016.0518; Quanjer PH, 2011, EUR RESPIR J, V37, P658, DOI 10.1183/09031936.00110010; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Stanojevic S, 2010, EUR RESPIR J, V36, P12, DOI 10.1183/09031936.00143209; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Team RC, 2016, R LANG ENV STAT COMP; Tu YK, 2013, INT J EPIDEMIOL, V42, P1327, DOI 10.1093/ije/dyt157; VANPELT W, 1994, AM J RESP CRIT CARE, V149, P1218, DOI 10.1164/ajrccm.149.5.8173762; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; WARE JH, 1990, AM J EPIDEMIOL, V132, P685, DOI 10.1093/oxfordjournals.aje.a115710; Weiss ST, 1996, AM J RESP CRIT CARE, V154, pS208, DOI 10.1164/ajrccm/154.6_Pt_2.S208; Wise RA, 1998, AM J RESP CRIT CARE, V157, P866, DOI 10.1164/ajrccm.157.3.9706076; XU X, 1994, EUR RESPIR J, V7, P1056; XU XP, 1995, AM J EPIDEMIOL, V141, P554, DOI 10.1093/oxfordjournals.aje.a117471	55	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197250	10.1371/journal.pone.0197250	http://dx.doi.org/10.1371/journal.pone.0197250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768509	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200071
J	Lengyel, M; Czirjak, G; Enyedi, P				Lengyel, Miklos; Czirjak, Gabor; Enyedi, Peter			TRESK background potassium channel is not gated at the helix bundle crossing near the cytoplasmic end of the pore	PLOS ONE			English	Article							2-PORE DOMAIN; K+ CHANNEL; FUNCTIONAL HETERODIMERS; MECHANISM; TREK-2; LEAK; BINDING; BLOCK	Two-pore domain K+ channels (K-2P) are responsible for background K+ currents and regulate the resting membrane potential and cellular excitability. Their activity is controlled by a large variety of physicochemical factors and intracellular signaling pathways. The majority of these effects converge on the intracellular C-terminus of the channels, resulting in the modification of the gating at the selectivity filter. Another gating mechanism, the activation gate at the helix bundle crossing is also well documented in other K+ channel families, however, it remains uncertain whether this type of gating is functional in K-2P channels. The regulation of TWIK-related spinal cord K+ channel (TRESK) is different from the other K-2P channels. Regulatory factors acting via the C-terminus are not known, instead channel activity is modified by the phosphorylation/dephosphorylation of the unusually long intracellular loop between the 2nd and 3rd transmembrane segments. These unique structural elements of the regulation lead us to examine channel gating at the bundle crossing region. Ba2+ was applied to the intracellular side of excised membrane patches and the characteristics of the channel block were determined. We compared the kinetics of the development of Ba 2+ block when the channels were phosphorylated (inhibited) or dephosphorylated (activated) and also in different mutants mimicking the two functional states. Neither the phosphorylation/dephosphorylation nor the point mutations influenced the development of Ba2+ block, suggesting that the conformational changes of the bundle crossing region do not contribute to the phosphorylation-dependent gating of TRESK.	[Lengyel, Miklos; Czirjak, Gabor; Enyedi, Peter] Semmelweis Univ, Dept Physiol, Budapest, Hungary	Semmelweis University	Enyedi, P (corresponding author), Semmelweis Univ, Dept Physiol, Budapest, Hungary.	enyedi.peter@med.semmelweis-univ.hu	; Lengyel, Miklos/E-6697-2016	Czirjak, Gabor/0000-0002-5485-2327; Lengyel, Miklos/0000-0001-6382-6369	Hungarian National Research Fund [OTKA K108496]; New National Excellence Program of the Ministry of Human Capacities [UNKP-17-3-I-SE-7]; Ministry of Human Capacities in the frame of Institutional Excellence Program for Higher Education	Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New National Excellence Program of the Ministry of Human Capacities; Ministry of Human Capacities in the frame of Institutional Excellence Program for Higher Education	This work was supported by the Hungarian National Research Fund (OTKA K108496) (PE). M.L. was supported by the New National Excellence Program of the Ministry of Human Capacities (UNKP-17-3-I-SE-7). The work was supported by the Ministry of Human Capacities in the frame of Institutional Excellence Program for Higher Education.	ARMSTRONG CM, 1982, J GEN PHYSIOL, V80, P663, DOI 10.1085/jgp.80.5.663; Ashmole I, 2009, J PHYSIOL-LONDON, V587, P4769, DOI 10.1113/jphysiol.2009.175430; Bagriantsev SN, 2012, EMBO J, V31, P3297, DOI 10.1038/emboj.2012.171; Bagriantsev SN, 2011, EMBO J, V30, P3594, DOI 10.1038/emboj.2011.230; Bautista DM, 2008, NAT NEUROSCI, V11, P772, DOI 10.1038/nn.2143; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Braun G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028119; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Czirjak B, 2004, J BIOL CHEM, V279, P18550, DOI 10.1074/jbc.M312229200; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Czirjak G, 2010, J BIOL CHEM, V285, P14549, DOI 10.1074/jbc.M110.102020; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Enyedi P, 2012, MOL CELL ENDOCRINOL, V353, P75, DOI 10.1016/j.mce.2011.11.009; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Feliciangeli S, 2015, J PHYSIOL-LONDON, V593, P2587, DOI 10.1113/jphysiol.2014.287268; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Niemeyer MI, 2016, MOL PHARMACOL, V90, P309, DOI 10.1124/mol.116.103895; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Kang D, 2006, AM J PHYSIOL-CELL PH, V291, pC138, DOI 10.1152/ajpcell.00629.2005; Lengyel M, 2016, J BIOL CHEM, V291, P13649, DOI 10.1074/jbc.M116.719039; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Lolicato M, 2017, NATURE, V547, P364, DOI 10.1038/nature22988; Ma XY, 2011, J BIOL CHEM, V286, P39813, DOI 10.1074/jbc.M111.264788; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Proks P, 2003, EMBO REP, V4, P70, DOI 10.1038/embor708; Sano Y, 2003, J BIOL CHEM, V278, P27406, DOI 10.1074/jbc.M206810200; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yoo S, 2009, NEUROSCI LETT, V465, P79, DOI 10.1016/j.neulet.2009.08.062; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197622	10.1371/journal.pone.0197622	http://dx.doi.org/10.1371/journal.pone.0197622			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763475	Green Submitted, Green Published, gold			2022-12-26	WOS:000432118800057
J	Xia, WW; Liu, CJ; Duan, S; Xu, S; Wang, KF; Zhu, ZQ; Liu, HY				Xia, Weiwei; Liu, Chenjun; Duan, Shuo; Xu, Shuai; Wang, Kaifeng; Zhu, Zhenqi; Liu, Haiying			The influence of spinal-pelvic parameters on the prevalence of endplate Modic changes in degenerative thoracolumbar/lumbar kyphosis patients	PLOS ONE			English	Article							LUMBAR; ADJACENT	Background The typical degeneration of the vertebral endplate shown in MRI imaging is Modic change. The aim of this study was to observe the distribution of the Modic changes of vertebral endplate in degenerative thoracolumbar/lumbar kyphosis (DTK/LK) patients and analyse the correlation between spinal-pelvic parameters and Modic changes. Methods The imaging data of 58 patients diagnosed with DTK/LK (coronal Cobb angle<10 degrees with sagittal imbalance) in our hospital from March 2016 to May 2017 were reviewed retrospectively. Observe the prevalence, type and distribution characteristics of Modic changes occurred at the vertebral endplate from T10 to Sl;analyse the correlation between Modic changes and disc degeneration, the sagittal vertical axis (SVA), thoracic kyphosis (TK), thoracolumbar kyphosis (TLK), lumbar lordosis (LL), sacral slope (SS), pelvic tilt (PT) and pelvic incidence (PI). Results Of the 928 intervertebral endplates from 58 patients, Modic changes occurred at 90 endplates (9.7%) of 30 patients (51.7%). 5 endplates (0.5%) of 3 patients (5.2%) were classified as type I, 68 endplates (7.3%) of 25 patients (43.1%) as type II, 17 endplates (1.8%) of 9 patients (15.5%) as type III. The location of the degenerative endplates: 2 (2.2%) superior and inferior endplates of L1, 3 (3.3%) inferior endplates of T11 and T12, 4 (4.4%) superior endplates of L2, 6 (6.7%) inferior endplates of L2 and L4, 8 (8.9%) superior endplates of Si, 9 (10%) superior endplates of L3, 11 (12.2%) inferior endplates of L3 and L5 and superior endplates of L4, 12 (13.3%) superior endplates of L5. Modic changes were significantly correlated with intervertebral disc degeneration (r = 0.414, p<0.01); the amount of Modic changes were significantly correlated with LL (r = -0.562, p = 0.012), SS (r = -0.46, p = 0.048), PT (r = 0.516, p = 0.024). Conclusions Most of the Modic changes of vertebral endplates in DTK/LK patients are type II which are prevalently located at L3/4, L4/5 and L5/S1. The Modic changes of vertebral endplates were found to be significantly correlated with disc degeneration, LL, SS, and PT.	[Xia, Weiwei; Liu, Chenjun; Duan, Shuo; Xu, Shuai; Wang, Kaifeng; Zhu, Zhenqi; Liu, Haiying] Peking Univ, Dept Spinal Surg, Peoples Hosp, Beijing, Peoples R China	Peking University	Liu, HY (corresponding author), Peking Univ, Dept Spinal Surg, Peoples Hosp, Beijing, Peoples R China.	Liu_haiying@263.net			National Natural Science Foundation of China [61474107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China, grant number 61474107. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005; Albert HB, 2008, MED HYPOTHESES, V70, P361, DOI 10.1016/j.mehy.2007.05.014; Albert HB, 2007, EUR SPINE J, V16, P977, DOI 10.1007/s00586-007-0336-8; Analysis R., 2007, LUMBAR DEGENERATIVE, V32, P2694; Barth M, 2008, SPINE, V33, P273, DOI 10.1097/BRS.0b013e31816201a6; Bruno AG, 2012, J BONE MINER RES, V27, P2144, DOI 10.1002/jbmr.1658; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; DEROOS A, 1987, AM J ROENTGENOL, V149, P531, DOI 10.2214/ajr.149.3.531; Espahbodi S, 2013, SPINE, V38, pE230, DOI 10.1097/BRS.0b013e31827ecd6e; Glassman SD, 2005, SPINE, V30, P2024, DOI 10.1097/01.brs.0000179086.30449.96; Han C, 2017, SCI REP-UK, V7, DOI 10.1038/srep46341; Hansson T, SPINE PHILA PA 1976, V6, P375; Jensen TS, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-81; Jensen TS, 2010, EUR SPINE J, V19, P129, DOI 10.1007/s00586-009-1184-5; Karppinen J, 2008, SPINE, V33, P1236, DOI 10.1097/BRS.0b013e318170fd0e; Lee CH, 2017, J KOREAN NEUROSURG S, V60, P125, DOI 10.3340/jkns.2016.0607.001; Li SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114993; Malinin T, 2007, SPINE, V32, pE603, DOI 10.1097/BRS.0b013e31815574e7; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; Mok FPS, 2016, SPINE J, V16, P32, DOI 10.1016/j.spinee.2015.09.060; Nizard RS, 2001, RADIOL CLIN N AM, V39, P55, DOI 10.1016/S0033-8389(05)70263-3; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; TAKEMITSU Y, 1988, SPINE, V13, P1317, DOI 10.1097/00007632-198811000-00019; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Wu HL, 2012, SPINE, V37, P1958, DOI 10.1097/BRS.0b013e31825bfb85	25	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197470	10.1371/journal.pone.0197470	http://dx.doi.org/10.1371/journal.pone.0197470			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763470	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800055
J	Himes, BE; Obraztsova, K; Lian, LR; Shumyatcher, M; Rue, R; Atochina-Vasserman, EN; Hur, SK; Bartolomei, MS; Evans, JF; Krymskaya, VP				Himes, Blanca E.; Obraztsova, Kseniya; Lian, Lurong; Shumyatcher, Maya; Rue, Ryan; Atochina-Vasserman, Elena N.; Hur, Stella K.; Bartolomei, Marisa S.; Evans, Jilly F.; Krymskaya, Vera P.			Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; MESSENGER-RNA; GROWTH; MTOR; INSULIN; SIROLIMUS; PATHWAY; DISEASE; STAT3	Lymphangioleiomyomatosis (LAM) is a rare, almost exclusively female lung disease linked to inactivating mutations in tuberous sclerosis complex 2 (TSC2), a tumor suppressor gene that controls cell metabolic state and growth via regulation of the mechanistic target of rapamycin (mTORC1) signaling. mTORC1 is frequently activated in human cancers and, although the mTORC1 inhibitor rapamycin has a cytostatic effect, it is, in general, unable to elicit a robust curative effect or tumor regression. Using RNA-Seq, we identified (1) Insulin-like Growth Factor (IGF2) as one of the genes with the highest fold-change difference between human TSC2-null and TSC2-expressing angiomyolipoma cells from a patient with LAM, and (2) the mouse IGF2 homolog IGF2, as a top-ranking gene according to fold change between Tsc2(-/-) and Tsc2(+/+) mouse embryo fibroblasts (MEFs). We extended transcript-level findings to protein level, observing increased IGF2 protein expression and Igf2 secretion by Tsc2(-/-) MEFs. Increased Igf2 expression was not due to epigenetic imprinting, but was partially mediated through the Stat3 pathway and was completely insensitive to rapamycin treatment. An siRNA-mediated decrease of Igf2 resulted in decreased Stat3 phosphorylation, suggesting presence of an autocrine Igf2/Stat3 amplification cycle in Tsc2(-/-) MEFs. In human pulmonary LAM lesions and metastatic cell clusters, high levels of IGF2 were associated with mTORC1 activation. In addition, treatment of three primary IGF2-expressing LAM lung cell lines with rapamycin did not result in IGF2 level changes. Thus, targeting of IGF2 signaling may be of therapeutic value to LAM patients, particularly those who are unresponsive to rapamycin.	[Himes, Blanca E.; Shumyatcher, Maya] Univ Penn, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Obraztsova, Kseniya; Lian, Lurong; Rue, Ryan; Atochina-Vasserman, Elena N.; Evans, Jilly F.; Krymskaya, Vera P.] Univ Penn, Perelman Sch Med, Penn Ctr Pulm Biol & Pulm, Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Hur, Stella K.; Bartolomei, Marisa S.] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA; [Hur, Stella K.; Bartolomei, Marisa S.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Krymskaya, VP (corresponding author), Univ Penn, Perelman Sch Med, Penn Ctr Pulm Biol & Pulm, Allergy & Crit Care Div, Philadelphia, PA 19104 USA.	krymskav@pennmedicine.upenn.edu	Atochina-Vasserman, Elena/AAN-2286-2020	Krymskaya, Vera/0000-0002-0584-4486; Bartolomei, Marisa/0000-0001-9410-5222; Atochina-Vasserman, Elena N/0000-0001-7950-7004	NIH NHLBI [R00 HL105663, R01 HL133433, RO1 HL131626, RO1 HL114085, R01 HL110551]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM051279] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH NHLBI R00 HL105663 (BEH), R01 HL133433 (BEH), RO1 HL131626 (VPK), RO1 HL114085 (VPK), and R01 HL110551 (VPK) (https://www.nhlbi.nih.gov/).	[Anonymous], 2021, LANG ENV STAT COMP; Barroca V, 2017, EBIOMEDICINE, V15, P150, DOI 10.1016/j.ebiom.2016.11.035; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Brown J, 2009, TRENDS BIOCHEM SCI, V34, P612, DOI 10.1016/j.tibs.2009.07.003; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6; Clermont F, 2012, EMBO MOL MED, V4, P688, DOI 10.1002/emmm.201201509; Cortes J, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.530; D'Armiento J, 2016, CANCER RES, V76, P844, DOI 10.1158/0008-5472.CAN-15-1287; Dai N, 2015, CELL METAB, V21, P609, DOI 10.1016/j.cmet.2015.03.006; Dai N, 2013, GENE DEV, V27, P301, DOI 10.1101/gad.209130.112; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; DAUGHADAY WH, 1988, NEW ENGL J MED, V319, P1434, DOI 10.1056/NEJM198812013192202; Ding M, 2016, NAT CELL BIOL, V18, P319, DOI 10.1038/ncb3311; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Friedbichler K, 2014, MOL CANCER THER, V13, P399, DOI 10.1158/1535-7163.MCT-13-0598; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goncharova EA, 2014, CELL REP, V7, P412, DOI 10.1016/j.celrep.2014.03.025; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Goncharova EA, 2009, MOL PHARMACOL, V76, P766, DOI 10.1124/mol.109.057042; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Haley VL, 2012, EMBO MOL MED, V4, P705, DOI 10.1002/emmm.201101105; Hardouin SN, 2011, DEVELOPMENT, V138, P203, DOI 10.1242/dev.054916; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hur SK, 2016, P NATL ACAD SCI US; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; Kalish JM, 2014, INT J DEV BIOL, V58, P291, DOI 10.1387/ijdb.140077mb; Krymskaya VP, 2017, ANNU REV MED, V68, P69, DOI 10.1146/annurev-med-050715-104245; Li XK, 2017, ONCOTARGET, V8, P36628, DOI 10.18632/oncotarget.16695; Lin L, 2009, ONCOGENE, V28, P961, DOI 10.1038/onc.2008.448; Livingstone C, 2013, ENDOCR-RELAT CANCER, V20, pR321, DOI 10.1530/ERC-13-0231; Manning BD, 2017, NEW ENGL J MED, V377, P1297, DOI 10.1056/NEJMcibr1709384; McCormack FX, 2014, AM J RESP CRIT CARE, V190, P1332, DOI 10.1164/rccm.201411-2032ED; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Seyama K, 2010, AM J PATHOL, V176, P2051, DOI 10.2353/ajpath.2010.091239; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Simpson A, 2017, TARGET ONCOL, V12, P571, DOI 10.1007/s11523-017-0514-5; Steigen SE, 2009, MODERN PATHOL, V22, P914, DOI 10.1038/modpathol.2009.48; Valencia JC, 2015, J INVEST MED, V49, P421; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	49	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197105	10.1371/journal.pone.0197105	http://dx.doi.org/10.1371/journal.pone.0197105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758070	gold, Green Published, Green Submitted			2022-12-26	WOS:000432082900027
J	Schultz, HS; Ostergaard, S; Sidney, J; Lamberth, K; Sette, A				Schultz, Heidi S.; Ostergaard, Soren; Sidney, John; Lamberth, Kasper; Sette, Alessandro			The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptides	PLOS ONE			English	Article							IMMUNOGENICITY; RESPONSES; AFFINITY; ALPHA; INDUCTION; TOLERANCE; EPITOPES; SEQUENCE; IMPACTS; SHARE	Immunogenicity is a major concern in drug development as anti-drug antibodies in many cases affect both patient safety and drug efficacy. Another concern is often the limited halflife of drugs, which can be altered by different chemical modifications, like acylation with fatty acids. However, acylation with fatty acids has been shown in some cases to modulate T cell activation. Therefore, to understand the role of acylation with fatty acids on immunogenicity we tested three immunogenic non-acylated peptides and 14 of their acylated analogues for binding to 26 common HLA class II alleles, and their ability to activate T cells in an ex vivo T cell assay. Changes in binding affinity associated with acylation with fatty acids were typically modest, though a significant decrease was observed for influenza HA acylated with a stearic acid, and affinities for DQ alleles were consistently increased. Importantly, we showed that for all three immunogenic peptides acylation with fatty acids decreased their capacity to activate T cells, a trend particularly evident with longer fatty acids typically positioned within the peptide HLA class II binding core region, or when closer to the C-terminus. With these results we have demonstrated that acylation with fatty acids of immunogenic peptides can lower their stimulatory capacity, which could be important knowledge for drug design and immunogenicity mitigation.	[Schultz, Heidi S.; Ostergaard, Soren; Lamberth, Kasper] Novo Nordisk AS, Global Res, Malov, Denmark; [Schultz, Heidi S.; Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	Novo Nordisk; La Jolla Institute for Immunology	Schultz, HS (corresponding author), Novo Nordisk AS, Global Res, Malov, Denmark.; Schultz, HS (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	HSHZ@novonordisk.com	Ostergaard, Soren/B-8123-2019; Sette, Alessandro/AFO-8916-2022	Ostergaard, Soren/0000-0002-9415-3352; 	Novo Nordisk A/S	Novo Nordisk A/S(Novo Nordisk)	HSS, SO and KL are employed by the commercial company: Novo Nordisk A/S. Novo Nordisk A/S provided support in the form of salaries for these authors, as well as provided input for study design, data collection, analysis, and preparation of the manuscript.	ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Almond RJ, 2013, EUR J IMMUNOL, V43, P170, DOI 10.1002/eji.201142345; Brawley JV, 2002, J IMMUNOL, V168, P3894, DOI 10.4049/jimmunol.168.8.3894; Bueno C, 2004, EUR J IMMUNOL, V34, P3497, DOI 10.1002/eji.200425369; Choi YI, 2014, AM DIAB ASS ADA 74 S; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Fineman MS, 2012, DIABETES OBES METAB, V14, P546, DOI 10.1111/j.1463-1326.2012.01561.x; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Greer JM, 2001, J IMMUNOL, V166, P6907, DOI 10.4049/jimmunol.166.11.6907; Hutter J, 2013, J IMMUNOL, V190, P220, DOI 10.4049/jimmunol.1201060; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; KRIEGER JI, 1991, J IMMUNOL, V146, P2331; Kumai T, 2014, CANCER IMMUNOL IMMUN, V63, P469, DOI 10.1007/s00262-014-1533-z; LAMB JR, 1982, NATURE, V300, P66, DOI 10.1038/300066a0; Lamberth K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1286; Livingston BD, 1997, J IMMUNOL, V159, P1383; Madsen CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050139; Mahlangu JN, 2015, J THROMB HAEMOST, V13, P1989, DOI 10.1111/jth.13141; Mann RJ, 2010, BRIT J PHARMACOL, V160, P1973, DOI 10.1111/j.1476-5381.2010.00834.x; McKinney DM, 2013, IMMUNOGENETICS, V65, P357, DOI 10.1007/s00251-013-0684-y; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; OSULLIVAN D, 1990, J IMMUNOL, V145, P1799; OSULLIVAN D, 1991, J IMMUNOL, V146, P1240; OSULLIVAN D, 1991, J IMMUNOL, V147, P2663; Pollaro L, 2010, MEDCHEMCOMM, V1, P319, DOI 10.1039/c0md00111b; Purcell AW, 2008, IMMUNOL CELL BIOL, V86, P574, DOI 10.1038/icb.2008.48; ROCHE PA, 1990, J IMMUNOL, V144, P1849; SETTE A, 1989, J IMMUNOL, V143, P1265; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sidney J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177140; Sidney J, 2010, J IMMUNOL, V185, P4189, DOI 10.4049/jimmunol.1001006; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Southwood S, 1998, J IMMUNOL, V160, P3363; St Louis J, 1999, J AUTOIMMUN, V12, P177, DOI 10.1006/jaut.1998.0275; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Streng-Ouwehand I, 2016, ELIFE, V5, DOI 10.7554/eLife.11765; Tsunoda I, 1999, VACCINE, V17, P675, DOI 10.1016/S0264-410X(98)00250-3; Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Wang YMC, 2016, AAPS J, V18, P395, DOI 10.1208/s12248-015-9857-y; Weber CA, 2009, ADV DRUG DELIVER REV, V61, P965, DOI 10.1016/j.addr.2009.07.001; Zhang L, 2015, BIOCONJUGATE CHEM, V26, P329, DOI 10.1021/bc500584t	44	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197407	10.1371/journal.pone.0197407	http://dx.doi.org/10.1371/journal.pone.0197407			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758051	Green Published, gold, Green Submitted			2022-12-26	WOS:000432082900045
J	Adams, FG; Stroeher, UH; Hassan, KA; Marri, S; Brown, MH				Adams, Felise G.; Stroeher, Uwe H.; Hassan, Karl A.; Marri, Shashikanth; Brown, Melissa H.			Resistance to pentamidine is mediated by AdeAB, regulated by AdeRS, and influenced by growth conditions in Acinetobacter baumannii ATCC 17978	PLOS ONE			English	Article							ESCHERICHIA-COLI; EFFLUX PUMP; PSEUDOMONAS-AERUGINOSA; MULTIDRUG-RESISTANCE; ANTIBIOTIC-RESISTANCE; HISTIDINE KINASE; DRUG-RESISTANCE; SYSTEM; GENE; EXPRESSION	In recent years, effective treatment of infections caused by Acinetobacter baumannii has become challenging due to the ability of the bacterium to acquire or up-regulate antimicrobial resistance determinants. Two component signal transduction systems are known to regulate expression of virulence factors including multidrug efflux pumps. Here, we investigated the role of the AdeRS two component signal transduction system in regulating the AdeAB efflux system, determined whether AdeA and/or AdeB can individually confer antimicrobial resistance, and explored the interplay between pentamidine resistance and growth conditions in A. baumannii ATCC 17978. Results identified that deletion of adeRS affected resistance towards chlorhexidine and 4',6-diamidino-2-phenylindole dihydrochloride, two previously defined AdeABC substrates, and also identified an 8-fold decrease in resistance to pentamidine. Examination of Delta adeA, Delta adeB and Delta adeAB cells augmented results seen for Delta adeRS and identified a set of dicationic AdeAB substrates. RNA-sequencing of AadeRS revealed transcription of 290 genes were >= 2-fold altered compared to the wildtype. Pentamidine shock significantly increased adeA expression in the wildtype, but decreased it in AadeRS, implying that AdeRS activates adeAB transcription in ATCC 17978. Investigation under multiple growth conditions, including the use of Biolog phenotypic microarrays, revealed resistance to pentamidine in ATCC 17978 and mutants could be altered by bioavailability of iron or utilization of different carbon sources. In conclusion, the results of this study provide evidence that AdeAB in ATCC 17978 can confer intrinsic resistance to a subset of dicationic compounds and in particular, resistance to pentamidine can be significantly altered depending on the growth conditions.	[Adams, Felise G.; Stroeher, Uwe H.; Brown, Melissa H.] Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia; [Hassan, Karl A.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW, Australia; [Marri, Shashikanth] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia; [Hassan, Karl A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia	Flinders University South Australia; Macquarie University; Flinders University South Australia; University of Newcastle	Brown, MH (corresponding author), Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia.	melissa.brown@flinders.edu.au	Brown, Melissa/V-2296-2017; Hassan, Karl/B-2802-2013	Brown, Melissa/0000-0001-6461-7550; Adams, Felise/0000-0002-6427-0689; Stroeher, Uwe/0000-0001-5705-7751; Marri, Shashikanth/0000-0002-0347-8670; Hassan, Karl/0000-0003-2031-9679	Australian National Health and Medical Research Council [1047509]; Flinders Medical Research Foundation; AJ and IM Naylon Scholarship; Playford Trust Ph.D. Scholarship	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Flinders Medical Research Foundation; AJ and IM Naylon Scholarship; Playford Trust Ph.D. Scholarship	This work was supported by the Australian National Health and Medical Research Council (Project Grant 1047509) and a Flinders Medical Research Foundation Grant to MHB and UHS. FGA was supported by AJ and IM Naylon and Playford Trust Ph.D. Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2010, ANTIMICROB AGENTS CH, V54, P3569, DOI 10.1128/AAC.00057-10; AMOS H, 1957, J BACTERIOL, V73, P172, DOI 10.1128/JB.73.2.172-177.1957; Blackwell GA, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00117-16; Brown MH, 2001, J MOL MICROB BIOTECH, V3, P163; Camarena L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000834; Chang TY, 2016, MICROBIOL RES, V183, P60, DOI 10.1016/j.micres.2015.11.010; Chuanchuen R, 2002, J BACTERIOL, V184, P5036, DOI 10.1128/JB.184.18.5036-5044.2002; CONRAD RS, 1979, ANTIMICROB AGENTS CH, V15, P59, DOI 10.1128/AAC.15.1.59; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; DAVID SA, 1994, BBA-LIPID LIPID MET, V1212, P167, DOI 10.1016/0005-2760(94)90250-X; Dorsey CW, 2002, APPL ENVIRON MICROB, V68, P6353, DOI 10.1128/AEM.68.12.6353-6360.2002; Eijkelkamp BA, 2013, INFECT IMMUN, V81, P2574, DOI 10.1128/IAI.00065-13; Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126; Ezraty B, 2016, FEMS MICROBIOL REV, V40, P418, DOI 10.1093/femsre/fuw004; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Giles SK, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0440-6; Hamidian M, 2014, J ANTIMICROB CHEMOTH, V69, P2625, DOI 10.1093/jac/dku188; HAMM RE, 1954, J AM CHEM SOC, V76, P2111, DOI 10.1021/ja01637a021; Hassan KA, 2013, P NATL ACAD SCI USA, V110, P20254, DOI 10.1073/pnas.1317052110; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Koteva K, 2010, NAT CHEM BIOL, V6, P327, DOI 10.1038/nchembio.350; Li LP, 2016, J ANTIMICROB CHEMOTH, V71, P1223, DOI 10.1093/jac/dkv460; Li L, 2016, P NATL ACAD SCI USA, V113, P1648, DOI 10.1073/pnas.1520300113; Li X, 2016, EUR J CLIN MICROBIOL, V35, P1371, DOI 10.1007/s10096-016-2674-0; Lin MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132843; Liou ML, 2014, J MICROBIOL IMMUNOL, V47, P275, DOI 10.1016/j.jmii.2012.12.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACRINA FL, 1983, GENE, V25, P145; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; Mine T, 1999, ANTIMICROB AGENTS CH, V43, P415, DOI 10.1128/AAC.43.2.415; Murray GL, 2017, J INFECT DIS, V215, pS52, DOI 10.1093/infdis/jiw529; Nemec A, 2007, J ANTIMICROB CHEMOTH, V60, P483, DOI 10.1093/jac/dkm231; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Nowak J, 2016, ANTIMICROB AGENTS CH, V60, P1085, DOI 10.1128/AAC.02413-15; PECSOK RL, 1955, J AM CHEM SOC, V77, P1489, DOI 10.1021/ja01611a025; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2007, ANTIMICROB AGENTS CH, V51, P2065, DOI 10.1128/AAC.01198-06; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P228, DOI 10.1093/jac/dkp427; Richmond GE, 2016, MBIO, V7, DOI 10.1128/mBio.00430-16; Saravanan R, 2017, VALUE ADDITION MED A, P1; Saroj SD, 2012, ANTIMICROB AGENTS CH, V56, P4955, DOI 10.1128/AAC.00739-12; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Stokes JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.28; Sugawara E, 2014, ANTIMICROB AGENTS CH, V58, P7250, DOI 10.1128/AAC.03728-14; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Tucker AT, 2014, MBIO, V5, DOI 10.1128/mBio.01313-14; Wang JF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192288; Wen YR, 2017, NUCLEIC ACIDS RES, V45, P9773, DOI 10.1093/nar/gkx624; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wong ILK, 2006, MOL BIOCHEM PARASIT, V150, P278, DOI 10.1016/j.molbiopara.2006.08.014; Wright MS, 2017, MBIO, V8, DOI [10.1128/mBio.02193-16, 10.1128/mbio.02193-16]; Yoon EJ, 2015, MBIO, V6, DOI 10.1128/mBio.00309-15; Yoon EJ, 2013, ANTIMICROB AGENTS CH, V57, P2989, DOI 10.1128/AAC.02556-12	61	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2018	13	5							e0197412	10.1371/journal.pone.0197412	http://dx.doi.org/10.1371/journal.pone.0197412			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF3LC	29750823	Green Submitted, gold, Green Published			2022-12-26	WOS:000431856300030
J	Bruno, A; Bassani, B; D'Urso, DG; Pitaku, I; Cassinotti, E; Pelosi, G; Boni, L; Dominioni, L; Noonan, DM; Mortara, L; Albini, A				Bruno, Antonino; Bassani, Barbara; D'Urso, Davide Giuseppe; Pitaku, Ilvana; Cassinotti, Elisa; Pelosi, Giuseppe; Boni, Luigi; Dominioni, Lorenzo; Noonan, Douglas M.; Mortara, Lorenzo; Albini, Adriana			Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	FASEB JOURNAL			English	Article						angiogenesis; STAT signaling; VEGF; STAT3; STAT5	NATURAL-KILLER-CELLS; MATRIX METALLOPROTEINASES; TUMOR MICROENVIRONMENT; PERIPHERAL-BLOOD; TISSUE INHIBITOR; EXPRESSION; MMP-9; INFLAMMATION; STAT5; CYTOTOXICITY	NK cells are effector lymphocytes involved in tumor immunosurveillance; however, in patients with solid malignancies, NK cells have compromised functions. We have previously reported that lung tumor-associated NK cells (TANKs; peripheral blood) and tumor-infiltrating NK cells (TINKs) show proangiogenic, decidual NK-like (dNK) phenotype. In this study, we functionally and molecularly investigated TINKs and TANKs from blood and tissue samples of patients with colorectal cancer (CRC), a neoplasm in which inflammation and angiogenesis have clinical relevance, and compared them to NK cells from controls and patients with nononcologic inflammatory bowel disease. CRC TINKs/TANKs showed decreased expression for the activatory marker NKG2D, impaired degranulation activity, a decidual-like NK polarization toward the CD56(bright)CD16(dim/-)CD9(+)CD49(+) subset. TINKs and TANKs secreted cytokines with proangiogenic activities, and induce endothelial cell proliferation, migration, adhesion, and the formation of capillary-like structures in vitro. dNK cells release specific proangiogenic factors; among which, angiogenin and invasion-associated enzymes related to the MMP9-TIMP1/2 axis. Here, we describe, for the first time, to our knowledge, the expression of angiogenin, MMP2/9, and TIMP by TANKs in patients with CRC. This phenotype could be relevant to the invasive capabilities and proangiogenic functions of CRC-NK cells and become a novel biomarker. STAT3/STAT5 activation was observed in CRC-TANKs, and treatment with pimozide, a STAT5 inhibitor, reduced endothelial cell capability to form capillary-like networks, inhibiting VEGF and angiogenin production without affecting the levels of TIMP1, TIMP2, and MMP9, indicating that STAT5 is involved in cytokine modulation but not invasion-associated molecules. Combination of Stat5 or MMP inhibitors with immunotherapy could help repolarize CRC TINKs and TANKs to anti-tumor antimetastatic ones.Bruno, A., Bassani, B., D'Urso, D. G., Pitaku, I., Cassinotti, E., Pelosi, G., Boni, L., Dominioni, L., Noonan, D. M., Mortara, L., Albini, A. Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer.	[Bruno, Antonino; Bassani, Barbara; D'Urso, Davide Giuseppe; Noonan, Douglas M.; Albini, Adriana] Ist Ricovero & Cura Carattere Sci IRCCS MultiMed, Vasc Biol & Angiogenesis Lab, Sci & Technol Pole PST, Milan, Italy; [Pitaku, Ilvana; Cassinotti, Elisa; Dominioni, Lorenzo] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy; [Noonan, Douglas M.; Mortara, Lorenzo] Univ Insubria, Dept Biotechnol & Life Sci, Via Dunant 3, I-21100 Varese, Italy; [Pelosi, Giuseppe] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Boni, Luigi] Univ Milan, Polyclin Hosp, Dept Med Surg Physiopathol & Transplantat, IRCCS, Milan, Italy; [Albini, Adriana] Univ Milano Bicocca, Dept Med & Surg, Monza, Italy	University of Insubria; University of Insubria; University of Milan; University of Milan; University of Milano-Bicocca	Noonan, DM (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Via Dunant 3, I-21100 Varese, Italy.	douglas.noonan@uninsubria.it	Albini, Adriana/J-3701-2018; Bruno, Antonino/J-7066-2016; bassani, barbara/AAB-5832-2019; BONI, LUIGI/AAC-6005-2022; Pelosi, Giuseppe/F-5073-2012	Bruno, Antonino/0000-0002-4790-0861; BONI, LUIGI/0000-0002-5906-3810; Cassinotti, Elisa/0000-0003-3780-6561; Bassani, Barbara/0000-0002-8002-1607; Pelosi, Giuseppe/0000-0003-4725-4692	Italian Association for Cancer Research, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) [2010NECHBX_003]; University of Insubria, Fondi di Ateneo per la Ricerca; Fondazione Umberto Veronesi; PhDITalent	Italian Association for Cancer Research, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN); University of Insubria, Fondi di Ateneo per la Ricerca; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); PhDITalent	The authors are grateful to Paola Corradino for data management and Simone Libertini for manuscript assistance (both from MultiMedica, Milan, Italy). This work was supported by the Italian Association for Cancer Research, Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale (PRIN) Grant 2010NECHBX_003 (to D.M.N.), and the University of Insubria, Fondi di Ateneo per la Ricerca (to L.M. and D.M.N.). A.B. was funded by a postdoctoral grant from Fondazione Umberto Veronesi, and is currently a permanent staff researcher awarded by the PhDITalent. B.B. was a participant in the Ph.D. Program in Biotechnology, Biosciences, and Surgical Technologies (School of Biological and Medical Sciences, University of Insubria). The authors declare no conflicts of interest.	Aghagolzadeh P, 2016, WORLD J GASTROENTERO, V22, P5678, DOI 10.3748/wjg.v22.i25.5678; Albini A, 2007, NAT PROTOC, V2, P504, DOI 10.1038/nprot.2006.466; Anacker J, 2011, MOL HUM REPROD, V17, P637, DOI 10.1093/molehr/gar033; Arber N, 2008, GASTROENTEROLOGY, V134, P1224, DOI 10.1053/j.gastro.2008.02.012; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Asfaha S, 2013, GASTROENTEROLOGY, V144, P155, DOI 10.1053/j.gastro.2012.09.057; Baeten CIM, 2006, CLIN GASTROENTEROL H, V4, P1351, DOI 10.1016/j.cgh.2006.08.005; Baginska J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00490; Blois SM, 2011, J REPROD IMMUNOL, V88, P86, DOI 10.1016/j.jri.2010.11.002; Bruno A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju200; Bruno A, 2013, NEOPLASIA, V15, P133, DOI 10.1593/neo.121758; Burmeister K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175563; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Cantoni C, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4684268; Carpentier G., 2012, IMAGEJ NEWS, V5, P133; Carrega P, 2014, J IMMUNOL, V192, P3805, DOI 10.4049/jimmunol.1301889; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Custodio A, 2013, CANCER TREAT REV, V39, P908, DOI 10.1016/j.ctrv.2013.02.004; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Edsparr K, 2010, J IMMUNOTHER, V33, P475, DOI 10.1097/CJI.0b013e3181d372a0; Edsparr K, 2009, IMMUNOL CELL BIOL, V87, P489, DOI 10.1038/icb.2009.35; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; Ferrara N, 2010, CURR OPIN HEMATOL, V17, P219, DOI 10.1097/MOH.0b013e3283386660; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gharagozloo M, 2015, BRATISL MED J, V116, P296, DOI 10.4149/BLL_2015_056; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Goda S, 2006, AM J PATHOL, V169, P445, DOI 10.2353/ajpath.2006.050676; Goodison S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047469; Gotthardt D, 2016, CANCER DISCOV, V6, P414, DOI 10.1158/2159-8290.CD-15-0732; Gotthardt D, 2014, BLOOD, V124, P2370, DOI 10.1182/blood-2014-03-564450; Gross CC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00606; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanna J, 2007, TRENDS IMMUNOL, V28, P201, DOI 10.1126/scitranslmed.3006850; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Herszenyi L, 2014, WORLD J GASTROENTERO, V20, P13246, DOI 10.3748/wjg.v20.i37.13246; Herszenyi L, 2012, INT J MOL SCI, V13, P13240, DOI 10.3390/ijms131013240; Hisai H, 2003, CLIN CANCER RES, V9, P4852; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jayson GC, 2016, LANCET, V388, P518, DOI 10.1016/S0140-6736(15)01088-0; Jensen SA, 2010, EUR J CANCER, V46, P3233, DOI 10.1016/j.ejca.2010.07.046; Katona TM, 2005, CLIN CANCER RES, V11, P8358, DOI 10.1158/1078-0432.CCR-05-0962; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Klintrup K, 2005, EUR J CANCER, V41, P2645, DOI 10.1016/j.ejca.2005.07.017; Krasnova Y, 2017, CLIN IMMUNOL, V177, P50, DOI 10.1016/j.clim.2015.10.001; Langers AMJ, 2012, BRIT J CANCER, V106, P1495, DOI 10.1038/bjc.2012.80; Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250; Le Bouteiller P, 2006, NAT MED, V12, P991, DOI 10.1038/nm0906-991; Lee BK, 2008, IN VIVO, V22, P593; Lee HH, 2017, ARCH PHARM RES, V40, P1037, DOI 10.1007/s12272-017-0951-9; Levi I, 2015, ONCOTARGET, V6, P1, DOI 10.18632/oncotarget.3453; Liu QQ, 2009, J VIROL, V83, P8705, DOI 10.1128/JVI.02666-08; Lopez-Soto A, 2017, CANCER CELL, V32, P135, DOI 10.1016/j.ccell.2017.06.009; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Montaldo E, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00646; Mortara L, 2017, CURR OPIN PHARMACOL, V35, P66, DOI 10.1016/j.coph.2017.05.009; Naruse K, 2009, HUM REPROD, V24, P553, DOI 10.1093/humrep/den408; Nelson EA, 2011, ONCOTARGET, V2, P518; Ni J, 2016, CANCER DISCOV, V6, P347, DOI 10.1158/2159-8290.CD-16-0247; Nilsson UW, 2010, CLIN CANCER RES, V16, P3659, DOI 10.1158/1078-0432.CCR-10-0501; Noonan DM, 2008, CANCER METAST REV, V27, P31, DOI 10.1007/s10555-007-9108-5; Ong S, 2017, CLIN IMMUNOL, V175, P26, DOI 10.1016/j.clim.2016.11.010; Peng YP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-738; Piatkiewicz P, 2016, DIABETOL METAB SYNDR, V8, DOI 10.1186/s13098-016-0152-6; Rajaganeshan R, 2007, BRIT J CANCER, V96, P1112, DOI 10.1038/sj.bjc.6603677; Rocca YS, 2013, INNATE IMMUN-LONDON, V19, P76, DOI 10.1177/1753425912453187; Rondanin R, 2014, BIOORG MED CHEM LETT, V24, P4568, DOI 10.1016/j.bmcl.2014.07.069; Santoni A, 2007, AM J REPROD IMMUNOL, V58, P280, DOI 10.1111/j.1600-0897.2007.00513.x; Scoville SD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00360; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005090; Shimoyama S, 1999, CLIN CANCER RES, V5, P1125; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Stetler-Stevenson WG, 2008, CANCER METAST REV, V27, P57, DOI 10.1007/s10555-007-9105-8; Stetler-Stevenson WG, 2014, CONNECT TISSUE RES, V55, P13, DOI 10.3109/03008207.2013.867339; Strydom DJ, 1998, CELL MOL LIFE SCI, V54, P811, DOI 10.1007/s000180050210; Sungur Can M., 2014, Critical Reviews in Oncogenesis, V19, P57; Urquidi V, 2012, CANCER EPIDEM BIOMAR, V21, P2149, DOI 10.1158/1055-9965.EPI-12-0428; Vitale M, 2014, EUR J IMMUNOL, V44, P1582, DOI 10.1002/eji.201344272; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Voron T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00070; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wallace AE, 2014, HUM REPROD, V29, P652, DOI 10.1093/humrep/deu017; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Zhou Q, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-13; Zingoni A, 2016, CRIT REV IMMUNOL, V36, P445, DOI 10.1615/CritRevImmunol.2017020166	90	65	69	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5365	5377		10.1096/fj.201701103R	http://dx.doi.org/10.1096/fj.201701103R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29763380	Green Submitted			2022-12-26	WOS:000447972500014
J	Ward, DM; Chen, OS; Li, LT; Kaplan, J; Bhuiyan, SA; Natarajan, SK; Bard, M; Cox, JE				Ward, Diane M.; Chen, Opal S.; Li, Liangtao; Kaplan, Jerry; Bhuiyan, Shah Alam; Natarajan, Selvamuthu K.; Bard, Martin; Cox, James E.			Altered sterol metabolism in budding yeast affects mitochondrial iron-sulfur (Fe-S) cluster synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron; iron-sulfur protein; sterol; mitochondria; yeast; Fe-S clusters	FRATAXIN HOMOLOG YFH1; SACCHAROMYCES-CEREVISIAE; INDUCED OLIGOMERIZATION; PROTEIN BIOGENESIS; CANDIDA-ALBICANS; HEME-SYNTHESIS; ACID SYNTHESIS; ACCUMULATION; DOXORUBICIN; TRANSPORTER	Ergosterol synthesis is essential for cellular growth and viability of the budding yeast Saccharomyces cerevisiae, and intracellular sterol distribution and homeostasis are therefore highly regulated in this species. Erg25 is an iron-containing C4-methyl sterol oxidase that contributes to the conversion of 4,4-dimethylzymosterol to zymosterol, a precursor of ergosterol. The ERG29 gene encodes an endoplasmic reticulum (ER)-associated protein, and here we identified a role for Erg29 in the methyl sterol oxidase step of ergosterol synthesis. ERG29 deletion resulted in lethality in respiring cells, but respiration-incompetent (Rho(-) or Rho(0)) cells survived, suggesting that Erg29 loss leads to accumulation of oxidized sterol metabolites that affect cell viability. Down-regulation of ERG29 expression in erg29 cells indeed led to accumulation of methyl sterol metabolites, resulting in increased mitochondrial oxidants and a decreased ability of mitochondria to synthesize iron-sulfur (Fe-S) clusters due to reduced levels of Yfh1, the mammalian frataxin homolog, which is involved in mitochondrial iron metabolism. Using a high-copy genomic library, we identified suppressor genes that permitted growth of erg29 cells on respiratory substrates, and these included genes encoding the mitochondrial proteins Yfh1, Mmt1, Mmt2, and Pet20, which reversed all phenotypes associated with loss of ERG29. Of note, loss of Erg25 also resulted in accumulation of methyl sterol metabolites and also increased mitochondrial oxidants and degradation of Yfh1. We propose that accumulation of toxic intermediates of the methyl sterol oxidase reaction increases mitochondrial oxidants, which affect Yfh1 protein stability. These results indicate an interaction between sterols generated by ER proteins and mitochondrial iron metabolism.	[Ward, Diane M.; Li, Liangtao; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84132 USA; [Chen, Opal S.] Univ Utah, Sch Med, DNA Sequencing Core, Salt Lake City, UT 84132 USA; [Bhuiyan, Shah Alam; Natarajan, Selvamuthu K.; Bard, Martin] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA; [Cox, James E.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Cox, James E.] Univ Utah, Sch Med, Metabol Core Res Facil, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Indiana University System; Indiana University-Purdue University Indianapolis; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ward, DM (corresponding author), Univ Utah, Sch Med, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84132 USA.	diane.mcveyward@path.utah.edu			National Institutes of Health (NIH) [DK030534, DK052380]; Friedreich's Ataxia Research Alliance (FARA) [10047373]; National Center for Research Resources (NCRR) Shared Instrumentation Grant [1S10OD021505]; NIH [U54 DK110858]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, R37DK030534, U54DK110858, R01DK052380] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021505] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich's Ataxia Research Alliance (FARA); National Center for Research Resources (NCRR) Shared Instrumentation Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by National Institutes of Health (NIH) Grants DK030534 and DK052380 (to D. M. W.), Friedreich's Ataxia Research Alliance (FARA) Grant 10047373 (to D. M. W.), National Center for Research Resources (NCRR) Shared Instrumentation Grant 1S10OD021505 (to J. E. C.), and sterol analysis through NIH-sponsored Grant U54 DK110858 (to J. E. C. and D. M. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Alimardani P, 2004, BIOCHEM J, V381, P195, DOI 10.1042/BJ20040297; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bard M, 1996, P NATL ACAD SCI USA, V93, P186, DOI 10.1073/pnas.93.1.186; Baudry K, 2001, J BIOL CHEM, V276, P12702, DOI 10.1074/jbc.M100274200; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P16922, DOI 10.1073/pnas.232392299; Chen OS, 2001, FEBS LETT, V509, P131, DOI 10.1016/S0014-5793(01)03137-4; Cocco E, 2013, MOL BIOL REP, V40, P6757, DOI 10.1007/s11033-013-2792-z; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Demuyser L, 2017, MBIO, V8, DOI [10.1128/mBio.00201-17, 10.1128/mbio.00201-17]; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Gachotte D, 1998, P NATL ACAD SCI USA, V95, P13794, DOI 10.1073/pnas.95.23.13794; Gachotte D, 1997, P NATL ACAD SCI USA, V94, P11173, DOI 10.1073/pnas.94.21.11173; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Hiltunen JK, 2010, BBA-BIOENERGETICS, V1797, P1195, DOI 10.1016/j.bbabio.2010.03.006; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109; Kalyanaraman B, 2007, CARDIOVASC TOXICOL, V7, P92, DOI 10.1007/s12012-007-0025-1; Kim MJ, 2012, BIOCHIMIE, V94, P2448, DOI 10.1016/j.biochi.2012.07.005; Kim MJ, 2010, J NEUROL SCI, V298, P64, DOI 10.1016/j.jns.2010.08.016; Kwok JC, 2004, MOL PHARMACOL, V65, P181, DOI 10.1124/mol.65.1.181; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li FY, 2001, FEBS LETT, V494, P79, DOI 10.1016/S0014-5793(01)02319-5; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li LT, 2014, J BIOL CHEM, V289, P17132, DOI 10.1074/jbc.M114.574723; Li LT, 2012, J BIOL CHEM, V287, P35709, DOI 10.1074/jbc.M112.395533; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 1997, J BIOL CHEM, V272, P28485, DOI 10.1074/jbc.272.45.28485; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; Maccarinelli F, 2014, J MOL MED, V92, P859, DOI 10.1007/s00109-014-1147-0; Melber A, 2016, ELIFE, V5, DOI 10.7554/eLife.15991; Moretti-Almeida G, 2013, FEBS LETT, V587, P3008, DOI 10.1016/j.febslet.2013.07.024; Mouli S, 2015, AM J PHYSIOL-HEART C, V309, pH844, DOI 10.1152/ajpheart.00182.2015; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Navarro-Sastre A, 2011, AM J HUM GENET, V89, P656, DOI 10.1016/j.ajhg.2011.10.005; Ness F, 2001, EUR J BIOCHEM, V268, P1585, DOI 10.1046/j.1432-1033.2001.02029.x; Paulsen IT, 1997, J MEMBRANE BIOL, V156, P99, DOI 10.1007/s002329900192; Polevoda B, 2006, YEAST, V23, P127, DOI 10.1002/yea.1340; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Runkoa AP, 2008, FEBS LETT, V582, P715, DOI 10.1016/j.febslet.2008.01.046; Santos R, 2003, BIOCHEM J, V375, P247, DOI 10.1042/BJ20030835; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Seguin A, 2011, J BIOL CHEM, V286, P6071, DOI 10.1074/jbc.M110.163253; Seguin A, 2009, MITOCHONDRION, V9, P130, DOI 10.1016/j.mito.2009.01.007; Snoek ISI, 2006, FEMS YEAST RES, V6, P393, DOI 10.1111/j.1567-1364.2005.00007.x; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Voisine C, 2000, MOL CELL BIOL, V20, P3677, DOI 10.1128/MCB.20.10.3677-3684.2000; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	68	14	14	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10782	10795		10.1074/jbc.RA118.001781	http://dx.doi.org/10.1074/jbc.RA118.001781			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29773647	Green Published, hybrid			2022-12-26	WOS:000437828400032
J	Pianalto, KM; Ost, KS; Brown, HE; Alspaugh, JA				Pianalto, Kaila M.; Ost, Kyla S.; Brown, Hannah E.; Alspaugh, J. Andrew			Characterization of additional components of the environmental pH-sensing complex in the pathogenic fungus Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbial pathogenesis; fungi; molecular biology; cell signaling; protein stability; environmental sensing; Nap1; pH sensing; Rim pathway	AMBIENT PH; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; MITOTIC EVENTS; SEXUAL CYCLE; RIM101; GENE; NAP1; RECEPTOR; PATHWAY	Pathogenic microorganisms must adapt to changes in their immediate surroundings, including alterations in pH, to survive the shift from the external environment to that of the infected host. In the basidiomycete fungal pathogen Cryptococcus neoformans, these pH changes are primarily sensed by the fungus-specific, alkaline pH-sensing Rim/Pal pathway. The C. neoformans Rim pathway has diverged significantly from that described in ascomycete fungi. We recently identified the C. neoformans putative pH sensor Rra1, which activates the Rim pathway in response to elevated pH. In this study, we probed the function of Rra1 by analyzing its cellular localization and performing protein co-immunoprecipitation to identify potential Rra1 interactors. We found that Rra1 does not strongly colocalize or interact with immediate downstream Rim pathway components. However, these experiments identified a novel Rra1 interactor, the previously uncharacterized C. neoformans nucleosome assembly protein 1 (Nap1), which was required for Rim pathway activation. We observed that Nap1 specifically binds to the C-terminal tail of the Rra1 sensor, probably promoting Rra1 protein stability. This function of Nap1 is conserved in fungi closely related to C. neoformans that contain Rra1 orthologs, but not in the more distantly related ascomycete fungus Saccharomyces cerevisiae. In conclusion, our findings have revealed the sophisticated, yet distinct, molecular mechanisms by which closely and distantly related microbial phyla rapidly adapt to environmental signals and changes, such as alterations in pH.	[Pianalto, Kaila M.; Ost, Kyla S.; Brown, Hannah E.; Alspaugh, J. Andrew] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Alspaugh, J. Andrew] Duke Univ, Sch Med, Dept Med, Durham, NC 27710 USA; [Ost, Kyla S.] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT 84112 USA	Duke University; Duke University; Utah System of Higher Education; University of Utah	Alspaugh, JA (corresponding author), Duke Univ, Sch Med, Box 102359, Durham, NC 27710 USA.	andrew.alspaugh@duke.edu	Alspaugh, Andrew/AAB-1664-2019	Alspaugh, Andrew/0000-0003-3009-627X; Ost, Kyla/0000-0003-4101-2836; Brown, Hannah/0000-0002-9175-8209; Pianalto, Kaila/0000-0002-1427-0154	National Institutes of Health R01 [AI074677, AI104533]; National Defense Science and Engineering Grant - Department of Defense, Office of Scientific Research [32 CFR 168a]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074677, P01AI104533, R56AI074677] Funding Source: NIH RePORTER	National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Grant - Department of Defense, Office of Scientific Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01 Grants AI074677 and AI104533 (to J.A.A.) as well as a National Defense Science and Engineering Grant (to K.M.P.) awarded by the Department of Defense, Office of Scientific Research, 32 CFR 168a. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Bertuzzi M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004413; Bignell E, 2005, MOL MICROBIOL, V55, P1072, DOI 10.1111/j.1365-2958.2004.04472.x; CADDICK MX, 1986, MOL GEN GENET, V203, P346, DOI 10.1007/BF00333978; Calvert MEK, 2008, MOL CELL BIOL, V28, P1313, DOI 10.1128/MCB.01035-07; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; Chen Y., 2014, MBIO, V5; Cornet M, 2014, EUKARYOT CELL, V13, P342, DOI 10.1128/EC.00313-13; Cramer KL, 2006, EUKARYOT CELL, V5, P1147, DOI 10.1128/EC.00145-06; Davis D, 2000, MOL CELL BIOL, V20, P971, DOI 10.1128/MCB.20.3.971-978.2000; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hervas-Aguilar A, 2010, J BIOL CHEM, V285, P18095, DOI 10.1074/jbc.M110.114371; Huang ZB, 2016, AQUAC RES, V47, P1737, DOI 10.1111/are.12628; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; KELLOGG DR, 1995, J CELL BIOL, V130, P675, DOI 10.1083/jcb.130.3.675; Kim Min Su, 2012, Methods Mol Biol, V845, P67, DOI 10.1007/978-1-61779-539-8_5; Kozubowski L, 2011, EUKARYOT CELL, V10, P1396, DOI 10.1128/EC.05087-11; Lamb TM, 2003, MOL CELL BIOL, V23, P677, DOI 10.1128/MCB.23.2.677-686.2003; Lamb TM, 2001, J BIOL CHEM, V276, P1850, DOI 10.1074/jbc.M008381200; Li WS, 1997, GENETICS, V145, P63; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Lucena-Agell D, 2016, MOL MICROBIOL, V101, P982, DOI 10.1111/mmi.13438; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Nichols CB, 2015, EUKARYOT CELL, V14, P626, DOI 10.1128/EC.00010-15; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Nishino K, 2015, J BIOL CHEM, V290, P30797, DOI 10.1074/jbc.M115.674382; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; O'Meara TR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000776; Obara K, 2014, MOL CELL BIOL, V34, P3525, DOI 10.1128/MCB.00408-14; Obara K, 2012, J BIOL CHEM, V287, P38473, DOI 10.1074/jbc.M112.394205; Ohkuni K, 2003, BIOCHEM BIOPH RES CO, V306, P5, DOI 10.1016/S0006-291X(03)00907-0; Ost KS, 2017, MBIO, V8, DOI [10.1128/mBio.02290-16, 10.1128/mbio.02290-16]; Ost KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005159; Penalva MA, 2008, TRENDS MICROBIOL, V16, P291, DOI 10.1016/j.tim.2008.03.006; Penalva MA, 2014, CURR OPIN MICROBIOL, V22, P49, DOI 10.1016/j.mib.2014.09.005; Price MS, 2008, INFECT IMMUN, V76, P5729, DOI 10.1128/IAI.00896-08; Rothfels K, 2005, MOL CELL BIOL, V25, P6772, DOI 10.1128/MCB.25.15.6772-6788.2005; Selvig Kyla, 2011, Mycobiology, V39, P249, DOI 10.5941/MYCO.2011.39.4.249; TILBURN J, 1995, EMBO J, V14, P779, DOI 10.1002/j.1460-2075.1995.tb07056.x; Tjandra H, 1998, CURR BIOL, V8, P991, DOI 10.1016/S0960-9822(07)00419-8; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu WJ, 2004, MOL BIOL CELL, V15, P5528, DOI 10.1091/mbc.E04-08-0666	51	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					9995	10008		10.1074/jbc.RA118.002741	http://dx.doi.org/10.1074/jbc.RA118.002741			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769315	hybrid, Green Published			2022-12-26	WOS:000437096700006
J	Tait, CA; L'Abbe, MR; Smith, PM; Rosella, LC				Tait, Christopher A.; L'Abbe, Mary R.; Smith, Peter M.; Rosella, Laura C.			The association between food insecurity and incident type 2 diabetes in Canada: A population-based cohort study	PLOS ONE			English	Article							HEALTH; PREVALENCE; MORTALITY; ONTARIO; HUNGER; INCOME; ADULTS; MELLITUS; DISEASE; TRENDS	Background A pervasive and persistent finding is the health disadvantage experienced by those in food insecure households. While clear associations have been identified between food insecurity and diabetes risk factors, less is known about the relationship between food insecurity and incident type 2 diabetes. The objective of this study is to investigate the association between household food insecurity and the future development of type 2 diabetes. Methods We used data from Ontario adult respondents to the 2004 Canadian Community Health Survey, linked to health administrative data (n = 4,739). Food insecurity was assessed with the Household Food Security Survey Module and incident type 2 diabetes cases were identified by the Ontario Diabetes Database. Multivariable adjusted Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for type 2 diabetes as a function of food insecurity. Results Canadians in food insecure households had more than 2 times the risk of developing type 2 diabetes compared to those in food secure households [HR = 2.40, 95% CI = 1.17-4.94]. Additional adjustment for BMI attenuated the association between food insecurity and type 2 diabetes [HR = 2.08, 95% CI = 0.99, 4.36]. Conclusions Our findings indicate that food insecurity is independently associated with increased diabetes risk, even after adjustment for a broad set of measured confounders. Examining diabetes risk from a broader perspective, including a comprehensive understanding of socioeconomic and biological pathways is paramount for informing policies and interventions aimed at mitigating the future burden of type 2 diabetes.	[Tait, Christopher A.; Smith, Peter M.; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Tait, Christopher A.; Rosella, Laura C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [L'Abbe, Mary R.] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada; [Smith, Peter M.] Inst Work & Hlth, Toronto, ON, Canada; [Smith, Peter M.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Rosella, Laura C.] Publ Hlth Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Institute for Work & Health; Monash University	Tait, CA (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.; Tait, CA (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.	christopher.tait@mail.utoronto.ca	labbe, mary/AAC-3392-2020; Smith, Peter/AAE-4293-2021	Smith, Peter/0000-0001-8286-4563	Public Health Ontario [2015-16-PIF-004]; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Public Health Ontario; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This project was funded by the Project Initiation Fund, an annual competitive grant provided internally through Public Health Ontario (2015-16-PIF-004) to Laura C Rosella. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC).; This project was funded by the Project Initiation Fund, an annual competitive grant provided internally through Public Health Ontario (2015-16-PIF-004). This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The datasets used were linked using unique encoded identifiers and analyzed at ICES. The authors acknowledge ICES Analyst Laura Holder for her role in data acquisition. The opinions, results, and conclusions reported in this paper are those of the authors and are independent of the funding sources. Parts of this material are based on data and information compiled and provided by the Canadian Institute of Health Information (CIHI). No endorsement by ICES, CIHI, or the Ontario MOHLTC is intended or should be inferred. Preliminary results from this study were presented at the 2017 Canadian Society for Epidemiology and Biostatics Biennial Meeting.	Association CD, 2016, REP CAN DIAB ASS DIA; Bickel G., 2000, J COOK GUIDE MEASURI; Bush M, 2007, CANADIAN COMMUNITY H; Canada CDPAo, WHO WE AR 2003; Canada H, 2007, CAN COMM HLTH SURV C; Canada H, 2003, HLTH LIV STRAT 2003; Canada PHAo, 2009, REP NAT DIAB SURV SY; Che J, 2001, Health Rep, V12, P11; Douketis JD, 2005, CAN MED ASSOC J, V172, P995, DOI 10.1503/cmaj.045170; Fitzgerald N, 2011, ETHNIC DIS, V21, P328; Garriguet Didier, 2009, Health Rep, V20, P41; Gucciardi E, 2009, DIABETES CARE; Gucciardi Enza, 2014, Curr Nutr Rep, V3, P324; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Holben DH, 2006, J AM DIET ASSOC, V106, P446, DOI 10.1016/j.jada.2006.01.016; Hollingshead AB, 2007, AM J PUBLIC HEALTH, V97, P1756; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Katzmarzyk PT, 2007, APPL PHYSIOL NUTR ME, V32, pS185, DOI 10.1139/H07-113; Kirkpatrick SI, 2008, J NUTR, V138, P604, DOI 10.1093/jn/138.3.604; Kirkpatrick SI, 2015, J NUTR, V145, P1596, DOI 10.3945/jn.114.208579; Kraut A, 2001, DIABETES CARE, V24, P64, DOI 10.2337/diacare.24.1.64; Lee JS, 2001, J NUTR, V131, P1503, DOI 10.1093/jn/131.5.1503; Lind M, 2013, DIABETOLOGIA, V56, P2601, DOI 10.1007/s00125-013-3063-1; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; McIntyre L, 2012, CAN J PUBLIC HEALTH, V103, pE428, DOI 10.1007/BF03405632; McLeod L, 2006, APPL ECON, V38, P2131, DOI 10.1080/00036840500427429; Montonen J, 2005, AM J EPIDEMIOL, V161, P219, DOI 10.1093/aje/kwi039; Morris E, 2005, CAN J PUBLIC HEALTH, V96, P201, DOI 10.1007/BF03403691; Ohinmaa A, 2004, CAN J DIABETES, V28, P116; Poppendieck J., 1999, SWEET CHARITY EMERGE; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Riches G, 2011, DEV PRACT, V21, P768, DOI 10.1080/09614524.2011.561295; Rivera LA, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0245-0; Roncarolo F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150250; Rosella LC, 2016, DIABETIC MED, V33, P395, DOI 10.1111/dme.12858; Rosella LC, 2015, DIABETES CARE, V38, P1299, DOI 10.2337/dc14-2474; Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Shah BR, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-142; Shields Margot, 2011, Health Rep, V22, P35; Tarasuk V, 2016, HOUSEHOLD FOOD INSEC; Tarasuk V, 2012, SUBMISSION CIVIL SOC; Tarasuk V, 2014, HOUSEHOLD FOOD INSEC; Tarasuk V, 2014, BRIT FOOD J, V116, P1405, DOI 10.1108/BFJ-02-2014-0077; Vozoris NT, 2003, J NUTR, V133, P120, DOI 10.1093/jn/133.1.120; Wakefield S, 2013, CRIT SOC POLICY, V33, P427, DOI 10.1177/0261018312458487; Webb KL, 2013, J HUNGER ENVIRON NUT, V8, P257, DOI 10.1080/19320248.2013.817169; Wodchis WP, 2013, GUIDELINES PERSON LE; Yu VL, 2004, CAN J PUBLIC HEALTH, V95, P366, DOI 10.1007/BF03405148	50	34	34	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0195962	10.1371/journal.pone.0195962	http://dx.doi.org/10.1371/journal.pone.0195962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0FF	29791453	Green Submitted, Green Published, gold			2022-12-26	WOS:000433077000008
J	Wang, W; Du, C; Lin, LX; Chen, W; Tan, L; Shen, J; Pearce, EN; Zhang, YX; Gao, M; Bian, JC; Wang, XM; Zhang, WQ				Wang, Wei; Du, Cong; Lin, Laixiang; Chen, Wen; Tan, Long; Shen, Jun; Pearce, Elizabeth N.; Zhang, Yixin; Gao, Min; Bian, Jianchao; Wang, Xiaoming; Zhang, Wanqi			Anthropometry-based 24-h urinary creatinine excretion reference for Chinese children	PLOS ONE			English	Article							REFERENCE VALUES; POTASSIUM; SODIUM; RATIO; MULTICENTER; POPULATION; CLEARANCE; CALCIUM; EXAMPLE; GROWTH	To establish 24-h urinary creatinine excretion reference ranges based on anthropometry in healthy Chinese children, a cross-sectional survey was conducted using twice-sampled 24-h urine and anthropometric variables. Age- and sex-specific 24-h creatinine excretion reference ranges (crude and related to individual anthropometric variables) were derived. During October 2013 and May 2014, urine samples were collected. Anthropometric variables were measured in the first survey. Data of 710 children (377 boys and 333 girls) aged 8-13 years who completed the study were analyzed. No significant difference was observed in 24-h urine volumes between the two samples (median [interquartile range): 855.0 [600.0-1272.0) mL vs. 900.0 [660.0-1220.0) mL, P = 0.277). The mean 24-h urine creatinine excretion was regarded as representative of absolute daily creatinine excretion in children. Sex-specific, body-weight-adjusted creatinine excretion reference values were 15.3 mg/kg/day (0.1353 mmol/kg/day) for boys and 14.3 mg/kg/day (0.1264 mmol/kg/day) for girls. Differences were significant between boys and girls within the same age group but not across different age groups within the same sex. Ideal 24-h creatinine excretion values for height were derived for potential determination of the creatinine height index. These data can serve as reference ranges to calculate ratios of analyte to creatinine. The creatinine height index can be used to assess somatic protein status.	[Wang, Wei; Du, Cong; Chen, Wen; Tan, Long; Zhang, Yixin; Gao, Min; Zhang, Wanqi] Tianjin Med Univ, Sch Publ Hlth, Dept Nutr & Food Sci, Tianjin, Peoples R China; [Lin, Laixiang] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin, Peoples R China; [Shen, Jun] Tianjin Med Univ, Dept Sanit Chem, Tianjin, Peoples R China; [Pearce, Elizabeth N.] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Bian, Jianchao; Wang, Xiaoming] Shandong Inst Endem Dis Control & Res, Dept Iodine Deficiency Disorders, Jinan, Shandong, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Boston University	Zhang, WQ (corresponding author), Tianjin Med Univ, Sch Publ Hlth, Dept Nutr & Food Sci, Tianjin, Peoples R China.	wqzhang@tmu.edu.cn	张, 万起/M-5158-2019	Pearce, Elizabeth/0000-0003-3799-0354	Chinese National Natural Science Foundation (NSFC) [81330064, 71774115]; Nestle Foundation; UNICEF China Nutrition [2016-1.2.2.6]	Chinese National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); Nestle Foundation(Nestle SA); UNICEF China Nutrition	This work was supported by Chinese National Natural Science Foundation (NSFC Grant No. 81330064, 71774115), the Nestle Foundation and UNICEF China Nutrition (No. 2016-1.2.2.6).	ALESSIO L, 1985, INT ARCH OCC ENV HEA, V55, P99, DOI 10.1007/BF00378371; BINGHAM SA, 1988, ANN CLIN BIOCHEM, V25, P610, DOI 10.1177/000456328802500603; BJORNSSON TD, 1979, CLIN PHARMACOKINET, V4, P200, DOI 10.2165/00003088-197904030-00003; BORSOOK H, 1947, J BIOL CHEM, V168, P493; Cundy T, 2000, DIABETES CARE, V23, P714, DOI 10.2337/diacare.23.5.714b; DESANTO NG, 1987, INT J PED NEPHROL, V8, P35; Endre ZH, 2016, NEPHRON, V132, P312, DOI 10.1159/000444456; Health CMo, 1997, WST971996 HLTH CMO; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Hou BS, 1990, CHIN J EPIDEMIOL, V9, P158; JAMES GD, 1988, AM J HYPERTENS, V1, P124, DOI 10.1093/ajh/1.2.124; Johner SA, 2016, EUR J NUTR, V55, P1275, DOI 10.1007/s00394-015-0941-y; Knudsen N, 2000, EUR J CLIN NUTR, V54, P361, DOI 10.1038/sj.ejcn.1600935; KNUIMAN JT, 1986, HUM NUTR-CLIN NUTR, V40C, P343; LIAPPIS N, 1984, KLIN PADIATR, V196, P367, DOI 10.1055/s-2008-1034097; Liu RW, 2009, CONT CLIN LAB DIAGNO; Matos V, 1999, AM J KIDNEY DIS, V34; Matos V, 1997, J PEDIATR-US, V131, P252, DOI 10.1016/S0022-3476(97)70162-8; Montenegro-Bethancourt G, 2015, THYROID, V25, P688, DOI 10.1089/thy.2015.0006; Poyrazoglu HM, 2009, PEDIATR INT, V51, P526, DOI 10.1111/j.1442-200X.2008.02785.x; Remer T, 2002, AM J CLIN NUTR, V75, P561, DOI 10.1093/ajcn/75.3.561; Safarinejad MR, 2003, PEDIATR NEPHROL, V18, P140, DOI 10.1007/s00467-002-1020-1; SUGITA O, 1992, ANN CLIN BIOCHEM, V29, P523, DOI 10.1177/000456329202900506; Tang ZJ, 1988, BEIJING YI KE DA XUE, V20, P435; Varnell CD, 2014, PEDIATR BLOOD CANCER, V61, P2074, DOI 10.1002/pbc.25089; VITERI FE, 1970, PEDIATRICS, V46, P696; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Wang B, 2014, J EXPO SCI ENV EPID, V24, P657, DOI 10.1038/jes.2014.36; WEMBER T, 1992, ANN HUM BIOL, V19, P361, DOI 10.1080/03014469200002232; Wu DQ, 2014, CLIN CHIM ACTA, V431, P239, DOI 10.1016/j.cca.2014.02.015	30	3	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197672	10.1371/journal.pone.0197672	http://dx.doi.org/10.1371/journal.pone.0197672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791502	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000052
J	Hubbeling, HG; Rosenberg, SM; Gonzalez-Robledo, MC; Cohn, JG; Villarreal-Garza, C; Partridge, AH; Knaul, FM				Hubbeling, Harper G.; Rosenberg, Shoshana M.; Cecilia Gonzalez-Robledo, Maria; Cohn, Julia G.; Villarreal-Garza, Cynthia; Partridge, Ann H.; Knaul, Felicia M.			Psychosocial needs of young breast cancer survivors in Mexico City, Mexico	PLOS ONE			English	Article							QUALITY-OF-LIFE; FERTILITY CONCERNS; AFRICAN-AMERICAN; SOCIAL SUPPORT; BODY-IMAGE; DEPRESSIVE SYMPTOMS; NATURAL MENOPAUSE; LATIN-AMERICA; WOMEN; HEALTH	Objective Young breast cancer survivors in Mexico face distinct psychosocial challenges that have not been characterized. This study aims to describe the psychosocial needs of young breast cancer survivors in Mexico at 5 or more years of survivorship, identifying areas of focus for early interventions. Methods Breast cancer patients diagnosed at age 40 or prior with 5 or more years since diagnosis were invited to participate in one-on-one 30-60 minute semi-structured audio-recorded interviews at the Instituto Nacional de Cancerologia in Mexico City. Transcripts were coded using thematic analysis with NVivo software. Results 25 women participated. Five major phenomena emerged from analysis: (1) minimization of fertility concerns; (2) persistence of body image disturbance over time; (3) barriers to employment during survivorship; (4) impact on family relationships and social networks; & (5) unmet psychological care and informational needs. Conclusions Early interventions with a focus on fertility loss education, access to reconstructive surgery and body image support, guidance during return-to-work, assistance with childcare,	[Hubbeling, Harper G.; Rosenberg, Shoshana M.; Partridge, Ann H.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Rosenberg, Shoshana M.; Partridge, Ann H.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Cecilia Gonzalez-Robledo, Maria] Inst Nacl Salud Publ, Ctr Invest Sistemas Salud, Cuernavaca, Morelos, Mexico; [Cohn, Julia G.] Harvard Univ, David Rockefeller Ctr Latin Amer Studies, Boston, MA 02115 USA; [Villarreal-Garza, Cynthia] Inst Nacl Cancerol, Dept Invest & Tumores Mamarios, Mexico City, DF, Mexico; [Villarreal-Garza, Cynthia] Tecnol Monterrey, Ctr Canc Mama, Monterrey, NL, Mexico; [Villarreal-Garza, Cynthia] Joven & Fuerte Programa Atenc Invest Mujeres Jove, Mexico City, DF, Mexico; [Knaul, Felicia M.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Coral Gables, FL 33124 USA; [Knaul, Felicia M.] Univ Miami, Inst Adv Study Amer, Coral Gables, FL 33124 USA; [Knaul, Felicia M.] Fdn Mexicana Salud, Programa Univ & Competitividad Salud, Mexico City, DF, Mexico; [Knaul, Felicia M.] Tomatelo Pecho, Mexico City, DF, Mexico	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Instituto Nacional de Salud Publica; Harvard University; Instituto Nacional de Cancerologia (INCAN); Tecnologico de Monterrey; University of Miami; University of Miami	Hubbeling, HG (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	harper_hubbeling@hms.harvard.edu	Villarreal-Garza, Cynthia/AFO-6993-2022	Villarreal-Garza, Cynthia/0000-0003-3587-339X; Cohn, Julia/0000-0002-8733-4278; Gripsrud, Birgitta Haga/0000-0003-2206-4673; Knaul, Felicia/0000-0002-0512-4788; GONZALEZ-ROBLEDO, MARIA CECILIA/0000-0002-4987-3684	Harvard Medical School Scholars in Medicine Office	Harvard Medical School Scholars in Medicine Office	This work was funded by a grant awarded to HGH from the Harvard Medical School Scholars in Medicine Office (https://hms.harvard.edu/departments/inedical-education/student-services/scholars-medicine-sim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2011, PSYCHO-ONCOLOGY, V20, P851, DOI 10.1002/pon.1792; Cordero MJA, 2015, NUTR HOSP, V31, P371, DOI 10.3305/nh.2015.31.1.7863; Ahmad S, 2015, CURR OPIN SUPPORT PA, V9, P271, DOI 10.1097/SPC.0000000000000162; [Anonymous], 2015, MED EC INF; Ashing-Giwa KT, 2004, PSYCHO-ONCOLOGY, V13, P408, DOI 10.1002/pon.750; Avis NE, 2013, BREAST CANCER RES TR, V139, P199, DOI 10.1007/s10549-013-2513-2; Avis NE, 2004, PSYCHO-ONCOL, V13, P295, DOI 10.1002/pon.744; Banerjee R, 2016, SUPPORT CARE CANCER, V24, P163, DOI 10.1007/s00520-015-2758-x; Blinder V, 2013, BREAST CANCER RES TR, V140, P407, DOI 10.1007/s10549-013-2625-8; Bloom Joan R, 2008, J Cancer Surviv, V2, P190, DOI 10.1007/s11764-008-0058-x; Bloom JR, 2004, PSYCHO-ONCOL, V13, P147, DOI 10.1002/pon.794; Borstelmann NA, 2015, PSYCHOONCOLOGY; Bouknight RR, 2006, J CLIN ONCOL, V24, P345, DOI 10.1200/JCO.2004.00.4929; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Carpenter-Song E, 2010, TRANSCULT PSYCHIATRY, V47, P224, DOI 10.1177/1363461510368906; Champion VL, 2014, CANCER-AM CANCER SOC, V120, P2237, DOI 10.1002/cncr.28737; Charon R, 2004, NEW ENGL J MED, V350, P862, DOI 10.1056/NEJMp038249; Chavarri-Guerra Y, 2012, LANCET ONCOL, V13, pE335, DOI 10.1016/S1470-2045(12)70246-2; Corney RH, 2014, PSYCHO-ONCOLOGY, V23, P20, DOI 10.1002/pon.3365; Dahl CAF, 2010, CANCER-AM CANCER SOC, V116, P3549, DOI 10.1002/cncr.25251; de los Monteros KE, 2011, INT J BEHAV MED, V18, P310, DOI 10.1007/s12529-010-9119-4; Fang SY, 2015, PSYCHOONCOLOGY; Ferlay J., 2013, IARC CANCERBASE; Frank AW, 2016, HEALTH-LONDON, V20, P9, DOI 10.1177/1363459315615395; Freedman RA, 2013, BREAST, V22, pS176, DOI 10.1016/j.breast.2013.07.034; Gallo LC, 2009, J PERS, V77, P1707, DOI 10.1111/j.1467-6494.2009.00598.x; Ganz PA, 2013, BREAST, V22, P606, DOI 10.1016/j.breast.2013.07.049; GarridoLatorre F, 1996, INT J GYNECOL OBSTET, V53, P159, DOI 10.1016/0020-7292(96)02655-0; Gotze H, 2015, PSYCHO-ONCOLOGY, V24, P787, DOI 10.1002/pon.3725; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Gorman JR, 2010, BREAST CANCER RES TR, V123, P477, DOI 10.1007/s10549-010-0768-4; Howard-Anderson J, 2012, JNCI-J NATL CANCER I, V104, P386, DOI 10.1093/jnci/djr541; Ilbawi AM, 2017, LANCET ONCOL, V18, P172, DOI 10.1016/S1470-2045(17)30041-4; Justo N, 2013, ONCOLOGIST, V18, P248, DOI 10.1634/theoncologist.2012-0373; Kaasa S, 2018, LANCET GLOB HEALTH, V6, P11; Kurowecki D, 2014, PSYCHO-ONCOLOGY, V23, P52, DOI 10.1002/pon.3370; Lee RJ, 2011, PSYCHO-ONCOLOGY, V20, P1044, DOI 10.1002/pon.1826; Lindbohm ML, 2014, PSYCHO-ONCOLOGY, V23, P634, DOI 10.1002/pon.3459; Loaring JM, 2015, HEALTH PSYCHOL, V34, P426, DOI 10.1037/hea0000195; Lokody I, 2015, LANCET ONCOL, V16, P1399, DOI 10.1016/S1470-2045(15)00382-4; Mackenzie CR, 2014, SOC SCI MED, V117, P96, DOI 10.1016/j.socscimed.2014.07.043; Mallinger JB, 2006, EUR J CANCER CARE, V15, P355, DOI 10.1111/j.1365-2354.2006.00666.x; Manne S, 2014, J FAM PSYCHOL, V28, P214, DOI 10.1037/a0036053; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mollica M, 2015, CANCER NURS, V38, P16, DOI 10.1097/NCC.0000000000000120; MULLAN F, 1985, NEW ENGL J MED, V313, P270, DOI 10.1056/NEJM198507253130421; Neuendorf KA, 2001, CONTENT ANAL GUIDEBO; Partridge AH, 2013, ONCOLOGIST, V18, pE19, DOI 10.1634/theoncologist.2013-0300; PETERSGOLDEN H, 1982, SOC SCI MED, V16, P483, DOI 10.1016/0277-9536(82)90057-0; Raque-Bogdan TL, 2015, J COUNS PSYCHOL, V62, P655, DOI 10.1037/cou0000068; Rowland JH, 2000, J NATL CANCER I, V92, P1422, DOI 10.1093/jnci/92.17.1422; Ruddy KJ, 2013, J ADOLESC YOUNG ADUL, V2, P153, DOI 10.1089/jayao.2013.0014; Ruddy KJ, 2014, J CLIN ONCOL, V32, P1151, DOI 10.1200/JCO.2013.52.8877; Salonen P, 2013, SCAND J CARING SCI, V27, P396, DOI 10.1111/j.1471-6712.2012.01050.x; Segrin C, 2014, PSYCHOL HEALTH MED, V19, P716, DOI 10.1080/13548506.2013.871304; Senkus E, 2013, PSYCHOONCOLOGY; Shulman LN, 2010, J ONCOL, V2010, DOI 10.1155/2010/595167; Snyder KA, 2010, J PSYCHOSOC ONCOL, V28, P413, DOI 10.1080/07347332.2010.484830; Strasser-Weippl K, 2015, LANCET ONCOL, V16, P1405, DOI 10.1016/S1470-2045(15)00218-1; Strauss A., 1998, BASICS QUALITATIVE R; Tiedtke C, 2010, PSYCHO-ONCOLOGY, V19, P677, DOI 10.1002/pon.1633; Vadaparampil ST, 2012, SUPPORT CARE CANCER, V20, P2559, DOI 10.1007/s00520-012-1380-4; Villarreal-Garza C, 2016, CLIN BREAST CANC; Villarreal-Garza C, 2016, BREAST J; Villarreal-Garza C, 2017, BREAST, V33, P71, DOI 10.1016/j.breast.2017.02.010; Villarreal-Garza Cynthia, 2013, Oncologist, V18 Suppl, P26, DOI 10.1634/theoncologist.18-S2-26; Walsh SR, 2011, FAMILIES SYSTEMS HLT, V23, P80; Yarker J, 2010, PSYCHO-ONCOLOGY, V19, P1078, DOI 10.1002/pon.1662; Zimmermann T, 2010, PSYCHO-ONCOLOGY, V19, P1061, DOI 10.1002/pon.1660	70	22	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197931	10.1371/journal.pone.0197931	http://dx.doi.org/10.1371/journal.pone.0197931			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG6DG	29787612	gold, Green Published, Green Submitted			2022-12-26	WOS:000432785700057
J	Van Reeth, C; Caro, G; Bockstaller, C; Michel, N				Van Reeth, Colin; Caro, Gael; Bockstaller, Christian; Michel, Nadia			Current and previous spatial distributions of oilseed rape fields influence the abundance and the body size of a solitary wild bee, Andrena cineraria, in permanent grasslands	PLOS ONE			English	Article							FLOWERING PLANTS; FORAGING RANGES; POPULATION; HYMENOPTERA; POLLINATION; DIVERSITY; RICHNESS; DYNAMICS; BEHAVIOR; DRIVE	Wild bees are essential pollinators whose survival partly depends on the capacity of their environment to offer a sufficient amount of nectar and pollen. Semi-natural habitats and mass-flowering crops such as oilseed rape provide abundant floristic resources for bees. The aim of this study was to evaluate the influences of the spatial distribution of semi-natural habitats and oilseed rape fields on the abundance and the mean body size of a solitary bee in grasslands. We focused on a generalist mining bee, Andrena cineraria, that forages and reproduces during oilseed rape flowering. In 21 permanent grasslands of Eastern France, we captured 1 287 individuals (1 205 males and 82 females) and measured the body size of male individuals. The flower density in grasslands was quantified during bee captures (2016) and the landscape surrounding grasslands was characterized during two consecutive years (2015 and 2016). The influence of oilseed rape was tested through its distribution in the landscape during both the current year of bee sampling and the previous year. Bee abundance was positively influenced by the flower density in grasslands and by the area covered by oilseed rape around grasslands in the previous year. The mean body size of A. cineraria was explained by the interaction between flower density in the grassland and the distance to the nearest oilseed rape field in the current year: the flower density positively influenced the mean body size only in grasslands distant from oilseed rape. A. cineraria abundance and body size distribution were not affected by the area of semi-natural habitats in the landscape. The spatial distribution of oilseed rape fields (during both the current and the previous year) as well as the local density of grassland flowers drive both bee abundance and the mean value of an intraspecific trait (body size) in permanent grasslands. Space-time variations of bee abundance and mean body size in grasslands may have important ecological implications on plant pollination and on interspecific interactions between pollinators. Specifically, a competition between bee species for nesting sites might occur in oilseed rape rich landscapes, thus raising important conservation issues for bee species that do not benefit from oilseed rape resources.	[Van Reeth, Colin; Caro, Gael; Michel, Nadia] Univ Lorraine, Lab Agron Environm UMR 1121, INRA, Vandoeuvre Les Nancy, France; [Bockstaller, Christian] Univ Lorraine, Lab Agron Environm UMR 1121, INRA, Colmar, France	INRAE; Universite de Lorraine; INRAE; Universite de Lorraine	Van Reeth, C (corresponding author), Univ Lorraine, Lab Agron Environm UMR 1121, INRA, Vandoeuvre Les Nancy, France.	c.v.reeth@gmail.com		Van Reeth, Colin/0000-0002-7070-9838				Albrecht M, 2007, J APPL ECOL, V44, P813, DOI 10.1111/j.1365-2664.2007.01306.x; Bosch J, 2002, ECOL ENTOMOL, V27, P129, DOI 10.1046/j.1365-2311.2002.00406.x; Dainese M, 2017, J APPL ECOL, V21, P91, DOI [10.1016/j.cois.2017.05.021, DOI 10.1016/J.COIS.2017.05.021]; Diekotter T, 2014, GCB BIOENERGY, V6, P219, DOI 10.1111/gcbb.12080; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eickwort GC, 1996, BEHAV ECOL SOCIOBIOL, V38, P227, DOI 10.1007/s002650050236; Fortel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104679; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; GEBHARDT M, 1987, Drosera, V87, P89; Goulson D, 2002, ANIM BEHAV, V64, P123, DOI 10.1006/anbe.2002.3041; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Herbertsson L, 2017, BASIC APPL ECOL, V24, P77, DOI 10.1016/j.baae.2017.08.001; Holzschuh A, 2016, ECOL LETT, V19, P1228, DOI 10.1111/ele.12657; Holzschuh A, 2013, OECOLOGIA, V172, P477, DOI 10.1007/s00442-012-2515-5; Holzschuh A, 2011, P ROY SOC B-BIOL SCI, V278, P3444, DOI 10.1098/rspb.2011.0268; Jauker F, 2016, BASIC APPL ECOL, V17, P714, DOI 10.1016/j.baae.2016.07.004; Jauker F, 2012, BASIC APPL ECOL, V13, P268, DOI 10.1016/j.baae.2012.03.010; KLOSTERMEYER E C, 1973, Journal of the Kansas Entomological Society, V46, P536; Kovacs-Hostyanszki A, 2011, AGR FOREST ENTOMOL, V13, P59, DOI 10.1111/j.1461-9563.2010.00498.x; Le Feon V, 2013, AGR ECOSYST ENVIRON, V166, P94, DOI 10.1016/j.agee.2011.06.020; Ludecke D., 2017, SJSTATS STAT FUNCTIO; Magrach A, 2017, ECOGRAPHY, V40, P1; Marrec R, 2015, AGR ECOSYST ENVIRON, V199, P282, DOI 10.1016/j.agee.2014.10.005; Michener C.D., 2007, BEES WORLD, Vsecond; Ne'eman G, 2006, J INSECT BEHAV, V19, P383, DOI 10.1007/s10905-006-9030-7; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parsche S, 2011, PERSPECT PLANT ECOL, V13, P27, DOI 10.1016/j.ppees.2010.12.001; Paxton RJ, 2005, APIDOLOGIE, V36, P145, DOI 10.1051/apido:2005007; Peat J, 2005, ECOL ENTOMOL, V30, P176, DOI 10.1111/j.0307-6946.2005.00676.x; Peat J, 2005, FUNCT ECOL, V19, P145, DOI 10.1111/j.0269-8463.2005.00946.x; Renauld M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150946; Riedinger V, 2015, ECOLOGY, V96, P1351, DOI 10.1890/14-1124.1; Rollin O, 2015, BIODIVERS CONSERV, V24, P1195, DOI 10.1007/s10531-014-0852-x; Roulston TH, 2002, EVOL ECOL, V16, P49, DOI 10.1023/A:1016048526475; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2008, ECOLOGY, V89, P1375, DOI 10.1890/06-1323.1; TEPEDINO VJ, 1984, APIDOLOGIE, V15, P83, DOI 10.1051/apido:19840108; Vanderplanck M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086209; Warzecha D, 2016, LANDSCAPE ECOL, V31, P1449, DOI 10.1007/s10980-016-0349-y; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Westrich P, 1989, WILDBIENEN BADEN WUR; Westrich Paul, 1996, Linnean Society Symposium Series, V18, P1; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Woodcock BA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12459; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003; Zuur Alain F., 2009, P1	50	5	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197684	10.1371/Journal.pone.0197684	http://dx.doi.org/10.1371/Journal.pone.0197684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787595	Green Published, gold, Green Submitted			2022-12-26	WOS:000432785700036
J	Wang, JQ; Fang, XY; Ge, L; Cao, FL; Zhao, LG; Wang, ZZ; Xiao, W				Wang, Jingqiu; Fang, Xianying; Ge, Lin; Cao, Fuliang; Zhao, Linguo; Wang, Zhenzhong; Xiao, Wei			Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol	PLOS ONE			English	Article							APOPTOSIS; CELL; INHIBITION; FLAVONOIDS; EXTRACT; LEAVES; L.	Kaempferol (kae) and its glycosides are widely distributed in nature and show multiple bioactivities, yet few reports have compared them. In this paper, we report the antitumor, antioxidant and anti-inflammatory activity differences of kae, kae-7-O-glucoside (kae-7-O-glu), kae-3-O-rhamnoside (kae-3-O-rha) and kae-3-O-rutinoside (kae-3-0-rut). Kae showed the highest antiproliferation effect on the human hepatoma cell line HepG2, mouse colon cancer cell line CT26 and mouse melanoma cell line B16F1. Kae also significantly inhibited AKT phosphorylation and cleaved caspase-9, caspase-7, caspase-3 and PARP in HepG2 cells. A kae-induced increase in DPPH and ABTS radical scavenging activity, inhibition of concanavalin A (Con A)-induced activation of T cell proliferation and NO or ROS production in LPS-induced RAW 264.7 macrophage cells were also seen. Kae glycosides were used to produce kae via environment-friendly enzymatic hydrolysis. Kae-7-O-glu and kae-3-0-rut were hydrolyzed to kae by beta-glucosidase and/or alpha-L-rhamnosidase. This paper demonstrates the application of enzymatic catalysis to obtain highly biologically active kae. This work provides a novel and efficient preparation of high-value flavone-related products.	[Wang, Jingqiu; Fang, Xianying; Ge, Lin; Cao, Fuliang] Nanjing Forestry Univ, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Wang, Jingqiu; Fang, Xianying; Ge, Lin; Cao, Fuliang; Zhao, Linguo] Nanjing Forestry Univ, Coll Chem Engn, Nanjing, Jiangsu, Peoples R China; [Zhao, Linguo] Jiangsu Key Lab Chem & Utilizat Agr & Forest Biom, Nanjing, Jiangsu, Peoples R China; [Wang, Zhenzhong; Xiao, Wei] Jiangsu Kanion Pharmaceut Co Ltd, Lianyungang, Peoples R China	Nanjing Forestry University; Nanjing Forestry University	Zhao, LG (corresponding author), Nanjing Forestry Univ, Coll Chem Engn, Nanjing, Jiangsu, Peoples R China.; Zhao, LG (corresponding author), Jiangsu Key Lab Chem & Utilizat Agr & Forest Biom, Nanjing, Jiangsu, Peoples R China.	njfu2304@163.com			National Key Research Development Program of China [2017YFD0600805]; National Natural Science Foundation of China [31600465, 31570565]; Forestry Achievements of Science and Technology to Promote Projects [[2017] 10]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Study on biocatalysis and transformation of natural drugs [028340002]; Jiangsu Kanion Pharmaceutical Co., Ltd.	National Key Research Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Forestry Achievements of Science and Technology to Promote Projects; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Study on biocatalysis and transformation of natural drugs; Jiangsu Kanion Pharmaceutical Co., Ltd.	This work was supported by The National Key Research Development Program of China, (Grant # 2017YFD0600805 to LZ); The National Natural Science Foundation of China (Grant No. 31600465 to XF); The National Natural Science Foundation of China (Grant # 31570565 to LZ); The Forestry Achievements of Science and Technology to Promote Projects ([2017] 10 to LZ); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); and The Study on biocatalysis and transformation of natural drugs (Grant No. 028340002). Authors ZW and WX received support in the form of salary from Jiangsu Kanion Pharmaceutical Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar OT, 2015, MOLECULES, V20, P17976, DOI 10.3390/molecules201017976; Almasi E, 2017, IRAN J ALLERGY ASTHM, V16, P107; [Anonymous], 2017, WIREL COMMUN MOB COM; Arif H., 2017, INT J BIOL MACROMOLE; Bognar E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065355; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen Y, 2017, CLIN EXPT PHARM PHYS, V44; Elsharkawy ER, 2017, PAK J PHARM SCI, V30, P399; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Ge L, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0342-9; Hou WC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162139; Hua Li, 2015, Journal of Agricultural and Food Chemistry, V63, P7198, DOI 10.1021/acs.jafc.5b01639; Hung TM, 2009, BIOORG MED CHEM LETT, V19, P4389, DOI 10.1016/j.bmcl.2009.05.070; Kim K. Y., 2015, J MICROBIOLOGY BIOTE, V26; Le Marchand L, 2002, BIOMED PHARMACOTHER, V56, P296, DOI 10.1016/S0753-3322(02)00186-5; Li FH, 2017, FOOD RES INT, V100, P873, DOI 10.1016/j.foodres.2017.06.052; Lopez-Lazaro M, 2010, MOL MED, V16, P144, DOI 10.2119/molmed.2009.00162; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marfe G, 2009, J CELL BIOCHEM, V106, P643, DOI 10.1002/jcb.22044; Muthukrishnan SD, 2015, NAT PROD RES, V29, P785, DOI 10.1080/14786419.2014.986125; Nam T. G., 2017, OXIDATIVE MED CELLUL, V2017, P1; Nascimento AM, 2017, J PHARMACEUT BIOMED, V145, P821, DOI 10.1016/j.jpba.2017.07.032; Neuhouser ML, 2004, NUTR CANCER, V50, P1, DOI 10.1207/s15327914nc5001_1; Park MJ, 2009, J MED FOOD, V12, P351, DOI 10.1089/jmf.2008.0006; Pei JJ, 2017, J AGR FOOD CHEM, V65, P6042, DOI 10.1021/acs.jafc.7b02320; Pu X, 2017, APOPTOSIS, V22, P357, DOI 10.1007/s10495-016-1323-5; Suchal K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051001; Tang XL, 2015, INFLAMMATION, V38, P94, DOI 10.1007/s10753-014-0011-2; Verma AR, 2009, FOOD CHEM TOXICOL, V47, P2196, DOI 10.1016/j.fct.2009.06.005; Wang LS, 2006, J AGR FOOD CHEM, V54, P9798, DOI 10.1021/jf0620719; Wu YT, 2016, BIOTECHNOL PROGR, V32, P735, DOI 10.1002/btpr.2255; Xie JC, 2015, J IND MICROBIOL BIOT, V42, P839, DOI 10.1007/s10295-015-1608-7; Xu Q., 2017, CARBOHYDRATE POLYM, V174; Yi XF, 2016, AFR J TRADIT COMPLEM, V13, P210, DOI 10.21010/ajtcam.v13i4.27; Zhao J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030587	35	140	143	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197563	10.1371/journal.pone.0197563	http://dx.doi.org/10.1371/journal.pone.0197563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771951	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900074
J	Brias, SG; Marsden, M; Forbester, J; Clement, M; Brandt, C; Harcourt, K; Kane, L; Chapman, L; Clare, S; Humphreys, IR				Brias, Silvia Gimeno; Marsden, Morgan; Forbester, Jessica; Clement, Mathew; Brandt, Cordelia; Harcourt, Katherine; Kane, Leanne; Chapman, Lucy; Clare, Simon; Humphreys, Ian R.			Interferon lambda is required for interferon gamma- expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection	PLOS ONE			English	Article							IFN-LAMBDA; VIRUS-INFECTION; VIRAL-INFECTIONS; NATURAL-KILLER; CUTTING EDGE; IL-10; IMMUNITY; INFLAMMATION; INDUCTION; INTERLEUKIN-10	Interferon lambda (IFN lambda)is a group of cytokines that belong to the IL-10 family. They exhibit antiviral activities against certain viruses during infection of the liver and mucosal tissues. Here we report that IFN lambda restricts in vitro replication of the beta-herpesvirus murine cytomegalovirus (mCMV). However, IFN lambda R1-deficient (Ifn lambda r1(-/-)) mice were not preferentially susceptible to mCMV infection in vivo during acute infection after systemic or mucosal challenge, or during virus persistence in the mucosa. Instead, our studies revealed that IFN lambda influences NK cell responses during mCMV infection. Ifn lambda r1(-/-) mice exhibited defective development of conventional interferon-gamma (IFN gamma)-expressing NK cells in the spleen during mCMV infection whereas accumulation of granzyme B-expressing NK cells was unaltered. In vitro, development of splenic IFN gamma(+) NK cells following stimulation with IL-12 or, to a lesser extent, IL-18 was abrogated by IFN lambda R1-deficiency. Thus, IFN lambda regulates NK cell responses during mCMV infection and restricts virus replication in vitro but is redundant in the control of acute and persistent mCMV replication within mucosal and non-mucosal tissues.	[Brias, Silvia Gimeno; Marsden, Morgan; Forbester, Jessica; Clement, Mathew; Chapman, Lucy; Humphreys, Ian R.] Cardiff Univ, Syst Immun Univ Res Inst, Sch Med, Inst Infect Immun, Cardiff, S Glam, Wales; [Forbester, Jessica; Brandt, Cordelia; Harcourt, Katherine; Kane, Leanne; Clare, Simon; Humphreys, Ian R.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England	Cardiff University; Wellcome Trust Sanger Institute	Humphreys, IR (corresponding author), Cardiff Univ, Syst Immun Univ Res Inst, Sch Med, Inst Infect Immun, Cardiff, S Glam, Wales.; Humphreys, IR (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	humphreysir@cardiff.ac.uk		Forbester, Jessica/0000-0002-3834-615X; Humphreys, Ian/0000-0002-9512-5337	Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences [WT098026, 207503/Z/17/Z]; Medical Research Council Doctoral Training Grant (DTG); Wellcome Trust [WT206194]	Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences(Wellcome Trust); Medical Research Council Doctoral Training Grant (DTG); Wellcome Trust(Wellcome TrustEuropean Commission)	I.R.H. is funded by a Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences (WT098026 and 207503/Z/17/Z). S.G.B. is funded by a Medical Research Council Doctoral Training Grant (DTG). Experiments at the WTSI were also funded by the Wellcome Trust grant WT206194 to S.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Biron CA, 2015, MED MICROBIOL IMMUN, V204, P345, DOI 10.1007/s00430-015-0412-3; Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Brias SG, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00211; Britt W J, 1996, VIROLOGY, V3, P2493; Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821; Chang WLW, 2010, P NATL ACAD SCI USA, V107, P22647, DOI 10.1073/pnas.1013794108; Clement M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006050; Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413; Ding SY, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001758; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Farrell HE, 2016, MBIO, V7, DOI 10.1128/mBio.00251-16; Griffiths SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003514; Hermant P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087906; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Humphreys IR, 2007, J EXP MED, V204, P1217, DOI 10.1084/jem.20062424; Jones M, 2010, J IMMUNOL, V185, P3583, DOI 10.4049/jimmunol.1001535; JORDAN MC, 1978, INFECT IMMUN, V21, P275, DOI 10.1128/IAI.21.1.275-280.1978; Jost NH, 2014, IMMUNOL CELL BIOL, V92, P860, DOI 10.1038/icb.2014.62; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Kramer B, 2011, P NATL ACAD SCI USA, V108, pE519, DOI 10.1073/pnas.1108850108; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Madera S, 2015, J IMMUNOL, V194, P1408, DOI 10.4049/jimmunol.1402001; Mandaric S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002846; Misumi I, 2014, J IMMUNOL, V192, P3596, DOI 10.4049/jimmunol.1301705; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Oakley OR, 2008, CLIN EXP IMMUNOL, V151, P155, DOI 10.1111/j.1365-2249.2007.03533.x; Oduro JD, 2016, J GEN VIROL, V97, P185, DOI 10.1099/jgv.0.000339; Orange JS, 1996, J IMMUNOL, V156, P1138; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Redpath S, 1999, J IMMUNOL, V162, P6701; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Souza-Fonseca-Guimaraes F, 2015, P NATL ACAD SCI USA, V112, pE2376, DOI 10.1073/pnas.1424241112; Stacey MA, 2017, J CLIN INVEST, V127, P1463, DOI 10.1172/JCI84889; Stacey MA, 2014, CELL HOST MICROBE, V15, P471, DOI 10.1016/j.chom.2014.03.003; Stacey MA, 2011, J IMMUNOL, V187, P2944, DOI 10.4049/jimmunol.1101021; Stack G, 2012, VIRUSES-BASEL, V4, P1182, DOI 10.3390/v4081182; Trilling M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002069; Wang YS, 2017, J IMMUNOL, V199, P1012, DOI 10.4049/jimmunol.1601430; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	48	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197596	10.1371/journal.pone.0197596	http://dx.doi.org/10.1371/journal.pone.0197596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768502	Green Published, gold, Green Accepted			2022-12-26	WOS:000432329200095
J	Hess, MC; Inoue, K; Tsakiris, ET; Hart, M; Morton, J; Dudding, J; Robertson, CR; Randklev, CR				Hess, Megan C.; Inoue, Kentaro; Tsakiris, Eric T.; Hart, Michael; Morton, Jennifer; Dudding, Jack; Robertson, Clinton R.; Randklev, Charles R.			Misidentification of sex for Lampsilis teres, Yellow Sandshell, and its implications for mussel conservation and wildlife management	PLOS ONE			English	Article							FRESH-WATER MUSSELS; HARVESTED BOBCATS; TENNESSEE RIVER; UNIONIDAE; BIVALVIA; POPULATION; DIMORPHISM; SHELL; SHAPE; ASSEMBLAGES	Correct identification of sex is an important component of wildlife management because changes in sex ratios can affect population viability. Identification of sex often relies on external morphology, which can be biased by intermediate or nondistinctive morphotypes and observer experience. For unionid mussels, research has demonstrated that species misidentification is common but less attention has been given to the reliability of sex identification. To evaluate whether this is an issue, we surveyed 117 researchers on their ability to correctly identify sex of Lampsilis teres (Yellow Sandshell), a wide ranging, sexually dimorphic species. Personal background information of each observer was analyzed to identify factors that may contribute to misidentification of sex. We found that median misidentification rates were similar to 20% across males and females and that observers falsely identified the number of female specimens more often (similar to 23%) than males (similar to 10%). Misidentification rates were partially explained by geographic region of prior mussel experience and where observers learned how to identify mussels, but there remained substantial variation among observers after controlling for these factors. We also used three morphometric methods (traditional, geometric, and Fourier) to investigate whether sex could be more correctly identified statistically and found that misidentification rates for the geometric and Fourier methods (which characterize shape) were less than 5% (on average 7% and 2% for females and males, respectively). Our results show that misidentification of sex is likely common for mussels if based solely on external morphology, which raises general questions, regardless of taxonomic group, about its reliability for conservation efforts.	[Hess, Megan C.; Inoue, Kentaro; Tsakiris, Eric T.; Hart, Michael; Morton, Jennifer; Dudding, Jack; Randklev, Charles R.] Texas A&M AgriLife Res Ctr Dallas, Texas A&M Nat Resources Inst, Dallas, TX 77843 USA; [Robertson, Clinton R.] Texas Pk & Wildlife, Inland Fisheries Div, San Marcos, TX USA		Randklev, CR (corresponding author), Texas A&M AgriLife Res Ctr Dallas, Texas A&M Nat Resources Inst, Dallas, TX 77843 USA.	crandklev@ag.tamu.edu	Inoue, Kentaro/H-5638-2019	Inoue, Kentaro/0000-0001-6087-3290; Khan, Jennifer/0000-0002-8336-3979	Texas Agrilife Research	Texas Agrilife Research	Financial support was provided by Texas Agrilife Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agatsuma Y, 2005, AQUACULTURE, V249, P449, DOI 10.1016/j.aquaculture.2005.04.054; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; [Anonymous], 2011, FED REGISTER, P62166; Asher AM, 2012, SOUTHEAST NAT, V11, P219, DOI 10.1656/058.011.0205; Barnhart MC, 2000, FISH HOSTS CULTURE M; Belant JL, 2011, J WILDLIFE MANAGE, V75, P256, DOI 10.1002/jwmg.26; Benitez HA, 2013, SEXUAL DIMORPHISM, P35; Berec L, 2001, AM NAT, V157, P217, DOI 10.1086/318626; Berg DJ, 2008, J N AM BENTHOL SOC, V27, P395, DOI 10.1899/07-091.1; Berger J, 2001, P ROY SOC B-BIOL SCI, V268, P131, DOI 10.1098/rspb.2000.1341; CAMPBELL SA, 1969, MAR BIOL, V4, P227, DOI 10.1007/BF00393898; Clayton JL, 2014, W VIRGINIA MUSSEL SU, P1; DOWNING JA, 1989, J N AM BENTHOL SOC, V8, P92, DOI 10.2307/1467405; Ferreira JG, 2016, AQUACULT INT, V24, P803, DOI 10.1007/s10499-015-9949-9; Fraser M, 2016, MAR ENVIRON RES, V120, P78, DOI 10.1016/j.marenvres.2016.07.008; Galbraith HS, 2009, HYDROBIOLOGIA, V636, P35, DOI 10.1007/s10750-009-9933-3; Garner JT, 1999, AM MIDL NAT, V141, P277, DOI 10.1674/0003-0031(1999)141[0277:RCOQMB]2.0.CO;2; Haag WR, 2014, HYDROBIOLOGIA, V735, P45, DOI 10.1007/s10750-013-1524-7; Haag WR, 2012, NORTH AMERICAN FRESHWATER MUSSELS: NATURAL HISTORY, ECOLOGY, AND CONSERVATION, P1, DOI 10.1017/CBO9781139048217; Haag WR, 2003, FRESHWATER BIOL, V48, P2118, DOI 10.1046/j.1365-2427.2003.01155.x; Hadfield JD, 2017, MCMCGIMM COURSE NOTE, P1; Haggerty TM, 2011, INVERTEBR REPROD DEV, V55, P230, DOI 10.1080/07924259.2011.574845; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HEARD W H, 1970, Malacologia, V10, P333; Hiller TL, 2014, WILDLIFE SOC B, V38, P752, DOI 10.1002/wsb.454; Hines A, 2007, ENVIRON SCI TECHNOL, V41, P3375, DOI 10.1021/es062745w; HOSMER DW, 2000, APPL LOGISTIC REGRES, pCH8; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; JIRKA KJ, 1992, J FRESHWATER ECOL, V7, P35, DOI 10.1080/02705060.1992.9664668; Joaquino Al-Axel O., 2017, Journal of Biodiversity and Environmental Sciences, V10, P43; Jolley DF, 2004, ENVIRON POLLUT, V132, P203, DOI 10.1016/j.envpol.2004.04.026; Kirtland JP, 1834, AM J SCI ARTS, V26, P117; KOTRLA MB, 1987, J MOLLUS STUD, V53, P13, DOI 10.1093/mollus/53.1.13; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Minton RL, 2011, J MOLLUS STUD, V77, P315, DOI 10.1093/mollus/eyr014; MNDNR, 2017, RAR SPEC GUID; ODNR USFWS OESFO, 2016, OH MUSS SURV PROT, P45; Ortmann A. E., 1918, Philadelphia Proceedings of the American Philosophical Society, V57; Parmalee P., 1998, FRESHWATER MUSSELS T; Parmalee PW, 1967, FRESH WATER MUSSELS; Petes LE, 2008, AQUAT BIOL, V3, P63, DOI 10.3354/ab00067; Rogers SO, 2001, J N AM BENTHOL SOC, V20, P582, DOI 10.2307/1468089; Rohlf FJ, 2003, TPSDIG32; Saha S, 2008, J N AM BENTHOL SOC, V27, P84, DOI 10.1899/07-004R.1; Shea CP, 2011, J N AM BENTHOL SOC, V30, P446, DOI 10.1899/10-073.1; Sheets HD, 2006, IMP SOFTWARE SERIES; Smith DR, 2015, FRESHW SCI, V34, P1324, DOI 10.1086/683121; Surber T, 1912, IDENTIFICATION GLOCH; Tsakiris ET, 2016, FRESHW SCI, V35, P958, DOI 10.1086/687839; Tsakiris ET, 2016, AM MIDL NAT, V175, P120; U.S. Fish and Wildlife Service (USFWS), 2009, FED REG, V74, P66260; USFWS, 2016, FED REGISTER, V82, P24654; USFWS (US Fish and Wildlife Service), 2009, FED REGISTER, V74, P66866; Vaughn CC, 2008, J N AM BENTHOL SOC, V27, P409, DOI 10.1899/07-058.1; Vaughn CC, 2001, FRESHWATER BIOL, V46, P1431, DOI 10.1046/j.1365-2427.2001.00771.x; Wedekind C, 2002, ANIM CONSERV, V5, P13, DOI 10.1017/S1367943002001026; Williams BW, 2011, J WILDLIFE MANAGE, V75, P1508, DOI 10.1002/jwmg.181; WILLIAMS JD, 1993, FISHERIES, V18, P6, DOI 10.1577/1548-8446(1993)018<0006:CSOFMO>2.0.CO;2; Williams JR, 2005, NEW ZEAL J MAR FRESH, V39, P851, DOI 10.1080/00288330.2005.9517357; Wisniewski JM, 2013, FRESHW SCI, V32, P1122, DOI 10.1899/12-145.1; Zieritz A, 2011, J MORPHOL, V272, P1365, DOI 10.1002/jmor.10990; Zieritz A, 2009, BIOL J LINN SOC, V98, P814, DOI 10.1111/j.1095-8312.2009.01329.x; Zimmerman GF, 2007, FUND APPL LIMNOL, V168, P299, DOI 10.1127/1863-9135/2007/0168-0299	63	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197107	10.1371/journal.pone.0197107	http://dx.doi.org/10.1371/journal.pone.0197107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768469	gold, Green Submitted, Green Published			2022-12-26	WOS:000432329200058
J	Chen, BJ; Liu, K; Zhou, LJ; Gomes-Silva, G; Sommer-Trembo, C; Plath, M				Chen, Bo-jian; Liu, Kai; Zhou, Lin-jun; Gomes-Silva, Guilherme; Sommer-Trembo, Carolin; Plath, Martin			Personality differentially affects individual mate choice decisions in female and male Western mosquitofish (Gambusia affinis)	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; DWELLING ATLANTIC MOLLIES; MALE MATING-BEHAVIOR; SEXUAL SELECTION; BODY-SIZE; ANIMAL PERSONALITY; BRACHYRAPHIS-EPISCOPI; EASTERN MOSQUITOFISH; SOCIAL INFORMATION; LOCOMOTOR-ACTIVITY	Consistent individual differences in behavioral tendencies (animal personality) can affect individual mate choice decisions. We asked whether personality traits affect male and female mate choice decisions similarly and whether potential personality effects are consistent across different mate choice situations. Using western mosquitofish (Gambusia affinis) as our study organism, we characterized focal individuals (males and females) twice for boldness, activity, and sociability/shoaling and found high and significant behavioral repeatability. Additionally, each focal individual was tested in two different dichotomous mate choice tests in which it could choose between computer-animated stimulus fish of the opposite sex that differed in body size and activity levels, respectively. Personality had different effects on female and male mate choice: females that were larger than average showed stronger preferences for large-bodied males with increasing levels of boldness/activity (i.e., towards more proactive personality types). Males that were larger than average and had higher shoaling tendencies showed stronger preferences for actively swimming females. Size-dependent effects of personality on the strength of preferences for distinct phenotypes of potential mating partners may reflect effects of age/experience (especially in females) and social dominance (especially in males). Previous studies found evidence for assortative mate choice based on personality types or hypothesized the existence of behavioral syndromes of individuals' choosiness across mate choice criteria, possibly including other personality traits. Our present study exemplifies that far more complex patterns of personality-dependent mate choice can emerge in natural systems.	[Chen, Bo-jian; Liu, Kai; Zhou, Lin-jun; Gomes-Silva, Guilherme; Sommer-Trembo, Carolin; Plath, Martin] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Gomes-Silva, Guilherme] Univ Fed Uberlandia, Dept Geog Saude Ambiental, Uberlandia, MG, Brazil; [Sommer-Trembo, Carolin] JW Goethe Univ Frankfurt, Dept Ecol & Evolut, Max von Laue Str, Frankfurt, Germany	Northwest A&F University - China; Universidade Federal de Uberlandia; Goethe University Frankfurt	Plath, M (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China.	mplath-zoology@gmx.de	SILVA, GUILHERME GOMES/AAN-9853-2021	Zhou, Linjun/0000-0002-8916-5834; Gomes Silva, Guilherme/0000-0002-5848-0997	Talent Support Funding of Northwest AF University [Z111021403, Z111021501]; Scientific Start-up Funding for Doctors of Northwest AF University [Z109021614]; Fundamental Research Funds for the Central Universities [Z109021710]	Talent Support Funding of Northwest AF University; Scientific Start-up Funding for Doctors of Northwest AF University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Our research was supported by Talent Support Funding (Z111021403 and Z111021501; to Martin Plath), Scientific Start-up Funding for Doctors (Z109021614; to Bo-jian Chen) of Northwest A&F University and Fundamental Research Funds for the Central Universities (Z109021710; to Bo-jian Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2013, ECOL LETT, V16, P47, DOI 10.1111/ele.12011; Amundsen T, 2001, P NATL ACAD SCI USA, V98, P13155, DOI 10.1073/pnas.211439298; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Archard GA, 2011, J FISH BIOL, V78, P593, DOI 10.1111/j.1095-8649.2010.02880.x; Ariyomo TO, 2013, BEHAV ECOL, V24, P1320, DOI 10.1093/beheco/art070; Baldauf SA, 2009, J FISH BIOL, V75, P738, DOI 10.1111/j.1095-8649.2009.02347.x; Barber I, 2001, ANIM BEHAV, V61, P975, DOI 10.1006/anbe.2000.1665; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Basolo AL, 2004, ANIM BEHAV, V68, P75, DOI 10.1016/j.anbehav.2003.07.019; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bierbach D, 2015, BEHAV ECOL, V26, P1314, DOI 10.1093/beheco/arv079; Bierbach D, 2014, BEHAV ECOL SOCIOBIOL, V68, P935, DOI 10.1007/s00265-014-1706-y; Bierbach D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/148348; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; BISAZZA A, 1989, ETHOLOGY, V83, P335, DOI 10.1111/j.1439-0310.1989.tb00541.x; BISAZZA A, 1993, MAR BEHAV PHYSIOL, V23, P257, DOI 10.1080/10236249309378869; Bisazza A, 2001, BEHAV ECOL, V12, P59, DOI 10.1093/oxfordjournals.beheco.a000379; BISCHOFF RJ, 1985, BEHAV ECOL SOCIOBIOL, V17, P253, DOI 10.1007/BF00300143; Boon AK, 2007, ECOL LETT, V10, P1094, DOI 10.1111/j.1461-0248.2007.01106.x; Boulton K, 2014, BEHAV ECOL SOCIOBIOL, V68, P791, DOI 10.1007/s00265-014-1692-0; Brommer JE, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2278-4; Brown C, 2005, ANIM BEHAV, V70, P1003, DOI 10.1016/j.anbehav.2004.12.022; Brown C, 2004, ANIM BEHAV, V68, P1325, DOI 10.1016/j.anbehav.2004.04.004; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Budaev SV, 1997, J COMP PSYCHOL, V111, P399, DOI 10.1037/0735-7036.111.4.399; Burns JG, 2008, J COMP PSYCHOL, V122, P344, DOI 10.1037/0735-7036.122.4.344; Casner AM, 2016, ETHOLOGY, V122, P561, DOI 10.1111/eth.12507; Chen T, 2011, BIOL LETTERS, V7, P343, DOI 10.1098/rsbl.2010.1020; Chouinard-Thuly L, 2017, CURR ZOOL, V63, P5, DOI 10.1093/cz/zow104; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cornuau JH, 2012, BEHAV ECOL SOCIOBIOL, V66, P1045, DOI 10.1007/s00265-012-1355-y; Cote J, 2012, ANIM BEHAV, V83, P1469, DOI 10.1016/j.anbehav.2012.03.019; Cote J, 2011, P ROY SOC B-BIOL SCI, V278, P1670, DOI 10.1098/rspb.2010.1892; Cote J, 2010, P ROY SOC B-BIOL SCI, V277, P1571, DOI 10.1098/rspb.2009.2128; Dadda M, 2005, ANIM BEHAV, V70, P463, DOI 10.1016/j.anbehav.2004.12.010; Deaton R, 2008, J FISH BIOL, V72, P1607, DOI 10.1111/j.1095-8649.2008.01827.x; Dochtermann NA, 2010, BEHAV ECOL, V21, P437, DOI 10.1093/beheco/arq021; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Doutrelant C, 2000, BEHAVIOUR, V137, P1655, DOI 10.1163/156853900502763; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Evans JP., 2011, ECOLOGY EVOLUTION PO, DOI [10.7208/chicago/9780226222769.001.0001, DOI 10.7208/CHICAGO/9780226222769.001.0001]; FARR L, 1978, COMP BIOCHEM PHYS A, V61, P401, DOI 10.1016/0300-9629(78)90054-3; FRANCK D, 1975, Zeitschrift fuer Tierpsychologie, V38, P472; Franck D., 2000, ETHOLOGY, V106, P381, DOI [10.1046/j.1439-0310.2000.00565.x, DOI 10.1046/J.1439-0310.2000.00565.X]; Gabriel PO, 2012, ETHOLOGY, V118, P76, DOI 10.1111/j.1439-0310.2011.01990.x; Gasparini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022329; Gebczynski AK, 2009, J EVOLUTION BIOL, V22, P1212, DOI 10.1111/j.1420-9101.2009.01734.x; GOATER CP, 1993, OIKOS, V66, P129, DOI 10.2307/3545205; Godin JGJ, 1996, P NATL ACAD SCI USA, V93, P10262, DOI 10.1073/pnas.93.19.10262; Gomes-Silva G., 2017, ANN BIOL SCI, V5, P25, DOI [10.21767/2348-1927.1000106, DOI 10.21767/2348-1927.1000106]; Gomez D, 2009, P ROY SOC B-BIOL SCI, V276, P2351, DOI 10.1098/rspb.2009.0168; Harris S, 2010, OIKOS, V119, P1711, DOI 10.1111/j.1600-0706.2010.18028.x; Head ML, 2015, ECOL EVOL, V5, P4999, DOI 10.1002/ece3.1775; Heinen-Kay JL, 2015, BEHAV ECOL, V26, P533, DOI 10.1093/beheco/aru228; Herdman EJE, 2004, ETHOLOGY, V110, P97, DOI 10.1111/j.1439-0310.2003.00960.x; Hoysak DJ, 2007, ETHOLOGY, V113, P1007, DOI 10.1111/j.1439-0310.2007.01413.x; HUGHES AL, 1985, BEHAV ECOL SOCIOBIOL, V17, P271, DOI 10.1007/BF00300146; Hughes AL, 2015, EVOL BIOL, V42, P366, DOI 10.1007/s11692-015-9315-x; Husak JF, 2006, EVOLUTION, V60, P2122, DOI 10.1111/j.0014-3820.2006.tb01849.x; Ihle M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002248; Jiang YX, 2013, AM NAT, V181, pE125, DOI 10.1086/670160; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; Kekalainen J, 2014, BEHAV ECOL SOCIOBIOL, V68, P197, DOI 10.1007/s00265-013-1634-2; Killen SS, 2016, FUNCT ECOL, V30, P576, DOI 10.1111/1365-2435.12527; Kodric-Brown A, 2001, BEHAV ECOL SOCIOBIOL, V50, P346, DOI 10.1007/s002650100374; KODRICBROWN A, 1993, BEHAV ECOL SOCIOBIOL, V32, P415, DOI 10.1007/BF00168825; Kortet R, 2019, ECOL PARASITOL IMMUN, V1, P1, DOI [10.4303/epi/235580, DOI 10.4303/EPI/235580]; Kralj-Fiser S, 2013, BEHAV ECOL, V24, P824, DOI 10.1093/beheco/art030; Kurvers RHJM, 2011, P ROY SOC B-BIOL SCI, V278, P2018, DOI 10.1098/rspb.2010.2266; Kurvers RHJM, 2010, ECOL LETT, V13, P829, DOI 10.1111/j.1461-0248.2010.01473.x; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Lafleur DL, 1997, ANIM BEHAV, V54, P579, DOI 10.1006/anbe.1996.0452; Laubu C, 2017, ANIM BEHAV, V126, P281, DOI 10.1016/j.anbehav.2017.02.020; Laubu C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501013; Lindholm A, 2002, AM NAT, V160, pS214, DOI 10.1086/342898; LINDSTROM K, 1993, ANIM BEHAV, V46, P1029, DOI 10.1006/anbe.1993.1289; MAJERUS MEN, 1986, TRENDS ECOL EVOL, V1, P1, DOI 10.1016/0169-5347(86)90056-X; Marler CA, 1997, EVOLUTION, V51, P1244, DOI 10.1111/j.1558-5646.1997.tb03971.x; Mazue GPF, 2015, BEHAV ECOL, V26, P900, DOI 10.1093/beheco/arv030; MCPEEK MA, 1992, BEHAV ECOL, V3, P1, DOI 10.1093/beheco/3.1.1; Montiglio PO, 2016, J ANIM ECOL, V85, P125, DOI 10.1111/1365-2656.12436; Moretz JA, 2007, BEHAV ECOL, V18, P556, DOI 10.1093/beheco/arm011; Morris MR, 2008, ETHOLOGY, V114, P977, DOI 10.1111/j.1439-0310.2008.01541.x; Morris MR, 2010, ANIM BEHAV, V79, P673, DOI 10.1016/j.anbehav.2009.12.018; Mretti EH, 2014, J HERPETOL, V48, P277, DOI 10.1670/10-339; Muraco JJ, 2014, BEHAV ECOL, V25, P200, DOI 10.1093/beheco/art106; Nelson CM, 1997, J INSECT BEHAV, V10, P557, DOI 10.1007/BF02765377; Passos C, 2015, REPROD BEHAV SEXUAL, P207, DOI [10.1201/b19016-16, DOI 10.1201/B19016-16]; PASTERNAK AF, 1995, PARASITOLOGY, V110, P395, DOI 10.1017/S0031182000064738; Peterson CC, 2006, COPEIA, P216, DOI 10.1643/0045-8511(2006)6[216:LPASSI]2.0.CO;2; Pilastro A, 2003, ANIM BEHAV, V65, P1161, DOI 10.1006/anbe.2003.2118; Pincemy G, 2009, ANIM BEHAV, V78, P1247, DOI 10.1016/j.anbehav.2009.07.041; Pitcher TE, 2003, P ROY SOC B-BIOL SCI, V270, P1623, DOI 10.1098/rspb.2002.2280; Plath M, 2006, NATURWISSENSCHAFTEN, V93, P103, DOI 10.1007/s00114-005-0072-z; Plath M, 2004, BEHAV ECOL SOCIOBIOL, V55, P596, DOI 10.1007/s00265-003-0750-9; Plath M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1727, DOI 10.1007/s00265-008-0601-9; Plath M, 2008, BEHAVIOUR, V145, P73, DOI 10.1163/156853908782687241; Plath Martin, 2011, Communicative & Integrative Biology, V4, P276, DOI 10.4161/cib.4.3.14916; Pollux BJA, 2014, NATURE, V513, P233, DOI 10.1038/nature13451; Polverino G, 2016, BEHAV ECOL SOCIOBIOL, V70, P2027, DOI 10.1007/s00265-016-2206-z; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054315; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451; Rahman MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105856; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Richardson C, 2010, P ROY SOC B-BIOL SCI, V277, P1247, DOI 10.1098/rspb.2009.1836; Riesch R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22968; Rios-Cardenas O, 2007, ANIM BEHAV, V74, P633, DOI 10.1016/j.anbehav.2007.01.002; Rosenthal GG, 2007, ANNU REV ECOL EVOL S, V38, P155, DOI 10.1146/annurev.ecolsys.38.091206.095745; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; Sato A, 2006, ICHTHYOL RES, V53, P398, DOI 10.1007/s10228-006-0364-0; Scharnweber K, 2011, ACTA ETHOL, V14, P77, DOI 10.1007/s10211-011-0097-6; Scherer U, 2017, ANIM BEHAV, V128, P117, DOI 10.1016/j.anbehav.2017.04.007; Scherer U, 2017, ETHOLOGY, V123, P560, DOI 10.1111/eth.12630; SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809; Schlupp I, 2001, BEHAVIOUR, V138, P277, DOI 10.1163/15685390151074438; Schuett W, 2011, ETHOLOGY, V117, P908, DOI 10.1111/j.1439-0310.2011.01945.x; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Schuett W, 2010, BIOL REV, V85, P217, DOI 10.1111/j.1469-185X.2009.00101.x; Servedio MR, 2009, EVOL ECOL, V23, P109, DOI 10.1007/s10682-007-9188-2; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Sih A, 2015, TRENDS ECOL EVOL, V30, P50, DOI 10.1016/j.tree.2014.11.004; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Smith BR, 2010, BEHAV ECOL, V21, P919, DOI 10.1093/beheco/arq084; Sommer-Trembo C, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0712-2; Tobler M, 2005, BIOL LETTERS, V1, P166, DOI 10.1098/rsbl.2005.0305; Trompf L, 2014, ANIM BEHAV, V88, P99, DOI 10.1016/j.anbehav.2013.11.022; Trott AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046025; Tudor MS, 2011, ANIM BEHAV, V82, P1313, DOI 10.1016/j.anbehav.2011.09.014; Walling CA, 2010, BEHAV ECOL SOCIOBIOL, V64, P541, DOI 10.1007/s00265-009-0869-4; WEBSTER JP, 1994, PARASITOLOGY, V109, P583, DOI 10.1017/S0031182000076460; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; Wilson RS, 2005, ANIM BEHAV, V70, P1387, DOI 10.1016/j.anbehav.2004.12.024; Wisenden BD, 2011, BEHAVIOUR, V148, P1443, DOI 10.1163/156853911X616530; Witte K, 2002, BEHAV ECOL SOCIOBIOL, V52, P194, DOI 10.1007/s00265-002-0503-1; Wong RY, 2011, ANIM BEHAV, V82, P691, DOI 10.1016/j.anbehav.2011.06.024; Xie Y, 2001, BIODIVERS CONSERV, V10, P1317, DOI 10.1023/A:1016695609745; Zimmer C, 2013, SEXUAL SELECTION EVO, P69	140	16	17	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197197	10.1371/journal.pone.0197197	http://dx.doi.org/10.1371/journal.pone.0197197			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF7AA	29763435	Green Submitted, Green Published, gold			2022-12-26	WOS:000432118800029
J	Si, Y; Wang, LH; Zhou, Q; Huang, XH				Si, Yong; Wang, Lihong; Zhou, Qing; Huang, Xiaohua			Effects of lanthanum and acid rain stress on the bio-sequestration of lanthanum in phytoliths in germinated rice seeds	PLOS ONE			English	Article							RARE-EARTH-ELEMENTS; CARBON SEQUESTRATION; BIOGEOCHEMICAL SEQUESTRATION; UNITED-STATES; SILICON; CHINA; SOIL; DEPOSITION; CHEMISTRY; RELEASE	REEs in the environment can be absorbed by plants and sequestered by plant phytoliths. Acid rain can directly or indirectly affect plant physiological functions. Currently, the effects of REEs and acid rain on phytolith-REEs complex in plants are not yet fully understood. In this study, a high-silicon accumulation crop, rice (Oryza sativa L.), was selected as a representative of plants, and orthogonal experiments were conducted under various levels of lanthanum [La(III)] and pH. The results showed that various La(III) concentrations could significantly improve the efficiency and sequestration of phytolith La(III) in germinated rice seeds. A pH of 4.5 promoted phytolith La(III) sequestration, while a pH of 3.5 inhibited sequestration. Compared with the single treatment with La(III), the combination of La(III) and acid rain inhibited the efficiency and sequestration of phytolith La(III). Correlation analysis showed that the efficiency of phytolith La(III) sequestration had no correlation with the production of phytolith but was closely correlated with the sequestration of phytolith La(III) and the physiological changes of germinated rice seeds. Phytolith morphology was an important factor affecting phytolith La(III) sequestration in germinated rice seeds, and the effect of tubes on sequestration was more significant than that of dumbbells. This study demonstrated that the formation of the phytolith and La(III) complex could be affected by exogenous La(III) and acid rain in germinated rice seeds.	[Si, Yong; Wang, Lihong; Zhou, Qing] Jiangnan Univ, Sch Environm & Civil Engn, State Key Lab Food Sci & Technol, Jiangsu Key Lab Anaerob Biotechnol, Wuxi, Jiangsu, Peoples R China; [Si, Yong; Wang, Lihong; Zhou, Qing] Suzhou Univ Sci & Technol, Jiangsu Cooperat Innovat Ctr Water Treatment Tech, Suzhou, Jiangsu, Peoples R China; [Huang, Xiaohua] Nanjing Normal Univ, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Sch Chem & Mat Sci, Jiangsu Key Lab Biomed Mat, Nanjing, Jiangsu, Peoples R China	Jiangnan University; Suzhou University of Science & Technology; Nanjing Normal University	Zhou, Q (corresponding author), Jiangnan Univ, Sch Environm & Civil Engn, State Key Lab Food Sci & Technol, Jiangsu Key Lab Anaerob Biotechnol, Wuxi, Jiangsu, Peoples R China.; Zhou, Q (corresponding author), Suzhou Univ Sci & Technol, Jiangsu Cooperat Innovat Ctr Water Treatment Tech, Suzhou, Jiangsu, Peoples R China.; Huang, XH (corresponding author), Nanjing Normal Univ, Jiangsu Collaborat Innovat Ctr Biomed Funct Mat, Sch Chem & Mat Sci, Jiangsu Key Lab Biomed Mat, Nanjing, Jiangsu, Peoples R China.	qingzhou510@yahoo.com; huangxiaohuanjnu@yahoo.com		Huang, Xiaohua/0000-0003-4150-0477	Research and Innovation Project for Postgraduates of Higher Education Institutions of Jiangsu Province [KYLX15_1164]; National Natural Science Foundation of China [31170477, 21371100, 21501068]	Research and Innovation Project for Postgraduates of Higher Education Institutions of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a Research and Innovation Project for Postgraduates of Higher Education Institutions of Jiangsu Province (KYLX15_1164), and a grant of the National Natural Science Foundation of China (Grant No. 31170477, 21371100, 21501068).; This research was supported by a Research and Innovation Project for Postgraduates of Higher Education Institutions of Jiangsu Province (KYLX15_1164) and a grant from the National Natural Science Foundation of China (Grant No. 31170477, 21371100, 21501068). The authors declare no competing financial interests.	Abbasi Tasneem, 2013, International Journal of Environmental Engineering, V5, P229, DOI 10.1504/IJEE.2013.054703; [Anonymous], [No title captured]; Biasioli M, 2012, CHEMOSPHERE, V88, P1241, DOI 10.1016/j.chemosphere.2012.03.081; Blecker SW, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2006GB002690; Cao XD, 2001, CHEMOSPHERE, V44, P655, DOI 10.1016/S0045-6535(00)00492-6; Cao ZhiHong, 2007, Acta Pedologica Sinica, V44, P838; Carter JA, 2009, QUATERN INT, V193, P20, DOI 10.1016/j.quaint.2007.11.013; Chen J, 2010, J ENVIRON MONITOR, V12, P1799, DOI 10.1039/c0em00116c; Daws MI, 2008, ANN BOT-LONDON, V102, P945, DOI 10.1093/aob/mcn186; Diatloff E, 1996, AUST J SOIL RES, V34, P735, DOI 10.1071/SR9960735; EPA, 2012, RARE EARTH ELEMENTS; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Honaine MF, 2012, PLANT BIOLOGY, V14, P596, DOI 10.1111/j.1438-8677.2011.00530.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Fraysse F, 2006, GEOCHIM COSMOCHIM AC, V70, P1939, DOI 10.1016/j.gca.2005.12.025; Fraysse F, 2009, CHEM GEOL, V258, P197, DOI 10.1016/j.chemgeo.2008.10.003; Gao XiaoJiang, 1999, China Environmental Science, V19, P149; Gu YS, 2016, J ARCHAEOL SCI, V68, P46, DOI 10.1016/j.jas.2015.08.003; Guo FS, 2015, SCI BULL, V60, P591, DOI 10.1007/s11434-015-0729-8; Haynes RJ, 2017, AGR ECOSYST ENVIRON, V245, P100, DOI 10.1016/j.agee.2017.04.021; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Hu ZY, 2006, COMMUN SOIL SCI PLAN, V37, P1381, DOI 10.1080/00103620600628680; Hu ZY, 2004, J PLANT NUTR, V27, P183, DOI 10.1081/PLN-120027555; Huang XH, 2000, J RARE EARTH, V18, P298; Ingamels CO, 1964, TALANTA, V11, P665; Jenkins E, 2009, J ARCHAEOL SCI, V36, P2402, DOI 10.1016/j.jas.2009.06.028; JIANG QH, 1995, REV PALAEOBOT PALYNO, V89, P481, DOI 10.1016/0034-6667(95)00033-9; Kamenik J, 2013, ENVIRON CHEM LETT, V11, P189, DOI 10.1007/s10311-012-0396-9; Karkanas P, 2010, QUATERN INT, V214, P63, DOI 10.1016/j.quaint.2009.10.017; KHAN MA, 1984, AM J BOT, V71, P481, DOI 10.2307/2443323; Lajtha K, 2013, BIOGEOCHEMISTRY, V116, P303, DOI 10.1007/s10533-013-9860-2; LANNING FC, 1987, ANN BOT-LONDON, V60, P361, DOI 10.1093/oxfordjournals.aob.a087456; Larssen T, 2000, ENVIRON POLLUT, V110, P89, DOI 10.1016/S0269-7491(99)00279-1; Larssen T, 2006, ENVIRON SCI TECHNOL, V40, P418, DOI 10.1021/es0626133; Li ZM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00529; Li ZM, 2013, CHINESE SCI BULL, V58, P2480, DOI 10.1007/s11434-013-5785-3; Liang T, 2014, ENVIRON MONIT ASSESS, V186, P1499, DOI 10.1007/s10661-013-3469-8; Liu TW, 2011, J PROTEOME RES, V10, P2579, DOI 10.1021/pr200056a; Loell M, 2011, J PLANT NUTR SOIL SC, V174, P644, DOI 10.1002/jpln.201000265; Lu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004448; Ma J.F., 2002, SOIL FERTILIZER PLAN; Ma J.F., 1990, THESIS; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2007, NATURE, V448, P209, DOI 10.1038/nature05964; Marschner H., 1995, J ECOL, V76, P1250; Menz FC, 2004, ENVIRON SCI POLICY, V7, P253, DOI 10.1016/j.envsci.2004.05.005; Meunier JD, 1999, GEOLOGY, V27, P835; Nguyen MN, 2014, J PLANT NUTR SOIL SC, V177, P349, DOI 10.1002/jpln.201300056; Motomura H, 2002, ANN BOT-LONDON, V90, P149, DOI 10.1093/aob/mcf148; Parr J., 2009, Sugar Tech, V11, P17, DOI 10.1007/s12355-009-0003-y; Parr J, 2010, GLOBAL CHANGE BIOL, V16, P2661, DOI 10.1111/j.1365-2486.2009.02118.x; Parr JF, 2011, PLANT SOIL, V342, P165, DOI 10.1007/s11104-010-0680-z; Parr JF, 2005, SOIL BIOL BIOCHEM, V37, P117, DOI 10.1016/j.soilbio.2004.06.013; Parr JF, 2001, REV PALAEOBOT PALYNO, V116, P203, DOI 10.1016/S0034-6667(01)00089-6; Piperno D.R., 1998, SMITHSONIAN CONTRIBU, P1, DOI [10.5479/si.0081024X.85, DOI 10.5479/SI.0081024X.85]; Puppe D, 2015, GEODERMA, V243, P196, DOI 10.1016/j.geoderma.2014.12.018; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; Redling K, 2006, THESIS TIERARZTLICHE, P322; Rodhe H, 2002, ENVIRON SCI TECHNOL, V36, P4382, DOI 10.1021/es020057g; Sabiha-Javied, 2010, J RADIOANAL NUCL CH, V284, P397, DOI 10.1007/s10967-010-0469-9; Sadeghi M, 2013, J GEOCHEM EXPLOR, V133, P202, DOI 10.1016/j.gexplo.2012.12.007; SANGSTER AG, 1970, ANN BOT-LONDON, V34, P245, DOI 10.1093/oxfordjournals.aob.a084359; Savant NK, 1997, ADV AGRON, V58, P151; Si Y, 2018, ENVIRON SCI POLLUT R, V25, P1; Singh A, 2008, J ENVIRON BIOL, V29, P15; Song ZL, 2014, EUR J AGRON, V53, P10, DOI 10.1016/j.eja.2013.11.004; Song ZL, 2012, EARTH-SCI REV, V115, P319, DOI 10.1016/j.earscirev.2012.09.006; Song ZL, 2012, GLOBAL CHANGE BIOL, V18, P3647, DOI 10.1111/gcb.12017; Stevens CJ, 2009, ENVIRON POLLUT, V157, P313, DOI 10.1016/j.envpol.2008.06.033; Stromberg CAE, 2004, PALAEOGEOGR PALAEOCL, V207, P239, DOI 10.1016/j.palaeo.2003.09.028; Struyf E, 2012, BIOGEOCHEMISTRY, V107, P9, DOI 10.1007/s10533-011-9590-2; Sun H, 1996, CHEMOSPHERE, V33, P1475; Suzuki Y, 2011, J ENVIRON MONITOR, V13, P3420, DOI 10.1039/c1em10590f; Thomas PJ, 2014, CHEMOSPHERE, V96, P57, DOI 10.1016/j.chemosphere.2013.07.020; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; Wai KM, 2005, ENVIRON SCI TECHNOL, V39, P6542, DOI 10.1021/es048897d; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang LH, 2010, SEED SCI TECHNOL, V38, P26, DOI 10.15258/sst.2010.38.1.03; Wang LH, 2014, P NATL ACAD SCI USA, V111, P12936, DOI 10.1073/pnas.1413376111; Wang XK, 2001, J RADIOANAL NUCL CH, V250, P267; Wang YJ, 1992, STUDY APPL PHYTOLITH; Wen XJ, 2013, ENVIRON EARTH SCI, V69, P843, DOI 10.1007/s12665-012-1969-4; Wickramasinghe DB, 2006, BIOL FERT SOILS, V42, P231, DOI 10.1007/s00374-005-0020-2; WILLIAMS RJP, 1986, CIBA F SYMP, V121, P24; Xiong BK, 1995, APPL RARE EARTH CHIN, P5; [杨维 YANG Wei], 2010, [中国农业气象, Chinese Journal of Agrometeorology], V31, P25; Yi L, 2010, ATMOS RES, V96, P173, DOI 10.1016/j.atmosres.2009.12.011; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhang GZ, 2017, ATMOS POLLUT RES, V8, P1031, DOI 10.1016/j.apr.2017.02.001; Zhao YX, 2010, ACTA METEOROL SIN, V24, P239; Zhao YY, 2016, ECOL RES, V31, P117, DOI 10.1007/s11284-015-1320-0; Zhou Q, 2000, J CHIN RARE EARTH SO, V18, P262; Zhu J. G., 1993, Pedosphere, V3, P299; Zuo XX, 2011, CHINESE SCI BULL, V56, P3451, DOI 10.1007/s11434-011-4674-x	95	1	1	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197365	10.1371/journal.pone.0197365	http://dx.doi.org/10.1371/journal.pone.0197365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF7AA	29763463	gold, Green Submitted, Green Published			2022-12-26	WOS:000432118800041
J	Tseng, YL; Chang, CC; Chen, YY; Liu, YS; Cheng, LL; Chang, JM; Wu, MH; Yen, YT				Tseng, Yau-Lin; Chang, Chao-Chun; Chen, Ying-Yuan; Liu, Yi-Sheng; Cheng, Lili; Chang, Jia-Ming; Wu, Ming-Ho; Yen, Yi-Ting			From one incision to one port: The surgical technique and the evolution of segmentectomy in patients with pulmonary tuberculosis	PLOS ONE			English	Article							ASSISTED THORACIC-SURGERY; MULTIDRUG-RESISTANT TUBERCULOSIS; LUNG-CANCER; THORACOSCOPIC SURGERY; ANATOMIC SEGMENTECTOMY; THORACOTOMY; RESECTION; LOBECTOMY; EXPERIENCE; MORBIDITY	Objectives We retrospectively reviewed the evolution of segmentectomy for pulmonary tuberculosis (TB) and the feasibility of multi- and single-incision video-assisted thoracoscopic segmentectomy. Methods Of 348 patients undergoing surgery for TB, the medical records of 121 patients undergoing segmentectomy between January 1996 and November 2015 were reviewed. Clinical information and computed tomography (CT) image characteristics were investigated and analyzed. Results Eighteen patients underwent direct or intended thoracotomy. Sixty-four underwent video-assisted thoracoscopic segmentectomy (VATS), including 53 multi-incision thoracoscopic segmentectomy (MITS), and 11 single-incision thoracoscopic segmentectomy (SITS). Thirty-nine were converted to thoracotomy. The intended thoracotomy group had more operative blood loss (p = 0.005) and hospital stay (p = 0.001) than the VATS group although the VATS group had higher grade of cavity (p = 0.007). The intended thoracotomy group did not differ from converted thoracotomy in operative time, blood loss, or hospital stay, and the grade of pleural thickening was higher in the converted thoracotomy group (p = 0.001). The converted thoracotomy group had more operative blood loss, hospital stay, and complication rate than the MITS group (p = 0.001, p<0.001, and p = 0.009, respectively). The MITS group had lower pleural thickening, peribronchial lymph node calcification, cavity, and tuberculoma grading than the converted thoracotomy group (p<0.001, p = 0.001, 0.001, and 0.017, respectively). The SITS group had lower grading in pleural thickening, peribronchial lymph node calcification, and aspergilloma grading than the converted thoracotomy group (p = 0.002, 0.010, and 0.031, respectively). Four patients in the intended thoracotomy group and seven in the converted thoracotomy group had complications compared with three patients in the MITS and two in the SITS group. Risk factors of conversion were pleural thickening and peribronchial lymph node calcification. Conclusion Although segmentectomy is technically challenging in patients with pulmonary TB, it could be safely performed using MITS or SITS and should be attempted in selected patients. Its efficacy for medical treatment failure needs investigation.	[Tseng, Yau-Lin; Chang, Chao-Chun; Chen, Ying-Yuan; Yen, Yi-Ting] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Med Coll, Dept Surg,Div Thorac Surg, Tainan, Taiwan; [Chen, Ying-Yuan; Chang, Jia-Ming; Yen, Yi-Ting] Natl Cheng Kung Univ, Med Coll, Inst Clin Med, Tainan, Taiwan; [Liu, Yi-Sheng; Cheng, Lili] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Med Coll, Dept Diagnost Radiol, Tainan, Taiwan; [Chang, Jia-Ming] Chia Yi Christian Hosp, Dept Surg, Div Thorac Surg, Chiayi, Taiwan; [Wu, Ming-Ho] Tainan Municipal Hosp, Dept Surg, Div Thorac Surg, Tainan, Taiwan; [Yen, Yi-Ting] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Med Coll, Div Trauma & Acute Care Surg,Dept Surg, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Yen, YT (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Med Coll, Dept Surg,Div Thorac Surg, Tainan, Taiwan.; Yen, YT (corresponding author), Natl Cheng Kung Univ, Med Coll, Inst Clin Med, Tainan, Taiwan.; Yen, YT (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Med Coll, Div Trauma & Acute Care Surg,Dept Surg, Tainan, Taiwan.	b85401067@gmail.com	Yen, Yi-Ting/AAQ-1691-2020; liu, yi/GXE-9662-2022		National Cheng Kung University Hospital Research [NCKUH-10601006]	National Cheng Kung University Hospital Research	This study is granted by the National Cheng Kung University Hospital Research Grant NCKUH-10601006 to Dr Yi-Ting Yen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins BZ, 2007, ANN THORAC SURG, V84, P1107, DOI 10.1016/j.athoracsur.2007.05.013; D'Amico TA, 2008, ANN THORAC SURG, V85, pS716, DOI 10.1016/j.athoracsur.2007.11.050; Dravniece G, 2009, EUR RESPIR J, V34, P180, DOI 10.1183/09031936.00047208; Gonzalez-Rivas D, 2013, J THORAC DIS, V5, pS234, DOI 10.3978/j.issn.2072-1439.2013.07.30; Gonzalez-Rivas D, 2013, ANN THORAC SURG, V95, P426, DOI 10.1016/j.athoracsur.2012.10.070; Gonzalez-Rivas D, 2012, EUR J CARDIO-THORAC, V42, pE169, DOI 10.1093/ejcts/ezs482; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kaseda S, 2000, ANN THORAC SURG, V70, P1644, DOI 10.1016/S0003-4975(00)01909-3; Kempker RR, 2012, CLIN INFECT DIS, V54, pE51, DOI 10.1093/cid/cir904; LANDRENEAU RJ, 1993, ANN THORAC SURG, V56, P1285, DOI 10.1016/0003-4975(93)90667-7; Leshnower BG, 2010, ANN THORAC SURG, V89, P1571, DOI 10.1016/j.athoracsur.2010.01.061; Li WWL, 2002, CHEST, V122, P584, DOI 10.1378/chest.122.2.584; Marrone MT, 2013, INT J TUBERC LUNG D, V17, P6, DOI 10.5588/ijtld.12.0198; Mohsen T, 2007, J THORAC CARDIOV SUR, V134, P194, DOI 10.1016/j.jtcvs.2007.03.022; Morita K, 2008, SURG ENDOSC, V22, P750, DOI 10.1007/s00464-007-9481-8; Nakayama S, 2011, SURG ENDOSC, V25, P2382, DOI 10.1007/s00464-010-1527-7; Nomori H, 2002, EUR J CARDIO-THORAC, V21, P155, DOI 10.1016/S1010-7940(01)01057-0; Park SK, 2009, INT J INFECT DIS, V13, P170, DOI 10.1016/j.ijid.2008.06.001; Schuchert MJ, 2010, J THORAC CARDIOV SUR, V140, P1168, DOI 10.1016/j.jtcvs.2010.06.064; Schuchert MJ, 2009, J THORAC CARDIOV SUR, V138, P1318, DOI 10.1016/j.jtcvs.2009.08.028; Shiraishi T, 2004, SURG ENDOSC, V18, P1657, DOI 10.1007/s00464-003-9269-4; Shiraishi Y, 2004, J THORAC CARDIOV SUR, V128, P523, DOI 10.1016/j.jtcvs.2004.06.012; Swanson SJ, 2010, SEMIN THORAC CARDIOV, V22, P244, DOI 10.1053/j.semtcvs.2010.10.014; Tseng YL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003511; Tseng YL, 2000, EUR J CARDIO-THORAC, V18, P666, DOI 10.1016/S1010-7940(00)00594-7; Wang HF, 2008, ANN THORAC SURG, V86, P1640, DOI 10.1016/j.athoracsur.2008.07.056; Wu MH, 2004, SURG TODAY, V34, P204, DOI 10.1007/s00595-003-2692-2; Yang CFJ, 2012, ANN THORAC SURG, V94, P668, DOI 10.1016/j.athoracsur.2012.03.080; Yen YT, 2013, ANN THORAC SURG, V95, P257, DOI 10.1016/j.athoracsur.2012.09.034; Yen YT, 2011, ANN THORAC SURG, V92, P290, DOI 10.1016/j.athoracsur.2011.02.039	30	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197283	10.1371/journal.pone.0197283	http://dx.doi.org/10.1371/journal.pone.0197283			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763423	gold, Green Published, Green Submitted			2022-12-26	WOS:000432118800035
J	Xia, YK; Fu, Z; Pan, LJ; Duan, FH				Xia, Yangkun; Fu, Zhuo; Pan, Lijun; Duan, Fenghua			Tabu search algorithm for the distance-constrained vehicle routing problem with split deliveries by order	PLOS ONE			English	Article							CRUDE-OIL TRANSPORTATION; TIME WINDOWS; SCHEDULING PROBLEMS; BRANCH; MODEL; HEURISTICS; COMPLEXITY; PRICE; CUT	The vehicle routing problem (VRP) has a wide range of applications in the field of logistics distribution. In order to reduce the cost of logistics distribution, the distance-constrained and capacitated VRP with split deliveries by order (DCVRPSDO) was studied. We show that the customer demand, which can't be split in the classical VRP model, can only be discrete split deliveries by order. A model of double objective programming is constructed by taking the minimum number of vehicles used and minimum vehicle traveling cost as the first and the second objective, respectively. This approach contains a series of constraints, such as single depot, single vehicle type, distance-constrained and load capacity limit, split delivery by order, etc. DCVRPSDO is a new type of VRP. A new tabu search algorithm is designed to solve the problem and the examples testing show the efficiency of the proposed algorithm. This paper focuses on constructing a double objective mathematical programming model for DCVRPSDO and designing an adaptive tabu search algorithm (ATSA) with good performance to solving the problem. The performance of the ATSA is improved by adding some strategies into the search process, including: (a) a strategy of discrete split deliveries by order is used to split the customer demand; (b) a multi-neighborhood structure is designed to enhance the ability of global optimization; (c) two levels of evaluation objectives are set to select the current solution and the best solution; (d) a discriminating strategy of that the best solution must be feasible and the current solution can accept some infeasible solution, helps to balance the performance of the solution and the diversity of the neighborhood solution; (e) an adaptive penalty mechanism will help the candidate solution be closer to the neighborhood of feasible solution; (f) a strategy of tabu releasing is used to transfer the current solution into a new neighborhood of the better solution.	[Xia, Yangkun; Fu, Zhuo] Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China; [Pan, Lijun] Hunan Inst Engn, Coll Management, Xiangtan, Hunan, Peoples R China; [Duan, Fenghua] Hunan Univ Sci & Technol, Business Sch, Xiangtan, Hunan, Peoples R China	Central South University; Hunan Institute of Engineering; Hunan University of Science & Technology	Fu, Z (corresponding author), Cent S Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China.	zhfu@csu.edu.cn	pan, lijun/GQI-0975-2022	Fu, Zhuo/0000-0001-7793-7115	National Natural Science Foundation of China [71271220]; China Society of Logistics [2016CSLKT3-077]; Fundamental Research Funds for the Central Universities of Central South University [2017zzts198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Society of Logistics; Fundamental Research Funds for the Central Universities of Central South University	This research was supported by the National Natural Science Foundation of China (ZF) (Grant: 71271220), the China Society of Logistics (YX) (Grant: 2016CSLKT3-077), and the Fundamental Research Funds for the Central Universities of Central South University (YX) (Grant: 2017zzts198). All other authors received no specific funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman R E., 2009, GUIDED NEIGHBORHOOD; Aleman RE, 2010, J HEURISTICS, V16, P441, DOI 10.1007/s10732-008-9101-3; Archetti C, 2006, TRANSPORT SCI, V40, P64, DOI 10.1287/trsc.1040.0103; Archetti C, 2005, TRANSPORT SCI, V39, P182, DOI 10.1287/trsc.1030.0084; Archetti C, 2012, INT T OPER RES, V19, P3, DOI 10.1111/j.1475-3995.2011.00811.x; Archetti C, 2011, NETWORKS, V58, P241, DOI 10.1002/net.20467; Archetti C, 2011, TRANSPORT SCI, V45, P285, DOI 10.1287/trsc.1100.0363; Archetti C, 2014, EUR J OPER RES, V238, P685, DOI 10.1016/j.ejor.2014.04.026; Archetti C, 2011, TRANSPORT RES C-EMER, V19, P741, DOI 10.1016/j.trc.2009.12.006; Belfiore P, 2013, COMPUT IND ENG, V64, P589, DOI 10.1016/j.cie.2012.11.007; Belfiore P, 2009, EUR J OPER RES, V199, P750, DOI 10.1016/j.ejor.2008.08.003; Berbotto L, 2014, ANN OPER RES, V222, P153, DOI 10.1007/s10479-012-1282-3; Chan FTS, 2014, INT J PROD RES, V52, P7436, DOI 10.1080/00207543.2014.932932; Chen P, 2017, INT T OPER RES, V24, P27, DOI 10.1111/itor.12250; Chen XP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132600; Chu JC, 2017, NETW SPAT ECON, V17, P41, DOI 10.1007/s11067-015-9317-3; DANTZIG GB, 1959, MANAGE SCI, V6, P80, DOI 10.1287/mnsc.6.1.80; Dong ZJ, 2015, TRANSPORT RES E-LOG, V79, P231, DOI 10.1016/j.tre.2015.05.002; DROR M, 1989, TRANSPORT SCI, V23, P141, DOI 10.1287/trsc.23.2.141; DROR M, 1994, DISCRETE APPL MATH, V50, P239, DOI 10.1016/0166-218X(92)00172-I; Fu Z, 2008, J OPER RES SOC, V59, P663, DOI 10.1057/palgrave.jors.2602371; Fu Z, 2005, J OPER RES SOC, V56, P267, DOI 10.1057/palgrave.jors.2601817; FU Z, 1994, J OPER RES SOC, V45, P384; Fu Z, 2007, ASIA PAC J OPER RES, V24, P831, DOI 10.1142/S0217595907001565; [符卓 Fu Zhuo], 2017, [中国管理科学, Chinese Journal of Management Science], V25, P78; Han AFW, 2016, TRANSPORT RES E-LOG, V88, P11, DOI 10.1016/j.tre.2016.01.014; Hiermann G, 2016, EUR J OPER RES, V252, P995, DOI 10.1016/j.ejor.2016.01.038; Ho SC, 2004, COMPUT OPER RES, V31, P1947, DOI 10.1016/S0305-0548(03)00155-2; Iv J. H. W., 2012, AM J OPER RES, V2, P207, DOI DOI 10.4236/AJOR.2012.22024; Jawarneh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130224; Lai M, 2017, J IND MANAG OPTIM, V8, P469; Luo ZX, 2017, TRANSPORT SCI, V51, P668, DOI 10.1287/trsc.2015.0666; Luo ZX, 2016, TRANSPORT RES E-LOG, V85, P69, DOI 10.1016/j.tre.2015.11.004; Moreno L, 2010, OPER RES LETT, V38, P302, DOI 10.1016/j.orl.2010.04.008; Mousavi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169817; Mu Q, 2011, J OPER RES SOC, V62, P742, DOI 10.1057/jors.2010.19; Nakao Y, 2007, J ADV MECH DES SYST, V1, P217, DOI 10.1299/jamdsm.1.217; Nishi T, 2014, COMPUT CHEM ENG, V60, P329, DOI 10.1016/j.compchemeng.2013.09.019; Rajappa Gautham Puttur, 2016, International Journal of Applied Industrial Engineering, V3, P55, DOI 10.4018/IJAIE.2016010104; Salani M, 2011, EUR J OPER RES, V213, P470, DOI 10.1016/j.ejor.2011.03.023; Wang HJ, 2014, TRANSPORT RES E-LOG, V69, P160, DOI 10.1016/j.tre.2014.06.006; Wang Y, 2015, EXPERT SYST APPL, V42, P5019, DOI 10.1016/j.eswa.2015.02.058; Wang Y, 2013, TRANSPORT RES REC, P120, DOI 10.3141/2378-13; Wang Y, 2014, EXPERT SYST APPL, V41, P521, DOI 10.1016/j.eswa.2013.07.078; Xia YK, 2019, CLUSTER COMPUT, V22, P15447, DOI 10.1007/s10586-018-2635-8; Xia YK, 2018, WIRELESS PERS COMMUN, V103, P595, DOI 10.1007/s11277-018-5464-4; Xia YK, 2019, CLUSTER COMPUT, V22, pS8725, DOI 10.1007/s10586-018-1957-x; [夏扬坤 Xia Yangkun], 2017, [计算机集成制造系统, Computer Integrated Manufacturing Systems], V23, P1520; Yan SY, 2015, COMPUT IND ENG, V87, P383, DOI 10.1016/j.cie.2015.05.034; Yin S, 2012, J ADV MECH DES SYST, V6, P687, DOI 10.1299/jamdsm.6.687; Zhang DZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192000; Zhang DZ, 2017, J ADV TRANSPORT, DOI 10.1155/2017/6350562	53	12	12	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0195457	10.1371/journal.pone.0195457	http://dx.doi.org/10.1371/journal.pone.0195457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF7AA	29763419	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800003
J	Kauppi, PE; Sandstrom, V; Lipponen, A				Kauppi, Pekka E.; Sandstrom, Vilma; Lipponen, Antti			Forest resources of nations in relation to human well-being	PLOS ONE			English	Article							LAND-USE CHANGE; BIODIVERSITY; TRANSITION; TRADE	A universal turnaround has been detected in many countries of the World from shrinking to expanding forests. The forest area of western Europe expanded already in the 19th century. Such early trends of forest resources cannot be associated with the rapid rise of atmospheric carbon dioxide nor with the anthropogenic climate change, which have taken place since the mid 20th century. Modern, most recent spatial patterns of forest expansions and contractions do not correlate with the geography of climate trends nor with dry versus moist areas. Instead, the forest resources trends of nations correlate positively with UNDP Human Development Index. This indicates that forest resources of nations have improved along with progress in human well-being. Highly developed countries apply modern agricultural methods on good farmlands and abandon marginal lands, which become available for forest expansion. Developed countries invest in sustainable programs of forest management and nature protection. Our findings are significant for predicting the future of the terrestrial carbon sink. They suggest that the large sink of carbon recently observed in forests of the World will persist, if the well-being of people continues to improve. However, despite the positive trends in domestic forests, developed nations increasingly outsource their biomass needs abroad through international trade, and all nations rely on unsustainable energy use and wasteful patterns of material consumption.	[Kauppi, Pekka E.; Sandstrom, Vilma] Univ Helsinki, Fac Biol & Environm Sci, Ecosyst & Environm Res Programme, Helsinki, Finland; [Kauppi, Pekka E.; Sandstrom, Vilma] Univ Helsinki, Helsinki Inst Sustainabil Sci HELSUS, Helsinki, Finland; [Lipponen, Antti] Finnish Meteorol Inst, Atmospher Res Ctr Eastern Finland, Kuopio, Finland	University of Helsinki; University of Helsinki; Finnish Meteorological Institute	Sandstrom, V (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Ecosyst & Environm Res Programme, Helsinki, Finland.; Sandstrom, V (corresponding author), Univ Helsinki, Helsinki Inst Sustainabil Sci HELSUS, Helsinki, Finland.	vilma.sandstrom@helsinki.fi	Sandström, Vilma/GSN-6689-2022; Sandström, Vilma/AAC-3308-2020; Lipponen, Antti/AAL-1445-2021	Sandström, Vilma/0000-0002-0475-7487; Sandström, Vilma/0000-0002-0475-7487; Lipponen, Antti/0000-0002-6902-9974	SITRA; Doctoral Programme of Sustainable Use of Renewable Natural Resources (AGFOREE) of the University of Helsinki	SITRA; Doctoral Programme of Sustainable Use of Renewable Natural Resources (AGFOREE) of the University of Helsinki	Pekka Kauppi is grateful to SITRA for funding support (April 2017). Vilma Sandstrom acknowledges funding from the Doctoral Programme of Sustainable Use of Renewable Natural Resources (AGFOREE) of the University of Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel JH, 2013, POPUL DEV REV, V38, P221, DOI 10.1111/j.1728-4457.2013.00561.x; Baccini A, 2017, SCIENCE, V358, P230, DOI 10.1126/science.aam5962; Ballantyne AP, 2012, NATURE, V488, P70, DOI 10.1038/nature11299; Bastin JF, 2017, SCIENCE, V356, P635, DOI 10.1126/science.aam6527; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CLAWSON M, 1979, SCIENCE, V204, P1168, DOI 10.1126/science.204.4398.1168; Cuaresma JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40678; DeFries RS, 1999, GLOBAL BIOGEOCHEM CY, V13, P803, DOI 10.1029/1999GB900037; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Erb KH, 2013, NAT CLIM CHANGE, V3, P854, DOI 10.1038/nclimate2004; Friis C, 2016, J LAND USE SCI, V11, P131, DOI 10.1080/1747423X.2015.1096423; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goldewijk KK, 2001, GLOBAL BIOGEOCHEM CY, V15, P417, DOI 10.1029/1999GB001232; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Gurjar BR, 2016, ATMOS ENVIRON, V142, P475, DOI 10.1016/j.atmosenv.2016.06.030; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Krausmann F, 2013, P NATL ACAD SCI USA, V110, P10324, DOI 10.1073/pnas.1211349110; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; MacDicken K, 2016, GLOBAL FOREST RESOUR, V2nd; Mather AS, 2007, INT FOREST REV, V9, P491, DOI 10.1505/ifor.9.1.491; Mather AS, 2004, SCOT GEOGR J, V120, P83, DOI 10.1080/00369220418737194; Mather AS, 1998, AREA, V30, P117, DOI 10.1111/j.1475-4762.1998.tb00055.x; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Meyfroidt P, 2010, P NATL ACAD SCI USA, V107, P20917, DOI 10.1073/pnas.1014773107; Moran D, 2017, NAT ECOL EVOL, V1, DOI [10.1038/41559-016-0023, 10.1038/s41559-016-0023]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Smil V., 2017, ENERGY CIVILIZATION; Stephens SS, 2007, J FOREST, V105, P307; Wada Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044571; Zhu ZC, 2016, NAT CLIM CHANGE, V6, P791, DOI [10.1038/nclimate3004, 10.1038/NCLIMATE3004]	37	33	33	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196248	10.1371/journal.pone.0196248	http://dx.doi.org/10.1371/journal.pone.0196248			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF6MZ	29758029	gold, Green Published			2022-12-26	WOS:000432082900009
J	Kitazume, H; Dayi, M; Tanaka, R; Kikuchi, T				Kitazume, Hiromi; Dayi, Mehmet; Tanaka, Ryusei; Kikuchi, Taisei			Assessment of the behaviour and survival of nematodes under low oxygen concentrations	PLOS ONE			English	Article							LIFE-HISTORY; ELEGANS; METABOLISM; HYPOXIA; EMBRYOS; STRESS; ANOXIA	Oxygen is required for the completion of almost all known metazoan lifecycles, but many metazoans harbour abilities to withstand varying degrees and periods of hypoxia. Caenorhabditis elegans, one of the most popular model organism is extensively used as a model for the study of hypoxia and anoxia biology and it has been found that this nematode is capable of tolerance to varying degrees of hypoxia. Considering the extremely high diversity of nematodes, the effects of low oxygen concentration and mechanisms of adaptation to oxygen depletion differ among species. In this study, we used a simple assay to examine anoxia tolerance in four nematode species, including three free-living and one plant parasitic nematode. We found that the plant parasitic nematode Bursaphelenchus xylophilus can survive more than 14 days under anoxic conditions. Comparisons of behaviour during anoxia induction and the repertoire of oxygen sensation genes among the tested species suggested the existence of different oxygen sensation systems between B. xylophilus and C. elegans, which quickly introduce suspended animation in response to oxygen depletion to survive long-term anoxia.	[Kitazume, Hiromi; Tanaka, Ryusei; Kikuchi, Taisei] Univ Miyazaki, Fac Med, Dept Infect Dis, Div Parasitol, Miyazaki, Japan; [Dayi, Mehmet] Duzce Univ, Fac Forestry, Konuralp Campus, Duzce, Turkey	University of Miyazaki; Duzce University	Kikuchi, T (corresponding author), Univ Miyazaki, Fac Med, Dept Infect Dis, Div Parasitol, Miyazaki, Japan.	taisei_kikuchi@med.miyazaki-u.ac.jp		Kikuchi, Taisei/0000-0003-2759-9167	Japan Society for the Promotion of Science KAKENHI [16H04722, 16K15267]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant Nos. 16H04722 and 16K15267 (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Atkinson H.J., 1980, P101; ATKINSON HJ, 1973, J EXP BIOL, V59, P255; BANAGE WB, 1966, OIKOS, V17, P113, DOI 10.2307/3564936; BRENNER S, 1974, GENETICS, V77, P71; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Clegg JS, 1997, J EXP BIOL, V200, P467; Collins James J, 2008, WormBook, P1, DOI 10.1895/wormbook.1.137.1; CROWE JH, 1975, J EXP ZOOL, V193, P323, DOI 10.1002/jez.1401930308; Danovaro R, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0263-4; De Ley Paul, 2006, WormBook, P1; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Foll RL, 1999, COMP BIOCHEM PHYS B, V124, P269, DOI 10.1016/S0305-0491(99)00130-3; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543; Hand SC, 1998, J EXP BIOL, V201, P1233; Hashimoto T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12808; Howe KL, 2017, MOL BIOCHEM PARASIT, V215, P2, DOI 10.1016/j.molbiopara.2016.11.005; Hu PJ, 2007, WORMBOOK, V25, P1; Iwahori H., 1985, Japanese Journal of Nematology, V15, P64; JENSEN P, 1995, MAR BIOL, V123, P131, DOI 10.1007/BF00350331; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Karim N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-525; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kiontke Karin, 2005, P1; LaMacchia JC, 2015, GENETICS, V201, P65, DOI 10.1534/genetics.115.179416; Leiser SF, 2013, J GERONTOL A-BIOL, V68, P1135, DOI 10.1093/gerona/glt016; Lutz PL, 1997, J EXP BIOL, V200, P411; Namiya Y., 1977, Japanese Journal of Nematology, V7, P6; Michel J.F., 1974, Advances Parasit, V12, P279, DOI 10.1016/S0065-308X(08)60390-5; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Padmanabha D, 2015, GENETICS, V199, P739, DOI 10.1534/genetics.114.173989; Palomares-Rius JE, 2013, PARASITOLOGY, V140, P445, DOI 10.1017/S0031182012001874; PERRY RN, 1989, PARASITOL TODAY, V5, P377, DOI 10.1016/0169-4758(89)90299-8; Rae R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002864; SHOOP WL, 1991, PARASITOL TODAY, V7, P51, DOI 10.1016/0169-4758(91)90189-U; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tyson Trevor, 2012, BMC Research Notes, V5, P68, DOI 10.1186/1756-0500-5-68; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; Wang Y, 2005, NEMATOLOGY, V7, P459, DOI 10.1163/156854105774355545	42	5	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197122	10.1371/journal.pone.0197122	http://dx.doi.org/10.1371/journal.pone.0197122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758056	Green Submitted, gold, Green Published			2022-12-26	WOS:000432082900030
J	Liu, H; Chen, W; Zhi, X; Chen, EJ; Wei, T; Zhang, J; Shen, J; Hu, LQ; Zhao, B; Feng, XH; Bai, XL; Liang, TB				Liu, Hao; Chen, Wei; Zhi, Xiao; Chen, En-Jiang; Wei, Tao; Zhang, Jian; Shen, Jian; Hu, Li-Qiang; Zhao, Bin; Feng, Xin-Hua; Bai, Xue-Li; Liang, Ting-Bo			Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility	ONCOGENE			English	Article							CANCER-CELLS; METASTASIS; RESISTANCE; MIGRATION; PROTEINS; VESICLES; INVASION; DENSIN-180; MICRORNAS; APOPTOSIS	Tumor self-seeding occurs when circulating malignant cells reinfiltrate the original tumor. The process may breed more aggressive tumor cells, which may contribute to cancer progression. In this study, we observed tumor self-seeding in mouse xenograft models of hepatocellular carcinoma (HCC) for the first time. We confirmed that circulating tumor cell uptake of tumor-derived exosomes, which are increasingly recognized as key instigators of cancer progression by facilitating cell-cell communication, promoted tumor self-seeding by enhancing the invasive and migration capability of recipient HCC cells. Horizontal transfer of exosomal microRNA-25-5p to anoikis-resistant HCC cells significantly enhanced their migratory and invasive abilities, whereas inhibiting microRNA-25-5p alleviated these effects. Our experiments delineate an exosome-based novel pathway employed by functional microRNA from the original tumor cells that can influence the biological fate of circulating tumor cells.	[Liu, Hao; Chen, Wei; Zhi, Xiao; Chen, En-Jiang; Wei, Tao; Zhang, Jian; Shen, Jian; Hu, Li-Qiang; Bai, Xue-Li; Liang, Ting-Bo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Zhejiang, Peoples R China; [Liu, Hao; Chen, Wei; Zhi, Xiao; Chen, En-Jiang; Wei, Tao; Zhang, Jian; Shen, Jian; Hu, Li-Qiang; Bai, Xue-Li; Liang, Ting-Bo] Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Zhejiang, Peoples R China; [Zhao, Bin; Feng, Xin-Hua] Zhejiang Univ, Life Sci Inst, Hangzhou, Zhejiang, Peoples R China; [Zhao, Bin; Feng, Xin-Hua] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Liang, TB (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Zhejiang, Peoples R China.; Liang, TB (corresponding author), Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Zhejiang, Peoples R China.	liangtingbo@zju.edu.cn	Chen, Wei/X-6211-2019		National Natural Science Foundation of China [81472212]; 973 Program of China [2014CB542101]; Key Program of Medical Scientific Research Foundation of Zhejiang Province, China [WKJ-ZJ-1410]; Key Program of Administration of Traditional Chinese Medicine of Zhejiang Province, China [2014ZZ007]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); Key Program of Medical Scientific Research Foundation of Zhejiang Province, China; Key Program of Administration of Traditional Chinese Medicine of Zhejiang Province, China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents	This work was supported by the National Natural Science Foundation of China (No. 81472212), 973 Program of China (No. 2014CB542101), Key Program of Medical Scientific Research Foundation of Zhejiang Province, China (No. WKJ-ZJ-1410), Key Program of Administration of Traditional Chinese Medicine of Zhejiang Province, China (No. 2014ZZ007) and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Atay S, 2014, P NATL ACAD SCI USA, V111, P711, DOI 10.1073/pnas.1310501111; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dondossola E, 2012, CANCER RES, V72, P449, DOI 10.1158/0008-5472.CAN-11-2944; Ekstrom EJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-88; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Harris DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117495; Hedlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016899; Heikkila E, 2007, MOL CELL BIOCHEM, V305, P9, DOI 10.1007/s11010-007-9522-6; Hendrix A, 2010, CANCER RES, V70, P9533, DOI 10.1158/0008-5472.CAN-10-3248; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Izawa I, 2002, J BIOL CHEM, V277, P5345, DOI 10.1074/jbc.M110052200; Janikashvili N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/430394; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Li BS, 2015, ONCOGENE, V34, P2556, DOI 10.1038/onc.2014.214; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Lv MM, 2014, TUMOR BIOL, V35, P10773, DOI 10.1007/s13277-014-2377-z; Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161; McKenzie AJ, 2016, CELL REP, V15, P978, DOI 10.1016/j.celrep.2016.03.085; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; PAGET S, 1989, CANCER METAST REV, V8, P98; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Wang CR, 2015, ONCOTARGET, V6, P36231, DOI 10.18632/oncotarget.4740; Zhang HY, 2012, ONCOL REP, V27, P594, DOI 10.3892/or.2011.1530; Zhang Y, 2013, J CANCER RES CLIN, V140, P329; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200; Zhang ZY, 2008, CANCER LETT, V267, P106, DOI 10.1016/j.canlet.2008.03.010; Zhou HL, 2014, RNA, V20, P1431, DOI 10.1261/rna.045757.114; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	37	36	38	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 6	2018	37	36					4964	4978		10.1038/s41388-018-0309-x	http://dx.doi.org/10.1038/s41388-018-0309-x			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS6QR	29786077				2022-12-26	WOS:000443823600005
J	Faulds, KJ; Egelston, JN; Sedivy, LJ; Mitchell, MK; Garimella, S; Kozlowski, H; D'Alessandro, A; Hansen, KC; Balsbaugh, JL; Phiel, CJ				Faulds, Kelsie J.; Egelston, Jennifer N.; Sedivy, Laura J.; Mitchell, Matthew K.; Garimella, Sanjana; Kozlowski, Hanna; D'Alessandro, Angelo; Hansen, Kirk C.; Balsbaugh, Jeremy L.; Phiel, Christopher J.			Glycogen synthase kinase-3 (GSK-3) activity regulates mRNA methylation in mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA methylation; pluripotency; stem cells; protein phosphorylation; ubiquitin	SELF-RENEWAL; BETA-CATENIN; MOLECULAR-MECHANISM; SIGNALING PATHWAYS; NUCLEAR-RNA; FTO GENE; OBESITY; INHIBITION; LITHIUM; M(6)A	Glycogen synthase kinase-3 (GSK-3) activity regulates multiple signal transduction pathways and is also a key component of the network responsible for maintaining stem cell pluripotency. Genetic deletion of Gsk-3 and Gsk-3 or inhibition of GSK-3 activity via small molecules promotes stem cell pluripotency, yet the mechanism underlying the role for GSK-3 in this process remains ambiguous. Another cellular process that has been shown to affect stem cell pluripotency is mRNA methylation (m(6)A). Here, we describe an intersection between these components, the regulation of m(6)A by GSK-3. We find that protein levels for the RNA demethylase, FTO (fat mass and obesity-associated protein), are elevated in Gsk-3;Gsk-3-deficient mouse embryonic stem cells (ESCs). FTO is normally phosphorylated by GSK-3, and MS identified the sites on FTO that are phosphorylated in a GSK-3-dependent fashion. GSK-3 phosphorylation of FTO leads to polyubiquitination, but in Gsk-3 knockout ESCs, that process is impaired, resulting in elevated levels of FTO protein. As a consequence of altered FTO protein levels, mRNAs in Gsk-3 knockout ESCs have 50% less m(6)A than WT ESCs, and m(6)A-Seq analysis reveals the specific mRNAs that have reduced m(6)A modifications. Taken together, we provide the first evidence for how m(6)A demethylation is regulated in mammalian cells and identify a putative novel mechanism by which GSK-3 activity regulates stem cell pluripotency.	[Faulds, Kelsie J.; Egelston, Jennifer N.; Sedivy, Laura J.; Mitchell, Matthew K.; Garimella, Sanjana; Kozlowski, Hanna; Phiel, Christopher J.] Univ Colorado, Dept Integrat Biol, 1150 12th St, Denver, CO 80204 USA; [D'Alessandro, Angelo; Hansen, Kirk C.] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Balsbaugh, Jeremy L.] Univ Colorado, Dept Chem & Biochem, Mass Spectrometry Core Facil, Boulder, CO 80309 USA; [Balsbaugh, Jeremy L.] Univ Connecticut, Prote & Metabol Facil, Ctr Open Res Resources & Equipment, Storrs, CT 06269 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Connecticut	Phiel, CJ (corresponding author), Univ Colorado, Dept Integrat Biol, 1150 12th St, Denver, CO 80204 USA.	christopher.phiel@ucdenver.edu	D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490; Mitchell, Matthew/0000-0003-4099-783X; Phiel, Christopher/0000-0002-9265-2676; BALSBAUGH, JEREMY/0000-0002-1852-8749	National Institutes of Health [R15GM119103-01]; University of Colorado Denver; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM119103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Denver; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R15GM119103-01 (to C. J. P.) and funding from the University of Colorado Denver. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bar-Nur O, 2014, NAT METHODS, V11, P1170, DOI [10.1038/nmeth.3142, 10.1038/NMETH.3142]; Bartman CM, 2015, EXP CELL RES, V330, P178, DOI 10.1016/j.yexcr.2014.07.020; Bartman CM, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00133; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bertero A, 2018, NATURE, V555, P256, DOI 10.1038/nature25784; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Campbell JM, 2012, STEM CELLS DEV, V21, P2430, DOI 10.1089/scd.2011.0598; Chen JK, 2011, CELL RES, V21, P884, DOI 10.1038/cr.2011.51; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Du TF, 2015, J AFFECT DISORDERS, V183, P279, DOI 10.1016/j.jad.2015.05.025; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hao J, 2006, DEV BIOL, V290, P81, DOI 10.1016/j.ydbio.2005.11.011; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449; Hishida T, 2015, STEM CELLS, V33, P713, DOI 10.1002/stem.1893; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kingham E, 2009, J CELL SCI, V122, P2311, DOI 10.1242/jcs.046557; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Lee MY, 2009, STEM CELLS, V27, P1858, DOI 10.1002/stem.124; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; McTaggart JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027968; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nam H, 2016, P NATL ACAD SCI USA, V113, P10513, DOI 10.1073/pnas.1611967113; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Sanchez-Ripoll Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060148; Schafer KN, 2013, J BIOL CHEM, V288, P32599, DOI 10.1074/jbc.M113.503474; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Tan FZ, 2015, J BIOL CHEM, V290, P4500, DOI 10.1074/jbc.M114.609016; Umehara H, 2007, STEM CELLS, V25, P2705, DOI 10.1634/stemcells.2007-0086; Voskas D, 2014, J CELL PHYSIOL, V229, P1312, DOI 10.1002/jcp.24603; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035892; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	82	17	17	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10731	10743		10.1074/jbc.RA117.001298	http://dx.doi.org/10.1074/jbc.RA117.001298			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29777057	Green Published, hybrid			2022-12-26	WOS:000437828400028
J	Li, QJ; Alsaidan, OA; Rai, S; Wu, M; Shen, HF; Beharry, Z; Almada, LL; Fernandez-Zapico, ME; Wang, LC; Cai, HJ				Li, Qianjin; Alsaidan, Omar A.; Rai, Sumit; Wu, Meng; Shen, Huifeng; Beharry, Zanna; Almada, Luciana L.; Fernandez-Zapico, Martin E.; Wang, Lianchun; Cai, Houjian			Stromal Gli signaling regulates the activity and differentiation of prostate stem and progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stromal cell; p63; sonic hedgehog (SHH); transforming growth factor (TGF-); prostate; Gli signaling	UROGENITAL SINUS MESENCHYME; SONIC-HEDGEHOG; MURINE PROSTATE; TGF-BETA; TISSUE RECOMBINANTS; ANDROGEN RECEPTOR; GROWTH-FACTOR; CANCER-CELLS; MORPHOGENESIS; BASAL	Interactions between cells in the stroma and epithelium facilitate prostate stem cell activity and tissue regeneration capacity. Numerous molecular signal transduction pathways, including the induction of sonic hedgehog (Shh) to activate the Gli transcription factors, are known to mediate the cross-talk of these two cellular compartments. However, the details of how these signaling pathways regulate prostate stem and progenitor cell activity remain elusive. Here we demonstrate that, although cell-autonomous epithelial Shh-Gli signaling is essential to determine the expression levels of basal cell markers and the renewal potential of epithelial stem and progenitor cells, stromal Gli signaling regulates prostate stem and progenitor cell activity by increasing the number and size of prostate spheroids in vitro. Blockade of stromal Gli signaling also inhibited prostate tissue regeneration in vivo. The inhibition of stromal Gli signaling suppressed the differentiation of basal and progenitor cells to luminal cells and limited prostate tubule secretory capability. Additionally, stromal cells were able to compensate for the deficiency of epithelial Shh signaling in prostate tissue regeneration. Mechanistically, suppression of Gli signaling increased the signaling factor transforming growth factor (TGF) in stromal cells. Elevation of exogenous TGF1 levels inhibited prostate spheroid formation, suggesting that a stromal Gli-TGF signaling axis regulates the activity of epithelial progenitor cells. Our study illustrates that Gli signaling regulates epithelial stem cell activity and renewal potential in both epithelial and stromal compartments.	[Li, Qianjin; Alsaidan, Omar A.; Wu, Meng; Shen, Huifeng; Cai, Houjian] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Rai, Sumit; Wang, Lianchun] Univ Georgia, Carbohydrate Res Ctr, Athens, GA 30602 USA; [Rai, Sumit; Wang, Lianchun] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Beharry, Zanna] Florida Gulf Coast Univ, Dept Chem & Phys, Ft Myers, FL 33965 USA; [Almada, Luciana L.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; State University System of Florida; Florida Gulf Coast University; Mayo Clinic	Cai, HJ (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	caihj@uga.edu	Alsaidan, Omar/AAB-6106-2021; Cai, Houjian/AAJ-1290-2020; Wu, Meng/N-9345-2014	Alsaidan, Omar/0000-0002-2848-2932; Beharry, Zanna/0000-0002-3900-8523; Wang, Lianchun/0000-0003-1454-2719; Wu, Meng/0000-0001-8436-2209	National Institutes of Health [R01CA172495, HL-09339, GM103390]; Department of Defense [W81XWH-15-1-0507]; NATIONAL CANCER INSTITUTE [R01CA172495] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01CA172495 (to H. C.) and HL-09339 and GM103390 (to L. W.) and Department of Defense Grant W81XWH-15-1-0507 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Cai HJ, 2012, CANCER RES, V72, P4672, DOI 10.1158/0008-5472.CAN-12-0228; Callier P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004340; Chen M, 2011, EXPERT REV ENDOCRINO, V6, P453, DOI 10.1586/EEM.11.24; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; CUNHA GR, 1981, J STEROID BIOCHEM, V14, P1317, DOI 10.1016/0022-4731(81)90338-1; DONJACOUR AA, 1993, ENDOCRINOLOGY, V132, P2342, DOI 10.1210/en.132.6.2342; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Furler RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040874; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Hager-Theodorides AL, 2005, BLOOD, V106, P1296, DOI 10.1182/blood-2005-03-0998; Hager-Theodorides AL, 2009, J IMMUNOL, V183, P3023, DOI 10.4049/jimmunol.0900152; Huang YQ, 2015, J BIOL CHEM, V290, P17745, DOI 10.1074/jbc.M115.661033; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Itoh N, 1998, ENDOCRINOLOGY, V139, P1378, DOI 10.1210/en.139.3.1378; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lim A, 2014, NAT CELL BIOL, V16, P1135, DOI 10.1038/ncb3057; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Ming JE, 1998, MOL MED TODAY, V4, P343, DOI 10.1016/S1357-4310(98)01299-4; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Peng YC, 2015, DEV BIOL, V400, P94, DOI 10.1016/j.ydbio.2015.01.019; Peng YC, 2013, P NATL ACAD SCI USA, V110, P20611, DOI 10.1073/pnas.1315729110; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/NCHEMBIO.1184, 10.1038/nchembio.1184]; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Risbridger GP, 2008, ENDOCRINOLOGY, V149, P4303, DOI 10.1210/en.2008-0465; Rodgers UR, 2016, ACS CHEM BIOL, V11, P3256, DOI 10.1021/acschembio.6b00896; Salm SN, 2002, PROSTATE, V51, P175, DOI 10.1002/pros.10075; Shigemura K, 2015, CURR DRUG TARGETS, V16, P258, DOI 10.2174/1389450115666141125122643; Solanki A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146910; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Wu M, 2016, J BIOL CHEM, V291, P25749, DOI 10.1074/jbc.M116.753129; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Yu M, 2013, DEV BIOL, V380, P87, DOI 10.1016/j.ydbio.2013.04.032	47	4	4	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10547	10560		10.1074/jbc.RA118.003255	http://dx.doi.org/10.1074/jbc.RA118.003255			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29773652	hybrid, Green Published			2022-12-26	WOS:000437828400015
J	Raghavan, S; Singh, NK; Mani, AM; Rao, GN				Raghavan, Somasundaram; Singh, Nikhlesh K.; Mani, Arul M.; Rao, Gadiparthi N.			Protease-activated receptor 1 inhibits cholesterol efflux and promotes atherogenesis via cullin 3-mediated degradation of the ABCA1 transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; atherosclerosis; cholesterol; macrophage; signal transduction	SMOOTH-MUSCLE-CELLS; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; THROMBIN GENERATION; ACCELERATES ATHEROSCLEROSIS; ENDOTHELIAL-CELLS; TISSUE FACTOR; IN-VITRO; KINASE 2; EXPRESSION	Although signaling of thrombin via its receptor protease-activated receptor 1 (Par1) is known to occur in atherothrombosis, its link to the actual pathogenesis of this condition is less clear. To better understand the role of thrombin-Par1 signaling in atherosclerosis, here we have studied their effects on cellular cholesterol efflux in mice. We found that by activating Par1 and cullin 3-mediated ubiquitination and degradation of ABC subfamily A member 1 (ABCA1), thrombin inhibits cholesterol efflux in both murine macrophages and smooth muscle cells. Moreover, disruption of the Par1 gene rescued ABCA1 from Western diet-induced ubiquitination and degradation and restored cholesterol efflux in apolipoprotein E-deficient (ApoE(-/-)) mice. Similarly, the Par1 deletion diminished diet-induced atherosclerotic lesions in the ApoE(-/-) mice. These observations for the first time indicate a role for thrombin-Par1 signaling in the pathogenesis of diet-induced atherosclerosis. We identify cullin 3 as a cullin-RING ubiquitin E3 ligase that mediates ABCA1 ubiquitination and degradation and thereby inhibits cholesterol efflux. Furthermore, compared with peripheral blood mononuclear cells (PBMCs) from ApoE(-/-) mice, the PBMCs from ApoE(-/-):Par1(-/-) mice exhibited decreased trafficking to inflamed arteries of Western diet-fed ApoE(-/-) mice. This finding suggested that besides inhibiting cholesterol efflux, thrombin-Par1 signaling also plays a role in the recruitment of leukocytes during diet-induced atherogenesis. Based on these findings, we conclude that thrombin-Par1 signaling appears to contribute to the pathogenesis of atherosclerosis by impairing cholesterol efflux from cells and by recruiting leukocytes to arteries.	[Raghavan, Somasundaram; Singh, Nikhlesh K.; Mani, Arul M.; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 71 S Manassas St, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 71 S Manassas St, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Raghavan, Somasundaram/M-7692-2019; Singh, Nikhlesh/AAA-4253-2020	Raghavan, Somasundaram/0000-0002-7385-7182; Singh, Nikhlesh/0000-0002-3665-6023; Mani, Arul Murugan/0000-0002-8943-7406	National Institutes of Health [HL103575]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL103575 (to G. N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleidi SM, 2015, J BIOL CHEM, V290, P24604, DOI 10.1074/jbc.M115.675579; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Austin KM, 2013, J BIOL CHEM, V288, P23105, DOI 10.1074/jbc.M113.467019; Borissoff JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055784; Borissoff JI, 2012, JACC-CARDIOVASC IMAG, V5, P1201, DOI 10.1016/j.jcmg.2012.01.023; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Camera M, 2012, THROMB RES, V129, P279, DOI 10.1016/j.thromres.2011.11.028; Chellan B, 2016, ARTERIOSCL THROM VAS, V36, P1101, DOI 10.1161/ATVBAHA.116.307306; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Crucet M, 2013, ATHEROSCLEROSIS, V229, P110, DOI 10.1016/j.atherosclerosis.2013.04.034; Dubland JA, 2016, CURR OPIN LIPIDOL, V27, P155, DOI 10.1097/MOL.0000000000000279; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Esmon CT, 2014, THROMB HAEMOSTASIS, V111, P625, DOI 10.1160/TH13-09-0730; Feng FY, 2007, ONCOGENE, V26, P3431, DOI 10.1038/sj.onc.1210129; Gadepalli R, 2013, J BIOL CHEM, V288, P30815, DOI 10.1074/jbc.M113.463414; Gadepalli R, 2012, ARTERIOSCL THROM VAS, V32, P2652, DOI 10.1161/ATVBAHA.112.253112; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Higashi Y, 2016, CIRCULATION, V133, P2263, DOI 10.1161/CIRCULATIONAHA.116.021805; Hsieh V, 2014, J BIOL CHEM, V289, P7524, DOI 10.1074/jbc.M113.515890; Jennings LK, 2009, AM J CARDIOL, V103, p4A, DOI 10.1016/j.amjcard.2008.11.017; Kalz J, 2014, J THROMB THROMBOLYS, V37, P45, DOI 10.1007/s11239-013-1026-5; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Kopec AK, 2014, J PHARMACOL EXP THER, V351, P288, DOI 10.1124/jpet.114.218545; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Maouche S, 2012, ARTERIOSCL THROM VAS, V32, P170, DOI 10.1161/ATVBAHA.111.232652; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; Mathew R, 2012, NATURE, V491, P619, DOI 10.1038/nature11548; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Mitropoulos Kostas A., 1994, Current Opinion in Lipidology, V5, P227, DOI 10.1097/00041433-199405030-00011; Negre-Salvayre A, 2017, FREE RADICAL BIO MED, V106, P118, DOI 10.1016/j.freeradbiomed.2017.02.006; Nguyen KT, 2001, HYPERTENSION, V38, P1038, DOI 10.1161/hy1101.092840; Ogura M, 2011, ARTERIOSCL THROM VAS, V31, P1980, DOI 10.1161/ATVBAHA.111.228478; Pelham CJ, 2012, CELL METAB, V16, P462, DOI 10.1016/j.cmet.2012.08.011; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Ricciarelli R, 2000, CIRCULATION, V102, P82, DOI 10.1161/01.CIR.102.1.82; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Sanchez C, 2012, ARTERIOSCL THROM VAS, V32, P2394, DOI 10.1161/ATVBAHA.112.250332; Sorci-Thomas MG, 2016, CIRC RES, V118, P679, DOI 10.1161/CIRCRESAHA.115.306246; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; ten Cate H, 2012, THROMB RES, V129, pS38, DOI 10.1016/j.thromres.2012.02.028; Tesauro M, 2005, CIRCULATION, V112, P2986, DOI 10.1161/CIRCULATIONAHA.105.553883; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; Westerterp M, 2016, ARTERIOSCL THROM VAS, V36, P1328, DOI 10.1161/ATVBAHA.115.306670; Wilcox JN, 2001, ANN NY ACAD SCI, V947, P433; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zhou YF, 1996, J CLIN INVEST, V98, P2129, DOI 10.1172/JCI119019	55	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10574	10589		10.1074/jbc.RA118.003491	http://dx.doi.org/10.1074/jbc.RA118.003491			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29777060	Green Published, hybrid			2022-12-26	WOS:000437828400017
J	Kramer, BJ; Davis, TW; Meyer, KA; Rosen, BH; Goleski, JA; Dick, GJ; Oh, G; Gobler, CJ				Kramer, Benjamin J.; Davis, Timothy W.; Meyer, Kevin A.; Rosen, Barry H.; Goleski, Jennifer A.; Dick, Gregory J.; Oh, Genesok; Gobler, Christopher J.			Nitrogen limitation, toxin synthesis potential, and toxicity of cyanobacterial populations in Lake Okeechobee and the St. Lucie River Estuary, Florida, during the 2016 state of emergency event	PLOS ONE			English	Article							MICROCYSTIS-AERUGINOSA; SUBTROPICAL LAKE; CLIMATE-CHANGE; HARMFUL CYANOBACTERIA; NUTRIENT POLLUTION; GENE-EXPRESSION; OSMOTIC-STRESS; FLOS-AQUAE; PHYTOPLANKTON; BLOOMS	Lake Okeechobee, FL, USA, has been subjected to intensifying cyanobacterial blooms that can spread to the adjacent St. Lucie River and Estuary via natural and anthropogenically-induced flooding events. In July 2016, a large, toxic cyanobacterial bloom occurred in Lake Okeechobee and throughout the St. Lucie River and Estuary, leading Florida to declare a state of emergency. This study reports on measurements and nutrient amendment experiments performed in this freshwater-estuarine ecosystem (salinity 0-25 PSU) during and after the bloom. In July, all sites along the bloom exhibited dissolved inorganic nitrogen-to phosphorus ratios < 6, while Microcystis dominated (> 95%) phytoplankton inventories from the lake to the central part of the estuary. Chlorophyll a and microcystin concentrations peaked (100 and 34 mu g L-1, respectively) within Lake Okeechobee and decreased eastwards. Metagenomic analyses indicated that genes associated with the production of microcystin (mcyE) and the algal neurotoxin saxitoxin (sxtA) originated from Microcystis and multiple diazotrophic genera, respectively. There were highly significant correlations between levels of total nitrogen, microcystin, and microcystin synthesis gene abundance across all surveyed sites (p < 0.001), suggesting high levels of nitrogen supported the production of microcystin during this event. Consistent with this, experiments performed with low salinity water from the St. Lucie River during the event indicated that algal biomass was nitrogen-limited. In the fall, densities of Microcystis and concentrations of microcystin were significantly lower, green algae co-dominated with cyanobacteria, and multiple algal groups displayed nitrogen-limitation. These results indicate that monitoring and regulatory strategies in Lake Okeechobee and the St. Lucie River and Estuary should consider managing loads of nitrogen to control future algal and microcystin-producing cyanobacterial blooms.	[Kramer, Benjamin J.; Goleski, Jennifer A.; Oh, Genesok; Gobler, Christopher J.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Davis, Timothy W.] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Meyer, Kevin A.] Univ Michigan, CIGLR, Ann Arbor, MI 48109 USA; [Meyer, Kevin A.; Dick, Gregory J.] Univ Michigan, Dept Earth & Environm Sci, Ann Arbor, MI 48109 USA; [Rosen, Barry H.] USGS, Orlando, FL USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University System of Ohio; Bowling Green State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; United States Department of the Interior; United States Geological Survey	Gobler, CJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	christopher.gobler@stonybrook.edu			Chicago Community Trust; NOM Great Lakes Environmental Research Laboratory; University of Michigan Cooperative Institute for Great Lakes Research	Chicago Community Trust; NOM Great Lakes Environmental Research Laboratory; University of Michigan Cooperative Institute for Great Lakes Research	This study was funded by Chicago Community Trust, received by CJG, http://cct.org. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by NOM Great Lakes Environmental Research Laboratory, received by TWD, https://www.glerl.noaa.gov. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by University of Michigan Cooperative Institute for Great Lakes Research, received by TWD, https://ciglr.seas.umich.edu. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri VK, 2014, CRIT REV ENV SCI TEC, V44, P1995, DOI 10.1080/10643389.2013.803797; Al-Tebrineh J, 2012, HARMFUL ALGAE, V15, P19, DOI 10.1016/j.hal.2011.11.001; Al-Tebrineh J, 2010, APPL ENVIRON MICROB, V76, P7836, DOI 10.1128/AEM.00174-10; Aldridge FJ., 1995, ARCH HYDROBIOL BEIH, V45, P177; Alexova R, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003749; [Anonymous], 2015, CHLOROPHYLL NITRATE; [Anonymous], 2016, CHLOROPHYLL NITRATE; [Anonymous], 2016, USGS SURF WAT DAIL D; [Anonymous], 2015, USGS SURF WAT DAIL D; [Anonymous], [No title captured]; Babele PK, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2540-4; Beaver JR, 2013, HYDROBIOLOGIA, V709, P213, DOI 10.1007/s10750-013-1451-7; Beutler M, 2002, PHOTOSYNTH RES, V72, P39, DOI 10.1023/A:1016026607048; Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Carey CC, 2012, WATER RES, V46, P1394, DOI 10.1016/j.watres.2011.12.016; Chaffin J.D., 2013, ADV MICROBIOLOGY, V3, P16, DOI [10.4236/aim.2013.36A003, DOI 10.4236/AIM.2013.36A003]; Chen L, 2015, ECOTOX ENVIRON SAFE, V122, P126, DOI 10.1016/j.ecoenv.2015.07.011; Codd G, 1988, CYANOBACTERIAL TOXIN, P283; Davis TW, 2015, ENVIRON SCI TECHNOL, V49, P7197, DOI 10.1021/acs.est.5b00799; Davis TW, 2010, AQUAT MICROB ECOL, V61, P149, DOI 10.3354/ame01445; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; Dawson RM, 1998, TOXICON, V36, P953, DOI 10.1016/S0041-0101(97)00102-5; Pinto PD, 2010, OIKOS, V119, P567, DOI 10.1111/j.1600-0706.2009.17924.x; Filstrup CT, 2016, INLAND WATERS, V6, P234, DOI 10.5268/IW-6.2.939; FLETT RJ, 1976, CAN J MICROBIOL, V22, P43, DOI 10.1139/m76-006; FOGG GE, 1974, ALGAL PHYSL BIOCH, P560; Gehringer MM, 2014, FEMS MICROBIOL ECOL, V88, P1, DOI 10.1111/1574-6941.12291; Ginn HP, 2010, APPL ENVIRON MICROB, V76, P4362, DOI 10.1128/AEM.01862-09; Gobler CJ, 2007, HARMFUL ALGAE, V6, P119, DOI 10.1016/j.hal.2006.08.003; Gobler CJ, 2016, HARMFUL ALGAE, V54, P87, DOI 10.1016/j.hal.2016.01.010; Graves GA, 2004, J AM WATER RESOUR AS, V40, P1405, DOI 10.1111/j.1752-1688.2004.tb01595.x; Harke MJ, 2016, HARMFUL ALGAE, V54, P4, DOI 10.1016/j.hal.2015.12.007; Harke MJ, 2016, ENVIRON SCI TECHNOL, V50, P604, DOI 10.1021/acs.est.5b03931; Harke MJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2275-9; Harke MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069834; Havens K, 1996, AMBIO, V25, P150; Havens KE, 1998, FRESHWATER BIOL, V39, P547, DOI 10.1046/j.1365-2427.1998.00308.x; Havens KE, 2001, ENVIRON POLLUT, V113, P1, DOI 10.1016/S0269-7491(00)00235-9; HAVENS KE, 1995, ENVIRON POLLUT, V89, P241, DOI 10.1016/0269-7491(94)00076-P; Havens KE, 2003, ENVIRON POLLUT, V122, P379, DOI 10.1016/S0269-7491(02)00304-4; James R. Thomas, 1995, Archiv fuer Hydrobiologie Supplementband, V107, P25; Jeppesen E, 2007, HYDROBIOLOGIA, V584, P239, DOI 10.1007/s10750-007-0596-7; Jones B., 1987, AQUATICS, V9, P21; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Lapointe BE, 2017, HARMFUL ALGAE, V70, P1, DOI 10.1016/j.hal.2017.09.005; Lapointe BE, 2012, J COASTAL RES, V28, P1345, DOI 10.2112/JCOASTRES-D-12-00070.1; Lee TA, 2015, ECOTOX ENVIRON SAFE, V114, P318, DOI 10.1016/j.ecoenv.2014.05.004; Lynn SG, 2000, J PHYCOL, V36, P510, DOI 10.1046/j.1529-8817.2000.98251.x; Martin-Luna B, 2015, LIMNETICA, V34, P205; McCarthy MJ, 2009, LIMNOLOGY, V10, P215, DOI 10.1007/s10201-009-0277-5; Middleton CM, 2014, FRESHWATER BIOL, V59, P2225, DOI 10.1111/fwb.12425; Muller S, 2015, HYDROBIOLOGIA, V744, P255, DOI 10.1007/s10750-014-2082-3; Mur LR, 1995, WATER SCI TECHNOL, V32, P25, DOI 10.1016/0273-1223(95)00676-1; Nixdorf B, 2003, HYDROBIOLOGIA, V502, P111, DOI 10.1023/B:HYDR.0000004274.65831.e5; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Oehrle S, 2017, TOXICON, V138, P169, DOI 10.1016/j.toxicon.2017.09.005; Orr PT, 1998, LIMNOL OCEANOGR, V43, P1604, DOI 10.4319/lo.1998.43.7.1604; Osswald J, 2007, ENVIRON INT, V33, P1070, DOI 10.1016/j.envint.2007.06.003; Paerl H. W., 2014, PLOS ONE, V9, P1; Paerl HW, 2016, ENVIRON SCI TECHNOL, V50, P10805, DOI 10.1021/acs.est.6b02575; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Phlips EJ, 2012, ESTUAR COAST, V35, P335, DOI 10.1007/s12237-011-9442-2; Reynolds C. S., 2006, ECOLOGY FRESHWATER P; Rosen B. H., 2017, 20171054 US GEOL SUR, P34; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Sharma R, 2013, J ENVIRON BIOL, V34, P941; Sim MS, 2012, APPL ENVIRON MICROB, V78, P8368, DOI 10.1128/AEM.01842-12; Smith VH, 2016, INLAND WATERS, V6, P147, DOI 10.5268/IW-6.2.937; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Stefanova L, 2016, CLIMATE SUMMARY FLOR; Sulcius S, 2015, MAR POLLUT BULL, V99, P264, DOI 10.1016/j.marpolbul.2015.07.057; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vezie C, 2002, MICROB ECOL, V43, P443, DOI 10.1007/s00248-001-0041-9; Yang Y, 2003, J APPL PHYCOL, V15, P379, DOI 10.1023/A:1026021021774; Yao B, 2017, ECOL RES, V32, P961, DOI 10.1007/s11284-017-1505-9	76	54	56	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196278	10.1371/journal.pone.0196278	http://dx.doi.org/10.1371/journal.pone.0196278			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791446	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000013
J	Valcarcel-Ocete, L; Fullaondo, A; Alkorta-Aranburu, G; Garcia-Barcina, M; Roos, RAC; Hjermind, LE; Saft, C; Frontali, M; Reilmann, R; Rickards, H; Zubiaga, AM; Aguirre, A				Valcarcel-Ocete, Leire; Fullaondo, Asier; Alkorta-Aranburu, Gorka; Garcia-Barcina, Maria; Roos, Raymund A. C.; Hjermind, Lena E.; Saft, Carsten; Frontali, Marina; Reilmann, Ralf; Rickards, Hugh; Zubiaga, Ana M.; Aguirre, Ana		REGISTRY Invest European Huntingto	Does arterial hypertension influence the onset of Huntington's disease?	PLOS ONE			English	Article							PARKINSON-DISEASE; ALZHEIMERS-DISEASE; RISK; AGE	Huntington's disease (HD) age of onset (AO) is mainly determined by the length of the CAG repeat expansion in the huntingtin gene. The remaining AO variability has been attributed to other little-known factors. A factor that has been associated with other neurodegenerative diseases is arterial hypertension (AHT). The aim of this study is to evaluate the contribution of AHT to the AO of HD. We used data from a cohort of 630 European HD patients with adult onset collected by the REGISTRY project of the European Huntington's Disease Network. Multiple linear regression and ANOVA, controlling for the CAG repeat number of the expanded allele (CAGexp) of each patient, were performed to assess the association between the AHT condition and the AO of the motor symptoms (mAO). The results showed a significant association between AHT and mAO, especially when we only considered the patients diagnosed with AHT prior to manifesting any HD signs (pre-HD AHT). Remarkably, despite the low number of cases, those patients developed motor symptoms 5-8 years later than normotensive patients in the most frequent CAGexp range (40-44). AHT is an age related condition and consequently, the age of the patient at the time of data collection could be a confounder variable. However, given that most pre-HD AHT patients included in our study had started treatment with antihypertensive drugs prior to the onset of HD, and that antihypertensive drugs have been suggested to confer a neuroprotective effect in other neurodegenerative diseases, raises the interest in elucidating the impact of AHT and/or AHT treatment in HD age of onset in further studies. A confirmation of our results in a larger sample set would open the possibility to significantly improve HD management.	[Valcarcel-Ocete, Leire; Fullaondo, Asier; Zubiaga, Ana M.; Aguirre, Ana] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, UPV EHU, Leioa, Spain; [Alkorta-Aranburu, Gorka] Univ Navarra, Human Genet, Navarra, Spain; [Garcia-Barcina, Maria] Basurto Univ Hosp, Genet Unit, OSI Bilbao Basurto, Bilbao, Spain; [Roos, Raymund A. C.] LUMC, Dept Neurol, Leiden, Netherlands; [Hjermind, Lena E.] Univ Copenhagen, Rigshosp, Danish Dementia Res Ctr, Dept Neurol,Neurogenet Clin, Copenhagen, Denmark; [Saft, Carsten] St Josef Hosp, Huntington Zentrum NRW Bochum, Bochum, Germany; [Frontali, Marina] CNR, Inst Expt Med, Rome, Italy; [Reilmann, Ralf] Univ Munster, George Huntington Inst, Munster, Germany; [Reilmann, Ralf] Univ Munster, Inst Clin Radiol, Munster, Germany; [Reilmann, Ralf] Univ Tubingen, Dept Neurodegenerat Dis, Tubingen, Germany; [Reilmann, Ralf] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Rickards, Hugh] Univ Birmingham, Dept Neurol, Birmingham, W Midlands, England	University of Basque Country; University of Navarra; Basurto Hospital; Leiden University; Leiden University Medical Center (LUMC); Rigshospitalet; University of Copenhagen; Ruhr University Bochum; Consiglio Nazionale delle Ricerche (CNR); University of Munster; University of Munster; Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Birmingham	Aguirre, A (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, UPV EHU, Leioa, Spain.	ana.aguirre@ehu.eus	Fullaondo, Asier/L-2848-2019; Fullaondo, Asier/G-7131-2019; zubiaga, ana/S-3457-2019; Mariotti, Caterina/AAP-9425-2021; Landwehrmeyer, Georg Bernhard/AHB-4443-2022; Romano, Silvia/P-7984-2015	Fullaondo, Asier/0000-0001-5387-4762; Fullaondo, Asier/0000-0001-5387-4762; zubiaga, ana/0000-0002-2132-9708; Mariotti, Caterina/0000-0003-2405-3564; Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Romano, Silvia/0000-0003-0499-8843; NOGUERA-PEREA, FUENSANTA/0000-0001-8498-5131; Valcarcel, Leire/0000-0001-7441-6795; Saft, Carsten/0000-0002-3983-7292	Basque Government Department of Industry [Saiotek PE08UN78, 09+ UEGV096/C01]; Basque Government Department of Education [IT634-13]; University of the Basque Country UPV/EHU [UFI11/20]	Basque Government Department of Industry(Basque Government); Basque Government Department of Education(Basque Government); University of the Basque Country UPV/EHU	This study was funded by Basque Government Department of Industry grants (Saiotek PE08UN78 and University-Company Program 09+ UEGV096/C01), by the Basque Government Department of Education (IT634-13) and by the University of the Basque Country UPV/EHU (UFI11/20). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2008, NEUROLOGY, V70, P1438, DOI 10.1212/01.wnl.0000303818.38960.44; Bielecka-Dabrowa A, 2011, CURR CARDIOVASC RISK, V5, P174, DOI 10.1007/s12170-010-0152-2; Duron E, 2009, AM J HYPERTENS, V22, P1020, DOI 10.1038/ajh.2009.119; Gusella JF, 2009, GENOME MED, V1, DOI 10.1186/gm80; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Murray IVJ, 2011, EXP BIOL MED, V236, P772, DOI 10.1258/ebm.2011.010355; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Qiu CX, 2011, HYPERTENSION, V57, P1094, DOI 10.1161/HYPERTENSIONAHA.111.171249; Ramos EM, 2012, HUM GENET, V131, P1833, DOI 10.1007/s00439-012-1205-z; Valcarcel-Ocete L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131573; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Yuan M, 2016, AM J ALZHEIMERS DIS, V31, P97, DOI 10.1177/1533317515587086	12	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197975	10.1371/journal.pone.0197975	http://dx.doi.org/10.1371/journal.pone.0197975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791508	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000072
J	Wang, WY; Ge, B; Shi, J; Zhou, X; Wu, LF; Tang, CH; Zhu, DC; Zhu, H; Mo, XB; Zhang, YH; Deng, FY; Lei, SF				Wang, Wen-Yu; Ge, Bing; Shi, Ju; Zhou, Xu; Wu, Long-Fei; Tang, Chang-Hua; Zhu, Dong-Cheng; Zhu, Hong; Mo, Xing-Bo; Zhang, Yong-Hong; Deng, Fei-Yan; Lei, Shu-Feng			Plasma gelsolin is associated with hip BMD in Chinese postmenopausal women	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ORGANIZATION; ACTIN; PROTEINS; FRACTURE	Gelsolin (GSN) protein, expressed in circulating monocytes, was previously reported to be associated with osteoporosis in both Chinese and Caucasian women. This study aims to test if plasma GSN protein level is associated with hip bone mineral density (BMD) in Chinese population. Based on two study Groups containing 6,308 old Chinese, we adopted extreme sampling scheme and selected 3 independent samples (Subgroups 1-3) for discovery, replication, and validation purposes. We tested plasma GSN concentration, and analyzed whether plasma GSN level differs between subjects with extremely low vs. high hip BMD. In Group 1 (N = 1,860), the plasma GSN level increased in the female with low BMD, which was discovered in the Subgroup 1 (N = 42, p = 0.093) and replicated in the Subgroup 2 (N = 39, p = 0.095). With more extreme sampling for the Subgroup 3 from the Group 2 (N = 4,448), the difference of plasma GSN level in the female with low BMD vs. high BMD is more significant (N = 45, p = 0.037). After the subjects were pooled from Subgroups 2 and 3, the difference in plasma GSN between low and high BMD subjects became even more significant (p = 0.016). The plasma GSN level was negatively correlated with total hip BMD (r =-0.26, p = 0.033). We concluded that plasma GSN was associated with hip BMD in Chinese postmenopausal women and plasma GSN might be a potential risk biomarker for osteoporosis.	[Wang, Wen-Yu; Zhou, Xu; Wu, Long-Fei; Zhu, Hong; Mo, Xing-Bo; Deng, Fei-Yan; Lei, Shu-Feng] Soochow Univ, Coll Med, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China; [Wang, Wen-Yu; Zhou, Xu; Wu, Long-Fei; Zhu, Hong; Mo, Xing-Bo; Zhang, Yong-Hong; Deng, Fei-Yan; Lei, Shu-Feng] Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Jiangsu, Peoples R China; [Ge, Bing; Shi, Ju; Tang, Chang-Hua; Zhu, Dong-Cheng] Sihong Peoples Hosp, Dept Orthoped, Suqian, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Lei, SF (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou, Jiangsu, Peoples R China.; Lei, SF (corresponding author), Soochow Univ, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Jiangsu, Peoples R China.	leisf@suda.edu.cn	Mo, Xingbo/I-7112-2013	Mo, Xingbo/0000-0001-8956-4918	Natural Science Foundation of China [31271336, 81502868, 81541068, 81473046, 81373010, 31401079, 81401343]; Natural Science Foundation of Jiangsu Province [BK20130300, BK20150346]; Natural Science Research Project of Jiangsu Provincial Higher Education [16KJA330001]; Startup Fund from Soochow University [Q413900112, Q413900712]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Research Project of Jiangsu Provincial Higher Education; Startup Fund from Soochow University; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	The study was supported by Natural Science Foundation of China (31271336, 81502868, 81541068, 81473046, 81373010, 31401079, and 81401343), the Natural Science Foundation of Jiangsu Province (BK20130300, BK20150346), the Natural Science Research Project of Jiangsu Provincial Higher Education (16KJA330001), the Startup Fund from Soochow University (Q413900112, Q413900712), and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Akisaka T, 2001, J BONE MINER RES, V16, P1248, DOI 10.1359/jbmr.2001.16.7.1248; Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Chen P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3712-7; Chen ZM, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1186/S12929-015-0197-0; Collin O, 2008, CURR BIOL, V18, P1288, DOI 10.1016/j.cub.2008.07.046; Deng FY, 2008, PROTEOMICS, V8, P4259, DOI 10.1002/pmic.200700480; Deng FY, 2014, BONE, V63, P69, DOI 10.1016/j.bone.2014.02.015; Deng RZ, 2015, ONCOL LETT, V9, P2129, DOI 10.3892/ol.2015.3002; Guey LT, 2011, GENET EPIDEMIOL, V35, P236, DOI 10.1002/gepi.20572; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Li-ChunHsieh K, 2015, J NEUROIMMUNOL, V287, P36, DOI 10.1016/j.jneuroim.2015.08.006; McGough AM, 2003, FEBS LETT, V552, P75, DOI 10.1016/S0014-5793(03)00932-3; Meddens MBM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13127; Park YJ, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.120; Peloso GM, 2016, EUR J HUM GENET, V24, P924, DOI 10.1038/ejhg.2015.197; Pulkkinen P, 2004, OSTEOPOROSIS INT, V15, P274, DOI 10.1007/s00198-003-1556-3; Qin YW, 2017, J BIOL CHEM, V292, P11021, DOI 10.1074/jbc.M116.770941; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Svedbom A, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0137-0; US Department of Health and Human Services, 2004, BON HLTH OST REP SUR; Zhang LC, 2017, SECUR COMMUN NETW, DOI 10.1155/2017/4842694; Zheng G, 2013, ANN HUM GENET, V77, P80, DOI 10.1111/j.1469-1809.2012.00733.x	25	3	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197732	10.1371/journal.pone.0197732	http://dx.doi.org/10.1371/journal.pone.0197732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787615	gold, Green Published, Green Submitted			2022-12-26	WOS:000432785700040
J	Correa, F; Stoore, C; Horlacher, P; Jimenez, M; Hidalgo, C; Alvarez Rojas, CA; Barros, GF; Ferreira, HB; Hernandez, M; Cabrera, G; Paredes, R				Correa, Felipe; Stoore, Caroll; Horlacher, Pamina; Jimenez, Mauricio; Hidalgo, Christian; Alvarez Rojas, Cristian A.; Barros, Guilherme Figueiredo; Ferreira, Henrique Bunselmeyer; Hernandez, Marcela; Cabrera, Gonzalo; Paredes, Rodolfo			First description of Echinococcus ortleppi and cystic echinococcosis infection status in Chile	PLOS ONE			English	Article							GRANULOSUS-SENSU-STRICTO; GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; HUMAN HYDATIDOSIS; GENOTYPE G1; CATTLE; HUMANS; PREVALENCE; RUMINANTS; ARGENTINA	Cystic echinococcosis (CE), a parasitic disease caused by the cestode Echinococcus granulosus sensu lato (s.l.), is a worldwide zoonotic infection. Although endemic in Chile, information on the molecular characteristics of CE in livestock remains scarce. Therefore we aimed to describe the status of infection with E. granulosus s.l. in cattle from central Chile and also to contribute to the study of the molecular epidemiology of this parasite. According to our results, the prevalence of CE is 18.84% in cattle, similar to previous reports from Chile, suggesting that the prevalence in Santiago Metropolitan area has not changed in the last 30 years. Most of the cysts were found only in lungs (51%), followed by concurrent infection in liver and lungs (30%), and only liver (19%). Molecular characterization of the genetic diversity and population structure of E. granulosus s.l. from cattle in central Chile was performed using a section of the cytochrome c oxidase subunit 1 (cox1) mitochondrial gene. E. granulosus sensu stricto (s.s.) (G1-G3 genotypes) was confirmed by RFLP-PCR to be the dominant species affecting cattle (284 samples/290 samples); we also report for the first time in Chile the presence of E. ortleppi (G5 genotype) (2 samples/61 samples). The Chilean E. granulosus s.s. parsimony network displayed 1 main haplotype. Additional studies using isolates from many locations across Chile and different intermediate hosts will provide more data on the molecular structure of E. granulosus s.s. within this region. Likewise, investigations of the importance of E. ortleppi in human infection in Chile deserve future attention.	[Correa, Felipe; Stoore, Caroll; Horlacher, Pamina; Jimenez, Mauricio; Hidalgo, Christian; Paredes, Rodolfo] Univ Andres Bello, Fac Ecol & Recursos Nat, Escuela Med Vet, Santiago, Chile; [Alvarez Rojas, Cristian A.] Univ Melbourne, Ctr Anim Biotechnol, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Alvarez Rojas, Cristian A.] Univ Zurich, Inst Parasitol, Zurich, Switzerland; [Barros, Guilherme Figueiredo; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Lab Genom Estrutural & Func, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Barros, Guilherme Figueiredo; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Lab Biol Mol Cestodeos, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Hernandez, Marcela] Univ Chile, Lab Biol Periodontal, Fac Odontol, Santiago, Chile; [Hernandez, Marcela] Univ Autonoma Chile, Fac Hlth Sci, Santiago, Chile; [Cabrera, Gonzalo] Univ Chile, Inst Ciencias Biomed, Fac Med, Programa Biol Celular & Mol, Santiago, Chile	Universidad Andres Bello; University of Melbourne; University of Zurich; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidad de Chile; Universidad Autonoma de Chile; Universidad de Chile	Paredes, R (corresponding author), Univ Andres Bello, Fac Ecol & Recursos Nat, Escuela Med Vet, Santiago, Chile.	rparedes@unab.cl	Ferreira, Henrique B/H-4189-2012; /AHC-8464-2022; Rojas, Cristian A Alvarez/AAR-1231-2020; Stoore, Caroll/V-8723-2019; paredes, rodolfo/V-1151-2019; Hernández, Marcela/I-3266-2013	Ferreira, Henrique B/0000-0003-3611-6040; Rojas, Cristian A Alvarez/0000-0002-8069-7607; Stoore, Caroll/0000-0001-9499-4314; paredes, rodolfo/0000-0002-5909-9362; Hernández, Marcela/0000-0001-8289-7314; Jimenez, Mauricio/0000-0003-4811-2514; Hidalgo, Christian/0000-0002-0780-6969; Correa, Felipe/0000-0002-4919-5764	Fondecyt-Chile [1161475]; Universidad Andres Bello [DI-1398-16/I, DI-1249-16/RG]; CNPq (Brazil)/CONICYT (Chile) [490.923/2008-9]	Fondecyt-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Universidad Andres Bello; CNPq (Brazil)/CONICYT (Chile)	This work was supported by Fondecyt-Chile [grant number 1161475]; Universidad Andres Bello [internal project DI-1398-16/I, Felipe Correa PhD Thesis]; Universidad Andres Bello [internal project DI-1249-16/RG, Rodolfo Paredes] and CNPq (Brazil)/CONICYT (Chile) [grant number 490.923/2008-9]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Jamett G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003090; Acosta-Jamett G, 2010, VET PARASITOL, V169, P102, DOI 10.1016/j.vetpar.2009.12.009; Addy F, 2017, PARASITOLOGY, V144, P450, DOI 10.1017/S0031182016001840; Addy F, 2017, INT J PARASITOL, V47, P923, DOI 10.1016/j.ijpara.2017.06.003; Adinehbeigi K., 2013, Comparative Clinical Pathology, V22, P233, DOI 10.1007/s00580-011-1391-4; Cucher MA, 2016, TROP MED INT HEALTH, V21, P166, DOI 10.1111/tmi.12647; Alvarez Rojas CA, 2017, PARASITOL INT, V66, P112, DOI 10.1016/j.parint.2016.12.001; Alvarez Rojas CA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1792-y; Alvarez Rojas CA, 2014, INT J PARASITOL, V44, P9, DOI 10.1016/j.ijpara.2013.08.008; Amer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118509; Andresiuk MV, 2009, REV ARGENT MICROBIOL, V41, P218; Apt W, 2000, PANAMERICAN J PUBLIC, V7, P8; Avila HG, 2017, PARASITOL INT, V66, P250, DOI 10.1016/j.parint.2017.02.001; Azlaf R, 2006, VET PARASITOL, V137, P83, DOI 10.1016/j.vetpar.2006.01.003; Balbinotti H, 2012, VET PARASITOL, V188, P255, DOI 10.1016/j.vetpar.2012.04.007; Bardonnet K, 2002, T ROY SOC TROP MED H, V96, P383, DOI 10.1016/S0035-9203(02)90369-X; Battelli G, 2009, VET RES COMMUN, V33, pS47, DOI 10.1007/s11259-009-9247-y; Boufana B, 2015, INT J PARASITOL, V45, P161, DOI 10.1016/j.ijpara.2014.10.005; Boufana B, 2014, T ROY SOC TROP MED H, V108, P706, DOI 10.1093/trstmh/tru138; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Carmena D, 2008, ZOONOSES PUBLIC HLTH, V55, P156, DOI 10.1111/j.1863-2378.2007.01100.x; Casulli A, 2008, VET PARASITOL, V155, P168, DOI 10.1016/j.vetpar.2008.04.004; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dalimi A, 2002, VET PARASITOL, V105, P161, DOI 10.1016/S0304-4017(02)00005-5; Daryani A, 2007, J HELMINTHOL, V81, P13, DOI 10.1017/S0022149X0720731X; Deplazes P, 2017, ADV PARASIT, V95, P315, DOI 10.1016/bs.apar.2016.11.001; Espinoza S, 2014, PARASITOL RES, V113, P139, DOI 10.1007/s00436-013-3636-4; Galindo M, 2008, EXP PARASITOL, V119, P524, DOI 10.1016/j.exppara.2008.04.013; Getaw A, 2010, ACTA TROP, V113, P221, DOI 10.1016/j.actatropica.2009.10.019; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001475; Ibrahim K, 2011, CHINESE MED J-PEKING, V124, P2829, DOI 10.3760/cma.j.issn.0366-6999.2011.18.006; Ibrahim MM, 2010, ACTA TROP, V113, P26, DOI 10.1016/j.actatropica.2009.08.029; Ito A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002937; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Konyaev SV, 2013, PARASITOLOGY, V140, P1637, DOI 10.1017/S0031182013001340; Kumsa B., 1994, THESIS ADDIS ABABA U; Lahmar S, 2013, J HELMINTHOL, V87, P318, DOI 10.1017/S0022149X12000430; Laurimae T, 2016, INFECT GENET EVOL, V45, P290, DOI 10.1016/j.meegid.2016.09.015; Luengo J, 1995, AVANCES CIENCIAS VET, V10; Manterola C, 2008, PARASITOL INT, V57, P342, DOI 10.1016/j.parint.2008.02.005; Martinez P, 2011, REV CHIL INFECTOL, V28, P585, DOI /S0716-10182011000700013; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Negash K, 2013, T ROY SOC TROP MED H; Negash K, 2013, T ROY SOC TROP MED H, V107, P229, DOI 10.1093/trstmh/trt003; Njoroge EM, 2002, VET PARASITOL, V104, P85, DOI 10.1016/S0304-4017(01)00614-8; Omer RA, 2010, VET PARASITOL, V169, P340, DOI 10.1016/j.vetpar.2010.01.004; Pednekar RP, 2009, VET PARASITOL, V165, P58, DOI 10.1016/j.vetpar.2009.06.021; Regassa A, 2009, TROP ANIM HEALTH PRO, V41, P1495, DOI 10.1007/s11250-009-9338-3; Romig T, 2017, ADV PARASIT, V95, P213, DOI 10.1016/bs.apar.2016.11.002; Romig T, 2015, VET PARASITOL, V213, P76, DOI 10.1016/j.vetpar.2015.07.035; Romig T, 2011, VET PARASITOL, V181, P43, DOI 10.1016/j.vetpar.2011.04.022; SAG, 2010, INF AN SAL AN NOT AU; Sanchez E, 2010, MEM I OSWALDO CRUZ, V105, P806, DOI 10.1590/S0074-02762010000600013; Sariozkan S, 2009, VET PARASITOL, V163, P330, DOI 10.1016/j.vetpar.2009.04.032; SERRA I, 1995, REV MED CHILE, V123, P659; Andresiuk MV, 2013, ACTA TROP, V127, P136, DOI 10.1016/j.actatropica.2013.04.008; Venegas J, 2014, REV MED CHILE, V142, P1023, DOI 10.4067/S0034-98872014000800010	58	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197620	10.1371/journal.pone.0197620	http://dx.doi.org/10.1371/journal.pone.0197620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771992	gold, Green Accepted, Green Published			2022-12-26	WOS:000432348900080
J	Pinweha, P; Pumirat, P; Cuccui, J; Jitprasutwit, N; Muangsombut, V; Srinon, V; Boonyuen, U; Thiennimitr, P; Vattanaviboon, P; Cia, F; Willcocks, S; Bancroft, GJ; Wren, BW; Korbsrisate, S				Pinweha, Peechanika; Pumirat, Pornpan; Cuccui, Jon; Jitprasutwit, Niramol; Muangsombut, Veerachat; Srinon, Varintip; Boonyuen, Usa; Thiennimitr, Parameth; Vattanaviboon, Paiboon; Cia, Felipe; Willcocks, Sam; Bancroft, Gregory J.; Wren, Brendan W.; Korbsrisate, Sunee			Inactivation of bpsl1039-1040 ATP-binding cassette transporter reduces intracellular survival in macrophages, biofilm formation and virulence in the murine model of Burkholderia pseudomallei infection	PLOS ONE			English	Article							ABC TRANSPORTERS; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; STRUCTURE PREDICTION; SALMONELLA-ENTERICA; MELIOIDOSIS; GROWTH; PATHOGENESIS; EXPRESSION; ORGANISMS	Burkholderia pseudomallei, a gram-negative intracellular bacillus, is the causative agent of a tropical infectious disease called melioidosis. Bacterial ATP-binding cassette (ABC) transporters import and export a variety of molecules across bacterial cell membranes. At present, their significance in B. pseudomallei pathogenesis is poorly understood. We report here characterization of the BPSL1039-1040 ABC transporter. B. pseudomalleicultured in M9 medium supplemented with nitrate, demonstrated that BPSL1039-1040 is involved in nitrate transport for B. pseudomallei growth under anaerobic, but not aerobic conditions, suggesting that BPSL1039-1040 is functional under reduced oxygen tension. In addition, a nitrate reduction assay supported the function of BPSL1039-1040 as nitrate importer. A bps/10391040deficient mutant showed reduced biofilm formation as compared with the wild-type strain (P = 0.027) when cultured in LB medium supplemented with nitrate under anaerobic growth conditions. This reduction was not noticeable under aerobic conditions. This suggests that a gradient in oxygen levels could regulate the function of BPSL1039-1040 in B. pseudomallei nitrate metabolism. Furthermore, the B. pseudomallei bps/1039-1040 mutant had a pronounced effect on plaque formation (P < 0.001), and was defective in intracellular survival in both non-phagocytic (HeLa) and phagocytic (J774A.1 macrophage) cells, suggesting reduced virulence in the mutant strain. The bps/1039-1040 mutant was found to be attenuated in a BALB/c mouse intranasal infection model. Complementation of the bpsl1039-1040deficient mutant with the plasmid-borne bpsl1039gene could restore the phenotypes observed. We propose that the ability to acquire nitrate for survival under	[Pinweha, Peechanika; Jitprasutwit, Niramol; Muangsombut, Veerachat; Srinon, Varintip; Korbsrisate, Sunee] Mahidol Univ, Fac Med, Dept Immunol, Siriraj Hosp, Bangkok, Thailand; [Pumirat, Pornpan] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Cuccui, Jon; Cia, Felipe; Willcocks, Sam; Bancroft, Gregory J.; Wren, Brendan W.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Boonyuen, Usa] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Thiennimitr, Parameth] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand; [Vattanaviboon, Paiboon] Chulabhorn Res Inst, Lab Biotechnol, Bangkok, Thailand	Mahidol University; Mahidol University; University of London; London School of Hygiene & Tropical Medicine; Mahidol University; Chiang Mai University; Chulabhorn Research Institute	Korbsrisate, S (corresponding author), Mahidol Univ, Fac Med, Dept Immunol, Siriraj Hosp, Bangkok, Thailand.; Wren, BW (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	brendan.wren@lshtm.ac.uk; sunee.kor@mahidol.ac.th	Vattanaviboon, Paiboon/V-1380-2019; Jitprasutwit, Niramol/AAU-5244-2021; Boonyuen, Usa/AAX-7128-2020; Thiennimitr, Parameth/AAH-1761-2019	Jitprasutwit, Niramol/0000-0002-4576-5408; Boonyuen, Usa/0000-0003-0640-6215; Thiennimitr, Parameth/0000-0002-6339-8744	Office of Higher Education Commission; Mahidol University under the National Research Universities Initiative; Siriraj Graduate Thesis Scholarship, Faculty of Medicine Siriraj Hospital, Mahidol University; Thailand Research Fund Grant [MRG5580040, TRG5880041]; ICTM grant from the Faculty of Tropical Medicine, Mahidol University; Royal Golden Jubilee-Ph.D. program [PHD0177/2554]; Faculty of Medicine Siriraj Hospital, Mahidol University; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University	Office of Higher Education Commission(Office of Higher Education Commission (OHEC)); Mahidol University under the National Research Universities Initiative; Siriraj Graduate Thesis Scholarship, Faculty of Medicine Siriraj Hospital, Mahidol University; Thailand Research Fund Grant(Thailand Research Fund (TRF)); ICTM grant from the Faculty of Tropical Medicine, Mahidol University; Royal Golden Jubilee-Ph.D. program(Thailand Research Fund (TRF)); Faculty of Medicine Siriraj Hospital, Mahidol University; Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University	This work was supported by the Office of Higher Education Commission and Mahidol University under the National Research Universities Initiative. P. Pinweha was supported by the Siriraj Graduate Thesis Scholarship, Faculty of Medicine Siriraj Hospital, Mahidol University. P. Pumirat was supported by the Thailand Research Fund Grant (MRG5580040) and ICTM grant from the Faculty of Tropical Medicine, Mahidol University. V. Srinon was supported by the Royal Golden Jubilee-Ph.D. program (PHD0177/2554) and Ph.D. scholarship from the Faculty of Medicine Siriraj Hospital, Mahidol University. P. Thiennimitr was supported by the Thailand Research Fund Grant (TRG5880041). S. Korbsrisate was supported by the Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Office of Higher Education Commission and Mahidol University under the National Research Universities Initiative. P. Pinweha was supported by the Siriraj Graduate Thesis Scholarship, Faculty of Medicine Siriraj Hospital, Mahidol University. P. Pumirat was supported by the Thailand Research Fund Grant (MRG5580040) and ICTM grant from the Faculty of Tropical Medicine, Mahidol University. V. Srinon was supported by the Royal Golden Jubilee-Ph.D. program (PHD0177/2554) and Ph.D. scholarship from the Faculty of Medicine Siriraj Hospital, Mahidol University. P. Thiennimitr was supported by the Thailand Research Fund Grant (TRG5880041). S. Korbsrisate was supported by the Chalermphrakiat Grant, Faculty of Medicine Siriraj Hospital, Mahidol University. We are very grateful to Prof. H.P. Schweizer (Colorado State University, USA) and Dr. N. Chantratita (Mahidol University, Thailand) for their kind supports with gene deletion mutagenesis; Dr. M. Thongdee (Faculty of Veterinary Science, Mahidol University) for her kind helps on genomic DNA extraction; and Prof. M.P. Stevens. (University of Edinburgh, UK) for his kind advice on bacterial cultures under anaerobic conditions.	Andreae CA, 2014, RES MICROBIOL, V165, P41, DOI 10.1016/j.resmic.2013.10.009; Berks BC, 1995, BBA-BIOENERGETICS, V1232, P97, DOI 10.1016/0005-2728(95)00092-5; Carpenter CD, 2014, INFECT IMMUN, V82, P660, DOI 10.1128/IAI.01057-13; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chin CY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1692-0; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; Cuccui J, 2007, INFECT IMMUN, V75, P1186, DOI 10.1128/IAI.01240-06; Dance DAB, 2000, ACTA TROP, V74, P159, DOI 10.1016/S0001-706X(99)00066-2; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Harland DN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-83; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Limmathurotsakul D, 2014, CLIN MICROBIOL INFEC, V20, pO854, DOI 10.1111/1469-0691.12614; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Limmathurotsakul D, 2010, AM J TROP MED HYG, V82, P1113, DOI 10.4269/ajtmh.2010.10-0038; Lin AE, 2009, INFECT IMMUN, V77, P4912, DOI 10.1128/IAI.00571-08; Lopez CM, 2009, APPL ENVIRON MICROB, V75, P6496, DOI 10.1128/AEM.01669-09; Lopez CA, 2015, INFECT IMMUN, V83, P3470, DOI 10.1128/IAI.00351-15; Mangalea MR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01353; Moule MG, 2014, MBIO, V5, DOI 10.1128/mBio.00926-13; Osborne SE, 2012, J BIOL CHEM, V287, P15242, DOI 10.1074/jbc.M112.348227; PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720; Perinet Simone, 2016, BMC Res Notes, V9, P23, DOI 10.1186/s13104-016-1840-x; Remy L, 2013, MOL MICROBIOL, V87, P730, DOI 10.1111/mmi.12126; Schneider E, 2001, RES MICROBIOL, V152, P303, DOI 10.1016/S0923-2508(01)01201-3; Silva TMA, 2011, INFECT IMMUN, V79, P1706, DOI 10.1128/IAI.01109-10; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STEWART V, 1988, J BACTERIOL, V170, P1589, DOI 10.1128/jb.170.4.1589-1597.1988; Tamura GS, 2002, INFECT IMMUN, V70, P2877, DOI 10.1128/IAI.70.6.2877-2885.2002; Tomii K, 1998, GENOME RES, V8, P1048, DOI 10.1101/gr.8.10.1048; Van Alst NE, 2007, INFECT IMMUN, V75, P3780, DOI 10.1128/IAI.00201-07; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467	41	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196202	10.1371/journal.pone.0196202	http://dx.doi.org/10.1371/journal.pone.0196202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771915	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900010
J	Caranica, C; Al-Omari, A; Deng, Z; Griffith, J; Nilsen, R; Mao, L; Arnold, J; Schuttler, HB				Caranica, C.; Al-Omari, A.; Deng, Z.; Griffith, J.; Nilsen, R.; Mao, L.; Arnold, J.; Schuttler, H-B			Ensemble methods for stochastic networks with special reference to the biological clock of Neurospora crassa	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; SINGLE-CELL; GENE-EXPRESSION; SIMULATION; NOISE; RESONANCE; SELECTION; DYNAMICS	A major challenge in systems biology is to infer the parameters of regulatory networks that operate in a noisy environment, such as in a single cell. In a stochastic regime it is hard to distinguish noise from the real signal and to infer the noise contribution to the dynamical behavior. When the genetic network displays oscillatory dynamics, it is even harder to infer the parameters that produce the oscillations. To address this issue we introduce a new estimation method built on a combination of stochastic simulations, mass action kinetics and ensemble network simulations in which we match the average periodogram and phase of the model to that of the data. The method is relatively fast (compared to Metropolis-Hastings Monte Carlo Methods), easy to parallelize, applicable to large oscillatory networks and large (similar to 2000 cells) single cell expression data sets, and it quantifies the noise impact on the observed dynamics. Standard errors of estimated rate coefficients are typically two orders of magnitude smaller than the mean from single cell experiments with on the order of similar to 1000 cells. We also provide a method to assess the goodness of fit of the stochastic network using the Hilbert phase of single cells. An analysis of phase departures from the null model with no communication between cells is consistent with a hypothesis of Stochastic Resonance describing single cell oscillators. Stochastic Resonance provides a physical mechanism whereby intracellular noise plays a positive role in establishing oscillatory behavior, but may require model parameters, such as rate coefficients, that differ substantially from those extracted at the macroscopic level from measurements on populations of millions of communicating, synchronized cells.	[Caranica, C.] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Al-Omari, A.] Yarmouk Univ, Dept Biomed Syst & Informat Engn, Irbid, Jordan; [Deng, Z.; Mao, L.] Univ Georgia, Coll Engn, Sch Elect & Comp Engn, Athens, GA 30602 USA; [Griffith, J.; Nilsen, R.; Arnold, J.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Griffith, J.] Univ Georgia, Coll Agr & Environm Sci, Athens, GA 30602 USA; [Schuttler, H-B] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Yarmouk University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Arnold, J (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	arnold@uga.edu	Al-Omari, Ahmad/AAE-9793-2020; Schuttler, Heinz-Bernd/AFT-0395-2022	Al-Omari, Ahmad/0000-0003-3927-225X; arnold, jonathan/0000-0001-5845-1048	NSF Molecular & Cellular BioSciences (Systems and Synthetic Biology (SSB)) [MCB-SSB/PHY-POLS-1713746]; NSF Physics of Living Systems (PoLS) [MCB-SSB/PHY-POLS-1713746]	NSF Molecular & Cellular BioSciences (Systems and Synthetic Biology (SSB)); NSF Physics of Living Systems (PoLS)	This work was supported by a joint award MCB-SSB/PHY-POLS-1713746, one award being from NSF Molecular & Cellular BioSciences (Systems and Synthetic Biology (SSB)) and the other award being from NSF Physics of Living Systems (PoLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Omari A, 2015, IEEE ACCESS, V3, P27, DOI 10.1109/ACCESS.2015.2399854; Andrews S. S., 2009, ENCY COMPLEXITY SYST, V9, P8730, DOI DOI 10.1007/978-0-387-30440-3_524; Arkin A, 1998, GENETICS, V149, P1633; Battogtokh D, 2002, P NATL ACAD SCI USA, V99, P16904, DOI 10.1073/pnas.262658899; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Castro-Longoria E, 2010, FUNGAL GENET BIOL, V47, P332, DOI 10.1016/j.fgb.2009.12.013; CHOI B, 2017, SCI REPORTS, V7, DOI DOI 10.1039/S41599017-17072-Z; Daigle B. J., 2012, BMC BIOINFORMATICS, V13; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; David S, 2017, J PHYS A, V50; Deng ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35828; Dong WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003105; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fearnhead P, 2012, J R STAT SOC B, V74, P419, DOI 10.1111/j.1467-9868.2011.01010.x; Frohlich F, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005030; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GANG H, 1993, PHYS REV LETT, V71, P807, DOI 10.1103/PhysRevLett.71.807; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Golightly A, 2011, INTERFACE FOCUS, V1, P807, DOI 10.1098/rsfs.2011.0047; Hamze F, 2010, INT J MOD PHYS C, V21, P603, DOI 10.1142/S0129183110015361; HAUTALA JA, 1977, J BACTERIOL, V130, P704, DOI 10.1128/JB.130.2.704-713.1977; Izumo M, 2006, PLOS COMPUT BIOL, V2, P1248, DOI 10.1371/journal.pcbi.0020136; Kendall M, 1979, ADV THEORY STAT, V2, P530; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kim Jae K, BIOPHYS J, V106, P2071, DOI [10.10168.bpj.2014.02.039, DOI 10.1016/J.BGJ.2014.02.039]; Kim JK, 2016, IET SYST BIOL, V10, P125, DOI 10.1049/iet-syb.2015.0090; Kim JK, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0218-3; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Komorowski M, 2009, BIOPHYS J, V96, P372, DOI 10.1016/j.bpj.2008.09.052; Larrondo LF, 2015, SCIENCE, V347, DOI 10.1126/science.1257277; Lee KK, 2016, FUNGAL GENET BIOL, V94, P11, DOI 10.1016/j.fgb.2016.06.004; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Lin YH, 2015, NATURE, V527, P54, DOI 10.1038/nature15710; Liu J.S., 2001, MONTE CARLO STRATEGI; MCADAMS HH, 1995, SCIENCE, V269, P650, DOI 10.1126/science.7624793; Paijmans J., 2015, PNAS US, V113, P4063; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Pothoulakis G, 2014, ACS SYNTH BIOL, V3, P182, DOI 10.1021/sb400089c; RAPPEL WJ, 1994, PHYS REV E, V50, P3249, DOI 10.1103/PhysRevE.50.3249; Reinker S, 2006, IEE P, V153; Robert C, 1999, MONTE CARLO STAT MET; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; Thomas P, 2013, J THEOR BIOL, V335, P222, DOI 10.1016/j.jtbi.2013.06.021; Tian T, 2007, BIOINFORMATICS, V23, DOI [10.1093/bioinformatiesibt1552, DOI 10.1093/BIOINFORMATIESIBT1552]; Tian TH, 2007, BIOINFORMATICS, V23, P84, DOI 10.1093/bioinformatics/btl552; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Ullner E, 2009, BIOPHYS J, V96, P3573, DOI 10.1016/j.bpj.2009.02.031; Vera M, 2016, ANNU REV GENET, V50, P267, DOI 10.1146/annurev-genet-120215-034854; Voit EO, 2017, WILEY INTERDISCIPLIN; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Whiteley M, 2017, NATURE, V551, P313, DOI 10.1038/nature24624; Wilkinson D.J, 2011, STOCHASTIC MODELLING; WU JL, 2011, BMC SYSTEMS BIOL, V5, DOI DOI 10.1186/1752.0509.5-187; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104	63	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196435	10.1371/journal.pone.0196435	http://dx.doi.org/10.1371/journal.pone.0196435			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768444	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200026
J	Lim, ST; Park, CH; Kim, SY; Nam, SJ; Kang, EY; Moon, BI; Lee, HJ; Jeon, YW; Gwak, H; Suh, YJ				Lim, Seung Taek; Park, Chan Heun; Kim, Sung Yong; Nam, Seok Jin; Kang, Eun Young; Moon, Byung-In; Lee, Hyouk Jin; Jeon, Ye Won; Gwak, Hongki; Suh, Young Jin			The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer	PLOS ONE			English	Article							CYCLOPHOSPHAMIDE; METHOTREXATE; PHENOTYPE; OUTCOMES; BENEFIT; IMPACT; TUMOR; WOMEN	Background The present study investigated the prognostic role of adjuvant systemic chemotherapy in patients with node negative, T1c triple negative breast cancer (TNBC) from a nationwide cohort. In addition, the prognostic effect between 3 different chemotherapy regimens were compared in node-negative T1c TNBC patients by subgroup analysis. Methods From the Korean breast cancer registry database, 1,151 T1c node negative TNBC patients were included in this study. Patients were categorized into four treatment groups according to chemotherapy regimen: (1) no chemotherapy, (2) adriamycin plus cyclophosphamide (AC), (3) adriamycin/epirubicin plus cyclophosphamide plus 5-FU (FAC/FEC), and (4) cyclophosphamide plus 5-FU plus methotrexate (CMF). Overall survival (OS) was evaluated between each patient group. Results Of the 1,151 T1c node negative TNBC patients, 1,006 received adjuvant chemotherapy, while 145 received no chemotherapy. Among the patients receiving adjuvant chemotherapy the distribution of regimens was: 586 AC, 168 FAC/FEC (126 FAC, 42 FEC), and 252 CMF. The mean follow-up time of the full study cohort was 87.98 +/- 33.56 months (range = 6-192 months). Patients in the no chemotherapy group showed significantly worse OS compared to each chemotherapy regimen group. However, when OS was compared between each chemotherapy regimen, no significant difference was found. Conclusions This study showed that adjuvant systemic chemotherapy improved OS in T1c node negative TNBC patients, regardless of chemotherapy between AC, FAC/FEC, and CMF regimens.	[Lim, Seung Taek; Jeon, Ye Won; Gwak, Hongki; Suh, Young Jin] Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Breast & Thyroid Surg Oncol,Dept Surg, Suwon, South Korea; [Park, Chan Heun] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Surg, Seoul, South Korea; [Kim, Sung Yong] Soonchunhyang Univ, Coll Med, Cheonan Hosp, Dept Surg, Cheonan, South Korea; [Nam, Seok Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Breast & Endocrine Surg,Dept Surg, Seoul, South Korea; [Kang, Eun Young] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Surg, Seongnam, South Korea; [Moon, Byung-In] Ewha Womans Univ, Sch Med, Dept Surg, Seoul, South Korea; [Lee, Hyouk Jin] Saegyaero Hosp, Dept Surg, Busan, South Korea	Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Ewha Womans University	Suh, YJ (corresponding author), Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Breast & Thyroid Surg Oncol,Dept Surg, Suwon, South Korea.	yjsuh@catholic.ac.kr	gwak, hongki/HGB-1082-2022	Gwak, Hongki/0000-0002-5132-588X	Korean Breast Cancer Society	Korean Breast Cancer Society	This article was supported by the Korean Breast Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cancello G, 2011, BREAST CANCER RES TR, V127, P713, DOI 10.1007/s10549-011-1465-7; Choi J, 2013, BREAST CANCER RES TR, V137, P417, DOI 10.1007/s10549-012-2383-z; Colleoni M, 2010, J CLIN ONCOL, V28, P2966, DOI 10.1200/JCO.2009.25.9549; Collins LC, 2012, BREAST CANCER RES TR, V131, P1061, DOI 10.1007/s10549-011-1872-9; Gorshein E, 2014, CLIN BREAST CANCER, V14, P309, DOI 10.1016/j.clbc.2014.02.007; Kaplan HG, 2009, BREAST J, V15, P454, DOI 10.1111/j.1524-4741.2009.00789.x; Kim HA, 2015, J BREAST CANCER, V18, P271, DOI 10.4048/jbc.2015.18.3.271; Kim JE, 2012, J BREAST CANCER, V15, P197, DOI 10.4048/jbc.2012.15.2.197; Kwon JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-557; Lee JA, 2010, BREAST CANCER RES TR, V123, P177, DOI 10.1007/s10549-010-0998-5; Migdady Y, 2013, BREAST, V22, P793, DOI 10.1016/j.breast.2013.02.014; Min SY, 2016, J BREAST CANCER, V19, P1, DOI 10.4048/jbc.2016.19.1.1; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; Olszewski AJ, 2013, BREAST CANCER RES TR, V138, P215, DOI 10.1007/s10549-013-2423-3; Park EH, 2017, J BREAST CANCER, V20, P1, DOI 10.4048/jbc.2017.20.1.1; Ryu JM, 2016, BREAST CANCER RES TR, V159, P489, DOI 10.1007/s10549-016-3943-4; Vaz-Luis I, 2014, J CLIN ONCOL, V32, P2142, DOI 10.1200/JCO.2013.53.1608; Wu CE, 2014, ANTICANCER RES, V34, P1301; Zumsteg ZS, 2013, ANN SURG ONCOL, V20, P3469, DOI 10.1245/s10434-013-3011-9	19	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197523	10.1371/journal.pone.0197523	http://dx.doi.org/10.1371/journal.pone.0197523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768496	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200090
J	Quan, AS; Eisen, MB				Quan, Allison S.; Eisen, Michael B.			The ecology of the Drosophila-yeast mutualism in wineries	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SACCHAROMYCES-CEREVISIAE; MOLECULAR-IDENTIFICATION; GUT MICROBIOTA; MELANOGASTER; OVIPOSITION; DISPERSAL; PREFERENCE; DATABASE; FUNGAL	The fruit fly, Drosophila melanogaster, is preferentially found on fermenting fruits. The yeasts that dominate the microbial communities of these substrates are the primary food source for developing D. melanogaster larvae, and adult flies manifest a strong olfactory system-mediated attraction for the volatile compounds produced by these yeasts during fermentation. Although most work on this interaction has focused on the standard laboratory yeast Saccharomyces cerevisiae, a wide variety of other yeasts naturally ferment fallen fruit. Here we address the open question of whether D. melanogaster preferentially associates with distinct yeasts in different, closely-related environments. We characterized the spatial and temporal dynamics of Drosophila-associated fungi in Northern California wineries that use organic grapes and natural fermentation using high-throughput, short-amplicon sequencing. We found that there is nonrandom structure in the fungal communities that are vectored by flies both between and within vineyards. Within wineries, the fungal communities associated with flies in cellars, fermentation tanks, and pomace piles are distinguished by varying abundances of a small number of yeast species. To investigate the origins of this structure, we assayed Drosophila attraction to, oviposition on, larval development in, and longevity when consuming the yeasts that distinguish vineyard microhabitats from each other. We found that wild fly lines did not respond differentially to the yeast species that distinguish winery habitats in habitat specific manner. Instead, this subset of yeast shares traits that make them attractive to and ensure their close association with Drosophila.	[Quan, Allison S.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Eisen, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Eisen, MB (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.; Eisen, MB (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	mbeisen@berkeley.edu		Quan, Allison/0000-0003-1194-4050	Howard Hughes Medical Institute Investigator Award; National Science Graduate Research Fellowship	Howard Hughes Medical Institute Investigator Award(Howard Hughes Medical Institute); National Science Graduate Research Fellowship	This research was supported by a Howard Hughes Medical Institute Investigator Award (MBE) and the National Science Graduate Research Fellowship (ASQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Anagnostou C, 2010, ENTOMOL EXP APPL, V136, P1, DOI 10.1111/j.1570-7458.2010.00997.x; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barata A, 2012, MICROB ECOL, V64, P416, DOI 10.1007/s00248-012-0041-y; Becher PG, 2018, ECOL EVOL, V8, P2962, DOI 10.1002/ece3.3905; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Becher PG, 2010, J CHEM ECOL, V36, P599, DOI 10.1007/s10886-010-9794-2; Bokulich NA, 2016, MBIO, V7, DOI 10.1128/mBio.00631-16; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066437; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2012, APPL ENVIRON MICROB, V78, P7327, DOI 10.1128/AEM.01741-12; Christiaens JF, 2014, CELL REP, V9, P425, DOI 10.1016/j.celrep.2014.09.009; Ciani M, 2010, FEMS YEAST RES, V10, P123, DOI 10.1111/j.1567-1364.2009.00579.x; Dobzhansky T., 1956, ECOLOGY, V37, P544, DOI [10.2307/1930178, DOI 10.2307/1930178]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elya C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167357; Fischer C, 2017, ELIFE, V6, DOI 10.7554/eLife.18855; GILBERT DG, 1980, OECOLOGIA, V46, P135, DOI 10.1007/BF00346979; Glassman SI, 2016, ISME J, V10, P1228, DOI 10.1038/ismej.2015.182; Goddard MR, 2010, ENVIRON MICROBIOL, V12, P63, DOI 10.1111/j.1462-2920.2009.02035.x; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hoang D, 2015, PEERJ, V3, DOI 10.7717/peerj.1116; Joseph RM, 2009, P NATL ACAD SCI USA, V106, P11352, DOI 10.1073/pnas.0901419106; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Lam SSTH, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv170; LAW R, 1986, BIOL J LINN SOC, V27, P251, DOI 10.1111/j.1095-8312.1986.tb01736.x; Lee PN, 2009, COLD SPRING HARB PRO, V2009; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; Nguyen NH, 2015, NEW PHYTOL, V205, P1389, DOI 10.1111/nph.12923; Nilsson RH, 2015, MICROBES ENVIRON, V30, P145, DOI 10.1264/jsme2.ME14121; Nishino R, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12110; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ollerton J, 2006, BIOL BARTER PATTERNS, P411; Palanca L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075332; RDevelopment CORE TEAM R, 2008, R LANG ENV STAT COMP; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; RICHMOND RC, 1979, BEHAV GENET, V9, P233, DOI 10.1007/BF01071304; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; SANG JH, 1961, J EXP BIOL, V38, P793; Schiabor KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113899; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; STARMER WT, 1986, J CHEM ECOL, V12, P1037, DOI 10.1007/BF01638995; Stefanini I, 2012, P NATL ACAD SCI USA, V109, P13398, DOI 10.1073/pnas.1208362109; Thompson JN, 2009, AM NAT, V173, P125, DOI 10.1086/595752; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Yamada R, 2015, CELL REP, V10, P865, DOI 10.1016/j.celrep.2015.01.018	58	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196440	10.1371/journal.pone.0196440	http://dx.doi.org/10.1371/journal.pone.0196440			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768432	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200027
J	Tuepker, A; Elnitsky, C; Newell, S; Zaugg, T; Henry, JA				Tuepker, Anais; Elnitsky, Christine; Newell, Summer; Zaugg, Tara; Henry, James A.			A qualitative study of implementation and adaptations to Progressive Tinnitus Management (PTM) delivery	PLOS ONE			English	Article							HEALTH-CARE	Background Tinnitus is a common condition, especially prevalent among military Veterans. Progressive Tinnitus Management (PTM) is an interdisciplinary, structured, stepped-care approach to providing clinical services, including teaching coping skills, to people bothered by tinnitus. PTM has been shown to be effective at reducing functional distress, but implementation of the intervention outside of a research setting has not been studied, even though dissemination is underway within the Veterans Health Administration (VHA) system in the United States. This study was designed to address a gap in knowledge of PTM clinical implementation to date, with a focus on factors facilitating or hindering implementation in VHA audiology and mental health clinic contexts, and whether implementing sites had developed intervention adaptations. Methods Qualitative interviews were conducted with 21 audiology and mental health clinicians and service chiefs across a regional service network. Interviews were transcribed and coded using a hybrid inductive-deductive analytic approach guided by existing implementation research frameworks and then iteratively developed for emergent themes. Results PTM prioritization was rare overall, with providers across disciplines challenged by lack of capacity for implementation, but with differences by discipline in challenges to prioritization. Where PTM was prioritized and delivered, this was facilitated by perception of unique value, provider's own experience of tinnitus, observation/experience with PTM delivery, intervention fit with provider's skills, and an environment with supportive leadership and adaptive reserve. PTM was frequently adapted to local contexts to address delivery challenges and diversify patient options. Adaptations included shifting from group to individual formats, reducing or combining sessions, and employing novel therapeutic approaches. Conclusions Existing adaptations highlight the need to better understand mechanisms underlying PTM's effectiveness, and research on the impact of adaptations on patient outcomes is an important next step. Prioritization of PTM is a key barrier to the scale up and spread of this evidence-based intervention. Developing clinician champions may facilitate dissemination, especially if accompanied by signals of systemic prioritization. Novel approaches exposing clinicians and administrators to PTM may identify and develop clinical champions. Acknowledging the potential for PTM adaptations may make delivery more feasible in the context of existing system constraints and priorities.	[Tuepker, Anais; Newell, Summer] VA Portland Healthcare Syst, CIVIC, Portland, OR 97239 USA; [Tuepker, Anais] Oregon Hlth & Sci Univ, Div Gen Internal Med, Portland, OR 97201 USA; [Elnitsky, Christine] Univ North Carolina Charlotte, Charlotte, NC USA; [Zaugg, Tara; Henry, James A.] VA Portland Healthcare Syst, NCRAR, Portland, OR USA; [Henry, James A.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; University of North Carolina; University of North Carolina Charlotte; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University	Newell, S (corresponding author), VA Portland Healthcare Syst, CIVIC, Portland, OR 97239 USA.	summer.newell@va.gov		Tuepker, Anais/0000-0002-9138-5043	Department of Veterans Affairs, Health Services Research and Development (HSR&D) Service Quality Enhancement Research Initiative (QUERI) [RRP 13-440]	Department of Veterans Affairs, Health Services Research and Development (HSR&D) Service Quality Enhancement Research Initiative (QUERI)(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Health Services Research and Development (HSR&D) Service Quality Enhancement Research Initiative (QUERI) (RRP 13-440) (JAH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson A, 1992, NOISE INDUCED HEARIN, P269; Chambers DA, 2016, AM J PREV MED, V51, pS124, DOI 10.1016/j.amepre.2016.05.011; Cohen DJ, 2008, AM J PREV MED, V35, pS381, DOI 10.1016/j.amepre.2008.08.005; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Essen A, 2013, SOC SCI MED, V93, P203, DOI 10.1016/j.socscimed.2012.08.035; Harvey G, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0398-2; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Henry J.A., 2010, PLURAL; Henry James A, 2015, Ear Hear, V36, P42, DOI 10.1097/AUD.0000000000000093; Henry JA, 2017, J AM ACAD AUDIOL, V28, P546, DOI 10.3766/jaaa.16067; Henry JA, 2016, AM J AUDIOL, V25, P153, DOI 10.1044/2016_AJA-15-0076; Kansagara D, 2014, J GEN INTERN MED, V29, P607, DOI 10.1007/s11606-013-2764-y; Kaplan HC, 2010, MILBANK Q, V88, P500, DOI 10.1111/j.1468-0009.2010.00611.x; Martinez-Devesa P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005233.pub3; McCullough MB, 2015, INTERPLAY CONTEXTUAL; Pawson R., 1997, REALISTIC EVALUATION; Penner MJ, 1995, MECH TINNITUS, P219; Roland LT, 2015, OTOLARYNG HEAD NECK, V152, P919, DOI 10.1177/0194599815571556; Tuepker A, 2014, J GEN INTERN MED, V29, P614, DOI 10.1007/s11606-013-2690-z; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Veterans Benefits Administration, 2016, ANN BEN REP FISC YEA	21	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196105	10.1371/journal.pone.0196105	http://dx.doi.org/10.1371/journal.pone.0196105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768430	Green Submitted, gold, Green Published			2022-12-26	WOS:000432329200013
J	Dutta, D; Johnson, S; Dalal, A; Deymier, MJ; Hunter, E; Byrareddy, SN				Dutta, Debashis; Johnson, Samuel; Dalal, Alisha; Deymier, Martin J.; Hunter, Eric; Byrareddy, Siddappa N.			High throughput generation and characterization of replication-competent clade C transmitter-founder simian human immunodeficiency viruses	PLOS ONE			English	Article							RHESUS MACAQUES; HIV-1; INFECTION; NEUTRALIZATION; ANTIBODIES; RESISTANCE; ENVELOPE; TYPE-1; MODEL; ENTRY	Traditional restriction endonuclease-based cloning has been routinely used to generate replication-competent simian-human immunodeficiency viruses (SHIV) and simian tropic HIV (stHIV). This approach requires the existence of suitable restriction sites or the introduction of nucleotide changes to create them. Here, using an In-Fusion cloning technique that involves homologous recombination, we generated SHIVs and stHIVs based on epidemio-logically linked Glade C transmitted/founder HIV molecular clones from Zambia. Replacing vif from these HIV molecular clones with vif of SIVmac239 resulted in chimeric genomes used to generate infectious stHIV viruses. Likewise, exchanging HIV envgenes and introducing N375 mutations to enhance macaque CD4 binding site and cloned into a SHIVAD8-EO backbone. The generated SHIVs and stHIV were infectious in TZMbI and ZB5 cells, as well as macaque PBMCs. Therefore, this method can replace traditional methods and be a valuable tool for the rapid generation and testing of molecular clones of stHIV and SHIV based on primary clinical isolates will be valuable to generate rapid novel challenge viruses for HIV vaccine/cure studies.	[Dutta, Debashis; Johnson, Samuel; Dalal, Alisha; Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Deymier, Martin J.; Hunter, Eric] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; Emory University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	sid.byrareddy@unmc.edu	Dutta, Debashis/L-4685-2019; Dutta, Debashis/GRJ-5304-2022	Dutta, Debashis/0000-0001-6038-2416; Byrareddy, Siddappa/0000-0002-6889-4640; Johnson, Samuel/0000-0002-9978-6968	National Institute of Allergy and Infectious Diseases [R01AI113883, R21AI114415]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI114415, R01AI113883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS105594] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Allergy and Infectious Diseases R01AI113883; R21AI114415 to SB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmal M, 2015, VIROLOGY, V475, P37, DOI 10.1016/j.virol.2014.10.032; Boyd DF, 2015, J VIROL, V89, P894, DOI 10.1128/JVI.02680-14; Chang HW, 2015, J VIROL, V89, P1965, DOI 10.1128/JVI.03279-14; Claiborne DT, 2014, JOVE-J VIS EXP, DOI 10.3791/51506; Del Prete GQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006572; Deymier MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005154; Deymier MJ, 2014, VIROLOGY, V468, P454, DOI 10.1016/j.virol.2014.08.018; Excler JL, 2014, CLIN VACCINE IMMUNOL, V21, P1023, DOI 10.1128/CVI.00230-14; Hatziioannou T, 2006, SCIENCE, V314, P95, DOI 10.1126/science.1130994; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Ishida Y, 2016, J GEN VIROL, V97, P1249, DOI 10.1099/jgv.0.000421; Jacobus AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119221; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Schader SM, 2012, ANTIMICROB AGENTS CH, V56, P4257, DOI 10.1128/AAC.00639-12; Sharma A, 2015, J MED PRIMATOL, V44, P296, DOI 10.1111/jmp.12179; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109; Siddappa NB, 2011, J MED PRIMATOL, V40, P120, DOI 10.1111/j.1600-0684.2010.00454.x; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Siddappa NB, 2009, J VIROL, V83, P1422, DOI 10.1128/JVI.02066-08; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Tartaglia LJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005431; Tian JH, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005094; Wares M, 2015, ANTIMICROB AGENTS CH, V59, P1942, DOI 10.1128/AAC.04829-14; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Zoubchenok D, 2017, J VIROL, V91, DOI 10.1128/JVI.02151-16; Zurawski G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153484	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196942	10.1371/journal.pone.0196942	http://dx.doi.org/10.1371/journal.pone.0196942			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758076	Green Submitted, gold, Green Published			2022-12-26	WOS:000432082900020
J	Li, D; Chen, YJ; Mei, H; Jiao, WJ; Song, HJ; Ye, L; Fang, EH; Wang, XJ; Yang, F; Huang, K; Zheng, LD; Tong, QS				Li, Dan; Chen, Yajun; Mei, Hong; Jiao, Wanju; Song, Huajie; Ye, Lin; Fang, Erhu; Wang, Xiaojing; Yang, Feng; Huang, Kai; Zheng, Liduan; Tong, Qiangsong			Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; NEUROBLASTOMA-CELLS; TUMOR-SUPPRESSOR; MESSENGER-RNA; PROTEIN NONO; METASTASIS; EXPRESSION; ANGIOGENESIS; INVASION; GENE	Emerging studies have indicated the essential functions of long noncoding RNAs (lncRNAs) during cancer progression. However, whether lncRNAs contribute to the upregulation of v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets-1), an established oncogenic protein facilitating tumor invasion and metastasis, in gastric cancer remains elusive. Herein, we identified Ets-1 promoter-associated noncoding RNA (pancEts-1) as a novel lncRNA associated with the gastric cancer progression via mining of publicly available datasets and rapid amplification of cDNA ends. RNA pull-down, RNA immunoprecipitation, in vitro binding, and RNA electrophoretic mobility shift assays indicated the binding of pancEts-1 to non-POU domain containing octamer binding (NONO) protein. Mechanistically, pancEts-1 facilitated the physical interaction between NONO and Ets related gene (ERG), resulting in increased ERG transactivation and transcription of Ets-1 associated with gastric cancer progression. In addition, pancEts-1 facilitated the growth and aggressiveness of gastric cancer cells via interacting with NONO. In gastric cancer tissues, pancEts-1, NONO, and ERG were upregulated and significantly correlated with Ets-1 levels. High levels of pancEts-1, NONO, ERG, or Ets-1 were respectively associated with poor survival of gastric cancer patients, whereas simultaneous expression of all of them (HR = 3.012, P = 0.105) was not an independent prognostic factor for predicting clinical outcome. Overall, these results demonstrate that lncRNA pancEts-1 exhibits oncogenic properties that drive the progression of gastric cancer via regulating the NONO/ERG/Ets-1 axis.	[Li, Dan; Mei, Hong; Song, Huajie; Ye, Lin; Fang, Erhu; Wang, Xiaojing; Yang, Feng; Tong, Qiangsong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Chen, Yajun; Jiao, Wanju; Zheng, Liduan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pathol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Huang, Kai; Zheng, Liduan; Tong, Qiangsong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Clin Ctr Human Genom Res, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tong, QS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.; Zheng, LD (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pathol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.; Zheng, LD; Tong, QS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Clin Ctr Human Genom Res, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	ld_zheng@hotmail.com; qs_tong@hotmail.com	Tong, Qiangsong/B-4500-2014	Tong, Qiangsong/0000-0002-2615-6404; Zheng, Liduan/0000-0001-5566-673X	National Natural Science Foundation of China [81772967, 81773094, 81672500, 81572423, 81402408, 81402301, 81472363, 81372667, 81272779]; Natural Science Foundation of Hubei Province [2014CFA012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	We appreciate Dr. Jean-Yves Masson for construct gifts. This work was granted by National Natural Science Foundation of China (81772967, 81773094, 81672500, 81572423, 81402408, 81402301, 81472363, 81372667, 81272779), and Natural Science Foundation of Hubei Province (2014CFA012).	Adamo P, 2016, ONCOGENE, V35, P403, DOI 10.1038/onc.2015.109; Behrens P, 2001, J PATHOL, V194, P43, DOI 10.1002/path.844; CHEN JH, 1993, ONCOGENE, V8, P133; Chen ZR, 2016, J CLIN INVEST, V126, P2267, DOI 10.1172/JCI85250; CHUMAKOV AM, 1993, J VIROL, V67, P2421, DOI 10.1128/JVI.67.4.2421-2425.1993; Davidson B, 2001, CLIN CANCER RES, V7, P551; Dittmer J, 2015, SEMIN CANCER BIOL, V35, P20, DOI 10.1016/j.semcancer.2015.09.010; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Dong XS, 2009, MOL ENDOCRINOL, V23, P1147, DOI 10.1210/me.2008-0357; Duraes C, 2014, VIRCHOWS ARCH, V464, P367, DOI 10.1007/s00428-013-1533-y; Fujimoto J, 2002, ANN ONCOL, V13, P1598, DOI 10.1093/annonc/mdf248; Gu CH, 2010, GENOMICS, V95, P278, DOI 10.1016/j.ygeno.2010.02.005; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Hallier M, 1996, J BIOL CHEM, V271, P11177, DOI 10.1074/jbc.271.19.11177; HART AH, 1995, ONCOGENE, V10, P1423; Ishiguro H, 2003, INT J CANCER, V105, P26, DOI 10.1002/ijc.11021; Jiang GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031379; Kabbout M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100693; Kitange G, 2000, CANCER, V89, P2292, DOI 10.1002/1097-0142(20001201)89:11<2292::AID-CNCR18>3.0.CO;2-0; Krietsch J, 2012, NUCLEIC ACIDS RES, V40, P10287, DOI 10.1093/nar/gks798; Leshem O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021650; Li D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0320-6; Li D, 2013, ONCOTARGET, V4, P2021, DOI 10.18632/oncotarget.1579; Li Y, 2017, CANCER LETT, V395, P31, DOI 10.1016/j.canlet.2017.02.035; Liu PY, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju113; Liu YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02254-6; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; McLaughlin F, 2001, BLOOD, V98, P3332, DOI 10.1182/blood.V98.12.3332; Meadows SM, 2011, SEMIN CELL DEV BIOL, V22, P976, DOI 10.1016/j.semcdb.2011.09.009; Michel AM, 2014, NUCLEIC ACIDS RES, V42, pD859, DOI 10.1093/nar/gkt1035; Naito S, 2002, BIOCHEM BIOPH RES CO, V291, P130, DOI 10.1006/bbrc.2002.6418; Pham DH, 2017, HUM MOL GENET, V26, P2042, DOI 10.1093/hmg/ddx094; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Singh AK, 2011, J BIOL CHEM, V286, P21961, DOI 10.1074/jbc.M111.238238; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Takai N, 2002, INT J MOL MED, V9, P287; Terry MB, 2002, SEMIN RADIAT ONCOL, V12, P111, DOI 10.1053/srao.30814; Tokuhara K, 2003, INT SURG, V88, P25; Tsofack SP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-145; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Wang ZQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.143; Wei JR, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-22; Xiang X, 2015, CANCER LETT, V359, P187, DOI 10.1016/j.canlet.2015.01.008; Xu TP, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0063-7; Yadav SP, 2014, HUM MOL GENET, V23, P2132, DOI 10.1093/hmg/ddt609; Yamaguchi E, 2007, TOHOKU J EXP MED, V213, P41, DOI 10.1620/tjem.213.41; Yamauchi T, 2012, BIOCHEM BIOPH RES CO, V425, P711, DOI 10.1016/j.bbrc.2012.07.103; Yang P, 2016, ONCOTARGET, V7, P42183, DOI 10.18632/oncotarget.9741; Zhang H, 2014, ONCOGENE, V33, P387, DOI 10.1038/onc.2012.574; Zhang HY, 2012, MOL CANCER THER, V11, P1454, DOI 10.1158/1535-7163.MCT-12-0001; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao X, 2016, ONCOGENE, V35, P3565, DOI 10.1038/onc.2015.422; Zheng LD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.293; Zheng LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055719; Zheng LD, 2013, MOL CANCER RES, V11, P182, DOI 10.1158/1541-7786.MCR-12-0534; Zheng LD, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-74; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33	58	31	33	3	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 30	2018	37	35					4871	4886		10.1038/s41388-018-0302-4	http://dx.doi.org/10.1038/s41388-018-0302-4			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS0BA	29773901	Green Published, hybrid			2022-12-26	WOS:000443146000008
J	McClurg, UL; Chit, NCTH; Azizyan, M; Edwards, J; Nabbi, A; Riabowol, KT; Nakjang, S; McCracken, SR; Robson, CN				McClurg, Urszula L.; Chit, Nay C. T. H.; Azizyan, Mahsa; Edwards, Joanne; Nabbi, Arash; Riabowol, Karl T.; Nakjang, Sirintra; McCracken, Stuart R.; Robson, Craig N.			Molecular mechanism of the TP53-MDM2-AR-AKT signalling network regulation by USP12	ONCOGENE			English	Article							DEUBIQUITINATING ENZYME USP12; ANDROGEN RECEPTOR; RESISTANCE; INHIBITORS; MDM2; PHOSPHORYLATION; IDENTIFICATION; UBIQUITINATION; CHEMOTHERAPY; DEGRADATION	The TP53-MDM2-AR-AKT signalling network plays a critical role in the development and progression of prostate cancer. However, the molecular mechanisms regulating this signalling network are not completely defined. By conducting transcriptome analysis, denaturing immunoprecipitations and immunopathology, we demonstrate that the TP53-MDM2-AR-AKT cross-talk is regulated by the deubiquitinating enzyme USP12 in prostate cancer. Our findings explain why USP12 is one of the 12 most commonly overexpressed cancer-associated genes located near an amplified super-enhancer. We find that USP12 deubiquitinates MDM2 and AR, which in turn controls the levels of the TP53 tumour suppressor and AR oncogene in prostate cancer. Consequently, USP12 levels are predictive not only of cancer development but also of patient's therapy resistance, relapse and survival. Therefore, our findings suggest that USP12 could serve as a promising therapeutic target in currently incurable castrate-resistant prostate cancer.	[McClurg, Urszula L.; Chit, Nay C. T. H.; Azizyan, Mahsa; Nakjang, Sirintra; McCracken, Stuart R.; Robson, Craig N.] Newcastle Univ, Northern Inst Canc Res, Newcastle Canc Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [McClurg, Urszula L.] Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Edwards, Joanne] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Wolfson Wohl Canc Res Ctr, Glasgow G61 1QH, Lanark, Scotland; [Nabbi, Arash; Riabowol, Karl T.] Univ Calgary, Arnie Charbonneau Canc Inst, Cumming Sch Med, Dept Oncol, Calgary, AB T2N 4N1, Canada; [Nakjang, Sirintra] Newcastle Univ, Bioinformat Support Unit, Fac Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; University of Glasgow; University of Calgary; Newcastle University - UK	McClurg, UL; Robson, CN (corresponding author), Newcastle Univ, Northern Inst Canc Res, Newcastle Canc Ctr, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; McClurg, UL (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Med Sch, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Urszula.McClurg@ncl.ac.uk; Craig.Robson@ncl.ac.uk	Edwards, Joanne/J-1903-2015	Edwards, Joanne/0000-0002-7192-6906; McClurg, Urszula/0000-0003-2631-4174; Nabbi, Arash/0000-0002-3195-7361	PC UK [PG09-23]; JGWP Foundation [BH142412]; JRE Scientific Committee Charity; Newcastle Healthcare Charity [JG/ML/0414]; Cancer Research UK [C27826/A15994]; Newcastle University	PC UK; JGWP Foundation; JRE Scientific Committee Charity; Newcastle Healthcare Charity; Cancer Research UK(Cancer Research UK); Newcastle University	ULM, SRM and CNR were funded by PC UK (PG09-23), JGWP Foundation (BH142412) and JRE Scientific Committee Charity, Newcastle Healthcare Charity (JG/ML/0414). CNR is supported by Cancer Research UK (C27826/A15994). NCTHC was funded by Newcastle University.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Attard G, 2016, NAT REV UROL, V13, P697, DOI 10.1038/nrurol.2016.212; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Binda O, 2013, EPIGENETICS-US, V8, P177, DOI 10.4161/epi.23416; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Burska UL, 2013, J BIOL CHEM, V288, P32641, DOI 10.1074/jbc.M113.485912; Chen JJ, 2011, CHEM BIOL, V18, P1390, DOI 10.1016/j.chembiol.2011.08.014; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Dexheimer TS, 2014, J MED CHEM, V57, P8099, DOI 10.1021/jm5010495; Dexheimer TS, 2010, PROBE REPORTS NIH MO; Dharadhar S, 2016, J STRUCT BIOL, V196, P437, DOI 10.1016/j.jsb.2016.09.011; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Joshi S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1531-3; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kirkegaard T, 2006, HISTOPATHOLOGY, V48, P787, DOI 10.1111/j.1365-2559.2006.02412.x; Lee JK, 2016, NEURO-ONCOLOGY, V18, P37, DOI 10.1093/neuonc/nov091; Li H, 2016, MOL CELL, V63, P249, DOI 10.1016/j.molcel.2016.05.031; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Liu JB, 2016, INT J ONCOL, V49, P2549, DOI 10.3892/ijo.2016.3752; Lohiya V, 2016, CLIN MED INSIGHTS-ON, V10, P57, DOI 10.4137/CMO.S34535; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Marques RB, 2015, EUR UROL, V67, P1177, DOI 10.1016/j.eururo.2014.08.053; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; McClurg UL, 2017, NUCLEIC ACIDS RES, V45, P1793, DOI 10.1093/nar/gkw1162; McClurg UL, 2015, ONCOTARGET, V6, P37724, DOI 10.18632/oncotarget.6075; McClurg UL, 2015, ONCOTARGET, V6, P9657, DOI 10.18632/oncotarget.3922; McClurg UL, 2014, ONCOTARGET, V5, P7081, DOI 10.18632/oncotarget.2162; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Mistry H, 2013, MOL CANCER THER, V12, P2651, DOI 10.1158/1535-7163.MCT-13-0103-T; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Poletto M, 2016, NUCLEIC ACIDS RES, V44, P3165, DOI 10.1093/nar/gkw015; Rigas AC, 2007, ONCOGENE, V26, P7611, DOI 10.1038/sj.onc.1210586; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sourisseau T, 2016, CELL CYCLE, V15, P295, DOI 10.1080/15384101.2015.1120918; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Wahi Divya, 2015, Syst Synth Biol, V9, P33, DOI 10.1007/s11693-015-9162-1; Willder JM, 2013, BRIT J CANCER, V108, P139, DOI 10.1038/bjc.2012.480; Xiong XP, 2016, J BIOL CHEM, V291, P25167, DOI 10.1074/jbc.M116.740639; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhang ZQ, 2012, J CANCER RES CLIN, V138, P1231, DOI 10.1007/s00432-012-1193-3	51	21	21	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 23	2018	37	34					4679	4691		10.1038/s41388-018-0283-3	http://dx.doi.org/10.1038/s41388-018-0283-3			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GR3SE	29755129	Green Accepted, Green Submitted			2022-12-26	WOS:000442514400004
J	Waldow, F; Kohler, TP; Hess, N; Schwudke, D; Hammerschmidt, S; Gisch, N				Waldow, Franziska; Kohler, Thomas P.; Hess, Nathalie; Schwudke, Dominik; Hammerschmidt, Sven; Gisch, Nicolas			Attachment of phosphorylcholine residues to pneumococcal teichoic acids and modification of substitution patterns by the phosphorylcholine esterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); mass spectrometry (MS); glycolipid structure; bacteria; cell wall; N-acetylgalactosamine; Phosphorylcholine esterase; Phosphorylcholine transferase; Streptococcus pneumoniae; Teichoic acid	STREPTOCOCCUS-PNEUMONIAE; CRYSTAL-STRUCTURE; CELL-WALL; CHOLINE; PEPTIDOGLYCAN; LIPOPROTEINS; REEVALUATION; AUTOLYSIS; PROTEINS; INSIGHTS	The bacterial lung pathogen Streptococcus pneumoniae has a unique nutritional requirement for exogenous choline and attaches phosphorylcholine (P-Cho) residues to the GalpNAc moieties of its teichoic acids (TAs) in its cell wall. Two phosphorylcholine transferases, LicD1 and LicD2, mediate the attachment of P-Cho to the O-6 positions of the two GalpNAc residues present in each repeating unit of pneumococcal TAs (pnTAs), of which only LicD1 has been determined to be essential. At the molecular level, the specificity of the P-Cho attachment to pnTAs by LicD1 and LicD2 remains still elusive. Here, using detailed structural analyses of pnTAs from a LicD2-deficient strain, we confirmed the specificity in the attachment of P-Cho residues to pnTA. LicD1 solely transfers P-Cho to -d-GalpNAc moieties, whereas LicD2 attaches P-Cho to -d-GalpNAc. Further, we investigated the role of the pneumococcal phosphorylcholine esterase (Pce) in the modification of the P-Cho substitution pattern of pnTAs. To clarify the specificity of Pce-mediated P-Cho hydrolysis, we evaluated different concentrations and pH conditions for the treatment of pneumococcal lipoteichoic acid with purified Pce. We show that Pce can hydrolyze both P-Cho residues of the terminal repeat of the pnTA chain and almost all P-Cho residues bound to -d-GalpNAc in vitro. However, hydrolysis in vivo was restricted to the terminal repeat. In summary, our findings indicate that LicD1 and LicD2 specifically transfer P-Cho to -d-GalpNAc and -d-GalpNAc moieties, respectively, and that Pce removes distinct P-Cho substituents from pnTAs.	[Waldow, Franziska; Schwudke, Dominik; Gisch, Nicolas] Leibniz Lung Ctr, Res Ctr Borstel, Div Bioanalyt Chem, Prior Area Infect, D-23845 Borstel, Germany; [Kohler, Thomas P.; Hess, Nathalie; Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Ctr Funct Genom Microbes, Dept Mol Genet & Infect Biol, Felix Hausdorff Str 8, D-17487 Greifswald, Germany	Forschungszentrum Borstel; Ernst Moritz Arndt Universitat Greifswald	Gisch, N (corresponding author), Leibniz Lung Ctr, Res Ctr Borstel, Div Bioanalyt Chem, Parkallee 4a-4c, D-23845 Borstel, Germany.	ngisch@fz-borstel.de	Schwudke, Dominik/B-3478-2013; Hammerschmidt, Sven/G-2598-2010	Schwudke, Dominik/0000-0002-1379-9451; Hammerschmidt, Sven/0000-0002-6382-6681; Gisch, Nicolas/0000-0003-3260-5269	Deutsche Forschungsgemeinschaft [GI 979/1-1, HA 3125/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants GI 979/1-1 (to N. G.) and HA 3125/5-1 (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Damjanovic M, 2007, J BACTERIOL, V189, P7105, DOI 10.1128/JB.00681-07; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; de las Rivas B, 2001, MICROB DRUG RESIST, V7, P213, DOI 10.1089/10766290152652756; Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026; Fischer W, 1997, MICROB DRUG RESIST, V3, P309, DOI 10.1089/mdr.1997.3.309; Gisch N, 2015, STREPTOCOCCUS PNEUMO, P145; Gisch N, 2013, J BIOL CHEM, V288, P15654, DOI 10.1074/jbc.M112.446963; Hermoso JA, 2005, NAT STRUCT MOL BIOL, V12, P533, DOI 10.1038/nsmb940; Hess N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01720-z; HOLTJE JV, 1974, J BIOL CHEM, V249, P7032; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; LOPEZ R, 1982, J BACTERIOL, V151, P1581, DOI 10.1128/JB.151.3.1581-1590.1982; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Saleh M, 2013, EMBO MOL MED, V5, P1852, DOI 10.1002/emmm.201202435; SANCHEZPUELLES JM, 1992, EUR J BIOCHEM, V203, P153, DOI 10.1111/j.1432-1033.1992.tb19840.x; Schenk M, 2009, IMMUNITY, V31, P847, DOI 10.1016/j.immuni.2009.11.008; Schulz C, 2014, MBIO, V5, DOI 10.1128/mBio.01858-14; Severin A, 1997, MICROB DRUG RESIST, V3, P391, DOI 10.1089/mdr.1997.3.391; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; Swiatlo E, 2002, INFECT IMMUN, V70, P412, DOI 10.1128/IAI.70.1.412-415.2002; TOMASZ A, 1968, P NATL ACAD SCI USA, V59, P86, DOI 10.1073/pnas.59.1.86; Vassal-Stermann E, 2014, J IMMUNOL, V193, P5699, DOI 10.4049/jimmunol.1400127; Vollmer W, 2001, MOL MICROBIOL, V39, P1610, DOI 10.1046/j.1365-2958.2001.02349.x; Yother J, 1998, J BACTERIOL, V180, P2093, DOI 10.1128/JB.180.8.2093-2101.1998; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x	29	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10620	10629		10.1074/jbc.RA118.003360	http://dx.doi.org/10.1074/jbc.RA118.003360			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29764936	Green Published, hybrid			2022-12-26	WOS:000437828400020
J	Tsukamoto, H; Takeuchi, S; Kubota, K; Kobayashi, Y; Kozakai, S; Ukai, I; Shichiku, A; Okubo, M; Numasaki, M; Kanemitsu, Y; Matsumoto, Y; Nochi, T; Watanabe, K; Aso, H; Tomioka, Y				Tsukamoto, Hiroki; Takeuchi, Shino; Kubota, Kanae; Kobayashi, Yohei; Kozakai, Sao; Ukai, Ippo; Shichiku, Ayumi; Okubo, Misaki; Numasaki, Muneo; Kanemitsu, Yoshitomi; Matsumoto, Yotaro; Nochi, Tomonori; Watanabe, Kouichi; Aso, Hisashi; Tomioka, Yoshihisa			Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKE-IRF3 axis activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-surface receptor; endotoxin; innate immunity; lipopolysaccharide (LPS); pathogen-associated molecular pattern (PAMP); pattern recognition receptor (PRR); TIR-domain-containing adapter-inducing interferon-B (TRIF); Toll-like receptor 4 (TLR4); CD14; LPS-binding protein (LBP)	INNATE IMMUNE-RESPONSES; GRAM-NEGATIVE BACTERIA; BINDING-PROTEIN; PATTERN-RECOGNITION; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODIES; SUBCELLULAR SITES; ADAPTIVE IMMUNITY; CELL-ACTIVATION; HUMAN MONOCYTES	Toll-like receptor 4 (TLR4) is an indispensable immune receptor for lipopolysaccharide (LPS), a major component of the Gram-negative bacterial cell wall. Following LPS stimulation, TLR4 transmits the signal from the cell surface and becomes internalized in an endosome. However, the spatial regulation of TLR4 signaling is not fully understood. Here, we investigated the mechanisms of LPS-induced TLR4 internalization and clarified the roles of the extracellular LPS-binding molecules, LPS-binding protein (LBP), and glycerophosphatidylinositol-anchored protein (CD14). LPS stimulation of CD14-expressing cells induced TLR4 internalization in the presence of serum, and an inhibitory anti-LBP mAb blocked its internalization. Addition of LBP to serum-free cultures restored LPS-induced TLR4 internalization to comparable levels of serum. The secretory form of the CD14 (sCD14) induced internalization but required a much higher concentration than LBP. An inhibitory anti-sCD14 mAb was ineffective for serum-mediated internalization. LBP lacking the domain for LPS transfer to CD14 and a CD14 mutant with reduced LPS binding both attenuated TLR4 internalization. Accordingly, LBP is an essential serum molecule for TLR4 internalization, and its LPS transfer to membrane-anchored CD14 (mCD14) is a prerequisite. LBP induced the LPS-stimulated phosphorylation of TBK1, IKKE, and IRF3, leading to IFN- expression. However, LPS-stimulated late activation of NF-B or necroptosis were not affected. Collectively, our results indicate that LBP controls LPS-induced TLR4 internalization, which induces TLR adaptor molecule 1 (TRIF)-dependent activation of the TBK1-IKKE-IRF3-IFN- pathway. In summary, we showed that LBP-mediated LPS transfer to mCD14 is required for serum-dependent TLR4 internalization and activation of the TRIF pathway.	[Tsukamoto, Hiroki; Takeuchi, Shino; Kubota, Kanae; Kobayashi, Yohei; Kozakai, Sao; Ukai, Ippo; Shichiku, Ayumi; Okubo, Misaki; Kanemitsu, Yoshitomi; Matsumoto, Yotaro; Tomioka, Yoshihisa] Tohoku Univ, Lab Oncol Pharm Practice & Sci, Grad Sch Pharmaceut Sci, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Numasaki, Muneo] Tohoku Univ, Inst Dev Aging & Canc, Dept Geriatr & Gerontol, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Nochi, Tomonori; Watanabe, Kouichi; Aso, Hisashi] Tohoku Univ, Grad Sch Agr Sci, Lab Funct Morphol, 468-Aoba, Sendai, Miyagi 9800845, Japan; [Nochi, Tomonori; Watanabe, Kouichi; Aso, Hisashi] Tohoku Univ, Grad Sch Agr Sci, Int Educ & Res Ctr Food & Agr Immunol CFAI, 468-Aoba, Sendai, Miyagi 9800845, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Tsukamoto, H (corresponding author), Tohoku Univ, Lab Oncol Pharm Practice & Sci, Grad Sch Pharmaceut Sci, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	tsukamoh@m.tohoku.ac.jp	Nochi, Tomonori/U-2533-2019; matsumoto, yotaro/AAC-4539-2019	Nochi, Tomonori/0000-0003-1800-6972; Tsukamoto, Hiroki/0000-0002-4585-1656	Japan Society for the Promotion of Science KAKENHI [26460058]; Takeda Science Foundation; Ichiro Kanehara Foundation; Research Foundation for Pharmaceutical Sciences; Tokyo Biochemical Research Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ichiro Kanehara Foundation; Research Foundation for Pharmaceutical Sciences; Tokyo Biochemical Research Foundation	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 26460058 (to H. T.), grants from the Takeda Science Foundation (to H. T.), The Ichiro Kanehara Foundation (to H. T.), the Research Foundation for Pharmaceutical Sciences (to H. T.), and the Tokyo Biochemical Research Foundation (to H. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Bahrun U, 2007, HYBRIDOMA, V26, P393, DOI 10.1089/hyb.2007.0523; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Cunningham MD, 2000, J IMMUNOL, V164, P3255, DOI 10.4049/jimmunol.164.6.3255; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Hoshino K, 1999, J IMMUNOL, V162, P3749; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Iovine NM, 1997, P NATL ACAD SCI USA, V94, P10973, DOI 10.1073/pnas.94.20.10973; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kagan JC, 2012, TRENDS IMMUNOL, V33, P442, DOI 10.1016/j.it.2012.06.005; Kato A, 2004, J IMMUNOL, V172, P6185, DOI 10.4049/jimmunol.172.10.6185; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Lee CC, 2012, NAT REV IMMUNOL, V12, P168, DOI 10.1038/nri3151; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prucha M, 2003, CRIT CARE, V7, pR154, DOI 10.1186/cc2386; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; RESTA R, 1994, J IMMUNOL, V153, P1046; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Schumann RR, 2011, BIOCHEM SOC T, V39, P989, DOI 10.1042/BST0390989; Stack J, 2014, J IMMUNOL, V193, P6090, DOI 10.4049/jimmunol.1401605; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; THEOFAN G, 1994, J IMMUNOL, V152, P3623; Tsukamoto H, 2017, FEBS LETT, V591, P2406, DOI 10.1002/1873-3468.12768; Tsukamoto H, 2013, BIOCHEM BIOPH RES CO, V440, P31, DOI 10.1016/j.bbrc.2013.09.004; Tsukamoto H, 2013, J IMMUNOL, V190, P195, DOI 10.4049/jimmunol.1201047; Tsukamoto H, 2012, INT IMMUNOL, V24, P495, DOI 10.1093/intimm/dxs053; Tsukamoto H, 2010, INT IMMUNOL, V22, P271, DOI 10.1093/intimm/dxq005; Vreugdenhil ACE, 2001, J CLIN INVEST, V107, P225, DOI 10.1172/JCI10832; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zweigner J, 2001, BLOOD, V98, P3800, DOI 10.1182/blood.V98.13.3800	50	67	75	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10186	10201		10.1074/jbc.M117.796631	http://dx.doi.org/10.1074/jbc.M117.796631			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29760187	hybrid, Green Published			2022-12-26	WOS:000437096700020
J	Higgins, K; McLaughlin, A; Perra, O; McCartan, C; McCann, M; Percy, A; Jordan, JA				Higgins, Kathryn; McLaughlin, Aisling; Perra, Oliver; McCartan, Claire; McCann, Mark; Percy, Andrew; Jordan, Julie-Ann			The Belfast Youth Development Study (BYDS): A prospective cohort study of the initiation, persistence and desistance of substance use from adolescence to adulthood in Northern Ireland	PLOS ONE			English	Article							DRUG-USE; ACADEMIC-ACHIEVEMENT; CANNABIS USE; ALCOHOL-USE; FAMILY; SCHOOL; DRINKING; SELECTION; CONFLICT; OUTCOMES	Background Substance misuse persists as a major public health issue worldwide with significant costs for society. The development of interventions requires methodologically sound studies to explore substance misuse causes and consequences. This Cohort description paper outlines the design of the Belfast Youth Development (BYDS), one of the largest cohort studies of its kind in the UK. The study was established to address the need for a long-term prospective cohort study to investigate the initiation, persistence and desistance of substance use, alongside life course processes in adolescence and adulthood. The paper provides an overview of BYDS as a longitudinal data source for investigating substance misuse and outlines the study measures, sample retention and characteristics. We also outline how the BYDS data have been used to date and highlight areas ripe for future work by interested researchers. Methods The study began in 2000/1 when participants (n = 3,834) were pupils in their first year of post-primary education (age 10/11 years, school year 8) from over 40 schools in Northern Ireland. Children were followed during the school years: Year 9 (in 2002; aged 12; n = 4,343), Year 10 (in 2003; aged 13; n = 4,522), Year 11 (in 2004; aged 14; n = 3,965) and Year 12 (in 2005; aged 15; n = 3,830) and on two more occasions: 2006/07 (aged 16/17; n = 2,335) and 2010/11 (aged 20/21; n = 2,087). Data were collected on substance use, family, schools, neighbourhoods, offending behaviour and mental health. The most novel aspect of the study was the collection of detailed social network data via friendship nominations allowing the investigation of the spread of substance use via friendship networks. In 2004 (school year 11; respondents aged 14), a sub-sample of participants' parents (n = 1,097) and siblings (n = 211) also completed measures on substance use and family dynamics. Results The most recent wave (in 2010/2011; respondents aged 20/21 years) indicated lifetime use of alcohol, tobacco and cannabis among the cohort was 94, 70 and 45 per cent, respectively. The paper charts the development of drug use behaviour and some of the key results to date are presented. We have also identified a number of key areas ripe for analysis by interested researchers including sexual health and education. Conclusions We have established a cohort with detailed data from adolescence to young adulthood, supplemented with parent and sibling reports and peer network data. The dataset, allowing for investigation of trajectories of adolescent substance use, associated factors and subsequent long-term outcomes, constitutes an important resource for longitudinal substance misuse research. A planned further wave as the cohort enter their late twenties and potential to link to administrative data sources, will further enrich the datasets.	[Higgins, Kathryn; McLaughlin, Aisling; McCartan, Claire; Percy, Andrew; Jordan, Julie-Ann] Queens Univ Belfast, Ctr Evidence & Social Innovat, Sch Social Sci Educ & Social Work, Belfast, Antrim, North Ireland; [Perra, Oliver] Queens Univ Belfast, Med Biol Ctr, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland; [McCann, Mark] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	Queens University Belfast; Queens University Belfast; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	McLaughlin, A (corresponding author), Queens Univ Belfast, Ctr Evidence & Social Innovat, Sch Social Sci Educ & Social Work, Belfast, Antrim, North Ireland.	aisling.mclaughlin@qub.ac.uk	Perra, Oliver/AAI-3231-2020; McLaughlin, Aisling/N-3566-2019	McLaughlin, Aisling/0000-0002-1561-0894; Higgins, Kathryn/0000-0002-1834-0279; Percy, Andrew/0000-0003-4156-1536	MRC [MC/PC/13 027]; Medical Research Council through the SPHSU Complexity in Health Improvement programme [MC_UU_12017/14 / SPHSU14]; Medical Research Council through Social Relationships and Health Improvement programme [MC_UU_12017/11 / SPHSU11]; Chief Scientist Office through the SPHSU Complexity in Health Improvement programme [MC_UU_12017/14 / SPHSU14]; Chief Scientist Office through Social Relationships and Health Improvement programme [MC_UU_12017/11 / SPHSU11]; Health and Social Care Research and Development Division of the Public Health Agency (HSC R&D Division), Northern Ireland; MRC [MC_PC_13027, MC_UU_12017/14, MC_UU_12017/11] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council through the SPHSU Complexity in Health Improvement programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council through Social Relationships and Health Improvement programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office through the SPHSU Complexity in Health Improvement programme; Chief Scientist Office through Social Relationships and Health Improvement programme; Health and Social Care Research and Development Division of the Public Health Agency (HSC R&D Division), Northern Ireland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MMcC holds a Medical Research Council/University fellowship supported by MRC partnership grant (MC/PC/13 027), and Medical Research Council and Chief Scientist Office through the SPHSU Complexity in Health Improvement (MC_UU_12017/14 / SPHSU14) and Social Relationships and Health Improvement (MC_UU_12017/11 / SPHSU11) programmes. BYDS was funded by the Health and Social Care Research and Development Division of the Public Health Agency (HSC R&D Division), Northern Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abar CC, 2015, J YOUTH ADOLESCENCE, V44, P1688, DOI 10.1007/s10964-014-0143-6; Bahr Stephen J, 2005, J Prim Prev, V26, P529, DOI 10.1007/s10935-005-0014-8; Balsa AI, 2011, ECON EDUC REV, V30, P1, DOI 10.1016/j.econedurev.2010.06.015; Cooper M.L., 1994, PSYCHOL ASSESSMENT, V6, P117, DOI [https://doi.org/10.1037/1040-3590.6.2.117, DOI 10.1037/1040-3590.6.2.117, 10.1037/1040-3590.6.2.117]; Creemers HE, 2010, ADDICTION, V105, P699, DOI 10.1111/j.1360-0443.2009.02819.x; de la Haye K, 2013, J RES ADOLESCENCE, V23, P474, DOI 10.1111/jora.12018; Deas D, 2006, J CLIN PSYCHIAT, V67, P18, DOI 10.4088/JCP.0706e02; EMCDDA, 2011, STAT B 2011 TABL GPS; European Monitoring Centre for Drugs and Drug Addiction, 2016, ESPAD REP 2015 RES E; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; Gopiram Poonam, 2014, Indian J Psychol Med, V36, P58, DOI 10.4103/0253-7176.127252; Henry DB, 2011, PSYCHOL ADDICT BEHAV, V25, P80, DOI 10.1037/a0021874; Higgins K, 2004, J SOC ISSUES, V60, P485, DOI 10.1111/j.0022-4537.2004.00368.x; Higgins K., 2011, ALCOHOL AFFLUENCE PA; Higgins K., 2016, TRAJECTORIES OFFENDI; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Home Office, 2014, DRUG MIS FIND 2013 1; Jacob N, 2016, EUR J PUBLIC HEALTH, V26, P102, DOI 10.1093/eurpub/ckv123; Johnston LD, 2016, MONITORING FUTURE NA; Legleye S., 2007, Journal of Substance Use, V12, P233, DOI 10.1080/14659890701476532; Mcaloney K, 2010, DRUG-EDUC PREV POLIC, V17, P443, DOI 10.3109/09687630903074826; McAloney K, 2009, J COMMUNITY PSYCHOL, V37, P635, DOI 10.1002/jcop.20322; McCann M, 2016, ADDICTION, V111, P843, DOI 10.1111/add.13258; McCann M, 2014, EUR J PUBLIC HEALTH, V24, P845, DOI 10.1093/eurpub/cku062; McCrystal P., 2007, J YOUTH STUD, V10, P35, DOI [10.1080/13676260701196103, DOI 10.1080/13676260701196103, 10/1080/13676260701196103]; McCrystal P, 2006, J ADOLESCENCE, V29, P829, DOI 10.1016/j.adolescence.2006.05.006; McCrystal P, 2009, INT J DRUG POLICY, V20, P357, DOI 10.1016/j.drugpo.2008.09.005; McLaughlin A., 2016, PARENTAL ALCOHOL USE; Moriarty J, 2015, J CRIM PSYCHOL, V5, P75, DOI 10.1108/JCP-01-2015-0003; Moriarty J, 2016, SOC SCI MED, V163, P37, DOI 10.1016/j.socscimed.2016.06.032; National Drug Intelligence Center, 2011, NAT DRUG THREAT ASS; O'Brien KHM, 2015, SUBST ABUS, V36, P82, DOI 10.1080/08897077.2014.934417; O'Malley M, 2015, SCHOOL PSYCHOL QUART, V30, P142, DOI 10.1037/spq0000076; O'Neill T, 2015, ALCOHOL INSIGHT; Peleg-Oren N, 2009, ALCOHOL CLIN EXP RES, V33, P1966, DOI 10.1111/j.1530-0277.2009.01035.x; Percy A, 2008, CHILD ABUSE REV, V17, P371, DOI 10.1002/car.1046; Perra O, 2012, J ADOLESCENCE, V35, P315, DOI 10.1016/j.adolescence.2011.08.009; Schofield TJ, 2015, DRUG ALCOHOL DEPEN, V157, P129, DOI 10.1016/j.drugalcdep.2015.10.020; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; The Centre for Social Justice, 2013, NO QUICK FIX EXP DEP	40	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0195192	10.1371/journal.pone.0195192	http://dx.doi.org/10.1371/journal.pone.0195192			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0FF	29791433	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000003
J	Ikeda, H; Komaba, M; Komaba, K; Matsuya, A; Kawakubo, A; Nakahara, F				Ikeda, Hisako; Komaba, Masayuki; Komaba, Kumiko; Matsuya, Ayaka; Kawakubo, Akihiro; Nakahara, Fumio			Social object play between captive bottlenose and Risso's dolphins	PLOS ONE			English	Article							COOPERATION	Many animal species engage in social object play with movable objects. Two bottlenose dolphins (Tursiops truncatus) and one Risso's dolphin (Grampus griseus) owned by the Kujukushima Aquarium, Japan, occasionally shared and played with an object. Herein, we report social object play between two dolphins exchanging a ball in water. Just before delivery of the ball, one dolphin made an action to request the ball from the dolphin that possessed the ball. This request behavior is also discussed in this report. This study is the first to report two different cetacean species engaging in social object play with one object.	[Ikeda, Hisako; Komaba, Masayuki; Komaba, Kumiko; Matsuya, Ayaka; Kawakubo, Akihiro] Kujukushima Aquarium Umi Kirara, Nagasaki, Japan; [Nakahara, Fumio] Tokiwa Univ, Mito, Ibaraki, Japan		Nakahara, F (corresponding author), Tokiwa Univ, Mito, Ibaraki, Japan.	fnakahar@tokiwa.ac.jp			Japan Society for the Promotion of Science KAKENHI [15H05709]; Kujukushima Aquarium - Umi Kirara	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kujukushima Aquarium - Umi Kirara	This study was supported by Japan Society for the Promotion of Science KAKENHI Grant Number #15H05709 to FN (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Kujukushima Aquarium - Umi Kirara provided support in the form of salaries for authors HI, MK, KK, AM, and AK, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contribution' section.	Bakeman R., 1982, PEER RELATIONSHIPS S, P99; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Bekoff M, 2001, J CONSCIOUSNESS STUD, V8, P81; Bekoff M., 1998, ANIMAL PLAY EVOLUTIO; Burghardt GM, 2005, GENESIS OF ANIMAL PLAY: TESTING THE LIMITS, P1; Delfour F, 1997, BEHAV PROCESS, V40, P183, DOI 10.1016/S0376-6357(97)00782-1; Greene WE, 2011, INT J COMP PSYCHOL, V24, P292, DOI DOI 10.5811/WESTJEM.2011.5.6700; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Horowitz A, 2016, ANIM COGN, V19, P779, DOI 10.1007/s10071-016-0976-3; Janik VM, 2015, CURR BIOL, V25, pR7, DOI 10.1016/j.cub.2014.09.010; Kuczaj SA, 2005, BEHAV BRAIN SCI, V28, P705, DOI 10.1017/S0140525X05370129; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Nakahara F, 2017, BEHAV PROCESS, V135, P8, DOI 10.1016/j.beproc.2016.11.009; Paulos R.D., 2010, INT J COMP PSYCHOL, V23, P701, DOI DOI 10.1016/J.SOCSCIMED.2010.01.002; Reyes JC, 1996, MAR MAMMAL SCI, V12, P301, DOI 10.1111/j.1748-7692.1996.tb00581.x; Samuels A, 1997, MAR MAMMAL SCI, V13, P70, DOI 10.1111/j.1748-7692.1997.tb00613.x; Shimada M, 2006, PRIMATES, V47, P342, DOI 10.1007/s10329-006-0187-7; Shimada M, 2010, JAPANESE MACAQUES, P375, DOI 10.1007/978-4-431-53886-8_18; Wells R., 1999, HDB MARINE MAMMALS, V6, P137; Yamamoto Shinya, 2011, Primate Research, V27, P95	20	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196658	10.1371/journal.pone.0196658	http://dx.doi.org/10.1371/journal.pone.0196658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791479	gold, Green Published, Green Submitted			2022-12-26	WOS:000433077000019
J	Matsushita, M; Yatabe, Y; Koyama, A; Katsuya, A; Ijichi, D; Miyagawa, Y; Ikezaki, H; Furukawa, N; Ikeda, M; Hashimoto, M				Matsushita, Masateru; Yatabe, Yusuke; Koyama, Asuka; Katsuya, Akiko; Ijichi, Daisuke; Miyagawa, Yusuke; Ikezaki, Hiroto; Furukawa, Noboru; Ikeda, Manabu; Hashimoto, Mamoru			Are saving appearance responses typical communication patterns in Alzheimer's disease?	PLOS ONE			English	Article							FRONTAL ASSESSMENT BATTERY; HEAD-TURNING SIGN; LEWY BODIES; COGNITIVE IMPAIRMENT; BEHAVIORAL SYMPTOMS; JAPANESE VERSION; DEMENTIA; DIAGNOSIS; VARIANT; SHAME	Introduction To keep up appearances, people with dementia sometimes pretend to know the correct answer, as seen during administration of neuropsychological tests such as the Mini-Mental State Examination (MMSE). These saving appearance responses (SARs) of people with dementia often lead to caregivers and/or medical staff underestimating the severity of dementia and impede proper early initiation of treatment. However, most descriptions of SARs are based on empirical knowledge of clinicians. In this study, we investigated whether SARs are typical communication patterns in people with Alzheimer's disease (AD), compared with mild cognitive impairment (MCI) or dementia with Lewy bodies (DLB). Methods The participants were 107 outpatients with AD, 16 with mixed AD with cerebrovascular dementia, 55 with MCI, and 30 with DLB. We assessed the occurrence of SARs during the MMSE. The relationships between the SARs and AD were examined by thex2 test and logistic regression analysis. Results People with AD who showed SARs were 57.9%, whereas those with MCI were 18.2% and DLB were 20.0% (P-with Bonferroni correction < 0.05). Although there were significant differences in some variables in each group of diagnosis, logistic regression analysis showed that people with AD were more likely to show SARs than those with MCI (Odds ratio = 3.48, 95% Confidential Interval = 1.18-10.28) and DLB (Odds ratio = 4.24, 95% Confidential Interval = 1.50-12.01), even after controlling for sex, estimated disease duration, MMSE, and frontal assessment battery scores. Conclusion The occurrence of SARs could be found most frequently in people with AD. Clinicians should develop a respectful attitude toward dementia patients with SARs because SARs imply conflicted feelings about questions that patients cannot answer correctly.	[Matsushita, Masateru; Furukawa, Noboru] Kumamoto Univ, Fac Life Sci, Ctr Med Educ & Res, Kumamoto, Japan; [Yatabe, Yusuke] Kumamoto Prefectural Govt, Mental Hlth & Welf Ctr, Dept Hlth & Welf, Kumamoto, Japan; [Koyama, Asuka; Katsuya, Akiko; Ijichi, Daisuke; Miyagawa, Yusuke; Hashimoto, Mamoru] Kumamoto Univ, Fac Life Sci, Dept Neuropsychiat, Kumamoto, Japan; [Ijichi, Daisuke] Atsuchi Neurosurg Hosp, Dept Rehabil, Kagoshima 4, Japan; [Ikezaki, Hiroto] Kumamoto Hlth Sci Univ, Dept Speech Language Hearing Sci, Kumamoto, Japan; [Ikeda, Manabu] Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka, Japan	Kumamoto University; Kumamoto University; Kumamoto Health Science University; Osaka University	Matsushita, M (corresponding author), Kumamoto Univ, Fac Life Sci, Ctr Med Educ & Res, Kumamoto, Japan.	matsushita815@gmail.com			JSPS KAKENHI [JP18K13324]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number JP18K13324 (Grant-in-Aid for Young Scientists). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boiger M, 2014, COGNITION EMOTION, V28, P1255, DOI 10.1080/02699931.2014.881324; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujisawa Yutaka, 2013, Nihon Ronen Igakkai Zasshi, V50, P392; Fukui T, 2011, DEMENT GER COGN D EX, V1, P310, DOI 10.1159/000332605; Heitz C, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0179-9; Kugo A, 2007, PSYCHIAT RES, V153, P69, DOI 10.1016/j.psychres.2006.04.004; Larner AJ, 2012, J NEUROL NEUROSUR PS, V83, P852, DOI 10.1136/jnnp-2011-301804; Larner AJ, 2005, J NEUROL NEUROSUR PS, V76, P1739, DOI 10.1136/jnnp.2005.068023; Matsuda M., 2009, HIGH BRAIN FUNCT RES, V29, P312; Matsushita M, 2017, PSYCHOGERIATRICS, V17, P377, DOI 10.1111/psyg.12253; McKeith IG, 2002, BRIT J PSYCHIAT, V180, P144, DOI 10.1192/bjp.180.2.144; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Modinos G, 2009, J NEUROPSYCH CLIN N, V21, P100, DOI 10.1176/appi.neuropsych.21.1.100; Nakaaki S, 2007, PSYCHIAT CLIN NEUROS, V61, P78, DOI 10.1111/j.1440-1819.2007.01614.x; Perri R, 2014, J ALZHEIMERS DIS, V39, P669, DOI 10.3233/JAD-131337; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Simard M, 2000, J NEUROPSYCH CLIN N, V12, P425, DOI 10.1176/appi.neuropsych.12.4.425; Sugishita M., 2010, JAPANESE J COGNITIVE, V12, P186, DOI DOI 10.11253/NINCHISHINKEIKAGAKU.12.186; Sznycer D, 2012, EVOL PSYCHOL-US, V10, P352, DOI 10.1177/147470491201000213; Tanabe H, 1999, DEMENT GERIATR COGN, V10, P50, DOI 10.1159/000051213	23	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197468	10.1371/journal.pone.0197468	http://dx.doi.org/10.1371/journal.pone.0197468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791460	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000039
J	Stoen, OG; Ordiz, A; Sahlen, V; Arnemo, JM; Saebo, S; Mattsing, G; Kristofferson, M; Brunberg, S; Kindberg, J; Swenson, JE				Stoen, Ole-Gunnar; Ordiz, Andres; Sahlen, Veronica; Arnemo, Jon M.; Saebo, Solve; Mattsing, Glenn; Kristofferson, Magnus; Brunberg, Sven; Kindberg, Jonas; Swenson, Jon E.			Brown bear (Ursus arctos) attacks resulting in human casualties in Scandinavia 1977-2016; management implications and recommendations	PLOS ONE			English	Article							LARGE CARNIVORES; BANGLADESH SUNDARBANS; MODEL SELECTION; POPULATION-SIZE; HUMAN FEAR; BEHAVIOR; CONSERVATION; CONFLICT; EXTINCTION; ENCOUNTERS	Human persecution and habitat loss have endangered large carnivore populations worldwide, but some are recovering, exacerbating old conflicts. Carnivores can injure and kill people; the most dramatic form of wildlife-human conflict. In Scandinavia, the brown bear (Ursus arctos) population increased from similar to 500 bears in 1977 to similar to 3300 in 2008, with an increase in injuries, fatalities, and public fear of bear attacks. We reviewed media coverage and interviewed victims to explore how bear population trends, hunter education, and other factors may have influenced the number of injuries and fatalities in Scandinavia from 1977 to 2016. We found 42 incidents with 42 injuries and 2 fatalities; 42 were adult men, one was an adult woman conducting forestry work, and one was a boy skiing off-piste. Thirty-three adult men were hunting bears, moose, or small game, often with a hunting dog, and 26 had shot at the bear at 8 11 m before injury. Eleven nonhunters were conducting forestry work, inspecting a hunting area, picking berries, tending livestock, hiking, harassing a denned bear, and one person was killed outside his house at night. Eight of the 11 incidents of non hunters involved female bears with cubs; three of these family groups were in dens and two were on carcasses. The annual number of hunters injured/killed was mostly influenced by the increase in the bear population size. The pattern was similar regarding injuries/fatalities to other outdoor users, but the relation with the bear population size was weaker than for hunters, and the null model was equally supported. Bear physiology at denning may make encounters with bears more risky in the fall, when bears show prehibernation behavior. Awareness and education efforts, especially among hunters, seem important to ensure human safety. Recreationists and forestry workers should avoid dense vegetation or make noise to warn bears of their presence.	[Stoen, Ole-Gunnar; Brunberg, Sven; Kindberg, Jonas; Swenson, Jon E.] Norwegian Inst Nat Res, Trondheim, Norway; [Stoen, Ole-Gunnar; Ordiz, Andres; Sahlen, Veronica; Swenson, Jon E.] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Sahlen, Veronica] Norwegian Environm Agcy, Trondheim, Norway; [Arnemo, Jon M.; Kindberg, Jonas] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden; [Arnemo, Jon M.] Inland Norway Univ Appl Sci, Fac Appl Ecol & Agr Sci, Dept Forestry & Wildlife Management, Koppang, Norway; [Saebo, Solve] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [Mattsing, Glenn] Rovdjursctr 5 Stora, Jarvso, Sweden; [Kristofferson, Magnus] Swedish Environm Protect Agcy, Stockholm, Sweden; [Kindberg, Jonas] Swedish Assoc Hunting & Wildlife Management, Oster Malma, Sweden	Norwegian Institute Nature Research; Norwegian University of Life Sciences; Swedish University of Agricultural Sciences; Inland Norway University of Applied Sciences; Norwegian University of Life Sciences	Stoen, OG (corresponding author), Norwegian Inst Nat Res, Trondheim, Norway.; Stoen, OG (corresponding author), Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway.	ole.stoen@nina.no	Støen, Ole-Gunnar/AAY-6457-2020; Swenson, Jon/AAE-2890-2019; Kindberg, Jonas/AAA-5058-2020	Kindberg, Jonas/0000-0003-1445-4524; Ordiz, Andres/0000-0002-6141-8457	Norwegian Environment Agency; Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; Austrian Science Fund; Polish-Norwegian Research Program [POL-NOR/198352/85/2013]; Center for Advanced Study in Oslo, Norway	Norwegian Environment Agency; Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; Austrian Science Fund(Austrian Science Fund (FWF)); Polish-Norwegian Research Program; Center for Advanced Study in Oslo, Norway	The Scandinavian Brown Bear Research Project (SBBRP) was funded by the Norwegian Environment Agency, the Swedish Environmental Protection Agency, the Swedish Association for Hunting and Wildlife Management, the Austrian Science Fund, and the Polish-Norwegian Research Program operated by the National Center for Research and Development under the Norwegian Financial Mechanism 2009-2014 in the frame of Project Contract No POL-NOR/198352/85/2013. We greatly acknowledge the support of Center for Advanced Study in Oslo, Norway that hosted our research project ("Climate effects on harvested large mammal populations") during the academic year 2015/16.	Ambarli H, 2008, URSUS, V19, P146, DOI 10.2192/1537-6176-19.2.146; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Barlow ACD, 2010, CONSERV BIOL, V24, P1338, DOI 10.1111/j.1523-1739.2010.01496.x; Baskin Leonid M., 2016, International Bear News, V25, P22; Bischof R, 2008, J WILDLIFE MANAGE, V72, P79, DOI 10.2193/2007-149; Bruskotter J. T., 2010, Human Dimensions of Wildlife, V15, P311, DOI 10.1080/10871209.2010.508068; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Camaros E, 2016, ARCHAEOL ANTHROP SCI, V8, P635, DOI 10.1007/s12520-015-0248-1; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; De Giorgio F, 2007, FORENSIC SCI INT, V173, P64, DOI 10.1016/j.forsciint.2006.08.026; Elfstrom M, 2014, J WILDLIFE MANAGE, V78, P881, DOI 10.1002/jwmg.727; Eriksson M, 2015, WILDLIFE BIOL, V21, P131, DOI 10.2981/wlb.00062; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Evans AL, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0140-6; Fernandez-Gil A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151541; Ferretti F, 2015, FRONT ECOL ENVIRON, V13, P412, DOI 10.1890/150109; Fredman P, 2012, MONITORING OUTDOOR R; Gore M. L., 2009, Human Dimensions of Wildlife, V14, P301, DOI 10.1080/10871200903160944; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Gustafsson T, 2015, J FORENSIC SCI, V60, P1658, DOI 10.1111/1556-4029.12870; Herrero S, 2005, WILDLIFE SOC B, V33, P362, DOI 10.2193/0091-7648(2005)33[362:FTFBBH]2.0.CO;2; Herrero S, 2011, J WILDLIFE MANAGE, V75, P596, DOI 10.1002/jwmg.72; Hertel AG, 2016, OECOLOGIA, V182, P1019, DOI 10.1007/s00442-016-3729-8; Inskip C, 2013, HUM ECOL, V41, P169, DOI 10.1007/s10745-012-9556-6; Johansson M, 2016, BIOL CONSERV, V201, P261, DOI 10.1016/j.biocon.2016.07.010; Johansson Maria, 2012, Human Dimensions of Wildlife, V17, P58, DOI 10.1080/10871209.2012.619001; Johansson Maria, 2011, Human Dimensions of Wildlife, V16, P15, DOI 10.1080/10871209.2011.535240; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Loe J, 2004, AMBIO, V33, P283, DOI 10.1639/0044-7447(2004)033[0283:LCAHSA]2.0.CO;2; Manchi S, 2005, WILDLIFE BIOL, V11, P123, DOI 10.2981/0909-6396(2005)11[123:DBOSBB]2.0.CO;2; Martin J, 2010, CAN J ZOOL, V88, P875, DOI 10.1139/Z10-053; Middaugh J P, 1987, Alaska Med, V29, P121; Moe TF, 2007, CAN J ZOOL, V85, P518, DOI 10.1139/Z07-034; Moen GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031699; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Nellemann C, 2007, BIOL CONSERV, V138, P157, DOI 10.1016/j.biocon.2007.04.011; Ordiz A, 2013, J APPL ECOL, V50, P306, DOI 10.1111/1365-2664.12047; Ordiz A, 2012, BIOL CONSERV, V152, P21, DOI 10.1016/j.biocon.2012.04.006; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Penteriani V, 2016, SCI REP-UK, V6, DOI 10.1038/srep20552; Peyton B., 1999, BEARS STATUS SURVEY; R Core Team, 2020, R LANG ENV STAT COMP; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Sahlen V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121576; Sahlen V, 2015, J WILDLIFE MANAGE, V79, P274, DOI 10.1002/jwmg.822; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Smith TS, 2018, WILD SOC B; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Steyaert SMJG, 2013, J ANIM ECOL, V82, P836, DOI 10.1111/1365-2656.12055; Swenson J, 1996, 404 NORW I NAT RES; Swenson J.E., 1999, BIOSPH CONS, V2, P1; Swenson J. E., 2000, ACTION PLAN CONSERVA, V114; Swenson JE, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00251; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Vougiouklakis T, 2006, AM J FOREN MED PATH, V27, P266, DOI 10.1097/01.paf.0000220930.00053.43; Zajac RM, 2012, J WILDLIFE MANAGE, V76, P1331, DOI 10.1002/jwmg.398; [No title captured]	62	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196876	10.1371/journal.pone.0196876	http://dx.doi.org/10.1371/journal.pone.0196876			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791471	gold, Green Published, Green Submitted			2022-12-26	WOS:000433077000025
J	Heraudeau, A; Delluc, A; Le Henaff, M; Lacut, K; Leroyer, C; Desrues, B; Couturaud, F; Tromeur, C				Heraudeau, Adeline; Delluc, Aurelien; Le Henaff, Mickael; Lacut, Karine; Leroyer, Christophe; Desrues, Benoit; Couturaud, Francis; Tromeur, Cecile			Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; PROTHROMBIN 20210A; MUTATION; GENE; PREVALENCE; FREQUENCY; SURVIVAL	Background Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mutation. The impact of the factor V Leiden on the risk of VTE in cancer patients remains uncertain. Objective To assess the impact of factor V Leiden mutation in cancer-associated thrombosis. Methods The EDITH hospital-based case-control study enrolled 182 patients with cancer and VTE as well as 182 control patients with cancer, matched for gender, age and cancer location, between 2000 and 2012, in the University Hospital of Brest. All cases and controls were genotyped for the factor V Leiden mutation and interviewed with a standardized questionnaire. Results Twenty one of 182 (11.5%) patients with cancer-associated thrombosis carried the factor V Leiden mutation and 4 of 182 (2.2%) controls with cancer but no venous thrombosis. In multivariate analysis including cancer stage and family history of VTE, cancer patients with factor V Leiden mutation had a seven -fold increased risk of venous thromboembolism (adjusted odds ratio [OR], 7.04; 95% CI, 2.01-24.63). Conclusion The pro-thrombotic Factor V Leiden mutation was found to be an independent additional risk factor for venous thromboembolism in cancer patients and might therefore be considered in the individual thrombotic risk assessment.	[Heraudeau, Adeline; Desrues, Benoit] Univ Rennes 1, Hop Pontchaillou, Serv Pneumol, Rue Henri Le Guilloux, Rennes, France; [Delluc, Aurelien; Lacut, Karine; Leroyer, Christophe; Couturaud, Francis; Tromeur, Cecile] Univ Brest, IFR, GETBO, EA3878, Brest, France; [Delluc, Aurelien; Leroyer, Christophe; Couturaud, Francis; Tromeur, Cecile] CHRU Cavale Blanche, Dept Med Interne & Pneumol, Blvd Tanguy Prigent, Brest, France; [Le Henaff, Mickael] Hop Scorff, Serv Pneumol, Ave Choiseul, Lorien, France; [Lacut, Karine; Couturaud, Francis; Tromeur, Cecile] CIC, INSERM, Brest, France; [Desrues, Benoit] ERL, INSERM, Rennes, France	CHU Rennes; Universite de Rennes; Universite de Bretagne Occidentale; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Institut National de la Sante et de la Recherche Medicale (Inserm)	Tromeur, C (corresponding author), Univ Brest, IFR, GETBO, EA3878, Brest, France.; Tromeur, C (corresponding author), CHRU Cavale Blanche, Dept Med Interne & Pneumol, Blvd Tanguy Prigent, Brest, France.; Tromeur, C (corresponding author), CIC, INSERM, Brest, France.	tromeurcecile@gmail.com	Couturaud, Francis/Q-1366-2019	Couturaud, Francis/0000-0002-1855-8032; leroyer, christophe/0000-0002-7601-1692; Lacut, Karine/0000-0002-4849-0454; tromeur, cecile/0000-0001-9161-7521	Programme Hospitalier de Recherche Clinique, France	Programme Hospitalier de Recherche Clinique, France	This study was supported by grants from Programme Hospitalier de Recherche Clinique, France,. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Blom JW, 2006, J THROMB HAEMOST, V4, P529, DOI 10.1111/j.1538-7836.2006.01804.x; Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715; Chew HK, 2006, ARCH INTERN MED, V166, P458; Decousus H, 2007, THROMB RES, V120, pS51, DOI 10.1016/S0049-3848(07)70130-5; Eichinger S, 2016, THROMB RES, V140, pS12, DOI 10.1016/S0049-3848(16)30092-5; Falanga A, 1998, HAEMOSTASIS, V28, P50; Farge D, 2010, THROMB RES, V125, pS108, DOI 10.1016/S0049-3848(10)70027-X; Garber JE, 2010, JNCI-J NATL CANCER I, V102, P942, DOI 10.1093/jnci/djq211; Gran OV, 2016, HAEMATOLOGICA, V101, P1046, DOI 10.3324/haematol.2016.147405; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Heit JA, 2001, THROMB HAEMOSTASIS, V86, P452, DOI 10.1161/ATVBAHA.108.162545; Kennedy M, 2005, BRIT J HAEMATOL, V128, P386, DOI 10.1111/j.1365-2141.2004.05327.x; Khorana AA, 2007, CANCER-AM CANCER SOC, V110, P2339, DOI 10.1002/cncr.23062; Leroyer C, 1998, THROMB HAEMOSTASIS, V80, P49; Leroyer C, 1997, CHEST, V111, P1603, DOI 10.1378/chest.111.6.1603; Malaponte G, 2013, CYTOKINE, V62, P64, DOI 10.1016/j.cyto.2013.02.017; Mandala M, 2010, ANN ONCOL, V21, P871, DOI 10.1093/annonc/mdp354; Oger E, 2007, THROMB RES, V120, P207, DOI 10.1016/j.thromres.2006.10.002; Pabinger I, 2015, J THROMB HAEMOST, V13, P17, DOI 10.1111/jth.12778; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; Sallah S, 2002, THROMB HAEMOSTASIS, V87, P575; Simone B, 2013, EUR J EPIDEMIOL, V28, P621, DOI 10.1007/s10654-013-9825-8; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753	27	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0194973	10.1371/journal.pone.0194973	http://dx.doi.org/10.1371/journal.pone.0194973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775482	gold, Green Published, Green Submitted			2022-12-26	WOS:000432521100004
J	Cateau, E; Herrault, PA; Sheeren, D; Ladet, S; Brustel, H				Cateau, Eugenie; Herrault, Pierre-Alexis; Sheeren, David; Ladet, Sylvie; Brustel, Herve			The influence of spatial and temporal discontinuities of forest habitats on the current presence of flightless saproxylic beetles	PLOS ONE			English	Article							PLANT-COMMUNITIES; DEAD WOOD; BIODIVERSITY; COLEOPTERA; ANCIENT	Flightless saproxylic beetles were selected in order to study the impact of temporal and spatial discontinuity of forests. They were chosen because: (1) they are unable to fly, making them dispersal-limited species, (2) they have a saproxylic diet, which means they are closely linked to the forest, and (3), they have rarely been studied. Forest temporal continuity was expected to be the main factor explaining the presence of these species, modulated by the past and present amount of forest in the surrounding landscape. Twenty-seven forests, distributed into three zones, were sampled in southwestern France. Flightless saproxylic beetles were surveyed using a Winkler extractor and a Berlese funnel. Their presence/absence were modelled using generalised linear mixed models, with zone variable as random effect. Two species showed significant zone effect and were only or more present in the zone with the highest present forest amount in a 0.5 km radius. In the model that converged, the only selected variable was the past amount of forest in the landscape. The size of the forest, the presence of dead wood and the forest temporal continuity were not included in this model. The importance of the amount of forest in the landscape supports the hypothesis that dispersal -limited species are affected by landscape characteristics. This study demonstrates an important link between the presence of Dienerella clathrata and the amount of forest in the past, which led to an indicator species analysis being performed.	[Cateau, Eugenie; Brustel, Herve] Univ Toulouse, UMR DYNAFOR 1201, INPT EI Purpan, Toulouse, France; [Herrault, Pierre-Alexis; Sheeren, David] Univ Toulouse, UMR DYNAFOR 1201, INP ENSAT, Toulouse, France; [Ladet, Sylvie] INRA, UMR DYNAFOR 1201, Toulouse, France; [Herrault, Pierre-Alexis] Univ Strasbourg, UMR CNRS LIVE 7362, Strasbourg, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; INRAE; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Cateau, E (corresponding author), Univ Toulouse, UMR DYNAFOR 1201, INPT EI Purpan, Toulouse, France.	eugenie.cateau@gmail.com	BRUSTEL, Hervé/AAS-2809-2020; Sheeren, David/G-9939-2014	Sheeren, David/0000-0001-8016-5355; Ladet, Sylvie/0000-0002-3079-9453	Midi-Pyrenees Region; Ecole d'Ingenieur de Purpan	Midi-Pyrenees Region(Region Occitanie); Ecole d'Ingenieur de Purpan	This work was supported by the Midi-Pyrenees Region and Ecole d'Ingenieur de Purpan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to A. Brin, C. Bouget and M. Deconchat for their helpful comments during the project, to O. Courtin for the species identification, to N. Defarge for his work in the field and it the laboratory and to R. Carrie and M. Goulard for their helpful comments during the analyses. We thank D. Goodfellow and Claire Tarring for corrections to the English. This research was funded by the Midi-Pyrenees Region and the Ecole d'Ingenieur de Purpan.	Andrieu E, 2011, LANDSCAPE URBAN PLAN, V103, P109, DOI 10.1016/j.landurbplan.2011.06.005; Archaux F, 2014, DISPERSION PERSISTEN; Avon C, 2015, LANDSCAPE URBAN PLAN, V144, P65, DOI 10.1016/j.landurbplan.2015.07.016; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berges L, 2016, DIVERS DISTRIB, V22, P3, DOI 10.1111/ddi.12384; Bijlsma R, 2010, OUDE BOSSEN OUDE BOS; Bosso L, 2013, J NAT CONSERV, V21, P72, DOI 10.1016/j.jnc.2012.10.003; Brin A, 2016, BIODIVERS CONSERV, V25, P587, DOI 10.1007/s10531-016-1076-z; Brin A, 2011, J INSECT CONSERV, V15, P653, DOI 10.1007/s10841-010-9364-5; Buse J, 2012, J INSECT CONSERV, V16, P93, DOI 10.1007/s10841-011-9396-5; Cateau E, 2016, REV ECOL-TERRE VIE, V71, P59; Cateau E, 2016, INSECT CONSERV DIVER, V9, P282, DOI 10.1111/icad.12165; Cateau E, 2015, CR BIOL, V338, P58, DOI 10.1016/j.crvi.2014.10.004; Dajoz R, 1977, COLEOPTERES COLYDIID; de Gasperis SR, 2016, J INSECT CONSERV, V20, P821, DOI 10.1007/s10841-016-9913-7; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ducasse J, 2008, REV FRANCAISE, P345; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dupouey Jean-Luc, 2002, Revue Forestiere Francaise (Nancy), V54, P521; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Flinn KM, 2005, FRONT ECOL ENVIRON, V3, P243, DOI 10.2307/3868486; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Franc N, 2007, BIOL CONSERV, V135, P86, DOI 10.1016/j.biocon.2006.09.021; Galibert H., 1932, Bull Soc Hist nat Toulouse, V63, P27; Goldberg E, 2007, J NAT CONSERV, V15, P109, DOI 10.1016/j.jnc.2007.04.001; Gossner MM, 2013, CONSERV BIOL, V27, P605, DOI 10.1111/cobi.12023; Heijerman Theodor, 2004, Nederlandse Faunistische Mededelingen, V21, P61; Hermy M, 1999, BIOL CONSERV, V91, P9, DOI 10.1016/S0006-3207(99)00045-2; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Herrault PA, 2016, LANDSCAPE ECOL, V31, P877, DOI 10.1007/s10980-015-0304-3; Hoffmann A, 1958, FAUNE FRANCE TROISIE; Horak J, 2013, J INSECT CONSERV, V17, P441, DOI 10.1007/s10841-012-9526-8; Janssen P, 2017, BIOL CONSERV, V205, P1, DOI 10.1016/j.biocon.2016.11.021; Janssen P, 2016, BIODIVERS CONSERV, V25, P1167, DOI 10.1007/s10531-016-1116-8; Kraus D., 2013, INTEGRATIVE APPROACH; Ladet S, 2013, C INT GEOM AN SPAT B, P139; Lassauce A, 2013, INSECT CONSERV DIVER, V6, P396, DOI 10.1111/j.1752-4598.2012.00214.x; Leather SR, 2014, INSECT CONSERV DIVER, V7, P314, DOI 10.1111/icad.12055; MAC ARTHUR ROBERT H., 1967; Marshall PL, 2000, ECOLOGY F R T REPORT; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Moretti M, 2006, OECOLOGIA, V149, P312, DOI 10.1007/s00442-006-0450-z; Muller J, 2010, EUR J FOREST RES, V129, P981, DOI 10.1007/s10342-010-0400-5; Muller J, 2010, BIOL CONSERV, V143, P2559, DOI 10.1016/j.biocon.2010.06.024; Noss RF, 1999, FOREST ECOL MANAG, V115, P135, DOI 10.1016/S0378-1127(98)00394-6; Orousset Jean, 2012, Coleopteriste, V15, P173; R Core Team, 2021, R LANGUAGE ENV STAT; Russo D, 2011, J INSECT CONSERV, V15, P685, DOI 10.1007/s10841-010-9366-3; Stokland JN, 2012, ECOL BIODIVERS CONS, P248; Tischendorf L, 2003, LANDSCAPE ECOL, V18, P41, DOI 10.1023/A:1022908109982; Victorsson J, 2013, FOREST ECOL MANAG, V290, P22, DOI 10.1016/j.foreco.2012.06.057	51	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197847	10.1371/journal.pone.0197847	http://dx.doi.org/10.1371/journal.pone.0197847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29772015	gold, Green Submitted, Green Published			2022-12-26	WOS:000432348900104
J	Fluschnik, N; Ojeda, F; Zeller, T; Jorgensen, T; Kuulasmaa, K; Becher, PM; Sinning, C; Blankenberg, S; Westermann, D				Fluschnik, Nina; Ojeda, Francisco; Zeller, Tanja; Jorgensen, Torben; Kuulasmaa, Kari; Becher, Peter Moritz; Sinning, Christoph; Blankenberg, Stefan; Westermann, Dirk			Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MACROPHAGE INHIBITORY CYTOKINE-1; MIDDLE-AGED MEN; CYSTATIN-C; CARDIOVASCULAR RISK; POPULATION; MORTALITY; ASSOCIATION; BIOMARKERS; PROGNOSIS	Background Growth differentiation factor-15 (GDF-15), Cystatin C and C-reactive protein (CRP) have been discussed as biomarkers for prediction of cardiac diseases. The aim of this study was to investigate the predictive value of single and repeated measurements of GDF-15 compared to Cystatin C and CRP for incidence of heart failure (HF) and death due to coronary heart disease (CHD) in the general population. Methods and results Levels of GDF-15, CRP and Cystatin C were determined in three repeated measurements collected 5 years apart in the DAN-MONICA (Danish-Multinational MONitoring of trends and determinants in Cardiovascular disease) cohort (participants at baseline n=3785). Cox regression models adjusted for cardiovascular risk factors revealed significantly increased hazard ratios (HR) for GDF-15 for incident HF 1.36 (HR per interquartile range (IQR) increase, 95% confidence interval (CI): 1.16; 1.59) and for death from CHD 1.51 (HR per IQR increase, 95% CI: 1.31, 1.75) (both with p<0.001). Joint modeling of time-to-event and longitudinal GDF-15 over a median 27-year follow-up period showed that the marker evolution was positively associated with death of CHD (HR per IQR increase 3.02 95% CI: (2.26, 4.04), p<0.001) and HF (HR per IQR increase 2.12 95% CI: (1.54, 2.92), p<0.001). However using Cox models with follow-up time starting at the time of the third examination, serial measurement of GDF-15, modeled as changes between the measurements, did not improve prediction over that of the most recent measurement. Conclusions GDF-15 is a promising biomarker for prediction of HF and death due to CHD in the general population, which may provide prognostic information to already established clinical biomarkers. Repeated measurements of GDF-15 displayed only a slight improvement in the prediction of these endpoints compared to a single measurement.	[Fluschnik, Nina; Ojeda, Francisco; Zeller, Tanja; Becher, Peter Moritz; Sinning, Christoph; Blankenberg, Stefan; Westermann, Dirk] Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Fluschnik, Nina; Zeller, Tanja; Sinning, Christoph; Blankenberg, Stefan; Westermann, Dirk] DZHK Affiliat, Partner Site Hamburg Kiel Lubeck, Berlin, Germany; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Kuulasmaa, Kari] Natl Inst Hlth & Welf, Helsinki, Finland	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Copenhagen; University of Copenhagen; Aalborg University; Finland National Institute for Health & Welfare	Fluschnik, N (corresponding author), Univ Heart Ctr Hamburg Eppendorf, Dept Gen & Intervent Cardiol, Hamburg, Germany.; Fluschnik, N (corresponding author), DZHK Affiliat, Partner Site Hamburg Kiel Lubeck, Berlin, Germany.	n.fluschnik@uke.de	Jørgensen, Torben/Z-1335-2018; Westermann, Dirk/D-1344-2011	Jorgensen, Torben/0000-0001-9453-2830; Westermann, Dirk/0000-0002-7542-1956; Kuulasmaa, Kari/0000-0003-2165-1411; Zeller, Tanja/0000-0003-3379-2641; Blankenberg, Stefan/0000-0001-6488-2362; Ojeda, Francisco/0000-0003-4037-144X	European Commission Seventh Framework Programme FP7 [HEALTH-F2-2011-278913, HEALTH-F4-2007-2014113, HEALTH-F3-2010-242244]; German Center for Cardiovascular Research (DZHK)	European Commission Seventh Framework Programme FP7; German Center for Cardiovascular Research (DZHK)	This work was supported by the European Commission Seventh Framework Programme FP7/2007-2013 [HEALTH-F2-2011-278913, [BiomarCaRE], the MORGAM Project is additionally funded by European Commission Seventh Framework Programme FP7/2007-2013 [HEALTH-F4-2007-2014113, ENGAGE and HEALTH-F3-2010-242244, CHANCES]. This has supported central coordination, workshops and part of the activities of the MORGAM Data Centre, at THL in Helsinki, Finland. TZ has been supported by the German Center for Cardiovascular Research (DZHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand IS, 2010, CIRCULATION, V122, P1387, DOI 10.1161/CIRCULATIONAHA.109.928846; Asar O, 2015, INT J EPIDEMIOL, V44, P334, DOI 10.1093/ije/dyu262; Atlas Writing G, 2017, EUROPEAN HEART J, DOI [10.1093/eurheartyehx628, DOI 10.1093/EURHEARTYEHX628]; Blankenberg S, 2010, CIRCULATION, V121, P2388, DOI 10.1161/CIRCULATIONAHA.109.901413; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Brown DA, 2003, CLIN CANCER RES, V9, P2642; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Core Team R, 2011, R LANG ENV STAT COMP; Corre J, 2012, CANCER RES, V72, P1395, DOI 10.1158/0008-5472.CAN-11-0188; Daniels LB, 2011, CIRCULATION, V123, P2101, DOI 10.1161/CIRCULATIONAHA.110.979740; Eggers KM, 2016, CLIN CHEM, V62, P485, DOI 10.1373/clinchem.2015.246876; Frank D, 2008, HYPERTENSION, V51, P309, DOI 10.1161/HYPERTENSIONAHA.107.098046; HASTIE T, 2009, SPRINGER SERIES STAT; Hughes MF, 2017, CLIN CHEM, V63, P334, DOI 10.1373/clinchem.2016.261172; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2009, CIRC-CARDIOVASC GENE, V2, P286, DOI 10.1161/CIRCGENETICS.108.824870; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Laaksonen DE, 2005, EUR HEART J, V26, P1783, DOI 10.1093/eurheartj/ehi237; Osler M, 2011, INT J EPIDEMIOL, V40, P602, DOI 10.1093/ije/dyq041; Parikh NI, 2008, AM J CARDIOL, V102, P1194, DOI 10.1016/j.amjcard.2008.06.039; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rizopoulos D, 2012, CH CRC BIOSTAT SER, P1, DOI 10.1201/b12208; Rohatgi A, 2012, CLIN CHEM, V58, P172, DOI 10.1373/clinchem.2011.171926; Shlipak Michael G, 2005, Am J Med, V118, P1416; Shlipak MG, 2006, ANN INTERN MED, V145, P237, DOI 10.7326/0003-4819-145-4-200608150-00003; Svensson-Farbom P, 2014, J INTERN MED, V275, P506, DOI 10.1111/joim.12169; Tice JA, 2003, AM J MED, V114, P199, DOI 10.1016/S0002-9343(02)01497-3; Van Burren S., 2012, FLEXIBLE IMPUTATION; Vasan RS, 2003, CIRCULATION, V107, P1486, DOI 10.1161/01.CIR.0000057810.48709.F6; Wallentin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078797; Wang TJ, 2012, CIRCULATION, V126, P1596, DOI 10.1161/CIRCULATIONAHA.112.129437; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Zeller T, 2014, EUR J EPIDEMIOL, V29, P777, DOI 10.1007/s10654-014-9952-x; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	36	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197497	10.1371/journal.pone.0197497	http://dx.doi.org/10.1371/journal.pone.0197497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771963	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900068
J	Kalman, R; Stawarz, A; Nunes, D; Zhang, D; Dela Cruz, MA; Mohanty, A; Subramanian, H; Backman, V; Roy, HK				Kalman, Richard; Stawarz, Andrew; Nunes, David; Zhang, Di; Dela Cruz, Mart A.; Mohanty, Arpan; Subramanian, Hariharan; Backman, Vadim; Roy, Hemant K.			Biophotonic detection of high order chromatin alterations in field carcinogenesis predicts risk of future hepatocellular carcinoma: A pilot study	PLOS ONE			English	Article							CANCER STATISTICS; GENE-EXPRESSION	Purpose Hepatocellular carcinoma (HCC) results from chronic inflammation/cirrhosis. Unfortunately, despite use of radiological/serological screening techniques, HCC ranks as a leading cause of cancer deaths. Our group has used alterations in high order chromatin as a marker for field carcinogenesis and hence risk for a variety of cancers (including colon, lung, prostate, ovarian, esophageal). In this study we wanted to address whether these chromatin alterations occur in HCC and if it could be used for risk stratification. Experimental design A case control study was performed in patients with cirrhosis who went on to develop HCC and patients with cirrhosis who did not develop cancer. We performed partial wave spectroscopic microscopy (PWS) which measures nanoscale alterations on formalin fixed deparaffinized liver biopsy specimens, 17 progressors and 26 non-progressors. Follow up was 2089 and 2892 days, respectively. Results PWS parameter disorder strength L-d were notably higher for the progressors (L-d = 1.47 +/- 0.76) than the non-progressors (L-d = 1.00 +/- 0.27) (p = 0.024). Overall, the Cohen's d effect size was 0.907 (90.7%). AUROC analysis yielded an area of 0.70. There was no evidence of confounding by gender, age, BMI, smoking status and race. Conclusions High order chromatin alterations, as detected by PWS, is altered in pre-malignant hepatocytes with cirrhosis and may predict future risk of HCC.	[Kalman, Richard] Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA; [Stawarz, Andrew; Zhang, Di; Subramanian, Hariharan; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Nunes, David; Dela Cruz, Mart A.; Mohanty, Arpan; Roy, Hemant K.] Boston Univ, Med Ctr, Dept Med, Boston, MA USA	Northwestern University; Boston University	Kalman, R (corresponding author), Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA.	rskalman@gmail.com	Roy, Hemant/AAC-9096-2020	Mohanty, Arpan/0000-0002-8408-8075	National Institutes of Health [R01EB016983, R33CA225323, R01CA200064, R01CA165309, R42CA168055]; NATIONAL CANCER INSTITUTE [R33CA225323, R01CA200064, R01CA165309, R42CA168055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM105538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants # R01EB016983; R33CA225323; R01CA200064; R01CA165309; R42CA168055 to Hemant Roy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Almassalha LM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41061; Backman V, 2011, GASTROENTEROLOGY, V140, P35, DOI 10.1053/j.gastro.2010.11.023; BARER R, 1954, NATURE, V173, P821, DOI 10.1038/173821b0; Bauer GM, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0027; Chandler JE, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.117002; Cherkezyan L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.033903; DAVIES HG, 1954, Q J MICROSC SCI, V95, P271; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hoshida Y, 2013, GASTROENTEROLOGY, V144, P1024, DOI 10.1053/j.gastro.2013.01.021; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Koschmann C, 2017, CANCER RES, V77, P227, DOI 10.1158/0008-5472.CAN-16-2301; Lee K, 2016, NUCLEUS-PHILA, V7, P352, DOI 10.1080/19491034.2016.1200770; Lochhead P, 2015, MODERN PATHOL, V28, P14, DOI 10.1038/modpathol.2014.81; Marazzi I, 2018, NAT REV MOL CELL BIO, V19, P245, DOI 10.1038/nrm.2017.113; Roy HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115999; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Subramanian H, 2009, CANCER RES, V69, P5357, DOI 10.1158/0008-5472.CAN-08-3895; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262	22	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197427	10.1371/journal.pone.0197427	http://dx.doi.org/10.1371/journal.pone.0197427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771950	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900058
J	Latif, H; Federowicz, S; Ebrahim, A; Tarasova, J; Szubin, R; Utrilla, J; Zengler, K; Palsson, BO				Latif, Haythem; Federowicz, Stephen; Ebrahim, Ali; Tarasova, Janna; Szubin, Richard; Utrilla, Jose; Zengler, Karsten; Palsson, Bernhard O.			ChIP-exo interrogation of Crp, DNA, and RNAP holoenzyme interactions	PLOS ONE			English	Article							AMP RECEPTOR PROTEIN; GENE ACTIVATOR PROTEIN; OPEN COMPLEX-FORMATION; ESCHERICHIA-COLI; TRANSCRIPTION ACTIVATION; BINDING-SITES; CAMP-CRP; DEPENDENT PROMOTERS; SINGLE-MOLECULE; ALPHA-SUBUNIT	Numerous in vitro studies have yielded a refined picture of the structural and molecular associations between Cyclic-AMP receptor protein (Crp), the DNA motif, and RNA polymerase (RNAP) holoenzyme. In this study, high-resolution ChIP-exonuclease (ChIP-exo) was applied to study Crp binding in vivo and at genome-scale. Surprisingly, Crp was found to provide little to no protection of the DNA motif under activating conditions. Instead, Crp demonstrated binding patterns that closely resembled those generated by 070. The binding patterns of both Crp and 070 are indicative of RNAP holoenzyme DNA footprinting profiles associated with stages during transcription initiation that occur post-recruitment. This is marked by a pronounced advancement of the template strand footprint profile to the +20 position relative to the transcription start site and a multimodal distribution on the nontemplate strand. This trend was also observed in the familial transcription factor, Fnr, but full protection of the motif was seen in the repressor ArcA. Given the time-scale of ChIP studies and that the rate-limiting step in transcription initiation is typically post recruitment, we propose a hypothesis where Crp is absent from the DNA motif but remains associated with RNAP holoenzyme post-recruitment during transcription initiation. The release of Crp from the DNA motif may be a result of energetic changes that occur as RNAP holoenzyme traverses the various stable intermediates towards elongation complex formation.	[Latif, Haythem; Federowicz, Stephen; Ebrahim, Ali; Tarasova, Janna; Szubin, Richard; Utrilla, Jose; Zengler, Karsten; Palsson, Bernhard O.] Univ Calif San Diego, Bioengn Dept, La Jolla, CA 92093 USA; [Zengler, Karsten; Palsson, Bernhard O.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Lyngby, Denmark	University of California System; University of California San Diego; Technical University of Denmark	Latif, H (corresponding author), Univ Calif San Diego, Bioengn Dept, La Jolla, CA 92093 USA.	halatif@ucsd.edu	Utrilla, Jose/A-3610-2013	Utrilla, Jose/0000-0003-3048-9241; Palsson, Bernhard/0000-0003-2357-6785	Novo Nordisk Foundation Center for Biosustainability [NNF16CC0021858]; NIH [GM057089, GM102098]; National Science Foundation Graduate Research Fellowship [DGE1144086]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Network Reconstruction, Genome Scale CHO in Silico Models] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM102098, R01GM057089] Funding Source: NIH RePORTER	Novo Nordisk Foundation Center for Biosustainability; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Novo Nordisk Foundation Center for Biosustainability Grant number NNF16CC0021858 and NIH Grants GM057089 and GM102098 provided financial support for this work to B.O.P. H.L. was supported through the National Science Foundation Graduate Research Fellowship under grant DGE1144086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Novo Nordisk Foundation Center for Biosustainability Grant number NNF16CC0021858 and NIH Grants GM057089 and GM102098 provided financial support for this work. H.L. was supported through the National Science Foundation Graduate Research Fellowship under grant DGE1144086.	ATTEY A, 1994, NUCLEIC ACIDS RES, V22, P4375, DOI 10.1093/nar/22.21.4375; Bai L, 2006, ANNU REV BIOPH BIOM, V35, P343, DOI 10.1146/annurev.biophys.35.010406.150153; Belyaeva TA, 1998, J MOL BIOL, V277, P789, DOI 10.1006/jmbi.1998.1666; Belyaeva TA, 1996, NUCLEIC ACIDS RES, V24, P2243, DOI 10.1093/nar/24.12.2243; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; BERG OG, 1988, J MOL BIOL, V200, P709, DOI 10.1016/0022-2836(88)90482-2; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Cho BK, 2006, BIOTECHNIQUES, V40, P67, DOI 10.2144/000112039; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Cho BK, 2008, P NATL ACAD SCI USA, V105, P19462, DOI 10.1073/pnas.0807227105; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; DECROMBRUGGHE B, 1984, SCIENCE, V224, P831, DOI 10.1126/science.6372090; EBRIGHT RH, 1984, P NATL ACAD SCI-BIOL, V81, P7274, DOI 10.1073/pnas.81.23.7274; Federowicz S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004264; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Germer J, 2001, MOL MICROBIOL, V41, P705, DOI 10.1046/j.1365-2958.2001.02548.x; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Hook-Barnard IG, 2007, GENE REGUL SYST BIO, V1, P275; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; KOLB A, 1993, NUCLEIC ACIDS RES, V21, P319, DOI 10.1093/nar/21.2.319; KOVACIC RT, 1987, J BIOL CHEM, V262, P13654; Kristensen HH, 1997, J MOL BIOL, V266, P866, DOI 10.1006/jmbi.1996.0852; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Lonetto MA, 1998, J MOL BIOL, V284, P1353, DOI 10.1006/jmbi.1998.2268; Mooney RA, 2005, MOL CELL, V20, P335, DOI 10.1016/j.molcel.2005.10.015; MYMRYK JS, 1994, NUCLEIC ACIDS RES, V22, P4344, DOI 10.1093/nar/22.20.4344; NIU W, 1994, J MOL BIOL, V243, P595, DOI 10.1016/0022-2836(94)90034-5; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Parkinson G, 1996, NAT STRUCT BIOL, V3, P837, DOI 10.1038/nsb1096-837; PEDERSEN H, 1995, MOL MICROBIOL, V17, P843, DOI 10.1111/j.1365-2958.1995.mmi_17050843.x; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rhodius VA, 2000, J MOL BIOL, V299, P311, DOI 10.1006/jmbi.2000.3737; Rhodius VA, 1997, NUCLEIC ACIDS RES, V25, P326, DOI 10.1093/nar/25.2.326; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; SCHICKOR P, 1990, EMBO J, V9, P2215, DOI 10.1002/j.1460-2075.1990.tb07391.x; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Sclavi B, 2005, P NATL ACAD SCI USA, V102, P4706, DOI 10.1073/pnas.0408218102; Seo SW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5910; Serandour AA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r147; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; TAGAMI H, 1995, NUCLEIC ACIDS RES, V23, P599, DOI 10.1093/nar/23.4.599; Tagami H, 1998, EMBO J, V17, P1759, DOI 10.1093/emboj/17.6.1759; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; VALENTINHANSEN P, 1982, EMBO J, V1, P1049, DOI 10.1002/j.1460-2075.1982.tb01295.x; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wade JT, 2004, P NATL ACAD SCI USA, V101, P17777, DOI 10.1073/pnas.0404305101; WEST D, 1993, MOL MICROBIOL, V10, P789, DOI 10.1111/j.1365-2958.1993.tb00949.x; Williams RM, 1996, NUCLEIC ACIDS RES, V24, P1112, DOI 10.1093/nar/24.6.1112; ZHOU YH, 1994, J MOL BIOL, V243, P603, DOI 10.1016/0022-2836(94)90035-3; ZHOU YH, 1993, P NATL ACAD SCI USA, V90, P6081, DOI 10.1073/pnas.90.13.6081; ZHOU YH, 1993, CELL, V73, P375, DOI 10.1016/0092-8674(93)90236-J	64	8	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197272	10.1371/journal.pone.0197272	http://dx.doi.org/10.1371/journal.pone.0197272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771928	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900042
J	Swacha, G; Botta-Dukat, Z; Kacki, Z; Pruchniewicz, D; Zolnierz, L				Swacha, Grzegorz; Botta-Dukat, Zoltan; Kacki, Zygmunt; Pruchniewicz, Daniel; Zolnierz, Ludwik			The effect of abandonment on vegetation composition and soil properties in Molinion meadows (SW Poland)	PLOS ONE			English	Article							SUB-ALPINE GRASSLANDS; BIOMASS CHEMICAL-PROPERTIES; PLANT-SPECIES RICHNESS; LAND-USE CHANGE; SOLIDAGO-GIGANTEA; ORGANIC-MATTER; ENVIRONMENTAL HETEROGENEITY; SEMINATURAL GRASSLAND; LITTER DECOMPOSITION; POLYGONO-TRISETION	Intermittently wet meadows of the Molinion alliance, as with many other grasslands of high nature value, have become increasingly exposed to abandonment due to their low economic value. The potential consequences of land abandonment are the decrease in species diversity and environmental alterations. The issue of land-use induced changes in plant species composition and soil physico-chemical parameters have been rarely studied in species-rich intermittently wet grasslands. In this study we attempt to i) to identify determinants of plant species composition patterns and ii) to investigate the effect of cessation of mowing on vegetation composition and soil properties. The study was conducted in an area of 36 ha covered with Molinion meadows, comprising of mown sites and sites that were left unmown for 10 years. In total, 120 and 80 vegetation plots were sampled from mown and unmown sites, respectively. In these plots we measured plant community composition and soil physicochemical parameters. The results have shown that the two groups of variables (soil properties and management) differ considerably in their ability to explain variation in plant species data. Soil variables explained four-fold more variation in plant species composition than management did. The content of soil organic matter, moisture, total nitrogen and exchangeable forms of potassium, calcium and magnesium were significantly higher in mown than in unmown grassland systems. The results revealed that soil organic matter was the component of the soil most strongly affected by management, followed by moisture, magnesium, calcium and potassium in that order. Each of these soil parameters was negatively correlated with the abundances of woody plants and invasive species. We concluded that low intensity, late time of mowing is suitable grassland management practice to ensure high plant species diversity and sustainability of the grassland ecological system while cessation of mowing not only lead to reduced plant species richness and diversity, but also to reduced nutrient levels in grassland soils.	[Swacha, Grzegorz; Kacki, Zygmunt] Univ Wroclaw, Bot Garden, Wroclaw, Poland; [Botta-Dukat, Zoltan] MTA Ctr Ecol Res, Inst Ecol & Bot, Vacratot, Hungary; [Pruchniewicz, Daniel; Zolnierz, Ludwik] Wroclaw Univ Environm & Life Sci, Dept Bot & Plant Ecol, Wroclaw, Poland	University of Wroclaw; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Wroclaw University of Environmental & Life Sciences	Swacha, G (corresponding author), Univ Wroclaw, Bot Garden, Wroclaw, Poland.	grzegorz.swacha@uwr.edu.pl	Pruchniewicz, Daniel/S-8541-2016; Swacha, Grzegorz/AAH-5469-2020; Botta-Dukat, Zoltan/B-2911-2015; Zolnierz, Ludwik/A-6793-2017	Pruchniewicz, Daniel/0000-0002-9841-0192; Swacha, Grzegorz/0000-0002-6380-2954; Botta-Dukat, Zoltan/0000-0002-9544-3474; Kacki, Zygmunt/0000-0002-2241-1631; Zolnierz, Ludwik/0000-0001-5457-0568				Allen SE, 1989, CHEM ANAL ECOLOGICAL; Austrheim G, 1999, BIOL CONSERV, V87, P369, DOI 10.1016/S0006-3207(98)00071-8; Bakker J.P., 1989, NATURE MANAGEMENT GR; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; Blackstock TH, 1999, GRASS FORAGE SCI, V54, P1, DOI 10.1046/j.1365-2494.1999.00157.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Chapuis-Lardy L, 2006, BIOL FERT SOILS, V42, P481, DOI 10.1007/s00374-005-0039-4; Chmolowska D, 2016, PLANT SOIL, V402, P317, DOI 10.1007/s11104-015-2788-7; Cong WF, 2014, J ECOL, V102, P1163, DOI 10.1111/1365-2745.12280; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Dassonville N, 2008, OECOLOGIA, V157, P131, DOI 10.1007/s00442-008-1054-6; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P3; FALINSKA K, 1989, ACTA SOC BOT POL, V58, P439; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Freschet GT, 2013, J ECOL, V101, P943, DOI 10.1111/1365-2745.12092; Fuchs R, 2013, BIOGEOSCIENCES, V10, P1543, DOI 10.5194/bg-10-1543-2013; Gamper SM, 2007, PLANT SOIL, V299, P101, DOI 10.1007/s11104-007-9366-6; Gaujour E, 2012, AGRON SUSTAIN DEV, V32, P133, DOI 10.1007/s13593-011-0015-3; Goslee SC, 2006, PLANT ECOL, V187, P203, DOI 10.1007/s11258-005-3495-x; Gross N, 2008, NEW PHYTOL, V180, P652, DOI 10.1111/j.1469-8137.2008.02577.x; Guidi C, 2014, FOREST ECOL MANAG, V328, P103, DOI 10.1016/j.foreco.2014.05.025; Hansson M, 2000, J VEG SCI, V11, P31, DOI 10.2307/3236772; Hejcman M, 2010, FLORA, V205, P577, DOI 10.1016/j.flora.2010.04.019; Hiltbrunner D, 2013, BIOGEOCHEMISTRY, V115, P251, DOI 10.1007/s10533-013-9832-6; HUDSON BD, 1994, J SOIL WATER CONSERV, V49, P189; Ilmarinen K, 2009, RESTOR ECOL, V17, P78, DOI 10.1111/j.1526-100X.2007.00341.x; Ilmarinen K, 2009, ACTA OECOL, V35, P838, DOI 10.1016/j.actao.2009.08.008; Isselstein J., 2005, Agronomy Research, V3, P139; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Kacki Z, 2010, POL J ENVIRON STUD, V19, P351; Klimek S, 2007, BIOL CONSERV, V134, P559, DOI 10.1016/j.biocon.2006.09.007; Kohler B, 2001, PLANT SOIL, V230, P323, DOI 10.1023/A:1010335825818; Korosi A, 2014, AGR ECOSYST ENVIRON, V196, P24, DOI 10.1016/j.agee.2014.06.019; Kotas P, 2017, ECOSYSTEMS, V20, P354, DOI 10.1007/s10021-016-0031-x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Leps J, 2014, J APPL ECOL, V51, P978, DOI 10.1111/1365-2664.12255; Li JY, 2017, BIOGEOSCIENCES, V14, P2685, DOI 10.5194/bg-14-2685-2017; Lundholm JT, 2009, J VEG SCI, V20, P377, DOI 10.1111/j.1654-1103.2009.05577.x; Mahaming AR, 2009, APPL SOIL ECOL, V41, P137, DOI 10.1016/j.apsoil.2008.11.003; Marriott CA, 2010, AGR ECOSYST ENVIRON, V139, P476, DOI 10.1016/j.agee.2010.09.005; Mladkova P, 2015, J APPL ECOL, V52, P1073, DOI 10.1111/1365-2664.12464; Myklestad A, 2004, GRASS FORAGE SCI, V59, P136, DOI 10.1111/j.1365-2494.2004.00413.x; Nosetto MD, 2005, GLOBAL CHANGE BIOL, V11, P1101, DOI 10.1111/j.1365-2486.2005.00975.x; Oelmann Y, 2009, BIOL CONSERV, V142, P2941, DOI 10.1016/j.biocon.2009.07.021; PALMER MW, 1994, FOLIA GEOBOT PHYTOTX, V29, P511, DOI 10.1007/BF02883148; Pavlu L, 2016, AGR ECOSYST ENVIRON, V217, P13, DOI 10.1016/j.agee.2015.10.026; Pavlu L, 2013, FLORA, V208, P599, DOI 10.1016/j.flora.2013.09.003; Pavlu L, 2011, FLORA, V206, P1020, DOI 10.1016/j.flora.2011.07.008; Pawlak W., 2008, ATLAS LOWER OPOLE SI; Peco B, 2017, AGR ECOSYST ENVIRON, V249, P215, DOI 10.1016/j.agee.2017.08.013; Pinke G, 2012, APPL VEG SCI, V15, P136, DOI 10.1111/j.1654-109X.2011.01158.x; Pruchniewicz D, 2014, FLORA, V209, P687, DOI 10.1016/j.flora.2014.09.001; Pysek P, 2002, BIOL CONSERV, V104, P13, DOI 10.1016/S0006-3207(01)00150-1; Quested H, 2007, FUNCT ECOL, V21, P1016, DOI 10.1111/j.1365-2435.2007.01324.x; Radojevie M, 2006, PRACTICAL ENV ANAL; Ribeiro S, 2014, BIODIVERS CONSERV, V23, P2903, DOI 10.1007/s10531-014-0754-y; Richard M, 2000, ECOGRAPHY, V23, P231, DOI 10.1111/j.1600-0587.2000.tb00279.x; Rosenthal G, 2010, FLORA, V205, P153, DOI 10.1016/j.flora.2009.02.003; Rudmann-Maurer K, 2008, BASIC APPL ECOL, V9, P494, DOI 10.1016/j.baae.2007.08.005; Rumpel C, 2015, J SOIL SCI PLANT NUT, V15, P353; Schaffers AP, 2000, J VEG SCI, V11, P225, DOI 10.2307/3236802; Scharfy D, 2009, J VEG SCI, V20, P1072, DOI 10.1111/j.1654-1103.2009.01105.x; Sorensen LI, 2008, SOIL BIOL BIOCHEM, V40, P2891, DOI 10.1016/j.soilbio.2008.08.009; Stefanowicz AM, 2017, SCI TOTAL ENVIRON, V574, P938, DOI 10.1016/j.scitotenv.2016.09.120; Swacha G, 2017, ACTA SOC BOT POL, V86, DOI 10.5586/asbp.3561; Szymura M, 2013, ACTA SOC BOT POL, V82, P107, DOI 10.5586/asbp.2013.005; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Uhlirova E, 2005, APPL SOIL ECOL, V28, P225, DOI 10.1016/j.apsoil.2004.08.002; Vandvik V, 2002, PLANT ECOL, V162, P233, DOI 10.1023/A:1020322205469; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Weber E, 2005, FLORA, V200, P109, DOI 10.1016/j.flora.2004.09.001; Wellstein C, 2007, AGR ECOSYST ENVIRON, V122, P203, DOI 10.1016/j.agee.2006.12.033; WESTHOFF V., 1978, CLASSIFICATION PLANT, P289; Zelnik I, 2008, BIOLOGIA, V63, P187, DOI 10.2478/s11756-008-0042-y; Ziter C, 2013, ECOLOGY, V94, P106, DOI 10.1890/11-2070.1	78	23	23	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197363	10.1371/journal.pone.0197363	http://dx.doi.org/10.1371/journal.pone.0197363			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29772019	Green Published, gold, Green Submitted			2022-12-26	WOS:000432348900053
J	Leeuwis, T; Peel, M; de Boer, WF				Leeuwis, Tim; Peel, Mike; de Boer, Willem F.			Complexity in African savannas: Direct, indirect, and cascading effects of animal densities, rainfall and vegetation availability	PLOS ONE			English	Article							ELEPHANT POPULATION; SOUTH-AFRICA; COMPETITION; HERBIVORES; SEASON; FACILITATION; ASSEMBLAGES; ECOSYSTEMS; STABILITY; WOODLAND	Savanna ecosystems are popular subjects for interaction studies. Multiple studies have been done on the impact of elephants on vegetation, the impact of grass and browse availability on animal densities or on competition between herbivore species. Previous studies showed that elephant densities are frequently negatively correlated with densities of tall trees, and that browse and grass availability are correlated with browser and grazer density respectively. Additionally, a competition effect between browse and grass availability has been reported. These relationships are usually analysed by testing direct relationships between e.g., herbivore densities and food availability, without addressing competition effects or other indirect effects. In this study, multiple interactions in a savanna system have been analysed simultaneously using Partial Least Square-Path Modelling (PLS-PM) using mammal and vegetation data from three different wildlife reserves in southern KwaZulu-Natal. The results showed that the processes that three separate models for the three areas provided the best understanding of the importance of the different interactions. These models suggest that elephants had a negative impact on trees, but also on grass availability. The impact is stronger when elephants are not able to migrate during the dry season. Browsers and grazers were correlated with browse and grass availability, but competition between browse and grass was not detected. This study shows that due to the complexity of the interactions in an ecosystem and differences in environmental factors, these interactions are best studied per area. PLS-PM can be a useful tool for estimating direct, indirect, and cascading effects of changing animal densities in conservation areas.	[Leeuwis, Tim; de Boer, Willem F.] Wageningen Univ, Resource Ecol Grp, Droevendaalsesteeg 3a, Wageningen, Netherlands; [Peel, Mike] Agr Res Council, Anim Prod Inst, Nelspruit, South Africa	Wageningen University & Research; Agricultural Research Council of South Africa	de Boer, WF (corresponding author), Wageningen Univ, Resource Ecol Grp, Droevendaalsesteeg 3a, Wageningen, Netherlands.	fred.deboer@wur.nl		de Boer, Willem Frederik/0000-0003-3208-8521; Peel, Mike/0000-0003-1284-3665	Royal Dutch Zoological Society	Royal Dutch Zoological Society	Funding was obtained from the Royal Dutch Zoological Society for TL.	[Anonymous], 2013, R PACKAGE NOTES; Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; Bodini A, 2016, ECOL COMPLEX, V28, P36, DOI 10.1016/j.ecocom.2016.10.001; Codron D, 2007, J ZOOL, V273, P21, DOI 10.1111/j.1469-7998.2007.00292.x; D'Onofrio D, 2015, WATER RESOUR RES, V51, P169, DOI 10.1002/2014WR015515; de Boer WF, 2015, EUR J WILDLIFE RES, V61, P491, DOI 10.1007/s10344-015-0919-3; Fritz H, 2002, OECOLOGIA, V131, P620, DOI 10.1007/s00442-002-0919-3; Govender N, 2006, J APPL ECOL, V43, P748, DOI 10.1111/j.1365-2664.2006.01184.x; Guldemond R, 2010, AFR J ECOL, V48, P180, DOI 10.1111/j.1365-2028.2009.01100.x; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; Jaremo J, 1996, OIKOS, V77, P238, DOI 10.2307/3546062; Kalwij JM, 2010, ECOL APPL, V20, P222, DOI 10.1890/09-0541.1; Kohi EM, 2011, BIOTROPICA, V43, P711, DOI 10.1111/j.1744-7429.2010.00724.x; Kohi EM, 2013, THESIS; Kos M, 2012, EUR J WILDLIFE RES, V58, P279, DOI 10.1007/s10344-011-0575-1; Makhabu SW, 2006, ACTA OECOL, V30, P136, DOI 10.1016/j.actao.2006.02.005; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Rutina LP, 2005, WILDLIFE BIOL, V11, P207, DOI 10.2981/0909-6396(2005)11[207:ELADWC]2.0.CO;2; SINCLAIR ARE, 1982, OECOLOGIA, V53, P364, DOI 10.1007/BF00389015; Skarpe C, 2004, AMBIO, V33, P276, DOI 10.1639/0044-7447(2004)033[0276:TROTGE]2.0.CO;2; Tambling CJ, 2013, BASIC APPL ECOL, V14, P694, DOI 10.1016/j.baae.2013.09.010; Tedder M, 2012, GRASSL SCI, V58, P238, DOI 10.1111/grs.12003; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Treydte AC, 2008, J VEG SCI, V19, P663, DOI 10.3170/2008-8-18435; Valeix M, 2008, ANIM CONSERV, V11, P391, DOI 10.1111/j.1469-1795.2008.00194.x; Valeix M, 2011, BIOL CONSERV, V144, P902, DOI 10.1016/j.biocon.2010.10.029; van Langevelde F, 2003, ECOLOGY, V84, P337, DOI 10.1890/0012-9658(2003)084[0337:EOFAHO]2.0.CO;2	29	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197149	10.1371/journal.pone.0197149	http://dx.doi.org/10.1371/journal.pone.0197149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768481	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200060
J	von Dewitz, B; Tamm, S; Hoflich, K; Voss, R; Hinrichsen, HH				von Dewitz, Burkhard; Tamm, Susanne; Hoeflich, Katharina; Voss, Ruediger; Hinrichsen, Hans-Harald			Use of existing hydrographic infrastructure to forecast the environmental spawning conditions for Eastern Baltic cod	PLOS ONE			English	Article							SPRAT SPRATTUS-SPRATTUS; GADUS-MORHUA; CLIMATE VARIABILITY; TIME-SERIES; SEA; RECRUITMENT; OXYGEN; HETEROGENEITY; MODELS; SYSTEM	The semi-enclosed nature and estuarine characteristics, together with its strongly alternating bathymetry, make the Baltic Sea prone to much stronger interannual variations in the abiotic environment, than other spawning habitats of Atlantic cod (Gadus morhua). Processes determining salinity and oxygen conditions in the basins are influenced both by long term gradual climate change, e.g. global warming, but also by short-term meteorological variations and events. Specifically one main factor influencing cod spawning conditions, the advection of highly saline and well-oxygenated water masses from the North Sea, is observed in irregular frequencies and causes strong interannual variations in stock productivity. This study investigates the possibility to use the available hydrographic process knowledge to predict the annual spawning conditions for Eastern Baltic cod in its most important spawning ground, the Bornholm Basin, only by salinity measurements from a specific location in the western Baltic. Such a prediction could serve as an environmental early warning indicator to inform stock assessment and management. Here we used a hydrodynamic model to hindcast hydrographic property fields for the last 40+ years. High and significant correlations were found for months early in the year between the 33m salinity level in the Arkona Basin and the oxygen-dependent cod spawning environment in the Bornholm Basin. Direct prediction of the Eastern Baltic cod egg survival in the Bornholm Basin based on salinity values in the Arkona Basin at the 33 m depth level is shown to be possible for eggs spawned by mid-age and young females, which currently predominate the stock structure. We recommend to routinely perform short-term predictions of the Eastern Baltic cod spawning environment, in order to generate environmental information highly relevant for stock dynamics. Our statistical approach offers the opportunity to make best use of permanently existing infrastructure in the western Baltic to timely provide scientific knowledge on the spawning conditions of Eastern Baltic cod. Furthermore it could be a tool to assist eco-system-based fisheries management with a cost-effective implementation by including the short term predictions as a simple indicator in the annual assessments.	[von Dewitz, Burkhard; Hoeflich, Katharina; Hinrichsen, Hans-Harald] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Tamm, Susanne] Fed Maritime & Hydrog Agcy, Hamburg, Germany; [Voss, Ruediger] Univ Kiel, Dept Econ, Sustainable Fishery, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	von Dewitz, B (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	bdewitz@geomar.de	Voss, Rudi/A-6113-2011	Hoflich, Katharina/0000-0001-7719-5596; Voss, Rudi/0000-0002-4299-8791	BONUS (INSPIRE project); BONUS (BIO-C3 project); joint Baltic Sea research and development programme [Art 185]; European Union's Seventh Programme for research, technological development and demonstration (Forschungszentrum Julich Beteiligungsgesellschaft mbH (Germany)) [03F0682A]; BMBF [03F0682A]; Granholms stiftelse; Baltic Eye at Stockholm University Baltic Sea Centre	BONUS (INSPIRE project); BONUS (BIO-C3 project); joint Baltic Sea research and development programme; European Union's Seventh Programme for research, technological development and demonstration (Forschungszentrum Julich Beteiligungsgesellschaft mbH (Germany)); BMBF(Federal Ministry of Education & Research (BMBF)); Granholms stiftelse; Baltic Eye at Stockholm University Baltic Sea Centre	The research leading to these results has received funding from BONUS (INSPIRE and BIO-C3 projects), the joint Baltic Sea research and development programme (Art 185), funded jointly from the European Union's Seventh Programme for research, technological development and demonstration (Forschungszentrum Julich Beteiligungsgesellschaft mbH (Germany) and BMBF (Grant No. 03F0682A). We also like to thank the DEMO project-"DEMOnstration exercise for Integrated Ecosystem Assessment and Advice of Baltic Sea fish stocks" financed by Granholms stiftelse and Baltic Eye at Stockholm University Baltic Sea Centre for support. None of the named funding sources were involved in study design; in collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Amante C., 2009, ETOPO1 1 ARC MINUTE; [Anonymous], 2009, INT COUNC EXPL SEA; Bagge Ole, 1994, Dana, V10, P1; Baranova T., 2011, ICES CM, V10, P22; Baumann H, 2006, CAN J FISH AQUAT SCI, V63, P2191, DOI 10.1139/F06-112; Blenckner T, 2015, P ROY SOC LOND B BIO, V282, P1803; Cardinale M, 2003, AQUAT LIVING RESOUR, V16, P283, DOI 10.1016/S0990-7440(03)00007-X; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; DURBIN J, 1971, BIOMETRIKA, V58, P1; Dutil JD, 2003, FISH OCEANOGR, V12, P502, DOI 10.1046/j.1365-2419.2003.00243.x; Eero M, 2007, ICES J MAR SCI, V64, P1257, DOI 10.1093/icesjms/fsm114; Elken J, 2015, REG CLIM STUD, P131, DOI 10.1007/978-3-319-16006-1_7; EU, 2010, OFFICIAL J EUROPEA L, V232, P14; Fennel W, 2001, AMBIO, V30, P232, DOI 10.1639/0044-7447(2001)030[0232:CBAOIM]2.0.CO;2; Franck H., 1987, Gerlands Beitraege zur Geophysik, V96, P517; Gustafsson EO, 2009, BOREAL ENVIRON RES, V14, P18; Hinrichsen HH, 2007, MAR ECOL PROG SER, V345, P245, DOI 10.3354/meps06989; Hinrichsen HH, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150338; Hinrichsen H-H, 2016, WORKSH DEVELPING INT; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; ICES, 2016, ICES ADV FISH OPP CA; Jonasson L, 2012, OCEAN SCI, V8, P37, DOI 10.5194/os-8-37-2012; Karpushevskaia A., 2016, REPORT BALTIC FISHER; Koster FW, 2017, ICES J MAR SCI, V74, P3, DOI 10.1093/icesjms/fsw172; Koster F, 2001, CAN J FISH AQUAT SCI, V58, P1534, DOI 10.1139/cjfas-58-8-1534; Koster FW, 2005, ICES J MAR SCI, V62, P1408, DOI 10.1016/j.icesjms.2005.05.004; KRAUSS W, 1991, J PHYS OCEANOGR, V21, P373, DOI 10.1175/1520-0485(1991)021<0373:WPWEBT>2.0.CO;2; Lehmann A, 2000, J MARINE SYST, V25, P333, DOI 10.1016/S0924-7963(00)00026-9; Lehmann A, 2002, TELLUS A, V54, P299, DOI 10.1034/j.1600-0870.2002.00289.x; Lehmann A, 2014, J MARINE SYST, V134, P20, DOI 10.1016/j.jmarsys.2014.02.012; Lepparanta M, 2009, SPRINGER-PRAX BOOKS, pXI; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; MacKenzie BR, 2000, MAR ECOL PROG SER, V193, P143, DOI 10.3354/meps193143; Mollmann C, 2011, MAR ECOL PROG SER, V431, P293, DOI 10.3354/meps09205; Mohrholz V, 2015, J MARINE SYST, V148, P152, DOI 10.1016/j.jmarsys.2015.03.005; Mollmann C, 2003, FISH OCEANOGR, V12, P360, DOI 10.1046/j.1365-2419.2003.00257.x; Novotny K., 2006, MAR GEOD, V29, P113, DOI DOI 10.1080/01490410600738054; Plikshs M, 2015, ACTA ICHTHYOL PISCAT, V45, P247, DOI 10.3750/AIP2015.45.3.04; Schinke H, 1998, CONT SHELF RES, V18, P67, DOI 10.1016/S0278-4343(97)00071-X; Stigebrandt A., 1987, Tellus, Series A (Dynamic Meteorology and Oceanography), V39A, P170, DOI 10.1111/j.1600-0870.1987.tb00298.x; Team BA, 2008, ASSESSMENT CLIMATE C; Vallin L, 2000, FISH RES, V49, P21, DOI 10.1016/S0165-7836(00)00194-6; Voss R, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00209; Voss R, 2014, MAR ECOL PROG SER, V498, P1, DOI 10.3354/meps10639; Voss R, 2012, PROG OCEANOGR, V107, P61, DOI 10.1016/j.pocean.2012.05.003; Wan Z, 2012, OCEAN SCI, V8, P683, DOI 10.5194/os-8-683-2012; Wasmund N, 2001, ESTUAR COAST SHELF S, V53, P849, DOI 10.1006/ecss.2001.0828; Wieland K, 2000, ICES J MAR SCI, V57, P452, DOI 10.1006/jmsc.1999.0522	48	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196477	10.1371/journal.pone.0196477	http://dx.doi.org/10.1371/journal.pone.0196477			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768443	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000432329200030
J	Imai, N; Furukawa, T; Tsujino, R; Kitamura, S; Yumoto, T				Imai, Nobuo; Furukawa, Takuya; Tsujino, Riyou; Kitamura, Shumpei; Yumoto, Takakazu			Factors affecting forest area change in Southeast Asia during 1980-2010	PLOS ONE			English	Article							ENVIRONMENTAL KUZNETS CURVE; AGRICULTURAL INTENSIFICATION; EMPIRICAL-ANALYSIS; POPULATION-GROWTH; WOOD PRODUCTION; LATIN-AMERICA; DEFORESTATION; TRANSITION; TRADE; DEMOCRACY	While many tropical countries are experiencing rapid deforestation, some have experienced forest transition (FT) from net deforestation to net reforestation. Numerous studies have identified causative factors of FT, among which forest scarcity has been considered as a prerequisite for FT. In fact, in SE Asia, the Philippines, Thailand and Viet Nam, which experienced FT since 1990, exhibited a lower remaining forest area (30 +/- 8%) than the other five countries (68 +/- 6%, Cambodia, Indonesia, Laos, Malaysia, and Myanmar) where forest loss continues. In this study, we examined 1) the factors associated with forest scarcity, 2) the proximate and/or underlying factors that have driven forest area change, and 3) whether causative factors changed across FT phases (from deforestation to net forest gain) during 1980-2010 in the eight SE Asian countries. We used production of wood, food, and export-oriented food commodities as proximate causes and demographic, social, economic and environmental factors, as well as land-use efficiency, and wood and food trade as underlying causes that affect forest area change. Remaining forest area in 1990 was negatively correlated with population density and potential land area of lowland forests, while positively correlated with per capita wood production. This implies that countries rich in accessible and productive forests, and higher population pressures are the ones that have experienced forest scarcity, and eventually FT. Food production and agricultural input were negatively and positively correlated, respectively, with forest area change during 1980-2009. This indicates that more food production drives deforestation, but higher efficiency of agriculture is correlated with forest gain. We also found a U-shaped response of forest area change to social openness, suggesting that forest gain can be achieved in both open and closed countries, but deforestation might be accelerated in countries undergoing societal transition. These results indicate the importance of environmental, agricultural and social variables on forest area dynamics, and have important implications for predicting future tropical forest change.	[Imai, Nobuo] Tokyo Univ Agr, Dept Forest Sci, Setagaya Ku, Tokyo, Japan; [Furukawa, Takuya] Forestry & Forest Prod Res Inst, Ctr Biodivers, Tsukuba, Ibaraki, Japan; [Tsujino, Riyou] Nara Univ Educ, Ctr Nat Environm Educ, Takabatake Cho, Nara, Japan; [Kitamura, Shumpei] Ishikawa Prefectural Univ, Dept Environm Sci, Nonoichi, Ishikawa, Japan; [Yumoto, Takakazu] Kyoto Univ, Primate Res Inst, Inuyama, Aichi, Japan	Tokyo University of Agriculture; Forestry & Forest Products Research Institute - Japan; Nara University Education; Ishikawa Prefecture University; Kyoto University	Imai, N (corresponding author), Tokyo Univ Agr, Dept Forest Sci, Setagaya Ku, Tokyo, Japan.	i96nobuo@gmail.com	Yumoto, Takakazu/B-6215-2013; Imai, Nobuo/AAR-7008-2020; Tsujino, Riyou/AAY-9301-2020; Furukawa, Takuya/AAK-8941-2020; KITAMURA, Shumpei/I-9923-2019	Imai, Nobuo/0000-0002-8435-7693; Furukawa, Takuya/0000-0003-2006-6560; KITAMURA, Shumpei/0000-0001-6253-2545	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [S9-1]; "International Program of Collaborative Research" - Center for Southeast Asian Studies (CSEAS), Kyoto University; Forestry Agency of Japan	Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); "International Program of Collaborative Research" - Center for Southeast Asian Studies (CSEAS), Kyoto University; Forestry Agency of Japan	This study was financially supported by the Environment Research and Technology Development Fund (S9-1) of the Ministry of the Environment, Japan, and the International Program of Collaborative Research funded by the Center for Southeast Asian Studies (CSEAS), Kyoto University to NI, and the "Project to support activities for promoting REDD+ by private companies and nongovernmental organizations" funded by the Forestry Agency of Japan to TF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Aide TM, 2013, BIOTROPICA, V45, P262, DOI 10.1111/j.1744-7429.2012.00908.x; Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; Barbier EB, 2010, LAND USE POLICY, V27, P98, DOI 10.1016/j.landusepol.2009.02.001; Barretto AGOP, 2013, GLOBAL CHANGE BIOL, V19, P1804, DOI 10.1111/gcb.12174; Bawa KS, 1997, NATURE, V386, P562, DOI 10.1038/386562a0; Bhattarai M, 2001, WORLD DEV, V29, P995, DOI 10.1016/S0305-750X(01)00019-5; Buitenzorgy M, 2011, ENVIRON RESOUR ECON, V48, P59, DOI 10.1007/s10640-010-9397-y; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Ceddia MG, 2014, P NATL ACAD SCI USA, V111, P7242, DOI 10.1073/pnas.1317967111; d'Annunzio R, 2015, FOREST ECOL MANAG, V352, P124, DOI 10.1016/j.foreco.2015.03.014; de Jong W, 2010, BIOTROPICA, V42, P3, DOI 10.1111/j.1744-7429.2009.00568.x; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Didia DO, 1997, GLOBAL ENVIRON CHANG, V7, P63, DOI 10.1016/S0959-3780(96)00024-6; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Ehrhardt-Martinez K, 2002, SOC SCI QUART, V83, P226, DOI 10.1111/1540-6237.00080; Ewers RM, 2006, GLOBAL ENVIRON CHANG, V16, P161, DOI 10.1016/j.gloenvcha.2005.12.001; FAO, 1995, FOR RES ASS 1990 GLO; FAO, 2014, GLOBAL FOREST RESOUR; FAO, 2010, GLOB FOR RES ASS 201, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Furukawa T, 2015, GLOB ECOL CONSERV, V4, P150, DOI 10.1016/j.gecco.2015.06.011; Grainger A, 1995, AREA, V27, P242; Grainger A, 2008, P NATL ACAD SCI USA, V105, P818, DOI 10.1073/pnas.0703015105; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Jha S, 2006, CONSERV BIOL, V20, P906, DOI 10.1111/j.1523-1739.2006.00398.x; Kastner T, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034015; Kastner T, 2011, GLOBAL ENVIRON CHANG, V21, P947, DOI 10.1016/j.gloenvcha.2011.05.003; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Kim SB, 2015, FOR SCI TECHNOL, V11, P166, DOI 10.1080/21580103.2014.977358; Lang G, 2002, ORGAN ENVIRON, V15, P109, DOI 10.1177/10826602015002001; Leblond JP, 2014, J LAND USE SCI, V9, P211, DOI 10.1080/1747423X.2013.786148; Li LQ, 2015, INT J FUZZY SYST, V2015, P12, DOI [DOI 10.1371/J0URNAL.P0NE.0144256, DOI 10.1016/J.ARCH0RALBI0.2015.12.002]; Li Q, 2006, INT STUD QUART, V50, P935, DOI 10.1111/j.1468-2478.2006.00432.x; Lim CL, 2017, CONSERV BIOL, V31, P1362, DOI 10.1111/cobi.12984; Mather AS, 2007, INT FOREST REV, V9, P491, DOI 10.1505/ifor.9.1.491; Mather AS, 1999, GLOBAL ENVIRON CHANG, V9, P105, DOI 10.1016/S0959-3780(98)00035-1; Mather AS, 1999, GEOGRAPHY, V84, P55; Mather AS, 1998, AREA, V30, P117, DOI 10.1111/j.1475-4762.1998.tb00055.x; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Meyfroidt P, 2008, GLOBAL CHANGE BIOL, V14, P1319, DOI 10.1111/j.1365-2486.2008.01575.x; Meyfroidt P, 2011, ANNU REV ENV RESOUR, V36, P343, DOI 10.1146/annurev-environ-090710-143732; Meyfroidt P, 2010, P NATL ACAD SCI USA, V107, P20917, DOI 10.1073/pnas.1014773107; Meyfroidt P, 2009, P NATL ACAD SCI USA, V106, P16139, DOI 10.1073/pnas.0904942106; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Nishijima S, 2016, ECOL INDIC, V71, P368, DOI 10.1016/j.ecolind.2016.07.008; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; RCore Team, 2020, R LANG ENV STAT COMP; Redo DJ, 2012, ANN ASSOC AM GEOGR, V102, P778, DOI 10.1080/00045608.2012.678036; Redo DJ, 2012, P NATL ACAD SCI USA, V109, P8839, DOI 10.1073/pnas.1201664109; Rudel TK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0405; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Sandel B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3474; Satake A, 2007, ECOL APPL, V17, P2024, DOI 10.1890/07-0283.1; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Van PN, 2007, J DEV ECON, V84, P291, DOI 10.1016/j.jdeveco.2005.10.004; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; Wolfersberger J, 2015, ECOL ECON, V119, P241, DOI 10.1016/j.ecolecon.2015.08.018	63	33	33	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197391	10.1371/journal.pone.0197391	http://dx.doi.org/10.1371/journal.pone.0197391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF7AA	29763452	Green Submitted, gold, Green Published			2022-12-26	WOS:000432118800047
J	Schraw, JM; Yiu, TT; Lupo, PJ; Tsavachidis, S; Rau, R; Bondy, ML; Rabin, KR; Shen, LL; Scheurer, ME				Schraw, Jeremy M.; Yiu, Teresa T.; Lupo, Philip J.; Tsavachidis, Spiridon; Rau, Rachel; Bondy, Melissa L.; Rabin, Karen R.; Shen, Lanlan; Scheurer, Michael E.			Maternal folate genes and aberrant DNA hypermethylation in pediatric acute lymphoblastic leukemia	PLOS ONE			English	Article							HUMAN CANCERS; METHYLATION; EXPRESSION; ORIGINS; TWINS; RISK	Background There is evidence that maternal genotypes in folate-related genes are associated with pediatric acute lymphoblastic leukemia (ALL) independent of offspring genotype. We evaluated the relationship between maternal genotypes in methionine synthase (MTR) and DNA methylation status in ALL to better characterize the molecular mechanism underlying this association. Procedure We obtained bone marrow samples from 51 patients with ALL at diagnosis and from 6 healthy donors. Mothers of patients provided a saliva sample and were genotyped at 11 tagSNPs in MTR. DNA methylation was measured in bone marrow mononuclear cells of patients and six healthy marrow donors. We used hierarchical clustering to identify patients with a hypermethylator phenotype based on 281 differentially methylated promoter CpGs. We used logistic regression to estimate the effects of maternal genotype on the likelihood of DNA hypermethylation in ALL and Ingenuity Pathway Analysis to identify networks enriched for differentially methylated genes. Results Twenty-two cases (43%) demonstrated promoter hypermethylation, which was more frequent among those with ETV6-RUNX1 fusion and initial white blood cell count < 50 x 10(9)/L. Maternal rs12759827 was associated with aberrant DNA methylation (odds ratio [OR] 4.67, 95% confidence interval 1.46-16.31); non-significantly elevated ORs were observed for all other SNPs. Aberrantly methylated promoter CpGs aligned to genes with known cancer-related functions. Discussion Maternal folate metabolic genotype may be associated with DNA methylation patterns in ALL in their offspring. Therefore, the effect of maternal genotypes on ALL susceptibility may act through aberrant promoter methylation, which may contribute to the in utero origins of ALL.	[Schraw, Jeremy M.; Yiu, Teresa T.; Lupo, Philip J.; Rau, Rachel; Rabin, Karen R.; Scheurer, Michael E.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Yiu, Teresa T.; Lupo, Philip J.; Rau, Rachel; Rabin, Karen R.; Shen, Lanlan; Scheurer, Michael E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Yiu, Teresa T.; Lupo, Philip J.; Rau, Rachel; Rabin, Karen R.; Scheurer, Michael E.] Texas Childrens Canc & Hematol Ctr, Houston, TX USA; [Tsavachidis, Spiridon; Bondy, Melissa L.] Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX 77030 USA; [Rau, Rachel] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Rau, Rachel] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Shen, Lanlan] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA)	Schraw, JM (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	schraw@bcm.edu		Scheurer, Michael/0000-0002-8379-6088; Rau, Rachel/0000-0003-4096-6603; Schraw, Jeremy/0000-0002-6674-9562; Lupo, Philip/0000-0003-0978-5863	United States National Cancer Institute [5R25CA160078-04]; Cancer Prevention Research Institute of Texas [RP160097]	United States National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention Research Institute of Texas	This work was supported by the United States National Cancer Institute through award 5R25CA160078-04 to Dr. Margaret Spitz. https://fundedresearch.cancer.gov/nciportfolio/search/details;jsessionid=A574DF0C4E5C34339B879233F051130C?action=abstract&grantNum=5R25CA160078-04&grantID=8693605&grtSCDC=FY%202014&absID=8693605&absSCDC=PUB2014. This work was supported by the Cancer Prevention Research Institute of Texas through award RP160097 to Dr. Margaret Spitz. http://www.cprit.state.tx.us/files/funded-grants/RP160097.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borssen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065373; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; Goh YI, 2007, CLIN PHARMACOL THER, V81, P685, DOI 10.1038/sj.clpt.6100100; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Ikeda S, 2012, J REPROD DEVELOP, V58, P38, DOI 10.1262/jrd.2011-002; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lupo PJ, 2014, PEDIATR HEMAT ONCOL, V31, P160, DOI 10.3109/08880018.2013.825684; Lupo PJ, 2012, CANCER CAUSE CONTROL, V23, P1797, DOI 10.1007/s10552-012-0058-z; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Pui CH, 2011, J CLIN ONCOL, V29, P4847, DOI 10.1200/JCO.2011.40.8245; Roman-Gomez J, 2006, CLIN CANCER RES, V12, P4845, DOI 10.1158/1078-0432.CCR-05-2592; Sandoval J, 2013, BRIT J HAEMATOL, V160, P406, DOI 10.1111/bjh.12113; SUPER HJG, 1994, BLOOD, V83, P641; Wang HG, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-77; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Wong NC, 2012, EPIGENETICS-US, V7, P535, DOI 10.4161/epi.20193; Yousefi P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2034-y	22	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197408	10.1371/journal.pone.0197408	http://dx.doi.org/10.1371/journal.pone.0197408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763473	gold, Green Published, Green Submitted			2022-12-26	WOS:000432118800048
J	Xue, X; Ren, JF; Sun, XL; Gui, Y; Feng, Y; Shu, BY; Wei, W; Lu, QM; Liang, Y; He, WC; Yang, JW; Dai, CS				Xue, Xian; Ren, Jiafa; Sun, Xiaoli; Gui, Yuan; Feng, Ye; Shu, Bingyan; Wei, Wei; Lu, Qingmiao; Liang, Yan; He, Weichun; Yang, Junwei; Dai, Chunsun			Protein kinase C drives fibroblast activation and kidney fibrosis by stimulating autophagic flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						kidney; fibroblast; signal transduction; cell signaling; fibrosis	MOLECULAR-MECHANISMS; LYSOSOME BIOGENESIS; MTOR; LAMP-2; PHOSPHORYLATION; TARGET; GROWTH; CELLS; AMPK	Kidney fibrosis is a histological hallmark of chronic kidney disease and arises in large part through extracellular matrix deposition by activated fibroblasts. The signaling protein complex mTOR complex 2 (mTORC2) plays a critical role in fibroblast activation and kidney fibrosis. Protein kinase C (PKC) is one of the major sub-pathways of mTORC2, but its role in fibroblast activation and kidney fibrosis remains to be determined. Here, we found that transforming growth factor 1 (TGF1) activates PKC signaling in cultured NRK-49F cells in a time-dependent manner. Blocking PKC signaling with the chemical inhibitor Go6976 or by transfection with PKC siRNA largely reduced expression of the autophagy-associated protein lysosomal-associated membrane protein 2 (LAMP2) and also inhibited autophagosome-lysosome fusion and autophagic flux in the cells. Similarly to chloroquine, Go6976 treatment and PKC siRNA transfection also markedly inhibited TGF1-induced fibroblast activation. In murine fibrotic kidneys with unilateral ureteral obstruction (UUO) nephropathy, PKC signaling is activated in the interstitial myofibroblasts. Go6976 administration largely blocked autophagic flux in fibroblasts in the fibrotic kidneys and attenuated the UUO nephropathy. Together, our findings suggest that blocking PKC activity may retard autophagic flux and thereby prevent fibroblast activation and kidney fibrosis.	[Xue, Xian; Ren, Jiafa; Sun, Xiaoli; Gui, Yuan; Feng, Ye; Shu, Bingyan; Wei, Wei; Lu, Qingmiao; Liang, Yan; He, Weichun; Yang, Junwei; Dai, Chunsun] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China; [Ren, Jiafa] Duke Univ, Div Nephrol, Dept Med, Durham, NC 27705 USA; [Ren, Jiafa] Durham Vet Affairs Med Ctr, Durham, NC 27705 USA	Nanjing Medical University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Dai, CS (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 North Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	daichunsun@njmu.edu.cn			National Science Foundation of China [81570611/H0503, 81770675/H0503]; Science Foundation of Jiangsu Province [BK20140048]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Jiangsu Province	This work was supported by National Science Foundation of China Grants 81570611/H0503 and 81770675/H0503 and Science Foundation of Jiangsu Province Grant BK20140048 (to C.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baisantry A, 2016, J AM SOC NEPHROL, V27, P1609, DOI 10.1681/ASN.2014111059; Bernard M, 2014, AUTOPHAGY, V10, P2193, DOI 10.4161/15548627.2014.981786; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Das G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008813; De Rechter S, 2016, PEDIATR NEPHROL, V31, P737, DOI 10.1007/s00467-015-3134-2; Del Principe D, 2013, J PATHOL, V229, P208, DOI 10.1002/path.4115; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Ding Y, 2010, J BIOL CHEM, V285, P37909, DOI 10.1074/jbc.M109.093724; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Gonnella R, 2015, BBA-MOL CELL RES, V1853, P1586, DOI 10.1016/j.bbamcr.2015.03.011; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Jiang HB, 2010, BIOCHEM BIOPH RES CO, V395, P471, DOI 10.1016/j.bbrc.2010.04.030; Jiang L, 2013, J AM SOC NEPHROL, V24, P1114, DOI 10.1681/ASN.2012050476; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Kim WY, 2012, NEPHROLOGY, V17, P148, DOI 10.1111/j.1440-1797.2011.01541.x; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Li JZ, 2014, KIDNEY INT, V86, P86, DOI 10.1038/ki.2013.559; Li Y, 2016, NAT CELL BIOL, V18, P1065, DOI 10.1038/ncb3407; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Livingston MJ, 2016, AUTOPHAGY, V12, P976, DOI 10.1080/15548627.2016.1166317; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizunoe Y, 2017, AUTOPHAGY, V13, P642, DOI 10.1080/15548627.2016.1274850; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Pereira EM, 2014, GENE, V536, P118, DOI 10.1016/j.gene.2013.11.063; Saftig P, 2008, AUTOPHAGY, V4, P510, DOI 10.4161/auto.5724; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Wang F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15182	42	21	23	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11119	11130		10.1074/jbc.RA118.002191	http://dx.doi.org/10.1074/jbc.RA118.002191			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29794026	hybrid, Green Published			2022-12-26	WOS:000438882800024
J	Taylor, IR; Ahmad, A; Wu, T; Nordhues, BA; Bhullar, A; Gestwicki, JE; Zuiderweg, ERP				Taylor, Isabelle R.; Ahmad, Atta; Wu, Taia; Nordhues, Bryce A.; Bhullar, Anup; Gestwicki, Jason E.; Zuiderweg, Erik R. P.			The disorderly conduct of Hsc70 and its interaction with the Alzheimer's-related Tau protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; microtubule-associated protein (MAP); protein conformation; protein complex; nuclear magnetic resonance (NMR)	MOLECULAR CHAPERONE DNAK; SUBSTRATE-BINDING DOMAIN; HEAT-SHOCK PROTEINS; E3 UBIQUITIN LIGASE; HSP70 CHAPERONES; HEAT-SHOCK-PROTEIN-70 HSP70; MEDIATED AUTOPHAGY; SELECTIVE UPTAKE; IN-VITRO; PEPTIDE	Hsp70 chaperones bind to various protein substrates for folding, trafficking, and degradation. Considerable structural information is available about how prokaryotic Hsp70 (DnaK) binds substrates, but less is known about mammalian Hsp70s, of which there are 13 isoforms encoded in the human genome. Here, we report the interaction between the human Hsp70 isoform heat shock cognate 71-kDa protein (Hsc70 or HSPA8) and peptides derived from the microtubule-associated protein Tau, which is linked to Alzheimer's disease. For structural studies, we used an Hsc70 construct (called BETA) comprising the substrate-binding domain but lacking the lid. Importantly, we found that truncating the lid does not significantly impair Hsc70's chaperone activity or allostery in vitro. Using NMR, we show that BETA is partially dynamically disordered in the absence of substrate and that binding of the Tau sequence GKVQIINKKG (with a K-D = 500 nm) causes dramatic rigidification of BETA. NOE distance measurements revealed that Tau binds to the canonical substrate-binding cleft, similar to the binding observed with DnaK. To further develop BETA as a tool for studying Hsc70 interactions, we also measured BETA binding in NMR and fluorescent competition assays to peptides derived from huntingtin, insulin, a second Tau-recognition sequence, and a KFERQ-like sequence linked to chaperone-mediated autophagy. We found that the insulin C-peptide binds BETA with high affinity (K-D < 100 nm), whereas the others do not (K-D > 100 m). Together, our findings reveal several similarities and differences in how prokaryotic and mammalian Hsp70 isoforms interact with different substrate peptides.	[Ahmad, Atta; Bhullar, Anup; Zuiderweg, Erik R. P.] Univ Michigan, Med Sch, Dept Biol Chem, 1500 Med Ctr Dr, Ann Arbor, MI 48109 USA; [Taylor, Isabelle R.; Wu, Taia; Gestwicki, Jason E.] Univ Calif San Francisco, Inst Neurodegenerat Dis, 675 Nelson Rising Ln, San Francisco, CA 94158 USA; [Nordhues, Bryce A.] Univ S Florida, Dept Mol Med, Tampa, FL 33613 USA; [Nordhues, Bryce A.] Univ S Florida, Byrd Alzheimers Inst, Tampa, FL 33613 USA	University of Michigan System; University of Michigan; University of California System; University of California San Francisco; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Zuiderweg, ERP (corresponding author), Univ Michigan, Med Sch, Dept Biol Chem, 1500 Med Ctr Dr, Ann Arbor, MI 48109 USA.; Gestwicki, JE (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, 675 Nelson Rising Ln, San Francisco, CA 94158 USA.	Jason.Gestwicki@ucsf.edu; zuiderwe@umich.edu		Taylor, Isabelle/0000-0003-1053-5677	National Institutes of Health [R01NS059690]; Protein Folding and Disease Program of the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM064337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Folding and Disease Program of the University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01NS059690 (to J. E. G. and E. R. P. Z.) and the Protein Folding and Disease Program of the University of Michigan (to E. R. P. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Caballero B, 2018, AGING CELL, V17, DOI 10.1111/acel.12692; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiappori F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23474; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Goddard TD., 2000, SPARKY 3; Hyberts SG, 2014, J MAGN RESON, V241, P60, DOI 10.1016/j.jmr.2013.11.014; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; KO ASC, 1971, EUR J BIOCHEM, V20, P190, DOI 10.1111/j.1432-1033.1971.tb01378.x; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Monsellier E, 2015, J BIOL CHEM, V290, P2560, DOI 10.1074/jbc.M114.603332; Montgomery DL, 1999, J MOL BIOL, V286, P915, DOI 10.1006/jmbi.1998.2514; Morozova K, 2016, J BIOL CHEM, V291, P18096, DOI 10.1074/jbc.M116.736744; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Morshauser RC, 1999, J MAGN RESON, V139, P232, DOI 10.1006/jmre.1999.1802; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Slepenkov SV, 2002, BIOCHEMISTRY-US, V41, P12224, DOI 10.1021/bi0263208; Smith MC, 2013, BIOCHEMISTRY-US, V52, P5354, DOI 10.1021/bi4009209; Smock RG, 2011, J BIOL CHEM, V286, P31821, DOI 10.1074/jbc.M111.265835; Stevens SY, 2003, PROTEIN SCI, V12, P2588, DOI 10.1110/ps.03269103; Swain JF, 2006, J BIOL CHEM, V281, P1605, DOI 10.1074/jbc.M509356200; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Young ZT, 2016, CELL CHEM BIOL, V23, P992, DOI 10.1016/j.chembiol.2016.04.014; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2015, P NATL ACAD SCI USA, V112, pE2865, DOI 10.1073/pnas.1506692112; Zuiderweg E. R., 2016, J BIOMOL NMR ASSIGNM; Zuiderweg ERP, 2013, J BIOMOL NMR, V57, P179, DOI 10.1007/s10858-013-9778-y	54	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10796	10809		10.1074/jbc.RA118.002234	http://dx.doi.org/10.1074/jbc.RA118.002234			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29764935	Green Published, hybrid			2022-12-26	WOS:000437828400033
J	Ingerslew, KS; Finke, DL				Ingerslew, Kathryn S.; Finke, Deborah L.			Multi-species suppression of herbivores through consumptive and non-consumptive effects	PLOS ONE			English	Article							PREDATION RISK; PEA APHID; LARVAL COMPETITION; ALARM PHEROMONE; PLANT-DAMAGE; PREY; HYMENOPTERA; PARASITOIDS; BEHAVIOR; STRENGTH	Most studies investigating the importance of non-consumptive interactions for herbivore suppression focus on pairwise interactions between one predator and one prey, ignoring any community context. Further, the potential for non-consumptive interactions to arise between herbivores and non-enemy organisms is commonly overlooked. We investigated the relative contributions of consumptive and non-consumptive effects to aphid suppression by a wasp assemblage containing both enemies and non-enemies. We examined the suppression of two aphid species with different defensive strategies, pea aphids (Acyrthosiphon pisum), which drop from their host plant to the ground, and green peach aphids (Myzus persicae), which remain on the plant and merely walk away. The expectation was that riskier defensive behaviors, like abandoning the plant, would result in larger non-consumptive effects. We found that the outcome of multi-species interactions differed depending on the mechanism of suppression, with interference among wasps in their consumptive effects and additivity in their non-consumptive effects. We also found that, despite differences in defensive strategies, the non-consumptive effects of wasps on aphid abundance were significant for both aphid species. Furthermore, when part of a multi-species assemblage, non-enemies enhanced aphid suppression via complementary non-consumptive effects with lethal enemies, but this increase in suppression was offset by disruption in the consumptive suppression of aphids by lethal enemies. We conclude that non-consumptive effects arise from interactions with both enemy and non-enemy species and that both can contribute to herbivore suppression when part of a broader community. We predict that encouraging the presence of non-enemy organisms may provide insurance against fluctuations in the size of consumptive enemy populations and buffer against herbivore outbreaks.	[Ingerslew, Kathryn S.; Finke, Deborah L.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Finke, DL (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	FinkeD@missouri.edu		Finke, Deborah/0000-0001-8291-1964	Agriculture and Food Research Initiative of the United States Department of Agriculture National Institute of Food and Agriculture [2009-02083]; National Institute of Food and Agriculture of the United States Department of Agriculture [2016-67011-25100]; University of Missouri Research Board	Agriculture and Food Research Initiative of the United States Department of Agriculture National Institute of Food and Agriculture; National Institute of Food and Agriculture of the United States Department of Agriculture; University of Missouri Research Board	This project was supported by the Agriculture and Food Research Initiative of the United States Department of Agriculture National Institute of Food and Agriculture grant # 2009-02083 (nifa.usda.gov/program/agriculture-and-food-research-initiative-afri, DLF), the National Institute of Food and Agriculture of the United States Department of Agriculture grant # 2016-67011-25100 (nifa.usda.gov, KSI), and the University of Missouri Research Board (research. missouri.edu/internal/board, DLF).	Almohamad R, 2014, INSECT SCI, V21, P181, DOI 10.1111/1744-7917.12037; BAI B, 1992, FUNCT ECOL, V6, P302, DOI 10.2307/2389521; Bilodeau E, 2013, EVOL ECOL, V27, P165, DOI 10.1007/s10682-012-9577-z; CLEGG JM, 1982, CAN J ZOOL, V60, P2245, DOI 10.1139/z82-289; CRONIN JT, 1993, ECOL ENTOMOL, V18, P293, DOI 10.1111/j.1365-2311.1993.tb01104.x; Davenport JM, 2014, OECOLOGIA, V176, P149, DOI 10.1007/s00442-014-2996-5; Davenport JM, 2013, ECOL EVOL, V3, P3063, DOI 10.1002/ece3.691; DIXON A. F. G., 1958, TRANS ROY ENTOMOL SOC LONDON, V110, P319; Donelan SC, 2017, ECOLOGY, V98, P403, DOI 10.1002/ecy.1647; Eubanks MD, 2014, CURR OPIN INSECT SCI, V2, P1, DOI 10.1016/j.cois.2014.06.005; Fill A, 2012, ECOL ENTOMOL, V37, P43, DOI 10.1111/j.1365-2311.2011.01333.x; Finke DL, 2012, ENTOMOL EXP APPL, V144, P45, DOI 10.1111/j.1570-7458.2012.01258.x; Francke DL, 2008, ENTOMOL EXP APPL, V127, P118, DOI 10.1111/j.1570-7458.2008.00678.x; Frid A, 2002, CONSERV ECOL, V6; Griffen BD, 2006, OECOLOGIA, V148, P702, DOI 10.1007/s00442-006-0414-3; Griffin JN, 2013, ECOLOGY, V94, P2180, DOI 10.1890/13-0179.1; Harri SA, 2009, ECOL ENTOMOL, V34, P20, DOI 10.1111/j.1365-2311.2008.01037.x; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Hermann SL, 2017, CURR OPIN INSECT SCI, V20, P54, DOI 10.1016/j.cois.2017.03.010; Hermann SL, 2014, OECOLOGIA, V176, P669, DOI 10.1007/s00442-014-3069-5; Hernandez SA, 2014, FRESHW SCI, V33, P124, DOI 10.1086/674360; HOFSVANG T, 1975, Entomophaga, V20, P11, DOI 10.1007/BF02373446; Ingerslew KS, 2017, ENVIRON ENTOMOL, V46, P75, DOI 10.1093/ee/nvw151; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Katano I, 2015, OIKOS, V124, P1427, DOI 10.1111/oik.02430; Kishida O, 2009, ECOLOGY, V90, P1217, DOI 10.1890/08-0238.1; KLINGAUF F., 1967, Zeitschrift fur Angewandte Entomologie, V60, P269; Lagrue C, 2015, OIKOS, V124, P1589, DOI 10.1111/oik.02272; Long EY, 2015, OECOLOGIA, V177, P1067, DOI 10.1007/s00442-014-3194-1; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Losey JE, 1998, OECOLOGIA, V115, P245, DOI 10.1007/s004420050513; Losey JE, 1998, ECOLOGY, V79, P2143, DOI 10.2307/176717; Luttbeg B, 2003, ECOLOGY, V84, P1140, DOI 10.1890/0012-9658(2003)084[1140:PSAEDA]2.0.CO;2; Luttbeg B, 2013, AM NAT, V181, P182, DOI 10.1086/668823; MCBRIEN H, 1990, ENTOMOL EXP APPL, V56, P145, DOI 10.1007/BF00163457; Montoya JM, 2009, ECOLOGY, V90, P2426, DOI 10.1890/08-0657.1; Nelson EH, 2007, OECOLOGIA, V151, P22, DOI 10.1007/s00442-006-0573-2; ODONNELL DJ, 1987, INT J INSECT MORPHOL, V16, P3, DOI 10.1016/0020-7322(87)90052-3; Orrock JL, 2013, ECOLOGY, V94, P573, DOI 10.1890/12-0502.1; Peacor SD, 2013, OECOLOGIA, V171, P1, DOI 10.1007/s00442-012-2394-9; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; PENNACCHIO F, 1989, Bollettino del Laboratorio di Entomologia Agraria Filippo Silvestri, V46, P163; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Preisser EL, 2009, ECOL LETT, V12, P315, DOI 10.1111/j.1461-0248.2009.01290.x; ROITBERG BD, 1979, J ANIM ECOL, V48, P111, DOI 10.2307/4104; ROITBERG BD, 1979, CAN ENTOMOL, V111, P515, DOI 10.4039/Ent111515-4; Rypstra AL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0948; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SOLUK DA, 1988, OIKOS, V52, P94, DOI 10.2307/3565987; STARY P, 1975, ACTA ENTOMOL BOHEMOS, V72, P156; Steffan SA, 2010, ECOLOGY, V91, P2242, DOI 10.1890/09-0787.1; Tautz J, 2008, CURR BIOL, V18, pR1125, DOI 10.1016/j.cub.2008.10.038; Thaler JS, 2008, ENTOMOL EXP APPL, V128, P34, DOI 10.1111/j.1570-7458.2008.00737.x; THOMAS IM, 1950, AUST J SCI RES SER B, V3, P113, DOI 10.1071/BI9500113; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; Utsumi S, 2010, POPUL ECOL, V52, P485, DOI 10.1007/s10144-010-0237-2; van Lenteren JC, 2006, ANNU REV ENTOMOL, V51, P609, DOI 10.1146/annurev.ento.51.110104.151129; Vandermoten S, 2012, INSECT BIOCHEM MOLEC, V42, P155, DOI 10.1016/j.ibmb.2011.11.008; VOLKL W, 1991, J APPL ENTOMOL, V111, P63, DOI 10.1111/j.1439-0418.1991.tb00295.x; Walzer A, 2009, OIKOS, V118, P934, DOI 10.1111/j.1600-0706.2008.17299.x; Xi XQ, 2013, OIKOS, V122, P1049, DOI 10.1111/j.1600-0706.2012.00126.x; Zamani AA, 2007, ENVIRON ENTOMOL, V36, P263, DOI 10.1603/0046-225X-36.2.263	64	7	7	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197230	10.1371/journal.pone.0197230	http://dx.doi.org/10.1371/journal.pone.0197230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791456	Green Submitted, Green Published, gold			2022-12-26	WOS:000433077000035
J	Yun, HY; Lee, J; Kim, H; Ryu, H; Shin, HC; Oh, BH; Ku, B; Kim, SJ				Yun, Hye-Yeoung; Lee, Jinhyuk; Kim, Hyunmin; Ryu, Hyojung; Shin, Ho-Chul; Oh, Byung-Ha; Ku, Bonsu; Kim, Seung Jun			Structural study reveals the temperature-dependent conformational flexibility of Tk-PTP, a protein tyrosine phosphatase from Thermococcus kodakaraensis KOD1	PLOS ONE			English	Article							DUAL-SPECIFICITY; CATALYTIC ACTIVATION; KINASE PHOSPHATASE; MECHANISM; ATOM; REGULATORS; DYNAMICS	Protein tyrosine phosphatases (PTPs) originating from eukaryotes or bacteria have been under intensive structural and biochemical investigation, whereas archaeal PTP proteins have not been investigated extensively; therefore, they are poorly understood. Here, we present the crystal structures of Tk-PTP derived from the hyperthermophilic archaeon Thermococcus kodakaraensis KOD1, in both the active and inactive forms. Tk-PTP adopts a common dual-specificity phosphatase (DUSP) fold, but it undergoes an atypical temperature-dependent conformational change in its P-loop and alpha 4-alpha 5 loop regions, switching between the inactive and active forms. Through comprehensive analyses of Tk-PTP, including additional structural determination of the G95A mutant form, enzymatic activity assays, and structural comparison with the other archaeal PTP, it was revealed that the presence of the GG motif in the P-loop is necessary but not sufficient for the structural flexibility of Tk-PTP. It was also proven that Tk-PTP contains dual general acid/base residues unlike most of the other DUSP proteins, and that both the residues are critical in its phosphatase activity. This work provides the basis for expanding our understanding of the previously uncharacterized PTP proteins from archaea, the third domain of living organisms.	[Yun, Hye-Yeoung; Shin, Ho-Chul; Ku, Bonsu; Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea; [Yun, Hye-Yeoung; Ku, Bonsu; Kim, Seung Jun] Univ Sci & Technol, Dept Biosci, KRIBB Sch, Daejeon, South Korea; [Lee, Jinhyuk; Ryu, Hyojung] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Daejeon, South Korea; [Lee, Jinhyuk; Ryu, Hyojung] Univ Sci & Technol, Dept Biotechnol, KRIBB Sch, Daejeon, South Korea; [Kim, Hyunmin; Oh, Byung-Ha] Korea Adv Inst Sci & Technol, KAIST Inst Biocentury, Dept Biol Sci, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Korea Advanced Institute of Science & Technology (KAIST)	Ku, B; Kim, SJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon, South Korea.; Ku, B; Kim, SJ (corresponding author), Univ Sci & Technol, Dept Biosci, KRIBB Sch, Daejeon, South Korea.	bku@kribb.re.kr; ksj@kribb.re.kr	Oh, Byung-Ha/C-2061-2011; Kim, Seung Jun/N-5248-2019	Kim, Seung Jun/0000-0002-6913-6358; Kim, Hyunmin/0000-0001-5227-4319; Ku, Bonsu/0000-0003-1784-8975	National Research Foundation of Korea - Ministry of Science and ICT (MSIT) [2015M3A9B5030308]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Creative Research; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Disease Target Structural Research	National Research Foundation of Korea - Ministry of Science and ICT (MSIT); Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Creative Research; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program for Disease Target Structural Research	This work was supported by the National Research Foundation of Korea funded by the Ministry of Science and ICT (MSIT) (Grant number 2015M3A9B5030308) to SJK and by the Korea Research Institute of Bioscience and Biotechnology Research Initiative Programs for Creative Research to BK and for Disease Target Structural Research to SJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Chu HM, 2007, PROTEINS, V66, P996, DOI 10.1002/prot.21262; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Denu JM, 1996, P NATL ACAD SCI USA, V93, P2493, DOI 10.1073/pnas.93.6.2493; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hong SB, 2005, BIOORG CHEM, V33, P34, DOI 10.1016/j.bioorg.2004.08.001; Jeon SJ, 2002, BIOCHEM BIOPH RES CO, V295, P508, DOI 10.1016/S0006-291X(02)00705-2; Jeong DG, 2014, ACTA CRYSTALLOGR D, V70, P421, DOI 10.1107/S1399004713029866; Kant S, 2015, MOL MICROBIOL, V97, P515, DOI 10.1111/mmi.13047; Koksal AC, 2009, J BIOL CHEM, V284, P10129, DOI 10.1074/jbc.M808362200; Koveal D, 2013, J MOL BIOL, V425, P2219, DOI 10.1016/j.jmb.2013.03.023; Ku B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187701; Ku B, 2016, BIOCHEM BIOPH RES CO, V478, P1217, DOI 10.1016/j.bbrc.2016.08.097; Kuznetsov VI, 2013, BIOCHEMISTRY-US, V52, P8012, DOI 10.1021/bi400776z; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mei G, 2008, BIOCHEMISTRY-US, V47, P9234, DOI 10.1021/bi800638v; Merkley ED, 2012, PROTEINS, V80, P546, DOI 10.1002/prot.23219; MilnerWhite EJ, 1997, PROTEIN SCI, V6, P2477; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Phan J, 2007, ACTA CRYSTALLOGR D, V63, P698, DOI 10.1107/S0907444907014904; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Tautz L, 2013, METHODS MOL BIOL, V1053, P179, DOI 10.1007/978-1-62703-562-0_13; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Wang WQ, 2003, CURR TOP MED CHEM, V3, P739, DOI 10.2174/1568026033452302; Xu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124330; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526; Zhu YZ, 2016, J PHYS CHEM B, V120, P3551, DOI 10.1021/acs.jpcb.5b12299	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197635	10.1371/journal.pone.0197635	http://dx.doi.org/10.1371/journal.pone.0197635			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791483	gold, Green Published			2022-12-26	WOS:000433077000047
J	Chao, AS; Chang, YL; Yang, LY; Chao, A; Chang, WY; Su, SY; Wang, CJ				Chao, An-Shine; Chang, Yao-Lung; Yang, Lan-Yan; Chao, Angel; Chang, Wei-Yang; Su, Sheng-Yuan; Wang, Chin-Jung			Laparoscopic uterine surgery as a risk factor for uterine rupture during pregnancy	PLOS ONE			English	Article							PERIPARTUM HYSTERECTOMY; MYOMECTOMY; EXPERIENCE	The incidence of uterine rupture through a previous cesarean scar (CS) is declining as a result of a lower parity and fewer options for vaginal birth after cesarean. However, uterine ruptures attributable to other causes that traumatize the myometrium are on the rise. To determine whether changes in the causes of uterine rupture had occurred in recent years, we retrospective retrieved the clinical records of all singletons with uterine rupture observed in the delivery room of a Taiwanese tertiary obstetric center over a 15-year period. The overall uterine rupture rate was 3.8 per 10,000 deliveries. A total of 22 cases in 20 women (with two of them experiencing two episodes). Seven uterine ruptures occurred through a previous cesarean scar (CS ruptures, 32%), 13 through a non-cesarean scar (non-CS ruptures, 59%), whereas the remaining two (9%) were in women who did not previously undergo any surgery. All of the 13 non-CS ruptures were identified in women with a history of laparoscopic procedures to the uterus. Specifically, 10 (76%) occurred after a previous laparoscopic myomectomy, one (8%) following a hysteroscopic myomectomy, and two (16%) after a laparoscopic wedge resection of cornual ectopic pregnancy. Severe bleeding (blood loss >1500 mL) requiring transfusions was more frequent in women who experienced non-CS compared with CS ruptures (10 versus 1 case, respectively, P = 0.024). Patients with a history of endoscopic uterine surgery should be aware of uterine rupture during pregnancy.	[Chao, An-Shine; Chang, Yao-Lung; Chao, Angel; Su, Sheng-Yuan; Wang, Chin-Jung] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Chao, An-Shine; Chang, Yao-Lung; Chao, Angel; Su, Sheng-Yuan; Wang, Chin-Jung] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Yang, Lan-Yan; Chang, Wei-Yang] Chang Gung Mem Hosp, Clin Trial Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chao, AS; Wang, CJ (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan.; Chao, AS; Wang, CJ (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	aschao1295@cgmh.org.tw; wang2260@cgmh.org.tw	yang, lan/GRJ-3120-2022	Chang, Wei-Yang/0000-0002-9977-2267; Yang, Lan-Yan/0000-0002-6305-540X	Chang Gung Medical Foundation [CORPG3G1021, CORPG3G1051, CMRPG3E0921, CMRPG3F1321];  [MOHW106-TDU-B-212-113005]	Chang Gung Medical Foundation; 	This study was financially supported by grants from Chang Gung Medical Foundation (CORPG3G1021, CORPG3G1051, CMRPG3E0921 and CMRPG3F1321) and MOHW106-TDU-B-212-113005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura Hirobumi, 2004, Journal of Nippon Medical School, V71, P69, DOI 10.1272/jnms.71.69; Banas T, 2005, J OBSTET GYNAECOL RE, V31, P527, DOI 10.1111/j.1447-0756.2005.00331.x; Chester JM, 2015, J OBSTET GYNAECOL, V35, P638, DOI 10.3109/01443615.2014.989823; Colmorn LB, 2015, ACTA OBSTET GYN SCAN, V94, P734, DOI 10.1111/aogs.12639; D'Arpe S, 2015, ARCH GYNECOL OBSTET, V291, P841, DOI 10.1007/s00404-014-3487-y; Dubuisson JB, 2000, HUM REPROD, V15, P869, DOI 10.1093/humrep/15.4.869; DUBUISSON JB, 1995, HUM REPROD, V10, P1475; Fitzpatrick KE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001184; Grande N, 2005, J MINIM INVAS GYN, V12, P301, DOI 10.1016/j.jmig.2005.05.009; Hockstein S, 2000, J REPROD MED, V45, P139; Kaczmarczyk M, 2007, BJOG-INT J OBSTET GY, V114, P1208, DOI 10.1111/j.1471-0528.2007.01484.x; Koo YJ, 2015, J MINIM INVAS GYN, V22, P1022, DOI 10.1016/j.jmig.2015.05.016; Landon MB, 2011, SEMIN PERINATOL, V35, P257, DOI 10.1053/j.semperi.2011.05.008; Li WH, 2016, TAIWAN J OBSTET GYNE, V55, P394, DOI 10.1016/j.tjog.2016.04.016; Lieng M, 2004, J AM ASSOC GYN LAP, V11, P92, DOI 10.1016/S1074-3804(05)60020-5; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Malzoni Mario, 2006, Surg Technol Int, V15, P123; Murphy DJ, 2006, CURR OPIN OBSTET GYN, V18, P135, DOI 10.1097/01.gco.0000192989.45589.57; Oktem O, 2001, J AM ASSOC GYN LAP, V8, P618; Parker WH, 2010, J MINIM INVAS GYN, V17, P551, DOI 10.1016/j.jmig.2010.04.015; Pelosi MA, 1997, AM J OBSTET GYNECOL, V177, P1547, DOI 10.1016/S0002-9378(97)70110-8; Pistofidis G, 2012, J MINIM INVAS GYN, V19, P762, DOI 10.1016/j.jmig.2012.07.003; Pritchard J, 2014, WILLIAMS OBSTET, P780; Smith D, 2015, AM J OBSTET GYNECOL, V213, pe81; Tinelli A, 2012, HUM REPROD, V27, P427, DOI 10.1093/humrep/der369; Xiaoxia Bai, 2014, Zhonghua Fu Chan Ke Za Zhi, V49, P331; Zwart JJ, 2009, BJOG-INT J OBSTET GY, V116, P1069, DOI 10.1111/j.1471-0528.2009.02136.x	27	10	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197307	10.1371/journal.pone.0197307	http://dx.doi.org/10.1371/journal.pone.0197307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787604	gold, Green Submitted, Green Published			2022-12-26	WOS:000432785700020
J	Kurczynska, M; Kotulska, M				Kurczynska, Monika; Kotulska, Malgorzata			Automated method to differentiate between native and mirror protein models obtained from contact maps	PLOS ONE			English	Article							STRUCTURE RECONSTRUCTION; CONFORMATIONS; PYTHON; PYROSETTA; IMAGES	Mirror protein structures are often considered as artifacts in modeling protein structures. However, they may soon become a new branch of biochemistry. Moreover, methods of protein structure reconstruction, based on their residue-residue contact maps, need methodology to differentiate between models of native and mirror orientation, especially regarding the reconstructed backbones. We analyzed 130 500 structural protein models obtained from contact maps of 1 305 SCOP domains belonging to all 7 structural classes. On average, the same numbers of native and mirror models were obtained among 100 models generated for each domain. Since their structural features are often not sufficient for differentiating between the two types of model orientations, we proposed to apply various energy terms (ETs) from PyRosetta to separate native and mirror models. To automate the procedure for differentiating these models, the k-means clustering algorithm was applied. Using total energy did not allow to obtain appropriate clusters the accuracy of the clustering for class A (all helices) was no more than 0.52. Therefore, we tested a series of different k-means clusterings based on various combinations of ETs. Finally, applying two most differentiating ETs for each class allowed to obtain satisfying results. To unify the method for differentiating between native and mirror models, independent of their structural class, the two best ETs for each class were considered. Finally, the k-means clustering algorithm used three common ETs: probability of amino acid assuming certain values of dihedral angles phi and psi, Ramachandran preferences and Coulomb interactions. The accuracies of clustering with these ETs were in the range between 0.68 and 0.76, with sensitivity and selectivity in the range between 0.68 and 0.87, depending on the structural class. The method can be applied to all fully-automated tools for protein structure reconstruction based on contact maps, especially those analyzing big sets of models.	[Kurczynska, Monika; Kotulska, Malgorzata] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland	Wroclaw University of Science & Technology	Kotulska, M (corresponding author), Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland.	malgorzata.kotulska@pwr.edu.pl	Kotulska, Małgorzata/AAR-7846-2020	Kotulska, Małgorzata/0000-0002-2015-5339	"Diamond Grant", Polish Ministry of Science and Higher Education [DI2011 002141]; Polish Ministry of Science and Higher Education	"Diamond Grant", Polish Ministry of Science and Higher Education; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was supported by "Diamond Grant" DI2011 002141, Polish Ministry of Science and Higher Education to M. Ku and Statuary Funds from Polish Ministry of Science and Higher Education to M. Ko.	Adhikari B, 2015, PROTEINS, V83, P1436, DOI 10.1002/prot.24829; ASZODI A, 1995, J MOL BIOL, V251, P308, DOI 10.1006/jmbi.1995.0436; ASZODI A, 1994, PROTEIN ENG, V7, P633, DOI 10.1093/protein/7.5.633; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Duarte JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-283; Hamelryck T, 2003, BIOINFORMATICS, V19, P2308, DOI 10.1093/bioinformatics/btg299; HAVEL TF, 1991, J MOL BIOL, V217, P1, DOI 10.1016/0022-2836(91)90603-4; Ho HK, 2008, BIOINFORMATICS, V24, P2934, DOI 10.1093/bioinformatics/btn566; Kachlishvili K, 2014, P NATL ACAD SCI USA, V111, P8458, DOI 10.1073/pnas.1407837111; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Konopka BM, 2014, J MEMBRANE BIOL, V247, P409, DOI 10.1007/s00232-014-9648-x; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kurczynska M, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-2975-3; Leaver-Fay A, 2013, METHOD ENZYMOL, V523, P109, DOI [10.1016/B978-0-12:394292-0.00006-0, 10.1016/B978-0-12-394292-0.00006-0]; Li YQ, 2009, PROTEINS, V76, P665, DOI 10.1002/prot.22380; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lund O, 1996, PROTEIN SCI, V5, P2217, DOI 10.1002/pro.5560051108; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Noel JK, 2012, J PHYS CHEM B, V116, P6880, DOI 10.1021/jp212623d; PASTORE A, 1991, PROTEINS, V10, P22, DOI 10.1002/prot.340100104; Pietal MJ, 2015, BIOINFORMATICS, V31, P3499, DOI 10.1093/bioinformatics/btv390; Vassura M, 2008, BIOINFORMATICS, V24, P1313, DOI 10.1093/bioinformatics/btn115; Vendruscolo M, 1997, FOLD DES, V2, P295, DOI 10.1016/S1359-0278(97)00041-2; Wang CK, 2016, J AM CHEM SOC, V138, P5706, DOI 10.1021/jacs.6b02575; Wang ZM, 2016, NAT CHEM, V8, P698, DOI [10.1038/NCHEM.2517, 10.1038/nchem.2517]; Wirth AJ, 2015, J AM CHEM SOC, V137, P7152, DOI 10.1021/jacs.5b02474	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0196993	10.1371/journal.pone.0196993	http://dx.doi.org/10.1371/journal.pone.0196993			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787567	Green Submitted, gold, Green Published			2022-12-26	WOS:000432785700008
J	Martins, T; Diniz, E; Felix, LM; Antunes, L				Martins, Tania; Diniz, Enoque; Felix, Luis M.; Antunes, Luis			Evaluation of anaesthetic protocols for laboratory adult zebrafish(Danio rerio)	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; MEDETOMIDINE-KETAMINE; NEUROSCIENCE RESEARCH; FISH; TOXICITY; ANALGESIA; PROPOFOL; TRICAINE; EXPOSURE; MS-222	In the last decades, the use of zebrafish (Danio rerio) in biomedical research has increased. Anaesthesia is daily used in fish during experimental procedures to avoid discomfort, stress or pain. Also, fish welfare and the reliability of results can be compromised if an unsuitable anaesthetic protocol is used. Therefore, we aimed to refine anaesthetic protocols to be used in adult zebrafish by evaluating the efficacy of different anaesthetics, used alone or in combination. For that, zebrafish were randomly assigned to 8 different groups: 100 mu g/mLMS-222 (MS); 0.2 mu g/mL etomidate (E); 0.2 mu g/mL etomidate + 100 mu g/mL lidocaine (E+L); 1.25 mu g/ mL propofol (P); 1.25 mu g/mL propofol + 100 mu g/mL lidocaine (P+L); 100 mu g/mL ketamine (K); 100 mu g/mL ketamine + 1.25 mu g/mL medetomidine (K+M); and 100 mu g/mL ketamine + 1.25 mu g/mL medetomidine/3.125 mu g/mL atipamezole (K+M/A). The animals were placed in an anaesthetic water bath, then, the following parameters were registered: time for equilibrium loss and anaesthesia induction, loss of sensitivity to soft and painful stimuli, respiratory rate, recovery time, and activity after recovery. The combined forms of E+L, P+L and K+M were the fastest to induce a surgical anaesthetic stage. Nevertheless, E+L induced respiratory depression, while K+M was shown to have the longer recovery time compared to MS 222, even when atipamezole was added. In conclusion, the P+L combination was shown to provide good anaesthesia with analgesia, without causing a major respiratory depression, providing as well a quick recovery, similar to MS-222.	[Martins, Tania; Diniz, Enoque; Felix, Luis M.; Antunes, Luis] Univ Tras Os Montes & Alto Douro UTAD, Ctr Res & Technol Agroenvironm & Biol Sci CITAB, Vila Real, Portugal; [Diniz, Enoque] UJES, FMV, DSA, Huambo, Angola; [Felix, Luis M.; Antunes, Luis] Univ Porto, Inst Invest & Innovat Hlth i3S, Porto, Portugal	University of Tras-os-Montes & Alto Douro; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Antunes, L (corresponding author), Univ Tras Os Montes & Alto Douro UTAD, Ctr Res & Technol Agroenvironm & Biol Sci CITAB, Vila Real, Portugal.; Antunes, L (corresponding author), Univ Porto, Inst Invest & Innovat Hlth i3S, Porto, Portugal.	lantunes@utad.pt	Martins, Tânia/O-4960-2018; Félix, Luis/G-5426-2011	Martins, Tânia/0000-0002-1546-0144; Félix, Luis/0000-0001-9870-6666; Antunes, Luis/0000-0002-9757-6879	University Jose Eduardo dos Santos (Huambo, Angola); Centre for the Research and Technology of Agro-Environmental and Biological Sciences - European Investment Funds by FEDER/COMPETE/POCI-Operacional Competitiveness and Internacionalization Programme [BI/CITAB/UTAD/VET/2015, POCI-01-0145-FEDER-006958]; National Funds by FCT - Portuguese Foundation for Science and Technology [UID/AGR/04033/2013]; European Investment Funds by FEDER/COMPETE/POCI-Operacional Competitiveness and Internacionalization Programme; National Funds through FCT - Portuguese Foundation for Science and Technology [FCOMP-01-0124-FEDER-028683 (PTDC/CVT-WEL/4672/2012)]	University Jose Eduardo dos Santos (Huambo, Angola); Centre for the Research and Technology of Agro-Environmental and Biological Sciences - European Investment Funds by FEDER/COMPETE/POCI-Operacional Competitiveness and Internacionalization Programme; National Funds by FCT - Portuguese Foundation for Science and Technology; European Investment Funds by FEDER/COMPETE/POCI-Operacional Competitiveness and Internacionalization Programme; National Funds through FCT - Portuguese Foundation for Science and Technology	University Jose Eduardo dos Santos (Huambo, Angola) (http://www.ujes-ao.org/) was the major funding, ensuring the execution of the research by ED for two years during his Master's programme. This work was also supported by additional funding: (TM) postdoctoral research grant BI/CITAB/UTAD/VET/2015 from the Centre for the Research and Technology of Agro-Environmental and Biological Sciences funded by European Investment Funds by FEDER/COMPETE/POCI-Operacional Competitiveness and Internacionalization Programme, under Project POCI-01-0145-FEDER-006958 and National Funds by FCT - Portuguese Foundation for Science and Technology, under the project UID/AGR/04033/2013; and European Investment Funds by FEDER/COMPETE/POCI-Operacional Competitiveness and Internacionalization Programme and by National Funds through FCT - Portuguese Foundation for Science and Technology under the project FCOMP-01-0124-FEDER-028683 (PTDC/CVT-WEL/4672/2012) (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablain J, 2013, TRENDS CELL BIOL, V23, P584, DOI 10.1016/j.tcb.2013.09.009; AMEND DF, 1982, T AM FISH SOC, V111, P337, DOI 10.1577/1548-8659(1982)111&lt;337:E&gt;2.0.CO;2; Avdesh A, 2012, JOVE-J VIS EXP, DOI 10.3791/4196; Bernstein PS, 1997, AM J OPHTHALMOL, V124, P843, DOI 10.1016/S0002-9394(14)71705-2; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Carter KM, 2011, REV FISH BIOL FISHER, V21, P51, DOI 10.1007/s11160-010-9188-0; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Collymore C, 2014, J AM ASSOC LAB ANIM, V53, P198; Davis MW, 2008, J AQUAT ANIM HEALTH, V20, P86, DOI 10.1577/H07-023.1; Felix LM, 2014, NEUROTOXICOL TERATOL, V41, P27, DOI 10.1016/j.ntt.2013.11.005; Fleming GJ, 2003, J ZOO WILDLIFE MED, V34, P153, DOI 10.1638/1042-7260(2003)034[0153:EOPAMF]2.0.CO;2; GholipourKanani H, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-76; Gibbs EM, 2013, FEBS J, V280, P4187, DOI 10.1111/febs.12412; Gomulka P, 2015, POL J VET SCI, V18, P147, DOI 10.1515/pjvs-2015-0019; Huang WC, 2010, ZEBRAFISH, V7, P297, DOI 10.1089/zeb.2010.0653; JALANKA HH, 1990, J ZOO WILDLIFE MED, V21, P259; Kalueff AV, 2014, PROG NEURO-PSYCHOPH, V55, P1, DOI 10.1016/j.pnpbp.2014.01.022; Kanungo J, 2013, J APPL TOXICOL, V33, P410, DOI 10.1002/jat.1751; Karmarkar SW, 2010, COMPARATIVE MED, V60, P256; Kohrs R, 1998, ANESTH ANALG, V87, P1186, DOI 10.1097/00000539-199811000-00039; Li YB, 2015, BRIT J CLIN PHARMACO, V80, P276, DOI 10.1111/bcp.12614; Martins T, 2016, LAB ANIM-UK, V50, P476, DOI 10.1177/0023677216670686; Miller SM, 2005, J ZOO WILDLIFE MED, V36, P673, DOI 10.1638/04034.1; Neiffer DL, 2009, ILAR J, V50, P343, DOI 10.1093/ilar.50.4.343; Park IS, 2011, LAB ANIMAL, V40, P45, DOI 10.1038/laban0211-45; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Readman GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073773; Riehl R, 2011, NEUROTOXICOL TERATOL, V33, P658, DOI 10.1016/j.ntt.2011.05.011; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P1, DOI 10.1002/9781444302264; Sanchez-Vazquez FJ, 2011, CHRONOBIOL INT, V28, P109, DOI 10.3109/07420528.2010.538105; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; Tavares B, 2013, ACTA MEDICA PORT, V26, P583; Valentim AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147747; Vitale G, 2014, ENDOCR-RELAT CANCER, V21, pR67, DOI 10.1530/ERC-13-0388; Warren KS, 2001, AM J PHYSIOL-HEART C, V281, pH1711, DOI 10.1152/ajpheart.2001.281.4.H1711; West G, 2014, ZOO ANIMAL AND WILDLIFE IMMOBILIZATION AND ANESTHESIA, 2ND EDITION, P1, DOI 10.1002/9781118792919; Williams TD, 2004, JAVMA-J AM VET MED A, V225, P417, DOI 10.2460/javma.2004.225.417; Wong D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088030; Zakhary SM, 2011, SYNAPSE, V65, P160, DOI 10.1002/syn.20830	40	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197846	10.1371/journal.pone.0197846	http://dx.doi.org/10.1371/journal.pone.0197846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787611	Green Submitted, gold, Green Published			2022-12-26	WOS:000432785700052
J	Bouma-Gregson, K; Kudela, RM; Power, ME				Bouma-Gregson, Keith; Kudela, Raphael M.; Power, Mary E.			Widespread anatoxin-a detection in benthic cyanobacterial mats throughout a river network	PLOS ONE			English	Article							FRESH-WATER CYANOBACTERIA; TOXIN TRACKING SPATT; LAND-SEA INTERFACE; HOMOANATOXIN-A; ALGAL TOXINS; MICROCYSTINS; ADSORPTION; COASTAL; GROWTH; IDENTIFICATION	Benthic algae fuel summer food webs in many sunlit rivers, and are hotspots for primary and secondary production and biogeochemical cycling. Concerningly, riverine benthic algal assemblages can become dominated by toxic cyanobacteria, threatening water quality and public health. In the Eel River in Northern California, over a dozen dog deaths have been attributed to cyanotoxin poisonings since 2000. During the summers of 2013-2015, we documented spatial and temporal patterns of cyanotoxin concentrations in the watershed, showing widespread distribution of anatoxin-a in benthic cyanobacterial mats. Solid phase adsorption toxin tracking (SPATT) samplers were deployed weekly to record dissolved microcystin and anatoxin-a levels at 10 sites throughout the watershed, and 187 Anabaena-dominated or Phormidium-dominated cyanobacterial mat samples were collected from 27 locations to measure intracellular anatoxin-a (ATX) and microcystins (MCY). Anatoxin-a levels were higher than microcystin for both SPATT (mean MCY = 0.8 and ATX = 4.8 ng g resin(-1) day(-1))and cyanobacterial mat samples (mean MCY = 0.074 and ATX = 1.89 mu g g(-1) DW). Of the benthic mats sampled, 58.9% had detectable anatoxin-a (max = 70.93 mu g g(-1) DW), while 37.6% had detectable microcystins (max = 2.29 mu g g(-1) DW). SPATT cyanotoxin levels peaked in mid-summer in warm mainstem reaches of the watershed. This is one of the first documentations of widespread anatoxin-a occurrence in benthic cyanobacterial mats in a North American watershed.	[Bouma-Gregson, Keith; Power, Mary E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Kudela, Raphael M.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA	University of California System; University of California Berkeley; University of California System; University of California Santa Cruz	Bouma-Gregson, K (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	kbg@berkeley.edu		Bouma-Gregson, Keith/0000-0002-0304-6034	US National Science Foundation's Eel River Critical Zone Observatory [EAR-1331940]; US Environmental Protection Agency Science to Achieve Results (STAR) Fellowship [91767101-0]; University of California Natural Reserve System Mathias summer graduate student grant; NorCal SETAC summer graduate student grant	US National Science Foundation's Eel River Critical Zone Observatory; US Environmental Protection Agency Science to Achieve Results (STAR) Fellowship; University of California Natural Reserve System Mathias summer graduate student grant; NorCal SETAC summer graduate student grant	This work was supported by the US National Science Foundation's Eel River Critical Zone Observatory [EAR-1331940]; a US Environmental Protection Agency Science to Achieve Results (STAR) Fellowship to KBG [91767101-0]; University of California Natural Reserve System Mathias summer graduate student grant to KBG; and a NorCal SETAC summer graduate student grant to KBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboal M, 2005, J APPL PHYCOL, V17, P231, DOI 10.1007/s10811-005-2999-z; [Anonymous], 2012, HPLC APPL NOT AN A M; Backer LC, 2013, TOXINS, V5, P1597, DOI 10.3390/toxins5091597; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bouma-Gregson K, 2017, HARMFUL ALGAE, V66, P79, DOI 10.1016/j.hal.2017.05.007; Cadel-Six S, 2007, APPL ENVIRON MICROB, V73, P7605, DOI 10.1128/AEM.01225-07; California CCHAB Network, 2016, APP CCHAB PREL CHANG; Campos A, 2010, INT J MOL SCI, V11, P268, DOI 10.3390/ijms11010268; Uriza EAC, 2017, TOXINS, V9, DOI 10.3390/toxins9120385; Carey CC, 2012, WATER RES, V46, P1394, DOI 10.1016/j.watres.2011.12.016; CARMICHAEL WW, 1979, TOXICON, V17, P229, DOI 10.1016/0041-0101(79)90212-5; Chorus I., 1999, Toxic cyanobacteria in water: a guide to their public health consequences, monitoring and management; DEVLIN JP, 1977, CAN J CHEM, V55, P1367, DOI 10.1139/v77-189; Fetscher AE, 2015, HARMFUL ALGAE, V49, P105, DOI 10.1016/j.hal.2015.09.002; Finlay JC, 2011, ECOLOGY, V92, P140, DOI 10.1890/09-2243.1; Garcia-Pichel F., 2003, ALGOLOGICAL STUDIES, V109, P213, DOI DOI 10.1127/1864-1318/2003/0109-0213; Gibble CM, 2016, HARMFUL ALGAE, V59, P59, DOI 10.1016/j.hal.2016.09.007; Gibble CM, 2014, HARMFUL ALGAE, V39, P146, DOI 10.1016/j.hal.2014.07.004; Gugger M, 2005, TOXICON, V45, P919, DOI 10.1016/j.toxicon.2005.02.031; Harland FMJ, 2013, TOXINS, V5, P2504, DOI 10.3390/toxins5122504; HART DD, 1985, OIKOS, V44, P40, DOI 10.2307/3544041; Heath M, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw021; Heath MW, 2011, AQUAT MICROB ECOL, V64, P69, DOI 10.3354/ame01516; Howard MDA, 2017, TOXINS, V9, DOI 10.3390/toxins9070231; Kaminski A, 2013, HARMFUL ALGAE, V28, P83, DOI 10.1016/j.hal.2013.05.014; Komarek J., 2013, SUSSWASSERFLORA MITT, V19/3; Kudela RM, 2017, COMP ANAL C, V78, P379, DOI 10.1016/bs.coac.2017.08.006; Kudela RM, 2011, HARMFUL ALGAE, V11, P117, DOI 10.1016/j.hal.2011.08.006; Lane JQ, 2010, LIMNOL OCEANOGR-METH, V8, P645, DOI 10.4319/lom.2010.8.0645; Li XC, 2016, HARMFUL ALGAE, V54, P54, DOI 10.1016/j.hal.2015.10.015; Lurling M, 2013, FRESHWATER BIOL, V58, P552, DOI 10.1111/j.1365-2427.2012.02866.x; MacKenzie L, 2004, TOXICON, V44, P901, DOI 10.1016/j.toxicon.2004.08.020; MacKenzie LA, 2010, CURR OPIN BIOTECH, V21, P326, DOI 10.1016/j.copbio.2010.01.013; McAllister TG, 2016, HARMFUL ALGAE, V55, P282, DOI 10.1016/j.hal.2016.04.002; Mekebri A, 2009, J CHROMATOGR A, V1216, P3147, DOI 10.1016/j.chroma.2009.01.095; Miller MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012576; Mohamed ZA, 2006, TOXICON, V47, P584, DOI 10.1016/j.toxicon.2006.01.029; Neilan BA, 2013, ENVIRON MICROBIOL, V15, P1239, DOI 10.1111/j.1462-2920.2012.02729.x; Omidi A, 2018, TOXIN REV, V37, P87, DOI 10.1080/15569543.2017.1326059; Osswald J, 2007, ENVIRON INT, V33, P1070, DOI 10.1016/j.envint.2007.06.003; Oudra B, 2009, ENVIRON MONIT ASSESS, V149, P437, DOI 10.1007/s10661-008-0220-y; PAERL HW, 1988, LIMNOL OCEANOGR, V33, P823, DOI 10.4319/lo.1988.33.4_part_2.0823; Peacock MB, 2018, HARMFUL ALGAE, V73, P138, DOI 10.1016/j.hal.2018.02.005; Power ME, 2008, ECOL MONOGR, V78, P263, DOI 10.1890/06-0902.1; Power ME, 2013, HYDROBIOLOGIA, V719, P119, DOI 10.1007/s10750-013-1510-0; Puschner B, 2008, J VET DIAGN INVEST, V20, P89, DOI 10.1177/104063870802000119; Quiblier C, 2013, WATER RES, V47, P5464, DOI 10.1016/j.watres.2013.06.042; R Core Team, 2021, R LANGUAGE ENV STAT; RAPALA J, 1994, LETT APPL MICROBIOL, V19, P423, DOI 10.1111/j.1472-765X.1994.tb00972.x; Rejmankova E, 2005, AQUAT BOT, V83, P87, DOI 10.1016/j.aquabot.2005.05.011; Sabater S, 2003, AQUAT MICROB ECOL, V32, P175, DOI 10.3354/ame032175; Scott J. T., 2012, ECOLOGY CYANOBACTERI, P271, DOI DOI 10.1007/978-94-007-3855-3_9; SIVONEN K, 1990, APPL ENVIRON MICROB, V56, P2650, DOI 10.1128/AEM.56.9.2650-2657.1990; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; Steinman Alan D., 1996, P341, DOI 10.1016/B978-012668450-6/50041-2; STEVENS DK, 1991, TOXICON, V29, P167, DOI 10.1016/0041-0101(91)90101-V; Tatters AO, 2017, TOXINS, V9, DOI 10.3390/toxins9030095; TUCHMAN NC, 1991, J N AM BENTHOL SOC, V10, P430, DOI 10.2307/1467668; US EPA Office of Water, 2015, HUM HLTH RE IN PRESS; Vadeboncoeur Y, 2017, ANNU REV ECOL EVOL S, V48, P255, DOI 10.1146/annurev-ecolsys-121415-032340; Wacklin P, 2009, FOTTEA, V9, P59, DOI 10.5507/fot.2009.005; Watermann F, 1999, MAR ECOL PROG SER, V187, P77, DOI 10.3354/meps187077; Whitton B.A., 2012, ECOLOGY CYANOBACTERI, P1, DOI DOI 10.1007/978-94-007-3855-3; Wood R, 2016, ENVIRON INT, V91, P276, DOI 10.1016/j.envint.2016.02.026; Wood SA, 2008, APPL ENVIRON MICROB, V74, P7243, DOI 10.1128/AEM.01243-08; Wood SA, 2017, MAR DRUGS, V15, DOI 10.3390/md15100307; Wood SA, 2017, FRESHW SCI, V36, P63, DOI 10.1086/690114; Wood SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141063; Wood SA, 2012, TOXINS, V4, P900, DOI 10.3390/toxins4100900; Wood SA, 2011, CHEMOSPHERE, V82, P888, DOI 10.1016/j.chemosphere.2010.10.055; Yang X, 2007, THESIS; Zendong Z, 2016, ENVIRON SCI TECHNOL, V50, P8522, DOI 10.1021/acs.est.6b02081; Zendong Z, 2014, TOXICON, V91, P57, DOI 10.1016/j.toxicon.2014.03.010	73	35	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197669	10.1371/journal.pone.0197669	http://dx.doi.org/10.1371/journal.pone.0197669			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775481	Green Submitted, Green Published, gold			2022-12-26	WOS:000432521100021
J	Coelho, MS; Carneiro, MAA; Branco, CA; Borges, RAX; Fernandes, GW				Coelho, Marcel Serra; Alves Carneiro, Marco Antonio; Branco, Cristina Alves; Xavier Borges, Rafael Augusto; Fernandes, Geraldo Wilson			Species turnover drives beta-diversity patterns across multiple spatial scales of plant-galling interactions in mountaintop grasslands	PLOS ONE			English	Article							BRAZILIAN PARAMOS; HOST-PLANT; ADAPTIVE SIGNIFICANCE; REGIONAL RICHNESS; FORMING INSECTS; MINAS-GERAIS; CAMPOS; GRADIENTS; ALTITUDE; RANGE	This study describes differences in species richness and composition of the assemblages of galling insects and their host plants at different spatial scales. Sampling was conducted along altitudinal gradients composed of campos rupestres and campos de altitude of two mountain complexes in southeastern Brazil: Espinhaco Range and Mantiqueira Range. The following hypotheses were tested: i) local and regional richness of host plants and galling insects are positively correlated; ii) beta diversity is the most important component of regional diversity of host plants and galling insects; and iii) Turnover is the main mechanism driving beta diversity of both host plants and galling insects. Local richness of galling insects and host plants increased with increasing regional richness of species, suggesting a pattern of unsaturated communities. The additive partition of regional richness (gamma) into local and beta components shows that local richnesses (alpha) of species of galling insects and host plants are low relative to regional richness; the beta (beta) component incorporates most of the regional richness. The multi-scale analysis of additive partitioning showed similar patterns for galling insects and host plants with the local component (alpha) incorporated a small part of regional richness. Beta diversity of galling insects and host plants were mainly the result of turnover, with little contribution from nesting. Although the species composition of galling insects and host plant species varied among sample sites, mountains and even mountain ranges, local richness remained relatively low. In this way, the addition of local habitats with different landscapes substantially affects regional richness. Each mountain contributes fundamentally to the composition of regional diversity of galling insects and host plants, and so the design of future conservation strategies should incorporate multiple scales.	[Coelho, Marcel Serra; Branco, Cristina Alves; Fernandes, Geraldo Wilson] Univ Fed Minas Gerais, ICB, DBG, Ecol Evolut & Biodiversidade, Belo Horizonte, MG, Brazil; [Coelho, Marcel Serra] Univ Estadual Paulista, UNESP, IB UNESP, Lab Phenol,Dept Bot, Rio Claro, SP, Brazil; [Alves Carneiro, Marco Antonio] Univ Fed Ouro Preto, ICEB, Lab Entomol Ecol, DEBIO, Ouro Preto, MG, Brazil; [Xavier Borges, Rafael Augusto] Univ Fed Rio Grande do Sul, Lab Bot, Porto Alegre, RS, Brazil	Universidade Federal de Minas Gerais; Universidade Estadual Paulista; Universidade Federal de Ouro Preto; Universidade Federal do Rio Grande do Sul	Coelho, MS (corresponding author), Univ Fed Minas Gerais, ICB, DBG, Ecol Evolut & Biodiversidade, Belo Horizonte, MG, Brazil.; Coelho, MS (corresponding author), Univ Estadual Paulista, UNESP, IB UNESP, Lab Phenol,Dept Bot, Rio Claro, SP, Brazil.	marcel.s.coelho@gmail.com	Fernandes, Geraldo/AAN-5602-2021	Fernandes, Geraldo/0000-0003-1559-6049; Coelho, Marcel/0000-0003-4918-3963	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	We thank ICMBio, IEF-MG, UFMG and UFOP for logistic support. We also thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP) for financial support.	Alves RJV, 2010, PLANT ECOL, V207, P67, DOI 10.1007/s11258-009-9654-8; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Blanche KR, 1996, AUST J ECOL, V21, P332, DOI 10.1111/j.1442-9993.1996.tb00616.x; Blanche KR, 2000, AUSTRAL ECOL, V25, P311, DOI 10.1046/j.1442-9993.2000.01040.x; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Caiafa Alessandra Nasser, 2005, Rodriguésia, V56, P163, DOI 10.1590/2175-78602005568712; Carneiro MAA, 2014, NEOTROPICAL INSECT G, P273, DOI DOI 10.1007/978-94-017-8783-316; Carneiro MAA, 2009, REV BRAS ENTOMOL, V53, P570, DOI 10.1590/S0085-56262009000400007; Carneiro MAA, 2009, REV BRAS ENTOMOL, V53, P365, DOI 10.1590/S0085-56262009000300010; Coelho MS, 2013, BIOTA NEOTROP, V13, P139, DOI 10.1590/S1676-06032013000400015; Coelho MS, 2013, BIOTA NEOTROP, V13, P102, DOI 10.1590/S1676-06032013000300013; Cornell Howard V., 1993, P243; CORNELL HV, 1985, ECOLOGY, V66, P1247, DOI 10.2307/1939178; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Cuevas-Reyes P, 2004, OIKOS, V107, P181, DOI 10.1111/j.0030-1299.2004.13263.x; Cuevas-Reyes P, 2004, J ECOL, V92, P707, DOI 10.1111/j.0022-0477.2004.00896.x; Cuevas-Reyes P, 2003, BIODIVERS CONSERV, V12, P411, DOI 10.1023/A:1022415907109; Dawkins R., 1982, pi; de Carvalho F, 2012, APPL SOIL ECOL, V52, P9, DOI 10.1016/j.apsoil.2011.10.001; Dreger-Jauffret F., 1992, P8; FERNANDES G. W., 2016, ECOLOGY CONSERVATION, V1, P345; FERNANDES GW, 1988, OECOLOGIA, V76, P161, DOI 10.1007/BF00379948; FERNANDES GW, 1992, OECOLOGIA, V90, P14, DOI 10.1007/BF00317803; Fernandes GW, 1996, TROP ZOOL, V9, P315, DOI 10.1080/03946975.1996.10539315; Fernandes GW, 1991, PLANT ANIMAL INTERAC, P91; Ferri M.G., 1980, VEGETACAO BRASILEIRA; Galvo MV, 1965, GEOGRAFIA BRASIL GRA, P91; Giulietti A.M., 1997, CTR PLANT DIVERSITY, V3, P397; Giulietti AM, 1987, B BOT U SAO PAULO, V9, P1, DOI DOI 10.11606/ISSN.2316-9052.V9I0P1-151; Goncalves-Alvim SJ, 2001, BIODIVERS CONSERV, V10, P79, DOI 10.1023/A:1016602213305; HAWKINS BA, 1992, J ANIM ECOL, V61, P361, DOI 10.2307/5328; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Lara ACF, 2002, TROP ZOOL, V15, P219, DOI 10.1080/03946975.2002.10531176; Loreau M, 2000, ECOL LETT, V3, P73, DOI 10.1046/j.1461-0248.2000.00127.x; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Martinelli Gustavo, 2007, Braz. J. Bot., V30, P587, DOI 10.1590/S0100-84042007000400005; Medianero Enrique, 2003, Acta Zool. Mex, P153; Medianero E, 2010, NEOTROP ENTOMOL, V39, P365, DOI 10.1590/S1519-566X2010000300009; Mello-Barreto H.L., 1949, B GEOGR, V14, P14; Mendonca MD, 2001, OIKOS, V95, P171, DOI 10.1034/j.1600-0706.2001.950120.x; Moreira AAN, 1977, GEOGRAFIA BRASIL REG; Negreiros D, 2014, PLANT ECOL, V215, P379, DOI 10.1007/s11258-014-0302-6; Nyman T, 2000, P NATL ACAD SCI USA, V97, P13184, DOI 10.1073/pnas.230294097; Price P.W., 1986, Proceedings of the Entomological Society of Washington, V88, P361; Price PW, 1998, J BIOGEOGR, V25, P581, DOI 10.1046/j.1365-2699.1998.2530581.x; Price PW, 1995, MACROEVOLUTIONARY TH; Price PW, 1997, BIOL GALL INDUCING A, P196; R Core Team, 2016, R FDN STAT COMP; Raman A, 2007, CURR SCI INDIA, V92, P748; Raman Anantanarayanan, 2005, P1; Resende FM, 2014, BRAZ J BIOL, V73, P709, DOI 10.1590/S1519-69842013000400005; Ribeiro-Mendes HN, 2002, TROP ZOOL, V15, P5, DOI 10.1080/03946975.2002.10531163; Ricklefs R, 1990, SPECIES DIVERSITY EC, P178; Rizzini CT, 1979, TRATADO FITOGEOGRAFI; Safford HD, 2001, BIOTROPICA, V33, P282; Safford HD, 1999, J BIOGEOGR, V26, P693, DOI 10.1046/j.1365-2699.1999.00313.x; Safford HD, 1999, J BIOGEOGR, V26, P713; Safford HD, 2007, J BIOGEOGR, V34, P1701, DOI 10.1111/j.1365-2699.2007.01732.x; Schaefer C.E., 2016, ECOLOGY CONSERVATION, P55; Shorthouse JD, 2005, BASIC APPL ECOL, V6, P407, DOI 10.1016/j.baae.2005.07.001; Shorthouse JD, 1998, BIOL INSECT ACARINA; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Srivastava DS, 1999, J ANIM ECOL, V68, P1, DOI 10.1046/j.1365-2656.1999.00266.x; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; STRONG DR, 1984, INSECTS PLANTS; Thompson JA, 1993, BRACKEN BIOL MANAGEM, P197; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; WEIS AE, 1988, ANNU REV ENTOMOL, V33, P467, DOI 10.1146/annurev.en.33.010188.002343; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wright Mark G., 1996, Biodiversity Letters, V3, P151, DOI 10.2307/2999733; Wright MG, 1998, OECOLOGIA, V115, P427, DOI 10.1007/s004420050537	73	16	16	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0195565	10.1371/journal.pone.0195565	http://dx.doi.org/10.1371/journal.pone.0195565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775458	Green Published, gold, Green Submitted			2022-12-26	WOS:000432521100006
J	Du, JM				Du, Jinming			Insurance optimizes complex interactive and cooperative behaviors in public goods games	PLOS ONE			English	Article							CLIMATE-CHANGE; DILEMMA; COMMONS; DYNAMICS; SUSTAINABILITY; EVOLUTION; TRAGEDY	Global cooperation is urgently needed to prevent risks of world-wide extreme events and disasters for sustainable development. In human societies, however, there exists bias toward interacting with partners with similar characteristics, but not contributing globally. We study how complex interactive behaviors evolve under risks through proposing a threshold public goods game model. In the model, individuals either play games with participants who own the same phenotype, or contribute to the collective target of global public goods. We further introduce an insurance compensation mechanism into the model to probe the evolution of global cooperation. It is found that the introduction of the insurance remarkably promotes the emergence of global cooperative behavior and inhibits the tendency to play games only with individuals of the same phenotype. Besides, contrary to models without insurance, global cooperation is strengthened with the increase of imitation intensities. In addition, high risk and high threshold are in favor of global cooperation.	[Du, Jinming] Northeastern Univ, Liaoning Engn Lab Operat Analyt & Optimizat Smart, Shenyang 110819, Liaoning, Peoples R China; [Du, Jinming] Northeastern Univ, Inst Ind & Syst Engn, Shenyang 110819, Liaoning, Peoples R China	Northeastern University - China; Northeastern University - China	Du, JM (corresponding author), Northeastern Univ, Liaoning Engn Lab Operat Analyt & Optimizat Smart, Shenyang 110819, Liaoning, Peoples R China.; Du, JM (corresponding author), Northeastern Univ, Inst Ind & Syst Engn, Shenyang 110819, Liaoning, Peoples R China.	dujinming@ise.neu.edu.cn	Du, Jinming/F-8006-2010	Du, Jinming/0000-0002-8146-9286	National Key Research and Development Program of China [2016YFB0901900]; National Natural Science Foundation of China (NSFC) [61703082]; Fundamental Research Funds for the Central Universities [N160403001]; Fund for Innovative Research Groups of the National Natural Science Foundation of China [71621061]; Major Program of National Natural Science Foundation of China [71790614]; Major International Joint Research Project of the National Natural Science Foundation of China [71520107004]; 111 Project [616009]	National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fund for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major International Joint Research Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project)	This research was supported by the National Key Research and Development Program of China (2016YFB0901900), the National Natural Science Foundation of China (NSFC) (Grant No. 61703082), the Fundamental Research Funds for the Central Universities (Grant No. N160403001), the Fund for Innovative Research Groups of the National Natural Science Foundation of China (Grant No. 71621061), the Major Program of National Natural Science Foundation of China (Grant No. 71790614), the Major International Joint Research Project of the National Natural Science Foundation of China (Grant No. 71520107004), and the 111 Project (616009) (JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal T, 2009, P NATL ACAD SCI USA, V106, P8597, DOI 10.1073/pnas.0902528106; Blackwell C, 2003, J ECON BEHAV ORGAN, V52, P115, DOI 10.1016/S0167-2681(02)00178-6; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Buchan NR, 2009, P NATL ACAD SCI USA, V106, P4138, DOI 10.1073/pnas.0809522106; Chen XJ, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052823; Chen XJ, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036101; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Dreber A, 2008, P NATL ACAD SCI USA, V105, P2261, DOI 10.1073/pnas.0800033105; Du J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036304; Du JM, 2018, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aa9bb6; Du JM, 2016, PHYS LETT A, V380, P1432, DOI 10.1016/j.physleta.2016.02.039; Du JM, 2014, EPL-EUROPHYS LETT, V107, DOI 10.1209/0295-5075/107/60005; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; Hilbe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066490; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Nordhaus W, 2015, AM ECON REV, V105, P1339, DOI 10.1257/aer.15000001; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Perc M, 2017, PHYS REP, V687, P1, DOI 10.1016/j.physrep.2017.05.004; Perc M, 2016, PHYS LETT A, V380, P2803, DOI 10.1016/j.physleta.2016.06.017; Pfeiffer T, 2006, NATURE, V441, P583, DOI 10.1038/441583a; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; Robertson R., 1992, GLOBALIZATION SOCIAL; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; Tavoni A, 2011, P NATL ACAD SCI USA, V108, P11825, DOI 10.1073/pnas.1102493108; Tollefson J, 2010, NATURE, V468, P875, DOI 10.1038/468875a; Traulsen A, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046129; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Traulsen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000270; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187	36	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197574	10.1371/journal.pone.0197574	http://dx.doi.org/10.1371/journal.pone.0197574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG2KJ	29775470	Green Submitted, Green Published, gold			2022-12-26	WOS:000432521100019
J	Agoro, R; Taleb, M; Quesniaux, VFJ; Mura, C				Agoro, Rafiou; Taleb, Meriem; Quesniaux, Valerie F. J.; Mura, Catherine			Cell iron status influences macrophage polarization	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR; HEPCIDIN EXPRESSION; PEPTIDE HEPCIDIN; INNATE IMMUNITY; MOUSE-LIVER; ACTIVATION; METABOLISM; INFLAMMATION; FERROPORTIN	Macrophages play crucial roles in innate immune response and in the priming of adaptive immunity, and are characterized by their phenotypic heterogeneity and plasticity. Reprogramming intracellular metabolism in response to microenvironmental signals is required for M1/M2 macrophage polarization and function. Here we assessed the influence of iron on the polarization of the immune response in vivo and in vitro. Iron-enriched diet increased M2 marker Arg1 and Ym1 expression in liver and peritoneal macrophages, while iron deficiency decreased Arg1 expression. Under LPS-induced inflammatory conditions, low iron diet exacerbated the proinflammatory response, while the IL-12/IL-10 balance decreased with iron-rich diet, thus polarizing toward type 2 response. Indeed, in vitro macrophage iron loading reduced the basal percentage of cells expressing M1 co-stimulatory CD86 and MHC-II molecules. Further, iron loading of macrophages prevented the pro-inflammatory response induced by LPS through reduction of NF-kB p65 nuclear translocation with decreased iNOS, IL-1 beta, IL-6, IL-12and TNF alpha expression. The increase of intracellular iron also reduced LPS-induced hepcidin gene expression and abolished ferroportin down-regulation in macrophages, in line with macrophage polarization. Thus, iron modulates the inflammatory response outcome, as elevated iron levels increased M2 phenotype and negatively regulated M1 proinflammatory LPS-induced response.	[Agoro, Rafiou; Taleb, Meriem; Quesniaux, Valerie F. J.; Mura, Catherine] CNRS, UMR 7355, Expt & Mol Immunol & Neurogenet, Orleans, France; [Agoro, Rafiou; Taleb, Meriem; Quesniaux, Valerie F. J.; Mura, Catherine] Univ Orleans, Orleans, France; [Agoro, Rafiou] NYU, Coll Dent, New York, NY USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; New York University	Mura, C (corresponding author), CNRS, UMR 7355, Expt & Mol Immunol & Neurogenet, Orleans, France.; Mura, C (corresponding author), Univ Orleans, Orleans, France.	catherine.mura@cnrs-orleans.fr	Agoro, Rafiou/AAI-2916-2020	AGORO, RAFIOU/0000-0002-5461-7685	European Regional Development Fund [2016-00110366]	European Regional Development Fund(European Commission)	This work received support from the European Regional Development Fund No 2016-00110366; ec.europa.eu/regional_policy/en/funding/erdf/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Agoro R, 2016, BLOOD CELL MOL DIS, V61, P16, DOI 10.1016/j.bcmd.2016.07.006; Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; ANDERSON MT, 1994, P NATL ACAD SCI USA, V91, P11527, DOI 10.1073/pnas.91.24.11527; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Beaumont C, 2009, SEMIN HEMATOL, V46, P328, DOI 10.1053/j.seminhematol.2009.06.004; Besson-Fournier C, 2012, BLOOD, V120, P431, DOI 10.1182/blood-2012-02-411470; Bohuslav J, 1998, J CLIN INVEST, V102, P1645, DOI 10.1172/JCI3877; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Cairo G, 2011, TRENDS IMMUNOL, V32, P241, DOI 10.1016/j.it.2011.03.007; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Gan ZS, 2017, MEDIAT INFLAMM, V2017, DOI [10.1155/2017/8570818, DOI 10.1155/2017/8570818]; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; GOODWIN JF, 1966, CLIN CHEM, V12, P47; Granger DL, 1996, METHOD ENZYMOL, V268, P142; Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017; Guida C, 2015, BLOOD, V125, P2265, DOI 10.1182/blood-2014-08-595256; Hardbower DM, 2016, AMINO ACIDS, V48, P2375, DOI 10.1007/s00726-016-2231-2; Hoeft K, 2017, ANESTHESIOLOGY, V127, P121, DOI 10.1097/ALN.0000000000001653; Huang BW, 2013, FASEB J, V27, P3763, DOI 10.1096/fj.12-226043; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Liu XB, 2005, BLOOD CELL MOL DIS, V35, P47, DOI 10.1016/j.bcmd.2005.04.006; Mackenzie EL, 2008, ANTIOXID REDOX SIGN, V10, P997, DOI 10.1089/ars.2007.1893; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Mills CD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00059; Muller M, 1996, MOL MED, V2, P247, DOI 10.1007/BF03401621; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Nairz M, 2015, IMMUNOBIOLOGY, V220, P280, DOI 10.1016/j.imbio.2014.09.010; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nguyen NB, 2006, AM J PHYSIOL-LUNG C, V291, pL417, DOI 10.1152/ajplung.00484.2005; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Okamoto T, 2004, AM J PHYSIOL-LUNG C, V286, pL198, DOI 10.1152/ajplung.00136.2003; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Porta C, 2015, SEMIN IMMUNOL, V27, P237, DOI 10.1016/j.smim.2015.10.003; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Shi XL, 1999, MOL CELL BIOCHEM, V194, P63, DOI 10.1023/A:1006904904514; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Yang FM, 2002, J BIOL CHEM, V277, P39786, DOI 10.1074/jbc.M201485200; Yin Q, 2015, ANNU REV IMMUNOL, V33, P393, DOI 10.1146/annurev-immunol-032414-112258; Zanganeh S, 2016, NAT NANOTECHNOL, V11, P986, DOI [10.1038/nnano.2016.168, 10.1038/NNANO.2016.168]	61	85	87	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196921	10.1371/journal.pone.0196921	http://dx.doi.org/10.1371/journal.pone.0196921			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771935	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900022
J	Benito-Gonzalei, E; Palacios-Cena, M; Fernandez-Munoz, JJ; Castaldo, M; Wang, KL; Catena, A; Arendt-Nielsen, L; Fernandez-de-las-Penas, C				Benito-Gonzalei, Elena; Palacios-Cena, Maria; Fernandez-Munoz, Juan J.; Castaldo, Matteo; Wang, Kelun; Catena, Antonella; Arendt-Nielsen, Lars; Fernandez-de-las-Penas, Cesar			Variables associated with sleep quality in chronic tension-type headache: A cross-sectional and longitudinal design	PLOS ONE			English	Article							HEALTH SURVEY SF-36; HOSPITAL ANXIETY; POOR SLEEP; PAIN; DEPRESSION; POPULATION; PREVALENCE; DISORDERS; MIGRAINE; VALIDITY	Objective To investigate variables associated at baseline (cross-sectional design) and at one year (longitudinal design) with the quality of sleep in chronic tension-type headache (CTTH). Methods One hundred and eighty (n = 180) and 135 individuals with CTTH participated in the cross-sectional and longitudinal design respectively. Clinical features were collected with a 4 weeks headache diary at baseline and one-year follow-up. Sleep quality was assessed at baseline and 1-year follow-up with the Pittsburgh Sleep Quality Index. Anxiety and depression (Hospital Anxiety and Depression Scale-HADS), burden of headache (Headache Disability Inventory-HDI), quality of life (SF-36 questionnaire), and pressure pain thresholds (PPTs) at trigeminal, extra-trigeminal and widespread area were assessed at baseline. Hierarchical regression analyses were conducted to determine the associations between variables at baseline and 1-year follow-up with sleep quality. Results At baseline positive correlations between sleep quality and headache intensity, headache frequency, headache duration, emotional and physical burden of headache and depression were observed. The regression analyses found that depression and emotional burden of headache explained 27.5% of the variance in sleep quality at baseline (r(2) = .262; F = 23.72 P < .001). At one-year, sleep quality was significantly associated with baseline burden of headache, depression, widespread PPTs, vitality and mental health domains. Regression analyses revealed that vitality, PPT over the second metacarpal and PPT over the neck explained 30.0% of the variance of sleep quality at one-year (r(2) = .269, F = 9.71, P < .001). Conclusions It seems that sleep quality exhibits a complex interaction in individuals with CTTH since depression and the emotional burden were associated with sleep quality at baseline, but vitality and PPTs over extra-trigeminal areas were associated with the quality of sleep at one-year.	[Benito-Gonzalei, Elena; Palacios-Cena, Maria; Fernandez-de-las-Penas, Cesar] Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Alcorcon, Spain; [Palacios-Cena, Maria; Castaldo, Matteo; Wang, Kelun; Arendt-Nielsen, Lars; Fernandez-de-las-Penas, Cesar] Aalborg Univ, Sch Med, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark; [Fernandez-Munoz, Juan J.] Univ Rey Juan Carlos, Dept Psychol, Alcorcon, Spain; [Castaldo, Matteo] Univ Siena, Master Sport Physiotherapy, Siena, Italy; [Castaldo, Matteo; Catena, Antonella] Poliambulatorio Fisioctr, Parma, Italy	Universidad Rey Juan Carlos; Aalborg University; Universidad Rey Juan Carlos; University of Siena	Fernandez-de-las-Penas, C (corresponding author), Univ Rey Juan Carlos, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Alcorcon, Spain.; Fernandez-de-las-Penas, C (corresponding author), Aalborg Univ, Sch Med, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark.	cesar.fernandez@urjc.es	Muñoz, Juan José Fernández/AAA-4498-2019; Arendt-Nielsen, Lars/T-4885-2018; castaldo, matteo/AAT-6421-2021	Muñoz, Juan José Fernández/0000-0001-5519-7515; Arendt-Nielsen, Lars/0000-0003-0892-1579				Baron J, 2017, HEADACHE, V57, P226, DOI 10.1111/head.12984; Beghi E, 2010, J HEADACHE PAIN, V11, P141, DOI 10.1007/s10194-010-0187-2; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Chiu HY, 2016, J PSYCHOSOM RES, V87, P85, DOI 10.1016/j.jpsychores.2016.06.010; Chiu YH, 2005, PAIN, V115, P316, DOI 10.1016/j.pain.2005.03.009; Cole JC, 2007, CLIN THER, V29, P2580, DOI 10.1016/j.clinthera.2007.12.005; de Tommaso M, 2016, CURR RHEUMATOL REV, V12, P1; de Tommaso M, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-64; Dodick DW, 2003, HEADACHE, V43, P282, DOI 10.1046/j.1526-4610.2003.03055.x; Engstrom M, 2014, CEPHALALGIA, V34, P455, DOI 10.1177/0333102413515339; Engstrom M, 2014, ACTA NEUROL SCAND, V129, P47, DOI 10.1111/ane.12237; Ferrante T, 2013, NEUROL SCI, V34, pS137, DOI 10.1007/s10072-013-1370-4; Fuensalida-Novo S, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0829-8; George SZ, 2011, PHYS THER, V91, P358, DOI 10.2522/ptj.20100192; Houle TT, 2012, PAIN, V153, P2432, DOI 10.1016/j.pain.2012.08.014; JACOBSON GP, 1995, HEADACHE, V35, P534, DOI 10.1111/j.1526-4610.1995.hed3509534.x; JACOBSON GP, 1994, NEUROLOGY, V44, P837, DOI 10.1212/WNL.44.5.837; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Jensen R, 2011, CEPHALALGIA, V31, P1549, DOI 10.1177/0333102411424212; Juang K D, 1999, Zhonghua Yi Xue Za Zhi (Taipei), V62, P749; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Nagappa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143697; Palacios-Cena M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0730-5; Passchier J, 1996, HEADACHE, V36, P556, DOI 10.1046/j.1526-4610.1996.3609556.x; Phillip D, 2007, CEPHALALGIA, V27, P1, DOI 10.1111/j.1468-2982.2007.01239.x; Probyn K, 2017, NEUROLOGY, V89, P291, DOI 10.1212/WNL.0000000000004112; Raggi A, 2015, ACTA NEUROL SCAND, V132, P16, DOI 10.1111/ane.12339; Rains JC, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-014-0520-2; Sancisi E, 2010, HEADACHE, V50, P1464, DOI 10.1111/j.1526-4610.2010.01711.x; Snaith R, 2011, HOSP ANXIETY DEPRESS; SPIEGELHALDER K, 2013, CU RR PSYCHIATRY REP, V15, DOI DOI 10.1007/811920-013-0364-; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Steiner TJ, 2015, J HEADACHE PAIN, V16, P1, DOI 10.1186/s10194-015-0544-2; Terry EL, 2013, PAIN, V154, P2759, DOI 10.1016/j.pain.2013.08.009; Uhlig BL, 2014, CEPHALALGIA, V34, P745, DOI 10.1177/0333102414540058; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wang J, 2013, EUR J NEUROL, V20, P689, DOI 10.1111/ene.12039; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zebenholzer K, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0603-3; Zhu Z, 2013, ACTA NEUROL BELG, V113, P229, DOI 10.1007/s13760-012-0159-1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zwart JA, 2003, EUR J NEUROL, V10, P147, DOI 10.1046/j.1468-1331.2003.00551.x	45	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197381	10.1371/journal.pone.0197381	http://dx.doi.org/10.1371/journal.pone.0197381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG0DP	29771988	Green Submitted, gold, Green Published			2022-12-26	WOS:000432348900054
J	Marrs, C; Chesmore, K; Menon, R; Williams, S				Marrs, Caroline; Chesmore, Kevin; Menon, Ramkumar; Williams, Scott			Maternal human telomerase reverse transcriptase variants are associated with preterm labor and preterm premature rupture of membranes	PLOS ONE			English	Article							CELLULAR SENESCENCE; HUMAN PARTURITION; LENGTH; CANCER; DISEASE; BIRTH; RISK; POLYMORPHISM; METAANALYSIS; OBESITY	Objective Premature aging and short telomere lengths of fetal tissues are associated with spontaneous preterm labor (PTL) and preterm premature rupture of membranes (pPROM). Maintenance of telomere length is performed by the enzyme telomerase. Human telomerase reverse transcriptase (hTERT) is a subunit of telomerase, and its dysfunction affects telomere shortening. This study assessed whether maternal or fetal genetic variations in the hTERT gene are associated with PTL or pPROM. Methods A case (PTL or pPROM) control (term birth) genetic association study was conducted in 654 non-Hispanic white mothers (438 term, 162 PTL, 54 pPROM) and 502 non-Hispanic white newborns (346 term, 116 PTB, 40 pPROM). Maternal and fetal DNA samples were genotyped for 23 single nucleotide polymorphisms (SNPs) within the hTERT gene. Allele frequencies were compared between cases and controls, stratified by PTL and pPROM. Maternal and fetal data were analyzed separately. Results Allelic differences in one SNP of hTERT (rs2853690) were significantly associated with both PTL (adjusted OR 2.24, 95%CI 1.64-3.06, p = 2.32e-05) and with pPROM (adjusted OR 7.54, 95%CI 3.96-14.33, p = 2.39e-07) in maternal DNA. There was no significant association between the hTERT SNPs analyzed and PTL or pPROM in the fetal samples. Conclusion hTERT polymorphisms in fetal DNA do not associate with PTL or pPROM risk; however, maternal genetic variations in hTERT may play a contributory role in risk of PTL and PPROM.	[Marrs, Caroline; Menon, Ramkumar] Univ Texas Med Branch, Div Maternal Fetal Med, Galveston, TX 77555 USA; [Chesmore, Kevin] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Williams, Scott] Case Western Reserve Univ, Cleveland, OH 44106 USA	University of Texas System; University of Texas Medical Branch Galveston; Dartmouth College; Case Western Reserve University	Menon, R (corresponding author), Univ Texas Med Branch, Div Maternal Fetal Med, Galveston, TX 77555 USA.	ram.menon@utmb.edu	Williams, Scott/Q-4812-2019	Williams, Scott/0000-0002-4835-9544	RO1 from the National Institute of Health (National Institute of Child Health and Human Development)	RO1 from the National Institute of Health (National Institute of Child Health and Human Development)	This study is supported by RO1 from the National Institute of Health (National Institute of Child Health and Human Development, https://www.nichd.nih.gov/Pages/index.aspx) to RM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutagawa O, 2007, PLACENTA, V28, P920, DOI 10.1016/j.placenta.2007.03.005; Bayram S, 2016, GENE, V585, P84, DOI 10.1016/j.gene.2016.03.030; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behnia F, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.05.041; Benetos A, 2004, HYPERTENSION, V43, P182, DOI 10.1161/01.HYP.0000113081.42868.f4; Biron-Shental T, 2011, EARLY HUM DEV, V87, P73, DOI 10.1016/j.earlhumdev.2010.08.024; Biron-Shental T, 2010, EARLY HUM DEV, V86, P451, DOI 10.1016/j.earlhumdev.2010.06.002; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brodsky SV, 2004, CIRC RES, V94, P377, DOI 10.1161/01.RES.0000111802.09964.EF; Cheng GH, 2013, BIOCHEM BIOPH RES CO, V442, P112, DOI 10.1016/j.bbrc.2013.11.022; Choi BJ, 2015, WORLD J GASTROENTERO, V21, P9328, DOI 10.3748/wjg.v21.i31.9328; Chuprin A, 2013, GENE DEV, V27, P2356, DOI 10.1101/gad.227512.113; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Culhane JF, 2011, SEMIN PERINATOL, V35, P234, DOI 10.1053/j.semperi.2011.02.020; D'Mello MJJ, 2015, CIRC-CARDIOVASC GENE, V8, P82, DOI 10.1161/CIRCGENETICS.113.000485; Dong D, 2017, ONCOTARGET, V8, P16109, DOI 10.18632/oncotarget.14884; Dutta EH, 2016, MOL HUM REPROD, V22, P143, DOI 10.1093/molehr/gav074; Gong L, 2016, CANCER BIOMARK, V17, P195, DOI 10.3233/CBM-160631; Hansen MEB, 2016, HUM MOL GENET, V25, P2324, DOI 10.1093/hmg/ddw070; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Hayflick Leonard, 1998, Keio Journal of Medicine, V47, P174; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Kim SY, 2006, YONSEI MED J, V47, P698, DOI 10.3349/ymj.2006.47.5.698; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Long N, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027849; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Martin Joyce A, 2010, Natl Vital Stat Rep, V59, P3; Martinez I, 2016, VIRULENCE, V7, P427, DOI 10.1080/21505594.2016.1144001; Menon R, 2016, HUM REPROD UPDATE, V22, P535, DOI 10.1093/humupd/dmw022; Menon R, 2016, AGING-US, V8, P216, DOI 10.18632/aging.100891; Menon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031136; Menon R, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-62; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Nishi H, 1998, INT J ONCOL, V12, P81; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.026; Shen TT, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.011; Shi Q, 2007, AM J PHYSIOL-HEART C, V292, pH2913, DOI 10.1152/ajpheart.01405.2006; Stone RC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006144; Tobler K, 2010, INT J OBESITY, V34, P687, DOI 10.1038/ijo.2009.280; Varela E, 2010, ONCOGENE, V29, P1561, DOI 10.1038/onc.2010.15; Velez DR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.051; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Zhang L, 2007, ORAL ONCOL, V43, P693, DOI 10.1016/j.oraloncology.2006.08.008; Zhang WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047029; Zhou F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-78	48	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0195963	10.1371/journal.pone.0195963	http://dx.doi.org/10.1371/journal.pone.0195963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771920	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900008
J	Moore, A				Moore, Alexandria			Context-dependent consumer control in New England tidal wetlands	PLOS ONE			English	Article							SALT-MARSH ECOSYSTEM; TROPHIC CASCADES; FIDDLER-CRABS; PREDATOR CONTROL; ENERGY-FLOW; IMPACT; BIODIVERSITY; DIVERSITY; HERBIVORY; DENSITY	Recent studies in coastal wetlands have indicated that consumers may play an important role in regulating large-scale ecosystem processes. Predator removal experiments have shown significant differences in above-ground biomass production in the presence of higher level consumers, or predators. These results indicate that predators play an important role in regulating biomass production, but the extent to which this regulation impacts additional ecosystem functions, such as nutrient cycling and organic matter accumulation, is unclear. This study evaluated the impact that consumers have on large-scale ecosystem processes within southern New England tidal wetlands and contributes to the general understanding of trophic control in these systems. I established enclosure cages within three coastal wetlands and manipulated the presence of green crab predators to assess how trophic interactions affect ecosystem functions. Findings suggest that although these consumers may exert some top-down effects, other environmental factors, such as other consumers not studied here or bottom-up interactions, may variably play a larger role in the maintenance of ecosystem processes within the region. These results indicate that the loss of top-down control as an important mechanism influencing ecosystem functions may not hold for all wetlands along the full extent of the New England coastline.	[Moore, Alexandria] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	Yale University	Moore, A (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	alexandria.moore@yale.edu		Moore, Alexandria/0000-0003-3563-7119	Connecticut Sea Grant of the University of Connecticut [PD-14-09]; Yale Institute for Biospheric Studies [0061AE]; Quebec Labrador Foundation (Sounds Conservancy Grant)	Connecticut Sea Grant of the University of Connecticut; Yale Institute for Biospheric Studies; Quebec Labrador Foundation (Sounds Conservancy Grant)	This work was supported by a Connecticut Sea Grant of the University of Connecticut (Award PD-14-09), http//seagrant uconn.edu/; AM received the funding; Yale Institute for Biospheric Studies (Award 0061AE), http://yibs.yale.edu/; AM received funding; and Quebec Labrador Foundation (Sounds Conservancy Grant), https://www.qlf.org/; AM received funding. All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belovsky GE, 2000, P NATL ACAD SCI USA, V97, P14412, DOI 10.1073/pnas.250483797; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; Bertness MD, 2014, ECOL LETT, V17, P830, DOI 10.1111/ele.12287; Bertness MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092916; Bertness MD, 2013, ECOLOGY, V94, P1937, DOI 10.1890/12-2150.1; Bertness MD, 2009, ECOLOGY, V90, P2108, DOI 10.1890/08-1396.1; BERTNESS MD, 1985, ECOLOGY, V66, P1042, DOI 10.2307/1940564; Coll M, 2012, AQUAT ECOL, V46, P55, DOI 10.1007/s10452-011-9381-9; Coverdale TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093296; Coverdale TC, 2013, CONSERV BIOL, V27, P1041, DOI 10.1111/cobi.12052; Coverdale TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073823; Coverdale TC, 2012, ECOLOGY, V93, P2085, DOI 10.1890/12-0010.1; Daleo P, 2009, J EXP MAR BIOL ECOL, V373, P66, DOI 10.1016/j.jembe.2009.03.005; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fanjul E, 2007, MAR ECOL PROG SER, V341, P177, DOI 10.3354/meps341177; Gittman RK, 2013, ECOLOGY, V94, P2709, DOI 10.1890/13-0152.1; Gregory GJ, 2011, J SEA RES, V66, P181, DOI 10.1016/j.seares.2011.05.009; Gribsholt B, 2003, MAR ECOL PROG SER, V259, P237, DOI 10.3354/meps259237; He Q, 2016, ECOL MONOGR, V86, P278, DOI 10.1002/ecm.1221; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hensel MJS, 2013, P NATL ACAD SCI USA, V110, P20621, DOI 10.1073/pnas.1312317110; Holdredge C, 2009, CONSERV BIOL, V23, P672, DOI 10.1111/j.1523-1739.2008.01137.x; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jennions MD, 2003, ANIM BEHAV, V66, P251, DOI 10.1006/anbe.2003.2190; Kuznetsova A., 2016, J STAT SOFTW, V2, P33; LUBCHENCO J, 1978, AM NAT, V112, P23, DOI 10.1086/283250; MILLER DON CURTIS, 1961, ZOOLOGICA [NEW YORK], V46, P89; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nelson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038558; ODUM E. P., 1959, PROC NATL ACAD SCI, V45, P617, DOI 10.1073/pnas.45.4.617; Osenberg CW, 1997, AM NAT, V150, P798, DOI 10.1086/286095; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; Peer N, 2015, AFR ZOOL, V50, P187, DOI 10.1080/15627020.2015.1055700; Penha-Lopes G, 2009, MAR POLLUT BULL, V58, P1694, DOI 10.1016/j.marpolbul.2009.06.015; Persson IL, 2005, OIKOS, V108, P297, DOI 10.1111/j.0030-1299.2005.13844.x; Reinsel KA, 2004, J EXP MAR BIOL ECOL, V313, P1, DOI 10.1016/j.jembe.2004.06.003; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Robertson GP, 1999, LT EC RES NETWK SER, V2, P258; Sala NM, 2008, OIKOS, V117, P1050, DOI 10.1111/j.0030-1299.2008.16296.x; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Schmitz OJ, 2004, ECOL LETT, V7, P403, DOI 10.1111/j.1461-0248.2004.00592.x; Schmitz OJ, 2003, ECOL LETT, V6, P156, DOI 10.1046/j.1461-0248.2003.00412.x; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Schmitz OJ, 2014, ECOSYSTEMS, V17, P344, DOI 10.1007/s10021-013-9715-7; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Silliman BR, 2002, P NATL ACAD SCI USA, V99, P10500, DOI 10.1073/pnas.162366599; SMALLEY AE, 1960, ECOLOGY, V41, P672, DOI 10.2307/1931800; Smith NF, 2009, MAR BIOL, V156, P2255, DOI 10.1007/s00227-009-1253-7; Smith-Ramesh LM, 2017, GLOBAL CHANGE BIOL, V23, P465, DOI 10.1111/gcb.13460; Strickland MS, 2013, P NATL ACAD SCI USA, V110, P11035, DOI 10.1073/pnas.1305191110; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; TEAL JM, 1962, ECOLOGY, V43, P614, DOI 10.2307/1933451; Wang JQ, 2010, ECOSYSTEMS, V13, P586, DOI 10.1007/s10021-010-9342-5; Weissberger EJ, 2009, J EXP MAR BIOL ECOL, V371, P60, DOI 10.1016/j.jembe.2009.01.005	59	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197170	10.1371/journal.pone.0197170	http://dx.doi.org/10.1371/journal.pone.0197170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771961	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900031
J	Proks, P; Kramer, H; Haythorne, E; Ashcroft, FM				Proks, Peter; Kramer, Holger; Haythorne, Elizabeth; Ashcroft, Frances M.			Binding of sulphonylureas to plasma proteins - A K-ATP channel perspective	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; ELECTRICAL-ACTIVITY; SERUM-ALBUMIN; GLIBENCLAMIDE; INSULIN; TOLBUTAMIDE; RECEPTOR; KIR6.2; BLOCK; NUCLEOTIDES	Sulphonylurea drugs stimulate insulin secretion from pancreatic (beta-cells primarily by inhibiting ATP sensitive potassium (K-ATP) channels in the (beta-cell membrane. The effective sulphonylurea concentration at its site of action is significantly attenuated by binding to serum albumin, which makes it difficult to compare in vitro and in vivo data. We therefore measured the ability of gliclazide and glibenclamide to inhibit K-ATP channels and stimulate insulin secretion in the presence of serum albumin. We used this data, together with estimates of free drug concentrations from binding studies, to predict the extent of sulphonylurea inhibition of K-ATP channels at therapeutic concentrations in vivo. K-ATP currents from mouse pancreatic beta-cells and Xenopus oocytes were measured using the patch-clamp technique. Gliclazide and glibenclamide binding to human plasma were determined in spiked plasma samples using an ultrafiltration-mass spectrometry approach. Bovine serum albumin (60g/l) produced a mild, non-significant reduction of gliclazide block of K-ATP currents in pancreatic beta-cells and Xenopus oocytes. In contrast, glibenclamide inhibition of recombinant K-ATP channels was dramatically suppressed by albumin (predicted free drug concentration <0.1%). Insulin secretion was also reduced. Free concentrations of gliclazide and glibenclamide in the presence of human plasma measured in binding experiments were 15% and 0.05%, respectively. Our data suggest the free concentration of glibenclamide in plasma is too low to account for the drug's therapeutic effect. In contrast, the free gliclazide concentration in plasma is high enough to close KATP channels and stimulate insulin secretion.	[Proks, Peter; Kramer, Holger; Haythorne, Elizabeth; Ashcroft, Frances M.] Univ Oxford, Oxford Ctr Gene Funct, Dept Physiol Anat & Genet, Oxford, England; [Kramer, Holger] Imperial Coll London, MRC London Inst Med Sci, London, England	University of Oxford; Imperial College London	Ashcroft, FM (corresponding author), Univ Oxford, Oxford Ctr Gene Funct, Dept Physiol Anat & Genet, Oxford, England.	frances.ashcroft@dpag.ox.ac.uk	Kramer, Holger/AAL-4433-2020	Kramer, Holger/0000-0002-6400-0945; Ashcroft, Frances/0000-0002-6970-1767; Proks, Peter/0000-0001-6097-3646; Haythorne, Elizabeth/0000-0003-3097-9240	Wellcome Trust [884655, 089795]; European Union: ERC Advanced grant [322620]; ERC Advanced Investigator award; Royal Society Research Wolfson Merit Award; BBSRC [BB/R017220/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Union: ERC Advanced grant; ERC Advanced Investigator award; Royal Society Research Wolfson Merit Award; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (https:/wellcome.ac.uk/): grant numbers 884655 and 089795 - to FMA; European Union: ERC Advanced grant (https://erc.europa.eu/funding/advanced-grants): 322620 - to FMA; ERC Advanced Investigator award (https://erc.europa.eu/funding/advanced-grants) - to FMA; and Royal Society Research Wolfson Merit Award (https://royalsociety.org/grants-schemes-awards/grants/wolfson-research-merit/) - to FMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmoneim AS, 2012, DIABETES OBES METAB, V14, P130, DOI 10.1111/j.1463-1326.2011.01496.x; Ammala C, 1996, NATURE, V379, P545, DOI 10.1038/379545a0; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Anguizola J, 2013, CLIN CHIM ACTA, V425, P64, DOI 10.1016/j.cca.2013.07.013; ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Brereton MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5639; BROWN KF, 1974, CAN J PHARM SCI, V9, P75; CARPENTIER JL, 1986, DIABETOLOGIA, V29, P259, DOI 10.1007/BF00454887; Doliba NM, 2011, AM J PHYSIOL-ENDOC M, V302, pE87, DOI [10.1152/ajpendo.00218.2011, DOI 10.1152/ARGENDO.00218.2011]; FERRER R, 1984, AM J PHYSIOL, V246, pC520, DOI 10.1152/ajpcell.1984.246.5.C520; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Gomis A, 1996, PFLUG ARCH EUR J PHY, V432, P510, DOI 10.1007/s004240050163; Gopalakrishnan M, 2000, BRIT J PHARMACOL, V129, P1323, DOI 10.1038/sj.bjp.0703181; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P497, DOI 10.1111/j.1469-7793.2000.00497.x; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; HELLMAN B, 1974, METABOLISM, V23, P839, DOI 10.1016/0026-0495(74)90117-6; HELLMAN B, 1984, ACTA ENDOCRINOL-COP, V105, P385, DOI 10.1530/acta.0.1050385; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; HSU PL, 1974, J PHARM SCI, V63, P570, DOI 10.1002/jps.2600630416; KOBAYASHI K, 1986, CHEM PHARM BULL, V34, P2957; KWONG TC, 1985, CLIN CHIM ACTA, V151, P193, DOI 10.1016/0009-8981(85)90082-8; Lahmann C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134476; Lawrence CL, 2001, DIABETOLOGIA, V44, P1019, DOI 10.1007/s001250100595; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.31054; Matsuda R, 2012, J CHROMATOGR A, V1265, P114, DOI 10.1016/j.chroma.2012.09.091; Matsuda R, 2011, ANAL BIOANAL CHEM, V401, P2811, DOI 10.1007/s00216-011-5382-8; McCulloch LJ, 2011, MOL GENET METAB, V104, P648, DOI 10.1016/j.ymgme.2011.08.026; Myngheer N, 2014, DIABETES CARE, V37, P3333, DOI 10.2337/dc14-1247; OLSEN KM, 1995, J CLIN PHARMACOL, V35, P739, DOI 10.1002/j.1552-4604.1995.tb04115.x; Park JY, 2003, CLIN PHARMACOL THER, V74, P334, DOI 10.1016/S0009-9236(03)00221-2; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Pertusa JAG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187547; Peters T., 1996, ALL ALBUMIN BIOCH GE; Proks P, 2005, HUM MOL GENET, V14, P2717, DOI 10.1093/hmg/ddi305; Proks P, 2002, DIABETES, V51, pS368, DOI 10.2337/diabetes.51.2007.S368; Proks P, 2013, DIABETES, V62, P3909, DOI 10.2337/db13-0531; Proks P, 2010, J GEN PHYSIOL, V136, P389, DOI 10.1085/jgp.201010475; Renstrom E, 2002, DIABETES, V51, pS33, DOI 10.2337/diabetes.51.2007.S33; Russ U, 2009, BRIT J PHARMACOL, V156, P354, DOI 10.1111/j.1476-5381.2008.00005.x; RYDBERG T, 1994, DIABETES CARE, V17, P1026, DOI 10.2337/diacare.17.9.1026; SARTOR G, 1980, DIABETOLOGIA, V18, P17, DOI 10.1007/BF01228296; SCHWANSTECHER M, 1994, BRIT J PHARMACOL, V113, P903, DOI 10.1111/j.1476-5381.1994.tb17078.x; SCHWANSTECHER M, 1991, N-S ARCH PHARMACOL, V343, P83; Seedher N, 2008, CHEM BIOL DRUG DES, V72, P290, DOI 10.1111/j.1747-0285.2008.00704.x; Seedher N, 2009, CENT EUR J CHEM, V7, P96, DOI 10.2478/s11532-008-0080-x; Seibert H, 2002, TOXICOL IN VITRO, V16, P289, DOI 10.1016/S0887-2333(02)00014-0; Smith DA, 2010, NAT REV DRUG DISCOV, V9, P929, DOI 10.1038/nrd3287; TSUCHIYA S, 1984, BIOCHEM PHARMACOL, V33, P2967, DOI 10.1016/0006-2952(84)90595-1; Zhang CL, 2009, SCIENCE, V325, P607, DOI 10.1126/science.1172256; ZUNKLER BJ, 1988, N-S ARCH PHARMACOL, V337, P225	53	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197634	10.1371/journal.pone.0197634	http://dx.doi.org/10.1371/journal.pone.0197634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29772022	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900083
J	Morley, JW; Selden, RL; Latour, RJ; Frolicher, TL; Seagraves, RJ; Pinsky, ML				Morley, James W.; Selden, Rebecca L.; Latour, Robert J.; Frolicher, Thomas L.; Seagraves, Richard J.; Pinsky, Malin L.			Projecting shifts in thermal habitat for 686 species on the North American continental shelf	PLOS ONE			English	Article							CLIMATE-CHANGE; RANGE SHIFTS; 21ST-CENTURY PROJECTIONS; FISHERIES MANAGEMENT; STANDARDIZING CATCH; MARINE FISHERIES; WARMING LEADS; OCEAN; ATLANTIC; DISTRIBUTIONS	Recent shifts in the geographic distribution of marine species have been linked to shifts in preferred thermal habitats. These shifts in distribution have already posed challenges for living marine resource management, and there is a strong need for projections of how species might be impacted by future changes in ocean temperatures during the 21st century. We modeled thermal habitat for 686 marine species in the Atlantic and Pacific oceans using long-term ecological survey data from the North American continental shelves. These habitat models were coupled to output from sixteen general circulation models that were run under high (RCP 8.5) and low (RCP 2.6) future greenhouse gas emission scenarios over the 21 st century to produce 32 possible future outcomes for each species. The models generally agreed on the magnitude and direction of future shifts for some species (448 or 429 under RCP 8.5 and RCP 2.6, respectively), but strongly disagreed for other species (116 or 120 respectively). This allowed us to identify species with more or less robust predictions. Future shifts in species distributions were generally poleward and followed the coastline, but also varied among regions and species. Species from the U.S. and Canadian west coast including the Gulf of Alaska had the highest projected magnitude shifts in distribution, and many species shifted more than 1000 km under the high greenhouse gas emissions scenario. Following a strong mitigation scenario consistent with the Paris Agreement would likely produce substantially smaller shifts and less disruption to marine management efforts. Our projections offer an important tool for identifying species, fisheries, and management efforts that are particularly vulnerable to climate change impacts.	[Morley, James W.; Selden, Rebecca L.; Pinsky, Malin L.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Latour, Robert J.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Frolicher, Thomas L.] Univ Bern, Phys Inst, Climate & Environm Phys, Bern, Switzerland; [Frolicher, Thomas L.] Univ Bern, Oeschger Ctr Climate Change Res, Bern, Switzerland; [Seagraves, Richard J.] Mid Atlantic Fishery Management Council, Delaware, OH USA; [Morley, James W.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA	Rutgers State University New Brunswick; William & Mary; Virginia Institute of Marine Science; University of Bern; University of Bern; University of North Carolina; University of North Carolina Chapel Hill	Morley, JW (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.; Morley, JW (corresponding author), Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA.	jwmorley@email.unc.edu	Frölicher, Thomas L/E-5137-2015; Froelicher, Thomas/AAG-9598-2019; Pinsky, Malin/K-2884-2015	Frölicher, Thomas L/0000-0003-2348-7854; Froelicher, Thomas/0000-0003-2348-7854; Pinsky, Malin/0000-0002-8523-8952; Selden, Rebecca/0000-0001-7956-5984	Pew Charitable Trusts [28295]; Mid-Atlantic Fishery Management Council; NOAA's "Understanding Climate Impacts on Fish Stocks and Fisheries to Inform Sustainable Management" initiative [OAR-CPO-2014-2004106]; NOAA's "Understanding Climate Impacts on Fish Stocks and Fisheries to Inform Sustainable Management" initiative (Office of Science and Technology); NSF [OCE-1426891, DEB-1616821]; NSF OCE Postdoctoral Research Fellowship [OCE-1521565]; Atlantic States Marine Fisheries Commission [NA14NMF4740362]; Swiss National Science Foundation grant [PP00P2_170687]; Nippon Foundation-UBC Nereus Program; National Oceanic and Atmospheric Administration (NOAA) through the Cooperative Institute for the North Atlantic Region (CINAR) [NA140AR4320158]	Pew Charitable Trusts; Mid-Atlantic Fishery Management Council; NOAA's "Understanding Climate Impacts on Fish Stocks and Fisheries to Inform Sustainable Management" initiative; NOAA's "Understanding Climate Impacts on Fish Stocks and Fisheries to Inform Sustainable Management" initiative (Office of Science and Technology); NSF(National Science Foundation (NSF)); NSF OCE Postdoctoral Research Fellowship; Atlantic States Marine Fisheries Commission; Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); Nippon Foundation-UBC Nereus Program; National Oceanic and Atmospheric Administration (NOAA) through the Cooperative Institute for the North Atlantic Region (CINAR)	Funding from The Pew Charitable Trusts (#28295), the Mid-Atlantic Fishery Management Council, NOAA's "FY14 Understanding Climate Impacts on Fish Stocks and Fisheries to Inform Sustainable Management" initiative (Competition OAR-CPO-2014-2004106 and the Office of Science and Technology), NSF #OCE-1426891 and #DEB-1616821. RLS is supported by an NSF OCE Postdoctoral Research Fellowship (#OCE-1521565). RJL acknowledges support provided by the Atlantic States Marine Fisheries Commission (#NA14NMF4740362). TLF acknowledges financial support from the Swiss National Science Foundation grant #PP00P2_170687. TLF, RLS, and MLP received support from the Nippon Foundation-UBC Nereus Program. This research was supported by the National Oceanic and Atmospheric Administration (NOAA) through the Cooperative Institute for the North Atlantic Region (CINAR) under Cooperative Agreement NA140AR4320158. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Bacheler N, 2011, SEDAR25DW02; Batt RD, 2017, ECOL LETT, V20, P1148, DOI 10.1111/ele.12812; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Buczkowski B.J., 2006, US GEOL SURV DATA SE; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Busch DS, 2016, MAR POLICY, V74, P58, DOI 10.1016/j.marpol.2016.09.001; Carton JA, 2016, UPDATED REANAL UNPUB; Cheung WWL, 2016, SCIENCE, V354, P1591, DOI 10.1126/science.aag2331; Cheung WWL, 2016, ICES J MAR SCI, V73, P1283, DOI 10.1093/icesjms/fsv250; Cheung WWL, 2016, ECOL MODEL, V325, P57, DOI 10.1016/j.ecolmodel.2015.12.018; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Colburn LL, 2016, MAR POLICY, V74, P323, DOI 10.1016/j.marpol.2016.04.030; Collins M, 2013, LONG TERM CLIMATE CH; Dana J. D., 1853, AM J SCI ARTS 2, V66, P153; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fay G, 2017, ECOL MODEL, V347, P1, DOI 10.1016/j.ecolmodel.2016.12.016; Folk R. L, 1980, PETROLOGY SEDIMENTAR; Fossheim M, 2015, NAT CLIM CHANGE, V5, P673, DOI 10.1038/NCLIMATE2647; Frolicher TL, 2016, GLOBAL BIOGEOCHEM CY, V30, P1224, DOI 10.1002/2015GB005338; Graler B, 2016, R J, V8, P204; Grieve BD, 2016, MAR ECOL PROG SER, V546, P225, DOI 10.3354/meps11638; Hare JA, 2016, PLOS ONE, P1; Hare JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052294; Hare JA, 2012, ICES J MAR SCI, V69, P1753, DOI 10.1093/icesjms/fss160; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hazen EL, 2013, NAT CLIM CHANGE, V3, P234, DOI 10.1038/NCLIMATE1686; HETTLER WF, 1992, FISH B-NOAA, V90, P405; Hijmans R.J., 2015, R PACKAGE VERSION, V2, P3; Hijmans R. J., 2016, GEOSPHERE SPHERICAL; Hijmans RJ., 2017, DISMO SPECIES DISTRI, V9, P1; Jones MC, 2015, FISH FISH, V16, P603, DOI 10.1111/faf.12081; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Kleisner KM, 2017, PROG OCEANOGR, V153, P24, DOI 10.1016/j.pocean.2017.04.001; Kleisner KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149220; KOENKER R., 2017, QUANTREG QUANTILE RE; Link JS, 2011, FISH FISH, V12, P461, DOI 10.1111/j.1467-2979.2010.00398.x; Loring DH, 1973, B FISH RES BOARD CAN, P182; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Meng KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158487; Methratta ET, 2006, MAR ECOL PROG SER, V326, P245, DOI 10.3354/meps326245; Miller K.A., 2004, MARINE RESOURCE EC, V19, P367, DOI DOI 10.1086/MRE.19.3.42629440; Mills KE, 2013, OCEANOGRAPHY, V26, P191, DOI 10.5670/oceanog.2013.27; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Morley JW, 2017, GLOBAL CHANGE BIOL, V23, P2590, DOI 10.1111/gcb.13578; NOAA and DoD, 2013, SYMB ABBR TERMS US P; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pershing AJ, 2015, SCIENCE, V350, P809, DOI 10.1126/science.aac9819; Pinsky ML, 2014, OCEANOGRAPHY, V27, P146, DOI 10.5670/oceanog.2014.93; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Planque B, 2011, ICES J MAR SCI, V68, P1045, DOI 10.1093/icesjms/fsr007; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Reid J.A., 2006, US GEOLOGICAL SURVEY, V182; Reid J.M., 2005, REPORT DATA SERIES, V118; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Robinson LM, 2015, DEEP-SEA RES PT II, V113, P225, DOI 10.1016/j.dsr2.2014.04.007; Rutterford LA, 2015, NAT CLIM CHANGE, V5, P569, DOI 10.1038/nclimate2607; Rykaczewski RR, 2015, GEOPHYS RES LETT, V42, P6424, DOI 10.1002/2015GL064694; Saba VS, 2016, J GEOPHYS RES-OCEANS, V121, P118, DOI 10.1002/2015JC011346; Selden RL, 2018, GLOBAL CHANGE BIOL, V24, P117, DOI 10.1111/gcb.13838; Shackell NL, 2013, CAN MANUSCR REP FISH, V3012; Sims DW, 2001, P ROY SOC B-BIOL SCI, V268, P2607, DOI 10.1098/rspb.2001.1847; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Stuart-Smith RD, 2017, NAT ECOL EVOL, V1, P1846, DOI 10.1038/s41559-017-0353-x; Sunday JM, 2015, ECOL LETT, V18, P944, DOI 10.1111/ele.12474; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Taylor K. E., 2012, AM METEROLOGICAL SOC, V485, P498; Thorson JT, 2014, FISH RES, V155, P168, DOI 10.1016/j.fishres.2014.02.036; Wang DW, 2015, NATURE, V518, P390, DOI 10.1038/nature14235; Weinert M, 2016, ESTUAR COAST SHELF S, V175, P157, DOI 10.1016/j.ecss.2016.03.024; Wisz MS, 2015, NAT CLIM CHANGE, V5, P261, DOI [10.1038/nclimate2500, 10.1038/NCLIMATE2500]; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wuenschel MJ, 2012, J EXP MAR BIOL ECOL, V436, P19, DOI 10.1016/j.jembe.2012.08.012	85	152	155	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196127	10.1371/journal.pone.0196127	http://dx.doi.org/10.1371/journal.pone.0196127			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768423	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200014
J	Sotelo, CG; Velasco, A; Perez-Martin, RI; Kappel, K; Schroder, U; Verrez-Bagnis, V; Jerome, M; Mendes, R; Silva, H; Mariani, S; Griffiths, A				Sotelo, Carmen G.; Velasco, Amaya; Perez-Martin, Ricardo, I; Kappel, Kristina; Schroeder, Ute; Verrez-Bagnis, Veronique; Jerome, Marc; Mendes, Rogerio; Silva, Helena; Mariani, Stefano; Griffiths, Andrew			Tuna labels matter in Europe: Mislabelling rates in different tuna products	PLOS ONE			English	Article							SEAFOOD; FISH; IDENTIFICATION; DNA; SUBSTITUTION	Tuna fisheries and processing represent economic activities of paramount importance around the world. Most of these products are traded for human consumption and in general are highly demanded commodities. However, not all tuna products achieve the same market price, some consumers are willing to pay a huge amount of money for certain species (i.e. Japanese market for Bluefin tuna) while other species are rather affordable (i.e. Skipjack tuna), therefore mislabelling has been observed frequently. We collected and analysed 545 tuna samples in six European countries, including fresh, frozen and canned products, and we have investigated whether or not these products were correctly labelled under European and national legislations. We found an overall mislabelling rate of 6.79%; in particular, 6.70% of the fresh and frozen tuna products and 7.84% of canned tuna were mislabelled, and only in the case of fresh and frozen tuna samples significant differences among countries were found. Mislabelling rates for Atlantic Bluefin tuna labelled products were very high, ranging from 50 up to 100%. In general, mislabelling was higher when specific names were included in the labels. The "tuna" umbrella term is a very popular one with consumers, but also one that remains vulnerable to ambiguity, hampering efforts towards market transparency and with potential negative consequences to the adequate management of tuna species stocks.	[Sotelo, Carmen G.; Velasco, Amaya; Perez-Martin, Ricardo, I] CSIC, Inst Invest Marinas, Vigo, Spain; [Kappel, Kristina; Schroeder, Ute] Mission Res Inc, Dept Safety & Qual Milk & Fish Prod, Hamburg, Germany; [Verrez-Bagnis, Veronique; Jerome, Marc] Ifremer, Nantes, France; [Mendes, Rogerio; Silva, Helena] IP, Portuguese Inst Sea & Atmosphere IPMA, Lisbon, Portugal; [Mariani, Stefano] Univ Salford, Sch Environm & Life Sci, Ecosyst & Environm Res Ctr, Manchester, England; [Griffiths, Andrew] Univ Exeter, Biosci, Exeter, Devon, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); Ifremer; Instituto Portugues do Mar e da Atmosfera; University of Manchester; University of Salford; University of Exeter	Sotelo, CG (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	carmen@iim.csic	Mendes, Rogerio/E-6900-2011; Perez-Martin, Ricardo I/A-2399-2013; Mariani, Stefano/A-2964-2012; Sotelo, Carmen Gonzalez/L-3696-2014; Fortino, Giancarlo/J-2950-2017; Verrez-Bagnis, Veronique/E-5551-2017	Mendes, Rogerio/0000-0003-4272-865X; Perez-Martin, Ricardo I/0000-0002-4918-9399; Mariani, Stefano/0000-0002-5329-0553; Sotelo, Carmen Gonzalez/0000-0002-0726-4370; Fortino, Giancarlo/0000-0002-4039-891X; Verrez-Bagnis, Veronique/0000-0002-7895-1581	LABELFISH project; EU Atlantic Area Programme [2011-1/163]; UK Department for Environment, Food Rural Affairs [FA0116]	LABELFISH project; EU Atlantic Area Programme; UK Department for Environment, Food Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	The work was funded by LABELFISH project, supported by the EU Atlantic Area Programme Project Number 2011-1/163 and the UK Department for Environment, Food & Rural Affairs grant FA0116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pardo MA, 2016, FOOD CONTROL, V62, P277, DOI 10.1016/j.foodcont.2015.10.048; [Anonymous], 2015, OCEAN EUR, P1; BARTLETT SE, 1991, CAN J FISH AQUAT SCI, V48, P309, DOI 10.1139/f91-043; Benard-Capelle J, 2015, PEERJ, V2, DOI 10.7717/peerj.714; BURGENER M, 1997, MOL SPECIES DIFFEREN; Commission E, 2015, FISH SUBST 2015; Cutarelli A, 2014, FOOD CONTROL, V37, P46, DOI 10.1016/j.foodcont.2013.08.009; D'Amico P, 2016, MAR POLICY, V71, P147, DOI 10.1016/j.marpol.2016.05.026; Everstine K, 2013, J FOOD PROTECT, V76, P723, DOI 10.4315/0362-028X.JFP-12-399; FAO, 2012, OV WORLDS ANCH SECT; Fromentin JM, 2014, MAR POLICY, V47, P8, DOI 10.1016/j.marpol.2014.01.018; Garcia-Vazquez E, 2011, J AGR FOOD CHEM, V59, P475, DOI 10.1021/jf103754r; Gordoa A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170809; Griffiths AM, 2014, FOOD CONTROL, V45, P95, DOI 10.1016/j.foodcont.2014.04.020; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanner R, 2011, MITOCHONDR DNA, V22, P27, DOI 10.3109/19401736.2011.596833; ISSF, 2017, ISSF TECH REP, P2; Jacquet JL, 2008, MAR POLICY, V32, P309, DOI 10.1016/j.marpol.2007.06.007; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lowell B., 2015, OCEANA, P1; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Mackie IM, 1999, TRENDS FOOD SCI TECH, V10, P9, DOI 10.1016/S0924-2244(99)00013-8; Mariani S, 2017, CONSERV LETT, V10, P781, DOI 10.1111/conl.12346; Mariani S, 2015, FRONT ECOL ENVIRON, V13, P536, DOI 10.1890/150119; Meyer A., 1993, BIOCH MOL BIOL FISHE, DOI DOI 10.1016/j.ympev.2004.07.013; NICHOLAS KB, 1997, EMBNET NEWS, V42, P1; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Stawitz CC, 2017, CONSERV LETT, V10, P681, DOI 10.1111/conl.12328; Vandamme SG, 2016, PEERJ, V4, DOI 10.7717/peerj.1891; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Warner K., 2013, OCEANA, P1; Warner K, 2016, DECEPTIVE DISHES SEA, P24; Xiong X, 2016, MAR POLICY, V68, P123, DOI 10.1016/j.marpol.2016.02.024	34	26	27	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196641	10.1371/journal.pone.0196641	http://dx.doi.org/10.1371/journal.pone.0196641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768435	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000432329200038
J	Zeng, ZX; Jiang, X; Li, XY; Wells, A; Luo, Y; Neapolitan, R				Zeng, Zexian; Jiang, Xia; Li, Xiaoyu; Wells, Alan; Luo, Yuan; Neapolitan, Richard			Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL WOMEN; REPLACEMENT THERAPY; HYSTERECTOMY; MENOPAUSE; MORTALITY; SYMPTOMS; SOCIETY	Objective By the 1990s it became popular for women to use hormone therapy (HT) to ease menopause symptoms. Bioidentical estrogen and progesterone are supplements whose molecular structures are identical to what is made in the human body, while synthetic supplements are ones whose structures are not. After the Women's Health Initiative found that the combined use of the synthetics conjugated equine estrogen (CEE) and medroxyprogesterone acetate (MPA) increased breast cancer risk, prescriptions for synthetic HT declined considerably. Since then there has been an increased interest in bioidentical HT; today there are a plethora of websites touting their benefits. However, no peer-reviewed articles support these claims. We performed a retrospective study with the objective of verifying the hypothesis that bioidentical HT is associated with decreased breast cancer risk than CEE & MPA. Methods We searched The Northwestern Medicine Enterprise Data Warehouse for women who initiated HT use after age 50. Women who did not take any HT drug after age 50 served as controls. Nine HT protocols were investigated for breast cancer risk. Results Significant results include CEE Alone is associated with decreased breast cancer risk (HR = 0.31), Other Synthetic Estrogen Alone is associated with increased breast cancer risk (HR = 1.49), Bioidentical Estrogen Alone is associated with decreased breast cancer risk(HR = 0.65), CEE & MPA is associated with reduced breast cancer risk (HR = 0.43), and CEE & MPA is associated with reduced breast cancer risk relative to Bioidentical Estrogen & Progesterone (HR = 0.25). Discussion Our results indicate CEE & MPA is superior to bioidentical HT as far as breast cancer risk. Furthermore, this combination is associated with decrease of breast cancer risk, contrary to previous findings. Additional retrospective studies are needed to confirm our results.	[Zeng, Zexian; Luo, Yuan; Neapolitan, Richard] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Jiang, Xia] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA USA; [Li, Xiaoyu] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Wells, Alan] Pittsburgh VA Hlth Syst, Pittsburgh, PA USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard T.H. Chan School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Neapolitan, R (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.	richard.neapolitan@northwestern.edu	zeng, zexian/AAK-4651-2021; Luo, Yuan/K-5563-2016	Luo, Yuan/0000-0003-0195-7456	National Library of Medicine [R01LM011663, R01LM011962]; NATIONAL LIBRARY OF MEDICINE [R01LM011962, R01LM011663] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Library of Medicine (https://www.nlm.nih.gov/, R01LM011663; and by the National Library of Medicine (https://www.nlm.nih.gov/), R01LM011962.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Avis NE, 2015, JAMA INTERN MED, V175, P531, DOI 10.1001/jamainternmed.2014.8063; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Files JA, 2011, MAYO CLIN PROC, V86, P673, DOI 10.4065/mcp.2010.0714; Fournier A, 2005, INT J CANCER, V114, P448, DOI 10.1002/ijc.20710; Hersh AL, 2004, JAMA-J AM MED ASSOC, V291, P47, DOI 10.1001/jama.291.1.47; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Lyytinen H, 2006, OBSTET GYNECOL, V108, P1354, DOI 10.1097/01.AOG.0000241091.86268.6e; Lyytinen H, 2009, OBSTET GYNECOL, V113, P65, DOI 10.1097/AOG.0b013e31818e8cd6; Pinkerton JV, 2017, MENOPAUSE, V24, P728, DOI 10.1097/GME.0000000000000921; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Sood R, 2014, INT J WOMENS HEALTH, V6, P47, DOI 10.2147/IJWH.S38342; Stuenkel CA, 2015, J CLIN ENDOCR METAB, V100, P3975, DOI 10.1210/jc.2015-2236	17	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197064	10.1371/journal.pone.0197064	http://dx.doi.org/10.1371/journal.pone.0197064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768475	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200054
J	Guo, XS; Riobo-Del Galdo, NA; Kim, EJ; Grant, GR; Manning, DR				Guo, Xueshui; Riobo-Del Galdo, Natalia A.; Kim, Eun Ji; Grant, Gregory R.; Manning, David R.			Overlap in signaling between Smoothened and the alpha subunit of the heterotrimeric G protein G(13)	PLOS ONE			English	Article							SONIC HEDGEHOG; ENDOTHELIAL-CELLS; OSTEOBLAST DIFFERENTIATION; MESENCHYMAL CELLS; SPINAL-CORD; RECEPTOR; ACTIVATION; PATHWAY; GLI3; RHO	The Hedgehog family of morphogens has long been known to utilize, through the 7-transmembrane protein Smoothened (Smo), the heterotrimeric G protein G(i) in both canonical and noncanonical forms of signaling. Other G proteins, while not specifically utilized by Smo, may nonetheless provide access to some of the events controlled by it. We reported several years ago that the G protein G(13) activates one or more forms of the Gli family of transcription factors. While the Gli transcription factors are well known targets for Smo, the uncertain mechanism of activation by G(13) and the identity of the targeted Gli(s) limited predictions as to the extent to which G(13 )might mimic Smo's actions. We evaluate here the potential for overlap in G(13 )and Smo signaling using C3H10T1/2 and 3T3-L1 cells as models of osteogenesis and adipogenesis, respectively. We find in C3H10T1/2 cells that a constitutively active form of G alpha(13)(G alpha(13)QL) increases Gli1 mRNA, as does a constitutively active form of Smo (SmoA1). We find as well that G alpha(13)QL induces alkaline phosphatase activity, a marker of osteogenesis, albeit the induction is far less substantial than that achieved by SmoA1. In 3T3-L1 cells both G alpha(13)QL and SmoA1 markedly suppress adipogenic differentiation as determined by triglyceride accumulation. RNA sequencing reveals that G alpha(13)QL and SmoA1 regulate many of the same genes but that quantitative and qualitative differences exist. Differences also exist, we find, between SmoA1 and purmorphamine, an agonist for Smo. Therefore, while comparisons of constitutively active proteins are informative, extrapolations to the setting of agonists require care.	[Guo, Xueshui; Manning, David R.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Riobo-Del Galdo, Natalia A.] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Riobo-Del Galdo, Natalia A.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Kim, Eun Ji; Grant, Gregory R.] Univ Penn, Perelman Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Grant, Gregory R.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Guo, Xueshui] Guangdong Med Univ, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; University of Leeds; University of Leeds; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Guangdong Medical University	Manning, DR (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.	manning@pennmedicine.upenn.edu	Guo, Xueshui/HCI-5665-2022; Galdo, Natalia Riobo-Del/AAP-2938-2020; Grant, Gregory Robert/I-3599-2019	Galdo, Natalia Riobo-Del/0000-0002-8942-7873; Grant, Gregory Robert/0000-0002-0139-7658	NIGMS [GM080396]; National Center for Advancing Translational Sciences [5UL1TR000003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080396] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIGMS grant GM080396 (XG, NAR-DG, DRM). National Center for Advancing Translational Sciences grant 5UL1TR000003 (EJK, GRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Belgacem YH, 2011, P NATL ACAD SCI USA, V108, P4482, DOI 10.1073/pnas.1018217108; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Douglas AE, 2011, J BIOL CHEM, V286, P30714, DOI 10.1074/jbc.M111.219279; Fasbender A, 1997, J BIOL CHEM, V272, P6479, DOI 10.1074/jbc.272.10.6479; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.E02-06-0356; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Kanda S, 2003, J BIOL CHEM, V278, P8244, DOI 10.1074/jbc.M210635200; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; Kinto N, 1997, FEBS LETT, V404, P319, DOI 10.1016/S0014-5793(97)00014-8; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Moers A, 2008, MOL CELL BIOL, V28, P1480, DOI 10.1128/MCB.00651-07; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Narayanan K, 2001, P NATL ACAD SCI USA, V98, P4516, DOI 10.1073/pnas.081075198; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Renault MA, 2010, J MOL CELL CARDIOL, V49, P490, DOI 10.1016/j.yjmcc.2010.05.003; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Sasaki N, 2010, MOL CELL NEUROSCI, V45, P335, DOI 10.1016/j.mcn.2010.07.006; Seasholtz TM, 1999, MOL PHARMACOL, V55, P949, DOI 10.1124/mol.55.6.949; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Spinella-Jaegle S, 2001, J CELL SCI, V114, P2085; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; Vuolo L, 2015, J CELL SCI, V128, P2928, DOI 10.1242/jcs.172635; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Ye D, 2013, DEVELOPMENT, V140, P789, DOI 10.1242/dev.085340; Yuan X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11024; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005	53	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197442	10.1371/journal.pone.0197442	http://dx.doi.org/10.1371/journal.pone.0197442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763457	Green Published, gold, Green Submitted			2022-12-26	WOS:000432118800053
J	Li, H; Ye, FF; Ren, JY; Wang, PY; Du, LL; Liu, JL				Li, Hui; Ye, Fangfu; Ren, Jing-Yi; Wang, Peng-Ye; Du, Li-Lin; Liu, Ji-Long			Active transport of cytoophidia in Schizosaccharomyces pombe	FASEB JOURNAL			English	Article						cytoophidium; actin filaments; motor proteins; microtubules	FISSION YEAST; SACCHAROMYCES-CEREVISIAE; CTP SYNTHASE; METABOLIC ENZYMES; DROSOPHILA-MELANOGASTER; V MYOSINS; BODIES; CELL; MECHANISM; PROTEINS	The metabolic enzyme cytidine triphosphate synthase has recently been found to form micrometer-sized filamentous structures termed cytoophidia, which are evolutionarily conserved across prokaryotes and eukaryotes. The cytoophidium represents a novel type of membraneless organelle and behaves dynamically inside the cell. The question of how cytoophidia transport is mediated, however, remains unanswered. For the first time, we detected in this study the active transport of cytoophidia, taking advantage of the fission yeast Schizosaccharomyces pombe as an excellent model for studying membraneless organelles. We demonstrated that actin filaments, not microtubules, are responsible for this transport. Furthermore, we determined that Myo52, a type of myosin V, is required for the active transport of cytoophidia. These results reveal the major players critical to the dynamics of cytoophidia and extend our understanding of intracellular transport of membraneless organelles.Li, H., Ye, F., Ren, J.-Y., Wang, P.-Y., Du, L.-L., Liu, J.-L. Active transport of cytoophidia in Schizosaccharomyces pombe.	[Li, Hui; Liu, Ji-Long] Univ Oxford, Dept Physiol Anat & Genet, Med Res Council Funct Genom Unit, Oxford, England; [Li, Hui; Ye, Fangfu; Wang, Peng-Ye] Chinese Acad Sci, Key Lab Soft Matter Phys, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing, Peoples R China; [Ye, Fangfu] Univ Chinese Acad Sci, Sch Phys Sci, Beijing, Peoples R China; [Ren, Jing-Yi; Du, Li-Lin] Natl Inst Biol Sci, Beijing, Peoples R China; [Liu, Ji-Long] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	University of Oxford; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; National Institute of Biological Sciences, Beijing; ShanghaiTech University	Liu, JL (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, South Parks Rd, Oxford OX1 3PT, England.	liujl3@shanghaitech.edu.cn	Li, Hui/C-7251-2019; Li, Hui/L-2704-2019	Li, Hui/0000-0003-0551-9912; Du, Li-Lin/0000-0002-1028-7397; Wang, Peng-Ye/0000-0002-9765-0610	UK Medical Research Council; National Natural Science Foundation of China [11674383]; MRC [MC_UU_12021/3, MC_U137788471] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank members of the J.-L.L. group, especially S. Ghosh, for discussion and comments. The authors are grateful to M. Balasubramanian (University of Warwick, Coventry, United Kingdom), T. Burke (University of Chicago, Chicago, IL, USA), T. Pollard (Yale University, New Haven, CT, USA), and the fission yeast community for reagents and discussions. This work was supported by the UK Medical Research Council and a grant from the National Natural Science Foundation of China (11674383). The authors declare no conflicts of interest.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Aughey GN, 2014, BIOL OPEN, V3, P1045, DOI 10.1242/bio.201410165; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Bond LM, 2013, FUTURE MED CHEM, V5, P41, DOI 10.4155/fmc.12.185; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; Chang CC, 2015, J CELL SCI, V128, P3550, DOI 10.1242/jcs.175265; Chen KN, 2011, J GENET GENOMICS, V38, P391, DOI 10.1016/j.jgg.2011.08.004; Clayton JE, 2010, CURR BIOL, V20, P1423, DOI 10.1016/j.cub.2010.07.026; East DA, 2011, J CELL SCI, V124, P1383, DOI 10.1242/jcs.078527; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fakhri N, 2014, SCIENCE, V344, P1031, DOI 10.1126/science.1250170; Fedorov R, 2009, NAT STRUCT MOL BIOL, V16, P80, DOI 10.1038/nsmb.1542; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Grallert A, 2007, J CELL SCI, V120, P4093, DOI 10.1242/jcs.012468; Guo M, 2014, CELL, V158, P822, DOI 10.1016/j.cell.2014.06.051; HAIMO LT, 1994, BIOESSAYS, V16, P727, DOI 10.1002/bies.950161007; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Keppeke GD, 2015, J GENET GENOMICS, V42, P287, DOI 10.1016/j.jgg.2015.04.002; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Li H, 2016, DATA BRIEF, V8, P40, DOI 10.1016/j.dib.2016.05.015; Li H, 2015, J AM CHEM SOC, V137, P436, DOI 10.1021/ja511273c; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045465; Liu JL, 2007, P NATL ACAD SCI USA, V104, P11655, DOI 10.1073/pnas.0704977104; Liu JL, 2016, ANNU REV CELL DEV BI, V32, P349, DOI 10.1146/annurev-cellbio-111315-124907; Liu JL, 2011, BIOESSAYS, V33, P159, DOI 10.1002/bies.201000129; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Lo Presti L, 2012, MOL BIOL CELL, V23, P4579, DOI 10.1091/mbc.E12-07-0499; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Motegi F, 2001, MOL BIOL CELL, V12, P1367, DOI 10.1091/mbc.12.5.1367; Noree C, 2014, MOL BIOL CELL, V25, P2282, DOI 10.1091/mbc.E14-04-0912; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Nover L., 1980, CELL COMPARTMENTATIO; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shen QJ, 2016, J GENET GENOMICS, V43, P393, DOI 10.1016/j.jgg.2016.03.008; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Strochlic TI, 2014, EMBO REP, V15, P1184, DOI 10.15252/embr.201438688; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; van Bergeijk P, 2016, TRENDS CELL BIOL, V26, P121, DOI 10.1016/j.tcb.2015.10.001; Wang B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.208102; Win TZ, 2001, J CELL SCI, V114, P69; Zhang J, 2014, BIOL OPEN, V3, P1092, DOI 10.1242/bio.20149613	52	16	17	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2018	32	11					5891	5898		10.1096/fj.201800045RR	http://dx.doi.org/10.1096/fj.201800045RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GW7TC	29782206	Green Published, hybrid			2022-12-26	WOS:000447172000011
J	Boetto, J; Apra, C; Bielle, F; Peyre, M; Kalamarides, M				Boetto, Julien; Apra, Caroline; Bielle, Franck; Peyre, Matthieu; Kalamarides, Michel			Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation	ONCOGENE			English	Article							CRANIOFACIAL DEVELOPMENT; SHH MEDULLOBLASTOMA; CELL CARCINOMA; MUTATIONS; HEDGEHOG; NF2; MOUSE; IDENTIFICATION; LOCALIZATION; INACTIVATION	Somatic activating mutations of smoothened (SMO), a component of the embryonic sonic hedgehog (SHH) signaling pathway, are found in 3-5% of grade I meningiomas, most of them corresponding to meningothelial meningiomas located at the anterior skull base. By generating different developmental stage-specific conditional activations in mice, we define a restricted developmental window during which conditional activation of Smo in Prostaglandin D2-synthase-positive mesoderm-derived meningeal layer of the skull base results in meningothelial meningioma formation. We show a selective vulnerability of the arachnoid from the skull base to Smo activation to initiate tumor development. This prenatal period and specific topography are correlated to the timing and location of SHH signaling involvement in the formation of craniofacial and meninges patterning, strongly corroborating the hypothesis of a developmental origin for Smo-activated meningiomas. Finally, we provide preclinical in vitro evidence of the efficacy of the SMO-inhibitor Sonidegib, supporting further preclinical and clinical evaluation of targeted treatment for refractory SMO-mutant meningiomas.	[Boetto, Julien; Apra, Caroline; Bielle, Franck; Peyre, Matthieu; Kalamarides, Michel] Sorbonne Univ, Inst Cerveau & Moelle Epiniere, INSERM, U1127,CNRS,UMR 7225,CRICM, F-75013 Paris, France; [Bielle, Franck] Hop La Pitie Salpetriere, AP HP, Dept Pathol, F-75013 Paris, France; [Peyre, Matthieu; Kalamarides, Michel] Hop La Pitie Salpetriere, AP HP, Dept Neurosurg, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Kalamarides, M (corresponding author), Sorbonne Univ, Inst Cerveau & Moelle Epiniere, INSERM, U1127,CNRS,UMR 7225,CRICM, F-75013 Paris, France.	michel.kalamarides@aphp.fr	Boetto, Julien/AAG-5777-2021	Boetto, Julien/0000-0003-2572-8594; Apra, Caroline/0000-0003-0944-9544; Peyre, Matthieu/0000-0001-8470-9516; Bielle, Franck/0000-0001-6564-6388	foundation ARC, France. [PJA 20131200431]; UM1 University, Montpellier, France	foundation ARC, France.; UM1 University, Montpellier, France	This work was supported by a grant from the foundation ARC (PJA 20131200431), France. J.B. was funded by a grant from UM1 University, Montpellier, France.	Abedalthagafi M, 2016, NEURO-ONCOLOGY, V18, P649, DOI 10.1093/neuonc/nov316; Boetto J, 2017, NEURO-ONCOLOGY, V19, P345, DOI 10.1093/neuonc/now276; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Clarke VE, 2016, NAT GENET, V48, P1253, DOI 10.1038/ng.3651; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; Giovannini M, 2000, GENE DEV, V14, P1617; Huttner HB, 2018, EBIOMEDICINE, V27, P176, DOI 10.1016/j.ebiom.2017.12.020; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Kalamarides M, 2011, ONCOGENE, V30, P2333, DOI 10.1038/onc.2010.609; Kalamarides M, 2002, GENE DEV, V16, P1060, DOI 10.1101/gad.226302; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kros J, 2001, J PATHOL, V194, P367, DOI 10.1002/path.909; Le Roux I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9528; Louis, 2016, WHO CLASSIFICATION G; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Marshall GM, 2014, NAT REV CANCER, V14, P277, DOI 10.1038/nrc3679; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; Migden MR, 2015, LANCET ONCOL, V16, P716, DOI 10.1016/S1470-2045(15)70100-2; Ohli J, 2015, ACTA NEUROPATHOL, V130, P307, DOI 10.1007/s00401-015-1453-9; Peyre M, 2013, ONCOGENE, V32, P4264, DOI 10.1038/onc.2012.436; Reuss DE, 2013, ACTA NEUROPATHOL, V125, P351, DOI 10.1007/s00401-013-1093-x; Rogers L, 2015, J NEUROSURG, V122, P4, DOI 10.3171/2014.7.JNS131644; Samkari A, 2015, EXPERT REV NEUROTHER, V15, P763, DOI 10.1586/14737175.2015.1052796; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Vitte J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00346-5; Xavier GM, 2016, DEV BIOL, V415, P198, DOI 10.1016/j.ydbio.2016.02.009; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Yuzawa S, 2016, MODERN PATHOL, V29, P708, DOI 10.1038/modpathol.2016.81	31	18	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 6	2018	37	36					4955	4963		10.1038/s41388-018-0328-7	http://dx.doi.org/10.1038/s41388-018-0328-7			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS6QR	29789719	Green Published			2022-12-26	WOS:000443823600004
J	Wang, PS; Chou, CH; Lin, CH; Yao, YC; Cheng, HC; Li, HY; Chuang, YC; Yang, CN; Ger, LP; Chen, YC; Lin, FC; Shen, TL; Hsiao, M; Lu, PJ				Wang, Po-Shun; Chou, Cheng-Han; Lin, Cheng-Han; Yao, Yun-Chin; Cheng, Hui-Chuan; Li, Hao-Yi; Chuang, Yu-Chung; Yang, Chia-Ning; Ger, Luo-Ping; Chen, Yu-Chia; Lin, Forn-Chia; Shen, Tang-Long; Hsiao, Michael; Lu, Pei-Jung			A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; REVEALS; ADENOCARCINOMA; INHIBITORS; PREDICTION; BIOMARKER; PATHWAY; GENES; BONE	Triple-negative breast cancer (TNBC) patients usually lead to poor prognosis and survival because of metastasis. The major sites for TNBC metastasis include the lungs, brain, liver, and bone. Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts longer than 200 nucleotides and have been reported as important regulators in BC metastasis. However, the underlying mechanisms for lncRNAs regulating TNBC metastasis are not fully understood. Here we found that linc-ZNF469-3 was highly expressed in lung-metastatic LM2-4175 TNBC cells and overexpression of linc-ZNF469-3 enhanced invasion ability and stemness properties in vitro and lung metastasis in vivo. Furthermore, we found linc-ZNF469-3 physically interacted with miR-574-5p and overexpression of miR-574-5p attenuated ZEB1 expression. Importantly, endogenous high expressions of linc-ZNF469-3 and ZEB1 were correlated with tumor recurrence in TNBC patients with lung metastasis. Taken together, our findings suggested that linc-ZNF469-3 promotes lung metastasis of TNBC through miR-574-5p-ZEB1 signaling axis and may be used as potential prognostic marker for TNBC patients.	[Wang, Po-Shun; Chou, Cheng-Han; Lin, Cheng-Han; Yao, Yun-Chin; Cheng, Hui-Chuan; Li, Hao-Yi; Lu, Pei-Jung] Natl Cheng Kung Univ, Inst Clin Med, Med Coll, Tainan 70403, Taiwan; [Chuang, Yu-Chung; Yang, Chia-Ning] Natl Univ Kaohsiung, Dept Life Sci, Kaohsiung 81148, Taiwan; [Ger, Luo-Ping] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 81362, Taiwan; [Chen, Yu-Chia] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung 81362, Taiwan; [Lin, Forn-Chia] Natl Cheng Kung Univ Hosp, Dept Radiat Oncol, Tainan 70403, Taiwan; [Shen, Tang-Long] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10617, Taiwan; [Hsiao, Michael] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Hsiao, Michael] Kaohsiung Med Univ, Dept Biochem, Coll Med, Kaohsiung 80708, Taiwan; [Lu, Pei-Jung] Natl Cheng Kung Univ Hosp, Dept Clin Med Res, Tainan 70403, Taiwan	National Cheng Kung University; National University Kaohsiung; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; Academia Sinica - Taiwan; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University Hospital	Lu, PJ (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Med Coll, Tainan 70403, Taiwan.; Hsiao, M (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.; Hsiao, M (corresponding author), Kaohsiung Med Univ, Dept Biochem, Coll Med, Kaohsiung 80708, Taiwan.; Lu, PJ (corresponding author), Natl Cheng Kung Univ Hosp, Dept Clin Med Res, Tainan 70403, Taiwan.	mhsiao@gate.sinica.edu.tw; pjlu2190@mail.ncku.edu.tw	Hsiao, Michael/U-6238-2019; Shen, Tang-Long/C-7460-2011	Hsiao, Michael/0000-0001-8529-9213; Chou, Cheng-Han/0000-0003-0534-0373; Shen, Tang-Long/0000-0001-6264-3608; Lin, Cheng-Han/0000-0001-5444-3999; Wang, Po-Shun/0000-0002-2344-980X	Ministry of Science and Technology [MOST 103-2320-B-006-048, MOST 105-2320-B-006-054]; National Cheng Kung University Hospital [NCKUH-10605012, NCKUH-10601003]; Academia Sinica and Ministry of Science and Technology [MOST106-0210-01-15-02, MOST 107-0210-01-19-01]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Cheng Kung University Hospital; Academia Sinica and Ministry of Science and Technology	This work was supported by the Ministry of Science and Technology [MOST 103-2320-B-006-048 and MOST 105-2320-B-006-054 to PJL] and National Cheng Kung University Hospital [NCKUH-10605012 and NCKUH-10601003 to FCL and PJL]. Academia Sinica and Ministry of Science and Technology [MOST106-0210-01-15-02, MOST 107-0210-01-19-01 to Michael Hsiao]. Funding for open access charge: Ministry of Science and Technology [MOST 103-2320-B-006-048 and MOST 105-2320-B-006-054]. We thank the National Center for Genome Medicine for assisting with RNA sequencing and the Center for Genome Medicine, National Cheng Kung University for the support of lncRNA annotation and bioinformatic analyses. We also thank Dr. Myriam Gorospe (National Institutes of Health, Baltimore, MD, USA) for the plasmid pMS2 (24 x), pMS2-lincRNA-p21, and pMS2-GST, and Dr. Tang-Long Shen (National Taiwan University, Taipei, Taiwan) for MDA-MB-231 cell lines including parental, LM2-4175, BrM-831, and BoM-1833.	Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Biesiada M, 2016, METHODS, V103, P120, DOI 10.1016/j.ymeth.2016.03.010; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Chuang YC, 2015, MOL BIOSYST, V11, P723, DOI 10.1039/c4mb00620h; Cui Z, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-47; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Di Cecilia S, 2016, CANCER RES, V76, P5615, DOI 10.1158/0008-5472.CAN-15-1824; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gumireddy K, 2013, EMBO J, V32, P2672, DOI 10.1038/emboj.2013.188; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hou P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.249; Hsu CY, 2016, AM J RESP CRIT CARE, V193, P869, DOI 10.1164/rccm.201412-2226OC; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Jiang YZ, 2016, CANCER RES, V76, P2105, DOI 10.1158/0008-5472.CAN-15-3284; Jin CJ, 2016, ONCOTARGET, V7, P51763, DOI 10.18632/oncotarget.10107; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee CC, 2017, RSC ADV, V7, P29871, DOI 10.1039/c7ra04099g; Lee S, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6374504; Li CL, 2017, NAT CELL BIOL, V19, P106, DOI 10.1038/ncb3464; Li T, 2015, CANCER RES, V75, P3181, DOI 10.1158/0008-5472.CAN-14-3721; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin AF, 2017, NAT CELL BIOL, V19, P238, DOI 10.1038/ncb3473; Lin AF, 2016, NAT CELL BIOL, V18, P213, DOI 10.1038/ncb3295; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu YP, 2013, CANCER RES, V73, P406, DOI 10.1158/0008-5472.CAN-12-1733; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Merola R, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0127-8; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Qi P, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0524-4; Redis RS, 2013, ONCOTARGET, V4, P1748, DOI 10.18632/oncotarget.1292; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tseng LM, 2013, NEOPLASMA, V60, P290, DOI 10.4149/neo_2013_038; van Kampen JGM, 2017, CANCER RES, V77, P2008, DOI 10.1158/0008-5472.CAN-16-2609; Velasco-Velazquez MA, 2011, AM J PATHOL, V179, P2, DOI 10.1016/j.ajpath.2011.03.005; Vennin C, 2015, ONCOTARGET, V6, P29209, DOI 10.18632/oncotarget.4976; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Xu Q, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.149; Yoon JH, 2012, METHODS, V58, P81, DOI 10.1016/j.ymeth.2012.07.004; Yuan SX, 2016, HEPATOLOGY, V63, P499, DOI 10.1002/hep.27893; Zhang YY, 2016, NAT STRUCT MOL BIOL, V23, P522, DOI 10.1038/nsmb.3211; Zhou ML, 2016, STEM CELLS, V34, P55, DOI 10.1002/stem.2219; Zhou R, 2016, SCI REP-UK, V6, DOI 10.1038/srep35714; Zhou R, 2015, ONCOTARGET, V6, P44609, DOI 10.18632/oncotarget.6338	57	49	55	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 23	2018	37	34					4662	4678		10.1038/s41388-018-0293-1	http://dx.doi.org/10.1038/s41388-018-0293-1			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GR3SE	29755127				2022-12-26	WOS:000442514400003
J	Du, JG; Wang, Q; Ziegler, SF; Zhou, BH				Du, Jianguang; Wang, Qun; Ziegler, Steven F.; Zhou, Baohua			FOXP3 interacts with hnRNPF to modulate pre-mRNA alternative splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						forkhead box P3 (FOXP3); heterogeneous nuclear ribonucleoprotein (hnRNP); RNA splicing; RNA-protein interaction; immunology; Treg; immunosuppression; alternative splicing	REGULATORY T-CELLS; BCL-X; RESPONSES; SCURFY; GENE; RECOGNITION; ENTEROPATHY; COMPLEX; PROTEIN; MOUSE	FOXP3 promotes the development and function of regulatory T cells mainly through regulating the transcription of target genes. RNA alternative splicing has been implicated in a wide range of physiological and pathophysiological processes. We report here that FOXP3 associates with heterogeneous nuclear ribonucleoprotein (hnRNP) F through the exon 2-encoded region of FOXP3 and the second quasi-RNA recognition motif (qRRM) of hnRNPF. FOXP3 represses the ability of hnRNPF to bind to its target pre-mRNA and thus modulates RNA alternative splicing. Furthermore, overexpression of mouse hnRNPF in in vitro-differentiated regulatory T cells (Tregs) reduced their suppressive function. Thus, our studies identify a novel mechanism by which FOXP3 regulates mRNA alternative splicing to modulate the function of regulatory T cells.	[Du, Jianguang; Wang, Qun; Zhou, Baohua] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Du, Jianguang; Wang, Qun; Zhou, Baohua] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Zhou, Baohua] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Ziegler, Steven F.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Wang, Qun] Femtera Labs LLC, 1800 N Capitol Ave, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Benaroya Research Institute; Virginia Mason Medical Center	Zhou, BH (corresponding author), 1044 W Walnut St, Indianapolis, IN 46202 USA.	zhoub@iu.edu			National Institutes of Health [R21 AI110773, R01 AI085046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI110773, R01AI085046] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R21 AI110773 and R01 AI085046 (to B. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bandukwala HS, 2011, IMMUNITY, V34, P479, DOI 10.1016/j.immuni.2011.02.017; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen CX, 2006, J BIOL CHEM, V281, P36828, DOI 10.1074/jbc.M608848200; Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488; Dominguez C, 2010, NAT STRUCT MOL BIOL, V17, P853, DOI 10.1038/nsmb.1814; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Ergun A, 2013, P NATL ACAD SCI USA, V110, P14324, DOI 10.1073/pnas.1311839110; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Haque R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2983; Lei LY, 2011, J IMMUNOL, V186, P2254, DOI 10.4049/jimmunol.1002503; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Loizou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018670; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ramsdell F, 2014, NAT REV IMMUNOL, V14, P343, DOI 10.1038/nri3650; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Sharabi A, 2010, J AUTOIMMUN, V34, P87, DOI 10.1016/j.jaut.2009.06.002; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Xie X, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005251; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	35	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10235	10244		10.1074/jbc.RA117.001349	http://dx.doi.org/10.1074/jbc.RA117.001349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29773655	Green Published, hybrid			2022-12-26	WOS:000437096700023
J	Treutlein, EM; Kern, K; Weigert, A; Tarighi, N; Schuh, CD; Nusing, RM; Schreiber, Y; Ferreiros, N; Brune, B; Geisslinger, G; Pierre, S; Scholich, K				Treutlein, Elsa-Marie; Kern, Katharina; Weigert, Andreas; Tarighi, Neda; Schuh, Claus-Dieter; Nuesing, Rolf M.; Schreiber, Yannick; Ferreiros, Nerea; Bruene, Bernhard; Geisslinger, Gerd; Pierre, Sandra; Scholich, Klaus			The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prostaglandin; G protein-coupled receptor (GPCR); neuroinflammation; pain; chemokine; CCL2; mast cells; neuropathic pain; peripheral neuron; Prostaglandin E2	SCIATIC-NERVE; MICE LACKING; SENSORY NEURONS; INJURED NERVE; MAST-CELLS; INFLAMMATION; MACROPHAGES; MODEL; RAT; E-2	Prostaglandin (PG) E-2 is an important lipid mediator that is involved in several pathophysiological processes contributing to fever, inflammation, and pain. Previous studies have shown that early and continuous application of nonsteroidal anti-inflammatory drugs significantly reduces pain behavior in the spared nerve injury (SNI) model for trauma-induced neuropathic pain. However, the role of PGE(2) and its receptors in the development and maintenance of neuropathic pain is incompletely understood but may help inform strategies for pain management. Here, we sought to define the nociceptive roles of the individual PGE(2) receptors (EP1-4) in the SNI model using EP knockout mice. We found that PGE(2) levels at the site of injury were increased and that the expression of the terminal synthase for PGE(2), cytosolic PGE synthase was up-regulated in resident positive macrophages located within the damaged nerve. Only genetic deletion of the EP3 receptor affected nociceptive behavior and reduced the development of late-stage mechanical allodynia as well as recruitment of immune cells to the injured nerve. Importantly, EP3 activation induced the release of CC-chemokine ligand 2 (CCL2), and antagonists against the CCL2 receptor reduced mechanical allodynia in WT but not in EP3 knockout mice. We conclude that selective inhibition of EP3 might present a potential approach for reducing chronic neuropathic pain.	[Treutlein, Elsa-Marie; Kern, Katharina; Tarighi, Neda; Schuh, Claus-Dieter; Nuesing, Rolf M.; Schreiber, Yannick; Ferreiros, Nerea; Geisslinger, Gerd; Pierre, Sandra; Scholich, Klaus] Univ Hosp Frankfurt, Pharmazentrum Frankfurt, Inst Clin Pharmacol, D-60590 Frankfurt, Germany; [Weigert, Andreas; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, D-60323 Frankfurt, Germany; [Geisslinger, Gerd] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol, D-60596 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Fraunhofer Gesellschaft	Scholich, K (corresponding author), Univ Klinikum Frankfurt, Pharmazentrum Frankfurt, Inst Clin Pharmacol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	scholich@em.uni-frankfurt.de	Schuh, Claus D/G-9032-2013; Weigert, Andreas/E-6540-2010	Weigert, Andreas/0000-0002-7529-1952	Deutsche Forschungsgemeinschaft [SCHO817/3-2, GRK2336 AVE, SFB1039]; Else Kroner Fresenius Foundation, Else Kroner Graduate School; Else Kroner Fresenius Foundation, Translational Research Innovation-Pharma Graduate School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Fresenius Foundation, Else Kroner Graduate School; Else Kroner Fresenius Foundation, Translational Research Innovation-Pharma Graduate School	This work was supported by Deutsche Forschungsgemeinschaft Grants SCHO817/3-2, GRK2336 AVE, and SFB1039 (TPA08, B04, B06, Z01) and by funds from the Else Kroner Fresenius Foundation as part of the Else Kroner Graduate School (to E.-M.T.) and as part of the Translational Research Innovation-Pharma Graduate School (to K.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Degousee N, 2012, CIRCULATION, V125, P2904, DOI 10.1161/CIRCULATIONAHA.112.099754; Duarte PC, 2012, EXP NEUROL, V234, P466, DOI 10.1016/j.expneurol.2012.01.021; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Gosselin RD, 2005, J NEUROCHEM, V95, P1023, DOI 10.1111/j.1471-4159.2005.03431.x; Grace PM, 2011, BRAIN BEHAV IMMUN, V25, P1322, DOI 10.1016/j.bbi.2011.04.003; Grosch S, 2017, EXPERT OPIN INV DRUG, V26, P51, DOI 10.1080/13543784.2017.1260544; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; Ley S, 2013, ONCOGENE, V32, P631, DOI 10.1038/onc.2012.77; Linke B, 2012, PROSTAG OTH LIPID M, V99, P15, DOI 10.1016/j.prostaglandins.2012.06.002; Linke B, 2009, J PROTEOME RES, V8, P4851, DOI 10.1021/pr900106v; Ma WY, 2008, NEUROSCI LETT, V437, P165, DOI 10.1016/j.neulet.2008.02.072; Ma WY, 2010, NEUROBIOL AGING, V31, P1227, DOI 10.1016/j.neurobiolaging.2008.08.002; Ma WY, 2005, J NEUROCHEM, V93, P664, DOI 10.1111/j.1471-4159.2005.03050.x; Ma WY, 2002, EUR J NEUROSCI, V15, P1037, DOI 10.1046/j.1460-9568.2002.01940.x; Ma WY, 2003, EXP NEUROL, V183, P581, DOI 10.1016/S0014-4886(03)00182-1; Muja N, 2004, GLIA, V46, P116, DOI 10.1002/glia.10349; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; Natura G, 2013, P NATL ACAD SCI USA, V110, P13648, DOI 10.1073/pnas.1300820110; Pierre S, 2017, J INVEST DERMATOL, V137, P686, DOI 10.1016/j.jid.2016.09.036; Pierre S, 2008, MOL CELL PROTEOMICS, V7, P2475, DOI 10.1074/mcp.M800201-MCP200; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Schafers M, 2004, EXP NEUROL, V185, P160, DOI 10.1016/j.expneurol.2003.09.015; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schuh CD, 2014, ANESTHESIOLOGY, V120, P447, DOI 10.1097/ALN.0b013e3182a76f74; Schuh CD, 2014, PAIN, V155, P545, DOI 10.1016/j.pain.2013.12.006; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Stamatovic SM, 2005, J CEREBR BLOOD F MET, V25, P593, DOI 10.1038/sj.jcbfm.9600055; STREIT WJ, 1985, J HISTOCHEM CYTOCHEM, V33, P1042, DOI 10.1177/33.10.4045182; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Syriatowicz JP, 1999, NEUROSCIENCE, V94, P587, DOI 10.1016/S0306-4522(99)00365-6; Takahashi M, 2004, NEUROSCI LETT, V363, P203, DOI 10.1016/j.neulet.2004.03.040; Takeuchi K, 1999, J PHYSIOL PHARMACOL, V50, P155; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Van Steenwinckel J, 2015, BRAIN BEHAV IMMUN, V45, P198, DOI 10.1016/j.bbi.2014.10.016; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Woodhams PL, 2007, EUR J PAIN, V11, P605, DOI 10.1016/j.ejpain.2006.09.005	42	20	20	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9685	9695		10.1074/jbc.RA118.002492	http://dx.doi.org/10.1074/jbc.RA118.002492			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29752406	Green Published, hybrid			2022-12-26	WOS:000436102300013
J	DeRouen, MC; Hu, L; McKinley, M; Gali, K; Patel, M; Clarke, C; Wakelee, H; Haile, R; Gomez, SL; Cheng, I				DeRouen, Mindy C.; Hu, Lauren; McKinley, Meg; Gali, Kathleen; Patel, Manali; Clarke, Christina; Wakelee, Heather; Haile, Robert; Gomez, Scarlett Lin; Cheng, Iona			Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; CIGARETTE-SMOKING; UNITED-STATES; HEALTH; HISPANICS; AREA; ATHEROSCLEROSIS; ADENOCARCINOMA; ACCULTURATION; EPIDEMIOLOGY	Background The relationships between neighborhood factors (i.e., neighborhood socioeconomic status (nSES) and ethnic enclave) and histologic subtypes of lung cancer for racial/ethnic groups, particularly Hispanics and Asian American/Pacific Islanders (AAPIs), are poorly understood. Methods We conducted a population-based study of 75,631 Californians diagnosed with lung cancer from 2008 through2012. We report incidence rate ratios (IRRs) for lung cancer histologic cell-types by nSES among racial/ethnic groups (non-Hispanic (NH) Whites, NH Blacks, Hispanics and AAPIs) and according to Hispanic or Asian neighborhood ethnic enclave status among Hispanics and AAPIs, respectively. In addition, we examined incidence jointly by nSES and ethnic enclave. Results Patterns of lung cancer incidence by nSES and ethnic enclave differed across race/ethnicity, sex, and histologic cell-type. For adenocarcinoma, Hispanic males and females, residing in both low nSES and high nSES neighborhoods that were low enclave, had higher incidence rates compared to those residing in low nSES, high enclave neighborhoods; males (IRR, 1.17 [95% CI, 1.04-1.32] and IRR, 1.15 [95% CI, 1.02-1.29], respectively) and females (IRR, 1.29 [95% CI, 1.15-1.44] and IRR, 1.51 [95% CI, 1.36-1.67], respectively). However, AAPI males residing in both low and high SES neighborhoods that were also low enclave had lower adenocarcinoma incidence. Conclusions Neighborhood factors differentially influence the incidence of lung cancer histologic cell types with heterogeneity in these associations by race/ethnicity and sex. For Hispanic males and females and AAPI males, neighborhood ethnic enclave status is strongly associated with lung adenocarcinoma incidence.	[DeRouen, Mindy C.; McKinley, Meg; Clarke, Christina; Gomez, Scarlett Lin; Cheng, Iona] Canc Prevent Inst Calif, Fremont, CA 94538 USA; [DeRouen, Mindy C.; Gomez, Scarlett Lin; Cheng, Iona] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [DeRouen, Mindy C.; McKinley, Meg; Gomez, Scarlett Lin; Cheng, Iona] Greater Bay Area Canc Registry, Fremont, CA 94538 USA; [Hu, Lauren] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Gali, Kathleen] Univ Calif Merced, Sch Social Sci Humanities & Arts, Dept Publ Hlth, Merced, CA USA; [Patel, Manali; Wakelee, Heather] Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA; [Patel, Manali] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Patel, Manali] Stanford Univ, Dept Med, Primary Care & Outcomes Res, Sch Med, Stanford, CA 94305 USA; [Patel, Manali; Clarke, Christina; Wakelee, Heather] Stanford Canc Inst, Stanford, CA USA; [Haile, Robert] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Gomez, Scarlett Lin; Cheng, Iona] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA	Cancer Prevention Institute of California; University of California System; University of California San Francisco; University of Hawaii System; University of California System; University of California Merced; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford Cancer Institute; Cedars Sinai Medical Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	DeRouen, MC (corresponding author), Canc Prevent Inst Calif, Fremont, CA 94538 USA.; DeRouen, MC (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; DeRouen, MC (corresponding author), Greater Bay Area Canc Registry, Fremont, CA 94538 USA.	MDeRouen@psg.ucsf.edu	Patel, Manali/Z-1666-2019; Gali, Kathleen/AAL-7478-2020; Wakelee, Heather/P-2623-2019	DeRouen, Mindy/0000-0002-7198-7629	Stanford Cancer Institute; National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201000140C, HHSN261201000035C, HHSN261201000034C]; California Department of Public Health [103885]; Centers for Disease Control and Prevention's National Program of Cancer Registries [U58DP003862-01]	Stanford Cancer Institute; National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Department of Public Health; Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Stanford Cancer Institute (M DeRouen, C Clarke, SL Gomez, I Cheng) and the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California (M McKinley). All other authors (L Hu, K Gali, M Patel, H Wakelee, and R Haile) did not receive funding for work on this manuscript. The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contract HHSN261201000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement U58DP003862-01 awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author (s) and endorsement by the State of California, Department of Public Health the National Cancer Institute, and the Centers for Disease Control and Prevention or their Contractors and Subcontractors is not intended nor should be inferred.	Abraido-Lanza AF, 2006, AM J PUBLIC HEALTH, V96, P1342, DOI 10.2105/AJPH.2005.064980; American Cancer Society, 2017, CANC FACTS FIG 2017; Arrieta O, 2011, J THORAC ONCOL, V6, P1955, DOI 10.1097/JTO.0b013e31822f655f; Butler DC, 2013, HEALTH SERV RES, V48, P539, DOI 10.1111/j.1475-6773.2012.01449.x; Charloux A, 1997, INT J EPIDEMIOL, V26, P14, DOI 10.1093/ije/26.1.14; COREIL J, 1991, PREV MED, V20, P508, DOI 10.1016/0091-7435(91)90048-9; Datta GD, 2006, SOC SCI MED, V63, P1034, DOI 10.1016/j.socscimed.2006.03.010; Ennis S. R., 2011, HISPANIC POPULATION; Eschbach K, 2005, CANCER-AM CANCER SOC, V103, P1036, DOI 10.1002/cncr.20885; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Gomez SL, 2011, CANCER CAUSE CONTROL, V22, P631, DOI 10.1007/s10552-011-9736-5; Hajat A, 2013, ENVIRON HEALTH PERSP, V121, P1325, DOI 10.1289/ehp.1206337; HAYNES SG, 1990, AM J PUBLIC HEALTH, V80, P47, DOI 10.2105/AJPH.80.Suppl.47; Kandula NR, 2009, AM J PUBLIC HEALTH, V99, P885, DOI 10.2105/AJPH.2007.131854; Kenfield SA, 2008, TOB CONTROL, V17, P198, DOI 10.1136/tc.2007.022582; Khuder SA, 2001, LUNG CANCER, V31, P139, DOI 10.1016/S0169-5002(00)00181-1; Krieger N, 1999, CANCER CAUSE CONTROL, V10, P525, DOI 10.1023/A:1008950210967; Lee JGL, 2015, AM J PUBLIC HEALTH, V105, pE8, DOI 10.2105/AJPH.2015.302777; Lewis DR, 2014, CANCER-AM CANCER SOC, V120, P2883, DOI 10.1002/cncr.28749; Mukherjea A, 2014, AM J HEALTH BEHAV, V38, P362, DOI 10.5993/AJHB.38.3.5; Osypuk TL, 2009, SOC SCI MED, V69, P110, DOI 10.1016/j.socscimed.2009.04.010; Perez-Stable EJ, 2001, AM J PUBLIC HEALTH, V91, P1424, DOI 10.2105/AJPH.91.9.1424; Pesch B, 2012, INT J CANCER, V131, P1210, DOI 10.1002/ijc.27339; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Sidorchuk A, 2009, CANCER CAUSE CONTROL, V20, P459, DOI 10.1007/s10552-009-9300-8; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Surveillance Research Program, SURV RES PROGR VERS; Wilkinson AV, 2005, AM J PUBLIC HEALTH, V95, P1043, DOI 10.2105/AJPH.2004.055319; Wong ML, 2013, J THORAC ONCOL, V8, P287, DOI 10.1097/JTO.0b013e31827bd7f5; Yang J., 2014, DEV AREA BASED SOCIO; Yin DX, 2010, CANCER CAUSE CONTROL, V21, P1721, DOI 10.1007/s10552-010-9601-y	33	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197146	10.1371/journal.pone.0197146	http://dx.doi.org/10.1371/journal.pone.0197146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0FF	29791458	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000033
J	Hayes, TR; Henderson, JM				Hayes, Taylor R.; Henderson, John M.			Scan patterns during scene viewing predict individual differences in clinical traits in a normative sample	PLOS ONE			English	Article							VISUAL-SPATIAL ATTENTION; EYE-MOVEMENTS; DEVELOPMENTAL DYSLEXIA; VISUOSPATIAL ATTENTION; AUTISM-SPECTRUM; DISORDER; CHILDREN; DEFICIT; IMPAIRMENT; VALIDATION	The relationship between viewer individual differences and gaze control has been largely neglected in the scene perception literature. Recently we have shown a robust association between individual differences in viewer cognitive capacity and scan patterns during scene viewing. These findings suggest other viewer individual differences may also be associated with scene gaze control. Here we expand our findings to quantify the relationship between individual differences in clinical traits and scene viewing behavior in a normative sample. The present study used Successor Representation Scanpath Analysis (SRSA) to quantify the strength of the association between individual differences in scan patterns during real world scene viewing and individual differences in viewer attention-deficit disorder, autism spectrum disorder, and dyslexia scores. The SRSA results revealed individual differences in vertical scan patterns that explained more than half of the variance in attention-deficit scores, a third of the variance in autism quotient scores, and about a quarter of the variance in dyslexia scores. These results suggest that individual differences in attention-deficit disorder, autism spectrum disorder, and dyslexia scores are most strongly associated with vertical scanning behaviors when viewing real-world scenes. More importantly, our results suggest scene scan patterns have promise as potential diagnostic tools and provide insight into the types of vertical scan patterns that are most diagnostic.	[Hayes, Taylor R.; Henderson, John M.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Henderson, John M.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hayes, TR (corresponding author), Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA.	taylor.r.hayes@gmail.com		Hayes, Taylor/0000-0003-0078-3642	National Eye Institute of the National Institutes of Health [R01EY027792]; NATIONAL EYE INSTITUTE [R01EY027792] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under award number R01EY027792. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aigner W, 2011, HUM-COMPUT INT-SPRIN, P1, DOI 10.1007/978-0-85729-079-3; Allen G, 2001, FRONT BIOSCI-LANDMRK, V6, pD105, DOI 10.2741/allen; [Anonymous], 2012, P S EYE TRACKING RES, DOI [DOI 10.1145/2168556.2168563, DOI 10.3758/s13428-012-0234-9]; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Carr LA, 2006, NEUROPSYCHOLOGY, V20, P430, DOI 10.1037/0894-4105.20.4.430; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; DAYAN P, 1993, NEURAL COMPUT, V5, P613, DOI 10.1162/neco.1993.5.4.613; Facoetti A, 2003, COGNITIVE BRAIN RES, V15, P154, DOI 10.1016/S0926-6410(02)00148-9; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Germano E, 2010, DEV NEUROPSYCHOL, V35, P475, DOI 10.1080/87565641.2010.494748; Harel J., 2006, NEURAL INFORM PROCES, P1; Hayes TR, 2017, J VISION, V17, DOI 10.1167/17.5.23; Hayes TR, 2015, INTELLIGENCE, V48, P1, DOI 10.1016/j.intell.2014.10.005; Hayes TR, 2011, J VISION, V11, DOI 10.1167/11.10.10; Haykin S., 2009, NEURAL NETWORKS LEAR; Hedge C, 2018, BEHAV RES METHODS, V50, P1166, DOI 10.3758/s13428-017-0935-1; Henderson JM, 2017, NAT HUM BEHAV, V1, P743, DOI 10.1038/s41562-017-0208-0; Holmqvist K., 2015, EYE TRACKING COMPREH; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2015, NEURON, V88, P442, DOI 10.1016/j.neuron.2015.10.033; Jasper L, 1995, ADULT ADD SCREENING; Karatekin C, 1999, J ABNORM CHILD PSYCH, V27, P35, DOI 10.1023/A:1022662323823; Kennedy DP, 2017, CURR BIOL, V27, P3554, DOI 10.1016/j.cub.2017.10.007; Koschack J, 2003, PSYCHOL MED, V33, P481, DOI 10.1017/S0033291702007067; Landry R, 2004, J CHILD PSYCHOL PSYC, V45, P1115, DOI 10.1111/j.1469-7610.2004.00304.x; Leitner Y, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00268; Lopez V, 2006, CLIN NEUROPHYSIOL, V117, P2540, DOI 10.1016/j.clinph.2006.07.313; Lundqvist LO, 2017, J AUTISM DEV DISORD, V47, P2080, DOI 10.1007/s10803-017-3128-y; Mason DJ, 2005, J CHILD PSYCHOL PSYC, V46, P1345, DOI 10.1111/j.1469-7610.2005.01428.x; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; NOTON D, 1971, VISION RES, V11, P929, DOI 10.1016/0042-6989(71)90213-6; NOTON D, 1971, SCIENCE, V171, P308, DOI 10.1126/science.171.3968.308; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Peyrin C, 2012, BRAIN LANG, V120, P381, DOI 10.1016/j.bandl.2011.12.015; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Sasson NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042457; Sasson NJ, 2008, AUTISM RES, V1, P31, DOI 10.1002/aur.4; Snowling MJ, 2008, Q J EXP PSYCHOL, V61, P142, DOI 10.1080/17470210701508830; Sofianopoulou A, 2008, CROSSING INTERNAL EX, P161; Spotorno S, 2017, J EXP PSYCHOL HUMAN, V43, P1717, DOI 10.1037/xhp0000456; SR Research, 2010, EYELINK 1000 USER MA; SR Research, 2010, EXP BUILD US MAN; Stark L., 1981, EYE MOVEMENTS COGNIT, P193; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1007/BF00115009; Takarae Y, 2004, BRAIN, V127, P2584, DOI 10.1093/brain/awh307; Tatler BW, 2017, PSYCHOL REV, V124, P267, DOI 10.1037/rev0000054; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; Vigneau F, 2006, INTELLIGENCE, V34, P261, DOI 10.1016/j.intell.2005.11.003; Vinegrad MA., 1994, EDUCARE, V48, P21; Wainwright JA, 1996, J AUTISM DEV DISORD, V26, P423, DOI 10.1007/BF02172827; Wang S, 2015, NEURON, V88, P604, DOI 10.1016/j.neuron.2015.09.042; Wilcockson TDW, 2016, SUBST USE MISUSE, V51, P15, DOI 10.3109/10826084.2015.1073322; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zoubrinetzky R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099337	59	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0196654	10.1371/journal.pone.0196654	http://dx.doi.org/10.1371/journal.pone.0196654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0FF	29791467	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000018
J	Wielders, CLC; van Nierop, P; Vormer, TL; Foijer, F; Verheij, J; Lodder, JC; Andersen, JB; Mansvelder, HD; te Riele, H				Wielders, Camiel L. C.; van Nierop, Pim; Vormer, Tinke L.; Foijer, Floris; Verheij, Joanne; Lodder, Johannes C.; Andersen, Jesper B.; Mansvelder, Huibert D.; te Riele, Hein			RNAi screening of subtracted transcriptomes reveals tumor suppression by taurine-activated GABA(A) receptors involved in volume regulation	PLOS ONE			English	Article							CELL-VOLUME; G(1) CONTROL; CHANNELS; EXPRESSION; RELEASE; KINASE; DIFFERENTIATION; RESISTANCE; COMPONENT; GROWTH	To identify coding and non-coding suppressor genes of anchorage-independent proliferation by efficient loss-of-function screening, we have developed a method for enzymatic production of low complexity shRNA libraries from subtracted transcriptomes. We produced and screened two LEGO (Low-complexity by Enrichment for Genes shut Off) shRNA libraries that were enriched for shRNA vectors targeting coding and non-coding polyadenylated transcripts that were reduced in transformed Mouse Embryonic Fibroblasts (MEFs). The LEGO shRNA libraries included-25 shRNA vectors per transcript which limited off-target artifacts. Our method identified 79 coding and non-coding suppressor transcripts. We found that taurine-responsive GABA(A) receptor subunits, including GABRA5 and GABRB3, were induced during the arrest of non-transformed anchor-deprived MEFs and prevented anchor less proliferation. We show that taurine activates chloride currents through GABA(A) receptors on MEFs, causing seclusion of cell volume in large membrane protrusions. Volume seclusion from cells by taurine correlated with reduced proliferation and, conversely, suppression of this pathway allowed anchorage-independent proliferation. In human cholangio-carcinomas, we found that several proteins involved in taurine signaling via GABA(A) receptors were repressed. Low GABRA5 expression typified hyperproliferative tumors, and loss of taurine signaling correlated with reduced patient survival, suggesting this tumor suppressive mechanism operates in vivo.	[Wielders, Camiel L. C.; Vormer, Tinke L.; te Riele, Hein] Netherlands Canc Inst, Div Tumor Biol & Immunol, Amsterdam, Netherlands; [van Nierop, Pim; Lodder, Johannes C.; Mansvelder, Huibert D.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Amsterdam, Netherlands; [Foijer, Floris] Univ Med Ctr Groningen, ERIBA, Groningen, Netherlands; [Verheij, Joanne] Acad Med Ctr, Div Pathol, Amsterdam, Netherlands; [Andersen, Jesper B.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	Netherlands Cancer Institute; Vrije Universiteit Amsterdam; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Copenhagen	te Riele, H (corresponding author), Netherlands Canc Inst, Div Tumor Biol & Immunol, Amsterdam, Netherlands.	h.t.riele@nki.nl	Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340; Foijer, Floris/0000-0003-0989-3127; wielders, camiel/0000-0003-3597-6997; Andersen, Jesper B/0000-0003-1760-5244; Verheij, Joanne/0000-0003-1283-630X	Netherlands Genomics Initiative Horizon Breakthrough Project [050-71-038]; Dutch Cancer Society [NKI 2002-2634]; Netherlands Organization for Scientific Research [ALW 819.02.013]	Netherlands Genomics Initiative Horizon Breakthrough Project; Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Genomics Initiative Horizon Breakthrough Project 050-71-038 (CW, HTR), URL: www.zonmw.nl; Dutch Cancer Society NKI 2002-2634 (HTR), URL: www.kwf.nl; Netherlands Organization for Scientific Research ALW 819.02.013 (CW, HTR), URL: www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Al-Wadei HAN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043376; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Andersen JB, 2012, GASTROENTEROLOGY, V142, P1021, DOI 10.1053/j.gastro.2011.12.005; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carton I, 2003, AM J PHYSIOL-CELL PH, V285, pC935, DOI 10.1152/ajpcell.00069.2003; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Di Ciano C, 2002, AM J PHYSIOL-CELL PH, V283, pC850, DOI 10.1152/ajpcell.00018.2002; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Dubois JM, 2012, PROG BIOPHYS MOL BIO, V108, P93, DOI 10.1016/j.pbiomolbio.2011.12.001; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Jia F, 2008, J NEUROSCI, V28, P106, DOI 10.1523/JNEUROSCI.3996-07.2008; Lambert IH, 2015, ACTA PHYSIOL, V213, P191, DOI 10.1111/apha.12365; Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5; Lin X, 2007, ONCOGENE, V26, P3972, DOI 10.1038/sj.onc.1210166; Marshall WF, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-101; Mohr SE, 2014, NAT REV MOL CELL BIO, V15, P591, DOI 10.1038/nrm3860; Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Roberts SS, 2004, J CLIN ONCOL, V22, P4127, DOI 10.1200/JCO.2004.02.032; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Saransaari P, 1999, NEUROSCIENCE, V94, P949, DOI 10.1016/S0306-4522(99)00384-X; Saransaari P, 2007, AMINO ACIDS, V32, P439, DOI 10.1007/s00726-006-0375-1; Saransaari P, 2004, AMINO ACIDS, V26, P91, DOI 10.1007/s00726-003-0004-1; Saxena A, 2011, WIRES SYST BIOL MED, V3, P527, DOI 10.1002/wsbm.135; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Sengupta S, 2014, ACTA NEUROPATHOL, V127, P593, DOI 10.1007/s00401-013-1205-7; Shennan DB, 2008, CELL PHYSIOL BIOCHEM, V21, P15, DOI 10.1159/000113743; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Sosa MS, 2011, CLIN CANCER RES, V17, P5850, DOI 10.1158/1078-0432.CCR-10-2574; Sudbery I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-175; Tamma G, 2007, AM J PHYSIOL-CELL PH, V292, pC1476, DOI 10.1152/ajpcell.00375.2006; Vormer TL, 2008, MOL CELL BIOL, V28, P7263, DOI 10.1128/MCB.00313-08; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Young TL, 2005, CURR BIOL, V15, P501, DOI 10.1016/j.cub.2005.02.027; Zhang EB, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.201	47	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0196979	10.1371/journal.pone.0196979	http://dx.doi.org/10.1371/journal.pone.0196979			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787571	Green Published, gold, Green Submitted			2022-12-26	WOS:000432785700007
J	Brocato, ER; Philpott, MK; Connon, CC; Ehrhardt, CJ				Brocato, Emily R.; Philpott, M. Katherine; Connon, Catherine C.; Ehrhardt, Christopher J.			Rapid differentiation of epithelial cell types in aged biological samples using autofluorescence and morphological signatures	PLOS ONE			English	Article							T-STRAIN SPORES; HUMAN SKIN; IDENTIFICATION; SEPARATION; BIOMARKER; MIXTURES; PROFILES; FACS; SEX	Establishing the tissue source of epithelial cells within a biological sample is an important capability for forensic laboratories. In this study we used Imaging Flow Cytometry (IFC) to analyze individual cells recovered from buccal, epidermal, and vaginal samples that had been dried between 24 hours and more than eight weeks. Measurements capturing the size, shape, and fluorescent properties of cells were collected in an automated manner and then used to build a multivariate statistical framework for differentiating cells based on tissue type. Results showed that epidermal cells could be distinguished from vaginal and buccal cells using a discriminant function analysis of IFC measurements with an average classification accuracy of 94%. Ultimately, cellular measurements such as these, which can be obtained non-destructively, may provide probative information for many types of biological samples and complement results from standard genetic profiling techniques.	[Brocato, Emily R.; Philpott, M. Katherine; Connon, Catherine C.; Ehrhardt, Christopher J.] Virginia Commonwealth Univ, Dept Forens Sci, Richmond, VA 23284 USA	Virginia Commonwealth University	Ehrhardt, CJ (corresponding author), Virginia Commonwealth Univ, Dept Forens Sci, Richmond, VA 23284 USA.	cehrhardt@vcu.edu	Ehrhardt, Christopher J./N-1937-2019	Ehrhardt, Christopher J./0000-0002-4909-0532; Brocato, Emily/0000-0003-4429-8155	National Institute of Justice Award [2013-DN-BX-K033, 2015-DN-BX-K024]; NIH-NCI [P30CA016059]	National Institute of Justice Award; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the National Institute of Justice Award numbers 2013-DN-BX-K033 and 2015-DN-BX-K024 (PI: Ehrhardt). Flow cytometry services in support of the project were provided by the VCU Massey Cancer Center, supported in part with funding from NIH-NCI P30CA016059. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dean L, 2015, FORENSIC SCI INT-GEN, V17, P8, DOI 10.1016/j.fsigen.2015.03.003; Ehrhardt CJ, 2015, J FORENSIC SCI, V60, P1022, DOI 10.1111/1556-4029.12771; Ehrhardt CJ, 2010, APPL ENVIRON MICROB, V76, P1902, DOI 10.1128/AEM.02443-09; Fereidouni F, 2014, J BIOPHOTONICS, V7, P589, DOI 10.1002/jbio.201200244; Forat S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147973; Haas C, 2008, FORENS SCI INT-GEN S, V1, P37, DOI 10.1016/j.fsigss.2007.10.064; Han YY, 2016, LAB CHIP, V16, P4639, DOI 10.1039/c6lc01063f; Hanssen EN, 2017, FORENSIC SCI INT-GEN, V30, P10, DOI 10.1016/j.fsigen.2017.05.009; Huberty C.J., 1994, APPL DISCRIMINANT AN; JOHNSON DR, 1989, FORENSIC SCI INT, V41, P41, DOI 10.1016/0379-0738(89)90234-X; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Legg KM, 2017, ELECTROPHORESIS, V38, P833, DOI 10.1002/elps.201600352; Lippens S, 2005, CELL DEATH DIFFER, V12, P1497, DOI 10.1038/sj.cdd.4401722; Paszkiewicz GM, 2008, CANCER EPIDEM BIOMAR, V17, P239, DOI 10.1158/1055-9965.EPI-07-0162; Philpott MK, 2017, ANAL BIOANAL CHEM, V409, P4167, DOI 10.1007/s00216-017-0364-0; PLEWIG G, 1970, J INVEST DERMATOL, V54, P19, DOI 10.1111/1523-1747.ep12551488; Seashols-Williams S, 2016, ELECTROPHORESIS, V37, P2780, DOI 10.1002/elps.201600258; Silva SS, 2015, FORENSIC SCI INT-GEN, V14, P1, DOI 10.1016/j.fsigen.2014.09.002; Taki T, 2015, LEGAL MED-TOKYO, V17, P471, DOI 10.1016/j.legalmed.2015.10.003; Verdon TJ, 2015, FORENSIC SCI INT-GEN, V14, P194, DOI 10.1016/j.fsigen.2014.10.019; ZENG HS, 1995, PHOTOCHEM PHOTOBIOL, V61, P639, DOI 10.1111/j.1751-1097.1995.tb09881.x	21	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197701	10.1371/journal.pone.0197701	http://dx.doi.org/10.1371/journal.pone.0197701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29772013	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900089
J	Matsumoto, YK; Kasai, M; Tomihara, K				Matsumoto, Yui K.; Kasai, Masanori; Tomihara, Kazuya			The enhancement effect of estradiol on contextual fear conditioning in female mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RECEPTOR-BETA KNOCKOUT; ESTROGEN-RECEPTOR; POSTMENOPAUSAL WOMEN; WORKING-MEMORY; PROGESTERONE; EXPRESSION; BEHAVIOR; ANXIETY; 17-BETA-ESTRADIOL	Several studies have reported regulatory effects of estrogens on fear conditioning in female rodents. However, these studies used different doses, durations, and/or administration methods, and reported inconsistent results. To clarify the effect of estrogen on fear conditioning, we investigated the effects of different doses and durations of estradiol administration on freezing behavior during contextual fear conditioning in ovariectomized (OVX) mice. In Experiment 1, OVX ICR mice received a single subcutaneous (s.c.) injection of either oil vehicle (control, 0.1 ml sesame oil) or varied doses (0.5 mu g/0.1 ml, 5 mu g/0.1 ml, or 50 mu g/0.1 ml) of 17 beta-estradiol-3-benzoate (EB). Fear conditioning was conducted two days post-EB treatment, and the mice were tested for the learned fear response the following day. In Experiment 2, OVX female mice received an s.c. implantation of a Silastic capsule (I.D. 1.98 x 20.0 mm) containing either vehicle or varied doses (0.05 mu g/0.1 ml, 0.5 mu g/0.1 ml, 5 mu g/0.1 ml, 50 mu g/0.1 ml) of EB. Two weeks after implantation, fear conditioning was conducted. During the tests conducted 24 h after conditioning, the high dose EB group showed longer freezing times in both experiments, and lower locomotor activity compared to the control or lower dose groups. In Experiment 3, serum estradiol concentrations of the mice that were treated like those in Experiment 2, were measured; the serum levels of estradiol increased linearly according to the dose of EB administered. The results suggest that mice treated with a high dose of EB exhibit enhanced fear learning, regardless of treatment duration. As a woman's vulnerability to emotional disorders increases in the peripregnancy period, during which estrogen levels are high, the results from the high-dose EB groups may be important for understanding the hormonal mechanisms involved in these disorders.	[Matsumoto, Yui K.] Kagoshima Univ, Fac Sci, Dept Chem & Biosci, Kagoshima, Japan; [Kasai, Masanori] Kagoshima Univ, Fac Sci, Grad Sch Sci & Engn, Dept Chem & Biosci, Kagoshima, Japan; [Tomihara, Kazuya] Kagoshima Univ, Fac Law Econ & Humanities, Dept Psychol, Kagoshima, Japan; [Matsumoto, Yui K.] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Funct Brain Res, Tokyo, Japan	Kagoshima University; Kagoshima University; Kagoshima University; National Center for Neurology & Psychiatry - Japan	Tomihara, K (corresponding author), Kagoshima Univ, Fac Law Econ & Humanities, Dept Psychol, Kagoshima, Japan.	tomihara@leh.kagoshima-u.ac.jp		Matsumoto, Yui/0000-0003-4725-3278	 [23530957]		This work was supported by a Grant-in-Aid for Scientific Research (C) (23530957) (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-23530957/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barha CK, 2010, NEUROPSYCHOPHARMACOL, V35, P547, DOI 10.1038/npp.2009.161; BARKLEY MS, 1979, BIOL REPROD, V20, P733, DOI 10.1095/biolreprod20.4.733; Bloch M, 2003, COMPR PSYCHIAT, V44, P234, DOI 10.1016/S0010-440X(03)00034-8; Brett M, 2001, PSYCHONEUROENDOCRINO, V26, P339, DOI 10.1016/S0306-4530(01)00003-8; Chang YJ, 2009, HIPPOCAMPUS, V19, P1142, DOI 10.1002/hipo.20581; Cornil CA, 2009, J NEUROENDOCRINOL, V21, P217, DOI 10.1111/j.1365-2826.2009.01822.x; Crawley RA, 2003, PSYCHOL PSYCHOTHER-T, V76, P69, DOI 10.1348/14760830260569265; Duff SJ, 2000, HORM BEHAV, V38, P262, DOI 10.1006/hbeh.2000.1625; Farquhar CM, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004143.pub2, 10.1002/14651858.CD003139.pub2, 10.1002/14651858.CD001122.pub2, 10.1002/14651858.CD003142.pub2]; Frye CA, 2014, STEROIDS, V81, P17, DOI 10.1016/j.steroids.2013.11.009; Gasbarri A, 2008, PSYCHONEUROENDOCRINO, V33, P964, DOI 10.1016/j.psyneuen.2008.04.007; Goodnick P J, 2000, Expert Opin Pharmacother, V1, P903, DOI 10.1517/14656566.1.5.903; Gu Q, 1998, J PHYSIOL-LONDON, V506, P745, DOI 10.1111/j.1469-7793.1998.745bv.x; Guo M, 2004, PROG NEURO-PSYCHOPH, V28, P115, DOI 10.1016/j.pnpbp.2003.09.027; Gupta RR, 2001, BRAIN RES, V888, P356, DOI 10.1016/S0006-8993(00)03116-4; Handa RJ, 2012, NEUROENDOCRINOLOGY, V96, P111, DOI 10.1159/000338397; Hart D, 2014, STEROIDS, V81, P49, DOI 10.1016/j.steroids.2013.11.004; Hatachi Atsuko, 2011, Japanese Journal of Animal Psychology, V61, P155, DOI 10.2502/janip.61.2.3; Hoffmann B, 2010, EXP CLIN ENDOCR DIAB, V118, P274, DOI 10.1055/s-0029-1231082; Ingberg E, 2012, GEN COMP ENDOCR, V175, P188, DOI 10.1016/j.ygcen.2011.11.014; Jasnow AM, 2006, HORM BEHAV, V49, P197, DOI 10.1016/j.yhbeh.2005.06.005; KIMURA D, 1994, CURR DIR PSYCHOL SCI, V3, P57, DOI 10.1111/1467-8721.ep10769964; Luine VN, 1998, HORM BEHAV, V34, P149, DOI 10.1006/hbeh.1998.1473; Lymer J, 2017, PSYCHONEUROENDOCRINO, V77, P131, DOI 10.1016/j.psyneuen.2016.11.019; Modder UIL, 2004, EUR J ENDOCRINOL, V151, P503, DOI 10.1530/eje.0.1510503; Morgan MA, 2001, HORM BEHAV, V40, P472, DOI 10.1006/hbeh.2001.1716; NELSON JF, 1981, BIOL REPROD, V24, P784, DOI 10.1095/biolreprod24.4.784; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P485, DOI 10.1016/0306-4530(92)90007-T; Rudolph M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032922; Rutkowski JM, 2013, AM J PATHOL, V183, P1596, DOI 10.1016/j.ajpath.2013.07.031; Sandstrom NJ, 2004, HORM BEHAV, V45, P128, DOI 10.1016/j.yhbeh.2003.09.010; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; SHARP K, 1993, BRIT J OBSTET GYNAEC, V100, P209, DOI 10.1111/j.1471-0528.1993.tb15232.x; Tang JR, 2001, BRAIN RES, V919, P232, DOI 10.1016/S0006-8993(01)03020-7; Tomihara K, 2009, PHYSIOL BEHAV, V96, P300, DOI 10.1016/j.physbeh.2008.10.014; TULCHINSKY D, 1972, AM J OBSTET GYNECOL, V112, P1095, DOI 10.1016/0002-9378(72)90185-8; Walf AA, 2008, BEHAV NEUROSCI, V122, P974, DOI 10.1037/a0012749; Walf AA, 2008, NEUROBIOL LEARN MEM, V89, P513, DOI 10.1016/j.nlm.2008.01.008; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Weiser MJ, 2010, BRAIN RES, V1336, P78, DOI 10.1016/j.brainres.2010.03.098; Wide JK, 2004, BEHAV BRAIN RES, V155, P45, DOI 10.1016/j.bbr.2004.04.001; Yamada K, 2010, BEHAV BRAIN RES, V213, P126, DOI 10.1016/j.bbr.2010.04.037; Zenclussen ML, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00032	46	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197441	10.1371/journal.pone.0197441	http://dx.doi.org/10.1371/journal.pone.0197441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763466	gold, Green Published, Green Submitted			2022-12-26	WOS:000432118800052
J	Berrun, A; Harris, E; Stachura, DL				Berrun, Arturo; Harris, Elena; Stachura, David L.			Isthmin 1 (ism1) is required for normal hematopoiesis in developing zebrafish	PLOS ONE			English	Article							STEM-CELLS INVITRO; BONE-MARROW; AORTIC ENDOTHELIUM; RUNX1 EXPRESSION; DEFINITIVE HEMATOPOIESIS; VERTEBRATE HEMATOPOIESIS; INSERTIONAL MUTAGENESIS; PRIMITIVE HEMATOPOIESIS; MYELOID PROGENITORS; EMBRYONIC BLOOD	Hematopoiesis is an essential and highly regulated biological process that begins with hematopoietic stem cells (HSCs). In healthy organisms, HSCs are responsible for generating a multitude of mature blood cells every day, yet the molecular pathways that instruct HSCs to self-renew and differentiate into post-mitotic blood cells are not fully known. To understand these molecular pathways, we investigated novel genes expressed in hematopoietic-supportive cell lines from the zebrafish (Danio rerio), a model system increasingly utilized to uncover molecular pathways important in the development of other vertebrate species. We performed RNA sequencing of the transcriptome of three stromal cell lines derived from different stages of embryonic and adult zebrafish and identified hundreds of highly expressed transcripts. For our studies, we focused on isthmin 1 (ism1)due to its shared synteny with its human gene ortholog and because it is a secreted protein. To characterize ism1, we performed loss-of-function experiments to identify if mature blood cell production was disrupted. Myeloid and erythroid lineages were visualized and scored with transgenic zebrafish expressing lineage-specific markers. ism1 knockdown led to reduced numbers of neutrophils, macrophages, and erythrocytes. Analysis of clonal methylcellulose assays from ism1 morphants also showed a reduction in total hematopoietic stem and progenitor cells (HSPCs). Overall, we demonstrate that ism1 is required for normal generation of HSPCs and their downstream progeny during zebrafish hematopoiesis. Further investigation into ism1 and its importance in hematopoiesis may elucidate evolutionarily conserved processes in blood formation that can be further investigated for potential clinical utility.	[Berrun, Arturo; Stachura, David L.] Calif State Univ Chico, Dept Biol Sci, Chico, CA 95929 USA; [Harris, Elena] Calif State Univ Chico, Dept Comp Sci, Chico, CA 95929 USA	California State University System; California State University Chico; California State University System; California State University Chico	Stachura, DL (corresponding author), Calif State Univ Chico, Dept Biol Sci, Chico, CA 95929 USA.	dstachura@csuchico.edu		Stachura, David/0000-0002-8993-0938	California State University Program for Education and Research in Biotechnology (CSUPERB); NSF MRI [1626406]; California State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK114732] Funding Source: NIH RePORTER	California State University Program for Education and Research in Biotechnology (CSUPERB); NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD)); California State University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the California State University Program for Education and Research in Biotechnology (CSUPERB; New Investigator Grant), a NSF MRI award (proposal 1626406), and a California State University Chico Internal Research Grant (to D.L.S.).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Amaral DB, 2018, GENESIS, V56, DOI 10.1002/dvg.23052; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Astuti Y, 2017, STEM CELL REP, V8, P177, DOI 10.1016/j.stemcr.2016.12.004; BERARDI AC, 1995, BLOOD, V86, P2123, DOI 10.1182/blood.V86.6.2123.bloodjournal8662123; Berrun AC, 2017, JOVE-J VIS EXP, DOI 10.3791/56836; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2010, BLOOD, V115, P2777, DOI 10.1182/blood-2009-09-244590; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Boulais PE, 2015, BLOOD, V125, P2621, DOI 10.1182/blood-2014-09-570192; Campbell C, 2015, EXP HEMATOL, V43, P1047, DOI 10.1016/j.exphem.2015.09.001; Carroll KJ, 2014, EXP HEMATOL, V42, P684, DOI 10.1016/j.exphem.2014.05.002; Charbord P, 2014, CELL STEM CELL, V15, P376, DOI 10.1016/j.stem.2014.06.005; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Ciau-Uitz A, 2014, EXP HEMATOL, V42, P669, DOI 10.1016/j.exphem.2014.06.001; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Cutler C, 2013, BLOOD, V122, P3074, DOI 10.1182/blood-2013-05-503177; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; de Haan G, 2003, DEV CELL, V4, P241, DOI 10.1016/S1534-5807(03)00018-2; Dexter T M, 1976, Methods Cell Biol, V14, P387, DOI 10.1016/S0091-679X(08)60498-7; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DEXTER TM, 1974, BRIT J HAEMATOL, V28, P525, DOI 10.1111/j.1365-2141.1974.tb06671.x; DEXTER TM, 1973, J CELL PHYSIOL, V82, P461, DOI 10.1002/jcp.1040820315; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Driever W, 1996, DEVELOPMENT, V123, P37; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; Frame JM, 2017, METHOD CELL BIOL, V138, P165, DOI 10.1016/bs.mcb.2016.08.004; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; GARTNER S, 1980, P NATL ACAD SCI-BIOL, V77, P4756, DOI 10.1073/pnas.77.8.4756; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Gore AV, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.312; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lam EYN, 2010, BLOOD, V116, P909, DOI 10.1182/blood-2010-01-264382; Lansdon LA, 2018, GENETICS, V208, P283, DOI 10.1534/genetics.117.300535; Lee Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6583; Lemischka I R, 1991, Semin Immunol, V3, P349; Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mitchell IC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008807; MOORE MAS, 1979, BLOOD CELLS, V5, P297; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nakazawa F, 2006, BLOOD, V108, P3335, DOI 10.1182/blood-2006-05-021386; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Oberlin E, 2002, DEVELOPMENT, V129, P4147; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Osorio L, 2014, CELL CYCLE, V13, P1571, DOI 10.4161/cc.28494; Paik EJ, 2010, ZEBRAFISH, V7, P61, DOI 10.1089/zeb.2009.0643; Pera EM, 2002, MECH DEVELOP, V116, P169, DOI 10.1016/S0925-4773(02)00123-5; Pouget C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6588; Ransom DG, 1996, DEVELOPMENT, V123, P311; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Ridges S, 2012, BLOOD, V119, P5621, DOI 10.1182/blood-2011-12-398818; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; Stachura DL, 2016, METHOD CELL BIOL, V133, P11, DOI 10.1016/bs.mcb.2016.03.022; Stachura DL, 2013, BLOOD, V122, P3918, DOI 10.1182/blood-2012-12-475392; Stachura DL, 2011, BLOOD, V118, P1274, DOI 10.1182/blood-2011-01-331199; Stachura DL, 2009, BLOOD, V114, P279, DOI 10.1182/blood-2009-02-203638; Svoboda O, 2016, NAT PROTOC, V11, P1007, DOI 10.1038/nprot.2016.053; Svoboda O, 2014, BLOOD, V124, P220, DOI 10.1182/blood-2014-03-564682; Tavian M, 1999, DEVELOPMENT, V126, P793; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Valle-Rios R, 2014, J INTERF CYTOK RES, V34, P795, DOI 10.1089/jir.2013.0137; Walmsley M, 2008, BLOOD, V111, P1157, DOI 10.1182/blood-2007-03-081323; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wolf A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44644; Xiang W, 2011, J CELL MOL MED, V15, P359, DOI 10.1111/j.1582-4934.2009.00961.x; Yamauchi H, 2006, EMBO REP, V7, P649, DOI 10.1038/sj.embor.7400685; Yeh JRJ, 2009, NAT CHEM BIOL, V5, P236, DOI 10.1038/nchembio.147; Yuan BQ, 2012, J NEURO-ONCOL, V109, P245, DOI 10.1007/s11060-012-0910-8; ZAPATA A, 1979, DEV COMP IMMUNOL, V3, P55, DOI 10.1016/S0145-305X(79)80006-3; Zhang Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.37; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	87	12	12	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196872	10.1371/journal.pone.0196872	http://dx.doi.org/10.1371/journal.pone.0196872			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758043	Green Published, gold, Green Submitted			2022-12-26	WOS:000432082900017
J	Sharma, A; Ramena, G; Yin, YF; Premkumar, L; Elble, RC				Sharma, Aarushi; Ramena, Grace; Yin, Yufang; Premkumar, Louis; Elble, Randolph C.			CLCA2 is a positive regulator of store-operated calcium entry and TMEM16A	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; BREAST-CANCER; ENDOPLASMIC-RETICULUM; ION-TRANSPORT; CA2+ ENTRY; CLONING; ANO1/TMEM16A; FAMILY; HCLCA2	The Chloride Channel Accessory (CLCA) protein family was first characterized as regulators of calcium-activated chloride channel (CaCC) currents (I-cacc), but the mechanism has not been fully established. We hypothesized that CLCAs might regulate I-cacc by modulating intracellular calcium levels. In cells stably expressing human CLCA2 or vector, we found by calcium imaging that CLCA2 moderately enhanced intracellular-store release but dramatically increased store-operated entry of calcium upon cytosolic depletion. Moreover, another family member, CLCA1, produced similar effects on intracellular calcium mobilization. Co-immunoprecipitation revealed that CLCA2 interacted with the plasma membrane store-operated calcium channel ORAI-1 and the ER calcium sensor STIM-1. The effect of CLCA2 on I-cacc was tested in HEK293 stably expressing calcium-activated chloride channel TMEM16A. Co-expression of CLCA2 nearly doubled I-cacc in response to a calcium ionophore. These results unveil a new mechanism by which CLCA family members activate I-cacc and suggest a broader role in calcium-dependent processes.	[Sharma, Aarushi; Yin, Yufang; Premkumar, Louis; Elble, Randolph C.] Southern Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62702 USA; [Ramena, Grace] Southern Illinois Univ, Sch Med, Med Microbiol Immunol & Cell Biol, Springfield, IL USA; [Elble, Randolph C.] Southern Illinois Univ, Sch Med, Simmons Canc Inst, Springfield, IL 62702 USA; [Sharma, Aarushi] Mayo Clin, Orlando, FL USA; [Ramena, Grace] Univ Arkansas, Pine Bluff, AR USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of Arkansas System; University of Arkansas Fayetteville	Elble, RC (corresponding author), Southern Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62702 USA.; Elble, RC (corresponding author), Southern Illinois Univ, Sch Med, Simmons Canc Inst, Springfield, IL 62702 USA.	relble2@siumed.edu	Sharma, Aarushi/J-4600-2019	Elble, Randolph/0000-0002-0955-0311	National Institutes of Health [1R15CA151094]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant 1R15CA151094 to RCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl H, 2013, BBA-REV CANCER, V1835, P180, DOI 10.1016/j.bbcan.2012.12.001; Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Alonso A, 2015, GASTROENTEROLOGY, V148, P794, DOI 10.1053/j.gastro.2014.12.030; Barro-Soria R, 2010, PFLUG ARCH EUR J PHY, V459, P485, DOI 10.1007/s00424-009-0745-0; Beckley JR, 2004, J BIOL CHEM, V279, P41634, DOI 10.1074/jbc.M408334200; Bergmeier W, 2013, CHANNELS, V7, P379, DOI 10.4161/chan.24302; Bill A, 2015, ONCOTARGET, V6, P9173, DOI 10.18632/oncotarget.3277; Bittremieux Mart, 2015, Oncoscience, V2, P233; Bittremieux M, 2016, BBA-MOL CELL RES, V1863, P1364, DOI 10.1016/j.bbamcr.2016.01.002; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cardenas C, 2016, CELL REP, V14, P2313, DOI [10.1016/j.celrep.2016.02.030, 10.1016/j.celrep.2016.03.045]; Chatterjee G, 2008, BIOCHEM BIOPH RES CO, V372, P412, DOI 10.1016/j.bbrc.2008.05.053; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Concepcion AR, 2016, J CLIN INVEST, V126, P4303, DOI 10.1172/JCI89056; Courjaret R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4916; Crutzen R, 2016, PFLUG ARCH EUR J PHY, V468, P573, DOI 10.1007/s00424-015-1758-5; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Danahay H, 2002, AM J PHYSIOL-LUNG C, V282, pL226, DOI 10.1152/ajplung.00311.2001; Edlund A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-87; Elble RC, 2006, J BIOL CHEM, V281, P29448, DOI 10.1074/jbc.M605919200; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; Elble RC, 2002, J BIOL CHEM, V277, P18586, DOI 10.1074/jbc.M200829200; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Forrest AS, 2012, AM J PHYSIOL-CELL PH, V303, pC1229, DOI 10.1152/ajpcell.00044.2012; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Giorgi C, 2015, P NATL ACAD SCI USA, V112, P1779, DOI 10.1073/pnas.1410723112; Gruber A. D., 2000, Current Genomics, V1, P201, DOI 10.2174/1389202003351526; Gruber AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1261; Gruber AD, 1999, CANCER RES, V59, P5488; Gruber AD, 1998, GENOMICS, V54, P200, DOI 10.1006/geno.1998.5562; Hamann M, 2009, J PHYSIOL-LONDON, V587, P2255, DOI 10.1113/jphysiol.2009.170159; Heinze C, 2014, J CLIN INVEST, V124, P675, DOI 10.1172/JCI70025; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Jin X, 2016, J PHYSIOL-LONDON, V594, P19, DOI 10.1113/jphysiol.2014.275107; Juul CA, 2014, PFLUG ARCH EUR J PHY, V466, P1899, DOI 10.1007/s00424-013-1428-4; Kunzelmann K, 2016, PFLUG ARCH EUR J PHY, V468, P475, DOI 10.1007/s00424-015-1767-4; Kuruma A, 2000, J GEN PHYSIOL, V115, P59, DOI 10.1085/jgp.115.1.59; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Milioli HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129711; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prevarskaya N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0097; Ramena G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147489; Rudd MF, 2006, BLOOD, V108, P638, DOI 10.1182/blood-2005-12-5022; Ruppersburg CC, 2014, MOL BIOL CELL, V25, P1793, DOI 10.1091/mbc.E13-10-0599; Sala-Rabanal M, 2015, ELIFE, V4, DOI 10.7554/eLife.05875; Sasaki Y, 2012, CANCER BIOL THER, V13, P1512, DOI 10.4161/cbt.22280; Schenk LK, 2016, CELL PHYSIOL BIOCHEM, V38, P2452, DOI 10.1159/000445596; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shinmura K, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/619273; Shiwarski DJ, 2014, CLIN CANCER RES, V20, P4673, DOI 10.1158/1078-0432.CCR-14-0363; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Strauss O, 2014, ADV EXP MED BIOL, V801, P113, DOI 10.1007/978-1-4614-3209-8_15; Tan X J, 2016, Zhonghua Xin Xue Guan Bing Za Zhi, V44, P411, DOI 10.3760/cma.j.issn.0253-3758.2016.05.009; Tan Xiaojun, 2015, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V32, P661, DOI 10.3760/cma.j.issn.1003-9406.2015.05.011; Tanikawa C, 2012, NEOPLASIA, V14, P141, DOI 10.1593/neo.111700; Vandecaetsbeek I, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004184; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Wang BX, 2015, J MOL CELL CARDIOL, V82, P22, DOI 10.1016/j.yjmcc.2015.02.020; Wang GQ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-21; Wang Q, 2016, AM J PHYSIOL-CELL PH, V310, pC1001, DOI 10.1152/ajpcell.00092.2016; Xu ZX, 2014, P NATL ACAD SCI USA, V111, P16760, DOI 10.1073/pnas.1419240111; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060861; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yazbeck P, 2017, SCI REP-UK, V7, DOI 10.1038/srep42758; Young FD, 2007, GASTROENTEROLOGY, V133, P1928, DOI 10.1053/j.gastro.2007.10.007; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	77	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196512	10.1371/journal.pone.0196512	http://dx.doi.org/10.1371/journal.pone.0196512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758025	Green Submitted, gold, Green Published			2022-12-26	WOS:000432082900013
J	Xu, TP; Wang, WY; Ma, P; Shuai, Y; Zhao, K; Wang, YF; Li, W; Xia, R; Chen, WM; Zhang, EB; Shu, YQ				Xu, Tong-peng; Wang, Wen-yu; Ma, Pei; Shuai, You; Zhao, Kun; Wang, Yan-fen; Li, Wei; Xia, Rui; Chen, Wen-ming; Zhang, Er-bao; Shu, Yong-qian			Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer	ONCOGENE			English	Article							COLORECTAL-CANCER; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; EXPRESSION; PROGRESSION; ENHANCER; GENE; INVASIVENESS	Accumulating data indicate that long noncoding RNAs (lncRNAs) serve as important modulators in biological processes and are dysregulated in diverse tumors. The function of FOXD2-AS1 in gastric cancer (GC) progression and related biological mechanisms remain undefined. A comprehensive analysis identified that FOXD2-AS1 enrichment was upregulated markedly in GC and positively correlated with a large tumor size, a later pathologic stage, and a poor prognosis. Gene-set enrichment analysis (GSEA) in GEO datasets uncovered that cell cycle and DNA replication associated genes were enriched in patients with high FOXD2-AS1 expression. Loss of FOXD2-AS1 function inhibited cell growth via inhibiting the cell cycle in GC, whereas upregulation of FOXD2-AS1 expression promoted cancer progression. The enhancer of zeste homolog 2 (EZH2) and lysine (K)-specific demethylase 1A (LSD1) proteins were found to serve as binding partners of FOXD2-AS1 and mediators of FOXD2-AS1 function. Mechanically, FOXD2-AS1 promoted GC tumorigenesis partly through EZH2 and LSD1 mediated EphB3 downregulation. The present results revealed that FOXD2-AS1 acted as a tumor inducer in GC partly through EphB3 inhibition by direct interaction with EZH2 and LSD1, and may prove to be a potential biomarker of carcinogenesis.	[Xu, Tong-peng; Wang, Wen-yu; Ma, Pei; Shuai, You; Zhao, Kun; Shu, Yong-qian] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Yan-fen] Yangzhou Univ, Affiliated Hosp, Dept Pathol, Yangzhou, Jiangsu, Peoples R China; [Li, Wei] CloudSeq Biotech Inc, Shanghai, Peoples R China; [Xia, Rui] Nanjing Chest Hosp, Dept Med Lab, 215 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Wen-ming] Jining 1 Peoples Hosp, Dept Oncol, Jining City 272011, Shandong, Peoples R China; [Zhang, Er-bao] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Yangzhou University; Nanjing Medical University	Xu, TP; Shu, YQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	tongpeng_xu_njmu@163.com; yongqian_shu@163.com	Shu, Yongqian/ABD-5698-2021; Ma, Pei/ABD-6343-2021	Shu, Yongqian/0000-0002-3034-685X; Wang, Wenyu/0000-0002-7374-4567; zhang, erbao/0000-0002-5752-7976	National Natural Science Foundation of China [81602071, 81672896]; Jiangsu Provincial Clinical Science and Technology Projects (Clinical Research Center) [BL2012008]; Natural Science Foundation of Jiangsu Province for Youth [BK20161066]; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine) [JX10231801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Clinical Science and Technology Projects (Clinical Research Center); Natural Science Foundation of Jiangsu Province for Youth(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was supported by the National Natural Science Foundation of China (81602071 and 81672896); Jiangsu Provincial Clinical Science and Technology Projects (Clinical Research Center, BL2012008); the Natural Science Foundation of Jiangsu Province for Youth (BK20161066); and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine, JX10231801). We thank CloudSeq Biotech, Inc. (Shanghai, China) for help with bioinformatics analyses.	Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen JS, 2016, NEOPLASMA, V63, P223, DOI 10.4149/207_150821N454; Cheng ASL, 2013, GASTROENTEROLOGY, V144, P122, DOI 10.1053/j.gastro.2012.10.002; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Hu Y, 2014, CANCER RES, V74, P6890, DOI 10.1158/0008-5472.CAN-14-0686; Hung CL, 2014, P NATL ACAD SCI USA, V111, P18697, DOI 10.1073/pnas.1415669112; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jagle S, 2014, P NATL ACAD SCI USA, V111, P4886, DOI 10.1073/pnas.1314523111; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kong R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0355-8; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Li T, 2016, ONCOGENE, V35, P1575, DOI 10.1038/onc.2015.223; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Muppirala UK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-489; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Petrovics G, 2004, ONCOGENE, V23, P605, DOI 10.1038/sj.onc.1207069; Ronsch K, 2015, MOL ONCOL, V9, P335, DOI 10.1016/j.molonc.2014.08.016; Sarma Kavitha, 2010, Proc Natl Acad Sci U S A, V107, P22196, DOI 10.1073/pnas.1009785107; Shang C, 2016, CANCER CHEMOTH PHARM, V77, P1061, DOI 10.1007/s00280-016-3029-3; Shen L, 2013, LANCET ONCOL, V14, pE535, DOI 10.1016/S1470-2045(13)70436-4; Shin J, 2015, MOL CELL, V57, P949, DOI 10.1016/j.molcel.2015.03.007; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Xu TP, 2015, ONCOGENE, V34, P5648, DOI 10.1038/onc.2015.18; Xu TP, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.205; Xu TP, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0063-7; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010	41	92	96	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 6	2018	37	36					5020	5036		10.1038/s41388-018-0308-y	http://dx.doi.org/10.1038/s41388-018-0308-y			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GS6QR	29789713				2022-12-26	WOS:000443823600009
J	Guo, Q; Grimmig, T; Gonzalez, G; Giobbie-Hurder, A; Berg, G; Carr, N; Wilson, BJ; Banerjee, P; Ma, J; Gold, JS; Nandi, B; Huang, Q; Waaga-Gasser, AM; Lian, CG; Murphy, GF; Frank, MH; Gasser, M; Frank, NY				Guo, Qin; Grimmig, Tanja; Gonzalez, Gabriel; Giobbie-Hurder, Anita; Berg, Gretchen; Carr, Nolan; Wilson, Brian J.; Banerjee, Pallavi; Ma, Jie; Gold, Jason S.; Nandi, Bisweswar; Huang, Qin; Waaga-Gasser, Ana Maria; Lian, Christine G.; Murphy, George F.; Frank, Markus H.; Gasser, Martin; Frank, Natasha Y.			ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; COLON-CANCER; DRUG-RESISTANCE; CARCINOMA-CELLS; LUNG-CANCER; MELANOMA; AXL; PROGRESSION; REGULATOR	ABC member B5 (ABCB5) mediates multidrug resistance (MDR) in diverse malignancies and confers clinically relevant 5-fluorouracil resistance to CD133-expressing cancer stem cells in human colorectal cancer (CRC). Because of its recently identified roles in normal stem cell maintenance, we hypothesized that ABCB5 might also serve MDR-independent functions in CRC. Here, in a prospective clinical study of 142 CRC patients, we found that ABCB5 mRNA transcripts previously reported not to be significantly expressed in healthy peripheral blood mononuclear cells are significantly enriched in patient peripheral blood specimens compared with non-CRC controls and correlate with CRC disease progression. In human-to-mouse CRC tumor xenotransplantation models that exhibited circulating tumor mRNA, we observed that cancer-specific ABCB5 knockdown significantly reduced detection of these transcripts, suggesting that the knockdown inhibited tumor invasiveness. Mechanistically, this effect was associated with inhibition of expression and downstream signaling of AXL receptor tyrosine kinase (AXL), a proinvasive molecule herein shown to be produced by ABCB5-positive CRC cells. Importantly, rescue of AXL expression in ABCB5-knockdown CRC tumor cells restored tumor-specific transcript detection in the peripheral blood of xenograft recipients, indicating that ABCB5 regulates CRC invasiveness, at least in part, by enhancing AXL signaling. Our results implicate ABCB5 as a critical determinant of CRC invasiveness and suggest that ABCB5 blockade might represent a strategy in CRC therapy, even independently of ABCB5's function as an MDR mediator.	[Guo, Qin; Gonzalez, Gabriel; Berg, Gretchen; Carr, Nolan; Banerjee, Pallavi; Frank, Natasha Y.] Vet Affairs Boston Healthcare Syst, Dept Med, Boston, MA 02132 USA; [Gold, Jason S.; Nandi, Bisweswar] Vet Affairs Boston Healthcare Syst, Dept Surg, Boston, MA 02132 USA; [Huang, Qin] Vet Affairs Boston Healthcare Syst, Dept Pathol, Boston, MA 02132 USA; [Guo, Qin; Gonzalez, Gabriel; Frank, Natasha Y.] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Gold, Jason S.; Nandi, Bisweswar] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Lian, Christine G.; Murphy, George F.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wilson, Brian J.; Frank, Markus H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Guo, Qin; Berg, Gretchen; Wilson, Brian J.; Banerjee, Pallavi; Ma, Jie; Frank, Markus H.; Frank, Natasha Y.] Harvard Med Sch, Boston Childrens Hosp, Transplant Res Program, Boston, MA 02115 USA; [Grimmig, Tanja; Waaga-Gasser, Ana Maria; Gasser, Martin] Univ Wurzburg, Dept Surg, D-97070 Wurzburg, Germany; [Giobbie-Hurder, Anita] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Wilson, Brian J.; Murphy, George F.; Frank, Markus H.; Frank, Natasha Y.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Wurzburg; Harvard University; Dana-Farber Cancer Institute; Harvard University	Frank, NY (corresponding author), Vet Affairs Boston Healthcare Syst, 1400 VFW Pkwy, Boston, MA 02132 USA.	nyfrank@bwh.harvard.edu	Nandi, Bisweswar/N-5815-2019; Gold, Jason S./O-5112-2014; Giobbie-Hurder, Anita/AAU-6193-2021; Frank, Markus/O-1625-2014	Gold, Jason S./0000-0002-2925-4755; Frank, Markus/0000-0002-1312-0488	Veterans Affairs Grants [BLRD 1I01BX000516, RRD 1I01RX000989]; Department of Defense translational team science award; NCI, National Institutes of Health [R01CA113796, R01CA158467, R01CA138231]; NATIONAL CANCER INSTITUTE [R01CA138231, R01CA113796, R01CA158467] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000989, I01BX000516] Funding Source: NIH RePORTER	Veterans Affairs Grants; Department of Defense translational team science award; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Grants BLR&D 1I01BX000516 and RR&D 1I01RX000989 Merit Review Awards and a Department of Defense translational team science award (to N.Y.F.) and NCI, National Institutes of Health, Grants R01CA113796, R01CA158467, and R01CA138231 (to M.H.F.). N.Y.F. and M.H.F. are co-inventors of the ABCB5-related United States patent 7,928,202 (Targeting ABCB5 for cancer therapy) assigned to Brigham and Women's Hospital (Boston, Massachusetts) and licensed to Ticeba GmbH (Heidelberg, Germany) and Rheacell GmbH & Co. KG (Heidelberg, Germany). M.H.F. serves as a scientific advisor to Ticeba GmbH and Rheacell GmbH & Co. KG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asiedu MK, 2014, ONCOGENE, V33, P1316, DOI 10.1038/onc.2013.57; Aya-Bonilla C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-390; Bates RC, 2004, EXP CELL RES, V299, P315, DOI 10.1016/j.yexcr.2004.05.033; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Chartrain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036762; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107013; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; Cheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115339; Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dunne PD, 2014, CLIN CANCER RES, V20, P164, DOI 10.1158/1078-0432.CCR-13-1354; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Frank NY, 2006, J CELL BIOL, V175, P99, DOI 10.1083/jcb.200511036; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gray ES, 2015, J INVEST DERMATOL, V135, P2040, DOI 10.1038/jid.2015.127; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Kemper K, 2012, STEM CELLS, V30, P2378, DOI 10.1002/stem.1233; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Kugimiya N, 2015, J CELL MOL MED, V19, P1569, DOI 10.1111/jcmm.12531; Liu YN, 2015, ONCOTARGET, V6, P10415, DOI 10.18632/oncotarget.3389; Ma J, 2010, BIOCHEM BIOPH RES CO, V402, P711, DOI 10.1016/j.bbrc.2010.10.091; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Quintana E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004599; Reid AL, 2013, BRIT J DERMATOL, V168, P85, DOI 10.1111/bjd.12057; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schmiegel W, 2010, Z GASTROENTEROL, V48, P65, DOI 10.1055/s-0028-1109936; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vuorte J, 2001, CYTOMETRY, V43, P290, DOI 10.1002/1097-0320(20010401)43:4<290::AID-CYTO1061>3.0.CO;2-X; Wilson BJ, 2014, CANCER RES, V74, P4196, DOI 10.1158/0008-5472.CAN-14-0582; Wilson BJ, 2011, CURR COLORECT CANC R, V7, P128, DOI 10.1007/s11888-011-0093-2; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221; WOLMARK N, 1983, CANCER, V51, P1315, DOI 10.1002/1097-0142(19830401)51:7<1315::AID-CNCR2820510723>3.0.CO;2-0; Yang G, 2015, MOL MED REP, V12, P3930, DOI 10.3892/mmr.2015.3890; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	54	32	32	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11166	11178		10.1074/jbc.RA118.003187	http://dx.doi.org/10.1074/jbc.RA118.003187			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789423	Green Published, hybrid			2022-12-26	WOS:000438882800028
J	Lim, H; Back, SM; Nam, J; Choi, H				Lim, Hyunjung; Back, Seung Min; Nam, Jeonghun; Choi, Hyuk			Determination of red blood cell deformability using centrifugal force in a three-dimensional printed mini-disk (3D-PMD)	PLOS ONE			English	Article							ERYTHROCYTE DEFORMABILITY; MICROFLUIDIC ANALYSIS; RBC DEFORMABILITY; WHOLE-BLOOD; HEMATOCRIT; RELEVANCE	Measuring red blood cell (RBC) deformability has become important for clinical disease diagnostics. Various methods for measuring RBC deformability have been developed; however, they require costly and large instruments, long measuring time, and skilled personnel. In this study, we present a three-dimensional-printed mini-disk (3D-PMD) for measuring RBC deformability to overcome the previous limitations. For a miniaturized and low-cost setup, the 3D-PMD was fabricated by a 3D printing technique, which had not yet been used for fabricating a lab-on-a-compact disk (LOCD). Using a 3D printing technique, a multi-layered fluidic channel on the mini CD could be fabricated easily. During rotation by a spinning motor, the difference of the length of compressed RBCs in the fluidic channel was measured and analysed as compressibility indices (CIs) of normal and glutaraldehyde-treated hardened RBCs. The rotation speed and time were decided as 3000 rpm and 30 min, respectively, at which the difference of CI values between normal and hardened RBCs was largest (CInormal-CIhardened = 0.195).	[Lim, Hyunjung; Back, Seung Min; Choi, Hyuk] Korea Univ, Grad Sch Med, Dept Med Sci, Seoul, South Korea; [Nam, Jeonghun] Korea Univ, Dept Lab Med, Coll Med, Seoul, South Korea; [Nam, Jeonghun] Korea Univ, Dept Emergency Med, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Choi, H (corresponding author), Korea Univ, Grad Sch Med, Dept Med Sci, Seoul, South Korea.; Nam, J (corresponding author), Korea Univ, Dept Lab Med, Coll Med, Seoul, South Korea.; Nam, J (corresponding author), Korea Univ, Dept Emergency Med, Coll Med, Seoul, South Korea.	jhnam77@gmail.com; hyuk76@korea.ac.kr		CHOI, HYUK/0000-0001-9109-3895	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1A09000962]; National Research Foundation of Korea (NRF) - Korean government (MSIP) [2016R1C1B1014991]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Research Foundation of Korea (NRF) - Korean government (MSIP)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2017R1D1A1A09000962). This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2016R1C1B1014991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2017R1D1A1A09000962). This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (No. 2016R1C1B1014991).	Alapan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07173; Andersson P, 2007, ANAL CHEM, V79, P4022, DOI 10.1021/ac061692y; Au AK, 2016, ANGEW CHEM INT EDIT, V55, P3862, DOI 10.1002/anie.201504382; Badr IHA, 2002, ANAL CHEM, V74, P5569, DOI 10.1021/ac025690z; Banerjee R, 1998, CLIN HEMORHEOL MICRO, V19, P21; Bennett-Guerrero E, 2007, P NATL ACAD SCI USA, V104, P17063, DOI 10.1073/pnas.0708160104; Berry SB, 2016, LAB CHIP, V16, P3689, DOI 10.1039/c6lc00895j; Biesiada G, 2006, CLIN HEMORHEOL MICRO, V34, P383; Bow H, 2011, LAB CHIP, V11, P1065, DOI 10.1039/c01c00472c; Cha S, 2012, ANAL CHEM, V84, P10471, DOI 10.1021/ac302763n; Chen XX, 2009, CLIN HEMORHEOL MICRO, V43, P241, DOI 10.3233/CH-2009-1234; CHIEN S, 1987, ANNU REV PHYSIOL, V49, P177, DOI 10.1146/annurev.ph.49.030187.001141; Cicco G, 1999, CLIN HEMORHEOL MICRO, V21, P169; Cicha I, 2000, VOX SANG, V79, P75, DOI 10.1159/000031216; Cluitmans JCA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/764268; Forsyth AM, 2010, MICROVASC RES, V80, P37, DOI 10.1016/j.mvr.2010.03.008; Gorkin R, 2010, LAB CHIP, V10, P1758, DOI 10.1039/b924109d; Grumann M, 2005, LAB CHIP, V5, P560, DOI 10.1039/b418253g; Guo Q, 2014, J BIOMECH, V47, P1767, DOI 10.1016/j.jbiomech.2014.03.038; Haeberle S, 2006, LAB CHIP, V6, P776, DOI 10.1039/b604145k; Hardeman MR, 2007, BIOMED HEALTH RES, V69, P242; Hardeman MR, 2003, TRANSFUSION, V43, P1533, DOI 10.1046/j.1537-2995.2003.00566.x; Ho CMB, 2015, LAB CHIP, V15, P3627, DOI 10.1039/c5lc00685f; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Huang S, 2015, LAB CHIP, V15, P448, DOI 10.1039/c4lc00768a; Huang S, 2013, INTEGR BIOL-UK, V5, P414, DOI 10.1039/c2ib20161e; JOHNSON RM, 1989, METHOD ENZYMOL, V173, P35; Kar S, 2015, ANALYST, V140, P1432, DOI 10.1039/c4an02020k; Kim J, 2015, J CELL BIOTECHNOL, V1, P63, DOI [10.3233/JCB-15007, DOI 10.3233/JCB-15007]; Kong LX, 2016, JALA-J LAB AUTOM, V21, P323, DOI 10.1177/2211068215588456; Li X, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4927197; Loh O, 2009, EXP MECH, V49, P105, DOI 10.1007/s11340-007-9099-8; MOKKEN FC, 1992, ANN HEMATOL, V64, P113, DOI 10.1007/BF01697397; Moore JL, 2011, MICROFLUID NANOFLUID, V10, P877, DOI 10.1007/s10404-010-0721-1; Nguyen NT, 2005, J MICROMECH MICROENG, V15, pR1, DOI 10.1088/0960-1317/15/2/R01; Riegger L, 2007, BIOMED MICRODEVICES, V9, P795, DOI 10.1007/s10544-007-9091-1; Schonbein H, 1996, CLIN HEMORHEOL MICRO, V16, P745; Shin S, 2004, KOREA-AUST RHEOL J, V16, P85; Song SH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4844895; Suresh S, 2015, Acta Biomater, V23 Suppl, pS3, DOI 10.1016/j.actbio.2015.07.015; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Thompson BL, 2016, ANAL CHIM ACTA, V924, P1, DOI 10.1016/j.aca.2016.04.028; Wiewiora M, 2010, CLIN HEMORHEOL MICRO, V44, P259, DOI 10.3233/CH-2010-1275; Zhang JL, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/12/125025; Zheng Y, 2014, LAB CHIP, V14, P577, DOI 10.1039/c3lc51151k	45	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5								10.1371/journal.pone.0197619	http://dx.doi.org/10.1371/journal.pone.0197619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787582	gold, Green Published, Green Submitted			2022-12-26	WOS:000432785700032
J	Gaube, S; Tsivrikos, D; Dollinger, D; Lermer, E				Gaube, Susanne; Tsivrikos, Dimitrios; Dollinger, Daniel; Lermer, Eva			How a smiley protects health: A pilot intervention to improve hand hygiene in hospitals by activating injunctive norms through emoticons	PLOS ONE			English	Article							CARE WORKERS; BEHAVIOR-CHANGE; TRANSMISSION; ADHERENCE; FEEDBACK; PERCEPTIONS; TECHNOLOGY; GUIDELINES; ATTITUDES; VISITORS	Hand hygiene practice in hospitals is unfortunately still widely insufficient, even though it is known that transmitting pathogens via hands is the leading cause of healthcare-associated infections. Previous research has shown that improving knowledge, providing feedback on past behaviour and targeting social norms are promising approaches to improve hand hygiene practices. The present field experiment was designed to direct people on when to perform hand hygiene and prevent forgetfulness. This intervention is the first to examine the effect of inducing injunctive social norms via an emoticon-basedfeed back system on hand hygiene behaviour. Electronic monitoring and feedback devices were installed in hospital patient rooms on top of hand-rub dispensers, next to the doorway, for a period of 17 weeks. In the emoticon condition, screens at the devices activated whenever a person entered or exited the room. Before using the alcohol-based hand-rub dispenser, a frowny face was displayed, indicating that hand hygiene should be performed. If the dispenser was subsequently used, this picture changed to a smiley face to positively reinforce the correct behaviour. Hand hygiene behaviour in the emoticon rooms significantly outperformed the behaviour in three other tested conditions. The strong effect in this field experiment indicates that activating injunctive norms may be a promising approach to improve hand hygiene behaviour. Theoretical and practical implications of these findings are discussed.	[Gaube, Susanne; Lermer, Eva] Univ Regensburg, Dept Expt Psychol, Regensburg, Germany; [Tsivrikos, Dimitrios] UCL, Div Psychol & Language Sci, London, England; [Dollinger, Daniel] Tech Univ Munich, Inst Flight Syst Dynam, Garching, Germany; [Lermer, Eva] FOM Univ Appl Sci, Munich, Germany	University of Regensburg; University of London; University College London; Technical University of Munich	Gaube, S (corresponding author), Univ Regensburg, Dept Expt Psychol, Regensburg, Germany.	susanne.gaube@psychologie.uni-regensburg.de	Lermer, Eva/AAG-7647-2019	Lermer, Eva/0000-0002-6600-9580; Gaube, Susanne/0000-0002-1633-4772	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Allegranzi B, 2013, J HOSP INFECT, V83, pS3, DOI 10.1016/S0195-6701(13)60003-1; Allegranzi B, 2009, J HOSP INFECT, V73, P305, DOI 10.1016/j.jhin.2009.04.019; Ardizzone LL, 2013, AM J INFECT CONTROL, V41, P487, DOI 10.1016/j.ajic.2012.05.029; Arien C, 2013, 92 TRB ANN M 2013 20, P1; Armellino D, 2012, CLIN INFECT DIS, V54, P1, DOI 10.1093/cid/cir773; Barnes SL, 2014, INFECT CONT HOSP EP, V35, P1156, DOI 10.1086/677632; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Bateson M, 2015, PEERJ, V3, DOI 10.7717/peerj.1443; Bateson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082055; Beyfus TA, 2016, AM J INFECT CONTROL, V44, P496, DOI 10.1016/j.ajic.2015.12.021; Birnbach DJ, 2017, J INFECT PUBLIC HEAL, V10, P295, DOI 10.1016/j.jiph.2016.05.015; Birnbach DJ, 2015, J INFECT PUBLIC HEAL, V8, P570, DOI 10.1016/j.jiph.2015.04.027; Birnbach DJ, 2012, AM J INFECT CONTROL, V40, P340, DOI 10.1016/j.ajic.2011.05.006; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Conway LJ, 2016, AM J INFECT CONTROL, V44, pE7, DOI 10.1016/j.ajic.2015.11.031; ECDC, ECDC ANN REP EUR ANT; Eiamsitrakoon T, 2013, INFECT CONT HOSP EP, V34, P1137, DOI 10.1086/673446; Ekstrom M, 2012, EXP ECON, V15, P530, DOI 10.1007/s10683-011-9312-6; Ellingson K, 2011, INFECT CONT HOSP EP, V32, P1091, DOI 10.1086/662179; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; European Centre for Disease Prevention and Control, ANN EP REP COMM DIS; Fisher DA, 2013, INFECT CONT HOSP EP, V34, P919, DOI 10.1086/671738; Fuller C, 2014, AM J INFECT CONTROL, V42, P106, DOI 10.1016/j.ajic.2013.07.019; Fuller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041617; Godin G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-36; Gould DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005186.pub3; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Huis A, 2013, INT J NURS STUD, V50, P464, DOI 10.1016/j.ijnurstu.2012.08.004; Huis A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-92; Hysong SJ, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-9; Istenes N, 2013, AM J INFECT CONTROL, V41, P793, DOI 10.1016/j.ajic.2012.11.012; King D, 2016, HEALTH PSYCHOL, V35, P96, DOI 10.1037/hea0000239; Kommission fur Krankenhaushygiene und Infektionspravention (KRINKO), 2016, BUNDESGESUNDHEITSBLA, V59, P1189, DOI [DOI 10.1007/S00103-016-2416-6, 10.1007/s00103-016-2416-6]; Kuliga S, 2011, P ENV 2 0 P 9 BIENN; Luangasanatip N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3728; Marra AR, 2014, AM J INFECT CONTROL, V42, P608, DOI 10.1016/j.ajic.2014.02.006; McLaws ML, 2012, AM J INFECT CONTROL, V40, P336, DOI 10.1016/j.ajic.2011.04.004; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Naikoba S, 2001, J HOSP INFECT, V47, P173, DOI 10.1053/jhin.2000.0882; Nettle D, 2013, EVOL HUM BEHAV, V34, P35, DOI 10.1016/j.evolhumbehav.2012.08.004; Nomura H, 2011, LOCAL ENVIRON, V16, P637, DOI 10.1080/13549839.2011.586026; Northover SB, 2017, EVOL HUM BEHAV, V38, P144, DOI 10.1016/j.evolhumbehav.2016.07.001; O'Boyle CA, 2001, AM J INFECT CONTROL, V29, P352, DOI 10.1067/mic.2001.18405; Oda R, 2015, EVOL PSYCHOL-US, V13, DOI 10.1177/1474704915594959; Pessoa-Silva CL, 2005, INFECT CONT HOSP EP, V26, P305, DOI 10.1086/502544; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Porzig-Drummond R, 2009, SOC SCI MED, V68, P1006, DOI 10.1016/j.socscimed.2009.01.013; Powell KL, 2012, ETHOLOGY, V118, P1096, DOI 10.1111/eth.12011; Sax H, 2007, INFECT CONT HOSP EP, V28, P1267, DOI 10.1086/521663; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Schultz PW, 2016, ENVIRON BEHAV, V48, P686, DOI 10.1177/0013916514553835; Schweizer ML, 2014, CLIN INFECT DIS, V58, P248, DOI 10.1093/cid/cit670; Shlomai NO, 2015, EUR J CLIN MICROBIOL, V34, P887, DOI 10.1007/s10096-015-2313-1; Srigley JA, 2015, J HOSP INFECT, V91, P202, DOI 10.1016/j.jhin.2015.06.019; Srigley JA, 2015, J HOSP INFECT, V89, P51, DOI 10.1016/j.jhin.2014.10.005; Sroka S, 2010, J HOSP INFECT, V74, P204, DOI 10.1016/j.jhin.2009.08.023; Storey SJ, 2014, J HOSP INFECT, V88, P84, DOI 10.1016/j.jhin.2014.06.014; Venkatesh AK, 2008, AM J INFECT CONTROL, V36, P199, DOI 10.1016/j.ajic.2007.11.005; von Lengerke T, 2016, PSYCHOL HANDEHYGIENE, DOI [10.1055/s-0042-107371, DOI 10.1055/S-0042-107371]; Whitby M, 2006, INFECT CONT HOSP EP, V27, P484, DOI 10.1086/503335; World Health Organization, REP BURD END HLTH CA; World Health Organization (WHO), WHO GUID HAND HYG HL	67	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197465	10.1371/journal.pone.0197465	http://dx.doi.org/10.1371/journal.pone.0197465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG2QJ	29782516	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100024
J	Mweetwa, T; Christianson, D; Becker, M; Creel, S; Rosenblatt, E; Merkle, J; Droge, E; Mwape, H; Masonde, J; Simpamba, T				Mweetwa, Thandiwe; Christianson, David; Becker, Matt; Creel, Scott; Rosenblatt, Elias; Merkle, Johnathan; Droge, Egil; Mwape, Henry; Masonde, Jones; Simpamba, Twakundine			Quantifying lion (Panthera leo) demographic response following a three-year moratorium on trophy hunting	PLOS ONE			English	Article							AFRICAN LIONS; PROTECTED AREA; LAND USES; POPULATIONS; CONSERVATION; ZAMBIA; DECLINES; WILL; SIZE	Factors that limit African lion populations are manifold and well-recognized, but their relative demographic effects remain poorly understood, particularly trophy hunting near protected areas. We identified and monitored 386 individual lions within and around South Luangwa National Park, Zambia, for five years (2008-2012) with trophy hunting and for three additional years (2013-2015) during a hunting moratorium. We used these data with mark-resight models to estimate the effects of hunting on lion survival, recruitment, and abundance. The best survival models, accounting for imperfect detection, revealed strong positive effects of the moratorium, with survival increasing by 17.1 and 14.0 percentage points in subadult and adult males, respectively. Smaller effects on adult female survival and positive effects on cub survival were also detected. The sex-ratio of cubs shifted from unbiased during trophy-hunting to female-biased during the moratorium. Closed mark-recapture models revealed a large increase in lion abundance during the hunting moratorium, from 116 lions in 2012 immediately preceding the moratorium to 209 lions in the last year of the moratorium. More cubs were produced each year of the moratorium than in any year with trophy hunting. Lion demographics shifted from a male-depleted population consisting mostly of adult (>= 4 years) females to a younger population with more (>29%) adult males. These data show that the three-year moratorium was effective at growing the Luangwa lion population and increasing the number of adult males. The results suggest that moratoria may be an effective tool for improving the sustainability of lion trophy hunting, particularly where systematic monitoring, conservative quotas, and age-based harvesting are difficult to enforce.	[Mweetwa, Thandiwe; Becker, Matt; Merkle, Johnathan; Mwape, Henry] Zambian Carnivore Programme, Mfuwe, Eastern Provinc, Zambia; [Christianson, David] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [Creel, Scott] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Rosenblatt, Elias] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Droge, Egil] Univ Oxford, Wildlife Conservat Res Unit, Tubney, England; [Masonde, Jones; Simpamba, Twakundine] Dept Natl Pk & Wildlife, Chilanga, Zambia	University of Arizona; Montana State University System; Montana State University Bozeman; University of Vermont; University of Oxford	Mweetwa, T (corresponding author), Zambian Carnivore Programme, Mfuwe, Eastern Provinc, Zambia.	thandiwemweetwa@gmail.com		Rosenblatt, Elias/0000-0001-7241-2109	World Wide Fund for Nature-Netherlands; Bennink Foundation; National Science Foundation Animal Behavior Program [IOS-1145749]; Painted Dog Conservation Inc; Mfuwe Lodge/Bushcamp Company; National Geographic's Big Cats Initiative; Tusk Trust; Seaworld and Busch Gardens Fund; Wildlife Conservation Network; Russell E. Train Education for Nature Program; Vulcan Inc	World Wide Fund for Nature-Netherlands; Bennink Foundation; National Science Foundation Animal Behavior Program; Painted Dog Conservation Inc; Mfuwe Lodge/Bushcamp Company; National Geographic's Big Cats Initiative(National Geographic Society); Tusk Trust; Seaworld and Busch Gardens Fund; Wildlife Conservation Network; Russell E. Train Education for Nature Program; Vulcan Inc	This work was supported by: 1. World Wide Fund for Nature-Netherlands, Website: https://wwwwnf.n1/, Grantees: Matt Becker; 2. The Bennink Foundation, Website: http://www..benninkfoundation.com/, Grantees: Matt Becker; 3. National Science Foundation Animal Behavior Program under IOS-1145749, Website: https.//,WAV.nsf.gov/funding/aboutfunding.isp, Grantees: Dave Christianson, Scott Creel, Matt Becker; 4. Painted Dog Conservation Inc, Website: http//www.painteridogconservation.iinetnet.au/, Grantees: Matt Becker; 5. Mfuwe Lodge/Bushcamp Company, Website: http://www. bushcampcompany.corn, Grantees: Matt Becker; 6. National Geographic's Big Cats Initiative, Website: https://www.nationalgeographic.org/ projects/big cats initiative!, Grantees: Matt Becker; 7. Tusk Trust, Website: litlp://www.tusk.org/, Grantees: Matt Becker; 8. Seaworld and Busch Gardens Fund, Website: https://conservationfund.org/, Grantees: Matt Becker; 9. Wildlife Conservation Network, Website: https://wildnet.org/, Grantees: Thandiwe Mweetwa; 10. Russell E. Train Education for Nature Program, Website: https://www.worldwildlife.org/initiatives/ russell-e-train-fellowships, Grantee: Thandiwe Mweetwa; 11. Vulcan Inc, Website: http://www.vulcan.com/, Grantee: Matt Becker. Though we received funding from commercial sources namely Painted Dog Conservation Inc, Mfuwe Lodge/Bushcamp Company, and Vulcan Inc, this does not alter our adherence to PLOS ONE policies on sharing data and materials. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee K, 2012, J MAMMAL, V93, P1420, DOI 10.1644/11-MAMM-A-231.1; Bauer H, 2016, PANTHERA LEO IUCN RE, V2016; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Becker MS, 2013, J WILDLIFE MANAGE, V77, P128, DOI 10.1002/jwmg.446; Begg CM, 2018, J APPL ECOL, V55, P139, DOI 10.1111/1365-2664.12951; BERTRAM BCR, 1975, J ZOOL, V177, P463; Brink H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162610; BYGOTT JD, 1979, NATURE, V282, P839, DOI 10.1038/282839a0; Caro TM, 2009, BIOL CONSERV, V142, P909, DOI 10.1016/j.biocon.2008.12.018; CAUGHLEY G, 1971, J REPROD FERTIL, V25, P145, DOI 10.1530/jrf.0.0250145; Chomba Chansa, 2014, Open Journal of Ecology, V4, P182; Conservation South Luangwa, 2008, ANN REP 2008 2016; Creel S, 2016, ECOL APPL, V26, P2347, DOI 10.1002/eap.1377; Creel S, 2015, SCIENCE, V350, P1473, DOI 10.1126/science.aac4768; Di Minin E, 2016, TRENDS ECOL EVOL, V31, P99, DOI 10.1016/j.tree.2015.12.006; Elliot NB, 2014, OIKOS, V123, P1049, DOI 10.1111/oik.01266; Fuente ADL, 2015, MAPPING SUBNATIONAL; Funston PJ, 2011, S AFR J WILDL RES, V41, P1, DOI 10.3957/056.041.0108; Groom RJ, 2014, ORYX, V48, P385, DOI 10.1017/S0030605312001457; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Lindsey PA, 2006, ANIM CONSERV, V9, P283, DOI 10.1111/j.1469-1795.2006.00034.x; Lindsey PA, 2013, ORYX, V47, P41, DOI 10.1017/S0030605311001049; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge AJ, 2016, BIOL CONSERV, V204, P247, DOI 10.1016/j.biocon.2016.10.024; Loveridge A. J., 2010, AFRICAN LIONS EDGE R; Loveridge AJ, 2017, J APPL ECOL, V54, P815, DOI 10.1111/1365-2664.12794; Miller JRB, 2016, BIOL CONSERV, V201, P160, DOI 10.1016/j.biocon.2016.07.003; PACKER C, 1983, AM NAT, V121, P716, DOI 10.1086/284097; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PENNYCUICK CJ, 1970, J ZOOL, V160, P497; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; Riggio J, 2016, P NATL ACAD SCI USA, V113, pE107, DOI 10.1073/pnas.1521506113; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Rosenblatt E, 2014, BIOL CONSERV, V180, P176, DOI 10.1016/j.biocon.2014.10.006; Schaller G. B., 1972, SERENGETI LION STUDY; Snyman A, 2015, ORYX, V49, P604, DOI 10.1017/S0030605313001336; Watson FGR, 2015, REG ENVIRON CHANGE, V15, P415, DOI 10.1007/s10113-014-0629-5; Western D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006140; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Whitman K.L., 2006, HUNTERS GUIDE AGING; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Yamazaki K, 1996, J WILDLIFE MANAGE, V60, P490, DOI 10.2307/3802066	46	7	7	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197030	10.1371/journal.pone.0197030	http://dx.doi.org/10.1371/journal.pone.0197030			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782514	Green Published, gold, Green Submitted			2022-12-26	WOS:000432537100015
J	Rahman, F; Hassan, M; Rosli, R; Almousally, I; Hanano, A; Murphy, DJ				Rahman, Farzana; Hassan, Mehedi; Rosli, Rozana; Almousally, Ibrahem; Hanano, Abdulsamie; Murphy, Denis J.			Evolutionary and genomic analysis of the caleosin/peroxygenase (CLO/PXG) gene/protein families in the Viridiplantae	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; CALEOSIN GENE FAMILY; OIL BODIES; MOLECULAR EVIDENCE; UNIQUE CALEOSIN; LIPID DROPLETS; FATTY-ACIDS; EXPRESSION; PEROXYGENASE; IDENTIFICATION	Bioinformatics analyses of caleosin/peroxygenases (CLO/PXG) demonstrated that these genes are present in the vast majority of Viridipiantae taxa for which sequence data are available. Functionally active CLO/PXG proteins with roles in abiotic stress tolerance and lipid droplet storage are present in some Trebouxiophycean and Chlorophycean green algae but are absent from the small number of sequenced Prasinophyceaen genomes. CLO/PXG-like genes are expressed during dehydration stress in Charophyte algae, a sister clade of the land plants (Embryophyta). CLO/PXG-like sequences are also present in all of the > 300 sequenced Embryophyte genomes, where some species contain as many as 10-12 genes that have arisen via selective gene duplication. Angiosperm genomes harbour at least one copy each of two distinct CLO/PX isoforms, termed H (high) and L (low), where H-forms contain an additional C-terminal motif of about 30-50 residues that is absent from L-forms. In contrast, species in other Viridipiantae taxa, including green algae, non-vascular plants, ferns and gymnosperms, contain only one (or occasionally both) of these isoforms per genome. Transcriptome and biochemical data show that CLO/PXG-like genes have complex patterns of developmental and tissue-specific expression. CLO/PXG proteins can associate with cytosolic lipid droplets and/or bilayer membranes. Many of the analysed isoforms also have peroxygenase activity and are involved in oxylipin metabolism. The distribution of CLO/PXG-like genes is consistent with an origin > 1 billion years ago in at least two of the earliest diverging groups of the Viridipiantae, namely the Chlorophyta and the Streptophyta, after the Viridipiantae had already diverged from other Archaeplastidal groups such as the Rhodophyta and Glaucophyta. While algal CLO/PXGs have roles in lipid packaging and stress responses, the Embryophyte proteins have a much wider spectrum of roles and may have been instrumental in the colonisation of terrestrial habitats and the subsequent diversification as the major land flora.	[Rahman, Farzana; Hassan, Mehedi; Rosli, Rozana; Murphy, Denis J.] Univ South Wales, Genom & Computat Biol Res Grp, Pontypridd, M Glam, Wales; [Rosli, Rozana] Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kuala Lumpur, Malaysia; [Almousally, Ibrahem; Hanano, Abdulsamie] Atom Energy Commiss Syria, Dept Mol Biol & Biotechnol, Damascus, Syria	University of South Wales; Malaysian Palm Oil Board	Murphy, DJ (corresponding author), Univ South Wales, Genom & Computat Biol Res Grp, Pontypridd, M Glam, Wales.	denis.murphy@southwales.ac.uk	Hanano, Abdulsamie/G-2623-2014; Murphy, Denis J/ABC-1734-2020; Hanano, Abdulsamie/V-6835-2019	Hanano, Abdulsamie/0000-0002-1699-106X; Murphy, Denis J/0000-0002-5291-2445; Rahman, Farzana/0000-0002-4785-5845	University of South Wales, UK; Malaysian Palm Oil Board; Atomic Energy Commission of Syria	University of South Wales, UK; Malaysian Palm Oil Board; Atomic Energy Commission of Syria	This work was made possible by support from the University of South Wales, UK, Malaysian Palm Oil Board, and Atomic Energy Commission of Syria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was made possible by support from the University of South Wales, UK, Malaysian Palm Oil Board, and Atomic Energy Commission of Syria. We thank Kirstie Goggin for useful comments on the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Aubert Y, 2010, PLANT CELL PHYSIOL, V51, P1975, DOI 10.1093/pcp/pcq155; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Benaragama I, 2017, PLANTA, DOI [10.1007/s00425-017-27291, DOI 10.1007/S00425-017-27291]; Benaragama I., THESIS; Berbee ML, 2017, ANNU REV MICROBIOL, V71, P41, DOI 10.1146/annurev-micro-030117-020324; Blanc G, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-5-r39; BLEE E, 1993, PLANT J, V4, P113, DOI 10.1046/j.1365-313X.1993.04010113.x; Blee E, 2012, FEBS J, V279, P3981, DOI 10.1111/j.1742-4658.2012.08757.x; Brocks JJ, 2017, NATURE, V548, P578, DOI 10.1038/nature23457; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chan CX, 2011, CURR BIOL, V21, P328, DOI 10.1016/j.cub.2011.01.037; Chang Y, 2015, GENOME BIOL EVOL, V7, P1590, DOI 10.1093/gbe/evv090; Charuchinda P, 2015, BIOSCI BIOTECH BIOCH, V79, P1119, DOI 10.1080/09168451.2015.1010480; Chen JCF, 1999, PLANT CELL PHYSIOL, V40, P1079, DOI 10.1093/oxfordjournals.pcp.a029490; Darby CA, 2017, BIOINFORMATICS, V33, P640, DOI 10.1093/bioinformatics/btw686; Davidi L, 2012, PLANTA, V236, P19, DOI 10.1007/s00425-011-1585-7; de Vries J, 2018, NEW PHYTOL, V217, P1428, DOI 10.1111/nph.14975; Delwiche CF, 2016, ADV BOT RES, V78, P255, DOI 10.1016/bs.abr.2016.02.002; Derelle R, 2016, MOL BIOL EVOL, V33, P2890, DOI 10.1093/molbev/msw168; Feng H, 2011, MOL BIOL REP, V38, P3857, DOI 10.1007/s11033-010-0501-8; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Frandsen G, 1996, J BIOL CHEM, V271, P343, DOI 10.1074/jbc.271.1.343; Froissard M, 2009, FEMS YEAST RES, V9, P428, DOI 10.1111/j.1567-1364.2009.00483.x; Fuchs C, 2013, J MOL CATAL B-ENZYM, V96, P52, DOI 10.1016/j.molcatb.2013.07.001; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Girke T, 2000, PLANT PHYSIOL, V124, P1570, DOI 10.1104/pp.124.4.1570; Hamberg M, 1996, PLANT PHYSIOL, V110, P807, DOI 10.1104/pp.110.3.807; Han K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02101; Hanano A, 2006, J BIOL CHEM, V281, P33140, DOI 10.1074/jbc.M605395200; Hanano A, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02025; Hanano A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00836; Hanano A, 2015, APPL ENVIRON MICROB, V81, P6129, DOI 10.1128/AEM.00867-15; Hanano A, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.991574; Hatje Klas, 2011, BMC Res Notes, V4, P265, DOI 10.1186/1756-0500-4-265; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hemschemeier A, 2013, PLANT CELL, V25, P3186, DOI 10.1105/tpc.113.115741; Hernandez-Pinzon I, 2001, PLANT PHYSIOL BIOCH, V39, P615, DOI 10.1016/S0981-9428(01)01274-8; Holzinger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110630; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; Hu LZ, 2014, INT J AGRIC BIOL, V16, P261; Hu LZ, 2013, ARCH BIOL SCI, V65, P863, DOI 10.2298/ABS1303863H; Hu R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-20; Hyun TK, 2013, GENE, V515, P454, DOI 10.1016/j.gene.2012.11.065; Jiang PL, 2008, PLANT CELL PHYSIOL, V49, P1390, DOI 10.1093/pcp/pcn103; Jiang PL, 2009, PLANT PHYSIOL BIOCH, V47, P1009, DOI 10.1016/j.plaphy.2009.07.004; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keller O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-278; Khalil HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-239; Khalil HB, 2011, PLANT MOL BIOL, V77, P145, DOI 10.1007/s11103-011-9801-1; Kim YY, 2011, PLANT CELL PHYSIOL, V52, P874, DOI 10.1093/pcp/pcr039; Kondo S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00952; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Lequeu J, 2003, PLANT J, V36, P155, DOI 10.1046/j.1365-313X.2003.01865.x; Lin IP, 2012, PLANT PHYSIOL BIOCH, V61, P80, DOI 10.1016/j.plaphy.2012.09.008; Liu MS, 2008, PLANT CELL PHYSIOL, V49, P653, DOI 10.1093/pcp/pcn040; Mackiewicz P, 2014, ACTA SOC BOT POL, V83, P263, DOI 10.5586/asbp.2014.044; Maeda Y, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0408; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Meesapyodsuk D, 2011, PLANT PHYSIOL, V157, P454, DOI 10.1104/pp.111.178822; Moczydlowska M, 2011, PALAEONTOLOGY, V54, P721, DOI 10.1111/j.1475-4983.2011.01054.x; Morris JL, 2018, P NATL ACAD SCI USA, V115, pE2274, DOI 10.1073/pnas.1719588115; Murphy DJ, 2012, PROTOPLASMA, V249, P541, DOI 10.1007/s00709-011-0329-7; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Murphy DJ, 2001, J PLANT PHYSIOL, V158, P471, DOI 10.1078/0176-1617-00359; Naested H, 2000, PLANT MOL BIOL, V44, P463, DOI 10.1023/A:1026564411918; Neves-Borges AC, 2012, GENET MOL BIOL, V35, P212, DOI 10.1590/S1415-47572012000200003; Odronitz Florian, 2008, BMC Genomics, V9, P422, DOI 10.1186/1471-2164-9-422; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; OWCZARZAK A, 1980, J INVERTEBR PATHOL, V35, P26, DOI 10.1016/0022-2011(80)90079-8; Partridge M, 2009, PLANT PHYSIOL BIOCH, V47, P796, DOI 10.1016/j.plaphy.2009.04.005; Pasaribu B, 2017, PLANT PHYSIOL BIOCH, V111, P20, DOI 10.1016/j.plaphy.2016.11.010; Pasaribu B, 2014, PLANT PHYSIOL BIOCH, V82, P142, DOI 10.1016/j.plaphy.2014.05.015; Pasaribu B, 2014, BIOTECHNOL LETT, V36, P175, DOI 10.1007/s10529-013-1332-1; Poxleitner M, 2006, PLANT J, V47, P917, DOI 10.1111/j.1365-313X.2006.02845.x; Purkrtova A Z, 2015, N TERMINUS SEED C SC, V579, P47; Purkrtova Z, 2008, J AGR FOOD CHEM, V56, P11217, DOI 10.1021/jf802305b; Qiu H, 2016, PLOS CURRENTS, V8; Rambaut A., 2018, FIGTREE; Richerioux N., THESIS; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Sanchez-Baracaldo P, 2017, P NATL ACAD SCI USA, V114, pE7737, DOI 10.1073/pnas.1620089114; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Schiffer PH, 2017, BIORXIV, DOI [10.1101/159152, DOI 10.1101/159152]; Sham A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125666; Sham A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113718; Shemesh Z, 2016, ALGAL RES, V18, P321, DOI 10.1016/j.algal.2016.07.002; Shen Y, 2016, GENOME WIDE CHARACTE, V68, P48; Shen Y, 2016, MOL GENET GENOMICS, V291, P971, DOI 10.1007/s00438-015-1156-x; Shen Y, 2014, BIOCHEM BIOPH RES CO, V448, P365, DOI 10.1016/j.bbrc.2014.04.115; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Song WL, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-124; Steemans P, 2009, SCIENCE, V324, P353, DOI 10.1126/science.1169659; STIBBS HH, 1979, J INVERTEBR PATHOL, V33, P159, DOI 10.1016/0022-2011(79)90149-6; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Umate Pavan, 2012, Genomics Proteomics & Bioinformatics, V10, P345, DOI 10.1016/j.gpb.2012.08.006; Villegente M, 2017, PROTEOMES, V5, DOI 10.3390/proteomes5030019; Wellman CH, 2015, PALAEONTOLOGY, V58, P601, DOI 10.1111/pala.12172; Yao LN, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1551-x; Yoneda K, 2016, PLANT CELL PHYSIOL, V57, P397, DOI 10.1093/pcp/pcv204; Yu WL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-91; Zeng LP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5956; Zhu XY, 2015, TRENDS PLANT SCI, V20, P483, DOI 10.1016/j.tplants.2015.05.010; ZIENKIEWICZ K, 2011, BMC PLANT BIOL, V11; Zienkiewicz K, 2016, BBA-MOL CELL BIOL L, V1861, P1269, DOI 10.1016/j.bbalip.2016.02.008; Zienkiewicz K, 2010, J EXP BOT, V61, P1537, DOI 10.1093/jxb/erq022	112	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196669	10.1371/journal.pone.0196669	http://dx.doi.org/10.1371/journal.pone.0196669			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771926	Green Submitted, Green Published, gold			2022-12-26	WOS:000432348900014
J	Liebrand, M; Kristek, J; Tzvi, E; Kramer, UM				Liebrand, Matthias; Kristek, Jascha; Tzvi, Elinor; Kraemer, Ulrike M.			Ready for change: Oscillatory mechanisms of proactive motor control	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; GO/NO-GO TASK; RESPONSE-INHIBITION; PREFRONTAL CORTEX; SUBTHALAMIC NUCLEUS; PHASE SYNCHRONIZATION; EEG DESYNCHRONIZATION; TIME-COURSE; STOP; ALPHA	Proactive motor control is a preparatory mechanism facilitating upcoming action inhibition or adaptation. Previous studies investigating proactive motor control mostly focused on response inhibition, as in the classical go-nogo or stop-signal tasks. However, everyday life rarely calls for the complete suppression of actions without subsequent behavioral adjustment. Therefore, we conducted a modified cued go-nogo-change task, in which cues indicated whether participants might have to change to an alternative action or inhibit the response to an upcoming target. Based on the dual-mechanisms of control framework and using electroencephalography (EEG), we investigated the role of the sensorimotor cortex and of prefrontal regions in preparing to change and cancel motor responses. We focused on mu and beta power over sensorimotor cortex ipsi- and contralateral to an automatic motor response and on prefrontal beta power. Over ipsilateral sensorimotor cortex, mu and beta power was relatively decreased when anticipating to change or inhibit the automatic motor behavior. Moreover, alpha phase coupling between ipsilateral motor cortex and prefrontal areas decreased when preparing to change, suggesting a decoupling of sensorimotor regions from prefrontal control. When the standard motor action actually had to be changed, prefrontal beta power increased, reflecting enhanced cognitive control. Our data highlight the role of the ipsilateral motor cortex in preparing to inhibit and change upcoming motor actions. Here, especially mu power and phase coupling seem to be critical to guide upcoming behavior.	[Liebrand, Matthias; Kristek, Jascha; Tzvi, Elinor; Kraemer, Ulrike M.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Liebrand, Matthias] Univ Lubeck, Grad Sch Comp Med & Life Sci, Lubeck, Germany; [Kraemer, Ulrike M.] Univ Lubeck, Inst Psychol 2, Lubeck, Germany	University of Lubeck; University of Lubeck; University of Lubeck	Kramer, UM (corresponding author), Univ Lubeck, Dept Neurol, Lubeck, Germany.; Kramer, UM (corresponding author), Univ Lubeck, Inst Psychol 2, Lubeck, Germany.	ulrike.kraemer@neuro.uni-luebeck.de	Krämer, Ulrike M./A-8871-2019; Krämer, Ulrike/AAF-2966-2020	Krämer, Ulrike M./0000-0002-3841-1812; Liebrand, Matthias/0000-0003-1139-5151; Tzvi-Minker, Elinor/0000-0002-2011-2101	University of Lubeck [SPP-C4]	University of Lubeck	This work was supported by intramural grants from the University of Lubeck (SPP-C4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2004, EXP BRAIN RES, V159, P14, DOI 10.1007/s00221-004-1928-8; Alegre M, 2013, EXP NEUROL, V239, P1, DOI 10.1016/j.expneurol.2012.08.027; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Babiloni C, 2004, NEUROPSYCHOLOGY, V18, P719, DOI 10.1037/0894-4105.18.4.719; Babiloni Fabio, 1995, Brain Topography, V8, P35, DOI 10.1007/BF01187668; Beaule V, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/627816; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianco V, 2017, NEUROIMAGE, V156, P388, DOI 10.1016/j.neuroimage.2017.05.043; Boecker M, 2013, INT J PSYCHOPHYSIOL, V87, P234, DOI 10.1016/j.ijpsycho.2012.09.009; Boenstrup M, 2014, EUR J NEUROSCI, V40, P2888, DOI 10.1111/ejn.12657; Braver T.S., 2008, VARIATION WORKING ME, P76, DOI [10.1093/acprof:oso/9780195168648.003.0004, DOI 10.1093/ACPROF:OSO/9780195168648.003.0004]; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Brinkman L, 2016, J NEUROSCI, V36, P8726, DOI 10.1523/JNEUROSCI.0868-16.2016; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Brown P, 1999, MOVEMENT DISORD, V14, P423, DOI 10.1002/1531-8257(199905)14:3<423::AID-MDS1006>3.0.CO;2-V; Buschman TJ, 2012, NEURON, V76, P838, DOI 10.1016/j.neuron.2012.09.029; Cheyne DO, 2013, EXP NEUROL, V245, P27, DOI 10.1016/j.expneurol.2012.08.030; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Daume J, 2017, J NEUROSCI, V37, P313, DOI [10.1523/JNEUROSCI.2130-16.2017, 10.1523/JNEUROSCI.2130-16.2016]; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Genc E, 2015, BEHAV BRAIN RES, V293, P1, DOI 10.1016/j.bbr.2015.07.016; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Helfrich RF, 2016, TRENDS COGN SCI, V20, P916, DOI 10.1016/j.tics.2016.09.007; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Hwang K, 2014, J NEUROSCI, V34, P9551, DOI 10.1523/JNEUROSCI.4889-13.2014; Jahfari S, 2012, J NEUROSCI, V32, P10870, DOI 10.1523/JNEUROSCI.0902-12.2012; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kajihara T, 2015, NEUROIMAGE, V118, P445, DOI 10.1016/j.neuroimage.2015.05.032; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Kayser J., 2009, CURRENT SOURCE DENSI; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kramer UM, 2013, CORTEX, V49, P837, DOI 10.1016/j.cortex.2012.05.003; Kramer UM, 2011, J COGNITIVE NEUROSCI, V23, P2481, DOI 10.1162/jocn.2010.21573; Kroeger J, 2010, EUR J NEUROSCI, V32, P1771, DOI 10.1111/j.1460-9568.2010.07442.x; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Liebrand M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00204; Logan Gordon D., 1994, P189; Maki H, 2010, CLIN NEUROPHYSIOL, V121, P492, DOI 10.1016/j.clinph.2009.11.078; Mazaheri A, 2009, HUM BRAIN MAPP, V30, P1791, DOI 10.1002/hbm.20763; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Rae CL, 2015, J NEUROSCI, V35, P786, DOI 10.1523/JNEUROSCI.3093-13.2015; Rangel-Gomez M, 2015, INT J PSYCHOPHYSIOL, V97, P233, DOI 10.1016/j.ijpsycho.2015.01.012; Ray NJ, 2012, NEUROIMAGE, V60, P271, DOI 10.1016/j.neuroimage.2011.12.035; Ruiz MH, 2009, HUM BRAIN MAPP, V30, P2689, DOI 10.1002/hbm.20700; Sadaghiani S, 2012, J NEUROSCI, V32, P14305, DOI 10.1523/JNEUROSCI.1358-12.2012; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Sauseng P, 2013, NEUROIMAGE, V65, P52, DOI 10.1016/j.neuroimage.2012.09.048; Serrien DJ, 2005, BRAIN, V128, P116, DOI 10.1093/brain/awh318; Shibata T, 1998, NEUROSCI RES, V31, P265, DOI 10.1016/S0168-0102(98)00046-7; Shibata T, 1997, NEUROSCI LETT, V233, P117, DOI 10.1016/S0304-3940(97)00652-6; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Solbakk AK, 2014, J COGNITIVE NEUROSCI, V26, P1528, DOI 10.1162/jocn_a_00561; Swann N, 2011, J NEUROSCI, V31, P5721, DOI 10.1523/JNEUROSCI.6135-10.2011; Swann N, 2009, J NEUROSCI, V29, P12675, DOI 10.1523/JNEUROSCI.3359-09.2009; Swann NC, 2013, CEREB CORTEX, V23, P2479, DOI 10.1093/cercor/bhs245; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; TEOLIS A, 1998, APPL NUM HARM ANAL, P1; Tzagarakis C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00246; van Wijk BCM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00252; Vecchio F, 2014, J COGNITIVE NEUROSCI, V26, P1883, DOI 10.1162/jocn_a_00615; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Vink M, 2015, EUR J NEUROSCI, V41, P1086, DOI 10.1111/ejn.12879; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; Wang HC, 1999, J NEUROL NEUROSUR PS, V66, P442, DOI 10.1136/jnnp.66.4.442; Wessel JR, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.12871; Wessel JR, 2016, NEUROBIOL AGING, V38, P205, DOI 10.1016/j.neurobiolaging.2015.10.014; Wessel JR, 2013, J NEUROSCI, V33, P19611, DOI 10.1523/JNEUROSCI.3468-13.2013; Zaepffel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060060; Zandbelt BB, 2013, HUM BRAIN MAPP, V34, P2015, DOI 10.1002/hbm.22047	77	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196855	10.1371/journal.pone.0196855	http://dx.doi.org/10.1371/journal.pone.0196855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF9WG	29768455	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200049
J	Yan, J; Li, GL; Guo, XQ; Li, Y; Cao, XC				Yan, Jun; Li, Guilin; Guo, Xingqi; Li, Yang; Cao, Xuecheng			Genome-wide classification, evolutionary analysis and gene expression patterns of the kinome in Gossypium	PLOS ONE			English	Article							RECEPTOR-LIKE-KINASE; PROTEIN-KINASES; PROVIDES INSIGHTS; PLANT DEVELOPMENT; DROUGHT STRESS; COTTON; ARABIDOPSIS; FAMILY; TOLERANCE; SEQUENCE	The protein kinase (PK, kinome) family is one of the largest families in plants and regulates almost all aspects of plant processes, including plant development and stress responses. Despite their important functions, comprehensive functional classification, evolutionary analysis and expression patterns of the cotton PK gene family has yet to be performed on PK genes. In this study, we identified the cotton kinomes in the Gossypium raimondii, Gossypium arboretum, Gossypium hirsutum and Gossypium barbadense genomes and classified them into 7 groups and 122-24 subfamilies using software HMMER v3.0 scanning and neighbor-joining (NJ) phylogenetic analysis. Some conserved exon-intron structures were identified not only in cotton species but also in primitive plants, ferns and moss, suggesting the significant function and ancient origination of these PK genes. Collinearity analysis revealed that 16.6 million years ago (Mya) cotton-specific whole genome duplication (WGD) events may have played a partial role in the expansion of the cotton kinomes, whereas tandem duplication (TD) events mainly contributed to the expansion of the cotton RLK group. Synteny analysis revealed that tetraploidization of G. hirsutum and G. barbadense contributed to the expansion of G. hirsutum and G. barbadense PKs. Global expression analysis of cotton PKs revealed stress-specific and fiber development-related expression patterns, suggesting that many cotton PKs might be involved in the regulation of the stress response and fiber development processes. This study provides foundational information for further studies on the evolution and molecular function of cotton PKs.	[Yan, Jun; Li, Yang; Cao, Xuecheng] Shandong Agr Univ, Coll Informat Sci & Engn, Tainan, Shandong, Peoples R China; [Yan, Jun; Li, Guilin; Guo, Xingqi] Shandong Agr Univ, Coll Life Sci, Tainan, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Cao, XC (corresponding author), Shandong Agr Univ, Coll Informat Sci & Engn, Tainan, Shandong, Peoples R China.	xccao@sdau.edu.cn			National Natural Science Foundation of China [32535238]; Young Teacher Innovation Fund of Shandong Agricultural University [140-23848]; First-class Discipline Fund, Key Cultivation Discipline Fund for NSFC; Fund for Fostering Talents of Information College [xxxy201707]; Natural Science Foundation of Shandong [ZR20166613]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teacher Innovation Fund of Shandong Agricultural University; First-class Discipline Fund, Key Cultivation Discipline Fund for NSFC; Fund for Fostering Talents of Information College; Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	This work was supported by the fund of National Natural Science Foundation of China (32535238). This work was also supported by the funding of J.Y: Young Teacher Innovation Fund of Shandong Agricultural University (140-23848), First-class Discipline Fund, Key Cultivation Discipline Fund for NSFC, and Fund for Fostering Talents of Information College (xxxy201707). This work was also supported by the Natural Science Foundation of Shandong (ZR20166613).	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Afzal AJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-43; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Ben-Nissan G, 2008, PLANT PHYSIOL, V148, P1897, DOI 10.1104/pp.108.129346; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; De Smet I, 2009, NAT CELL BIOL, V11, P1166, DOI 10.1038/ncb1009-1166; Eddy Sean R, 2009, Genome Inform, V23, P205; Fischer I, 2016, PLANT PHYSIOL, V170, P1595, DOI 10.1104/pp.15.01470; Gao LL, 2012, MOL PLANT, V5, P143, DOI 10.1093/mp/ssr062; Gao Weifan, 2012, Int J Plant Genomics, V2012, P613812, DOI 10.1155/2012/613812; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hirt H, 2011, PLANT SIGNAL BEHAV, V6, P1030, DOI 10.4161/psb.6.7.15580; Huang QS, 2008, PLANT CELL REP, V27, P1869, DOI 10.1007/s00299-008-0603-0; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Ji HT, 2013, MOL PLANT, V6, P275, DOI 10.1093/mp/sst017; Jun Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep15048; Kozik A, 2002, BIOINFORMATICS, V18, P335, DOI 10.1093/bioinformatics/18.2.335; Krupnova T, 2009, CURR BIOL, V19, P518, DOI 10.1016/j.cub.2009.02.021; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehti-Shiu MD, 2012, PHILOS T R SOC B, V367, P2619, DOI 10.1098/rstb.2012.0003; Lehti-Shiu MD, 2009, PLANT PHYSIOL, V150, P12, DOI 10.1104/pp.108.134353; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li YC, 2013, CLIN EXP PHARMACOL P, V40, P635, DOI 10.1111/1440-1681.12143; Li YL, 2005, MOL GENET GENOMICS, V273, P217, DOI 10.1007/s00438-005-1115-z; Li YZ, 2013, FEBS J, V280, P5128, DOI 10.1111/febs.12488; Lin WW, 2013, J INTEGR PLANT BIOL, V55, P1188, DOI 10.1111/jipb.12071; Liu JY, 2015, J EXP BOT, V66, P1919, DOI 10.1093/jxb/eru537; Lu Wenjing, 2013, PLoS One, V8, pe68503, DOI 10.1371/journal.pone.0068503; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mohannath G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087592; Motose H, 2011, PLANT J, V67, P993, DOI 10.1111/j.1365-313X.2011.04652.x; Nigam D, 2014, PLANT BIOTECHNOL J, V12, P204, DOI 10.1111/pbi.12129; Niu EL, 2016, MOL GENET GENOMICS, V291, P1137, DOI 10.1007/s00438-016-1169-0; Ou Y, 2016, CELL RES, V26, P686, DOI 10.1038/cr.2016.63; Ouyang SQ, 2010, PLANT J, V62, P316, DOI 10.1111/j.1365-313X.2010.04146.x; Padmalatha KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-624; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Pilotti Massimo, 2014, BMC Res Notes, V7, P884, DOI 10.1186/1756-0500-7-884; Rameneni JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142255; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saidi Y, 2012, TRENDS PLANT SCI, V17, P39, DOI 10.1016/j.tplants.2011.10.002; Sakamoto T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-229; Shen W, 2009, PLANT PHYSIOL, V150, P996, DOI 10.1104/pp.108.132787; Shi J, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-22; Shi J, 2010, PLANT MOL BIOL, V74, P1, DOI 10.1007/s11103-010-9661-0; Shi YL, 2014, MOL BIOL REP, V41, P411, DOI 10.1007/s11033-013-2875-x; Shimotohno A, 2003, FEBS LETT, V534, P69, DOI 10.1016/S0014-5793(02)03780-8; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Singh A, 2012, J PLANT BIOCHEM BIOT, V21, pS100, DOI 10.1007/s13562-012-0150-1; Vaid N, 2013, MOL PLANT, V6, P1405, DOI 10.1093/mp/sst033; Van Damme D, 2011, PLANT CELL, V23, P4013, DOI 10.1105/tpc.111.089565; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Walford SA, 2012, PLANT J, V71, P464, DOI 10.1111/j.1365-313X.2012.05003.x; Wang C, 2016, PLANT CELL PHYSIOL, V57, P1629, DOI 10.1093/pcp/pcw090; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang YX, 2011, J PLANT PHYSIOL, V168, P2260, DOI 10.1016/j.jplph.2011.07.014; Wang YX, 2010, PLANT J, V64, P230, DOI 10.1111/j.1365-313X.2010.04320.x; Wang YP, 2012, ANN NY ACAD SCI, V1256, P1, DOI 10.1111/j.1749-6632.2011.06384.x; Wei KF, 2014, MOL BREEDING, V33, P155, DOI 10.1007/s11032-013-9941-x; Wu T, 2009, MOL BIOL REP, V36, P2365, DOI 10.1007/s11033-009-9459-9; Wu YZ, 2016, MOL PLANT, V9, P289, DOI 10.1016/j.molp.2015.12.011; Xing HT, 2011, PLANTA, V234, P229, DOI 10.1007/s00425-011-1389-9; Yamaguchi M, 1998, PLANT J, V16, P613, DOI 10.1046/j.1365-313x.1998.00338.x; Yan J, 2017, PLANT MOL BIOL, V95, P227, DOI 10.1007/s11103-017-0637-1; Yuan DJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17662; Zan YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-318; Zhang BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051091; Zhang L, 2012, J EXP BOT, V63, P3935, DOI 10.1093/jxb/ers086; Zhang LA, 2011, FEBS J, V278, P1367, DOI 10.1111/j.1742-4658.2011.08056.x; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhao J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-110; Zhu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080218; Zulawski M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-548	83	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197392	10.1371/journal.pone.0197392	http://dx.doi.org/10.1371/journal.pone.0197392			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768506	Green Submitted, Green Published, gold			2022-12-26	WOS:000432329200079
J	Bentsen, T; May, T; Kressner, AA; Dau, T				Bentsen, Thomas; May, Tobias; Kressner, Abigail A.; Dau, Torsten			The benefit of combining a deep neural network architecture with ideal ratio mask estimation in computational speech segregation to improve speech intelligibility	PLOS ONE			English	Article							HEARING-IMPAIRED LISTENERS; MODULATION ANALYSIS; NOISE; ALGORITHM; SEPARATION; RECOGNITION; SYSTEMS; BINARY	Computational speech segregation attempts to automatically separate speech from noise. This is challenging in conditions with interfering talkers and low signal-to-noise ratios. Recent approaches have adopted deep neural networks and successfully demonstrated speech intelligibility improvements. A selection of components may be responsible for the success with these state-of-the-art approaches: the system architecture, a time frame concatenation technique and the learning objective. The aim of this study was to explore the roles and the relative contributions of these components by measuring speech intelligibility in normal-hearing listeners. A substantial improvement of 25.4 percentage points in speech intelligibility scores was found going from a subband-based architecture, in which a Gaussian Mixture Model-based classifier predicts the distributions of speech and noise for each frequency channel, to a state-of-the-art deep neural network-based architecture. Another improvement of 13.9 percentage points was obtained by changing the learning objective from the ideal binary mask, in which individual time-frequency units are labeled as either speech- or noise-dominated, to the ideal ratio mask, where the units are assigned a continuous value between zero and one. Therefore, both components play significant roles and by combining them, speech intelligibility improvements were obtained in a six-talker condition at a low signal-to-noise ratio.	[Bentsen, Thomas; May, Tobias; Kressner, Abigail A.; Dau, Torsten] Tech Univ Denmark, Dept Elect Engn, Hearing Syst Grp, Lyngby, Denmark	Technical University of Denmark	Bentsen, T (corresponding author), Tech Univ Denmark, Dept Elect Engn, Hearing Syst Grp, Lyngby, Denmark.	thobe@elektro.dtu.dk	Kressner, Abbie/ABH-7005-2020; May, Tobias/N-6062-2016; Dau, Torsten/AAJ-3709-2020; Kressner, Abigail Anne/M-7848-2016	May, Tobias/0000-0002-5463-5509; Dau, Torsten/0000-0001-8110-4343; Kressner, Abigail Anne/0000-0003-4274-3948	Oticon Centre of Excellence for Hearing and Speech Sciences; EU FET grant Two!Ears [ICT-618075]; Danish Council for Independent Research (DFF) [DFF-5054-00072]	Oticon Centre of Excellence for Hearing and Speech Sciences; EU FET grant Two!Ears; Danish Council for Independent Research (DFF)(Det Frie Forskningsrad (DFF))	Thomas Bentsen (THOBE) was funded by Oticon Centre of Excellence for Hearing and Speech Sciences. Tobias May (TOBMAY) was funded by the EU FET grant Two!Ears, ICT-618075. Abigail A. Kressner (AAKRESS) was funded by the Danish Council for Independent Research (DFF) with grant number DFF-5054-00072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentsen T., 2016, P INT 2016 SEPT 8 12, P170; Bentsen T, 2018, J ACOUST SOC AM, V143, P248, DOI 10.1121/1.5020273; Brons I, 2012, J ACOUST SOC AM, V132, P2690, DOI 10.1121/1.4747006; Chen Jiadi, 2015, INT J ANTENN PROPAG, V2015, P12, DOI DOI 10.1016/J.EJPHAR.2015.12.038; Chen JT, 2016, J ACOUST SOC AM, V139, P2604, DOI 10.1121/1.4948445; Chen JT, 2015, LECT NOTES COMPUT SC, V9237, P83, DOI 10.1007/978-3-319-22482-4_10; Dreschler WA, 2001, AUDIOLOGY, V40, P148; FESTEN JM, 1990, J ACOUST SOC AM, V88, P1725, DOI 10.1121/1.400247; Gelderblom FB, 2017, INTERSPEECH, P1968, DOI 10.21437/Interspeech.2017-1041; Han K, 2012, J ACOUST SOC AM, V132, P3475, DOI 10.1121/1.4754541; Healy EW, 2017, J ACOUST SOC AM, V141, P4230, DOI 10.1121/1.4984271; Healy EW, 2015, J ACOUST SOC AM, V138, P1660, DOI 10.1121/1.4929493; Hummersone C, 2014, SIGNALS COMMUN TECHN, P349, DOI 10.1007/978-3-642-55016-4_12; Jensen J, 2016, IEEE-ACM T AUDIO SPE, V24, P2009, DOI 10.1109/TASLP.2016.2585878; Jensen J, 2012, IEEE T AUDIO SPEECH, V20, P92, DOI 10.1109/TASL.2011.2157685; Kim G, 2009, J ACOUST SOC AM, V126, P1486, DOI 10.1121/1.3184603; Kolbaek M, 2017, IEEE-ACM T AUDIO SPE, V25, P153, DOI 10.1109/TASLP.2016.2628641; KOLLMEIER B, 1994, J ACOUST SOC AM, V95, P1593, DOI 10.1121/1.408546; Kressner AA, 2016, J ACOUST SOC AM, V139, P3033, DOI 10.1121/1.4952439; LYON RF, 1997, DIVERSITY AUDITORY M, P205; May T., 2013, P WASPAA, P1, DOI DOI 10.1109/WASPAA.2013.6701821; May T, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P170; May T, 2014, J ACOUST SOC AM, V136, P3350, DOI 10.1121/1.4901711; May T, 2014, J ACOUST SOC AM, V136, pEL398, DOI 10.1121/1.4901133; Narayanan A, 2013, INT CONF ACOUST SPEE, P7092, DOI 10.1109/ICASSP.2013.6639038; Nielsen JB, 2011, INT J AUDIOL, V50, P202, DOI 10.3109/14992027.2010.524254; Nielsen JB, 2009, INT J AUDIOL, V48, P729, DOI 10.1080/14992020903019312; Taal CH, 2011, IEEE T AUDIO SPEECH, V19, P2125, DOI 10.1109/TASL.2011.2114881; Tchorz J, 2003, IEEE T SPEECH AUDI P, V11, P184, DOI 10.1109/TSA.2003.811542; Wang DL, 2005, SPEECH SEPARATION BY HUMANS AND MACHINES, P181, DOI 10.1007/0-387-22794-6_12; Wang YX, 2014, IEEE-ACM T AUDIO SPE, V22, P1849, DOI 10.1109/TASLP.2014.2352935; Wang YX, 2013, IEEE T AUDIO SPEECH, V21, P1381, DOI 10.1109/TASL.2013.2250961; Zhang XL, 2016, IEEE-ACM T AUDIO SPE, V24, P967, DOI 10.1109/TASLP.2016.2536478	35	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196924	10.1371/journal.pone.0196924	http://dx.doi.org/10.1371/journal.pone.0196924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763459	Green Submitted, Green Published, gold			2022-12-26	WOS:000432118800019
J	Fujita, S; Sato, D; Kasai, H; Ohashi, M; Tsukue, S; Takekoshi, Y; Gomi, K; Shintani, T				Fujita, Shoki; Sato, Daichi; Kasai, Hirokazu; Ohashi, Masataka; Tsukue, Shintaro; Takekoshi, Yutaro; Gomi, Katsuya; Shintani, Takahiro			The C-terminal region of the yeast monocarboxylate transporter Jen1 acts as a glucose signal-responding degron recognized by the -arrestin Rod1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; glucose; arrestin; ubiquitylation (ubiquitination); E3 ubiquitin ligase; protein degradation; degron; monocarboxylate transporter; nutrient regulation; plasma membrane transporter; Rsp5	PERMEASE GENE JEN1; SACCHAROMYCES-CEREVISIAE; ALPHA-ARRESTIN; INDUCED UBIQUITYLATION; PHEROMONE RESPONSE; PROTEIN; ENDOCYTOSIS; SWITCH; PHOSPHORYLATION; EXPRESSION	In response to changes in nutrient conditions, cells rearrange the composition of plasma membrane (PM) transporters to optimize their metabolic flux. Not only transcriptional gene regulation, but also inactivation of specific transporters is important for fast rearrangement of the PM. In eukaryotic cells, endocytosis plays a role in transporter inactivation, which is triggered by ubiquitination of these transporters. The Nedd4 family E3 ubiquitin ligase is responsible for ubiquitination of the PM transporters and requires that a series of -arrestin proteins are targeted to these transporters. The mechanism by which an -arrestin recognizes its cognate transporters in response to environmental signals is of intense scientific interest. Excess substrates or signal transduction pathways are known to initiate recognition of transporters by -arrestins. Here, we identified an endocytic-sorting signal in the monocarboxylate transporter Jen1 from yeast (Saccharomyces cerevisiae), whose endocytic degradation depends on the Snf1-glucose signaling pathway. We found that the C-terminal 20-amino acid-long region of Jen1 contains an amino acid sequence required for association of Jen1 to the -arrestin Rod1, as well as lysine residues important for glucose-induced Jen1 ubiquitination. Notably, fusion of this region to the methionine permease, Mup1, whose endocytosis is normally induced by excess methionine, was sufficient for Mup1 to undergo glucose-induced, Rod1-mediated endocytosis. Taken together, our results demonstrate that the Jen1 C-terminal region acts as a glucose-responding degron for -arrestin-mediated endocytic degradation of Jen1.	[Fujita, Shoki; Sato, Daichi; Kasai, Hirokazu; Ohashi, Masataka; Tsukue, Shintaro; Takekoshi, Yutaro; Gomi, Katsuya; Shintani, Takahiro] Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Sendai, Miyagi 9800845, Japan	Tohoku University	Shintani, T (corresponding author), 468-1 Aramaki Aza Aoba,Aoba Ku, Sendai, Miyagi 9800845, Japan.	takahiro.shintani.d7@tohoku.ac.jp	SHINTANI, Takahiro/ABE-1267-2020; Fujita, Shoki/AAY-9793-2021	Shintani, Takahiro/0000-0001-6630-5892	Japan Society for the Promotion of Science (JSPS) Core-to-Core Program; JSPS KAKENHI [JP26450084, JP17J02369]	Japan Society for the Promotion of Science (JSPS) Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Core-to-Core Program (A. Advanced Research Networks entitled "Establishment of international agricultural immunology research-core for a quantum improvement in food safety") and JSPS KAKENHI Grants JP26450084 (to T. S.) and JP17J02369 (to S. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Akita O, 2000, BIOSCI BIOTECH BIOCH, V64, P980, DOI 10.1271/bbb.64.980; Alvaro CG, 2016, GENETICS, V203, P299, DOI 10.1534/genetics.115.186122; Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; Andrade RP, 2001, FUNGAL GENET BIOL, V32, P105, DOI 10.1006/fgbi.2001.1254; Aubry L, 2013, PROG MOL BIOL TRANSL, V118, P21, DOI 10.1016/B978-0-12-394440-5.00002-4; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; Brachmann CB, 1998, YEAST, V14, P115; Burke D., 2000, METHODS YEAST GENETI; Cain NE, 2011, MOL BIOL CELL, V22, P1919, DOI 10.1091/mbc.E10-10-0800; Chang CI, 2014, BIOL OPEN, V3, P297, DOI 10.1242/bio.20146866; Ghaddar K, 2014, MOL CELL BIOL, V34, P4447, DOI 10.1128/MCB.00699-14; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guiney EL, 2016, MOL BIOL CELL, V27, P4043, DOI 10.1091/mbc.E16-08-0570; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Keener JM, 2013, TRAFFIC, V14, P412, DOI 10.1111/tra.12039; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Llopis-Torregrosa V, 2016, J BIOL CHEM, V291, P14973, DOI 10.1074/jbc.M116.733923; Lodi T, 2002, MOL GENET GENOMICS, V266, P838, DOI 10.1007/s00438-001-0604-y; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Novoselova TV, 2012, EUKARYOT CELL, V11, P463, DOI 10.1128/EC.00009-12; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Paiva S, 2002, BIOCHEM J, V363, P737, DOI 10.1042/0264-6021:3630737; Paiva S, 2009, J BIOL CHEM, V284, P19228, DOI 10.1074/jbc.M109.008318; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Talaia G, 2017, J MOL BIOL, V429, P3678, DOI 10.1016/j.jmb.2017.09.014; Waldhart AN, 2017, CELL REP, V19, P2005, DOI 10.1016/j.celrep.2017.05.041; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035	34	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10926	10936		10.1074/jbc.RA117.001062	http://dx.doi.org/10.1074/jbc.RA117.001062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29789424	Green Published, hybrid			2022-12-26	WOS:000438882800007
J	Hershberger, KA; Abraham, DM; Liu, J; Locasale, JW; Grimsrud, PA; Hirschey, MD				Hershberger, Kathleen A.; Abraham, Dennis M.; Liu, Juan; Locasale, Jason W.; Grimsrud, Paul A.; Hirschey, Matthew D.			Ablation of Sirtuin5 in the postnatal mouse heart results in protein succinylation and normal survival in response to chronic pressure overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sirtuin; protein acylation; proteomics; stress; cardiac hypertrophy	CARDIAC-HYPERTROPHY; SIRT5; MICE; IDENTIFICATION; METABOLOMICS; UNIVERSAL; TAMOXIFEN; ACYLATION; DATABASE	Mitochondrial Sirtuin 5 (SIRT5) is an NAD(+)-dependent demalonylase, desuccinylase, and deglutarylase that controls several metabolic pathways. A number of recent studies point to SIRT5 desuccinylase activity being important in maintaining cardiac function and metabolism under stress. Previously, we described a phenotype of increased mortality in whole-body SIRT5KO mice exposed to chronic pressure overload compared with their littermate WT controls. To determine whether the survival phenotype we reported was due to a cardiac-intrinsic or cardiac-extrinsic effect of SIRT5, we developed a tamoxifen-inducible, heart-specific SIRT5 knockout (SIRT5KO) mouse model. Using our new animal model, we discovered that postnatal cardiac ablation of Sirt5 resulted in persistent accumulation of protein succinylation up to 30 weeks after SIRT5 depletion. Succinyl proteomics revealed that succinylation increased on proteins of oxidative metabolism between 15 and 31 weeks after ablation. Heart-specific SIRT5KO mice were exposed to chronic pressure overload to induce cardiac hypertrophy. We found that, in contrast to whole-body SIRT5KO mice, there was no difference in survival between heart-specific SIRT5KO mice and their littermate controls. Overall, the data presented here suggest that survival of SIRT5KO mice may be dictated by a multitissue or prenatal effect of SIRT5.	[Hershberger, Kathleen A.; Liu, Juan; Locasale, Jason W.; Grimsrud, Paul A.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Hershberger, Kathleen A.; Liu, Juan; Locasale, Jason W.; Grimsrud, Paul A.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27701 USA; [Hershberger, Kathleen A.; Liu, Juan; Locasale, Jason W.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Abraham, Dennis M.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Abraham, Dennis M.] Duke Univ, Med Ctr, Duke Cardiovasc Physiol Core, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Div Endocrinol Metab & Nutr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Hirschey, MD (corresponding author), Duke Mol Physiol Inst, 300 N Duke St, Durham, NC 27701 USA.	matthew.hirschey@duke.edu	Hershberger, Kathleen/AAP-2098-2020; Locasale, Jason W/ABE-6505-2020; Grimsrud, Paul A./GWZ-9287-2022	Hershberger, Kathleen/0000-0002-3349-6140; Locasale, Jason W/0000-0002-7766-3502; Grimsrud, Paul A./0000-0002-4706-914X; Hirschey, Matthew/0000-0003-4541-5376	American Heart Association [12SDG8840004, 12IRG9010008]; NIA, National Institutes of Health [R01AG045351]; NIDDK, National Institutes of Health [P30DK096493]; Ruth L. Kirschstein National Service Research Award F31 Predoctoral Fellowship [1F31HL127959-03]; NIGMS, National Institutes of Health [5T32GM007105-40]; NHLBI, National Institutes of Health [1K08HL125905-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL125905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018164] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ruth L. Kirschstein National Service Research Award F31 Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by American Heart Association Grants 12SDG8840004 and 12IRG9010008; NIA, National Institutes of Health Grant R01AG045351; and NIDDK, National Institutes of Health Award P30DK096493. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Ruth L. Kirschstein National Service Research Award F31 Predoctoral Fellowship 1F31HL127959-03 and a NIGMS, National Institutes of Health training grant to the Duke University Pharmacological Sciences Training Program (5T32GM007105-40).; Supported by NHLBI, National Institutes of Health Grant 1K08HL125905-01.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bersell K, 2013, DIS MODEL MECH, V6, P1459, DOI 10.1242/dmm.010447; Boylston JA, 2015, J MOL CELL CARDIOL, V88, P73, DOI 10.1016/j.yjmcc.2015.09.005; Chen W, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-55; DEMARIA AN, 1979, AM J CARDIOL, V43, P1, DOI 10.1016/0002-9149(79)90036-5; Di Segni E, 1997, J AM SOC ECHOCARDIOG, V10, P926; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fernandez-Marcos PJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00425; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hershberger KA, 2017, J BIOL CHEM, V292, P19767, DOI 10.1074/jbc.M117.809897; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Horton JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84897; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Lesack Kyle, 2011, J Pathol Inform, V2, P52, DOI 10.4103/2153-3539.91130; Lexow J, 2013, DIS MODEL MECH, V6, P1470, DOI 10.1242/dmm.010470; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Martin AS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93885; McDonnell E, 2016, CELL REP, V17, P1463, DOI 10.1016/j.celrep.2016.10.012; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Samak M, 2016, MED SCI MONIT BASIC, V22, P75, DOI 10.12659/MSMBR.900437; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wagner GR, 2017, CELL METAB, V25, P823, DOI 10.1016/j.cmet.2017.03.006; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang F, 2017, CELL REP, V19, P2331, DOI 10.1016/j.celrep.2017.05.065; Winnik S, 2015, EUR HEART J, V36, P3404, DOI 10.1093/eurheartj/ehv290; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yates JR, 2015, J AM SOC MASS SPECTR, V26, P1804, DOI 10.1007/s13361-015-1220-0; Yu JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02806	42	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10630	10645		10.1074/jbc.RA118.002187	http://dx.doi.org/10.1074/jbc.RA118.002187			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29769314	hybrid, Green Published			2022-12-26	WOS:000437828400021
J	Park, SK; Herrnreiter, A; Pfister, SL; Gauthier, KM; Falck, BA; Falck, JR; Campbell, WB				Park, Sang-Kyu; Herrnreiter, Anja; Pfister, Sandra L.; Gauthier, Kathryn M.; Falck, Benjamin A.; Falck, John R.; Campbell, William B.			GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial cell; cyclooxygenase (COX); connexin; smooth muscle; fatty acid	SOLUBLE EPOXIDE HYDROLASE; GAP JUNCTIONAL COMMUNICATION; CORONARY SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; 14,15-EPOXYEICOSATRIENOIC ACID; INSULIN-SECRETION; INTERNATIONAL UNION; GLUCOSE-HOMEOSTASIS; BETA-CELLS	Endothelium-derived epoxyeicosatrienoic acids (EETs) have numerous vascular activities mediated by G protein-coupled receptors. Long-chain free fatty acids and EETs activate GPR40, prompting us to investigate the role of GPR40 in some vascular EET activities. 14,15-EET, 11,12-EET, arachidonic acid, and the GPR40 agonist GW9508 increase intracellular calcium concentrations in human GPR40-overexpressing HEK293 cells (EC50 = 0.58 +/- 0.08 m, 0.91 +/- 0.08 m, 3.9 +/- 0.06 m, and 19 +/- 0.37 nm, respectively). EETs with cis- and trans-epoxides had similar activities, whereas substitution of a thiirane sulfur for the epoxide oxygen decreased the activities. 8,9-EET, 5,6-EET, and the epoxide hydrolysis products 11,12- and 14,15-dihydroxyeicosatrienoic acids were less active than 11,12-EET. The GPR40 antagonist GW1100 and siRNA-mediated GPR40 silencing blocked the EET- and GW9508-induced calcium increases. EETs are weak GPR120 agonists. GPR40 expression was detected in human and bovine endothelial cells (ECs), smooth muscle cells, and arteries. 11,12-EET concentration-dependently relaxed preconstricted coronary arteries; however, these relaxations were not altered by GW1100. In human ECs, 11,12-EET increased MAP kinase (MAPK)-mediated ERK phosphorylation, phosphorylation and levels of connexin-43 (Cx43), and expression of cyclooxygenase-2 (COX-2), all of which were inhibited by GW1100 and the MAPK inhibitor U0126. Moreover, siRNA-mediated GPR40 silencing decreased 11,12-EET-induced ERK phosphorylation. These results indicated that GPR40 is a low-affinity EET receptor in vascular cells and arteries. We conclude that epoxidation of arachidonic acid to EETs enhances GPR40 agonist activity and that 11,12-EET stimulation of GPR40 increases Cx43 and COX-2 expression in ECs via ERK phosphorylation.	[Park, Sang-Kyu; Herrnreiter, Anja; Pfister, Sandra L.; Gauthier, Kathryn M.; Campbell, William B.] Dept Pharmacol & Toxicol Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Park, Sang-Kyu; Herrnreiter, Anja; Pfister, Sandra L.; Gauthier, Kathryn M.; Campbell, William B.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Falck, Benjamin A.; Falck, John R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Medical College of Wisconsin; University of Texas System; University of Texas Southwestern Medical Center Dallas	Campbell, WB (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	wbcamp@mcw.edu			National Institutes of Health from NHLBI [HL-83297, HL-111392]; Ralph and Marian Falk Medical Research Trust Bank of America, N.A.; Robert A. Welch Foundation [I-0011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111392, R01HL083297] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ralph and Marian Falk Medical Research Trust Bank of America, N.A.; Robert A. Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL-83297 and HL-111392 from NHLBI, the Ralph and Marian Falk Medical Research Trust Bank of America, N.A., Trustee Grant, and Robert A. Welch Foundation Award I-0011. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Behm DJ, 2009, J PHARMACOL EXP THER, V328, P231, DOI 10.1124/jpet.108.145102; Bertrand R, 2016, J LABELLED COMPD RAD, V59, P604, DOI 10.1002/jlcr.3412; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Campbell W B, 2001, Med Sci Monit, V7, P578; Campbell WB, 2006, AM J PHYSIOL-HEART C, V290, pH64, DOI 10.1152/ajpheart.00516.2005; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; CAPDEVILA J, 1981, P NATL ACAD SCI-BIOL, V78, P5362, DOI 10.1073/pnas.78.9.5362; CAPDEVILA J, 1982, P NATL ACAD SCI-BIOL, V79, P767, DOI 10.1073/pnas.79.3.767; Chen JK, 2001, MOL CELL BIOL, V21, P6322, DOI 10.1128/MCB.21.18.6322-6331.2001; Chen YJ, 2016, INT S HIGH PERF COMP, P40, DOI 10.1109/HPCA.2016.7446052; Chen YM, 2011, BIOCHEMISTRY-US, V50, P3840, DOI 10.1021/bi102070w; Davidge ST, 2001, CIRC RES, V89, P650, DOI 10.1161/hh2001.098351; de Wit C, 2000, CIRC RES, V86, P649, DOI 10.1161/01.RES.86.6.649; Dhanasekaran A, 2006, AM J PHYSIOL-HEART C, V291, pH517, DOI 10.1152/ajpheart.00953.2005; Ding YD, 2014, J PHARMACOL EXP THER, V350, P14, DOI 10.1124/jpet.114.214254; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; FALCK JR, 1990, METHOD ENZYMOL, V187, P357; Falck JR, 2003, AM J PHYSIOL-HEART C, V284, pH337, DOI 10.1152/ajpheart.00831.2001; Fang X, 1999, HYPERTENSION, V34, P1242, DOI 10.1161/01.HYP.34.6.1242; Fisslthaler B, 1999, NATURE, V401, P493, DOI 10.1038/46816; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Fleming I, 2007, PROSTAG OTH LIPID M, V82, P60, DOI 10.1016/j.prostaglandins.2006.05.003; Fredholm BB, 2014, J MOL MED, V92, P201, DOI 10.1007/s00109-013-1101-6; Fredholm BB, 2011, PHARMACOL REV, V63, P1, DOI 10.1124/pr.110.003285; Fukushima K, 2015, BIOCHEM BIOPH RES CO, V465, P512, DOI 10.1016/j.bbrc.2015.08.050; Gauthier KM, 2002, J PHYSIOL-LONDON, V545, P829, DOI 10.1113/jphysiol.2002.029843; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; HENRICH WL, 1990, AM J PHYSIOL, V258, pE269, DOI 10.1152/ajpendo.1990.258.2.E269; Honore JC, 2013, ARTERIOSCL THROM VAS, V33, P954, DOI 10.1161/ATVBAHA.112.300943; Hu H, 2009, BIOCHEM BIOPH RES CO, V390, P557, DOI 10.1016/j.bbrc.2009.10.004; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jiang HL, 2008, J PHARMACOL EXP THER, V326, P330, DOI 10.1124/jpet.107.134858; Jiang HL, 2011, AM J PHYSIOL-HEART C, V300, pH1990, DOI 10.1152/ajpheart.01267.2010; Kameritsch P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.105; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P595, DOI 10.1161/01.ATV.0000116219.09040.8c; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen BT, 2007, TRENDS PHARMACOL SCI, V28, P32, DOI 10.1016/j.tips.2006.11.002; Larsen BT, 2006, AM J PHYSIOL-HEART C, V290, pH491, DOI 10.1152/ajpheart.00927.2005; Li PL, 1997, CIRC RES, V80, P877; Lin MT, 2015, PULM CIRC, V5, P279, DOI 10.1086/680166; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Luther JM, 2016, PROSTAG OTH LIPID M, V125, P2, DOI 10.1016/j.prostaglandins.2016.07.010; Ma SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113130; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; MARCHENKO SM, 1993, J PHYSIOL-LONDON, V462, P735, DOI 10.1113/jphysiol.1993.sp019579; Mena SJ, 2016, INNATE IMMUN-LONDON, V22, P479, DOI 10.1177/1753425916656765; Michaelis UR, 2005, ARTERIOSCL THROM VAS, V25, P321, DOI 10.1161/01.ATV.0000151648.58516.eb; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Node K, 2001, J BIOL CHEM, V276, P15983, DOI 10.1074/jbc.M100439200; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Popp R, 2002, CIRC RES, V90, P800, DOI 10.1161/01.RES.0000015328.20581.D6; Pozzi A, 2005, J BIOL CHEM, V280, P27138, DOI 10.1074/jbc.M501730200; REVTYAK GE, 1988, AM J PHYSIOL, V255, pC214, DOI 10.1152/ajpcell.1988.255.2.C214; REVTYAK GE, 1988, AM J PHYSIOL, V254, pC8, DOI 10.1152/ajpcell.1988.254.1.C8; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Siangjong L, 2013, AM J PHYSIOL-HEART C, V304, pH382, DOI 10.1152/ajpheart.00690.2012; Snyder GD, 2002, AM J PHYSIOL-HEART C, V283, pH1936, DOI 10.1152/ajpheart.00321.2002; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sun JX, 2002, CIRC RES, V90, P1020, DOI 10.1161/01.RES.0000017727.35930.33; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; van Kempen MJA, 1999, HISTOCHEM CELL BIOL, V112, P479, DOI 10.1007/s004180050432; Vangaveti V, 2010, THER ADV ENDOCRINOL, V1, P165, DOI 10.1177/2042018810381066; VANVOORHIS BJ, 1993, J CLIN ENDOCR METAB, V76, P1555, DOI 10.1210/jc.76.6.1555; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Weston AH, 2005, BRIT J PHARMACOL, V145, P775, DOI 10.1038/sj.bjp.0706256; Wohlfeil ER, 1997, BBA-LIPID LIPID MET, V1345, P109, DOI 10.1016/S0005-2760(96)00170-1; WONG PYK, 1993, J LIPID MEDIATOR, V6, P199; Yamada H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25912; Yang C, 2014, PROSTAG OTH LIPID M, V112, P1, DOI 10.1016/j.prostaglandins.2014.05.001; Yang C, 2010, PROSTAG OTH LIPID M, V93, P44, DOI 10.1016/j.prostaglandins.2010.06.004; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; Yang WQ, 2007, J PHARMACOL EXP THER, V321, P1023, DOI 10.1124/jpet.107.119651; Yin GT, 2014, MOL CELL BIOCHEM, V394, P101, DOI 10.1007/s11010-014-2085-4; Zhang J, 2014, FEBS LETT, V588, P1365, DOI 10.1016/j.febslet.2014.02.003; Zhang Y, 2007, J MOL ENDOCRINOL, V38, P651, DOI 10.1677/JME-06-0048	86	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10675	10691		10.1074/jbc.RA117.001297	http://dx.doi.org/10.1074/jbc.RA117.001297			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29777058	Green Published, hybrid			2022-12-26	WOS:000437828400024
J	Jing, DW; Du, ZY; Wang, MY; Wang, QH; Ma, HL; Liu, FC; Ma, BY; Dong, YF				Jing, Da-wei; Du, Zhen-yu; Wang, Ming-you; Wang, Qing-hua; Ma, Hai-lin; Liu, Fang-chun; Ma, Bing-yao; Dong, Yu-feng			Regulatory effects of root pruning on leaf nutrients, photosynthesis, and growth of trees in a closed-canopy poplar plantation	PLOS ONE			English	Article							WATER-USE EFFICIENCY; DROUGHT TOLERANCE; ARABIDOPSIS; WHEAT; RICE	A plantation of 5-year-old poplar Populus x euramericana cv. 'Neva' was used to study the regulatory effects of root pruning on nutrients, photosynthetic characteristics, and water-use efficiency (WUE) of leaves and growth rates of diameter at breast height (DBH; 1.3 m), tree height, and volume. Six root-pruning treatments were conducted with different combinations of intensity (at a distance of six, eight or ten times DBH from the trunk) and orientation (on two or four sides of the trees). Results showed that the N, P, K, photosynthetic rate, transpiration rate, and stomatal conductance of leaves were all significantly decreased by root pruning over the initial period following root pruning (30 days), but increased in the subsequent investigations. The values of the above indexes peaked in 8-2 treatment (i.e., eight times DBH distance on two sides). The leaf WUE in 8-2 treatment, and average growth rates of DBH, tree height and volume, were the highest among all treatments within 3 years of root pruning. The results indicated that the root pruning based on the appropriate selection of intensity and orientation had significant positive effects on leaf nutrients, photosynthesis, and growth of trees in a closed-canopy poplar plantation.	[Jing, Da-wei] Dezhou Univ, Coll Resources Environm & Planning, Dezhou, Shandong, Peoples R China; [Du, Zhen-yu; Wang, Qing-hua; Ma, Hai-lin; Liu, Fang-chun; Ma, Bing-yao; Dong, Yu-feng] Shandong Acad Forestry, Inst Resource & Environm, Jinan, Shandong, Peoples R China; [Wang, Ming-you] Dezhou Univ, Coll Ecol & Garden Architecture, Dezhou, Shandong, Peoples R China	Dezhou University; Dezhou University	Du, ZY (corresponding author), Shandong Acad Forestry, Inst Resource & Environm, Jinan, Shandong, Peoples R China.	zydu007@163.com	Wang, Qinghua/GVT-3252-2022		National Natural Science Foundation of China [31500513, 31570614]; Key Agricultural Application Technology Innovation Program of Shandong Province; Shandong Provincial Doctoral Foundation [BS2015NY013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Agricultural Application Technology Innovation Program of Shandong Province; Shandong Provincial Doctoral Foundation	The present study was funded by the National Natural Science Foundation of China (Grant Nos. 31500513 to DJ and 31570614), the Key Agricultural Application Technology Innovation Program of Shandong Province to ZD, and Shandong Provincial Doctoral Foundation (BS2015NY013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asin L, 2007, SCI HORTIC-AMSTERDAM, V113, P142, DOI 10.1016/j.scienta.2007.02.008; Bragg DC, 2008, SOUTH J APPL FOR, V32, P38, DOI 10.1093/sjaf/32.1.38; Briggs NA, 2012, CAN J FOREST RES, V42, P1858, DOI [10.1139/x2012-123, 10.1139/X2012-123]; Cao X, 2012, PLANT BIOLOGY, V14, P612, DOI 10.1111/j.1438-8677.2011.00531.x; Desrochers A, 2015, ANN FOREST SCI, V72, P425, DOI 10.1007/s13595-014-0443-8; DesRochers A, 2009, FOREST ECOL MANAG, V258, P2062, DOI 10.1016/j.foreco.2009.07.059; Dobrowolska D, 2011, FORESTRY, V84, P133, DOI 10.1093/forestry/cpr001; Du ZY, 2012, FOREST SYST, V21, P236, DOI 10.5424/fs/2012212-02634; Du ZY, 2013, SILVA FENN, V47, DOI 10.14214/sf.970; Fan XW, 2008, PHYSIOL PLANTARUM, V132, P283, DOI 10.1111/j.1399-3054.2007.01007.x; Fang SZ, 1999, BIOMASS BIOENERG, V17, P415, DOI 10.1016/S0961-9534(99)00060-4; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; Jing DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187685; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Krabel D, 2015, CAN J FOREST RES, V45, P1289, DOI 10.1139/cjfr-2015-0126; Larcheveque M, 2011, TREE PHYSIOL, V31, P240, DOI 10.1093/treephys/tpr011; Lu R., 1999, ANAL METHODS SOIL AG, P18; Luttschwager D, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1968-7; Ma SC, 2013, J INTEGR AGR, V12, P989, DOI 10.1016/S2095-3119(13)60476-1; Meng XY, 1996, FOREST MEASUREMENT, P158; Ren BB, 2015, PLANT SOIL, V396, P397, DOI 10.1007/s11104-015-2603-5; Tilki F, 2006, NEW FOREST, V32, P243, DOI 10.1007/s11056-006-9001-z; WONG SC, 1978, PLANT PHYSIOL, V62, P670, DOI 10.1104/pp.62.4.670; [杨洪强 Yang Hongqiang], 2002, [植物学通报, Chinese Bulletin of Botany], V19, P56; Yang S, 2010, HORTIC SCI, V37, P14, DOI 10.17221/29/2009-HORTSCI; Yang SJ, 2011, PLANT SOIL ENVIRON, V57, P493, DOI 10.17221/38/2011-PSE; Yang SJ, 2012, FRUITS, V67, P429, DOI 10.1051/fruits/2012038; Zhao QuanZhi, 2007, Scientia Agricultura Sinica, V40, P1064; Zhao XY, 2014, NEW FOREST, V45, P21, DOI 10.1007/s11056-013-9389-1	29	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5								10.1371/journal.pone.0197515	http://dx.doi.org/10.1371/journal.pone.0197515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782538	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100028
J	Hassan, A; Arnold, BM; Caine, S; Toosi, BM; Verge, VMK; Muir, GD				Hassan, Atiq; Arnold, Breanna M.; Caine, Sally; Toosi, Behzad M.; Verge, Valerie M. K.; Muir, Gillian D.			Acute intermittent hypoxia and rehabilitative training following cervical spinal injury alters neuronal hypoxia- and plasticity-associated protein expression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-I; PHRENIC MOTOR FACILITATION; CENTRAL-NERVOUS-SYSTEM; FACTOR MESSENGER-RNA; CORD-INJURY; NEUROTROPHIC FACTOR; FUNCTIONAL RECOVERY; TARGET GENES; HIPPOCAMPAL-NEURONS	One of the most promising approaches to improve recovery after spinal cord injury (SCI) is the augmentation of spontaneously occurring plasticity in uninjured neural pathways. Acute intermittent hypoxia (AIH, brief exposures to reduced O-2 levels alternating with normal O-2 levels) initiates plasticity in respiratory systems and has been shown to improve recovery in respiratory and non-respiratory spinal systems after SCI in experimental animals and humans. Although the mechanism by which AIH elicits its effects after SCI are not well understood, AIH is known to alter protein expression in spinal neurons in uninjured animals. Here, we examine hypoxia- and plasticity-related protein expression using immunofluorescence in spinal neurons in SCI rats that were treated with AIH combined with motor training, a protocol which has been demonstrated to improve recovery of forelimb function in this lesion model. Specifically, we assessed protein expression in spinal neurons from animals with incomplete cervical SCI which were exposed to AIH treatment + motor training either for 1 or 7 days. AIH treatment consisted of 10 episodes of AIH: (5 min 11% O-2: 5 min 21% O-2) for 7 days beginning at 4 weeks post-SCI. Both 1 or 7 days of AIH treatment + motor training resulted in significantly increased expression of the transcription factor hypoxiainducible factor-1 alpha (HIF-1 alpha) relative to normoxia-treated controls, in neurons both proximal (cervical) and remote (lumbar) to the SCI. All other markers examined were significantly elevated in the 7 day AIH + motor training group only, at both cervical and lumbar levels. These markers included vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), and phosphorylated and nonphosphorylated forms of the BDNF receptor tropomyosin-related kinase B (TrkB). In summary, AIH induces plasticity at the cellular level after SCI by altering the expression of major plasticity- and hypoxia-related proteins at spinal regions proximal and remote to the SCI. These changes occur under the same AIH protocol which resulted in recovery of limb function in this animal model. Thus AIH, which induces plasticity in spinal circuitry, could also be an effective therapy to restore motor function after nervous system injury.	[Hassan, Atiq; Arnold, Breanna M.; Caine, Sally; Toosi, Behzad M.; Muir, Gillian D.] Univ Saskatchewan, WCVM, Dept Biomed Sci, Saskatoon, SK, Canada; [Hassan, Atiq; Arnold, Breanna M.; Verge, Valerie M. K.; Muir, Gillian D.] Univ Saskatchewan, Cameco MS Neurosci Res Ctr, Saskatoon, SK, Canada; [Verge, Valerie M. K.] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Muir, GD (corresponding author), Univ Saskatchewan, WCVM, Dept Biomed Sci, Saskatoon, SK, Canada.; Muir, GD (corresponding author), Univ Saskatchewan, Cameco MS Neurosci Res Ctr, Saskatoon, SK, Canada.	gillian.muir@usask.ca	Hassan, Atiq Ul/AAW-3881-2020	Hassan, Atiq Ul/0000-0002-7972-6415; Muir, Gillian/0000-0002-6426-1651	US Department of Defense [SC090355P1]; Saskatchewan Health Research Fund [2668, 3695, 6362]	US Department of Defense(United States Department of Defense); Saskatchewan Health Research Fund	This work was supported by the US Department of Defense SC090355P1 (GDM), Saskatchewan Health Research Fund 2668 (VMV, GDM), Saskatchewan Health Research Fund 3695 (GDM, VMV), and Saskatchewan Health Research Fund 6362 (GDM, VMV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Ballermann M, 2006, J NEUROTRAUM, V23, P897, DOI 10.1089/neu.2006.23.897; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Calvani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038388; Chavez JC, 2002, J NEUROSCI, V22, P8922; Cho Y, 2015, NEURON, V88, P720, DOI 10.1016/j.neuron.2015.09.050; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Crosson LA, 2009, MOL VIS, V15, P296; Dale EA, 2014, PHYSIOLOGY, V29, P39, DOI 10.1152/physiol.00012.2013; Dale EA, 2012, J NEUROSCI, V32, P5973, DOI 10.1523/JNEUROSCI.3873-11.2012; Dale-Nagle EA, 2011, J NEUROSCI, V31, P7682, DOI 10.1523/JNEUROSCI.0239-11.2011; de Leon RD, 2011, J NEUROTRAUM, V28, P1021, DOI 10.1089/neu.2010.1699; Devinney MJ, 2013, ANN NY ACAD SCI, V1279, P143, DOI 10.1111/nyas.12085; Dougherty BJ, 2015, J NEUROPHYSIOL, V114, P1784, DOI 10.1152/jn.00539.2015; Dupont-Versteegden EE, 2004, MUSCLE NERVE, V29, P73, DOI 10.1002/mus.10511; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fouad K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00187; Fuller DD, 2003, J NEUROSCI, V23, P2993; Garraway SM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9857201; Golder FJ, 2005, J NEUROSCI, V25, P2925, DOI 10.1523/JNEUROSCI.0148-05.2005; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Guo W, 2014, J CELL SCI, V127, P2249, DOI 10.1242/jcs.139964; Hayes HB, 2014, NEUROLOGY, V82, P104, DOI 10.1212/01.WNL.0000437416.34298.43; Hiebert GW, 2002, J NEUROSCI RES, V69, P160, DOI 10.1002/jnr.10275; Hoffman MS, 2011, J PHYSIOL-LONDON, V589, P1397, DOI 10.1113/jphysiol.2010.201657; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Jia JM, 2008, J BIOL CHEM, V283, P21242, DOI 10.1074/jbc.M800282200; Joseph MS, 2012, NEUROSCIENCE, V224, P135, DOI 10.1016/j.neuroscience.2012.08.024; Kanagal SG, 2009, EXP NEUROL, V216, P193, DOI 10.1016/j.expneurol.2008.11.028; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Keeler BE, 2012, BRAIN RES, V1438, P8, DOI 10.1016/j.brainres.2011.12.015; Khan M, 2015, DRUG DES DEV THER, V9, P2233, DOI 10.2147/DDDT.S77115; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Krum JM, 1998, EXP NEUROL, V154, P57, DOI 10.1006/exnr.1998.6930; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Liao GY, 2015, MOL METAB, V4, P471, DOI 10.1016/j.molmet.2015.03.003; Lovett-Barr MR, 2012, J NEUROSCI, V32, P3591, DOI 10.1523/JNEUROSCI.2908-11.2012; Ma L, 2011, J NEUROSCI, V31, P2079, DOI 10.1523/JNEUROSCI.5348-10.2011; Macias M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-144; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Mantilla CB, 2013, EXP NEUROL, V247, P101, DOI 10.1016/j.expneurol.2013.04.002; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; Navarrete-Opazo A, 2014, AM J PHYSIOL-REG I, V307, pR1181, DOI 10.1152/ajpregu.00208.2014; Novikova LN, 2002, J COMP NEUROL, V452, P255, DOI 10.1002/cne.10381; Nowacka MM, 2012, NEUROPEPTIDES, V46, P1, DOI 10.1016/j.npep.2011.05.005; Prosser-Loose EJ, 2015, J NEUROTRAUM, V32, P1403, DOI 10.1089/neu.2014.3789; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Samarajeewa A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00391; Satriotomo I, 2016, NEUROSCIENCE, V322, P479, DOI 10.1016/j.neuroscience.2016.02.060; Satriotomo I, 2012, EXP NEUROL, V237, P103, DOI 10.1016/j.expneurol.2012.05.020; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SENGER DR, 1986, CANCER RES, V46, P5629; Skup M, 2014, ACTA NEUROBIOL EXP, V74, P121; Spencer-Segal JL, 2011, J NEUROSCI, V31, P6780, DOI 10.1523/JNEUROSCI.0910-11.2011; STEIN I, 1995, MOL CELL BIOL, V15, P5363; Streijger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078765; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Toth Andrea, 2011, Recent Pat CNS Drug Discov, V6, P107; Trumbower RD, 2012, NEUROREHAB NEURAL RE, V26, P163, DOI 10.1177/1545968311412055; Vavrek R, 2006, BRAIN, V129, P1534, DOI 10.1093/brain/awl087; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Weishaupt N, 2013, BEHAV BRAIN RES, V239, P31, DOI 10.1016/j.bbr.2012.10.047; Weishaupt N, 2012, EXP NEUROL, V238, P254, DOI 10.1016/j.expneurol.2012.09.001; Wilkerson JER, 2009, EXP NEUROL, V217, P116, DOI 10.1016/j.expneurol.2009.01.017; Xiaowei H, 2006, SPINAL CORD, V44, P35, DOI 10.1038/sj.sc.3101813; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Ying Z, 2005, EXP NEUROL, V193, P411, DOI 10.1016/j.expneurol.2005.01.015; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhang B, 2004, NEUROSCIENCE, V126, P433, DOI 10.1016/j.neuroscience.2004.03.057	82	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197486	10.1371/journal.pone.0197486	http://dx.doi.org/10.1371/journal.pone.0197486			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775479	Green Published, Green Submitted, gold			2022-12-26	WOS:000432521100017
J	Taylor, DDJ; Slocum, AH; Whittle, AJ				Taylor, David D. J.; Slocum, Alexander H.; Whittle, Andrew J.			Analytical scaling relations to evaluate leakage and intrusion in intermittent water supply systems	PLOS ONE			English	Article							QUALITY; RISKS	Intermittent water supplies (IWS) deliver piped water to one billion people; this water is often microbially contaminated. Contaminants that accumulate while IWS are depressurized are flushed into customers' homes when these systems become pressurized. In addition, during the steady-state phase of IWS, contaminants from higher-pressure sources (e.g., sewers) may continue to intrude where pipe pressure is low. To guide the operation and improvement of IWS, this paper proposes an analytic model relating supply pressure, supply duration, leakage, and the volume of intruded, potentially-contaminated, fluids present during flushing and steady-state. The proposed model suggests that increasing the supply duration may improve water quality during the flushing phase, but decrease the subsequent steady-state water quality. As such, regulators and academics should take more care in reporting if water quality samples are taken during flushing or steady-state operational conditions. Pipe leakage increases with increased supply pressure and/or duration. We propose using an equivalent orifice area (EOA) to quantify pipe quality. This provides a more stable metric for regulators and utilities tracking pipe repairs. Finally, we show that the volume of intruded fluid decreases in proportion to reductions in EOA. The proposed relationships are applied to self-reported performance indicators for IWS serving 108 million people described in the IBNET database and in the Benchmarking and Data Book of Water Utilities in India. This application shows that current high-pressure, continuous water supply targets will require extensive EOA reductions. For example, in order to achieve national targets, utilities in India will need to reduce their EOA by a median of at least 90%.	[Taylor, David D. J.; Slocum, Alexander H.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Whittle, Andrew J.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Taylor, DDJ (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	daviddtaylor@alum.mit.edu	Whittle, Andrew/AAE-1377-2022	Meyer, David/0000-0003-0979-118X	MIT Tata Center for Technology and Design; Natural Sciences and Engineering Research Council of Canada	MIT Tata Center for Technology and Design; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was generously supported by the MIT Tata Center for Technology and Design. Supplementary funding for this work came from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Madi M, 2013, WATER INT, V38, P263, DOI 10.1080/02508060.2013.794404; Adane M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181516; American Water Works Association, 2009, WAT AUD LOSS CONTR P; Andey SP, 2007, AM WATER WORKS ASS J, V99, p[99, 12], DOI [10.1002/j.1551-8833.2007.tb08011.x, DOI 10.1002/J.1551-8833.2007.TB08011.X]; Asian Development Bank, 2007, BENCHM DAT BOOK WAT; Benjamin M.M., 2013, WATER QUALITY ENG PH; Besner MC, 2011, WATER RES, V45, P961, DOI 10.1016/j.watres.2010.10.035; Bivins AW, 2017, ENVIRON SCI TECHNOL, V51, P7542, DOI 10.1021/acs.est.7b01014; Blokker E. J. M., 2008, Drinking Water and Engineering Science, V1, P27; Box George E. P., 1979, ROBUSTNESS STAT, P201, DOI 10.1016/B978-0-12-438150-6.50018-2; Colombo AF, 2002, J WATER RES PL-ASCE, V128, P441, DOI 10.1061/(ASCE)0733-9496(2002)128:6(441); Ebacher G, 2012, WATER RES, V46, P4017, DOI 10.1016/j.watres.2012.05.006; Elala D, 2011, WATER SCI TECH-W SUP, V11, P400, DOI 10.2166/ws.2011.064; Ercumen A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001892; Erickson JJ, 2017, WATER RES, V114, P338, DOI 10.1016/j.watres.2017.02.009; Fan LX, 2014, WATER RESOUR MANAG, V28, P853, DOI 10.1007/s11269-014-0520-7; Flemming HC, 2002, WA SCI TECHNOL, V2, P271, DOI 10.2166/ws.2002.0032; Fox S, 2016, J HYDRAUL ENG, V142, DOI 10.1061/(ASCE)HY.1943-7900.0001040; Frauendorfer R, 2013, ISSUES CHALLENGES RE; Galaitsi SE, 2016, WATER SWITZERLAND, V8; Goyal RV, 2015, APPL WATER SCI, V5, P311, DOI 10.1007/s13201-014-0193-7; Hamilton S, 2015, LEAK DETECTION TECHN; Harbour J, 2001, PATHOGEN INTRUSION D; Health of Towns Association, 1846, REP COMM MEMB ASS LO; Kumpel E, 2016, ENVIRON SCI TECHNOL, V50, P542, DOI 10.1021/acs.est.5b03973; Kumpel E, 2014, ENVIRON SCI TECHNOL, V48, P2766, DOI 10.1021/es405054u; Kumpel E, 2013, WATER RES, V47, P5176, DOI 10.1016/j.watres.2013.05.058; Laspidou C, 2017, DEALING COMPLEX INTE, P5; Lindley TR, 2002, J AM WATER WORKS ASS, V94, P66; McIntosh A. C., 2014, URBAN WATER SUPPLY S; Ministry of Urban Development, 1999, MAN WAT SUPPL TREATM, V3rd; Mohapatra S, 2014, WATER RESOUR MANAG, V28, P3745, DOI 10.1007/s11269-014-0707-y; Shaheed A, 2014, TROP MED INT HEALTH, V19, P186, DOI 10.1111/tmi.12229; Solgi M, 2016, J PIPELINE SYST ENG, V7, DOI 10.1061/(ASCE)PS.1949-1204.0000233; Solgi M, 2015, J PIPELINE SYST ENG, V6, DOI 10.1061/(ASCE)PS.1949-1204.0000198; Subbaraman R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133241; Taylor D., 2014, THESIS; Vairavamoorthy K, 2007, P I CIVIL ENG-WAT M, V160, P123, DOI 10.1680/wama.2007.160.2.123; Vairavamoorthy K, 2007, ENVIRON MODELL SOFTW, V22, P951, DOI 10.1016/j.envsoft.2006.05.027; Van den Berg C., 2010, IBNET WATER SUPPLY S, DOI [10.1596/978-0-8213-8582-1, DOI 10.1596/978-0-8213-8582-1]; World Bank, 2011, ICR00001950 WORLD BA	41	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0196887	10.1371/journal.pone.0196887	http://dx.doi.org/10.1371/journal.pone.0196887			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775462	gold, Green Submitted, Green Published			2022-12-26	WOS:000432521100009
J	Pittet, V; Vaucher, C; Froehlich, F; Maillard, MH; Michetti, P				Pittet, Valerie; Vaucher, Carla; Froehlich, Florian; Maillard, Michel H.; Michetti, Pierre		Swiss IBD Cohort Study Grp	Patient-reported healthcare expectations in inflammatory bowel diseases	PLOS ONE			English	Article							SHARED DECISION-MAKING; SATISFACTION; OUTCOMES; PERCEPTIONS; ACTIVATION; MANAGEMENT; PHYSICIANS; KNOWLEDGE; MODEL; VIEWS	Background Patient-reported experience is an important component of a holistic approach to quality of care. Patients' expectations of treatments and global disease management may indicate their illness representations and their satisfaction and hopes regarding quality of care. Objective To study expectations of patients with inflammatory bowel disease. Methods Two focus groups were conducted with 14 patients to explore their expectations about treatments and disease management. From qualitative content analyses of focus group discussions, we built a 22-item expectations questionnaire that was sent to 1756 patients of the Swiss IBD cohort. Answers were collected on a visual analog scale from 0 to 100, and medians (interquartile range [IQR]) calculated. Factor analysis identified main expectation dimensions, and multivariate analyses were performed to describe associations with patient characteristics. Results Of 1094 patients (62%) included in the study, 54% were female, 54% had Crohn's disease, 35% had tertiary education, and 72% were employed. Expectation dimensions comprised realistic, predictive, and ideal expectations and were linked to information, communication, daily care, and disease recognition. Half (11 of 22) of the expectations were ranked as very high (median score > 70), the 2 most important being good coordination between general practitioners and specialists (median score: 89, IQR: 71-96) and information on treatment adverse events (89, IQR: 71-96). Women had overall higher levels of expectations than did men. Expectations were not associated with psychosocial measures, except those related to disease recognition, and most of them were highly associated with increased concerns on disease constraints and uncertainty. Conclusions Patients have high expectations for information and communication among caregivers, the levels varying by gender and region. Patients also appear to request more active participation in their disease management.	[Pittet, Valerie; Vaucher, Carla] Lausanne Univ Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Froehlich, Florian; Maillard, Michel H.] Lausanne Univ Hosp, Div Gastroenterol & Hepatol, Lausanne, Switzerland; [Froehlich, Florian] Basel Univ Hosp, Div Gastroenterol & Hepatol, Basel, Switzerland; [Michetti, Pierre] Gastroenterol Beaulieu SA, Crohn & Colitis Ctr, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel	Pittet, V (corresponding author), Lausanne Univ Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	valerie.pittet@chuv.cn		Pittet, Valerie/0000-0003-2208-966X	Swiss National Science Foundation (SNSF) [33CS30-148422, 32473B-138498]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This study was supported by the Swiss National Science Foundation (SNSF), 33CS30-148422 (Swiss IBD cohort study) and 32473B-138498 (Appropriateness of care in IBD) to Valerie Pittet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albada A, 2012, FAM CANCER, V11, P85, DOI 10.1007/s10689-011-9479-1; Baars JE, 2010, DIGESTION, V81, P113, DOI 10.1159/000253862; Bennett AL, 2015, WORLD J GASTROENTERO, V21, P4457, DOI 10.3748/wjg.v21.i15.4457; Bowling A, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16300; Casellas F, 2014, J CROHNS COLITIS; Casellas F, 2013, REV ESP ENFERM DIG, V105, P385, DOI 10.4321/s1130-01082013000700003; Casellas Francesc, 2013, J Crohns Colitis, V7, pe249, DOI 10.1016/j.crohns.2012.10.003; Catalan-Serra I, 2015, GASTROENT HEPAT-BARC, V38, P355, DOI 10.1016/j.gastrohep.2014.09.003; Conway T, 1997, Int J Health Care Qual Assur Inc Leadersh Health Serv, V10, P131, DOI 10.1108/09526869710167058; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Faller H, 2000, Rehabilitation (Stuttg), V39, P205; Guarini A, 2017, ANN GASTROENTEROL, V30, P96, DOI 10.20524/aog.2016.0100; Hair JF, 1998, MULTIVAR DATA ANAL, VXX, P1; Janzen JA, 2006, HEALTH EXPECT, V9, P37, DOI 10.1111/j.1369-7625.2006.00363.x; Jelsness-Jorgensen LP, 2016, SCAND J GASTROENTERO, V51, P434, DOI 10.3109/00365521.2015.1102319; Jones R, 2009, BRIT J GEN PRACT, V59, P415, DOI 10.3399/bjgp09X420761; Koutroubakis IE, 2016, INFLAMM BOWEL DIS, V22, P100, DOI 10.1097/MIB.0000000000000587; KRAVITZ RL, 1994, J GEN INTERN MED, V9, P75, DOI 10.1007/BF02600205; Kravitz RL, 2001, ANN INTERN MED, V134, P881, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00012; Lesnovska KP, 2017, J CLIN NURS; Licina Paul, 2012, Evid Based Spine Care J, V3, P13, DOI 10.1055/s-0032-1328138; LINDERPELZ S, 1982, SOC SCI MED, V16, P577, DOI 10.1016/0277-9536(82)90311-2; McDermott E, 2015, INFLAMM BOWEL DIS, V21, P353, DOI 10.1097/MIB.0000000000000287; Mikocka-Walus Antonina, 2013, J Crohns Colitis, V7, pe120, DOI 10.1016/j.crohns.2012.08.004; Munson GW, 2009, J GEN INTERN MED, V24, P809, DOI 10.1007/s11606-009-1002-0; Pieper C, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-17; Pittet V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171864; Pittet V, 2009, INT J EPIDEMIOL, V38, P922, DOI 10.1093/ije/dyn180; Randell RL, 2013, INFLAMM BOWEL DIS, V19, P1428, DOI 10.1097/MIB.0b013e3182813434; Rao JK, 2000, ARCH FAM MED, V9, P1148, DOI 10.1001/archfami.9.10.1148; Rosemberg A, 2016, STUD HEALTH TECHNOL, V225, P700, DOI 10.3233/978-1-61499-658-3-700; Sack C, 2012, J CROHNS COLITIS, V6, P302, DOI 10.1016/j.crohns.2011.08.019; Sadlo A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-97; SANCHEZMENEGAY C, 1994, J GEN INTERN MED, V9, P404, DOI 10.1007/BF02629524; Sanders JN, 2016, AM J OBSTET GYNECOL, V215, P58, DOI 10.1016/j.ajog.2016.01.188; Selby L, 2011, DIGEST DIS SCI, V56, P819, DOI 10.1007/s10620-010-1329-8; Shah SL, 2015, INFLAMM BOWEL DIS, V21, P2975, DOI 10.1097/MIB.0000000000000575; Siegel CA, 2015, DIGEST DIS SCI, V60, P2636, DOI 10.1007/s10620-015-3675-z; Taft TH, 2016, CLIN EXP GASTROENTER, V9, P49, DOI 10.2147/CEG.S83533; Tan M, 2012, INTERN MED J, V42, P801, DOI 10.1111/j.1445-5994.2011.02586.x; THOMPSON AGH, 1995, INT J QUAL HEALTH C, V7, P127, DOI 10.1093/intqhc/7.2.127; Vasudevan A, 2013, J CROHNS COLITIS, V7, pE367, DOI 10.1016/j.crohns.2013.02.012; Vaucher C, 2016, SCAND J GASTROENTERO, V51, P1056, DOI 10.3109/00365521.2016.1147065; White H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012257	44	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197351	10.1371/journal.pone.0197351	http://dx.doi.org/10.1371/journal.pone.0197351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG0DP	29772017	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900051
J	Luo, SG; Sun, YX; Hou, J; Kong, XR; Wang, P; Zhang, QN; Sundell, J				Luo, Shugang; Sun, Yuexia; Hou, Jing; Kong, Xiangrui; Wang, Pan; Zhang, Qingnan; Sundell, Jan			Pet keeping in childhood and asthma and allergy among children in Tianjin area, China	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; SCHOOL-CHILDREN; SKIN SYMPTOMS; DOG OWNERSHIP; RISK-FACTOR; 1ST YEAR; EXPOSURE; SENSITIZATION; HOME; CAT	This study aims to find out the relationship between pet keeping in childhood and asthma and allergy among children aged 0- 8 years old in Tianjin, China. Parental or guardians reports of 7360 children were analyzed. 1490 (21.6%) families kept pets at the time of the survey (current), among them 4.0% cats, and 14.7% dogs. For the first year of life of children (early), 1196 (18.4%) families kept pets, and among them 3.2% cats, and 13.7% dogs. Exposure to a pet in early childhood significantly increased the risk of current wheeze, current dry cough, and diagnosed rhinitis. 17.9% of parents reported an avoidance behavior, i.e., had removed or refrained a pet due to asthma or allergy in the family. After adjustment for avoidance behavior, the negative effect of pet keeping on children's health became even more obvious, with e.g. an AOR of 3.37 (1.58-7.19) for diagnosed asthma, 3.60 (2.07-6.27) for diagnosed rhinitis, 1.92 (1.31-2.81) for diagnosed eczema. A dose-response relationship between pet keeping at current and current wheeze, current eczema and diagnosed eczema was found. In conclusion, pet exposure in early life of children in Tianjin is a risk factor for asthma and allergies among children aged 0-8 years old.	[Luo, Shugang; Sun, Yuexia; Hou, Jing; Kong, Xiangrui; Wang, Pan; Zhang, Qingnan; Sundell, Jan] Tianjin Univ, Sch Environm Sci & Engn, Tianjin Key Lab Indoor Air Environm Qual Control, Tianjin, Peoples R China	Tianjin University	Sun, YX (corresponding author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin Key Lab Indoor Air Environm Qual Control, Tianjin, Peoples R China.	yuexiasun@tju.edu.cn	Hou, Jing/AAK-6669-2021	Luo, Shugang/0000-0002-9916-6443	National Key Research and Development Program of China [2017YFC0702700]; National Natural Science Foundation of China [21207097]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Key Research and Development Program of China (2017YFC0702700) (http://www.most.gov.cn/) and the National Natural Science Foundation of China (21207097) (http://www.nsfc.gov.cn/) to YXS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1998, INDOOR AIR, V8, P219, DOI 10.1111/j.1600-0668.1998.00003.x; Apelberg BJ, 2001, J ALLERGY CLIN IMMUN, V107, P455, DOI 10.1067/mai.2001.113240; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x; Bornehag CG, 2003, ALLERGY, V58, P939, DOI 10.1034/j.1398-9995.2003.00050.x; Campo P, 2006, J ALLERGY CLIN IMMUN, V118, P1271, DOI 10.1016/j.jaci.2006.08.008; Dong GH, 2009, INDOOR AIR, V19, P166, DOI 10.1111/j.1600-0668.2008.00576.x; Fukao T., 2005, ALLERGOL INT, V54, P521, DOI DOI 10.2332/ALLERGOLINT.54.521; Hesselmar B, 1999, CLIN EXP ALLERGY, V29, P611; Holscher B, 2002, PEDIAT ALLERG IMM-UK, V13, P334, DOI 10.1034/j.1399-3038.2002.02063.x; INGRAM JM, 1995, J ALLERGY CLIN IMMUN, V96, P449, DOI 10.1016/S0091-6749(95)70286-5; Leynaert B, 2001, AM J RESP CRIT CARE, V164, P1829, DOI 10.1164/ajrccm.164.10.2103137; Lombardi E, 2010, PEDIATR ALLERGY IMMU, V21, P268, DOI 10.1111/j.1399-3038.2009.00910.x; Medjo B, 2013, PEDIATR INT, V55, P133, DOI 10.1111/ped.12071; Naydenov K, 2008, PEDIAT ALLERG IMM-UK, V19, P702, DOI 10.1111/j.1399-3038.2008.00721.x; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Perzanowski MS, 2002, AM J RESP CRIT CARE, V166, P696, DOI 10.1164/rccm.2201035; Pyrhonen K, 2015, PEDIAT ALLERG IMM-UK, V26, P247, DOI 10.1111/pai.12369; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Salo PM, 2004, ANN EPIDEMIOL, V14, P543, DOI 10.1016/j.annepidem.2003.09.015; Sun YX, 2007, SCI TOTAL ENVIRON, V387, P276, DOI 10.1016/j.scitotenv.2007.07.001; Sundell J, 2017, INDOOR AIR, V27, P708, DOI 10.1111/ina.12368; Sundell J, 2013, CHINESE SCI BULL, V58, P4179, DOI 10.1007/s11434-013-9897-6; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; Wang H, 2013, CHINESE SCI BULL, V58, P4259, DOI 10.1007/s11434-013-5774-6; Wang LF, 2015, BUILD ENVIRON, V93, P54, DOI 10.1016/j.buildenv.2015.02.010; Zheng TZ, 2002, AM J EPIDEMIOL, V156, P977, DOI 10.1093/aje/kwf127	28	14	15	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197274	10.1371/journal.pone.0197274	http://dx.doi.org/10.1371/journal.pone.0197274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768461	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200073
J	Pathmanathan, I; Pasipamire, M; Pals, S; Dokubo, EK; Preko, P; Ao, T; Mazibuko, S; Ongole, J; Dhlamini, T; Haumba, S				Pathmanathan, Ishani; Pasipamire, Munyaradzi; Pals, Sherri; Dokubo, E. Kainne; Preko, Peter; Ao, Trong; Mazibuko, Sikhathele; Ongole, Janet; Dhlamini, Themba; Haumba, Samson			High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; TREATMENT OUTCOMES; INFECTION; INITIATION; AFRICA; TRIAL; START	Background Swaziland has the highest adult HIV prevalence and second highest rate of TB/HIV coinfection globally. Recently, the Ministry of Health and partners have increased integration and co-location of TB/HIV services, but the timing of antiretroviral therapy (ART) relative to TB treatment-a marker of program quality and predictor of outcomes-is unknown. Methods We conducted a retrospective analysis of programmatic data from 11 purposefully-sampled facilities to evaluate timely ART provision for HIV-positive TB patients enrolled on TB treatment between July-November 2014. Timely ART was defined as within two weeks of TB treatment initiation for patients with CD4<50/mu L or missing, and within eight weeks otherwise. Descriptive statistics were estimated and logistic regression used to assess factors independently associated with timely ART. Results Of 466 HIV-positive TB patients, 51.5% were male, median age was 35 (interquartile range [IQR]: 29-42), and median CD4 was 137/mu L (IQR: 58-268). 189 (40.6%) were on ART prior to, and five (1.8%) did not receive ART within six months of TB treatment initiation. Median time to ART after TB treatment initiation was 15 days (IQR: 14-28). Almost 90% started ART within eight weeks, and 45.5% of those with CD4<50/mu L started within two weeks. Using thresholds for "timely ART" according to baseline CD4 count, 73.3% of patients overall received timely ART after TB treatment initiation. Patients with CD4 50-200/mu L or >= 200/ mu L had significantly higher odds of timely ART than patients with CD4<50/mu L, with adjusted odds ratios of 11.5 (95% confidence interval [CI]: 5.0-26.6) and 9.6 (95% CI: 4.6-19.9), respectively. TB cure or treatment completion was achieved by 71.1% of patients at six months, but this was not associated with timely ART. Conclusions This study demonstrates the relative success of integrated and co-located TB/HIV services in Swaziland, and shows that timely ART uptake for HIV-positive TB patients can be achieved in resource-limited, but integrated settings. Gaps remain in getting patients with CD4<50/mu L to receive ART within the recommended two weeks post TB treatment initiation.	[Pathmanathan, Ishani; Pals, Sherri; Dokubo, E. Kainne] United States Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA; [Pathmanathan, Ishani] United States Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Pasipamire, Munyaradzi; Mazibuko, Sikhathele] Minist Hlth, Swaziland Natl AIDS Programme, Mbabane, Swaziland; [Preko, Peter; Ao, Trong] United States Ctr Dis Control & Prevent, Div Global HIV & TB, Ezulwini, Swaziland; [Ongole, Janet; Haumba, Samson] Univ Res Co LLC, Mbabane, Swaziland; [Dhlamini, Themba] Minist Hlth, Swaziland Natl TB Control Program, Manzini, Swaziland; [Dokubo, E. Kainne] United States Ctr Dis Control & Prevent, Div Global Hlth Protect, Monrovia, Liberia; [Preko, Peter] Columbia Univ, ICAP, Mbabane, Swaziland		Pathmanathan, I (corresponding author), United States Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA.; Pathmanathan, I (corresponding author), United States Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	ydi6@cdc.gov			ASSIST project - United States (U.S.) government through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) [AIDOAA-A-12-00101]	ASSIST project - United States (U.S.) government through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)	Funding for the study was made possible through the Cooperative Agreement Number AIDOAA-A-12-00101 to University Research Co., LLC (URC) under the ASSIST project, which is funded by the United States (U.S.) government through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR).	Abay Solomon M, 2015, J Int Assoc Provid AIDS Care, V14, P560, DOI 10.1177/2325957415599210; [Anonymous], 2017, SWAZILAND HIV INCIDE; [Anonymous], 2017, SWAZ HIV AIDS EST; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Degu WA, 2012, 144 CROI; Haumba S, 2015, PUBLIC HEALTH ACTION, V5, P103, DOI 10.5588/pha.15.0008; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Kanyerere HS, 2012, PUBLIC HEALTH ACTION, V2, P174, DOI 10.5588/pha.12.0029; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Kerschberger B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046988; Lawn SD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-258; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Ministry of Health, 2015, REP JOINT EXT REV KI; Naidoo K, 2013, CURR OPIN INFECT DIS, V26, P35, DOI 10.1097/QCO.0b013e32835ba8f9; National TB Control Program, 2015, ANN TB PROGR REP 201; Nglazi MD, 2012, SAMJ S AFR MED J, V102, P936, DOI [10.7196/SAMJ.6024, 10.7196/samj.6024]; Owiti P, 2015, PUBLIC HEALTH ACTION, V5, P36, DOI 10.5588/pha.14.0092; Patel MR, 2014, INT J TUBERC LUNG D, V18, P694, DOI 10.5588/ijtld.13.0807; Pepper DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019484; Swaziland Integrated HIV Management Guidelines, 2015, HIV TEST COUNS; Takarinda KC, 2012, PUBLIC HEALTH ACTION, V2, P50, DOI 10.5588/pha.12.0011; Tweya H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-183; WHO, 2017, GLOB TUB REP 2017; WHO, 2016, CONGUID UANT DRU; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2015, GLOB TUB REP 2014 SW; Yende-Zuma N, 2016, JAIDS-J ACQ IMM DEF, V72, P430, DOI 10.1097/QAI.0000000000000995; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	30	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196831	10.1371/journal.pone.0196831	http://dx.doi.org/10.1371/journal.pone.0196831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768503	Green Published, gold, Green Submitted			2022-12-26	WOS:000432329200047
J	Pittiglio, C; Khomenko, S; Beltran-Alcrudo, D				Pittiglio, Claudia; Khomenko, Sergei; Beltran-Alcrudo, Daniel			Wild boar mapping using population-density statistics: From polygons to high resolution raster maps	PLOS ONE			English	Article							ESTIMATING SPECIES ABUNDANCE; SUS-SCROFA; MODELS; AGGREGATION; FRAMEWORK; WORLD	The wild boar is an important crop raider as well as a reservoir and agent of spread of swine diseases. Due to increasing densities and expanding ranges worldwide, the related economic losses in livestock and agricultural sectors are significant and on the rise. Its management and control would strongly benefit from accurate and detailed spatial information on species distribution and abundance, which are often available only for small areas. Data are commonly available at aggregated administrative units with little or no information about the distribution of the species within the unit. In this paper, a four-step geostatistical downscaling approach is presented and used to disaggregate wild boar population density statistics from administrative units of different shape and size (polygons) to 5 km resolution raster maps by incorporating auxiliary fine scale environmental variables. 1) First a stratification method was used to define homogeneous bioclimatic regions for the analysis; 2) Under a geostatistical framework, the wild boar densities at administrative units, i.e. subnational areas, were decomposed into trend and residual components for each bioclimatic region. Quantitative relationships between wild boar data and environmental variables were estimated through multiple regression and used to derive trend components at 5 km spatial resolution. Next, the residual components (i.e., the differences between the trend components and the original wild boar data at administrative units) were downscaled at 5 km resolution using area-topoint kriging. The trend and residual components obtained at 5 km resolution were finally added to generate fine scale wild boar estimates for each bioclimatic region. 3) These maps were then mosaicked to produce a final output map of predicted wild boar densities across most of Eurasia. 4) Model accuracy was assessed at each different step using input as well as independent data. We discuss advantages and limits of the method and its potential application in animal health.	[Pittiglio, Claudia; Khomenko, Sergei; Beltran-Alcrudo, Daniel] Food & Agr Org United Nations, Anim Prod & Hlth Div, Viale Terme Caracalla, Rome, Italy	Food & Agriculture Organization of the United Nations (FAO)	Beltran-Alcrudo, D (corresponding author), Food & Agr Org United Nations, Anim Prod & Hlth Div, Viale Terme Caracalla, Rome, Italy.	Daniel.BeltranAlcrudo@fao.org	Beltran-Alcrudo, Daniel/AAL-7358-2021	Beltran-Alcrudo, Daniel/0000-0002-8646-357X	European Union's Seventh Framework Programme (FP7) [311931]	European Union's Seventh Framework Programme (FP7)	Funded by European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 311931 (ASFORCE - Targeted research effort on African swine fever).	Acevedo P, 2007, EPIDEMIOL INFECT, V135, P519, DOI 10.1017/S0950268806007059; Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Acevedo P, 2014, ECOL INDIC, V36, P594, DOI 10.1016/j.ecolind.2013.09.019; Alessi J., 2014, J COAST CONSERV, V18, P1; Allison P. D., 1999, LOGISTIC REGRESSION; [Anonymous], 2011, MODIS VEGETATION CON; Apollonio M., 2010, EUROPEAN UNGULATES T; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Barbosa AM, 2009, ECOL MODEL, V220, P747, DOI 10.1016/j.ecolmodel.2008.12.004; Bholowalia P., 2014, INT J COMP APPL, V105, P17, DOI 10.5120/18405-9674; Bosch J, 2014, SPAN J AGRIC RES, V12, P16; Bosch J, 2012, FOLIA ZOOL, V61, P138, DOI 10.25225/fozo.v61.i2.a7.2012; Boucher A, 2006, REMOTE SENS ENVIRON, V104, P264, DOI 10.1016/j.rse.2006.04.020; Boyce MS, 2015, J ANIMAL ECOLOGY; Carnevali L., 2009, BANCA DATI UNGULATI, V117, P1; Cowled BD, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-3; Depner K, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5068; Diaz T. E., 2004, BIOCLIMATIC BIOGEOGR; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Estrada A, 2012, BIOL CONSERV, V152, P37, DOI 10.1016/j.biocon.2012.03.031; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; He FL, 2000, AM NAT, V156, P553, DOI 10.1086/303403; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jimenez-Valverde A, 2009, ANN ZOOL FENN, V46, P451, DOI 10.5735/086.046.0606; Karami M, 2010, 2010 INT WILD PIG S; Khomenko S., 2013, EMPRES WATCH, V28, P1; Kyriakidis PC, 2004, GEOGR ANAL, V36, P259, DOI 10.1111/j.1538-4632.2004.tb01135.x; Leslie E, 2014, TRANSBOUND EMERG DIS, V61, P432, DOI 10.1111/tbed.12044; Leuteritz T.E., 2008, IUCN RED LIST THREAT; Lewis JS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44152; Liu XH, 2008, INT J GEOGR INF SCI, V22, P431, DOI 10.1080/13658810701492225; Liu XH, 2008, SCI CHINA SER E, V51, P62, DOI 10.1007/s11431-008-5006-5; Massei G, 2004, GALEMYS, P16; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; McClure ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133771; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; Merli E, 2006, ACTA THERIOL, V51, P383, DOI 10.1007/BF03195185; Metzger MJ, 2013, GLOBAL ECOL BIOGEOGR, V22, P630, DOI 10.1111/geb.12022; Opsteegh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016240; Pardo-Iguzquiza E, 2006, REMOTE SENS ENVIRON, V102, P86, DOI 10.1016/j.rse.2006.02.014; Park NW, 2013, ADV METEOROL, V2013, DOI 10.1155/2013/237126; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pittiglio C, 2012, INT J APPL EARTH OBS, V14, P61, DOI 10.1016/j.jag.2011.08.006; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2014, R LANG ENV STAT COMP; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Rodriguez E, 2006, PHOTOGRAMM ENG REM S, V72, P249, DOI 10.14358/PERS.72.3.249; Rossell C, 2007, ATLAS LIBRO ROJO MAM, P348; Ruiz-Fons F, 2008, VET J, V176, P158, DOI 10.1016/j.tvjl.2007.02.017; Sales LP, 2017, J ANIM ECOL, V86, P1214, DOI 10.1111/1365-2656.12721; Saulich MIAoa, 2007, INTERACTIVE AGR ECOL; Snow NP, 2017, J APPL ECOL, V54, P2022, DOI 10.1111/1365-2664.12866; Tranmer M, 1998, ENVIRON PLANN A, V30, P817, DOI 10.1068/a300817; Tranmer M, 1997, LOGISTIC REGRESSION; Tsachalidis EP, 2009, ACTA SILVATICA LIGNA, V5; Ward MP, 2015, AUST VET J, V93, P4, DOI 10.1111/avj.12278; Wenger SJ, 2012, METHODS ECOL EVOL, V3, P260, DOI 10.1111/j.2041-210X.2011.00170.x; Yin DY, 2014, METHODS ECOL EVOL, V5, P336, DOI 10.1111/2041-210X.12159	60	45	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0193295	10.1371/journal.pone.0193295	http://dx.doi.org/10.1371/journal.pone.0193295			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768413	gold, Green Submitted, Green Published			2022-12-26	WOS:000432329200003
J	Solomon, AM; Westbrook, T; Field, GD; McGee, AW				Solomon, Alexander M.; Westbrook, Teleza; Field, Greg D.; McGee, Aaron W.			Nogo receptor 1 is expressed by nearly all retinal ganglion cells	PLOS ONE			English	Article							RNA-BINDING PROTEIN; AXON REGENERATION; OPTIC-NERVE; AMACRINE CELLS; MOUSE; PLASTICITY; MYELIN; CNS; IDENTIFICATION; LOCALIZATION	A variety of conditions ranging from glaucoma to blunt force trauma lead to optic nerve atrophy. Identifying signaling pathways for stimulating axon growth in the optic nerve may lead to treatments for these pathologies. Inhibiting signaling by the nogo-66 receptor 1 (NgR1) promotes the re-extension of axons following a crush injury to the optic nerve, and while NgR1 mRNA and protein expression are observed in the retinal ganglion cell (RGC) layer and inner nuclear layer, which retinal cell types express NgR1 remains unknown. Here we determine the expression pattern of NgR1 in the mouse retina by co-labeling neurons with characterized markers of specific retinal neurons together with antibodies specific for NgR1 or Green Fluorescent Protein expressed under control of the ngr1 promoter. We demonstrate that more than 99% of RGCs express NgR1. Thus, inhibiting NgR1 function may ubiquitously promote the regeneration of axons by RGCs. These results provide additional support for the therapeutic potential of NgR1 signaling in reversing optic nerve atrophy.	[Solomon, Alexander M.; McGee, Aaron W.] Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Pediat,Dev Neurosci Program,Saban Res Inst, Los Angeles, CA 90007 USA; [Westbrook, Teleza; Field, Greg D.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA; [McGee, Aaron W.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA	Children's Hospital Los Angeles; University of Southern California; Duke University; University of Louisville	McGee, AW (corresponding author), Univ Southern Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dept Pediat,Dev Neurosci Program,Saban Res Inst, Los Angeles, CA 90007 USA.; Field, GD (corresponding author), Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27708 USA.; McGee, AW (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	aaron.mcgee@louisville.edu; field@neuro.duke.edu; aaron.mcgee@louisville.edu	Field, Greg/AAI-1428-2021	Field, Greg/0000-0001-5942-2679; McGee, Aaron/0000-0003-0843-4973	National Eye Institute [R01EY021580, R01EY027193]; Disney Award for Amblyopia Research from Research to Prevent Blindness; Whitehall Foundation; NATIONAL EYE INSTITUTE [R01EY024567, R01EY027193, R01EY021580] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Disney Award for Amblyopia Research from Research to Prevent Blindness; Whitehall Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research is supported by the National Eye Institute to AWM (R01EY021580) and to GDF (R01EY027193), a Disney Award for Amblyopia Research from Research to Prevent Blindness (www.rpbusa.org) to AWM, and a grant from the Whitehall Foundation to GDF.	Apara A, 2014, NEURAL REGEN RES, V9, P1418, DOI 10.4103/1673-5374.139454; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Baldwin KT, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00023; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Bleckert A, 2014, CURR BIOL, V24, P310, DOI 10.1016/j.cub.2013.12.020; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Duan X, 2015, NEURON, V85, P1244, DOI 10.1016/j.neuron.2015.02.017; Ford KJ, 2012, VISUAL NEUROSCI, V29, P61, DOI 10.1017/S0952523811000216; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fu QL, 2011, INVEST OPHTH VIS SCI, V52, P8374, DOI 10.1167/iovs.11-7667; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Huber AB, 2002, J NEUROSCI, V22, P3553; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim JE, 2003, NEURON, V38, P187, DOI 10.1016/S0896-6273(03)00147-8; Kim TJ, 2006, INVEST OPHTH VIS SCI, V47, P2757, DOI 10.1167/iovs.05-1442; Kurimoto T, 2013, J NEUROSCI, V33, P14816, DOI 10.1523/JNEUROSCI.5511-12.2013; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Liu XZ, 2014, NEURAL REGEN RES, V9, P815, DOI 10.4103/1673-5374.131597; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Masland RH, 2005, TRENDS NEUROSCI, V28, P395, DOI 10.1016/j.tins.2005.06.002; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Muller LPD, 2007, J COMP NEUROL, V505, P177, DOI 10.1002/cne.21487; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; SCHWAB ME, 1985, J NEUROSCI, V5, P2415; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Stephany CE, 2014, J NEUROSCI, V34, P11631, DOI 10.1523/JNEUROSCI.0545-14.2014; Su Y, 2009, NEUROSCI LETT, V460, P223, DOI 10.1016/j.neulet.2009.05.072; Thompson A, 2017, CURR OPIN NEUROBIOL, V42, P136, DOI 10.1016/j.conb.2016.12.007; Valiente-Soriano FJ, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00131; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Vidal-Sanz M, 2015, NEURAL REGEN RES, V10, P1228, DOI 10.4103/1673-5374.162751; VOIGT T, 1986, J COMP NEUROL, V248, P19, DOI 10.1002/cne.902480103; Wang J, 2008, J NEUROSCI RES, V86, P1721, DOI 10.1002/jnr.21626; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang LQ, 2016, J COMP NEUROL, V524, P2322, DOI 10.1002/cne.23953; Wang XX, 2015, INVEST OPHTH VIS SCI, V56, P1357, DOI 10.1167/iovs.14-15472; Wang XX, 2011, ANN NEUROL, V70, P805, DOI 10.1002/ana.22527; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yin YQ, 2009, P NATL ACAD SCI USA, V106, P19587, DOI 10.1073/pnas.0907085106; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015	54	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196565	10.1371/journal.pone.0196565	http://dx.doi.org/10.1371/journal.pone.0196565			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768445	Green Published, Green Submitted, gold			2022-12-26	WOS:000432329200035
J	Beckwitt, CH; Shiraha, K; Wells, A				Beckwitt, Colin H.; Shiraha, Keisuke; Wells, Alan			Lipophilic statins limit cancer cell growth and survival, via involvement of Akt signaling	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST; APOPTOSIS; SIMVASTATIN; DORMANCY; INVASIVENESS; RECURRENCE; PATHWAY; KINASE; DEATH	The HMG-CoA reductase inhibitors, statins, have been used as lipid lowering drugs for decades and several epidemiological studies suggest statin usage correlates with a decreased incidence of cancer specific mortality in patients. However, the mechanism of this mortality benefit remains unclear. Here, we demonstrate that statin drug lipophilicity and affinity for its target enzyme, HMGCR, determine their growth suppressive potency against various tumor cell lines. The lipophilic atorvastatin decreases cancer cell proliferation and survival in vitro. Statin sensitivity coincided with Ras localization to the cytosol instead of the membrane, consistent with a decrement in prenylation. To investigate signaling pathways that may be involved with sensitivity to statin therapy, we employed inhibitors of the P13K-Akt and Mek-Erk signaling cascades. We found that inhibition of P13K signaling through Akt potentiated statin sensitivity of breast cancer cells in vitro and in co-culture with primary human hepatocytes. The same effect was not observed with inhibition of Mek signaling through Erk. Moreover, the sensitivity of breast cancer cells to atorvastatin-mediated growth suppression correlated with a decrease in EGF-mediated phosphorylation of Akt. As an increase in Akt activity has been shown to be involved in the metastasis and metastatic outgrowth of many cancer types (including breast), these data suggest a mechanism by which statins may reduce cancer specific mortality in patients.	[Beckwitt, Colin H.; Shiraha, Keisuke; Wells, Alan] Univ Pittsburgh, Pathol, Pittsburgh, PA 15260 USA; [Beckwitt, Colin H.; Wells, Alan] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Beckwitt, Colin H.; Wells, Alan] Pittsburgh VA Hlth Syst, Pittsburgh, PA 15240 USA; [Wells, Alan] Univ Pittsburgh, Bioengn, Pittsburgh, PA 15260 USA; [Wells, Alan] Univ Pittsburgh, Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Shiraha, Keisuke] Okayama Univ, Med Sch, Kita Ku, Okayama, Okayama, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Okayama University	Wells, A (corresponding author), Univ Pittsburgh, Pathol, Pittsburgh, PA 15260 USA.; Wells, A (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA.; Wells, A (corresponding author), Pittsburgh VA Hlth Syst, Pittsburgh, PA 15240 USA.; Wells, A (corresponding author), Univ Pittsburgh, Bioengn, Pittsburgh, PA 15260 USA.; Wells, A (corresponding author), Univ Pittsburgh, Computat & Syst Biol, Pittsburgh, PA 15260 USA.	wellsa@upmc.edu		Wells, Alan/0000-0002-1637-8150; Beckwitt, Colin/0000-0002-9576-0920	VA Merit Program [I01BX003368]; NIH/NCATS/NCI [UH3TR000496]; NCI [F30CA199947]; NIH CATER Training Program [T32 EB001026]; NATIONAL CANCER INSTITUTE [F30CA199947] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001026] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003368] Funding Source: NIH RePORTER	VA Merit Program; NIH/NCATS/NCI; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH CATER Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by grants from the VA Merit Program (I01BX003368) and NIH/NCATS/NCI (UH3TR000496) to AW, and NCI (F30CA199947) and NIH CATER Training Program (T32 EB001026) to CHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Ahern TP, 2011, JNCI-J NATL CANCER I, V103, P1461, DOI 10.1093/jnci/djr291; Allison M, 2012, NAT BIOTECHNOL, V30, P571, DOI 10.1038/nbt0712-571a; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Campbell MJ, 2006, CANCER RES, V66, P8707, DOI 10.1158/0008-5472.CAN-05-4061; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Clark AM, 2017, LAB CHIP, V17, P156, DOI 10.1039/c6lc01171c; Clark AM, 2014, EXP BIOL MED MAYWOOD; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deftereos SN, 2011, WIRES SYST BIOL MED, V3, P323, DOI 10.1002/wsbm.147; Denoyelle C, 2001, CARCINOGENESIS, V22, P1139, DOI 10.1093/carcin/22.8.1139; Endo A, 2010, P JPN ACAD B-PHYS, V86, P484, DOI 10.2183/pjab.86.484; Gazzerro P, 2012, PHARMACOL REV, V64, P102, DOI 10.1124/pr.111.004994; Gbelcova H, 2008, INT J CANCER, P122; Gelb MH, 1997, SCIENCE, V275, P1750, DOI 10.1126/science.275.5307.1750; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Grille SJ, 2003, CANCER RES, V63, P2172; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Haukka J, 2010, INT J CANCER, V126, P279, DOI 10.1002/ijc.24536; Hoque A, 2008, CANCER EPIDEM BIOMAR, V17, P88, DOI 10.1158/1055-9965.EPI-07-0531; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Kang S, 2009, ONCOL REP, V21, P1317, DOI 10.3892/or_00000357; Kim N-G, 2011, P NATL ACAD SCI USA, P108; Kochuparambil ST, 2011, J PHARMACOL EXP THER, V336, P496, DOI 10.1124/jpet.110.174870; Kwan ML, 2008, BREAST CANCER RES TR, V109, P573, DOI 10.1007/s10549-007-9683-8; Ma B, 2016, HEPATOLOGY, V64, P1725, DOI 10.1002/hep.28755; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; McKenney JM, 2003, CLIN CARDIOL, V26, P32, DOI 10.1002/clc.4960261507; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Menter DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028813; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Ogunwobi OO, 2008, AM J GASTROENTEROL, V103, P825, DOI 10.1111/j.1572-0241.2007.01773.x; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Pelaia G, 2012, CELL PROLIFERAT, V45, P557, DOI 10.1111/j.1365-2184.2012.00846.x; REDDY CC, 1994, BIOTECHNOL PROGR, V10, P377, DOI 10.1021/bp00028a006; Reddy CC, 1996, J CELL PHYSIOL, V166, P512, DOI 10.1002/(SICI)1097-4652(199603)166:3<512::AID-JCP6>3.0.CO;2-S; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Shibata MA, 2004, CARCINOGENESIS, V25, P1887, DOI 10.1093/carcin/bgh201; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Stewart A, 2013, PLOS CURR; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Wang AG, 2016, BRIT J CANCER, V115, P129, DOI 10.1038/bjc.2016.149; Wang TT, 2016, ONCOTARGET, V7, P2532, DOI 10.18632/oncotarget.6304; Warita K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07593; Wells A, 2013, CANCER RES, V73, P3811, DOI 10.1158/0008-5472.CAN-13-0356; Wheeler SE, 2014, BRIT J CANCER, V111, P2342, DOI 10.1038/bjc.2014.533; Wishart DS, 2017, NUCLEIC ACIDS RES, DOI [10.1093/nar/gkx1037/4602867, DOI 10.1093/NAR/GKX1037/4602867]; Zhang X, 2013, TOXICOL SCI, V134, P73, DOI 10.1093/toxsci/kft085	52	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197422	10.1371/journal.pone.0197422	http://dx.doi.org/10.1371/journal.pone.0197422			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763460	Green Published, Green Submitted, gold			2022-12-26	WOS:000432118800049
J	Dai, M; Lin, Y; El-Amouri, SS; Kohls, M; Pan, D				Dai, Mei; Lin, Yi; El-Amouri, Salim S.; Kohls, Mara; Pan, Dao			Comprehensive evaluation of blood-brain barrier-forming micro-vasculatures: Reference and marker genes with cellular composition	PLOS ONE			English	Article							TIME RT-PCR; ALZHEIMERS-DISEASE; HURLER-SYNDROME; RAT-BRAIN; REVERSE TRANSCRIPTION; RNA QUANTIFICATION; LYSOSOMAL-ENZYME; QPCR; EXPRESSION; INTEGRITY	Primary brain microvessels (BrMV) maintain the cellular characters and molecular signatures as displayed in vivo, and serve as a vital tool for biomedical research of the blood-brain barrier (BBB) and the development/optimization of brain drug delivery. The variations of relative purities or cellular composition among different BrMV samples may have significant consequences in data interpretation and research outcome, especially for experiments with high-throughput genomics and proteomics technologies. In this study, we aimed to identify suitable reference gene (RG) for accurate normalization of real-time RT-qPCR analysis, and determine the proper marker genes (MG) for relative purity assessment in BrMV samples. Out of five housekeeping genes, beta-actin was selected as the most suitable RG that was validated by quantifying mRNA levels of alpha-L-iduronidase in BrMV isolated from mice with one or two expressing alleles. Four marker genes highly/selectively expressed in BBB-forming capillary endothelial cells were evaluated by RT-qPCR for purity assessment, resulting in Cldn5 and Pecam1 as most suitable MGs that were further confirmed by immunofluorescent analysis of cellular components. Plvap proved to be an indicator gene for the presence of fenestrated vessels in BrMV samples. This study may contribute to the building blocks toward overarching research needs on the blood-brain barrier.	[Dai, Mei; Lin, Yi; El-Amouri, Salim S.; Pan, Dao] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Kohls, Mara; Pan, Dao] Univ Cincinnati, Dept Pediat, Sch Med, Cincinnati, OH 45220 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Pan, D (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Pan, D (corresponding author), Univ Cincinnati, Dept Pediat, Sch Med, Cincinnati, OH 45220 USA.	Dao.Pan@cchmc.org	LIN, YI/AAC-3335-2020	LIN, YI/0000-0001-8209-1185; Pan, Dao/0000-0003-2433-0285	Cincinnati Children's Hospital Medical Center [RIP2015]; National Institute of Neurological Disorders and Stroke [R01 NS086134, R01 NS064330]; Cincinnati Children's Hospital Medical Center RIP; NIH [R01 NS086134, R01 NS064330]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064330, R01NS086134] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Medical Center; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cincinnati Children's Hospital Medical Center RIP; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by Cincinnati Childrens Hospital Medical Center (RIP2015) and the National Institute of Neurological Disorders and Stroke (grants R01 NS086134 and R01 NS064330) (to D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank John Strickley for his excellent technical assistance in animal handling and sample collection. This work is supported by Cincinnati Children's Hospital Medical Center RIP awards and NIH grants (R01 NS086134 and R01 NS064330) (to D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Banks WA, 2010, FORUM NUTR, V63, P102, DOI 10.1159/000264398; BOWMAN PD, 1981, IN VITRO CELL DEV B, V17, P353; Bustin SA, 2013, NAT METHODS, V10, P1063, DOI 10.1038/nmeth.2697; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Chechi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032265; Cheung TT, 2017, PEERJ, V5, DOI 10.7717/peerj.2909; Clarke LA, 1997, HUM MOL GENET, V6, P503, DOI 10.1093/hmg/6.4.503; Dai M, 2014, P NATL ACAD SCI USA, V111, P2680, DOI 10.1073/pnas.1323155111; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; de Wit NM, 2017, NEUROBIOL DIS, V107, P57, DOI 10.1016/j.nbd.2016.09.015; Dogrukol-Ak D, 2009, J CEREBR BLOOD F MET, V29, P411, DOI 10.1038/jcbfm.2008.131; Drozd E, 2016, CANCER GENOM PROTEOM, V13, P161; Duda J, 2018, METHODS MOL BIOL, V1723, P335, DOI 10.1007/978-1-4939-7558-7_19; Durrenberger PF, 2012, ACTA NEUROPATHOL, V124, P893, DOI 10.1007/s00401-012-1027-z; El-Amouri SS, 2013, MOL BIOTECHNOL, V53, P63, DOI 10.1007/s12033-012-9519-6; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gasparic MB, 2010, ANAL BIOANAL CHEM, V396, P2023, DOI 10.1007/s00216-009-3418-0; Gomez-Zepeda D, 2017, J NEUROCHEM, V142, P597, DOI 10.1111/jnc.14095; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kaisar MA, 2017, EXPERT OPIN DRUG DIS, V12, P89, DOI 10.1080/17460441.2017.1253676; Kong QS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130865; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Martin JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158462; Martins PK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28348; Menezes MJ, 2014, J NEUROSCI, V34, P15260, DOI 10.1523/JNEUROSCI.3678-13.2014; Montagne A, 2017, J EXP MED, V214, P3151, DOI 10.1084/jem.20171406; Navarro E, 2015, CLIN CHIM ACTA, V439, P231, DOI 10.1016/j.cca.2014.10.017; Ochocinska MJ, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0061-6; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Pan D, 2008, BRAIN RES, V1188, P241, DOI 10.1016/j.brainres.2007.10.036; Pan D, 2011, J BIOL CHEM, V286, P30492, DOI 10.1074/jbc.M110.206516; Pan D, 2011, CURR PHARM BIOTECHNO, V12, P884, DOI 1389-2010/11 $58.00+.00; Paul D, 2013, MICROVASC RES, V86, P1, DOI 10.1016/j.mvr.2012.12.001; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034983; Porte B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171048; Robertson RT, 2015, HISTOCHEM CELL BIOL, V143, P225, DOI 10.1007/s00418-014-1301-3; Rydbirk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37116; Salvalaio M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156452; Sanjuan-Jimenez R, 2017, CLIN CHIM ACTA, V469, P1, DOI 10.1016/j.cca.2017.03.014; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shue EH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-29; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288; Takamori LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09156-7; Taki FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094311; Toth A., 2011, CNS DRUG DISCOV, V6, P107; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00811; Wang DR, 2009, P NATL ACAD SCI USA, V106, P19958, DOI 10.1073/pnas.0908528106; Wen SX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167736; Yousif S, 2007, BRAIN RES, V1134, P1, DOI 10.1016/j.brainres.2006.11.089; Yu DZ, 2012, NEUROBIOL AGING, V33, P2942, DOI 10.1016/j.neurobiolaging.2012.02.023; Zhai ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064786; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhou Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185288; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zyzynska-Granica B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051547	68	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197379	10.1371/journal.pone.0197379	http://dx.doi.org/10.1371/journal.pone.0197379			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763456	gold, Green Published, Green Submitted			2022-12-26	WOS:000432118800045
J	Kang, JY; Kim, JY; Kim, KB; Park, JW; Cho, H; Hahm, JY; Chae, YC; Kim, D; Kook, H; Rhee, S; Ha, NC; Seo, SB				Kang, Joo-Young; Kim, Ji-Young; Kim, Kee-Beom; Park, Jin Woo; Cho, Hana; Hahm, Ja Young; Chae, Yun-Cheol; Kim, Daehwan; Kook, Hyun; Rhee, Sangmyeong; Ha, Nam-Chul; Seo, Sang-Beom			KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing	FASEB JOURNAL			English	Article						histone demethylase; H3K79 methylation; SIRT1; transcription	METHYL-LYSINE ANALOGS; PRC1 COMPLEX; CPG ISLANDS; EMBRYONIC FIBROBLASTS; DIVERSE FUNCTIONS; H3; DOMAIN; GENE; PROTEIN; LANGUAGE	The methylation of histone H3 lysine 79 (H3K79) is an active chromatin marker and is prominent in actively transcribed regions of the genome; however, demethylase of H3K79 remains unknown despite intensive research. Here, we show that KDM2B, also known as FBXL10 and a member of the Jumonji C family of proteins known for its histone H3K36 demethylase activity, is a di- and trimethyl H3K79 demethylase. We demonstrate that KDM2B induces transcriptional repression of HOXA7 and MEIS1via occupancy of promoters and demethylation of H3K79. Furthermore, genome-wide analysis suggests that H3K79 methylation levels increase when KDM2B is depleted, which indicates that KDM2B functions as an H3K79 demethylase in vivo. Finally, stable KDM2B-knockdown cell lines exhibit displacement of NAD(+)-dependent deacetylase sirtuin-1 (SIRT1) from chromatin, with concomitant increases in H3K79 methylation and H4K16 acetylation. Our findings identify KDM2B as an H3K79 demethylase and link its function to transcriptional repression via SIRT1-mediated chromatin silencing.Kang, J.-Y., Kim, J.-Y., Kim, K.-B., Park, J. W., Cho, H., Hahm, J. Y., Chae, Y.-C., Kim, D., Kook, H., Rhee, S., Ha, N.-C., Seo, S.-B. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.	[Kang, Joo-Young; Kim, Ji-Young; Kim, Kee-Beom; Park, Jin Woo; Cho, Hana; Hahm, Ja Young; Chae, Yun-Cheol; Kim, Daehwan; Rhee, Sangmyeong; Seo, Sang-Beom] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, 221 Heukseok Dong, Seoul 156756, South Korea; [Kook, Hyun] Chonnam Natl Univ, Med Res Ctr Gene Regulat, Dept Pharmacol, Gwangju, South Korea; [Ha, Nam-Chul] Seoul Natl Univ, Dept Food & Anim Biotechnol, Seoul, South Korea; [Kook, Hyun] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	Chung Ang University; Chonnam National University; Seoul National University (SNU); Seoul National University (SNU)	Seo, SB (corresponding author), Chung Ang Univ, Coll Nat Sci, Dept Life Sci, 221 Heukseok Dong, Seoul 156756, South Korea.	sangbs@cau.ac.kr	Kook, Hyun/AAR-5405-2021; Kim, Kee-Beom/AAG-9225-2022; Kim, Kee-Beom/AFL-8804-2022	Kook, Hyun/0000-0002-0740-1806; Kim, Kee-Beom/0000-0003-0132-8924; Kim, Kee-Beom/0000-0003-0132-8924	Chung-Ang University Excellent Student Scholarship in 2013; National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology (ICT), and Future Planning [NRF-2016R1A4A1008035]; Ministry of Science and Technology, Basic Science Research Program [NRF-2017R1A2B4004407]	Chung-Ang University Excellent Student Scholarship in 2013; National Research Foundation of Korea (NRF) - Ministry of Science, Information and Communication Technology (ICT), and Future Planning; Ministry of Science and Technology, Basic Science Research Program	The authors thank Dr. Jin Young Kim and Dr. Ju Yeon Lee (Korea Basic Science Institute, Ochang Headquarters, Division of Bioconvergence Analysis) for nano-liquid chromatography LTQ-Orbitrap analysis. ChIP-seq data are available from the Gene Expression Omnibus under Accession No. GSE89052. The authors thank Dr. Vivian Bardwell (University of Minnesota, Minneapolis, MN, USA) for providing EFplink2-FLAG-KDM2B. This work was supported by the Chung-Ang University Excellent Student Scholarship in 2013 (to J.-Y.K.); Grant NRF-2016R1A4A1008035 (to J.-Y.K., J.W.P., H.C., J.Y.H., and Y.-C.C.) from the National Research Foundation of Korea (NRF), funded by the Ministry of Science, Information and Communication Technology (ICT), and Future Planning; and Grant NRF-2017R1A2B4004407 (to J.-Y.K. and J.Y.H.) funded by the Ministry of Science and Technology, Basic Science Research Program. The authors declare no conflicts of interest.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Beguelin W, 2016, CANCER CELL, V30, P197, DOI 10.1016/j.ccell.2016.07.006; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bitoun E, 2007, HUM MOL GENET, V16, P92, DOI 10.1093/hmg/ddl444; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Chen CW, 2015, NAT MED, V21, P335, DOI 10.1038/nm.3832; Cheng ZJ, 2014, GENE DEV, V28, P1758, DOI 10.1101/gad.246561.114; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Farcas AM, 2012, ELIFE, V1, DOI 10.7554/eLife.00205; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Gilan O, 2016, NAT STRUCT MOL BIOL, V23, P673, DOI 10.1038/nsmb.3249; He J, 2013, NAT CELL BIOL, V15, P373, DOI 10.1038/ncb2702; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Im H, 2003, J BIOL CHEM, V278, P18346, DOI 10.1074/jbc.M300890200; Jia GS, 2009, CELL RES, V19, P1217, DOI 10.1038/cr.2009.110; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lee SH, 2013, CANCER LETT, V335, P397, DOI 10.1016/j.canlet.2013.02.051; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mersfelder EL, 2006, NUCLEIC ACIDS RES, V34, P2653, DOI 10.1093/nar/gkl338; Millar CB, 2004, COLD SPRING HARB SYM, V69, P193, DOI 10.1101/sqb.2004.69.193; Morishita M, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0025-x; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Mueller D, 2007, BLOOD, V110, P4445, DOI 10.1182/blood-2007-05-090514; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Okada Y, 2006, NAT CELL BIOL, V8, P1017, DOI 10.1038/ncb1464; Ooga M, 2008, BIOL REPROD, V78, P413, DOI 10.1095/biolreprod.107.063453; Park JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12485; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Singer MS, 1998, GENETICS, V150, P613; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan JY, 2011, CANCER CELL, V20, P563, DOI 10.1016/j.ccr.2011.09.008; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; van den Boom V, 2016, CELL REP, V14, P332, DOI 10.1016/j.celrep.2015.12.034; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wu XD, 2013, MOL CELL, V49, P1134, DOI 10.1016/j.molcel.2013.01.016; Wysocka J, 2005, CELL, V122, P654, DOI 10.1016/j.cell.2005.08.022; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027	69	38	39	2	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5737	5750		10.1096/fj.201800242R	http://dx.doi.org/10.1096/fj.201800242R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29763382	Green Submitted			2022-12-26	WOS:000447972500044
J	Raguimova, ON; Smolin, N; Bovo, E; Bhayani, S; Autry, JM; Zima, AV; Robia, SL				Raguimova, Olga N.; Smolin, Nikolai; Bovo, Elisa; Bhayani, Siddharth; Autry, Joseph M.; Zima, Aleksey V.; Robia, Seth L.			Redistribution of SERCA calcium pump conformers during intracellular calcium signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium ATPase; calcium imaging; calcium transport; calcium intracellular release; conformational change; membrane biophysics; membrane transport; fluorescence resonance energy transfer (FRET); sarcoplasmic reticulum (SR); endoplasmic reticulum (ER)	SARCOPLASMIC-RETICULUM CA2+-ATPASE; RESONANCE ENERGY-TRANSFER; CA2+ ATPASE; CRYSTAL-STRUCTURES; PHOSPHOLAMBAN OLIGOMERIZATION; ACTUATOR DOMAINS; HIGH-THROUGHPUT; GENE-THERAPY; TRANSPORT; BINDING	The conformational changes of a calcium transport ATPase were investigated with molecular dynamics (MD) simulations as well as fluorescence resonance energy transfer (FRET) measurements to determine the significance of a discrete structural element for regulation of the conformational dynamics of the transport cycle. Previous MD simulations indicated that a loop in the cytosolic domain of the SERCA calcium transporter facilitates an open-to-closed structural transition. To investigate the significance of this structural element, we performed additional MD simulations and new biophysical measurements of SERCA structure and function. Rationally designed in silico mutations of three acidic residues of the loop decreased SERCA domain-domain contacts and increased domain-domain separation distances. Principal component analysis of MD simulations suggested decreased sampling of compact conformations upon N-loop mutagenesis. Deficits in headpiece structural dynamics were also detected by measuring intramolecular FRET of a Cer-YFP-SERCA construct (2-color SERCA). Compared with WT, the mutated 2-color SERCA shows a partial FRET response to calcium, whereas retaining full responsiveness to the inhibitor thapsigargin. Functional measurements showed that the mutated transporter still hydrolyzes ATP and transports calcium, but that maximal enzyme activity is reduced while maintaining similar calcium affinity. In live cells, calcium elevations resulted in concomitant FRET changes as the population of WT 2-color SERCA molecules redistributed among intermediates of the transport cycle. Our results provide novel insights on how the population of SERCA pumps responds to dynamic changes in intracellular calcium.	[Raguimova, Olga N.; Smolin, Nikolai; Bovo, Elisa; Bhayani, Siddharth; Zima, Aleksey V.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Autry, Joseph M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Loyola University Chicago; University of Minnesota System; University of Minnesota Twin Cities	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.	srobia@luc.edu	Autry, Joseph M./X-6839-2019	Autry, Joseph M./0000-0002-1144-725X	National Institute of Health "Loyola Research Computing Core" [1G20RR030939]; National Science Foundation [ACI-1548562]; Stampede and Stampede2 at the Texas Advanced Computing Center (TACC) through XSEDE allocation [TG-MCB130108]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR030939] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130231, R01HL092321] Funding Source: NIH RePORTER	National Institute of Health "Loyola Research Computing Core"; National Science Foundation(National Science Foundation (NSF)); Stampede and Stampede2 at the Texas Advanced Computing Center (TACC) through XSEDE allocation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful for helpful suggestions from Howard S. Young. This work was also supported by equipment and facilities provided by National Institute of Health "Loyola Research Computing Core" Grant 1G20RR030939. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation Grant ACI-1548562, as well as Stampede and Stampede2 at the Texas Advanced Computing Center (TACC) through XSEDE allocation TG-MCB130108.	Abrol N, 2014, J BIOL CHEM, V289, P25855, DOI 10.1074/jbc.M114.562579; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bian TF, 2016, BIOCHEM BIOPH RES CO, V481, P206, DOI 10.1016/j.bbrc.2016.10.096; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Blackwell DJ, 2016, BIOPHYS J, V111, P1192, DOI 10.1016/j.bpj.2016.08.005; Bleeker NP, 2013, MOL PHARMACEUT, V10, P4358, DOI 10.1021/mp400458u; Bovo E, 2016, AM J PHYSIOL-HEART C, V311, pH268, DOI 10.1152/ajpheart.00175.2016; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Chen B, 2008, BIOCHEMISTRY-US, V47, P12448, DOI 10.1021/bi8014289; Clausen JD, 2016, STRUCTURE, V24, P617, DOI 10.1016/j.str.2016.02.018; Clifford RJ, 2009, J BIOL CHEM, V284, P22905, DOI 10.1074/jbc.M109.030536; Cornea RL, 2000, J BIOL CHEM, V275, P41487, DOI 10.1074/jbc.M008195200; DHALLA NS, 1993, CAN J CARDIOL, V9, P873; Dyla M, 2017, NATURE, V551, P346, DOI 10.1038/nature24296; Fernandez-de Gortari E., 2018, BIORXIV, DOI [doi.org/10.1101/310607, DOI 10.1101/310607]; FERNANDEZBELDA F, 1984, J BIOL CHEM, V259, P9687; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gadella TWJ., 2011, FRET FLIM TECHNIQUES; Gadsby DC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1673; Greenberg B, 2016, LANCET, V387, P1178, DOI 10.1016/S0140-6736(16)00082-9; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Hayward C, 2015, HUM GENE THER, V26, P293, DOI 10.1089/hum.2015.018; HENDERSON IMJ, 1994, BIOCHEM J, V297, P615, DOI 10.1042/bj2970615; HENDERSON IMJ, 1994, BIOCHEM J, V297, P625, DOI 10.1042/bj2970625; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040369; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1994, BIOPHYS J, V66, P554, DOI 10.1016/S0006-3495(94)80872-0; INESI G, 1988, METHOD ENZYMOL, V157, P154; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES LR, 1979, BIOCHIM BIOPHYS ACTA, V557, P230, DOI 10.1016/0005-2736(79)90105-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; KISS E, 1995, CIRC RES, V77, P759, DOI 10.1161/01.RES.77.4.759; Kitao A, 1998, PROTEINS, V33, P496, DOI 10.1002/(SICI)1097-0134(19981201)33:4<496::AID-PROT4>3.3.CO;2-T; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lock JT, 2015, CELL CALCIUM, V58, P638, DOI 10.1016/j.ceca.2015.10.003; Lockamy EL, 2011, BIOCHEM BIOPH RES CO, V408, P388, DOI 10.1016/j.bbrc.2011.04.023; Ma HL, 2005, BIOCHEMISTRY-US, V44, P8090, DOI 10.1021/bi050332m; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MINTZ E, 1995, J BIOL CHEM, V270, P27160, DOI 10.1074/jbc.270.45.27160; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Periasamy M, 2008, CARDIOVASC RES, V77, P265, DOI 10.1093/cvr/cvm056; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reddy LG, 2003, BIOCHEMISTRY-US, V42, P4585, DOI 10.1021/bi026995a; Ritter M, 2000, AM J PHYSIOL-HEART C, V278, pH666, DOI 10.1152/ajpheart.2000.278.2.H666; Robia SL, 2007, CIRC RES, V101, P1123, DOI 10.1161/CIRCRESAHA.107.159947; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; SAGARA Y, 1992, J BIOL CHEM, V267, P12606; Sato E, 2018, BIOORG MED CHEM LETT, V28, P298, DOI 10.1016/j.bmcl.2017.12.050; Savignac M, 2011, BBA-MOL CELL RES, V1813, P1111, DOI 10.1016/j.bbamcr.2010.12.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Smolin N, 2015, J PHYS CHEM B, V119, P1407, DOI 10.1021/jp511433v; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tournier AL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.208106; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Yamada H, 1996, BIOCHEM BIOPH RES CO, V225, P215, DOI 10.1006/bbrc.1996.1156; Yamasaki K, 2015, J BIOL CHEM, V290, P27868, DOI 10.1074/jbc.M115.693770; Young HS, 2001, J MOL BIOL, V308, P231, DOI 10.1006/jmbi.2001.4558	83	16	16	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					10843	10856		10.1074/jbc.RA118.002472	http://dx.doi.org/10.1074/jbc.RA118.002472			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	29764938	hybrid, Green Published			2022-12-26	WOS:000438882800001
J	Sharma, S; Oot, RA; Wilkens, S				Sharma, Stuti; Oot, Rebecca A.; Wilkens, Stephan			MgATP hydrolysis destabilizes the interaction between subunit H and yeast V-1-ATPase, highlighting H's role in V-ATPase regulation by reversible disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; protein assembly; protein conformation; biophysics; isothermal titration calorimetry (ITC); biolayer interferometry; MgADP inhibition; protein-protein interaction; reversible disassembly; V-1-ATPase	VACUOLAR ATPASE; SACCHAROMYCES-CEREVISIAE; AFFINITY PURIFICATION; STRUCTURAL FEATURES; ROTATION MECHANISM; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; PROTON PUMP; CELLS; MOTOR	Vacuolar H+-ATPases (V-ATPases; V1Vo-ATPases) are rotary-motor proton pumps that acidify intracellular compartments and, in some tissues, the extracellular space. V-ATPase is regulated by reversible disassembly into autoinhibited V-1-ATPase and V-o proton channel sectors. An important player in V-ATPase regulation is subunit H, which binds at the interface of V-1 and V-o. H is required for MgATPase activity in holo-V-ATPase but also for stabilizing the MgADP-inhibited state in membrane-detached V-1. However, how H fulfills these two functions is poorly understood. To characterize the H-V-1 interaction and its role in reversible disassembly, we determined binding affinities of full-length H and its N-terminal domain (H-NT) for an isolated heterodimer of subunits E and G (EG), the N-terminal domain of subunit a (a(NT)), and V-1 lacking subunit H (V1H). Using isothermal titration calorimetry (ITC) and biolayer interferometry (BLI), we show that H-NT binds EG with moderate affinity, that full-length H binds a(NT) weakly, and that both H and H-NT bind V1H with high affinity. We also found that only one molecule of H-NT binds V1H with high affinity, suggesting conformational asymmetry of the three EG heterodimers in V1H. Moreover, MgATP hydrolysis-driven conformational changes in V-1 destabilized the interaction of H or H-NT with V1H, suggesting an interplay between MgADP inhibition and subunit H. Our observation that H binding is affected by MgATP hydrolysis in V-1 points to H's role in the mechanism of reversible disassembly.	[Sharma, Stuti; Oot, Rebecca A.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			National Institutes of Health [GM058600]; SUNY Upstate Medical University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SUNY Upstate Medical University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM058600 and a Bridge Grant from SUNY Upstate Medical University (to S.W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Brown D, 1997, J EXP BIOL, V200, P257; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Futai M, 2012, BBA-BIOENERGETICS, V1817, P1711, DOI 10.1016/j.bbabio.2012.03.015; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; HO MN, 1993, J BIOL CHEM, V268, P18286; Isaka Y, 2017, BIOPHYS J, V112, P911, DOI 10.1016/j.bpj.2017.01.029; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kishikawa J, 2014, J BIOL CHEM, V289, P403, DOI 10.1074/jbc.M113.523498; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; MacLeod KJ, 1999, J BIOL CHEM, V274, P32869, DOI 10.1074/jbc.274.46.32869; Mazhab-Jafari MT, 2016, NATURE, V539, P118, DOI 10.1038/nature19828; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Nakano M, 2008, J BIOL CHEM, V283, P20789, DOI 10.1074/jbc.M801276200; Oot RA, 2017, PROTEIN SCI, V26, P896, DOI 10.1002/pro.3147; Oot RA, 2016, EMBO J, V35, P1694, DOI 10.15252/embj.201593447; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Rawson S, 2015, STRUCTURE, V23, P461, DOI 10.1016/j.str.2014.12.016; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sharma S, 2017, PROTEIN SCI, V26, P1070, DOI 10.1002/pro.3143; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Stam NJ, 2017, J BIOL CHEM, V292, P1749, DOI 10.1074/jbc.M116.766790; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; ZHANG JM, 1994, J BIOL CHEM, V269, P23518; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365; Zhou M, 2014, NAT CHEM, V6, P208, DOI [10.1038/nchem.1868, 10.1038/NCHEM.1868]	56	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10718	10730		10.1074/jbc.RA118.002951	http://dx.doi.org/10.1074/jbc.RA118.002951			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29754144	Green Published, hybrid			2022-12-26	WOS:000437828400027
J	Munch, J; Billig, G; Hubner, CA; Leinders-Zufall, T; Zufall, F; Jentsch, TJ				Muench, Jonas; Billig, Gwendolyn; Huebner, Christian A.; Leinders-Zufall, Trese; Zufall, Frank; Jentsch, Thomas J.			Ca2+-activated Cl- currents in the murine vomeronasal organ enhance neuronal spiking but are dispensable for male-male aggression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; signal transduction; electrophysiology; patch clamp; neurobiology; TMEM16A; TMEM16B	ACTIVATED CHLORIDE CHANNELS; INTERSTITIAL-CELLS; EXPRESSION; TMEM16A; PROTEIN; RECEPTOR; BEHAVIOR; MICE; GENE; TRANSLATION	Ca2+-activated Cl- currents have been observed in many physiological processes, including sensory transduction in mammalian olfaction. The olfactory vomeronasal (or Jacobson's) organ (VNO) detects molecular cues originating from animals of the same species or from predators. It then triggers innate behaviors such as aggression, mating, or flight. In the VNO, Ca2+-activated Cl- channels (CaCCs) are thought to amplify the initial pheromone-evoked receptor potential by mediating a depolarizing Cl- efflux. Here, we confirmed the co-localization of the Ca2+-activated Cl- channels anoctamin 1 (Ano1, also called TMEM16A) and Ano2 (TMEM16B) in microvilli of apically and basally located vomeronasal sensory neurons (VSNs) and their absence in supporting cells of the VNO. Both channels were expressed as functional isoforms capable of giving rise to Ca2+-activated Cl- currents. Although these currents persisted in the VNOs of mice lacking Ano2, they were undetectable in olfactory neuron-specific Ano1 knockout mice irrespective of the presence of Ano2. The loss of Ca2+-activated Cl- currents resulted in diminished spontaneous and drastically reduced pheromone-evoked spiking of VSNs. Although this indicated an important role of anoctamin channels in VNO signal amplification, the lack of this amplification did not alter VNO-dependent male-male territorial aggression in olfactory Ano1/Ano2 double knockout mice. We conclude that Ano1 mediates the bulk of Ca2+-activated Cl- currents in the VNO and that Ano2 plays only a minor role. Furthermore, vomeronasal signal amplification by CaCCs appears to be dispensable for the detection of male-specific pheromones and for near-normal aggressive behavior in mice.	[Muench, Jonas; Billig, Gwendolyn; Jentsch, Thomas J.] Leibniz Forschungsinst Mol Pharmakol, D-13125 Berlin, Germany; [Muench, Jonas; Billig, Gwendolyn; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Muench, Jonas] Free Univ Berlin, Grad Program, D-14195 Berlin, Germany; [Huebner, Christian A.] Univ Klinikum Jena, Inst Humangenet, D-07747 Jena, Germany; [Leinders-Zufall, Trese; Zufall, Frank] Univ Saarland, Ctr Integrat Physiol & Mol Med, D-66421 Homburg, Germany; [Jentsch, Thomas J.] Charite Univ Med Berlin, NeuroCure Cluster Excellence, D-10117 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Friedrich Schiller University of Jena; Saarland University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), FMP MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Leinders-Zufall, Trese/S-3664-2019; Billig, Gwendolyn M/A-1297-2012; Leinders-Zufall, Trese/B-4103-2009; Zufall, Frank/AAE-5290-2021	Leinders-Zufall, Trese/0000-0002-0678-362X; Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [JE164/10-1, SFB 894]; NeuroCure Cluster of Excellence grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure Cluster of Excellence grant	This work was supported in part by Deutsche Forschungsgemeinschaft Grants JE164/10-1 (to T. J. J.) and SFB 894 (to F. Z.) and a NeuroCure Cluster of Excellence grant (to T. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Amjad A, 2015, J GEN PHYSIOL, V145, P285, DOI 10.1085/jgp.201411348; BEAN NJ, 1982, PHYSIOL BEHAV, V29, P433, DOI 10.1016/0031-9384(82)90262-1; BELLRINGER JF, 1980, J REPROD FERTIL, V59, P223, DOI 10.1530/jrf.0.0590223; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chamero P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09638-8; Chamero P, 2012, TRENDS NEUROSCI, V35, P597, DOI 10.1016/j.tins.2012.04.011; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Cherkashin AP, 2016, PFLUG ARCH EUR J PHY, V468, P305, DOI 10.1007/s00424-015-1751-z; CLANCY AN, 1984, J NEUROSCI, V4, P2222; Connelly T, 2013, J NEUROPHYSIOL, V110, P55, DOI 10.1152/jn.00910.2012; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Davis AJ, 2010, AM J PHYSIOL-CELL PH, V299, pC948, DOI 10.1152/ajpcell.00018.2010; Dibattista M, 2017, CHANNELS, V11, P399, DOI 10.1080/19336950.2017.1307489; Dibattista M, 2012, J GEN PHYSIOL, V140, P3, DOI 10.1085/jgp.201210780; Ferrera L, 2011, BBA-BIOMEMBRANES, V1808, P2214, DOI 10.1016/j.bbamem.2011.05.017; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Ha GE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13791; He J, 2010, J NEUROSCI, V30, P7473, DOI 10.1523/JNEUROSCI.0825-10.2010; Heinze C, 2014, J CLIN INVEST, V124, P675, DOI 10.1172/JCI70025; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Ishii T, 2011, MOL CELL NEUROSCI, V46, P397, DOI 10.1016/j.mcn.2010.11.002; Kelliher KR, 2006, EUR J NEUROSCI, V23, P3385, DOI 10.1111/j.1460-9568.2006.04866.x; Kim S, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0230-y; Kim S, 2012, NAT NEUROSCI, V15, P1236, DOI 10.1038/nn.3173; Kim S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1368; KLEENE SJ, 1991, J NEUROSCI, V11, P3624; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 2018, CELL CHEM BIOL, V25, P215, DOI 10.1016/j.chembiol.2017.11.008; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; MARUNIAK JA, 1986, PHYSIOL BEHAV, V37, P655, DOI 10.1016/0031-9384(86)90300-8; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; NEUREITHER F, 2017, PHYSL REP, V5, DOI DOI 10.14814/PHY2.13373; Norlin EM, 2003, CURR BIOL, V13, P1214, DOI 10.1016/S0960-9822(03)00452-4; Pietra G, 2016, J GEN PHYSIOL, V148, P293, DOI 10.1085/jgp.201611622; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Reisert J, 2010, J GEN PHYSIOL, V136, P529, DOI 10.1085/jgp.201010528; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Saidu SP, 2013, J GEN PHYSIOL, V141, P691, DOI 10.1085/jgp.201210937; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schutze S, 2016, J BIOL CHEM, V291, P5566, DOI 10.1074/jbc.M115.681098; Schwaller B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004051; Sondo E, 2014, BBA-BIOMEMBRANES, V1838, P89, DOI 10.1016/j.bbamem.2013.08.010; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Ubby I, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-75; Ukhanov K, 2007, J NEUROPHYSIOL, V98, P2357, DOI 10.1152/jn.00642.2007; Untiet V, 2016, CHEM SENSES, V41, P22, DOI 10.1093/chemse/bjw077; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang C, 2010, J GEN PHYSIOL, V135, P3, DOI 10.1085/jgp.200910265; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142160; Zufall F, 2005, PFLUG ARCH EUR J PHY, V451, P61, DOI 10.1007/s00424-005-1432-4	64	8	8	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10392	10403		10.1074/jbc.RA118.003153	http://dx.doi.org/10.1074/jbc.RA118.003153			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769308	Green Published, hybrid			2022-12-26	WOS:000437096700036
J	Kirsten, TB; Casarin, RC; Bernardi, MM; Felicio, LF				Kirsten, Thiago Berti; Casarin, Renato C.; Bernardi, Maria M.; Felicio, Luciano F.			Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway	PLOS ONE			English	Article							PRENATAL IMMUNE ACTIVATION; SPECTRUM DISORDERS; INSULIN SENSITIVITY; SOCIAL-BEHAVIOR; GAMMA AGONISTS; RODENT MODELS; PLASMA LEPTIN; BRAIN-INJURY; EXPOSURE; RATS	Autism is characterized by social deficits, communication abnormalities, and repetitive behaviors. The risk factors appear to include genetic and environmental conditions, such as prenatal infections and maternal dietary factors. Previous investigations by our group have demonstrated that prenatal exposure to lipopolysaccharide (LPS), which mimics infections by gram-negative bacteria, induces autistic-like behaviors. No effective treatment yet exists for autism. Therefore, we used our rat model to test a possible treatment for autism. We selected pioglitazone to block or ease the impairments induced by LPS because although this drug was designed as an anti-diabetic drug (it has an insulin effect), it also exerts anti-inflammatory effects. Juvenile offspring were treated daily with pioglitazone, and the main behaviors related to autism, namely, socialization (play behavior) and communication (50 kHz ultrasonic vocalizations), were studied. Biomarkers linked to autism and/or pioglitazone were also studied to attempt to understand the mechanisms involved, namely, IL-6, TNFalpha, MCP-1, insulin, and leptin. Prenatal LPS exposure induced social deficits and communicational abnormalities in juvenile rat offspring as well as elevated plasma IL-6 levels. Daily postnatal pioglitazone treatment blocked the impairments found in terms of the time spent on social interaction, the number of vocalizations (i.e., autistic-like behaviors) and the elevated plasma IL-6 levels. Thus, pioglitazone appears to be a relevant candidate for the treatment of autism. The present findings may contribute to a better understanding and treatment of autism and associated diseases.	[Kirsten, Thiago Berti; Felicio, Luciano F.] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil; [Kirsten, Thiago Berti; Bernardi, Maria M.] Univ Paulista, Environm & Expt Pathol, Sao Paulo, Brazil; [Casarin, Renato C.; Bernardi, Maria M.] Univ Paulista, Grad Program Dent, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Paulista; Universidade Paulista	Kirsten, TB (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Pathol, Sao Paulo, Brazil.; Kirsten, TB (corresponding author), Univ Paulista, Environm & Expt Pathol, Sao Paulo, Brazil.	thik@outlook.com	Bernardi, M. M./H-8418-2012; Kirsten, Thiago Berti/AAS-2166-2021; Bernardi, Maria/T-6813-2019	Bernardi, M. M./0000-0002-6860-9416; Kirsten, Thiago Berti/0000-0002-4032-4355; Casarin, Renato/0000-0003-1743-5855	Sao Paulo Research Foundation (FAPESP) [12/07007-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [CAPES/Premio 1029/2014]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by the Sao Paulo Research Foundation (FAPESP grant no. 12/07007-8) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES/Premio 1029/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ayadhi Laila Y, 2005, Neurosciences (Riyadh), V10, P155; Alzamendi A, 2012, PPAR RES, V2012, DOI 10.1155/2012/259093; [Anonymous], 1994, DSM 4 PERVASIVE DEV; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Ashwood P, 2008, J AUTISM DEV DISORD, V38, P169, DOI 10.1007/s10803-006-0353-1; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Berger Joel, 2002, Diabetes Technol Ther, V4, P163, DOI 10.1089/15209150260007381; Blardi P, 2010, NEUROSCI LETT, V479, P54, DOI 10.1016/j.neulet.2010.05.027; Bongartz T, 2005, RHEUMATOLOGY, V44, P126, DOI 10.1093/rheumatology/keh423; Boris M, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-3; Burgdorf J, 2013, BEHAV BRAIN RES, V251, P18, DOI 10.1016/j.bbr.2013.04.022; Cai ZW, 2000, PEDIATR RES, V47, P64, DOI 10.1203/00006450-200001000-00013; Duval C, 2002, TRENDS MOL MED, V8, P422, DOI 10.1016/S1471-4914(02)02385-7; Feinstein Douglas L, 2003, Diabetes Technol Ther, V5, P67, DOI 10.1089/152091503763816481; Fernell Elisabeth, 2013, Clin Epidemiol, V5, P33, DOI 10.2147/CLEP.S41714; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Gardener H, 2009, BRIT J PSYCHIAT, V195, P7, DOI 10.1192/bjp.bp.108.051672; Ghaleiha A, 2015, PSYCHIAT RES, V229, P181, DOI 10.1016/j.psychres.2015.07.043; Gillies PS, 2000, DRUGS, V60, P333, DOI 10.2165/00003495-200060020-00009; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Hanefeld M, 2001, INT J CLIN PRACT, P27; Herbert MR, 2010, CURR OPIN NEUROL, V23, P103, DOI 10.1097/WCO.0b013e328336a01f; Johnson NL, 2013, J NURS SCHOLARSHIP, V45, P69, DOI 10.1111/j.1547-5069.2012.01483.x; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Katayama K, 2003, GASTROENTEROLOGY, V124, P1315, DOI 10.1016/S0016-5085(03)00262-2; Kirsten TB, 2015, LIFE SCI, V130, P12, DOI 10.1016/j.lfs.2015.02.027; Kirsten TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082244; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Kirsten TB, 2010, NEUROIMMUNOMODULAT, V17, P240, DOI 10.1159/000290040; Kirsten TB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134565; Kirsten TB, 2011, PHYSIOL BEHAV, V104, P417, DOI 10.1016/j.physbeh.2011.04.049; Kirsten TB, 2011, LIFE SCI, V89, P15, DOI 10.1016/j.lfs.2011.04.023; Kirsten TB, 2010, BEHAV BRAIN RES, V211, P77, DOI 10.1016/j.bbr.2010.03.009; Landreth G, 2006, EXP NEUROL, V199, P245, DOI 10.1016/j.expneurol.2006.04.006; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; MacFabe DF, 2011, BEHAV BRAIN RES, V217, P47, DOI 10.1016/j.bbr.2010.10.005; McPheeters ML, 2011, PEDIATRICS, V127, pE1312, DOI 10.1542/peds.2011-0427; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Meyer U, 2007, NEUROSCIENTIST, V13, P241, DOI 10.1177/1073858406296401; Meyer U, 2006, BRAIN BEHAV IMMUN, V20, P378, DOI 10.1016/j.bbi.2005.11.003; Meyer U, 2012, NEUROPHARMACOLOGY, V62, P1308, DOI 10.1016/j.neuropharm.2011.01.009; Meyer U, 2011, PEDIATR RES, V69, p26R, DOI 10.1203/PDR.0b013e318212c196; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Miyazaki Y, 2008, DIABETES OBES METAB, V10, P1204, DOI 10.1111/j.1463-1326.2008.00880.x; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Negrotto L, 2016, JAMA NEUROL, V73, P520, DOI 10.1001/jamaneurol.2015.4807; PANKSEPP J, 1980, BEHAV NEURAL BIOL, V30, P197, DOI 10.1016/S0163-1047(80)91077-8; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Park SW, 2007, J PHARMACOL EXP THER, V320, P1002, DOI 10.1124/jpet.106.113472; Parker-Athill EC, 2010, NEUROSIGNALS, V18, P113, DOI 10.1159/000319828; Pfutzner Andreas, 2010, J Diabetes Sci Technol, V4, P706; Pletnikov MV, 1999, BEHAV BRAIN RES, V100, P43, DOI 10.1016/S0166-4328(98)00111-9; Qiu D, 2015, INT J CLIN PHARM TH, V53, P746, DOI 10.5414/CP202339; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Samuelsson AM, 2006, AM J PHYSIOL-REG I, V290, pR1345, DOI 10.1152/ajpregu.00268.2005; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Soto AMS, 2013, LIFE SCI, V92, P852, DOI 10.1016/j.lfs.2013.03.003; Takahashi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014115; Theoharides TC, 2009, EXPERT OPIN PHARMACO, V10, P2127, DOI 10.1517/14656560903107789; Tsilioni I, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.142; Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3; Vanhala R, 2001, DEV MED CHILD NEUROL, V43, P614, DOI 10.1017/S0012162201001116; Wei H, 2013, NEUROSCIENCE, V252, P320, DOI 10.1016/j.neuroscience.2013.08.025; Wink LK, 2010, EXPERT OPIN EMERG DR, V15, P481, DOI 10.1517/14728214.2010.487860; Wohr M, 2013, BEHAV BRAIN RES, V251, P5, DOI 10.1016/j.bbr.2013.05.047; Zhang HL, 2011, NEUROSCIENCE, V176, P381, DOI 10.1016/j.neuroscience.2010.12.029	67	20	21	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197060	10.1371/journal.pone.0197060	http://dx.doi.org/10.1371/journal.pone.0197060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GH0FF	29791472	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000029
J	Ulbrich, S; Janning, P; Seidel, R; Matschke, J; Gonsberg, A; Jung, S; Glatzel, M; Engelhard, M; Winklhofer, KF; Tatzelt, J				Ulbrich, Sarah; Janning, Petra; Seidel, Ralf; Matschke, Jakob; Gonsberg, Anika; Jung, Sebastian; Glatzel, Markus; Engelhard, Martin; Winklhofer, Konstanze F.; Tatzelt, Joerg			Alterations in the brain interactome of the intrinsically disordered N-terminal domain of the cellular prion protein (PrPC) in Alzheimer's disease	PLOS ONE			English	Article							AMYLOID-BETA OLIGOMERS; ENDOPLASMIC-RETICULUM; KNOCKOUT MICE; SCRAPIE PRION; STRESS; NEURODEGENERATION; IDENTIFICATION; NEUTRALIZATION; NEUROTOXICITY; PATHOGENESIS	The cellular prion protein (PrPC) is implicated in neuroprotective signaling and neurotoxic pathways in both prion diseases and Alzheimer's disease (AD). Specifically, the intrinsically disordered N-terminal domain (N-PrP) has been shown to interact with neurotoxic ligands, such as A beta and Scrapie prion protein (PrPSc), and to be crucial for the neuroprotective activity of PrPC. To gain further insight into cellular pathways tied to PrP, we analyzed the brain interactome of N-PrP. As a novel approach employing recombinantly expressed PrP and intein-mediated protein ligation, we used N-PrP covalently coupled to beads as a bait for affinity purification. N-PrP beads were incubated with human AD or control brain lysates. N-PrP binding partners were then identified by electrospray ionization tandem mass spectrometry (nano ESI-MS/MS). In addition to newly identified proteins we found many previously described PrP interactors, indicating a crucial role of the intrinsically disordered part of PrP in mediating protein interactions. Moreover, some interactors were found only in either non AD or AD brain, suggesting aberrant PrPC interactions in the pathogenesis of AD.	[Ulbrich, Sarah; Gonsberg, Anika; Jung, Sebastian; Tatzelt, Joerg] Ruhr Univ Bochum, Dept Biochem Neurodegenerat Dis, Inst Biochem & Pathobiochem, Bochum, Germany; [Janning, Petra; Seidel, Ralf; Engelhard, Martin] Max Planck Inst Mol Physiol, Dortmund, Germany; [Matschke, Jakob; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Winklhofer, Konstanze F.] Ruhr Univ Bochum, Dept Mol Cell Biol, Inst Biochem & Pathobiochem, Bochum, Germany	Ruhr University Bochum; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruhr University Bochum	Tatzelt, J (corresponding author), Ruhr Univ Bochum, Dept Biochem Neurodegenerat Dis, Inst Biochem & Pathobiochem, Bochum, Germany.	Joerg.Tatzelt@rub.de	Glatzel, Markus/G-3356-2011; Glatzel, Markus/V-8844-2019; Matschke, Jakob/F-6641-2013	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Matschke, Jakob/0000-0001-6080-0198; Winklhofer, Konstanze/0000-0002-7256-8231; Jung, Sebastian/0000-0002-0365-5710; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft [TA 167/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was funded by a grant of the Deutsche Forschungsgemeinschaft to JT (TA 167/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmeppen HC, 2013, FEBS J, V280, P4338, DOI 10.1111/febs.12196; Beland M, 2014, NEUROBIOL AGING, V35, P1537, DOI 10.1016/j.neurobiolaging.2014.02.001; Beland M, 2012, J NEUROSCI, V32, P13255, DOI 10.1523/JNEUROSCI.2236-12.2012; Beland M, 2012, J NEUROCHEM, V120, P853, DOI 10.1111/j.1471-4159.2011.07613.x; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Bravard A, 2015, NUCLEIC ACIDS RES, V43, P904, DOI 10.1093/nar/gku1342; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Chesebro B, 2003, BRIT MED BULL, V66, P1, DOI 10.1093/bmb/66.1.1; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dohler F, 2014, BRAIN, V137, P873, DOI 10.1093/brain/awt375; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Fluharty BR, 2013, J BIOL CHEM, V288, P7857, DOI 10.1074/jbc.M112.423954; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Glatzel M, 2015, PRION, V9, P244, DOI 10.1080/19336896.2015.1065371; Gu YP, 2006, MOL CELL BIOL, V26, P2697, DOI 10.1128/MCB.26.7.2697-2715.2006; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Iraci N, 2015, VIRUS RES, V207, P62, DOI 10.1016/j.virusres.2014.10.015; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Lundberg P, 2002, BIOCHEM BIOPH RES CO, V299; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mays CE, 2014, FEBS J, V281, P862, DOI 10.1111/febs.12654; McDonald AJ, 2014, PRION, V8, DOI [10.4161/pri.28796, DOI 10.4161/PRI.28796PMID:24721836]; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Miesbauer M, 2009, J BIOL CHEM, V284, P24384, DOI 10.1074/jbc.M109.023135; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger UK, 2011, TOP CURR CHEM, V305, P101, DOI 10.1007/128_2011_160; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitz M, 2014, PRION, V8, P381, DOI 10.4161/19336896.2014.983746; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Smith LM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024075; Spielhaupter C, 2001, J BIOL CHEM, V276, P44604, DOI 10.1074/jbc.M103289200; Tompa P, 2015, CURR OPIN STRUC BIOL, V35, P49, DOI 10.1016/j.sbi.2015.08.009; Torres M, 2015, VIRUS RES, V207, P69, DOI 10.1016/j.virusres.2014.12.018; Um JW, 2012, NAT NEUROSCI, V15, P1227, DOI 10.1038/nn.3178; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Wadia JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003314; Wang GH, 2011, CELL BIOL INT, V35, P553, DOI 10.1042/CBI20090391; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; Weissmann C, 1996, COLD SPRING HARB SYM, V61, P511; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396	62	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197659	10.1371/journal.pone.0197659	http://dx.doi.org/10.1371/journal.pone.0197659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791485	Green Published, Green Submitted, gold			2022-12-26	WOS:000433077000048
J	Rockett, IRH; Caine, ED; Stack, S; Connery, HS; Nolte, KB; Lilly, CL; Miller, TR; Nelson, LS; Putnam, SL; Nestadt, PS; Jia, HM				Rockett, Ian R. H.; Caine, Eric D.; Stack, Steven; Connery, Hilary S.; Nolte, Kurt B.; Lilly, Christa L.; Miller, Ted R.; Nelson, Lewis S.; Putnam, Sandra L.; Nestadt, Paul S.; Jia, Haomiao			Method overtness, forensic autopsy, and the evidentiary suicide note: A multilevel National Violent Death Reporting System analysis	PLOS ONE			English	Article							UNDETERMINED DEATHS; MORTALITY DATA; PUBLIC-HEALTH; RATES; CERTIFICATION; CORONERS; VALIDITY; SURVEILLANCE; STATISTICS; FINLAND	Objective Higher prevalence of suicide notes could signify more conservatism in accounting and greater proneness to undercounting of suicide by method. We tested two hypotheses: (1) an evidentiary suicide note is more likely to accompany suicides by drug-intoxication and by other poisoning, as less violent and less forensically overt methods, than suicides by firearm and hanging/suffocation; and (2) performance of a forensic autopsy attenuates any observed association between overtness of method and the reported presence of a note. Methods This multilevel (individual/county), multivariable analysis employed a generalized linear mixed model (GLMM). Representing the 17 states participating in the United States National Violent Death Reporting System throughout 2011-2013, the study population comprised registered suicides, aged 15 years and older. Decedents totaled 32,151. The outcome measure was relative odds of an authenticated suicide note. Results An authenticated suicide note was documented in 31% of the suicide cases. Inspection of the full multivariable model showed a suicide note was more likely to manifest among drug intoxication (adjusted odds ratio [OR], 1.70; 95% CI, 1.56, 1.85) and other poisoning suicides (OR, 2.12; 1.85, 2.42) than firearm suicides, the referent. Respective excesses were larger when there was no autopsy or autopsy status was unknown (OR, 1.86; 95% CI, 1.61, 2.14) and (OR, 2.25; 95% CI, 1.86, 2.72) relative to the comparisons with a forensic autopsy (OR, 1.62, 95% CI, 1.45, 1.82 and OR, 2.01; 95% CI, 1.66, 2.43). Hanging/suffocation suicides did not differ from the firearm referent given an autopsy. Conclusions Suicide requires substantial affirmative evidence to establish manner of death, and affirmation of drug intoxication suicides appears to demand an especially high burden of proof. Findings and their implications argue for more stringent investigative standards, better training, and more resources to support comprehensive and accurate case ascertainment, as the foundation for developing evidence-based suicide prevention initiatives.	[Rockett, Ian R. H.] West Virginia Univ, Dept Epidemiol, Morgantown, WV 26506 USA; [Rockett, Ian R. H.; Putnam, Sandra L.] West Virginia Univ, Injury Control Res Ctr, Morgantown, WV 26506 USA; [Caine, Eric D.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; [Caine, Eric D.] Univ Rochester, Med Ctr, Injury Control Res Ctr Suicide Prevent, Rochester, NY 14642 USA; [Stack, Steven] Wayne State Univ, Dept Criminal Justice, Detroit, MI USA; [Stack, Steven] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA; [Connery, Hilary S.] McLean Hosp, Div Alcohol & Drug Abuse, Boston, MA USA; [Connery, Hilary S.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Nolte, Kurt B.] Univ New Mexico, Sch Med, Off Med Investigator, Albuquerque, NM 87131 USA; [Lilly, Christa L.] West Virginia Univ, Dept Biostat, Morgantown, WV USA; [Miller, Ted R.] Pacific Inst Res & Evaluat, Calverton, MD USA; [Miller, Ted R.] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia; [Nelson, Lewis S.] Rutgers New Jersey Med Sch, Dept Emergency Med, Newark, NJ USA; [Nestadt, Paul S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Nestadt, Paul S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Jia, Haomiao] Columbia Univ, Sch Nursing, New York, NY USA; [Jia, Haomiao] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA	West Virginia University; West Virginia University; University of Rochester; University of Rochester; Wayne State University; Wayne State University; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; University of New Mexico; West Virginia University; Pacific Institute for Research & Evaluation (PIRE); Curtin University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Columbia University; Columbia University	Rockett, IRH (corresponding author), West Virginia Univ, Dept Epidemiol, Morgantown, WV 26506 USA.; Rockett, IRH (corresponding author), West Virginia Univ, Injury Control Res Ctr, Morgantown, WV 26506 USA.	irockett@hsc.wvu.edu	Lilly, Christa L/R-6644-2017; Nestadt, Paul/ABG-6191-2021; Jia, Haomiao/AAU-8276-2021	Lilly, Christa L/0000-0002-0009-0638; Nestadt, Paul/0000-0002-2479-703X; Rockett, Ian/0000-0002-4584-9337; Miller, Ted/0000-0002-0958-2639	National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention [R49CE002109, R49CE002093]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE002109, R49CE002093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Grants R49CE002109 and R49CE002093 from the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention. They provided salary support for three authors (IRHR, EDC, HJ) and consulting fees for another (SS). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Blair JM, 2016, MMWR SURVEILL SUMM, V65, P1, DOI [10.15585/mmwr.ss6510a1, DOI 10.15585/MMWR.SS6510A1]; Breiding M J, 2006, Inj Prev, V12 Suppl 2, pii49, DOI 10.1136/ip.2006.012591; Byard RW., 2007, SCAND J FORENSIC SCI, V13, P10; Callanan VJ, 2009, SUICIDE LIFE-THREAT, V39, P558, DOI 10.1521/suli.2009.39.5.558; Carpenter B, 2009, MED SCI LAW, V49, P101, DOI 10.1258/rsmmsl.49.2.101; Center for Disease Control and Prevention, 2017, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention, NAT VIOL DEATH REP S; Centers for Disease Control and Prevention, 2015, PUBL HLTH LAW PROGR; Centers for Disease Control and Prevention (CDC), 2006, MMWR-MORBID MORTAL W, V55, P721; COHEN SL, 1974, LIFE THREATENING BEH, V4, P75; Committee on Identifying the Needs of the Forensic Sciences Community National Research Council, 2009, STRENGTHENING FORENS; Cooper PN, 1995, MED SCI LAW, V35, P319, DOI 10.1177/002580249503500409; Croft PR, 2006, J FORENSIC SCI, V51, P651, DOI 10.1111/j.1556-4029.2006.00128.x; Donaldson AE, 2006, INJURY PREV, V12, P338, DOI 10.1136/ip.2005.011171; Eisenwort B, 2006, NERVENARZT, V77, P1355, DOI 10.1007/s00115-005-1965-y; Fisher D., 2000, FORENSIC EXAM, V9, P24; Goldsmith S.K., 2002, REDUCING SUICIDE NAT; Hanzlick RL., 2014, ACAD FORENSIC PATHOL, V4, P2, DOI [10.23907/2014.001, DOI 10.23907/2014.001]; Health Resources and Services Administration Bureau of Health Workforce National Center for Health Workforce Analysis, 2015, COUNT AR HLTH RES FI; Hedegaard H, 2017, NCHS DATA BRIEF, V273, p1 ; Hoyert DL, 2007, VITAL HLTH STAT, V20, P1; Hoyert Donna L, 2011, NCHS Data Brief, P1; Huguet N, 2012, SUICIDE LIFE-THREAT, V42, P185, DOI 10.1111/j.1943-278X.2012.00081.x; Institute of Medicine, 2006, HOSP BAS EM CAR BREA; Institute of Medicine, 2006, EM MED SERV CROSSR; Institute of Medicine, 2003, MED DEATH INV SYST W; Jougla E, 2002, REV EPIDEMIOL SANTE, V50, P49; Kaplan MS, 2017, AM J PREV MED, V53, P130, DOI 10.1016/j.amepre.2017.01.043; Kapusta ND, 2011, ARCH GEN PSYCHIAT, V68, P1050, DOI 10.1001/archgenpsychiatry.2011.66; Karch D., 2006, Morbidity and Mortality Weekly Report, V55, P1245; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Logan JE, 2009, HOMICIDE STUD, V13, P385, DOI 10.1177/1088767909348323; Lunetta P, 2007, INJURY PREV, V13, P282, DOI 10.1136/ip.2006.012922; National Association of Medical Examiners, 2016, FOR AUT PERF STAND; NELSON FL, 1978, SUICIDE LIFE-THREAT, V8, P75; Neuilly MA, 2013, HOMICIDE STUD, V17, P339, DOI 10.1177/1088767913494387; OCARROLL PW, 1989, SUICIDE LIFE-THREAT, V19, P1; Ohberg A, 1998, ACTA PSYCHIAT SCAND, V98, P214, DOI 10.1111/j.1600-0447.1998.tb10069.x; OVENSTONE IM, 1973, BRIT J PSYCHIAT, V123, P15, DOI 10.1192/bjp.123.1.15; Palmer BS, 2015, J PUBLIC HEALTH-UK, V37, P157, DOI 10.1093/pubmed/fdu024; Parai JL, 2006, ANN EPIDEMIOL, V16, P805, DOI 10.1016/j.annepidem.2006.01.006; Parks SE, 2014, MMWR SURVEILL SUMM, V63, P1; Acinas MP, 2015, ACTAS ESP PSIQUIATRI, V43, P69; Paulozzi LJ, 2004, INJURY PREV, V10, P47, DOI 10.1136/ip.2003.003434; PLATT S, 1988, SOC PSYCH PSYCH EPID, V23, P217, DOI 10.1007/BF01787820; Rockett IRH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190200; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; Rockett IRH, 2010, CRISIS, V31, P227, DOI 10.1027/0227-5910/a000071; Rockett IRH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-35; Rockett IRH, 1999, SUICIDE LIFE-THREAT, V29, P141; Scourfield J, 2012, SOC SCI MED, V74, P466, DOI 10.1016/j.socscimed.2010.01.054; Shields LBE, 2006, AM J FOREN MED PATH, V27, P106, DOI 10.1097/01.paf.0000220913.19508.99; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Sorenson SB, 1997, EVALUATION REV, V21, P43, DOI 10.1177/0193841X9702100103; Stack S, 2018, SUICIDE LIFE-THREAT, V48, P12, DOI 10.1111/sltb.12320; Steenkamp M, 2006, Inj Prev, V12 Suppl 2, pii3, DOI 10.1136/ip.2006.012518; Stone DM, 2017, AM J PUBLIC HEALTH, V107, P1233, DOI [10.2105/AJPH.2017.303863, 10.2105/ajph.2017.303863]; Stone DH, 2002, FINAL REPORT EUROPEA; Timmermans S, 2005, AM SOCIOL REV, V70, P311, DOI 10.1177/000312240507000206; TUCKMAN J, 1959, AM J PSYCHIAT, V116, P59, DOI 10.1176/ajp.116.1.59; Varnik P, 2012, INJURY PREV, V18, P321, DOI 10.1136/injuryprev-2011-040070; Waldhoer T, 2003, J CLIN EPIDEMIOL, V56, P891, DOI 10.1016/S0895-4356(03)00076-3; WARSHAUER ME, 1978, AM J PUBLIC HEALTH, V68, P383, DOI 10.2105/AJPH.68.4.383; Ylijoki-Sorensen S, 2014, FORENSIC SCI INT, V244, P289, DOI 10.1016/j.forsciint.2014.09.016; Ylijoki-Sorensen S, 2014, FORENSIC SCI INT, V244, P158, DOI 10.1016/j.forsciint.2014.08.035	65	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197805	10.1371/journal.pone.0197805	http://dx.doi.org/10.1371/journal.pone.0197805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG6DG	29787584	Green Submitted, Green Published, gold			2022-12-26	WOS:000432785700048
J	Owuor, TO; Reid, M; Reschke, L; Hagemann, I; Greco, S; Modi, Z; Moley, KH				Owuor, Theresa O.; Reid, Michaela; Reschke, Lauren; Hagemann, Ian; Greco, Suellen; Modi, Zeel; Moley, Kelle H.			Maternal obesogenic diet induces endometrial hyperplasia, an early hallmark of endometrial cancer, in a diethylstilbestrol mouse model	PLOS ONE			English	Article							HELSINKI BIRTH COHORT; PROTEIN RESTRICTION; BREAST-CANCER; IN-UTERO; OBESITY; RISK; PREGNANCY; HYPERTENSION; DYSFUNCTION; OVERWEIGHT	Thirty-eight percent of US adult women are obese, meaning that more children are now born of overweight and obese mothers, leading to an increase in predisposition to several adult onset diseases. To explore this phenomenon, we developed a maternal obesity animal model by feeding mice a diet composed of high fat/high sugar (HF/HS) and assessed both maternal diet and offspring diet on the development of endometrial cancer (ECa). We show that maternal diet by itself did not lead to ECa initiation in wildtype offspring of the C57BI/6J mouse strain. While offspring fed a HF/HS post-weaning diet resulted in poor metabolic health and decreased uterine weight (regardless of maternal diet), it did not lead to ECa. We also investigated the effects of the maternal obesogenic diet on ECa development in a Diethylstilbestrol (DES) carcinogenesis mouse model. All mice injected with DES had reproductive tract lesions including decreased number of glands, condensed and hyalinized endometrial stroma, and fibrosis and increased collagen deposition that in some mice extended into the myometrium resulting in extensive disruption and loss of the inner and outer muscular layers. Fifty percent of DES mice that were exposed to maternal HF/HS diet developed several features indicative of the initial stages of carcinogenesis including focal glandular and atypical endometrial hyperplasia versus 0% of their Chow counterparts. There was an increase in phospho-Akt expression in DES mice exposed to maternal HF/HS diet, a regulator of persistent proliferation in the endometrium, and no difference in total Akt, phospho-PTEN and total PTEN expression. In summary, maternal HF/HS diet exposure induces endometrial hyperplasia and other precancerous phenotypes in mice treated with DES. This study suggests that maternal obesity alone is not sufficient for the development of ECa, but has an additive effect in the presence of a secondary insult such as DES.	[Owuor, Theresa O.; Reid, Michaela; Reschke, Lauren; Modi, Zeel; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Hagemann, Ian] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Greco, Suellen] Washington Univ, Sch Med, Div Comparat Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.	moleyk@wustl.edu	Hagemann, Ian/ABB-2854-2021	Hagemann, Ian/0000-0002-3855-9745	National Cancer Institute, NIH [U54 CA155496]; NATIONAL CANCER INSTITUTE [U54CA155496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, P30DK056341] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Cancer Institute, NIH, U54 CA155496 (Colditz) to KHM, title: A Multilevel Approach to Energy Balance and Cancer across the Lifecourse. I was PI of Project #1 of this cooperative U54 grant.	Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; [Anonymous], 1998, CLIN GUID ID EV TREA, P228; Benesh EC, 2013, SCI REP-UK, V3, DOI 10.1038/srep03466; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Cohn BA, 2015, J CLIN ENDOCR METAB, V100, P2865, DOI 10.1210/jc.2015-1841; Couse JF, 1997, MOL CARCINOGEN, V19, P236, DOI 10.1002/(SICI)1098-2744(199708)19:4<236::AID-MC4>3.0.CO;2-A; de Assis S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2058; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Eriksson JG, 2015, ANN MED, V47, P94, DOI 10.3109/07853890.2015.1004360; Eriksson JG, 2014, ANN MED, V46, P434, DOI 10.3109/07853890.2014.919728; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; GIUSTI RM, 1995, ANN INTERN MED, V122, P778, DOI 10.7326/0003-4819-122-10-199505150-00008; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Heerwagen MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067791; Ho SM, 2017, REPROD TOXICOL, V68, P85, DOI 10.1016/j.reprotox.2016.07.011; Howlader N., 2016, SEER CANC STAT REV, P1975; IARC, 2002, IARC HDB CANC PREV, V6; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kwong WY, 2000, DEVELOPMENT, V127, P4195; La Merrill M, 2010, ENVIRON HEALTH PERSP, V118, P596, DOI 10.1289/ehp.0901047; LangleyEvans SC, 1996, J NUTR, V126, P1578, DOI 10.1093/jn/126.6.1578; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; Mekada K, 2009, EXP ANIM TOKYO, V58, P141, DOI 10.1538/expanim.58.141; Miyagawa S, 2004, J MOL ENDOCRINOL, V32, P663, DOI 10.1677/jme.0.0320663; Morice P, 2016, LANCET, V387, P1094, DOI 10.1016/S0140-6736(15)00130-0; Nair S, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/368543; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Paz G, 2011, FRONT BIOSCI-LANDMRK, V16, P1634, DOI 10.2741/3810; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Reverte V, 2011, AM J PHYSIOL-RENAL, V301, pF327, DOI 10.1152/ajprenal.00110.2011; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Sanderson M, 1998, PAEDIATR PERINAT EP, V12, P397; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schouten LJ, 2004, JNCI-J NATL CANCER I, V96, P1635, DOI 10.1093/jnci/djh291; Soriano D, 1999, HUM REPROD, V14, P215, DOI 10.1093/humrep/14.1.215; Stevens VL, 2014, CANCER CAUSE CONTROL, V25, P321, DOI 10.1007/s10552-013-0333-7; Suen AA, 2016, MOL CANCER RES, V14, P849, DOI 10.1158/1541-7786.MCR-16-0084; Thomas CC, 2009, OBSTET GYNECOL, V114, P22, DOI 10.1097/AOG.0b013e3181ab6784; Torres-Rovira L, 2014, J STEROID BIOCHEM, V139, P130, DOI 10.1016/j.jsbmb.2013.01.004; Turdi S, 2013, J MOL CELL CARDIOL, V55, P117, DOI 10.1016/j.yjmcc.2012.12.007; Vickers MH, 2011, ENDOCRINOLOGY, V152, P1378, DOI 10.1210/en.2010-1093; Walker BE, 2003, ANTICANCER RES, V23, P4689; Wolin KY, 2010, ONCOLOGIST, V15, P556, DOI 10.1634/theoncologist.2009-0285; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x	49	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0186390	10.1371/journal.pone.0186390	http://dx.doi.org/10.1371/journal.pone.0186390			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775456	Green Submitted, Green Published, gold			2022-12-26	WOS:000432521100001
J	Pavankumar, TL; Sinha, AK; Ray, MK				Pavankumar, Theetha L.; Sinha, Anurag K.; Ray, Malay K.			Biochemical characterization of RecBCD enzyme from an Antarctic Pseudomonas species and identification of its cognate Chi (chi) sequence	PLOS ONE			English	Article							RECOMBINATION HOTSPOT-CHI; DOUBLE-STRAND BREAKS; HOT-SPOT CHI; ESCHERICHIA-COLI; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; NUCLEASE ACTIVITY; LOW-TEMPERATURE; SYRINGAE LZ4W; REGULATORY SEQUENCE	Pseudomonas syringae Lz4W RecBCD enzyme, RecBCD(Ps), is a trimeric protein complex comprised of RecC, RecB, and RecD subunits. RecBCD enzyme is essential for P. syringae growth at low temperature, and it protects cells from low temperature induced replication arrest. In this study, we show that the RecBCD(Ps) enzyme displays distinct biochemical behaviors. Unlike E. coli RecBCD enzyme, the RecD subunit is indispensable for RecBCD(Ps) function. The RecD motor activity is essential for the Chi-like fragments production in P. syringae, highlighting a distinct role for P. syringae RecD subunit in DNA repair and recombination process. Here, we demonstrate that the RecBCD(Ps) enzyme recognizes a unique octameric DNA sequence, 5'-GCTGGCGC-3' (Chi(ps)) that attenuates nuclease activity of the enzyme when it enters dsDNA from the 3'-end. We propose that the reduced translocation activities manifested by motor-defective mutants cause cold sensitivity in P. syrinage; emphasizing the importance of DNA processing and recombination functions in rescuing low temperature induced replication fork arrest.	[Pavankumar, Theetha L.; Sinha, Anurag K.; Ray, Malay K.] Ctr Cellular & Mol Biol, CSIR, Hyderabad, India; [Pavankumar, Theetha L.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Sinha, Anurag K.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of California System; University of California Davis; University of Copenhagen	Pavankumar, TL; Ray, MK (corresponding author), Ctr Cellular & Mol Biol, CSIR, Hyderabad, India.; Pavankumar, TL (corresponding author), Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA.	pavan@ucdavis.edu; malay.ccmb@gmail.com	Pavankumar, Theetha L/R-6118-2017; Sinha, Anurag/L-3936-2019; Sinha, Anurag/GXA-0049-2022	Pavankumar, Theetha L/0000-0003-1845-9592; Sinha, Anurag/0000-0002-6051-4930; 	Council of Scientific and Industrial Research (CSIR), Government of India; Department of Science and Technology (DST), Government of India; CSIR, India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	Research in M.K.R. laboratory is supported by the Council of Scientific and Industrial Research (CSIR), Government of India. A part of the work was supported by a grant to M.K.R. from Department of Science and Technology (DST), Government of India. T.L.P and A.K.S. acknowledge CSIR, India for research fellowships.	Amundsen SK, 2000, P NATL ACAD SCI USA, V97, P7399, DOI 10.1073/pnas.130192397; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENE DEV, V11, P571, DOI 10.1101/gad.11.5.571; Anderson DG, 1999, J BIOL CHEM, V274, P27139, DOI 10.1074/jbc.274.38.27139; Arakawa K, 2007, GENE, V392, P239, DOI 10.1016/j.gene.2006.12.022; Arnold DA, 1998, J BIOL CHEM, V273, P16476, DOI 10.1074/jbc.273.26.16476; Chedin F, 1998, MOL MICROBIOL, V29, P1369, DOI 10.1046/j.1365-2958.1998.01018.x; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; DIXON DA, 1993, CELL, V73, P87, DOI 10.1016/0092-8674(93)90162-J; DIXON DA, 1995, J BIOL CHEM, V270, P16360, DOI 10.1074/jbc.270.27.16360; DIXON DA, 1994, P NATL ACAD SCI USA, V91, P2980, DOI 10.1073/pnas.91.8.2980; EGGLESTON AK, 1993, J MOL BIOL, V231, P605, DOI 10.1006/jmbi.1993.1313; El Karoui M, 1999, RES MICROBIOL, V150, P579, DOI 10.1016/S0923-2508(99)00132-1; Halpern D, 2007, PLOS GENET, V3, P1614, DOI 10.1371/journal.pgen.0030153; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; Handa N, 2012, P NATL ACAD SCI USA, V109, P8901, DOI 10.1073/pnas.1206076109; HIOM K, 1995, CELL, V80, P787, DOI 10.1016/0092-8674(95)90357-7; KORANGY F, 1992, J BIOL CHEM, V267, P1727; KORNBERG A, 1978, J BIOL CHEM, V253, P3298; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; LOVETT ST, 1988, GENETICS, V120, P37; MCKITTRICK NH, 1989, J MOL BIOL, V210, P485, DOI 10.1016/0022-2836(89)90125-3; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Pavankumar TL, 2016, METHOD ENZYMOL, V581, P1, DOI 10.1016/bs.mie.2016.09.010; Pavankumar TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009412; Regha K, 2005, GENETICS, V170, P1473, DOI 10.1534/genetics.104.038943; ROSAMOND J, 1979, J BIOL CHEM, V254, P8646; Satapathy AK, 2008, FEBS J, V275, P1835, DOI 10.1111/j.1742-4658.2008.06342.x; SHIVAJI S, 1989, APPL ENVIRON MICROB, V55, P767, DOI 10.1128/AEM.55.3.767-770.1989; Sinha AK, 2013, MOL MICROBIOL, V89, P792, DOI 10.1111/mmi.12315; SMITH GR, 1981, J VIROL, V37, P336, DOI 10.1128/JVI.37.1.336-342.1981; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; STAHL FW, 1977, GENETICS, V86, P715; Sun JZ, 2006, BIOCHEMISTRY-US, V45, P131, DOI 10.1021/bi051150v; TAYLOR AF, 1985, CELL, V41, P153, DOI 10.1016/0092-8674(85)90070-4; TAYLOR AF, 1995, J BIOL CHEM, V270, P24459, DOI 10.1074/jbc.270.41.24459; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Yu M, 1998, P NATL ACAD SCI USA, V95, P981, DOI 10.1073/pnas.95.3.981	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197476	10.1371/journal.pone.0197476	http://dx.doi.org/10.1371/journal.pone.0197476			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775464	Green Published, Green Submitted, gold			2022-12-26	WOS:000432521100016
J	Bundt, C; Ruitenberg, MFL; Abrahamse, EL; Notebaert, W				Bundt, Carsten; Ruitenberg, Marit F. L.; Abrahamse, Elger L.; Notebaert, Wim			Early and late indications of item-specific control in a Stroop mouse tracking study	PLOS ONE			English	Article							COGNITIVE CONTROL; PROCESS DISSOCIATIONS; CONFIDENCE-INTERVALS; AUTOMATIC PROCESSES; ACTION SELECTION; INTERFERENCE; ACTIVATION; ATTENTION; CONTINGENCY; CONGRUENCY	Previous studies indicated that cognitive conflict continues to bias actions even after a movement has been initiated. The present paper examined whether cognitive control also biases actions after movement initiation. To this end, we had participants perform a Stroop task in which we manipulated the item-specific proportion of (in)congruent trials (80% congruent vs. 20% congruent). Importantly, participants responded via mouse movements, allowing us to evaluate various movement parameters: initiation times, movement times, and movement accuracy. Results showed that mouse movements were faster and more accurate during congruent trials compared to incongruent trials. Moreover, we observed that this congruency effect was larger for 80% congruent compared to 20% congruent items, which reflects item specific cognitive control. Notably, when responses were initiated very fast rendering virtually no time for stimulus processing before movement onset this item-specific control was observed only in movement times. However, for relatively slow initiated responses, item specific control was observed both in initiation and in movement times. These findings demonstrate that item-specific cognitive control biases actions before and after movement initiation.	[Bundt, Carsten; Ruitenberg, Marit F. L.; Abrahamse, Elger L.; Notebaert, Wim] Univ Ghent, Dept Expt Psychol, Ghent, Belgium; [Ruitenberg, Marit F. L.] Univ Michigan, Dept Kinesiol, Ann Arbor, MI 48109 USA; [Abrahamse, Elger L.] Basque Ctr Cognit Brain & Language, San Sebastian, Spain; [Abrahamse, Elger L.] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain	Ghent University; University of Michigan System; University of Michigan; Basque Foundation for Science	Bundt, C (corresponding author), Univ Ghent, Dept Expt Psychol, Ghent, Belgium.	bundt.carsten@googlemail.com		Bundt, Carsten/0000-0002-3464-2330	Special Research Fund of Ghent University (BOF) [B0F13/24j/080]; Research Foundation Flanders (FWO) [1262214N]; BOF [BOF15/PD0/135]; FWO [12C4715N]; Ghent University BOF initiative [B0F13/24j/080]; Research Foundation - Flanders (FWO) [1262214N]; Ghent University [B0F15/PD0/135]	Special Research Fund of Ghent University (BOF)(Ghent University); Research Foundation Flanders (FWO)(FWO); BOF; FWO(FWO); Ghent University BOF initiative; Research Foundation - Flanders (FWO)(FWO); Ghent University(Ghent University)	This work was supported by the Special Research Fund of Ghent University (BOF) (grant number: B0F13/24j/080). MFLR was supported in part by the Research Foundation Flanders (FWO) as a Pegasus Marie Curie Fellow (grant number: 1262214N) and by a BOF postdoctoral fellowship (grant number: BOF15/PD0/135). ELA was supported by the FWO (grant number: 12C4715N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Nathalie Schouppe for her assistance in running the experiment. CB was supported by a doctoral grant from the Ghent University BOF initiative (B0F13/24j/080) in part awarded to WN. MFLR was supported in part by the Research Foundation - Flanders (FWO) as a Pegasus Marie Curie Fellow (1262214N) and by a postdoctoral fellowship from Ghent University (B0F15/PD0/135). ELA was supported by the FWO (12C4715N).	Abrahamse EL, 2013, J EXP PSYCHOL LEARN, V39, P1552, DOI 10.1037/a0032426; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Barca L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116193; Barca L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035932; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown TL, 2002, J EXP PSYCHOL GEN, V131, P220, DOI 10.1037//0096-3445.131.2.220; Bugg JM, 2013, J EXP PSYCHOL HUMAN, V39, P433, DOI 10.1037/a0029145; Bugg JM, 2012, CURR DIR PSYCHOL SCI, V21, P302, DOI 10.1177/0963721412453586; Bugg JM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00367; Calderon CB, 2015, J EXP PSYCHOL GEN, V144, P737, DOI 10.1037/xge0000087; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Duthoo W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01001; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Erb CD, 2016, COGNITION, V152, P114, DOI 10.1016/j.cognition.2016.03.015; Faulkenberry TJ, 2016, ACTA PSYCHOL, V163, P114, DOI 10.1016/j.actpsy.2015.11.010; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Freeman JB, 2009, PSYCHOL SCI, V20, P1183, DOI 10.1111/j.1467-9280.2009.02422.x; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Incera S, 2016, BILING-LANG COGN, V19, P610, DOI 10.1017/S1366728915000218; Jacoby LL, 2003, PSYCHON B REV, V10, P638, DOI 10.3758/BF03196526; Kadosh RC, 2007, J COGNITIVE NEUROSCI, V19, P957, DOI 10.1162/jocn.2007.19.6.957; LINDSAY DS, 1994, J EXP PSYCHOL HUMAN, V20, P219, DOI 10.1037/0096-1523.20.2.219; LOGAN GD, 1979, MEM COGNITION, V7, P166, DOI 10.3758/BF03197535; LOWE DG, 1982, CAN J PSYCHOL, V36, P684, DOI 10.1037/h0080661; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mordkoff JT, 2012, PSYCHON B REV, V19, P750, DOI 10.3758/s13423-012-0257-3; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Pratte MS, 2010, ATTEN PERCEPT PSYCHO, V72, P2013, DOI 10.3758/APP.72.7.2013; Scherbaum S, 2010, COGNITION, V115, P407, DOI 10.1016/j.cognition.2010.02.004; Schmidt JR, 2008, J EXP PSYCHOL LEARN, V34, P514, DOI 10.1037/0278-7393.34.3.514; Schmidt JR, 2007, CONSCIOUS COGN, V16, P421, DOI 10.1016/j.concog.2006.06.010; Servant M, 2015, J NEUROSCI, V35, P10371, DOI 10.1523/JNEUROSCI.0078-15.2015; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TREISMAN A, 1969, NATURE, V222, P437, DOI 10.1038/222437a0; Verguts T, 2008, PSYCHOL REV, V115, P518, DOI 10.1037/0033-295X.115.2.518; Verguts T, 2009, TRENDS COGN SCI, V13, P252, DOI 10.1016/j.tics.2009.02.007	39	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197278	10.1371/journal.pone.0197278	http://dx.doi.org/10.1371/journal.pone.0197278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG0DP	29771931	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900043
J	Liu, T; Wang, WC; Ji, YN; Wang, YM; Liu, XN; Cao, LY; Liu, SQ				Liu, Tong; Wang, Wanchao; Ji, Yannan; Wang, Yiming; Liu, Xining; Cao, Liying; Liu, Siqing			Association between different combination of measures for obesity and new-onset gallstone disease	PLOS ONE			English	Article							IDEAL CARDIOVASCULAR HEALTH; RISK-FACTORS; GALLBLADDER-DISEASE; UNITED-STATES; WEIGHT-LOSS; PREVALENCE; POPULATION; CHINESE; TAIWAN; MEN	Background Body mass index(BMI) is a calculation index of general obesity. Waist circumference(WC) is a measure of body-fat distribution and always used to estimate abdominal obesity. An important trait of general obesity and abdominal obesity is their propensity to coexist. Using one single measure of obesity could not estimate persons at risk for GSD precisely. Objectives This study aimed to compare the predictive values of various combination of measures for obesity(BMI, WC, waist to hip ratio) for new-onset GSD. Methods We prospectively studied the predictive values of various combination of measures for obesity for new-onset GSD in a cohort of 88,947 participants who were free of prior gallstone disease, demographic characteristics and biochemical parameters were recorded. Results 4,329 participants were identified to have GSD among 88,947 participants during 713 345 person-years of follow-up. Higher BMI, WC and waist to hip ratio (WHtR) were significantly associated with higher risks of GSD in both genders even after adjustment for potential confounders. In males, the hazard ratio for the highest versus lowest BMI, WC, WHtR were 1.63(1.47-1.79), 1.53(1.40-1.68), 1.44(1.31 -1.58), respectively. In females, the hazard ratio for the highest versus lowest BMI, WC, WHtR were 2.11 (1.79-2.49), 1.85(1.55-2.22), 1.84(1.55-2.19), respectively. In male group, the combination of BMI+WC improved the predictive ability of the model more clearly than other combinations after adding them to the multivariate model in turn, while for females the best predictive combination was BMI+ WHtR. Conclusions Elevated BMI, WC and WHtR were independent risk factors for new-onset GSD in both sex groups after additional adjustment was made for potential confounders. In males, the combination of BMI+WC seemed to be the most predictable model to evaluate the effect of obesity on new-onset GSD, while the best combination in females was BMI+WHtR.	[Liu, Tong] North China Univ Sci & Technol, Grad Sch, Tangshan, Peoples R China; [Liu, Tong; Wang, Wanchao; Wang, Yiming; Liu, Xining; Cao, Liying; Liu, Siqing] North China Univ Sci & Technol, Dept Hepatobiliary Surg, Kailuan Gen Hosp, Tangshan, Peoples R China; [Ji, Yannan] Chende Med Univ, Sch Basic Med, Chende, Peoples R China	North China University of Science & Technology; North China University of Science & Technology	Cao, LY; Liu, SQ (corresponding author), North China Univ Sci & Technol, Dept Hepatobiliary Surg, Kailuan Gen Hosp, Tangshan, Peoples R China.	caoliying@kailuan.com.cn; siqingliu@163.com						AMARAL JF, 1985, AM J SURG, V149, P551, DOI 10.1016/S0002-9610(85)80055-6; Angelico F, 1997, ITAL J GASTROENTEROL, V29, P249; Attili AF, 1997, HEPATOLOGY, V26, P809, DOI 10.1002/hep.510260401; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Chen CH, 2006, J GASTROEN HEPATOL, V21, P1737, DOI 10.1111/j.1440-1746.2006.04381.x; Chen CY, 1998, AGE AGEING, V27, P437, DOI 10.1093/ageing/27.4.437; Chen JY, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-83; Despres JP, 2001, BMJ-BRIT MED J, V322, P716, DOI 10.1136/bmj.322.7288.716; Dubrac S, 2001, J HEPATOL, V35, P550, DOI 10.1016/S0168-8278(01)00180-5; Erlinger S, 2000, EUR J GASTROEN HEPAT, V12, P1347, DOI 10.1097/00042737-200012120-00015; Everhart JE, 2009, GASTROENTEROLOGY, V136, P376, DOI 10.1053/j.gastro.2008.12.015; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Festi D, 2008, WORLD J GASTROENTERO, V14, P5282, DOI 10.3748/wjg.14.5282; FISCHER J, 1990, J AM DIET ASSOC, V90, P1697; Guglielmo D, 2018, MMWR-MORBID MORTAL W, V67, P485, DOI 10.15585/mmwr.mm6717a2; HAFFNER SM, 1989, AM J EPIDEMIOL, V129, P587, DOI 10.1093/oxfordjournals.aje.a115171; HEATON KW, 1991, EUR J GASTROEN HEPAT, V3, P745; Jia ZX, 2011, DIABETES RES CLIN PR, V92, P265, DOI 10.1016/j.diabres.2011.01.021; Johansen C, 1996, GUT, V39, P439, DOI 10.1136/gut.39.3.439; KAMEDA H, 1984, JPN J MED, V23, P109; Kono S, 1995, SCAND J GASTROENTERO, V30, P1228, DOI 10.3109/00365529509101637; LU SN, 1990, J CLIN GASTROENTEROL, V12, P542, DOI 10.1097/00004836-199010000-00011; Matta J, 2018, PRESSE MED, V47, P434, DOI 10.1016/j.lpm.2018.03.023; Ruhl CE, 2011, GASTROENTEROLOGY, V140, P508, DOI 10.1053/j.gastro.2010.10.060; Salinas G, 2004, SURG LAPARO ENDO PER, V14, P250; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Sebo P, 2008, PREV MED, V47, P389, DOI 10.1016/j.ypmed.2008.06.012; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Tsai CJ, 2004, AM J CLIN NUTR, V80, P38; Villalpando CG, 1997, ARCH MED RES, V28, P543; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839; Zhu L, 2014, WORLD J GASTROENTERO, V20, P14942, DOI 10.3748/wjg.v20.i40.14942; Zhuang X, 1999, Zhonghua Liu Xing Bing Xue Za Zhi, V20, P181	34	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196457	10.1371/journal.pone.0196457	http://dx.doi.org/10.1371/journal.pone.0196457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29772027	gold, Green Submitted, Green Published			2022-12-26	WOS:000432348900013
J	Bertuccio, CA; Wang, TT; Hamilton, KL; Rodriguez-Gil, DJ; Condliffe, SB; Devor, DC				Bertuccio, Claudia A.; Wang, Tony T.; Hamilton, Kirk L.; Rodriguez-Gil, Diego J.; Condliffe, Steven B.; Devor, Daniel C.			Plasma membrane insertion of KCa2.3 (SK3) is dependent upon the SNARE proteins, syntaxin-4 and SNAP23	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; SENSITIVE POTASSIUM CHANNELS; INTERMEDIATE CONDUCTANCE; ENDOTHELIAL-CELLS; SURFACE EXPRESSION; TERMINAL DOMAIN; SKCA CHANNELS; KCA3.1; TRAFFICKING; HIK1	We previously demonstrated endocytosis of KCa2.3 is caveolin-1-, dynamin II- and Rab5-dependent. KCa2.3 then enters Rab35/EPI64C- and RME-1-containing recycling endosomes and is returned to the plasma membrane (PM). Herein, we report on the mechanism by which KCa2.3 is inserted into the PM during recycling and following exit from the Golgi. We demonstrate KCa2.3 colocalizes with SNAP-23 and Syntaxin-4 in the PM of HEK and endothelial cells by confocal immunofluorescence microscopy. We further show KCa2.3 can be co-immunoprecipitated with SNAP-23 and Syntaxin-4. Overexpression of either Syntaxin-4 or SNAP-23 increased PM expression of KCa2.3, whereas shRNA-mediated knockdown of these SNARE proteins significantly decreased PM KCa2.3 expression, as assessed by cell surface biotinylation. Whole-cell patch clamp studies confirmed knockdown of SNAP-23 significantly decreased the apamin sensitive, KCa2.3 current. Using standard biotinylation/stripping methods, we demonstrate shRNA mediated knockdown of SNAP-23 inhibits recycling of KCa2.3 following endocytosis, whereas scrambled shRNA had no effect. Finally, using biotin ligase acceptor peptide (BLAP)-tagged KCa2.3, coupled with ER-resident biotin ligase (BirA), channels could be biotinylated in the ER after which we evaluated their rate of insertion into the PM following Golgi exit. We demonstrate knockdown of SNAP-23 significantly slows the rate of Golgi to PM delivery of KCa2.3. The inhibition of both recycling and PM delivery of newly synthesized KCa2.3 channels likely accounts for the decreased PM expression observed following knockdown of these SNARE proteins. In total, our results suggest insertion of KCa2.3 into the PM depends upon the SNARE proteins, Syntaxin-4 and SNAP-23.	[Bertuccio, Claudia A.; Devor, Daniel C.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Wang, Tony T.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Hamilton, Kirk L.; Condliffe, Steven B.] Univ Otago, Sch Biomed Sci, Dept Physiol, Dunedin, New Zealand; [Rodriguez-Gil, Diego J.] East Tennessee State Univ, Quillen Coll Med, Dept Biomed Sci, Johnson City, TN USA; [Wang, Tony T.] SRI Int, Harrisonburg, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Otago; East Tennessee State University; SRI International	Devor, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	dd2@pitt.edu		Devor, Daniel/0000-0003-3013-5179	National Institutes of Health [HL092157]; University of Otago Research Grant; School of Biomedical Sciences of the University of Otago	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Otago Research Grant; School of Biomedical Sciences of the University of Otago	This work was supported by a previous grant from the National Institutes of Health grant (HL092157) to DCD in addition to the Department of Cell Biology, University of Pittsburgh. SBC was supported by a University of Otago Research Grant. KLH was supported by a Dean's Bequest grant from the School of Biomedical Sciences of the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absi M, 2007, BRIT J PHARMACOL, V151, P332, DOI 10.1038/sj.bjp.0707222; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Bailey MA, 2010, J GEN PHYSIOL, V136, P367, DOI 10.1085/jgp.201010430; Balut CM, 2012, CHEMMEDCHEM, V7, P1741, DOI 10.1002/cmdc.201200226; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Balut CM, 2010, AM J PHYSIOL-CELL PH, V299, pC1015, DOI 10.1152/ajpcell.00120.2010; Bertuccio CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092013; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Chang N, 2011, J BIOL CHEM, V286, P23308, DOI 10.1074/jbc.M111.217950; Chen PC, 2011, AM J PHYSIOL-CELL PH, V300, pC506, DOI 10.1152/ajpcell.00429.2010; Condliffe SB, 2013, J BIOL CHEM, V288, P33873, DOI 10.1074/jbc.M113.497701; Dunn CA, 2012, J BIOL CHEM, V287, P2600, DOI 10.1074/jbc.M111.276261; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; FULLER SD, 1985, EMBO J, V4, P297, DOI 10.1002/j.1460-2075.1985.tb03629.x; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gao YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044150; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Garneau L, 2009, J BIOL CHEM, V284, P389, DOI 10.1074/jbc.M805700200; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Girault A, 2012, CURR MED CHEM, V19, P697, DOI 10.2174/092986712798992039; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; Hamilton KL, 2003, J BIOL CHEM, V278, P16690, DOI 10.1074/jbc.M212959200; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Jones HM, 2007, CHANNELS, V1, P80, DOI 10.4161/chan.3999; Jones HM, 2005, J BIOL CHEM, V280, P37257, DOI 10.1074/jbc.M508601200; Jones HM, 2004, J BIOL CHEM, V279, P15531, DOI 10.1074/jbc.M400069200; Klein H, 2007, J GEN PHYSIOL, V129, P299, DOI 10.1085/jgp.200609726; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Lee WS, 2003, J BIOL CHEM, V278, P25940, DOI 10.1074/jbc.M302091200; Lin MT, 2012, AM J PHYSIOL-CELL PH, V303, pC318, DOI 10.1152/ajpcell.00058.2012; Ma X, 2010, ARTERIOSCL THROM VAS, V30, P2249, DOI 10.1161/ATVBAHA.110.212084; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nicolaou SA, 2007, AM J PHYSIOL-CELL PH, V292, pC1431, DOI 10.1152/ajpcell.00376.2006; Predescu SA, 2005, J BIOL CHEM, V280, P37130, DOI 10.1074/jbc.M505659200; Rodriguez-Gil DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056561; Roncarati R, 2005, MOL CELL NEUROSCI, V28, P314, DOI 10.1016/j.mcn.2004.09.015; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Skalski M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-62; Soldovieri MV, 2014, HUM MUTAT, V35, P356, DOI 10.1002/humu.22500; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; STOLZ DB, 1992, J CELL SCI, V103, P39; Sun TJ, 2005, AM J PHYSIOL-RENAL, V288, pF284, DOI 10.1152/ajprenal.00320.2004; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200	47	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0196717	10.1371/journal.pone.0196717	http://dx.doi.org/10.1371/journal.pone.0196717			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768434	Green Published, gold			2022-12-26	WOS:000432329200043
J	Gale, CR; Cukic, I; Chastin, SF; Dall, PM; Dontje, ML; Skelton, DA; Deary, IJ				Gale, Catharine R.; Cukic, Iva; Chastin, Sebastien F.; Dall, Philippa M.; Dontje, Manon L.; Skelton, Dawn A.; Deary, Ian J.		Seniors USP Team	Attitudes to ageing and objectively-measured sedentary and walking behaviour in older people: The Lothian Birth Cohort 1936	PLOS ONE			English	Article							POSITIVE SELF-PERCEPTIONS; PHYSICAL-ACTIVITY; NEGATIVE PERCEPTIONS; SITTING TIME; ADULTS; MORTALITY; METAANALYSIS; PREDICT; ASSOCIATION; STEREOTYPES	Background Prolonged sitting and low activity-both common in older people-are associated with increased mortality and poorer health. Whether having a more negative attitude to ageing is associated with higher levels of these behaviours is unclear. Objective We investigated the prospective relationship between attitudes to ageing and objectively measured sedentary and walking behaviour. Methods Participants were 271 members of the Lothian Birth Cohort 1936. At age 72 years, participants completed the Attitudes to Ageing Questionnaire which assesses attitudes on three domains-Psychosocial loss, Physical change and Psychological growth. At age 79 years, participants wore an activPAL activity monitor for seven days. The outcome measures were average daily time spent sedentary, number of sit-to-stand transitions, and step count. Results There were no significant associations between any of the Attitude to Ageing domain scores and time spent sedentary or number of sit-to-stand transitions. In sex-adjusted analysis, having a more positive attitude to ageing as regards Physical change was associated with a slightly higher daily step count, for a SD increment in score, average daily step count was greater by 1.5% (95% CI 0.6%, 2.4%). On further adjustment for potential confounding factors these associations were no longer significant. Conclusion We found no evidence that attitudes to ageing at age 72 were predictive of sedentary or walking behaviour seven years later. Future studies should examine whether attitudes to ageing are associated with objectively measured walking or sedentary behaviour at the same point in time. The existence of such an association could inform the development of interventions.	[Gale, Catharine R.; Cukic, Iva; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Dept Psychol, Edinburgh, Midlothian, Scotland; [Gale, Catharine R.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Chastin, Sebastien F.; Dall, Philippa M.; Dontje, Manon L.; Skelton, Dawn A.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Inst Appl Hlth Res, Glasgow, Lanark, Scotland; [Chastin, Sebastien F.] Univ Ghent, Dept Movement & Sports Sci, Fac Med & Hlth Sci, Ghent, Belgium	University of Edinburgh; University of Southampton; Glasgow Caledonian University; Ghent University	Gale, CR (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Dept Psychol, Edinburgh, Midlothian, Scotland.; Gale, CR (corresponding author), Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England.	crg@mrc.soton.ac.uk	Chastin, Sebastien/ABF-1455-2020; Cukic, Iva/HGE-8252-2022; Deary, Ian J/C-6297-2009; Skelton, Dawn A/B-7552-2013	Chastin, Sebastien/0000-0003-1421-9348; Deary, Ian J/0000-0002-1733-263X; Skelton, Dawn A/0000-0001-6223-9840; Dontje, Manon/0000-0002-0348-9556; Dall, Philippa/0000-0002-1958-1517; Gale, Catharine/0000-0002-3361-8638; Cukic, Iva/0000-0002-2010-1648	UK Medical Research Council (MRC) as part of the Lifelong Health and Wellbeing Initiative (LLHW) [MR/K025023/1]; Disconnected Mind project; Age UK; MRC [Mr/M01311/1, G1001245/96077]; BBSRC; MRC as part of the LLHW [MW K026992/1]; MRC [MR/K025023/1, MC_U147585819, G0400491, MC_U147585827, MC_UU_12011/2] Funding Source: UKRI	UK Medical Research Council (MRC) as part of the Lifelong Health and Wellbeing Initiative (LLHW)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Disconnected Mind project; Age UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC as part of the LLHW(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Seniors USP (Understanding Sedentary Patterns) project is funded by the UK Medical Research Council (MRC) as part of the Lifelong Health and Wellbeing Initiative (LLHW) [MR/K025023/1 (DS)]. LBC1936 data collection is supported by the Disconnected Mind project (funded by Age UK and MRC [Mr/M01311/1 and G1001245/96077] (ID)) and undertaken within the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (funded by the BBSRC and MRC as part of the LLHW [MW K026992/1] (ID)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; Ajzen I., 1988, ATTITUDES PERSONALIT; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Beyer AK, 2015, PSYCHOL HEALTH, V30, P671, DOI 10.1080/08870446.2015.1014370; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Chastin SFM, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0409-3; Chastin SFM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0292-3; Chastin SFM, 2014, INT J ENV RES PUB HE, V11, P773, DOI 10.3390/ijerph110100773; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Dionigi R. A., 2015, J GERIATRICS, DOI [10.1155/2015/954027, DOI 10.1155/2015/954027]; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Emile M, 2014, PSYCHOL SPORT EXERC, V15, P198, DOI 10.1016/j.psychsport.2013.11.002; Freeman AT, 2016, J AFFECT DISORDERS, V199, P132, DOI 10.1016/j.jad.2016.03.042; Harvey JA, 2013, INT J ENV RES PUB HE, V10, P6645, DOI 10.3390/ijerph10126645; Kotter-Gruhn D, 2009, PSYCHOL AGING, V24, P654, DOI 10.1037/a0016510; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Laidlaw K, 2007, INT J GERIATR PSYCH, V22, P367, DOI 10.1002/gps.1683; Levy BR, 2014, PSYCHOL SCI, V25, P2127, DOI 10.1177/0956797614551970; Levy BR, 2002, J PERS SOC PSYCHOL, V83, P261, DOI 10.1037//0022-3514.83.2.261; Levy BR, 2002, J GERONTOL B-PSYCHOL, V57, pP409, DOI 10.1093/geronb/57.5.P409; McGee MA, 1998, AGE AGEING, V27, P605, DOI 10.1093/ageing/27.5.605; North MS, 2015, PSYCHOL BULL, V141, P993, DOI 10.1037/a0039469; Palacios CS, 2009, ARCH GERONTOL GERIAT, V48, P385, DOI 10.1016/j.archger.2008.03.007; Robertson DA, 2016, PSYCHOL AGING, V31, P71, DOI 10.1037/pag0000061; Robertson DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123260; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Sargent-Cox K, 2017, INT PSYCHOGERIATR, V29, P1, DOI 10.1017/S1041610216001939; Sargent-Cox KA, 2014, J GERONTOL B-PSYCHOL, V69, P168, DOI 10.1093/geronb/gbt005; Sargent-Cox KA, 2012, PSYCHOL AGING, V27, P750, DOI 10.1037/a0027578; Sarkisian CA, 2005, J GEN INTERN MED, V20, P911, DOI 10.1111/j.1525-1497.2005.0204.x; Sellers C, 2016, GAIT POSTURE, V43, P42, DOI 10.1016/j.gaitpost.2015.10.020; Shenkin SD, 2014, INT PSYCHOGERIATR, V26, P1417, DOI 10.1017/S1041610214000301; Wurm S, 2010, PSYCHOL HEALTH, V25, P25, DOI 10.1080/08870440802311314; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	35	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197357	10.1371/journal.pone.0197357	http://dx.doi.org/10.1371/journal.pone.0197357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GF9WG	29768507	Green Published, Green Accepted, gold			2022-12-26	WOS:000432329200076
J	Frybova, B; Drabek, J; Lochmannova, J; Douda, L; Hlava, S; Zemkova, D; Mixa, V; Kyncl, M; Zeman, L; Rygl, M; Keil, R				Frybova, Barbora; Drabek, Jiri; Lochmannova, Jindra; Douda, Ladislav; Hlava, Stepan; Zemkova, Daniela; Mixa, Vladimir; Kyncl, Martin; Zeman, Lubos; Rygl, Michal; Keil, Radan			Cholelithiasis and choledocholithiasis in children; risk factors for development	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; BODY-MASS INDEX; INTRAABDOMINAL PRESSURE; GALLSTONE-DISEASE; OBESE CHILDREN; CHILDHOOD; ADOLESCENTS; PREVALENCE; IMPACT; SEX	Purpose To compare anthropometric data (body mass index [BMI]) in patients without lithiasis to patients with symptomatic simple cholelithiasis or choledocholithiasis. Methods We retrospectively reviewed data from 147 patients undergoing laparoscopic cholecystectomy between 2001-2015. Complete growth data from 98 patients was compared with anthropometric data from the population of the Czech Republic and a control group (BMI of 100 consecutive patients without biliary stones in abdominal ultrasound who were admitted to a surgical department for suspected appendicitis). Results The BMI of 75 children with simple cholelithiasis and 23 with choledocholithiasis was compared to the standard Czech pediatric population and to the control group. The median age (simple cholelithiasis and choledocholithiasis) was 16 years, and 35 patients (24%) had a family history of gallstones. Types of lithiasis included multiple (n = 120), solitary (n = 11), and sludge (n = 10). Five cases had polyps and one had gallbladder dysplasia. Patients with simple cholelithiasis had significantly higher BMI compared to the control group without cholelithiasis (p<0.0001) and the standard Czech population (p = 0.03). Patients with choledocholithiasis had a mean BMI significantly higher than that of the general population (p = 0.001) and the control group (p = 0.0001). Patients with choledocholithiasis had significantly higher BMI than those with simple cholelithiasis (p = 0.03). Conclusion Patients with cholelithiasis had significantly higher BMI than the general population, and patients with choledocholithiasis had significantly higher BMI than patients with simple lithiasis. Elevated BMI is a risk factor for developing choledocholithiasis. ERCP and early laparoscopic cholecystectomy in patients with choledocholithiasis offer equivalent outcomes in patients with simple cholelithiasis.	[Frybova, Barbora; Zeman, Lubos; Rygl, Michal] Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Pediat Surg, Prague, Czech Republic; [Drabek, Jiri; Lochmannova, Jindra; Hlava, Stepan; Keil, Radan] Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Internal Med, Prague, Czech Republic; [Douda, Ladislav] Charles Univ Prague, Univ Hosp Hradec Kralove, Fac Med Hradec Kralove, Dept Internal Med Gastroenterol 2, Hradec Kralove, Czech Republic; [Zemkova, Daniela] Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Pediat, Prague, Czech Republic; [Mixa, Vladimir] Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Anaesthesiol & Intens Care Med, Prague, Czech Republic; [Kyncl, Martin] Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Radiol, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Charles University Prague; Motol University Hospital; Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; Motol University Hospital; Charles University Prague; General University Hospital Prague; Motol University Hospital; Charles University Prague; Motol University Hospital	Keil, R (corresponding author), Charles Univ Prague, Univ Hosp Motol Prague, Fac Med 2, Dept Internal Med, Prague, Czech Republic.	radan.keil@fnmotol.cz	Drábek, Jiří/AAI-6723-2021; Keil, Radan/AAQ-6496-2021; Douda, Ladislav/ABE-5291-2020; Frybova, Barbora/AAW-2792-2020	Douda, Ladislav/0000-0003-0131-6608; 	Ministry of Health, Czech Republic-conceptual development of research organization, Motol University Hospital, Prague, Czech Republic [00064203]	Ministry of Health, Czech Republic-conceptual development of research organization, Motol University Hospital, Prague, Czech Republic	This work was supported by Ministry of Health, Czech Republic-conceptual development of research organization, Motol University Hospital, Prague, Czech Republic 00064203, www.mzcr.cz. No funding bodies had any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Balanescu RN, 2015, CHIRURGIA-BUCHAREST, V110, P559; BALDRIDGE AD, 1995, J PEDIATR-US, V127, P700, DOI 10.1016/S0022-3476(95)70156-7; Buck Marcia L., 2009, PEDIATRIC PHARMACOTH, V15; Chiloiro M, 1999, INT J OBESITY, V23, P1303, DOI 10.1038/sj.ijo.0801071; Ejike JC, 2010, INTENS CARE MED, V36, P329, DOI 10.1007/s00134-009-1708-9; Farkas DT, 2012, SURG ENDOSC, V26, P964, DOI 10.1007/s00464-011-1978-5; Fradin K, 2014, J PEDIATR GASTR NUTR, V58, P102, DOI 10.1097/MPG.0b013e3182a939cf; Huang JS, 2013, J PEDIATR GASTR NUTR, V56, P99, DOI 10.1097/MPG.0b013e31826d3c62; Jaruvongvanich V, 2016, DIGEST DIS SCI, V61, P2389, DOI 10.1007/s10620-016-4125-2; Jeanty C, 2015, J PEDIATR SURG, V50, P1289, DOI 10.1016/j.jpedsurg.2014.10.051; Kaechele V, 2006, J PEDIATR GASTR NUTR, V42, P66, DOI 10.1097/01.mpg.0000187816.31213.06; Kiuru E, 2014, IN VIVO, V28, P615; Kobzova J., 2004, Central European Journal of Public Health, V12, P126; Koebnick C, 2012, J PEDIATR GASTR NUTR, V55, P328, DOI 10.1097/MPG.0b013e31824d256f; Lambert DM, 2005, OBES SURG, V15, P1225, DOI 10.1381/096089205774512546; Lammert F, 2016, J HEPATOL, V65, P146, DOI 10.1016/j.jhep.2016.03.005; Loria P, 2005, J GASTROEN HEPATOL, V20, P1176, DOI 10.1111/j.1440-1746.2005.03924.x; Noblett K L, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P323, DOI 10.1007/BF02765589; Pastucha D, 2010, BIOMED PAP, V154, P77, DOI 10.5507/bp.2010.013; Pozo MJ, 2004, CURR MED CHEM, V11, P1801, DOI 10.2174/0929867043364955; Sahuquillo J, 2008, NEUROSURGERY, V62, P143, DOI 10.1227/01.NEU.0000311071.33615.E1; Sanchez NC, 2001, AM SURGEON, V67, P243; SCHJOLDAGER BTG, 1994, ANN NY ACAD SCI, V713, P207, DOI 10.1111/j.1749-6632.1994.tb44067.x	23	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0196475	10.1371/journal.pone.0196475	http://dx.doi.org/10.1371/journal.pone.0196475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763444	Green Submitted, Green Published, gold			2022-12-26	WOS:000432118800011
J	Balogh, SL; Huber, DPW; Lindgren, BS				Balogh, Sharleen L.; Huber, Dezene P. W.; Lindgren, B. Staffan			Single-generation effects on terpenoid defenses in lodgepole pine populations following mountain pine beetle infestation	PLOS ONE			English	Article							DENDROCTONUS-PONDEROSAE COLEOPTERA; METHYL JASMONATE; BRITISH-COLUMBIA; PRIMARY ATTRACTION; GENETIC-VARIATION; CHEMICAL DEFENSE; RANGE EXPANSION; BARK BEETLES; SCOLYTIDAE; AGGREGATION	The recent mountain pine beetle outbreak in western Canada provides an opportunity to study the selection and heritability of tree defenses. We examined terpenoid-based defenses of seedling lodgepole pines which were offspring of mature trees subjected to high levels of mountain pine beetle selective pressure. Seedlings were grown from one of three types of cones: old cones on live trees; young cones on live trees; and cones on trees killed by beetles. Offspring thus represented crosses of non-surviving (NS) x surviving (S), S x S, and NS x NS parents, respectively. Methyl jasmonate was used to induce a defensive reaction in the seedlings. Seed source had a significant effect on levels of ten different terpenes, but not on total terpene concentrations. When the seedlings were grouped by location and treatment type, the seedlings of different cone types could be almost entirely distinguished by terpene profiles.	[Balogh, Sharleen L.; Huber, Dezene P. W.; Lindgren, B. Staffan] Univ North British Columbia, Nat Resources & Environm Studies Inst, Prince George, BC, Canada	University of Northern British Columbia	Huber, DPW (corresponding author), Univ North British Columbia, Nat Resources & Environm Studies Inst, Prince George, BC, Canada.	huber@unbc.ca	Huber, Dezene P.W./AAG-9638-2019	Huber, Dezene P.W./0000-0002-6495-1759; Lindgren, B. Staffan/0000-0003-3581-2853	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; Province of British Columbia; University of Northern British Columbia; NSERC; UNBC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; Province of British Columbia; University of Northern British Columbia; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); UNBC	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada (SLB, DPWH, BSL), the Canada Research Chairs Program (DPWH), the Canada Foundation for Innovation (DPWH), the British Columbia Knowledge Development Fund (DPWH), the Province of British Columbia (BSL), and the University of Northern British Columbia (SLB). Graduate research stipend funds were supplied to SLB via NSERC and UNBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton KE, 2017, ECOL LETT, V20, P403, DOI 10.1111/ele.12744; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BORDEN JH, 1987, CAN J FOREST RES, V17, P118, DOI 10.1139/x87-023; Borden JH, 2008, J ECON ENTOMOL, V101, P1266, DOI 10.1603/0022-0493(2008)101[1266:SBOMFA]2.0.CO;2; Burke JL, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1778; Burleigh J., 2014, FIELD GUIDE FOREST D; BYERS JA, 1983, SCIENCE, V220, P624, DOI 10.1126/science.220.4597.624; Carroll AL, 2004, PACIF FOR C, V399, P223; CEREZKE H F, 1972, Canadian Journal of Forest Research, V2, P11, DOI 10.1139/x72-003; Clark EL, 2012, ENVIRON ENTOMOL, V41, P392, DOI 10.1603/EN11295; Clark EL, 2014, PEERJ, V2, DOI 10.7717/peerj.240; Clark EL, 2010, CAN ENTOMOL, V142, P557, DOI 10.4039/n10-022; CONN JE, 1983, CAN J FOREST RES, V13, P320, DOI 10.1139/x83-045; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; CROTEAU R, 1981, PLANT PHYSIOL, V67, P820, DOI 10.1104/pp.67.4.820; Cudmore TJ, 2010, J APPL ECOL, V47, P1036, DOI 10.1111/j.1365-2664.2010.01848.x; Erbilgin N, 2000, J CHEM ECOL, V26, P2527, DOI 10.1023/A:1005532612117; Erbilgin N, 2017, OECOLOGIA, V184, P469, DOI 10.1007/s00442-017-3865-9; Feng YJ, 2012, J CHEM ECOL, V38, P984, DOI 10.1007/s10886-012-0155-1; Ferrenberg S, 2014, OECOLOGIA, V174, P1283, DOI 10.1007/s00442-013-2841-2; GIJZEN M, 1993, ACS SYM SER, V525, P8; Gould N, 2008, CAN J FOREST RES, V38, P677, DOI 10.1139/X07-193; Harborne J.B., 1999, CHEM PLANTS, V26, P1, DOI DOI 10.1142/9789812817273_0001; Heijari J, 2005, ENTOMOL EXP APPL, V115, P117, DOI 10.1111/j.1570-7458.2005.00263.x; HOBSON KR, 1993, J CHEM ECOL, V19, P1837, DOI 10.1007/BF00983790; Huber DPW, 2005, TREE PHYSIOL, V25, P1075, DOI 10.1093/treephys/25.8.1075; Hudgins JW, 2004, TREE PHYSIOL, V24, P251, DOI 10.1093/treephys/24.3.251; Hudgins JW, 2003, TREE PHYSIOL, V23, P361, DOI 10.1093/treephys/23.6.361; HYNUM BG, 1980, CAN ENTOMOL, V112, P185, DOI 10.4039/Ent112185-2; Kannaste A., 2008, THESIS; KLIMETZEK D, 1980, EXPERIENTIA, V36, P1343, DOI 10.1007/BF01960087; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LOTAN JE, 1967, FOREST SCI, V13, P55; Maclauchlan L. E., 2015, Journal of Ecosystems and Management, V15, punpaginated; Michelozzi M, 1999, ACTA BOT GALLICA, V146, P73, DOI 10.1080/12538078.1999.10515803; MOECK HA, 1991, CAN ENTOMOL, V123, P299, DOI 10.4039/Ent123299-2; Ott DS, 2011, J CHEM ECOL, V37, P1002, DOI 10.1007/s10886-011-0003-8; PITMAN GB, 1969, CAN ENTOMOL, V101, P143, DOI 10.4039/Ent101143-2; Pureswaran DS, 2004, BIOCHEM SYST ECOL, V32, P1109, DOI 10.1016/j.bse.2004.04.006; R Core Team, 2021, R LANGUAGE ENV STAT; RAFFA KF, 1983, CAN ENTOMOL, V115, P723, DOI 10.4039/Ent115723-7; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; REID RW, 1967, CAN J BOTANY, V45, P1115, DOI 10.1139/b67-116; RENWICK JAA, 1976, SCIENCE, V191, P199, DOI 10.1126/science.1246609; Safranyik L., 2006, The mountain pine beetle: a synthesis of biology, management and impacts on lodgepole pine; Saint-Germain M, 2007, AGR FOREST ENTOMOL, V9, P227, DOI 10.1111/j.1461-9563.2007.00337.x; Sampedro L, 2011, PLANT ECOL, V212, P397, DOI 10.1007/s11258-010-9830-x; SEYBOLD SJ, 1993, J CHEM ECOL, V19, P1809, DOI 10.1007/BF00982310; Venables WN., 2002, MODERN APPL STAT S, V4; Wallis C, 2008, NEW PHYTOL, V177, P767, DOI 10.1111/j.1469-8137.2007.02307.x; Wallis CM, 2010, CAN J FOREST RES, V40, P2333, DOI 10.1139/X10-178; Whitehill JGA, 2016, PLANT CELL ENVIRON, V39, P1646, DOI 10.1111/pce.12654; WOOD DL, 1976, SCIENCE, V192, P896, DOI 10.1126/science.1273574; Yanchuk AD, 2008, TREE GENET GENOMES, V4, P171, DOI 10.1007/s11295-007-0098-9	54	3	3	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0196063	10.1371/journal.pone.0196063	http://dx.doi.org/10.1371/journal.pone.0196063			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758027	Green Published, gold, Green Submitted			2022-12-26	WOS:000432082900006
J	Manoharan, VK; Varghese, BP; Paldurai, A; Samal, SK				Manoharan, Vinoth K.; Varghese, Berin P.; Paldurai, Anandan; Samal, Siba K.			Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine	PLOS ONE			English	Article							INCREASED REPLICATION; REVERSE GENETICS; F-PROTEIN; EFFICACY; CHALLENGE; CHICKENS; STRAINS; PARAMYXOVIRUSES; CANDIDATE; VIRULENCE	Newcastle disease (ND) causes severe economic loss to poultry industry worldwide. Frequent outbreaks of ND in commercial chickens vaccinated with live vaccines suggest a need to develop improved vaccines that are genetically matched against circulating Newcastle disease virus (NDV) strains. In this study, the fusion protein cleavage site (FPCS) sequence of NDV strain Banjarmasin/010 (Banj), a genotype VII NDV, was individually modified using primer mutagenesis to those of avian paramyxovirus (APMV) serotypes 2, 7 and 8 and compared with the recombinant Banjarmasin (rBanj) with avirulent NDV LaSota cleavage site (rBanj-LaSota). These FPCS mutations changed the in vitro cell-to-cell fusion activity and made rBanj FPCS mutant viruses highly attenuated in chickens. When chickens immunized with the rBanj FPCS mutant viruses and challenged with the virulent Banj, there was reduced challenge virus shedding observed compared to chickens immunized with the heterologous vaccine strain LaSota. Among the genotype VII NDV Banj vaccine candidates, rBanj-LaSota and rBanj containing FPCS of APMV-8 induced highest neutralizing antibody titers and protected chickens with reduced challenge virus shedding. These results show the effect of the F protein cleavage site sequence in generating genotype VII matched NDV vaccines.	[Manoharan, Vinoth K.; Varghese, Berin P.; Paldurai, Anandan; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Samal, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu		parambethu varghese, Berin/0000-0002-7819-9086				Abolnik C, 2004, ARCH VIROL, V149, P603, DOI 10.1007/s00705-003-0218-2; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Alexander DJ, 1997, DIS POULTRY, P541; Cardenas-Garcia S, 2015, BIOLOGICALS, V43, P136, DOI 10.1016/j.biologicals.2014.11.003; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Herczeg J, 1999, ARCH VIROL, V144, P2087, DOI 10.1007/s007050050624; Hu SL, 2009, VACCINE, V27, P904, DOI 10.1016/j.vaccine.2008.11.091; Hu ZL, 2011, AVIAN DIS, V55, P391, DOI 10.1637/9633-122410-Reg.1; Huang ZH, 2001, J GEN VIROL, V82, P1729, DOI 10.1099/0022-1317-82-7-1729; Jeon WJ, 2008, J VET SCI, V9, P295, DOI 10.4142/jvs.2008.9.3.295; Kim S. C., 2013, PLOS ONE, V8; Kim SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173965; Liu MM, 2015, BIOTECHNOL LETT, V37, P1287, DOI 10.1007/s10529-015-1799-z; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Manoharan VK, 2016, J GEN VIROL, V97, P287, DOI 10.1099/jgv.0.000350; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2013, DEV COMP IMMUNOL, V41, P505, DOI 10.1016/j.dci.2013.06.007; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; *OIE, 2009, TERR MAN; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roohani K, 2015, J VET SCI, V16, P447, DOI 10.4142/jvs.2015.16.4.447; Samal SK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P69; SCHEID A, 1977, VIROLOGY, V80, P54, DOI 10.1016/0042-6822(77)90380-4; Susta L, 2015, VET PATHOL, V52, P120, DOI 10.1177/0300985814521247; Tirumurugaan KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028414; Xiao S, 2012, PLOS ONE, V7; Xiao S, 2012, J VIROL, V86, P3828, DOI 10.1128/JVI.06765-11; Zhang R, 2010, VET MICROBIOL, V141, P246, DOI 10.1016/j.vetmic.2009.09.020	29	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197253	10.1371/journal.pone.0197253	http://dx.doi.org/10.1371/journal.pone.0197253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758054	Green Submitted, Green Published, gold			2022-12-26	WOS:000432082900038
J	Marley, KB; Kuehn, LA; Keele, JW; Wileman, BW; Gonda, MG				Marley, Kara B.; Kuehn, Larry A.; Keele, John W.; Wileman, Benjamin W.; Gonda, Michael G.			Genetic variation in humoral response to an Escherichia coli O157:H7 vaccine in beef cattle	PLOS ONE			English	Article							GENOMIC PREDICTION; IMMUNE-RESPONSE; SEQUENCE DATA; ACCURACY; DISEASE; VARIABILITY; SELECTION; EFFICACY	Individuals often respond differently to the same vaccine; some of this variation may be caused by genetic differences among animals. Our objective was to estimate heritability and identify genomic regions associated with humoral response to an Escherichia coli O157:H7 vaccine in beef cattle. Crossbred beef cattle (n = 651) were vaccinated with a commercially available E. coli O157:H7 vaccine. Serum was collected at time of initial vaccination (d 0), booster (d 21), and d 56 after initial vaccination. Total antibodies specific to siderophore receptor and porin proteins in the vaccine were quantified by enzyme-linked immunosorbent assay. Genomic DNA was isolated from whole blood and genotyped with the bovine Gene-Seek Genomic Profiler-High Density 78K or 26K Single Nucleotide Polymorphism BeadChip and imputed to 777,000 SNP genotypes. Heritability was estimated by restricted maximum likelihood (REML) using both 1) pedigree and 2) genomic relationships among individuals. Fixed effects were contemporary group, calf age, sex, principal components from SNP genotype data, and pedigree-derived heterozygosity effects. Additive and dominance effects of SNPs were estimated individually while accounting for contemporary group, sex, and the top 20 principal components calculated from the genomic relationship matrix. Heritability of initial response to vaccination (d 21 -d 0) was 0.10 +/- 0.175 using pedigree relationships and 0.14 +/- 0.149 using genomic relationships, but neither estimate was statistically different from zero. Heritability of booster (d 56 -d 21) and overall (d 56 -d 0) responses were low and not statistically significant from zero. There were no clusters of linked SNP associated with vaccine response, but eight regionally isolated SNPs were significantly associated with initial or overall response to vaccination. Regional genetic variation for initial response to an E. coli O157:H7 vaccine was observed, although overall heritability of this response was not statistically significant from zero.	[Marley, Kara B.; Gonda, Michael G.] South Dakota State Univ, Dept Anim Sci, Brookings, SD 57007 USA; [Kuehn, Larry A.; Keele, John W.] USDA, Meat Anim Res Ctr, Clay Ctr, NE 68933 USA; [Wileman, Benjamin W.] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA	South Dakota State University; United States Department of Agriculture (USDA); Kansas State University	Gonda, MG (corresponding author), South Dakota State Univ, Dept Anim Sci, Brookings, SD 57007 USA.	Michael.Gonda@sdstate.edu		Gonda, Michael/0000-0003-1776-1335; Kuehn, Larry/0000-0002-7573-5365	South Dakota Beef Industry Council; USDA-NIFA; Epitopix, Inc.	South Dakota Beef Industry Council; USDA-NIFA(United States Department of Agriculture (USDA)); Epitopix, Inc.	This research was funded by the South Dakota Beef Industry Council and through USDA-NIFA Hatch funds. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Epitopix, Inc. provided support in the form of salary for author BW but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Adler M, 2015, PHYSIOL GENOMICS, V47, P470, DOI 10.1152/physiolgenomics.00015.2015; Baxter R, 2009, VACCINE, V28, P28, DOI 10.1016/j.vaccine.2009.09.131; Chu AY, 2016, NAT GENET, DOI [10.1038/ng.3738, DOI 10.1038/NG.3738PMID:27918534]; Daetwyler HD, 2012, J ANIM SCI, V90, P3375, DOI 10.2527/jas.2011-4557; Fox JT, 2009, FOODBORNE PATHOG DIS, V6, P893, DOI 10.1089/fpd.2009.0336; Glass EJ, 2012, VET IMMUNOL IMMUNOP, V148, P90, DOI 10.1016/j.vetimm.2011.05.009; Gowane GR, 2013, RES VET SCI, V95, P156, DOI 10.1016/j.rvsc.2013.03.001; Klein NP, 2007, PEDIATR INFECT DIS J, V26, P300, DOI 10.1097/01.inf.0000257454.74513.07; Leach RJ, 2013, J ANIM SCI, V91, P3564, DOI 10.2527/jas.2012-5911; Leach RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033526; Leach RJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-107; Lee YC, 2006, VACCINE, V24, P5335, DOI 10.1016/j.vaccine.2006.04.021; Lwelamira J, 2009, TROP ANIM HEALTH PRO, V41, P51, DOI 10.1007/s11250-008-9153-2; MacLeod IM, 2014, GENETICS, V198, P1671, DOI 10.1534/genetics.114.168344; Mentzer AJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0341; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; O'Neill RG, 2006, VACCINE, V24, P4007, DOI 10.1016/j.vaccine.2005.11.049; Posteraro B, 2014, VACCINE, V32, P1661, DOI 10.1016/j.vaccine.2014.01.057; Snelling WM, 2015, J ANIM SCI, V93, P5128, DOI 10.2527/jas.2015-9356; Turner SD, 2014, BIORXIV, DOI 10. 1101/005165 , 2014 .; VanRaden PM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0243-7; Varela NP, 2013, ZOONOSES PUBLIC HLTH, V60, P253, DOI 10.1111/j.1863-2378.2012.01523.x; Visscher PM, 2015, GENETICS, V199, P223, DOI 10.1534/genetics.114.171017; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Wheeler TL, PRELIMINARY RESULTS	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197347	10.1371/journal.pone.0197347	http://dx.doi.org/10.1371/journal.pone.0197347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758060	Green Submitted, Green Published, gold			2022-12-26	WOS:000432082900042
J	Sung, MW; Shaik, R; TerBush, AD; Osteryoung, KW; Vitha, S; Holzenburg, A				Sung, Min Woo; Shaik, Rahamthulla; TerBush, Allan D.; Osteryoung, Katherine W.; Vitha, Stanislav; Holzenburg, Andreas			The chloroplast division protein ARC6 acts to inhibit disassembly of GDP-bound FtsZ2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; cytoskeleton; GTPase; single particle analysis; structural model; Arabidopsis; chloroplast division	PLASTID DIVISION; ESCHERICHIA-COLI; ASSEMBLY DYNAMICS; FLUORESCENCE RECOVERY; GENE FAMILIES; CELL; RING; ARABIDOPSIS; GTP; IDENTIFICATION	Chloroplasts host photosynthesis and fulfill other metabolic functions that are essential to plant life. They have to divide by binary fission to maintain their numbers throughout cycles of cell division. Chloroplast division is achieved by a complex ring-shaped division machinery located on both the inner (stromal) and the outer (cytosolic) side of the chloroplast envelope. The inner division ring (termed the Z ring) is formed by the assembly of tubulin-like FtsZ1 and FtsZ2 proteins. ARC6 is a key chloroplast division protein that interacts with the Z ring. ARC6 spans the inner envelope membrane, is known to stabilize or maintain the Z ring, and anchors the Z ring to the inner membrane through interaction with FtsZ2. The underlying mechanism of Z ring stabilization is not well-understood. Here, biochemical and structural characterization of ARC6 was conducted using light scattering, sedimentation, and light and transmission EM. The recombinant protein was purified as a dimer. The results indicated that a truncated form of ARC6 (tARC6), representing the stromal portion of ARC6, affects FtsZ2 assembly without forming higher-order structures and exerts its effect via FtsZ2 dynamics. tARC6 prevented GDP-induced FtsZ2 disassembly and caused a significant net increase in FtsZ2 assembly when GDP was present. Single particle analysis and 3D reconstruction were performed to elucidate the structural basis of ARC6 activity. Together, the data reveal that a dimeric form of tARC6 binds to FtsZ2 filaments and does not increase FtsZ polymerization rates but rather inhibits GDP-associated FtsZ2 disassembly.	[Sung, Min Woo; Shaik, Rahamthulla; Holzenburg, Andreas] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [TerBush, Allan D.] Michigan State Univ, Biochem & Mol Biol Grad Program, E Lansing, MI 48824 USA; [TerBush, Allan D.; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Vitha, Stanislav; Holzenburg, Andreas] Texas A&M Univ, Microscopy & Imaging Ctr, 301 Old Main Dr, College Stn, TX 77843 USA; [Holzenburg, Andreas] Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Brownsville, TX 78550 USA; [Holzenburg, Andreas] Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Edinburg, TX 78550 USA; [Holzenburg, Andreas] Univ Texas Rio Grande Valley, Sch Med, Dept Biomed Sci, Harlingen, TX 78550 USA	Texas A&M University System; Texas A&M University College Station; Michigan State University; Michigan State University; Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley	Vitha, S (corresponding author), Texas A&M Univ, Microscopy & Imaging Ctr, 301 Old Main Dr, College Stn, TX 77843 USA.	vitha@tamu.edu	Shaik, Rahamthulla/AAP-5107-2020	Vitha, Stanislav/0000-0003-3262-8399	National Science Foundation [MCB-1121943, MCB-1719376]	National Science Foundation(National Science Foundation (NSF))	Supported by National Science Foundation Grants MCB-1121943 and MCB-1719376 (to K. W. O.).	Ajjawi I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025368; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Andreu JM, 2004, MOLECULES IN TIME AND SPACE: BACTERIAL SHAPE, DIVISON AND PHYLOGENY, P133, DOI 10.1007/0-306-48579-6_7; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03983-4; Chen YD, 2011, BIOCHEMISTRY-US, V50, P4675, DOI 10.1021/bi200106d; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Colletti KS, 2000, CURR BIOL, V10, P507, DOI 10.1016/S0960-9822(00)00466-8; Du SS, 2015, MOL MICROBIOL, V95, P173, DOI 10.1111/mmi.12854; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; El-Kafafi ES, 2005, BIOCHEM J, V387, P669, DOI 10.1042/BJ20041281; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Glynn JM, 2008, PLANT CELL, V20, P2460, DOI 10.1105/tpc.108.061440; Glynn JM, 2009, PLANT J, V59, P700, DOI 10.1111/j.1365-313X.2009.03905.x; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Huecas S, 2004, FEBS LETT, V569, P43, DOI 10.1016/j.febslet.2004.05.048; Irieda H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03698-6; Itoh R, 2001, PLANT PHYSIOL, V127, P1644, DOI 10.1104/pp.010386; Johnson CB, 2015, MICROSC MICROANAL, V21, P313, DOI 10.1017/S1431927615000082; Johnson CB, 2013, MICROSC MICROANAL, V19, P507, DOI 10.1017/S143192761300038X; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koksharova OA, 2002, J BACTERIOL, V184, P5524, DOI 10.1128/JB.184.19.5524-5528.2002; Krol E., 2013, JOVE-J VIS EXP, V2013; Kuchibhatla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028262; Li Y, 2013, SCIENCE, V341, P392, DOI 10.1126/science.1239248; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUTKENHAUS J, 1993, MOL MICROBIOL, V9, P403, DOI 10.1111/j.1365-2958.1993.tb01701.x; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Maple J, 2007, EMBO REP, V8, P293, DOI 10.1038/sj.embor.7400902; Marbouty M, 2009, MOL MICROBIOL, V74, P409, DOI 10.1111/j.1365-2958.2009.06873.x; Martin W, 1999, EUR J PHYCOL, V34, P287, DOI 10.1017/S0967026299002231; Mazouni K, 2004, MOL MICROBIOL, V52, P1145, DOI 10.1111/j.1365-2958.2004.04042.x; McAndrew RS, 2008, BIOCHEM J, V412, P367, DOI 10.1042/BJ20071354; Miyagishima S, 2003, PLANT CELL, V15, P655, DOI 10.1105/tpc.009373; Miyagishima SY, 2004, J MOL EVOL, V58, P291, DOI 10.1007/s00239-003-2551-1; Modi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115918; Nakanishi H, 2009, CURR BIOL, V19, P151, DOI 10.1016/j.cub.2008.12.018; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Okazaki K, 2010, PLANT SIGNAL BEHAV, V5, P164, DOI 10.4161/psb.5.2.10461; Olson BJSC, 2010, J BIOL CHEM, V285, P20634, DOI 10.1074/jbc.M110.122614; Osteryoung KW, 2014, ANNU REV PLANT BIOL, V65, P443, DOI 10.1146/annurev-arplant-050213-035748; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Osteryoung KW, 2001, ANNU REV PLANT PHYS, V52, P315, DOI 10.1146/annurev.arplant.52.1.315; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PYKE KA, 1994, PLANT PHYSIOL, V106, P1169, DOI 10.1104/pp.106.3.1169; Rabut G., 2005, LIVE CELL IMAGING LA, P101; ROBINSON SP, 1983, PLANT PHYSIOL, V73, P238, DOI 10.1104/pp.73.2.238; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz AJ, 2009, MOL PLANT, V2, P1211, DOI 10.1093/mp/ssp077; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shimada H, 2004, PLANT CELL PHYSIOL, V45, P960, DOI 10.1093/pcp/pch130; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Smith AG, 2011, ARCH BIOCHEM BIOPHYS, V513, P94, DOI 10.1016/j.abb.2011.07.001; Smith AG, 2010, FEBS LETT, V584, P166, DOI 10.1016/j.febslet.2009.11.044; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stokes KD, 2003, GENE, V320, P97, DOI 10.1016/S0378-1119(03)00814-X; Stokes KD, 2000, PLANT PHYSIOL, V124, P1668, DOI 10.1104/pp.124.4.1668; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; TerBush AD, 2018, PLANT PHYSIOL, V176, P295, DOI 10.1104/pp.17.00558; TerBush AD, 2016, MICROSC MICROANAL, V22, P275, DOI 10.1017/S1431927616000143; TerBush AD, 2013, CURR OPIN CELL BIOL, V25, P461, DOI 10.1016/j.ceb.2013.04.006; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; Tian L, 2014, CURR OPIN PLANT BIOL, V22, P77, DOI 10.1016/j.pbi.2014.09.007; VALENTINE RC, 1968, BIOCHEMISTRY-US, V7, P2143, DOI 10.1021/bi00846a017; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Wang L, 2017, J PLANT BIOL, V60, P154, DOI 10.1007/s12374-016-0418-4; Wang WH, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.11; Yoshida Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.95, 10.1038/nplants.2016.95]; Zhang M, 2016, PLANT PHYSIOL, V170, P250, DOI 10.1104/pp.15.01460; Zhang M, 2013, PLANT CELL, V25, P1787, DOI 10.1105/tpc.113.111047; Zhang M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-101	85	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10692	10706		10.1074/jbc.RA117.000999	http://dx.doi.org/10.1074/jbc.RA117.000999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29769312	Green Published, hybrid			2022-12-26	WOS:000437828400025
J	Tiedt, O; Fuchs, J; Eisenreich, W; Boll, M				Tiedt, Oliver; Fuchs, Jonathan; Eisenreich, Wolfgang; Boll, Matthias			A catalytically versatile benzoyl-CoA reductase, key enzyme in the degradation of methyl- and halobenzoates in denitrifying bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biodegradation; radical; enzyme mechanism; coenzyme A (CoA); reductase; aromatic metabolism; benzoyl-coenzyme A; Birch reduction; enzymatic dehalogenation	ANAEROBIC AROMATIC METABOLISM; ARCHAEON FERROGLOBUS-PLACIDUS; THAUERA-AROMATICA; 4-HYDROXYBENZOYL-COA REDUCTASE; CLOSTRIDIUM-DIFFICILE; ELECTRON-ACCEPTORS; COENZYME; DEHALOGENASE; DEHYDRATASE; MECHANISM	Class I benzoyl-CoA (BzCoA) reductases (BCRs) are key enzymes in the anaerobic degradation of aromatic compounds. They catalyze the ATP-dependent reduction of the central BzCoA intermediate and analogues of it to conjugated cyclic 1,5-dienoyl-CoAs probably by a radical-based, Birch-like reduction mechanism. Discovered in 1995, the enzyme from the denitrifying bacterium Thauera aromatica (BCRTar) has so far remained the only isolated and biochemically accessible BCR, mainly because BCRs are extremely labile, and their heterologous production has largely failed so far. Here, we describe a platform for the heterologous expression of the four structural genes encoding a designated 3-methylbenzoyl-CoA reductase from the related denitrifying species Thauera chlorobenzoica (MBRTcl) in Escherichia coli. This reductase represents the prototype of a distinct subclass of ATP-dependent BCRs that were proposed to be involved in the degradation of methyl-substituted BzCoA analogues. The recombinant MBRTcl had an -subunit architecture, contained three low-potential [4Fe-4S] clusters, and was highly oxygen-labile. It catalyzed the ATP-dependent reductive dearomatization of BzCoA with 2.3-2.8 ATPs hydrolyzed per two electrons transferred and preferentially dearomatized methyl- and chloro-substituted analogues in meta- and para-positions. NMR analyses revealed that 3-methylbenzoyl-CoA is regioselectively reduced to 3-methyl-1,5-dienoyl-CoA. The unprecedented reductive dechlorination of 4-chloro-BzCoA to BzCoA probably via HCl elimination from a reduced intermediate allowed for the previously unreported growth of T. chlorobenzoica on 4-chlorobenzoate. The heterologous expression platform established in this work enables the production, isolation, and characterization of bacterial and archaeal BCR and BCR-like radical enzymes, for many of which the function has remained unknown.	[Tiedt, Oliver; Fuchs, Jonathan; Boll, Matthias] Albert Ludwigs Univ Freiburg, Fak Biol Mikrobiol, D-79104 Freiburg, Germany; [Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, D-85747 Garching, Germany	University of Freiburg; Technical University of Munich	Boll, M (corresponding author), Fac Biol, Inst Biol 2, Schanzlestr 1, D-79104 Freiburg, Germany.	matthias.boll@biologie.uni-freiburg.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279	German Research Foundation, Deutsche Forschungsgemeinschaft [BO 1565/14-1]	German Research Foundation, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft Project BO 1565/14-1. The authors declare that they have no conflicts of interest with the contents of this article.	Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; BIEGERT T, 1993, EUR J BIOCHEM, V213, P555, DOI 10.1111/j.1432-1033.1993.tb17794.x; Blanksby SJ, 2003, ACCOUNTS CHEM RES, V36, P255, DOI 10.1021/ar020230d; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; Boll M, 2000, J BIOL CHEM, V275, P21889, DOI 10.1074/jbc.M001833200; Boll M, 2005, BBA-BIOENERGETICS, V1707, P34, DOI 10.1016/j.bbabio.2004.01.009; Boll M, 2001, J BIOL CHEM, V276, P47853, DOI 10.1074/jbc.M106766200; Boll M, 1997, EUR J BIOCHEM, V244, P840, DOI 10.1111/j.1432-1033.1997.00840.x; Boll M, 1998, EUR J BIOCHEM, V251, P946, DOI 10.1046/j.1432-1327.1998.2510946.x; Boll M, 2000, J BIOL CHEM, V275, P31857, DOI 10.1074/jbc.M001508200; Boll M, 2014, ENVIRON MICROBIOL, V16, P612, DOI 10.1111/1462-2920.12328; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breese K, 1998, EUR J BIOCHEM, V256, P148, DOI 10.1046/j.1432-1327.1998.2560148.x; Buckel W, 2014, CHEMBIOCHEM, V15, P2188, DOI 10.1002/cbic.201402270; Buckel W, 2012, BBA-PROTEINS PROTEOM, V1824, P1278, DOI 10.1016/j.bbapap.2011.11.009; Chae JC, 2008, FEMS MICROBIOL LETT, V281, P203, DOI 10.1111/j.1574-6968.2008.01106.x; CHANG KH, 1992, BIOCHEMISTRY-US, V31, P5605, DOI 10.1021/bi00139a025; CROOKS GP, 1995, J AM CHEM SOC, V117, P10791, DOI 10.1021/ja00149a001; Dagley S, 1971, Adv Microb Physiol, V6, P1, DOI 10.1016/S0065-2911(08)60066-1; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; Dong J, 2003, BIOCHEMISTRY-US, V42, P9482, DOI 10.1021/bi0347656; Dong J, 2002, BIOCHEMISTRY-US, V41, P7453, DOI 10.1021/bi020186+; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; HAGGBLOM MM, 1993, APPL ENVIRON MICROB, V59, P1162; Haggblom MM, 1996, FEMS MICROBIOL LETT, V144, P213, DOI 10.1111/j.1574-6968.1996.tb08533.x; Jeoung JH, 2018, P NATL ACAD SCI USA, V115, P2994, DOI 10.1073/pnas.1720489115; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joshi S, 2017, J AM CHEM SOC, V139, P10952, DOI 10.1021/jacs.7b04209; Juarez JF, 2013, ENVIRON MICROBIOL, V15, P148, DOI 10.1111/j.1462-2920.2012.02818.x; KAZUMI J, 1995, APPL MICROBIOL BIOT, V43, P929, DOI 10.1007/BF02431930; Kim J, 2005, FEBS J, V272, P550, DOI 10.1111/j.1742-4658.2004.04498.x; Kim J, 2010, CHEMPHYSCHEM, V11, P1307, DOI 10.1002/cphc.200900876; Knauer SH, 2012, BIOCHEMISTRY-US, V51, P6609, DOI 10.1021/bi300571z; Knauer SH, 2011, J AM CHEM SOC, V133, P4342, DOI 10.1021/ja1076537; Kung JW, 2010, J AM CHEM SOC, V132, P9850, DOI 10.1021/ja103448u; Kung JW, 2009, P NATL ACAD SCI USA, V106, P17687, DOI 10.1073/pnas.0905073106; Kuntze K, 2011, MOL MICROBIOL, V82, P758, DOI 10.1111/j.1365-2958.2011.07856.x; Lahme S, 2012, ENVIRON MICROBIOL, V14, P1118, DOI 10.1111/j.1462-2920.2011.02693.x; Lau EY, 2001, P NATL ACAD SCI USA, V98, P9527, DOI 10.1073/pnas.161282698; Loffler C, 2011, ENVIRON MICROBIOL, V13, P696, DOI 10.1111/j.1462-2920.2010.02374.x; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Mobitz H, 2004, BIOCHEMISTRY-US, V43, P1376, DOI 10.1021/bi0358871; Mobitz H, 2002, BIOCHEMISTRY-US, V41, P1752, DOI 10.1021/bi0113770; Peters JE, 2003, J BACTERIOL, V185, P2017, DOI 10.1128/JB.185.6.2017-2021.2003; PFENNIG N, 1978, INT J SYST BACTERIOL, V28, P283, DOI 10.1099/00207713-28-2-283; Rabideau PW., 1992, ORG REACT, V48, P1, DOI DOI 10.1002/0471264180.or042.01; SCHACHTER D, 1953, J BIOL CHEM, V203, P925; Schmid G, 2016, BIOCHEMISTRY-US, V55, P5578, DOI 10.1021/acs.biochem.6b00729; Schmid G, 2015, ENVIRON MICROBIOL, V17, P3289, DOI 10.1111/1462-2920.12785; Song B, 2002, FEMS MICROBIOL LETT, V213, P183, DOI 10.1111/j.1574-6968.2002.tb11303.x; Song B, 2000, INT J SYST EVOL MICR, V50, P551, DOI 10.1099/00207713-50-2-551; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Thiele B, 2008, J AM CHEM SOC, V130, P14050, DOI 10.1021/ja805091w; Thiele B, 2008, J BIOL CHEM, V283, P20713, DOI 10.1074/jbc.M802841200; Tiedt O, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02579; Tiedt O, 2016, MBIO, V7, DOI 10.1128/mBio.00990-16; TSCHECH A, 1984, ARCH MICROBIOL, V137, P163, DOI 10.1007/BF00414460; Unciuleac M, 2004, STRUCTURE, V12, P2249, DOI 10.1016/j.str.2004.10.008; Unciuleac M, 2001, P NATL ACAD SCI USA, V98, P13619, DOI 10.1073/pnas.241375598; Weinert T, 2015, NAT CHEM BIOL, V11, P586, DOI 10.1038/nchembio.1849; Yamamoto S, 2006, IUBMB LIFE, V58, P248, DOI 10.1080/15216540600719655	63	13	13	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10264	10274		10.1074/jbc.RA118.003329	http://dx.doi.org/10.1074/jbc.RA118.003329			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29769313	Green Published, hybrid			2022-12-26	WOS:000437096700025
J	Montesinos-Navarro, A; Estrada, A; Font, X; Matias, MG; Meireles, C; Mendoza, M; Honrado, JP; Prasad, HD; Vicente, JR; Early, R				Montesinos-Navarro, Alicia; Estrada, Alba; Font, Xavier; Matias, Miguel G.; Meireles, Catarina; Mendoza, Manuel; Honrado, Joao P.; Prasad, Hari D.; Vicente, Joana R.; Early, Regan			Community structure informs species geographic distributions	PLOS ONE			English	Article							BAYESIAN NETWORK MODEL; BIOTIC INTERACTIONS; FACILITATION; INFERENCE; COOCCURRENCE; ASSEMBLAGES; MANAGEMENT; DIVERSITY; EVOLUTION; DYNAMICS	Understanding what determines species' geographic distributions is crucial for assessing global change threats to biodiversity. Measuring limits on distributions is usually, and necessarily, done with data at large geographic extents and coarse spatial resolution. However, survival of individuals is determined by processes that happen at small spatial scales. The relative abundance of coexisting species (i.e. 'community structure') reflects assembly processes occurring at small scales, and are often available for relatively extensive areas, so could be useful for explaining species distributions. We demonstrate that Bayesian Network Inference (BNI) can overcome several challenges to including community structure into studies of species distributions, despite having been little used to date. We hypothesized that the relative abundance of coexisting species can improve predictions of species distributions. In 1570 assemblages of 68 Mediterranean woody plant species we used BNI to incorporate community structure into Species Distribution Models (SDMs), alongside environmental information. Information on species associations improved SDM predictions of community structure and species distributions moderately, though for some habitat specialists the deviance explained increased by up to 15%. We demonstrate that most species associations (95%) were positive and occurred between species with ecologically similar traits. This suggests that SDM improvement could be because species co-occurrences are a proxy for local ecological processes. Our study shows that Bayesian Networks, when interpreted carefully, can be used to include local conditions into measurements of species' large-scale distributions, and this information can improve the predictions of species distributions.	[Montesinos-Navarro, Alicia; Matias, Miguel G.; Meireles, Catarina; Mendoza, Manuel] Univ Evora, InBIO CIBIO Ctr Invest Biodiversidade & Recursos, Evora, Portugal; [Montesinos-Navarro, Alicia] Spanish Sci Council CSIC, Ctr Invest Desertificac CIDE, CSIC UV GV, Valencia, Spain; [Estrada, Alba] Oviedo Univ, Res Unit Biodivers UMIB, UO CSIC PA, Campus Mieres, Mieres, Spain; [Font, Xavier] Univ Barcelona, Fac Biol, Dept Biol Vegetal, Barcelona, Spain; [Matias, Miguel G.] Imperial Coll London, Ascot, Berks, England; [Mendoza, Manuel] Spanish Sci Council CSIC, Dept Biogeog & Global Change, Natl Museum Nat Hist MNCN, Madrid, Spain; [Honrado, Joao P.; Vicente, Joana R.] Univ Porto, InBIO CIBIO Ctr Invest Biodiversidade & Recursos, Campus Agr Vairao, Vairao, Portugal; [Honrado, Joao P.; Vicente, Joana R.] Univ Porto, Fac Ciencias, Edificio FC4 Biol, Porto, Portugal; [Prasad, Hari D.] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal, Saudi Arabia; [Early, Regan] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Cornwall Campus, Penryn, Cornwall, England	University of Evora; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); Universidade do Porto; Universidade do Porto; King Abdullah University of Science & Technology; University of Exeter	Montesinos-Navarro, A (corresponding author), Univ Evora, InBIO CIBIO Ctr Invest Biodiversidade & Recursos, Evora, Portugal.; Montesinos-Navarro, A (corresponding author), Spanish Sci Council CSIC, Ctr Invest Desertificac CIDE, CSIC UV GV, Valencia, Spain.	ali.montesinos@gmail.com	Meireles, Catarina/Y-3760-2019; Matias, Miguel G/D-4294-2019; DASARI, HARI PRASAD/AAD-5446-2019; Font, Xavier/O-4935-2019; Navarro, Alicia Montesinos/K-6707-2012; Mendoza, Manuel/K-3839-2017; ESTRADA, ALBA/A-9632-2018; Vicente, Joana/L-7434-2013; Honrado, Joao/L-8365-2013	Matias, Miguel G/0000-0001-9198-2051; DASARI, HARI PRASAD/0000-0003-0628-4481; Font, Xavier/0000-0002-7253-8905; Navarro, Alicia Montesinos/0000-0003-4656-0321; ESTRADA, ALBA/0000-0003-2727-1970; Vicente, Joana/0000-0003-0382-0189; Meireles, Catarina/0000-0001-7079-9290; Honrado, Joao/0000-0001-8443-4276	FCT Project "QuerCom" [EXPUAAG-GLO/2488/2013]; ERA-Net BiodivERsA project "EC21C" [BIODIVERSA/0003/2011]; Bolsa de Investigacao de Pos-doutoramento [BI_Pos-Doc_UEvora_Catedra Rui Nabeiro_EXPL_AAG-GL0_2488_2013]; Ministry of Economy and Competitivity [FPDI-2013-16266, IJCI-2015-23498]; Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM); POPH/FSE funds; National Funds through FCT Foundation for Science and Technology under the Portuguese Science Foundation (FCT) [SFRH/BPD/84044/2012]; Principado de Asturias, Spain [CN-17-022]	FCT Project "QuerCom"; ERA-Net BiodivERsA project "EC21C"; Bolsa de Investigacao de Pos-doutoramento; Ministry of Economy and Competitivity; Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM); POPH/FSE funds; National Funds through FCT Foundation for Science and Technology under the Portuguese Science Foundation (FCT); Principado de Asturias, Spain	This work was funded by FCT Project "QuerCom" (EXPUAAG-GLO/2488/2013) and the ERA-Net BiodivERsA project "EC21C" (BIODIVERSA/0003/2011). A.M.N. was supported by a Bolsa de Investigacao de Pos-doutoramento (BI_Pos-Doc_UEvora_Catedra Rui Nabeiro_EXPL_AAG-GL0_2488_2013) and postdoctoral fellowships from the Ministry of Economy and Competitivity (FPDI-2013-16266 and IJCI-2015-23498). MGM acknowledges support by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM). J. Vicente is supported by POPH/FSE funds and by National Funds through FCT Foundation for Science and Technology under the Portuguese Science Foundation (FCT) through Post-doctoral grant SFRH/BPD/84044/2012. AE has a postodoctoral contract funded by the project CN-17-022 (Principado de Asturias, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by FCT Project "QuerCom" (EXPL/AAG-GLO/2488/2013) and the ERA -Net BiodivERsA project "EC21C" (BIODIVERSA/0003/2011). A.M.N. was supported by a Bolsa de Investigacao de Pos-doutoramento (BI_Pos-Doc_UEvora_Catedra Rui Nabeiro_EXPL_AAG-GL0_2488_2013) and postdoctoral fellowships from the Ministry of Economy and Competitivity (FPDI-2013-16266 and IJCI-2015-23498). MGM acknowledges support by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Programme (FORECOMM). J. Vicente is supported by POPH/FSE funds and by National Funds through FCT Foundation for Science and Technology under the Portuguese Science Foundation (FCT) through Post-doctoral grant SFRH/BPD/84044/2012. AE has a postdoctoral contract funded by the project CN-17-022 (Principado de Asturias, Spain). We are grateful to OneGeology for providing the geological data.	Ackerly David D., 2003, International Journal of Plant Sciences, V164, pS165, DOI 10.1086/368401; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Axelrod D. I., 1973, MEDITERRANEAN TYPE E; AXELROD DI, 1975, ANN MO BOT GARD, V62, P280, DOI 10.2307/2395199; Bernard-Verdier M, 2012, J ECOL, V100, P1422, DOI 10.1111/1365-2745.12003; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Callaway R. M., 2007, POSITIVE INTERACTION; Castroviejo S., 1993, FLORA IBERICA, V3; Chai LE, 2014, COMPUT BIOL MED, V48, P55, DOI 10.1016/j.compbiomed.2014.02.011; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Cressie N, 2015, STAT SPATIAL DATA; Darwin C, 1859, ORIGIN SPECIES MEANS; Diamond J.M., 1975, P342; Do Amaral Franco J, 2014, FLORA IBERICA, V16; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Douglas SJ, 2014, J NAT CONSERV, V22, P235, DOI 10.1016/j.jnc.2014.01.004; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Font X, 2010, WALDOKOLOGIE LANDSCH, V9, P15; Goulding R, 2012, WATER RES, V46, P4933, DOI 10.1016/j.watres.2012.03.044; Haemig PD, 2001, BIODIVERS CONSERV, V10, P527, DOI 10.1023/A:1016654326822; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; HERRERA CM, 1992, AM NAT, V140, P421, DOI 10.1086/285420; Herrera CM, 1984, STUDIA OECOLOGICA, V5, P7; Holmes SE, 2010, BIOL INVASIONS, V12, P2303, DOI 10.1007/s10530-009-9645-7; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kissling W.D., 2012, Journal of Biogeography, V39, P2163; Kupfer P, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-40; Kuppuswamy U, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-10; Larsen PE, 2012, NAT METHODS, V9, P621, DOI [10.1038/NMETH.1975, 10.1038/nmeth.1975]; Lenoir J, 2013, GLOBAL CHANGE BIOL, V19, P1470, DOI 10.1111/gcb.12129; Levine JM, 2017, NATURE, V546, P56, DOI 10.1038/nature22898; Marcot BG, 2001, FOREST ECOL MANAG, V153, P29, DOI 10.1016/S0378-1127(01)00452-2; MARSHALL JK, 1965, J ECOL, V53, P447, DOI 10.2307/2257988; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Meier ES, 2010, ECOGRAPHY, V33, P1038, DOI 10.1111/j.1600-0587.2010.06229.x; Meineri E, 2017, ECOGRAPHY, V40, P1003, DOI 10.1111/ecog.02494; Metcalfe DJ, 2005, J ECOL, V93, P632, DOI 10.1111/j.1365-2745.2005.01021.x; Milns I, 2010, ECOLOGY, V91, P1892, DOI 10.1890/09-0731.1; Minchin P.R., 2015, R PACKAGE VERSION, V2, P1; Mori T, 2014, ECOLOGY, V95, P132, DOI 10.1890/13-0914.1; Needham CJ, 2006, NAT BIOTECHNOL, V24, P51, DOI 10.1038/nbt0106-51; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Castillo JP, 2010, ECOLOGY, V91, P3656, DOI 10.1890/10-0720.1; PALAMAREV E, 1989, PLANT SYST EVOL, V162, P93, DOI 10.1007/BF00936912; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pellissier L, 2012, ECOGRAPHY, V35, P684, DOI 10.1111/j.1600-0587.2011.07047.x; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180; Price JN, 2014, FUNCT ECOL, V28, P509, DOI 10.1111/1365-2435.12186; Quinn JL, 2003, ANIM BEHAV, V65, P297, DOI 10.1006/anbe.2003.2063; Ramakrishnan AP, 2010, MOL ECOL, V19, P1134, DOI 10.1111/j.1365-294X.2010.04543.x; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Scott J. M., 2002, PREDICTING SPECIES O; Scutari M., 2014, BAYESIAN NETWORKS EX; Scutari M, 2013, ARTIF INTELL MED, V57, P207, DOI 10.1016/j.artmed.2012.12.006; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Sebastian-Gonzalez E, 2010, P ROY SOC B-BIOL SCI, V277, P2983, DOI 10.1098/rspb.2010.0244; Shafiei M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003918; Skamarock W., 2005, DESCRIPTION ADV RES; Stamps J, 2005, ECOLOGY, V86, P2860, DOI 10.1890/05-0290; Staniczenko P. P. A., 2017, ECOLOGY LETT; Valiente-Banuet A, 2007, ECOL LETT, V10, P1029, DOI 10.1111/j.1461-0248.2007.01100.x; Valiente-Banuet A, 2006, P NATL ACAD SCI USA, V103, P16812, DOI 10.1073/pnas.0604933103; Valiente-Banuet A, 2013, ANNU REV ECOL EVOL S, V44, P347, DOI 10.1146/annurev-ecolsys-110512-135855; Valladares F, 2014, ECOL LETT, V17, P1351, DOI 10.1111/ele.12348; Venable W, 2002, MODERN APPL STAT S P; WEIHER E, 1995, OIKOS, V73, P323, DOI 10.2307/3545956; Wilson AJ, 2013, PREV VET MED, V110, P45, DOI 10.1016/j.prevetmed.2013.02.006; Wilson J., 1999, ECOLOGICAL ASSEMBLY; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	76	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197877	10.1371/journal.pone.0197877	http://dx.doi.org/10.1371/journal.pone.0197877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791491	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000433077000066
J	Pan, Y; Duron, C; Bush, EC; Ma, Y; Sims, PA; Gutmann, DH; Radunskaya, A; Hardin, J				Pan, Yuan; Duron, Christina; Bush, Erin C.; Ma, Yu; Sims, Peter A.; Gutmann, David H.; Radunskaya, Ami; Hardin, Johanna			Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma	PLOS ONE			English	Article							OPTIC-NERVE GLIOMA; EXPRESSION ANALYSIS; MAPK PATHWAY; NEUROFIBROMATOSIS-1; ACTIVATION; INHIBITION; ASTROCYTE; CELLS; GLIOGENESIS; REGULATOR	Conventional differential expression analyses have been successfully employed to identify genes whose levels change across experimental conditions. One limitation of this approach is the inability to discover central regulators that control gene expression networks. In addition, while methods for identifying central nodes in a network are widely implemented, the bioinformatics validation process and the theoretical error estimates that reflect the uncertainty in each step of the analysis are rarely considered. Using the betweenness centrality measure, we identified Etv5 as a potential tissue-level regulator in murine neurofibromatosis type 1 (Nf1) low-grade brain tumors (optic gliomas). As such, the expression of Etv5 and Etv5 target genes were increased in multiple independently-generated mouse optic glioma models relative to non-neoplastic (normal healthy) optic nerves, as well as in the cognate human tumors (pilocytic astrocytoma) relative to normal human brain. Importantly, differential Etv5 and Etv5 network expression was not directly the result of Nf1 gene dysfunction in specific cell types, but rather reflects a property of the tumor as an aggregate tissue. Moreover, this differential Etv5 expression was independently validated at the RNA and protein levels. Taken together, the combined use of network analysis, differential RNA expression findings, and experimental validation highlights the potential of the computational network approach to provide new insights into tumor biology.	[Pan, Yuan; Ma, Yu; Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Duron, Christina] Claremont Grad Univ, Dept Math, Claremont, CA USA; [Bush, Erin C.; Sims, Peter A.] Columbia Univ, Med Ctr, Dept Syst Biol, New York, NY USA; [Bush, Erin C.; Sims, Peter A.] Columbia Univ, Dept Biochem & Mol Biophys, Med Ctr, New York, NY USA; [Radunskaya, Ami; Hardin, Johanna] Pomona Coll, Dept Math, Claremont, CA 91711 USA	Washington University (WUSTL); Claremont Colleges; Claremont Graduate School; Columbia University; Columbia University; Claremont Colleges; Pomona College	Hardin, J (corresponding author), Pomona Coll, Dept Math, Claremont, CA 91711 USA.	jo.hardin@pomona.edu		Gutmann, David/0000-0002-3127-5045; Pan, Yuan/0000-0002-9465-8289; Duron, Christina/0000-0003-2927-3259; Sims, Peter/0000-0002-3921-4837; Radunskaya, Ami/0000-0002-2353-5046	James S. McDonnell Foundation; National Cancer Institute [1R01-CA195692-01]; McDonnell Center fellowship; NATIONAL CANCER INSTITUTE [R01CA214146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097211] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); McDonnell Center fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the James S. McDonnell Foundation (to DHG); and the National Cancer Institute (1R01-CA195692-01 to DHG, AR, and JH). YP was supported by a McDonnell Center fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenaru ML, 2005, ANN NEUROL, V57, P119, DOI 10.1002/ana.20337; Bajenaru ML, 2003, CANCER RES, V63, P8573; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitkreutz D, 2012, P NATL ACAD SCI USA, V109, P9209, DOI 10.1073/pnas.1201416109; Breunig JJ, 2015, CELL REP, V12, P258, DOI 10.1016/j.celrep.2015.06.012; Chen YH, 2015, CELL REP, V10, P1899, DOI 10.1016/j.celrep.2015.02.041; Collins VP, 2015, ACTA NEUROPATHOL, V129, P775, DOI 10.1007/s00401-015-1410-7; Creixell P, 2015, NAT METHODS, V12, P615, DOI [10.1038/nmeth.3440, 10.1038/NMETH.3440]; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; Daginakatte GC, 2008, CANCER RES, V68, P10358, DOI 10.1158/0008-5472.CAN-08-2506; Dasgupta B, 2005, CANCER RES, V65, P236; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Hegedus B, 2008, HUM MOL GENET, V17, P2956, DOI 10.1093/hmg/ddn194; Hegedus B, 2008, CANCER RES, V68, P1520, DOI 10.1158/0008-5472.CAN-07-5916; Henriquez NV, 2013, CANCER RES, V73, P5834, DOI 10.1158/0008-5472.CAN-13-1299; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Kaul A, 2015, NEURO-ONCOLOGY, V17, P843, DOI 10.1093/neuonc/nou329; Kaul A, 2015, NEURO-ONCOLOGY, V17, P670, DOI 10.1093/neuonc/nou287; Kaul A, 2012, GENE DEV, V26, P2561, DOI 10.1101/gad.200907.112; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lachmann A, 2016, BIOINFORMATICS, V32, P2233, DOI 10.1093/bioinformatics/btw216; Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031; Listernick R, 2007, ANN NEUROL, V61, P189, DOI 10.1002/ana.21107; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Manns M, 2005, EUR J NEUROSCI, V22, P2180, DOI 10.1111/j.1460-9568.2005.04410.x; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Narang V, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004504; Pan Y, 2017, ONCOTARGET, V8, P52474, DOI 10.18632/oncotarget.17193; Pan Y, 2017, ONCOTARGET, V8, P32977, DOI 10.18632/oncotarget.16516; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; Power PF, 2013, J ORTHOP RES, V31, P493, DOI 10.1002/jor.22227; Sandsmark DK, 2007, CANCER RES, V67, P4790, DOI 10.1158/0008-5472.CAN-06-4470; Smithson LJ, 2016, GENE DEV, V30, P1383, DOI 10.1101/gad.279661.116; Solga AC, 2017, ONCOTARGET; Solga AC, 2015, NEOPLASIA, V17, P776, DOI 10.1016/j.neo.2015.10.002; Thompson EG, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002583; Toonen JA, HUM MOL GENET; Toonen JA, 2017, NEURO-ONCOLOGY, V19, P808, DOI 10.1093/neuonc/now267; West J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00802; Wong KK, 2005, CANCER RES, V65, P76; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	44	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0190001	10.1371/journal.pone.0190001	http://dx.doi.org/10.1371/journal.pone.0190001			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787563	Green Published, gold, Green Submitted			2022-12-26	WOS:000432785700001
J	Falcone, B; Wada, A; Parasuraman, R; Callan, DE				Falcone, Brian; Wada, Atsushi; Parasuraman, Raja; Callan, Daniel E.			Individual differences in learning correlate with modulation of brain activity induced by transcranial direct current stimulation	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; FUNCTIONAL CONNECTIVITY; PARIETAL CORTEX; CORTICAL EXCITABILITY; ELECTRIC-FIELDS; COLOR CONSTANCY; TDCS; ATTENTION; NETWORKS; POLARIZATION	Transcranial direct current stimulation (tDCS) has been shown to enhance cognitive performance on a variety of tasks. It is hypothesized that tDCS enhances performance by affecting task related cortical excitability changes in networks underlying or connected to the site of stimulation facilitating long term potentiation. However, many recent studies have called into question the reliability and efficacy of tDCS to induce modulatory changes in brain activity. In this study, our goal is to investigate the individual differences in tDCS induced modulatory effects on brain activity related to the degree of enhancement in performance, providing insight into this lack of reliability. In accomplishing this goal, we used functional magnetic resonance imaging (fMRI) concurrently with tDCS stimulation (1 mA, 30 minutes duration) using a visual search task simulating real world conditions. The experiment consisted of three fMRI sessions: pre-training (no performance feedback), training (performance feedback which included response accuracy and target location and either real tDCS or sham stimulation given), and post-training (no performance feedback). The right posterior parietal cortex was selected as the site of anodal tDCS based on its known role in visual search and spatial attention processing. Our results identified a region in the right precentral gyrus, known to be involved with visual spatial attention and orienting, that showed tDCS induced task related changes in cortical excitability that were associated with individual differences in improved performance. This same region showed greater activity during the training session for target feedback of incorrect (target-error feedback) over correct trials for the tDCS stim over sham group indicating greater attention to target features during training feedback when trials were incorrect. These results give important insight into the nature of neural excitability induced by tDCS as it relates to variability in individual differences in improved performance shedding some light the apparent lack of reliability found in tDCS research.	[Falcone, Brian; Parasuraman, Raja] George Mason Univ, Ctr Excellence Neuroergon Technol & Cognit CENTEC, Fairfax, VA 22030 USA; [Wada, Atsushi; Callan, Daniel E.] Osaka Univ, Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, Osaka, Japan	George Mason University; National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Falcone, B (corresponding author), George Mason Univ, Ctr Excellence Neuroergon Technol & Cognit CENTEC, Fairfax, VA 22030 USA.; Callan, DE (corresponding author), Osaka Univ, Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, Osaka, Japan.	BrianLFalcone@gmail.com; dcallan@nict.go.jp		Callan, Daniel/0000-0002-8851-6065	National Institute of Information and Communications Technology; National Science Foundation [1414852]; Japan Society for the Promotion of Science; Air Force Office of Sponsored Research grant [FA9550-10-1-0385]; Japan Society for the Promotion of Science, Kakenhi [18K12024]	National Institute of Information and Communications Technology; National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Air Force Office of Sponsored Research grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Japan Society for the Promotion of Science, Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by National Institute of Information and Communications Technology, DC, AW; National Science Foundation sponsored East Asia and Pacific Summer Institutes fellowship award 1414852, funded in collaboration with Japan Society for the Promotion of Science, BF; Air Force Office of Sponsored Research grant FA9550-10-1-0385, RP; and Japan Society for the Promotion of Science, Kakenhi, Grant Number (18K12024), DC, AW.	Amadi U, 2014, NEUROIMAGE, V88, P155, DOI 10.1016/j.neuroimage.2013.11.037; Antal A, 2012, RESTOR NEUROL NEUROS, V30, P255, DOI 10.3233/RNN-2012-110208; Antal A, 2011, NEUROIMAGE, V55, P590, DOI 10.1016/j.neuroimage.2010.11.085; Barbur JL, 2008, NEUROPSYCHOLOGIA, V46, P853, DOI 10.1016/j.neuropsychologia.2007.11.032; Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Baudewig J, 2001, MAGN RESON MED, V45, P196, DOI 10.1002/1522-2594(200102)45:2<196::AID-MRM1026>3.0.CO;2-1; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; Bolognini N, 2010, BRAIN RES, V1349, P76, DOI 10.1016/j.brainres.2010.06.053; Brunoni AR, 2014, BRAIN COGNITION, V86, P1, DOI 10.1016/j.bandc.2014.01.008; Callan D, NEUROERGONIMCS BRAIN; Callan DE, 2016, FRONTIERS HUMAN NEUR, V10; Clark VP, 2011, NEUROSCI LETT, V500, P67, DOI 10.1016/j.neulet.2011.05.244; Clarke S, 1998, EXP BRAIN RES, V123, P154, DOI 10.1007/s002210050556; Coffman BA, 2014, NEUROIMAGE, V85, P895, DOI 10.1016/j.neuroimage.2013.07.083; Coffman BA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-108; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Coull JT, 1998, J NEUROSCI, V18, P7426; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; Dumoulin SO, 2007, VISION RES, V47, P1608, DOI 10.1016/j.visres.2007.01.031; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eklund A., 2016, P NATL ACAD SCI USA; Ellison A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093767; Falcone B, NEUROERGONIMCS BRAIN; Falcone B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034993; Faria P, 2012, EPILEPSY BEHAV, V25, P417, DOI 10.1016/j.yebeh.2012.06.027; Garcia-Cossio E, 2016, NEUROIMAGE, V140, P33, DOI 10.1016/j.neuroimage.2015.09.068; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Hanley CJ, 2016, NEUROIMAGE, V140, P20, DOI 10.1016/j.neuroimage.2015.12.021; Holland R, 2016, NEUROIMAGE, V140, P126, DOI 10.1016/j.neuroimage.2016.01.037; Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021; Horvath JC, 2015, BRAIN STIMUL, V8, P535, DOI 10.1016/j.brs.2015.01.400; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Hunter MA, 2015, BRAIN RES, V1594, P92, DOI 10.1016/j.brainres.2014.09.066; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jalali R, 2017, J NEUROPHYSIOL, V118, P655, DOI 10.1152/jn.00896.2016; Jefferys JGR, 2003, RADIAT PROT DOSIM, V106, P321, DOI 10.1093/oxfordjournals.rpd.a006367; Keeser D, 2011, J NEUROSCI, V31, P15284, DOI 10.1523/JNEUROSCI.0542-11.2011; KENNARD C, 1995, P ROY SOC B-BIOL SCI, V260, P169, DOI 10.1098/rspb.1995.0076; Khan B, 2013, PROC SPIE, V8565, DOI 10.1117/12.2003446; Kim CR, 2012, BRAIN STIMUL, V5, P462, DOI 10.1016/j.brs.2011.08.002; Ko MH, 2008, NEUROSCI LETT, V448, P171, DOI 10.1016/j.neulet.2008.10.050; Krishnamurthy V, 2015, NEUROSCI LETT, V604, P80, DOI 10.1016/j.neulet.2015.07.042; Kwon YH, 2011, NEUROSCI LETT, V492, P105, DOI 10.1016/j.neulet.2011.01.066; Lauro LJR, 2014, CORTEX, V58, P99, DOI 10.1016/j.cortex.2014.05.003; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Mannion DJ, 2010, NEUROIMAGE, V52, P600, DOI 10.1016/j.neuroimage.2010.04.248; Marshall TR, 2016, NEUROIMAGE, V140, P41, DOI 10.1016/j.neuroimage.2015.09.069; Meinzer M, 2012, J NEUROSCI, V32, P1859, DOI 10.1523/JNEUROSCI.4812-11.2012; Nakano T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000670; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2004, CLIN NEUROPHYSIOL, V115, P2419, DOI 10.1016/j.clinph.2004.05.001; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Parasuraman R, 2013, FRONTIERS HUMAN NEUR, V7; Pena-Gomez C, 2012, BRAIN STIMUL, V5, P252, DOI 10.1016/j.brs.2011.08.006; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; Polania R, 2011, NEUROIMAGE, V54, P2287, DOI 10.1016/j.neuroimage.2010.09.085; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Roy A, 2014, IEEE T BIO-MED ENG, V61, P1967, DOI 10.1109/TBME.2014.2311071; Schestatsky P, 2013, JOVE-J VIS EXP, DOI 10.3791/50426; Song M, 2014, NEUROREPORT, V25, P1433, DOI 10.1097/WNR.0000000000000283; Stagg CJ, 2009, EUR J NEUROSCI, V30, P1412, DOI 10.1111/j.1460-9568.2009.06937.x; Sun HC, 2015, VISION RES, V109, P149, DOI 10.1016/j.visres.2014.11.012; Thielscher A, 2008, NEUROSCIENCE, V151, P730, DOI 10.1016/j.neuroscience.2007.11.040; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Underwood E, 2016, SCIENCE, V352, P397, DOI 10.1126/science.352.6284.397; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Vernet M, 2014, FRONTIERS INTEGRATIV, V8; Vinberg J, 2008, J NEUROPHYSIOL, V99, P1380, DOI 10.1152/jn.01223.2007; Wada A, 2014, NEUROIMAGE, V98, P243, DOI 10.1016/j.neuroimage.2014.05.001; Walsh VQ, 2013, BRAIN STIMUL, V6, P715, DOI 10.1016/j.brs.2013.08.001; Weber MJ, 2014, HUM BRAIN MAPP, V35, P3673, DOI 10.1002/hbm.22429; Westwood SJ, 2017, NEUROPSYCHOLOGIA, V104, P234, DOI 10.1016/j.neuropsychologia.2017.07.031; Westwood SJ, 2017, CORTEX, V86, P64, DOI 10.1016/j.cortex.2016.10.016; Zheng X, 2011, NEUROIMAGE, V58, P26, DOI 10.1016/j.neuroimage.2011.06.018	82	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197192	10.1371/journal.pone.0197192	http://dx.doi.org/10.1371/journal.pone.0197192			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782510	Green Published, gold, Green Submitted			2022-12-26	WOS:000432537100016
J	Cordeiro, NGF; Dubert, J; Nolasco, R; Barton, ED				Ferreira Cordeiro, Nuno Goncalo; Dubert, Jesus; Nolasco, Rita; Desmond Barton, Eric			Transient response of the Northwestern Iberian upwelling regime	PLOS ONE			English	Article							OCEAN DYNAMICS EXPERIMENT; NW SPAIN; POLEWARD CURRENT; GALICIAN COAST; RIAS BAIXAS; VARIABILITY; WIND; PENINSULA; SHELF; RELAXATION	The hydrography and dynamics of NW Iberian margin were explored for July 2009, based on a set of in situ and remote sensing observations. Zonal sections of standard CTD casts, towed CTD (SeaSoar), Acoustic Doppler Current Profilers (ADCP) and Lagrangian surveys were made to characterize cycles of upwelling and relaxation in this region. Two periods of northerly winds, bounded by relaxation periods, were responsible for the formation of an upwelling front extending to the shelf edge. An equatorward flow was quickly set up on the shelf responding to the northerly wind pulses. South of Cape Silleiro, the development and subsequent relaxation of an upwelling event was intensively surveyed in the shelf, following a Lagrangian drifter transported by the upwelling jet. This region is part of an upwelling center extending from Cape Silleiro to Porto, where the surface temperature was colder than the neighboring regions, under upwelling favorable winds. As these winds relaxed, persistent poleward flow developed, originating south of the upwelling center and consisting in an inner-shelf tongue of warm waters. During an event of strong southerly wind, the poleward flow was observed to extend to the whole continental shelf. Although the cruise was executed during summertime, the presence of river-plumes was observed over the shelf. The interaction of the plumes with the circulation on the shelf was also described in terms of coastal convergence and offshore advection. The sampling of the offshore and slope regions showed the presence of the Iberian poleward current offshore and a persistent equatorward flow over the upper slope.	[Ferreira Cordeiro, Nuno Goncalo; Dubert, Jesus; Nolasco, Rita] Univ Aveiro, Dept Fis, Aveiro, Portugal; [Ferreira Cordeiro, Nuno Goncalo; Dubert, Jesus; Nolasco, Rita] Univ Aveiro, CESAM, Aveiro, Portugal; [Desmond Barton, Eric] CSIC, Inst Invest Marinas, Vigo, Spain	Universidade de Aveiro; Universidade de Aveiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Cordeiro, NGF (corresponding author), Univ Aveiro, Dept Fis, Aveiro, Portugal.; Cordeiro, NGF (corresponding author), Univ Aveiro, CESAM, Aveiro, Portugal.	ngfc@ua.pt	Dubert, Jesus/B-7517-2008; Nolasco, Rita TS/D-1809-2019		Spanish Ministry of Education and Science [CTM2007-66408-C02-01/MAR]; Portuguese Science and Technology Foundation (FCT) [SFRH/BD/101070/2014]; Centro de Estudos do Ambiente e do Mar [UID/AMB/50017/2013]; FCT/MEC through national funds; FEDER; Compete	Spanish Ministry of Education and Science(Spanish Government); Portuguese Science and Technology Foundation (FCT)(Portuguese Foundation for Science and Technology); Centro de Estudos do Ambiente e do Mar; FCT/MEC through national funds; FEDER(European Commission); Compete	This work was carried out under the framework of the multidisciplinary project "Canaries-Iberian Marine Ecosystem Exchanges (CAIBEX)" (CTM2007-66408-C02-01/MAR) (Spanish Ministry of Education and Science). NGF Cordeiro was supported by the Portuguese Science and Technology Foundation (FCT) through PhD fellowship SFRH/BD/101070/2014. Financial support was provided by Centro de Estudos do Ambiente e do Mar (UID/AMB/50017/2013), FCT/MEC through national funds, and the co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Salgado XA, 2000, ESTUAR COAST SHELF S, V51, P821, DOI 10.1006/ecss.2000.0714; Alvarez-Salgado XA, 2003, PROG OCEANOGR, V56, P281, DOI 10.1016/S0079-6611(03)00007-7; AlvarezSalgado XA, 1997, CONT SHELF RES, V17, P1247, DOI 10.1016/S0278-4343(97)00014-9; ALVAREZSALGADO XA, 1993, J GEOPHYS RES-OCEANS, V98, P14447, DOI 10.1029/93JC00458; Ambar I, 1994, P 2 INT C AIR SEA IN, P311; Austin JA, 2002, J PHYS OCEANOGR, V32, P2171, DOI 10.1175/1520-0485(2002)032<2171:TISRTW>2.0.CO;2; Barton ED, 2015, PROG OCEANOGR, V134, P173, DOI 10.1016/j.pocean.2015.01.014; Carvalho D, 2012, OCEAN MODEL, V56, P31, DOI 10.1016/j.ocemod.2012.08.002; Castro CG, 1997, J MAR RES, V55, P321, DOI 10.1357/0022240973224436; FIEDLER PC, 1990, INT J REMOTE SENS, V11, P999, DOI 10.1080/01431169008955072; Gan JP, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004660; Gan JP, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000768; HAYNES R, 1990, J GEOPHYS RES-OCEANS, V95, P11425, DOI 10.1029/JC095iC07p11425; Huthnance JM, 2002, J MARINE SYST, V32, P107, DOI 10.1016/S0924-7963(02)00034-9; MCCLAIN CR, 1986, J GEOPHYS RES-OCEANS, V91, P8470, DOI 10.1029/JC091iC07p08470; Moita MT, 2003, ACTA OECOL, V24, pS125, DOI 10.1016/S1146-609X(03)00011-0; Nolasco R, 2013, OCEAN DYNAM, V63, P1041, DOI 10.1007/s10236-013-0647-8; NYKJAER L, 1994, J GEOPHYS RES-OCEANS, V99, P14197, DOI 10.1029/94JC00814; Otero P, 2008, J MARINE SYST, V72, P238, DOI 10.1016/j.jmarsys.2007.05.016; Otero P, 2013, OCEAN DYNAM, V63, P115, DOI 10.1007/s10236-012-0585-x; Peliz A, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001443; Peliz A, 2002, J MARINE SYST, V35, P61, DOI 10.1016/S0924-7963(02)00076-3; Peliz A, 2005, DEEP-SEA RES PT I, V52, P621, DOI 10.1016/j.dsr.2004.11.005; Pringle JM, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005016; Pringle JM, 2002, J PHYS OCEANOGR, V32, P3101, DOI 10.1175/1520-0485(2002)032<3101:EOWDUA>2.0.CO;2; Relvas P, 2005, CONT SHELF RES, V25, P29, DOI 10.1016/j.csr.2004.09.006; Relvas P., 2002, J GEOPHYS RES, V107, P1, DOI DOI 10.1029/2000JC000456; Relvas P, 2007, PROG OCEANOGR, V74, P149, DOI 10.1016/j.pocean.2007.04.021; Ribeiro AC, 2005, J MARINE SYST, V53, P87, DOI 10.1016/j.jmarsys.2004.05.031; Rossi V, 2010, OCEAN MODEL, V31, P51, DOI 10.1016/j.ocemod.2009.10.002; Rossi V, 2013, CONT SHELF RES, V59, P97, DOI 10.1016/j.csr.2013.04.008; SEND U, 1987, J GEOPHYS RES-OCEANS, V92, P1683, DOI 10.1029/JC092iC02p01683; Sordo I, 2001, ESTUAR COAST SHELF S, V53, P787, DOI 10.1006/ecss.2000.0788; Sousa FM, 1995, PROCESSOS MESOESCALA; Taboada JJ, 2005, J ATMOS OCEAN SCI, V10, P377, DOI [10.1080/17417530601127472, DOI 10.1080/17417530601127472]; Teles-Machado A, 2016, PROG OCEANOGR, V140, P134, DOI 10.1016/j.pocean.2015.05.021; Moita MT, 2016, HARMFUL ALGAE, V53, P17, DOI 10.1016/j.hal.2015.12.002; Tilstone GH, 2003, MAR ECOL PROG SER, V252, P89, DOI 10.3354/meps252089; Torres R, 2007, CONT SHELF RES, V27, P1759, DOI 10.1016/j.csr.2007.02.005; Torres R, 2006, CONT SHELF RES, V26, P1134, DOI 10.1016/j.csr.2006.03.009; Torres R, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001361; Washburn L, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007502; WOOSTER WS, 1976, J MAR RES, V34, P131	43	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197627	10.1371/journal.pone.0197627	http://dx.doi.org/10.1371/journal.pone.0197627			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29772008	Green Published, gold, Green Submitted			2022-12-26	WOS:000432348900081
J	Hynds, RE; Gowers, KHC; Nigro, E; Butler, CR; Bonfanti, P; Giangreco, A; Prele, CM; Janes, SM				Hynds, Robert E.; Gowers, Kate H. C.; Nigro, Ersilia; Butler, Colin R.; Bonfanti, Paola; Giangreco, Adam; Prele, Cecilia M.; Janes, Sam M.			Cross-talk between human airway epithelial cells and 3T3-J2 feeder cells involves partial activation of human MET by murine HGF	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; JUNCTIONAL EPIDERMOLYSIS-BULLOSA; HUMAN EPIDERMAL-KERATINOCYTES; STEM-CELLS; FIBROBLAST COCULTURES; ROCK INHIBITOR; LUNG STEM; IN-VITRO; STAT6; REGENERATION	There is considerable interest in the ex vivo propagation of primary human basal epithelial stem/progenitor cells with a view to their use in drug development, toxicity testing and regenerative medicine. These cells can be expanded in co-culture with mitotically inactivated 3T3-J2 murine embryonic feeder cells but, similar to other epithelial cell culture systems employing 3T3-J2 cells, the aspects of cross-talk between 3T3-J2 cells and human airway basal cells that are critical for their expansion remain largely unknown. In this study, we investigated secreted growth factors that are produced by 3T3-J2 cells and act upon primary human airway basal cells. We found robust production of hepatocyte growth factor (HGF) from fibroblast feeder cells following mitotic inactivation. Consistent with the limited cross species reactivity of murine HGF on the human HGF receptor (MET; HGFR), MET inhibition did not affect proliferative responses in human airway basal cells and HGF could not replace feeder cells in this culture system. However, we found that murine HGF is not completely inactive on human airway epithelial cells or cancer cell lines but stimulates the phosphorylation of GRB2-associated-binding protein 2 (GAB2) and signal transducer and activator of transcription 6 (STAT6). Although HGF induces phosphorylation of STAT6 tyrosine 641 (Y641), there is no subsequent STAT6 nuclear translocation or STAT6-driven transcriptional response. Overall, these findings highlight the relevance of cross-species protein interactions between murine feeder cells and human epithelial cells in 3T3-J2 co-culture and demonstrate that STAT6 phosphorylation occurs in response to MET activation in epithelial cells. However, STAT6 nuclear translocation does not occur in response to HGF, precluding the transcriptional activity of STAT6.	[Hynds, Robert E.; Gowers, Kate H. C.; Nigro, Ersilia; Butler, Colin R.; Giangreco, Adam; Janes, Sam M.] UCL, UCL Resp, Lungs Living Res Ctr, London, England; [Hynds, Robert E.] UCL, UCL Canc Inst, CRUK Lung Canc Ctr Excellence, London, England; [Hynds, Robert E.; Bonfanti, Paola] Francis Crick Inst, London, England; [Nigro, Ersilia] Univ Campania L Vanvitelli, Dipartimento Sci Cardiotorac & Resp, Naples, Italy; [Bonfanti, Paola] UCL Inst Child Hlth, Stem Cell & Regenerat Med Sect, London, England; [Bonfanti, Paola] Great Ormond St Hosp Sick Children, London, England; [Bonfanti, Paola] UCL, Inst Immun & Transplantat, London, England; [Prele, Cecilia M.] Univ Western Australia, Ctr Cell Therapy & Regenerat Med, Sch Biomed Sci, Perth, WA, Australia; [Prele, Cecilia M.] Univ Western Australia, Inst Resp Hlth, Perth, WA, Australia	University of London; University College London; University of London; University College London; Francis Crick Institute; Universita della Campania Vanvitelli; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of Western Australia; University of Western Australia	Janes, SM (corresponding author), UCL, UCL Resp, Lungs Living Res Ctr, London, England.; Prele, CM (corresponding author), Univ Western Australia, Ctr Cell Therapy & Regenerat Med, Sch Biomed Sci, Perth, WA, Australia.; Prele, CM (corresponding author), Univ Western Australia, Inst Resp Hlth, Perth, WA, Australia.	cecilia.prele@uwa.edu.au; s.janes@ucl.ac.uk	Hynds, Robert E/F-9516-2012	Hynds, Robert E/0000-0002-2170-8791; Janes, Sam/0000-0002-6634-5939; Butler, Colin/0000-0003-4192-0519; Nigro, Ersilia/0000-0001-5637-1685; Bonfanti, Paola/0000-0001-9655-3766; Giangreco, Adam/0000-0002-4031-7219	UWA-HMGU-UCL Collaborative Seed Funding Award; BBSRC-CASE PhD studentship; CRUK Lung Cancer Centre of Excellence; Roy Castle Lung Cancer Foundation [2016/07/HYNDS, 2016/17/JANES]; European Research Council [ERC-Stg-2014 639429]; Rosetrees Trust [A1411, A1179]; GOSH Charity [V6116]; Cystic Fibrosis Trust [SRC006]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London [17DS20]; ERC Starting Grant [260290]; Rosetrees Trust; Welton Trust; Garfield Weston Trust; UCLH Charitable Foundation; UCLH BRC;  [WT209199/Z/17/Z]; MRC [G108/596] Funding Source: UKRI	UWA-HMGU-UCL Collaborative Seed Funding Award; BBSRC-CASE PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CRUK Lung Cancer Centre of Excellence; Roy Castle Lung Cancer Foundation; European Research Council(European Research Council (ERC)European Commission); Rosetrees Trust(Rosetrees Trust); GOSH Charity; Cystic Fibrosis Trust; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London; ERC Starting Grant(European Research Council (ERC)); Rosetrees Trust(Rosetrees Trust); Welton Trust; Garfield Weston Trust; UCLH Charitable Foundation; UCLH BRC; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a UWA-HMGU-UCL Collaborative Seed Funding Award (S.J., C.M. P. and R.E.H.). R.E.H. was supported by a BBSRC-CASE PhD studentship (awarded to A.G.) and is now a Sir Henry Wellcome Postdoctoral Fellow (WT209199/Z/17/Z). R.E.H. also receives support from the CRUK Lung Cancer Centre of Excellence and the Roy Castle Lung Cancer Foundation (2016/07/HYNDS). P.B. is a UCL Excellence Fellow and is supported by the European Research Council (ERC-Stg-2014 639429), the Rosetrees Trust (A1411 and A1179), the GOSH Charity (V6116) and the Cystic Fibrosis Trust (SRC006), and the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London (17DS20). A.G. was supported by an ERC Starting Grant (260290). S.M.J. is a Wellcome Trust Senior Fellow in Clinical Science (WT107963/Z/15/Z) and is supported by the Rosetrees Trust, the Roy Castle Lung Cancer Foundation (2016/17/JANES), the Welton Trust, the Garfield Weston Trust, the UCLH Charitable Foundation, and the UCLH BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoncello I, 2016, J CELL PHYSIOL, V231, P2582, DOI 10.1002/jcp.25404; Blease K, 2002, AM J PATHOL, V160, P481, DOI 10.1016/S0002-9440(10)64867-5; Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Butler CR, 2016, AM J RESP CRIT CARE, V194, P156, DOI 10.1164/rccm.201507-1414OC; Chapman S, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt449; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Daines MO, 2003, J BIOL CHEM, V278, P30971, DOI 10.1074/jbc.M301094200; Day RM, 2002, ONCOGENE, V21, P2201, DOI 10.1038/sj.onc.1205289; De Rosa L, 2014, STEM CELL REP, V2, P1, DOI 10.1016/j.stemcr.2013.11.001; Francone TD, 2007, MOL CANCER THER, V6, P1460, DOI 10.1158/1535-7163.MCT-06-0466; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Gowers KHC, 2018, J TISSUE ENG REGEN M, V12, pE313, DOI 10.1002/term.2466; Hamilton N, 2014, LARYNGOSCOPE, V124, P961, DOI 10.1002/lary.24469; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hynds RE, 2019, METHODS MOL BIOL, V1576, P43, DOI 10.1007/7651_2016_5; Hynds RE, 2018, EMBO MOL MED, V10, P139, DOI 10.15252/emmm.201708213; Hynds RE, 2013, STEM CELLS, V31, P417, DOI 10.1002/stem.1290; Ikebuchi F, 2013, CELL BIOCHEM FUNCT, V31, P298, DOI 10.1002/cbf.2898; Kanai A, 2011, DNA RES, V18, P379, DOI 10.1093/dnares/dsr025; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lefebvre J, 2012, FASEB J, V26, P1387, DOI 10.1096/fj.11-197723; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Maas-Szabowski N, 1999, J CELL SCI, V112, P1843; Masuda A, 1997, CANCER RES, V57, P4898; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Mikita T, 1998, J BIOL CHEM, V273, P17634, DOI 10.1074/jbc.273.28.17634; Murata T, 1996, J IMMUNOL, V156, P2972; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; OCONNOR NE, 1981, LANCET, V1, P75; Okada M, 2004, PEDIATR RES, V56, P336, DOI 10.1203/01.PDR.0000134255.58638.59; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Palechor-Ceron N, 2013, AM J PATHOL, V183, P1862, DOI 10.1016/j.ajpath.2013.08.009; Panganiban RAM, 2011, ACTA PHARMACOL SIN, V32, P12, DOI 10.1038/aps.2010.90; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pennacchietti S, 2014, CANCER RES, V74, P6598, DOI 10.1158/0008-5472.CAN-14-0761; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Reynolds SD, 2016, AM J RESP CELL MOL, V55, P323, DOI 10.1165/rcmb.2015-0274MA; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Shen BQ, 1997, AM J PHYSIOL-LUNG C, V272, pL1115, DOI 10.1152/ajplung.1997.272.6.L1115; Skibinski G, 2007, AM J PHYSIOL-LUNG C, V293, pL69, DOI 10.1152/ajplung.00299.2006; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Suzuki D, 2015, J INVEST DERMATOL, V135, P2894, DOI 10.1038/jid.2015.235; Teixeira VH, 2013, ELIFE, V2, DOI 10.7554/eLife.00966; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Walford Hannah H, 2013, JAKSTAT, V2, pe25301, DOI 10.4161/jkst.25301; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; YOSHIMURA T, 1987, J IMMUNOL, V139, P788; Zahm JM, 2000, J CELL PHYSIOL, V185, P447, DOI 10.1002/1097-4652(200012)185:3<447::AID-JCP16>3.0.CO;2-D; Zhang X, 2012, FASEB J, V26, P4603, DOI 10.1096/fj.12-211755; Zhang YW, 2005, ONCOGENE, V24, P101, DOI 10.1038/sj.onc.1208181; Zou HY, 2012, MOL CANCER THER, V11, P1036, DOI 10.1158/1535-7163.MCT-11-0839	56	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197129	10.1371/journal.pone.0197129	http://dx.doi.org/10.1371/journal.pone.0197129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771943	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900030
J	Kagi, L; Bettoni, C; Pastor-Arroyo, EM; Schnitzbauer, U; Hernando, N; Wagner, CA				Kagi, Larissa; Bettoni, Carla; Pastor-Arroyo, Eva M.; Schnitzbauer, Udo; Hernando, Nati; Wagner, Carsten A.			Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3	PLOS ONE			English	Article							D-3 1-ALPHA-HYDROXYLASE GENE; PARATHYROID-HORMONE; 25-HYDROXYVITAMIN D-3; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; RECEPTOR GENE; D-DEFICIENCY; RAT-KIDNEY; EXPRESSION; PHOSPHORUS; MICE	Background The 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) together with parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) regulates calcium (Ca2+) and phosphate (Pi) homeostasis, 1,25(OH)(2)D-3 synthesis is mediated by hydroxylases of the cytochrome P450 (Cyp) family. Vitamin D is first modified in the liver by the 25-hydroxylases CYP2R1 and CYP27A1 and further activated in the kidney by the 1 alpha-hydroxylase CYP27B1, while the renal 24-hydroxylase CYP24A1 catalyzes the first step of its inactivation. While the kidney is the main organ responsible for circulating levels of active 1,25(OH)(2)D-3, other organs also express some of these enzymes. Their regulation, however, has been studied less. Methods and results Here we investigated the effect of several Pi-regulating factors including dietary Pi, PTH and FGF23 on the expression of the vitamin D hydroxylases and the vitamin D receptor VDR in renal and extrarenal tissues of mice. We found that with the exception of Cyp24a1, all the other analyzed mRNAs show a wide tissue distribution. High dietary Pi mainly upregulated the hepatic expression of Cyp27a1 and Cyp2r1 without changing plasma 1,25(OH)(2)D-3. FGF23 failed to regulate the expression of any of the studied hydroxylases at the used dosage and treatment length. As expected, renal mRNA expression of Cyp27b1 was reduced and Cyp24a1 was increased in response to 1,25(OH)(2)D-3 treatment. However, the 25-hydroxylases were rather unaffected by 1,25(OH)(2)D-3 treatment. Conclusions The analyzed vitamin D hydroxylases are regulated in a tissue and treatment-specific manner.	[Kagi, Larissa; Bettoni, Carla; Pastor-Arroyo, Eva M.; Schnitzbauer, Udo; Hernando, Nati; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Kagi, Larissa; Bettoni, Carla; Pastor-Arroyo, Eva M.; Schnitzbauer, Udo; Hernando, Nati; Wagner, Carsten A.] Natl Ctr Competence Res NCCR Kidney CH, Zurich, Switzerland	University of Zurich	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Wagner, CA (corresponding author), Natl Ctr Competence Res NCCR Kidney CH, Zurich, Switzerland.	Wagnerca@access.uzh.ch		Wagner, Carsten/0000-0002-9874-8898	Schweizerischer Nationalfonds zur Forderung der Wissenschaft [31003A_176125]; Swiss National Science Foundation [31003A_176125]	Schweizerischer Nationalfonds zur Forderung der Wissenschaft; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Schweizerischer Nationalfonds zur Forderung der Wissenschaft (www.snf.ch) under the agreement no 31003A_176125 to CAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by a grant from the Swiss National Science Foundation to CAW (31003A_176125).	Adams JS, 2014, J STEROID BIOCHEM, V144, P22, DOI 10.1016/j.jsbmb.2013.12.009; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Berndt T, 2009, PHYSIOLOGY, V24, P17, DOI 10.1152/physiol.00034.2008; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Bourgeois S, 2013, PFLUG ARCH EUR J PHY, V465, P1557, DOI 10.1007/s00424-013-1298-9; Brenza HL, 2000, ARCH BIOCHEM BIOPHYS, V381, P143, DOI 10.1006/abbi.2000.1970; Canaff L, 2002, J BIOL CHEM, V277, P30337, DOI 10.1074/jbc.M201804200; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Chow ECY, 2013, AM J PHYSIOL-ENDOC M, V304, pE977, DOI 10.1152/ajpendo.00489.2012; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Dinour D, 2013, J UROLOGY, V190, P552, DOI 10.1016/j.juro.2013.02.3188; Erben R. G., 2016, BONE; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Haussler MR, 2012, REV ENDOCR METAB DIS, V13, P57, DOI 10.1007/s11154-011-9199-8; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; HOLICK MF, 1980, SCIENCE, V210, P203, DOI 10.1126/science.6251551; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Jeon Un Sil, 2008, Electrolyte Blood Press, V6, P68, DOI 10.5049/EBP.2008.6.2.68; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Keusch I, 1998, KIDNEY INT, V54, P1224, DOI 10.1046/j.1523-1755.1998.00115.x; Khundmiri SJ, 2016, COMPR PHYSIOL, V6, P561, DOI 10.1002/cphy.c140071; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Lanzano L, 2011, AM J PHYSIOL-CELL PH, V301, pC850, DOI 10.1152/ajpcell.00412.2010; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Marsell R, 2008, NEPHROL DIAL TRANSPL, V23, P827, DOI 10.1093/ndt/gfm672; Murayama A, 1998, BIOCHEM BIOPH RES CO, V249, P11, DOI 10.1006/bbrc.1998.9098; Perez AV, 2008, DIGESTION, V77, P22, DOI 10.1159/000116623; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; PORTALE AA, 1984, J CLIN INVEST, V73, P1580, DOI 10.1172/JCI111365; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Schmid A, 2013, ADV NUTR, V4, P453, DOI 10.3945/an.113.003780; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; SHINKI T, 1992, J BIOL CHEM, V267, P13757; Silver J, 2009, KIDNEY INT, V75, P898, DOI 10.1038/ki.2008.642; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; St-Arnaud R, 2000, ENDOCRINOLOGY, V141, P2658, DOI 10.1210/en.141.7.2658; Takeyama K, 2011, BIOSCI BIOTECH BIOCH, V75, P208, DOI 10.1271/bbb.100684; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zhang MYH, 2002, ENDOCRINOLOGY, V143, P587, DOI 10.1210/en.143.2.587; Zhu JG, 2013, P NATL ACAD SCI USA, V110, P15650, DOI 10.1073/pnas.1315006110	50	23	24	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0195427	10.1371/journal.pone.0195427	http://dx.doi.org/10.1371/journal.pone.0195427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771914	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000432348900003
J	Yang, S; Li, XT; Huang, F; Huang, YJ; Liu, XL; Wu, JY; Wang, QN; Deng, ZH; Chen, RK; Zhang, MQ				Yang, Shan; Li, Xueting; Huang, Fei; Huang, Yongji; Liu, Xinlong; Wu, Jiayun; Wang, Qinnan; Deng, Zuhu; Chen, Rukai; Zhang, Muqing			A new method based on SNP of nrDNA-ITS to identify Saccharum spontaneum and its progeny in the genus Saccharum	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; NUCLEAR RIBOSOMAL DNA; GENETIC DIVERSITY; MICROSATELLITE MARKERS; SSR MARKERS; SUGARCANE; SEQUENCES; RDNA; PCR; IDENTIFICATION	The identification of germplasm resources is an important aspect of sugarcane breeding. The aim of this study was to introduce a new method for identifying Saccharum spontaneum and its progeny. First, we cloned and sequenced nuclear ribosomal DNA internal transcribed spacer (nrDNA-ITS) sequences from 20 Saccharum germplasms. Analysis of these nrDNA-ITS sequences showed a stable mutation at base 89. Primers (FO13, RO13, FI16, and RI16) were then designed for tetra-primer amplification refractory mutation system (ARMS) PCR based on mutations at base 89 of the nrDNA-ITS sequence. An additional 71 Saccharum germplasms were identified using this tetra-primer ARMS PCR method, which confirmed that the method using the described primers successfully identified Saccharum spontaneum and progeny. These results may help improve the efficiency of modern molecular breeding of sugarcane and lay a foundation for identification of sugarcane germplasms and the relationships among them.	[Yang, Shan; Li, Xueting; Huang, Fei; Huang, Yongji; Deng, Zuhu; Chen, Rukai] Fujian Agr & Forestry Univ, Natl Engn Res Ctr Sugarcane, Fuzhou, Fujian, Peoples R China; [Liu, Xinlong] Yunnan Acad Agr Sci, Sugarcane Res Inst, Yunnan Key Lab Sugarcane Genet Improvement, Kaiyuan, Peoples R China; [Wu, Jiayun; Wang, Qinnan] Guangzhou Sugarcane Ind Res Inst, Guangdong Prov Bioengn Inst, Guangzhou, Guangdong, Peoples R China; [Deng, Zuhu; Zhang, Muqing] Guangxi Univ, Guangxi Collaborat Innovat Ctr Sugar Ind, Nanning, Peoples R China	Fujian Agriculture & Forestry University; Yunnan Academy of Agricultural Sciences; Guangdong Academy of Sciences; Institute of Nanfan & Seed Industry, Guangdong Academy of Sciences; Guangxi University	Deng, ZH (corresponding author), Fujian Agr & Forestry Univ, Natl Engn Res Ctr Sugarcane, Fuzhou, Fujian, Peoples R China.; Deng, ZH (corresponding author), Guangxi Univ, Guangxi Collaborat Innovat Ctr Sugar Ind, Nanning, Peoples R China.	dengzuhu@163.com		zhang, muqing/0000-0003-3138-3422; Yang, Shan/0000-0003-4965-8658	National Natural Science Foundation of China [31571730, 31401440]; science and technology major project of the Fujian Province of China [2015NZ0002-2]; special fund for scientific and technological innovation of the Fujian Agriculture and Forestry University [KFA17168A]; open project of the Key Laboratory of Conservation and Utilization of Subtropical Agricultural Biological Resources [SKLCUSA-b201606]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); science and technology major project of the Fujian Province of China; special fund for scientific and technological innovation of the Fujian Agriculture and Forestry University; open project of the Key Laboratory of Conservation and Utilization of Subtropical Agricultural Biological Resources	This work was funded by the National Natural Science Foundation of China (31571730 and 31401440) and was supported by the science and technology major project of the Fujian Province of China (2015NZ0002-2) and special fund for scientific and technological innovation of the Fujian Agriculture and Forestry University (KFA17168A). This project was also supported by an open project of the Key Laboratory of Conservation and Utilization of Subtropical Agricultural Biological Resources (SKLCUSA-b201606). These funding institutions played no role in study design, data collection or analysis, or manuscript preparation.	Bacci M, 2001, GENET MOL BIOL, V24, P169, DOI 10.1590/S1415-47572001000100023; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Besse P, 2014, METHODS MOL BIOL, V1115, P141, DOI 10.1007/978-1-62703-767-9_7; Blattner FR, 2016, PLANT SYST EVOL, V302, P239, DOI 10.1007/s00606-015-1259-1; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Brown JS, 2007, GENET RESOUR CROP EV, V54, P627, DOI 10.1007/s10722-006-0035-z; Chandra A, 2014, GENOME, V57, P363, DOI 10.1139/gen-2014-0072; Clarkson JJ, 2016, PHYTOTAXA, V259, P6, DOI 10.11646/phytotaxa.259.1.4; De Smet R, 2013, P NATL ACAD SCI USA, V110, P2898, DOI 10.1073/pnas.1300127110; Devarumath RM, 2012, SUGAR TECH, V14, P334, DOI 10.1007/s12355-012-0168-7; Dkhar J, 2012, PLANT SYST EVOL, V298, P93, DOI 10.1007/s00606-011-0526-z; Edme SJ, 2006, HEREDITY, V97, P366, DOI 10.1038/sj.hdy.6800888; Garces-Claver A, 2007, THEOR APPL GENET, V115, P907, DOI 10.1007/s00122-007-0617-y; Heinz DJ, 1987, DEV CROP SCI; Hou YP, 2013, AUSTRALAS PLANT PATH, V42, P73, DOI 10.1007/s13313-012-0162-2; Huang SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-717; Irvine JE, 1999, THEOR APPL GENET, V98, P186, DOI 10.1007/s001220051057; Koloren O, 2016, BIOTECHNOL BIOTEC EQ, V30, P929, DOI 10.1080/13102818.2016.1188674; Liu XiHong, 2014, Botanical Research, V3, P32, DOI 10.12677/BR.2014.31007; Liu XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151524; Luo Yu-ming, 2006, Yaoxue Xuebao, V41, P840; Mary S, 2006, GENET RESOUR CROP EV, V53, P1221, DOI 10.1007/s10722-005-2433-z; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Naciri Y, 2015, TAXON, V64, P3, DOI 10.12705/641.24; Piperidis G, 2010, MOL GENET GENOMICS, V284, P65, DOI 10.1007/s00438-010-0546-3; Porebski S, 1997, PLANT MOL BIOL REP, V15, P8, DOI 10.1007/BF02772108; Qian Jin, 2009, Acta Agronomica Sinica, V35, P1021; SANG T, 1995, P NATL ACAD SCI USA, V92, P6813, DOI 10.1073/pnas.92.15.6813; Selvi A, 2006, GENET RESOUR CROP EV, V53, P831, DOI 10.1007/s10722-004-6376-6; Shiba M, 2006, BIOL PHARM BULL, V29, P315, DOI 10.1248/bpb.29.315; Szabo Z, 2005, EUPHYTICA, V146, P87, DOI 10.1007/s10681-005-5685-y; Medrano RFV, 2014, MOL BIOTECHNOL, V56, P599, DOI 10.1007/s12033-014-9734-4; Wang P., 2016, CHROMOSOME GENETIC A; Waters ER, 1996, GENOME, V39, P150, DOI 10.1139/g96-020; Yang CF, 2016, SUGAR TECH, V18, P8, DOI 10.1007/s12355-014-0355-9; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zhang SB, 2015, EUPHYTICA, V206, P793, DOI 10.1007/s10681-015-1525-x	37	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2018	13	5							e0197458	10.1371/journal.pone.0197458	http://dx.doi.org/10.1371/journal.pone.0197458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9WG	29768494	gold, Green Published, Green Submitted			2022-12-26	WOS:000432329200085
J	Klein, ME; Dickson, MA; Antonescu, C; Qin, LX; Dooley, SJ; Barlas, A; Manova, K; Schwartz, GK; Crago, AM; Singer, S; Koff, A; Tap, WD				Klein, Mary E.; Dickson, Mark A.; Antonescu, Cristina; Qin, Li-Xuan; Dooley, Scott J.; Barlas, Afsar; Manova, Katia; Schwartz, Gary K.; Crago, Aimee M.; Singer, Samuel; Koff, Andrew; Tap, William D.			PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence	ONCOGENE			English	Article							BREAST-CANCER; DEDIFFERENTIATED LIPOSARCOMA; TUMOR-GROWTH; PALBOCICLIB; COMPLEXES; CDK6; SUPPRESSION; PROGRESSION; SURVIVAL; SARCOMA	CDK4/6 inhibitors are being used to treat a variety of human malignancies. In well-differentiated and dedifferentiated liposarcoma their clinical promise is associated with their ability to downregulate the MDM2 protein. The downregulation of MDM2 following treatment with CDK4/6 inhibitors also induces many cultured tumor cell lines derived from different types of malignancies to progress from quiescence into senescence. Here we used cultured human cell lines and defined a role for PDLIM7 and CDH18, regulating MDM2 protein in CDK4/6 inhibitor-treated cells. Materials from our previous phase II trials with palbociclib were then used to demonstrate that expression of CDH18 protein was associated with response, measured as both progression-free survival and overall survival. This supports the hypothesis that the biologic transition from quiescence to senescence has clinical relevance for this class of drugs.	[Klein, Mary E.; Koff, Andrew] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10065 USA; [Klein, Mary E.; Koff, Andrew] Mem Sloan Kettering Canc Ctr, Programs Mol, 1275 York Ave, New York, NY 10065 USA; [Dickson, Mark A.; Tap, William D.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA; [Dickson, Mark A.; Tap, William D.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Antonescu, Cristina] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10065 USA; [Qin, Li-Xuan] Mem Sloan Kettering Canc Ctr, Dept Epidemiol, 1275 York Ave, New York, NY 10065 USA; [Qin, Li-Xuan] Mem Sloan Kettering Canc Ctr, Dept Biostat, 1275 York Ave, New York, NY 10065 USA; [Dooley, Scott J.] Univ Penn, Perelman Sch Med, Dept Ophthalmol, Ctr Adv Retinal & Ocular Therapeut, Philadelphia, PA 19104 USA; [Barlas, Afsar; Manova, Katia] Mem Sloan Kettering Canc Ctr, Dev Biol, 1275 York Ave, New York, NY 10065 USA; [Schwartz, Gary K.] Columbia Univ, Med Ctr, Div Hematol & Oncol, Herbert Irving Pavil 9th Floor, New York, NY 10032 USA; [Crago, Aimee M.; Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10065 USA; [Crago, Aimee M.; Singer, Samuel] Weill Cornell Med Coll, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Columbia University; Memorial Sloan Kettering Cancer Center; Cornell University	Koff, A (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10065 USA.; Koff, A (corresponding author), Mem Sloan Kettering Canc Ctr, Programs Mol, 1275 York Ave, New York, NY 10065 USA.	koffa@mskcc.org			NIH/NCI Cancer Center Support Grant [P30 CA008748]; NCI Soft Tissue Sarcoma SPORE [CA140146]; Maloris Foundation; Linn Fund from Cycle For Survival; Heidi Connery Memorial Research Grant from the Sarcoma Foundation of America; NATIONAL CANCER INSTITUTE [P50CA217694, P30CA008748, P50CA140146] Funding Source: NIH RePORTER	NIH/NCI Cancer Center Support Grant; NCI Soft Tissue Sarcoma SPORE; Maloris Foundation; Linn Fund from Cycle For Survival; Heidi Connery Memorial Research Grant from the Sarcoma Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Annalee Tai for technical assistance, Maura Dickler for discussions on the clinical impact of palbociclib in breast cancer, and Marta Kovatcheva, Caroline Gleason, Andrew Schade (Eli Lilly and Company), Michael Overholtzer and others in our laboratories for discussions during the course of these studies. The research was funded in part through NIH/NCI Cancer Center Support Grant P30 CA008748 and the NCI Soft Tissue Sarcoma SPORE CA140146 (AK, WDT, MD, GKS). Additional funding was provided by the Maloris Foundation, The Linn Fund from Cycle For Survival, and a Heidi Connery Memorial Research Grant from the Sarcoma Foundation of America to AK.	Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Baughn LB, 2006, CANCER RES, V66, P7661, DOI 10.1158/0008-5472.CAN-06-1098; Bollard J, 2017, GUT, V66, P1286, DOI 10.1136/gutjnl-2016-312268; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Dickson MA, 2016, JAMA ONCOL, V2, P937, DOI 10.1001/jamaoncol.2016.0264; Dickson MA, 2013, J CLIN ONCOL, V31, P2024, DOI 10.1200/JCO.2012.46.5476; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Gong XQ, 2017, CANCER CELL, V32, P761, DOI 10.1016/j.ccell.2017.11.006; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Jung CR, 2010, J CLIN INVEST, V120, P4493, DOI 10.1172/JCI42674; Kanojia D, 2015, ONCOTARGET, V6, P42429, DOI 10.18632/oncotarget.6464; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Kovatcheva M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00540-5; Kovatcheva M, 2015, ONCOTARGET, V6, P8226, DOI 10.18632/oncotarget.3364; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Riley Maurisa F, 2012, Genes Cancer, V3, P226, DOI 10.1177/1947601912455322; Shapiro GI, 2017, CANCER CELL, V32, P721, DOI 10.1016/j.ccell.2017.11.013; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tan MCB, 2016, ANN SURG, V263, P593, DOI 10.1097/SLA.0000000000001149; Urban AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164042; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Witkiewicz AK, 2015, ONCOTARGET, V6, P15788, DOI 10.18632/oncotarget.3819; Yang C, 2017, ONCOGENE, V36, P2255, DOI 10.1038/onc.2016.379; Yoshida A, 2016, CANCER RES, V76, P2990, DOI 10.1158/0008-5472.CAN-15-2931	38	22	23	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 13	2018	37	37					5066	5078		10.1038/s41388-018-0332-y	http://dx.doi.org/10.1038/s41388-018-0332-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT3LT	29789718	Green Published, hybrid			2022-12-26	WOS:000444405300003
J	Gala, K; Li, Q; Sinha, A; Razavi, P; Dorso, M; Sanchez-Vega, F; Chung, YR; Hendrickson, R; Hsieh, JJ; Berger, M; Schultz, N; Pastore, A; Abdel-Wahab, O; Chandarlapaty, S				Gala, Kinisha; Li, Qing; Sinha, Amit; Razavi, Pedram; Dorso, Madeline; Sanchez-Vega, Francisco; Chung, Young Rock; Hendrickson, Ronald; Hsieh, James J.; Berger, Michael; Schultz, Nikolaus; Pastore, Alessandro; Abdel-Wahab, Omar; Chandarlapaty, Sarat			KMT2C mediates the estrogen dependence of breast cancer through regulation of ER alpha enhancer function	ONCOGENE			English	Article							ACTIVATING SIGNAL COINTEGRATOR-2; METHYLTRANSFERASE MLL3; GENE-EXPRESSION; CRUCIAL ROLES; DNA-BINDING; RECEPTOR; COMPLEX; TUMORS; BRAF(V600E); MACROPHAGE	Estrogen receptor alpha (ER alpha) is a ligand-activated nuclear receptor that directs proliferation and differentiation in selected cancer cell types including mammary-derived carcinomas. These master-regulatory functions of ER alpha require trans-acting elements such as the pioneer factor FOXA1 to establish a genomic landscape conducive to ER alpha control. Here, we identify the H3K4 methyltransferase KMT2C as necessary for hormone-driven ER alpha activity and breast cancer proliferation. KMT2C knockdown suppresses estrogen-dependent gene expression and causes H3K4me1 and H3K27ac loss selectively at ER alpha enhancers. Correspondingly, KMT2C loss impairs estrogen-driven breast cancer proliferation but has no effect on ER- breast cells. Whereas KMT2C loss disrupts estrogen-driven proliferation, it conversely promotes tumor outgrowth under hormone-depleted conditions. In accordance, KMT2C is one of the most frequently mutated genes in ER-positive breast cancer with KMT2C deletion correlating with significantly shorter progression-free survival on anti-estrogen therapy. From a therapeutic standpoint, KMT2C-depleted cells that develop hormone-independence retain their dependence on ER alpha, displaying ongoing sensitivity to ER alpha antagonists. We conclude that KMT2C is a key regulator of ER alpha activity whose loss uncouples breast cancer proliferation from hormone abundance.	[Gala, Kinisha; Chandarlapaty, Sarat] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA; [Gala, Kinisha; Li, Qing; Razavi, Pedram; Dorso, Madeline; Chung, Young Rock; Berger, Michael; Abdel-Wahab, Omar; Chandarlapaty, Sarat] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Sinha, Amit] Basepair Inc, New York, NY USA; [Sanchez-Vega, Francisco; Hsieh, James J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hendrickson, Ronald] Mem Sloan Kettering Canc Ctr, Microchem & Prote Core Facil, 1275 York Ave, New York, NY 10021 USA; [Schultz, Nikolaus; Pastore, Alessandro] Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA; [Chandarlapaty, Sarat] Weill Cornell Med Coll, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Chandarlapaty, S (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA.; Chandarlapaty, S (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Chandarlapaty, S (corresponding author), Weill Cornell Med Coll, New York, NY 10065 USA.	chandars@mskcc.org	Schultz, Nikolaus/ABE-6347-2020	Razavi, Pedram/0000-0003-4236-0576; Sanchez-Vega, Francisco/0000-0002-2990-4893; Chung, Young Rock/0000-0001-5752-8322	Anna Fuller Foundation; Cancer Couch Foundation; NCI Cancer Center Support Grant (CCSG) [P30 CA08748]; Susan G. Komen Foundation; Geoffrey Beene Cancer Research Center; Grayer Fellowship; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Anna Fuller Foundation; Cancer Couch Foundation; NCI Cancer Center Support Grant (CCSG); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Geoffrey Beene Cancer Research Center; Grayer Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank P. Chi for plasmids and cells, C. Sawyers for plasmids, M. Jasin and S. Lowe for mice and S. Monette for assistance with mouse pathology. We would like to thank J. Reis-Filho, W. Toy, Z. Li, A. Smith, R. Levine, N. Rosen and P. Chi for their helpful discussions. This work was funded by generous support of the Anna Fuller Foundation, the Cancer Couch Foundation, and the NCI Cancer Center Support Grant (CCSG, P30 CA08748). SC is funded by the Susan G. Komen Foundation. KG is funded by the Geoffrey Beene Cancer Research Center and a Grayer Fellowship. AP is a Mildred-Scheel Postdoctoral Research Fellow of the Deutsche Krebshilfe e.V.	Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010; Ansari KI, 2012, J MOL ENDOCRINOL, V48, P61, DOI 10.1530/JME-11-0078; Ansari KI, 2011, J MOL BIOL, V411, P334, DOI 10.1016/j.jmb.2011.05.050; Ansari KI, 2011, BIOCHEMISTRY-US, V50, P3517, DOI 10.1021/bi102037t; Bhan A, 2013, J MOL BIOL, V425, P3707, DOI 10.1016/j.jmb.2013.01.022; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dumont JA, 1996, CELL GROWTH DIFFER, V7, P351; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Guo XY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0328-y; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jeng MH, 1998, ENDOCRINOLOGY, V139, P4164, DOI 10.1210/en.139.10.4164; Johnston SRD, 1999, CLIN CANCER RES, V5, P251; Joseph R, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.109; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kannengiesser C, 2008, MOL ONCOL, V1, P425, DOI 10.1016/j.molonc.2008.01.002; Kim DH, 2015, HEPATOLOGY, V61, P1012, DOI 10.1002/hep.27578; Kim DH, 2009, MOL ENDOCRINOL, V23, P1556, DOI 10.1210/me.2009-0099; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Lee S, 2009, MOL ENDOCRINOL, V23, P610, DOI 10.1210/me.2008-0455; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Malorni L, 2016, MOL CANCER RES, V14, P470, DOI 10.1158/1541-7786.MCR-15-0423; MASAMURA S, 1995, J CLIN ENDOCR METAB, V80, P2918, DOI 10.1210/jc.80.10.2918; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Razavi P, 2016, CANC RES; Richart L, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1152346; Richart L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10153; Sato K, 2016, CLIN BREAST CANCER, V17, pe135; Schiff R, 2000, J NATL CANCER I, V92, P1926, DOI 10.1093/jnci/92.23.1926; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; Wang CY, 2011, MOL ENDOCRINOL, V25, P1527, DOI 10.1210/me.2011-1037; Wellbrock C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002734; Won HH, 2013, JOVE-J VIS EXP, V80, P50710; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Z, 2016, CELL REP, V16, P3146, DOI 10.1016/j.celrep.2016.08.048; Zhou YM, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-59	60	65	67	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 23	2018	37	34					4692	4710		10.1038/s41388-018-0273-5	http://dx.doi.org/10.1038/s41388-018-0273-5			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GR3SE	29755131	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000442514400005
J	Everman, ER; Delzeit, JL; Hunter, FK; Gleason, JM; Morgan, TJ				Everman, Elizabeth R.; Delzeit, Jennifer L.; Hunter, F. Kate; Gleason, Jennifer M.; Morgan, Theodore J.			Costs of cold acclimation on survival and reproductive behavior in Drosophila melanogaster	PLOS ONE			English	Article							COURTSHIP SONG CHARACTERS; GENETIC REFERENCE PANEL; MATING SUCCESS; THERMAL-ACCLIMATION; MALE PHEROMONE; SHOCK INJURY; TEMPERATURE; FIELD; ADAPTATION; PLASTICITY	Fitness is determined by the ability of an organism to both survive and reproduce; however, the mechanisms that lead to increased survival may not have the same effect on reproductive success. We used nineteen natural Drosophila melanogaster genotypes from the Drosophila Genetic Reference Panel to determine if adaptive plasticity following short-term acclimation through rapid cold-hardening (RCH) affects mating behavior and mating success. We confirmed that exposure to the acclimation temperature is beneficial to survival following cold stress; however, we found that this same acclimation temperature exposure led to less efficient male courtship and a significant decrease in the likelihood of mating. Cold tolerance and the capacity to respond plastically to cold stress were not correlated with mating behavior following acclimation, suggesting that the genetic control of the physiological effects of the cold temperature exposure likely differ between survival and behavioral responses. We also tested whether the exposure of males to the acclimation temperature influenced courtship song. This exposure again significantly increased courtship duration; however, courtship song was unchanged. These results illustrate costs of short-term acclimation on survival and reproductive components of fitness and demonstrate the pronounced effect that short-term thermal environment shifts can have on reproductive success.	[Everman, Elizabeth R.; Delzeit, Jennifer L.; Hunter, F. Kate; Morgan, Theodore J.] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Gleason, Jennifer M.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Everman, Elizabeth R.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	Kansas State University; University of Kansas; University of Kansas	Morgan, TJ (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	tjmorgan@ksu.edu	Everman, Elizabeth/ABB-9145-2021; Gleason, Jennifer/E-7089-2012	Everman, Elizabeth/0000-0002-3190-4171; Hunter, Frances (Kate)/0000-0003-2163-5913; Morgan, Theodore/0000-0003-4535-2061; Gleason, Jennifer/0000-0002-0544-3404	National Science Foundation [NSF IOS-1051770]; NSF REU-Site award [NSF DBI- 1460802]; Undergraduate Research Mentoring in Ecological Genomics Grant [NSF DBI-1041199]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NSF REU-Site award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Undergraduate Research Mentoring in Ecological Genomics Grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation award NSF IOS-1051770 (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1051770) to T.J.M. Two undergraduate scientists, J.D. and F.K.H., were supported by the NSF REU-Site award (NSF DBI- 1460802; https://www.nsf.gov/awardsearch/showAward?AWD_ID=1460802). J.D. was also supported by an Undergraduate Research Mentoring in Ecological Genomics Grant (NSF DBI-1041199; https://www.nsf.gov/awardsearch/showAward?AWD_ID=1041199). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPI J, 1995, J INSECT BEHAV, V8, P67, DOI 10.1007/BF01990970; Basson CH, 2012, EVOLUTION, V66, P296, DOI 10.1111/j.1558-5646.2011.01419.x; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; Best AR, 2012, ANIM BEHAV, V83, P1483, DOI 10.1016/j.anbehav.2012.03.022; Bontonou G, 2013, J EVOLUTION BIOL, V26, P2008, DOI 10.1111/jeb.12206; CHEN CP, 1987, PHYSIOL ZOOL, V60, P297, DOI 10.1086/physzool.60.3.30162282; Colinet H, 2012, FUNCT ECOL, V26, P84, DOI 10.1111/j.1365-2435.2011.01898.x; COULSON SC, 1992, J INSECT PHYSIOL, V38, P421, DOI 10.1016/0022-1910(92)90118-W; CZAJKA MC, 1990, J EXP BIOL, V148, P245; Dick CA, 2013, PHYSIOL BIOCHEM ZOOL, V86, P432, DOI 10.1086/671462; Dolgin ES, 2006, J EVOLUTION BIOL, V19, P1894, DOI 10.1111/j.1420-9101.2006.01168.x; Everman ER, 2018, EVOLUTION, V72, P303, DOI 10.1111/evo.13408; Everman ER, 2017, PHYSIOL ENTOMOL, V42, P291, DOI 10.1111/phen.12191; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; Fasolo AG, 2004, BIOL J LINN SOC, V83, P197, DOI 10.1111/j.1095-8312.2004.00380.x; Franks SJ, 2012, ANNU REV GENET, V46, P185, DOI 10.1146/annurev-genet-110711-155511; Gaertner BE, 2015, G3-GENES GENOM GENET, V5, P531, DOI 10.1534/g3.114.014811; Geister TL, 2007, BEHAV ECOL, V18, P658, DOI 10.1093/beheco/arm024; Gerken AR, 2015, P NATL ACAD SCI USA, V112, P4399, DOI 10.1073/pnas.1503456112; Gibbs AG, 1998, J EXP BIOL, V201, P71; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Gorczyca M, 1987, DROS INFO SERV, V66, P157; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; HARDELAND R, 1971, AM NAT, V105, P198, DOI 10.1086/282717; HAWLEY AWL, 1975, CAN J ZOOL, V53, P768, DOI 10.1139/z75-091; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hoikkala A, 1997, J INSECT BEHAV, V10, P193, DOI 10.1007/BF02765552; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Ju RT, 2011, J INSECT PHYSIOL, V57, P1577, DOI 10.1016/j.jinsphys.2011.08.012; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Kelty JD, 1999, J INSECT PHYSIOL, V45, P719, DOI 10.1016/S0022-1910(99)00040-2; Kelty JD, 2001, J EXP BIOL, V204, P1659; Kelty J, 2007, PHYSIOL ENTOMOL, V32, P343, DOI 10.1111/j.1365-3032.2007.00584.x; KILIAS G, 1980, EVOLUTION, V34, P730, DOI 10.1111/j.1558-5646.1980.tb04012.x; Kingsolver JG, 1998, AM ZOOL, V38, P545; Koveos DS, 2001, ENTOMOL EXP APPL, V101, P257, DOI 10.1023/A:1019200726723; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; KYRIACOU CP, 1982, ANIM BEHAV, V30, P794, DOI 10.1016/S0003-3472(82)80152-8; Lee RE, 2006, CRYOBIOLOGY, V52, P459, DOI 10.1016/j.cryobiol.2006.03.003; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; LEROI AM, 1994, P NATL ACAD SCI USA, V91, P1917, DOI 10.1073/pnas.91.5.1917; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Noh S, 2017, ECOL EVOL, V7, P5248, DOI 10.1002/ece3.3112; Overgaard J, 2011, J THERM BIOL, V36, P409, DOI 10.1016/j.jtherbio.2011.07.005; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; R Core Team, 2013, R LANG ENV STAT COMP; RITCHIE MG, 1995, J EVOLUTION BIOL, V8, P463, DOI 10.1046/j.1420-9101.1995.8040463.x; Ritchie MG, 1998, ANIM BEHAV, V56, P713, DOI 10.1006/anbe.1998.0799; ROGAN JC, 1977, AM EDUC RES J, V14, P493, DOI 10.2307/1162346; Savarit F, 2002, J EXP BIOL, V205, P3241; Schou MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130307; Scott M, 1997, ENTOMOL EXP APPL, V85, P211, DOI 10.1023/A:1003173612155; Shreve SM, 2004, J EXP BIOL, V207, P1797, DOI 10.1242/jeb.00951; Sinclair BJ, 2006, PHYSIOL ENTOMOL, V31, P98, DOI 10.1111/j.1365-3032.2005.00481.x; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; TOOLSON EC, 1989, EVOLUTION, V43, P468, DOI 10.1111/j.1558-5646.1989.tb04242.x; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; Wang G, 2014, NAT CLIM CHANGE, V4, P988, DOI 10.1038/NCLIMATE2378; Wang XH, 2003, CRYOLETTERS, V24, P331; Westerman E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146546; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zimmerman DW, 1998, J EXP EDUC, V67, P55, DOI 10.1080/00220979809598344	69	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197822	10.1371/journal.pone.0197822	http://dx.doi.org/10.1371/journal.pone.0197822			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791517	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000063
J	Zhang, C; Chen, SY; Zhou, GY; Jin, YF; Zhang, RG; Yang, HY; Xi, YL; Ren, JC; Duan, GC				Zhang, Chao; Chen, Shuaiyin; Zhou, Guangyuan; Jin, Yuefei; Zhang, Rongguang; Yang, Haiyan; Xi, Yuanlin; Ren, Jingchao; Duan, Guangcai			Involvement of the renin-angiotensin system in the progression of severe hand-foot-and-mouth disease	PLOS ONE			English	Article							ENZYME 2 ACE2; CONVERTING ENZYME; ENTEROVIRUS 71; LUNG INJURY; CHINA; INFECTION; SINGAPORE; EPIDEMIC	Background Hand-foot-and-mouth disease (HFMD) is generally considered as a mild exanthematous disease to infants and young children worldwide. HFMD cases are usually mild and self-limiting but for few cases leads to complicated severe clinical outcomes, and even death. Previous studies have indicated that serum Ang ll levels in patients with H7N9 infection were related to the severity of infection. However, the mechanisms underlying the pathogenesis of severe HFMD remain unclear. This study was undertaken to clarify the role of the renin-angiotensin system (RAS) in the progression of severe HFMD. Methods In the present study, 162 children including HFMD patients and healthy controls were recruited. The data was analyzed by time-series fashion. Concentrations of angiotensin II (Ang II) and noradrenaline (NA) in serum of patients were measured with ELISA. We established a mouse model for enterovirus 71 (EV71) infection and determined concentrations of Ang II, NA in tissue lysates at 3, 5 and 7 days post infection (dpi). Results The concentrations of Ang II and NA in serum of the HFMD patients with mild or severe symptoms were significantly higher than that in healthy controls. Additionally, the concentrations of Ang II and NA in serum of severe cases were significantly higher than those mild cases and the increased concentrations of Ang II and NA showed the same time trend during the progression of HFMD in the severe cases. Furthermore, the concentrations of Ang II and NA in target organs of EV71-infected mice including brains, skeletal muscle, and lungs were increased with the progression of EV71 infection in mice. Histopathological alterations were observed in the brains, skeletal muscle and lungs of EV71-infected mice. Conclusion Our study suggested that activation of the RAS is implicated in the pathogenesis of severe HFMD.	[Zhang, Chao; Chen, Shuaiyin; Jin, Yuefei; Zhang, Rongguang; Yang, Haiyan; Xi, Yuanlin; Duan, Guangcai] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol, Zhengzhou, Henan, Peoples R China; [Zhou, Guangyuan; Ren, Jingchao] Xinxiang Med Univ, Sch Publ Hlth, Dept Epidemiol, Xinxiang, Henan, Peoples R China	Zhengzhou University; Xinxiang Medical University	Duan, GC (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol, Zhengzhou, Henan, Peoples R China.	gcduan@zzu.edu.cn	Jin, Yuefei/AAL-5163-2020; Jin, Yuefei/AES-4089-2022; Chen, Shuaiyin/AAS-7933-2021		National Natural Science Foundation of China [81172740, 81573205]; key scientific research projects at the Colleges and Universities of Henan Province [15A330003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key scientific research projects at the Colleges and Universities of Henan Province	This work was supported by National Natural Science Foundation of China, grant numbers: 81172740 and 81573205 (URL: http://www.nsfc.gov.cn/publish/portal/tab131/); and key scientific research projects at the Colleges and Universities of Henan Province, grant number: 15A330003 (URL: http://www.haedu.gov.cn/).	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Dang DJ, 2017, ONCOTARGET, V8, P81014, DOI 10.18632/oncotarget.21250; Duan GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112676; Guo XS, 2017, J RENIN-ANGIO-ALDO S, V18, DOI 10.1177/1470320317708894; Han CH, 2017, UNDERSEA HYPERBAR M, V44, P39; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang FM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4595; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Inoue M, 2018, CLIN EXP HYPERTENS, V40, P624, DOI 10.1080/10641963.2017.1416119; Jerng JS, 2007, THORAX, V62, P527, DOI 10.1136/thx.2006.061945; Jin YF, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0911-5; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Liao CC, 2014, J VIROL, V88, P12485, DOI 10.1128/JVI.00692-14; Lin YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188975; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Mou J, 2014, EPIDEMIOL INFECT, V142, P776, DOI 10.1017/S0950268813001453; NikNadia NMN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004562; Ong KC, 2008, J NEUROPATH EXP NEUR, V67, P532, DOI 10.1097/NEN.0b013e31817713e7; Perdomo-Pantoja A, 2018, J NEURO-ONCOL, V138, P1, DOI 10.1007/s11060-018-2789-5; RICHARDSON HB, 1965, J PEDIATR-US, V67, P6, DOI 10.1016/S0022-3476(65)80297-9; Ventarola D, 2015, CLIN DERMATOL, V33, P340, DOI 10.1016/j.clindermatol.2014.12.011; Wang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147532; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yamamura H, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0280-1; Yang PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07027; Yang YW, 2018, SCI TOTAL ENVIRON, V630, P820, DOI 10.1016/j.scitotenv.2018.02.262; Zou Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4594	28	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2018	13	5							e0197861	10.1371/journal.pone.0197861	http://dx.doi.org/10.1371/journal.pone.0197861			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0FF	29791486	Green Published, gold, Green Submitted			2022-12-26	WOS:000433077000065
J	Scott, DM; Baker, R; Charmen, N; Karlsson, H; Yarnell, RW; Mill, AC; Smith, GC; Tolhurst, BA				Scott, Dawn M.; Baker, Rowenna; Charmen, Naomi; Karlsson, Heidi; Yarnell, Richard W.; Mill, Aileen C.; Smith, Graham C.; Tolhurst, Bryony A.			A citizen science based survey method for estimating the density of urban carnivores	PLOS ONE			English	Article							FOXES VULPES-VULPES; BADGERS MELES-MELES; RED FOXES; RANGING BEHAVIOR; ECHINOCOCCUS-MULTILOCULARIS; POPULATION; PATTERNS; TRENDS; ORGANIZATION; HUMANS	Globally there are many examples of synanthropic carnivores exploiting growth in urbanisation. As carnivores can come into conflict with humans and are potential vectors of zoonotic disease, assessing densities in suburban areas and identifying factors that influence them are necessary to aid management and mitigation. However, fragmented, privately owned land restricts the use of conventional carnivore surveying techniques in these areas, requiring development of novel methods. We present a method that combines questionnaire distribution to residents with field surveys and GIS, to determine relative density of two urban carnivores in England, Great Britain. We determined the density of: red fox (Vulpes vulpes) social groups in 14, approximately 1 km(2) suburban areas in 8 different towns and cities; and Eurasian badger (Metes metes) social groups in three suburban areas of one city. Average relative fox group density (FGD) was 3.72 km(-2), which was double the estimates for cities with resident foxes in the 1980's. Density was comparable to an alternative estimate derived from trapping and GPS-tracking, indicating the validity of the method. However, FGD did not correlate with a national dataset based on fox sightings, indicating unreliability of the national data to determine actual densities or to extrapolate a national population estimate. Using species-specific clustering units that reflect social organisation, the method was additionally applied to suburban badgers to derive relative badger group density (BGD) for one city (Brighton, 2.41 km(-2)). We demonstrate that citizen science approaches can effectively obtain data to assess suburban carnivore density, however publicly derived national data sets need to be locally validated before extrapolations can be undertaken. The method we present for assessing densities of foxes and badgers in British towns and cities is also adaptable to other urban carnivores elsewhere. However this transferability is contingent on species traits meeting particular criteria, and on resident responsiveness.	[Scott, Dawn M.; Baker, Rowenna; Charmen, Naomi; Karlsson, Heidi; Tolhurst, Bryony A.] Univ Brighton, Conservat Ecol & Zoonosis Res Grp, Brighton, E Sussex, England; [Yarnell, Richard W.] Nottingham Trent Univ, Sch Anim Rural & Environm Sci, Brackenhurst Campus, Southwell, England; [Mill, Aileen C.] Newcastle Univ, Ctr Wildlife Management, Newcastle Upon Tyne, Tyne & Wear, England; [Smith, Graham C.] Anim & Plant Hlth Agcy, York, N Yorkshire, England	University of Brighton; Nottingham Trent University; Newcastle University - UK; Animal & Plant Health Agency UK	Scott, DM (corresponding author), Univ Brighton, Conservat Ecol & Zoonosis Res Grp, Brighton, E Sussex, England.	dawn.scott@brighton.ac.uk	Tolhurst, Bryony/AAT-9022-2020; Smith, Graham C/J-2593-2013	Tolhurst, Bryony/0000-0002-0198-5046; Smith, Graham C/0000-0002-9897-6794; Yarnell, Richard/0000-0001-6584-7374; Baker, Rowenna/0000-0002-5751-4999; Scott, Dawn/0000-0002-9570-2739	Earthwatch Institute, Urban Mammals Project Grant; University of Brighton; APHA	Earthwatch Institute, Urban Mammals Project Grant; University of Brighton; APHA	The project was partially funded by Earthwatch Institute (earthwatch.org), Urban Mammals Project Grant (DS) for the first year. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The University of Brighton (DS) and APHA (DS) provided supplementary funds to cover equipment and travel costs. Universities of Nottingham Trent and Newcastle supported undergraduate students involved with the project data collection at respective cities. Academics at these institutes had a role in study design, data collection and analysis, decision to publish, and/or preparation of the manuscript.	Atterby H, 2015, MAMMAL RES, V60, P9, DOI 10.1007/s13364-014-0209-6; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Baker PJ, 2007, BEHAV ECOL, V18, P716, DOI 10.1093/beheco/arm035; Baker PJ, 2004, BEHAV ECOL, V15, P766, DOI 10.1093/beheco/arh077; Baker PJ, 2000, ANIM BEHAV, V59, P127, DOI 10.1006/anbe.1999.1285; Bateman PW, 2012, J ZOOL, V287, P1, DOI 10.1111/j.1469-7998.2011.00887.x; Brochier B, 2007, PREV VET MED, V80, P65, DOI 10.1016/j.prevetmed.2007.01.004; Cervinka J, 2014, URBAN ECOSYST, V17, P893, DOI 10.1007/s11252-014-0364-1; Cliquet F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001535; Dallimer M, 2011, BIOL LETTERS, V7, P763, DOI 10.1098/rsbl.2011.0025; Davies ZG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039692; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Davison J, 2008, J ZOOL, V275, P190, DOI 10.1111/j.1469-7998.2008.00424.x; Davison J, 2009, J ZOOL, V277, P45, DOI 10.1111/j.1469-7998.2008.00509.x; Delahay RJ, 2013, EPIDEMIOL INFECT, V141, P1445, DOI 10.1017/S0950268813000721; Delahay RJ, 2009, MAMMAL REV, V39, P53, DOI 10.1111/j.1365-2907.2008.00135.x; Gehrt SD., 2010, URBAN CARNIVORES ECO; Gloor S, 2001, MAMM BIOL, V66, P155; HARRIS S, 1986, J ANIM ECOL, V55, P575, DOI 10.2307/4740; HARRIS S, 1986, J ANIM ECOL, V55, P605, DOI 10.2307/4742; HARRIS S, 1986, J ANIM ECOL, V55, P593, DOI 10.2307/4741; HARRIS S, 1981, J APPL ECOL, V18, P455, DOI 10.2307/2402406; Harris S., 1987, Symposia of the Zoological Society of London, P313; HARRIS S, 1985, BIOLOGIST, V32, P259; Harris S., 1995, REV BRIT MAMMALS POP; Harris S, 2001, URBAN FOXES; Hegglin D, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-247; Herr J, 2009, J ZOOL, V277, P54, DOI 10.1111/j.1469-7998.2008.00510.x; Huck M, 2008, J ANIM ECOL, V77, P905, DOI 10.1111/j.1365-2656.2008.01415.x; Judge J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03809; Kauhala K, 2016, MAMMAL RES, V61, P25, DOI 10.1007/s13364-015-0250-0; Kozlowski AJ, 2008, AM MIDL NAT, V160, P191, DOI 10.1674/0003-0031(2008)160[191:NOARPB]2.0.CO;2; Learmount J, 2012, VET PARASITOL, V190, P447, DOI 10.1016/j.vetpar.2012.07.003; Levi T, 2012, P NATL ACAD SCI USA, V109, P10942, DOI 10.1073/pnas.1204536109; MacDonald DWN, 1982, DISTRIBUTION ECOLOGY, P123; Marks CA, 1999, WILDLIFE RES, V26, P763, DOI 10.1071/WR98059; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Nouvellet P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061588, 10.1371/currents.outbreaks.097a904d3f3619db2fe78d24bc776098]; R Core Team, 2021, R LANGUAGE ENV STAT; Robertson CPJ, 2000, ACTA THERIOL, V45, P525, DOI 10.4098/AT.arch.00-51; Sadlier LMJ, 2004, MAMMAL REV, V34, P75, DOI 10.1046/j.0305-1838.2003.00029.x; Salek M, 2015, MAMMAL REV, V45, P1, DOI 10.1111/mam.12027; Saunders G, 1997, MAMMALIA, V61, P497; Scott DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099059; Singer A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-79; Smith GC, 2003, J WILDLIFE DIS, V39, P278, DOI 10.7589/0090-3558-39.2.278; Soulsbury CD, 2007, MAMMAL REV, V37, P278, DOI 10.1111/j.1365-2907.2007.00101.x; Soulsbury CD, 2015, WILDLIFE RES, V42, P541, DOI 10.1071/WR14229; Soulsbury CD, 2010, URBAN CARNIVORES ECO; Stamps JA, 2009, AM NAT, V174, P623, DOI 10.1086/644526; Tolhurst B, 2016, APPL ANIM BEHAV SCI, V181, P182, DOI 10.1016/j.applanim.2016.05.004; Toms MP, 2006, MAMMAL REV, V36, P309, DOI 10.1111/j.1365-2907.2006.00094.x; Wilkinson D, 2001, MAMMAL REV, V31, P107, DOI 10.1046/j.1365-2907.2001.00076.x	53	15	15	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197445	10.1371/journal.pone.0197445	http://dx.doi.org/10.1371/journal.pone.0197445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787598	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000432785700027
J	Sillo, HB; Masota, NE; Kisoma, S; Rago, L; Mgoyela, V; Kaale, EA				Sillo, Hiiti B.; Masota, Nelson E.; Kisoma, Sunday; Rago, Lembit; Mgoyela, Veronica; Kaale, Eliangiringa A.			Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market	PLOS ONE			English	Article							MEDICATION INFORMATION; PUBLIC-HEALTH; BENEFITS; ATTITUDE; BELGIUM; NEEDS	Background Availability of correct and adequate information about medicines is an important aspect in ensuring rational use of medicines and hence facilitating safety and expected efficacy of medicines during therapy. Package inserts have proven to be a good source of information to the prescribers and patients whereby they have been useful in highlighting important information pertaining proper use and handling of the medicines. The present study was aimed at establishing the extent to which package inserts of medicines circulating on the markets of the East African Community (EAC) Partner States conform to medicines information requirements as established in the harmonized guidelines as well as national guidelines. Methods A total of 99 package inserts from six (6) types of medicines namely Albendazole, Artemether/Lumefantrine (ALu), Ciprofloxacin, Paracetamol, Amoxicillin and Metronidazole were purposefully collected from three EAC Partner States: Kenya, Tanzania and Uganda. The medicines were selected based on their indications as first line treatments, high rates of utilization within the medicines supply system and their positions in treatment of diseases of public importance across EAC Partner States. The inserts were evaluated on the availability of information regarding fifteen (15) parameters as extracted from the EAC harmonized guidelines for registration of medicines. Moreover, comparisons were made between the percentage conformity of the branded versus generic products, markets from which the samples were collected, origin of the manufacturer and type of medicine. Results Majority (93.9-100%) of the medicines' package inserts highly conformed to the inclusion of the information regarding the description and composition of the medications, indications, dosage and methods of administration, warnings and precautions, contraindications and storage conditions. However, the information on handling and disposal, container package description, excipients used, clinical pharmacology of the medicines, and directions regarding overdose ranked the least in conformance with conformity ranging from 13.1-52.5%. The parameter with the lowest observed percentage conformity among the branded products scored 50% as compared to 10.8% among the generic products. Moreover, there was no significant difference (P<0.05) in the percentage conformity of the package inserts collected from each of the three Partner States as compared to the average from studied medicines. A generally good conformity was observed among medicines manufactured by European based manufacturers as compared to those based in Asia and EAC Partner States. In addition, Pls of Albendazole, Ciprofloxacin, Amoxicillin and Artemether/Lumefantrine did show overall high conformity across most of the product information requirements. Conclusion Our study revealed the existence of a significant number of medicinal products circulating on the markets of EAC Partner States without necessary compliance with all product information requirements. We therefore recommend that NMRAs ensure thorough pre-market assessment of product information as well as strengthening their post marketing surveillance to ensure that medicines circulating on the market comply to medicines information requirements at all times. Emphasis should also be given to manufacturers on the importance of inclusion of appropriate and adequate product information for the safety of patients, including advocating for inclusion of patient-friendly and easy to understand medicines information.	[Sillo, Hiiti B.; Kisoma, Sunday] Tanzania Food & Drugs Regulatory Author, Dar Es Salaam, Tanzania; [Masota, Nelson E.; Mgoyela, Veronica; Kaale, Eliangiringa A.] MUHAS Dar Es Salaam, Dept Med Chem, Sch Pharm, Dar Es Salaam, Tanzania; [Masota, Nelson E.; Kaale, Eliangiringa A.] MUHAS Dar Es Salaam, Pharmaceut R&D Lab, Sch Pharm, Dar Es Salaam, Tanzania; [Rago, Lembit] CIOMS, Geneva, Switzerland		Kaale, EA (corresponding author), MUHAS Dar Es Salaam, Dept Med Chem, Sch Pharm, Dar Es Salaam, Tanzania.; Kaale, EA (corresponding author), MUHAS Dar Es Salaam, Pharmaceut R&D Lab, Sch Pharm, Dar Es Salaam, Tanzania.	elia.kaale@gmail.com	Rago, Lembit/AAF-4732-2019; Kaale, Eliangiringa/AAC-8561-2019	Kaale, Eliangiringa/0000-0001-6008-3539; Masota, Nelson/0000-0001-7375-7803	Tanzanian Commission for Science and Technology (COSTECH)	Tanzanian Commission for Science and Technology (COSTECH)	The study on which this manuscript is based was funded by Tanzanian Commission for Science and Technology (COSTECH). The COSTECH had no input in the study design, data collection, analysis or the preparation of the manuscript.; Authors would like to express their sincere gratitude to the Tanzanian Commission for Science and Technology (COSTECH) for funding this study. The officials in the NMRAs of Tanzania, Kenya and Uganda are sincerely appreciated for their good support during the data collection and conduct of this study. The School of Pharmacy at Muhimbili University of Health and Allied Sciences (MUHAS) is acknowledged for providing space and material support towards successful completion of this study.	Al-Aqeel SA, 2012, DRUG HEALTHC PATIENT, V4, P33, DOI 10.2147/DHPS.S29402; [Anonymous], 2014, COMPENDIUM MED EVALU; Bandesha G, 1996, INT J PHARM PRACT, V4, P246, DOI DOI 10.1111/J.2042-7174.1996.TB00875.X; Bhosale UA., 2016, ASIAN J PHARM AJP FR, V10; Centers for Disease Control and Prevention (CDC), 2012, MMWR-MORBID MORTAL W, V61, P10; European Medicines Agency, EMA APPR MED; Fuchs J, 2006, INT J CLIN PHARM TH, V44, P8; GIBBS S, 1989, BRIT J CLIN PHARMACO, V28, P345, DOI 10.1111/j.1365-2125.1989.tb05436.x; Hamrosi KK, 2014, HEALTH EXPECT, V17, P220, DOI 10.1111/j.1369-7625.2011.00753.x; HERMANN F, 1978, BRIT MED J, V2, P1132, DOI 10.1136/bmj.2.6145.1132; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; JOUBERT P, 1975, CLIN PHARMACOL THER, V18, P507; JOUBERT P, 1975, CLIN PHARMACOL THER, V18, P663; Ministry of Health, 2012, ESS MED HLTH SUPPL L; Ministry of Health, 2016, KENYA ESSENTIAL MED; Ministry of Health and Social Welfare, 2013, STANDARD TREATMENT G; Mssusa AK, 2016, CLIN DRUG INVEST, V36, P401, DOI 10.1007/s40261-016-0385-z; Naem-Kettana WS, 2012, PHARM PRACT-SPAIN, V10, P57; Ndomondo-Sigonda M, 2011, CLIN PHARMACOL THER, V89, P176, DOI 10.1038/clpt.2010.299; Popowska M, 2010, J ENVIRON QUAL, V39, P1679, DOI 10.2134/jeq2009.0499; Shivkar YM, 2009, J POSTGRAD MED, V55, P104, DOI 10.4103/0022-3859.52840; 't Hoen EFM, 2014, J PUBLIC HEALTH POL, V35, P137, DOI 10.1057/jphp.2013.53; van Dijk L, 2014, STUDY PACKAGE LEAFLE; Vander Stichele RH, 2002, DRUG INF J, V36, P201; VanderStichele RH, 1996, PATIENT EDUC COUNS, V28, P5, DOI 10.1016/0738-3991(96)00866-X; VANDERSTICHELE RH, 1991, DICP ANN PHARMAC, V25, P1002, DOI 10.1177/106002809102500916; VANHAECHT CHM, 1990, EUR J CLIN PHARMACOL, V39, P551, DOI 10.1007/BF00316093; VANHAECHT CHM, 1991, PATIENT EDUC COUNS, V17, P205, DOI 10.1016/0738-3991(91)90061-9; Young A, 2017, RES SOC ADMIN PHARM, V13, P1186, DOI 10.1016/j.sapharm.2016.10.006	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 22	2018	13	5							e0197490	10.1371/journal.pone.0197490	http://dx.doi.org/10.1371/journal.pone.0197490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG6DG	29787579	Green Published, Green Submitted, gold			2022-12-26	WOS:000432785700029
J	Rahmel, T; Schafer, ST; Frey, UH; Adamzik, M; Peters, J				Rahmel, Tim; Schaefer, Simon T.; Frey, Ulrich H.; Adamzik, Michael; Peters, Juergen			Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria	PLOS ONE			English	Article							SEPTIC SHOCK; SERUM MIR-122; LIVER-INJURY; DEFINITIONS; MORTALITY; MECHANISM; MARKER	Background Sepsis is now operationally defined as life-threatening organ dysfunction caused by an infection, identified by an acute change in SOFA-Score of at least two points, including clinical chemistry such as creatinine or bilirubin concentrations. However, little knowledge exists about organ-specific microRNAs as potentially new biomarkers. Accordingly, we tested the hypotheses that micro-RNA-122, the foremost liver-related micro-RNA (miR), 1) discriminates between sepsis and infection, 2) is an early predictor for mortality, and 3) improves the prognostic value of the SOFA-score. Methods We analyzed 108 patients with sepsis (infection + increase SOFA-Score >= 2) within the first 24h of ICU admission and as controls 20 patients with infections without sepsis (infection + SOFA-Score <= 1). Total circulating miR was isolated from serum and relative miR-122 expression was measured (using spiked-in cel-miR-54) and associated with 30-day survival. Results 30-day survival of the sepsis patients was 63%. miR-122 expression was 40-fold higher in non-survivors (p = 0.001) and increased almost 6-fold in survivors (p = 0.013) compared to controls. miR-122 serum-expression discriminated both between sepsis vs. infection (AUC 0.760, sensitivity 58.3%, specificity 95%) and survivors vs. non-survivors (AUC 0.728, sensitivity 42.5%, specificity 94%). Multivariate Cox-regression analysis revealed miR-122 (HR 4.3; 95%-CI 2.0-8.9, p<0.001) as independent prognostic factor for 30-day mortality. Furthermore, the predictive value for 30-day mortality of the SOFA-Score (AUC 0.668) was improved by adding miR-122 (AUC 0.743; net reclassification improvement 0.37, p<0.001; integrated discrimination improvement 0.07, p = 0.007). Conclusions Increased miR-122 serum concentration supports the discrimination between infection and sepsis, is an early and independent risk factor for 30-day mortality, and improves the prognostic value of the SOFA-Score, suggesting a potential role for miR-122 in sepsis-related prediction models.	[Rahmel, Tim; Adamzik, Michael] Univ Klinikum Knappschaftskrankenhaus Bochum, Klin Anasthesiol Intensivmed & Schmerztherapie, Bochum, Germany; [Schaefer, Simon T.; Frey, Ulrich H.; Adamzik, Michael; Peters, Juergen] Univ Duisburg Essen, Klin Anasthesiol & Intensivmed, Essen, Germany; [Schaefer, Simon T.; Frey, Ulrich H.; Adamzik, Michael; Peters, Juergen] Univ Klinikum Essen, Essen, Germany; [Schaefer, Simon T.] Ludwig Maximilians Univ Munchen, Klin Anaesthesiol, Munich, Germany; [Frey, Ulrich H.] Marien Hosp Herne, Klin Anasthesiol Operat Intensivmed Schmerz & Pal, Herne, Germany	Ruhr University Bochum; University of Duisburg Essen; University of Duisburg Essen; University of Munich; Ruhr University Bochum; St. Marien Hospital	Rahmel, T (corresponding author), Univ Klinikum Knappschaftskrankenhaus Bochum, Klin Anasthesiol Intensivmed & Schmerztherapie, Bochum, Germany.	Tim.Rahmel@ruhr-uni-bochum.de	Adamzik, Michael/HGE-9286-2022; Rahmel, Tim/AAI-1566-2020; Schaefer, Simon Thomas/AAA-8869-2021; Frey, Ulrich H/C-2752-2019	Rahmel, Tim/0000-0002-7039-6288; Schaefer, Simon Thomas/0000-0001-7289-6000; Frey, Ulrich/0000-0003-2961-6629	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum	The authors acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum to TR, just for financial support for publication costs. This had no impact on our design or study, collection, analysis and interpretation of data.	Adamzik M, 2012, CRIT CARE, V16, DOI 10.1186/cc11425; Angus DC, 2013, NEW ENGL J MED, V369, P2063, DOI 10.1056/NEJMc1312359; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bai XW, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0532-y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauer M, 2013, CURR OPIN CRIT CARE, V19, P123, DOI 10.1097/MCC.0b013e32835eba6d; Benz F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010078; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Dolin HH, 2017, SHOCK; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Kim H, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0252-y; Leelahavanichkul A, 2015, HEPATOL RES, V45, P1341, DOI 10.1111/hepr.12501; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Roderburg C, 2015, LIVER INT, V35, P1172, DOI 10.1111/liv.12627; SepNet Critical Care Trials Grp, 2016, INTENS CARE MED, V42, P1980, DOI 10.1007/s00134-016-4504-3; Siaj R, 2012, HEPATOL INT, V6, P770, DOI 10.1007/s12072-012-9348-5; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stammet P, 2012, CRIT CARE MED, V40, P3209, DOI 10.1097/CCM.0b013e31825fdd5e; Trebicka J, 2013, J HEPATOL, V58, P234, DOI 10.1016/j.jhep.2012.10.015; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Engelen TSR, 2018, CRIT CARE CLIN, V34, P139, DOI 10.1016/j.ccc.2017.08.010; Verma P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01274; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang HJ, 2014, CLIN CHEM LAB MED, V52, P927, DOI 10.1515/cclm-2013-0899; Wang HJ, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0704-9; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	35	22	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197637	10.1371/journal.pone.0197637	http://dx.doi.org/10.1371/journal.pone.0197637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782519	Green Published, Green Submitted, gold			2022-12-26	WOS:000432537100037
J	Rooijakkers, BJM; Ikonen, MS; Linder, MB				Rooijakkers, Bart J. M.; Ikonen, Martina S.; Linder, Markus B.			Fungal-type carbohydrate binding modules from the coccolithophore Emiliania huxleyi show binding affinity to cellulose and chitin	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TRICHODERMA-REESEI; CELLOBIOHYDROLASE-I; DOMAIN; PROTEIN; CALCIFICATION; CELLULASES; DATABASE; ENZYMES	Six fungal-type cellulose binding domains were found in the genome of the coccolithophore Emiliania huxleyi and cloned and expressed in Escherichia coll. Sequence comparison indicate high similarity to fungal cellulose binding domains, raising the question of why these domains exist in coccolithophores. The proteins were tested for binding with cellulose and chitin as ligands, which resulted in the identification of two functional carbohydrate binding modules: EHUX2 and EHUX4. Compared to benchmark fungal cellulose binding domain CeI7A-CBM1 from Trichoderma reesei, these proteins showed slightly lower binding to birch and bacterial cellulose, but were more efficient chitin binders. Finally, a set of cellulose binding domains was created based on the shuffling of one well-functioning and one non-functional domain. These were characterized in order to get more information of the binding domain's sequence -function relationship, indicating characteristic differences between the molecular basis of cellulose versus chitin recognition. As previous reports have showed the presence of cellulose in coccoliths and here we find functional cellulose binding modules, a possible connection is discussed.	[Rooijakkers, Bart J. M.; Ikonen, Martina S.; Linder, Markus B.] Aalto Univ, Sch Chem Engn, Dept Bioprod & Biosyst, Espoo, Finland	Aalto University	Linder, MB (corresponding author), Aalto Univ, Sch Chem Engn, Dept Bioprod & Biosyst, Espoo, Finland.	markus.linder@aalto.fi	Linder, Markus B/E-5879-2011; Linder, Markus/N-8043-2019	Linder, Markus B/0000-0002-7271-6441; Linder, Markus/0000-0002-7271-6441	Academy of Finland	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arola S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35358; Benner I, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0049; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BROWN RM, 1969, SCIENCE, V166, P894, DOI 10.1126/science.166.3907.894; Corstjens PLAM, 1998, J PHYCOL, V34, P622, DOI 10.1046/j.1529-8817.1998.340622.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edvardsen B, 2000, PHYCOLOGIA, V39, P19, DOI 10.2216/i0031-8884-39-1-19.1; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gaciarz A, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0419-5; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Green JC, 1996, J MARINE SYST, V9, P33, DOI 10.1016/0924-7963(96)00014-0; Hatahet F, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-67; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; HENRISSAT B, 1994, CELLULOSE, V1, P169, DOI 10.1007/BF00813506; Henrissat B., 1991, BIOCHEM J, P280; HERTH W, 1972, PLANTA, V105, P79, DOI 10.1007/BF00385167; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Holtz LM, 2013, GREEN BIOSYNTHESIS OF NANOPARTICLES: MECHANISMS AND APPLICATIONS, P132, DOI 10.1079/9781780642239.0132; ITOH T, 1990, J CELL SCI, V95, P309; Jordan RW, 2004, MICROPALEONTOLOGY, V50, P55, DOI 10.2113/50.Suppl_1.55; Kayano K, 2011, MAR BIOTECHNOL, V13, P83, DOI 10.1007/s10126-010-9272-4; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1997, J BIOTECHNOL, V57, P15, DOI 10.1016/S0168-1656(97)00087-4; Linder M, 1999, FEBS LETT, V447, P13, DOI 10.1016/S0014-5793(99)00253-7; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martinez T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137481; Mateos FV, 1997, MOL PLANT MICROBE IN, V10, P1045, DOI 10.1094/MPMI.1997.10.9.1045; Mattinen ML, 1997, PROTEIN SCI, V6, P294; Mattinen ML, 1998, EUR J BIOCHEM, V256, P279, DOI 10.1046/j.1432-1327.1998.2560279.x; Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9; Nagasawa H, 2013, BIOSCI BIOTECH BIOCH, V77, P1991, DOI 10.1271/bbb.130464; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Tomme P, 1996, CELLULOSE BINDING DO, P142, DOI [10.1021/BK-1995-0618.CH010, DOI 10.1021/BK-1995-0618.CH010]; Varnai A, 2014, CARBOHYDRATE BINDING, P103, DOI [10.1016/B978-0-12-800260-5.00004, DOI 10.1016/B978-0-12-800260-5.00004]; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilson DB, 2009, CURR OPIN BIOTECH, V20, P295, DOI 10.1016/j.copbio.2009.05.007; Xu JT, 2016, BIOGEOSCIENCES, V13, P4637, DOI 10.5194/bg-13-4637-2016; Yoshida M, 2005, APPL ENVIRON MICROB, V71, P4548, DOI 10.1128/AEM.71.8.4548-4555.2005; Young JR, 2003, REV MINERAL GEOCHEM, V54, P189, DOI 10.2113/0540189; Young JR, 1999, J STRUCT BIOL, V126, P195, DOI 10.1006/jsbi.1999.4132	48	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2018	13	5							e0197875	10.1371/journal.pone.0197875	http://dx.doi.org/10.1371/journal.pone.0197875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2QJ	29782536	Green Submitted, Green Published, gold			2022-12-26	WOS:000432537100048
J	Alex, A; Antunes, A				Alex, Anoop; Antunes, Agostinho			Genus-wide comparison of Pseudovibrio bacterial genomes reveal diverse adaptations to different marine invertebrate hosts	PLOS ONE			English	Article							III SECRETION SYSTEM; LEUCINE-RICH REPEATS; PV. TOMATO DC3000; EXTRACELLULAR-MATRIX; ESCHERICHIA-COLI; SP-NOV.; PROTEIN; SEQUENCE; IDENTIFICATION; EVOLUTION	Bacteria belonging to the genus Pseudovibrio have been frequently found in association with a wide variety of marine eukaryotic invertebrate hosts, indicative of their versatile and symbiotic lifestyle. A recent comparison of the sponge-associated Pseudovibrio genomes has shed light on the mechanisms influencing a successful symbiotic association with sponges. In contrast, the genomic architecture of Pseudovibrio bacteria associated with other marine hosts has received less attention. Here, we performed genus-wide comparative analyses of 18 Pseudovibrio isolated from sponges, coral, tunicates, flatworm, and sea-water. The analyses revealed a certain degree of commonality among the majority of sponge- and coral-associated bacteria. Isolates from other marine invertebrate host, tunicates, exhibited a genetic repertoire for cold adaptation and specific metabolic abilities including mucin degradation in the Antarctic tunicate-associated bacterium Pseudovibrio sp. Tun.PHSC04_5.14. Reductive genome evolution was simultaneously detected in the flatworm-associated bacteria and the sponge-associated bacterium P. axinellae AD2, through the loss of major secretion systems (type IIINI) and virulence/symbioses factors such as proteins involved in adhesion and attachment to the host. Our study also unraveled the presence of a CRISPR-Cas system in P. stylochi UST20140214-052 a flatworm-associated bacterium possibly suggesting the role of CRISPR-based adaptive immune system against the invading virus particles. Detection of mobile elements and genomic islands (GIs) in all bacterial members highlighted the role of horizontal gene transfer for the acquisition of novel genetic features, likely enhancing the bacterial ecological fitness. These findings are insightful to understand the role of genome diversity in Pseudovibrio as an evolutionary strategy to increase their colonizing success across a wide range of marine eukaryotic hosts.	[Alex, Anoop; Antunes, Agostinho] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, Porto, Portugal; [Alex, Anoop; Antunes, Agostinho] Univ Porto, Fac Sci, Dept Biol, Porto, Portugal	Universidade do Porto; Universidade do Porto	Alex, A; Antunes, A (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, Porto, Portugal.; Alex, A; Antunes, A (corresponding author), Univ Porto, Fac Sci, Dept Biol, Porto, Portugal.	anoopthycaud@gmail.com; aantunes@ciimar.up.pt		Alex, Anoop/0000-0001-5788-1089; Antunes, Agostinho/0000-0002-1328-1732	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/99251/2013]; MarInfo - Integrated Platform for Marine Data Acquisition and Analysis - North Portugal Regional Operational Program (NORTE), under the PORTUGAL through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000031]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); MarInfo - Integrated Platform for Marine Data Acquisition and Analysis - North Portugal Regional Operational Program (NORTE), under the PORTUGAL through the European Regional Development Fund (ERDF)	Anoop Alex was funded by the Fundacao para a Ciencia e a Tecnologia (FCT) SFRH/BPD/99251/2013 grant. Agostinho Antunes was supported by the MarInfo - Integrated Platform for Marine Data Acquisition and Analysis (reference NORTE-01-0145-FEDER-000031), a project supported by the North Portugal Regional Operational Program (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF).	Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Alex A, 2015, GENOME BIOL EVOL, V7, P3022, DOI 10.1093/gbe/evv199; Alex A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080653; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Allen MA, 2009, ISME J, V3, P1012, DOI 10.1038/ismej.2009.45; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bondarev V, 2013, ENVIRON MICROBIOL, V15, P2095, DOI 10.1111/1462-2920.12123; Bone Q, 2003, J MAR BIOL ASSOC UK, V83, P907, DOI 10.1017/S002531540300804Xh; Brinkman FSL, 2002, GENOME RES, V12, P1159, DOI 10.1101/gr.341802; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Burgsdorf I, 2015, MBIO, V6, DOI 10.1128/mBio.00391-15; Burstein D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10613; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cases I, 2003, TRENDS MICROBIOL, V11, P248, DOI 10.1016/S0966-842X(03)00103-3; Coleman SA, 2003, MICROB PATHOGENESIS, V34, P179, DOI 10.1016/S0882-4010(03)00005-6; COLLINSON SK, 1993, J BACTERIOL, V175, P12, DOI 10.1128/JB.175.1.12-18.1993; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Cortez D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r65; Croucher NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6471; Crowley SP, 2014, MAR DRUGS, V12, P5916, DOI 10.3390/md12125916; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Diallo MD, 2012, ISME J, V6, P1325, DOI 10.1038/ismej.2011.202; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Esteves AIS, 2013, FEMS MICROBIOL ECOL, V85, P519, DOI 10.1111/1574-6941.12140; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Fan Lu, 2012, Proc Natl Acad Sci U S A, V109, pE1878, DOI 10.1073/pnas.1203287109; Fukunaga Y, 2006, INT J SYST EVOL MICR, V56, P343, DOI 10.1099/ijs.0.63879-0; Gophna U, 2001, INFECT IMMUN, V69, P2659, DOI 10.1128/IAI.69.4.2659-2665.2001; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Graca AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078992; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Harland DN, 2005, RES MICROBIOL, V156, P434, DOI 10.1016/j.resmic.2004.12.002; Heise T, 2006, P NATL ACAD SCI USA, V103, P3375, DOI 10.1073/pnas.0507749103; Henry T, 2006, P NATL ACAD SCI USA, V103, P13497, DOI 10.1073/pnas.0605443103; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Horn H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01751; Hosoya S, 2007, INT J SYST EVOL MICR, V57, P1952, DOI 10.1099/ijs.0.64922-0; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Huang QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033759; Huxley-Jones J, 2007, MATRIX BIOL, V26, P2, DOI 10.1016/j.matbio.2006.09.008; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jernigan KK, 2015, PEERJ, V3, DOI 10.7717/peerj.732; Jernigan KK, 2014, PEERJ, V2, DOI 10.7717/peerj.264; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kiyohara M, 2012, J BIOL CHEM, V287, P693, DOI 10.1074/jbc.M111.277384; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kopf M, 2014, DNA RES, V21, P255, DOI 10.1093/dnares/dst055; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kyrpides NC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001920; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Liu M, 2012, ISME J, V6, P1515, DOI 10.1038/ismej.2012.1; Liu MY, 2011, ISME J, V5, P427, DOI 10.1038/ismej.2010.139; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; Medema MH, 2013, MOL BIOL EVOL, V30, P1218, DOI 10.1093/molbev/mst025; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Merkl R, 2006, J MOL EVOL, V62, P1, DOI 10.1007/s00239-004-0311-5; Mohr TJ, 2008, J BACTERIOL, V190, P2858, DOI 10.1128/JB.01757-07; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nelson WC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00713; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Nylander JA, 2004, PROGRAM DISTRIBUTED; O' Halloran JA, 2011, J APPL MICROBIOL, V110, P1495, DOI 10.1111/j.1365-2672.2011.05008.x; Offord V, 2010, DEV COMP IMMUNOL, V34, P1035, DOI 10.1016/j.dci.2010.05.004; Oliveira PH, 2014, NUCLEIC ACIDS RES, V42, P10618, DOI 10.1093/nar/gku734; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Penesyan A, 2011, MAR DRUGS, V9, P1391, DOI 10.3390/md9081391; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Pritchard L, 2016, ANAL METHODS-UK, V8, P12, DOI [10.1039/c5ay02550h, 10.1039/C5AY02550H]; R Core Team, 2020, R LANG ENV STAT COMP; Raina JB, 2016, PEERJ, V4, DOI 10.7717/peerj.2275; Reynolds D, 2016, MOL ECOL, V25, P5242, DOI 10.1111/mec.13812; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; Romano S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00387; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Santos OCS, 2010, RES MICROBIOL, V161, P604, DOI 10.1016/j.resmic.2010.05.013; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sertan-de Guzman AA, 2007, FEMS MICROBIOL LETT, V277, P188, DOI 10.1111/j.1574-6968.2007.00950.x; Shieh WY, 2004, INT J SYST EVOL MICR, V54, P2307, DOI 10.1099/ijs.0.63107-0; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Snipen L, 2010, STAND GENOMIC SCI, V2, P135, DOI 10.4056/sigs.38923; Spada F, 2001, J BIOL CHEM, V276, P20624, DOI 10.1074/jbc.M100438200; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thomas T, 2010, ISME J, V4, P1557, DOI 10.1038/ismej.2010.74; Thomas T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003252; Tian RM, 2016, ENVIRON MICROBIOL, V18, P2481, DOI 10.1111/1462-2920.13161; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Varner JA, 1996, J BIOL CHEM, V271, P16119; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Warnes M. G. R., 2016, PACKAGE GPLOTS; Wei HL, 2015, CELL HOST MICROBE, V17, P752, DOI 10.1016/j.chom.2015.05.007; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Wu M, 2012, BIOINFORMATICS, V28, P1033, DOI 10.1093/bioinformatics/bts079; Xu Y, 2015, ANTON LEEUW INT J G, V108, P127, DOI 10.1007/s10482-015-0470-y; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang Y, 2016, INT J SYST EVOL MICR, V66, P2025, DOI 10.1099/ijsem.0.000984	125	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0194368	10.1371/journal.pone.0194368	http://dx.doi.org/10.1371/journal.pone.0194368			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG2KJ	29775460	Green Published, Green Submitted, gold			2022-12-26	WOS:000432521100003
J	Yourkavitch, J; Lich, KH; Flax, VL; Okello, ES; Kadzandira, J; Katahoire, AR; Munthali, AC; Thomas, JC				Yourkavitch, Jennifer; Lich, Kristen Hassmiller; Flax, Valerie L.; Okello, Elialilia S.; Kadzandira, John; Katahoire, Anne Ruhweza; Munthali, Alister C.; Thomas, James C.			Interactions among poverty, gender, and health systems affect women's participation in services to prevent HIV transmission from mother to child: A causal loop analysis	PLOS ONE			English	Article							OPTION B PLUS; ACTIVE ANTIRETROVIRAL THERAPY; BARRIERS; MALAWI; PROGRAM; MODEL; CONSEQUENCES; LILONGWE; CARE	Retention in care remains an important issue for prevention of mother-to-child transmission (PMTCT) programs according to WHO guidelines, formerly called the "Option B+" approach. The objective of this study was to examine how poverty, gender, and health system factors interact to influence women's participation in PMTCT services. We used qualitative research, literature, and hypothesized variable connections to diagram causes and effects in causal loop models. We found that many factors, including antiretroviral therapy (ART) use, service design and quality, stigma, disclosure, spouse/partner influence, decision-making autonomy, and knowledge about PMTCT, influence psychosocial health, which in turn affects women's participation in PMTCT services. Thus, interventions to improve psychosocial health need to address many factors to be successful. We also found that the design of PMTCT services, a modifiable factor, is important because it affects several other factors. We identified 66 feedback loops that may contribute to policy resistance-that is, a policy's failure to have its intended effect. Our findings point to the need for a multipronged intervention to encourage women's continued participation in PMTCT services and for longitudinal research to quantify and test our causal loop model.	[Yourkavitch, Jennifer; Flax, Valerie L.; Thomas, James C.] Univ N Carolina, Carolina Populat Ctr, MEASURE Evaluat, Chapel Hill, NC 27599 USA; [Yourkavitch, Jennifer] ICF, Rockville, MD 20850 USA; [Lich, Kristen Hassmiller] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Flax, Valerie L.] RTI Int, Durham, NC USA; [Okello, Elialilia S.] Makerere Univ, Dept Psychiat, Kampala, Uganda; [Okello, Elialilia S.; Katahoire, Anne Ruhweza] Makerere Univ, Child Hlth & Dev Ctr, Kampala, Uganda; [Kadzandira, John; Munthali, Alister C.] Univ Malawi, Chancellor Coll, Ctr Social Res, Zomba, Malawi; [Thomas, James C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; Makerere University; Makerere University; University of Malawi; University of North Carolina; University of North Carolina Chapel Hill	Yourkavitch, J (corresponding author), Univ N Carolina, Carolina Populat Ctr, MEASURE Evaluat, Chapel Hill, NC 27599 USA.; Yourkavitch, J (corresponding author), ICF, Rockville, MD 20850 USA.	jennifer.yourkavitch@icf.com	Okello, Elialilia/S-8238-2019	Flax, Valerie/0000-0003-0200-3355	USAID under MEASURE Evaluation [AID-OAA-L-14-00004]; Carolina Population Center [P2CHD050924]; ICF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER	USAID under MEASURE Evaluation(United States Agency for International Development (USAID)); Carolina Population Center; ICF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by USAID under MEASURE Evaluation (AID-OAA-L-14-00004) and supported by the Carolina Population Center (P2CHD050924). The funder provided support in the form of a salary through ICF for JY but neither USAID nor ICF had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Bwirire LD, 2008, T ROY SOC TROP MED H, V102, P1195, DOI 10.1016/j.trstmh.2008.04.002; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Clouse K, 2014, JAIDS-J ACQ IMM DEF, V67, pE12, DOI 10.1097/QAI.0000000000000263; Coutsoudis A, 2013, S AFR J HIV MED, V14, P8, DOI 10.7196/SAJHIVMED.898; Dangerfield BC, 2001, SYST DYNAM REV, V17, P119, DOI 10.1002/sdr.211; Duff P, 2012, INT J WOMENS HEALTH, V4, P227, DOI 10.2147/IJWH.S31807; Elwell K, 2016, AIDS CARE, V28, P971, DOI 10.1080/09540121.2016.1153586; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Flax V, 2016, MEASURE EVALUATION P; Flax VL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178298; Gourlay A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18588; Hodgson I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111421; Homer J, 2004, SYST DYNAM REV, V20, P199, DOI 10.1002/sdr.295; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; HOMER JB, 1991, INTERFACES, V21, P26, DOI 10.1287/inte.21.3.26; HOMER JB, 1993, SYST DYNAM REV, V9, P49, DOI 10.1002/sdr.4260090104; Kebaabetswe PM, 2007, AIDS CARE, V19, P355, DOI 10.1080/09540120600942407; Kim MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148466; Kyomuhendo Grace Bantebya, 2006, WOMEN WORK DOMESTIC; Lich KH, 2016, TRANSL BEHAV MED, V6, P17, DOI 10.1007/s13142-016-0390-z; LUGINBUHL W, 1981, J PUBLIC HLTH POLICY, V2, P1103; Matheson R, 2015, J INT AIDS SOC, V18, P50, DOI 10.7448/IAS.18.6.20286; Ngarina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085310; Otiso K.M., 2006, CULTURE CUSTOMS UGAN; ROBERTS C, 1990, J OPER RES SOC, V41, P273, DOI 10.1038/sj/jors/0410401; Shroufi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064717; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; Vrazo AC, 2018, TROP MED INT HEALTH, V23, P136, DOI 10.1111/tmi.13014; Webb R, 2013, UNDERSTANDING PERSPE; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2016, GUID UPD HIV INF FEE; Yourkavitch J, 2016, MEASURE EVALUATION P; Zhou A, 2016, SOC SCI MED, V158, P52, DOI 10.1016/j.socscimed.2016.04.013	34	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2018	13	5							e0197239	10.1371/journal.pone.0197239	http://dx.doi.org/10.1371/journal.pone.0197239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GG2KJ	29775467	Green Published, Green Submitted, gold			2022-12-26	WOS:000432521100013
J	Liang, DC; Woo, JI; Shao, H; Born, WK; O'Brien, RL; Kaplan, HJ; Su, DM				Liang, Dongchun; Woo, Jeong-Im; Shao, Hui; Born, Willi K.; O'Brien, Rebecca L.; Kaplan, Henry J.; Su, Deming			Ability of gamma delta T cells to modulate the Foxp3 T cell response is dependent on adenosine	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RECEPTOR EXPRESSION; IMMUNE SUPPRESSION; IFN-GAMMA; GENERATION; MOUSE; MICE; INFLAMMATION; ACTIVATION; UVEITIS	Whether gamma delta T cells inhibit or enhance the Foxp3 T cell response depends upon their activation status. The critical enhancing effector in the supernatant is adenosine. Activated gamma delta T cells express adenosine receptors at high levels, which enables them to deprive Foxp3(+) T cells of adenosine, and to inhibit their expansion. Meanwhile, cell-free supernatants of gamma delta T cell cultures enhance Foxp3 T cell expansion. Thus, inhibition and enhancement by gamma delta T cells of Foxp3 T cell response are a reflection of the balance between adenosine production and absorption by gamma delta T cells. Non-activated gamma delta T cells produce adenosine but bind little, and thus enhance the Foxp3 T cell response. Activated gamma delta T cells express high density of adenosine receptors and have a greatly increased ability to bind adenosine. Extracellular adenosine metabolism and expression of adenosine receptor A2ARs by gamma delta T cells played a major role in the outcome of gamma delta and Foxp3 T cell interactions. A better understanding of the functional conversion of gamma delta T cells could lead to gamma delta T cell-targeted immunotherapies for related diseases.	[Liang, Dongchun; Woo, Jeong-Im; Su, Deming] UCLA, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90095 USA; [Liang, Dongchun; Woo, Jeong-Im; Su, Deming] UCLA, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Shao, Hui; Kaplan, Henry J.] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40292 USA; [Born, Willi K.; O'Brien, Rebecca L.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Louisville; National Jewish Health	Su, DM (corresponding author), UCLA, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90095 USA.; Su, DM (corresponding author), UCLA, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.	Dsun@doheny.org		Sun, Deming/0000-0003-4851-0416	 [NIH\NEI\EY018827];  [NIH\NEI\EY022403]; NATIONAL EYE INSTITUTE [R01EY022403, R01EY018827] Funding Source: NIH RePORTER	; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH\NEI\EY018827 and NIH\NEI\EY022403.	Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Blackburn MR, 2000, J EXP MED, V192, P159, DOI 10.1084/jem.192.2.159; Born W, 1999, Adv Immunol, V71, P77; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Cheng L, 2008, J NEUROIMMUNOL, V203, P3, DOI 10.1016/j.jneuroim.2008.06.007; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Desrosiers MD, 2007, J IMMUNOL, V179, P1884, DOI 10.4049/jimmunol.179.3.1884; Dionisotti S, 1996, J PHARMACOL EXP THER, V278, P1209; Do JS, 2012, IMMUNOL CELL BIOL, V90, P396, DOI 10.1038/icb.2011.50; Do J, 2016, EUR J IMMUNOL, V46, P340, DOI 10.1002/eji.201545919; Dodd J, 2009, J IMMUNOL, V182, P1174, DOI 10.4049/jimmunol.182.2.1174; DSouza CD, 1997, J IMMUNOL, V158, P1217; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hayday A, 1997, CURR OPIN IMMUNOL, V9, P884, DOI 10.1016/S0952-7915(97)80193-8; Hocher B, 2010, KIDNEY INT, V78, P438, DOI 10.1038/ki.2010.204; Huang YF, 2015, J IMMUNOL, V195, P5572, DOI 10.4049/jimmunol.1501604; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Liang DC, 2017, J IMMUNOL, V198, P1429, DOI 10.4049/jimmunol.1601510; Liang DC, 2016, J IMMUNOL, V196, P2646, DOI 10.4049/jimmunol.1502294; Liang DC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150078; Liang DC, 2015, IMMUN INFLAMM DIS, V3, P360, DOI 10.1002/iid3.74; Liang DC, 2014, J IMMUNOL, V193, P5498, DOI 10.4049/jimmunol.1401959; Liang DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108932; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Muller CE, 2011, BBA-BIOMEMBRANES, V1808, P1290, DOI 10.1016/j.bbamem.2010.12.017; Muschaweckh A, 2017, J IMMUNOL, V199, P2668, DOI 10.4049/jimmunol.1700287; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Neely CF, 1997, AM J PHYSIOL-LUNG C, V272, pL353, DOI 10.1152/ajplung.1997.272.2.L353; Nian H, 2012, INVEST OPHTH VIS SCI, V53, P897, DOI 10.1167/iovs.11-8297; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; Nian H, 2010, INVEST OPHTH VIS SCI, V51, P4661, DOI 10.1167/iovs.09-5045; Ohta A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00190; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rajan AJ, 2000, J IMMUNOL, V164, P2120, DOI 10.4049/jimmunol.164.4.2120; Spahn TW, 1999, EUR J IMMUNOL, V29, P4060, DOI 10.1002/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Visperas A, 2014, EUR J IMMUNOL, V44, P2448, DOI 10.1002/eji.201344331; Wei W, 2013, J IMMUNOL, V190, P138, DOI 10.4049/jimmunol.1103721; Xaus J, 1999, J IMMUNOL, V162, P3607; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zocchi C, 1996, J PHARMACOL EXP THER, V276, P398	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197189	10.1371/journal.pone.0197189	http://dx.doi.org/10.1371/journal.pone.0197189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771938	gold, Green Published, Green Submitted			2022-12-26	WOS:000432348900033
J	Martinez, KA; Romano-Keeler, J; Zackular, JP; Moore, DJ; Brucker, RM; Hooper, C; Meng, SF; Brown, N; Mallal, S; Reese, J; Aronoff, DM; Shin, H; Dominguez-Bello, MG; Weitkamp, JH				Martinez, Keith A., II; Romano-Keeler, Joann; Zackular, Joseph P.; Moore, Daniel J.; Brucker, Robert M.; Hooper, Christopher; Meng, Shufang; Brown, Naoko; Mallal, Simon; Reese, Jeff; Aronoff, David M.; Shin, Hakdong; Dominguez-Bello, Maria Gloria; Weitkamp, Jorn-Hendrik			Bacterial DNA is present in the fetal intestine and overlaps with that in the placenta in mice	PLOS ONE			English	Article							MICROBIOME VARIES; GUT MICROBIOME; ASSOCIATION; NEWBORNS; DELIVERY; BIRTH; MODE	Bacterial DNA has been reported in the placenta and amniotic fluid by several independent groups of investigators. However, it's taxonomic overlap with fetal and maternal bacterial DNA in different sites has been poorly characterized. Here, we determined the presence of bacterial DNA in the intestines and placentas of fetal mice at gestational day 17 (n = 13). These were compared to newborn intestines (n = 15), maternal sites (mouth, n = 6; vagina, n = 6; colon, n = 7; feces, n = 8), and negative controls to rule out contamination. The V4 region of the bacterial 16S rRNA gene indicated a pattern of bacterial DNA in fetal intestine similar to placenta but with higher phylogenetic diversity than placenta or newborn intestine. Firmicutes were the most frequently assignable phylum. SourceTracker analysis suggested the placenta as the most commonly identifiable origin for fetal bacterial DNA, but also over 75% of fetal gut genera overlapped with maternal oral and vaginal taxa but not with maternal or newborn feces. These data provide evidence for the presence of bacterial DNA in the mouse fetus.	[Martinez, Keith A., II; Dominguez-Bello, Maria Gloria] Sackler Inst, Dept Microbiol, New York, NY 10065 USA; [Martinez, Keith A., II; Shin, Hakdong] NYU, Sch Med, Dept Translat Med, New York, NY USA; [Romano-Keeler, Joann; Moore, Daniel J.; Hooper, Christopher; Meng, Shufang; Brown, Naoko; Reese, Jeff; Weitkamp, Jorn-Hendrik] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Zackular, Joseph P.; Moore, Daniel J.; Mallal, Simon; Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Brucker, Robert M.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Mallal, Simon; Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN USA; [Mallal, Simon] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA, Australia; [Reese, Jeff] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Romano-Keeler, Joann] Mednax Corp, St Thomas Midtown, Div Neonatol, Nashville, TN USA; [Brucker, Robert M.] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA; [Shin, Hakdong] Sejong Univ, Coll Life Sci, Dept Food Sci & Biotechnol, Seoul, South Korea; [Dominguez-Bello, Maria Gloria] Rutgers Univ New Jersey, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA	New York University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Murdoch University; Vanderbilt University; Harvard University; Sejong University; Rutgers State University New Brunswick	Dominguez-Bello, MG (corresponding author), Sackler Inst, Dept Microbiol, New York, NY 10065 USA.; Weitkamp, JH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.; Dominguez-Bello, MG (corresponding author), Rutgers Univ New Jersey, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA.	mg.dominguez-bello@rutgers.edu; hendrik.weitkamp@vanderbilt.edu	Moore, Daniel J/A-4924-2008; Moore, Daniel/V-6145-2019; Weitkamp, Joern-Hendrik/AAZ-8272-2020; Mallal, Simon Alexander/HDM-9561-2022	Moore, Daniel J/0000-0002-6889-9345; Moore, Daniel/0000-0002-6889-9345; Weitkamp, Joern-Hendrik/0000-0002-6654-4823; Mallal, Simon Alexander/0000-0002-7036-1309; Reese, Jeff/0000-0001-8751-6146; Aronoff, David/0000-0003-4587-6121; Zackular, Joseph/0000-0002-3228-3055	National Institutes of Health (NIH) Loan Repayment Program; Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD) [T32HD068256]; National Institute Of Diabetes and Digestive Kidney Diseases (NIDDK) [T32DK007673, K08DK090146]; National Institute of Allergy and Infectious Diseases (NIAID) [F32FAI120553]; Vanderbilt Diabetes Center [P30DK20593]; NICHD [R01 HD081121, K08HD061607]; Investigators in the Pathogenesis of Infectious Disease grant from the Burroughs Wellcome Fund; Global Alliance to Prevent Prematurity and Stillbirth (GAPPS); Emch Foundation; CD Foundation; Institutional Research Training Award [T32 AI007180]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD068256, K08HD061607, R01HD081121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007673, P30DK020593, K08DK090146] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Loan Repayment Program; Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute Of Diabetes and Digestive Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vanderbilt Diabetes Center; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Investigators in the Pathogenesis of Infectious Disease grant from the Burroughs Wellcome Fund; Global Alliance to Prevent Prematurity and Stillbirth (GAPPS); Emch Foundation; CD Foundation; Institutional Research Training Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by the National Institutes of Health (NIH) Loan Repayment Program and the Eunice Kennedy Shriver National Institute Of Child Health & Human Development (NICHD) T32HD068256 (to JRK), the National Institute Of Diabetes and Digestive Kidney Diseases (NIDDK) T32DK007673, the National Institute of Allergy and Infectious Diseases (NIAID) F32FAI120553 (to JPZ), the NIDDK K08DK090146 and the Vanderbilt Diabetes Center P30DK20593 (to DM), NICHD R01 HD081121 (to JR), An Investigators in the Pathogenesis of Infectious Disease grant from the Burroughs Wellcome Fund and a grant from the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) (to DA), the Emch and C&D Foundations (to MGDB), the NICHD K08HD061607 (to JHW), and an Institutional Research Training Award T32 AI007180 (to KAMII). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NICHD, NIDDK, NSF, or NIH.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Amarasekara R, 2015, J OBSTET GYNAECOL RE, V41, P662, DOI 10.1111/jog.12619; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Antony KM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.12.041; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Chernikova DA, 2016, J MATERN-FETAL NEO M, V29, P99, DOI 10.3109/14767058.2014.987748; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Chu Derrick M, 2016, Genome Med, V8, P77, DOI 10.1186/s13073-016-0330-z; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Junicke H, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0035-x; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Pammi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176669; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Prince AL, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.193; Romano-Keeler J, 2014, GUT MICROBES, V5, P192, DOI 10.4161/gmic.28442; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129; Zheng J, 2015, NUTRIENTS, V7, P6924, DOI 10.3390/nu7085315; Zheng W, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0110-9	34	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197439	10.1371/journal.pone.0197439	http://dx.doi.org/10.1371/journal.pone.0197439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771989	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900060
J	Mauka, WI; Mtuy, TB; Mahande, MJ; Msuya, SE; Mboya, IB; Juma, A; Philemon, RN				Mauka, Wilhellmuss, I; Mtuy, Tara B.; Mahande, Michael J.; Msuya, Sia E.; Mboya, Innocent B.; Juma, Abdul; Philemon, Rune N.			Risk factors for inappropriate blood requisition among hospitals in Tanzania	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SUB-SAHARAN AFRICA; TRANSFUSION SERVICES; CELL TRANSFUSION; CHILDREN; APPROPRIATENESS; MORTALITY; ANEMIA; SURGERY; NIGERIA	Background Blood is a critical aspect of treatment in life saving situations, increasing demand. Blood requisition practices greatly effect sufficient supply in blood banks. This study aimed to determine the risk factors for inappropriate blood requisition in Tanzania. Methods This was a cross sectional study using secondary data of 14,460 patients' blood requests from 42 transfusion hospitals. Primary data were obtained by using cluster-sampling design. Data were analysed using a two-level mixed-effects Poisson regression to determine fixedeffects of individual-level factors and hospital level factors associated with inappropriate blood requests. P-value < 0.05 (2-tails) was considered statistically significant. Results Inappropriate requisition was 28.8%. Factors significantly associated with inappropriate requisition were; reporting pulse rate and capillary refill decrease the risk (RR 0.74; 95% CI 0.64, 0.84) and (RR 0.73; 95% CI 0.63, 0.85) respectively and the following increased the risk; having surgery during hospital stay (RR 1.22; 95% C11.06,1.4); being in general surgical ward (RR 3.3; 95% CI 2.7, 4.2), paediatric ward (RR 1.8; 95% C11.2, 2.7), obstetric ward (RR2.5; 95% CI 2.0, 3.1), gynaecological ward (RR2.1; 95% C11.5, 2.9), orthopaedics ward (RR 3.8; 95% CI 2.2, 6.7). Age of the patient, pallor and confirmation of pre-transfusion haemoglobin level were also significantly associated with inappropriate requisition. Majority of appropriate requisitions within the wards were marked in internal medicine (91.7%) and gynaecological wards (77.8%). Conclusions The proportion of inappropriate blood requests was high. Blood requisition was determined by clinical and laboratory findings and the ward patients were admitted to. Adherence to transfusion guidelines is recommended to assure the best use of limited blood supply.	[Mauka, Wilhellmuss, I; Mtuy, Tara B.; Mahande, Michael J.; Msuya, Sia E.; Mboya, Innocent B.; Philemon, Rune N.] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania; [Juma, Abdul] Natl Blood Transfus Serv, Dar Es Salaam, Tanzania; [Mauka, Wilhellmuss, I] Northern Zone Blood Transfus Serv, Moshi, Tanzania; [Philemon, Rune N.] Kilimanjaro Christian Med Ctr, Dept Paediat, Moshi, Tanzania; [Mtuy, Tara B.] London Sch Hyg & Trop Med, Dept Clin Res, London, England	Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine	Mauka, WI (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania.; Mauka, WI (corresponding author), Northern Zone Blood Transfus Serv, Moshi, Tanzania.	wilhemauka@yahoo.com	Mahande, Michael Johnson J/I-6359-2015; Mboya, Innocent/AAE-6488-2020	Mahande, Michael Johnson J/0000-0002-7750-7657; Mboya, Innocent/0000-0001-9861-5879				Akoko LO, 2015, TANZAN J HLTH RES, V17, P1; Allain JP, 2011, BRIT J HAEMATOL, V154, P763, DOI 10.1111/j.1365-2141.2011.08708.x; Arewa OP, 2009, NIGER J CLIN PRACT, V12, P429; Ayantunde AA, 2008, BMC SURG, V8, P1, DOI [10.1001/jama.2010.1446, DOI 10.1001/JAMA.2010.1446]; Barr PJ, 2011, TRANSFUSION, V51, P1684, DOI 10.1111/j.1537-2995.2011.03130.x; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bates I, 2008, BJOG-INT J OBSTET GY, V115, P1331, DOI 10.1111/j.1471-0528.2008.01866.x; Bugge HF, 2013, VOX SANG, V104, P37, DOI 10.1111/j.1423-0410.2012.01628.x; Butler EK, 2015, TRANSFUSION, V55, P1058, DOI 10.1111/trf.13010; Chalya PL, 2016, TANZAN J HLTH RES, V18, P1, DOI DOI 10.4314/THRB.V18I4; Chen DW, 2012, INT J GERONTOL, V6, P16, DOI 10.1016/j.ijge.2011.09.022; Desalu I, 2008, TRANSFUSION MED, V18, P211, DOI 10.1111/j.1365-3148.2008.00858.x; Diaz-Quijano FA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-14; Drammeh B, 2017, TRANSFUS MED REV; Du Pont-Thibodeau G, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-16; Ebose EM, 2009, AFR J BIOTECHNOL, V8, P5922; Friedman MT, 2006, ARCH PATHOL LAB MED, V130, P474; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Katsaliaki K, 2008, HEALTH POLICY, V86, P276, DOI 10.1016/j.healthpol.2007.11.004; Kerkhoff AD, 2015, OPEN FORUM INFECT DI, V2, P10; Kiguli S, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0246-7; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Lackritz EM, 1997, AIDS, V11, P1487, DOI 10.1097/00002030-199712000-00013; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; Lingegowda Jyothi B, 2016, J Lab Physicians, V8, P41, DOI 10.4103/0974-2727.176232; Makroo R N, 2007, Asian J Transfus Sci, V1, P59, DOI 10.4103/0973-6247.33847; Mauka WI, 2015, J BLOOD TRANSFUS, V2015, P6; MOHCDGCE, 2015, CLIN GUID APPR US BL; MOHSW, 2005, TANZ NAT BLOOD TRANS, P1; Mpoya A, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1112-4; Mueller Y, 2012, TROP MED INT HEALTH, V17, P1457, DOI 10.1111/j.1365-3156.2012.03095.x; Mwambungu A, 2015, INT J HLTH SCI, V3, P278; Natukunda B, 2010, TRANSFUSION MED, V20, P134, DOI 10.1111/j.1365-3148.2010.00992.x; Niraj G, 2003, BRIT J ANAESTH, V91, P586, DOI 10.1093/bja/aeg207; Osei EN, 2013, TRANSFUSION MED, V23, P160, DOI 10.1111/tme.12028; Paramjit K, 2013, NATL J INTEGR RES ME, V4, P123; Pitman JP, 2015, TRANSFUS MED REV, V29, P45, DOI 10.1016/j.tmrv.2014.11.003; Pule PI, 2014, BLOOD TRANSFUS, V2014, P7; Roberts DJ, 2016, HEMATOL ONCOL CLIN N, V30, P477, DOI 10.1016/j.hoc.2015.11.011; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Shander A, 2011, TRANSFUS MED REV, V25, P232, DOI 10.1016/j.tmrv.2011.02.001; Smithson P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141112; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Vamvakas EC, 2009, BLOOD, V113, P3406, DOI 10.1182/blood-2008-10-167643; WHO, 2002, CLIN US BLOOD; WHO, 2002, CLIN US BLOOD, P349; Wilson K, 2002, TRANSFUSION, V42, P1224, DOI 10.1046/j.1537-2995.2002.00185.x; World Health Organization, 2001, CLIN US BLOOD MED OB; Yong Mellissa, 2011, Clin Epidemiol, V3, P91, DOI 10.2147/CLEP.S17146; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	50	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196453	10.1371/journal.pone.0196453	http://dx.doi.org/10.1371/journal.pone.0196453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771998	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000432348900012
J	Oh, D; Yu, Y; Lee, H; Jeon, JH; Wanner, BL; Ritchie, K				Oh, Dongmyung; Yu, Yang; Lee, Hochan; Jeon, Jae-Hyung; Wanner, Barry L.; Ritchie, Ken			Asymmetric polar localization dynamics of the serine chemoreceptor protein Tsr in Escherichia coli	PLOS ONE			English	Article							BACTERIAL CHEMORECEPTOR; CELLS; MEMBRANE; COMPLEX; GENE; ICSA; OLD	The spatial location of proteins in living cells can be critical for their function. For example, the E. coli chemotaxis machinery is localized to the cell poles. Here we describe the polar localization of the serine chemoreceptor Tsr using a strain synthesizing a fluorescent TsrVenus fusion at a low level from a single-copy chromosomal construct. Using photobleaching and imaging during recovery by new synthesis, we observed distinct asymmetry between a bright (old) pole and a dim (new) pole. The old pole was shown to be a more stable cluster and to recover after photobleaching faster, which is consistent with the hypothesis that newly synthesized Tsr proteins are inserted directly at or near the old pole. The new pole was shown to be a less stable cluster and to exchange proteins freely with highly mobile Tsr-Venus proteins diffusing in the membrane. We propose that the new pole arises from molecules escaping from the old pole and diffusing to the new pole where a more stable cluster forms over time. Our localization imaging data support a model in which a nascent new pole forms prior to stable cluster formation.	[Oh, Dongmyung; Lee, Hochan; Ritchie, Ken] Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA; [Yu, Yang] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Jeon, Jae-Hyung] Pohang Univ Sci & Technol, Dept Phys, Pohang, South Korea; [Wanner, Barry L.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Oh, Dongmyung] Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore; [Yu, Yang] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pohang University of Science & Technology (POSTECH); Harvard University; Harvard Medical School; National University of Singapore; University of Southern California	Oh, D; Ritchie, K (corresponding author), Purdue Univ, Dept Phys & Astron, W Lafayette, IN 47907 USA.; Wanner, BL (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.; Oh, D (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore.	mbiod@nus.edu.sg; Barry_Wanner@hms.harvard.edu; kpritchie@purdue.edu	Yu, Yang/ABG-9106-2020	Yu, Yang/0000-0002-9157-8478	U.S. National Institutes of Health [GM62662]; National Science Foundation [1244286]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062662] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the U.S. National Institutes of Health award GM62662 to B. L. W. and completed under support by National Science Foundation award 1244286 to B. L. W., on which K. P. R. was a co-principal investigator during years 1 and 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the U.S. National Institutes of Health award GM62662 to B. L. W. and completed under support by National Science Foundation award 1244286 to B. L. W., on which K. P. R. was a co-principal investigator during years 1 and 2.	Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; AMES P, 1994, J BACTERIOL, V176, P6340, DOI 10.1128/jb.176.20.6340-6348.1994; Biteen JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000448; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; Draper W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14838; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Jadwin JA, 2016, ELIFE, V5, DOI 10.7554/eLife.11835; Jain S, 2006, J BACTERIOL, V188, P4841, DOI 10.1128/JB.00326-06; MADDOCK JR, 1993, J BACTERIOL, V175, P7125, DOI 10.1128/JB.175.22.7125-7129.1993; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neeli-Venkata R, 2016, BIOPHYS J, V111, P2512, DOI 10.1016/j.bpj.2016.10.024; Oh D., 2010, SINGLE MOL STUDIES R; Oh D, 2014, BIOPHYS J, V106, P145, DOI 10.1016/j.bpj.2013.09.059; Ping LY, 2008, MOL MICROBIOL, V69, P1427, DOI 10.1111/j.1365-2958.2008.06372.x; Robbins JR, 2001, MOL MICROBIOL, V41, P861, DOI 10.1046/j.1365-2958.2001.02552.x; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; SANDBERG T, 1979, REV INFECT DIS, V1, P838; Santos TMA, 2014, MOL MICROBIOL, V92, P985, DOI 10.1111/mmi.12609; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shiomi D, 2006, MOL MICROBIOL, V60, P894, DOI 10.1111/j.1365-2958.2006.05145.x; Steinhauer J, 1999, MOL MICROBIOL, V32, P367, DOI 10.1046/j.1365-2958.1999.01356.x; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Thiem S, 2007, EMBO J, V26, P1615, DOI 10.1038/sj.emboj.7601610; Wanner B.L., 1994, METH MOL G, V3, P291; Wanner BL, 1997, CH MICROBIOL SER, P104; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0195887	10.1371/journal.pone.0195887	http://dx.doi.org/10.1371/journal.pone.0195887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771911	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900006
J	Ruhnke, L; Sradnick, J; Al-Mekhlafi, M; Gerlach, M; Gembardt, F; Hohenstein, B; Todorov, VT; Hugo, C				Ruhnke, Leo; Sradnick, Jan; Al-Mekhlafi, Moath; Gerlach, Michael; Gembardt, Florian; Hohenstein, Bernd; Todorov, Vladimir T.; Hugo, Christian			Progenitor Renin Lineage Cells are not involved in the regeneration of glomerular endothelial cells during experimental renal thrombotic microangiopathy	PLOS ONE			English	Article							VASCULAR DEVELOPMENT; KIDNEY; INJURY; REPAIR; LEADS	Endothelial cells (EC) frequently undergo primary or secondary injury during kidney disease such as thrombotic microangiopathy or glomerulonephritis. Renin Lineage Cells (RLCs) serve as a progenitor cell niche after glomerular damage in the adult kidney. However, it is not clear whether RLCs also contribute to endothelial replenishment in the glomerulus following endothelial injury. Therefore, we investigated the role of RLCs as a potential progenitor niche for glomerular endothelial regeneration. We used an inducible tet-on tripletransgenic reporter strain mRen-rtTAm2/LC1/LacZ to pulse-label the renin-producing RLCs in adult mice. Unilateral kidney EC damage (EC model) was induced by renal artery perfusion with concanavalin/anti-concanavalin. In this model glomerular EC injury and depletion developed within 1 day while regeneration occurred after 7 days. LacZ-labelled RLCs were restricted to the juxtaglomerular compartment of the afferent arterioles at baseline conditions. In contrast, during the regenerative phase of the EC model (day 7) a subset of LacZtagged RLCs migrated to the glomerular tuft. Intraglomerular RLCs did not express renin anymore and did not stain for glomerular endothelial or podocyte cell markers, but for the mesangial cell markers alpha 8-integrin and PDGFR beta. Accordingly, we found pronounced mesangial cell damage parallel to the endothelial injury induced by the EC model. These results demonstrated that in our EC model RLCs are not involved in endothelial regeneration. Rather, recruitment of RLCs seems to be specific for the repair of the concomitantly damaged mesangium.	[Ruhnke, Leo; Sradnick, Jan; Al-Mekhlafi, Moath; Gerlach, Michael; Gembardt, Florian; Hohenstein, Bernd; Todorov, Vladimir T.; Hugo, Christian] Tech Univ Dresden, Dept Internal Med 3, Div Nephrol, Univ Hosp Carl Gustav Carus, Fetscherstr 74, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Todorov, VT; Hugo, C (corresponding author), Tech Univ Dresden, Dept Internal Med 3, Div Nephrol, Univ Hosp Carl Gustav Carus, Fetscherstr 74, Dresden, Germany.	vladimir.todorov@ukdd.de; christian.hugo@ukdd.de	Gembardt, Florian/H-2360-2011	Gembardt, Florian/0000-0003-2739-345X; Gerlach, Michael/0000-0002-6831-751X	Deutsche Forschungsgemeinschaft [GE 2845/1-1, HO 2522/6-1, SFB 699/B1, TO 679/1-1, TO 679/2-1, HU 600/6-1, HU 600/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) Grants GE 2845/1-1 (to F.G.); HO 2522/6-1 (to B.H.); SFB 699/B1, TO 679/1-1, TO 679/2-1 (to V.T.T.) and HU 600/6-1, HU 600/8-1 (to C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile DP, 2007, KIDNEY INT, V72, P151, DOI 10.1038/sj.ki.5002312; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Castrop H, 2010, PHYSIOL REV, V90, P607, DOI 10.1152/physrev.00011.2009; Desch M, 2011, PFLUG ARCH EUR J PHY, V461, P567, DOI 10.1007/s00424-011-0956-z; Eng E, 2005, KIDNEY INT, V68, P695, DOI 10.1111/j.1523-1755.2005.00448.x; Eng E, 2003, MICROVASC RES, V65, P137, DOI 10.1016/S0026-2862(03)00004-9; Gomez RA, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0711-8; Hickmann L, 2017, KIDNEY INT, V92, P1419, DOI 10.1016/j.kint.2017.04.014; Hohenstein B, 2008, NEPHROL DIAL TRANSPL, V23, P1144, DOI 10.1093/ndt/gfm774; Hohenstein B, 2017, KIDNEY INT, V91, P9, DOI 10.1016/j.kint.2016.08.033; Hu Y, 2016, J AM SOC NEPHROL, V27, P1984, DOI 10.1681/ASN.2015060610; IRUELAARISPE L, 1995, AM J PATHOL, V147, P1715; Lachmann P, 2017, J AM SOC NEPHROL, V28, P3479, DOI 10.1681/ASN.2017020173; Lichtnekert J, 2016, J AM SOC NEPHROL, V27, P3611, DOI 10.1681/ASN.2015080877; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Lopez MLSS, 2004, DEV CELL, V6, P719; Patschan D, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/828369; Pippin JW, 2015, AM J PHYSIOL-RENAL, V309, pF341, DOI 10.1152/ajprenal.00438.2014; Schirutschke H, 2013, AM J PHYSIOL-RENAL, V305, pF1042, DOI 10.1152/ajprenal.00653.2012; Schwarzenberger C, 2015, AM J PHYSIOL-RENAL, V308, pF1238, DOI 10.1152/ajprenal.00535.2014; Sequeira-Lopez MLS, 2015, AM J PHYSIOL-REG I, V309, pR650, DOI 10.1152/ajpregu.00313.2015; Sequeira-Lopez MLS, 2015, AM J PHYSIOL-REG I, V308, pR138, DOI 10.1152/ajpregu.00428.2014; Sims-Lucas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065993; Sradnick J, 2016, J AM SOC NEPHROL, V27, P1714, DOI 10.1681/ASN.2015030321; Starke C, 2015, J AM SOC NEPHROL, V26, P48, DOI 10.1681/ASN.2014030265	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0196752	10.1371/journal.pone.0196752	http://dx.doi.org/10.1371/journal.pone.0196752			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29771991	Green Published, gold, Green Submitted			2022-12-26	WOS:000432348900017
J	Selvaraj, V; Maheshwari, Y; Hajeri, S; Chen, JC; McCollum, TG; Yokomi, R				Selvaraj, Vijayanandraj; Maheshwari, Yogita; Hajeri, Subhas; Chen, Jianchi; McCollum, Thomas Greg; Yokomi, Raymond			Development of a duplex droplet digital PCR assay for absolute quantitative detection of "Candidatus Liberibacter asiaticus"	PLOS ONE			English	Article							REAL-TIME PCR; DNA COPY NUMBER; DISEASE MANAGEMENT; DIAPHORINA-CITRI; GREENING DISEASE; QUANTIFICATION; BACTERIUM; SYSTEM	Huanglongbing (HLB, citrus greening) is a devastating citrus disease affecting citrus production worldwide. It is associated with the bacterium "Candidatus Liberibacter asiaticus" (CLas) and is vectored by the Asian citrus psyllid (ACP). Currently, diagnosis of CLas in regulatory samples is based on real-time quantitative polymerase chain reaction (qPCR) using 16S rRNA gene specific primers/probe. The detection of CLas using qPCR is challenging due to low pathogen titer and uneven distribution in infected plants and exacerbated by sampling issues and presence of inhibitors. This study evaluated a duplex droplet digital polymerase chain reaction (ddPCR) using multi-copy gene targets, 16S and RNR, to simultaneously detect CLas DNA targets in the same sample for unambiguous detection of the HLB pathogen in DNA extracts from citrus leaves and ACP. Standard curve analyses on tenfold dilution series with plasmid, citrus leaf and ACP DNA showed that both ddPCR and qPCR exhibited good linearity and efficiency in the duplex assay. CLas-infected low titer samples were used to validate the duplex ddPCR and qPCR performance and demonstrated that detection rate is higher when both 16S and RNR primers were used in duplex assay. However, the receiver operating characteristic analysis indicated that area under the curve for RNR primer was significantly broader, compared to 16S primers for CLas detection at low target titer. The absolute quantification of CLas at variable titers was reproducible and repeatable for both primer sets and the ddPCR showed higher resilience to PCR inhibitors with citrus leaf and ACP extracts. Hence, the resultant duplex ddPCR assay resulted in a significantly improved detection platform for diagnosis of CLas in samples with low pathogen titer.	[Selvaraj, Vijayanandraj; Maheshwari, Yogita; Chen, Jianchi; Yokomi, Raymond] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA 93648 USA; [Hajeri, Subhas] Cent Calif Tristeza Eradicat Agcy, Citrus Pest Detect Program, Tulare, CA USA; [McCollum, Thomas Greg] USDA ARS, US Hort Res Lab, Ft Pierce, FL USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Selvaraj, V; Yokomi, R (corresponding author), USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA 93648 USA.	vijay.selvaraj@ars.usda.gov; ray.yokomi@ars.usda.gov		Maheshwari, Yogita/0000-0003-1781-4572; selvaraj, vijayanandraj/0000-0002-0544-3009; Yokomi, Raymond/0000-0002-5658-2279	California Citrus Research Board [YOK-17 (ARS 58-2034-7-018)]; Citrus Research Board [5300-17AA (ARS17-5300-191)]	California Citrus Research Board; Citrus Research Board	This work was supported by the California Citrus Research Board YOK-17 (ARS 58-2034-7-018) (http://www.ccnb.info) to RKY and Citrus Research Board 5300-17AA (ARS17-5300-191) (http://citrusresearch.org/) to RKY. Funders provided priority areas of research in their Request for Funds (RFP) and awarded the grant on a competitive basis. The funders had no role in the design, data collection or preparation of the manuscript.	[Anonymous], 1991, MOL TECHNIQUES TAXON; Bove JM, 2006, J PLANT PATHOL, V88, P7; Cen HY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01509; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Keremane ML, 2015, CROP PROT, V68, P41, DOI 10.1016/j.cropro.2014.10.026; Kim TG, 2013, J ENVIRON SCI HEAL A, V48, P417, DOI 10.1080/10934529.2013.728915; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, PHYTOPATHOLOGY, V99, P139, DOI 10.1094/PHYTO-99-2-0139; Maheshwari Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184751; Morgan JK, 2012, MOL CELL PROBE, V26, P90, DOI 10.1016/j.mcp.2011.12.001; Narouei-Khandan HA, 2016, EUR J PLANT PATHOL, V144, P655, DOI 10.1007/s10658-015-0804-7; Okuda M, 2005, PLANT DIS, V89, P705, DOI 10.1094/PD-89-0705; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Razi MF, 2014, PHYTOPATHOLOGY, V104, P257, DOI 10.1094/PHYTO-08-13-0224-R; SCHNEIDER H, 1968, PHYTOPATHOLOGY, V58, P1155; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Taylor SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02217-x; United States Department of Agriculture Animal and Plant Health Inspection Service Plant Protection and Quarantine, 2012, NEW PEST RESP GUID C; Zheng Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep39020; Zhong X, 2018, J INTEG AGR, V17, P60345	26	26	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 17	2018	13	5							e0197184	10.1371/journal.pone.0197184	http://dx.doi.org/10.1371/journal.pone.0197184			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GG0DP	29772016	Green Published, Green Submitted, gold			2022-12-26	WOS:000432348900032
J	Wise, LM; Bodaan, CJ; Stuart, GS; Real, NC; Lateef, Z; Mercer, AA; Riley, CB; Theoret, CL				Wise, Lyn M.; Bodaan, Christa J.; Stuart, Gabriella S.; Real, Nicola C.; Lateef, Zabeen; Mercer, Andrew A.; Riley, Christopher B.; Theoret, Christine L.			Treatment of limb wounds of horses with orf virus IL-10 and VEGF-E accelerates resolution of exuberant granulation tissue, but does not prevent its development	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AMINO-ACID-SEQUENCE; MICROVASCULAR OCCLUSION; VASCULAR-PERMEABILITY; HYPERTROPHIC SCARS; HYALURONIC-ACID; EQUINE MODEL; SKIN WOUNDS; ANGIOGENESIS; INFLAMMATION	Bandaging of limb wounds in horses leads to formation of exuberant granulation tissue (EGT) that retards healing due to protracted inflammation, aberrant vascularisation and delayed epithelialisation. EGT is not observed if wounds are left undressed or when wounds are on the body. A previous study showed that short-term administration of proteins derived from orf virus dampened inflammation and promoted epithelialisation of open wounds in horses. Here, we investigated the impact of orf virus interleukin-10 and vascular endothelial growth factor-E on the development and resolution of EGT. Excisional wounds were created on the forelimb of four horses, and bandages were maintained until full healing to induce EGT formation. Matching body wounds were created to ensure EGT was limited to the limb, and to differentiate the effects of the viral proteins on normal healing and on EGT formation. Viral proteins or the hydrogel vehicle control were administered topically to site-matched wounds at day 1, with repeat administration at day 8. Wound healing and EGT formation were monitored macroscopically. Wound margin samples were harvested at 2, 7 and 14 days, and at full healing, with histology used to observe epithelialisation, immunofluorescence used to detect inflammatory cells, angiogenesis and cell death, and qPCR to measure expression of genes regulating inflammation and angiogenesis. Limb wounds developed EGT, and exhibited slower healing than body wounds. Viral protein treatment did not accelerate healing at either location nor limit EGT formation in limb wounds. Treatment of limb wounds did however increase epithelialisation and angiogenesis, without dampening inflammatory cell infiltration or gene expression. The healed wounds also had less occlusion and death of blood vessels and fewer epidermal rete ridges following viral protein treatment. These findings indicate that the viral protein treatment does not suppress wound inflammation or EGT formation, but does promote vascular and epidermal repair and EGT resolution.	[Wise, Lyn M.; Stuart, Gabriella S.; Real, Nicola C.; Lateef, Zabeen] Univ Otago, Dept Pharmacol & Toxicol, Dunedin, New Zealand; [Wise, Lyn M.; Stuart, Gabriella S.; Real, Nicola C.; Mercer, Andrew A.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Bodaan, Christa J.; Riley, Christopher B.; Theoret, Christine L.] Massey Univ, Sch Vet Sci, Palmerston North, New Zealand; [Theoret, Christine L.] Univ Montreal, Comparat Tissue Healing Lab, Dept Biomed Vet, Montreal, PQ, Canada	University of Otago; University of Otago; Massey University; Universite de Montreal	Wise, LM (corresponding author), Univ Otago, Dept Pharmacol & Toxicol, Dunedin, New Zealand.; Wise, LM (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	lyn.wise@otago.ac.nz	Mercer, Andrew A/G-6635-2015; Theoret, Christine/C-7320-2015	Theoret, Christine/0000-0002-7893-2495; Wise, Lyn/0000-0003-0646-8424; Mercer, Andrew/0000-0003-3697-1071; Riley, Christopher/0000-0001-8679-7986; Lateef, Zabeen/0000-0001-5987-7665	New Zealand Equine Research Foundation [RM 18049]; Health Research Council of New Zealand [13/774]	New Zealand Equine Research Foundation; Health Research Council of New Zealand(Health Research Council of New Zealand)	This study was supported by contract #RM 18049 from the New Zealand Equine Research Foundation (http://www.nzerf.co.nz/) and by contract #13/774 from the Health Research Council of New Zealand (http://www.hrc.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124302; Beer H D, 2000, Vitam Horm, V59, P217, DOI 10.1016/S0083-6729(00)59008-6; Bennett JR, 2016, VIRUS RES, V213, P230, DOI 10.1016/j.virusres.2015.12.015; Berry DB, 2003, AM J VET RES, V64, P88, DOI 10.2460/ajvr.2003.64.88; Bodaan CJ, 2016, WOUND REPAIR REGEN, V24, P966, DOI 10.1111/wrr.12488; Bussieres G, 2008, RES VET SCI, V85, P294, DOI 10.1016/j.rvsc.2007.10.011; Celeste CJ, 2013, VET SURG, V42, P147, DOI 10.1111/j.1532-950X.2012.00966.x; Celeste CJ, 2011, WOUND REPAIR REGEN, V19, P89, DOI 10.1111/j.1524-475X.2010.00639.x; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dart AJ, 2009, AUST VET J, V87, P215, DOI 10.1111/j.1751-0813.2009.00428.x; Deschene K, 2011, WOUND REPAIR REGEN, V19, P250, DOI 10.1111/j.1524-475X.2010.00663.x; DiPietro LA, 2016, J LEUKOCYTE BIOL, V100, P979, DOI 10.1189/jlb.4MR0316-102R; Dubuc V, 2006, CAN J VET RES, V70, P206; Ducharme-Desjarlais M, 2005, AM J VET RES, V66, P1133, DOI 10.2460/ajvr.2005.66.1133; Fronza M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112297; Galeano M, 2003, DIABETOLOGIA, V46, P546, DOI 10.1007/s00125-003-1064-1; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Gordon A, 2008, WOUND REPAIR REGEN, V16, P70, DOI 10.1111/j.1524-475X.2007.00326.x; Hanft J. R., 2008, J WOUND CARE, V17, P30, DOI [DOI 10.12968/JOWC.2008.17.1.27917, 10.12968/jowc.2008.17.1.27917, DOI 10.12968/jowc.2008.17.1.27917]; Hashimoto Ichiro, 2002, Journal of Medical Investigation, V49, P61; Helmbold P, 2006, J INVEST DERMATOL, V126, P1419, DOI 10.1038/sj.jid.5700275; Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033; HOWARD RD, 1993, AM J VET RES, V54, P2150; Hsu KC, 2017, WOUNDS, V29, P154; Johnson KE, 2014, ADV WOUND CARE, V3, P647, DOI 10.1089/wound.2013.0517; Jumper N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172955; Kavasi RM, 2017, FOOD CHEM TOXICOL, V101, P128, DOI 10.1016/j.fct.2017.01.012; Kieran I, 2013, WOUND REPAIR REGEN, V21, P428, DOI 10.1111/wrr.12043; King A, 2014, ADV WOUND CARE, V3, P315, DOI 10.1089/wound.2013.0461; KISCHER CW, 1992, J SUBMICR CYTOL PATH, V24, P281; KNIGHTON DR, 1981, SURGERY, V90, P262; Lawlor KT, 2015, INT J MOL SCI, V16, P28098, DOI 10.3390/ijms161226078; Lee HB, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103048; Lepault E, 2005, WOUND REPAIR REGEN, V13, P520, DOI 10.1111/j.1067-1927.2005.00073.x; Limandjaja GC, 2017, BRIT J DERMATOL, V176, P116, DOI 10.1111/bjd.14844; Litwiniuk M, 2016, WOUNDS, V28, P78; Ma XY, 2015, INT J MOL MED, V35, P1246, DOI 10.3892/ijmm.2015.2135; Mills Stuart J, 2013, Cells, V2, P621, DOI 10.3390/cells2030621; O'Brien L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003826.pub3; Ogawa R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030606; Paquet-Fifield S, 2009, J CLIN INVEST, V119, P2795, DOI 10.1172/JCI38535; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Roth A, 2005, ARTHRITIS RES THER, V7, pR677, DOI 10.1186/ar1725; Serban MA, 2008, CURR PROTOC CELL BIO; SHAKESPEARE V, 1991, BRIT J PLAST SURG, V44, P219, DOI 10.1016/0007-1226(91)90131-3; SMITH JE, 1979, AM J PHYSIOL, V236, pH725, DOI 10.1152/ajpheart.1979.236.5.H725; Sorensen MA, 2014, WOUND REPAIR REGEN, V22, P647, DOI 10.1111/wrr.12207; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com; Theoret C, 2017, EQUINE WOUND MANAGEM, P550; Theoret CL, 2016, NEW ZEAL VET J, V64, P90, DOI 10.1080/00480169.2015.1091396; Theoret CL, 2013, VET SURG, V42, P783, DOI 10.1111/j.1532-950X.2013.12055.x; Theoret CL, 2013, WOUND REPAIR REGEN, V21, P365, DOI 10.1111/wrr.12018; Theoret CL, 2002, VET SURG, V31, P266, DOI 10.1053/jvet.2002.32394; Ud-Din S, 2014, EXP DERMATOL, V23, P615, DOI 10.1111/exd.12457; Wakelin KA, 2016, VET DERMATOL, V27, P434, DOI 10.1111/vde.12370; Wietecha MS, 2013, CURR TOP MICROBIOL, V367, P3, DOI 10.1007/82_2012_287; Wilmink JM, 1999, EQUINE VET J, V31, P61, DOI 10.1111/j.2042-3306.1999.tb03792.x; Wise LM, 1999, P NATL ACAD SCI USA, V96, P3071, DOI 10.1073/pnas.96.6.3071; Wise LM, 2003, J BIOL CHEM, V278, P38004, DOI 10.1074/jbc.M301194200; Wise LM, 2007, VIRUS RES, V128, P115, DOI 10.1016/j.virusres.2007.04.018; Wise LM, 2018, ADV WOUND CARE, V7, P283, DOI 10.1089/wound.2016.0721; Wise LM, 2014, WOUND REPAIR REGEN, V22, P356, DOI 10.1111/wrr.12169; Wise LM, 2012, CELL MICROBIOL, V14, P1376, DOI 10.1111/j.1462-5822.2012.01802.x; Yates CC, 2010, AM J PATHOL, V176, P1743, DOI 10.2353/ajpath.2010.090564; Zhang Qunzhou, 2006, Exp Cell Res, V312, P145, DOI 10.1016/j.yexcr.2005.10.006; Zheng Y, 2007, ARTERIOSCL THROM VAS, V27, P503, DOI 10.1161/01.ATV.0000256459.06671.3c; Zheng YJ, 2006, ARTERIOSCL THROM VAS, V26, P2019, DOI 10.1161/01.ATV.0000233336.53574.a1	69	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2018	13	5							e0197223	10.1371/journal.pone.0197223	http://dx.doi.org/10.1371/journal.pone.0197223			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF7AA	29763436	Green Submitted, Green Published, gold			2022-12-26	WOS:000432118800030
J	Rubio-Solsona, E; Marti, S; Vilchez, JJ; Palau, F; Hoenicka, J				Rubio-Solsona, Estrella; Marti, Salvador; Vilchez, Juan J.; Palau, Francesc; Hoenicka, Janet			ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; SKELETAL-MUSCLE; RIP KINASES; PROGENITOR CELLS; SATELLITE CELLS; DIFFERENTIATION; MIGRATION; GROWTH; MYOBLASTS; DEATH	Ankyrin repeat and kinase domain containing 1 (ANKK1) gene has been widely related to neuropsychiatry disorders. The localization of ANKK1 in neural progenitors and its correlation with the cell cycle has suggested its participation in development. However, ANKK1 functions still need to be identified. Here, we have further characterized the ANKK1 localization in vivo and in vitro, by using immunolabeling, quantitative real-time PCR and Western blot in the myogenic lineage. Histologic investigations in mice and humans revealed that ANKK1 is expressed in precursors of embryonic and adult muscles. In mice embryos, ANKK1 was found in migrating myotubes where it shows a polarized cytoplasmic distribution, while proliferative myoblasts and satellite cells show different isoforms in their nuclei and cytoplasm. In vitro studies of ANKK1 protein isoforms along the myogenic progression showed the decline of nuclear ANKK1-kinase until its total exclusion in myotubes. In adult mice, ANKK1 was expressed exclusively in the Fast-Twitch muscles fibers subtype. The induction of glycolytic metabolism in C2C12 cells with high glucose concentration or treatment with berberine caused a significant increase in the ANKK1 mRNA. Similarly, C2C12 cells under hypoxic conditions caused the increase of nuclear ANKK1. These results altogether show a relationship between ANKK1 gene regulation and the metabolism of muscles during development and in adulthood. Finally, we found ANKK1 expression in regenerative fibers of muscles from dystrophic patients. Future studies in ANKK1 biology and the pathological response of muscles will reveal whether this protein is a novel muscle disease biomarker.	[Rubio-Solsona, Estrella; Marti, Salvador; Vilchez, Juan J.; Palau, Francesc] CIBERER, CIBERER Biobank, Valencia, Spain; [Rubio-Solsona, Estrella; Palau, Francesc; Hoenicka, Janet] Ctr Invest Principe Felipe, Valencia, Spain; [Vilchez, Juan J.] Hosp Univ & Politecn La Fe, Dept Neurol, Valencia, Spain; [Vilchez, Juan J.] Inst Invest Sanitaria La Fe IIS La Fe, Neuromuscular Res Unit, Valencia, Spain; [Vilchez, Juan J.] Univ Valencia, Dept Med, Sch Med, Valencia, Spain; [Palau, Francesc] Hosp St Joan Deu, Dept Genet & Mol Med, Barcelona, Spain; [Palau, Francesc; Hoenicka, Janet] Inst Recerca St Joan Deu, Lab Neurogenet & Mol Med, Barcelona, Spain; [Palau, Francesc] Univ Barcelona, Div Pediat, Sch Med, Barcelona, Spain; [Hoenicka, Janet] CIBER Salud Mental CIBERSAM, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center; Hospital Universitari i Politecnic La Fe; University of Valencia; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Hoenicka, J (corresponding author), Ctr Invest Principe Felipe, Valencia, Spain.; Hoenicka, J (corresponding author), Inst Recerca St Joan Deu, Lab Neurogenet & Mol Med, Barcelona, Spain.; Hoenicka, J (corresponding author), CIBER Salud Mental CIBERSAM, Madrid, Spain.	jhoenicka@gmail.com	Pérez, Salvador Martí/K-6450-2017; Hoenicka, Janet/B-2908-2014; Palau, Francesc/A-9391-2014	Pérez, Salvador Martí/0000-0002-5827-4851; Hoenicka, Janet/0000-0002-6790-6988; Palau, Francesc/0000-0002-8635-5421; Vilchez, Juan J/0000-0002-0532-2872	Fundacion Isabel Gemio; Instituto de Salud Carlos III [PI15/01013]	Fundacion Isabel Gemio; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported by the Fundacion Isabel Gemio (http://www.fundacionisabelgemio.com) (JJV and FP), and Instituto de Salud Carlos III (ES) grant PI15/01013 (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2010, EXP CELL RES, V316, P126, DOI 10.1016/j.yexcr.2009.10.006; Agbulut O, 2003, BIOL CELL, V95, P399, DOI 10.1016/S0248-4900(03)00087-X; Barlow JW, 2006, PEDIATR BLOOD CANCER, V47, P773, DOI 10.1002/pbc.20650; Bolinches-Amoros A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00124; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; Capkovic KL, 2008, EXP CELL RES, V314, P1553, DOI 10.1016/j.yexcr.2008.01.021; CASHMAN NR, 1987, ANN NEUROL, V21, P481, DOI 10.1002/ana.410210512; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Ehlers S, 2008, EUR J CELL BIOL, V87, P163, DOI 10.1016/j.ejcb.2007.08.003; Espana-Serrano L, 2017, CEREB CORTEX, V27, P2809, DOI 10.1093/cercor/bhw129; Garrido E, 2011, NEUROTOX RES, V20, P32, DOI 10.1007/s12640-010-9219-6; Grichko VP, 2000, J APPL PHYSIOL, V88, P473, DOI 10.1152/jappl.2000.88.2.473; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Hauerslev S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066929; Higuchi I, 1999, INTERNAL MED, V38, P412, DOI 10.2169/internalmedicine.38.412; Hoenicka J, 2010, AM J MED GENET B, V153B, P948, DOI 10.1002/ajmg.b.31065; Hoenicka J, 2010, BIOL PSYCHIAT, V67, P3, DOI 10.1016/j.biopsych.2009.08.012; Humphries F, 2015, CELL DEATH DIFFER, V22, P225, DOI 10.1038/cdd.2014.126; HURKO O, 1983, NEUROLOGY, V33, P737, DOI 10.1212/WNL.33.6.737; Keire Paul, 2013, Methods Mol Biol, V946, P431, DOI 10.1007/978-1-62703-128-8_28; KELLY AM, 1969, J CELL BIOL, V42, P135, DOI 10.1083/jcb.42.1.135; Krieger F, 2013, NEUROBIOL DIS, V54, P169, DOI 10.1016/j.nbd.2012.12.010; Kurosaka Satoshi, 2008, Birth Defects Research, V84, P102, DOI 10.1002/bdrc.20125; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee SJ, 2014, BIOCHEM BIOPH RES CO, V455, P147, DOI 10.1016/j.bbrc.2014.10.115; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Mathewson MA, 2012, J ANAT, V221, P443, DOI 10.1111/j.1469-7580.2012.01559.x; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; Mitchell PO, 2001, AM J PHYSIOL-CELL PH, V281, pC1706, DOI 10.1152/ajpcell.2001.281.5.C1706; Mota NR, 2012, GENET MOL BIOL, V35, P912, DOI 10.1590/S1415-47572012000600004; Munz B, 2002, MOL CELL BIOL, V22, P5879, DOI 10.1128/MCB.22.16.5879-5886.2002; Okamoto K, 2001, AM J PHYSIOL-ENDOC M, V281, pE479, DOI 10.1152/ajpendo.2001.281.3.E479; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Ponce G, 2009, NEUROTOX RES, V16, P50, DOI 10.1007/s12640-009-9046-9; Ramnarain DB, 2008, CELL DEATH DIFFER, V15, P344, DOI 10.1038/sj.cdd.4402268; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rubio-Solsona E, 2015, 38 C SPAN SOC BIOCH; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Wu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088450; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Zhang DW, 2010, CELL MOL IMMUNOL, V7, P243, DOI 10.1038/cmi.2010.10	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2018	13	5							e0197254	10.1371/journal.pone.0197254	http://dx.doi.org/10.1371/journal.pone.0197254			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF6MZ	29758057	gold, Green Published, Green Submitted			2022-12-26	WOS:000432082900039
